PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fang, CB; Zhou, DX; Zhan, SX; He, Y; Lin, Z; Huang, C; Li, J				Fang, Cheng-bo; Zhou, De-xi; Zhan, Shu-xiang; He, Yong; Lin, Zhen; Huang, Cheng; Li, Jun			Amelioration of Experimental Autoimmune Uveitis by Leflunomide in Lewis Rats	PLOS ONE			English	Article							TH17 CELLS; INTRAVITREAL INJECTION; BEHCETS-DISEASE; T-CELLS; UVEORETINITIS; INHIBITION; GAMMA; IL-17; DIFFERENTIATION; PROLIFERATION	Purpose: To investigate the efficacy of leflunomide in experimental autoimmune uveitis (EAU) in rats. Methods: Lewis rats were immunized with interphotoreceptor retinoid-binding peptide (IRBP) in order to generate EAU. Rats received three dose of leflunomide through intragastric administration (prevention or treatment protocols) after immunization at three separate doses (3 mg/kg/d; 6 mg/kg/d; 12 mg/kg/d). Cyclosporin A was administered as a positive) control. Rats were euthanized during peak disease activity (day 14 or 15). Treatment effectiveness was evaluated in vivo using clinical EAU scoring (d14) and histopathological evaluation of enucleated eyes after experimental termination. The expression levels of inflammatory cytokines in the serum were quantified by ELISA. Eyeball of rats were harvested and mRNA expression of interleukin 17 (IL17) and IFN-gamma were quantified through RT-PCR. Intracellular expression of interleukin (IL)-17 in the activated CD4(+) T cells was assessed by flow cytometry. The effects of leflunomide inhibition on immune responses in rats were investigated in isolated lymphocytes. Results: Histopathological and clinical data revealed severe intraocular inflammation in the immunized rat. Inflammation reached its peak on day 14 in this EAU model. Treatment with leflunomide significantly prevented and treated EAU-induced ocular inflammation and decreased clinical and pathological scores compared to vehicle-treated eyes. Gene expression of IL17 and IFN-gamma was markedly reduced in leflunomide-treated eyes. Leflunomide significantly decreased the serum levels of IL17 and IFN-gamma. The study of IL17+ T cells in peripheral blood and spleen by flow cytometry showed a decreased number of Th17 cell in rats of leflunomide prevented group. Lymphocytes from animals treated with leflunomide had decreased antigen-specific proliferation in vitro compared with lymphocytes from untreated animals. Conclusions: Oral administration of leflunomide effectively suppressed IRBP-induced uveitis in rats. These results suggest that leflunomide may be potentially clinical application in uveitis.	[Fang, Cheng-bo; Zhou, De-xi; Zhan, Shu-xiang; He, Yong; Lin, Zhen; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei, Peoples R China; [Fang, Cheng-bo] Anhui Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei, Peoples R China.	Lj@ahmu.edu.cn	周, 德喜/ABF-6374-2020		National Natural Science Foundation of China [81273525, 81272686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant (No. 81273525, No. 81272686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RK, 2004, METH MOLEC MED, V102, P395; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Bansal R, 2010, INDIAN J OPHTHALMOL, V58, P45, DOI 10.4103/0301-4738.58471; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Camelo S, 2009, J OCUL PHARMACOL TH, V25, P9, DOI 10.1089/jop.2008.0074; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V272, P460; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Chi W, 2010, MOL VIS, V16, P880; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P3567, DOI 10.1167/iovs.09-4393; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Egli A, 2009, TRANSPLANTATION, V88, P1161, DOI 10.1097/TP.0b013e3181bca422; Hamzaoui K, 2011, CLIN EXP RHEUMATOL, V29, pS71; He CY, 2012, RHEUMATOL INT, V32, P633, DOI 10.1007/s00296-010-1630-z; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin D, 2012, INFLAMM RES, V61, P53, DOI 10.1007/s00011-011-0388-4; Johansen A, 1998, TRANSPL IMMUNOL, V6, P48, DOI 10.1016/S0966-3274(98)80034-8; KAWASHIMA H, 1988, INVEST OPHTH VIS SCI, V29, P1265; Korn T, 2004, J LEUKOCYTE BIOL, V76, P950, DOI 10.1189/jlb.0504308; Korn T, 2001, BRAIN, V124, P1791, DOI 10.1093/brain/124.9.1791; Kowalczuk L, 2009, INVEST OPHTH VIS SCI, V50, P1761, DOI 10.1167/iovs.08-3027; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Murphy CC, 2004, BRIT J OPHTHALMOL, V88, P412, DOI 10.1136/bjo.2003.028506; Murray PI, 1999, CLIN EXP IMMUNOL, V117, P455; NUSSENBLATT RB, 1981, J CLIN INVEST, V67, P1228, DOI 10.1172/JCI110138; Oh-i K, 2007, BRIT J OPHTHALMOL, V91, P237, DOI 10.1136/bjo.2006.103168; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; ROBERTSON SM, 1994, AGENTS ACTIONS, V42, P167, DOI 10.1007/BF01983486; Roy M, 2007, CAN J OPHTHALMOL, V42, P634, DOI 10.3129/i07-085; Schattenkirchner M, 2000, IMMUNOPHARMACOLOGY, V47, P291, DOI 10.1016/S0162-3109(00)00194-6; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; Stosic-Grujicic S, 1999, CLIN EXP IMMUNOL, V117, P44; Takeuchi M, 2010, ACTA OPHTHALMOL, V88, P257, DOI 10.1111/j.1755-3768.2009.01536.x; Thorne JE, 2005, AM J OPHTHALMOL, V140, P45, DOI 10.1016/j.ajo.2005.01.035; Varron L, 2011, REV MED INTERNE, V32, P86, DOI 10.1016/j.revmed.2010.09.003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yang Y, 2012, INVEST OPHTH VIS SCI, V53, P1012, DOI 10.1167/iovs.11-8505; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; Zhang R, 2009, CURR EYE RES, V34, P297, DOI 10.1080/02713680902741696	47	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62071	10.1371/journal.pone.0062071	http://dx.doi.org/10.1371/journal.pone.0062071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626769	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400133
J	Grieco, P; Carotenuto, A; Auriemma, L; Limatola, A; Di Maro, S; Merlino, F; Mangoni, ML; Luca, V; Di Grazia, A; Gatti, S; Campiglia, P; Gomez-Monterrey, I; Novellino, E; Catania, A				Grieco, Paolo; Carotenuto, Alfonso; Auriemma, Luigia; Limatola, Antonio; Di Maro, Salvatore; Merlino, Francesco; Mangoni, Maria Luisa; Luca, Vincenzo; Di Grazia, Antonio; Gatti, Stefano; Campiglia, Pietro; Gomez-Monterrey, Isabel; Novellino, Ettore; Catania, Anna			Novel alpha-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; TEMPORIN-L; CANDIDACIDAL ACTIVITY; SIDE-CHAINS; AMINO-ACID; BETA; RESIDUE; HELIX; SPECTROSCOPY; SELECTIVITY	Previous investigations indicate that alpha-melanocyte-stimulating hormone (alpha-MSH) and certain synthetic analogues of it exert antimicrobial effects against bacteria and yeasts. However, these molecules have weak activity in standard microbiology conditions and this hampers a realistic clinical use. The aim in the present study was to identify novel peptides with broad-spectrum antimicrobial activity in growth medium. To this purpose, the Gly10 residue in the [DNal(2')-7,Phe-12]-MSH(6-13) sequence was replaced with conventional and unconventional amino acids with different degrees of conformational rigidity. Two derivatives in which Gly10 was replaced by the residues Aic and Cha, respectively, had substantial activity against Candida strains, including C. albicans, C. glabrata, and C. krusei and against gram-positive and gram-negative bacteria. Conformational analysis indicated that the helical structure along residues 8-13 is a key factor in antimicrobial activity. Synthetic analogues of alpha-MSH can be valuable agents to treat infections in humans. The structural preferences associated with antimicrobial activity identified in this research can help further development of synthetic melanocortins with enhanced biological activity.	[Grieco, Paolo; Carotenuto, Alfonso; Auriemma, Luigia; Limatola, Antonio; Di Maro, Salvatore; Merlino, Francesco; Gomez-Monterrey, Isabel; Novellino, Ettore] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Mangoni, Maria Luisa; Luca, Vincenzo; Di Grazia, Antonio] Univ Roma La Sapienza, Dept Biochem Sci, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gatti, Stefano; Catania, Anna] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Preclin Invest, Milan, Italy; [Campiglia, Pietro] Univ Salerno, Dept Pharmaceut Sci, I-84100 Salerno, Italy	University of Naples Federico II; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Salerno	Catania, A (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Preclin Invest, Milan, Italy.	anna.catania@guest.unimi.it	Carotenuto, Alfonso/C-8491-2014; LUCA, Vincenzo/AAV-7385-2020; Campiglia, Pietro/J-5625-2018; Gatti, Stefano/AAE-3281-2022; Merlino, Francesco/K-7866-2019; Gatti, Stefano/M-1780-2015; Grieco, Paolo/AAB-9034-2019	Carotenuto, Alfonso/0000-0001-7532-5449; LUCA, Vincenzo/0000-0002-7834-0334; Gatti, Stefano/0000-0003-2209-4338; Merlino, Francesco/0000-0002-9607-229X; Gatti, Stefano/0000-0003-2209-4338; Grieco, Paolo/0000-0002-6854-8123; Catania, Anna/0000-0002-8261-7973; Mangoni, Maria Luisa/0000-0002-5991-5868; Novellino, Ettore/0000-0002-2181-2142; Campiglia, Pietro/0000-0002-1069-2181	Italian Ministry of Education, University and Research (PRIN) [2010MCLBCZ_002]; Fondazione Fiera Milano, Italy	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Fiera Milano, Italy	This work was supported by Italian Ministry of Education, University and Research (PRIN 2008, 2010MCLBCZ_002) and by Fondazione Fiera Milano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BENEDETTI E, 1989, INT J BIOL MACROMOL, V11, P353, DOI 10.1016/0141-8130(89)90007-X; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; Carotenuto A, 2007, CHEM BIOL DRUG DES, V69, P68, DOI 10.1111/j.1747-0285.2007.00473.x; Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2007, J LEUKOCYTE BIOL, V81, P383, DOI 10.1189/jlb.0706426; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Degenkolb T, 2008, CHEM BIODIVERS, V5, P1817, DOI 10.1002/cbdv.200890171; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Formaggio F, 2005, CHEM-EUR J, V11, P2395, DOI 10.1002/chem.200400892; Frackenpohl J, 2001, CHEMBIOCHEM, V2, P445, DOI 10.1002/1439-7633(20010601)2:6<445::AID-CBIC445>3.3.CO;2-I; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Grieco P, 2005, J MED CHEM, V48, P1384, DOI 10.1021/jm040890j; Grieco P, 2003, J MED CHEM, V46, P850, DOI 10.1021/jm0204338; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Madhuri, 2009, PEPTIDES, V30, P1627, DOI 10.1016/j.peptides.2009.06.020; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350; Masman MF, 2006, BIOORGAN MED CHEM, V14, P7604, DOI 10.1016/j.bmc.2006.07.007; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; SCHILLER PW, 1991, J MED CHEM, V34, P3125, DOI 10.1021/jm00114a023; Schnarr NA, 2001, J AM CHEM SOC, V123, P11081, DOI 10.1021/ja015912v; Shireen T, 2012, PEPTIDES, V37, P334, DOI 10.1016/j.peptides.2012.05.025; Singh M, 2011, ANTIMICROB AGENTS CH, V55, P1920, DOI 10.1128/AAC.00957-10; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Thakur AK, 2001, J PEPT RES, V57, P455, DOI 10.1034/j.1399-3011.2001.00839.x; Venkatraman J, 2001, CHEM REV, V101, P3131, DOI 10.1021/cr000053z; Vijayalakshmi S, 2000, BIOPOLYMERS, V53, P84, DOI 10.1002/(SICI)1097-0282(200001)53:1<84::AID-BIP8>3.3.CO;2-N; Wuthrich K, 1986, NMR PROTEINS NUCL AC	38	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61614	10.1371/journal.pone.0061614	http://dx.doi.org/10.1371/journal.pone.0061614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626703	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400067
J	Guerit, D; Philipot, D; Chuchana, P; Toupet, K; Brondello, JM; Mathieu, M; Jorgensen, C; Noel, D				Guerit, David; Philipot, Didier; Chuchana, Paul; Toupet, Karine; Brondello, Jean-Marc; Mathieu, Marc; Jorgensen, Christian; Noel, Daniele			Sox9-Regulated miRNA-574-3p Inhibits Chondrogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							EXPRESSION; GENE; CHONDROCYTE; MICRORNAS; CANCER; TRANSCRIPTION; HOMEOSTASIS; REPRESSION; CARTILAGE; BINDING	The aim of this study was to identify new microRNAs (miRNAs) that are modulated during the differentiation of mesenchymal stem cells (MSCs) toward chondrocytes. Using large scale miRNA arrays, we compared the expression of miRNAs in MSCs (day 0) and at early time points (day 0.5 and 3) after chondrogenesis induction. Transfection of premiRNA or antagomiRNA was performed on MSCs before chondrogenesis induction and expression of miRNAs and chondrocyte markers was evaluated at different time points during differentiation by RT-qPCR. Among miRNAs that were modulated during chondrogenesis, we identified miR-574-3p as an early up-regulated miRNA. We found that miR-574-3p up-regulation is mediated via direct binding of Sox9 to its promoter region and demonstrated by reporter assay that retinoid X receptor (RXR)alpha is one gene specifically targeted by the miRNA. In vitro transfection of MSCs with premiR-574-3p resulted in the inhibition of chondrogenesis demonstrating its role during the commitment of MSCs towards chondrocytes. In vivo, however, both up-and down-regulation of miR-574-3p expression inhibited differentiation toward cartilage and bone in a model of heterotopic ossification. In conclusion, we demonstrated that Sox9-dependent up-regulation of miR-574-3p results in RXR alpha down-regulation. Manipulating miR-574-3p levels both in vitro and in vivo inhibited chondrogenesis suggesting that miR-574-3p might be required for chondrocyte lineage maintenance but also that of MSC multipotency.	[Guerit, David; Philipot, Didier; Chuchana, Paul; Toupet, Karine; Brondello, Jean-Marc; Mathieu, Marc; Jorgensen, Christian; Noel, Daniele] Hop St Eloi, INSERM, U844, Montpellier, France; [Guerit, David; Philipot, Didier; Chuchana, Paul; Toupet, Karine; Brondello, Jean-Marc; Mathieu, Marc; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, UFR Med, Montpellier, France; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol Therapeut, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Noel, D (corresponding author), Hop St Eloi, INSERM, U844, Montpellier, France.	daniele.noel@inserm.fr	Noel, Daniele/E-5719-2016; Brondello, Jean-Marc/U-8232-2017	Brondello, Jean-Marc/0000-0001-5991-3945; Noel, Daniele/0000-0002-3498-3776; jorgensen, christian/0000-0001-6947-8094	Inserm Institute; University of Montpellier I; Fondation pour la Recherche Medicale (FRM); Region Languedoc-Roussillon	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie)	Work in the laboratory Inserm U844 was supported by the Inserm Institute, the University of Montpellier I and funding from the Fondation pour la Recherche Medicale (FRM). D. Philipot was granted by "Region Languedoc-Roussillon and University of Montpellier I''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chikh A, 2011, EMBO J, V30, P4261, DOI 10.1038/emboj.2011.302; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Guerit D., 2011, Clinical Investigation, V1, P1269; Ham O, 2012, BIOMATERIALS, V33, P4500, DOI 10.1016/j.biomaterials.2012.03.025; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hua DS, 2012, OMICS, V16, P690, DOI 10.1089/omi.2012.0069; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Sengupta S, 2009, STEM CELLS, V27, P1524, DOI 10.1002/stem.84; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Su YY, 2012, INT IMMUNOPHARMACOL, V13, P468, DOI 10.1016/j.intimp.2012.05.016; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031861; Yu ZL, 2006, BIOCHEM BIOPH RES CO, V340, P929, DOI 10.1016/j.bbrc.2005.12.100; Zhong N, 2012, OSTEOARTHR CARTILAGE, V20, P593, DOI 10.1016/j.joca.2012.03.002; Zhou CX, 2012, GENE, V507, P95, DOI 10.1016/j.gene.2012.06.073	35	76	79	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62582	10.1371/journal.pone.0062582	http://dx.doi.org/10.1371/journal.pone.0062582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626837	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400201
J	Nguyen, HP; Hubener, J; Weber, JJ; Grueninger, S; Riess, O; Weiss, A				Huu Phuc Nguyen; Huebener, Jeannette; Weber, Jonasz Jeremiasz; Grueninger, Stephan; Riess, Olaf; Weiss, Andreas			Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice	PLOS ONE			English	Article							BIOMARKER-DEVELOPMENT; NUCLEAR-LOCALIZATION; CLEAVAGE; AGGREGATION; HUNTINGTIN; PATHOGENESIS; PROTEOLYSIS; INHIBITION; MANIFESTATION; DEGENERATION	Spinocerebellar Ataxia Type 3 (SCA3), also known as Machado-Joseph disease, is an autosomal dominantly inherited neurodegenerative disease caused by an expanded polyglutamine stretch in the ataxin-3 protein. A pathological hallmark of the disease is cerebellar and brainstem atrophy, which correlates with the formation of intranuclear aggregates in a specific subset of neurons. Several studies have demonstrated that the formation of aggregates depends on the generation of aggregation-prone and toxic intracellular ataxin-3 fragments after proteolytic cleavage of the full-length protein. Despite this observed increase in aggregated mutant ataxin-3, information on soluble mutant ataxin-3 levels in brain tissue is lacking. A quantitative method to analyze soluble levels will be a useful tool to characterize disease progression or to screen and identify therapeutic compounds modulating the level of toxic soluble ataxin-3. In the present study we describe the development and application of a quantitative and easily applicable immunoassay for quantification of soluble mutant ataxin-3 in human cell lines and brain samples of transgenic SCA3 mice. Consistent with observations in Huntington disease, transgenic SCA3 mice reveal a tendency for decrease of soluble mutant ataxin-3 during disease progression in fractions of the cerebellum, which is inversely correlated with aggregate formation and phenotypic aggravation. Our analyses demonstrate that the time-resolved Forster resonance energy transfer immunoassay is a highly sensitive and easy method to measure the level of soluble mutant ataxin-3 in biological samples. Of interest, we observed a tendency for decrease of soluble mutant ataxin-3 only in the cerebellum of transgenic SCA3 mice, one of the most affected brain regions in Spinocerebellar Ataxia Type 3 but not in whole brain tissue, indicative of a brain region selective change in mutant ataxin-3 protein homeostasis.	[Huu Phuc Nguyen; Huebener, Jeannette; Weber, Jonasz Jeremiasz; Riess, Olaf] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Grueninger, Stephan; Weiss, Andreas] Novartis Inst BioMed Res, Basel, Switzerland; [Weiss, Andreas] IRBM Promidis, Pomezia, Italy	Eberhard Karls University of Tubingen; Novartis	Hubener, J (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.	Jeannette.huebener@med.uni-tuebingen.de	Hübener-Schmid, Jeannette/AAR-5512-2021; Nguyen, Huu Phuc/HDO-3462-2022; Weber, Jonasz Jeremiasz/AAL-8101-2021; Nguyen, Huu Phuc/F-5390-2015	Hübener-Schmid, Jeannette/0000-0002-4973-0923; Nguyen, Huu Phuc/0000-0001-6139-788X; Weber, Jonasz Jeremiasz/0000-0003-3758-1569; Nguyen, Huu Phuc/0000-0001-6139-788X	fortune program of the University of Tuebingen [1987-10]	fortune program of the University of Tuebingen	The study was supported by the fortune program of the University of Tuebingen (No. 1987-10 to Jeannette Hubener). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Bertram L, 2011, PROG NEUROBIOL, V95, P501, DOI 10.1016/j.pneurobio.2011.09.011; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Bidinosti M, 2012, J BIOL CHEM, V287, P33691, DOI 10.1074/jbc.M112.379792; Cottet Martin, 2012, Front Endocrinol (Lausanne), V3, P92, DOI 10.3389/fendo.2012.00092; Cowin RM, 2012, BEHAV BRAIN RES, V229, P308, DOI 10.1016/j.bbr.2011.12.045; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hubener J, 2013, HUM MOL GENET, V22, P508, DOI 10.1093/hmg/dds449; Jung J, 2009, HUM MOL GENET, V18, P4843, DOI 10.1093/hmg/ddp456; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Ran CZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019362; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004	32	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62043	10.1371/journal.pone.0062043	http://dx.doi.org/10.1371/journal.pone.0062043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626768	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400132
J	Imai, T; Tamai, K; Oizumi, S; Oyama, K; Yamaguchi, K; Sato, I; Satoh, K; Matsuura, K; Saijo, S; Sugamura, K; Tanaka, N				Imai, Takayuki; Tamai, Keiichi; Oizumi, Sayuri; Oyama, Kyoko; Yamaguchi, Kazunori; Sato, Ikuro; Satoh, Kennichi; Matsuura, Kazuto; Saijo, Shigeru; Sugamura, Kazuo; Tanaka, Nobuyuki			CD271 Defines a Stem Cell-Like Population in Hypopharyngeal Cancer	PLOS ONE			English	Article							SELF-RENEWAL; RECEPTOR P75(NTR); INITIATING CELLS; ORAL-CANCER; NECK-CANCER; IDENTIFICATION; CARCINOMA; EXPRESSION; RESISTANCE; NANOG	Cancer stem cells contribute to the malignant phenotypes of a variety of cancers, but markers to identify human hypopharyngeal cancer (HPC) stem cells remain poorly understood. Here, we report that the CD271(+) population sorted from xenotransplanted HPCs possesses an enhanced tumor-initiating capability in immunodeficient mice. Tumors generated from the CD271(+) cells contained both CD271(+) and CD271(-) cells, indicating that the population could undergo differentiation. Immunohistological analyses of the tumors revealed that the CD271(+) cells localized to a perivascular niche near CD34(+) vasculature, to invasive fronts, and to the basal layer. In accordance with these characteristics, a stemness marker, Nanog, and matrix metalloproteinases (MMPs), which are implicated in cancer invasion, were significantly up-regulated in the CD271(+) compared to the CD271(-) cell population. Furthermore, using primary HPC specimens, we demonstrated that high CD271 expression was correlated with a poor prognosis for patients. Taken together, our findings indicate that CD271 is a novel marker for HPC stem-like cells and for HPC prognosis.	[Imai, Takayuki; Tamai, Keiichi; Oizumi, Sayuri; Oyama, Kyoko; Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi 9811293, Japan; [Yamaguchi, Kazunori; Satoh, Kennichi; Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Imai, Takayuki; Matsuura, Kazuto; Saijo, Shigeru] Miyagi Canc Ctr, Dept Head & Neck Surg, Natori, Miyagi 9811293, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Dept Pathol, Natori, Miyagi 9811293, Japan; [Imai, Takayuki; Tamai, Keiichi; Yamaguchi, Kazunori; Tanaka, Nobuyuki] Tohoku Univ, Grad Sch Med, Dept Canc Sci, Sendai, Miyagi 980, Japan	Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Tohoku University	Tanaka, N (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	tanaka@med.tohoku.ac.jp	Tamai, Keiichi/AAW-8261-2021	Tamai, Keiichi/0000-0003-0813-5885	JSPS KAKENHI [24300326, 21791589, 24592613]; JST; CREST; Ministry of Health, Labour and Welfare; Takeda Medical foundation; Ichiro Kanehara foundation; Grants-in-Aid for Scientific Research [23592521, 22590713, 25860572] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Medical foundation; Ichiro Kanehara foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 24300326, 21791589, 24592613, JST CREST, and grants-in-aid from the Ministry of Health, Labour and Welfare, and Takeda Medical foundation, the Ichiro Kanehara foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bankfalvi A, 2000, J ORAL PATHOL MED, V29, P291, DOI 10.1034/j.1600-0714.2000.290701.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Berrino F, 1998, EUR J CANCER, V34, P2154, DOI 10.1016/S0959-8049(98)00328-1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bryne M, 1998, ANTICANCER RES, V18, P4757; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chaubal S, 1999, ANTICANCER RES, V19, P2237; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; DAY GL, 1994, J NATL CANCER I, V86, P131, DOI 10.1093/jnci/86.2.131; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XM, 2012, ACTA OTO-LARYNGOL, V132, P314, DOI 10.3109/00016489.2011.639086; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016/j.oraloncology.2010.11.011; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494; Nakshatri H, 2009, CURR STEM CELL RES T, V4, P50, DOI 10.2174/157488809787169110; Oh SY, 2012, EUR J CANC; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pullen NA, 2012, J NEURO-ONCOL, V106, P461, DOI 10.1007/s11060-011-0691-5; Ritchie KE, 2012, CANC LETT; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; Soland TM, 2008, HISTOPATHOLOGY, V53, P62, DOI 10.1111/j.1365-2559.2008.03063.x; Spector JG, 2001, LARYNGOSCOPE, V111, P1079, DOI 10.1097/00005537-200106000-00028; Wei XD, 2009, HEAD NECK-J SCI SPEC, V31, P94, DOI 10.1002/hed.20935; Yang JP, 2011, CHINESE MED J-PEKING, V124, P1055, DOI 10.3760/cma.j.issn.0366-6999.2011.07.020; Zhang J, 2012, ONCOGENE; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	48	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62002	10.1371/journal.pone.0062002	http://dx.doi.org/10.1371/journal.pone.0062002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626764	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400128
J	Krelin, Y; Berkovich, L; Amit, M; Gil, Z				Krelin, Yakov; Berkovich, Liron; Amit, Moran; Gil, Ziv			Association between Tumorigenic Potential and the Fate of Cancer Cells in a Syngeneic Melanoma Model	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-LIKE CELLS; NUDE-MICE; TUMOR; IDENTIFICATION; CARCINOMA; GROWTH; DIFFERENTIATION; HETEROGENEITY; EXPRESSION	The self-renewal potential of a cancer cell can be estimated by using particular assays, which include xenotransplantation in immunocompromised animals or culturing in non-adherent serum-free stem-cells media (SCM). However, whether cells with self-renewal potential actually contribute to disease is unknown. Here we investigated the tumorigenic potential and fate of cancer cells in an in-vivo melanoma model. We examined cell lines which were derived from the same parental line: a non-metastatic cell line (K1735/16), a metastatic cell line (K1735/M4) and a cell line which was selected in non-adherent conditions (K1735/16S). All cell lines exhibited similar proliferation kinetics when grown on culture plates. K1735/16 cells grown in soft agar or in suspension non-adherent conditions failed to form colonies or spheroids, whereas the other cell lines showed prominent colonogenicity and spheroid formation capacity. By using sphere limiting dilution analysis (SLDA) in serum-free media, K1735/16S and K1735/M4 cells grown in suspension were capable of forming spheroids even in low frequencies of concentrations, as opposed to K1735/16 cells. The tumorigenic potential of the cell lines was determined in SCID mice using intra footpad injections. Palpable tumors were evident in all mice. In agreement with the in-vitro studies, the K1735/M4 cell line exhibited the highest growth kinetics, followed by the K1735/16S cell line, whereas the K1735/16 cell line had the lowest tumor growth potential (P<0.001). In contrast, when we repeated the experiments in syngeneic C3H/HeN mice, the K1735/16 cell line produced macroscopic tumors 30-100 days after injection, whereas K1735/M4 and K1735/16S derived tumors regressed spontaneously in 90-100% of mice. TUNEL analysis revealed significantly higher number of apoptotic cells in K1735/16S and K1735/M4 cell line-derived tumors compared to K1735/16 tumors (P<0.001). The models we have examined here raised the possibility, that cells with high-tumorigenic activity may be more immunogenic and hence are more susceptible to immune-regulation.	[Krelin, Yakov; Berkovich, Liron; Gil, Ziv] Tel Aviv Univ, Sackler Fac Hlth, Tel Aviv Sourasky Med Ctr, Lab Appl Canc Res, IL-69978 Tel Aviv, Israel; [Amit, Moran; Gil, Ziv] Technion Israel Inst Technol, Rambam Med Ctr, Rappaport Sch Med, Dept Otolaryngol Head & Neck Surg, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Krelin, Y (corresponding author), Meir Med Ctr, Gen Surg Res Lab, Kefar Sava, Israel.	kreliny@gmail.com; ziv@baseofskull.org			Israel Science Foundation [1680/08, 482/11]; Israel Cancer Association [20090068]; Israeli Ministry of Health [3-7355]; Weizmann Institute - Sourasky Medical Center; Tel Aviv Sourasky Intramural Grant; ICRF [2011-601-BGPC]; US-Israel Binational Science Foundation [2007312]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israeli Ministry of Health; Weizmann Institute - Sourasky Medical Center; Tel Aviv Sourasky Intramural Grant; ICRF; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This research was supported by the Israel Science Foundation (number 1680/08 and 482/11), the Israel Cancer Association (grant donated by Ellen and Emanuel Kronitz in memory of Dr Leon Kronitz number 20090068), the Israeli Ministry of Health (number 3-7355), the Weizmann Institute - Sourasky Medical Center Joint Grant, the Tel Aviv Sourasky Intramural Grant, the ICRF Barbara S. Goodman endowed research career development award (2011-601-BGPC) and a grant from the US-Israel Binational Science Foundation (number 2007312) to Z.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cremona CA, 2009, J CELL SCI, V122, P3272, DOI 10.1242/jcs.047126; Dou J, 2009, CELL BIOL INT, V33, P807, DOI 10.1016/j.cellbi.2009.05.003; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; FIDLER IJ, 1981, J NATL CANCER I, V67, P947; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gedye C, 2009, CANCER IMMUNOL IMMUN, V58, P1635, DOI 10.1007/s00262-009-0672-0; Girouard SD, 2012, LAB INVEST; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Kim RJ, 2010, CANCER LETT, V287, P172, DOI 10.1016/j.canlet.2009.06.010; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; KRIPKE ML, 1979, JNCI-J NATL CANCER I, V63, P541, DOI 10.1093/jnci/63.3.541; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LINNEMANN D, 1989, INT J CANCER, V43, P709, DOI 10.1002/ijc.2910430428; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Saalbach A, 2002, MICROVASC RES, V64, P86, DOI 10.1006/mvre.2002.2401; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shanesmith RP, 2011, AM J DERMATOPATH, V33, P663, DOI 10.1097/DAD.0b013e318214ae8a; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Steponkiene S, 2011, INT J NANOMED, V6, P2437, DOI 10.2147/IJN.S24477; Strizzi L, 2008, CELL CYCLE, V7, P1931, DOI 10.4161/cc.7.13.6236; SUTHERLAND RM, 1977, JNCI-J NATL CANCER I, V58, P1849, DOI 10.1093/jnci/58.6.1849; TALMADGE JE, 1982, J NATL CANCER I, V69, P975; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Yoon CH, 2012, ONCOGENE; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62124	10.1371/journal.pone.0062124	http://dx.doi.org/10.1371/journal.pone.0062124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626777	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400141
J	Sotelo, JR; Canclini, L; Kun, A; Sotelo-Silveira, JR; Xu, L; Wallrabe, H; Calliari, A; Rosso, G; Cal, K; Mercer, JA				Sotelo, Jose R.; Canclini, Lucia; Kun, Alejandra; Sotelo-Silveira, Jose R.; Xu, Lei; Wallrabe, Horst; Calliari, Aldo; Rosso, Gonzalo; Cal, Karina; Mercer, John A.			Myosin-Va-Dependent Cell-To-Cell Transfer of RNA from Schwann Cells to Axons	PLOS ONE			English	Article							PERIAXOPLASMIC RIBOSOMAL PLAQUES; PROTEIN-SYNTHESIS; NEUROFILAMENT PROTEIN; LOCAL SYNTHESIS; MESSENGER-RNAS; MYELIN SHEATH; GLIA; TRAFFICKING; EXPRESSION	To better understand the role of protein synthesis in axons, we have identified the source of a portion of axonal RNA. We show that proximal segments of transected sciatic nerves accumulate newly-synthesized RNA in axons. This RNA is synthesized in Schwann cells because the RNA was labeled in the complete absence of neuronal cell bodies both in vitro and in vivo. We also demonstrate that the transfer is prevented by disruption of actin and that it fails to occur in the absence of myosin-Va. Our results demonstrate cell-to-cell transfer of RNA and identify part of the mechanism required for transfer. The induction of cell-to-cell RNA transfer by injury suggests that interventions following injury or degeneration, particularly gene therapy, may be accomplished by applying them to nearby glial cells (or implanted stem cells) at the site of injury to promote regeneration.	[Sotelo, Jose R.; Canclini, Lucia; Kun, Alejandra; Rosso, Gonzalo; Cal, Karina] Inst Invest Biol Clemente Estable, Dept Prot & Nucle Acids, Montevideo, Uruguay; [Kun, Alejandra] Univ Republica, Fac Ciencias, Biochem Sect, Montevideo, Uruguay; [Sotelo-Silveira, Jose R.] Inst Invest Biol Clemente Estable, Dept Genet, Montevideo, Uruguay; [Sotelo-Silveira, Jose R.] Univ Republica, Fac Ciencias, Dept Cell Biol, Montevideo, Uruguay; [Xu, Lei; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT USA; [Wallrabe, Horst] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Mercer, John A.] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Calliari, Aldo] Univ Republica, Fac Vet, Dept Biochem Mol & Cell Biol, Biophys Area, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; McLaughlin Research Institute for Biomedical Sciences, Inc.; University of Virginia; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Universidad de la Republica, Uruguay	Sotelo, JR (corresponding author), Inst Invest Biol Clemente Estable, Dept Prot & Nucle Acids, Montevideo, Uruguay.	sotelo@iibce.edu.uy; jam@mri.montana.edu	González, Alejandra Elizabeth Kun/AAB-7929-2019; Canclini, Lucía/AAH-4792-2021	González, Alejandra Elizabeth Kun/0000-0002-7070-0171; Canclini, Lucía/0000-0001-7421-611X; Mercer, John/0000-0003-0307-4438; Sotelo-Silveira, Jose Roberto/0000-0002-4758-8556; Rosso, Gonzalo/0000-0003-4847-9850	National Institutes of Health [R03 TW007220]; Pedeciba; MEyC; ANII; Consejo Superior de Investigaciones Cientificas and Fcien-UdelaR; Department of Biotechnology, Government of India; FOGARTY INTERNATIONAL CENTER [R03TW007220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pedeciba; MEyC; ANII; Consejo Superior de Investigaciones Cientificas and Fcien-UdelaR; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	JAM and JRS were supported by National Institutes of Health grant R03 TW007220. JRS-S, AK, AC and LC were supported by Pedeciba, MEyC, and ANII. JRS and AK were supported by Consejo Superior de Investigaciones Cientificas and Fcien-UdelaR. JAM was supported by inStem institutional funds from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2001, BIOL RES, V34, P103; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; BENECH C, 1982, EXP NEUROL, V76, P72, DOI 10.1016/0014-4886(82)90102-9; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Chen Y, 2006, J FLUORESC, V16, P95, DOI 10.1007/s10895-005-0024-1; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; Crispino M, 2009, RESULTS PROBL CELL D, V48, P243, DOI 10.1007/400_2009_9; CUTILLO V, 1983, NEUROCHEM RES, V8, P1621, DOI 10.1007/BF00964163; EDSTROM JE, 1962, BIOCHIM BIOPHYS ACTA, V61, P178, DOI 10.1016/0926-6550(62)90080-4; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Eyman M, 2007, EUR J NEUROSCI, V25, P341, DOI 10.1111/j.1460-9568.2007.05304.x; Fabrizi C, 1997, J NEUROSCI RES, V50, P291; JAKOUBEK B, 1965, J NEUROCHEM, V12, P845, DOI 10.1111/j.1471-4159.1965.tb10269.x; KELLY BM, 1992, J CELL BIOL, V118, P397, DOI 10.1083/jcb.118.2.397; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; LASEK RJ, 1977, J CELL BIOL, V74, P501, DOI 10.1083/jcb.74.2.501; Li YC, 2005, NEUROSCI RES, V53, P298, DOI 10.1016/j.neures.2005.07.006; Pearce J, 2003, J COMP NEUROL, V464, P449, DOI 10.1002/cne.10828; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; ROBERSON MD, 1992, J NEUROSCI RES, V33, P156, DOI 10.1002/jnr.490330120; SEARLE AG, 1952, HEREDITY, V6, P395, DOI 10.1038/hdy.1952.48; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; SOTELO JR, 1992, NEUROSCI LETT, V144, P174, DOI 10.1016/0304-3940(92)90743-Q; Sotelo-Silveira J, 2008, J NEUROCHEM, V104, P545, DOI 10.1111/j.1471-4159.2007.04999.x; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Sotelo-Silveira JR, 2004, J NEUROBIOL, V60, P187, DOI 10.1002/neu.20015; Sotelo-Silveira JR, 2000, J NEUROSCI RES, V62, P65, DOI 10.1002/1097-4547(20001001)62:1<65::AID-JNR7>3.0.CO;2-Z; Twiss JL, 2009, TRENDS CELL BIOL, V19, P236, DOI 10.1016/j.tcb.2009.02.007; Van Horck FPG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.18pe11; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281	35	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61905	10.1371/journal.pone.0061905	http://dx.doi.org/10.1371/journal.pone.0061905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626749	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400113
J	Kirchner, H; Heppner, KM; Holland, J; Kabra, D; Tschop, MH; Pfluger, PT				Kirchner, Henriette; Heppner, Kristy M.; Holland, Jenna; Kabra, Dhiraj; Tschoep, Matthias H.; Pfluger, Paul T.			Ablation of Ghrelin O-Acyltransferase Does Not Improve Glucose Intolerance or Body Adiposity in Mice on a Leptin-Deficient ob/ob Background	PLOS ONE			English	Article							DES-ACYL GHRELIN; HORMONE SECRETAGOGUE RECEPTOR; STIMULATES INSULIN-SECRETION; UNACYLATED GHRELIN; BETA-CELLS; FOOD-INTAKE; GROWTH; ENDOCRINE; HUMANS; PEPTIDE	Type 2 Diabetes is a global health burden and based on current estimates will become an even larger problem in the future. Developing new strategies to prevent and treat diabetes is a scientific challenge of high priority. The stomach hormone ghrelin has been associated with playing a role in the regulation of glucose homeostasis. However, its precise mechanism and impact on whole glucose metabolism remains to be elucidated. This study aims to clarify the role of the two ghrelin isoforms acyl- and desacyl ghrelin in regulating glucose homeostasis. Therefore ghrelin activating enzyme Ghrelin-O-acyltransferase (GOAT) was ablated in leptin-deficient ob/ob mice to study whether specific acyl ghrelin deficiency or desacyl ghrelin abundance modifies glucose tolerance on a massively obese background. As targeted deletion of acyl ghrelin does not improve glucose homeostasis in our GOAT-ob/ob mouse model we conclude that neither acyl ghrelin nor the increased ratio of desacyl/acyl ghrelin is crucial for controlling glucose homeostasis in the here presented model of massive obesity induced by leptin deficiency.	[Kirchner, Henriette] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Heppner, Kristy M.; Holland, Jenna; Tschoep, Matthias H.; Pfluger, Paul T.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH USA; [Kabra, Dhiraj; Tschoep, Matthias H.; Pfluger, Paul T.] Helmholtz Ctr Munich, Inst Diabet & Obes, Neuherberg, Germany	Karolinska Institutet; University of Cincinnati; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pfluger, PT (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH USA.	paul.pfluger@helmholtz-muenchen.de	Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014	Pfluger, Paul T/0000-0002-8118-7588; Tschoep, Matthias/0000-0002-4744-371X	US National Institute of Health [R24DK093434-01];  [FP7- HEALTH- 2009- 241592 EurOCHIP]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK093434] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institute of Health grant R24DK093434-01 and the FP7- HEALTH- 2009- 241592 EurOCHIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, J NEUROENDOCRINOL, V14, P555, DOI 10.1046/j.1365-2826.2002.00811.x; Ariyasu H, 2005, ENDOCRINOLOGY, V146, P355, DOI 10.1210/en.2004-0629; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Broglio F, 2003, J CLIN ENDOCR METAB, V88, P1537, DOI 10.1210/jc.2002-021504; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Colombo M, 2003, PANCREAS, V27, P161, DOI 10.1097/00006676-200308000-00009; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Delhanty PJD, 2007, AM J PHYSIOL-ENDOC M, V293, pE302, DOI 10.1152/ajpendo.00377.2006; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Gauna C, 2007, AM J PHYSIOL-ENDOC M, V293, pE697, DOI 10.1152/ajpendo.00219.2007; Gauna C, 2006, MOL CELL ENDOCRINOL, V251, P103, DOI 10.1016/j.mce.2006.03.040; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Kiewiet RM, 2009, EUR J ENDOCRINOL, V161, P567, DOI 10.1530/EJE-09-0339; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Ma XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE422, DOI 10.1152/ajpendo.00576.2011; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Reed JA, 2008, AM J PHYSIOL-ENDOC M, V294, pE752, DOI 10.1152/ajpendo.00463.2007; Reimer MK, 2003, ENDOCRINOLOGY, V144, P916, DOI 10.1210/en.2002-220819; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Volante M, 2002, J CLIN ENDOCR METAB, V87, P1300, DOI 10.1210/jc.87.3.1300; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	38	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61822	10.1371/journal.pone.0061822	http://dx.doi.org/10.1371/journal.pone.0061822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630616	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500069
J	Madar, S; Harel, E; Goldstein, I; Stein, Y; Kogan-Sakin, I; Kamer, I; Solomon, H; Dekel, E; Tal, P; Goldfinger, N; Friedlander, G; Rotter, V				Madar, Shalom; Harel, Einav; Goldstein, Ido; Stein, Yan; Kogan-Sakin, Ira; Kamer, Iris; Solomon, Hilla; Dekel, Elya; Tal, Perry; Goldfinger, Naomi; Friedlander, Gilgi; Rotter, Varda			Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts- Secreted Interferon Beta	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; GENE-EXPRESSION; STROMAL FIBROBLASTS; TARGET WIG-1; CANCER; CELLS; GROWTH; INDUCTION; REGULATOR; CARCINOMA	Mutations in the p53 tumor suppressor protein are highly frequent in tumors and often endow cells with tumorigenic capacities. We sought to examine a possible role for mutant p53 in the cross-talk between cancer cells and their surrounding stroma, which is a crucial factor affecting tumor outcome. Here we present a novel model which enables individual monitoring of the response of cancer cells and stromal cells (fibroblasts) to co-culturing. We found that fibroblasts elicit the interferon beta (IFN beta) pathway when in contact with cancer cells, thereby inhibiting their migration. Mutant p53 in the tumor was able to alleviate this response via SOCS1 mediated inhibition of STAT1 phosphorylation. IFN beta on the other hand, reduced mutant p53 RNA levels by restricting its RNA stabilizer, WIG1. These data underscore mutant p53 oncogenic properties in the context of the tumor microenvironment and suggest that mutant p53 positive cancer patients might benefit from IFN beta treatment.	[Madar, Shalom; Harel, Einav; Goldstein, Ido; Stein, Yan; Kogan-Sakin, Ira; Kamer, Iris; Solomon, Hilla; Dekel, Elya; Tal, Perry; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Friedlander, Gilgi] Weizmann Inst Sci, Fac Biochem, Biol Serv Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Rotter, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	varda.rotter@weizmann.ac.il	Goldstein, Ido/Y-6554-2019	Goldstein, Ido/0000-0003-0139-1499; Friedlander, Gerard/0000-0002-6854-4261; Stein, Yan/0000-0003-0335-5897	Flight Attendant Medical Research Institute Center of Excellence grant	Flight Attendant Medical Research Institute Center of Excellence grant	Grant Support: Flight Attendant Medical Research Institute Center of Excellence grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; BAUER EA, 1979, CANCER RES, V39, P4594; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Buganim Y, 2011, CARCINOGENESIS, V32, P1749, DOI 10.1093/carcin/bgr203; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Dong P., 2012, ONCOGENE; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Famulski W, 2006, NEOPLASMA, V53, P43; Fillmore RA, 2009, INT J CANCER, V125, P556, DOI 10.1002/ijc.24276; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; GINSBERG D, 1991, MOL CELL BIOL, V11, P582, DOI 10.1128/MCB.11.1.582; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Israeli D, 1997, EMBO J, V16, P4384, DOI 10.1093/emboj/16.14.4384; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Kogan-Sakin I, 2009, CARCINOGENESIS, V30, P698, DOI 10.1093/carcin/bgp043; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; Madar S, 2011, CELL CYCLE, V10, P736, DOI 10.4161/cc.10.5.14928; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Mueller L, 2007, AM J PATHOL, V171, P1608, DOI 10.2353/ajpath.2007.060661; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Natsume A, 2005, CANCER RES, V65, P7573, DOI 10.1158/0008-5472.CAN-05-0036; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rasmussen AA, 1998, BREAST CANCER RES TR, V47, P219, DOI 10.1023/A:1005903000777; Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solomon H, 2011, J PATHOL, V225, P475, DOI 10.1002/path.2988; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Testoni B, 2011, ONCOGENE, V30, P2670, DOI 10.1038/onc.2010.635; Tjandra SS, 2007, CANCER RES, V67, P7124, DOI 10.1158/0008-5472.CAN-07-0686; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.11332; Tsai YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024291; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; VANDENHOOFF A, 1988, ADV CANCER RES, V50, P159, DOI 10.1016/S0065-230X(08)60437-6; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vilborg A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.33; Vilborg A, 2011, CELL DEATH DIFFER, V18, P1434, DOI 10.1038/cdd.2011.20; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang BX, 2011, J INTERF CYTOK RES, V31, P545, DOI 10.1089/jir.2010.0158; Witz IP, 2009, CANCER MICROENVIRON, V2, pS9, DOI 10.1007/s12307-009-0025-8; Tian Y, 2006, WORLD J GASTROENTERO, V12, P415, DOI 10.3748/wjg.v12.i3.415; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828	62	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61353	10.1371/journal.pone.0061353	http://dx.doi.org/10.1371/journal.pone.0061353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630584	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500030
J	Chiang, YJ; Ho, KC; Sun, CT; Chiu, JJ; Lee, FJ; Liao, F; Yang-Yen, HF; Yen, JJY				Chiang, Yun-Jung; Ho, Kun-Chin; Sun, Chien-Tsang; Chiu, Jeng-Jiann; Lee, Fang-Jen; Liao, Fang; Yang-Yen, Hsin-Fang; Yen, Jeffrey Jong-Young			CBAP Functions as a Novel Component in Chemokine-Induced ZAP70-Mediated T-Cell Adhesion and Migration	PLOS ONE			English	Article							VAV PROTOONCOGENE PRODUCT; HIGH ENDOTHELIAL VENULES; LYMPH-NODES; TRANSENDOTHELIAL MIGRATION; INTEGRIN ACTIVATION; FILAMIN BINDING; LYMPHOCYTES; TALIN; SUBUNIT; GTPASES	Activated chemokine receptor initiates inside-out signaling to transiently trigger activation of integrins, a process involving multiple components that have not been fully characterized. Here we report that GM-CSF/IL-3/IL-5 receptor common beta-chain-associated protein (CBAP) is required to optimize this inside-out signaling and activation of integrins. First, knockdown of CBAP expression in human Jurkat T cells caused attenuated CXC chemokine ligand-12 (CXCL12)-induced cell migration and integrin alpha 4 beta 1- and alpha L beta 2-mediated cell adhesion in vitro, which could be rescued sufficiently upon expression of murine CBAP proteins. Freshly isolated CBAP-deficient primary T cells also exhibited diminution of chemotaxis toward CC chemokine ligand-21 (CCL21) and CXCL12, and these chemokines-induced T-cell adhesions in vitro. Adoptive transfer of isolated naive T cells demonstrated that CBAP deficiency significantly reduced lymph node homing ability in vivo. Finally, migration of T cell-receptor-activated T cells induced by inflammatory chemokines was also attenuated in CBAP-deficient cells. Further analyses revealed that CBAP constitutively associated with both integrin beta 1 and ZAP70 and that CBAP is required for chemokine-induced initial binding of the talin-Vav1 complex to integrin beta 1 and to facilitate subsequent ZAP70-mediated dissociation of the talin-Vav1 complex and Vav1 phosphorylation. Within such an integrin signaling complex, CBAP likely functions as an adaptor and ultimately leads to activation of both integrin alpha 4 beta 1 and Rac1. Taken together, our data suggest that CBAP indeed can function as a novel signaling component within the ZAP70/Vav1/talin complex and plays an important role in regulating chemokine-promoted T-cell trafficking.	[Chiang, Yun-Jung; Liao, Fang; Yen, Jeffrey Jong-Young] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Chiang, Yun-Jung; Ho, Kun-Chin; Sun, Chien-Tsang; Liao, Fang; Yen, Jeffrey Jong-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang-Yen, Hsin-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chiu, Jeng-Jiann] Natl Hlth Res Inst, Div Med Engn Res, Miaoli, Taiwan; [Ho, Kun-Chin; Lee, Fang-Jen; Yang-Yen, Hsin-Fang; Yen, Jeffrey Jong-Young] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Yen, Jeffrey Jong-Young] Acad Sinica, Taiwan Mouse Clin, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Yen, JJY (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	bmjyen@ibms.sinica.edu.tw	Liao, Fang/S-7021-2018; Yen, Jeffrey Jong-Young/Q-5134-2018; Yang-Yen, Hsin-Fang/ABA-5808-2021; Chiu, Jeng-Jiann/E-3980-2010	Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Yang-Yen, Hsin-Fang/0000-0001-9048-4800; LEE, FANG-JEN/0000-0002-2167-2426; Chiang, Yun-Jung/0000-0001-5024-8977	National Science Council, Taiwan [NSC95-2320-B-001-038-MY3, NSC99-2628-B-001-006-MY3]; Academia Sinica	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	The work was supported by grants awarded to Jeffrey J.-Y. Yen from the National Science Council, Taiwan (NSC95-2320-B-001-038-MY3; NSC99-2628-B-001-006-MY3) and intramural fund of Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; del Valle-Perez B, 2010, J BIOL CHEM, V285, P10748, DOI 10.1074/jbc.M109.062984; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kao CJ, 2008, ONCOGENE, V27, P1397, DOI 10.1038/sj.onc.1210778; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lin YP, 2010, MOL IMMUNOL, V47, P2022, DOI 10.1016/j.molimm.2010.04.011; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Minsaas L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012212; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Phillips R, 2002, EUR J IMMUNOL, V32, P837, DOI 10.1002/1521-4141(200203)32:3<837::AID-IMMU837>3.0.CO;2-Q; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SPANGRUDE GJ, 1984, J IMMUNOL, V132, P354; Stofega Mary, 2006, V332, P269; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Uberti B, 2010, ONCOGENE, V29, P6581, DOI 10.1038/onc.2010.384; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yang CY, 2009, J IMMUNOL, V182, P2959, DOI 10.4049/jimmunol.0803550	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61761	10.1371/journal.pone.0061761	http://dx.doi.org/10.1371/journal.pone.0061761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620790	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500070
J	Monribot-Villanueva, J; Juarez-Uribe, RA; Palomera-Sanchez, Z; Gutierrez-Aguiar, L; Zurita, M; Kennison, JA; Vazquez, M				Monribot-Villanueva, Juan; Alejandro Juarez-Uribe, R.; Palomera-Sanchez, Zoraya; Gutierrez-Aguiar, Lucia; Zurita, Mario; Kennison, James A.; Vazquez, Martha			TnaA, an SP-RING Protein, Interacts with Osa, a Subunit of the Chromatin Remodeling Complex BRAHMA and with the SUMOylation Pathway in Drosophila melanogaster	PLOS ONE			English	Article							PIAS-LIKE PROTEIN; ANDROGEN RECEPTOR; SUMO PATHWAY; TRANSCRIPTION; ENCODES; LIGASE; GENES; SPECIFICITY; CONJUGATION; ACTIVATION	Tonalli A (TnaA) is a Drosophila melanogaster protein with an XSPRING domain. The XSPRING domain harbors an SP-RING zinc-finger, which is characteristic of proteins with SUMO E3 ligase activity. TnaA is required for homeotic gene expression and is presumably involved in the SUMOylation pathway. Here we analyzed some aspects of the TnaA location in embryo and larval stages and its genetic and biochemical interaction with SUMOylation pathway proteins. We describe that there are at least two TnaA proteins (TnaA(130) and TnaA(123)) differentially expressed throughout development. We show that TnaA is chromatin-associated at discrete sites on polytene salivary gland chromosomes of third instar larvae and that tna mutant individuals do not survive to adulthood, with most dying as third instar larvae or pupae. The tna mutants that ultimately die as third instar larvae have an extended life span of at least 4 to 15 days as other SUMOylation pathway mutants. We show that TnaA physically interacts with the SUMO E2 conjugating enzyme Ubc9, and with the BRM complex subunit Osa. Furthermore, we show that tna and osa interact genetically with SUMOylation pathway components and individuals carrying mutations for these genes show a phenotype that can be the consequence of misexpression of developmental-related genes.	[Monribot-Villanueva, Juan; Alejandro Juarez-Uribe, R.; Palomera-Sanchez, Zoraya; Gutierrez-Aguiar, Lucia; Zurita, Mario; Vazquez, Martha] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Fisiol Mol & Genet Desarrollo, Cuernavaca 62191, Morelos, Mexico; [Kennison, James A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Vazquez, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Fisiol Mol & Genet Desarrollo, Cuernavaca 62191, Morelos, Mexico.	mvazquez@ibt.unam.mx		Vazquez, Martha/0000-0003-0329-8802	Direccion General Asuntos del Personal Academico (DGAPA) [IN208808]; Consejo Nacional Ciencia y Tecnologia (CONACyT) [99654]; United States National Institutes of Health, National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001005] Funding Source: NIH RePORTER	Direccion General Asuntos del Personal Academico (DGAPA); Consejo Nacional Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); United States National Institutes of Health, National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from Direccion General Asuntos del Personal Academico (DGAPA) grant IN208808 (http://dgapa.unam.mx/html/papiit/papit.html), and Consejo Nacional Ciencia y Tecnologia (CONACyT) grant 99654 (http://www.conacyt.gob.mx) to M.V. and in part by the Intramural Research Program of the United States National Institutes of Health, National Institute of Child Health and Human Development (NICHD) (http://dir.nichd.nih.gov/dirweb/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Apionishev S, 2001, GENES CELLS, V6, P215, DOI 10.1046/j.1365-2443.2001.00413.x; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035717; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Chiu HL, 2005, DEV BIOL, V288, P60, DOI 10.1016/j.ydbio.2005.08.008; Corona DFV, 2004, METHOD ENZYMOL, V377, P70; Daniels M, 2004, DEVELOPMENT, V131, P5613, DOI 10.1242/dev.01449; Dasso M, 2004, CURRENT PROTOCOLS CE; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Elfring LK, 1998, GENETICS, V148, P251; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huang L, 2005, DEV BIOL, V280, P407, DOI 10.1016/j.ydbio.2005.02.006; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; Kanakousaki K, 2012, DEVELOPMENT, V139, P2751, DOI 10.1242/dev.082974; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kingston R, 2001, CURRENT PROTOCOLS MO; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Lomeli H, 2011, CELL MOL LIFE SCI, V68, P4045, DOI 10.1007/s00018-011-0792-5; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; REBAY I, 2000, DROSOPHILA PROTOCOLS, P389; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schnorr JD, 2001, GENETICS, V159, P609; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Smith M, 2011, J BIOL CHEM, V286, P11391, DOI 10.1074/jbc.M110.214569; Song YJ, 2011, MOL CELLS, V32, P221, DOI 10.1007/s10059-011-1020-8; SUN X, 2003, DROS INF SERV, V86, P79; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2008, CELL CYCLE, V7, P1738, DOI 10.4161/cc.7.12.6156; Talamillo A, 2008, BIOCHEM SOC T, V36, P868, DOI 10.1042/BST0360868; Talamillo A, 2008, DEVELOPMENT, V135, P1659, DOI 10.1242/dev.020685; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tang ZS, 2008, FEBS J, V275, P3003, DOI 10.1111/j.1742-4658.2008.06459.x; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; van Wijk SJL, 2011, GENE DEV, V25, P1763, DOI 10.1101/gad.17593511; Vazquez M, 1999, DEVELOPMENT, V126, P733; Vazquez M, 2008, GENETICS, V180, P835, DOI 10.1534/genetics.108.093492; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	59	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62251	10.1371/journal.pone.0062251	http://dx.doi.org/10.1371/journal.pone.0062251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620817	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500097
J	Wang, DR; Moothart, DR; Lowy, DR; Qian, XL				Wang, Dunrui; Moothart, Daniel R.; Lowy, Douglas R.; Qian, Xiaolan			The Expression of Glyceraldehyde-3-Phosphate Dehydrogenase Associated Cell Cycle (GACC) Genes Correlates with Cancer Stage and Poor Survival in Patients with Solid Tumors	PLOS ONE			English	Article							GAPDH; GLYCOLYSIS; METABOLISM; APOPTOSIS; GROWTH; DEATH; FOXM1	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is often used as a stable housekeeping marker for constant gene expression. However, the transcriptional levels of GAPDH may be highly up-regulated in some cancers, including non-small cell lung cancers (NSCLC). Using a publically available microarray database, we identified a group of genes whose expression levels in some cancers are highly correlated with GAPDH up-regulation. The majority of the identified genes are cell cycle-dependent (GAPDH Associated Cell Cycle, or GACC). The up-regulation pattern of GAPDH positively associated genes in NSCLC is similar to that observed in cultured fibroblasts grown under conditions that induce anti-senescence. Data analysis demonstrated that up-regulated GAPDH levels are correlated with aberrant gene expression related to both glycolysis and gluconeogenesis pathways. Down-regulation of fructose-1,6-bisphosphatase (FBP1) in gluconeogenesis in conjunction with up-regulation of most glycolytic genes is closely related to high expression of GAPDH in the tumors. The data presented demonstrate that up-regulation of GAPDH positively associated genes is proportional to the malignant stage of various tumors and is associated with an unfavourable prognosis. Thus, this work suggests that GACC genes represent a potential new signature for cancer stage identification and disease prognosis.	[Wang, Dunrui] W2MOTIF LLC, San Diego, CA USA; [Lowy, Douglas R.; Qian, Xiaolan] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Moothart, Daniel R.] Amer Qualex Inc, San Clemente, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, DR (corresponding author), W2MOTIF LLC, San Diego, CA USA.	dunrui@yahoo.com			Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research	Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research	This research was supported in part by the Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Barbini L, 2007, MOL CELL BIOCHEM, V300, P19, DOI 10.1007/s11010-006-9341-1; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Brooksbank C, 2003, NUCLEIC ACIDS RES, V31, P43, DOI 10.1093/nar/gkg066; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chuang DM, 1996, NAT MED, V2, P609, DOI 10.1038/nm0696-609; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Denko N, 2000, CLIN CANCER RES, V6, P480; Gresner P, 2009, ACTA BIOCHIM POL, V56, P307; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lavallard VJ, 2009, CANCER RES, V69, P3013, DOI 10.1158/0008-5472.CAN-08-2731; Lee SY, 2012, J MICROBIOL BIOTECHN, V22, P571, DOI 10.4014/jmb.1110.10010; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Ma RYM, 2010, METHODS MOL BIOL, V647, P113, DOI 10.1007/978-1-60761-738-9_6; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Obama K, 2008, CLIN CANCER RES, V14, P1333, DOI 10.1158/1078-0432.CCR-07-1381; Pavloff N, 1992, DNA Seq, V2, P227, DOI 10.3109/10425179209020807; PERSONS DA, 1989, MOL CARCINOGEN, V2, P88, DOI 10.1002/mc.2940020207; Phadke M, 2011, BIOCHEM BIOPH RES CO, V411, P409, DOI 10.1016/j.bbrc.2011.06.165; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; SCHEK N, 1988, CANCER RES, V48, P6354; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Taubes Gary, 2012, Science, V335, P31, DOI 10.1126/science.335.6064.31; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	34	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61262	10.1371/journal.pone.0061262	http://dx.doi.org/10.1371/journal.pone.0061262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620736	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500016
J	Musinguzi, G; Nuwaha, F				Musinguzi, Geofrey; Nuwaha, Fred			Prevalence, Awareness and Control of Hypertension in Uganda	PLOS ONE			English	Article							POPULATION-BASED SURVEY; LOW-INCOME COUNTRIES; SUB-SAHARAN AFRICA; RISK-FACTORS; DISEASE; MORTALITY; DISTRICT; BURDEN	Background: Prevention and control of hypertension are critical in reducing morbidity and mortality attributable to cardiovascular diseases. Awareness of hypertension is a pre-condition for control and prevention. This study estimated the proportion of adults who were hypertensive, were aware of their hypertension and those that achieved adequate control. Methods: We conducted a community based cross sectional survey among people >= 15 years in Buikwe and Mukono districts of Uganda. People had their blood pressure measured and were interviewed about their social-demographic characteristics. Hypertension was defined as systolic blood pressure >= 140 mmHg, or diastolic blood pressure >= 90 mmHg, or previous diagnosis of hypertension. Participants were classified as hypertensive aware if they reported that they had previously been informed by a health professional that they had hypertension. Control of hypertension among those aware was if systolic blood pressure was <140 mmHg and diastolic blood pressure was <90 mmHg. Results: The age standardized prevalence of hypertension was 27.2% (95% CI 25.9-28.5) similar among females (27.7%) and males (26.4%). Prevalence increased linearly with age, and age effect was more marked among females. Among the hypertensive participants, awareness was 28.2% (95% CI 25.4-31.0) higher among females (37.0%) compared to males (12.4%). Only 9.4% (95% CI 7.5-11.1) of all hypertensive participants were controlled. Control was higher among females (13.2%) compared to males (2.5%). Conclusion: More than a quarter of the adult population had hypertension but awareness and control was very low. Measures are needed to enhance control, awareness and prevention of hypertension.	[Musinguzi, Geofrey; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda	Makerere University	Musinguzi, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	mgeof@musph.ac.ug			Makerere University Infectious Diseases Institute (TARGETS II)	Makerere University Infectious Diseases Institute (TARGETS II)	This work was supported by a grant from Makerere University Infectious Diseases Institute (TARGETS II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Maher D, 2011, INT J EPIDEMIOL, V40, P160, DOI 10.1093/ije/dyq156; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Ministry of Health Uganda, 2010, HLTH SECT STRAT INV; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Uganda Bureau of Statistics, 2006, 2002 UG POP HOUS CEN; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; Whelton PK, 2004, J HUM HYPERTENS, V18, P545, DOI 10.1038/sj.jhh.1001701; *WHO, 2004, CAM BURD DIAB CAMBOD; WHO, 2008, STEPS MAN; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2004, GLOB BURD DIS DEATHS; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	27	80	80	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62236	10.1371/journal.pone.0062236	http://dx.doi.org/10.1371/journal.pone.0062236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614041	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200126
J	Dal Santo, S; Vannozzi, A; Tornielli, GB; Fasoli, M; Venturini, L; Pezzotti, M; Zenoni, S				Dal Santo, Silvia; Vannozzi, Alessandro; Tornielli, Giovanni Battista; Fasoli, Marianna; Venturini, Luca; Pezzotti, Mario; Zenoni, Sara			Genome-Wide Analysis of the Expansin Gene Superfamily Reveals Grapevine-Specific Structural and Functional Characteristics	PLOS ONE			English	Article							CELL-WALL EXTENSION; MAIZE PRIMARY ROOT; TRANSCRIPTIONAL ANALYSIS; MULTIGENE FAMILY; EXPRESSION; IDENTIFICATION; SEQUENCE; PLANT; INTEGRATION; PROTEINS	Background: Expansins are proteins that loosen plant cell walls in a pH-dependent manner, probably by increasing the relative movement among polymers thus causing irreversible expansion. The expansin superfamily (EXP) comprises four distinct families: expansin A (EXPA), expansin B (EXPB), expansin-like A (EXLA) and expansin-like B (EXLB). There is experimental evidence that EXPA and EXPB proteins are required for cell expansion and developmental processes involving cell wall modification, whereas the exact functions of EXLA and EXLB remain unclear. The complete grapevine (Vitis vinifera) genome sequence has allowed the characterization of many gene families, but an exhaustive genome-wide analysis of expansin gene expression has not been attempted thus far. Methodology/Principal Findings: We identified 29 EXP superfamily genes in the grapevine genome, representing all four EXP families. Members of the same EXP family shared the same exon-intron structure, and phylogenetic analysis confirmed a closer relationship between EXP genes from woody species, i.e. grapevine and poplar (Populus trichocarpa), compared to those from Arabidopsis thaliana and rice (Oryza sativa). We also identified grapevine-specific duplication events involving the EXLB family. Global gene expression analysis confirmed a strong correlation among EXP genes expressed in mature and green/vegetative samples, respectively, as reported for other gene families in the recently-published grapevine gene expression atlas. We also observed the specific co-expression of EXLB genes in woody organs, and the involvement of certain grapevine EXP genes in berry development and post-harvest withering. Conclusion: Our comprehensive analysis of the grapevine EXP superfamily confirmed and extended current knowledge about the structural and functional characteristics of this gene family, and also identified properties that are currently unique to grapevine expansin genes. Our data provide a model for the functional characterization of grapevine gene families by combining phylogenetic analysis with global gene expression profiling.	[Dal Santo, Silvia; Tornielli, Giovanni Battista; Fasoli, Marianna; Venturini, Luca; Pezzotti, Mario; Zenoni, Sara] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Vannozzi, Alessandro] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy	University of Verona; University of Padua	Zenoni, S (corresponding author), Univ Verona, Dept Biotechnol, I-37100 Verona, Italy.	sara.zenoni@univr.it	Tornielli, Giovanni Battista/AAG-1735-2019; zenoni, sara/B-9202-2019	Tornielli, Giovanni Battista/0000-0001-5027-0269; Fasoli, Marianna/0000-0003-1101-8129; zenoni, sara/0000-0002-0496-8161; Venturini, Luca/0000-0001-7824-1507; Vannozzi, Alessandro/0000-0003-4033-477X; Dal Santo, Silvia/0000-0001-5012-1140	"Completamento del Centro di Genomica Funzionale e Vegetale" project	"Completamento del Centro di Genomica Funzionale e Vegetale" project	This work was supported by the "Completamento del Centro di Genomica Funzionale e Vegetale" project founded by the Cariverona bank foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2005, BIOINFORMATICS, V21, P3596, DOI 10.1093/bioinformatics/bti609; Belfield EJ, 2005, J EXP BOT, V56, P817, DOI 10.1093/jxb/eri076; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Carey RE, 2007, ANN BOT-LONDON, V99, P1131, DOI 10.1093/aob/mcm044; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Civello PM, 1999, PLANT PHYSIOL, V121, P1273, DOI 10.1104/pp.121.4.1273; Colmer TD, 2004, PLANT MOL BIOL, V56, P423, DOI 10.1007/s11103-004-3844-5; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Dal Santo S, 2011, PLANT SIGNAL BEHAV, V6, P2031, DOI 10.4161/psb.6.12.18110; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Dermatsev V, 2010, MOL PLANT PATHOL, V11, P121, DOI [10.1111/j.1364-3703.2009.00581.x, 10.1111/j.1364-3703.2009.00581.X]; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Fudali S, 2008, PHYSIOL PLANTARUM, V132, P370, DOI 10.1111/j.1399-3054.2007.01017.x; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Giordano W, 2004, MOL PLANT MICROBE IN, V17, P613, DOI 10.1094/MPMI.2004.17.6.613; Glissant D, 2008, J INT SCI VIGNE VIN, V42, P1; Gray-Mitsumune M, 2004, PLANT PHYSIOL, V135, P1552, DOI 10.1104/pp.104.039321; Guillaumie S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-165; Hayama H, 2003, POSTHARVEST BIOL TEC, V29, P1, DOI 10.1016/S0925-5214(02)00216-8; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Ishimaru M, 2007, J PLANT PHYSIOL, V164, P1675, DOI 10.1016/j.jplph.2006.07.017; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kudla U, 2005, FEBS LETT, V579, P2451, DOI 10.1016/j.febslet.2005.03.047; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Li F, 2012, J BIOTECHNOL; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Malacarne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029762; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Moldes D, 2003, BIOTECHNOL LETT, V25, P491, DOI 10.1023/A:1022660230653; Nunan KJ, 1998, PLANT PHYSIOL, V118, P783, DOI 10.1104/pp.118.3.783; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Powell ALT, 2003, J AGR FOOD CHEM, V51, P7450, DOI 10.1021/jf034165d; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Rizzini FM, 2009, POSTHARVEST BIOL TEC, V52, P247, DOI 10.1016/j.postharvbio.2008.12.004; Rolle L, 2009, J SCI FOOD AGR, V89, P1973, DOI 10.1002/jsfa.3686; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sampedro J, 2006, J PLANT RES, V119, P11, DOI 10.1007/s10265-005-0253-z; Sasidharan R, 2008, PLANT PHYSIOL, V148, P1557, DOI 10.1104/pp.108.125518; Schlosser J, 2008, PROTOPLASMA, V232, P255, DOI 10.1007/s00709-008-0280-9; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Vassilopoulou E, 2007, INT ARCH ALLERGY IMM, V143, P92, DOI 10.1159/000098657; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vicens A, 2009, J AGR FOOD CHEM, V57, P2955, DOI 10.1021/jf803416w; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wang GJ, 2011, SECUR COMMUN NETW, V4, P1, DOI 10.1002/sec.195; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wenzel CL, 2008, PLANT CELL PHYSIOL, V49, P457, DOI 10.1093/pcp/pcn023; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Xu BZ, 2001, EUR J BIOCHEM, V268, P3718, DOI 10.1046/j.1432-1327.2001.02280.x; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zamboni A, 2010, PLANT PHYSIOL, V154, P1439, DOI 10.1104/pp.110.160275; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Zoccatelli G, 2013, AUSTR J GRA IN PRESS	83	79	83	6	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62206	10.1371/journal.pone.0062206	http://dx.doi.org/10.1371/journal.pone.0062206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614035	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400162
J	Holm, B; Thorborg, K; Husted, H; Kehlet, H; Bandholm, T				Holm, Bente; Thorborg, Kristian; Husted, Henrik; Kehlet, Henrik; Bandholm, Thomas			Surgery-Induced Changes and Early Recovery of Hip-Muscle Strength, Leg-Press Power, and Functional Performance after Fast-Track Total Hip Arthroplasty: A Prospective Cohort Study	PLOS ONE			English	Article							KNEE-EXTENSION STRENGTH; OSTEOARTHRITIS OUTCOME SCORE; QUADRICEPS STRENGTH; REPLACEMENT; EXERCISE; MOBILITY; PROGRAM; ATROPHY; WALKING; EDEMA	Background: By measuring very early changes in muscle strength and functional performance after fast-track total hip arthroplasty (THA), post-operative rehabilitation, introduced soon after surgery, can be designed to specifically target identified deficits. Objective(s): Firstly, to quantify changes (compared to pre-operative values) in hip muscle strength, leg-press power, and functional performance in the first week after THA, and secondly, to explore relationships between the muscle strength changes, and changes in hip pain, systemic inflammation, and thigh swelling. Design: Prospective, cohort study. Setting: Convenience sample of patients receiving a THA at Copenhagen University Hospital, Hvidovre, Denmark, between March and December 2011. Participants: Thirty-five patients (65.9 +/- 7.2 years) undergoing THA. Main outcome measures: Hip muscle strength, leg-press power, performance-based function, and self-reported disability were determined prior to, and 2 and 8 days after, THA (Day 2 and 8, respectively). Hip pain, thigh swelling, and C-Reactive Protein were also determined. Results: Five patients were lost to follow-up. Hip muscle strength and leg press power were substantially reduced at Day 2 (range of reductions: 41-58%, P<0.001), but less pronounced at Day 8 (range of reductions: 23-31%, P<0.017). Self-reported symptoms and function (HOOS: Pain, Symptoms, and ADL) improved at Day 8 (P<0.014). Changes in hip pain, C-Reactive Protein, and thigh swelling were not related to the muscle strength and power losses. Conclusion(s): Hip muscle strength and leg-press power decreased substantially in the first week after THA - especially at Day 2 - with some recovery at Day 8. The muscle strength loss and power loss were not related to changes in hip pain, systemic inflammation, or thigh swelling. In contrast, self-reported symptoms and function improved. These data on surgery-induced changes in muscle strength may help design impairment-directed, post-operative rehabilitation to be introduced soon after surgery.	[Holm, Bente; Husted, Henrik; Kehlet, Henrik] Copenhagen Univ Hosp, Lundbeck Ctr Fast Track Hip & Knee Arthroplasty, Hvidovre, Denmark; [Holm, Bente; Thorborg, Kristian; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Phys Therapy Phys Med & Rehabil Res Copenhag, Hvidovre, Denmark; [Thorborg, Kristian] Copenhagen Univ Hosp, Arthroscop Ctr Amager, Copenhagen, Denmark; [Thorborg, Kristian; Husted, Henrik; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Orthoped Surg, Hvidovre, Denmark; [Kehlet, Henrik] Copenhagen Univ Hosp, Rigshosp, Sect Surg Pathophysiol, Copenhagen, Denmark; [Bandholm, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bandholm, T (corresponding author), Copenhagen Univ Hosp, Dept Phys Therapy Phys Med & Rehabil Res Copenhag, Hvidovre, Denmark.	thomas.bandholm@hvh.regionh.dk	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Kehlet, Henrik/0000-0002-2209-1711	Lundbeck Foundation, Hellerup, Denmark	Lundbeck Foundation, Hellerup, Denmark(Lundbeckfonden)	The study was supported by a grant from The Lundbeck Foundation, Hellerup, Denmark (www.lundbeckfonden.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandholm T, 2012, ARCH PHYS MED REHAB, V93, P1292, DOI 10.1016/j.apmr.2012.02.014; BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Bertocci GE, 2004, AM J PHYS MED REHAB, V83, P1, DOI 10.1097/01.PHM.0000098047.26314.93; Chou Shih-Wei, 2008, Chang Gung Med J, V31, P576; Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012; DELORME TL, 1945, J BONE JOINT SURG, V27, P645; Freeman S, CLIN BIOMECH BRISTOL; Frost KL, 2006, J REHABIL RES DEV, V43, P435, DOI 10.1682/JRRD.2005.06.0100; Gilbey HJ, 2003, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000053168.71678.2b; Gossec L, 2011, J RHEUMATOL, V38, P1765, DOI 10.3899/jrheum.110403; Hall GM, 2001, BRIT J ANAESTH, V87, P537, DOI 10.1093/bja/87.4.537; Holm B, 2011, PM&R, V3, P117, DOI 10.1016/j.pmrj.2010.10.019; Holm B, 2010, ARCH PHYS MED REHAB, V91, P1770, DOI 10.1016/j.apmr.2010.07.229; Holstege MS, 2011, ARCH PHYS MED REHAB, V92, P236, DOI 10.1016/j.apmr.2010.10.015; Husby VS, 2009, ARCH PHYS MED REHAB, V90, P1658, DOI 10.1016/j.apmr.2009.04.018; Husted H, 2008, ACTA ORTHOP, V79, P168, DOI 10.1080/17453670710014941; Husted H, 2011, ACTA ORTHOP, V82, P679, DOI 10.3109/17453674.2011.636682; Jan MH, 2004, ARCH PHYS MED REHAB, V85, P1943, DOI 10.1016/j.apmr.2004.02.011; Jensen C, 2011, OSTEOARTHR CARTILAGE, V19, P1108, DOI 10.1016/j.joca.2011.06.011; Kazmi SSH, 2007, J TRAUMA, V62, P701, DOI 10.1097/01.ta.0000196968.45151.7f; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kennedy DM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-100; Kristensen MT, 2009, CLIN BIOMECH, V24, P218, DOI 10.1016/j.clinbiomech.2008.10.003; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lowe CJM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-98; Manini TM, 2007, J AM GERIATR SOC, V55, P451, DOI 10.1111/j.1532-5415.2007.01087.x; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Mizner RL, 2011, J ARTHROPLASTY, V26, P728, DOI 10.1016/j.arth.2010.06.004; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rasch A, 2009, J BONE JOINT SURG BR, V91B, P583, DOI 10.1302/0301-620X.91B5.21477; Rasch A, 2007, ACTA ORTHOP, V78, P505, DOI 10.1080/17453670710014158; Rasch A, 2010, ACTA ORTHOP, V81, P183, DOI 10.3109/17453671003793204; Reardon K, 2001, INTERN MED J, V31, P7, DOI 10.1046/j.1445-5994.2001.00007.x; Rice DA, 2010, SEMIN ARTHRITIS RHEU, V40, P250, DOI 10.1016/j.semarthrit.2009.10.001; Rossi MD, 2006, J STRENGTH COND RES, V20, P262, DOI 10.1519/R-16234.1; SHIH CH, 1994, CLIN ORTHOP RELAT R, P115; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Stevens-Lapsley JE, 2011, PM&R, V3, P541, DOI 10.1016/j.pmrj.2011.03.002; Suetta C, 2004, J AM GERIATR SOC, V52, P2016, DOI 10.1111/j.1532-5415.2004.52557.x; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; Suetta C, 2008, J APPL PHYSIOL, V105, P180, DOI 10.1152/japplphysiol.01354.2007; Talis VL, 2008, CLIN BIOMECH, V23, P424, DOI 10.1016/j.clinbiomech.2007.11.010; Thorborg K, 2010, SCAND J MED SCI SPOR, V20, P493, DOI 10.1111/j.1600-0838.2009.00958.x; Trudelle-Jackson E, 2004, ARCH PHYS MED REHAB, V85, P1056, DOI 10.1016/j.apmr.2003.11.022; VAZ MD, 1993, J ORTHOP SPORT PHYS, V18, P526, DOI 10.2519/jospt.1993.18.4.526; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031_9406(05)61264_3, DOI 10.1016/S0031-9406(05)61264-3]	50	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62109	10.1371/journal.pone.0062109	http://dx.doi.org/10.1371/journal.pone.0062109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130DR	23614020	Green Submitted, Green Published, gold			2022-12-25	WOS:000317893400154
J	Roversi, P; Ryffel, B; Togbe, D; Maillet, I; Teixeira, M; Ahmat, N; Paesen, GC; Lissina, O; Boland, W; Ploss, K; Caesar, JJE; Leonhartsberger, S; Lea, SM; Nunn, MA				Roversi, Pietro; Ryffel, Bernhard; Togbe, Dieudonnee; Maillet, Isabelle; Teixeira, Mauro; Ahmat, Nurfilza; Paesen, Guido C.; Lissina, Olga; Boland, Wilhelm; Ploss, Kerstin; Caesar, Joseph J. E.; Leonhartsberger, Susanne; Lea, Susan M.; Nunn, Miles A.			Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TICK ORNITHODOROS-MOUBATA; AIRWAY HYPERRESPONSIVENESS; LEUKOCYTE RECRUITMENT; LIPID MEDIATORS; INHIBITOR; C5A; INFLAMMATION; GENERATION; DISEASE	Molecules that simultaneously inhibit independent or co-dependent proinflammatory pathways may have advantages over conventional monotherapeutics. OmCI is a bifunctional protein derived from blood-feeding ticks that specifically prevents complement (C)-mediated C5 activation and also sequesters leukotriene B4 (LTB4) within an internal binding pocket. Here, we examined the effect of LTB4 binding on OmCI structure and function and investigated the relative importance of C-mediated C5 activation and LTB4 in a mouse model of immune complex-induced acute lung injury (IC-ALI). We describe two crystal structures of bacterially expressed OmCI: one binding a C16 fatty acid and the other binding LTB4 (C20). We show that the C5 and LTB4 binding activities of the molecule are independent of each other and that OmCI is a potent inhibitor of experimental IC-ALI, equally dependent on both C5 inhibition and LTB4 binding for full activity. The data highlight the importance of LTB4 in IC-ALI and activation of C5 by the complement pathway C5 convertase rather than by non-C proteases. The findings suggest that dual inhibition of C5 and LTB4 may be useful for treatment of human immune complex-dependent diseases.	[Roversi, Pietro; Caesar, Joseph J. E.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Ryffel, Bernhard; Togbe, Dieudonnee; Maillet, Isabelle; Teixeira, Mauro] Univ Orleans, CNRS, UMR7355, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Cape Town, IIDMM, ZA-7701 Cape Town, South Africa; [Togbe, Dieudonnee] ArtImmune SAS, F-45071 Orleans, France; [Ahmat, Nurfilza; Paesen, Guido C.; Lissina, Olga; Nunn, Miles A.] CEH, Wallingford OX10 8BB, Oxon, England; [Boland, Wilhelm; Ploss, Kerstin] Max Planck Inst Chem Okol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Leonhartsberger, Susanne] Wacker Biotech GmbH, D-07745 Jena, Germany	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; UK Centre for Ecology & Hydrology (UKCEH); Max Planck Society; Wacker Chemie	Nunn, MA (corresponding author), CEH, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	amn@ceh.ac.uk	Teixeira, Mauro M/A-4587-2008; Lea, Susan M/B-7678-2009; Togbe, Dieudonnee/AAE-1135-2020; Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Boland, Wilhelm/K-7762-2012	Teixeira, Mauro M/0000-0002-6944-3008; Lea, Susan M/0000-0001-9287-8053; Togbe, Dieudonnee/0000-0001-6658-414X; Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Boland, Wilhelm/0000-0001-6784-2534	Wellcome Trust [077082]; Agence Nationale pour la Recherche [ANR 2007 MIME-103-02]; Fondation pour la Recherche Medicale [FRM allergy DAL 2007 0822007]; Fond Europeen de Developpement Regional [FEDER Asthme 1575-32168]; Le Studium Orleans, CNRS, Orleans, France; British Biology Research Council [ALRJOD0]; Natural Environment Research Council, UK; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fond Europeen de Developpement Regional; Le Studium Orleans, CNRS, Orleans, France; British Biology Research Council; Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by Grant 077082 from the Wellcome Trust (to S. M. L. and P. R.).; Supported by the Agence Nationale pour la Recherche (ANR 2007 MIME-103-02), the Fondation pour la Recherche Medicale (FRM allergy DAL 2007 0822007), the "Fond Europeen de Developpement Regional" (FEDER Asthme 1575-32168), and Le Studium Orleans, CNRS, Orleans, France.; Supported by Grant ALRJOD0 from the British Biology Research Council (to S. M. L. and M. N.).; Supported by the Natural Environment Research Council, UK. To whom correspondence should be addressed: CEH, Maclean Bldg., Wallingford OX10 8BB, United Kingdom. Tel.: 44-1491-692636; Fax: 44-1491-692424; E-mail: amn@ceh.ac.uk.	Allendorf DJ, 2005, J IMMUNOL, V174, P7050, DOI 10.4049/jimmunol.174.11.7050; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; Belanger C, 2008, IMMUNOLOGY, V124, P295, DOI 10.1111/j.1365-2567.2007.02767.x; Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; de Lima WT, 1998, EUR J PHARMACOL, V358, P69; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dube LM, 1999, CLIN REV ALLERG IMMU, V17, P213, DOI 10.1007/BF02737605; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELS AOS, 1982, P NATL ACAD SCI-BIOL, V79, P7866, DOI 10.1073/pnas.79.24.7866; Fleming SD, 2008, J SURG RES, V150, P196, DOI 10.1016/j.jss.2008.02.010; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; HENDERSON WR, 1991, AM REV RESPIR DIS, V143, pS86, DOI 10.1164/ajrccm/143.5_Pt_2.S86; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P798, DOI 10.1038/nrd3581; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; IMAGAWA DK, 1987, MOL IMMUNOL, V24, P1263, DOI 10.1016/0161-5890(87)90120-9; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; KOLB WP, 1981, AM REV RESPIR DIS, V123, P226; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Leonhardsberger S., 2006, BIOPROCESS INT, V4, P64; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; Paesen GA, 2000, BBA-PROTEIN STRUCT M, V1482, P92, DOI 10.1016/S0167-4838(00)00168-0; Peng T, 2005, J CLIN INVEST, V115, P1590, DOI 10.1172/JCI22906; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Steil AA, 1998, EUR J PHARMACOL, V361, P93, DOI 10.1016/S0014-2999(98)00680-3; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; TAVARESDELIMA W, 1989, BRAZ J MED BIOL RES, V22, P745; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watford WT, 2000, AM J PHYSIOL-LUNG C, V279, pL790, DOI 10.1152/ajplung.2000.279.5.L790	58	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18789	18802		10.1074/jbc.M112.420331	http://dx.doi.org/10.1074/jbc.M112.420331			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23625922	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000321335800017
J	Zhou, PP; Wang, ZL; Yuan, XJ; Zhou, CH; Liu, LL; Wan, XL; Zhang, F; Ding, XD; Wang, CG; Xiong, SD; Wang, Z; Yuan, JD; Li, Q; Zhang, Y				Zhou, Peipei; Wang, Zhilong; Yuan, Xiujie; Zhou, Cuihong; Liu, Lulu; Wan, Xiaoling; Zhang, Feng; Ding, Xiaodan; Wang, Chuangui; Xiong, Sidong; Wang, Zhen; Yuan, Jinduo; Li, Qiang; Zhang, Yan			Mixed Lineage Leukemia 5 (MLL5) Protein Regulates Cell Cycle Progression and E2F1-responsive Gene Expression via Association with Host Cell Factor-1 (HCF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HERPES-SIMPLEX-VIRUS; CHROMOSOME BAND 7Q22; HISTONE METHYLTRANSFERASE; PROTEOLYTIC CLEAVAGE; COACTIVATOR HCF-1; DNA-REPLICATION; O-GLCNACYLATION; MAMMALIAN CDC6; E2F	Trithorax group proteins methylate lysine 4 of histone 3 (H3K4) at active gene promoters. MLL5 protein, a member of the Trithorax protein family, has been implicated in the control of the cell cycle progression; however, the underlying molecular mechanism(s) have not been fully determined. In this study, we found that the MLL5 protein can associate with the cell cycle regulator "host cell factor" (HCF-1). The interaction between MLL5 and HCF-1 is mediated by the "HCF-1 binding motif" (HBM) of the MLL5 protein and the Kelch domain of the HCF-1 protein. Confocal microscopy showed that the MLL5 protein largely colocalized with HCF-1 in the nucleus. Knockdown of MLL5 resulted in reduced cell proliferation and cell cycle arrest in the G(1) phase. Moreover, down-regulation of E2F1 target gene expression and decreased H3K4me3 levels at E2F1-responsive promoters were observed in MLL5 knockdown cells. Additionally, the core subunits, including ASH2L, RBBP5, and WDR5, that are necessary for effective H3K4 methyltransferase activities of the Trithorax protein complexes, were absent in the MLL5 complex, suggesting that a distinct mechanism may be used by MLL5 for exerting its H3K4 methyltransferase activity. Together, our findings demonstrate that MLL5 could associate with HCF-1 and then be recruited to E2F1-responsive promoters to stimulate H3K4 trimethylation and transcriptional activation, thereby facilitating the cell cycle G(1) to S phase transition.	[Zhou, Peipei; Wang, Zhilong; Yuan, Xiujie; Zhou, Cuihong; Liu, Lulu; Wan, Xiaoling; Zhang, Feng; Ding, Xiaodan; Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Liu, Lulu; Wan, Xiaoling; Xiong, Sidong] Soochow Univ, Inst Biol & Med Sci, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Wang, Chuangui] E China Normal Univ, Coll Life Sci, Shanghai 200241, Peoples R China; [Wang, Zhen; Yuan, Jinduo] Shandong Normal Univ, Key Lab Anim Resistence Shandong Prov, Dept Biotechnol, Jinan 250014, Shandong, Peoples R China; [Li, Qiang] Fudan Univ, Childrens Hosp, Shanghai 201102, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Soochow University - China; East China Normal University; East China Normal University; Shandong Normal University; Fudan University	Zhang, Y (corresponding author), 411 Hefei Rd, Shanghai 200025, Peoples R China.	yan_zhang@sibs.ac.cn	Wan, Xiaoling/T-1813-2019; 周, 翠红/ACA-7979-2022; Wang, Zhen/GYI-9962-2022	Wang, Zhen/0000-0002-1215-1661	National Natural Science Foundation of China [30971672, 81090410, 81270618]; National Basic Research Program of China [2010CB945600, 2011CB966300]; 100 Talent Program of the Chinese Academy of Sciences; Shanghai Pujiang Program [11PJ1401800]; Ministry of Education of China [20093704120004]; Shandong Province [BS2010SW031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 100 Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education of China(Ministry of Education, China); Shandong Province	This work was supported by National Natural Science Foundation of China Grants 30971672, 81090410, and 81270618, National Basic Research Program of China Grants 2010CB945600 and 2011CB966300, and grants from the 100 Talent Program of the Chinese Academy of Sciences (to Y. Z.), Shanghai Pujiang Program Grant 11PJ1401800 (to Q. L.), Research Fund for the Doctoral Program from Ministry of Education of China Grant 20093704120004, and Award Research Funds for Young Scholars from Shandong Province Grant BS2010SW031 (to J. Y.).	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Austenaa L, 2012, IMMUNITY, V36, P572, DOI 10.1016/j.immuni.2012.02.016; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fischer K, 1997, BLOOD, V89, P2036, DOI 10.1182/blood.V89.6.2036; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kratz CP, 2001, GENOMICS, V77, P171, DOI 10.1006/geno.2001.6636; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; La Boissiere S, 1999, EMBO J, V18, P480; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Liu H, 2009, BLOOD, V113, P1395, DOI 10.1182/blood-2008-11-185801; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mangone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009020; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Narayanan A, 2005, J BIOL CHEM, V280, P1369, DOI 10.1074/jbc.M410178200; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Peng H, 2010, P NATL ACAD SCI USA, V107, P2461, DOI 10.1073/pnas.0911128107; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905	56	44	51	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17532	17543		10.1074/jbc.M112.439729	http://dx.doi.org/10.1074/jbc.M112.439729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629655	Green Published, hybrid			2022-12-25	WOS:000320380600044
J	Sanz, S; Bandini, G; Ospina, D; Bernabeu, M; Marino, K; Fernandez-Becerra, C; Izquierdo, L				Sanz, Silvia; Bandini, Giulia; Ospina, Diego; Bernabeu, Maria; Marino, Karina; Fernandez-Becerra, Carmen; Izquierdo, Luis			Biosynthesis of GDP-fucose and Other Sugar Nucleotides in the Blood Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; ANCHORED MEMBRANE-PROTEINS; TRYPANOSOMA-BRUCEI; MALARIA PARASITES; INTRAERYTHROCYTIC STAGE; LEISHMANIA-MAJOR; IN-VITRO; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; GALACTOSE PYROPHOSPHORYLASE; LIQUID-CHROMATOGRAPHY	Carbohydrate structures play important roles in many biological processes, including cell adhesion, cell-cell communication, and host-pathogen interactions. Sugar nucleotides are activated forms of sugars used by the cell as donors for most glycosylation reactions. Using a liquid chromatography-tandem mass spectrometry-based method, we identified and quantified the pools of UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, GDP-mannose, and GDP-fucose in Plasmodium falciparum intraerythrocytic life stages. We assembled these data with the in silico functional reconstruction of the parasite metabolic pathways obtained from the P. falciparum annotated genome, exposing new active biosynthetic routes crucial for further glycosylation reactions. Fucose is a sugar present in glycoconjugates often associated with recognition and adhesion events. Thus, the GDP-fucose precursor is essential in a wide variety of organisms. P. falciparum presents homologues of GDP-mannose 4,6-dehydratase and GDP-L-fucose synthase enzymes that are active in vitro, indicating that most GDP-fucose is formed by a de novo pathway that involves the bioconversion of GDP-mannose. Homologues for enzymes involved in a fucose salvage pathway are apparently absent in the P. falciparum genome. This is in agreement with in vivo metabolic labeling experiments showing that fucose is not significantly incorporated by the parasite. Fluorescence microscopy of epitope-tagged versions of P. falciparum GDP-mannose 4,6-dehydratase and GDP-L-fucose synthase expressed in transgenic 3D7 parasites shows that these enzymes localize in the cytoplasm of P. falciparum during the intraerythrocytic developmental cycle. Although the function of fucose in the parasite is not known, the presence of GDP-fucose suggests that the metabolite may be used for further fucosylation reactions.	[Sanz, Silvia; Ospina, Diego; Bernabeu, Maria; Fernandez-Becerra, Carmen; Izquierdo, Luis] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, CEK, Barcelona 08036, Spain; [Bandini, Giulia; Marino, Karina] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Dundee	Izquierdo, L (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, CEK, 1A Planta,Rossello 149-153, Barcelona 08036, Spain.	luis.izquierdo@cresib.cat	Izquierdo, Luis/L-9291-2015; Bandini, Giulia/ABC-4413-2021; Fernandez Becerra, Carmen/L-2069-2014	Izquierdo, Luis/0000-0002-3704-9874; Fernandez Becerra, Carmen/0000-0001-5154-0013; Bernabeu, Maria/0000-0001-7212-6209; Marino, Karina Valeria/0000-0002-0581-8640; Ospina Loaiza, Diego Andres/0000-0001-6308-6364; Sanz Sender, Silvia/0000-0003-4334-3284; Bandini, Giulia/0000-0002-8885-3643	Spanish Ministry of Economy and Competitiveness [SAF2010-21069]; Catalan Government (Research and Universities Commission); Ramon y Cajal Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115063] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Catalan Government (Research and Universities Commission); Ramon y Cajal Program(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Spanish Ministry of Economy and Competitiveness Grant SAF2010-21069 (to L. I).; Recipient of a travel fellowship from the Catalan Government (Research and Universities Commission) and support from the Ramon y Cajal Program and Grant SAF2010-21069 (Spanish Ministry of Economy and Competitiveness).	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aoki K, 2010, ACTA CRYSTALLOGR F, V66, P333, DOI 10.1107/S1744309110001740; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Azzouz N, 2005, MOL BIOCHEM PARASIT, V142, P12, DOI 10.1016/j.molbiopara.2005.02.011; Azzouz Nahid, 2008, V446, P183, DOI 10.1007/978-1-60327-084-7_13; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bernabeu M, 2012, CELL MICROBIOL, V14, P386, DOI 10.1111/j.1462-5822.2011.01726.x; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Crabb BS, 2004, METH MOL B, V270, P263; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; DAYALDRAGER R, 1991, CARBOHYD RES, V209, pC5, DOI 10.1016/0008-6215(91)80172-J; Delorenzi M, 2002, INFECT IMMUN, V70, P4510, DOI 10.1128/IAI.70.8.4510-4522.2002; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Dickmanns A, 2011, J MOL BIOL, V405, P461, DOI 10.1016/j.jmb.2010.10.057; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; DIECKMANNSCHUPPERT A, 1992, PARASITOL RES, V78, P416, DOI 10.1007/BF00931698; DIECKMANNSCHUPPERT A, 1993, EUR J BIOCHEM, V216, P779, DOI 10.1111/j.1432-1033.1993.tb18198.x; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GEARY TG, 1985, J PROTOZOOL, V32, P608, DOI 10.1111/j.1550-7408.1985.tb03087.x; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; ISSELBACHER KJ, 1958, J BIOL CHEM, V232, P429; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; Kooij TWA, 2006, NAT REV MICROBIOL, V4, P344, DOI 10.1038/nrmicro1392; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lamerz AC, 2010, GLYCOBIOLOGY, V20, P872, DOI 10.1093/glycob/cwq045; Leslie N, 2005, MOL GENET METAB, V85, P21, DOI 10.1016/j.ymgme.2005.01.004; Litterer LA, 2006, PLANT PHYSIOL BIOCH, V44, P171, DOI 10.1016/j.plaphy.2006.04.004; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Meissner M, 2007, APPL MICROBIOL BIOT, V75, P963, DOI 10.1007/s00253-007-0946-4; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Nasir-ud-Din, 1992, Biochemical Society Transactions, V20, p388S; NASIRUDDIN, 1992, BIOCHEM INT, V27, P55; Olszewski KL, 2011, MOL BIOCHEM PARASIT, V175, P95, DOI 10.1016/j.molbiopara.2010.09.001; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Ramasamy R, 2012, EXP PARASITOL, V130, P314, DOI 10.1016/j.exppara.2012.02.017; Rhomberg S, 2006, FEBS J, V273, P2244, DOI 10.1111/j.1742-4658.2006.05239.x; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; ROTH E, 1990, BLOOD CELLS, V16, P453; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Sakata T, 2007, MOL BIOSYST, V3, P841, DOI 10.1039/b703924g; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004; Woodrow CJ, 2000, P NATL ACAD SCI USA, V97, P9931, DOI 10.1073/pnas.170153097	77	29	32	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16506	16517		10.1074/jbc.M112.439828	http://dx.doi.org/10.1074/jbc.M112.439828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615908	Green Published, hybrid			2022-12-25	WOS:000320378900027
J	Jordana-Lluch, E; Carolan, HE; Gimenez, M; Sampath, R; Ecker, DJ; Quesada, MD; Modol, JM; Armestar, F; Blyn, LB; Cummins, LL; Ausina, V; Martro, E				Jordana-Lluch, Elena; Carolan, Heather E.; Gimenez, Montserrat; Sampath, Rangarajan; Ecker, David J.; Quesada, M. Dolores; Modol, Josep M.; Armestar, Fernando; Blyn, Lawrence B.; Cummins, Lendell L.; Ausina, Vicente; Martro, Elisa			Rapid Diagnosis of Bloodstream Infections with PCR Followed by Mass Spectrometry	PLOS ONE			English	Article							REAL-TIME PCR; MULTIPLEX PCR; ANTIMICROBIAL THERAPY; EMERGENCY-DEPARTMENT; WHOLE-BLOOD; IDENTIFICATION; SEPSIS; PATHOGENS; CULTURE; PERFORMANCE	Achieving a rapid microbiological diagnosis is crucial for decreasing morbidity and mortality of patients with a bloodstream infection, as it leads to the administration of an appropriate empiric antimicrobial therapy. Molecular methods may offer a rapid alternative to conventional microbiological diagnosis involving blood culture. In this study, the performance of a new technology that uses broad-spectrum PCR coupled with mass spectrometry (PCR/ESI-MS) was evaluated for the detection of microorganisms directly from whole blood. A total of 247 whole blood samples and paired blood cultures were prospectively obtained from 175 patients with a suspicion of sepsis. Both sample types were analyzed using the PCR/ESI-MS technology, and the results were compared with those obtained by conventional identification methods. The overall agreement between conventional methods and PCR/ESI-MS performed in blood culture aliquots was 94.2% with 96.8% sensitivity and 98.5% specificity for the molecular method. When comparing conventional methods with PCR/ESI-MS performed in whole blood specimens, the overall agreement was 77.1% with 50% sensitivity and 93.8% specificity for the molecular method. Interestingly, the PCR/ESI-MS technology led to the additional identification of 13 pathogens that were not found by conventional methods. Using the PCR/ESI-MS technology the microbiological diagnosis of bloodstream infections could be anticipated in about half of the patients in our setting, including a small but significant proportion of patients newly diagnosed. Thus, this promising technology could be very useful for the rapid diagnosis of sepsis in combination with traditional methods.	[Jordana-Lluch, Elena; Gimenez, Montserrat; Quesada, M. Dolores; Ausina, Vicente; Martro, Elisa] Univ Autonoma Barcelona, Hosp Univ Germans Trias i Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Dept Microbiol, Badalona, Spain; [Carolan, Heather E.; Sampath, Rangarajan; Ecker, David J.; Blyn, Lawrence B.; Cummins, Lendell L.] Ibis Biosci, Carlsbad, CA USA; [Modol, Josep M.] Hosp Univ Germans Trias i Pujol, Badalona, Spain; [Armestar, Fernando] Hosp Univ Germans Trias i Pujol, Intens Care Unit, Badalona, Spain; [Ausina, Vicente] CIBER Enfermedades Resp CIBERES, Bunyola, Spain; [Martro, Elisa] CIBER Epidemiol & Salud Publ, Barcelona, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Ausina, V (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias i Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Dept Microbiol, Badalona, Spain.	vausina.germanstrias@gencat.cat	Martró, Elisa/K-9688-2015; JORDANA LLUCH, ELENA/L-2976-2015	Martró, Elisa/0000-0002-2867-6649; JORDANA LLUCH, ELENA/0000-0002-1115-2048; Gimenez, Montserrat/0000-0001-8841-810X; Ecker, David/0000-0003-4350-9037; Armestar, Fernando/0000-0002-6374-1418; AUSINA, VICENTE/0000-0002-1798-9869	Ministerio de Economia y Competitividad [CP09/00044, PTA2011-5619-T]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I); "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC)	Ministerio de Economia y Competitividad(Spanish Government); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I); "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC)	This work was partially funded by grant numbers CP09/00044 ("Miguel Servet") (EM), and PTA2011-5619-T ("Personal Tecnico de Apoyo") from "Ministerio de Economia y Competitividad", "Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)" and the "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC) (EJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2012, ANAESTH INTENS CARE, V40, P958, DOI 10.1177/0310057X1204000606; Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bravo D, 2011, INT J INFECT DIS, V15, pE326, DOI 10.1016/j.ijid.2011.01.003; Chen KF, 2011, J VIROL METHODS, V173, P60, DOI 10.1016/j.jviromet.2011.01.007; Dean A., OPENEPI OPEN SOURCE; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Fitting C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038916; Gimenez M, 2010, 50 INT C ANT AG CHEM; Jordana-Lluch E, 2010, AM SOC MICR ASM 110; Kaleta EJ, 2011, CLIN CHEM, V57, P1057, DOI 10.1373/clinchem.2011.161968; Kollef MH, 1999, CHEST, V115, P8, DOI 10.1378/chest.115.1.8; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Lehmann LE, 2010, CRIT CARE, V14, DOI 10.1186/cc9294; Leitner E, 2012, J MICROBIOL METH, V22, P253; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Pasqualini L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11; Quesada MD, 2010, CLIN MICROBIOL INFEC, V16, P137, DOI 10.1111/j.1469-0691.2009.02907.x; Rath PM, 2012, J CLIN MICROBIOL, V50, P2069, DOI 10.1128/JCM.00745-12; Reimer LG, 1997, CLIN MICROBIOL REV, V10, P444, DOI 10.1128/CMR.10.3.444; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Struelens MJ, 2010, INTENS CARE MED, V36, P193, DOI 10.1007/s00134-009-1710-2; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wiesinger-Mayr H, 2011, J MICROBIOL METH, V85, P206, DOI 10.1016/j.mimet.2011.03.003	35	40	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62108	10.1371/journal.pone.0062108	http://dx.doi.org/10.1371/journal.pone.0062108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626775	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400139
J	Mikhail, AS; Eetezadi, S; Allen, C				Mikhail, Andrew S.; Eetezadi, Sina; Allen, Christine			Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere (R)	PLOS ONE			English	Article							DRUG DISTRIBUTION; ANTICANCER DRUGS; WHOLE-BODY; CANCER; PENETRATION; DELIVERY; TISSUE; MODEL; NANOPARTICLES; DOXORUBICIN	While 3-D tissue models have received increasing attention over the past several decades in the development of traditional anti-cancer therapies, their potential application for the evaluation of advanced drug delivery systems such as nanomedicines has been largely overlooked. In particular, new insight into drug resistance associated with the 3-D tumor microenvironment has called into question the validity of 2-D models for prediction of in vivo anti-tumor activity. In this work, a series of complementary assays was established for evaluating the in vitro efficacy of docetaxel (DTX) -loaded block copolymer micelles (BCM+DTX) and Taxotere (R) in 3-D multicellular tumor spheroid (MCTS) cultures. Spheroids were found to be significantly more resistant to treatment than monolayer cultures in a cell line dependent manner. Limitations in treatment efficacy were attributed to mechanisms of resistance associated with properties of the spheroid microenvironment. DTX-loaded micelles demonstrated greater therapeutic effect in both monolayer and spheroid cultures in comparison to Taxotere (R). Overall, this work demonstrates the use of spheroids as a viable platform for the evaluation of nanomedicines in conditions which more closely reflect the in vivo tumor microenvironment relative to traditional monolayer cultures. By adaptation of traditional cell-based assays, spheroids have the potential to serve as intermediaries between traditional in vitro and in vivo models for high-throughput assessment of therapeutic candidates.	[Mikhail, Andrew S.; Eetezadi, Sina; Allen, Christine] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mikhail, Andrew S.; Allen, Christine] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Allen, Christine] Spatiotemporal Targeting & Amplificat Radiat Resp, Toronto, ON, Canada	University of Toronto; University of Toronto	Allen, C (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	cj.allen@utoronto.ca	Mikhail, Andrew S./AAE-7439-2019	Mikhail, Andrew S./0000-0001-9206-5765; Allen, Christine/0000-0002-4916-3965	NSERC; Government of Ontario; NSERC CREATE Biointerfaces training program; Ontario Trillium scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Ontario; NSERC CREATE Biointerfaces training program; Ontario Trillium scholarship	A. Mikhail is the recipient of post-graduate scholarships from NSERC and the Government of Ontario. S. Eetezadi is funded by the NSERC CREATE Biointerfaces training program and holds an Ontario Trillium scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER H, 1987, BRIT J CANCER, V56, P325, DOI 10.1038/bjc.1987.197; [Anonymous], 2010, PRESCR INF TAX; Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166; Baur M, 2008, J CANCER RES CLIN, V134, P125, DOI 10.1007/s00432-007-0259-0; CAVALLARO G, 1994, INT J PHARM, V111, P31, DOI 10.1016/0378-5173(94)90399-9; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; Chetprayoon P, 2012, ACTA BIOMAT IN PRESS; Cowan DSM, 2001, INT J CANCER, V91, P120, DOI 10.1002/1097-0215(20010101)91:1<120::AID-IJC1021>3.0.CO;2-Y; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Elliott N, 2010, J PHARM SCI, V100, P2; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fonseca C, 2002, J CONTROL RELEASE, V83, P273, DOI 10.1016/S0168-3659(02)00212-2; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Han M, 2009, MOL THER, V17, P1404, DOI 10.1038/mt.2009.119; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardelauf H, 2011, LAB CHIP, V11, P419, DOI 10.1039/c0lc00089b; Hicks KO, 1997, BRIT J CANCER, V76, P894, DOI 10.1038/bjc.1997.481; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hosoya H, 2012, BIOCHEM BIOPH RES CO, V419, P32, DOI 10.1016/j.bbrc.2012.01.117; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim JW, 2011, ANTICANCER RES, V31, P3237; Kim TH, 2010, BIOMATERIALS, V31, P7386, DOI 10.1016/j.biomaterials.2010.06.004; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; MARUSIC M, 1994, CELL PROLIFERAT, V27, P73, DOI 10.1111/j.1365-2184.1994.tb01407.x; Mikhail AS, 2010, BIOMACROMOLECULES, V11, P1273, DOI 10.1021/bm100073s; Mikhail AS, 2009, J CONTROL RELEASE, V138, P214, DOI 10.1016/j.jconrel.2009.04.010; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; NEDERMAN T, 1984, CANCER RES, V44, P3090; Nemati F, 1996, INT J PHARM, V138, P237, DOI 10.1016/0378-5173(96)04559-0; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Oishi M, 2007, CHEMMEDCHEM, V2, P1290, DOI 10.1002/cmdc.200700076; Okubo H, 2002, ARTIF ORGANS, V26, P497, DOI 10.1046/j.1525-1594.2002.06836.x; Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049; Panyam J, 2003, PHARM RES-DORDR, V20, P212, DOI 10.1023/A:1022219003551; Perche F, 2012, J CONTROL R IN PRESS; PHILLIPS RM, 1990, JNCI-J NATL CANCER I, V82, P1457, DOI 10.1093/jnci/82.18.1457; ROTIN D, 1986, CANCER RES, V46, P2821; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tannock IF, 2002, CLIN CANCER RES, V8, P878; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tsukioka Y, 2002, JPN J CANCER RES, V93, P1145, DOI 10.1111/j.1349-7006.2002.tb01217.x; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Yoo HS, 2004, J CONTROL RELEASE, V96, P273, DOI 10.1016/j.jconrel.2004.02.003; Yoo HS, 2004, J CONTROL RELEASE, V100, P247, DOI 10.1016/j.jconrel.2004.08.017; Zahedi P, 2012, J CONTROL RELEASE, V158, P379, DOI 10.1016/j.jconrel.2011.11.025	51	94	96	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62630	10.1371/journal.pone.0062630	http://dx.doi.org/10.1371/journal.pone.0062630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626842	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400206
J	Nijjar, S; Woodland, HR				Nijjar, Sarbjit; Woodland, Hugh R.			Localisation of RNAs into the Germ Plasm of Vitellogenic Xenopus Oocytes	PLOS ONE			English	Article							MATERNAL MESSENGER-RNA; P GRANULE COMPONENTS; VEGETAL CORTEX; MITOCHONDRIAL CLOUD; BINDING PROTEIN; BALBIANI BODY; OSKAR RNA; TRANSPORT; CELL; VG1	We have studied the localisation of mRNAs in full-grown Xenopus laevis oocytes by injecting fluorescent RNAs, followed by confocal microscopy of the oocyte cortex. Concentrating on RNA encoding the Xenopus Nanos homologue, nanos1 (formerly Xcat2), we find that it consistently localised into aggregated germ plasm ribonucleoprotein (RNP) particles, independently of cytoskeletal integrity. This implies that a diffusion/entrapment-mediated mechanism is active, as previously reported for previtellogenic oocytes. Sometimes this was accompanied by localisation into scattered particles of the "late'', Vg1/VegT pathway; occasionally only late pathway localisation was seen. The Xpat RNA behaved in an identical fashion and for neither RNA was the localisation changed by any culture conditions tested. The identity of the labelled RNP aggregates as definitive germ plasm was confirmed by their inclusion of abundant mitochondria and co-localisation with the germ plasm protein Hermes. Further, the nanos1/Hermes RNP particles are interspersed with those containing the germ plasm protein Xpat. These aggregates may be followed into the germ plasm of unfertilized eggs, but with a notable reduction in its quantity, both in terms of injected molecules and endogenous structures. Our results conflict with previous reports that there is no RNA localisation in large oocytes, and that during mid-oogenesis even germ plasm RNAs localise exclusively by the late pathway. We find that in mid oogenesis nanos1 RNA also localises to germ plasm but also by the late pathway. Late pathway RNAs, Vg1 and VegT, also may localise into germ plasm. Our results support the view that mechanistically the two modes of localisation are extremely similar, and that in an injection experiment RNAs might utilise either pathway, the distinction in fates being very subtle and subject to variation. We discuss these results in relation to their biological significance and the results of others.	[Nijjar, Sarbjit; Woodland, Hugh R.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Woodland, HR (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	h.r.woodland@warwick.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alarcon VB, 2001, J CELL SCI, V114, P1731; Allen L, 2003, DIFFERENTIATION, V71, P311, DOI 10.1046/j.1432-0436.2003.7106003.x; BEREKELYA LA, 2007, DIFFERENTIATION; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Choo S, 2005, DEV BIOL, V278, P103, DOI 10.1016/j.ydbio.2004.10.019; Claussen M, 2004, DEVELOPMENT, V131, P4263, DOI 10.1242/dev.01283; Claussen M, 2004, DEV BIOL, V266, P270, DOI 10.1016/j.ydbio.2003.09.043; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DALE L, 1989, EMBO J, V8, P1057, DOI 10.1002/j.1460-2075.1989.tb03473.x; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; DRUMMOND DR, 1985, J CELL BIOL, V100, P1148, DOI 10.1083/jcb.100.4.1148; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Gagnon JA, 2011, METHODS MOL BIOL, V714, P71, DOI 10.1007/978-1-61779-005-8_5; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Gerber WV, 1999, MECH DEVELOP, V80, P77, DOI 10.1016/S0925-4773(98)00195-6; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Guedes S, 1997, DEVELOPMENT, V124, P731; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; HEASMAN J, 1984, DEV BIOL, V105, P458, DOI 10.1016/0012-1606(84)90303-8; Heasman J, 2001, DEV BIOL, V240, P377, DOI 10.1006/dbio.2001.0495; Heinrich B, 2009, RNA, V15, P524, DOI 10.1261/rna.975309; Hird SN, 1996, DEVELOPMENT, V122, P1303; Hudson C, 1998, MECH DEVELOP, V73, P159, DOI 10.1016/S0925-4773(98)00047-1; King ML, 2005, BIOL CELL, V97, P19; Kloc M, 2000, DEV BIOL, V217, P221, DOI 10.1006/dbio.1999.9554; Kloc M, 1996, DEV BIOL, V180, P119, DOI 10.1006/dbio.1996.0289; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; KLOC M, 1994, SCIENCE, V265, P1101, DOI 10.1126/science.7520603; Kloc M, 2002, DEV BIOL, V241, P79, DOI 10.1006/dbio.2001.0488; Kloc M, 2001, INT REV CYTOL, V203, P63; Kloc M, 2007, EXP CELL RES, V313, P1639, DOI 10.1016/j.yexcr.2007.02.018; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; KU M, 1993, DEVELOPMENT, V119, P1161; Kwon S, 2002, CURR BIOL, V12, P558, DOI 10.1016/S0960-9822(02)00740-6; Lai FF, 2012, DEVELOPMENT, V139, P1476, DOI 10.1242/dev.079608; Lai FF, 2011, MECH DEVELOP, V128, P153, DOI 10.1016/j.mod.2010.12.001; Lewis RA, 2004, MECH DEVELOP, V121, P101, DOI 10.1016/j.mod.2003.09.009; MacArthur H, 1999, MECH DEVELOP, V84, P75, DOI 10.1016/S0925-4773(99)00075-1; MacArthur H, 2000, MECH DEVELOP, V95, P291, DOI 10.1016/S0925-4773(00)00357-9; Macdonald PM, 2011, CURR OPIN GENET DEV, V21, P407, DOI 10.1016/j.gde.2011.04.005; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; RICHARDSON PT, 1991, CARBOHYD RES, V213, P19, DOI 10.1016/S0008-6215(00)90594-9; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Song HW, 2007, DIFFERENTIATION, V75, P519, DOI 10.1111/j.1432-0436.2006.00155.x; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Yaniv K, 2001, INT REV CYTOL, V203, P521; YISRAELI JK, 1988, NATURE, V336, P592, DOI 10.1038/336592a0; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Zearfoss NR, 2004, DEV BIOL, V267, P60, DOI 10.1016/j.ydbio.2003.10.032; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhou Y, 1996, DEVELOPMENT, V122, P2947; Zhou Y, 2004, IUBMB LIFE, V56, P19, DOI 10.1080/15216540310001658886; Zhou Y, 1996, DEV BIOL, V179, P173, DOI 10.1006/dbio.1996.0249; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	65	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61847	10.1371/journal.pone.0061847	http://dx.doi.org/10.1371/journal.pone.0061847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626739	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400103
J	Wu, PH; Lin, YT; Lee, TC; Lin, MY; Kuo, MC; Chiu, YW; Hwang, SJ; Chen, HC				Wu, Ping-Hsun; Lin, Yi-Ting; Lee, Tzu-Chi; Lin, Ming-Yen; Kuo, Mei-Chuan; Chiu, Yi-Wen; Hwang, Shang-Jyh; Chen, Hung-Chun			Predicting Mortality of Incident Dialysis Patients in Taiwan - A Longitudinal Population-Based Study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; STAGE RENAL-DISEASE; MAINTENANCE HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; REPLACEMENT THERAPY; BLOOD-PRESSURE; SURVIVAL; OUTCOMES; ESRD	Background: Comorbid conditions are highly prevalent among patients with end-stage renal disease (ESRD) and index score is a predictor of mortality in dialysis patients. The aim of this study is to perform a population-based cohort study to investigate the survival rate by age and Charlson comorbidity index (CCI) in incident dialysis patients. Methods: Using the catastrophic illness registration of the Taiwan National Health Insurance Research Database for all patients from 1 January 1998 to 31 December 2008, individuals newly diagnosed with ESRD and receiving dialysis for more than 90 days were eligible for our study. Individuals younger than 18 years or renal transplantation patients either before or after dialysis were excluded. We calculated the CCI, age-weighted CCI by Deyo-Charlson method according to ICD-9 code and categorized CCI into six groups as index scores < 3, 4-6, 7-9, 10-12, 13-15, > 15. Cox regression models were used to analyze the association between age, CCI and survival, and the risk markers of survival. Results: There were 79,645 incident dialysis patients, whose mean age (+/- SD) was 60.96 (+/- 13.92) years; 51.43% of patients were women and 51.2% were diabetic. In cox proportional hazard models and stratifying by age, older patients had significantly higher mortality than younger patients. The mortality risk was higher in persons with higher CCI as compared with low CCI. Mortality increased steadily with higher age or comorbidity both for unadjusted and for adjusted models. For all age groups, mortality rates increased in different CCI groups with the highest rates occurring in the oldest age groups. Conclusions: Age and CCI are both strong predictors of survival in Taiwan. The older age or higher comorbidity index in incident dialysis patient is associated with lower long-term survival rates. These population-based estimates may assist clinicians who make decisions when patients need long-term dialysis.	[Wu, Ping-Hsun; Lin, Ming-Yen; Kuo, Mei-Chuan; Chiu, Yi-Wen; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lin, Yi-Ting; Lee, Tzu-Chi] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Lin, Yi-Ting] Kaohsiung Med Univ, Coll Med, Dept Publ Hlth, Kaohsiung, Taiwan; [Wu, Ping-Hsun] Kaohsiung Med Univ, Coll Med, Dept Internal Med, Kaohsiung, Taiwan; [Kuo, Mei-Chuan; Chiu, Yi-Wen; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	mechku@kmu.edu.tw	Lin, Ming Yen/A-8637-2010; Wu, Ping-Hsun/S-8746-2017; LIN, YI-TING/S-8855-2017	Lin, Ming Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; LIN, YI-TING/0000-0002-5833-0040				Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Beddhu S, 2000, AM J MED, V108, P609, DOI 10.1016/S0002-9343(00)00371-5; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chang YK, 2012, MEDICINE, V91, P144, DOI 10.1097/MD.0b013e318256538e; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fried L, 2001, AM J KIDNEY DIS, V37, P337, DOI 10.1053/ajkd.2001.21300; Geddes CC, 2006, NEPHROL DIAL TRANSPL, V21, P945, DOI 10.1093/ndt/gfi326; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Huang CC, 2008, PERITON DIALYSIS INT, V28, pS15; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; KOPPLE JD, 1994, AM J KIDNEY DIS, V24, P1002, DOI 10.1016/S0272-6386(12)81075-4; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Lee CC, 2009, PERITON DIALYSIS INT, V29, P182; Lee CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-100; Luo JC, 2011, CAN MED ASSOC J, V183, pE1345, DOI 10.1503/cmaj.110299; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Mazzuchi N, 2000, KIDNEY INT, V58, P2147; Miskulin D, 2009, CLIN J AM SOC NEPHRO, V4, P1818, DOI 10.2215/CJN.00640109; Miskulin DC, 2004, NEPHROL DIAL TRANSPL, V19, P413, DOI 10.1093/ndt/gfg571; Miskulin DC, 2003, AM J KIDNEY DIS, V41, P149, DOI 10.1053/ajkd.2003.50034; Ng YY, 2012, NEPHROL DIAL TRANSPL; Nicolucci A, 1992, ASAIO J, V38, pM291, DOI 10.1097/00002480-199207000-00040; Port FK, 1999, AM J KIDNEY DIS, V33, P507, DOI 10.1016/S0272-6386(99)70188-5; Ueshima H, 2003, J HUM HYPERTENS, V17, P631, DOI 10.1038/sj.jhh.1001606; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	34	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61930	10.1371/journal.pone.0061930	http://dx.doi.org/10.1371/journal.pone.0061930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626754	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400118
J	Yin, W; Ye, XQ; Fan, HL; Bian, ZA				Yin, Wei; Ye, Xiaoqian; Fan, Huali; Bian, Zhuan			Methylation State of the EDA Gene Promoter in Chinese X-Linked Hypohidrotic Ectodermal Dysplasia Carriers	PLOS ONE			English	Article							DNA METHYLATION; BREAST-CANCER; CELL-LINES; MUTATIONS; IDENTIFICATION; SEQUENCE; BINDING; PROTEIN; FAMILY; ECTODYSPLASIN	Introduction: Hypodontia, hypohidrosis, sparse hair and characteristic faces are the main characters of X-linked hypohidrotic ectodermal dysplasia (XLHED) which is caused by genetic ectodysplasin A (EDA) deficiency. Heterozygous female carriers tend to have mild to moderate XLHED phenotype, even though 30% of them present no obvious symptom. Methods: A large Chinese XLHED family was reported and the entire coding region and exon-intron boundaries of EDA gene were sequenced. To elucidate the mechanism for carriers' tempered phenotype, we analyzed the methylation level on four sites of the promoter of EDA by the pyrosequencing system. Results: A known frameshift mutation (c.573-574 insT) was found in this pedigree. Combined with the pedigrees we reported before, 120 samples comprised of 23 carrier females from 11 families and 97 healthy females were analyzed for the methylation state of EDA promoter. Within 95% confidence interval (CI), 18 (78.26%) carriers were hypermethylated at these 4 sites. Conclusion: Chinese XLHED carriers often have a hypermethylated EDA promoter.	[Yin, Wei; Ye, Xiaoqian; Bian, Zhuan] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Yin, Wei; Ye, Xiaoqian; Bian, Zhuan] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Yin, Wei] Dalian Med Univ, Coll Stomatol, Dept Endodont & Periodont, Dalian, Liaoning, Peoples R China; [Fan, Huali] Hangzhou Stomatol Hosp, Gen Dept 2, Hangzhou, Zhejiang, Peoples R China	Wuhan University; Wuhan University; Dalian Medical University	Bian, ZA (corresponding author), Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China.	bz@whuss.com			National Natural Scientific Foundation of China [30500562, 30772417, 30930099, 81120108010]; Chenguang Plan for Distinguished Youth of Wuhan, China [200850731374]; Open Research Fund Program of Hubei-MOST KLOS KLOBME [201103]; Foundation for the Author of National Excellent Doctoral Dissertation [2007B69]; Program for New Century Excellent Talents in University, Ministry of Education, China	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chenguang Plan for Distinguished Youth of Wuhan, China; Open Research Fund Program of Hubei-MOST KLOS KLOBME; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University, Ministry of Education, China(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Scientific Foundation of China (30500562, 30772417, 30930099 (Monumental Projects) and 81120108010 (International cooperation and exchange projects)), the Chenguang Plan for Distinguished Youth of Wuhan, China (200850731374), the Open Research Fund Program of Hubei-MOST KLOS & KLOBME (201103), the Foundation for the Author of National Excellent Doctoral Dissertation (2007B69) and the Program for New Century Excellent Talents in University, Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chassaing N, 2006, HUM MUTAT, V27, P255, DOI 10.1002/humu.20295; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Deng GR, 2004, CANCER RES, V64, P2692, DOI 10.1158/0008-5472.CAN-03-3000; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Fan Hua-Li, 2007, Zhonghua Kou Qiang Yi Xue Za Zhi, V42, P272; Fan HL, 2008, EUR J ORAL SCI, V116, P412, DOI 10.1111/j.1600-0722.2008.00555.x; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lux W, 2005, J THROMB HAEMOST, V3, P1009, DOI 10.1111/j.1538-7836.2005.01276.x; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Nan XS, 1996, MOL CELL BIOL, V16, P414; Paakkonen K, 2001, Hum Mutat, V17, P349, DOI 10.1002/humu.33; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Rivenbark AG, 2006, LAB INVEST, V86, P1233, DOI 10.1038/labinvest.3700485; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Vincent MC, 2001, EUR J HUM GENET, V9, P355, DOI 10.1038/sj.ejhg.5200635; Yin W, 2010, J DENT RES, V89, P813, DOI 10.1177/0022034510366804	23	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62203	10.1371/journal.pone.0062203	http://dx.doi.org/10.1371/journal.pone.0062203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626789	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400153
J	Gauvreau, D; Gupta, A; Fisette, A; Tom, FQ; Cianflone, K				Gauvreau, Danny; Gupta, Abhishek; Fisette, Alexandre; Tom, Fun-Qun; Cianflone, Katherine			Deficiency of C5L2 Increases Macrophage Infiltration and Alters Adipose Tissue Function in Mice	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; INSULIN-RESISTANCE; CHEMOATTRACTANT RECEPTOR; COMPLEMENT C3; C5A RECEPTORS; OBESITY; INFLAMMATION; EXPRESSION; DISEASE; ANAPHYLATOXINS	Background: Obesity is considered as a systemic chronic low grade inflammation characterized by increased serum pro-inflammatory proteins and accumulation of macrophages within white adipose tissue (WAT) of obese patients. C5L2, a 7transmembrane receptor, serves a dual function, binding the lipogenic hormone acylation stimulating protein (ASP), and C5a, involved in innate immunity. Aim: We evaluated the impact of C5L2 on macrophage infiltration in WAT of wildtype (Ctl) and C5L2 knock-out (C5L2(-/-)) mice over 6, 12 and 24 weeks on a chow diet and moderate diet-induced obesity (DIO) conditions. Results: In Ctl mice, WAT C5L2 and C5a receptor mRNA increased (up to 10-fold) both over time and with DIO. By contrast, in C5L2(-/-), there was no change in C5aR in WAT. C5L2(-/-) mice displayed higher macrophage content in WAT, varying by time, fat depot and diet, associated with altered systemic and WAT cytokine patterns compared to Ctl mice. However, in all cases, the M1 (pro-) vs M2 (anti-inflammatory) macrophage proportion was unchanged but C5L2(-/-) adipose tissue secretome appeared to be more chemoattractant. Moreover, C5L2(-/-) mice have increased food intake, increased WAT, and altered WAT lipid gene expression, which is reflected systemically. Furthermore, C5L2(-/-) mice have altered glucose/insulin metabolism, adiponectin and insulin signalling gene expression in WAT, which could contribute to development of insulin resistance. Conclusion: Disruption of C5L2 increases macrophage presence in WAT, contributing to obesity-associated pathologies, and further supports a dual role of complement in WAT. Understanding this effect of the complement system pathway could contribute to targeting treatment of obesity and its comorbidities.	[Gauvreau, Danny; Gupta, Abhishek; Fisette, Alexandre; Tom, Fun-Qun; Cianflone, Katherine] Univ Laval, Inst Univ Cardiol & Pneumol Quebec Res Ctr CRIUCP, Quebec City, PQ, Canada; [Gauvreau, Danny; Fisette, Alexandre; Cianflone, Katherine] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Cianflone, K (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec Res Ctr CRIUCP, Quebec City, PQ, Canada.	Katherine.cianflone@criucpq.ulaval.ca		Fisette, Alexandre/0000-0002-0466-0845	Natural Science and Engineering Council of Canada (NSERC); Obesity Training Program; Centre de Recherche Institut Universitaire de Cardiologie et Pneumologie de Quebec (Heart and Lung University Research Institute of Quebec) (CRIUCPQ); CIHR	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Obesity Training Program; Centre de Recherche Institut Universitaire de Cardiologie et Pneumologie de Quebec (Heart and Lung University Research Institute of Quebec) (CRIUCPQ); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Natural Science and Engineering Council of Canada (NSERC to KC). K. Cianflone holds a Canada Research Chair in Adipose Tissue. D. Gauvreau is supported by a grant from the Obesity Training Program and the Centre de Recherche Institut Universitaire de Cardiologie et Pneumologie de Quebec (Heart and Lung University Research Institute of Quebec) (CRIUCPQ). A Gupta holds a Hope Scholarship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cianflone K, 1997, ARTERIOSCL THROM VAS, V17, P1239; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fisette A, 2012, C5L2 RECEPTOR DISRUP; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gordon S, 2011, EUR J IMMUNOL, V41, P2472, DOI 10.1002/eji.201141715; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Innis Sheila M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P359, DOI 10.1097/MED.0b013e3282be90b9; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Maslowska M, 1997, INT J OBESITY, V21, P261, DOI 10.1038/sj.ijo.0800396; Maslowska M, 1999, EUR J CLIN INVEST, V29, P679, DOI 10.1046/j.1365-2362.1999.00514.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nedvidkova J, 2005, PHYSIOL RES, V54, P133, DOI 10.33549/physiolres.930600; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Ohinata K, 2009, PROSTAG OTH LIPID M, V90, P81, DOI 10.1016/j.prostaglandins.2009.09.001; Ohinata K, 2008, ADV EXP MED BIOL, V632, P35, DOI 10.1007/978-0-387-78952-1_3; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okada H, 2011, ANTICANCER RES, V31, P2511; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Roth J, 2011, AM J CLIN NUTR, V93, p875S, DOI 10.3945/ajcn.110.001909; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; YASRUEL Z, 1991, LIPIDS, V26, P495, DOI 10.1007/BF02536592; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	52	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60795	10.1371/journal.pone.0060795	http://dx.doi.org/10.1371/journal.pone.0060795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630572	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500007
J	Laxmivandana, R; Yergolkar, P; Gopalkrishna, V; Chitambar, SD				Laxmivandana, Rongala; Yergolkar, Prasanna; Gopalkrishna, Varanasi; Chitambar, Shobha D.			Characterization of the Non-Polio Enterovirus Infections Associated with Acute Flaccid Paralysis in South-Western India	PLOS ONE			English	Article							EPIDEMIOLOGY; CHILDREN; DISEASE; SURVEILLANCE; MENINGITIS; DIVERSITY; DIAGNOSIS; STRAINS	Non-polio enteroviruses (NPEVs) have been reported frequently in association with acute flaccid paralysis (AFP) cases during Polio Surveillance Programs (PSPs) worldwide. However, there is limited understanding on the attributes of their infections. This study reports characteristics of NPEVs isolated from AFP cases, investigated during PSPs held in 2009-2010, in Karnataka and Kerala states of south-western India having varied climatic conditions. NPEV cell culture isolates derived from stool specimens that were collected from 422 of 2186 AFP cases (<1-14 years age) and 17 of 41 asymptomatic contacts; and details of all AFP cases/contacts were obtained from National Polio Laboratory, Bangalore. The distribution of NPEV infections among AFP cases and circulation pattern of NPEV strains were determined by statistical analysis of the data. Genotyping of all NPEV isolates was carried out by partial VP1 gene sequencing and phylogenetic analysis. NPEV positive AFP cases were significantly higher in children aged <2 years; with residual paralysis; in summer months; and in regions with relatively hot climate. Genotyping of NPEVs identified predominance of human enteroviruses (HEV)-B species [81.9%-Echoviruses (E): 57.3%; coxsackieviruses (CV) B: 15%; numbered EVs: 8.9%; CVA9: 0.7%] and low levels of HEV-A [14.5%-CVA: 6%; numbered EVs: 8.5%] and HEV-C [3.6%-CVA: 2.6%; numbered EVs: 1%] species, encompassing 63 genotypes. EV76 (6.3%) and each of E3, CVB3 and E9 (4.97%) were found frequently during 2009 while E11 (6.7%), CVB1 (6.1%), E7 (5.1%) and E20 (5.1%) were detected commonly in 2010. A marked proportion of AFP cases from children aged,2 years; presenting with fever; and from north and south interior parts of Karnataka state was detected with E/numbered EVs than that found with CVA/CVB. This study highlights the extensive genetic diversity and diverse circulation patterns of NPEV strains in AFP cases from different populations and climatic conditions.	[Laxmivandana, Rongala; Gopalkrishna, Varanasi; Chitambar, Shobha D.] Natl Inst Virol, Enter Viruses Grp, Pune, Maharashtra, India; [Yergolkar, Prasanna] Natl Inst Virol, Bangalore Unit, Bangalore, Karnataka, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Chitambar, SD (corresponding author), Natl Inst Virol, Enter Viruses Grp, Pune, Maharashtra, India.	drshobha.niv@gmail.com	Gopalkrishna, Varanasi/G-8709-2017	Gopalkrishna, Varanasi/0000-0003-4511-5648	Indian Council of Medical Research (ICMR), New Delhi	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	Funding provided by Indian Council of Medical Research (ICMR), New Delhi, URL:www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P153; [Anonymous], 2006, ETH GUID BIOM RES HU; Apostol LN, 2012, J MED VIROL, V84, P624, DOI 10.1002/jmv.23242; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Dhole TN, 2009, J PAEDIATR CHILD H, V45, P409, DOI 10.1111/j.1440-1754.2009.01529.x; Dietz V, 1995, B WORLD HEALTH ORGAN, V73, P597; dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Gharbi J, 2006, DIAGN MICR INFEC DIS, V54, P31, DOI 10.1016/j.diagmicrobio.2005.08.017; Heim A, 2005, J MED MICROBIOL, V54, P1, DOI 10.1099/jmm.0.45894-0; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3; Jiang BF, 2012, J MED VIROL, V84, P1803, DOI 10.1002/jmv.23391; Julian KG, 2003, EMERG INFECT DIS, V9, P1082; Kapoor A, 2004, INDIAN J MED RES, V119, P149; Kapoor Amit, 2001, Indian Journal of Pediatrics, V68, P927, DOI 10.1007/BF02722583; Kliegman RM, 2020, NELSON TXB PEDIAT; Mahadevan S, 2005, Indian J Pediatr, V72, P267, DOI 10.1007/BF02859273; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Minor P, 1995, P 6 REP INT COMM TAX, P329; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Nadkarni SS, 2003, J MED VIROL, V70, P81, DOI 10.1002/jmv.10360; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Oyero O G, 2010, Afr J Med Med Sci, V39 Suppl, P201; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Pallansch M., 2007, FIELDS VIROL, P839; Persu Ana, 2009, Roum Arch Microbiol Immunol, V68, P20; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Rao GSLHVP, 2005, AGR METEOROLOGY; Saeed M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-6; Savolainen-Kopra C, 2009, VIRUS RES, V139, P32, DOI 10.1016/j.virusres.2008.10.003; Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/00001432-200310000-00002; Stanway G.B.F., 2005, VIRUS TAXONOMY CLASS, P757; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The department of immunization vaccines and biological, 2007, WHO POL LAB MAN S; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Vashisht Neetu, 2012, Indian J Med Ethics, V9, P114; WHO, 2004, POL LAB MAN; Yang Tsou-Tong, 2005, Journal of Microbiology Immunology and Infection, V38, P417	44	54	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61650	10.1371/journal.pone.0061650	http://dx.doi.org/10.1371/journal.pone.0061650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630606	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500056
J	Liao, XL; Cheng, L; Xu, P; Lu, GQ; Wachholtz, M; Sun, XW; Chen, SL				Liao, Xiaolin; Cheng, Lei; Xu, Peng; Lu, Guoqing; Wachholtz, Michael; Sun, Xiaowen; Chen, Songlin			Transcriptome Analysis of Crucian Carp (Carassius auratus), an Important Aquaculture and Hypoxia-Tolerant Species	PLOS ONE			English	Article							CROSS-AMPLIFICATION; MICROSATELLITE MARKERS; CLONAL DIVERSITY; GIBELIO BLOCH; RNA-SEQ; DISCOVERY; GENE; GENERATION; DATABASE; FISHES	The crucian carp is an important aquaculture species and a potential model to study genome evolution and physiological adaptation. However, so far the genomics and transcriptomics data available for this species are still scarce. We performed de novo transcriptome sequencing of four cDNA libraries representing brain, muscle, liver and kidney tissues respectively, each with six specimens. The removal of low quality reads resulted in 2.62 million raw reads, which were assembled as 127,711 unigenes, including 84,867 isotigs and 42,844 singletons. A total of 22,273 unigenes were found with significant matches to 14,449 unique proteins. Around14,398 unigenes were assigned with at least one Gene Ontology (GO) category in 84,876 total assignments, and 6,382 unigenes were found in 237 predicted KEGG pathways. The gene expression analysis revealed more genes expressed in brain, more up-regulated genes in muscle and more down-regulated genes in liver as compared with gene expression profiles of other tissues. In addition, 23 enzymes in the glycolysis/gluconeogenesis pathway were recovered. Importantly, we identified 5,784 high-quality putative SNP and 11,295 microsatellite markers which include 5,364 microsatellites with flanking sequences >= 50 bp. This study produced the most comprehensive genomic resources that have been derived from crucian carp, including thousands of genetic markers, which will not only lay a foundation for further studies on polyploidy origin and anoxic survival but will also facilitate selective breeding of this important aquaculture species.	[Liao, Xiaolin; Chen, Songlin] Chinese Acad Fishery Sci, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst, Minist Agr, Qingdao, Peoples R China; [Cheng, Lei; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liao, Xiaolin; Lu, Guoqing; Wachholtz, Michael] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; University of Nebraska System	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst, Minist Agr, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Xu, Peng/J-4018-2012; Sun, Xiaowen/F-1516-2014	Xu, Peng/0000-0002-1531-5078; 	Special Fund for Agro-scientific Research in the Public Interest [200903045]; National Basic Research Program of China [2010CB126303]	Special Fund for Agro-scientific Research in the Public Interest; National Basic Research Program of China(National Basic Research Program of China)	Funding was provided by the grants from the Special Fund for Agro-scientific Research in the Public Interest (200903045) and National Basic Research Program of China (2010CB126303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Chen X.L., 1982, MONOGRAPHS CYPRINIDA; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; Gorr TA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P733, DOI 10.1086/648581; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jia ZY, 2006, MOL ECOL NOTES, V6, P1141, DOI 10.1111/j.1471-8286.2006.01464.x; Jia Zhi-Ying, 2008, Yichuan, V30, P1459, DOI 10.3724/SP.J.1005.2008.01459; JOHNSTON IA, 1983, J EXP BIOL, V104, P73; KNOX D, 1980, MAR BIOL, V56, P7, DOI 10.1007/BF00390588; Kuroshu RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010517; Li FB, 2008, ANIM GENET, V39, P28, DOI 10.1111/j.1365-2052.2007.01671.x; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; Shan Yunfeng, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-49; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; VORNANEN M, 1994, CAN J ZOOL, V72, P433, DOI 10.1139/z94-061; Vornanen M, 2009, FISH PHYSIOL, V27, P397, DOI 10.1016/S1546-5098(08)00009-5; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang J, 2008, SCI CHINA SER C, V51, P544, DOI 10.1007/s11427-008-0070-4; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang Zhong-Wei, 2011, BMC Res Notes, V4, P82, DOI 10.1186/1756-0500-4-82; Xiao J, 2010, BMC GENET, V12, pe20; Yue GH, 2002, MOL ECOL NOTES, V2, P534, DOI 10.1046/j.1471-8286.2002.00308.x; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zheng XH, 2010, BIOCHEM GENET, V48, P624, DOI 10.1007/s10528-010-9344-1; Zhong XP, 2009, COMP BIOCHEM PHYS B, V152, P161, DOI 10.1016/j.cbpb.2008.10.013	38	76	83	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62308	10.1371/journal.pone.0062308	http://dx.doi.org/10.1371/journal.pone.0062308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630630	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500087
J	Mitrpant, C; Porensky, P; Zhou, HY; Price, L; Muntoni, F; Fletcher, S; Wilton, SD; Burghes, AHM				Mitrpant, Chalermchai; Porensky, Paul; Zhou, Haiyan; Price, Loren; Muntoni, Francesco; Fletcher, Sue; Wilton, Steve D.; Burghes, Arthur H. M.			Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy	PLOS ONE			English	Article							SURVIVAL-MOTOR-NEURON; DELIVERY; EXON; ELEMENT; PROTEIN; RESCUE; LENGTH; MICE	Spinal muscular atrophy (SMA) is caused by loss of the Survival Motor Neuron 1 (SMN1) gene, resulting in reduced SMN protein. Humans possess the additional SMN2 gene (or genes) that does produce low level of full length SMN, but cannot adequately compensate for loss of SMN1 due to aberrant splicing. The majority of SMN2 gene transcripts lack exon 7 and the resultant SMND7 mRNA is translated into an unstable and non-functional protein. Splice intervention therapies to promote exon 7 retention and increase amounts of full-length SMN2 transcript offer great potential as a treatment for SMA patients. Several splice silencing motifs in SMN2 have been identified as potential targets for antisense oligonucleotide mediated splice modification. A strong splice silencer is located downstream of exon 7 in SMN2 intron 7. Antisense oligonucleotides targeting this motif promoted SMN2 exon 7 retention in the mature SMN2 transcripts, with increased SMN expression detected in SMA fibroblasts. We report here systematic optimisation of phosphorodiamidate morpholino oligonucleotides (PMO) that promote exon 7 retention to levels that rescued the phenotype in a severe mouse model of SMA after intracerebroventricular delivery. Furthermore, the PMO gives the longest survival reported to date after a single dosing by ICV.	[Mitrpant, Chalermchai; Price, Loren; Fletcher, Sue; Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, QE Med Ctr 2, Perth, WA 6009, Australia; [Mitrpant, Chalermchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Porensky, Paul] Wexner Ohio State Univ, Med Ctr, Dept Neurol Surg, Columbus, OH USA; [Zhou, Haiyan; Muntoni, Francesco] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Zhou, Haiyan; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Burghes, Arthur H. M.] Wexner Ohio State Univ, Med Ctr, Dept Mol & Cellular Biochem & Neurol, Columbus, OH USA	University of Western Australia; Mahidol University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Mitrpant, C (corresponding author), Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, QE Med Ctr 2, Perth, WA 6009, Australia.	chalermchai.mitrpant@uwa.edu.au; burghes.1@osu.edu	Mitrpant, Chalermchai/HDN-9842-2022; Mitrpant, Chalermchai/AAX-6699-2021	Mitrpant, Chalermchai/0000-0001-9311-7977; Burghes, Arthur/0000-0001-9031-1555; Fletcher, Sue/0000-0002-8632-641X; Wilton, Steve/0000-0002-9400-893X; Flynn, Loren/0000-0001-5249-547X	National Institutes of Health [R01 HD060586, RC2 NS069476]; AFM/SMA Europe; Spinal Muscular Atrophy Association of Australia; Parry Foundation of Australia; Thailand Research Fund [MRG5580095]; UCL Therapeutic Innovation Fund; Wellcome Trust [097815/Z/11/Z]; UCL Biomedical Research Centre [CBRC 161]; Department of Neurosurgery residency program at Ohio State University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Great Ormond Street Hospital Children's Charity; ICH/GOSH Biomedical Research Centre; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFM/SMA Europe; Spinal Muscular Atrophy Association of Australia; Parry Foundation of Australia; Thailand Research Fund(Thailand Research Fund (TRF)); UCL Therapeutic Innovation Fund; Wellcome Trust(Wellcome TrustEuropean Commission); UCL Biomedical Research Centre; Department of Neurosurgery residency program at Ohio State University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Great Ormond Street Hospital Children's Charity; ICH/GOSH Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health R01 HD060586 (AHMB), RC2 NS069476 (AHMB), AFM/SMA Europe (SDW), the Spinal Muscular Atrophy Association of Australia and the Parry Foundation of Australia (SDW) and Thailand Research Fund MRG5580095 (CM), UCL Therapeutic Innovation Fund, the Wellcome Trust Institutional Strategic Support Fund (Grant reference 097815/Z/11/Z) and UCL Biomedical Research Centre (Grant reference CBRC 161), and the Wellcome Trust Value in People awarded grant to HZ (Grant code FPEG). PP was supported by the Department of Neurosurgery residency program at Ohio State University. CM was supported by a Chalermprakiat grant from Faculty of Medicine, Siriraj Hospital, Mahidol University. FM is supported by Great Ormond Street Hospital Children's Charity and the ICH/GOSH Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-57; Bebee TW, 2010, FRONT BIOSCI-LANDMRK, V15, P1191, DOI 10.2741/3670; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2010, BIOCHEM BIOPH RES CO, V391, P835, DOI 10.1016/j.bbrc.2009.11.148; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gebski BL, 2003, HUM MOL GENET, V12, P1801, DOI 10.1093/hmg/ddg196; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Mitrpant C, 2009, MOL THER, V17, P1418, DOI 10.1038/mt.2009.49; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Zhou H, 2013, HUMAN GENE THERAPY	32	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62114	10.1371/journal.pone.0062114	http://dx.doi.org/10.1371/journal.pone.0062114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630626	Green Published, gold			2022-12-25	WOS:000317911500081
J	Whitehead, H; Jonsen, ID				Whitehead, Hal; Jonsen, Ian D.			Inferring Animal Densities from Tracking Data Using Markov Chains	PLOS ONE			English	Article								The distributions and relative densities of species are keys to ecology. Large amounts of tracking data are being collected on a wide variety of animal species using several methods, especially electronic tags that record location. These tracking data are effectively used for many purposes, but generally provide biased measures of distribution, because the starts of the tracks are not randomly distributed among the locations used by the animals. We introduce a simple Markov-chain method that produces unbiased measures of relative density from tracking data. The density estimates can be over a geographical grid, and/or relative to environmental measures. The method assumes that the tracked animals are a random subset of the population in respect to how they move through the habitat cells, and that the movements of the animals among the habitat cells form a time-homogenous Markov chain. We illustrate the method using simulated data as well as real data on the movements of sperm whales. The simulations illustrate the bias introduced when the initial tracking locations are not randomly distributed, as well as the lack of bias when the Markov method is used. We believe that this method will be important in giving unbiased estimates of density from the growing corpus of animal tracking data.	[Whitehead, Hal; Jonsen, Ian D.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Whitehead, H (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	hwhitehe@dal.ca		Jonsen, Ian/0000-0001-5423-6076	Natural Sciences and Engineering Research Council of Canada; International Whaling Commission; Cetacean Society International; Whale and Dolphin Conservation Society	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); International Whaling Commission; Cetacean Society International; Whale and Dolphin Conservation Society	The sperm whale field research was funded by the Natural Sciences and Engineering Research Council of Canada, the International Whaling Commission, Cetacean Society International, and the Whale and Dolphin Conservation Society, and was carried out under permits from the Galapagos National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; CHATFIELD C, 1973, ROY STAT SOC C-APP, V22, P7; Croxall J, 2004, GLOB PROC TRACK WORK; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Pedersen MW, 2011, OIKOS, V120, P1281, DOI 10.1111/j.1600-0706.2011.19044.x; Stroock D. W., 2005, INTRO MARKOV PROCESS; Turchin Peter, 1998; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H., 1986, REPORTS INT WHALING, V8, P149	10	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60901	10.1371/journal.pone.0060901	http://dx.doi.org/10.1371/journal.pone.0060901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630574	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500008
J	Chaidir, L; Parwati, I; Annisa, J; Muhsinin, S; Meilana, I; Alisjahbana, B; van Crevel, R				Chaidir, Lidya; Parwati, Ida; Annisa, Jessi; Muhsinin, Soni; Meilana, Intan; Alisjahbana, Bachti; van Crevel, Reinout			Implementation of LED Fluorescence Microscopy for Diagnosis of Pulmonary and HIV-Associated Tuberculosis in a Hospital Setting in Indonesia	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; MYCOBACTERIUM-TUBERCULOSIS; SENSITIVITY; PREVALENCE	Background: Fluorescence microscopy (FM) has not been implemented widely in TB endemic settings and little evaluation has been done in HIV-infected patients. We evaluated diagnostic performance, time and costs of FM with light-emitting diodes technology (LED-FM), compared with conventional (Zieh-Neelsen) microscopy in a hospital in Indonesia which acts as referral centre for HIV-infected patients. Method: We included pulmonary tuberculosis suspects from the outpatient and HIV clinic. Direct and concentrated sputum smears were examined using LED-FM and ZN microscopy by two technicians who were blinded for the HIV-status and the result of the comparative test. Mean reading time per slide was recorded and cost of each slide was calculated. Mycobacteria culture served as the reference standard. Results: Among 404 tuberculosis suspects from the outpatient clinic and 256 from the HIV clinic, mycobacteria culture was positive in 12.6% and 27%, respectively. The optimal sensitivity of LED-FM was achieved by using a threshold of >= 2 AFB/length. LED-FM had a higher sensitivity (75.5% vs. 54.9%, P<0.01) but lower specificity (90.0% vs 96.6%, P<0.01) compared to ZN microscopy. HIV was associated with a lower sensitivity but similar specificity. The average reading time using LED-FM was significantly shorter (2.23 +/- 0.78 vs 5.82 +/- 1.60 minutes, P<0.01), while costs per slide were similar. Conclusion: High sensitivity of LED-FM combined with shorter reading time of sputum smear slides make this method a potential alternative to ZN microscopy. Additional data on specificity are needed for effective implementation of this technique in high burden TB laboratories.	[Chaidir, Lidya; Annisa, Jessi; Muhsinin, Soni; Meilana, Intan; Alisjahbana, Bachti] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Parwati, Ida] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Clin Pathol, Bandung, Indonesia; [van Crevel, Reinout] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Chaidir, L (corresponding author), Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia.	lidya.chaidir@gmail.com	van Crevel, reinout/A-6636-2010; Muhsinin, Soni/U-9983-2019; Muhsinin, Soni/AAD-7905-2021; CHAIDIR, LIDYA/GSM-8277-2022	van Crevel, reinout/0000-0002-6233-6410; Parwati, Ida/0000-0002-9700-589X	Indonesian ministry of education and culture; VIDI from the Netherlands Organization for Scientific Research (NWO) [017.106.310]; IMPACT; European Commission [SANTE/2005/105-033]	Indonesian ministry of education and culture(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); VIDI from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); IMPACT(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Lidya Chaidir has a fellowship from the Indonesian ministry of education and culture. Reinout van Crevel has a VIDI-grant from the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl; 017.106.310). This study was financially supported by IMPACT, a 5-year HIV program supported by the European Commission (SANTE/2005/105-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Alvarez-Uria Gerardo, 2012, Tuberc Res Treat, V2012, P932862, DOI 10.1155/2012/932862; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020175; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Habtamu M, 2012, INT J TUBERC LUNG D, V16, P402, DOI 10.5588/ijtld.10.0762; Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Mahendradhata Y, 2008, T ROY SOC TROP MED H, V102, P1003, DOI 10.1016/j.trstmh.2008.04.042; Matee M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-68; Minion J, 2011, J CLIN MICROBIOL, V49, P2024, DOI 10.1128/JCM.00507-11; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Prasanthi K, 2005, Indian J Med Microbiol, V23, P179; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Shenai S, 2011, INT J TUBERC LUNG D, V15, P483, DOI 10.5588/ijtld.10.0229; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Van Deun A, 2002, INT J TUBERC LUNG D, V6, P222; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; Whitelaw A, EUR RESP J; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2007, PROP REV CAS DEF SPU; World Health Organization Policy Statement, 2011, FLUOR LIGHT EM DIOD	27	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61727	10.1371/journal.pone.0061727	http://dx.doi.org/10.1371/journal.pone.0061727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620787	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500067
J	Khowawisetsut, L; Pattanapanyasat, K; Onlamoon, N; Mayne, AE; Little, DM; Villinger, F; Ansari, AA				Khowawisetsut, Ladawan; Pattanapanyasat, Kovit; Onlamoon, Nattawat; Mayne, Ann E.; Little, Dawn M.; Villinger, Francois; Ansari, Aftab A.			Relationships between IL-17(+) Subsets, Tregs and pDCs That Distinguish among SIV Infected Elite Controllers, Low, Medium and High Viral Load Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; AIDS PROGRESSION; HIV-1 INFECTION; LYMPHOID-TISSUE; NK CELLS; ACTIVATION	Comprehensive studies of the frequencies and absolute numbers of the various cell lineages that synthesize IL-17 in the blood and corresponding gastrointestinal (GI) tissues, their correlation with CD4(+) Tregs, CD8(+) Tregs, total and IFN-alpha synthesizing plasmacytoid dendritic cells (pDC) relative to plasma viral load in SIV infection has been lacking. The unique availability of SIV infected rhesus macaques (RM) classified as Elite Controllers (EC), and those with Low, Intermediate and High Viral Loads (HVL) provided a unique opportunity to address this issue. Results of these studies showed that EC demonstrated a remarkable ability to reverse changes that are induced acutely by SIV in the various cell lineages. Highlights of the differences between EC and HVL RM within Gastro-intestinal tissues (GIT) was the maintenance and/or increases in the levels of IL-17 synthesizing CD4, CD8, and NK cells and pDCs associated with slight decreases in the levels of CD4(+) Tregs and IFN-alpha synthesizing pDCs in EC as compared with decreases in the levels of IL-17 synthesizing CD4, CD8 and NK cells associated with increases in pDCs and IFN-alpha synthesizing pDCs in HVL monkeys. A previously underappreciated role for CD8(+) Tregs was also noted with a moderate increase in ECs but further increases of CD8(+) Tregs with increasing VL in viremic monkeys. Positive correlations between plasma VL and decreases in the levels of Th17, Tc17, NK-17, CD4(+) Tregs and increases in the levels of CD8(+) Tregs, total and IFN-alpha synthesizing pDCs were also noted. This study also identified 2 additional IL-17(+) subsets in GIT as CD3(-)2/CD8(+)/NKG2a(-) 2 and CD3(+)/CD8(+)/NKG2a(+) subsets. Studies also suggest a limited role for IFN-alpha synthesizing pDCs in chronic immune activation despite persistent up-regulation of ISGs. Finally, elevated persistent innate immune responses appear associated with poor prognosis. These findings provide an initial foundation for markers important to follow for vaccine design.	[Khowawisetsut, Ladawan; Mayne, Ann E.; Little, Dawn M.; Villinger, Francois; Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Khowawisetsut, Ladawan; Pattanapanyasat, Kovit; Onlamoon, Nattawat] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Pattanapanyasat, Kovit; Onlamoon, Nattawat] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand; [Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA 30322 USA	Emory University; Mahidol University; Mahidol University; Emory University	Pattanapanyasat, K (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.	kovit.pat@mahidol.ac.th; pathaaa@emory.edu	Khowawisetsut, Ladawan/GLR-7783-2022; Onlamoon, Nattawat/AAR-8390-2020	Khowawisetsut, Ladawan/0000-0003-1585-495X; Onlamoon, Nattawat/0000-0002-8784-3005	Thailand Research Fund (TRF)-The Royal Golden Jubilee Ph.D. Program [PHD/0198/2550]; National Institutes of Health-National Institute of Allergy and Infectious Diseases [RO1 AI078773, OD 51POD1113]; TRF, Senior Research Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098628, R01AI078773] Funding Source: NIH RePORTER	Thailand Research Fund (TRF)-The Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TRF, Senior Research Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Ms. Ladawan Khowawisetsut was financially supported by a fellowship from the Thailand Research Fund (TRF)-The Royal Golden Jubilee Ph.D. Program (PHD/0198/2550), and the studies reported above are in partial fulfillment of her doctoral thesis. Professor Kovit Pattanapanyasat is the recipient of the TRF, Senior Research Scholar Award. Supported by a grant from the National Institutes of Health-National Institute of Allergy and Infectious Diseases RO1 AI078773 and OD 51POD1113 to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Benlahrech A, 2011, CURR OPIN HIV AIDS, V6, P373, DOI 10.1097/COH.0b013e328349592a; Bostik Pavel, 2010, HIV Therapy, V4, P483, DOI [10.2217/hiv.10.28, 10.2217/HIV.10.28]; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chevalier MF, 2012, BLOOD; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Diop OM, 2008, J VIROL, V82, P5145, DOI 10.1128/JVI.02433-07; Donhauser N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033925; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Gol-Ara M, 2012, ARTHRITIS, DOI 10.1155/2012/805875; Goubier A, 2012, J INVEST DERMATOL; Gougeon ML, 2012, EXP CELL RES, V318, P1260, DOI 10.1016/j.yexcr.2012.03.012; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; HEISE C, 1994, J INFECT DIS, V169, P1116, DOI 10.1093/infdis/169.5.1116; Hughes R, 2012, REV MED VIROL, V22, P257, DOI 10.1002/rmv.1708; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Jeron A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-705; Kader M, 2009, J MED PRIMATOL, V38, P32, DOI 10.1111/j.1600-0684.2009.00373.x; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Kwa S, 2011, BLOOD, V118, P2763, DOI 10.1182/blood-2011-02-339515; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Levy JA, 2012, AIDS RES HUM RETROV, V7, P7; Machmach K, 2012, J VIROL, V86, P4245, DOI 10.1128/JVI.07114-11; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mattapallil JJ, 1999, J VIROL, V73, P6661, DOI 10.1128/JVI.73.8.6661-6669.1999; Matzinger SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029255; Micci L, 2012, BLOOD, V120, P3925, DOI 10.1182/blood-2012-04-420240; Moanna Abeer, 2005, Curr HIV/AIDS Rep, V2, P16, DOI 10.1007/s11904-996-0004-3; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; O'Brien M, 2013, ADV EXP MED BIOL, V762, P71, DOI 10.1007/978-1-4614-4433-6_3; Pitha PM, 2011, VIRUSES-BASEL, V3, P1179, DOI 10.3390/v3071179; Ploquin MJY, 2012, AIDS, V26, P1269, DOI 10.1097/QAD.0b013e328353e46b; Qin SL, 2008, J IMMUNOL, V180, P5530, DOI 10.4049/jimmunol.180.8.5530; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reeves RK, 2012, J INFECT DIS, V206, P1462, DOI 10.1093/infdis/jis408; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Reeves RK, 2011, J IMMUNOL METHODS, V367, P95, DOI 10.1016/j.jim.2011.02.002; Rosenzweig M, 2000, J IMMUNOL, V165, P3461, DOI 10.4049/jimmunol.165.6.3461; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saito S, 2007, SEMIN IMMUNOPATHOL, V29, P115, DOI 10.1007/s00281-007-0067-2; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Vanderford TH, 2012, BLOOD, V119, P5750, DOI 10.1182/blood-2012-02-411496; VILLINGER F, 1993, CYTOKINE, V5, P469, DOI 10.1016/1043-4666(93)90038-7; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wack A, 2011, CURR OPIN VIROL, V1, P184, DOI 10.1016/j.coviro.2011.05.015; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Wonderlich ER, 2011, IMMUNOL RES, V50, P228, DOI 10.1007/s12026-011-8220-3; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Ye J, 2012, AM J PATHOL; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038; Zeng M, 2012, TRENDS IMMUNOL, V33, P306, DOI 10.1016/j.it.2012.04.002	67	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61264	10.1371/journal.pone.0061264	http://dx.doi.org/10.1371/journal.pone.0061264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620737	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500017
J	Walline, CC; Sehra, S; Fisher, AJ; Guindon, LM; Kratzke, IM; Montgomery, JB; Lipking, KP; Glosson, NL; Benson, HL; Sandusky, GE; Wilkes, DS; Brutkiewicz, RR; Kaplan, MH; Blum, JS				Walline, Crystal C.; Sehra, Sarita; Fisher, Amanda J.; Guindon, Lynette M.; Kratzke, Ian M.; Montgomery, Jessica B.; Lipking, Kelsey P.; Glosson, Nicole L.; Benson, Heather L.; Sandusky, George E.; Wilkes, David S.; Brutkiewicz, Randy R.; Kaplan, Mark H.; Blum, Janice S.			Allergic Airway Disease in Mice Alters T and B Cell Responses during an Acute Respiratory Poxvirus Infection	PLOS ONE			English	Article							VACCINIA VIRUS-INFECTION; SYNCYTIAL VIRUS; IN-VIVO; IMMUNE-RESPONSES; VIRAL-INFECTIONS; IFN-GAMMA; ASTHMA; IL-10; ANTIGEN; INTERLEUKIN-10	Pulmonary viral infections can exacerbate or trigger the development of allergic airway diseases via multiple mechanisms depending upon the infectious agent. Respiratory vaccinia virus transmission is well established, yet the effects of allergic airway disease on the host response to intra-pulmonary vaccinia virus infection remain poorly defined. As shown here BALB/c mice with preexisting airway disease infected with vaccinia virus developed more severe pulmonary inflammation, higher lung virus titers and greater weight loss compared with mice inoculated with virus alone. This enhanced viremia was observed despite increased pulmonary recruitment of CD8(+) T effectors, greater IFN gamma production in the lung, and high serum levels of anti-viral antibodies. Notably, flow cytometric analyses of lung CD8(+) T cells revealed a shift in the hierarchy of immunodominant viral epitopes in virus inoculated mice with allergic airway disease compared to mice treated with virus only. Pulmonary IL-10 production by T cells and antigen presenting cells was detected following virus inoculation of animals and increased dramatically in allergic mice exposed to virus. IL-10 modulation of host responses to this respiratory virus infection was greatly influenced by the localized pulmonary microenvironment. Thus, blocking IL-10 signaling in virus-infected mice with allergic airway disease enhanced pulmonary CD4(+) T cell production of IFN gamma and increased serum antiviral IgG1 levels. In contrast, pulmonary IFN gamma and virus-specific IgG1 levels were reduced in vaccinia virus-treated mice with IL-10 receptor blockade. These observations demonstrate that pre-existing allergic lung disease alters the quality and magnitude of immune responses to respiratory poxviruses through an IL-10-dependent mechanism.	[Walline, Crystal C.; Guindon, Lynette M.; Kratzke, Ian M.; Montgomery, Jessica B.; Glosson, Nicole L.; Brutkiewicz, Randy R.; Kaplan, Mark H.; Blum, Janice S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA; [Sehra, Sarita; Glosson, Nicole L.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN USA; [Fisher, Amanda J.; Benson, Heather L.; Wilkes, David S.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN USA; [Lipking, Kelsey P.; Sandusky, George E.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Blum, JS (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA.	jblum@iupui.edu	Kratzke, Ian/AAB-2711-2021; Walline, Crystal/M-8815-2019; Walline, Crystal/H-9514-2018	Kratzke, Ian/0000-0001-6849-4412; Walline, Crystal/0000-0002-0116-7991; Brutkiewicz, Randy/0000-0002-7396-480X; Kaplan, Mark/0000-0002-2923-8245	United States National Institutes of Health [PO1 AI056097, T32 HL007910, R01 AI46455, U19 AI070448, R01 AI095282, P30 DK090948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046455, U19AI070448, P01AI056097, R01AI057459, R01AI079065, R01AI095282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the United States National Institutes of Health under award numbers PO1 AI056097; T32 HL007910 (C.C.W.); R01 AI46455 (R.R.B.); U19 AI070448 and R01 AI095282 (M. H. K.); P30 DK090948 (J.S.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2012, TOXICOL SCI; Anderson VE, 2009, VIROLOGY, V391, P25, DOI 10.1016/j.virol.2009.06.009; Barends M, 2004, CLIN EXP ALLERGY, V34, P488, DOI 10.1111/j.1365-2222.2004.01906.x; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Chattopadhyay PK, 2008, CYTOM PART A, V73A, P1001, DOI 10.1002/cyto.a.20642; Cohen ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020597; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dai HH, 2010, J IMMUNOL, V185, P803, DOI 10.4049/jimmunol.1000661; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Dulek DE, 2011, BBA-GEN SUBJECTS, V1810, P1080, DOI 10.1016/j.bbagen.2011.01.012; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Hales BJ, 2008, THORAX, V63, P221, DOI 10.1136/thx.2006.069492; Hansen SJ, 2011, VIROLOGY, V412, P411, DOI 10.1016/j.virol.2011.01.024; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jackson DJ, 2010, IMMUNOL ALLERGY CLIN, V30, P513, DOI 10.1016/j.iac.2010.08.004; John AE, 2005, EUR J IMMUNOL, V35, P108, DOI 10.1002/eji.200425439; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kloepfer KM, 2010, IMMUNOL ALLERGY CLIN, V30, P553, DOI 10.1016/j.iac.2010.08.002; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481; LIGHTWOOD R, 1970, J PEDIATR-US, V77, P59, DOI 10.1016/S0022-3476(70)80045-2; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; Marsland BJ, 2004, CLIN EXP ALLERGY, V34, P1299, DOI 10.1111/j.1365-2222.2004.02021.x; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Melgert BN, 2010, AM J RESP CELL MOL, V42, P595, DOI 10.1165/rcmb.2009-0016OC; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Papadopoulos NG, 1998, THORAX, V53, P913, DOI 10.1136/thx.53.11.913; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Reading PC, 2003, J GEN VIROL, V84, P1973, DOI 10.1099/vir.0.19285-0; SCHEIFELE DW, 1972, PEDIATRICS, V50, P867; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; Spesock AH, 2011, VIROLOGY, V417, P87, DOI 10.1016/j.virol.2011.05.010; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Telcian AG, 2011, J INFECT DIS, V203, P85, DOI 10.1093/infdis/jiq020; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764; Wertheimer ER, 2012, VACCINE, V30, P985, DOI 10.1016/j.vaccine.2011.12.049; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Zdrenghea MT, 2012, MICROBES INFECT, V14, P495, DOI 10.1016/j.micinf.2012.01.002	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62222	10.1371/journal.pone.0062222	http://dx.doi.org/10.1371/journal.pone.0062222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620814	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500094
J	Zhu, P; Lin, H; Han, Y; Lin, Y; Xu, Y; Zhang, ZQ				Zhu, Ping; Lin, Han; Han, Yi; Lin, Yi; Xu, Yue; Zhang, Zhaoqiang			A Computational Fluid Dynamic Analysis of Peri-Bracket Salivary Flow Influencing the Microbial and Periodontal Parameters	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ADHESION; COLONIZATION; PLAQUE	Fixed vestibular appliances decrease the "self-cleansing" action of saliva and promote aggregation of dental plaque by disturbing the salivary flow field on tooth surfaces, leading to a higher prevalence of enamel demineralization and periodontal diseases. In the current study, we investigated the salivary dynamic characteristics of plaque retention and periodontal status around appliances during orthodontic treatment. By reconstructing lower central incisors and orthodontic appliances, we simulated saliva flow on the tooth surface and then characterized and quantified the salivary flow pattern surrounding the bracket and archwire. In parallel, we tested the total peri-bracket bacterial counts and periodontal status to assess interrelations. Our results demonstrate that orthodontic appliances disturb the salivary flow field on tooth surfaces and can lead to a decrease in salivary velocity and an increase in bacterial numbers. Local vortexes forming in the areas gingival to the bracket, together with the narrow space limitation, contributed to the periodontal inflammatory response. This study confirms that changes in salivary flow are an obvious predisposing factor for bacterial accumulation, and advances the ability to replicate, in vitro, the salivary characteristics of plaque retention and periodontal status around appliances during orthodontic treatment.	[Zhu, Ping; Lin, Han; Lin, Yi; Xu, Yue] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangdong Prov Key Lab Stomatol, Dept Orthodont,Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Han, Yi] Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhaoqiang] Hosp Stomatol, Guangzhou Med Coll, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Xu, Y (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangdong Prov Key Lab Stomatol, Dept Orthodont,Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	kou9315@hotmail.com	Zhang, Zhaoqiang/AAE-3664-2019; 兆强, 张/GRJ-1212-2022; Xu, yue/HGE-1737-2022; Lin, Yi/AHA-3225-2022	Zhang, Zhaoqiang/0000-0002-9183-7273; 兆强, 张/0000-0002-9183-7273; Lin, Yi/0000-0003-2875-7542	Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091100453]; National Natural Science Foundation of China [81271115]; Science Foundation of the Key Hospital Clinical Program of the Ministry of China [2010-439]	Special Project on the Integration of Industry, Education and Research of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Key Hospital Clinical Program of the Ministry of China	Funding was provided by (1) Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091100453), http://pro.gdstc.gov.cn/stms/main.jsp; (2) The National Natural Science Foundation of China (81271115), http://www.nsfc.gov.cn/Portal0/default152.htm; and (3) The Science Foundation of the Key Hospital Clinical Program of the Ministry of China (2010-439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2012, J ORAL SCI, V54, P293, DOI 10.2334/josnusd.54.293; DAWES C, 1989, J DENT RES, V68, P1483, DOI 10.1177/00220345890680110301; Ertekin C, 2011, DYSPHAGIA, V26, P183, DOI 10.1007/s00455-010-9319-8; Faltermeier A, 2008, AM J ORTHOD DENTOFAC, V133, pS99, DOI 10.1016/j.ajodo.2007.03.024; Haddad Ana Cristina Soares Santos, 2009, Braz. oral res., V23, P399; HILLAM DG, 1977, J CLIN PERIODONTOL, V4, P56, DOI 10.1111/j.1600-051X.1977.tb01883.x; MATTINGLY JA, 1983, J DENT RES, V62, P1209, DOI 10.1177/00220345830620120601; Naranjo AA., 2006, AM J ORTHOD DENTOFAC, V130, p275., DOI 10.1016/j.ajodo.2005.10.022; Otsuki T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-91; Ristic M, 2008, Int J Dent Hyg, V6, P129, DOI 10.1111/j.1601-5037.2008.00283.x; Rodriguez-Hernandez AG, 2011, J MATER SCI-MATER M, V22, P1913, DOI 10.1007/s10856-011-4366-8; Skold-Larsson K, 2012, ACTA ODONTOL SCAND; Sukontapatipark W, 2001, EUR J ORTHODONT, V23, P475, DOI 10.1093/ejo/23.5.475; Surlin P, 2012, ROM J MORPHOL EMBRYO, V53, P161; Surlin P, 2010, ROM J MORPHOL EMBRYO, V51, P515; Tenuta Livia Maria Andalo, 2003, Pesqui Odontol Bras, V17, P326; Turkkahraman H, 2005, ANGLE ORTHOD, V75, P231; van Gastel J, 2009, ANGLE ORTHOD, V79, P915, DOI 10.2319/092908-507.1; Xu Y, 2012, LARYNGOSCOPE, V122, P1051, DOI 10.1002/lary.23226; Yang IH, 2011, ANGLE ORTHOD, V81, P326, DOI 10.2319/062210-343.1	20	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62242	10.1371/journal.pone.0062242	http://dx.doi.org/10.1371/journal.pone.0062242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620815	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500095
J	Bubenik, JL; Miniard, AC; Driscoll, DM				Bubenik, Jodi L.; Miniard, Angela C.; Driscoll, Donna M.			Alternative Transcripts and 3 ' UTR Elements Govern the Incorporation of Selenocysteine into Selenoprotein S	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA EXPRESSION; SERUM AMYLOID-A; THIOREDOXIN REDUCTASE; BINDING PROTEIN; HEPG2 CELLS; UGA CODONS; INFLAMMATORY RESPONSE; GENE-EXPRESSION; ADIPOSE-TISSUE	Selenoprotein S (SelS) is a 189 amino acid trans-membrane protein that plays an important yet undefined role in the unfolded protein response. It has been proposed that SelS may function as a reductase, with the penultimate selenocysteine (Sec(188)) residue participating in a selenosulfide bond with cysteine (Cys(174)). Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript. Here we identify multiple mechanisms that regulate the expression of SelS. The human SelS gene encodes two transcripts (variants 1 and 2), which differ in their 3'UTR sequences due to an alternative splicing event that removes the SECIS element from the variant 1 transcript. Both transcripts are widely expressed in human cell lines, with the SECIS-containing variant 2 mRNA being more abundant. In vitro experiments demonstrate that the variant 1 3'UTR does not allow readthrough of the UGA/Sec codon. Thus, this transcript would produce a truncated protein that does not contain Sec and cannot make the selenosulfide bond. While the variant 2 3'UTR does support Sec insertion, its activity is weak. Bioinformatic analysis revealed two highly conserved stem-loop structures, one in the proximal part of the variant 2 3'UTR and the other immediately downstream of the SECIS element. The proximal stem-loop promotes Sec insertion in the native context but not when positioned far from the UGA/Sec codon in a heterologous mRNA. In contrast, the 140 nucleotides downstream of the SECIS element inhibit Sec insertion. We also show that endogenous SelS is enriched at perinuclear speckles, in addition to its known localization in the endoplasmic reticulum. Our results suggest the expression of endogenous SelS is more complex than previously appreciated, which has implications for past and future studies on the function of this protein.	[Bubenik, Jodi L.; Miniard, Angela C.; Driscoll, Donna M.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Driscoll, Donna M.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Bubenik, JL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	bubenij@ccf.org; driscod@ccf.org			National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK078591]; American Heart Association Great Rivers Affiliate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078591] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Great Rivers Affiliate(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant number DK078591 (DMD) and a post-doctoral fellowship from the American Heart Association Great Rivers Affiliate (JLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Carlson BA, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P23; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Donovan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035581; Driscoll DM, 2004, EMBO REP, V5, P140, DOI 10.1038/sj.embor.7400080; Du JL, 2008, CHINESE MED J-PEKING, V121, P1165, DOI 10.1097/00029330-200807010-00003; Du SQ, 2010, BBA-GEN SUBJECTS, V1800, P511, DOI 10.1016/j.bbagen.2010.01.005; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fletcher JE, 2001, RNA, V7, P1442; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; Fradejas N, 2008, J MOL NEUROSCI, V35, P259, DOI 10.1007/s12031-008-9069-3; Fradejas N, 2011, GLIA, V59, P959, DOI 10.1002/glia.21168; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gao Y, 2003, DIABETES, V52, P929, DOI 10.2337/diabetes.52.4.929; Gao Y, 2007, BIOCHEM BIOPH RES CO, V356, P636, DOI 10.1016/j.bbrc.2007.03.018; Gasdaska JR, 1999, J BIOL CHEM, V274, P25379, DOI 10.1074/jbc.274.36.25379; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GUENZI S, 1994, EUR J IMMUNOL, V24, P2477, DOI 10.1002/eji.1830241033; Hofacker Ivo L., 2007, V395, P527; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Karlsson HKR, 2004, DIABETES, V53, P1424, DOI 10.2337/diabetes.53.6.1424; Kelly E, 2009, J BIOL CHEM, V284, P16891, DOI 10.1074/jbc.M109.006288; KEREM A, 1993, J BIOL CHEM, V268, P180; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; Seeher S, 2012, CURR PROTEIN PEPT SC, V13, P337, DOI 10.2174/138920312801619448; Seiderer J, 2007, TISSUE ANTIGENS, V70, P238, DOI 10.1111/j.1399-0039.2007.00888.x; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Xu XM, 2010, P NATL ACAD SCI USA, V107, P21430, DOI 10.1073/pnas.1009947107; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zeng JH, 2008, ARCH BIOCHEM BIOPHYS, V478, P1, DOI 10.1016/j.abb.2008.07.016	61	28	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62102	10.1371/journal.pone.0062102	http://dx.doi.org/10.1371/journal.pone.0062102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614019	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400153
J	Liao, LJ; Chou, HW; Wang, CT; Chung, CS; Lai, MS				Liao, Li-Jen; Chou, Hsu-Wen; Wang, Chi-Te; Chung, Chen-Shuan; Lai, Mei-Shu			The Impact of Second Primary Malignancies on Head and Neck Cancer Survivors: A Nationwide Cohort Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CURE FRACTION; PREVALENT	Background: Head and neck cancer (HNC) is associated with a high rate of developing second primary malignancies(SPMs). But the impact on survival remains poorly understood before. Therefore, we want to estimate the impact of SPMs on HNC survivors. Methods and Findings: Between 1986 and 2008, a total of 9,996 SPMs were recorded for 93,891 patients with an initial diagnosis of HNC by the Taiwan Cancer Registry. Patients were followed with national death registry database to 2011. Using the Kaplan-Meier method, a time-dependent covariate was employed to compare the survival rates between patients with and without SPMs. A Cox proportional hazards model that treated age and sex as confounders was used to examine the hazard ratios of SPMs. The relative survival rates were calculated using age-and sex-specific life tables for the population. Parametric mixture cure fraction models were then employed to estimate the percentage of cancer survivors who would be cured. Use of the Kaplan-Meier method showed that the crude survival rates differed significantly for patients with and patients without SPMs (log-rank test <0.01). For the results of Cox proportional hazards regression analysis, SPMs had a significant influence on survival rates with univariate (HR 2.59,95% CI 2.53to 2.65) and multivariate analysis (HR 2.34, 2.28 to 2.40). Patients with SPMs of nasopharyngeal carcinoma (NPC) had the highest cure rate at 39%, where as esophageal and lung cancer had the worst prognosis, with a cure rate of 11%. Conclusions: A worse prognosis was found for second primary cancer such as esophageal or lung cancer. Patients and healthcare providers must strongly consider and have a high clinical suspicion of these SPMs.	[Liao, Li-Jen; Chou, Hsu-Wen; Wang, Chi-Te; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Liao, Li-Jen; Wang, Chi-Te] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chung, Chen-Shuan] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Ctr Comparat Effectiveness Res, Taipei, Taiwan	National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Lai, MS (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	mslai@ntu.edu.tw		Lai, Mei-shu/0000-0001-6130-3468	National Science Council of the Republic of China [NSC-100-2314-B418-005]; Far Eastern Memorial Hospital [FEMH - 2012 - C - 028]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Far Eastern Memorial Hospital	This study was supported by the National Science Council of the Republic of China (URL: http://web1.nsc.gov.tw/mp.aspx?mp=7, Grant NSC-100-2314-B418-005) and by grants from the Far Eastern Memorial Hospital (URL: http://hos.femh.org.tw/newfemh/NetFemhEn/index_about_xml.aspx?sub=5, Grant FEMH - 2012 - C - 028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Begg CB, 2002, JNCI-J NATL CANCER I, V94, P1044; Chen MC, 2011, J CANCER RES CLIN, V137, P115, DOI 10.1007/s00432-010-0865-0; Chen PT, 2011, JPN J CLIN ONCOL, V41, P1336, DOI 10.1093/jjco/hyr152; Chung CS, 2010, J FORMOS MED ASSOC, V109, P408, DOI 10.1016/S0929-6646(10)60072-1; De Angelis R, 1999, STAT MED, V18, P441, DOI 10.1002/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Forastiere AA, 2000, ONCOLOGY-NY, V14, P163; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Lambert PC, 2007, STATA J, V7, P351, DOI 10.1177/1536867X0700700304; Lambert PC, 2007, BIOSTATISTICS, V8, P576, DOI 10.1093/biostatistics/kxl030; LICCIARDELLO JTW, 1989, INT J RADIAT ONCOL, V17, P467, DOI 10.1016/0360-3016(89)90096-5; Morris LGT, 2011, CANCER CAUSE CONTROL, V22, P671, DOI 10.1007/s10552-011-9739-2; Morris LGT, 2011, J CLIN ONCOL, V29, P739, DOI 10.1200/JCO.2010.31.8311; Parkin DM, 1992, CANC INCIDENCE 5 CON, VVI; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rowland JH, 2006, J CLIN ONCOL, V24, P5101, DOI 10.1200/JCO.2006.09.2700; van der Schroeff MP, 2010, HEAD NECK-J SCI SPEC, V32, P1613, DOI 10.1002/hed.21369; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306	20	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62116	10.1371/journal.pone.0062116	http://dx.doi.org/10.1371/journal.pone.0062116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614023	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400155
J	Hennen, E; Safina, D; Haussmann, U; Worsdorfer, P; Edenhofer, F; Poetsch, A; Faissner, A				Hennen, Eva; Safina, Dina; Haussmann, Ute; Woersdoerfer, Philipp; Edenhofer, Frank; Poetsch, Ansgar; Faissner, Andreas			A LewisX Glycoprotein Screen Identifies the Low Density Lipoprotein Receptor-related Protein 1 (LRP1) as a Modulator of Oligodendrogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SIGNALING PATHWAY; CRE RECOMBINASE; NEURAL DEVELOPMENT; NERVOUS-SYSTEM; PROLIFERATION; MIGRATION; KNOCKOUT; NEURONS; CNS	In the developing and adult CNS multipotent neural stem cells reside in distinct niches. Specific carbohydrates and glycoproteins are expressed in these niche microenvironments which are important regulators of stem cell maintenance and differentiation fate. LewisX (LeX), also known as stage-specific embryonic antigen-1 or CD15, is a defined carbohydrate moiety expressed in niche microenvironments of the developing and adult CNS. LeX-glycans are involved in stem cell proliferation, migration, and stemness. A few LeX carrier proteins are known, but a systematic analysis of the targets of LeX glycosylation in vivo has not been performed so far. Using LeX glycosylation as a biomarker we aimed to discover new glycoproteins with a potential functional relevance for CNS development. By immunoaffinity chromatography we enriched LeX glycoproteins from embryonic and postnatal mouse brains and used one-dimensional nLC-ESI-MS/MS for their identification. We could validate phosphacan, tenascin-C, and L1-CAM as major LeX carrier proteins present in vivo. Furthermore, we identified LRP1, a member of theLDLreceptor family, as a new LeX carrier protein expressed by mouse neural stem cells. Surprisingly, little is known about LRP1 function for neural stem cells. Thus, we generated Lrp1 knock-out neural stem cells by Cre-mediated recombination and investigated their properties. Here, we provide first evidence that LRP1 is necessary for the differentiation of neural stem cells toward oligodendrocytes. However, this function is independent of LeX glycosylation.	[Hennen, Eva; Safina, Dina; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Haussmann, Ute; Poetsch, Ansgar] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany; [Woersdoerfer, Philipp; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, D-53105 Bonn, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Bonn	Faissner, A (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Univ Str 150,NDEF 05-593, D-44780 Bochum, Germany.	andreas.faissner@rub.de	Faissner, Andreas/A-5314-2008; Poetsch, Ansgar/A-1862-2013; Edenhofer, Frank/ABG-9458-2020	Faissner, Andreas/0000-0002-2211-8259; Poetsch, Ansgar/0000-0002-7540-3475; Edenhofer, Frank/0000-0002-6489-714X; Worsdorfer, Philipp/0000-0003-3398-3229	German Research Foundation Deutsche Forschungsgemeinschaft Grants [Fa 159/16-1, ED79/1-2]; Federal Ministry of Education and Research Grant [BMBF 01GN0503]	German Research Foundation Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Federal Ministry of Education and Research Grant	This work was supported by the German Research Foundation Deutsche Forschungsgemeinschaft Grants Fa 159/16-1 (to A. F.) and ED79/1-2 (to F. E.) and by the Federal Ministry of Education and Research Grant BMBF 01GN0503 (to A. F.).	BAZIN H, 1984, J IMMUNOL METHODS, V66, P261, DOI 10.1016/0022-1759(84)90337-5; BU GJ, 1994, J BIOL CHEM, V269, P18521; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Czopka T, 2009, CELL TISSUE RES, V338, P161, DOI 10.1007/s00441-009-0868-9; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Gan HT, 2011, J NEUROCHEM, V117, P565, DOI 10.1111/j.1471-4159.2011.07227.x; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Haussmann U, 2012, J PROTEOMICS, V75, P2649, DOI 10.1016/j.jprot.2012.03.005; Hennen E, 2012, INT J BIOCHEM CELL B, V44, P830, DOI 10.1016/j.biocel.2012.02.019; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Li YL, 2009, FEBS LETT, V583, P703, DOI 10.1016/j.febslet.2009.01.013; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Meng H, 2010, J BIOL CHEM, V285, P23045, DOI 10.1074/jbc.M110.144634; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Streit A, 1996, J NEUROCHEM, V66, P834; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	31	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16538	16545		10.1074/jbc.M112.419812	http://dx.doi.org/10.1074/jbc.M112.419812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615909	hybrid, Green Published			2022-12-25	WOS:000320378900030
J	Ajj, H; Chesnel, A; Pinel, S; Plenat, F; Flament, S; Dumond, H				Ajj, Hussein; Chesnel, Amand; Pinel, Sophie; Plenat, Francois; Flament, Stephane; Dumond, Helene			An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism	PLOS ONE			English	Article							ESTROGEN-RECEPTOR GPER; BREAST-CANCER CELLS; GERM-CELLS; DNA METHYLATION; BISPHENOL-A; TESTICULAR-TUMORS; EXPRESSION; NONYLPHENOL; RISK; RATS	Long chain alkylphenols are man-made compounds still present in industrial and agricultural processes. Their main use is domestic and they are widespread in household products, cleansers and cosmetics, leading to a global environmental and human contamination. These molecules are known to exert estrogen-like activities through binding to classical estrogen receptors. In vitro, they can also interact with the G-protein coupled estrogen receptor. Testicular germ cell tumor etiology and progression are proposed to be stimulated by lifelong estrogeno-mimetic exposure. We studied the transduction signaling pathways through which an alkyphenol mixture triggers testicular cancer cell proliferation in vitro and in vivo. Proliferation assays were monitored after exposure to a realistic mixture of 4-tert-octylphenol and 4-nonylphenol of either TCam-2 seminoma derived cells, NT2/D1 embryonal carcinoma cells or testis tumor in xenografted nude mice. Specific pharmacological inhibitors and gene-silencing strategies were used in TCam-2 cells in order to demonstrate that the alkylphenol mix triggers CREB-phosphorylation through a rapid, ER alpha 36-PI3kinase non genomic pathway. Microarray analysis of the mixture target genes revealed that this pathway can modulate the expression of the DNA-methyltransferase-3 (Dnmt3) gene family which is involved in DNA methylation control. Our results highlight a key role for ER alpha 36 in alkylphenol non genomic signaling in testicular germ cell tumors. Hence, ER alpha 36-dependent control of the epigenetic status opens the way for the understanding of the link between endocrine disruptor exposure and the burden of hormone sensitive cancers.	[Ajj, Hussein; Chesnel, Amand; Pinel, Sophie; Plenat, Francois; Flament, Stephane; Dumond, Helene] Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Dumond, H (corresponding author), Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, Vandoeuvre Les Nancy, France.	helene.dumond@univ-lorraine.fr		Dumond, Helene/0000-0002-9697-3901	ANSES [APR EST 08-09]; Syrian Government fellowship	ANSES; Syrian Government fellowship	This work was supported by ANSES (APR EST 08-09). HA is the recipient of a Syrian Government fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; Beiki O, 2010, CANCER EPIDEM BIOMAR, V19, P1053, DOI 10.1158/1055-9965.EPI-09-1190; Berner C, 2011, ANN NUTR METAB, V57, P183, DOI 10.1159/000321514; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Biswal BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053003; Borghese B, 2012, AM J PATHOL, V180, P1781, DOI 10.1016/j.ajpath.2012.01.009; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chevalier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034672; Cyriac Sanju, 2012, Indian J Hum Genet, V18, P119, DOI 10.4103/0971-6866.96679; Dobrzynska MM, 2012, DRUG CHEM TOXICOL, V35, P36, DOI 10.3109/01480545.2011.586036; Frassinetti S, 2011, ECOTOX ENVIRON SAFE, V74, P253, DOI 10.1016/j.ecoenv.2010.10.039; Fucic A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S8; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kilian E, 2007, ANDROLOGIA, V39, P128, DOI 10.1111/j.1439-0272.2007.00777.x; Kristensen DG, 2012, CANCER GENET-NY, V205, P425, DOI 10.1016/j.cancergen.2012.05.003; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Li ZY, 2012, TOXICOL IN VITRO, V26, P769, DOI 10.1016/j.tiv.2012.05.017; Liao HF, 2012, BIOL CELL, V104, P571, DOI 10.1111/boc.201100109; Long Fan, 2004, In Silico Biology, V4, P395; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; McClusky LM, 2007, TOXICOL SCI, V95, P249, DOI 10.1093/toxsci/kfl141; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Minami K, 2010, CLIN CANCER RES, V16, P2751, DOI 10.1158/1078-0432.CCR-09-3338; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Muller S, 1998, ENVIRON TOXICOL PHAR, V5, P257, DOI 10.1016/S1382-6689(98)00009-X; Okamoto K, 2012, INT J UROL, V19, P504, DOI 10.1111/j.1442-2042.2012.02986.x; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Raecker T, 2011, CHEMOSPHERE, V82, P1533, DOI 10.1016/j.chemosphere.2010.11.065; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1975, ACTA PATH MICRO IM A, VA 83, P127; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Sun MY, 2012, GENET MOL RES, V11, P4330, DOI 10.4238/2012.September.26.1; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; Vega Aurelie, 2012, Front Endocrinol (Lausanne), V3, P150, DOI 10.3389/fendo.2012.00150; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Walton EL, 2011, EPIGENETICS-US, V6, P1373, DOI 10.4161/epi.6.11.17978; Wang L, 2010, ONCOL REP, V23, P1109, DOI 10.3892/or_00000739; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Willoughby KN, 2005, ENDOCRINE, V26, P161, DOI 10.1385/ENDO:26:2:161; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2012, ONCOL REP, V27, P2057, DOI 10.3892/or.2012.1722; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	58	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61758	10.1371/journal.pone.0061758	http://dx.doi.org/10.1371/journal.pone.0061758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626723	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400087
J	Bizuayehu, TT; Fernandes, JMO; Johansen, SD; Babiak, I				Bizuayehu, Teshome Tilahun; Fernandes, Jorge M. O.; Johansen, Steinar D.; Babiak, Igor			Characterization of Novel Precursor miRNAs Using Next Generation Sequencing and Prediction of miRNA Targets in Atlantic Halibut	PLOS ONE			English	Article							MICRORNA TARGETS; EXPRESSION; IDENTIFICATION; RECOGNITION; BINDING; LENGTH; GENES; MODE	Background: microRNAs (miRNAs) are implicated in regulation of many cellular processes. miRNAs are processed to their mature functional form in a step-wise manner by multiple proteins and cofactors in the nucleus and cytoplasm. Many miRNAs are conserved across vertebrates. Mature miRNAs have recently been characterized in Atlantic halibut (Hippoglossus hippoglossus L.). The aim of this study was to identify and characterize precursor miRNA (pre-miRNAs) and miRNA targets in this non-model flatfish. Discovery of miRNA precursor forms and targets in non-model organisms is difficult because of limited source information available. Therefore, we have developed a methodology to overcome this limitation. Methods: Genomic DNA and small transcriptome of Atlantic halibut were sequenced using Roche 454 pyrosequencing and SOLiD next generation sequencing (NGS), respectively. Identified pre-miRNAs were further validated with reverse-transcription PCR. miRNA targets were identified using miRanda and RNAhybrid target prediction tools using sequences from public databases. Some of miRNA targets were also identified using RACE-PCR. miRNA binding sites were validated with luciferase assay using the RTS34st cell line. Results: We obtained more than 1.3 M and 92 M sequence reads from 454 genomic DNA sequencing and SOLiD small RNA sequencing, respectively. We identified 34 known and 9 novel pre-miRNAs. We predicted a number of miRNA target genes involved in various biological pathways. miR-24 binding to kisspeptin 1 receptor-2 (kiss1-r2) was confirmed using luciferase assay. Conclusion: This study demonstrates that identification of conserved and novel pre-miRNAs in a non-model vertebrate lacking substantial genomic resources can be performed by combining different next generation sequencing technologies. Our results indicate a wide conservation of miRNA precursors and involvement of miRNA in multiple regulatory pathways, and provide resources for further research on miRNA in non-model animals.	[Bizuayehu, Teshome Tilahun; Fernandes, Jorge M. O.; Johansen, Steinar D.; Babiak, Igor] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway; [Johansen, Steinar D.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	Nord University; UiT The Arctic University of Tromso	Babiak, I (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	igor.babiak@uin.no	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Babiak, Igor/0000-0002-1462-2690	Research Council of Norway [182653/V10, 165272/S40]; University of Nordland	Research Council of Norway(Research Council of Norway); University of Nordland	This work was supported by the Research Council of Norway (www.forskningsradet.no), grants 182653/V10 and 165272/S40. TTB thanks Research Council of Norway and University of Nordland (www.uin.no) for funding his PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Ganassin RC, 1999, IN VITRO CELL DEV-AN, V35, P80; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Mechaly AS, 2010, MOL CELL ENDOCRINOL, V317, P78, DOI 10.1016/j.mce.2009.11.005; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Overgard AC, 2012, MOL BIOL REP, V39, P2201, DOI 10.1007/s11033-011-0969-x; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shookhoff JM, 2010, GENESIS, V48, P282, DOI 10.1002/dvg.20623; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Witkos TM, 2011, CURR MOL MED, V11, P93; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Xia JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017537; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504	44	23	63	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61378	10.1371/journal.pone.0061378	http://dx.doi.org/10.1371/journal.pone.0061378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626677	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400040
J	Paxton, RJ; Taylor, WC; Chang, SN; Courneya, KS; Jones, LA				Paxton, Raheem J.; Taylor, Wendell C.; Chang, Shine; Courneya, Kerry S.; Jones, Lovell A.			Lifestyle Behaviors of African American Breast Cancer Survivors: A Sisters Network, Inc. Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY TRIALS; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIORS; BODY-SIZE; HEALTH; RISK; WOMEN; ASSOCIATIONS; OBESITY	Introduction: African American breast cancer survivors experience poor cancer outcomes that may, in part, be remedied by healthy lifestyle choices. Few studies have evaluated the health and lifestyle behaviors of this population. The purpose of this study was to characterize the health and lifestyle habits of African American breast cancer survivors and evaluate the socio-demographic and medical correlates of these behaviors. Methods: A total of 470 African American breast cancer survivors (mean age = 54 years) participated in an online survey. All participants completed measures assessing medical and demographic characteristics, physical activity, and sedentary behavior. Chi-square tests for association, nonparametric tests, and logistic regression models were used to assess associations. All statistical tests were two sided. Results: Almost half (47%) of the women met the current guidelines for physical activity, almost half (47%) were obese, and many reported having high blood pressure (53%) or diabetes (21%). The prevalence of high blood pressure, diabetes, and high cholesterol increased by age (P<0.001), and obese women had a higher prevalence of high blood pressure (63% vs. 44%) and diabetes (21% vs. 12%) than did non-obese women (all P<0.05). Obese women participated in significantly fewer total minutes of physical activity per week (100 minutes/week) than did non- obese women (150 minutes/week; P<0.05). The number of comorbid conditions was associated with increased odds for physical inactivity (odds ratio = 1.40) and obesity (odds ratio = 2.22). Conclusion: Many African American breast cancer survivors had chronic conditions that may be exacerbated by poor lifestyle choices. Our results also provide evidence that healthy lifestyle interventions among obese African American breast cancer survivors are urgently needed.	[Paxton, Raheem J.; Jones, Lovell A.] Univ Texas MD Anderson Canc Ctr, Univ Houston, Dorothy I Height Ctr Hlth Equ & Evaluat Res, Houston, TX 77030 USA; [Taylor, Wendell C.] Univ Texas Hlth Sci Ctr Houston, Div Hlth Promot & Behav Sci, Houston, TX USA; [Chang, Shine] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Courneya, Kerry S.] Univ Alberta, Fac Dept Phys Educ & Recreat, Edmonton, AB, Canada	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Alberta	Paxton, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Univ Houston, Dorothy I Height Ctr Hlth Equ & Evaluat Res, Houston, TX 77030 USA.	rjpaxton@mdanderson.org	Courneya, Kerry/AAJ-2712-2021; Taylor, Wendell/S-3516-2019; Paxton, Raheem/AAN-8842-2020	Chang, Shine/0000-0003-3804-9697; Paxton, Raheem/0000-0001-9430-7051	National Cancer Institute [5K01CA158000]; MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [K01CA158000, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by National Cancer Institute grant 5K01CA158000 to RJP and by MD Anderson's Cancer Center Support Grant (CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, BREAST CANC SOURCEBO; [Anonymous], 2010, CANC FACTS FIG AFR A; Belanger LJ, 2011, J CANCER SURVIV, V5, P44, DOI 10.1007/s11764-010-0146-6; Bertram LAC, 2011, CANCER CAUSE CONTROL, V22, P427, DOI 10.1007/s10552-010-9714-3; CDC, 2008, 2008 PHYS ACT GUID A; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Gardiner PA, 2011, J AM GERIATR SOC, V59, P788, DOI 10.1111/j.1532-5415.2011.03390.x; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hall IJ, 2000, AM J EPIDEMIOL, V151, P754, DOI 10.1093/oxfordjournals.aje.a010275; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Ibrahim EM, 2011, MED ONCOL, V28, P753, DOI 10.1007/s12032-010-9536-x; Innos K, 2008, BREAST CANCER RES TR, V111, P531, DOI 10.1007/s10549-007-9807-1; Jones BA, 1997, AM J EPIDEMIOL, V146, P394, DOI 10.1093/oxfordjournals.aje.a009292; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Liao Youlian, 2011, Morbidity and Mortality Weekly Report, V60, P1; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Lynch BM, 2011, EUR J CANCER CARE, V20, P514, DOI 10.1111/j.1365-2354.2010.01205.x; Mosher CE, 2009, CANCER-AM CANCER SOC, V115, P4001, DOI 10.1002/cncr.24436; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Palmer JR, 2007, CANCER EPIDEM BIOMAR, V16, P1795, DOI 10.1158/1055-9965.EPI-07-0336; Paxton RJ, 2012, CANCER-AM CANCER SOC, V118, P4024, DOI 10.1002/cncr.27389; Paxton RJ, 2011, CANCER-AM CANCER SOC, V117, P3805, DOI 10.1002/cncr.25957; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Schmitz KH, 2005, CANCER EPIDEM BIOMAR, V14, P1588, DOI 10.1158/1055-9965.EPI-04-0703; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Sundaram AA, 2005, AM J PREV MED, V29, P25, DOI 10.1016/j.amepre.2005.07.027; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Taylor WC, 2011, CURR CARDIOVASC RISK, V5, P350, DOI 10.1007/s12170-011-0174-4; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tudor-Locke C, 2011, J OCCUP ENVIRON MED, V53, P1382, DOI 10.1097/JOM.0b013e31823c1402	34	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61854	10.1371/journal.pone.0061854	http://dx.doi.org/10.1371/journal.pone.0061854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626740	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400104
J	Shin, SW; Jung, E; Kim, S; Kim, JH; Kim, EG; Lee, J; Park, D				Shin, Seoung Woo; Jung, Eunsun; Kim, Seungbeom; Kim, Jang-Hyun; Kim, Eui-Gyun; Lee, Jongsung; Park, Deokhoon			Antagonizing Effects and Mechanisms of Afzelin against UVB-Induced Cell Damage	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; INDUCED DNA-DAMAGE; HUMAN SKIN; IN-VITRO; PREVENTS PHOTOCARCINOGENESIS; INHIBITION; RADIATION; MICE; ACTIVATION; EXPRESSION	Ultraviolet (UV) radiation induces DNA damage, oxidative stress, and inflammatory processes in human keratinocytes, resulting in skin inflammation, photoaging, and photocarcinogenesis. Adequate protection of skin against the harmful effects of UV irradiation is essential. Therefore, in this study, we investigated the protective effects of afzelin, one of the flavonoids, against UV irradiation in human keratinocytes and epidermal equivalent models. Spectrophotometric measurements revealed that the afzelin extinction maxima were in the UVB and UVA range, and UV transmission below 376 nm was < 10%, indicating UV-absorbing activity of afzelin. In the phototoxicity assay using the 3T3 NRU phototoxicity test (3T3-NRU-PT), afzelin presented a tendency to no phototoxic potential. In addition, in order to investigate cellular functions of afzelin itself, cells were treated with afzelin after UVB irradiation. In human keratinocyte, afzelin effectively inhibited the UVB-mediated increase in lipid peroxidation and the formation of cyclobutane pyrimidine dimers. Afzelin also inhibited UVB-induced cell death in human keratinocytes by inhibiting intrinsic apoptotic signaling. Furthermore, afzelin showed inhibitory effects on UVB-induced release of pro-inflammatory mediators such as interleukin-6, tumor necrosis factor-alpha, and prostaglandin-E-2 in human keratinocytes by interfering with the p38 kinase pathway. Using an epidermal equivalent model exposed to UVB radiation, anti-apoptotic activity of afzelin was also confirmed together with a photoprotective effect at the morphological level. Taken together, our results suggest that afzelin has several cellular activities such as DNA-protective, antioxidant, and anti-inflammatory as well as UV-absorbing activity and may protect human skin from UVB-induced damage by a combination of UV-absorbing and cellular activities.	[Shin, Seoung Woo; Jung, Eunsun; Kim, Seungbeom; Park, Deokhoon] Biospectrum Life Sci Inst, Seoungnam City, Gyunggi Do, South Korea; [Kim, Jang-Hyun] Dermiskin Life Sci Inst, Pyeongtaek City, Gyunggi Do, South Korea; [Kim, Eui-Gyun] ChiroChem Co Ltd, Taejon, South Korea		Lee, J (corresponding author), Eulji Univ, Dept Dermatol Hlth Management, Songnam, South Korea.	jslee@eulji.ac.kr; pdh@biospectrum.com		Shin, Seoungwoo/0000-0001-5354-7286	Small and Medium Business Administration of Korea [SM 123791]	Small and Medium Business Administration of Korea	This study was supported by a grant from the Small and Medium Business Administration of Korea (Grant number: SM 123791). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; Afaq F, 2006, EXP DERMATOL, V15, P678, DOI 10.1111/j.1600-0625.2006.00466.x; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Beissert S, 1999, J INVEST DERM SYMP P, V4, P61, DOI 10.1038/sj.jidsp.5640183; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; Birt DF, 1997, ANTICANCER RES, V17, P85; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Cho JW, 2005, EXP MOL MED, V37, P186, DOI 10.1038/emm.2005.25; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Diantini A, 2012, ONCOL LETT, V3, P1069, DOI 10.3892/ol.2012.596; Dinkova-Kostova AT, 2008, PLANTA MED, V74, P1548, DOI 10.1055/s-2008-1081296; Elsner Peter, 2007, J Dtsch Dermatol Ges, V5, P166, DOI 10.1111/j.1610-0387.2007.06099.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Holzhutter HG, 1997, ATLA-ALTERN LAB ANIM, V25, P445; Huang CC, 2007, MOLECULES, V12, P1845, DOI 10.3390/12081845; Julsing MK, 2006, BIOMOL ENG, V23, P265, DOI 10.1016/j.bioeng.2006.08.001; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287; Katiyar SK, 2000, PHOTOCHEM PHOTOBIOL, V72, P788, DOI 10.1562/0031-8655(2000)072<0788:KOULIC>2.0.CO;2; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; LASAROW RM, 1992, J INVEST DERMATOL, V98, P725, DOI 10.1111/1523-1747.ep12499927; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liebsch M, 2002, TOXICOL LETT, V127, P127, DOI 10.1016/S0378-4274(01)00492-1; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Mallikarjuna G, 2004, CANCER RES, V64, P6349, DOI 10.1158/0008-5472.CAN-04-1632; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Meeran SM, 2006, CANCER RES, V66, P5512, DOI 10.1158/0008-5472.CAN-06-0218; Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Mnich CD, 2009, EXP DERMATOL, V18, P69, DOI 10.1111/j.1600-0625.2008.00765.x; Morquio A, 2005, PHYTOTHER RES, V19, P486, DOI 10.1002/ptr.1665; Narbutt J, 2007, EXP DERMATOL, V16, P837, DOI 10.1111/j.1600-0625.2007.00598.x; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rodriguez-Burford C, 2005, J INVEST DERMATOL, V125, P1317, DOI 10.1111/j.0022-202X.2005.23960.x; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Schwarz A, 2008, PHOTOCHEM PHOTOBIOL, V84, P350, DOI 10.1111/j.1751-1097.2007.00265.x; Sivamani RK, 2009, J DERMATOL TREAT, V20, P186, DOI 10.1080/09546630802683868; Tak JK, 2009, FREE RADICAL BIO MED, V46, P1177, DOI 10.1016/j.freeradbiomed.2009.01.023; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; Verschooten L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1016, DOI 10.1562/2006-04-27-IR-884.1; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Yusuf N, 2007, PHOTODERMATOL PHOTO, V23, P48, DOI 10.1111/j.1600-0781.2007.00262.x	60	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61971	10.1371/journal.pone.0061971	http://dx.doi.org/10.1371/journal.pone.0061971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626759	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400123
J	Zhang, HY; Fu, HH; Wang, JX; Sun, LL; Jiang, YM; Zhang, LL; Gao, HC				Zhang, Haiyan; Fu, Huihui; Wang, Jixuan; Sun, Linlin; Jiang, Yaoming; Zhang, Lili; Gao, Haichun			Impacts of Nitrate and Nitrite on Physiology of Shewanella oneidensis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MICROBIAL RESPONSES; REACTION-MECHANISMS; NITROSATIVE STRESS; GENE-EXPRESSION; OXIDE; REDUCTASE; NAP; IDENTIFICATION; DISSOCIATION	Shewanella oneidensis exhibits a remarkable versatility in anaerobic respiration, which largely relies on its diverse respiratory pathways. Some of these are expressed in response to the existence of their corresponding electron acceptors (EAs) under aerobic conditions. However, little is known about respiration and the impact of non-oxygen EAs on the physiology of the microorganism when oxygen is present. Here we undertook a study to elucidate the basis for nitrate and nitrite inhibition of growth under aerobic conditions. We discovered that nitrate in the form of NaNO3 exerts its inhibitory effects as a precursor to nitrite at low concentrations and as an osmotic-stress provider (Na+) at high concentrations. In contrast, nitrite is extremely toxic, with 25 mM abolishing growth completely. We subsequently found that oxygen represses utilization of all EAs but nitrate. To order to utilize EAs with less positive redox potential, such as nitrite and fumarate, S. oneidensis must enter the stationary phase, when oxygen respiration becomes unfavorable. In addition, we demonstrated that during aerobic respiration the cytochrome bd oxidase confers S. oneidensis resistance to nitrite, which likely functions via nitric oxide (NO).	[Zhang, Haiyan; Fu, Huihui; Wang, Jixuan; Sun, Linlin; Jiang, Yaoming; Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Haiyan; Fu, Huihui; Wang, Jixuan; Sun, Linlin; Jiang, Yaoming; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Haiyan; Zhang, Lili] Tarim Univ, Coll Life Sci, Alar, Xinjiang, Peoples R China	Zhejiang University; Zhejiang University; Tarim University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Natural Science Foundation of Zhejiang province [R3110096]; Major Program of Science and Technology Department of Zhejiang [2009C12061]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Major Program of Science and Technology Department of Zhejiang	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (31270097), and Natural Science Foundation of Zhejiang province (R3110096) and Major Program of Science and Technology Department of Zhejiang (2009C12061) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Borisov VB, 2007, BIOCHEM BIOPH RES CO, V355, P97, DOI 10.1016/j.bbrc.2007.01.118; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Bowman LAH, 2011, ADV MICROB PHYSIOL, V59, P135, DOI 10.1016/B978-0-12-387661-4.00006-9; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Cruz-Garcia C, 2007, J BACTERIOL, V189, P656, DOI 10.1128/JB.01194-06; Dong YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0039386]; Dunn AK, 2010, MOL MICROBIOL, V77, P44, DOI 10.1111/j.1365-2958.2010.07194.x; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gavira M, 2002, J BACTERIOL, V184, P1693, DOI 10.1128/JB.184.6.1693-1702.2002; Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; Goh EB, 2005, J BACTERIOL, V187, P4890, DOI 10.1128/JB.187.14.4890-4899.2005; Gon S, 2002, J BACTERIOL, V184, P1262, DOI 10.1128/JB.184.5.1262-1269.2002; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jepson BJN, 2006, BIOCHEM SOC T, V34, P122, DOI 10.1042/BST0340122; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; Price MS, 2007, BIOCHEMISTRY-US, V46, P13677, DOI 10.1021/bi7019035; Pullan ST, 2008, METHOD ENZYMOL, V437, P499, DOI 10.1016/S0076-6879(07)37025-0; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Sarti P, 2003, FREE RADICAL BIO MED, V34, P509, DOI 10.1016/S0891-5849(02)01326-6; Sears HJ, 1997, MICROBIOL-UK, V143, P3767, DOI 10.1099/00221287-143-12-3767; Shirodkar S, 2011, ENVIRON MICROBIOL, V13, P108, DOI 10.1111/j.1462-2920.2010.02313.x; Simpson PJL, 2010, MICROBIOL-SGM, V156, P302, DOI 10.1099/mic.0.034421-0; Sindelar JJ, 2012, NITRIC OXIDE-BIOL CH, V26, P259, DOI 10.1016/j.niox.2012.03.011; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Zhou G, 2013, ISME J IN PRESS; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	47	31	32	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62629	10.1371/journal.pone.0062629	http://dx.doi.org/10.1371/journal.pone.0062629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626841	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400205
J	Bredlau, JP; Mohajer, YJ; Cameron, TM; Kester, KM; Fine, ML				Bredlau, Justin P.; Mohajer, Yasha J.; Cameron, Timothy M.; Kester, Karen M.; Fine, Michael L.			Characterization and Generation of Male Courtship Song in Cotesia congregata (Hymenoptera: Braconidae)	PLOS ONE			English	Article							SAY HYMENOPTERA; SOUND; COMMUNICATION; SIGNALS; FLIGHT; POPULATIONS; ACOUSTICS; RESPONSES; DYNAMICS; LANGUAGE	Background: Male parasitic wasps attract females with a courtship song produced by rapid wing fanning. Songs have been described for several parasitic wasp species; however, beyond association with wing fanning, the mechanism of sound generation has not been examined. We characterized the male courtship song of Cotesia congregata (Hymenoptera: Braconidae) and investigated the biomechanics of sound production. Methods and Principal Findings: Courtship songs were recorded using high-speed videography (2,000 fps) and audio recordings. The song consists of a long duration amplitude-modulated "buzz" followed by a series of pulsatile higher amplitude "boings," each decaying into a terminal buzz followed by a short inter-boing pause while wings are stationary. Boings have higher amplitude and lower frequency than buzz components. The lower frequency of the boing sound is due to greater wing displacement. The power spectrum is a harmonic series dominated by wing repetition rate similar to 220 Hz, but the sound waveform indicates a higher frequency resonance similar to 5 kHz. Sound is not generated by the wings contacting each other, the substrate, or the abdomen. The abdomen is elevated during the first several wing cycles of the boing, but its position is unrelated to sound amplitude. Unlike most sounds generated by volume velocity, the boing is generated at the termination of the wing down stroke when displacement is maximal and wing velocity is zero. Calculation indicates a low Reynolds number of similar to 1000. Conclusions and Significance: Acoustic pressure is proportional to velocity for typical sound sources. Our finding that the boing sound was generated at maximal wing displacement coincident with cessation of wing motion indicates that it is caused by acceleration of the wing tips, consistent with a dipole source. The low Reynolds number requires a high wing flap rate for flight and predisposes wings of small insects for sound production.	[Bredlau, Justin P.; Mohajer, Yasha J.; Kester, Karen M.; Fine, Michael L.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Cameron, Timothy M.] Miami Univ, Dept Mech & Mfg Engn, Oxford, OH 45056 USA	Virginia Commonwealth University; University System of Ohio; Miami University	Fine, ML (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	mfine@vcu.edu	Fine, Michael/I-2656-2019	Fine, Michael/0000-0001-9665-1462; Kester, Karen M/0000-0001-6052-7806; Bredlau, Justin/0000-0001-6722-9764	Thomas F & Kate Jeffress Memorial Trust [J-976]	Thomas F & Kate Jeffress Memorial Trust	This work was supported by the Thomas F & Kate Jeffress Memorial Trust, Grant Number J-976 to K. M. Kester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae Y, 2008, J ACOUST SOC AM, V124, P72, DOI 10.1121/1.2932340; Beckage NE, 2008, INSECT IMMUNOLOGY, P1; Benelli G, 2012, J PEST SCI, V85, P55, DOI 10.1007/s10340-011-0394-x; BENNETCLARK HC, 1968, J EXP BIOL, V49, P117; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Canale A, 2013, B ENTOMOL RES, V103, P303, DOI 10.1017/S0007485312000715; Chapman R.F., 2012, INSECTS STRUCTURE FU; Danci A, 2010, ENTOMOL EXP APPL, V136, P142, DOI 10.1111/j.1570-7458.2010.01013.x; Dickinson MH, 1996, J EXP BIOL, V199, P2085; Dickinson MH, 1998, AM ZOOL, V38, P718; Dolphin K, 2001, BIOL J LINN SOC, V73, P279, DOI [10.1111/j.1095-8312.2001.tb01363.x, 10.1006/bijl.2001.0537]; Drosopoulos S, 2006, INSECT SOUNDS COMMUN; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; FIELD SA, 1993, J INSECT BEHAV, V6, P737, DOI 10.1007/BF01201673; GORDH G, 1978, HILGARDIA, V46, P37, DOI 10.3733/hilg.v46n02p037; Goriely A, 2002, PHYS REV LETT, V88, P1; Harwood SH, 1998, J INVERTEBR PATHOL, V71, P271, DOI 10.1006/jipa.1997.4745; HENRY CS, 1980, ANN ENTOMOL SOC AM, V73, P617, DOI 10.1093/aesa/73.6.617; Hrncir M, 2006, CONT T ENT, P421; Joyce AL, 2010, ENTOMOL EXP APPL, V137, P153, DOI 10.1111/j.1570-7458.2010.01048.x; Joyce AL, 2008, ENTOMOL EXP APPL, V127, P39, DOI 10.1111/j.1570-7458.2008.00670.x; Joyce AL, 2010, BIOCONTROL, V55, P573, DOI 10.1007/s10526-010-9278-x; KESTER KM, 1991, J INSECT BEHAV, V4, P727, DOI 10.1007/BF01052227; Kester KM, 2002, CHEMOECOLOGY, V12, P1, DOI 10.1007/s00049-002-8320-6; KESTER KM, 1994, OECOLOGIA, V99, P151, DOI 10.1007/BF00317096; Krombein KV, 1979, CATALOG HYMENOPTERA, V2, P1253; LaSalle J., 1991, Redia, V74, P315; Lentz AJ, 2008, J INSECT BEHAV, V21, P34, DOI 10.1007/s10905-007-9102-3; Lentz-Ronning AJ, 2013, J INSECT BEHAV, V26, P165, DOI 10.1007/s10905-012-9345-5; Michel-Salzat A, 2004, SYST ENTOMOL, V29, P371, DOI 10.1111/j.0307-6970.2004.00246.x; MICHELSEN A, 1987, J COMP PHYSIOL A, V161, P633, DOI 10.1007/BF00605005; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Myhrvold NP, 1997, PALEOBIOLOGY, V23, P393, DOI 10.1017/S0094837300019801; PRINGLE JWS, 1949, J PHYSIOL-LONDON, V108, P226, DOI 10.1113/jphysiol.1949.sp004326; Rupprecht R, 1981, BIOL INLAND WATERS, V2, P30; Russell DA, 1999, AM J PHYS, V67, P660, DOI 10.1119/1.19349; Shyy W, 2008, CAMB AERO SER, P1; SIVINSKI J, 1989, ANN ENTOMOL SOC AM, V82, P116, DOI 10.1093/aesa/82.1.116; Sueur J, 2005, J ACOUST SOC AM, V118, P530, DOI 10.1121/1.1932227; Tietz H. M, 1972, INDEX DESCRIBED LIFE; TOWNE W F, 1985, Behavioral Ecology and Sociobiology, V16, P185, DOI 10.1007/BF00295154; Villagra CA, 2011, B ENTOMOL RES, V101, P573, DOI 10.1017/S0007485311000174; VINSON S B, 1972, Environmental Entomology, V1, P409, DOI 10.1093/ee/1.4.409; VONFRISCH K, 1974, SCIENCE, V185, P663, DOI 10.1126/science.185.4152.663; WEISFOGH T, 1973, J EXP BIOL, V59, P169; WENNER ADRIAN M., 1962, ANIMAL BEHAVIOUR, V10, P79, DOI 10.1016/0003-3472(62)90135-5	47	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62051	10.1371/journal.pone.0062051	http://dx.doi.org/10.1371/journal.pone.0062051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630622	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500077
J	Vicente, S; Diaz-Freitas, B; Peleteiro, M; Sanchez, A; Pascual, DW; Gonzalez-Fernandez, A; Alonso, MJ				Vicente, Sara; Diaz-Freitas, Belen; Peleteiro, Mercedes; Sanchez, Alejandro; Pascual, David W.; Gonzalez-Fernandez, Africa; Alonso, Maria J.			A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach	PLOS ONE			English	Article							CHITOSAN NANOPARTICLES; DENDRITIC CELLS; PARTICULATE VACCINES; IMMUNE-RESPONSES; PROTEIN ANTIGENS; MOLECULAR-WEIGHT; DELIVERY-SYSTEMS; IMMUNOGENICITY; ADJUVANT; MICE	The recognized necessity for new antigen delivery carriers with the capacity to boost, modulate and prolong neutralizing immune responses prompted our approach, in which we describe a multifunctional nanocarrier consisting of an oily nanocontainer protected by a polymeric shell made of chitosan (CS), named CS nanocapsules (CSNC). The CS shell can associate the antigen on its surface, whereas the oily core might provide additional immunostimulating properties. In this first characterization of the system, we intended to study the influence of different antigen organizations on the nanocarrier's surface (using the recombinant hepatitis B surface antigen -rHBsAg- as a model antigen) on their long-term immunopotentiating effect, without any additional immunostimulant. Thus, two prototypes of antigen-loaded CSNC (CSNC+ and CSNC-), exhibiting similar particle size (200 nm) and high antigen association efficiency (>80%), were developed with different surface composition (polymer/antigen ratios) and surface charge (positive/negative, respectively). The biological evaluation of these nanovaccines evidenced the superiority of the CSNC+ as compared to CSNC- and alum-rHBsAg in terms of neutralizing antibody responses, following intramuscular vaccination. Moreover, a single dose of CSNC+ led to similar IgG levels to the positive control. The IgG1/IgG2a ratio suggested a mixed Th1/Th2 response elicited by CSNC+, in contrast to the typical Th2-biased response of alum. Finally, CSNC+ could be freeze-dried without altering its physicochemical properties and adjuvant effect in vivo. In conclusion, the evaluation of CSNC+ confirms its interesting features for enhancing, prolonging and modulating the type of immune response against subunit antigens, such as rHBsAg.	[Vicente, Sara; Alonso, Maria J.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Pharm & Pharmaceut Technol Dept, Santiago De Compostela, Spain; [Diaz-Freitas, Belen; Peleteiro, Mercedes; Gonzalez-Fernandez, Africa] Univ Vigo, Biomed Res Ctr CINBIO, Inst Biomed Res IBIV, Vigo 36310, Spain; [Sanchez, Alejandro] Univ Santiago de Compostela, Sch Pharm, Pharm & Pharmaceut Technol Dept, Santiago De Compostela, Spain; [Sanchez, Alejandro] Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Pascual, David W.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA	Universidade de Santiago de Compostela; Universidade de Vigo; CINBIO; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Alonso, MJ (corresponding author), Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Pharm & Pharmaceut Technol Dept, Santiago De Compostela, Spain.	mariaj.alonso@usc.es	Pascual, David/AAC-2248-2022; Peleteiro, Mercedes/J-9844-2014; González-Fernández, África/E-2641-2012; Alonso, Maria Jose/K-3893-2014	Peleteiro, Mercedes/0000-0003-1752-1331; González-Fernández, África/0000-0002-9226-4825; Alonso, Maria Jose/0000-0001-7187-9567; Gonzalez-Fernandez, Africa/0000-0001-5906-3901	Bill and Melinda Gates Foundation; Ministry of Science and Innovation, Spain [2010 CSD2006-00012]; Competitive Reference Groups SUDOE-FEDER [SOE1/P1/E014]; Spanish Ministry of Education (FPU predoctoral grants); Montana Agricultural Experiment Station; US Department of Agriculture Formula Funds	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Competitive Reference Groups SUDOE-FEDER; Spanish Ministry of Education (FPU predoctoral grants); Montana Agricultural Experiment Station; US Department of Agriculture Formula Funds(United States Department of Agriculture (USDA))	This work was supported by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Consolider Ingenio 2010 CSD2006-00012 (Ministry of Science and Innovation, Spain) and Competitive Reference Groups SUDOE-FEDER (SOE1/P1/E014). SV and MP acknowledge a fellowship from the Spanish Ministry of Education (FPU predoctoral grants). DWP was in part supported by Montana Agricultural Experiment Station and US Department of Agriculture Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bal SM, 2010, J CONTROL RELEASE, V142, P374, DOI 10.1016/j.jconrel.2009.11.018; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; Borges O, 2008, INT IMMUNOPHARMACOL, V8, P1773, DOI 10.1016/j.intimp.2008.08.013; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Chen GH, 2007, DRY TECHNOL, V25, P29, DOI 10.1080/07373930601161179; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; Dang YB, 2011, CARBOHYD POLYM, V83, P1075, DOI 10.1016/j.carbpol.2010.08.071; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Friede M, 2005, ADV DRUG DELIVER REV, V57, P325, DOI 10.1016/j.addr.2004.10.001; Garcia-Fuentes M, 2012, J CONTROL RELEASE, V161, P496, DOI 10.1016/j.jconrel.2012.03.017; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Jiang L, 2007, J GENE MED, V9, P253, DOI 10.1002/jgm.1017; Ma YF, 2011, NANOSCALE, V3, P2307, DOI 10.1039/c1nr10166h; Oyarzun-Ampuero FA, 2010, J DRUG DELIV SCI TEC, V20, P259, DOI 10.1016/S1773-2247(10)50043-1; PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Prego C, 2006, J NANOSCI NANOTECHNO, V6, P2921, DOI 10.1166/jnn.2006.429; Prego C, 2010, VACCINE, V28, P2607, DOI 10.1016/j.vaccine.2010.01.011; Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023; Shouval D, 2003, J HEPATOL, V39, pS70, DOI 10.1016/S0168-8278(03)00125-1; Sloat BR, 2010, INT J PHARMACEUT, V393, P197, DOI 10.1016/j.ijpharm.2010.04.003; Sloat BR, 2010, J CONTROL RELEASE, V141, P93, DOI 10.1016/j.jconrel.2009.08.023; Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007; van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5; Vicente S, 2010, J DRUG DELIV SCI TEC, V20, P267, DOI 10.1016/S1773-2247(10)50044-3; Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Villiers C, 2009, MOL CELL PROTEOMICS, V8, P1252, DOI 10.1074/mcp.M800589-MCP200; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Wen ZS, 2011, MAR DRUGS, V9, P1038, DOI 10.3390/md9061038; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034; ZAPATA MI, 1984, J PHARM SCI, V73, P3, DOI 10.1002/jps.2600730103; Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082; Zwiorek K, 2008, PHARM RES-DORDR, V25, P551, DOI 10.1007/s11095-007-9410-5	42	42	42	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62500	10.1371/journal.pone.0062500	http://dx.doi.org/10.1371/journal.pone.0062500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614052	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500095
J	de Langavant, LC; Fenelon, G; Benisty, S; Boisse, MF; Jacquemot, C; Bachoud-Levi, AC				de Langavant, Laurent Cleret; Fenelon, Gilles; Benisty, Sarah; Boisse, Marie-Francoise; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine			Awareness of Memory Deficits in Early Stage Huntington's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; COGNITIVE DECLINE; SELF-AWARENESS; DEPRESSION; UNAWARENESS; DYSFUNCTION; DEMENTIA; INSIGHT; ANOSOGNOSIA	Patients with Huntington's disease (HD) are often described as unaware of their motor symptoms, their behavioral disorders or their cognitive deficits, including memory. Nevertheless, because patients with Parkinson's disease (PD) remain aware of their memory deficits despite striatal dysfunction, we hypothesize that early stage HD patients in whom degeneration predominates in the striatum can accurately judge their own memory disorders whereas more advanced patients cannot. In order to test our hypothesis, we compared subjective questionnaires of memory deficits (in HD patients and in their proxies) and objective measures of memory dysfunction in patients. Forty-six patients with manifest HD attending the out-patient department of the French National Reference Center for HD and thirty-three proxies were enrolled. We found that HD patients at an early stage of the disease (Stage 1) were more accurate than their proxies at evaluating their own memory deficits, independently from their depression level. The proxies were more influenced by patients' functional decline rather than by patients' memory deficits. Patients with moderate disease (Stage 2) misestimated their memory deficits compared to their proxies, whose judgment was nonetheless influenced by the severity of both functional decline and depression. Contrasting subjective memory ratings from the patients and their objective memory performance, we demonstrate that although HD patients are often reported to be unaware of their neurological, cognitive and behavioral symptoms, it is not the case for memory deficits at an early stage. Loss of awareness of memory deficits in HD is associated with the severity of the disease in terms of CAG repeats, functional decline, motor dysfunction and cognitive impairment, including memory deficits and executive dysfunction.	[de Langavant, Laurent Cleret; Fenelon, Gilles; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, INSERM, U955 E01, F-94010 Creteil, France; [de Langavant, Laurent Cleret; Fenelon, Gilles; Bachoud-Levi, Anne-Catherine] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [de Langavant, Laurent Cleret; Fenelon, Gilles; Benisty, Sarah; Boisse, Marie-Francoise; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] Hop H Mondor A Chenevier, AP HP, Ctr Reference Maladie Huntington, Creteil, France; [de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Bachoud-Levi, AC (corresponding author), Hop Henri Mondor, INSERM, U955 E01, F-94010 Creteil, France.	bachoud@gmail.com	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; Fenelon, Gilles/R-3361-2018	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Cleret de Langavant, Laurent/0000-0001-6551-4641; Jacquemot, Charlotte/0000-0002-6611-0742				Adam S., 2004, EVALUATION TROUBLES; Amanzio M, 2011, BRAIN, V134, P1061, DOI 10.1093/brain/awr020; [Anonymous], 1976, GERIATRIC PSYCHIAT; Bachoud-Levi AC, 2001, NEUROLOGY, V56, P1052, DOI 10.1212/WNL.56.8.1052; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; DALLABARBA G, 1995, NEUROPSYCHOLOGIA, V33, P247; De Souza J, 2010, MOVEMENT DISORD, V25, P91, DOI 10.1002/mds.22837; Deckel AW, 1996, ARCH CLIN NEUROPSYCH, V11, P295, DOI 10.1093/arclin/11.4.295; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Duff K, 2010, J NEUROPSYCH CLIN N, V22, P196, DOI 10.1176/appi.neuropsych.22.2.196; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Grober E, 2008, J AM GERIATR SOC, V56, P944, DOI 10.1111/j.1532-5415.2008.01652.x; Haley AP, 2009, AM J GERIAT PSYCHIAT, V17, P976, DOI 10.1097/JGP.0b013e3181b208ef; Ho AK, 2006, MOVEMENT DISORD, V21, P385, DOI 10.1002/mds.20739; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P1089, DOI 10.1136/jnnp.53.12.1089; Hoth KF, 2007, J CLIN EXP NEUROPSYC, V29, P365, DOI 10.1080/13803390600718958; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ivory SJ, 1999, NEUROPSYCHOLOGIA, V37, P817, DOI 10.1016/S0028-3932(98)00131-6; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Markova IS, 2001, PSYCHOPATHOLOGY, V34, P245, DOI 10.1159/000049317; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; McGlynn SM, 1991, AWARENESS DEFICITS B; MICHON A, 1994, J NEUROL NEUROSUR PS, V57, P805, DOI 10.1136/jnnp.57.7.805; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Peschanski M, 2004, BRAIN, P1; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Rey A, 1964, LEXAMEN CLINIQUE PSY; SCHACTER DL, 1991, AWARENESS DEFICIT BR, P127; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Sitek EJ, 2012, NEUROL NEUROCHIR POL, V46, P318, DOI 10.5114/ninp.2012.30262; Sitek EJ, 2011, J INT NEUROPSYCH SOC, V17, P788, DOI 10.1017/S1355617711000725; Sitek EJ, 2011, AGING MENT HEALTH, V15, P150, DOI 10.1080/13607863.2010.508773; Snowden JS, 1998, ARCH NEUROL-CHICAGO, V55, P801, DOI 10.1001/archneur.55.6.801; SQUIRE LR, 1988, J CLIN EXP NEUROPSYC, V10, P727, DOI 10.1080/01688638808402810; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Thieben MJ, 2002, BRAIN, V125, P1815, DOI 10.1093/brain/awf179; Vitale C, 2001, NEUROL SCI, V22, P105, DOI 10.1007/s100720170066	41	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61676	10.1371/journal.pone.0061676	http://dx.doi.org/10.1371/journal.pone.0061676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JA	23620779	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500059
J	Furutani, N; Hondo, M; Kageyama, H; Tsujino, N; Mieda, M; Yanagisawa, M; Shioda, S; Sakurai, T				Furutani, Naoki; Hondo, Mari; Kageyama, Haruaki; Tsujino, Natsuko; Mieda, Michihiro; Yanagisawa, Masashi; Shioda, Seiji; Sakurai, Takeshi			Neurotensin Co-Expressed in Orexin-Producing Neurons in the Lateral Hypothalamus Plays an Important Role in Regulation of Sleep/Wakefulness States	PLOS ONE			English	Article							ADULT-RAT BRAIN; OREXIN/HYPOCRETIN NEURONS; HYPOCRETIN/OREXIN NEURONS; MESOLIMBIC DOPAMINE; ENERGY-BALANCE; RECEPTOR; MICE; SYSTEMS; AROUSAL; SLEEP	Both orexin and neurotensin are expressed in the lateral hypothalamic area (LHA) and have been implicated in the regulation of feeding, motor activity and the reward system. A double label immunofluorescence and in situ hybridization studies showed that neurotensin colocalizes with orexin in neurons of the LHA. Pharmacological studies suggested that neurotensin excites orexin-producing neurons (orexin neurons) through activation of neurotensin receptor-2 (NTSR-2) and non-selective cation channels. In situ hybridization study showed that most orexin neurons express neurotensin receptor-2 mRNA but not neurotensin receptor-1 (Ntsr-1) mRNA. Immunohistochemical studies showed that neurotensin-immunoreactive fibers make appositions to orexin neurons. A neurotensin receptor antagonist decreased Fos expression in orexin neurons and wakefulness time in wild type mice when administered intraperitoneally. However, the antagonist did not evoke any effect on these parameters in orexin neuron-ablated mice. These observations suggest the importance of neurotensin in maintaining activity of orexin neurons. The evidence presented here expands our understanding of the regulatory mechanism of orexin neurons.	[Furutani, Naoki; Hondo, Mari; Tsujino, Natsuko; Mieda, Michihiro; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan; [Kageyama, Haruaki; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Hondo, Mari; Yanagisawa, Masashi] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan; [Hondo, Mari; Yanagisawa, Masashi; Sakurai, Takeshi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Kanazawa University; Showa University; University of Tsukuba; University of Tsukuba; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp		Mieda, Michihiro/0000-0002-2451-7034	Government of Japan through "Funding Program for Next Generation World-Leading Researchers"; Grants-in-Aid for Scientific Research [24390052, 24700322] Funding Source: KAKEN	Government of Japan through "Funding Program for Next Generation World-Leading Researchers"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Government of Japan through its "Funding Program for Next Generation World-Leading Researchers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; CHABRY J, 1994, J NEUROCHEM, V63, P19; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Ferraro L, 2007, BRAIN RES REV, V55, P144, DOI 10.1016/j.brainresrev.2007.03.006; Fu LY, 2004, J NEUROSCI, V24, P8741, DOI 10.1523/JNEUROSCI.2268-04.2004; Geisler S, 2006, PEPTIDES, V27, P2364, DOI 10.1016/j.peptides.2006.03.037; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horvath TL, 1999, J COMP NEUROL, V415, P145; HOSLI E, 1995, NEUROSCIENCE, V66, P627, DOI 10.1016/0306-4522(95)00005-4; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Lepee-Lorgeoux I, 1999, DEV BRAIN RES, V113, P115, DOI 10.1016/S0165-3806(99)00009-7; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu ZW, 2007, J NEUROPHYSIOL, V97, P837, DOI 10.1152/jn.00873.2006; Martin S, 2003, J NEUROSCI, V23, P1198, DOI 10.1523/JNEUROSCI.23-04-01198.2003; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Najimi M, 2002, FEBS LETT, V512, P329, DOI 10.1016/S0014-5793(02)02285-8; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Peyron C, 1998, J NEUROSCI, V18, P9996; Reti IM, 2002, J NEUROCHEM, V82, P1561, DOI 10.1046/j.1471-4159.2002.01141.x; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; Spassova MA, 2004, BBA-MOL CELL RES, V1742, P9, DOI 10.1016/j.bbamcr.2004.09.001; Takai Y, 2004, J PHYSIOL-LONDON, V559, P899, DOI 10.1113/jphysiol.2004.065607; Takayasu S, 2006, P NATL ACAD SCI USA, V103, P7438, DOI 10.1073/pnas.0602371103; Tsujino N, 2005, J NEUROSCI, V25, P7459, DOI 10.1523/JNEUROSCI.1193-05.2005; Tsunematsu T, 2008, J NEUROSCI, V28, P228, DOI 10.1523/JNEUROSCI.3490-07.2008; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Walker N, 1998, MOL BRAIN RES, V57, P193, DOI 10.1016/S0169-328X(98)00074-6; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Yamanaka A, 2006, J NEUROPHYSIOL, V96, P284, DOI 10.1152/jn.01361.2005; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yamanaka A, 2010, J NEUROSCI, V30, P12642, DOI 10.1523/JNEUROSCI.2120-10.2010; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	48	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62391	10.1371/journal.pone.0062391	http://dx.doi.org/10.1371/journal.pone.0062391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620827	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500108
J	Islam, SS; Mokhtari, RB; Kumar, S; Maalouf, J; Arab, S; Yeger, H; Farhat, WA				Islam, Syed S.; Mokhtari, Reza Bayat; Kumar, Sushil; Maalouf, Joe; Arab, Sara; Yeger, Herman; Farhat, Walid A.			Spatio-Temporal Distribution of Smads and Role of Smads/TGF-beta/BMP-4 in the Regulation of Mouse Bladder Organogenesis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; GROWTH-FACTOR-BETA; MESENCHYMAL-EPITHELIAL INTERACTIONS; TGF-BETA; IDENTIFICATION; DIFFERENTIATION; INHIBITOR; INDUCTION; APOPTOSIS; REVEALS	Although Shh, TGF-beta and BMP-4 regulate radial patterning of the bladder mesenchyme and smooth muscle differentiation, it is not known what transcription factors, local environmental cues or signaling cascades mediate bladder smooth muscle differentiation. We investigated the expression patterns of signaling mediated by Smad2 and Smad3 in the mouse embryonic bladder from E12.5 to E16.5 by using qRT-PCR, in situ hybridization and antibodies specifically recognizing individual Smad proteins. The role of Smad2 and Smad3 during smooth muscle formation was examined by disrupting the Smad2/3 signaling pathway using T beta R1 inhibitor SB-431542 in organ culture system. qRT-PCR results showed that R-Smads, Co-Smad and i-Smads were all expressed during bladder development. RNA ISH for BMP-4 and immunostaining of TGF-beta 1 showed that BMP-4 and TGF-beta 1 were expressed in the transitional epithelium, lamina propia and muscularis mucosa. Smad1, Smad5 and Smad8 were first expressed in the bladder epithelium and continued to be expressed in the transitional epithelium, muscularis mesenchyme and lamina propia as the bladder developed. Smad2, Smad3 and Smad4 were first detected in the bladder epithelium and subsequently were expressed in the muscularis mesenchyme and lamina propia. Smad6 and Smad7 showed overlapping expression with R-Smads, which are critical for bladder development. In bladder explants (E12.5 to E16.5) culture, Smad2 and Smad3 were found localized within the nuclei, suggesting critical transcriptional regulatory effects during bladder development. E12.5 to E16.5 bladders were cultured with and without T beta R1 inhibitor SB-431542 and assessed by qRT-PCR and immunofluorescence. After three days in culture in SB-431542, alpha-SMA, Smad2 and Smad3 expressions were significantly decreased compared with controls, however, with no significant changes in the expression of smooth muscle myosin heavy chain (SM-Myh. Based on the Smad expression patterns, we suggest that individual or combinations of Smads may be necessary during mouse bladder organogenesis and may be critical mediators for bladder smooth muscle differentiation.	[Islam, Syed S.; Kumar, Sushil; Farhat, Walid A.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Mokhtari, Reza Bayat; Yeger, Herman] Hosp Sick Children, Res Inst, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Maalouf, Joe; Arab, Sara] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Farhat, WA (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	walid.farhat@sickkids.ca	Islam, Syed/AAS-7468-2021; Farhat, Walid/AAM-4580-2021; Islam, Syed/AAV-1215-2021	Kumar, Sushil/0000-0002-5082-8602				Alison MR, 1995, HUM EXP TOXICOL, V14, P935, DOI 10.1177/096032719501401201; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Barendrecht MM, 2007, J PHARMACOL EXP THER, V322, P117, DOI 10.1124/jpet.106.119115; Baskin LS, 1996, J UROLOGY, V156, P1820, DOI 10.1016/S0022-5347(01)65545-9; Baskin LS, 1996, WORLD J UROL, V14, P301; BASKIN LS, 1997, FRONT BIOSCI, V2, P592; Brading AF, 2005, NAT CLIN PRACT UROL, V2, P546, DOI 10.1038/ncpuro0340; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chang H, 1999, DEVELOPMENT, V126, P1631; Cheng W, 2008, J UROLOGY, V180, P1543, DOI 10.1016/j.juro.2008.06.003; CUNHA GR, 1989, BIOL REPROD, V40, P861, DOI 10.1095/biolreprod40.4.861; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Doi H, 2009, BIOCHEM BIOPH RES CO, V381, P654, DOI 10.1016/j.bbrc.2009.02.116; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Ishisaki A, 1998, J BIOL CHEM, V273, P24293, DOI 10.1074/jbc.273.38.24293; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Li J, 2006, DIFFERENTIATION, V74, P30, DOI 10.1111/j.1432-0436.2006.00057.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Liu BC, 2010, INT J DEV BIOL, V54, P175, DOI 10.1387/ijdb.082610bl; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Shiroyanagi Y, 2007, DIFFERENTIATION, V75, P968, DOI 10.1111/j.1432-0436.2007.00187.x; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Staack A, 2005, DIFFERENTIATION, V73, P121, DOI 10.1111/j.1432-0436.2005.00014.x; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Vrljicak P, 2004, AM J PHYSIOL-RENAL, V286, pF625, DOI 10.1152/ajprenal.00152.2003; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	48	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61340	10.1371/journal.pone.0061340	http://dx.doi.org/10.1371/journal.pone.0061340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620745	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500025
J	Sunku, K; de Groot, HJM; Pandit, A				Sunku, Kiran; de Groot, Huub. J. M.; Pandit, Anjali			Insights into the Photoprotective Switch of the Major Light-harvesting Complex II (LHCII) A PRESERVED CORE OF ARGININE-GLUTAMATE INTERLOCKED HELICES COMPLEMENTED BY ADJUSTABLE LOOPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B-COMPLEX; ENERGY-DISSIPATION; PHOTOSYSTEM-I; CHLAMYDOMONAS-REINHARDTII; EXCITONIC INTERACTIONS; PERTURBATION-THEORY; CRYSTAL-STRUCTURE; PIGMENT-BINDING; PROTEIN; MECHANISM	Light-harvesting antennae of the LHC family form transmembrane three-helix bundles of which two helices are interlocked by conserved arginine-glutamate (Arg-Glu) ion pairs that form ligation sites for chlorophylls. The antenna proteins of photosystem II have an intriguing dual function. In excess light, they can switch their conformation from a light-harvesting into a photoprotective state, in which the excess and harmful excitation energies are safely dissipated as heat. Here we applied magic angle spinning NMR and selective Arg isotope enrichment as a noninvasive method to analyze the Arg structures of the major light-harvesting complex II (LHCII). The conformations of the Arg residues that interlock helix A and B appear to be preserved in the light-harvesting and photoprotective state. Several Arg residues have very downfield-shifted proton NMR responses, indicating that they stabilize the complex by strong hydrogen bonds. For the Arg C-alpha chemical shifts, differences are observed between LHCII in the active, light-harvesting and in the photoprotective, quenched state. These differences are attributed to a conformational change of the Arg residue in the stromal loop region. We conclude that the interlocked helices of LHCII form a rigid core. Consequently, the LHCII conformational switch does not involve changes in A/B helix tilting but likely involves rearrangements of the loops and helical segments close to the stromal and lumenal ends.	[Sunku, Kiran; de Groot, Huub. J. M.] Leiden Univ, Dept Solid State NMR, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands; [Pandit, Anjali] Vrije Univ Amsterdam, Biophys Grp, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Pandit, A (corresponding author), Vrije Univ Amsterdam, Dept Phys, Fac Sci, De Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands.	a.pandit@vu.nl	de Groot, Huub J. M./J-4741-2012; de Groot, Huub/GXV-7380-2022	de Groot, Huub J. M./0000-0002-8796-1212; sunku, kiran/0000-0002-3343-8493	HARVEST Marie Curie Research Training Network [PITN-GA-2009-238017]	HARVEST Marie Curie Research Training Network	This work was supported by the HARVEST Marie Curie Research Training Network (Grant PITN-GA-2009-238017).	ABRAHAM RJ, 1983, J AM CHEM SOC, V105, P5734, DOI 10.1021/ja00356a005; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; DITCHFIELD R, 1981, CHEM PHYS, V63, P185, DOI 10.1016/0301-0104(81)80320-5; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Facelli JC, 1998, J PHYS CHEM B, V102, P2111, DOI 10.1021/jp9800970; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Johnson MP, 2011, PLANT SIGNAL BEHAV, V6, P1386, DOI 10.4161/psb.6.9.16503; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Kirchhoff H, 2011, P NATL ACAD SCI USA, V108, P20248, DOI 10.1073/pnas.1104141109; Kruger TPJ, 2010, BIOPHYS J, V98, P3093, DOI 10.1016/j.bpj.2010.03.028; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liao PN, 2012, PHOTOSYNTH RES, V111, P237, DOI 10.1007/s11120-011-9690-9; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MCWEENY R, 1962, PHYS REV, V126, P1028, DOI 10.1103/PhysRev.126.1028; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Pandit A, 2013, BBA-BIOENERGETICS, V1827, P738, DOI 10.1016/j.bbabio.2013.02.015; Pandit A, 2012, PHOTOSYNTH RES, V111, P219, DOI 10.1007/s11120-011-9674-9; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Pandit A, 2011, BBA-BIOENERGETICS, V1807, P437, DOI 10.1016/j.bbabio.2011.01.007; Pandit A, 2010, J PHYS CHEM B, V114, P6207, DOI 10.1021/jp100688u; Pandit A, 2010, BIOCHEMISTRY-US, V49, P478, DOI 10.1021/bi9016236; Park SH, 2005, J MOL BIOL, V350, P310, DOI 10.1016/j.jmb.2005.05.004; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Gammeren AJ, 2005, J BIOMOL NMR, V31, P279, DOI 10.1007/s10858-005-1604-8; van Gammeren AJ, 2005, J AM CHEM SOC, V127, P3213, DOI 10.1021/ja044215a; van Oort B, 2011, PHYS CHEM CHEM PHYS, V13, P12614, DOI 10.1039/c1cp20331b; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wawrzyniak PK, 2008, PHYS CHEM CHEM PHYS, V10, P6971, DOI 10.1039/b810457c; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; WOLINSKI K, 1980, MOL PHYS, V41, P1419, DOI 10.1080/00268978000103631; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009	62	10	10	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19796	19804		10.1074/jbc.M113.456111	http://dx.doi.org/10.1074/jbc.M113.456111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23629658	Green Published, hybrid			2022-12-25	WOS:000321515800048
J	Malik, RU; Ritt, M; DeVree, BT; Neubig, RR; Sunahara, RK; Sivaramakrishnan, S				Malik, Rabia U.; Ritt, Michael; DeVree, Brian T.; Neubig, Richard R.; Sunahara, Roger K.; Sivaramakrishnan, Sivaraj			Detection of G Protein-selective G Protein-coupled Receptor (GPCR) Conformations in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; TERNARY COMPLEX MODEL; BETA(2)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVATION; RETINITIS-PIGMENTOSA; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; INVERSE AGONISTS; MOLECULAR-BASIS	Although several recent studies have reported that GPCRs adopt multiple conformations, it remains unclear how subtle conformational changes are translated into divergent downstream responses. In this study, we report on a novel class of FRET-based sensors that can detect the ligand/mutagenic stabilization of GPCR conformations that promote interactions with G proteins in live cells. These sensors rely on the well characterized interaction between a GPCR and the C terminus of a G alpha subunit. We use these sensors to elucidate the influence of the highly conserved (E/D) RY motif on GPCR conformation. Specifically, Glu/Asp but not Arg mutants of the (E/D) RY motif are known to enhance basal GPCR signaling. Hence, it is unclear whether ionic interactions formed by the (E/D) RY motif ( ionic lock) are necessary to stabilize basal GPCR states. We find that mutagenesis of the beta 2-AR (E/D) RY ionic lock enhances interaction with G(s). However, only Glu/Asp but not Arg mutants increase G protein activation. In contrast, mutagenesis of the opsin (E/D) RY ionic lock does not alter its interaction with transducin. Instead, opsin-specific ionic interactions centered on residue Lys-296 are both necessary and sufficient to promote interactions with transducin. Effective suppression of beta 2-AR basal activity by inverse agonist ICI 118,551 requires ionic interactions formed by the (E/D) RY motif. In contrast, the inverse agonist metoprolol suppresses interactions with G(s) and promotes G(i) binding, with concomitant pertussis toxin-sensitive inhibition of adenylyl cyclase activity. Taken together, these studies validate the use of the new FRET sensors while revealing distinct structural mechanisms for ligand-dependent GPCR function.	[Malik, Rabia U.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [DeVree, Brian T.; Neubig, Richard R.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu	soler, martha maricel m gomez/L-6025-2014; DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020	soler, martha maricel m gomez/0000-0002-4412-8108; Neubig, Richard/0000-0003-0501-0008; DeVree, Brian/0000-0003-0582-8125	American Heart Association National Scientist Development Grant [13SDG14270009]; McKay award; Rackham Merit fellowship	American Heart Association National Scientist Development Grant(American Heart Association); McKay award; Rackham Merit fellowship	This work was supported by American Heart Association National Scientist Development Grant 13SDG14270009 and McKay award (to S. S.) and the Rackham Merit fellowship (to R. U. M.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Clark MJ, 2004, J PHARMACOL EXP THER, V310, P215, DOI 10.1124/jpet.103.064824; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Lem J, 2004, TRENDS MOL MED, V10, P150, DOI 10.1016/j.molmed.2004.02.009; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Musarella M. A., 2011, J OPHTHALMOL, P1; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Rudling JE, 2000, BRIT J PHARMACOL, V131, P933, DOI 10.1038/sj.bjp.0703644; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	44	49	49	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17167	17178		10.1074/jbc.M113.464065	http://dx.doi.org/10.1074/jbc.M113.464065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629648	hybrid, Green Published			2022-12-25	WOS:000320380600014
J	Ye, F; Zhang, J; Liu, HC; Hilgenfeld, R; Zhang, RH; Kong, XQ; Li, LC; Lu, JY; Zhang, XL; Li, DH; Jiang, HL; Yang, CG; Luo, C				Ye, Fei; Zhang, Jie; Liu, Hongchuan; Hilgenfeld, Rolf; Zhang, Ruihan; Kong, Xiangqian; Li, Lianchun; Lu, Junyan; Zhang, Xinlei; Li, Donghai; Jiang, Hualiang; Yang, Cai-Guang; Luo, Cheng			Helix Unfolding/Refolding Characterizes the Functional Dynamics of Staphylococcus aureus Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENERGY LANDSCAPE; STRESS TOLERANCE; BETA-LACTONES; RECOGNITION; VIRULENCE; INSIGHTS; ASSOCIATION; ACTIVATION; TERMINUS	The ATP-dependent Clp protease (ClpP) plays an essential role not only in the control of protein quality but also in the regulation of bacterial pathogen virulence, making it an attractive target for antibacterial treatment. We have previously determined the crystal structures of Staphylococcus aureus ClpP (SaClpP) in two different states, extended and compressed. To investigate the dynamic switching of ClpP between these states, we performed a series of molecular dynamics simulations. During the structural transition, the long and straight helix E in the extended SaClpP monomer underwent an unfolding/refolding process, resulting in a kinked helix very similar to that in the compressed monomer. As a stable intermediate in the molecular dynamics simulation, the compact state was suggested and subsequently identified in x-ray crystallographic experiment. Our combined studies also determined that Ala(140) acted as a "hinge" during the transition between the extended and compressed states, and Glu(137) was essential for stabilizing the compressed state. Overall, this study provides molecular insights into the dynamics and mechanism of the functional conformation changes of SaClpP. Given the highly conserved sequences of ClpP proteins among different species, these findings potentially reflect a switching mechanism for the dynamic process shared in the whole ClpP family in general and thus aid in better understand the principles of Clp protease assembly and function.	[Ye, Fei; Zhang, Jie; Liu, Hongchuan; Hilgenfeld, Rolf; Zhang, Ruihan; Kong, Xiangqian; Li, Lianchun; Lu, Junyan; Zhang, Xinlei; Jiang, Hualiang; Yang, Cai-Guang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23538 Lubeck, Germany; [Zhang, Xinlei] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Peoples R China; [Li, Donghai] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Yang, Cai-Guang] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Lubeck; Air Force Military Medical University; Nanjing University; Lanzhou University	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; yangcg@simm.ac.cn; cluo@mail.shcnc.ac.cn	zhang, ruihan/GZA-3812-2022; Kong, Xiangqian/J-4500-2017; Hilgenfeld, Rolf/C-9675-2011	Kong, Xiangqian/0000-0002-9596-7825; Lu, Junyan/0000-0002-9211-0746; Zhang, Ruihan/0000-0002-7350-1370	National High Technology Research and Development Program of China [2012AA020302]; National Natural Science Foundation of China [21172234, 90913010, 81230076, 21210003, 21021063]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2013ZX09507-004]; Key Project of Chinese National Programs for Fundamental Research and Development [2009CB918502]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2010T1S6]; Deutsche Forschungsgemeinschaft Cluster of Excellence [306]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; Key Project of Chinese National Programs for Fundamental Research and Development; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; Deutsche Forschungsgemeinschaft Cluster of Excellence(German Research Foundation (DFG))	This work was supported in part by National High Technology Research and Development Program of China Grant 2012AA020302; National Natural Science Foundation of China Grants 21172234, 90913010, 81230076, 21210003, and 21021063; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2013ZX09507-004; and Key Project of Chinese National Programs for Fundamental Research and Development Grant 2009CB918502.; Supported by a Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, Grant 2010T1S6, and by Deutsche Forschungsgemeinschaft Cluster of Excellence 306.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BUSHEY MM, 1989, J CHROMATOGR, V480, P301, DOI 10.1016/S0021-9673(01)84299-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Fletcher R., 1980, PRACTICAL METHODS OP, V1, P1; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Garcia AE, 2001, PROTEINS, V42, P345, DOI 10.1002/1097-0134(20010215)42:3<345::AID-PROT50>3.0.CO;2-H; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maglica Z, 2009, STRUCTURE, V17, P508, DOI 10.1016/j.str.2009.02.014; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walsh C, 2005, CHEM REV, V105, P391, DOI 10.1021/cr030100y; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Williams KJ, 2009, CURR OPIN INVEST DR, V10, P157; Wong P, 2004, J STRUCT BIOL, V146, P79, DOI 10.1016/j.jsb.2003.11.006; YANG AS, 1994, J MOL BIOL, V237, P602, DOI 10.1006/jmbi.1994.1258; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	54	32	32	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17643	17653		10.1074/jbc.M113.452714	http://dx.doi.org/10.1074/jbc.M113.452714			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625918	hybrid, Green Published			2022-12-25	WOS:000320380600055
J	Sundivakkam, PC; Natarajan, V; Malik, AB; Tiruppathi, C				Sundivakkam, Premanand C.; Natarajan, Viswanathan; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Store-operated Ca2(+) Entry (SOCE) Induced by Protease-activated Receptor-1 Mediates STIM1 Protein Phosphorylation to Inhibit SOCE in Endothelial Cells through AMP-activated Protein Kinase and p38 beta Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; P38 MAP-KINASES; CA2+ ENTRY; CALCIUM-ENTRY; TRPC1 EXPRESSION; TARGET SITES; CHANNELS; PATHWAY; ORAI1; CRAC	The Ca2(+) sensor STIM1 is crucial for activation of store-operated Ca2(+) entry (SOCE) through transient receptor potential canonical and Orai channels. STIM1 phosphorylation serves as an "off switch" for SOCE. However, the signaling pathway for STIM1 phosphorylation is unknown. Here, we show that SOCE activates AMP-activated protein kinase (AMPK); its effector p38 beta mitogen-activated protein kinase (p38 beta MAPK) phosphorylates STIM1, thus inhibiting SOCE in human lung microvascular endothelial cells. Activation of AMPK using 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside (AICAR) resulted in STIM1 phosphorylation on serine residues and prevented protease-activated receptor-1 (PAR-1)-induced Ca2(+) entry. Furthermore, AICAR pretreatment blocked PAR-1-induced increase in the permeability of mouse lung microvessels. Activation of SOCE with thrombin caused phosphorylation of isoform beta 1 but not beta 2 of theAMPKcatalytic subunit. Moreover, knockdown of AMPK beta 1 augmented SOCE induced by thrombin. Interestingly, SB203580, a selective inhibitor of p38 MAPK, blocked STIM1 phosphorylation and led to sustained STIM1puncta formation and Ca2(+) entry. Of the three p38 MAPK isoforms expressed in endothelial cells, p38 beta knockdown prevented PAR-1-mediated STIM1 phosphorylation and potentiated SOCE. In addition, inhibition of the SOCE downstream target CaM kinase kinase beta (CaMKK beta) or knockdown of AMPK beta 1 suppressed PAR-1-mediated phosphorylation of p38 beta and hence STIM1. Thus, our findings demonstrate that SOCE activates CaMKK beta-AMPK beta 1-p38 beta MAPK signaling to phosphorylate STIM1, thereby suppressing endothelial SOCE and permeability responses.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol MC868, Coll Med, 835 South Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu		Malik, Asrar/0000-0002-8205-7128	National Institutes of Health [GM058531, P01HL077806]; postdoctoral fellowship from Midwest Affiliate American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); postdoctoral fellowship from Midwest Affiliate American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM058531 and P01HL077806. This work was also supported by a postdoctoral fellowship from Midwest Affiliate American Heart Association (to P.C.S.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Ferrari G, 2012, MOL CANCER RES, V10, P605, DOI 10.1158/1541-7786.MCR-11-0507; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Thors B, 2011, BBA-MOL CELL RES, V1813, P322, DOI 10.1016/j.bbamcr.2010.12.001; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	43	41	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17030	17041		10.1074/jbc.M112.411272	http://dx.doi.org/10.1074/jbc.M112.411272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625915	Green Published, hybrid			2022-12-25	WOS:000320378900074
J	Wallin, H; Abrahamson, M; Ekstrom, U				Wallin, Hanna; Abrahamson, Magnus; Ekstrom, Ulf			Cystatin C Properties Crucial for Uptake and Inhibition of Intracellular Target Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITORS; BREAST-CANCER CELLS; CATHEPSIN-B; PROTEASE INHIBITORS; ESCHERICHIA-COLI; REACTIVE-SITE; EXPRESSION; INVASION; RECEPTOR; BINDING	To elucidate the molecular requirements for cancer cell internalization of the extracellular cysteine protease inhibitor cystatin C, 12 variants of the protein were produced and used for uptake experiments in MCF-7 cells. Variants with alterations in the cysteine cathepsin binding region (( Delta 1-10)-, K5A-, R8G-, (R8G, L9G, V10G)-, (R8G, L9G, V10G, W106G)-, and W106Gcystatin C) were internalized to a very low extent compared with the wild-type inhibitor. Substitutions of N39 in the legumain binding region (N39K-and N39A-cystatin C) decreased the internalization and (R24A, R25A)-cystatin C, with substitutions of charged residues not involved in enzyme inhibition, was not taken up at all. Two variants, W106F-and K75A-cystatin C, showed that the internalization can be positively affected by engineering of the cystatin molecule. Microscopy revealed vesicular co-localization of internalized cystatin C with the lysosomal marker proteins cathepsin D and legumain. Activities of both cysteine cathepsins and legumain, possible target enzymes associated with cancer cell invasion and metastasis, were down-regulated in cell homogenates following cystatin C uptake. A positive effect on regulation of intracellular enzyme activity by a cystatin variant selected from uptake properties was illustrated by incubating cells with W106Fcystatin C. This resulted in more efficient down-regulation of intracellular legumain activity than when cells were incubated with wild-type cystatin C. Uptake experiments in prostate cancer cells corroborated that the cystatin C internalization is generally relevant and confirmed an increased uptake of W106F-cystatin C, in PC3 cells. Thus, intracellular cysteine proteases involved in cancer-promoting processes might be controled by cystatin uptake.	[Wallin, Hanna; Abrahamson, Magnus; Ekstrom, Ulf] Lund Univ, Dept Lab Med, SE-22185 Lund, Sweden	Lund University	Abrahamson, M (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem & Pharmacol, SE-22185 Lund, Sweden.	Magnus.Abrahamson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022		Faculty of Medicine at Lund University and BioCARE; Swedish Research Council [05196]; Osterberg Foundation	Faculty of Medicine at Lund University and BioCARE; Swedish Research Council(Swedish Research CouncilEuropean Commission); Osterberg Foundation	This study was supported by the Faculty of Medicine at Lund University and BioCARE, and in part by grants from the Swedish Research Council (no. 05196) and the A. Osterberg Foundation.	ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Alvarez-Fernandez M, 2005, J BIOL CHEM, V280, P18221, DOI 10.1074/jbc.M411914200; BASTHOLM L, 1994, BIOTECH HISTOCHEM, V69, P61, DOI 10.3109/10520299409106263; Bjork I, 1996, BIOCHEMISTRY-US, V35, P10720, DOI 10.1021/bi960420u; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Chen XB, 2010, BIOCHEM BIOPH RES CO, V391, P1070, DOI 10.1016/j.bbrc.2009.12.022; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; DALBOGE H, 1989, GENE, V79, P325, DOI 10.1016/0378-1119(89)90214-X; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Ekstrom U, 2008, FEBS J, V275, P4571, DOI 10.1111/j.1742-4658.2008.06600.x; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; Ishibashi O, 1999, Cancer Biochem Biophys, V17, P69; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Kolkhorst V, 1998, J CANCER RES CLIN, V124, P598, DOI 10.1007/s004320050221; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCADDAN PB, 1993, INVAS METAST, V13, P301; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Xing R, 1998, BIOCHEM J, V336, P667, DOI 10.1042/bj3360667; Xing RY, 1998, CANCER RES, V58, P904	37	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17019	17029		10.1074/jbc.M113.453449	http://dx.doi.org/10.1074/jbc.M113.453449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629651	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000320378900073
J	Alter, MD				Alter, Mark D.			Studying Gene Expression System Regulation at the Program Level	PLOS ONE			English	Article							SELF-ORGANIZATION; CHAOS; NETWORKS; GENOME	Understanding how gene expression systems influence biological outcomes is an important goal for diverse areas of research. Gene expression profiling allows for the simultaneous measurement of expression levels for thousands of genes and the opportunity to use this information to increase biological understanding. Yet, the best way to relate this immense amount of information to biological outcomes is far from clear. Here, a novel approach to gene expression systems research is presented that focuses on understanding gene expression systems at the level of gene expression program regulation. It is suggested that such an approach has important advantages over current techniques and may provide novel insights into how gene expression systems are regulated to shape biological outcomes such as the development of disease or response to treatment.	Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	University of Pennsylvania	Alter, MD (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	markalter1968@gmail.com			National Institute of Mental Health [5K08MH080228-01A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080228] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding from the National Institute of Mental Health - 5K08MH080228-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BARTON S, 1994, AM PSYCHOL, V49, P5, DOI 10.1037/0003-066X.49.1.5; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; CARPENTER GA, 1987, ANN NY ACAD SCI, V504, P33, DOI 10.1111/j.1749-6632.1987.tb48724.x; Coffey DS, 1998, NAT MED, V4, P882, DOI 10.1038/nm0898-882; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Gandal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041215; Gandal MJ, 2012, PLOS ONE IN PRESS; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Lopez-Boado YS, 2010, INHAL TOXICOL, V22, P234, DOI 10.3109/08958370903191437; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rogge GA, 2012, NEUROPSYCHOPHARMACOL; Skar P, 2004, J ANAL PSYCHOL, V49, P243, DOI 10.1111/j.1465-5922.2004.00456.x; Skinner JE, 1996, INTEGR PHYS BEH SCI, V31, P122, DOI 10.1007/BF02699784; Wall MichaelE., 2003, SINGULAR VALUE DECOM; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61324	10.1371/journal.pone.0061324	http://dx.doi.org/10.1371/journal.pone.0061324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626674	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400035
J	Nordfeldt, S; Angarne-Lindberg, T; Nordwall, M; Krevers, B				Nordfeldt, Sam; Angarne-Lindberg, Teresia; Nordwall, Maria; Krevers, Barbro			Parents of Adolescents with Type 1 Diabetes - Their Views on Information and Communication Needs and Internet Use. A Qualitative Study	PLOS ONE			English	Article							YOUNG-CHILDREN; PATIENT; CARE; RESPONSIBILITY; INTERVENTIONS; SYMPTOMS; SIBLINGS; STRESS; TRUST; YOUTH	Background: Little is known about parents' views on the use of online resources for information, education and support regarding childhood type 1 diabetes (T1DM). Considering the rapidly evolving new communication practices, parents' perspectives need to be explored. The main purpose of this paper was to explore parents' perceptions of their information-seeking, Internet use, and social networking online. This applied to their everyday life, including the contexts of T1DM and contact with peers. A second aim was to identify implications for future development of Internet use in this respect. Methodology/Principal Findings: Twenty-seven parents of 24 young persons aged 10-17 with T1DM participated in eight focus group interviews during their regular visits to a county hospital. Focus group discussions were video/audio-taped, transcribed and analysed using inductive qualitative content analysis. Self-reported demographic and medical information was also collected. A main theme was Finding things out, including two sub-themes, Trust and Suitability. The latter were key factors affecting parents' perceptions of online resources. Parents' choice of information source was related to the situation, previous experiences and knowledge about sources and, most importantly, the level of trust in the source. A constantly present background theme was Life situation, including two sub-themes, Roles and functions and Emotions and needs. Parents' information-seeking regarding T1DM varied greatly, and was closely associated with their life situation, the adolescents development phases and the disease trajectory. Conclusions/Significance: Health practitioners and system developers need to focus on creating trust and suitability for users' needs. They should understand the children's diverse needs, which depend on their life situation, on the children's development, and on the disease trajectory. To enhance trust in online health information and support services, the participation of local practitioners is crucial.	[Nordfeldt, Sam; Angarne-Lindberg, Teresia] Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden; [Nordfeldt, Sam] Linkoping Univ, Dept Med & Hlth Sci, Ctr Med Technol Assessment, Linkoping, Sweden; [Nordwall, Maria] Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden; [Nordwall, Maria] Vrinnevi Hosp, Paediat Clin, Norrkoping, Sweden; [Krevers, Barbro] Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nordfeldt, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden.	sam.nordfeldt@liu.se			Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden	Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden	This study was supported by the Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Barlow JH, 2004, CHILD CARE HLTH DEV, V30, P637, DOI 10.1111/j.1365-2214.2004.00474.x; Bartlett YK, 2011, PATIENT EDUC COUNS, V83, P113, DOI 10.1016/j.pec.2010.05.029; Borzekowski DLG, 2006, DEV PSYCHOL, V42, P450, DOI 10.1037/0012-1649.42.3.450; Brink SJ, 2002, J PEDIATR ENDOCR MET, V15, P1113; Elf M, 2011, INFORM HEALTH SOC CA, V36, P206, DOI 10.3109/17538157.2011.553298; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Fern E.F., 2001, ADV FOCUS GROUP RES, DOI [10.4135/9781412990028, DOI 10.4135/9781412990028]; Fox S, 2002, INTERNET USERS DECID; Grey M, 2011, NURS RES, V60, P173, DOI 10.1097/NNR.0b013e3182159c8f; Hanberger L, 2006, DIABETES RES CLIN PR, V72, P197, DOI 10.1016/j.diabres.2005.10.009; Harris PR, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1821; Jaser SS, 2011, CURR DIABETES REP, V11, P480, DOI 10.1007/s11892-011-0222-y; Karlsson A, 2008, INT J NURS STUD, V45, P562, DOI 10.1016/j.ijnurstu.2006.08.022; Kerr C, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e13; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed; Lindstrom C, 2010, ACTA PAEDIATR, V99, P427, DOI 10.1111/j.1651-2227.2009.01586.x; Loos M, 2006, SOC WORK HEALTH CARE, V43, P53, DOI 10.1300/J010v43n04_04; Lowes L, 2000, J ADV NURS, V32, P41, DOI 10.1046/j.1365-2648.2000.01418.x; Martenson EK, 2009, INT J NURS PRACT, V15, P185, DOI 10.1111/j.1440-172X.2009.01743.x; Morgan D.L., 1997, FOCUS GROUPS QUALITA, V2nd ed., DOI [10.4135/9781412984287, DOI 10.4135/9781412984287]; Nordfeldt S, 2012, J MED INTER IN PRESS; Nordfeldt S, 2012, J MED INTERNET RES, V14, P279, DOI 10.2196/jmir.1987; Nordfeldt S, 2012, FUTURE INTERNET, V4, P514, DOI 10.3390/fi4020514; Nordfeldt S, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1267; Nordqvist C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1152; Patton M.Q., 1980, QUALITATIVE RES EVAL; Patton SR, 2011, J CLIN PSYCHOL MED S, V18, P345, DOI 10.1007/s10880-011-9256-1; Peyrot M, 2009, PEDIATR DIABETES, V10, P37, DOI 10.1111/j.1399-5448.2009.00612.x; Ravert RD, 2004, DIABETES EDUCATOR, V30, P827, DOI 10.1177/014572170403000518; Smaldone A, 2011, J PEDIATR HEALTH CAR, V25, P87, DOI 10.1016/j.pedhc.2009.09.003; Stallwood L, 2006, J SPEC PEDIATR NURS, V11, P158, DOI 10.1111/j.1744-6155.2006.00062.x; Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076; Tarrant C, 2003, BRIT J GEN PRACT, V53, P798; Travaline JM, 2005, J AM OSTEOPATH ASSOC, V105, P13; Valere T, 1999, DIABETES-METAB RES, V15, P156; van't Riet A, 2001, INT J MED INFORM, V64, P1, DOI 10.1016/S1386-5056(01)00185-X; WIKBLAD KF, 1991, J ADV NURS, V16, P837, DOI 10.1111/j.1365-2648.1991.tb01765.x	39	27	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62096	10.1371/journal.pone.0062096	http://dx.doi.org/10.1371/journal.pone.0062096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626772	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400136
J	Qiu, Y; Ding, Y; Zou, LY; Tan, ZP; Liu, TP; Fu, XL; Xu, WY				Qiu, Yuan; Ding, Yan; Zou, Lingyun; Tan, Zhangping; Liu, Taiping; Fu, Xiaolan; Xu, Wenyue			Divergent Roles of Amino Acid Residues Inside and Outside the BB Loop Affect Human Toll-Like Receptor (TLR)2/2, TLR2/1 and TLR2/6 Responsiveness	PLOS ONE			English	Article							CUTTING EDGE; LEPROMATOUS LEPROSY; INNATE IMMUNITY; POLYMORPHISM; MACROPHAGES; DOMAINS; LIPOPROTEINS; CHAPERONE; MUTATION; BINDING	TLR2 specifically recognizes a wide range of ligands by homodimerizing or heterodimerizing with TLR1 or TLR6. However, the molecular basis of the specific signalling transduction induced by TLR2 homodimerization or heterodimerization with TLR1 or TLR6 is largely unknown. In this study, we found three amino acid residues, two (663L and 688N) outside and one (681P) inside the BB loop, which were conserved in all of the TLRs, except for the TLR3 toll/IL-1R(TIR) domain. The responsiveness of human TLR2/2, TLR2/1 or TLR2/6 was completely lost when 663L and 688N were replaced with the corresponding amino acid residues in the TLR3 TIR domain, respectively. However, the response of TLR2 (P681A) to the high concentration of TLR2/TLR6 agonist was almost intact, but the activity of TLR2 (P681A) was greatly reduced when stimulated with the TLR2/1 agonist or the TLR2/2 agonist. Although the surface expression of TLR2 (L663E) was sharply reduced, both the intracellular distribution and the surface expression of all of the other TLR2 mutants were unchanged. The ability of all three TLR2 mutants to recruit MyD88, was consistent with their responsivenesses. Computer modelling indicated that the surface negative charge of all of the TLR2 mutants' BB loops was reduced. Thus, our data demonstrated that the 663L and 688N residues outside of the BB loop were essential for the responsiveness of TLR2/2, TLR2/1 and TLR2/6, but the 681P residue inside of the BB loop exhibited divergent roles in TLR2/2, TLR2/1 and TLR2/6 signalling transduction, thereby providing clues regarding the specific signalling transduction of TLR2/2, TLR2/1 and TLR2/6.	[Qiu, Yuan; Ding, Yan; Tan, Zhangping; Liu, Taiping; Xu, Wenyue] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Fu, Xiaolan] Third Mil Med Univ, Inst Immunol, PLA, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Xu, WY (corresponding author), Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China.	xuwenyue@gmail.com		Xu, Wenyue/0000-0003-3681-5052	Scientific Research Innovation Foundation for Students from Third Military Medical University	Scientific Research Innovation Foundation for Students from Third Military Medical University	This work is supported by a Scientific Research Innovation Foundation for Students grant from Third Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; DUNNE A, 2003, SCI STKE, V25, pRE3; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kormann MSD, 2009, ALLERGY, V64, P636, DOI 10.1111/j.1398-9995.2008.01891.x; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yanagimoto S, 2009, J BIOL CHEM, V284, P3513, DOI 10.1074/jbc.M803086200; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	29	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61508	10.1371/journal.pone.0061508	http://dx.doi.org/10.1371/journal.pone.0061508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626692	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400056
J	Saderne, V; Fietzek, P; Herman, PMJ				Saderne, Vincent; Fietzek, Peer; Herman, Peter Maria Jozef			Extreme Variations of pCO(2) and pH in a Macrophyte Meadow of the Baltic Sea in Summer: Evidence of the Effect of Photosynthesis and Local Upwelling	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SEAGRASS PHOTOSYNTHESIS; SEAWATER ACIDIFICATION; MARINE MACROALGAE; INORGANIC CARBON; TOTAL ALKALINITY; CO2; CALCIFICATION; IMPACTS; METABOLISM	The impact of ocean acidification on benthic habitats is a major preoccupation of the scientific community. However, the natural variability of pCO(2) and pH in those habitats remains understudied, especially in temperate areas. In this study we investigated temporal variations of the carbonate system in nearshore macrophyte meadows of the western Baltic Sea. These are key benthic ecosystems, providing spawning and nursery areas as well as food to numerous commercially important species. In situ pCO(2), pH (total scale), salinity and PAR irradiance were measured with a continuous recording sensor package dropped in a shallow macrophyte meadow (Eckernforde bay, western Baltic Sea) during three different weeks in July (pCO(2) and PAR only), August and September 2011. The mean (+/- SD) pCO(2) in July was 3836117 mu atm. The mean (+/- SD) pCO(2) and pH(tot) in August were 239 +/- 20 mu atm and 8.22 +/- 0.1, respectively. The mean (+/- SD) pCO(2) and pH(tot) in September were 1082 +/- 711 mu atm and 7.83 +/- 0.40, respectively. Daily variations of pCO(2) due to photosynthesis and respiration (difference between daily maximum and minimum) were of the same order of magnitude: 281 +/- 88 mu atm, 219 +/- 89 mu atm and 1488 +/- 574 mu atm in July, August and September respectively. The observed variations of pCO(2) were explained through a statistical model considering wind direction and speed together with PAR irradiance. At a time scale of days to weeks, local upwelling of elevated pCO(2) water masses with offshore winds drives the variation. Within days, primary production is responsible. The results demonstrate the high variability of the carbonate system in nearshore macrophyte meadows depending on meteorology and biological activities. We highlight the need to incorporate these variations in future pCO(2) scenarios and experimental designs for nearshore habitats.	[Saderne, Vincent] GEOMAR Helmholtz Ctr Ocean Res Kiel, Benthic Ecol Grp, Kiel, Schleswig Holst, Germany; [Saderne, Vincent; Herman, Peter Maria Jozef] NIOZ Royal Netherlands Inst Sea Res, Yerseke, Zeeland, Netherlands; [Fietzek, Peer] CONTROS Syst & Solut GmbH, Kiel, Schleswig Holst, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Saderne, V (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Benthic Ecol Grp, Kiel, Schleswig Holst, Germany.	vsaderne@geomar.de	Herman, Peter M.J./A-9018-2011; Saderne, Vincent/ABE-5850-2020	Herman, Peter M.J./0000-0003-2188-6341; saderne, vincent/0000-0003-3968-2718; Fietzek, Peer/0000-0002-3555-1115	European community, Marie Curie ITN CALMARO [PITN-GA-2008-215157]	European community, Marie Curie ITN CALMARO	This work was funded by the European community, Marie Curie ITN CALMARO (PITN-GA-2008-215157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; ANEER G, 1989, FISH RES, V8, P169, DOI 10.1016/0165-7836(89)90030-1; Appelhans YS, 2012, MAR ECOL PROG SER, V459, P85, DOI 10.3354/meps09697; Assmann S, 2011, OCEAN SCI, V7, P597, DOI 10.5194/os-7-597-2011; BACK S, 1992, MAR ECOL PROG SER, V84, P71, DOI 10.3354/meps084071; Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; Bange HW, 2010, BIOGEOSCIENCES, V7, P1279, DOI 10.5194/bg-7-1279-2010; Bange H.W., 2011, LOICZ IN PRESS, V2011, P16; Barron C, 2003, ECOSYSTEMS, V6, P144, DOI 10.1007/s10021-002-0402-3; Barron C, 2009, MAR ECOL PROG SER, V374, P75, DOI 10.3354/meps07715; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; Beldowski J, 2010, J MARINE SYST, V81, P252, DOI 10.1016/j.jmarsys.2009.12.020; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023053; Brasse S, 1999, J SEA RES, V42, P93, DOI 10.1016/S1385-1101(99)00020-9; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fietzek P, 2011, OCEANS 2011, P1, DOI DOI 10.23919/OCEANS.2011.6107129; Fietzek P., 2010, OCEANOBS09 SUSTAINED, P1; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Gattuso JP, 1997, J PHYCOL, V33, P729, DOI 10.1111/j.0022-3646.1997.00729.x; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gazeau F, 2005, MAR ECOL PROG SER, V301, P23, DOI 10.3354/meps301023; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Grawe U, 2011, COAST RES LIBR, V1, P3, DOI 10.1007/978-94-007-0400-8_1; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hjalmarsson S, 2008, CONT SHELF RES, V28, P593, DOI 10.1016/j.csr.2007.11.010; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Israel A, 2002, GLOBAL CHANGE BIOL, V8, P831, DOI 10.1046/j.1365-2486.2002.00518.x; Karez R, 2008, KARTIERUNG MARINER P; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Krey J, 1965, KIELER MEERESFORSCH, V21, P135; Lavigne H., 2010, SEACARB SEAWATER CAR; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Melzner F., 2012, MAR BIOL; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Myrberg K, 2003, BOREAL ENVIRON RES, V8, P97; Neumann T, 2011, COAST RES LIBR, V1, P23, DOI 10.1007/978-94-007-0400-8_2; OHNO M, 1976, Internationale Revue der Gesamten Hydrobiologie, V61, P665, DOI 10.1002/iroh.3510610510; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; PEREZ FF, 1987, MAR CHEM, V21, P315, DOI 10.1016/0304-4203(87)90054-5; Rees SA, 2007, CORAL REEFS, V26, P177, DOI 10.1007/s00338-006-0166-x; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Riebesell U, 2010, GUIDE TO BEST PRACTI; Schneider B, 2011, COAST RES LIBR, V1, P33, DOI 10.1007/978-94-007-0400-8_3; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Solomon S., 2007, CLIMATE CHANGE 2007, V4; Thomas H, 1999, J MARINE SYST, V22, P53, DOI 10.1016/S0924-7963(99)00030-5; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE	65	84	86	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62689	10.1371/journal.pone.0062689	http://dx.doi.org/10.1371/journal.pone.0062689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626849	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000318008400213
J	Ahn, B; Empinado, HM; Al-Rajhi, M; Judge, AR; Ferreira, LF				Ahn, Bumsoo; Empinado, Hyacinth M.; Al-Rajhi, Monsour; Judge, Andrew R.; Ferreira, Leonardo F.			Diaphragm Atrophy and Contractile Dysfunction in a Murine Model of Pulmonary Hypertension	PLOS ONE			English	Article							MYOFIBRILLAR PROTEIN OXIDATION; RAT SKELETAL-MUSCLE; HEART-FAILURE RATS; ARTERIAL-HYPERTENSION; HYDROGEN-PEROXIDE; CARDIAC CACHEXIA; MICE; INHIBITION; EXPRESSION; MOUSE	Pulmonary hypertension (PH) causes loss of body weight and inspiratory (diaphragm) muscle dysfunction. A model of PH induced by drug (monocrotaline, MCT) has been extensively used in mice to examine the etiology of PH. However, it is unclear if PH induced by MCT in mice reproduces the loss of body weight and diaphragm muscle dysfunction seen in patients. This is a pre-requisite for widespread use of mice to examine mechanisms of cachexia and diaphragm abnormalities in PH. Thus, we measured body and soleus muscle weight, food intake, and diaphragm contractile properties in mice after 6-8 weeks of saline (control) or MCT (600 mg/kg) injections. Body weight progressively decreased in PH mice, while food intake was similar in both groups. PH decreased (P < 0.05) diaphragm maximal isometric specific force, maximal shortening velocity, and peak power. Protein carbonyls in whole-diaphragm lysates and the abundance of select myofibrillar proteins were unchanged by PH. Our findings show diaphragm isometric and isotonic contractile abnormalities in a murine model of PH induced by MCT. Overall, the murine model of PH elicited by MCT mimics loss of body weight and diaphragm muscle weakness reported in PH patients.	[Ahn, Bumsoo; Empinado, Hyacinth M.; Al-Rajhi, Monsour; Ferreira, Leonardo F.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Judge, Andrew R.] Univ Florida, Dept Phys Therapy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ferreira, LF (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.	Ferreira@hhp.ufl.edu	Ahn, Bumsoo/AAK-3818-2021; Ahn, Bumsoo/GNP-7749-2022	Ahn, Bumsoo/0000-0002-2743-7099; Ferreira, Leonardo/0000-0001-6581-5882	National Institutes of Health [R00-HL098453-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in part, by funds from National Institutes of Health grant R00-HL098453-01. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Argadine HM, 2009, J APPL PHYSIOL, V107, P438, DOI 10.1152/japplphysiol.91247.2008; Bullimore SR, 2010, CAN J PHYSIOL PHARM, V88, P937, DOI [10.1139/y10-068, 10.1139/Y10-068]; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; Canton M, 2006, EUR HEART J, V27, P875, DOI 10.1093/eurheartj/ehi751; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; Cho YJ, 2009, COMPARATIVE MED, V59, P350; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; Dalla Libera L, 2005, J MOL CELL CARDIOL, V38, P803, DOI 10.1016/j.yjmcc.2005.02.023; de Man FS, 2011, AM J RESP CRIT CARE, V183, P1411, DOI 10.1164/rccm.201003-0354OC; Degens H, 2010, PFLUG ARCH EUR J PHY, V460, P863, DOI 10.1007/s00424-010-0866-5; Dumitrascu Rio, 2008, BMC Pulm Med, V8, P25, DOI 10.1186/1471-2466-8-25; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Habedank D, 2009, INT J CARDIOL, V133, P46, DOI 10.1016/j.ijcard.2007.11.077; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Humbert M, 2007, CHEST, V132, P365, DOI 10.1378/chest.07-0903; Ismail HM, 2007, J GEN INTERN MED, V22, P148, DOI 10.1007/s11606-006-0032-0; Kabitz HJ, 2008, CLIN SCI, V114, P165, DOI 10.1042/CS20070238; Kanj NA, 1999, TOXICOL LETT, V105, P177, DOI 10.1016/S0378-4274(98)00398-1; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; le Roux CW, 2005, HEART, V91, P241, DOI 10.1136/hrt.2003.026880; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Machiels HA, 2001, ACTA PHYSIOL SCAND, V173, P313, DOI 10.1046/j.1365-201X.2001.00895.x; Manders E, 2012, AM J PHYSIOL-LUNG C, V303, pL1070, DOI 10.1152/ajplung.00135.2012; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; MOLTENI A, 1989, VIRCHOWS ARCH B, V57, P149, DOI 10.1007/BF02899076; Moopanar TR, 2005, J PHYSIOL-LONDON, V564, P189, DOI 10.1113/jphysiol.2005.083519; Nih/Od/Oer/Olaw, 2010, GUID CAR US LAB AN; Nishii Y, 2006, J THROMB HAEMOST, V4, P2331, DOI 10.1111/j.1538-7836.2006.02174.x; Ottenheijm CAC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-12; Qin L, 2010, J THROMB HAEMOST, V8, P808, DOI 10.1111/j.1538-7836.2010.03751.x; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rubenfire M, 2007, CRIT CARE CLIN, V23, P801, DOI 10.1016/j.ccc.2007.07.006; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Schwaiblmair M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-23; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; Steffen BT, 2008, J APPL PHYSIOL, V105, P1950, DOI 10.1152/japplphysiol.90884.2008; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Hees HWH, 2008, INT J CARDIOL, V128, P326, DOI 10.1016/j.ijcard.2007.06.080; van Hees HWH, 2008, AM J PHYSIOL-LUNG C, V294, pL1260, DOI 10.1152/ajplung.00035.2008; Vescovo G, 1998, J MOL CELL CARDIOL, V30, P2449, DOI 10.1006/jmcc.1998.0807; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468	47	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62702	10.1371/journal.pone.0062702	http://dx.doi.org/10.1371/journal.pone.0062702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614054	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500098
J	Geyeregger, R; Freimuller, C; Stevanovic, S; Stemberger, J; Mester, G; Dmytrus, J; Lion, T; Rammensee, HG; Fischer, G; Eiz-Vesper, B; Lawitschka, A; Matthes, S; Fritsch, G				Geyeregger, Rene; Freimueller, Christine; Stevanovic, Stefan; Stemberger, Julia; Mester, Gabor; Dmytrus, Jasmin; Lion, Thomas; Rammensee, Hans-Georg; Fischer, Gottfried; Eiz-Vesper, Britta; Lawitschka, Anita; Matthes, Susanne; Fritsch, Gerhard			Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application	PLOS ONE			English	Article							ADENOVIRUS INFECTION; ADOPTIVE TRANSFER; PERIPHERAL-BLOOD; IMMUNE RECONSTITUTION; PEDIATRIC RECIPIENTS; TRANSPLANT PATIENTS; PREEMPTIVE THERAPY; MULTIPLE VIRUSES; CYTOMEGALOVIRUS; CD8(+)	Adenoviral infections are a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients. Adoptive transfer of donor-derived human adenovirus (HAdV)-specific T-cells represents a promising treatment option. However, the difficulty in identifying and selecting rare HAdV-specific T-cells, and the short time span between patients at high risk for invasive infection and viremia are major limitations. We therefore developed an IL-15-driven 6 to 12 day short-term protocol for in vitro detection of HAdV-specific T cells, as revealed by known MHC class I multimers and a newly identified adenoviral CD8 T-cell epitope derived from the E1A protein for the frequent HLA-type A*02: 01 and IFN-gamma. Using this novel and improved diagnostic approach we observed a correlation between adenoviral load and reconstitution of CD8(+) and CD4(+) HAdV-specific T-cells including central memory cells in HSCT-patients. Adaption of the 12-day protocol to good manufacturing practice conditions resulted in a 2.6-log (mean) expansion of HAdV-specific T-cells displaying high cytolytic activity (4-fold) compared to controls and low or absent alloreactivity. Similar protocols successfully identified and rapidly expanded CMV-, EBV-, and BKV-specific T-cells. Our approach provides a powerful clinical-grade convertible tool for rapid and cost-effective detection and enrichment of multiple virus-specific T-cells that may facilitate broad clinical application.	[Geyeregger, Rene; Freimueller, Christine; Stemberger, Julia; Dmytrus, Jasmin; Fritsch, Gerhard] St Anna Childrens Hosp, Childrens Canc Res Inst, Dept Clin Cell Biol, A-1090 Vienna, Austria; [Geyeregger, Rene; Freimueller, Christine; Stemberger, Julia; Dmytrus, Jasmin; Fritsch, Gerhard] St Anna Childrens Hosp, Childrens Canc Res Inst, FACS Core Unit, A-1090 Vienna, Austria; [Lion, Thomas; Lawitschka, Anita; Matthes, Susanne; Fritsch, Gerhard] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Lion, Thomas] St Anna Childrens Hosp, Childrens Canc Res Inst, Dept Mol Microbiol, A-1090 Vienna, Austria; [Stevanovic, Stefan; Mester, Gabor; Rammensee, Hans-Georg] Univ Tubingen, Dept Immunol, Inst Cell Biol, Tubingen, Germany; [Fischer, Gottfried] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Lawitschka, Anita; Matthes, Susanne] St Anna Childrens Hosp, Dept Stem Cell Transplantat, A-1090 Vienna, Austria	Saint Anna Children's Hospital; Saint Anna Children's Hospital; Medical University of Vienna; Saint Anna Children's Hospital; Eberhard Karls University of Tubingen; Medical University of Vienna; Hannover Medical School; Saint Anna Children's Hospital	Geyeregger, R (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, Dept Clin Cell Biol, Kinderspitalgasse 6, A-1090 Vienna, Austria.	rene.geyeregger@ccri.at	Lion, MD, PhD, Professor, Thomas/C-3241-2016	Lion, MD, PhD, Professor, Thomas/0000-0001-9346-0994	Eurostars Grant [E! 5744 (FFG 829495)]; Clinical Trial Investigator Driven (CTID)-RG-Matthes; German Children's Cancer Foundation	Eurostars Grant; Clinical Trial Investigator Driven (CTID)-RG-Matthes; German Children's Cancer Foundation	This work was supported in part by grants from Eurostars Grant E! 5744 (FFG 829495), Clinical Trial Investigator Driven (CTID)-RG-Matthes and the German Children's Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abate D, 2012, TRANSPLANTATION, V93, P536, DOI 10.1097/TP.0b013e31824215db; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Comoli P, 2008, BLOOD CELL MOL DIS, V40, P68, DOI 10.1016/j.bcmd.2007.06.020; Comoli P, 2007, AM J TRANSPLANT, V7, P1648, DOI 10.1111/j.1600-6143.2007.01823.x; Dohnal AM, 2009, J CELL MOL MED, V13, P125, DOI 10.1111/j.1582-4934.2008.00304.x; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Feuchtinger T, 2006, BRIT J HAEMATOL, V134, P64, DOI 10.1111/j.1365-2141.2006.06108.x; Feuchtinger T, 2005, BRIT J HAEMATOL, V128, P503, DOI 10.1111/j.1365-2141.2004.05331.x; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; George D, 2012, BRIT J HAEMATOL, V156, P99, DOI 10.1111/j.1365-2141.2010.08468.x; Gerdemann U, 2012, MOL THER, V20, P1622, DOI 10.1038/mt.2012.130; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Gratama JW, 2010, BLOOD, V116, P1655, DOI 10.1182/blood-2010-03-273508; Guerin-El Khourouj V, 2011, BIOL BLOOD MARROW TR, V17, P476, DOI 10.1016/j.bbmt.2010.09.010; Heemskerk B, 2005, J INFECT DIS, V191, P520, DOI 10.1086/427513; Hoffman JA, 2001, BIOL BLOOD MARROW TR, V7, P388, DOI 10.1053/bbmt.2001.v7.pm11529489; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Lankester AC, 2004, CLIN INFECT DIS, V38, P1521, DOI 10.1086/420817; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Leen AM, 2009, BLOOD, V114, P4283, DOI 10.1182/blood-2009-07-232454; Linn YC, 2012, BONE MARROW TRANSPL, V47, P957, DOI 10.1038/bmt.2011.202; Lion T, 2003, BLOOD, V102, P1114, DOI 10.1182/blood-2002-07-2152; Lion T, 2010, LEUKEMIA, V24, P706, DOI 10.1038/leu.2010.4; Melenhorst JJ, 2010, BLOOD, V116, P4700, DOI 10.1182/blood-2010-06-289991; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Myers GD, 2005, BONE MARROW TRANSPL, V36, P1001, DOI 10.1038/sj.bmt.1705164; Ohrmalm L, 2011, BONE MARROW TRANSPL, V46, P267, DOI 10.1038/bmt.2010.86; Olive M, 2002, HUM GENE THER, V13, P1167, DOI 10.1089/104303402320138952; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Schilham MW, 2002, CLIN INFECT DIS, V35, P526, DOI 10.1086/341770; Schipper RF, 1996, HUM IMMUNOL, V51, P95, DOI 10.1016/S0198-8859(96)00138-3; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Sellar RS, 2012, CYTOTHERAPY, V14, P391, DOI 10.3109/14653249.2012.662769; Serangeli C, 2010, VIROLOGY, V397, P277, DOI 10.1016/j.virol.2009.10.049; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Symeonidis N, 2007, TRANSPL INFECT DIS, V9, P108, DOI 10.1111/j.1399-3062.2006.00184.x; Uhlin M, 2012, CLIN INFECT DIS; Vellinga J, 2005, J VIROL, V79, P3206, DOI 10.1128/JVI.79.5.3206-3210.2005; Veltrop-Duits LA, 2006, EUR J IMMUNOL, V36, P2410, DOI 10.1002/eji.200535786; Watcharananan SP, 2010, PEDIATR TRANSPLANT, V14, P675, DOI 10.1111/j.1399-3046.2010.01325.x; Zandvliet ML, 2012, J IMMUNOTHER, V35, P142, DOI 10.1097/CJI.0b013e318243f1ed; Zandvliet ML, 2011, J IMMUNOTHER, V34, P307, DOI 10.1097/CJI.0b013e318213cb90; Zandvliet ML, 2010, HAEMATOL-HEMATOL J, V95, P1943, DOI 10.3324/haematol.2010.022947	49	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e59592	10.1371/journal.pone.0059592	http://dx.doi.org/10.1371/journal.pone.0059592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630567	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500003
J	Chay, WY; Chew, SH; Ong, WS; Busmanis, I; Li, XY; Thung, S; Ngo, L; Lim, SL; Lim, YK; Chia, YN; Koh, E; Pang, C; Soh, LT; Wang, J; Ho, TH; Tay, SK; Lim-Tan, SK; Lim, KH; Chia, JWK; Goh, LK				Chay, Wen-Yee; Chew, Sung-Hock; Ong, Whee-Sze; Busmanis, Inny; Li, Xinyun; Thung, Sharyl; Ngo, Lynette; Lim, Sheow-Lei; Lim, Yong-Kuei; Chia, Yin-Nin; Koh, Elisa; Pang, Cindy; Soh, Lay-Tin; Wang, Jin; Ho, Tew-Hong; Tay, Sun-Kuie; Lim-Tan, Soo-Kim; Lim, Kiat-Hon; Chia, John Whay-Kuang; Goh, Liang-Kee			HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer	PLOS ONE			English	Article							GASTRIC-CANCER; VALIDATION; TUMORS	Mucinous epithelial ovarian cancer has a poor prognosis in the advanced stages and responds poorly to conventional chemotherapy. We aim to elucidate the clinicopathological factors and incidence of HER2 expression of this cancer in a large Asian retrospective cohort from Singapore. Of a total of 133 cases, the median age at diagnosis was 48.3 years (range, 15.8-89.0 years), comparatively younger than western cohorts. Most were Chinese (71%), followed by Malays (16%), others (9.0%), and Indians (5%). 24% were noted to have a significant family history of malignancy of which breast and gastrointestinal cancers the most prominent. Majority of the patients (80%) had stage I disease at diagnosis. Information on HER2 status was available in 113 cases (85%). Of these, 31 cases (27.4%) were HER2+, higher than 18.8% reported in western population. HER2 positivity appeared to be lower among Chinese and higher among Malays patients (p = 0.052). With the current standard of care, there was no discernible impact of HER2 status on overall survival. (HR = 1.79; 95% CI, 0.66-4.85; p = 0.249). On the other hand, positive family history of cancer, presence of lymphovascular invasion, and ovarian surface involvements were significantly associated with inferior overall survival on univariate and continued to be statistically significant after adjustment for stage. While these clinical factors identify high risk patients, it is promising that the finding of a high incidence of HER2 in our Asian population may allow development of a HER2 targeted therapy to improve the management of mucinous ovarian cancers.	[Chay, Wen-Yee; Ngo, Lynette; Soh, Lay-Tin; Chia, John Whay-Kuang] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Chew, Sung-Hock; Lim-Tan, Soo-Kim] KK Women & Childrens Hosp, Dept Pathol, Singapore, Singapore; [Ong, Whee-Sze] Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Busmanis, Inny; Lim, Kiat-Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Li, Xinyun; Thung, Sharyl] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lim, Sheow-Lei; Lim, Yong-Kuei; Chia, Yin-Nin] KK Women & Childrens Hosp, Dept Gynecol Oncol, Singapore, Singapore; [Koh, Elisa; Pang, Cindy; Ho, Tew-Hong; Tay, Sun-Kuie] Singapore Gen Hosp, Dept Obstet & Gynecol, Singapore, Singapore; [Wang, Jin; Goh, Liang-Kee] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Goh, Liang-Kee] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); KK Women's & Children's Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; KK Women's & Children's Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore	Chay, WY (corresponding author), Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore.	chay.w.y@nccs.com.sg; liang.goh@duke-nus.edu.sg			Khoo Discovery Award [KDP/2008/0002, KDP/2009/0006]; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR); Ministry of Health, Singapore	Khoo Discovery Award; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore)	This study was supported by the Khoo Discovery Award (KDP/2008/0002 and KDP/2009/0006) and Duke-NUS Signature Research Program Phase 1 funded by the Agency for Science, Technology and Research (A*STAR), and the Ministry of Health, Singapore, awarded to LKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2013, J PATHOL, V229, P111, DOI 10.1002/path.4088; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Elsawaf Z, 2011, BREAST CARE, V6, P273, DOI 10.1159/000331643; Gram IT, 2012, INT J CANCER, V130, P2204, DOI 10.1002/ijc.26235; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Gurung A, 2013, HISTOPATHOLOGY, V62, P59, DOI 10.1111/his.12033; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Huang RY, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-47; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kurman RJ, 2000, HUM PATHOL, V31, P1439, DOI 10.1016/S0046-8177(00)80020-9; McAlpine JN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-433; McCaughan H, 2012, J CLIN PATHOL, V65, P670, DOI 10.1136/jclinpath-2011-200616; Pectasides D, 2005, GYNECOL ONCOL, V97, P436, DOI 10.1016/j.ygyno.2004.12.056; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Schiavone MB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.049; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Yan B, 2011, J CLIN PATHOL, V64, P1097, DOI 10.1136/jclinpath-2011-200082	20	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61565	10.1371/journal.pone.0061565	http://dx.doi.org/10.1371/journal.pone.0061565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620766	Green Published, gold			2022-12-25	WOS:000317909500046
J	Nys, J; Smulski, CR; Tardivel, A; Willen, L; Kowalczyk, C; Donze, O; Huard, B; Hess, H; Schneider, P				Nys, Josquin; Smulski, Cristian R.; Tardivel, Aubry; Willen, Laure; Kowalczyk, Christine; Donze, Olivier; Huard, Bertrand; Hess, Henry; Schneider, Pascal			No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR FAMILY; B-LYMPHOCYTE STIMULATOR; ACTIVATING FACTOR; DEFICIENT MICE; DENDRITIC CELLS; CUTTING EDGE; FC-RECEPTORS; PLASMA-CELLS; TNF-ALPHA	Myeloid cells express the TNF family ligands BAFF/BLyS and APRIL, which exert their effects on B cells at different stages of differentiation via the receptors BAFFR, TACI (Transmembrane Activator and CAML-Interactor) and/or BCMA (B Cell Maturation Antigen). BAFF and APRIL are proteins expressed at the cell membrane, with both extracellular and intracellular domains. Therefore, receptor/ligand engagement may also result in signals in ligand-expressing cells via so-called "reverse signalling". In order to understand how TACI-Fc (atacicept) technically may mediate immune stimulation instead of suppression, we investigated its potential to activate reverse signalling through BAFF and APRIL. BAFFR-Fc and TACI-Fc, but not Fn14-Fc, reproducibly stimulated the ERK and other signalling pathways in bone marrow-derived mouse macrophages. However, these effects were independent of BAFF or APRIL since the same activation profile was observed with BAFF- or APRIL-deficient cells. Instead, cell activation correlated with the presence of high molecular mass forms of BAFFR-Fc and TACI-Fc and was strongly impaired in macrophages deficient for Fc receptor gamma chain. Moreover, a TACI-Fc defective for Fc receptor binding elicited no detectable signal. Although these results do not formally rule out the existence of BAFF or APRIL reverse signalling (via pathways not tested in this study), they provide no evidence in support of reverse signalling and point to the importance of using appropriate specificity controls when working with Fc receptor-expressing myeloid cells.	[Nys, Josquin; Smulski, Cristian R.; Tardivel, Aubry; Willen, Laure; Kowalczyk, Christine; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Donze, Olivier] Adipogen SA, Epalinges, Switzerland; [Huard, Bertrand] Med Univ Ctr, Dept Pathoimmunol, Geneva, Switzerland; [Huard, Bertrand] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Hess, Henry] Merck Serono, Darmstadt, Germany	University of Lausanne; University of Geneva; University of Geneva; Merck KGaA; EMD Serono Inc.	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch	huard, bertrand/L-8011-2013	huard, bertrand/0000-0003-1358-6576; Schneider, Pascal/0000-0003-0677-9409; Smulski, Cristian/0000-0003-4186-8116	Swiss National Science Foundation; Institute of Arthritis Research; Merck-Serono; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research; Merck-Serono(Merck & Company); University of Lausanne	This study was supported by grants of the Swiss National Science Foundation to Pascal Schneider, by the Institute of Arthritis Research and by Merck-Serono. The funders had no role in study design, data collection, analysis and decision to publish. Henry Hess, a co-author employee of Merck-Serono, participated to the preparation of the manuscript.; The authors have the following interests. This research was financed in part by a research agreement bewteen Merck-Serono and the University of Lausanne. Henry Hess, who is employed by Merck-Serono provided the essential reagent. Olivier Donze is employed by Adipogen SA. Atacicept, the drug under investigation in this paper, is being developed by Merck-Serono. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDERSON P, 1990, P NATL ACAD SCI USA, V87, P2274, DOI 10.1073/pnas.87.6.2274; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Cachero TG, 2006, BIOCHEMISTRY-US, V45, P2006, DOI 10.1021/bi051685o; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Diaz-de-Durana Y, 2006, BLOOD, V107, P594, DOI 10.1182/blood-2004-12-4708; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Hartung Hans-Peter, 2010, Ther Adv Neurol Disord, V3, P205, DOI 10.1177/1756285610371146; Jacobi AM, 2010, ARTHRITIS RHEUM-US, V62, P201, DOI 10.1002/art.27189; Jeon ST, 2010, IMMUNOL CELL BIOL, V88, P148, DOI 10.1038/icb.2009.75; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Lee Sang-Min, 2010, Immune Netw, V10, P173, DOI 10.4110/in.2010.10.5.173; Lee SM, 2010, IMMUNOLOGY, V131, P350, DOI 10.1111/j.1365-2567.2010.03306.x; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mantchev GT, 2007, J IMMUNOL, V179, P2282, DOI 10.4049/jimmunol.179.4.2282; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Nestorov I, 2010, J PHARM SCI-US, V99, P524, DOI 10.1002/jps.21839; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Pena-Rossi C, 2009, LUPUS, V18, P547, DOI 10.1177/0961203309102803; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tak PP, 2008, ARTHRITIS RHEUM-US, V58, P61, DOI 10.1002/art.23178; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61350	10.1371/journal.pone.0061350	http://dx.doi.org/10.1371/journal.pone.0061350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620746	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500026
J	Chen, PJ; Arikawa, K; Yang, EC				Chen, Pei-Ju; Arikawa, Kentaro; Yang, En-Cheng			Diversity of the Photoreceptors and Spectral Opponency in the Compound Eye of the Golden Birdwing, Troides aeacus formosanus	PLOS ONE			English	Article							BUTTERFLY PAPILIO-XUTHUS; PIERIS-RAPAE-CRUCIVORA; VISUAL PIGMENTS; OMMATIDIAL TYPE; MESSENGER-RNAS; INSECT RETINA; COLOR-VISION; NARROW-BAND; ULTRAVIOLET; RECEPTORS	The compound eye of the Golden Birdwing, Troides aeacus formosanus (Papilionidae, Lepidoptera), is furnished with three types of ommatidia, which are clearly different in pigmentation around the rhabdom. Each ommatidium contains nine photoreceptors, whose spectral sensitivities were analyzed electrophysiologically. We identified nine spectral types of photoreceptor with sensitivities peaking at 360 nm (UV), 390 nm (V), 440 nm (B), 510 nm (BG), 540 nm (sG), 550 nm (dG), 580 nm (O), 610 nm (R), and 630 nm (dR) respectively. The spectral sensitivities of the V, O, R and dR receptors did not match the predicted spectra of any visual pigments, but with the filtering effects of the pigments around the rhabdom, they can be reasonably explained. In some of the receptors, negative-going responses were observed when they were stimulated at certain wavelengths, indicating antagonistic interactions between photoreceptors.	[Chen, Pei-Ju; Yang, En-Cheng] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Arikawa, Kentaro] Sokendai Hayama Grad Univ Adv Studies, Lab Neuroethol, Hayama, Japan; [Yang, En-Cheng] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	National Taiwan University; Graduate University for Advanced Studies - Japan; National Taiwan University	Yang, EC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	ecyang@ntu.edu.tw		YANG, EN-CHENG/0000-0002-5793-5427; Arikawa, Kentaro/0000-0002-4365-0762	JSPS (Japanese Society for Promotion of Science) [21247009]; MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) [INSECT-1101]; Forestry Bureau, Council of Agriculture, Executive Yuan, Taiwan, ROC	JSPS (Japanese Society for Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); Forestry Bureau, Council of Agriculture, Executive Yuan, Taiwan, ROC	This work was supported in part by the JSPS (Japanese Society for Promotion of Science) Grants-in-Aid for Scientific Research No. 21247009 and the MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) grant (Elucidation of biological mechanisms of photoresponse and development of advanced 1 technologies utilizing light) No. INSECT-1101 to KA. This work was supported by the Forestry Bureau, Council of Agriculture, Executive Yuan, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 1997, J EXP BIOL, V200, P2501; Arikawa K, 1999, VISION RES, V39, P1, DOI 10.1016/S0042-6989(98)00070-4; Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; Arikawa K, 2003, J NEUROSCI, V23, P4527; Arikawa K, 1999, ZOOL SCI, V23, P199; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HORRIDGE GA, 1983, J COMP PHYSIOL, V150, P271, DOI 10.1007/BF00605018; ICHIKAWA T, 1986, BRAIN RES, V397, P381, DOI 10.1016/0006-8993(86)90643-8; JARVILEHTO M, 1971, Z VERGL PHYSIOL, V75, P422, DOI 10.1007/BF00630561; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2006, INVERTEBRATE VISION, P250; KELLY KM, 1990, J COMP PHYSIOL A, V167, P745, DOI 10.1007/BF00189765; KIEN J, 1977, J COMP PHYSIOL, V113, P35, DOI 10.1007/BF00610452; Kinoshita M, 2006, ZOOL SCI, V23, P199, DOI 10.2108/zsj.23.199; Kitamoto J, 2000, J EXP BIOL, V203, P2887; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MATIC T, 1983, J COMP PHYSIOL, V152, P169, DOI 10.1007/BF00611182; Matsushita A, 2012, P ROY SOC B-BIOL SCI, V279, P3482, DOI 10.1098/rspb.2012.0475; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MENZEL R, 1976, J COMP PHYSIOL, V108, P11, DOI 10.1007/BF00625437; Menzel R, 1979, HDB SENSORY PHYSL, VVII/6A, P503; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Ogawa Y, 2012, J COMP PHYSIOL A, V198, P857, DOI 10.1007/s00359-012-0756-8; OSORIO D, 1986, J EXP BIOL, V122, P193; Rela L, 2007, J NEUROPHYSIOL, V97, P1405, DOI 10.1152/jn.00973.2006; RIBI WA, 1978, CELL TISSUE RES, V195, P299; SHAW SR, 1978, CELL TISSUE RES, V188, P35; SHAW SR, 1975, NATURE, V255, P480, DOI 10.1038/255480a0; SHAW SR, 1981, NEURONES IMPULSES, P61; SNYDER AW, 1973, J COMP PHYSIOL, V87, P99, DOI 10.1007/BF01352157; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; STAVENGA DG, 2000, HDB BIOL PHYS, V3, P527; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Stavenga DG, 2011, J COMP PHYSIOL A, V197, P373, DOI 10.1007/s00359-010-0622-5; SWIHART SL, 1970, J INSECT PHYSIOL, V16, P1623, DOI 10.1016/0022-1910(70)90262-3; Takemura SY, 2006, J COMP NEUROL, V494, P663, DOI 10.1002/cne.20830; Takemura SY, 2005, J COMP NEUROL, V483, P341, DOI 10.1002/cne.20446; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; Wakakuwa M, 2004, J EXP BIOL, V207, P2803, DOI 10.1242/jeb.01078; Wakakuwa M, 2007, PHOTOCHEM PHOTOBIOL, V83, P27, DOI 10.1562/2006-03-03-IR-831; Wu WY, 2007, J INSECT PHYSIOL, V53, P509, DOI 10.1016/j.jinsphys.2007.02.003; YANG EC, 1991, J COMP PHYSIOL A, V169, P663; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010	47	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62240	10.1371/journal.pone.0062240	http://dx.doi.org/10.1371/journal.pone.0062240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614043	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400167
J	Liu, Y; Liu, CC; Lin, KJ; Wang, GR				Liu, Yang; Liu, Chengcheng; Lin, Kejian; Wang, Guirong			Functional Specificity of Sex Pheromone Receptors in the Cotton Bollworm Helicoverpa armigera	PLOS ONE			English	Article							HELIOTHIS-ARMIGERA; OLFACTORY RECEPTORS; TOBACCO BUDWORM; MOLECULAR-BASIS; BOMBYX-MORI; MOTH; IDENTIFICATION; RESPONSES; LEPIDOPTERA; EXPRESSION	Male moths can accurately perceive the sex pheromone emitted from conspecific females by their highly accurate and specific olfactory sensory system. Pheromone receptors are of special importance in moth pheromone reception because of their central role in chemosensory signal transduction processes that occur in olfactory receptor neurons in the male antennae. There are a number of pheromone receptor genes have been cloned, however, only a few have been functionally characterized. Here we cloned six full-length pheromone receptor genes from Helicoverpa armigera male antennae. Real-time PCR showing all genes exhibited male-biased expression in adult antennae. Functional analyses of the six pheromone receptor genes were then conducted in the heterologous expression system of Xenopus oocytes. HarmOR13 was found to be a specific receptor for the major sex pheromone component Z11-16:Ald. HarmOR6 was equally tuned to both of Z9-16: Ald and Z9-14: Ald. HarmOR16 was sensitively tuned to Z11-16: OH. HarmOR11, HarmOR14 and HarmOR15 failed to respond to the tested candidate pheromone compounds. Our experiments elucidated the functions of some pheromone receptor genes of H. armigera. These advances may provide remarkable evidence for intraspecific mating choice and speciation extension in moths at molecular level.	[Liu, Yang; Liu, Chengcheng; Lin, Kejian; Wang, Guirong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, GR (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	grwang@ippcaas.cn	lin, ke/GZM-8300-2022	Liu, Yang/0000-0002-3424-7111	National Natural Science Foundation of China [31230062, 31071752]; National Basic Research Program of China [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (Grant No. 31230062 and 31071752) and the National Basic Research Program of China (Grant No. 2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Blomquist GJ, 2003, INSECT PHEROMONE BIO; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; DUNKELBLUM E, 1980, PHYTOPARASITICA, V8, P209, DOI 10.1007/BF03158319; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fujii T, 2011, P NATL ACAD SCI USA, V108, P18038, DOI 10.1073/pnas.1107282108; GOTHILF S, 1978, EXPERIENTIA, V34, P853, DOI 10.1007/BF01939662; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; KARLSON P, 1959, ANNU REV ENTOMOL, V4, P39, DOI 10.1146/annurev.en.04.010159.000351; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; KEHAT M, 1990, J INSECT BEHAV, V3, P75, DOI 10.1007/BF01049196; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei H, 1999, J NEUROPHYSIOL, V81, P1113, DOI 10.1152/jn.1999.81.3.1113; Liu M., 1994, INSECT SCI, V1, P77, DOI [10.1111/j.1744-7917.1994.tb00197.x, DOI 10.1111/J.1744-7917.1994.TB00197.X]; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; NESBITT BF, 1980, ENTOMOL EXP APPL, V27, P306, DOI 10.1007/BF00333842; PICCARDI P, 1977, J INSECT PHYSIOL, V23, P1443, DOI 10.1016/0022-1910(77)90170-6; Pophof B, 1997, PHYSIOL ENTOMOL, V22, P239, DOI 10.1111/j.1365-3032.1997.tb01164.x; ROELOFS WL, 1995, P NATL ACAD SCI USA, V92, P44, DOI 10.1073/pnas.92.1.44; ROTHSCHILD GHL, 1978, J AUST ENTOMOL SOC, V17, P389; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; SCHNEIDER D, 1992, NATURWISSENSCHAFTEN, V79, P241, DOI 10.1007/BF01175388; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Vasquez GM, 2011, INSECT MOL BIOL, V20, P115, DOI 10.1111/j.1365-2583.2010.01044.x; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Witzgall P, 2010, PHEROLIST; Wu CAIH, 1993, ACTA ENTOMOLOGICA SI, V4, P000; Wu Deming, 1997, Entomologia Sinica, V4, P350; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yasukochi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018843; Zhang JP, 2012, J INSECT PHYSIOL, V58, P1209, DOI 10.1016/j.jinsphys.2012.05.018; Zhang Shuai, 2009, Acta Entomologica Sinica, V52, P728	52	35	49	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e62094	10.1371/journal.pone.0062094	http://dx.doi.org/10.1371/journal.pone.0062094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23614018	Green Submitted, gold, Green Published			2022-12-25	WOS:000317563300050
J	Schallreuter, KU; Salem, MAEL; Holtz, S; Panske, A				Schallreuter, Karin U.; Salem, Mohammed A. E. L.; Holtz, Sarah; Panske, A.			Basic evidence for epidermal H2O2/ONOO--mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS	FASEB JOURNAL			English	Article						FT-Raman spectroscopy; ROS; RNS; MSRA; MSRB; thioredoxin reductase	METHIONINE-SULFOXIDE-REDUCTASE; HYDROGEN-PEROXIDE H2O2; AFFECTS IMMUNE-RESPONSE; L-TRYPTOPHAN METABOLISM; FT-RAMAN SPECTROSCOPY; FENTON CHEMISTRY; OXIDATIVE STRESS; IN-VITRO; MELANOCYTES; MELATONIN	Nonsegmental vitiligo (NSV) is characterized by loss of inherited skin color. The cause of the disease is still unknown despite accumulating in vivo and in vitro evidence of massive epidermal oxidative stress via H2O2 and peroxynitrite (ONOO-) in affected individuals. The most favored hypothesis is based on autoimmune mechanisms. Strictly segmental vitiligo (SSV) with dermatomal distribution is a rare entity, often associated with stable outcome. Recently, it was documented that this form can be associated with NSV (mixed vitiligo). We here asked the question whether ROS and possibly ONOO- could be players in the pathogenesis of SSV. Our in situ results demonstrate for the first time epidermal biopterin accumulation together with significantly decreased epidermal catalase, thioredoxin/thioreoxin reductase, and MSRA/MSRB expression. Moreover, we show epidermal ONOO- accumulation. In vivo FT-Raman spectroscopy reveals the presence of H2O2, methionine sulfoxide, and tryptophan metabolites; i.e., N-formylkynurenine and kynurenine, implying Fenton chemistry in the cascade (n=10). Validation of the basic data stems from successful repigmentation of skin and eyelashes in affected individuals, regardless of SSV or segmental vitiligo in association with NSV after reduction of epidermal H2O2 (n=5). Taken together, our contribution strongly supports H2O2/ONOO-mediated stress in the pathogenesis of SSV. Our findings offer new treatment intervention for lost skin and hair color.	[Schallreuter, Karin U.; Salem, Mohammed A. E. L.; Holtz, Sarah; Panske, A.] Ernst Moritz Arndt Univ Greifswald, Inst Pigmentary Disorders, Greifswald, Germany; [Schallreuter, Karin U.] Univ Bradford, Sch Life Sci, Ctr Skin Sci, Bradford BD7 1DP, W Yorks, England	Ernst Moritz Arndt Universitat Greifswald; University of Bradford	Schallreuter, KU (corresponding author), Univ Bradford, Sch Life Sci, Ctr Skin Sci, Bradford BD7 1DP, W Yorks, England.	k.schallreuter@bradford.ac.uk			American Vitiligo Research Foundation (Clearwater, FL, USA)	American Vitiligo Research Foundation (Clearwater, FL, USA)	The authors thank the patients who participated in this study. This study has been supported by the American Vitiligo Research Foundation (Clearwater, FL, USA) and by private donations. The authors declare no conflict of interest.	BOLOGNIA JL, 1994, J AM ACAD DERMATOL, V31, P157, DOI 10.1016/S0190-9622(94)70143-1; Cartaxo SB, 2010, ACTA CIR BRAS, V25, P351, DOI 10.1590/S0102-86502010000400010; Chavan B, 2006, J INVEST DERMATOL, V126, P2481, DOI 10.1038/sj.jid.5700425; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; ELMOFTY AM, 1980, INT J DERMATOL, V19, P237; Ezzedine K, 2012, BRIT J DERMATOL, V166, P539, DOI 10.1111/j.1365-2133.2011.10709.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gibbons NQ, 2006, J INVEST DERMATOL, V126, P2576, DOI 10.1038/sj.jid.5700612; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Happle R, 2007, J AM ACAD DERMATOL, V57, P690, DOI 10.1016/j.jaad.2007.06.039; Hasse S, 2004, J INVEST DERMATOL, V122, P307, DOI 10.1046/j.0022-202X.2004.22230.x; Huggins RH, 2005, ACTA DERMATOVEN ALP, V14, P137; Jung S, 2002, FEBS LETT, V527, P91, DOI 10.1016/S0014-5793(02)03171-X; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; KOGA M, 1988, BRIT J DERMATOL, V118, P223, DOI 10.1111/j.1365-2133.1988.tb01778.x; KOGA M, 1977, BRIT J DERMATOL, V97, P255, DOI 10.1111/j.1365-2133.1977.tb15180.x; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Manga P, 2006, AM J PATHOL, V169, P1652, DOI 10.2353/ajpath.2006.050769; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ogawa Fumihide, 2006, Nihon Rinsho Meneki Gakkai Kaishi, V29, P349; Pey AL, 2006, FASEB J, V20, P2130, DOI 10.1096/fj.06-5835fje; Picardo M, 2012, BRIT J DERMATOL, V166, P472, DOI 10.1111/j.1365-2133.2012.10839.x; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2008, INT J DERMATOL, V47, P743, DOI 10.1111/j.1365-4632.2008.03660.x; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 2007, ARCH DERMATOL RES, V299, P225, DOI 10.1007/s00403-007-0748-7; Schallreuter KU, 2012, FASEB J, V26, P2471, DOI 10.1096/fj.11-201897; Schallreuter KU, 2012, FASEB J, V26, P2457, DOI 10.1096/fj.11-197137; Schallreuter KU, 2011, AUTOIMMUNE DISEASES OF THE SKIN: PATHOGENESIS, DIAGNOSIS, MANAGEMENT, THIRD EDITION, P435, DOI 10.1007/978-3-211-99225-8_19; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; SCHALLREUTER KU, 1995, DERMATOLOGY, V190, P223, DOI 10.1159/000246690; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schallreuter KU, 2006, BIOCHEM BIOPH RES CO, V342, P145, DOI 10.1016/j.bbrc.2006.01.124; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Schallreuter KU, 2001, J PHOTOCH PHOTOBIO B, V64, P179, DOI 10.1016/S1011-1344(01)00235-4; SCHALLREUTER KU, 1992, BIOCHEM BIOPH RES CO, V189, P72, DOI 10.1016/0006-291X(92)91527-W; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Spencer JD, 2007, J INVEST DERMATOL, V127, P411, DOI 10.1038/sj.jid.5700538; Taieb A, 2008, PIGM CELL MELANOMA R, V21, P646, DOI 10.1111/j.1755-148X.2008.00511.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Thiele JJ, 1999, J INVEST DERMATOL, V113, P335, DOI 10.1046/j.1523-1747.1999.00693.x; Thody AJ, 1999, ANN NY ACAD SCI, V885, P217, DOI 10.1111/j.1749-6632.1999.tb08679.x; Tobin DJ, 2000, J PATHOL, V191, P407; van Geel N, 2013, BRIT J DERMATOL, V168, P56, DOI 10.1111/bjd.12013; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435	57	30	31	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3113	3122		10.1096/fj.12-226779	http://dx.doi.org/10.1096/fj.12-226779			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23629861				2022-12-25	WOS:000329877600018
J	Ho, JCS; Storm, P; Rydstrom, A; Ben, BW; Alsin, F; Sullivan, L; Ambite, I; Mok, KH; Northen, T; Svanborg, C				Ho, James C. S.; Storm, Petter; Rydstrom, Anna; Ben Bowen; Alsin, Fredrik; Sullivan, Louise; Ambite, Ines; Mok, K. H.; Northen, Trent; Svanborg, Catharina			Lipids as Tumoricidal Components of Human alpha-Lactalbumin Made Lethal to Tumor Cells (HAMLET) UNIQUE AND SHARED EFFECTS ON SIGNALING AND DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; APOPTOSIS-LIKE MECHANISM; AP2 GENE-EXPRESSION; OLEIC-ACID; CYTOTOXIC COMPLEXES; FOURIER HOLOGRAPHY; EQUINE LYSOZYME; CANCER; PROTEIN; METABOLISM	Long-chain fatty acids are internalized by receptor-mediated mechanisms or receptor-independent diffusion across cytoplasmic membranes and are utilized as nutrients, building blocks, and signaling intermediates. Here we describe how the association of long-chain fatty acids to a partially unfolded, extracellular protein can alter the presentation to target cells and cellular effects. HAMLET ( human alpha-lactalbumin made lethal to tumor cells) is a tumoricidal complex of partially unfolded alpha-lactalbumin and oleic acid (OA). As OA lacks independent tumoricidal activity at concentrations equimolar to HAMLET, the contribution of the lipid has been debated. We show by natural abundance C-13 NMR that the lipid in HAMLET is deprotonated and by chromatography that oleate rather than oleic acid is the relevant HAMLET constituent. Compared with HAMLET, oleate ( 175 mu M) showed weak effects on ion fluxes and gene expression. Unlike HAMLET, which causes metabolic paralysis, fatty acid metabolites were less strongly altered. The functional overlap increased with higher oleate concentrations ( 500 mu M). Cellular responses to OA were weak or absent, suggesting that deprotonation favors cellular interactions of fatty acids. Fatty acids may thus exert some of their essential effects on host cells when in the deprotonated state and when presented in the context of a partially unfolded protein.	[Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, S-22362 Lund, Sweden; [Ben Bowen; Alsin, Fredrik; Northen, Trent] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Sullivan, Louise; Mok, K. H.] Trinity Coll Dublin, Inst Biomed Sci, Coll Green, Dublin 2, Ireland	Lund University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Trinity College Dublin	Svanborg, C (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, Solvegatan 23, S-22362 Lund, Sweden.	catharina.svanborg@med.lu.se	Ambite, Ines/AAG-6615-2020; Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Northen, Trent/0000-0001-8404-3259; Ambite, Ines/0000-0003-1470-671X; Rydstrom, Anna/0000-0002-3404-7195; Mok, K Hun/0000-0003-3663-2002; Storm, Petter/0000-0002-7655-3731	National Institutes of Health [U54 CA 112970]; Sharon D. Lund Foundation grant; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical Sciences); NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sharon D. Lund Foundation grant; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 CA 112970. This study was also supported by a Sharon D. Lund Foundation grant and by the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, and the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society. Support was also obtained from the Danish Council for Independent Research (Medical Sciences).	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; AMRI EZ, 1991, J LIPID RES, V32, P1449; ANDERSON MP, 1990, P NATL ACAD SCI USA, V87, P7334, DOI 10.1073/pnas.87.18.7334; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Brest P, 2007, CANCER RES, V67, P11327, DOI 10.1158/0008-5472.CAN-07-1153; Calder PC, 1997, ANN NUTR METAB, V41, P203, DOI 10.1159/000177997; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; Covey SD, 2007, BIOCHEM BIOPH RES CO, V355, P67, DOI 10.1016/j.bbrc.2007.01.135; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Das UN, 2005, PROSTAG LEUKOTR ESS, V72, P173, DOI 10.1016/j.plefa.2004.10.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; GRIMALDI PA, 1992, P NATL ACAD SCI USA, V89, P10930, DOI 10.1073/pnas.89.22.10930; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; NOZAKA M, 1978, BIOCHEMISTRY-US, V17, P3753, DOI 10.1021/bi00611a013; PERMYAKOV EA, 1985, BIOPHYS CHEM, V21, P21, DOI 10.1016/0301-4622(85)85003-1; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson J, 2006, BIOCHEM BIOPH RES CO, V345, P260, DOI 10.1016/j.bbrc.2006.04.081; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Pettersson-Kastberg J, 2009, ANN MED, V41, P162, DOI 10.1080/07853890802502614; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Schnars U., 2005, DIGITAL HOLOGRAPHY D; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Vukojevic V, 2010, LANGMUIR, V26, P14782, DOI 10.1021/la1026416; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	58	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17460	17471		10.1074/jbc.M113.468405	http://dx.doi.org/10.1074/jbc.M113.468405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629662	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000320380600038
J	Kugler, JE; Horsch, M; Huang, D; Furusawa, T; Rochman, M; Garrett, L; Becker, L; Bohla, A; Holter, SM; Prehn, C; Rathkolb, B; Racz, I; Aguilar-Pimentel, JA; Adler, T; Adamski, J; Beckers, J; Busch, DH; Eickelberg, O; Klopstock, T; Ollert, M; Stoger, T; Wolf, E; Wurst, W; Yildirim, AO; Zimmer, A; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Garfinkel, B; Orly, J; Ovcharenko, I; Bustin, M				Kugler, Jamie E.; Horsch, Marion; Huang, Di; Furusawa, Takashi; Rochman, Mark; Garrett, Lillian; Becker, Lore; Bohla, Alexander; Hoelter, Sabine M.; Prehn, Cornelia; Rathkolb, Birgit; Racz, Ildiko; Aguilar-Pimentel, Juan Antonio; Adler, Thure; Adamski, Jerzy; Beckers, Johannes; Busch, Dirk H.; Eickelberg, Oliver; Klopstock, Thomas; Ollert, Markus; Stoeger, Tobias; Wolf, Eckhard; Wurst, Wolfgang; Yildirim, Ali Oender; Zimmer, Andreas; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Garfinkel, Benny; Orly, Joseph; Ovcharenko, Ivan; Bustin, Michael			High Mobility Group N Proteins Modulate the Fidelity of the Cellular Transcriptional Profile in a Tissue- and Variant-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H1; BINDING-PROTEIN; CHROMOSOMAL-PROTEINS; CHROMATIN-STRUCTURE; IONIZING-RADIATION; TRIBBLES HOMOLOG; HMG PROTEINS; GENE; EXPRESSION; MOUSE	The nuclei of most vertebrate cells contain members of the high mobility group N (HMGN) protein family, which bind specifically to nucleosome core particles and affect chromatin structure and function, including transcription. Here, we study the biological role of this protein family by systematic analysis of phenotypes and tissue transcription profiles in mice lacking functional HMGN variants. Phenotypic analysis of Hmgn1(tm1/tm1), Hmgn3(tm1/tm1), and Hmgn5(tm1/tm1) mice and their wild type littermates with a battery of standardized tests uncovered variant-specific abnormalities. Gene expression analysis of four different tissues in each of the Hmgn(tm1/tm1) lines reveals very little overlap between genes affected by specific variants in different tissues. Pathway analysis reveals that loss of an HMGN variant subtly affects expression of numerous genes in specific biological processes. We conclude that within the biological framework of an entire organism, HMGNs modulate the fidelity of the cellular transcriptional profile in a tissue- and HMGN variant-specific manner.	[Kugler, Jamie E.; Furusawa, Takashi; Rochman, Mark; Bustin, Michael] NCI, Prot Sect, Lab Metab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Horsch, Marion; Becker, Lore; Prehn, Cornelia; Rathkolb, Birgit; Adler, Thure; Adamski, Jerzy; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Huang, Di; Ovcharenko, Ivan] NIH, Computat Biol Branch, NCBI, Natl Lib Med, Bethesda, MD 20892 USA; [Adamski, Jerzy; Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85350 Freising Weihenstephan, Germany; [Garrett, Lillian; Hoelter, Sabine M.; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, German Mouse Clin,Comprehens Pneumol Ctr, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Aguilar-Pimentel, Juan Antonio] Tech Univ Munich, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Ctr Allergy & Environm, Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Biederstein, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Clin Res Div Mol & Clin Allergotoxicol, D-80290 Munich, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Klopstock, Thomas; de Angelis, Martin Hrabe] Tech Univ Munich, German Ctr Vertigo & Balance Disorders, D-80290 Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] German Ctr Neurodegenerat Dis, Site Munich, Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Ctr Lung Res, Munich, Germany; [Garfinkel, Benny; Orly, Joseph] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Hebrew University of Jerusalem	Bustin, M (corresponding author), NCI, Prot Sect, Lab Metab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	Zimmer, Andreas/B-8357-2009; Bustin, Michael/G-6155-2015; Becker, Lore/E-3717-2010; Racz, I./C-3074-2009; Fuchs, Helmut/M-7347-2014; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/AAJ-1203-2020; Hölter, Sabine M./N-5868-2014; Garfinkel, Benny/AAF-2030-2020; Stöger, Tobias/M-9861-2014; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012	Racz, I./0000-0002-1549-3616; Fuchs, Helmut/0000-0002-5143-2677; Becker, Lore/0000-0002-6890-4984; Hölter, Sabine M./0000-0003-4878-5241; Garfinkel, Benny/0000-0002-2790-1349; Stöger, Tobias/0000-0002-2790-0389; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Yildirim, Ali Onder/0000-0003-1969-480X; Wolf, Eckhard/0000-0002-0430-9510; Prehn, Cornelia/0000-0002-1274-4715; Adamski, Jerzy/0000-0001-9259-0199; Ollert, Markus W./0000-0002-8055-0103; Rochman, Mark/0000-0002-0818-927X; Garrett, Lillian/0000-0003-4880-7076; Wurst, Wolfgang/0000-0003-4422-7410	National Institutes of Health grants from the Center for Cancer Research, NCI; Research Program of the National Library of Medicine; United States-Israeli Binational Foundation [2009326]; German Federal Ministry of Education and Research; German Center for Vertigo and Balance Disorders [01 EO 0901]; Infrafrontier [01KX1012]; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society [HA-21]; National Genome Research Network-Plus [01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868]; NATIONAL CANCER INSTITUTE [ZIABC011154] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Institutes of Health grants from the Center for Cancer Research, NCI; Research Program of the National Library of Medicine; United States-Israeli Binational Foundation(US-Israel Binational Science Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; Infrafrontier; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society; National Genome Research Network-Plus; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health grants from the Center for Cancer Research, NCI. This work was also supported by the Research Program of the National Library of Medicine; Grant 2009326 from the United States-Israeli Binational Foundation; German Federal Ministry of Education and Research to the German Center for Diabetes Research; German Center for Vertigo and Balance Disorders Grant 01 EO 0901, Infrafrontier Grant 01KX1012, and Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society Grant HA-21.; We thank Reinhard Seeliger, Anke Bettenbrock, Jan Einicke, Michael Farberbock, Ralf Fischer, Corinne Graf, Christine Hollauer, Elfi Holupirek, Maria Kugler, Soren Kundt, Simon Orth, Florian Schleicher, Ann-Elisabeth Schwarz, Nadine Senger, Yvonne Sonntag, Bettina Sperling, Alida Theil, and Anja Wohlbier, as well as the mouse embryonic fibroblasts animal caretaker team for expert technical assistance. The German Mouse Clinic was supported by National Genome Research Network-Plus Grants 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, and GS0868.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergboer JGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032045; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Bhan S, 2008, GENE, V414, P10, DOI 10.1016/j.gene.2008.01.025; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2010, BBA-GENE REGUL MECH, V1799, P15, DOI 10.1016/j.bbagrm.2009.11.001; Cejkova P, 2005, VIRCHOWS ARCH, V446, P416, DOI 10.1007/s00428-005-1214-6; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Furusawa T, 2010, BBA-GENE REGUL MECH, V1799, P69, DOI 10.1016/j.bbagrm.2009.11.011; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hock R, 1998, J CELL BIOL, V143, P1427, DOI 10.1083/jcb.143.6.1427; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Ito Y, 2002, J HISTOCHEM CYTOCHEM, V50, P1273, DOI 10.1177/002215540205000914; Jolliffe, 2002, PRINCIPAL COMPONENT; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kurahashi T, 2010, J CELL BIOCHEM, V109, P49, DOI 10.1002/jcb.22377; Kusakabe M, 2010, INT J CANCER, V126, P1895, DOI 10.1002/ijc.24947; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lim JH, 2002, J BIOL CHEM, V277, P20774, DOI 10.1074/jbc.M200404200; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mountjoy KG, 2010, BIOCHEM J, V428, P305, DOI 10.1042/BJ20091957; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Ogawa R, 2008, DIS ESOPHAGUS, V21, P288, DOI 10.1111/j.1442-2050.2007.00759.x; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Postnikov YV, 2012, MOL CELL BIOL, V32, P1844, DOI 10.1128/MCB.06429-11; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; ROBERTS B, 1992, GENE, V121, P255, DOI 10.1016/0378-1119(92)90129-D; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Schumacher T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035613; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun M, 2002, MOL MED, V8, P655, DOI 10.1007/BF03402176; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Ueda T, 2009, MOL CELL BIOL, V29, P5264, DOI 10.1128/MCB.00526-09; West KL, 2001, J BIOL CHEM, V276, P25959, DOI 10.1074/jbc.M101692200	68	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16690	16703		10.1074/jbc.M113.463315	http://dx.doi.org/10.1074/jbc.M113.463315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620591	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000320378900044
J	Giskeodegard, GF; Bertilsson, H; Selnaes, KM; Wright, AJ; Bathen, TF; Viset, T; Halgunset, J; Angelsen, A; Gribbestad, IS; Tessem, MB				Giskeodegard, Guro F.; Bertilsson, Helena; Selnaes, Kirsten M.; Wright, Alan J.; Bathen, Tone F.; Viset, Trond; Halgunset, Jostein; Angelsen, Anders; Gribbestad, Ingrid S.; Tessem, May-Britt			Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness	PLOS ONE			English	Article							H-1 HR-MAS; PROTON MR SPECTROSCOPY; PATHOLOGICAL ANALYSIS; GLEASON SCORE; 3 T; TISSUE; TOOL	Separating indolent from aggressive prostate cancer is an important clinical challenge for identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment. The purpose of this study was to assess prostate cancer aggressiveness by metabolic profiling of prostatectomy tissue and to identify specific metabolites as biomarkers for aggressiveness. Prostate tissue samples (n = 158, 48 patients) with a high cancer content (mean: 61.8%) were obtained using a new harvesting method, and metabolic profiles of samples representing different Gleason scores (GS) were acquired by high resolution magic angle spinning magnetic resonance spectroscopy (HR-MAS). Multivariate analysis (PLS, PLS-DA) and absolute quantification (LCModel) were used to examine the ability to predict cancer aggressiveness by comparing low grade (GS = 6, n = 30) and high grade (GS >= 7, n = 81) cancer with normal adjacent tissue (n = 47). High grade cancer tissue was distinguished from low grade cancer tissue by decreased concentrations of spermine (p = 0.0044) and citrate (p = 7.73.10(-4)), and an increase in the clinically applied (total choline+creatine+polyamines)/citrate (CCP/C) ratio (p = 2.17.10(-4)). The metabolic profiles were significantly correlated to the GS obtained from each tissue sample (r = 0.71), and cancer tissue could be distinguished from normal tissue with sensitivity 86.9% and specificity 85.2%. Overall, our findings show that metabolic profiling can separate aggressive from indolent prostate cancer. This holds promise for the benefit of applying in vivo magnetic resonance spectroscopy (MRS) within clinical MR imaging investigations, and HR-MAS analysis of transrectal ultrasound-guided biopsies has a potential as an additional diagnostic tool.	[Giskeodegard, Guro F.; Selnaes, Kirsten M.; Bathen, Tone F.; Gribbestad, Ingrid S.; Tessem, May-Britt] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, MI Lab, Trondheim, Norway; [Giskeodegard, Guro F.; Selnaes, Kirsten M.; Bathen, Tone F.; Gribbestad, Ingrid S.; Tessem, May-Britt] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Bertilsson, Helena; Halgunset, Jostein] NTNU, Dept Lab Med & Childrens & Womens Hlth, Trondheim, Norway; [Bertilsson, Helena; Angelsen, Anders] Univ Trondheim Hosp, Dept Urol, St Olavs Hosp, Trondheim, Norway; [Wright, Alan J.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Viset, Trond; Halgunset, Jostein] Univ Trondheim Hosp, St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway; [Angelsen, Anders] NTNU, Dept Canc Res & Clin Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Radboud University Nijmegen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Tessem, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, MI Lab, Trondheim, Norway.	may-britt.tessem@ntnu.no	Selnæs, Kirsten/HHN-7771-2022		Central Norway Regional Health Authority (RHA); Liaison Committee between the RHA; Liaison Committee between the Norwegian University of Science and Technology (NTNU); Norwegian Cancer Society	Central Norway Regional Health Authority (RHA); Liaison Committee between the RHA; Liaison Committee between the Norwegian University of Science and Technology (NTNU); Norwegian Cancer Society(Norwegian Cancer Society)	The study was supported by grants from the Central Norway Regional Health Authority (RHA)(http://www.helse-midt.no/), the Liaison Committee between the RHA and the Norwegian University of Science and Technology (NTNU) (http://www.ntnu.no/dmf/rad/samorg), the Norwegian Cancer Society (https://kreftforeningen.no/en/about-us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Bertilsson H, 2012, THESIS NORWEGIAN U S; Bertilsson H, 2012, CLIN CANCER RES, V18, P3261, DOI 10.1158/1078-0432.CCR-11-2929; Bertilsson H, 2011, PROSTATE, V71, P461, DOI 10.1002/pros.21260; Cheng LL, 2001, FEBS LETT, V494, P112, DOI 10.1016/S0014-5793(01)02329-8; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Futterer JJ, 2007, INVEST RADIOL, V42, P116; Garcia-Martin ML, 2011, MAGN RESON MED, V65, P329, DOI 10.1002/mrm.22631; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Keshari KR, 2011, NMR BIOMED, V24, P691, DOI 10.1002/nbm.1738; Klomp DWJ, 2011, NMR BIOMED, V24, P299, DOI 10.1002/nbm.1592; Kobus T, 2011, EUR UROL, V60, P1074, DOI 10.1016/j.eururo.2011.03.002; Kurhanewicz J, 2008, CURR OPIN UROL, V18, P71, DOI 10.1097/MOU.0b013e3282f19d01; Moestue SA, 2012, P NATL ACAD SCI USA, V109, pE2506, DOI 10.1073/pnas.1208226109; Opstad KS, 2010, J MAGN RESON IMAGING, V31, P289, DOI 10.1002/jmri.22039; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rantalainen M, 2006, J PROTEOME RES, V5, P2642, DOI 10.1021/pr060124w; Santos CF, 2010, NMR BIOMED, V23, P391, DOI 10.1002/nbm.1474; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scheenen TWJ, 2007, RADIOLOGY, V245, P507, DOI 10.1148/radiol.2451061444; Selnaes KM, 2012, NMR BIOMEDICINE; Shukla-Dave A, 2007, RADIOLOGY, V245, P499, DOI 10.1148/radiol.2452062201; Swanson MG, 2008, MAGN RESON MED, V60, P33, DOI 10.1002/mrm.21647; Swanson MG, 2006, MAGN RESON MED, V55, P1257, DOI 10.1002/mrm.20909; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Swanson MG, 2001, MAGN RESON MED, V45, P973, DOI 10.1002/mrm.1130; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; van Asten JJA, 2008, MAGN RESON MATER PHY, V21, P435, DOI 10.1007/s10334-008-0156-9; van der Graaf M, 2000, MAGN RESON MATER PHY, V10, P153, DOI 10.1016/S1352-8661(00)00082-X; Verma S, 2010, AM J ROENTGENOL, V194, P1414, DOI 10.2214/AJR.10.4312; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wilson M, 2009, NMR BIOMED, V22, P213, DOI 10.1002/nbm.1306; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zakian KL, 2005, RADIOLOGY, V234, P804, DOI 10.1148/radiol.2343040363	38	121	125	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62375	10.1371/journal.pone.0062375	http://dx.doi.org/10.1371/journal.pone.0062375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626811	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400175
J	Gulino, LM; Ouwerkerk, D; Kang, AYH; Maguire, AJ; Kienzle, M; Klieve, AV				Gulino, Lisa-Maree; Ouwerkerk, Diane; Kang, Alicia Y. H.; Maguire, Anita J.; Kienzle, Marco; Klieve, Athol V.			Shedding Light on the Microbial Community of the Macropod Foregut Using 454-Amplicon Pyrosequencing	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; FIBROLYTIC ENZYMES; METHANE PRODUCTION; GREY-KANGAROO; RUMEN; DIVERSITY; ECOLOGY; DIET; DIGESTIBILITY	Twenty macropods from five locations in Queensland, Australia, grazing on a variety of native pastures were surveyed and the bacterial community of the foregut was examined using 454-amplicon pyrosequencing. Specifically, the V3/V4 region of 16S rRNA gene was examined. A total of 5040 OTUs were identified in the data set (post filtering). Thirty-two OTUs were identified as 'shared' OTUS (i.e. present in all samples) belonging to either Firmicutes or Bacteroidetes (Clostridiales/Bacteroidales). These phyla predominated the general microbial community in all macropods. Genera represented within the shared OTUs included: unclassified Ruminococcaceae, unclassified Lachnospiraceae, unclassified Clostridiales, Peptococcus sp. Coprococcus spp., Streptococcus spp., Blautia sp., Ruminoccocus sp., Eubacterium sp., Dorea sp., Oscillospira sp. and Butyrivibrio sp. The composition of the bacterial community of the foregut samples of each the host species (Macropus rufus, Macropus giganteus and Macropus robustus) was significantly different allowing differentiation between the host species based on alpha and beta diversity measures. Specifically, eleven dominant OTUs that separated the three host species were identified and classified as: unclassified Ruminococcaceae, unclassified Bacteroidales, Prevotella spp. and a Syntrophococcus sucromutans. Putative reductive acetogens and fibrolytic bacteria were also identified in samples. Future work will investigate the presence and role of fibrolytics and acetogens in these ecosystems. Ideally, the isolation and characterization of these organisms will be used for enhanced feed efficiency in cattle, methane mitigation and potentially for other industries such as the biofuel industry.	[Gulino, Lisa-Maree; Ouwerkerk, Diane; Kang, Alicia Y. H.; Maguire, Anita J.; Kienzle, Marco] Dept Agr Forestry & Fisheries, Rumen Ecol Unit, Dutton Pk, Qld, Australia; [Klieve, Athol V.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Gulino, Lisa-Maree; Ouwerkerk, Diane; Klieve, Athol V.] Queensland Alliance Agr & Food Innovat, Ctr Anim Sci, St Lucia, Qld, Australia	Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland	Gulino, LM (corresponding author), Dept Agr Forestry & Fisheries, Rumen Ecol Unit, Dutton Pk, Qld, Australia.	Lisa-Maree.Gulino@daff.qld.gov.au	Ouwerkerk, Diane/N-6691-2019; Ouwerkerk, Diane/B-7881-2015	Ouwerkerk, Diane/0000-0002-8559-7808	Department of Agriculture, Fisheries and Forestry, Queensland, Queensland Enteric Methane Hub project	Department of Agriculture, Fisheries and Forestry, Queensland, Queensland Enteric Methane Hub project	The work was funded by the Department of Agriculture, Fisheries and Forestry, Queensland as part of the Queensland Enteric Methane Hub project (http://www.industry.qld.gov.au/key-industries/839.htm). The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; AYERS WA, 1958, J BACTERIOL, V76, P504, DOI 10.1128/JB.76.5.504-509.1958; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Beauchemin K.A., 2003, J ANIM SCI, V81, pE37, DOI [DOI 10.2527/2003.8114_SUPPL_2E37X, 10.2527/2003.8114_suppl_2E37x, DOI 10.2527/2003.8114_]; Beauchemin KA, 1997, CAN J ANIM SCI, V77, P645, DOI 10.4141/A97-050; Beauchemin KA, 1995, CAN J ANIM SCI, V75, P641, DOI 10.4141/cjas95-096; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bryant MP, 1986, RUMINOCOCCUS BERGEYS, P1093; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DELLOW DW, 1982, AUST J ZOOL, V30, P767, DOI 10.1071/ZO9820767; Dellow DW, 1988, AUSTR J ZOOLOGY, V31, P433; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Forsberg Cecil W., 1997, P319; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; HESPELL RB, 1987, APPL ENVIRON MICROB, V53, P2849, DOI 10.1128/AEM.53.12.2849-2853.1987; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hume I.D., 1999, MARSUPIAL NUTR; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; Klieve AV, 2012, J APPL MICROBIOL, V113, P1065, DOI 10.1111/j.1365-2672.2012.05428.x; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Madsen J, 2012, J ANIM SCI, V90, P1364, DOI 10.2527/jas.2011-4011; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; ODENYO AA, 1994, APPL ENVIRON MICROB, V60, P3697, DOI 10.1128/AEM.60.10.3697-3703.1994; ORR D M, 1975, Tropical Grasslands, V9, P21; Ouwerkerk D, 2005, LETT APPL MICROBIOL, V41, P327, DOI 10.1111/j.1472-765X.2005.01774.x; Ouwerkerk D, 2009, ANIM PROD SCI, V49, P1043, DOI 10.1071/EA08294; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selinger LB, 1996, ANAEROBE, V2, P263, DOI 10.1006/anae.1996.0036; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shinkai T, 2007, APPL ENVIRON MICROB, V73, P1646, DOI 10.1128/AEM.01896-06; Stevenson DM, 2007, APPL MICROBIAL CELL, P75; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Wallace RJ, 1997, ANAEROBE, V3, P35, DOI 10.1006/anae.1996.0065; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wright ADG, 2011, ANIM FEED SCI TECH, V166-67, P248, DOI 10.1016/j.anifeedsci.2011.04.015; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011	64	26	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61463	10.1371/journal.pone.0061463	http://dx.doi.org/10.1371/journal.pone.0061463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626688	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000318008400052
J	Jensen, L; Farook, MF; Reiter, LT				Jensen, Laura; Farook, M. Febin; Reiter, Lawrence T.			Proteomic Profiling in Drosophila Reveals Potential Dube3a Regulation of the Actin Cytoskeleton and Neuronal Homeostasis	PLOS ONE			English	Article							UBIQUITIN LIGASE; PROXIMAL 15Q; GLIAL-CELLS; PROTEIN; UBE3A; DEGRADATION; EXPRESSION; MUTATIONS; SYNAPSE; E6-AP	The molecular defects associated with Angelman syndrome (AS) and 15q duplication autism are directly correlated to expression levels of the E3 ubiquitin ligase protein UBE3A. Here we used Drosophila melanogaster to screen for the targets of this ubiquitin ligase under conditions of both decreased (as in AS) or increased (as in dup(15)) levels of the fly Dube3a or human UBE3A proteins. Using liquid phase isoelectric focusing of proteins from whole fly head extracts we identified a total of 50 proteins that show changes in protein, and in some cases transcriptional levels, when Dube3a fluctuates. We analyzed head extracts from cytoplasmic, nuclear and membrane fractions for Dube3a regulated proteins. Our results indicate that Dube3a is involved in the regulation of cellular functions related to ATP synthesis/metabolism, actin cytoskeletal integrity, both catabolism and carbohydrate metabolism as well as nervous system development and function. Sixty-two percent of the proteins were > 50% identical to homologous human proteins and 8 have previously be shown to be ubiquitinated in the fly nervous system. Eight proteins may be regulated by Dube3a at the transcript level through the transcriptional co-activation function of Dube3a. We investigated one autism-associated protein, ATP alpha, and found that it can be ubiquitinated in a Dube3a dependent manner. We also found that Dube3a mutants have significantly less filamentous actin than wild type larvae consistent with the identification of actin targets regulated by Dube3a. The identification of UBE3A targets is the first step in unraveling the molecular etiology of AS and duplication 15q autism.	[Jensen, Laura; Farook, M. Febin; Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Reiter, LT (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA.	lreiter@uthsc.edu	Reiter, Lawrence/H-4161-2019	Reiter, Lawrence/0000-0002-4100-2630	Autism Speaks; NIH NINDS [R01 NS059902-03]; Neurosciences Institute at UTHSC; NIH NCRR [1 S10 RR027221-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059902] Funding Source: NIH RePORTER	Autism Speaks; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neurosciences Institute at UTHSC; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Autism Speaks grant and NIH NINDS grant R01 NS059902-03 to LTR. Additional support was provided by the Neurosciences Institute at UTHSC and by NIH NCRR grant 1 S10 RR027221-01 to William E. Armstrong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cook EH, 1997, AM J HUM GENET, V60, P928; Cummings ED, 2007, J PROTEOME RES, V6, P1603, DOI 10.1021/pr060472y; Dennis NR, 2006, AM J MED GENET A, V140A, P434, DOI 10.1002/ajmg.a.31091; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Ferdousy F, 2011, NEUROBIOL DIS, V41, P669, DOI 10.1016/j.nbd.2010.12.001; Franco M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002188; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Ji LN, 2009, LIFE SCI, V85, P788, DOI 10.1016/j.lfs.2009.10.008; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Joslyn CA, 2004, BIOINFORMATICS, V20, P169, DOI 10.1093/bioinformatics/bth921; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kim SA, 2005, FEBS LETT, V579, P6559, DOI 10.1016/j.febslet.2005.10.043; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Mao R, 2000, GENET MED, V2, P131, DOI 10.1097/00125817-200003000-00003; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; McKusick-Nathans Institute of Genetic Medicine, 2012, ONL MEND INH MAN OMI; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Mohandas TK, 1999, AM J MED GENET, V82, P294, DOI 10.1002/(SICI)1096-8628(19990212)82:4<294::AID-AJMG4>3.3.CO;2-L; Nasu J, 2010, J CELL BIOCHEM, V111, P676, DOI 10.1002/jcb.22752; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Reiter LT, 2006, HUM MOL GENET, V15, P2825, DOI 10.1093/hmg/ddl225; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; SCHUBIGER M, 1994, NEURON, V12, P373, DOI 10.1016/0896-6273(94)90278-X; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473; Veltman MWM, 2005, J AUTISM DEV DISORD, V35, P117, DOI 10.1007/s10803-004-1039-1; Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	56	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61952	10.1371/journal.pone.0061952	http://dx.doi.org/10.1371/journal.pone.0061952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626758	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400122
J	Kobayashi, K; Oyama, S; Numata, A; Rahman, MM; Kumura, H				Kobayashi, Ken; Oyama, Shoko; Numata, Atsushi; Rahman, Md. Morshedur; Kumura, Haruto			Lipopolysaccharide Disrupts the Milk-Blood Barrier by Modulating Claudins in Mammary Alveolar Tight Junctions	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSES; MASTITIS; GLAND; PROTEINS; PERMEABILITY; EXPRESSION; PHOSPHORYLATION; EPITHELIUM; MOLECULES	Mastitis, inflammation of the mammary gland, is the most costly common disease in the dairy industry, and is caused by mammary pathogenic bacteria, including Escherichia coli. The bacteria invade the mammary alveolar lumen and disrupt the blood-milk barrier. In normal mammary gland, alveolar epithelial tight junctions (TJs) contribute the blood-milk barrier of alveolar epithelium by blocking the leakage of milk components from the luminal side into the blood serum. In this study, we focused on claudin subtypes that participate in the alveolar epithelial TJs, because the composition of claudins is an important factor that affects TJ permeability. In normal mouse lactating mammary glands, alveolar TJs consist of claudin-3 without claudin-1, -4, and -7. In lipopolysaccharide (LPS)-induced mastitis, alveolar TJs showed 2-staged compositional changes in claudins. First, a qualitative change in claudin-3, presumably caused by phosphorylation and participation of claudin-7 in alveolar TJs, was recognized in parallel with the leakage of fluorescein isothiocyanate-conjugated albumin (FITC-albumin) via the alveolar epithelium. Second, claudin-4 participated in alveolar TJs with claudin-3 and claudin-7 12 h after LPS injection. The partial localization of claudin-1 was also observed by immunostaining. Coinciding with the second change of alveolar TJs, the severe disruption of the blood-milk barrier was recognized by ectopic localization of beta-casein and much leakage of FITC-albumin. Furthermore, the localization of toll-like receptor 4 (TLR4) on the luminal side and NF kappa B activation by LPS was observed in the alveolar epithelial cells. We suggest that the weakening and disruption of the blood-milk barrier are caused by compositional changes of claudins in alveolar epithelial TJs through LPS/TLR4 signaling.	[Kobayashi, Ken; Oyama, Shoko; Numata, Atsushi; Rahman, Md. Morshedur; Kumura, Haruto] Hokkaido Univ, Res Fac Agr, Lab Dairy Food Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Kobayashi, K (corresponding author), Hokkaido Univ, Res Fac Agr, Lab Dairy Food Sci, Sapporo, Hokkaido, Japan.	kkobaya@anim.agr.hokudai.ac.jp		KUMURA, Haruto/0000-0002-7225-665X	Japan Society of Promotion of Science [24780281]; Ministry of Education, Culture, Sports, Science, and Technology	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (24780281) from the Japan Society of Promotion of Science and a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers RM, 2011, J MAMMARY GLAND BIOL, V16, P275, DOI 10.1007/s10911-011-9231-3; Angelow S, 2007, CURR OPIN NEPHROL HY, V16, P459, DOI 10.1097/MNH.0b013e32820ac97d; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barlow J, 2011, J MAMMARY GLAND BIOL, V16, P383, DOI 10.1007/s10911-011-9235-z; Baumert A, 2009, J DAIRY RES, V76, P356, DOI 10.1017/S0022029909004129; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Blanchard AAA, 2006, DNA CELL BIOL, V25, P79, DOI 10.1089/dna.2006.25.79; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; Burton JL, 2003, VET CLIN N AM-FOOD A, V19, P1, DOI 10.1016/S0749-0720(02)00073-7; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Butt AM, 2012, MOL BIOL REP, V39, P1359, DOI 10.1007/s11033-011-0870-7; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Choi HJ, 2012, TOXICOL LETT, V211, P289, DOI 10.1016/j.toxlet.2012.04.012; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clarkson RWE, 1999, J MAMMARY GLAND BIOL, V4, P165, DOI 10.1023/A:1018725207969; Connelly L, 2010, J CELL PHYSIOL, V222, P73, DOI 10.1002/jcp.21922; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; de Kruif CG, 2012, ADV COLLOID INTERFAC, V171, P36, DOI 10.1016/j.cis.2012.01.002; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Fujibe M, 2004, EXP CELL RES, V295, P36, DOI 10.1016/j.yexcr.2003.12.014; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Gonen E, 2007, CELL MICROBIOL, V9, P2826, DOI 10.1111/j.1462-5822.2007.00999.x; Gu BB, 2010, INT IMMUNOPHARMACOL, V10, P799, DOI 10.1016/j.intimp.2010.04.022; Ibeagha-Awemu EM, 2008, VET RES, V39, DOI 10.1051/vetres:2007047; Itoh M, 2003, J MAMMARY GLAND BIOL, V8, P449, DOI 10.1023/B:JOMG.0000017431.45314.07; Kamekura R, 2010, HISTOCHEM CELL BIOL, V133, P339, DOI 10.1007/s00418-009-0674-1; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kobayashi K, 2011, HISTOCHEM CELL BIOL, V136, P587, DOI 10.1007/s00418-011-0863-6; Lehmann M, 2012, J DAIRY SCI, V96, P1681; Linzell JL, 2009, J MAMMARY GLAND BIOL, V14, P271, DOI 10.1007/s10911-009-9130-z; LINZELL JL, 1973, J PHYSIOL-LONDON, V230, pP13, DOI 10.1113/jphysiol.1973.sp010185; Liu Y, 2012, TUMOR BIOL, V33, P2307, DOI 10.1007/s13277-012-0493-1; Markov AG, 2012, PFLUG ARCH EUR J PHY, V463, P391, DOI 10.1007/s00424-011-1034-2; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; MCFADDEN TB, 1987, J DAIRY SCI, V70, P259, DOI 10.3168/jds.S0022-0302(87)80005-X; MCFADDEN TB, 1988, J DAIRY SCI, V71, P826, DOI 10.3168/jds.S0022-0302(88)79623-X; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Nguyen DA, 2001, J ENDOCRINOL, V170, P347, DOI 10.1677/joe.0.1700347; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; Nishiyama R, 2001, J BIOL CHEM, V276, P35571, DOI 10.1074/jbc.M106013200; Notebaert S, 2008, COMP IMMUNOL MICROB, V31, P551, DOI 10.1016/j.cimid.2007.10.004; Notebaert S, 2008, CELL MICROBIOL, V10, P1249, DOI 10.1111/j.1462-5822.2008.01123.x; Oguro M, 2011, J GASTROENTEROL, V46, P629, DOI 10.1007/s00535-011-0390-1; Pitelka DR, 2009, J MAMMARY GLAND BIOL, V14, P295, DOI 10.1007/s10911-009-9131-y; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; Schmitz S, 2004, DOMEST ANIM ENDOCRIN, V26, P111, DOI 10.1016/j.domaniend.2003.09.003; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Spencer JP, 2008, AM FAM PHYSICIAN, V78, P727; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stelwagen K, 1998, J DAIRY SCI, V81, P434, DOI 10.3168/jds.S0022-0302(98)75594-8; Stelwagen K, 1998, J ENDOCRINOL, V159, P173, DOI 10.1677/joe.0.1590173; Stelwagen K, 1997, AM J PHYSIOL-REG I, V273, pR379, DOI 10.1152/ajpregu.1997.273.1.R379; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Tang YM, 2010, AM J PATHOL, V176, P158, DOI 10.2353/ajpath.2010.090548; Tsukita S, 2000, ANN NY ACAD SCI, V915, P129, DOI 10.1111/j.1749-6632.2000.tb05235.x; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wellnitz O, 2011, J DAIRY SCI, V94, P5405, DOI 10.3168/jds.2010-3931; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	65	64	70	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62187	10.1371/journal.pone.0062187	http://dx.doi.org/10.1371/journal.pone.0062187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626786	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400150
J	Liu, YC; Hung, CS; Wu, YW; Lee, YC; Lin, YH; Lin, C; Lo, MT; Chan, CC; Ma, HP; Ho, YL; Chen, CH				Liu, Yu-Chen; Hung, Chi-Sheng; Wu, Yen-Wen; Lee, Yi-Chin; Lin, Yen-Hung; Lin, Chen; Lo, Men-Tzung; Chan, Chun-Chieh; Ma, Hsi-Pin; Ho, Yi-Lwun; Chen, Chien-Hung			Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability	PLOS ONE			English	Article							ASIA-PACIFIC REGION; METABOLIC-SYNDROME; LEPTIN CONCENTRATIONS; SYSTEM ACTIVITY; NERVOUS-SYSTEM; RISK; POPULATION; ATHEROSCLEROSIS; MANAGEMENT; PLASMA	Background: Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular atherosclerosis independent of classical risk factors. This study investigated the influence of NAFLD on autonomic changes, which is currently unknown. Methods: Subjects without an overt history of cardiovascular disease were enrolled during health checkups. The subjects diagnosed for NAFLD using ultrasonography underwent 5-min heart rate variability (HRV) measurements that was analyzed using the following indices: (1) the time domain with the standard deviation of N-N (SDNN) intervals and root mean square of successive differences between adjacent N-N intervals (rMSSD); (2) the frequency domain with low frequency (LF) and high frequency (HF) components; and (3) symbolic dynamics analysis. Routine blood biochemistry data and serum leptin levels were analyzed. Homeostasis model assessment of insulin resistance (HOMA-IR) was measured. Results: Of the 497 subjects (mean age, 46.2 years), 176 (35.4%) had NAFLD. The HRV indices (Ln SDNN, Ln rMSSD, Ln LF, and Ln HF) were significantly decreased in the NAFLD group (3.51 vs 3.62 ms, 3.06 vs 3.22 ms, 5.26 vs 5.49 ms(2), 4.49 vs 5.21 ms 2, respectively, all P<0.05). Ln SDNN was significantly lower in the NAFLD group after adjustment for age, sex, hypertension, dyslipidemia, metabolic syndrome, body mass index, smoking, estimated glomerular filtration rate, HOMA-IR, and leptin (P<0.05). In the symbolic dynamic analysis, 0 V percentage was significantly higher in the NAFLD group (33.8% vs 28.7%, P = 0.001) and significantly correlated with linear HRV indices (Ln SDNN, Ln rMSSD, and Ln HF). Conclusions: NAFLD is associated with decreased Ln SDNN and increased 0 V percentage. The former association was independent of conventional cardiovascular risk factors and serum biomarkers (insulin resistance and leptin). Further risk stratification of autonomic dysfunction with falls or cardiovascular diseases by these HRV parameters is required in patients with NAFLD.	[Liu, Yu-Chen; Hung, Chi-Sheng; Lin, Yen-Hung; Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Liu, Yu-Chen; Hung, Chi-Sheng; Lin, Yen-Hung; Ho, Yi-Lwun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liu, Yu-Chen; Wu, Yen-Wen] Far Eastern Poly Clin, Dept Internal Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Med Imaging, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Div Cardiol, Cardiovasc Med Ctr, Taipei, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Yi-Chin] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Div Biomed Stat, Taipei 10764, Taiwan; [Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Tao Yuan, Taiwan; [Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Chan, Chun-Chieh; Ma, Hsi-Pin] Natl Tsing Hua Univ, Dept Elect Engn, Hsinchu, Taiwan; [Chen, Chien-Hung] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei 100, Taiwan; [Chen, Chien-Hung] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Central University; National Central University; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Ho, YL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan.	ylho@ntu.edu.tw	liu, yuchen/GYQ-6286-2022; Lin, Yen-Hung/AAQ-1242-2020; huang, yuting/T-4341-2019	Lin, Yen-Hung/0000-0001-8153-1441; Lin, Chen/0000-0001-6261-8509; HO, YI-LWUN/0000-0002-8936-9570; WU, YEN-WEN/0000-0003-1520-1166	Smart-Health Technology Research & Development Center of National Taiwan University [10R71608-1/101R7608-1]; Taiwan National Science Council [NSC 100-2220-E-002-020, 101-2220-E-002-020]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC) [100-2911-I-008-001]	Smart-Health Technology Research & Development Center of National Taiwan University; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC)	This study was supported by Smart-Health Technology Research & Development Center of National Taiwan University (grant no. 10R71608-1/101R7608-1) and the Taiwan National Science Council (grant numbers NSC 100-2220-E-002-020, 101-2220-E-002-020), and the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC grant number 100-2911-I-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Augustyniak RA, 2006, AM J PHYSIOL-REG I, V290, pR726, DOI 10.1152/ajpregu.00768.2004; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Camm AJ, 1996, CIRCULATION, V93, P1043; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Dekker JM, 1997, AM J EPIDEMIOL, V145, P899, DOI 10.1093/oxfordjournals.aje.a009049; Dogru T, 2012, DIABETES RES CLIN PR, V96, P47, DOI 10.1016/j.diabres.2011.11.022; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Fietta P, 2005, Minerva Med, V96, P65; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Leung YM, 2008, CHINESE J PHYSIOL, V51, P1; Li XM, 2012, ATHEROSCLEROSIS, V224, P480, DOI 10.1016/j.atherosclerosis.2012.07.002; Liao DP, 1998, DIABETES CARE, V21, P2116, DOI 10.2337/diacare.21.12.2116; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; Machado MV, 2012, EUR J GASTROEN HEPAT, V24, P1166, DOI 10.1097/MEG.0b013e32835609b0; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Meyerfeldt U, 2002, INT J CARDIOL, V84, P141, DOI 10.1016/S0167-5273(02)00139-0; Min KB, 2008, PACE, V31, P584, DOI 10.1111/j.1540-8159.2008.01045.x; Newton JL, 2010, DIGEST DIS, V28, P214, DOI 10.1159/000282089; Newton JL, 2009, CLIN AUTON RES, V19, P319, DOI 10.1007/s10286-009-0031-4; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Paolisso G, 2000, J CLIN ENDOCR METAB, V85, P1810, DOI 10.1210/jc.85.5.1810; Pruvot E, 2000, CIRCULATION, V101, P2398, DOI 10.1161/01.CIR.101.20.2398; Reilly MP, 2004, J CLIN ENDOCR METAB, V89, P3872, DOI 10.1210/jc.2003-031676; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Shusterman V, 1998, J AM COLL CARDIOL, V32, P1891, DOI 10.1016/S0735-1097(98)00468-9; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Singh M, 2010, INT J CARDIOL, V140, P266, DOI 10.1016/j.ijcard.2009.07.019; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; VALKAMA JO, 1995, J AM COLL CARDIOL, V25, P437, DOI 10.1016/0735-1097(94)00392-4; Volti GL, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-62; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347	40	60	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61803	10.1371/journal.pone.0061803	http://dx.doi.org/10.1371/journal.pone.0061803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626730	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400094
J	Matsuzaki, S; Darcha, C				Matsuzaki, Sachiko; Darcha, Claude			In Vitro Effects of a Small-Molecule Antagonist of the Tcf/beta-Catenin Complex on Endometrial and Endometriotic Cells of Patients with Endometriosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GENE-EXPRESSION; EPITHELIAL-CELLS; RNA INTEGRITY; BETA; PERITONEAL; INHIBITORS; MIGRATION; IMPACT; WOMEN	Background: Our previous studies suggested that aberrant activation of Wnt/beta-catenin signaling might be involved in the pathophysiology of endometriosis. We hypothesized that inhibition of Wnt/beta-catenin signaling might result in inhibition of cell proliferation, migration, and/or invasion of endometrial and endometriotic epithelial and stromal cells of patients with endometriosis. Objectives: The aim of the present study was to evaluate the effects of a small-molecule antagonist of the Tcf/beta-catenin complex (PKF 115-584) on cell proliferation, migration, and invasion of endometrial and endometriotic epithelial and stromal cells. Methods: One hundred twenty-six patients (78 with and 48 without endometriosis) with normal menstrual cycles were recruited. In vitro effects of PKF 115-584 on cell proliferation, migration, and invasion and on the Tcf/beta-catenin target genes were evaluated in endometrial epithelial and stromal cells of patients with and without endometriosis, and in endometrial and endometriotic epithelial and stromal cells of the same patients. Results: The inhibitory effects of PKF 115-584 on cell migration and invasion in endometrial epithelial and stromal cells of patients with endometriosis prepared from the menstrual phase were significantly higher than those of patients without endometriosis. Levels of total and active forms of MMP-9 were significantly higher in epithelial and stromal cells prepared from menstrual endometrium in patients with endometriosis compared to patients without endometriosis. Treatment with PKF 115-584 inhibited MMP-9 activity to undetectable levels in both menstrual endometrial epithelial and stromal cells of patients with endometriosis. The number of invasive cells was significantly higher in epithelial and stromal cells of endometriotic tissue compared with matched eutopic endometrium of the same patients. Treatment with PKF 115-584 decreased the number of invasive endometriotic epithelial cells by 73% and stromal cells by 75%. Conclusions: The present findings demonstrated that cellular mechanisms known to be involved in endometriotic lesion development are inhibited by targeting the Wnt/beta-catenin pathway.	[Matsuzaki, Sachiko] CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France; [Matsuzaki, Sachiko] Clermont Univ, Univ Auvergne, ISIT UMR6284, Clermont Ferrand, France; [Matsuzaki, Sachiko] Univ Clermont Ferrand 2, Photochim Mol & Macromol Lab, CNRS, ISIT UMR6284, Clermont Ferrand, France; [Darcha, Claude] CHU Clermont Ferrand, Serv Anat & Cytol Pathol, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Matsuzaki, S (corresponding author), CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France.	sachikoma@aol.com			Karl Storz Endoscopy & GmbH (Tuttlingen, Germany)	Karl Storz Endoscopy & GmbH (Tuttlingen, Germany)	This study was supported in part by Karl Storz Endoscopy & GmbH (Tuttlingen, Germany). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2010, ENDOCRINOLOGY, V151, P1341, DOI 10.1210/en.2009-0923; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Canis M, 2003, HUM REPROD, V18, P5, DOI 10.1093/humrep/deg012; Chevronnay HPG, 2012, BBA-PROTEINS PROTEOM, V1824, P146, DOI 10.1016/j.bbapap.2011.09.003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collette T, 2004, HUM REPROD, V19, P1257, DOI 10.1093/humrep/deh290; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; GAETJE R, 1995, LANCET, V346, P1463, DOI 10.1016/S0140-6736(95)92474-4; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Han SJ, 2012, NAT MED, V18, P1102, DOI 10.1038/nm.2826; Hull ML, 2008, AM J PATHOL, V173, P700, DOI 10.2353/ajpath.2008.071128; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kyama CM, 2006, FERTIL STERIL, V85, P1667, DOI 10.1016/j.fertnstert.2005.11.060; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Matsuzaki S, 2012, HUM REPROD, V27, P1613, DOI 10.1093/humrep/des081; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; Matsuzaki S, 2010, J CLIN ENDOCR METAB, V95, P3437, DOI 10.1210/jc.2009-2713; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sugawara J, 1997, BIOL REPROD, V57, P936, DOI 10.1095/biolreprod57.4.936; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Watanabe K, 2011, P NATL ACAD SCI USA, V108, P5929, DOI 10.1073/pnas.1103102108; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yu Q, 2000, GENE DEV, V14, P163; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1	38	56	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61690	10.1371/journal.pone.0061690	http://dx.doi.org/10.1371/journal.pone.0061690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626717	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400081
J	Nfon, CK; Leung, A; Smith, G; Embury-Hyatt, C; Kobinger, G; Weingartl, HM				Nfon, Charles K.; Leung, Anders; Smith, Greg; Embury-Hyatt, Carissa; Kobinger, Gary; Weingartl, Hana M.			Immunopathogenesis of Severe Acute Respiratory Disease in Zaire ebolavirus-Infected Pigs	PLOS ONE			English	Article							VIRUS-INFECTION; GENE-EXPRESSION; LUNG PATHOLOGY; RESTON VIRUS; T-CELL; TRANSMISSION; HOST; REPLICATION; MACROPHAGES; INSIGHTS	Ebola viruses (EBOV) are filamentous single-stranded RNA viruses of the family Filoviridae. Zaire ebolavirus (ZEBOV) causes severe haemorrhagic fever in humans, great apes and non-human primates (NHPs) with high fatality rates. In contrast, Reston ebolavirus (REBOV), the only species found outside Africa, is lethal to some NHPs but has never been linked to clinical disease in humans despite documented exposure. REBOV was isolated from pigs in the Philippines and subsequent experiments confirmed the susceptibility of pigs to both REBOV and ZEBOV with predilection for the lungs. However, only ZEBOV caused severe lung pathology in 5-6 weeks old pigs leading to respiratory distress. To further elucidate the mechanisms for lung pathology, microarray analysis of changes in gene expression was performed on lung tissue from ZEBOV-infected pigs. Furthermore, systemic effects were monitored by looking at changes in peripheral blood leukocyte subsets and systemic cytokine responses. Following oro-nasal challenge, ZEBOV replicated mainly in the respiratory tract, causing severe inflammation of the lungs and consequently rapid and difficult breathing. Neutrophils and macrophages infiltrated the lungs but only the latter were positive for ZEBOV antigen. Genes for proinflammatory cytokines, chemokines and acute phase proteins, known to attract immune cells to sites of infection, were upregulated in the lungs, causing the heavy influx of cells into this site. Systemic effects included a decline in the proportion of monocyte/dendritic and B cells and a mild proinflammatory cytokine response. Serum IgM was detected on day 5 and 6 post infection. In conclusion, a dysregulation/over-activation of the pulmonary proinflammatory response may play a crucial role in the pathogenesis of ZEBOV infection in 5-6 weeks old pigs by attracting inflammatory cells to the lungs.	[Nfon, Charles K.; Smith, Greg; Embury-Hyatt, Carissa; Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Leung, Anders; Kobinger, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; [Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Canadian Food Inspection Agency; Public Health Agency of Canada; University of Manitoba	Nfon, CK (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	Charles.nfon@inspection.gc.ca; Hana.Weingartl@inspection.gc.ca			Defence Research and Development Canada through the Chemical, Biological, Radiological and Nuclear (CBRN) Research and Technology Initiative (CRTI) Cluster Activity fund [CRTI-3780-2011-30va-17]	Defence Research and Development Canada through the Chemical, Biological, Radiological and Nuclear (CBRN) Research and Technology Initiative (CRTI) Cluster Activity fund	Funding was provided from Defence Research and Development Canada through the Chemical, Biological, Radiological and Nuclear (CBRN) Research and Technology Initiative (CRTI) Cluster Activity fund; CRTI-3780-2011-30va-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Franks TJ, 2003, HUM PATHOL, V34, P743, DOI 10.1016/S0046-8177(03)00367-8; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Ghafouri B, 2003, BIOCHEM SOC T, V31, P810, DOI 10.1042/BST0310810; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; GOODMAN RB, 1992, BIOCHEMISTRY-US, V31, P10483, DOI 10.1021/bi00158a011; Gupta M, 2007, VIROLOGY, V364, P45, DOI 10.1016/j.virol.2007.02.017; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Jahrling PB, 1996, ARCH VIROL, P115; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; JONES M, 1993, J IMMUNOL, V150, P5429; Kobinger GP, 2011, J INFECT DIS, V204, P200, DOI 10.1093/infdis/jir077; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Larsen T, 2007, J INFECT DIS, V196, pS323, DOI 10.1086/520589; Lawson SR, 1997, VIRUS RES, V51, P105, DOI 10.1016/S0168-1702(97)00086-5; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Marsh GA, 2011, J INFECT DIS, V204, pS804, DOI 10.1093/infdis/jir300; MINNICOZZI M, 1995, MEDIAT INFLAMM, V4, P331, DOI 10.1155/S0962935195000536; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; Wyers M, 1999, J INFECT DIS, V179, pS54, DOI 10.1086/514300; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	35	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61904	10.1371/journal.pone.0061904	http://dx.doi.org/10.1371/journal.pone.0061904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626748	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400112
J	Serlin, Y; Tal, G; Chassidim, Y; Parmet, Y; Tomkins, O; Knyazer, B; Friedman, A; Levy, J				Serlin, Yonatan; Tal, Geva; Chassidim, Yoash; Parmet, Yisrael; Tomkins, Oren; Knyazer, Boris; Friedman, Alon; Levy, Jaime			Novel Fluorescein Angiography-Based Computer-Aided Algorithm for Assessment of Retinal Vessel Permeability	PLOS ONE			English	Article							AGREEMENT	Purpose: To present a novel method for quantitative assessment of retinal vessel permeability using a fluorescein angiography-based computer algorithm. Methods: Twenty-one subjects (13 with diabetic retinopathy, 8 healthy volunteers) underwent fluorescein angiography (FA). Image pre-processing included removal of non-retinal and noisy images and registration to achieve spatial and temporal pixel-based analysis. Permeability was assessed for each pixel by computing intensity kinetics normalized to arterial values. A linear curve was fitted and the slope value was assigned, color-coded and displayed. The initial FA studies and the computed permeability maps were interpreted in a masked and randomized manner by three experienced ophthalmologists for statistical validation of diagnosis accuracy and efficacy. Results: Permeability maps were successfully generated for all subjects. For healthy volunteers permeability values showed a normal distribution with a comparable range between subjects. Based on the mean cumulative histogram for the healthy population a threshold (99.5%) for pathological permeability was determined. Clear differences were found between patients and healthy subjects in the number and spatial distribution of pixels with pathological vascular leakage. The computed maps improved the discrimination between patients and healthy subjects, achieved sensitivity and specificity of 0.974 and 0.833 respectively, and significantly improved the consensus among raters for the localization of pathological regions. Conclusion: The new algorithm allows quantification of retinal vessel permeability and provides objective, more sensitive and accurate evaluation than the present subjective clinical diagnosis. Future studies with a larger patients' cohort and different retinal pathologies are awaited to further validate this new approach and its role in diagnosis and treatment follow-up. Successful evaluation of vasculature permeability may be used for the early diagnosis of brain microvascular pathology and potentially predict associated neurological sequelae. Finally, the algorithm could be implemented for intraoperative evaluation of micovascular integrity in other organs or during animal experiments.	[Serlin, Yonatan; Chassidim, Yoash; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Neurobiol, IL-84105 Beer Sheva, Israel; [Tal, Geva] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Parmet, Yisrael] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Ind Engn & Management, IL-84105 Beer Sheva, Israel; [Tomkins, Oren] Moorfields Eye Hosp, London, England; [Tomkins, Oren] Royal Surrey Cty Hosp, Guildford, Surrey, England; [Knyazer, Boris; Levy, Jaime] Soroka Univ, Med Ctr, Dept Ophthalmol, Beer Sheva, Israel; [Knyazer, Boris; Levy, Jaime] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Friedman, Alon] Charite, Neurocure Res Ctr, Inst Neurophysiol, D-13353 Berlin, Germany	Ben Gurion University; Ben Gurion University; Ben Gurion University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Royal Surrey County Hospital; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Friedman, A (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Neurobiol, IL-84105 Beer Sheva, Israel.	alonf@bgu.ac.il	Knyazer, Boris/AAM-6854-2020; Knyazer., Boris/D-8969-2014; PARMET, YISRAEL/F-1982-2012	Knyazer, Boris/0000-0002-9246-3226; Knyazer., Boris/0000-0002-9246-3226; PARMET, YISRAEL/0000-0002-2071-7338; Tomkins-Netzer, Oren/0000-0002-1015-1641	BG Negev Technologies, Beer-Sheva, Israel; BG Negev Technologies	BG Negev Technologies, Beer-Sheva, Israel; BG Negev Technologies	This study was partially supported by Fakheri funds for applied research, BG Negev Technologies, Beer-Sheva, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors have the following interests. This study was partially supported by BG Negev Technologies. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bennett TJ, 2009, CLIN EXP OPHTHALMOL, V37, P2, DOI 10.1111/j.1442-9071.2008.01812.x; Berger JW, 2000, INVEST OPHTH VIS SCI, V41, P2286; Chakravarthy U, 2007, INVEST OPHTH VIS SCI, V48, P349, DOI 10.1167/iovs.06-0493; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Kaiser RS, 2002, RETINA-J RET VIT DIS, V22, P683, DOI 10.1097/00006982-200212000-00001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lobo CL, 1999, ARCH OPHTHALMOL-CHIC, V117, P631; McKenzie DP, 1996, J PSYCHIAT RES, V30, P483, DOI 10.1016/S0022-3956(96)00033-7; Nguyen TT, 2010, PSYCHOSOM MED, V72, P535, DOI 10.1097/PSY.0b013e3181da90f4; NOVOTNY HR, 1961, CIRCULATION, V24, P82, DOI 10.1161/01.CIR.24.1.82; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Serlin Yonatan, 2011, Cardiovasc Psychiatry Neurol, V2011, P609202, DOI 10.1155/2011/609202	15	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61599	10.1371/journal.pone.0061599	http://dx.doi.org/10.1371/journal.pone.0061599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626701	Green Published, gold			2022-12-25	WOS:000318008400065
J	Wang, T; Chen, XP; Zhu, FH; Li, HF; Li, L; Yang, QL; Chi, XY; Yu, SL; Liang, XQ				Wang, Tong; Chen, Xiaoping; Zhu, Fanghe; Li, Haifen; Li, Ling; Yang, Qingli; Chi, Xiaoyuan; Yu, Shanlin; Liang, Xuanqiang			Characterization of Peanut Germin-Like Proteins, AhGLPs in Plant Development and Defense	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; BARLEY OXALATE OXIDASE; HORDEUM-VULGARE L.; SALT STRESS; ARACHIS-HYPOGAEA; OXIDATIVE BURST; GENE-EXPRESSION; MESSENGER-RNA; RESISTANCE; WHEAT	Background: Germin-like superfamily members are ubiquitously expressed in various plant species and play important roles in plant development and defense. Although several GLPs have been identified in peanut (Arachis hypogaea L.), their roles in development and defense remain unknown. In this research, we study the spatiotemporal expression of AhGLPs in peanut and their functions in plant defense. Results: We have identified three new AhGLP members (AhGLP3b, AhGLP5b and AhGLP7b) that have distinct but very closely related DNA sequences. The spatial and temporal expression profiles revealed that each peanut GLP gene has its distinct expression pattern in various tissues and developmental stages. This suggests that these genes all have their distinct roles in peanut development. Subcellular location analysis demonstrated that AhGLP2 and 5 undergo a protein transport process after synthesis. The expression of all AhGLPs increased in responding to Aspergillus flavus infection, suggesting AhGLPs' ubiquitous roles in defense to A. flavus. Each AhGLP gene had its unique response to various abiotic stresses (including salt, H2O2 stress and wound), biotic stresses (including leaf spot, mosaic and rust) and plant hormone stimulations (including SA and ABA treatments). These results indicate that AhGLPs have their distinct roles in plant defense. Moreover, in vivo study of AhGLP transgenic Arabidopsis showed that both AhGLP2 and 3 had salt tolerance, which made transgenic Arabidopsis grow well under 100 mM NaCl stress. Conclusions: For the first time, our study analyzes the AhGLP gene expression profiles in peanut and reveals their roles under various stresses. These results provide an insight into the developmental and defensive roles of GLP gene family in peanut.	[Wang, Tong; Chen, Xiaoping; Zhu, Fanghe; Li, Haifen; Liang, Xuanqiang] Guangdong Acad Agr Sci, Crops Res Inst, Guangzhou, Guangdong, Peoples R China; [Wang, Tong; Yang, Qingli; Chi, Xiaoyuan; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China; [Wang, Tong; Li, Ling] S China Normal Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; South China Normal University	Liang, XQ (corresponding author), Guangdong Acad Agr Sci, Crops Res Inst, Guangzhou, Guangdong, Peoples R China.	Liang-804@163.com			National Natural Science Foundation of China [30971819, 31200211, 30900907]; Natural Science Foundation of Guangdong and Shandong Province [10151064001000002, ZR2012CQ031]; Science and Technology Planning Project of Guangdong Province [2011B010500019]; Pearl River Science and Technology Nova of Guangzhou [2011J2200035]; earmarked fund for Modern Agro-industry Technology Research System [nycycx-19, CARS-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong and Shandong Province; Science and Technology Planning Project of Guangdong Province; Pearl River Science and Technology Nova of Guangzhou; earmarked fund for Modern Agro-industry Technology Research System	This research was funded by grants from National Natural Science Foundation of China (No. 30971819, 31200211 and 30900907), Natural Science Foundation of Guangdong and Shandong Province (No. 10151064001000002 and ZR2012CQ031), Science and Technology Planning Project of Guangdong Province (2011B010500019), Pearl River Science and Technology Nova of Guangzhou (No. 2011J2200035) and supported by the earmarked fund for Modern Agro-industry Technology Research System (No. nycycx-19, CARS-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alos E, 2008, PLANT PHYSIOL, V147, P1300, DOI 10.1104/pp.108.119917; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Bhattacharjee S, 2005, CURR SCI INDIA, V89, P1113; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Caliskan M, 2004, PLANTA, V219, P132, DOI 10.1007/s00425-003-1199-9; Caliskan M, 2009, GENET MOL RES, V8, P1250, DOI 10.4238/vol8-4gmr623; Chakraborty S, 2002, PROTEIN SCI, V11, P2138, DOI 10.1110/ps.0206802; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; de Jesus WC, 2001, PHYTOPATHOLOGY, V91, P1045, DOI 10.1094/PHYTO.2001.91.11.1045; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; DUMAS B, 1993, CR ACAD SCI III-VIE, V316, P793; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; Gucciardo S, 2007, J EXP BOT, V58, P1161, DOI 10.1093/jxb/erl282; Guo Baozhu, 2009, Int J Plant Genomics, V2009, P715605, DOI 10.1155/2009/715605; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; HURKMAN WJ, 1991, PLANT PHYSIOL, V97, P366, DOI 10.1104/pp.97.1.366; HURKMAN WJ, 1994, PLANT PHYSIOL, V104, P803, DOI 10.1104/pp.104.2.803; Hurkman WJ, 1996, PLANT PHYSIOL, V110, P971, DOI 10.1104/pp.110.3.971; Kamal AHM, 2012, MOL BIOL REP, V39, P9059, DOI 10.1007/s11033-012-1777-7; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kukavica B, 2005, PROTOPLASMA, V226, P191, DOI 10.1007/s00709-005-0112-8; LANE BG, 1992, EUR J BIOCHEM, V209, P961, DOI 10.1111/j.1432-1033.1992.tb17369.x; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Li Hui-yu, 2010, Journal of Forestry Research (Harbin), V21, P323, DOI 10.1007/s11676-010-0078-z; Liang HY, 2001, PLANT MOL BIOL, V45, P619, DOI 10.1023/A:1010631318831; Liang XQ, 2005, PHYTOPATHOLOGY, V95, P506, DOI 10.1094/PHYTO-95-0506; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone DM, 2005, PLANT PHYSIOL, V137, P1354, DOI 10.1104/pp.104.057232; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Lu M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-620, 10.1186/1471-2164-12-16]; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Moeder Wolfgang, 2010, Plant Signal Behav, V5, P1231, DOI 10.4161/psb.5.10.12836; Nakata M, 2004, PLANT MOL BIOL, V56, P381, DOI 10.1007/s11103-004-3475-x; Nakata M, 2002, PLANT CELL PHYSIOL, V43, P1568, DOI 10.1093/pcp/pcf178; NELSON SC, 1989, J NEMATOL, V21, P654; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; Rodriguez-Lopez M, 2001, FEBS LETT, V490, P44, DOI 10.1016/S0014-5793(01)02135-4; Schweizer P, 1999, PLANT J, V20, P540, DOI 10.1046/j.1365-313x.1999.00624.x; Segarra CI, 2003, J EXP BOT, V54, P1335, DOI 10.1093/jxb/erg139; Tabuchi T KT, 2003, PHYSIOL PLANTARUM, V118, P9; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Vallelian-Bindschedler L, 1998, PLANT MOL BIOL, V37, P297, DOI 10.1023/A:1005982715972; Wang T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-267; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	59	54	64	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61722	10.1371/journal.pone.0061722	http://dx.doi.org/10.1371/journal.pone.0061722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626720	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400084
J	Zhu, WF; Zhao, HM; Xiang, DH; Chen, XJ				Zhu, Weifang; Zhao, Heming; Xiang, Dehui; Chen, Xinjian			A Flattest Constrained Envelope Approach for Empirical Mode Decomposition	PLOS ONE			English	Article							HILBERT SPECTRUM	Empirical mode decomposition (EMD) is an adaptive method for nonlinear, non-stationary signal analysis. However, the upper and lower envelopes fitted by cubic spline interpolation (CSI) may often occur overshoots. In this paper, a new envelope fitting method based on the flattest constrained interpolation is proposed. The proposed method effectively integrates the difference between extremes into the cost function, and applies a chaos particle swarm optimization method to optimize the derivatives of the interpolation nodes. The proposed method was tested on three different types of data: ascertain signal, random signals and real electrocardiogram signals. The experimental results show that: (1) The proposed flattest envelope effectively solves the overshoots caused by CSI method and the artificial bends caused by piecewise parabola interpolation (PPI) method. (2) The index of orthogonality of the intrinsic mode functions (IMFs) based on the proposed method is 0.04054, 0.02222 +/- 0.01468 and 0.04013 +/- 0.03953 for the ascertain signal, random signals and electrocardiogram signals, respectively, which is lower than the CSI method and the PPI method, and means the IMFs are more orthogonal. (3) The index of energy conversation of the IMFs based on the proposed method is 0.96193, 0.93501 +/- 0.03290 and 0.93041 +/- 0.00429 for the ascertain signal, random signals and electrocardiogram signals, respectively, which is closer to 1 than the other two methods and indicates the total energy deviation amongst the components is smaller. (4) The comparisons of the Hilbert spectrums show that the proposed method overcomes the mode mixing problems very well, and make the instantaneous frequency more physically meaningful.	[Zhu, Weifang; Zhao, Heming; Xiang, Dehui; Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China	Soochow University - China	Chen, XJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China.	xjchen@suda.edu.cn	Chen, Xinjian/E-8592-2016; Xiang, Dehui/B-1938-2016	Xiang, Dehui/0000-0001-7873-9778; Chen, Xinjian/0000-0002-0871-293X	National Natural Science Foundation of China (NSFC) [61101217]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJD510005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (NSFC) under Grant 61101217 and in part by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China under Grant 11KJD510005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Bi N, 2007, IEEE T IMAGE PROCESS, V16, P1956, DOI 10.1109/TIP.2007.901206; Chen QH, 2006, ADV COMPUT MATH, V24, P171, DOI 10.1007/s10444-004-7614-3; [高尚 Gao Shang], 2006, [模式识别与人工智能, Pattern recognition and artificial intelligence], V19, P266; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kopsinis Y, 2008, IEEE T SIGNAL PROCES, V56, P1, DOI 10.1109/TSP.2007.901155; Manel BV, 2008, COMPUT BIOL MED, V38, P1; Molla MKI, 2007, IEEE T AUDIO SPEECH, V15, P893, DOI 10.1109/TASL.2006.885254; Moody GB, 2001, IEEE ENG MED BIOL, V20, P70, DOI 10.1109/51.932728; Qin SR, 2006, MECH SYST SIGNAL PR, V20, P1941, DOI 10.1016/j.ymssp.2005.07.002; Rilling G, 2008, IEEE T SIGNAL PROCES, V56, P85, DOI 10.1109/TSP.2007.906771; Sauer T, 2010, NUMERICAL ANAL, P128; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xu ZG, 2010, DIGIT SIGNAL PROCESS, V20, P77, DOI 10.1016/j.dsp.2009.06.009; Yang AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014612; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zhao J.P., 2001, J ZHEJIANG U SCI, V2, P247, DOI [DOI 10.1631/JZUS.2001.0247], 10.1631/jzus.2001.0247, DOI 10.1631/JZUS.2001.0247]; [钟佑明 Zhong Youming], 2002, [振动工程学报, Journal of Vibration Engineering], V15, P233; Zhu WF, 2008, J INFORM COMPUTATION, V5, P505	19	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61739	10.1371/journal.pone.0061739	http://dx.doi.org/10.1371/journal.pone.0061739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626721	Green Published, gold			2022-12-25	WOS:000318008400085
J	Zhu, ZX; Tong, XR; Zhu, ZH; Liang, MM; Cui, WY; Su, KK; Li, MD; Zhu, J				Zhu, Zhixiang; Tong, Xiaoran; Zhu, Zhihong; Liang, Meimei; Cui, Wenyan; Su, Kunkai; Li, Ming D.; Zhu, Jun			Development of GMDR-GPU for Gene-Gene Interaction Analysis and Its Application to WTCCC GWAS Data for Type 2 Diabetes	PLOS ONE			English	Article							BODY-MASS INDEX; DIMENSIONALITY REDUCTION METHOD; FTO GENE; MISSING HERITABILITY; SEQUENCE VARIANTS; FAT MASS; ASSOCIATION; RISK; OBESITY; EPISTASIS	Although genome-wide association studies (GWAS) have identified a significant number of single-nucleotide polymorphisms (SNPs) associated with many complex human traits, the susceptibility loci identified so far can explain only a small fraction of the genetic risk. Among other possible explanations, the lack of a comprehensive examination of gene-gene interaction (GxG) is often considered a source of the missing heritability. Previously, we reported a model-free Generalized Multifactor Dimensionality Reduction (GMDR) approach for detecting GxG in both dichotomous and quantitative phenotypes. However, the computational burden and less efficient implementation of the original programs make them impossible to use for GWAS. In this study, we developed a graphics processing unit (GPU)-based GMDR program (named GWAS-GPU), which is able not only to analyze GWAS data but also to run much faster than the earlier version of the GMDR program. As a demonstration of the program, we used the GMDR-GPU software to analyze a publicly available GWAS dataset on type 2 diabetes (T2D) from the Wellcome Trust Case Control Consortium. Through an exhaustive search of pair-wise interactions and a selected search of three-to five-way interactions conditioned on significant pair-wise results, we identified 24 core SNPs in six genes (FTO: rs9939973, rs9940128, rs9922047, rs1121980, rs9939609, rs9930506; TSPAN8: rs1495377; TCF7L2: rs4074720, rs7901695, rs4506565, rs4132670, rs10787472, rs11196205, rs10885409, rs11196208; L3MBTL3: rs10485400, rs4897366; CELF4: rs2852373, rs608489; RUNX1: rs445984, rs1040328, rs990074, rs2223046, rs2834970) that appear to be important for T2D. Of these core SNPs, 11 in FTO, TSPAN8, and TCF7L2 have been reported to be associated with T2D, obesity, or both, providing an independent replication of previously reported SNPs. Importantly, we identified three new susceptibility genes; i.e., L3MBTL3, CELF4, and RUNX1, for T2D, a finding that warrants further investigation with independent samples.	[Zhu, Zhixiang; Tong, Xiaoran; Zhu, Zhihong; Liang, Meimei; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Zhixiang; Cui, Wenyan; Su, Kunkai; Li, Ming D.] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA	Zhejiang University; Zhejiang University; University of Virginia	Li, MD (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ml2km@virginia.edu; jzhu@zju.edu.cn	Zhu, Jun/B-9945-2009; Zhu, Zhihong/F-8720-2015	Zhu, Zhihong/0000-0002-6783-3037	National Basic Research Program of China [2009CB118404]; Key Technologies R&D Program in China [2009ZX08009004B]; National Natural Science Foundation of China [81273223]; Microsoft Research Asia; Microsoft Server; Tools Business Department; NIH [DA-012844]; Wellcome Trust [076113]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Key Technologies R&D Program in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Microsoft Research Asia(Microsoft); Microsoft Server(Microsoft); Tools Business Department; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Basic Research Program of China (2009CB118404), Key Technologies R&D Program in China (2009ZX08009004B), National Natural Science Foundation of China grant 81273223, Microsoft Research Asia, Microsoft Server and Tools Business Department, and NIH grant DA-012844. Funding for the Wellcome Trust Case Control Consortium project was provided by the Wellcome Trust under award 076113. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Angeli CB, 2011, OBESITY, V19, P1244, DOI 10.1038/oby.2010.325; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gallo JM, 2010, RNA BIOL, V7, P474, DOI 10.4161/rna.7.4.12345; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gylfe AE, 2010, INT J CANCER, V127, P2974, DOI 10.1002/ijc.25529; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Lee SY, 2007, BIOINFORMATICS, V23, P2589, DOI 10.1093/bioinformatics/btm396; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meins M, 2002, CYTOGENET GENOME RES, V97, P254, DOI 10.1159/000066619; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Moleres A, 2011, BR J NUTR, V29, P1; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Muendlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017978; Neuman RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009903; Nock NL, 2011, CARCINOGENESIS, V32, P748, DOI 10.1093/carcin/bgr026; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramya K., 2011, DIABETES TECHNOL THE, V13, P33, DOI DOI 10.1089/dia.2010.0071; Rees SD, 2011, DIABETIC MED, V28, P673, DOI 10.1111/j.1464-5491.2011.03257.x; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Schwarz DF, 2010, BIOINFORMATICS, V26, P1752, DOI 10.1093/bioinformatics/btq257; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silberschatz A, 2011, OPERATING SYSTEM CON; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Wang ZH, 2009, AM J HUM GENET, V85, P667, DOI 10.1016/j.ajhg.2009.10.006; Yang YX, 2005, CLIN GASTROENTEROL H, V3, P587, DOI 10.1016/S1542-3565(05)00152-7; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	58	44	46	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61943	10.1371/journal.pone.0061943	http://dx.doi.org/10.1371/journal.pone.0061943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626757	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400121
J	Engstrom, A; de la Torre, TZG; Stromme, M; Nilsson, M; Herthnek, D				Engstrom, Anna; de la Torre, Teresa Zardan Gomez; Stromme, Maria; Nilsson, Mats; Herthnek, David			Detection of Rifampicin Resistance in Mycobacterium tuberculosis by Padlock Probes and Magnetic Nanobead-Based Readout	PLOS ONE			English	Article							TO-CIRCLE AMPLIFICATION; CLINICAL SPECIMENS; DRUG-RESISTANCE; GENOME SEQUENCE; RAPID DETECTION; DETECTION ASSAY; DNA-SEQUENCES; REPLICATION; TECHNOLOGY; POLYMERASE	Control of the global epidemic tuberculosis is severely hampered by the emergence of drug-resistant Mycobacterium tuberculosis strains. Molecular methods offer a more rapid means of characterizing resistant strains than phenotypic drug susceptibility testing. We have developed a molecular method for detection of rifampicin-resistant M. tuberculosis based on padlock probes and magnetic nanobeads. Padlock probes were designed to target the most common mutations associated with rifampicin resistance in M. tuberculosis, i.e. at codons 516, 526 and 531 in the gene rpoB. For detection of the wild type sequence at all three codons simultaneously, a padlock probe and two gap-fill oligonucleotides were used in a novel assay configuration, requiring three ligation events for circularization. The assay also includes a probe for identification of the M. tuberculosis complex. Circularized probes were amplified by rolling circle amplification. Amplification products were coupled to oligonucleotide-conjugated magnetic nanobeads and detected by measuring the frequency-dependent magnetic response of the beads using a portable AC susceptometer.	[Engstrom, Anna] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Engstrom, Anna] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [de la Torre, Teresa Zardan Gomez; Stromme, Maria] Uppsala Univ, Dept Engn Sci, Div Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden; [Herthnek, David] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Uppsala University; Stockholm University; Uppsala University	Nilsson, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden.	mats.nilsson@scilifelab.se	Lyander, Anna/AAS-8942-2020		Carl Trygger Foundation; VINNOVA (Swedish Governmental Agency for Innovation Systems); Innovative Medicines Initiative; European Union; European Federation of Pharmacetical Industries and Associations (RAPP-ID project) [115153]; FORMAS (the Swedish Research Council (VR)	Carl Trygger Foundation; VINNOVA (Swedish Governmental Agency for Innovation Systems)(Vinnova); Innovative Medicines Initiative; European Union(European Commission); European Federation of Pharmacetical Industries and Associations (RAPP-ID project); FORMAS (the Swedish Research Council (VR)	The work was funded by the Carl Trygger Foundation, FORMAS (the Swedish Research Council (VR)), VINNOVA (Swedish Governmental Agency for Innovation Systems), and the Innovative Medicines Initiative, a public-private partnership between the European Union, and the European Federation of Pharmacetical Industries and Associations (RAPP-ID project, grant agreement, no. 115153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073; BROWN WF, 1963, J APPL PHYS, V34, P1319, DOI 10.1063/1.1729489; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; de la Torre TZG, 2011, BIOSENS BIOELECTRON, V29, P195, DOI 10.1016/j.bios.2011.08.019; Edwards KJ, 2009, PLANT BIOTECHNOL J, V7, P375, DOI 10.1111/j.1467-7652.2009.00413.x; Engstrom A, 2012, J CLIN MICROBIOL, V50, P2026, DOI 10.1128/JCM.06664-11; Fadeel B, 2010, J INTERN MED, V267, P2, DOI 10.1111/j.1365-2796.2009.02186.x; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Goransson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031068; Goransson J, 2010, ANAL CHEM, V82, P9138, DOI 10.1021/ac102133e; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Jureen P, 2006, J CLIN MICROBIOL, V44, P1925, DOI 10.1128/JCM.02210-05; Ke RQ, 2011, J CLIN MICROBIOL, V49, P4279, DOI 10.1128/JCM.00713-11; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Luo JY, 1996, NUCLEIC ACIDS RES, V24, P3071, DOI 10.1093/nar/24.15.3071; MARKO JF, 1994, MACROMOLECULES, V27, P981, DOI 10.1021/ma00082a015; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; Nilsson M, 2002, HUM MUTAT, V19, P410, DOI 10.1002/humu.10073; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rice JE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks731; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Stromberg M, 2008, BIOSENS BIOELECTRON, V24, P696, DOI 10.1016/j.bios.2008.06.043; Stromberg M, 2008, NANO LETT, V8, P816, DOI 10.1021/nl072760e; Stromberg M, 2009, ANAL CHEM, V81, P3398, DOI 10.1021/ac900561r; Varadan VK, 2009, ENG MED BIOL, P239; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62015	10.1371/journal.pone.0062015	http://dx.doi.org/10.1371/journal.pone.0062015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630621	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500076
J	Fang, QZ; Mok, PY; Thomas, AE; Haddad, DJ; Saini, SA; Clifford, BT; Kapasi, NK; Danforth, OM; Usui, M; Ye, WS; Luu, E; Sharma, R; Bartel, MJ; Pathmanabhan, JA; Ang, AAS; Sievers, RE; Lee, RJ; Springer, ML				Fang, Qizhi; Mok, Pamela Y.; Thomas, Anila E.; Haddad, Daniel J.; Saini, Shereen A.; Clifford, Brian T.; Kapasi, Neel K.; Danforth, Olivia M.; Usui, Minako; Ye, Weisheng; Luu, Emmy; Sharma, Rikki; Bartel, Maya J.; Pathmanabhan, Jeremy A.; Ang, Andrew A. S.; Sievers, Richard E.; Lee, Randall J.; Springer, Matthew L.			Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants	PLOS ONE			English	Article							PRIMARY MYOBLASTS; VEGF; ANGIOGENESIS; EXPRESSION; INJECTION; DELIVERY; TRANSDIFFERENTIATION; TRANSPLANTATION; FLUORESCENT; MYOCARDIUM	Pleiotrophin (PTN) is a growth factor with both pro-angiogenic and limited pro-tumorigenic activity. We evaluated the potential for PTN to be used for safe angiogenic gene therapy using the full length gene and a truncated gene variant lacking the domain implicated in tumorigenesis. Mouse myoblasts were transduced to express full length or truncated PTN (PTN or T-PTN), along with a LacZ reporter gene, and injected into mouse limb muscle and myocardium. In cultured myoblasts, PTN was expressed and secreted via the Golgi apparatus, but T-PTN was not properly secreted. Nonetheless, no evidence of uncontrolled growth was observed in cells expressing either form of PTN. PTN gene delivery to myocardium, and non-ischemic skeletal muscle, did not result in a detectable change in vascularity or function. In ischemic hindlimb at 14 days post-implantation, intramuscular injection with PTN-expressing myoblasts led to a significant increase in skin perfusion and muscle arteriole density. We conclude that (1) delivery of the full length PTN gene to muscle can be accomplished without tumorigenesis, (2) the truncated PTN gene may be difficult to use in a gene therapy context due to inefficient secretion, (3) PTN gene delivery leads to functional benefit in the mouse acute ischemic hindlimb model.	[Fang, Qizhi; Mok, Pamela Y.; Haddad, Daniel J.; Clifford, Brian T.; Danforth, Olivia M.; Lee, Randall J.; Springer, Matthew L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Thomas, Anila E.; Saini, Shereen A.; Kapasi, Neel K.; Usui, Minako; Ye, Weisheng; Luu, Emmy; Sharma, Rikki; Bartel, Maya J.; Pathmanabhan, Jeremy A.; Ang, Andrew A. S.; Sievers, Richard E.; Lee, Randall J.; Springer, Matthew L.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [Lee, Randall J.; Springer, Matthew L.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, RJ (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	lee@medicine.ucsf.edu; matt.springer@ucsf.edu			American Heart Association [0535244N]; UCSF Academic Senate Committee on Research Individual Investigator Award; National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering grant [R03 EB005802]; NIH Heart, Lung, and Blood Institute grant [R01 HL086917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB005802] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); UCSF Academic Senate Committee on Research Individual Investigator Award; National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering grant; NIH Heart, Lung, and Blood Institute grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by a grant from the American Heart Association (0535244N), a UCSF Academic Senate Committee on Research Individual Investigator Award, National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering grant R03 EB005802, and NIH Heart, Lung, and Blood Institute grant R01 HL086917 to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Banfi A, 2012, FASEB J, V26; Baumgartner I, 2009, MOL THER, V17, P914, DOI 10.1038/mt.2009.24; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chen HM, 2009, BLOOD, V113, P1992, DOI 10.1182/blood-2008-02-133751; CHIEN GL, 1995, CARDIOVASC RES, V30, P405, DOI 10.1016/0008-6363(95)00060-7; Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Heiss C, 2008, J CELL PHYSIOL, V215, P366, DOI 10.1002/jcp.21313; Henry TD, 2007, J AM COLL CARDIOL, V50, P1038, DOI 10.1016/j.jacc.2007.06.010; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; Lee RJ, 2000, CIRCULATION, V102, P898; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Menetrey J, 1999, TISSUE ENG, V5, P435, DOI 10.1089/ten.1999.5.435; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Ozawa CR, 2000, GENE THERAPY, P61; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rissanen TT, 2005, CIRCULATION, V112, P3937, DOI 10.1161/CIRCULATIONAHA.105.543124; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; Springer ML, 2007, FASEB J, V21, P2074, DOI 10.1096/fj.06-7700com; Springer ML, 2000, J GENE MED, V2, P279; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Springer ML, 2003, MOL THER, V7, P441, DOI 10.1016/S1525-0016(03)00010-8; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; Springer ML, 1997, CURRENT PROTOCOLS HU; Swift S., 2001, CURRENT PROTOCOLS IM; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; Thein E, 2002, EUR SURG RES, V34, P215, DOI 10.1159/000063392; von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009641; Wang X., 2011, J TISSUE SCI ENG, V3, P2; Wang XY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002814; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zhang N, 1999, Curr Opin Hematol, V6, P44, DOI 10.1097/00062752-199901000-00008; Zhang N, 1999, J BIOL CHEM, V274, P12959, DOI 10.1074/jbc.274.19.12959	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61413	10.1371/journal.pone.0061413	http://dx.doi.org/10.1371/journal.pone.0061413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630585	Green Published, gold			2022-12-25	WOS:000317911500032
J	Fujii, Y; Okada, A; Yasui, T; Niimi, K; Hamamoto, S; Hirose, M; Kubota, Y; Tozawa, K; Hayashi, Y; Kohri, K				Fujii, Yasuhiro; Okada, Atsushi; Yasui, Takahiro; Niimi, Kazuhiro; Hamamoto, Shuzo; Hirose, Masahito; Kubota, Yasue; Tozawa, Keiichi; Hayashi, Yutaro; Kohri, Kenjiro			Effect of Adiponectin on Kidney Crystal Formation in Metabolic Syndrome Model Mice via Inhibition of Inflammation and Apoptosis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INSULIN-RESISTANCE; STONE DISEASE; CELL-DEATH; NEPHROLITHIASIS; EXPRESSION; OXALATE; MOUSE; UROLITHIASIS; OBESITY	The aims of the present study were to elucidate a possible mechanism of kidney crystal formation by using a metabolic syndrome (MetS) mouse model and to assess the effectiveness of adiponectin treatment for the prevention of kidney crystals. Further, we performed genome-wide expression analyses for investigating novel genetic environmental changes. Wild-type (+/+) mice showed no kidney crystal formation, whereas ob/ob mice showed crystal depositions in their renal tubules. However, this deposition was remarkably reduced by adiponectin. Expression analysis of genes associated with MetS-related kidney crystal formation identified 259 genes that were >2.0-fold up-regulated and 243 genes that were <0.5-fold down-regulated. Gene Ontology (GO) analyses revealed that the up-regulated genes belonged to the categories of immunoreaction, inflammation, and adhesion molecules and that the down-regulated genes belonged to the categories of oxidative stress and lipid metabolism. Expression analysis of adiponectin-induced genes related to crystal prevention revealed that the numbers of up- and down-regulated genes were 154 and 190, respectively. GO analyses indicated that the up-regulated genes belonged to the categories of cellular and mitochondrial repair, whereas the down-regulated genes belonged to the categories of immune and inflammatory reactions and apoptosis. The results of this study provide compelling evidence that the mechanism of kidney crystal formation in the MetS environment involves the progression of an inflammation and immunoresponse, including oxidative stress and adhesion reactions in renal tissues. This is the first report to prove the preventive effect of adiponectin treatment for kidney crystal formation by renoprotective activities and inhibition of inflammation and apoptosis.	[Fujii, Yasuhiro; Okada, Atsushi; Yasui, Takahiro; Niimi, Kazuhiro; Hamamoto, Shuzo; Hirose, Masahito; Kubota, Yasue; Tozawa, Keiichi; Hayashi, Yutaro; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan	Nagoya City University	Okada, A (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan.	a-okada@med.nagoya-cu.ac.jp	YASUI, Takahiro/E-6401-2018	YASUI, Takahiro/0000-0003-2197-2477; Okada, Atsushi/0000-0003-2080-3794	Japanese Ministry of Education, Culture, Sports, Science and Technology [23249074, 23592374, 23592375, 23791770, 23791774, 23791775, 22591797, 22791481, 22791479, 22791484, 21791517, 21791520]; Grants-in-Aid for Scientific Research [22791481, 25462524] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (Nos. 23249074, 23592374, 23592375, 23791770, 23791774, 23791775, 22591797, 22791481, 22791479, 22791484, 21791517, and 21791520) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Asplin JR, 1997, KIDNEY INT, V52, P1602, DOI 10.1038/ki.1997.491; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; Byer K, 2005, J UROLOGY, V173, P640, DOI 10.1097/01.ju.0000143190.49888.c7; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; Curhan GC, 2008, KIDNEY INT, V73, P489, DOI 10.1038/sj.ki.5002708; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Fischer S, 2000, AM J RESP CRIT CARE, V162, P1932, DOI 10.1164/ajrccm.162.5.9910064; Hirose M, 2008, UROL RES, V36, P139, DOI 10.1007/s00240-008-0143-7; Jeong MH, 2004, CELL RES, V14, P295, DOI 10.1038/sj.cr.295; KOHRI K, 1993, J BIOL CHEM, V268, P15180; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Okada A, 2008, J BONE MINER RES, V23, P1629, DOI 10.1359/JBMR.080514; Okada A, 2007, UROL RES, V35, P89, DOI 10.1007/s00240-007-0082-8; Okada A, 2010, J BONE MINER RES, V25, P2425, DOI 10.1002/jbmr.158; Okada A, 2009, J BONE MINER RES, V24, P908, DOI [10.1359/JBMR.081245, 10.1359/jbmr.081245]; Onaran M, 2009, UROLOGY, V74, P1004, DOI 10.1016/j.urology.2009.05.010; Pucci ML, 2006, AM J PHYSIOL-RENAL, V290, pF641, DOI 10.1152/ajprenal.00426.2004; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yasui T, 2007, SCAND J UROL NEPHROL, V41, P419, DOI 10.1080/00365590701318296; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034	29	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61343	10.1371/journal.pone.0061343	http://dx.doi.org/10.1371/journal.pone.0061343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630583	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500029
J	Hoffmann, U; Pink, M; Lauer, U; Heimesaat, MM; Winsauer, C; Kruglov, A; Schlawe, K; Leichsenring, C; Liesenfeld, O; Hamann, A; Syrbe, U				Hoffmann, Ute; Pink, Matthias; Lauer, Uta; Heimesaat, Markus M.; Winsauer, Caroline; Kruglov, Andrei; Schlawe, Kerstin; Leichsenring, Claudia; Liesenfeld, Oliver; Hamann, Alf; Syrbe, Uta			Regulation and Migratory Role of P-Selectin Ligands during Intestinal Inflammation	PLOS ONE			English	Article							CD4(+) T-CELLS; HOMING RECEPTOR PATTERNS; DENDRITIC CELLS; TOXOPLASMA-GONDII; GLYCOPROTEIN LIGAND-1; CD43 FUNCTIONS; RETINOIC ACID; LYMPH-NODES; SCID MICE; EXPRESSION	Dendritic cells from mesenteric lymph nodes (MLN) can convert retinal to retinoic acid (RA), which promotes induction of the gut-specific homing receptor alpha 4 beta 7. In contrast, priming within peripheral lymph nodes leads to upregulation of E-and P-selectin ligands (E-and P-lig). Apart from its alpha 4 beta 7 promoting effect, RA was shown to suppress E- and P-lig induction in vitro. However, enhanced frequencies of P-lig(+)CD4(+) T cells were reported during intestinal inflammation. To understand this contradiction, we first determined whether location of intestinal inflammation, that is, ileitis or colitis, affects P-lig induction. Both conditions promoted P-lig expression on CD4(+) T cells; however, P-lig expressed on T cells facilitated Th1 cell recruitment only into the inflamed colon but not into inflamed small intestine induced by oral Toxoplasma gondii infection. A majority of P-lig(+)CD4(+) T cells found within MLN during intestinal inflammation co-expressed alpha 4 beta 7 confirming their activation in the presence of RA. Mesenteric P-lig(+)CD4(+) cells co-expressed the 130 kDa isoform of CD43 which requires activity of core 2 (beta) 1,6-N-acetyl-glycosaminyltransferase-I (C2GlcNAcT-I) suggesting that C2GlcNAcT-I contributes to P-lig expression under these conditions. To test whether inflammatory mediators can indeed overrule the inhibitory effect of RA on P-lig expression we stimulated CD4(+) T cells either polyclonal in the presence of IL-12 and IFN gamma or by LPS-activated MLN-derived dendritic cells. Both conditions promoted P-lig induction even in the presence of RA. While RA impeded the induction of fucosyltransferase-VII it did not affect IL-12-dependent C2GlcNAcT-I induction suggesting that C2GlcNAcT-I can support P-lig expression even if fucosyltransferase-VII mRNA upregulation is dampened.	[Hoffmann, Ute; Pink, Matthias; Lauer, Uta; Winsauer, Caroline; Kruglov, Andrei; Schlawe, Kerstin; Leichsenring, Claudia; Hamann, Alf; Syrbe, Uta] Deutsch Rheumaforschungszentrum, Berlin, Germany; [Heimesaat, Markus M.; Liesenfeld, Oliver] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany; [Syrbe, Uta] Charite, Klin Gastroenterol Infektiol & Rheumatol, D-13353 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Syrbe, U (corresponding author), Deutsch Rheumaforschungszentrum, Berlin, Germany.	Uta.Syrbe@charite.de	Kruglov, Andrey/AAP-2023-2021; Kruglov, Andrey A/F-7543-2017; Syrbe, Uta/T-7557-2017	Kruglov, Andrey A/0000-0002-4597-2087; Heimesaat, Markus/0000-0001-6399-651X; Syrbe, Uta/0000-0001-8463-7890	Deutsche Forschungsgemeinschaft [TR 52, SFB 633]; BMBF (CIPP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (CIPP)	This work was supported by the Deutsche Forschungsgemeinschaft (TR 52, SFB 633) and BMBF (CIPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2007, J INVEST DERMATOL, V127, P1964, DOI 10.1038/sj.jid.5700805; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Barran P, 1997, GLYCOBIOLOGY, V7, P129, DOI 10.1093/glycob/7.1.129; Bonder CS, 2005, AM J PATHOL, V167, P1647, DOI 10.1016/S0002-9440(10)61248-5; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Doebis C, 2008, AM J PATHOL, V173, P1067, DOI 10.2353/ajpath.2008.080052; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Haddad W, 2003, J EXP MED, V198, P369, DOI 10.1084/jem.20020691; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Inoue T, 2005, J LEUKOCYTE BIOL, V77, P287, DOI 10.1189/jlb.0204104; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JONES AT, 1994, J IMMUNOL, V153, P3426; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kretschmer U, 2004, EUR J IMMUNOL, V34, P3070, DOI 10.1002/eji.200424972; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Ostanin DV, 2007, AM J PHYSIOL-GASTR L, V292, pG1706, DOI 10.1152/ajpgi.00573.2006; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rijcken EM, 2004, AM J PHYSIOL-GASTR L, V287, pG115, DOI 10.1152/ajpgi.00207.2003; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Rivera-Nieves J, 2008, INFLAMM BOWEL DIS, V14, P1715, DOI 10.1002/ibd.20501; Siegmund K, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P497, DOI 10.1002/352760779X.ch23; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sydora BC, 2002, CLIN EXP IMMUNOL, V129, P35, DOI 10.1046/j.1365-2249.2002.01892.x; Syrbe U, 2004, BLOOD, V104, P3243, DOI 10.1182/blood-2003-09-3047; Thoma S, 1998, EUR J IMMUNOL, V28, P1785, DOI 10.1002/(SICI)1521-4141(199806)28:06<1785::AID-IMMU1785>3.0.CO;2-Y; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62055	10.1371/journal.pone.0062055	http://dx.doi.org/10.1371/journal.pone.0062055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630623	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500078
J	Merrick, BA; Phadke, DP; Auerbach, SS; Mav, D; Stiegelmeyer, SM; Shah, RR; Tice, RR				Merrick, B. Alex; Phadke, Dhiral P.; Auerbach, Scott S.; Mav, Deepak; Stiegelmeyer, Suzy M.; Shah, Ruchir R.; Tice, Raymond R.			RNA-Seq Profiling Reveals Novel Hepatic Gene Expression Pattern in Aflatoxin B1 Treated Rats	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; GENOME; OVEREXPRESSION; IDENTIFICATION; CARCINOGENESIS; TRANSCRIPTS; FOLLISTATIN; HEPATOCYTES	Deep sequencing was used to investigate the subchronic effects of 1 ppm aflatoxin B1 (AFB1), a potent hepatocarcinogen, on the male rat liver transcriptome prior to onset of histopathological lesions or tumors. We hypothesized RNA-Seq would reveal more differentially expressed genes (DEG) than microarray analysis, including low copy and novel transcripts related to AFB1's carcinogenic activity compared to feed controls (CTRL). Paired-end reads were mapped to the rat genome (Rn4) with TopHat and further analyzed by DESeq and Cufflinks-Cuffdiff pipelines to identify differentially expressed transcripts, new exons and unannotated transcripts. PCA and cluster analysis of DEGs showed clear separation between AFB1 and CTRL treatments and concordance among group replicates. qPCR of eight high and medium DEGs and three low DEGs showed good comparability among RNA-Seq and microarray transcripts. DESeq analysis identified 1,026 differentially expressed transcripts at greater than two-fold change (p<0.005) compared to 626 transcripts by microarray due to base pair resolution of transcripts by RNA-Seq, probe placement within transcripts or an absence of probes to detect novel transcripts, splice variants and exons. Pathway analysis among DEGs revealed signaling of Ahr, Nrf2, GSH, xenobiotic, cell cycle, extracellular matrix, and cell differentiation networks consistent with pathways leading to AFB1 carcinogenesis, including almost 200 upregulated transcripts controlled by E2f1-related pathways related to kinetochore structure, mitotic spindle assembly and tissue remodeling. We report 49 novel, differentially-expressed transcripts including confirmation by PCR-cloning of two unique, unannotated, hepatic AFB1-responsive transcripts (HAfT's) on chromosomes 1.q55 and 15.q11, overexpressed by 10 to 25-fold. Several potentially novel exons were found and exon refinements were made including AFB1 exon-specific induction of homologous family members, Ugt1a6 and Ugt1a7c. We find the rat transcriptome contains many previously unidentified, AFB1-responsive exons and transcripts supporting RNA-Seq's capabilities to provide new insights into AFB1-mediated gene expression leading to hepatocellular carcinoma.	[Merrick, B. Alex; Auerbach, Scott S.; Tice, Raymond R.] Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Phadke, Dhiral P.; Mav, Deepak; Stiegelmeyer, Suzy M.; Shah, Ruchir R.] Syst Res & Applicat Int, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Merrick, BA (corresponding author), Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.	merrick@niehs.nih.gov			National Toxicology Program Division at the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH); Division of Intramural Research at the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103227] Funding Source: NIH RePORTER	National Toxicology Program Division at the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH); Division of Intramural Research at the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Programs of the National Toxicology Program Division and Division of Intramural Research at the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH). The statements, opinions, or conclusions contained therein do not necessarily represent the statements, opinions, or conclusions of NIH or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Asim M, 2011, CLIN BIOCHEM, V44, P1235, DOI 10.1016/j.clinbiochem.2011.07.017; Asselta R, 2010, BLOOD, V115, P2065, DOI 10.1182/blood-2009-09-245092; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bisgaard HC, 2002, AM J PATHOL, V161, P1187, DOI 10.1016/S0002-9440(10)64395-7; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; BUTLER WH, 1969, CANCER RES, V29, P2206; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Coban Z, 2012, J CELL BIOCHEM, V113, P2179, DOI 10.1002/jcb.24104; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Ding L, 2010, HUM MOL GENET, V19, pR188, DOI 10.1093/hmg/ddq391; Dolle L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693; Enoch MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029369; Fang ZD, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-26; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao WH, 2010, TOXICOL APPL PHARM, V247, P211, DOI 10.1016/j.taap.2010.06.015; Givan Scott A, 2012, Methods Mol Biol, V883, P201, DOI 10.1007/978-1-61779-839-9_16; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Hanioka N, 2012, CHEMOSPHERE, V89, P526, DOI 10.1016/j.chemosphere.2012.05.039; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Huang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026168; Josse R, 2012, TOXICOL APPL PHARM, V258, P176, DOI 10.1016/j.taap.2011.10.019; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kirk GD, 2006, CARCINOGENESIS, V27, P2070, DOI 10.1093/carcin/bgl060; Kishi M, 2008, BIOCHEM BIOPH RES CO, V377, P815, DOI 10.1016/j.bbrc.2008.10.043; Kobayashi K, 2012, DRUG METABOLISM PHAR; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LAWS ER, 1991, J NEUROSURG, V74, P1025; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maruo Y, 2005, CURR DRUG METAB, V6, P91, DOI 10.2174/1389200053586064; Merrick BA, 2012, CHEM RES TOXICOL, V25, P1132, DOI 10.1021/tx3000945; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; National Toxicology Program, 2011, Rep Carcinog, V12, P32; Nayak S, 2010, J ETHNOPHARMACOL, V127, P641, DOI 10.1016/j.jep.2009.12.010; Neckar J, 2012, PHYSIOL GENOMICS, V44, P173, DOI 10.1152/physiolgenomics.00083.2011; Ng KTP, 2011, EUR J CANCER, V47, P2299, DOI 10.1016/j.ejca.2011.05.032; Ooe H, 2012, J CELL PHYSIOL, V227, P2363, DOI 10.1002/jcp.22971; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; Ricke RM, 2011, CELL CYCLE, V10, P3645, DOI 10.4161/cc.10.21.18156; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts ME, 2011, EUR RESPIR J, V37, P1482, DOI 10.1183/09031936.00039710; Shankar K, 2012, ENDOCRINOLOGY, V153, P1999, DOI 10.1210/en.2011-1833; Shirabe K, 2011, LIVER INT, V31, P1366, DOI 10.1111/j.1478-3231.2011.02572.x; Silins I, 2004, ARCH TOXICOL, V78, P540, DOI 10.1007/s00204-004-0570-3; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Sze KMF, 2011, HEPATOLOGY, V53, P1558, DOI 10.1002/hep.24232; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRZOS RJ, 1978, MUTAT RES, V58, P79, DOI 10.1016/0165-1218(78)90097-6; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wogan G. N., 2011, FOOD ADDIT CONTAM A, V1, P1; WOGAN GN, 1967, CANCER RES, V27, P2370; Wood SH, 2012, AGE; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729	81	42	45	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61768	10.1371/journal.pone.0061768	http://dx.doi.org/10.1371/journal.pone.0061768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630614	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500067
J	Ortiz-Perez, JT; Riera, M; Bosch, X; De Caralt, TM; Perea, RJ; Pascual, J; Soler, MJ				Ortiz-Perez, Jose T.; Riera, Marta; Bosch, Xavier; De Caralt, Teresa M.; Perea, Rosario J.; Pascual, Julio; Soler, Maria Jose			Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study	PLOS ONE			English	Article							CARDIAC MAGNETIC-RESONANCE; HEART-FAILURE; UP-REGULATION; ACE2; DYSFUNCTION; EXPRESSION; ANGIOTENSIN-CONVERTING-ENZYME-2; CARBOXYPEPTIDASE; RATS	Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotective peptide. Serum soluble ACE2 (sACE2) activity is raised in chronic heart failure, suggesting a compensatory role in left ventricular dysfunction. Our aim was to study the relationship between sACE2 activity, infarct size, left ventricular systolic function and remodeling following ST-elevation myocardial infarction (STEMI). A contrast-enhanced cardiac magnetic resonance study was performed acutely in 95 patients with first STEMI and repeated at 6 months to measure LV end-diastolic volume index, ejection fraction and infarct size. Baseline sACE2 activities, measured by fluorescent enzymatic assay 24 to 48 hours and at 7 days from admission, were compared to that obtained in 22 matched controls. Patients showed higher sACE2 at baseline than controls (104.4 [87.4-134.8] vs 74.9 [62.8-87.5] RFU/mu l/hr, p<0.001). At seven days, sACE2 activity significantly increased from baseline (115.5 [92.9-168.6] RFU/mu l/hr, p<0.01). An inverse correlation between sACE2 activity with acute and follow-up ejection fraction was observed (r = -0.519, p<0.001; r = -0.453, p = 0.001, respectively). Additionally, sACE2 directly correlated with infarct size (r = 0.373, p<0.001). Both, infarct size (beta = -0.470 [95% CI: -0.691: -0.248], p<0.001) and sACE2 at 7 days (beta = -0.025 [95% CI: -0.048: -0.002], p = 0.030) were independent predictors of follow-up ejection fraction. Patients with sACE2 in the upper tertile had a 4.4 fold increase in the incidence of adverse left ventricular remodeling (95% confidence interval: 1.3 to 15.2, p = 0.027). In conclusion, serum sACE2 activity rises in relation to infarct size, left ventricular systolic dysfunction and is associated with the occurrence of left ventricular remodeling.	[Ortiz-Perez, Jose T.; Bosch, Xavier] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Thorax Inst, Hosp Clin, Barcelona, Spain; [Riera, Marta; Pascual, Julio; Soler, Maria Jose] Hosp del Mar, Dept Nephrol, Inst Hosp Mar Invest Med, Barcelona, Spain; [De Caralt, Teresa M.; Perea, Rosario J.] Univ Barcelona, Ctr Diagnost Imaging, Dept Radiol, Hosp Clin, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona	Ortiz-Perez, JT (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Thorax Inst, Hosp Clin, Barcelona, Spain.	jtortiz@clinic.ub.es	Riera, Marta/V-5016-2017; Soler, Maria Jose/ABC-4410-2021; Bosch, Xavier/E-7890-2014; Perez, Jose Tomas Ortiz/AAE-6676-2021; Soler, Maria José/AAP-4454-2020	Riera, Marta/0000-0003-4362-7965; Bosch, Xavier/0000-0002-0133-1587; Perez, Jose Tomas Ortiz/0000-0001-8043-6055; Soler, Maria José/0000-0003-3621-0766	Spanish Society of Cardiology; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [FIS-FEDER PI081688]	Spanish Society of Cardiology; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Society of Cardiology [Grant for Clinical Research 2011 to Jose T Ortiz Perez] and Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [FIS-FEDER PI081688 to Maria Jose Soler Romeo]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Garabelli PJ, 2008, EXP PHYSIOL, V93, P613, DOI 10.1113/expphysiol.2007.040246; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Hokimoto S, 1996, CIRCULATION, V94, P1513, DOI 10.1161/01.CIR.94.7.1513; Huang LL, 2003, J BIOL CHEM, V278, P15532, DOI 10.1074/jbc.M212934200; Soler MJ, 2012, NEPHRON CLIN PRACT, V121, pC144, DOI 10.1159/000345508; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Ortiz-Perez JT, 2007, EUR HEART J, V28, P1750, DOI 10.1093/eurheartj/ehm212; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Y, 2010, J CARD FAIL, V16, P157, DOI 10.1016/j.cardfail.2009.09.005; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	23	62	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61695	10.1371/journal.pone.0061695	http://dx.doi.org/10.1371/journal.pone.0061695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630610	gold, Green Submitted, Green Published			2022-12-25	WOS:000317911500061
J	Battista, N; Di Sabatino, A; Di Tommaso, M; Biancheri, P; Rapino, C; Giuffrida, P; Papadia, C; Montana, C; Pasini, A; Vanoli, A; Lanzarotto, F; Villanacci, V; Corazza, GR; Maccarrone, M				Battista, Natalia; Di Sabatino, Antonio; Di Tommaso, Monia; Biancheri, Paolo; Rapino, Cinzia; Giuffrida, Paolo; Papadia, Cinzia; Montana, Chiara; Pasini, Alessandra; Vanoli, Alessandro; Lanzarotto, Francesco; Villanacci, Vincenzo; Corazza, Gino R.; Maccarrone, Mauro			Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; ENDOCANNABINOID SYSTEM; PHARMACOGENETIC TRIAL; GENE POLYMORPHISM; ACTIVATION; GUT; CB1; PHENOTYPE; COLITIS; CELLS	Anandamide (AEA) is the prominent member of the endocannabinoid family and its biological action is mediated through the binding to both type-1 (CB1) and type-2 (CB2) cannabinoid receptors (CBR). The presence of AEA and CBR in the gastrointestinal tract highlighted their pathophysiological role in several gut diseases, including celiac disease. Here, we aimed to investigate the expression of CBR at transcriptional and translational levels in the duodenal mucosa of untreated celiac patients, celiac patients on a gluten-free diet for at least 12 months and control subjects. Also biopsies from treated celiac patients cultured ex vivo with peptic-tryptic digest of gliadin were investigated. Our data show higher levels of both CB1 and CB2 receptors during active disease and normal CBR levels in treated celiac patients. In conclusion, we demonstrate an up-regulation of CB1 and CB2 mRNA and protein expression, that points to the therapeutic potential of targeting CBR in patients with celiac disease.	[Battista, Natalia; Di Tommaso, Monia; Rapino, Cinzia] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Battista, Natalia; Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy; [Di Sabatino, Antonio; Biancheri, Paolo; Giuffrida, Paolo; Pasini, Alessandra; Corazza, Gino R.] Univ Pavia, Dept Internal Med, Fdn IRCCS Policlin S Matteo, Ctr Studio & Cura Malattia Celiaca, I-27100 Pavia, Italy; [Papadia, Cinzia; Montana, Chiara] Parma Univ Hosp, Gastroenterol Unit, Parma, Italy; [Vanoli, Alessandro] Univ Pavia, Dept Mol Med, Fdn IRCCS Policlin S Matteo, Ctr Studio & Cura Malattia Celiaca, I-27100 Pavia, Italy; [Lanzarotto, Francesco] Spedali Civil Brescia, Dept Gastroenterol, I-25125 Brescia, Italy; [Villanacci, Vincenzo] Spedali Civil Brescia, Dept Pathol, I-25125 Brescia, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Ctr Integrated Res, Rome, Italy	University of Teramo; IRCCS Santa Lucia; IRCCS Fondazione San Matteo; University of Pavia; University of Parma; University Hospital of Parma; IRCCS Fondazione San Matteo; University of Pavia; Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; University Campus Bio-Medico - Rome Italy	Battista, N (corresponding author), Univ Teramo, Dept Biomed Sci, Teramo, Italy.	nbattista@unite.it	Battista, Natalia/AAC-2529-2019; Di Sabatino, Antonio/K-8015-2016; Biancheri, Paolo/AAC-2394-2022; Vanoli, Alessandro/J-4469-2016; Pasini, Alessandra/AAP-8573-2021; Corazza, Gino Roberto/K-8500-2016; Pasini, Alessandra/K-5937-2016; Maccarrone, Mauro/K-5398-2012	Di Sabatino, Antonio/0000-0002-0302-8645; Biancheri, Paolo/0000-0002-8163-9062; Vanoli, Alessandro/0000-0002-2976-7032; Pasini, Alessandra/0000-0002-2768-6263; Corazza, Gino Roberto/0000-0001-9532-0573; Maccarrone, Mauro/0000-0002-3990-2963; Papadia, Cinzia/0000-0003-2234-8262; Battista, Natalia/0000-0002-1936-6710	Associazione Italiana Celiachia; Fondazione TERCAS	Associazione Italiana Celiachia; Fondazione TERCAS	This project was partly supported by the Associazione Italiana Celiachia to GRC, and by Fondazione TERCAS (2009-2012 project) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhouayek M, 2012, TRENDS MOL IN PRESS; Battista N, 2012, J NUTR BIOCHEM, V23, P1245, DOI 10.1016/j.jnutbio.2011.06.017; Battista N, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00009; Camilleri M, 2013, AM J PHYSIOL-GASTR L, V304, pG553, DOI 10.1152/ajpgi.00376.2012; Cani PD, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03866.x; Caruso MG, 2012, J NUTRIGENET NUTRIGE, V5, P305, DOI 10.1159/000343563; D'Addario C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039186; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; D'Argenio G, 2007, J MOL MED, V85, P523, DOI 10.1007/s00109-007-0192-3; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Di Marzo V, 2011, NEUROGASTROENT MOTIL, V23, P391, DOI 10.1111/j.1365-2982.2011.01689.x; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Di Sabatino A, 2009, GUT, V58, P777, DOI 10.1136/gut.2008.149096; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Murillo Rodriguez E, 2011, MOL BIOCH GENETIC AS, P88; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Park JM, 2011, J CLIN GASTROENTEROL, V45, P45, DOI 10.1097/MCG.0b013e3181dd1573; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Proto MC, 2012, J CELL PHYSIOL, V227, P250, DOI 10.1002/jcp.22727; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042259; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Schicho R, 2011, CAN J GASTROENTEROL, V25, P377, DOI 10.1155/2011/953975; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Storr M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009453; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wong BS, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01874.x; Wong BS, 2011, GASTROENTEROLOGY, V141, P1638, DOI 10.1053/j.gastro.2011.07.036; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62078	10.1371/journal.pone.0062078	http://dx.doi.org/10.1371/journal.pone.0062078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620805	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500085
J	Evans, BE; Greaves-Lord, K; Euser, AS; Tulen, JHM; Franken, IHA; Huizink, AC				Evans, Brittany E.; Greaves-Lord, Kirstin; Euser, Anja S.; Tulen, Joke H. M.; Franken, Ingmar H. A.; Huizink, Anja C.			Determinants of Physiological and Perceived Physiological Stress Reactivity in Children and Adolescents	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; REPEATED PSYCHOSOCIAL STRESS; MENSTRUAL-CYCLE PHASE; HEART-RATE REACTIVITY; SALIVARY CORTISOL; SOCIAL STRESS; CARDIOVASCULAR REACTIVITY; LIFE EVENTS; HPA AXIS; INDIVIDUAL-DIFFERENCES	Aims: Abnormal physiological stress reactivity is increasingly investigated as a vulnerability marker for various physical and psychological health problems. However, studies are inconsistent in taking into account potential covariates that may influence the developing stress system. We systematically tested determinants (individual, developmental, environmental and substance use-related) of physiological and perceived physiological stress reactivity. We also examined the relation between physiological and perceived physiological stress reactivity. Method: In a stratified sample of 363 children (7-12 years) and 344 adolescents (13-20 years) from the general population, we examined cortisol, heart rate, respiratory sinus arrhythmia and perceived physiological stress reactivity to a psychosocial stress procedure. Results: Using multivariate linear regression models, we found that individual, developmental, environmental and substance use-related factors were related to each of the stress response indices. These determinant factors were different for each of the stress reactivity indices, and different in children versus adolescents. Perceived physiological stress reactivity predicted cortisol reactivity in adolescents only. All other relations between perceived physiological and physiological stress reactivity were not significant. Conclusions: As physiological stress variables are often examined as vulnerability markers for the development of health problems, we maintain that it is essential that future studies take into consideration factors that may account for found relations. Our study provides an overview and indication of which variables should be considered in the investigation of the relation between physiological stress indices and illness.	[Evans, Brittany E.; Greaves-Lord, Kirstin; Euser, Anja S.] Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care, Amsterdam, Netherlands; [Euser, Anja S.; Franken, Ingmar H. A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [Tulen, Joke H. M.] Erasmus Univ, Dept Psychiat, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC	Evans, BE (corresponding author), Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands.	b.e.evans@vu.nl	Franken, Ingmar/AAB-7562-2019; Evans, Brittany/R-1258-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Evans, Brittany/0000-0002-5053-8373; Franken, Ingmar/0000-0002-7853-2694	ZonMW [3116.0002]; ERAB [0609]	ZonMW(Netherlands Organization for Health Research and Development); ERAB	This project is supported by ZonMW grant 3116.0002 and partly by ERAB grant 0609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardal E, 1995, EUR J CLIN CHEM CLIN, V33, P927; Alpert BS, 1992, INDIVIDUAL DIFFERENC, P187; Amone-P'olak K, 2009, J AM ACAD CHILD PSY, V48, P1031, DOI 10.1097/CHI.0b013e3181b39595; Armstead CA, 2010, ETHNIC DIS, V20, P251; Bauer AM, 2002, J DEV BEHAV PEDIATR, V23, P102, DOI 10.1097/00004703-200204000-00007; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; BOYCE WT, 1992, PEDIATRICS, V90, P483; BOYCE WT, 1990, J DEV BEHAV PEDIATR, V11, P105; Buss A., 1984, TEMPERAMENT EARLY DE; CAPLAN RD, 1979, J PSYCHOSOM RES, V23, P181, DOI 10.1016/0022-3999(79)90003-5; Childs E, 2010, PSYCHOPHYSIOLOGY, V47, P550, DOI 10.1111/j.1469-8986.2009.00961.x; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; DAVIS C, 1988, INT J PSYCHOPHYSIOL, V6, P299, DOI 10.1016/0167-8760(88)90017-7; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; DERRYBERRY D, 1988, J PERS SOC PSYCHOL, V55, P958, DOI 10.1037/0022-3514.55.6.958; Diamond LM, 2012, DEV PSYCHOL, V48, P918, DOI 10.1037/a0026901; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dieleman GC, 2010, PSYCHONEUROENDOCRINO, V35, P1223, DOI 10.1016/j.psyneuen.2010.02.012; Dockray S, 2009, J ADOLESCENT HEALTH, V45, P344, DOI 10.1016/j.jadohealth.2009.06.014; Doussard-Roosevelt JA, 2003, DEV PSYCHOBIOL, V43, P230, DOI 10.1002/dev.10136; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Ellenbogen MA, 2009, PSYCHONEUROENDOCRINO, V34, P773, DOI 10.1016/j.psyneuen.2008.12.011; Elzinga BM, 2008, PSYCHONEUROENDOCRINO, V33, P227, DOI 10.1016/j.psyneuen.2007.11.004; Engert V, 2010, J PSYCHIATR NEUROSCI, V35, P370, DOI 10.1503/jpn.100022; Evans BE, 2012, DRUG ALCOHOL DEPEN, V126, P296, DOI 10.1016/j.drugalcdep.2012.05.031; Evans BE, 2012, ADDICTION, V107, P312, DOI 10.1111/j.1360-0443.2011.03568.x; Frick P. J., 1991, ALABAMA PARENTING QU; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Girdler SS, 1997, PSYCHOSOM MED, V59, P294, DOI 10.1097/00006842-199705000-00012; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Greaves-Lord K, 2007, J AFFECT DISORDERS, V102, P55, DOI 10.1016/j.jad.2006.12.009; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Gunnar MR, 2009, DEV PSYCHOPATHOL, V21, P69, DOI 10.1017/S0954579409000054; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; HELLHAMMER DH, 1993, PSYCHOTHER PSYCHOSOM, V60, P8, DOI 10.1159/000288675; Hollenstein T, 2012, DEV PSYCHOBIOL, V54, P207, DOI 10.1002/dev.20582; Huizink AC, 2006, ADDICTION, V101, P1581, DOI 10.1111/j.1360-0443.2006.01570.x; Jessop DS, 2008, STRESS, V11, P1, DOI 10.1080/10253890701365527; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; KAGAN J, 1987, CHILD DEV, V58, P1459, DOI 10.1111/j.1467-8624.1987.tb03858.x; Kagan J, 1997, CHILD DEV, V68, P139, DOI 10.1111/j.1467-8624.1997.tb01931.x; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kirschbaum C., 2010, ENCY PSYCHOPHARMACOL; Klimes-Dougan B, 2001, DEV PSYCHOPATHOL, V13, P695, DOI 10.1017/S0954579401003157; Korhonen T, 2008, DRUG ALCOHOL DEPEN, V97, P33, DOI 10.1016/j.drugalcdep.2008.03.015; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; LIANG SW, 1995, PEDIATRICS, V96, P1101; Linden W, 1997, J PSYCHOSOM RES, V42, P117, DOI 10.1016/S0022-3999(96)00240-1; Lovallo W.R., 2005, STRESS HLTH BIOL PSY; Lovallo WR, 2012, BIOL PSYCHIAT, V71, P344, DOI 10.1016/j.biopsych.2011.10.018; Lovallo WR, 2011, BIOL PSYCHOL, V86, P121, DOI 10.1016/j.biopsycho.2010.01.006; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Markus MT, 2003, PERS INDIV DIFFER, V34, P503, DOI 10.1016/S0191-8869(02)00090-9; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mulder LJM, 1988, COMPUTERS PSYCHOL ME, P39; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Musante L, 2000, PSYCHOSOM MED, V62, P760, DOI 10.1097/00006842-200011000-00004; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Ortiz J, 2004, J AM ACAD CHILD PSY, V43, P154, DOI 10.1097/00004583-200402000-00010; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Roemmich JN, 2007, OBESITY, V15, P2303, DOI 10.1038/oby.2007.273; Rohleder N, 2003, PSYCHONEUROENDOCRINO, V28, P261, DOI 10.1016/S0306-4530(02)00019-7; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Seyle H., 1950, STRESS PHYSL PATHOLO; Spear LP, 2009, DEV PSYCHOPATHOL, V21, P87, DOI 10.1017/S0954579409000066; Statistics C.B.f., 2011, STAT NEIGHB 2004 201; Statistics C.B.o., 2010, STAND CLASS PROF; Straneva P, 2000, OBSTET GYNECOL, V95, P78, DOI 10.1016/S0029-7844(99)00497-4; Stroud LR, 2009, DEV PSYCHOPATHOL, V21, P47, DOI 10.1017/S0954579409000042; Sumter SR, 2010, PSYCHONEUROENDOCRINO, V35, P1510, DOI 10.1016/j.psyneuen.2010.05.004; SUSMAN EJ, 2004, HDB ADOLESCENT PSYCH, P15, DOI DOI 10.1002/9780471726746.CH2; Tarullo AR, 2006, HORM BEHAV, V50, P632, DOI 10.1016/j.yhbeh.2006.06.010; THAYER RE, 1970, PSYCHOPHYSIOLOGY, V7, P86, DOI 10.1111/j.1469-8986.1970.tb02278.x; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186; Tyrka AR, 2007, ACTA PSYCHIAT SCAND, V115, P395, DOI 10.1111/j.1600-0447.2006.00941.x; van Leeuwen AP, 2011, ADDICTION, V106, P1484, DOI 10.1111/j.1360-0443.2011.03448.x; VANSTEENIS HG, 1994, MED ENG PHYS, V16, P355, DOI 10.1016/1350-4533(90)90001-O; Westenberg PM, 2009, BIOL PSYCHOL, V82, P116, DOI 10.1016/j.biopsycho.2009.06.005; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008	95	62	64	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61724	10.1371/journal.pone.0061724	http://dx.doi.org/10.1371/journal.pone.0061724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JA	23620785	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500065
J	Lv, ZY; Sun, J; Liu, YF				Lv, Zongyang; Sun, Jian; Liu, Yingfang			Structural and Functional Insights into Saccharomyces cerevisiae Riboflavin Biosynthesis Reductase RIB7	PLOS ONE			English	Article							BIFUNCTIONAL DEAMINASE-REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DEFICIENCY; SEQUENCE	Saccharomyces cerevisiae RIB7 (ScRIB7) is a potent target for anti-fungal agents because of its involvement in the riboflavin biosynthesis pathway as a NADPH-dependent reductase. However, the catalytic mechanism of riboflavin biosynthesis reductase (RBSRs) is controversial, and enzyme structure information is still lacking in eukaryotes. Here we report the crystal structure of Saccharomyces cerevisiae RIB7 at 2.10 angstrom resolution and its complex with NADPH at 2.35 angstrom resolution. ScRIB7 exists as a stable homodimer, and each subunit consists of nine central beta-sheets flanked by five helices, resembling the structure of RIB7 homologues. A conserved G(76)-X-G(78)-X-n-G(181)-G(182) motif is present at the NADPH pyrophosphate group binding site. Activity assays confirmed the necessity of Thr79, Asp83, Glu180 and Gly182 for the activity of ScRIB7. Substrate preference of ScRIB7 was altered by mutating one residue (Thr35) to a Lysine, implying that ScRIB7 Thr35 and its corresponding residue, a lysine in bacteria, are important in substrate-specific recognition.	[Lv, Zongyang; Sun, Jian; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Lv, Zongyang; Sun, Jian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	liuy@ibp.ac.cn	Lv, Zongyang/M-9307-2018	Lv, Zongyang/0000-0002-8862-113X	Ministry of Science and Technology (973 Programs) [2011CB910304]	Ministry of Science and Technology (973 Programs)	This work was supported by grants to YL from the Ministry of Science and Technology (973 Programs 2011CB910304) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Chatwell L, 2006, J MOL BIOL, V359, P1334, DOI 10.1016/j.jmb.2006.04.045; Chen HZ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-13; Chen SC, 2009, J BIOL CHEM, V284, P1725, DOI 10.1074/jbc.M805820200; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hedtke B, 2012, PLANT MOL BIOL, V78, P77, DOI 10.1007/s11103-011-9846-1; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HOLLANDER I, 1979, BIOCHEM BIOPH RES CO, V89, P759, DOI 10.1016/0006-291X(79)90694-6; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Kompis IM, 2005, CHEM REV, V105, P593, DOI 10.1021/cr0301144; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Magalhaes MLB, 2008, BIOCHEMISTRY-US, V47, P6499, DOI 10.1021/bi800264g; Manthey KC, 2005, J NUTR, V135, P978, DOI 10.1093/jn/135.5.978; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NIELSEN P, 1981, BIOCHIM BIOPHYS ACTA, V662, P312, DOI 10.1016/0005-2744(81)90044-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMACHANDRAN GN, 1990, CURR SCI INDIA, V59, P813; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Romisch-Margl W, 2008, FEBS J, V275, P4403, DOI 10.1111/j.1742-4658.2008.06586.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shao H, 2007, J MOL BIOL, V369, P265, DOI 10.1016/j.jmb.2007.03.040; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stenmark P, 2007, J MOL BIOL, V373, P48, DOI 10.1016/j.jmb.2006.12.009; Takami Y, 2004, OPHTHAL RES, V36, P156, DOI 10.1159/000077329; Wang XQ, 2006, J MOL BIOL, V358, P1341, DOI 10.1016/j.jmb.2006.03.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61249	10.1371/journal.pone.0061249	http://dx.doi.org/10.1371/journal.pone.0061249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620735	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500015
J	Rybak, AP; Ingram, AJ; Tang, DM				Rybak, Adrian P.; Ingram, Alistair J.; Tang, Damu			Propagation of Human Prostate Cancer Stem-Like Cells Occurs through EGFR-Mediated ERK Activation	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ANCHORAGE-INDEPENDENT GROWTH; TYROSINE KINASE INHIBITOR; TUMOR-INITIATING CELLS; ANDROGEN RECEPTOR; NUDE MICE; IN-VITRO; PROTEIN; IDENTIFICATION; EXPRESSION	Prostate cancer stem-like cells (PCSCs) are being intensely investigated largely owing to their contributions towards prostate tumorigenesis, however, our understanding of PCSC biology, including their critical pathways, remains incompletely understood. While epidermal growth factor (EGF) is widely used in maintaining PCSC cells in vitro, the importance of EGF-dependent signaling and its downstream pathways in PCSC self-renewal are not well characterized. By investigating DU145 sphere cells, a population of prostate cancer cells with stem-like properties, we report here that epidermal growth factor receptor (EGFR) signaling plays a critical role in the propagation of DU145 PCSCs. Activation of EGFR signaling via addition of EGF and ectopic expression of a constitutively-active EGFR mutant (EGFRvIII) increased sphere formation. Conversely, inhibition of EGFR signaling by using EGFR inhibitors (AG1478 and PD168393) and knockdown of EGFR significantly inhibited PCSC self-renewal. Consistent with the MEK-ERK pathway being a major target of EGFR signaling, activation of the MEK-ERK pathway contributed to EGFR-facilitated PCSC propagation. Modulation of EGFR signaling affected extracellular signal-related kinase (ERK) activation. Inhibition of ERK activation through multiple approaches, including treatment with the MEK inhibitor U0126, ectopic expression of dominant-negative MEK1(K97M), and knockdown of either ERK1 or ERK2 resulted in a robust reduction in PCSC propagation. Collectively, the present study provides evidence that EGFR signaling promotes PCSC self-renewal, in part, by activating the MEK-ERK pathway.	[Rybak, Adrian P.; Ingram, Alistair J.; Tang, Damu] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Rybak, Adrian P.; Ingram, Alistair J.; Tang, Damu] Father Sean OSullivan Res Inst, Hamilton, ON, Canada; [Rybak, Adrian P.; Ingram, Alistair J.; Tang, Damu] St Josephs Hosp, HCKR, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University	Tang, DM (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	damut@mcmaster.ca	Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521; Rybak, Adrian/0000-0002-4933-0946	Canadian Institutes of Health Research [RMS 79-71]; St. Joseph's HealthCare at Hamilton, ON, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's HealthCare at Hamilton, ON, Canada	This research was supported by a grant (RMS 79-71) from the Canadian Institutes of Health Research to DT and by financial support from St. Joseph's HealthCare at Hamilton, ON, Canada, to the Hamilton Center for Kidney Research (HCKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai CQ, 2008, ONCOGENE, V27, P3201, DOI 10.1038/sj.onc.1210983; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; COLBURN NH, 1978, CANCER RES, V38, P624; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; Dhir R, 2002, PROSTATE, V51, P241, DOI 10.1002/pros.10079; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; GILL GN, 1984, J BIOL CHEM, V259, P7755; Gioeli D, 1999, CANCER RES, V59, P279; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; Hong SK, 2011, EXP CELL RES, V317, P2671, DOI 10.1016/j.yexcr.2011.08.008; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Li H, 2008, EXP CELL RES, V314, P92, DOI 10.1016/j.yexcr.2007.08.011; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Moon C, 2008, CANCER LETT, V266, P116, DOI 10.1016/j.canlet.2008.02.065; Ni Z, 2000, CANCER RES, V60, P1225; Nielsen JS, 2004, INT J GYNECOL CANCER, V14, P1086, DOI 10.1111/j.1048-891X.2004.14606.x; Olapade-Olaopa EO, 2000, BRIT J CANCER, V82, P186; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Ross JS, 2007, ADV ANAT PATHOL, V14, P353, DOI 10.1097/PAP.0b013e31814a52c4; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Salvatori L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031467; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei FX, 2010, CELL SIGNAL, V22, P1783, DOI 10.1016/j.cellsig.2010.07.007; Williams Heinric, 2009, V472, P439, DOI 10.1007/978-1-60327-492-0_21; Yamamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046979	54	23	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61716	10.1371/journal.pone.0061716	http://dx.doi.org/10.1371/journal.pone.0061716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620784	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500064
J	Scaramuzzino, C; Monaghan, J; Milioto, C; Lanson, NA; Maltare, A; Aggarwal, T; Casci, I; Fackelmayer, FO; Pennuto, M; Pandey, UB				Scaramuzzino, Chiara; Monaghan, John; Milioto, Carmelo; Lanson, Nicholas A., Jr.; Maltare, Astha; Aggarwal, Tanya; Casci, Ian; Fackelmayer, Frank O.; Pennuto, Maria; Pandey, Udai Bhan			Protein Arginine Methyltransferase 1 and 8 Interact with FUS to Modify Its Sub-Cellular Distribution and Toxicity In Vitro and In Vivo	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ANDROGEN RECEPTOR TOXICITY; NEURODEGENERATIVE DISEASE; BINDING PROTEIN; MUTATIONS; TDP-43; METHYLATION; FUS/TLS; FAMILY; GENE	Amyotrophic lateral sclerosis (ALS) is a late onset and progressive motor neuron disease. Mutations in the gene coding for fused in sarcoma/translocated in liposarcoma (FUS) are responsible for some cases of both familial and sporadic forms of ALS. The mechanism through which mutations of FUS result in motor neuron degeneration and loss is not known. FUS belongs to the family of TET proteins, which are regulated at the post-translational level by arginine methylation. Here, we investigated the impact of arginine methylation in the pathogenesis of FUS-related ALS. We found that wild type FUS (FUS-WT) specifically interacts with protein arginine methyltransferases 1 and 8 (PRMT1 and PRMT8) and undergoes asymmetric dimethylation in cultured cells. ALS-causing FUS mutants retained the ability to interact with both PRMT1 and PRMT8 and undergo asymmetric dimethylation similar to FUS-WT. Importantly, PRMT1 and PRMT8 localized to mutant FUS-positive inclusion bodies. Pharmacologic inhibition of PRMT1 and PRMT8 activity reduced both the nuclear and cytoplasmic accumulation of FUS-WT and ALS-associated FUS mutants in motor neuron-derived cells and in cells obtained from an ALS patient carrying the R518G mutation. Genetic ablation of the fly homologue of human PRMT1 (DART1) exacerbated the neurodegeneration induced by overexpression of FUS-WT and R521H FUS mutant in a Drosophila model of FUS-related ALS. These results support a role for arginine methylation in the pathogenesis of FUS-related ALS.	[Scaramuzzino, Chiara; Milioto, Carmelo; Aggarwal, Tanya; Pennuto, Maria] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Monaghan, John; Lanson, Nicholas A., Jr.; Maltare, Astha; Casci, Ian; Pandey, Udai Bhan] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Fackelmayer, Frank O.] Fdn Res & Technol Hellas IMBB FORTH, Lab Epigenet & Chromosome Biol, Dept Biomed Res, Inst Mol Biol & Biotechnol, Ioannina, Greece	Istituto Italiano di Tecnologia - IIT; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Pennuto, M (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	maria.pennuto@iit.it; upande@lsuhsc.edu	Pennuto, Maria/E-3270-2019	Pennuto, Maria/0000-0001-8634-0767; Scaramuzzino, Chiara/0000-0001-9454-8701; Milioto, Carmelo/0000-0002-3844-0728	Robert Packard Center for ALS at Johns Hopkins; Amyotrophic Lateral Sclerosis Association; National Institute of Health [1P30GM103340-01A1]; Muscular Dystrophy Association [196646]; Thierry-Latran Foundation; COST action [TD0905]; Marie-Curie Reintegration Grant [FP7-256448]; Siena Biotech (Italy); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	Robert Packard Center for ALS at Johns Hopkins; Amyotrophic Lateral Sclerosis Association; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Thierry-Latran Foundation; COST action(European Cooperation in Science and Technology (COST)); Marie-Curie Reintegration Grant(European Commission); Siena Biotech (Italy); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Robert Packard Center for ALS at Johns Hopkins (UBP), Amyotrophic Lateral Sclerosis Association (UBP), the National Institute of Health 1P30GM103340-01A1 Neuroscience COBRE (UBP), Muscular Dystrophy Association (196646 to MP), Thierry-Latran Foundation (MP), COST action TD0905 (FOF), and a Marie-Curie Reintegration Grant (FP7-256448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; UBP is an Academic Editor of PLOS ONE. MP received support from Siena Biotech (Italy). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aman P, 1996, GENOMICS, V37, P1, DOI 10.1006/geno.1996.0513; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hanson KA, 2012, WIRES RNA, V3, P265, DOI 10.1002/wrna.111; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lanson Jr NA, 2013, HUM MOL GENET; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Palazzolo I, 2010, J NEUROSCI RES, V88, P2207, DOI 10.1002/jnr.22389; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Ticozzi N, 2011, ARCH ITAL BIOL, V149, P65, DOI 10.4449/aib.v149i1.1262; Tradewell ML, 2012, HUM MOL GENET, V21, P136, DOI 10.1093/hmg/ddr448; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	52	67	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61576	10.1371/journal.pone.0061576	http://dx.doi.org/10.1371/journal.pone.0061576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620769	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500049
J	Kenyon, JJ; Hall, RM				Kenyon, Johanna J.; Hall, Ruth M.			Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes	PLOS ONE			English	Article							O-ANTIGENIC POLYSACCHARIDE; K1 CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; SEROLOGICAL CHARACTERIZATION; ESCHERICHIA-COLI; GENE-CLUSTER; BIOCHEMICAL-CHARACTERIZATION; STRAIN; LIPOPOLYSACCHARIDE; SEQUENCE	Extracellular polysaccharides are major immunogenic components of the bacterial cell envelope. However, little is known about their biosynthesis in the genus Acinetobacter, which includes A. baumannii, an important nosocomial pathogen. Whether Acinetobacter sp. produce a capsule or a lipopolysaccharide carrying an O antigen or both is not resolved. To explore these issues, genes involved in the synthesis of complex polysaccharides were located in 10 complete A. baumannii genome sequences, and the function of each of their products was predicted via comparison to enzymes with a known function. The absence of a gene encoding a WaaL ligase, required to link the carbohydrate polymer to the lipid A-core oligosaccharide (lipooligosaccharide) forming lipopolysaccharide, suggests that only a capsule is produced. Nine distinct arrangements of a large capsule biosynthesis locus, designated KL1 to KL9, were found in the genomes. Three forms of a second, smaller variable locus, likely to be required for synthesis of the outer core of the lipid A-core moiety, were designated OCL1 to OCL3 and also annotated. Each K locus includes genes for capsule export as well as genes for synthesis of activated sugar precursors, and for glycosyltransfer, glycan modification and oligosaccharide repeat-unit processing. The K loci all include the export genes at one end and genes for synthesis of common sugar precursors at the other, with a highly variable region that includes the remaining genes in between. Five different capsule loci, KL2, KL6, KL7, KL8 and KL9 were detected in multiply antibiotic resistant isolates belonging to global clone 2, and two other loci, KL1 and KL4, in global clone 1. This indicates that this region is being substituted repeatedly in multiply antibiotic resistant isolates from these clones.	[Kenyon, Johanna J.; Hall, Ruth M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Hall, RM (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	ruth.hall@sydney.edu.au	Kenyon, Johanna J/AAA-3622-2022	Kenyon, Johanna J/0000-0002-1487-6105	National Health and Medical Research Council of Australia (NHMRC) [APP1026189]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) grant APP1026189 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Barnhart D, 2012, CARBOHYD POLYM, V88, P257, DOI 10.1016/j.carbpol.2011.12.006; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Burrows LL, 2000, INFECT IMMUN, V68, P931, DOI 10.1128/IAI.68.2.931-936.2000; Chen CC, 2011, J BACTERIOL, V193, P2361, DOI 10.1128/JB.00244-11; Choudhury B, 2008, CARBOHYD RES, V343, P238, DOI 10.1016/j.carres.2007.11.003; Cunneen MM, 2007, MOL BIOL EVOL, V24, P1355, DOI 10.1093/molbev/msm058; D'Souza JM, 2005, FEMS MICROBIOL LETT, V244, P27, DOI 10.1016/j.femsle.2005.01.012; Dams-Kozlowska H, 2008, APPL MICROBIOL BIOT, V81, P201, DOI 10.1007/s00253-008-1664-2; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Fregolino E, 2011, CARBOHYD RES, V346, P973, DOI 10.1016/j.carres.2011.03.024; Fregolino E, 2010, EUR J ORG CHEM, V2010, P1345, DOI 10.1002/ejoc.200901396; Glover KJ, 2006, BIOCHEMISTRY-US, V45, P5343, DOI 10.1021/bi0602056; Hanuszkiewicz A, 2008, EUR J ORG CHEM, V2008, P6183, DOI 10.1002/ejoc.200800887; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; HASELEY SR, 1994, CARBOHYD RES, V258, P199, DOI 10.1016/0008-6215(94)84086-5; Haseley SR, 1997, EUR J BIOCHEM, V244, P761, DOI 10.1111/j.1432-1033.1997.00761.x; HASELEY SR, 1994, CARBOHYD RES, V264, P73, DOI 10.1016/0008-6215(94)00179-0; Haseley SR, 1996, EUR J BIOCHEM, V237, P266, DOI 10.1111/j.1432-1033.1996.0266n.x; HASELEY SR, 1995, EUR J BIOCHEM, V233, P899, DOI 10.1111/j.1432-1033.1995.899_3.x; Haseley SR, 1997, EUR J BIOCHEM, V245, P477, DOI 10.1111/j.1432-1033.1997.t01-1-00477.x; Huang H, 2012, J ANTIMICROB CHEMOTH, V67, P2825, DOI 10.1093/jac/dks327; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; KAPLAN N, 1982, APPL ENVIRON MICROB, V44, P1335, DOI 10.1128/AEM.44.6.1335-1341.1982; KAPLAN N, 1985, EUR J BIOCHEM, V152, P453, DOI 10.1111/j.1432-1033.1985.tb09218.x; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu CC, 2013, INT J ANTIMICROB AG, V41, P318, DOI 10.1016/j.ijantimicag.2012.12.010; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mercaldi MP, 2008, BIOMACROMOLECULES, V9, P1988, DOI 10.1021/bm800239p; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Nakar D, 2001, MICROBIOL-SGM, V147, P1937, DOI 10.1099/00221287-147-7-1937; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P1504, DOI 10.1093/jac/dkr163; Pantophlet R, 1999, EUR J BIOCHEM, V263, P587, DOI 10.1046/j.1432-1327.1999.00550.x; Pantophlet R, 2008, ACINETOBACTER MOL MI; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Perepelov AV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P19, DOI 10.1134/S0006297910010037; Perepelov AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P416, DOI 10.1134/S0006297909040099; Perepelov AV, 2009, J CARBOHYD CHEM, V28, P463, DOI 10.1080/07328300903296394; Pinta E, 2009, CHEM-EUR J, V15, P9747, DOI 10.1002/chem.200901255; Rahn A, 2003, J BACTERIOL, V185, P5882, DOI 10.1128/JB.185.19.5882-5890.2003; Reeves PP, 2002, CURR TOP MICROBIOL, V264, P109; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Russo TA, 2013, INFECT IMMUN, V81, P915, DOI 10.1128/IAI.01184-12; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Sun YM, 2012, APPL ENVIRON MICROB, V78, P3966, DOI 10.1128/AEM.07825-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiente E, 2008, INFECT IMMUN, V76, P1628, DOI 10.1128/IAI.01393-07; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vinogradov EV, 2003, CARBOHYD RES, V338, P2751, DOI 10.1016/j.carres.2003.05.001; Vinogradov EV, 2002, EUR J BIOCHEM, V269, P422, DOI 10.1046/j.0014-2956.2001.02647.x; Vinogradov EV, 1997, EUR J BIOCHEM, V243, P167, DOI 10.1111/j.1432-1033.1997.0167a.x; Vinogradov EV, 1998, J BIOL CHEM, V273, P28122, DOI 10.1074/jbc.273.43.28122; Westman EL, 2009, J BIOL CHEM, V284, P11854, DOI 10.1074/jbc.M808583200; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang H, 2006, BIOCHEMISTRY-US, V45, P8163, DOI 10.1021/bi060446d; Zhou H, 2011, ANTIMICROB AGENTS CH, V55, P4506, DOI 10.1128/AAC.01134-10	73	167	171	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62160	10.1371/journal.pone.0062160	http://dx.doi.org/10.1371/journal.pone.0062160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614028	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400158
J	Sheu, JJC; Lee, CC; Hua, CH; Li, CI; Lai, MT; Lee, SC; Cheng, J; Chen, CM; Chan, C; Chao, SCC; Chen, JY; Chang, JY; Lee, CH				Sheu, J. J-C; Lee, C-C; Hua, C-H; Li, C-I; Lai, M-T; Lee, S-C; Cheng, J.; Chen, C-M; Chan, C.; Chao, S. C-C; Chen, J-Y; Chang, J-Y; Lee, C-H			LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling	ONCOGENE			English	Article						LRIG1; head and neck cancers; EGFR; MAPK; SPHK1; ECM remodeling	GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; NASOPHARYNGEAL CARCINOMA; NEGATIVE REGULATOR; BREAST-CANCER; SPHINGOSINE 1-PHOSPHATE; MESENCHYMAL TRANSITION; TUMOR PROGRESSION; GENE-EXPRESSION; ACTIVATION	EGFR overexpression and chromosome 3p deletion are two frequent events in head and neck cancers. We previously mapped the smallest region of recurrent copy-number loss at 3p12.2-p14.1. LRIG1, a negative regulator of EGFR, was found at 3p14, and its copy-number loss correlated with poor clinical outcome. Inducible expression of LRIG1 in head and neck cancer TW01 cells, a line with low LRIG1 levels, suppressed cell proliferation in vitro and tumor growth in vivo. Gene expression profiling, quantitative RT-PCR, chromatin immunoprecipitation, and western blot analysis demonstrated that LRIG1 modulated extracellular matrix (ECM) remodeling and EGFR-MAPK-SPHK1 transduction pathway by suppressing expression of EGFR ligands/activators, MMPs and SPHK1. In addition, LRIG1 induction triggered cell morphology changes and integrin inactivation, which coupled with reduced SNAI2 expression. By contrast, knockdown of endogenous LRIG1 in TW06 cells, a line with normal LRIG1 levels, significantly enhanced cell proliferation, migration and invasiveness. Such tumor-promoting effects could be abolished by specific MAPK or SPHK1 inhibitors. Our data suggest LRIG1 as a tumor suppressor for head and neck cancers; LRIG1 downregulation in cancer cells enhances EGFR-MAPK-SPHK1 signaling and ECM remodeling activity, leading to malignant phenotypes of head and neck cancers.	[Sheu, J. J-C; Cheng, J.; Chen, C-M; Chan, C.; Chao, S. C-C] China Med Univ Hosp, Ctr Human Genet, Taichung, Taiwan; [Sheu, J. J-C] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Sheu, J. J-C] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Lee, C-C; Li, C-I; Chen, J-Y; Chang, J-Y; Lee, C-H] Natl Inst Canc Res, Natl Hlth Res Inst, Zhunan Town 35053, Taiwan; [Hua, C-H] China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lai, M-T] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lai, M-T] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, S-C] Chung Shan Med Univ, Coll Med Sci & Technol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Lee, CH (corresponding author), Natl Inst Canc Res, Natl Hlth Res Inst, R2,R1211,Keyan Rd, Zhunan Town 35053, Taiwan.	jimsheu@mail.cmu.edu.tw; chlee124@nhri.org.tw	Lee, Chia-Huei/B-1063-2010; Chen, Jen-Yang/D-2085-2010; Chang, Jang-Yang/D-2099-2010	Lee, Chia-Huei/0000-0002-8847-3288; Lee, Shan-Chih/0000-0001-6583-1575; Cheng, Jack/0000-0002-9305-0781	National Science Council, Taiwan [NSC99-2320-B-400-009, NSC100-2325-B-400-014, NSC101-2320-B-039-006]; National Health Research Institutes, Taiwan [CA-101-PP-01]; China Medical University Hospital, Taiwan [DMR99-047]; Department of Health, Taiwan [DOH101-TD-C-111-004, DOH101-TD-C-111-005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); China Medical University Hospital, Taiwan; Department of Health, Taiwan	We thank Dr Mien-Chie Hung (MD Anderson Cancer Center, TX, USA) and Dr Yosef Yarden (Weizmann Institute, Israel) for their critical comments on this study, which was supported by grants from the National Science Council, Taiwan (NSC99-2320-B-400-009, NSC100-2325-B-400-014, NSC101-2320-B-039-006 and NSC101-2320-B-039-006), the National Health Research Institutes, Taiwan (CA-101-PP-01), China Medical University Hospital, Taiwan (DMR99-047), and the Department of Health, Taiwan (DOH101-TD-C-111-004 and DOH101-TD-C-111-005).	Abhold EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032459; Burtness B, 2005, EXPERT OPIN BIOL TH, V5, P1085, DOI 10.1517/14712598.5.8.1085; Chang H, 2002, CELL COMMUN ADHES, V9, P239, DOI 10.1080/15419060216303; Chang SJ, 2007, J ENDOCRINOL, V193, P393, DOI 10.1677/JOE-06-0168; Chevronnay HPG, 2012, BBA-PROTEINS PROTEOM, V1824, P146, DOI 10.1016/j.bbapap.2011.09.003; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Huang ZX, 2004, GENE CHROMOSOME CANC, V40, P307, DOI 10.1002/gcc.20036; Jensen KB, 2008, CANCER LETT, V272, P23, DOI 10.1016/j.canlet.2008.06.014; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jin YS, 2005, CANCER GENET CYTOGEN, V156, P1, DOI 10.1016/j.cancergencyto.2004.04.023; Koy S, 2008, HEAD NECK-J SCI SPEC, V30, P1105, DOI 10.1002/hed.20857; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; LIN CT, 1990, LAB INVEST, V62, P713; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Ljuslinder I, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2248; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Ma BBT, 2003, HEAD NECK-J SCI SPEC, V25, P864, DOI 10.1002/hed.10307; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Ordonez-Moran P, 2012, EMBO J, V31, P2064, DOI 10.1038/emboj.2012.73; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2011, CANCER RES, V71, P6576, DOI 10.1158/0008-5472.CAN-11-2364; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Ruan L, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-35; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sheu JJC, 2009, CANCER EPIDEM BIOMAR, V18, P2709, DOI 10.1158/1055-9965.EPI-09-0349; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Shida D, 2004, FEBS LETT, V577, P333, DOI 10.1016/j.febslet.2004.10.024; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Song WM, 2000, DEV BIOL, V227, P606, DOI 10.1006/dbio.2000.9919; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	48	43	43	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1375	1384		10.1038/onc.2013.98	http://dx.doi.org/10.1038/onc.2013.98			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23624915				2022-12-25	WOS:000332943500005
J	Ohkubo, H; Ito, Y; Minamino, T; Mishima, T; Hirata, M; Hosono, K; Shibuya, M; Yokomizo, T; Shimizu, T; Watanabe, M; Majima, M				Ohkubo, Hirotoki; Ito, Yoshiya; Minamino, Tsutomu; Mishima, Toshiaki; Hirata, Mitsuhiro; Hosono, Kanako; Shibuya, Masabumi; Yokomizo, Takehiko; Shimizu, Takao; Watanabe, Masahiko; Majima, Masataka			Leukotriene B-4 type-1 receptor signaling promotes liver repair after hepatic ischemia/reperfusion injury through the enhancement of macrophage recruitment	FASEB JOURNAL			English	Article						BLT1; regeneration; neutrophil; sinusoid	ENDOTHELIAL-GROWTH-FACTOR; ISCHEMIA-REPERFUSION INJURY; CELL-GROWTH; REGENERATION; MICE; ANGIOGENESIS; NEUTROPHIL; FIBROSIS; PATHWAY; ATHEROSCLEROSIS	Recruited macrophages play a critical role in liver repair after acute liver injury. Leukotriene B-4 (LTB4) is a potent chemoattractant for macrophages. In this study, we investigated the role of LTB4 receptor type 1 (BLT1) in liver repair during hepatic ischemia/reperfusion (I/R) injury. BLT1-knockout mice (BLT1-/-) or their wild-type counterparts (WT) were subjected to partial hepatic I/R. Compared with WT, BLT1-/- exhibited delayed liver repair and hepatocyte proliferation accompanied by a 70% reduction in the recruitment of macrophages and a 70-80% attenuation in hepatic expression of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and VEGF receptor 1 (VEGFR1). Disruption of BLT1 signaling also reduced the expression of EGF by 67% on recruited macrophages expressing VEGFR1 in the injured liver. Treatment of WT mice with an EGF-neutralizing antibody delayed liver repair and reduced macrophage recruitment, compared with control immunoglobulin G (IgG). BLT1 signaling enhanced the expression of VEGF, VEGFR1, and EGF in isolated peritoneal macrophages in vitro. These results indicate that BLT1 signaling plays a role in liver repair after hepatic I/R through enhanced expression of EGF in recruited macrophages and that the development of a specific agonist for BLT1 could be useful for liver recovery from acute liver injury.Ohkubo, H., Ito, Y., Minamino, T., Mishima, T., Hirata, M., Hosono, K., Shibuya, M., Yokomizo, T., Shimizu, T., Watanabe, M., Majima, M. Leukotriene B-4 type-1 receptor signaling promotes liver repair after hepatic ischemia/reperfusion injury through the enhancement of macrophage recruitment.	[Ohkubo, Hirotoki; Hosono, Kanako; Majima, Masataka] Kitasato Univ, Dept Pharmacol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Ohkubo, Hirotoki; Ito, Yoshiya; Mishima, Toshiaki; Hirata, Mitsuhiro; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Minamino, Tsutomu] Kitasato Univ, Dept Gastroenterol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Shibuya, Masabumi] Jobu Univ, Gakubunkan Inst Physiol & Med, Gunma, Japan; [Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Tokyo, Japan	Kitasato University; Kitasato University; Kitasato University; Juntendo University; National Center for Global Health & Medicine - Japan	Majima, M (corresponding author), Kitasato Univ, Dept Pharmacol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp	Yokomizo, Takehiko/P-5673-2016; Majima, Masataka/ABH-3063-2021; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; 	High-Tech Research Center of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Integrative Research Program of the Graduate School of Medical Science, Kitasato University	High-Tech Research Center of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Integrative Research Program of the Graduate School of Medical Science, Kitasato University	The authors thank Michiko Ogino, Kyoko Yoshikawa, and Mieko Hamano for technical assistance. This work was supported by research grants from the High-Tech Research Center of the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported by the Integrative Research Program of the Graduate School of Medical Science, Kitasato University. The authors declare no conflicts of interest.	Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Brancato S. K., AM J PATHOL, V178, P19; Clavien PA, 2008, SWISS MED WKLY, V138, P361, DOI 2008/25/smw-12231; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Fenton SE, 1996, J BIOL CHEM, V271, P30870, DOI 10.1074/jbc.271.48.30870; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Hasegawa T, 2007, AM J PHYSIOL-GASTR L, V292, pG1385, DOI 10.1152/ajpgi.00246.2006; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; HUGHES H, 1992, PROSTAG LEUKOTR ESS, V45, P113, DOI 10.1016/0952-3278(92)90226-9; Ito S, 2008, SHOCK, V30, P87, DOI 10.1097/SHK.0b013e31815d06a1; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jala VR, 2004, TRENDS IMMUNOL, V25, P315, DOI 10.1016/j.it.2004.04.003; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kato T, 2011, TOXICOL SCI, V120, P218, DOI 10.1093/toxsci/kfq366; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Koyama S, 2001, AM J PHYSIOL-LUNG C, V280, pL1203, DOI 10.1152/ajplung.2001.280.6.L1203; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Minamino T, 2012, TOXICOL APPL PHARM, V259, P104, DOI 10.1016/j.taap.2011.12.013; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Teoh N, 2004, HEPATOLOGY, V39, P412, DOI 10.1002/hep.20035; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Titos E, 2003, FASEB J, V17, P1745, DOI 10.1096/fj.02-1157fje; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	46	17	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3132	3143		10.1096/fj.13-227421	http://dx.doi.org/10.1096/fj.13-227421			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23629862				2022-12-25	WOS:000329877600020
J	Rancourt, RC; Harris, HR; Barault, L; Michels, KB				Rancourt, Rebecca C.; Harris, Holly R.; Barault, Ludovic; Michels, Karin B.			The prevalence of loss of imprinting of H19 and IGF2 at birth	FASEB JOURNAL			English	Article						allele-specific expression; DNA methylation; genomic; cohort	BECKWITH-WIEDEMANN-SYNDROME; UNIPARENTAL DISOMY; CHROMOSOME 11P15; GENE-EXPRESSION; WILMS-TUMOR; METHYLATION; BREAST; REGION; LOCUS; HYPOMETHYLATION	Imprinted genes are monoallelically expressed according to the parent of origin and are critical for proper placental and embryonic development. Disruption of methylation patterns at imprinted loci resulting in loss of imprinting (LOI) may lead to serious imprinting disorders (e.g., Beckwith-Wiedemann syndrome) and is described in some cancers (e.g., Wilms' tumor). As most research has focused on children with cancer or other abnormal phenotypes, the imprinting status in healthy infants at birth has not been characterized. We examined the prevalence of H19 and IGF2 LOI at birth by allele-specific expression assays analysis on 114 human individuals. Overall expression and methylation analyses were performed on a subset of samples. We found that LOI of H19 was observed for 4% of individuals in cord blood and 3.3% in placenta, and for IGF2 of 22% of individuals in the cord blood and 0% in placenta. Interestingly, LOI status did not correspond to aberrant methylation levels of the imprinted DMRs or with changes in overall gene expression for the majority of individuals. Our observations suggest that LOI is present in phenotypically healthy infants. Determining a normal human epigenotype range is important for discovering factors required to maintain a healthy pregnancy and embryonic development.Rancourt, R. C., Harris, H. R., Barault, L., Michels, K. B. The prevalence of loss of imprinting of H19 and IGF2 at birth.	[Rancourt, Rebecca C.; Harris, Holly R.; Barault, Ludovic; Michels, Karin B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Rancourt, Rebecca C.; Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Harris, Holly R.] Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet	Michels, KB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr,Dept Obstet Gyneco, 221 Longwood Ave, Boston, MA 02115 USA.	kmichels@research.bwh.harvard.edu	Harris, Holly/AAK-6844-2020; Barault, Ludovic/J-2472-2016	Harris, Holly/0000-0002-2572-6727; Barault, Ludovic/0000-0001-5227-5047; Rancourt, Rebecca/0000-0003-2696-7220	National Cancer Institute, U.S. National Institutes of Health [5R21CA128382]; NATIONAL CANCER INSTITUTE [R21CA128382] Funding Source: NIH RePORTER	National Cancer Institute, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the Epigenetic Birth Cohort participants. The authors thank Joelle Perkins for genotyping analyses and Eliza Gardiner, Michelle Peters, and Seema Sannesy for help with data and specimen collection. The authors also thank members of the K. B. M. laboratory for helpful discussions of the project: Amy Non, Alexandra Binder, Timothy Barrow, and Benedetta Izzi. This project was supported by Public Health Research grant 5R21CA128382 from the National Cancer Institute, U.S. National Institutes of Health (principal investigator: K. B. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Barault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055896; Brown KW, 2008, MOL CANCER RES, V6, P1114, DOI 10.1158/1541-7786.MCR-08-0002; Catchpoole D, 2000, J MED GENET, V37, P212, DOI 10.1136/jmg.37.3.212; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; DAVIES SM, 1994, CANCER RES, V54, P2560; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Frost J. M., 2010, PLOS ONE, V5; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Kagami M, 2012, EPIGENETICS-US, V7, P1142, DOI 10.4161/epi.21937; Lambertini L, 2008, EPIGENETICS-US, V3, P261, DOI 10.4161/epi.3.5.6755; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Rancourt RC, 2012, HUM REPROD, V27, P2208, DOI 10.1093/humrep/des151; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Wang WH, 1996, J BIOL CHEM, V271, P27863, DOI 10.1074/jbc.271.44.27863; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Wong HL, 2006, BIOTECHNIQUES, V41, P734, DOI 10.2144/000112305	46	25	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3335	3343		10.1096/fj.12-225284	http://dx.doi.org/10.1096/fj.12-225284			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23620526	Green Published			2022-12-25	WOS:000329877600038
J	Seki, T; Gong, LJ; Williams, AJ; Sakai, N; Todi, SV; Paulson, HL				Seki, Takahiro; Gong, Lijie; Williams, Aislinn J.; Sakai, Norio; Todi, Sokol V.; Paulson, Henry L.			JosD1, a Membrane-targeted Deubiquitinating Enzyme, Is Activated by Ubiquitination and Regulates Membrane Dynamics, Cell Motility, and Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE DISEASE PROTEIN; MACHADO-JOSEPH-DISEASE; INDUCED MACROPINOCYTOSIS; ATAXIN-3; SUBSTRATE; CHAINS	The functional diversity of deubiquitinating enzymes (DUBs) is not well understood. The MJD family of DUBs consists of four cysteine proteases that share a catalytic "Josephin" domain. The family is named after the DUB ATXN3, which causes the neuro-degenerative disease Machado-Joseph disease. The two closely related Josephin domain-containing (JosD) proteins 1 and 2 consist of little more than the Josephin domain. To gain insight into the properties of Josephin domains, we investigated JosD1 and JosD2. JosD1 and JosD2 were found to differ fundamentally in many respects. In vitro, only JosD2 can cleave ubiquitin chains. In contrast, JosD1 cleaves ubiquitin chains only after it is monoubiquitinated, a form of posttranslational-dependent regulation shared with ATXN3. A significant fraction of JosD1 is monoubiquitinated in diverse mouse tissues. In cell-based studies, JosD2 localizes to the cytoplasm whereas JosD1 preferentially localizes to the plasma membrane, particularly when ubiquitinated. The membrane occupancy by JosD1 suggests that it could participate in membrane-dependent events such as cell motility and endocytosis. Indeed, time-lapse imaging revealed that JosD1 enhances membrane dynamics and cell motility. JosD1 also influences endocytosis in cultured cells by increasing the uptake of endocytic markers of macropinocytosis while decreasing those for clathrin- and caveolae-mediated endocytosis. Our results establish that two closely related DUBs differ markedly in activity and function and that JosD1, a membrane-associated DUB whose activity is regulated by ubiquitination, helps regulate membrane dynamics, cell motility, and endocytosis.	[Seki, Takahiro; Gong, Lijie; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Seki, Takahiro; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Williams, Aislinn J.] Univ Iowa, Program Neurosci, Iowa City, IA 52242 USA; [Williams, Aislinn J.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; Hiroshima University; University of Iowa; University of Iowa; Wayne State University; Wayne State University	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,BSRB 4100, Ann Arbor, MI 48109 USA.	henryp@umich.edu	Williams, Aislinn/T-5661-2017; Williams, Aislinn/V-2742-2019; Sakai, Norio/AAM-5822-2021	Williams, Aislinn/0000-0002-8139-2303; Williams, Aislinn/0000-0002-8139-2303; Sakai, Norio/0000-0002-6648-8761; Seki, Takahiro/0000-0002-9894-4768	National Institutes of Health [R00 NS064097, R01 NS038712]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064097, R01NS038712] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25293061] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 NS064097 (to S. V. T.) and R01 NS038712 (to H. L. P.).	Al Soraj M, 2012, J CONTROL RELEASE, V161, P132, DOI 10.1016/j.jconrel.2012.03.015; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burrows JF, 2012, FRONT BIOSCI-LANDMRK, V17, P1184, DOI 10.2741/3980; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Kabayama H, 2009, MOL CELL NEUROSCI, V40, P27, DOI 10.1016/j.mcn.2008.08.009; Kolpak AL, 2009, J NEUROSCI, V29, P10488, DOI 10.1523/JNEUROSCI.2355-09.2009; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Loch CM, 2012, BBA-MOL CELL RES, V1823, P2069, DOI 10.1016/j.bbamcr.2012.05.006; Orme M, 2012, EMBO J, V31, P1, DOI 10.1038/emboj.2011.452; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Sippl W, 2011, FUTURE ONCOL, V7, P619, DOI [10.2217/FON.11.39, 10.2217/fon.11.39]; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	33	44	52	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17145	17155		10.1074/jbc.M113.463406	http://dx.doi.org/10.1074/jbc.M113.463406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625928	Green Published, hybrid			2022-12-25	WOS:000320380600012
J	Estrada, DF; Laurence, JS; Scott, EE				Estrada, D. Fernando; Laurence, Jennifer S.; Scott, Emily E.			Substrate-modulated Cytochrome P450 17A1 and Cytochrome b7(5) Interactions Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							17,20-LYASE ACTIVITY; P450 OXIDOREDUCTASE; ABIRATERONE ACETATE; STRUCTURAL-ANALYSIS; MASS-SPECTROMETRY; CATIONIC CHARGES; BINDING-SITE; HUMAN CYP17; B(5); REDUCTASE	The membrane heme protein cytochrome b(5) (b(5)) can enhance, inhibit, or have no effect on cytochrome P450 (P450) catalysis, depending on the specific P450, substrate, and reaction conditions, but the structural basis remains unclear. Here the interactions between the soluble domain of microsomal b(5) and the catalytic domain of the bifunctional steroidogenic cytochrome P450 17A1 (CYP17A1) were investigated. CYP17A1 performs both steroid hydroxylation, which is unaffected by b5, and an androgen-forming lyase reaction that is facilitated 10-fold by b5. NMR chemical shift mapping of b5 titrations with CYP17A1 indicates that the interaction occurs in an intermediate exchange regime and identifies charged surface residues involved in the protein/protein interface. The role of these residues is confirmed by disruption of the complex upon mutagenesis of either the anionic b(5) residues (Glu-48 or Glu-49) or the corresponding cationic CYP17A1 residues (Arg-347, Arg-358, or Arg-449). Cytochrome b(5) binding to CYP17A1 is also mutually exclusive with binding of NADPH-cytochrome P450 reductase. To probe the differential effects of b(5) on the two CYP17A1mediated reactions and, thus, communication between the superficial b(5) binding site and the buried CYP17A1 active site, CYP17A1/b(5) complex formation was characterized with either hydroxylase or lyase substrates bound to CYP17A1. Significantly, the CYP17A1/b(5) interaction is stronger when the hydroxylase substrate pregnenolone is present in the CYP17A1 active site than when the lyase substrate 17 alpha-hydroxypregnenolone is in the active site. These findings form the basis for a clearer understanding of this important interaction by directly measuring the reversible binding of the two proteins, providing evidence of communication between the CYP17A1 active site and the superficial proximal b(5) binding site.	[Estrada, D. Fernando; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Laurence, Jennifer S.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu	Laurence, Jennifer/N-8027-2013	Laurence, Jennifer/0000-0002-1686-5979	NIGMSNational Institutes of Health [F32 GM103069, R01 GM076343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103069, R01GM076343] Funding Source: NIH RePORTER	NIGMSNational Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMSNational Institutes of Health Grant F32 GM103069 (to D.F.E.) and R01 GM076343 (to E.E.S.).	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Banci L, 1997, EUR J BIOCHEM, V249, P270, DOI 10.1111/j.1432-1033.1997.t01-1-00270.x; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gilep AA, 2001, ARCH BIOCHEM BIOPHYS, V390, P215, DOI 10.1006/abbi.2001.2372; GORSKY LD, 1986, DRUG METAB DISPOS, V14, P89; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lee-Robichaud P, 1999, BIOCHEM J, V342, P309, DOI 10.1042/0264-6021:3420309; LeeRobichaud P, 1997, BIOCHEM J, V321, P857, DOI 10.1042/bj3210857; LIN D, 1994, MOL ENDOCRINOL, V8, P392, DOI 10.1210/me.8.3.392; Liu Y, 2007, J ANDROL, V28, P453, DOI 10.2164/jandrol.106.002006; Miller WL, 2012, J CLIN ENDOCR METAB, V97, P59, DOI 10.1210/jc.2011-2161; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Mulrooney SB, 2004, BBA-GEN SUBJECTS, V1674, P319, DOI 10.1016/j.bbagen.2004.08.001; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NEW MI, 1970, J CLIN INVEST, V49, P1930, DOI 10.1172/JCI106412; Nguyen AD, 2009, ENDOCRINOLOGY, V150, P1748, DOI 10.1210/en.2008-1303; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU, p[133, 448]; Pechurskaya TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P806, DOI 10.1134/S0006297908070092; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SCHENKMAN JB, 1994, ARCH BIOCHEM BIOPHYS, V314, P234, DOI 10.1006/abbi.1994.1435; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; Zamaratskaia G, 2008, ANIMAL, V2, P190, DOI 10.1017/S1751731107001103; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	48	69	70	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17008	17018		10.1074/jbc.M113.468926	http://dx.doi.org/10.1074/jbc.M113.468926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620596	Green Published, hybrid			2022-12-25	WOS:000320378900072
J	Blanchard, C; Roll, R; Roll, JP; Kavounoudias, A				Blanchard, Caroline; Roll, Regine; Roll, Jean-Pierre; Kavounoudias, Anne			Differential Contributions of Vision, Touch and Muscle Proprioception to the Coding of Hand Movements	PLOS ONE			English	Article							SENSORY INTEGRATION; POSTURAL RESPONSES; TENDON VIBRATION; PERCEPTION; VELOCITY; MOTION; MOTOR; DISCRIMINATION; INFORMATION; AFFERENTS	To further elucidate the mechanisms underlying multisensory integration, this study examines the controversial issue of whether congruent inputs from three different sensory sources can enhance the perception of hand movement. Illusory sensations of clockwise rotations of the right hand were induced by either separately or simultaneously stimulating visual, tactile and muscle proprioceptive channels at various intensity levels. For this purpose, mechanical vibrations were applied to the pollicis longus muscle group in the subjects' wrists, and a textured disk was rotated under the palmar skin of the subjects' right hands while a background visual scene was projected onto the rotating disk. The elicited kinaesthetic illusions were copied by the subjects in real time and the EMG activity in the adductor and abductor wrist muscles was recorded. The results show that the velocity of the perceived movements and the amplitude of the corresponding motor responses were modulated by the nature and intensity of the stimulation. Combining two sensory modalities resulted in faster movement illusions, except for the case of visuo-tactile co-stimulation. When a third sensory input was added to the bimodal combinations, the perceptual responses increased only when a muscle proprioceptive stimulation was added to a visuo-tactile combination. Otherwise, trisensory stimulation did not override bimodal conditions that already included a muscle proprioceptive stimulation. We confirmed that vision or touch alone can encode the kinematic parameters of hand movement, as is known for muscle proprioception. When these three sensory modalities are available, they contribute unequally to kinaesthesia. In addition to muscle proprioception, the complementary kinaesthetic content of visual or tactile inputs may optimize the velocity estimation of an on-going movement, whereas the redundant kinaesthetic content of the visual and tactile inputs may rather enhance the latency of the perception.	[Blanchard, Caroline; Roll, Regine; Kavounoudias, Anne] Aix Marseille Univ, CNRS, LNIA UMR 7260, Marseille, France; [Roll, Jean-Pierre] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Kavounoudias, A (corresponding author), Aix Marseille Univ, CNRS, LNIA UMR 7260, Marseille, France.	Anne.Kavounoudias@univ-amu.fr	BLANCHARD, Caroline/N-6392-2014	BLANCHARD, Caroline/0000-0002-3055-1511; Kavounoudias, Anne/0000-0002-2712-8739	Agence Nationale de la Recherche [ANR12-JSH2-0005-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by grants from Agence Nationale de la Recherche #ANR12-JSH2-0005-01, http://www.agence-nationale-recherche.fr/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti J-M, 2012, EXPT BRAIN RES; Becker W, 2002, EXP BRAIN RES, V144, P458, DOI 10.1007/s00221-002-1053-5; Blanchard C, 2011, BRAIN RES, V1382, P219, DOI 10.1016/j.brainres.2011.01.066; BRANDT T, 1972, PFLUG ARCH EUR J PHY, pR98; Breugnot C, 2006, TEXT RES J, V76, P835, DOI 10.1177/0040517506069349; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; Calvin-Figuiere S, 1999, EXP BRAIN RES, V124, P342, DOI 10.1007/s002210050631; Casini L, 2006, BRAIN RES, V1121, P200, DOI 10.1016/j.brainres.2006.08.124; Clement G, 1985, VESTIBULAR VISUAL CO, P99; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Collins DF, 2000, J PHYSIOL-LONDON, V529, P505, DOI 10.1111/j.1469-7793.2000.00505.x; COLLINS JG, 1980, BRAIN RES, V198, P307, DOI 10.1016/0006-8993(80)90746-5; Cordo PJ, 2011, J NEUROPHYSIOL, V105, P1879, DOI 10.1152/jn.00201.2010; Dokka K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000680; Dokka K, 2009, GAIT POSTURE, V30, P211, DOI 10.1016/j.gaitpost.2009.05.001; Duclos C, 2007, GAIT POSTURE, V26, P595, DOI 10.1016/j.gaitpost.2006.12.005; Edin BB, 2004, J NEUROPHYSIOL, V92, P3233, DOI 10.1152/jn.00628.2004; ESSICK GK, 1995, J NEUROSCI, V15, P848; FELDMAN AG, 1982, NEUROSCI LETT, V31, P147, DOI 10.1016/0304-3940(82)90107-0; GIBSON JJ, 1954, PSYCHOL REV, V61, P304, DOI 10.1037/h0061885; Grill SE, 1995, J PHYSIOL-LONDON, V489, P593, DOI 10.1113/jphysiol.1995.sp021075; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Hagura N, 2007, J NEUROSCI, V27, P7047, DOI 10.1523/JNEUROSCI.0970-07.2007; Hlavacka F, 1996, NEUROSCI LETT, V210, P83, DOI 10.1016/0304-3940(96)12667-7; Jurgens R, 2006, EXP BRAIN RES, V174, P528, DOI 10.1007/s00221-006-0486-7; KATZ R, 1978, ELECTROEN CLIN NEURO, V45, P90, DOI 10.1016/0013-4694(78)90345-0; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; Miscio G, 2001, CLIN NEUROPHYSIOL, V112, P884, DOI 10.1016/S1388-2457(01)00468-0; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Nougier V, 1996, EXP BRAIN RES, V109, P473; Orban GA, 1998, EXP BRAIN RES, V122, P9, DOI 10.1007/s002210050486; ORBAN GA, 1984, VISION RES, V24, P33, DOI 10.1016/0042-6989(84)90141-X; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; ROLL JP, 1980, ARCH ITAL BIOL, V118, P51; Romaiguere P, 2005, NEUROREPORT, V16, P693, DOI 10.1097/00001756-200505120-00008; Romaiguere P, 2003, COGNITIVE BRAIN RES, V16, P74, DOI 10.1016/S0926-6410(02)00221-5; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Smetanin BN, 2012, NEUROPHYSIOLOGY+, V43, P377, DOI 10.1007/s11062-012-9237-5; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stenneken P, 2006, NEUROREPORT, V17, P545, DOI 10.1097/01.wnr.0000209013.01470.f8; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; TARDYGERVET MF, 1986, BEHAV BRAIN RES, V20, P161, DOI 10.1016/0166-4328(86)90001-X; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; Vidal M, 2010, EXP BRAIN RES, V200, P37, DOI 10.1007/s00221-009-1980-5; Westphal PC, 1877, ARCH PSYCHIAT, V7, P666, DOI [10.1007/BF02041882, DOI 10.1007/BF02041882]	53	50	51	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62475	10.1371/journal.pone.0062475	http://dx.doi.org/10.1371/journal.pone.0062475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626826	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400190
J	Blank, S; Seismann, H; McIntyre, M; Ollert, M; Wolf, S; Bantleon, FI; Spillner, E				Blank, Simon; Seismann, Henning; McIntyre, Mareike; Ollert, Markus; Wolf, Sara; Bantleon, Frank I.; Spillner, Edzard			Vitellogenins Are New High Molecular Weight Components and Allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris Venom	PLOS ONE			English	Article							YELLOW JACKET VENOM; ANTIGENIC CROSS-REACTIVITY; HOUSE-DUST MITE; BEE-VENOM; HONEY-BEE; STRUCTURAL-ANALYSIS; MAJOR ALLERGEN; INSECT CELLS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Background/Objectives: Anaphylaxis due to hymenoptera stings is one of the most severe clinical outcomes of IgE-mediated hypersensitivity reactions. Although allergic reactions to hymenoptera stings are often considered as a general model for the underlying principles of allergic disease, venom immunotherapy is still hampered by severe systemic side effects and incomplete protection. The identification and detailed characterization of all allergens of hymenoptera venoms might result in an improvement in this field and promote the detailed understanding of the allergological mechanism. Our aim was the identification and detailed immunochemical and allergological characterization of the low abundant IgE-reactive 200 kDa proteins of Apis mellifera and Vespula vulgaris venom. Methods/Principal Findings: Tandem mass spectrometry-based sequencing of a 200 kDa venom protein yielded peptides that could be assigned to honeybee vitellogenin. The coding regions of the honeybee protein as well as of the homologue from yellow jacket venom were cloned from venom gland cDNA. The newly identified 200 kDa proteins share a sequence identity on protein level of 40% and belong to the family of vitellogenins, present in all oviparous animals, and are the first vitellogenins identified as components of venom. Both vitellogenins could be recombinantly produced as soluble proteins in insect cells and assessed for their specific IgE reactivity. The particular vitellogenins were recognized by approximately 40% of sera of venom-allergic patients even in the absence of cross-reactive carbohydrate determinants. Conclusion: With the vitellogenins of Apis mellifera and Vespula vulgaris venom a new homologous pair of venom allergens was identified and becomes available for future applications. Due to their allergenic properties the honeybee and the yellow jacket venom vitellogenin were designated as allergens Api m 12 and Ves v 6, respectively.	[Blank, Simon; Seismann, Henning; Wolf, Sara; Bantleon, Frank I.; Spillner, Edzard] Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany; [McIntyre, Mareike; Ollert, Markus] Tech Univ Munich, Clin Res Div Mol & Clin Allergotoxicol, Dept Dermatol & Allergy Biederstein, D-80290 Munich, Germany	University of Hamburg; Technical University of Munich	Blank, S (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany.	blank@chemie.uni-hamburg.de; spillner@chemie.uni-hamburg.de	Blank, Simon/M-7708-2013	spillner, edzard/0000-0003-0999-5254; Ollert, Markus W./0000-0002-8055-0103; Seismann, Henning/0000-0001-5199-2247				Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amo A, 2010, J AGR FOOD CHEM, V58, P7453, DOI 10.1021/jf101403h; ARBESMAN CE, 1976, CLIN ALLERGY, V6, P587, DOI 10.1111/j.1365-2222.1976.tb01945.x; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Blank S, 2012, CLIN EXP ALLERGY, V42, P976, DOI 10.1111/j.1365-2222.2012.03966.x; Blank S, 2011, ALLERGY, V66, P1322, DOI 10.1111/j.1398-9995.2011.02667.x; Blank S, 2011, PROTEIN PEPTIDE LETT, V18, P415, DOI 10.2174/092986611794653923; Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; DUDLER T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P201, DOI 10.1016/0005-2760(92)90188-2; ENGELMANN F, 1977, BIOCHEM BIOPH RES CO, V78, P641, DOI 10.1016/0006-291X(77)90227-3; Engels W, 1990, HONEY BEE REPROD VIT; Epton MJ, 2001, INT ARCH ALLERGY IMM, V124, P57, DOI 10.1159/000053668; Epton MJ, 1999, INT ARCH ALLERGY IMM, V120, P185, DOI 10.1159/000024266; Fujikawa A, 1996, MOL IMMUNOL, V33, P311, DOI 10.1016/0161-5890(95)00127-1; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V128, P248, DOI 10.1016/j.jaci.2011.02.020; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2010, J ALLERGY CLIN IMMUN, V125; KING TP, 1985, J ALLERGY CLIN IMMUN, V75, P621, DOI 10.1016/0091-6749(85)90040-5; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; Lee JM, 2000, INSECT BIOCHEM MOLEC, V30, P189, DOI 10.1016/S0965-1748(99)00127-7; Li JL, 2010, J COMP PHYSIOL B, V180, P161, DOI 10.1007/s00360-009-0434-5; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MULLER U, 1992, J ALLERGY CLIN IMMUN, V89, P529, DOI 10.1016/0091-6749(92)90319-W; Muller UR, 2002, ALLERGY, V57, P570, DOI 10.1034/j.1398-9995.2002.02157.x; Muller UR, 1988, INSEKTENSTICHALLERGI; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Perez-Gordo M, 2008, ALLERGY, V63, P479, DOI 10.1111/j.1398-9995.2007.01614.x; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Rueff F, 1996, ALLERGY, V51, P216, DOI 10.1111/j.1398-9995.1996.tb04596.x; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Shimizu Y, 2009, J AGR FOOD CHEM, V57, P2314, DOI 10.1021/jf8031759; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Valenta R, 2002, CURR OPIN IMMUNOL, V14, P718, DOI 10.1016/S0952-7915(02)00402-8; WHEELER DE, 1990, ARCH INSECT BIOCHEM, V14, P253, DOI 10.1002/arch.940140405	56	59	63	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62009	10.1371/journal.pone.0062009	http://dx.doi.org/10.1371/journal.pone.0062009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626765	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400129
J	Hare, JI; Neijzen, RW; Anantha, M; Dos Santos, N; Harasym, N; Webb, MS; Allen, TM; Bally, MB; Waterhouse, DN				Hare, Jennifer I.; Neijzen, Robert W.; Anantha, Malathi; Dos Santos, Nancy; Harasym, Natashia; Webb, Murray S.; Allen, Theresa M.; Bally, Marcel B.; Waterhouse, Dawn N.			Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C (TM)) and 5-Fluorouracil	PLOS ONE			English	Article							PHASE-II TRIAL; COLON-CANCER; ANTITUMOR-ACTIVITY; IN-VITRO; CLINICAL PHARMACOKINETICS; THERAPEUTIC-EFFICACY; DEPENDENT ACTIVITY; CPT-11; DRUG; TUMOR	Purpose: To investigate the use of liposomal irinotecan (Irinophore C (TM)) plus or minus 5-fluorouracil (5-FU) for the treatment of colorectal cancer. Experimental Design: The effect of irinotecan (IRI) and/or 5-FU exposure times on cytotoxicity was assessed in vitro against HT-29 or LS174T human colon carcinoma cells. The pharmacokinetics and biodistribution of Irinophore C (TM) (IrC (TM)) and 5-FU, administered alone or in combination, were compared in vivo. A subcutaneous model of HT-29 human colorectal cancer in Rag2-M mice was utilized to assess the efficacy of IrC (TM) alone, and in combination with 5-FU. Results: The cytotoxicity of IRI and 5-FU were strongly dependent on exposure time. Synergistic interactions were observed following prolonged exposure to IRI/5-FU combinations. Pharmacokinetics/biodistribution studies demonstrated that the 5-FU elimination rate was decreased significantly when 5-FU was co-administered intravenously with IrC (TM), versus alone. Significant decreases in 5-FU elimination were also observed in plasma, with an associated increase of 5-FU in some tissues when 5-FU was given by intraperitoneal injection and IrC (TM) was given intravenously. The elimination of IrC (TM) was not significantly different when administered alone or in combination with 5-FU. Therapeutic studies demonstrated that single agent IrC (TM) was significantly more effective than the combination of IRI/5-FU; surprisingly, IrC (TM)/5-FU combinations were no more effective than IrC (TM) alone. The administration of combinations of 5-FU (16 mg/kg) and IrC (TM) (60 mg IRI/kg) showed increased toxicity when compared to IrC (TM) alone. Treatment with IrC (TM) alone (60 mg IRI/kg) delayed the time required for a 5-fold increase in initial tumor volume to day 49, compared to day 23 for controls. When IrC (TM) (40 mg IRI/kg) was used in combination with 5-FU (16 mg/kg), the time to increase tumor volume 5-fold was 43 days, which was comparable to that achieved when using IrC (TM) alone (40 mg IRI/kg). Conclusions: Single agent IrC (TM) was well tolerated and has significant therapeutic potential. IrC (TM) may be a suitable replacement for IRI treatment, but its use with free 5-FU is complicated by IrC (TM)-engendered changes in 5-FU pharmacokinetics/biodistribution which are associated with increased toxicity when using the combination.	[Hare, Jennifer I.; Allen, Theresa M.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Neijzen, Robert W.] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [Anantha, Malathi; Dos Santos, Nancy; Bally, Marcel B.; Waterhouse, Dawn N.] BC Canc Agcy, Vancouver, BC, Canada; [Harasym, Natashia; Webb, Murray S.; Allen, Theresa M.; Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Bally, Marcel B.; Waterhouse, Dawn N.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of Alberta; Utrecht University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Waterhouse, DN (corresponding author), BC Canc Agcy, Vancouver, BC, Canada.	dwater@bccrc.ca		Waterhouse, Dawn/0000-0001-9810-450X; Bally, Marcel/0000-0002-1994-4787	Canadian Institutes of Health Research [82583]; Terry Fox Research Institute [2008-010]; Pfizer/Centre for Drug Research and Development Innovation Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; Pfizer/Centre for Drug Research and Development Innovation Fund	This work was supported by the Canadian Institutes of Health Research (Funding Reference Number 82583) and matching funds from the Terry Fox Research Institute (Project ID 2008-010). Funding for this research was also provided by Pfizer/Centre for Drug Research and Development Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, COL CANC FACTS FIG 2; American Cancer Society, 2013, CANC FACTS FIG 2013; American Cancer Society, 2008, GLOB CANC FACTS FIG; ARBUCK SG, 1989, CANCER, V63, P1036, DOI 10.1002/1097-0142(19890315)63:6+<1036::AID-CNCR2820631309>3.0.CO;2-K; Azrak RG, 2004, CLIN CANCER RES, V10, P1121, DOI 10.1158/1078-0432.CCR-0913-3; Baker JHE, 2008, CLIN CANCER RES, V14, P7260, DOI 10.1158/1078-0432.CCR-08-0736; Barone C, 2007, BRIT J CANCER, V96, P21, DOI 10.1038/sj.bjc.6603496; BURKE TG, 1994, J MED CHEM, V37, P40, DOI 10.1021/jm00027a005; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Drummond DC, 2006, CANCER RES, V66, P3271, DOI 10.1158/0008-5472.CAN-05-4007; Ebrahimnejad P, 2010, NANOMED-NANOTECHNOL, V6, P478, DOI 10.1016/j.nano.2009.10.003; Fajardo AD, 2012, DIS COLON RECTUM, V55, P1044, DOI 10.1097/DCR.0b013e318265ad42; Falcone A, 2001, J CLIN ONCOL, V19, P3456, DOI 10.1200/JCO.2001.19.15.3456; FASSBERG J, 1992, J PHARM SCI, V81, P676, DOI 10.1002/jps.2600810718; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48; FRAILE RJ, 1980, CANCER RES, V40, P2223; Guichard S, 1997, INT J CANCER, V73, P729, DOI 10.1002/(SICI)1097-0215(19971127)73:5<729::AID-IJC20>3.0.CO;2-#; Guichard S, 1999, BRIT J CANCER, V80, P364, DOI 10.1038/sj.bjc.6690364; Guichard S, 1998, BIOCHEM PHARMACOL, V55, P667, DOI 10.1016/S0006-2952(97)00541-8; Harasym TO, 2007, ONCOL RES, V16, P361; Hattori Y, 2009, J CONTROL RELEASE, V136, P30, DOI 10.1016/j.jconrel.2009.01.013; HEGGIE GD, 1987, CANCER RES, V47, P2203; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HOPE MJ, 1986, CHEM PHYS LIPIDS, V40, P89, DOI 10.1016/0009-3084(86)90065-4; HOUGHTON JA, 1979, CANCER RES, V39, P2406; Humerickhouse R, 2000, CANCER RES, V60, P1189; Hwang Jimmy J, 2004, Oncology (Williston Park), V18, P26; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KAWATO Y, 1991, CANCER RES, V51, P4187; Khanna R, 2000, CANCER RES, V60, P4725; Lavelle F, 1996, SEMIN ONCOL, V23, P11; Leichman CG, 1997, J CLIN ONCOL, V15, P3223, DOI 10.1200/JCO.1997.15.10.3223; Liu CN, 2002, INT J ONCOL, V21, P303; Machover D, 1997, CANCER, V80, P1179, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G; Mans DRA, 1999, EUR J CANCER, V35, P1851, DOI 10.1016/S0959-8049(99)00222-1; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Mayer LD, 2007, MOL INTERV, V7, P216, DOI 10.1124/mi.7.4.8; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; Messerer CL, 2004, CLIN CANCER RES, V10, P6638, DOI 10.1158/1078-0432.CCR-04-0221; Miyazaki K, 2006, J GASTROENTEROL, V41, P140, DOI 10.1007/s00535-005-1733-6; Mullany S, 1998, CANCER CHEMOTH PHARM, V42, P391, DOI 10.1007/s002800050835; Nakajima TE, 2008, INT J CANCER, V122, P2148, DOI 10.1002/ijc.23381; PAGE B, 1993, INT J ONCOL, V3, P473; Patankar N, 2011, PHARM RES-DORDR, V28, P848, DOI 10.1007/s11095-010-0340-2; Pavillard V, 2001, BRIT J CANCER, V85, P1077, DOI 10.1054/bjoc.2001.2027; Peng CL, 2009, BIOMATERIALS, V30, P3614, DOI 10.1016/j.biomaterials.2009.03.048; PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; POOL GL, 1982, LIPIDS, V17, P448, DOI 10.1007/BF02535225; Ramsay E, 2008, EUR J PHARM BIOPHARM, V68, P607, DOI 10.1016/j.ejpb.2007.08.011; Ramsay E, 2006, PHARM RES-DORDR, V23, P2799, DOI 10.1007/s11095-006-9111-5; Ramsay EC, 2008, CLIN CANCER RES, V14, P1208, DOI 10.1158/1078-0432.CCR-07-0780; RIVORY LP, 1994, CANCER RES, V54, P6330; Rothenberg ML, 1996, J CLIN ONCOL, V14, P1128, DOI 10.1200/JCO.1996.14.4.1128; Rothenberg ML, 1999, CANCER-AM CANCER SOC, V85, P786, DOI 10.1002/(SICI)1097-0142(19990215)85:4<786::AID-CNCR5>3.0.CO;2-9; Saliba F, 1998, J CLIN ONCOL, V16, P2745, DOI 10.1200/JCO.1998.16.8.2745; Saltz LB, 1996, J CLIN ONCOL, V14, P2959, DOI 10.1200/JCO.1996.14.11.2959; Saltz LB, 2001, ONCOLOGIST, V6, P81, DOI 10.1634/theoncologist.6-1-81; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Senter PD, 2001, BIOCONJUGATE CHEM, V12, P1074, DOI 10.1021/bc0155420; SUGARBAKER PH, 1985, SEMIN ONCOL, V12, P101; Tan BR, 2005, AM SOC CLIN ONC M; Tardi P, 2009, LEUKEMIA RES, V33, P129, DOI 10.1016/j.leukres.2008.06.028; Tardi PG, 2009, MOL CANCER THER, V8, P2266, DOI 10.1158/1535-7163.MCT-09-0243; Thomas AM, 2011, J CONTROL RELEASE, V150, P212, DOI 10.1016/j.jconrel.2010.11.018; Vaillant JC, 2000, ANN SURG, V231, P449, DOI 10.1097/00000658-200004000-00001; van Kuilenburg ABP, 2001, CLIN CANCER RES, V7, P1149; Verreault M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-124; Wiseman LR, 1996, DRUGS, V52, P606, DOI 10.2165/00003495-199652040-00013; Wolmark N, 1998, J CLIN ONCOL, V16, P301; Xu G, 2002, CLIN CANCER RES, V8, P2605	73	21	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62349	10.1371/journal.pone.0062349	http://dx.doi.org/10.1371/journal.pone.0062349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626804	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400168
J	Mukai, C; Gao, LZ; Bergkvist, M; Nelson, JL; Hinchman, MM; Travis, AJ				Mukai, Chinatsu; Gao, Lizeng; Bergkvist, Magnus; Nelson, Jacquelyn L.; Hinchman, Meleana M.; Travis, Alexander J.			Biomimicry Enhances Sequential Reactions of Tethered Glycolytic Enzymes, TPI and GAPDHS	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FIBROUS SHEATH; MURINE SPERMATOZOA; PROTEIN BIOCHIPS; MOUSE; HEXOKINASE; STRATEGIES; CELLS; GENE; ATP	Maintaining activity of enzymes tethered to solid interfaces remains a major challenge in developing hybrid organic-inorganic devices. In nature, mammalian spermatozoa have overcome this design challenge by having glycolytic enzymes with specialized targeting domains that enable them to function while tethered to a cytoskeletal element. As a step toward designing a hybrid organic-inorganic ATP-generating system, we implemented a biomimetic site-specific immobilization strategy to tether two glycolytic enzymes representing different functional enzyme families: triose phosphoisomerase (TPI; an isomerase) and glyceraldehyde 3-phosphate dehydrogenase (GAPDHS; an oxidoreductase). We then evaluated the activities of these enzymes in comparison to when they were tethered via classical carboxyl-amine crosslinking. Both enzymes show similar surface binding regardless of immobilization method. Remarkably, specific activities for both enzymes were significantly higher when tethered using the biomimetic, site-specific immobilization approach. Using this biomimetic approach, we tethered both enzymes to a single surface and demonstrated their function in series in both forward and reverse directions. Again, the activities in series were significantly higher in both directions when the enzymes were coupled using this biomimetic approach versus carboxyl-amine binding. Our results suggest that biomimetic, site-specific immobilization can provide important functional advantages over chemically specific, but non-oriented attachment, an important strategic insight given the growing interest in recapitulating entire biological pathways on hybrid organic-inorganic devices.	[Mukai, Chinatsu; Gao, Lizeng; Nelson, Jacquelyn L.; Hinchman, Meleana M.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Bergkvist, Magnus] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Travis, AJ (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	ajt32@cornell.edu		Gao, Lizeng/0000-0003-0265-4027; Bergkvist, Magnus/0000-0002-5226-6615; Hinchman, Meleana/0000-0002-7642-9458; Mukai, Chinatsu/0000-0003-0080-9371	U.S. National Institutes of Health Pioneer Award [8DP1-EB016541]; NYSTAR Center for Life Science Enterprise grant; JSPS [21770105]; JSPS Institutional Program for Young Researcher Overseas Visits [R10]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP1EB016541] Funding Source: NIH RePORTER	U.S. National Institutes of Health Pioneer Award; NYSTAR Center for Life Science Enterprise grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a U.S. National Institutes of Health Pioneer Award (8DP1-EB016541), NYSTAR Center for Life Science Enterprise grant (AJT), and by JSPS Grants-in-Aid for Scientific Research (Wakate B: 21770105) and JSPS Institutional Program for Young Researcher Overseas Visits R10 (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Du YZ, 2005, CHEM COMMUN, P2080, DOI 10.1039/b500327j; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Fischer T, 2007, J MATER CHEM, V17, P943, DOI 10.1039/b615278c; Halliwell CM, 2001, ANAL BIOCHEM, V295, P257, DOI 10.1006/abio.2001.5182; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P9618, DOI 10.1002/anie.200801711; Keighron JD, 2010, LANGMUIR, V26, P18992, DOI 10.1021/la1040882; Keighron JD, 2011, MINIMAL CELL: THE BIOPHYSICS OF CELL COMPARTMENT AND ORIGIN OF CELL FUNCTIONALITY, P3, DOI 10.1007/978-90-481-9944-0_1; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Luo TJM, 2005, NAT MATER, V4, P220, DOI 10.1038/nmat1322; Mori C, 1998, MOL REPROD DEV, V49, P374, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;374::AID-MRD4&gt;3.0.CO;2-K; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Mukai C, 2009, CHEM BIOL, V16, P1013, DOI 10.1016/j.chembiol.2009.08.009; Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H; Pescador P, 2008, LANGMUIR, V24, P14108, DOI 10.1021/la8027435; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; STOREY BT, 1975, FERTIL STERIL, V26, P1257; Tachibana S, 2006, ANAL BIOCHEM, V359, P72, DOI 10.1016/j.ab.2006.09.006; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 1999, J BIOL CHEM, V274, P34467, DOI 10.1074/jbc.274.48.34467; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Voet D, 2010, ELECT TRANSPORT OXID, P823; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869; Westhoff D, 1997, J CELL SCI, V110, P1821; Yan L, 1997, LANGMUIR, V13, P6704, DOI 10.1021/la970762g; Zebda A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1365	28	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61434	10.1371/journal.pone.0061434	http://dx.doi.org/10.1371/journal.pone.0061434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626684	gold, Green Published			2022-12-25	WOS:000318008400047
J	Tanaka, A; Woltjen, K; Miyake, K; Hotta, A; Ikeya, M; Yamamoto, T; Nishino, T; Shoji, E; Sehara-Fujisawa, A; Manabe, Y; Fujii, N; Hanaoka, K; Era, T; Yamashita, S; Isobe, K; Kimura, E; Sakurai, H				Tanaka, Akihito; Woltjen, Knut; Miyake, Katsuya; Hotta, Akitsu; Ikeya, Makoto; Yamamoto, Takuya; Nishino, Tokiko; Shoji, Emi; Sehara-Fujisawa, Atsuko; Manabe, Yasuko; Fujii, Nobuharu; Hanaoka, Kazunori; Era, Takumi; Yamashita, Satoshi; Isobe, Ken-ichi; Kimura, En; Sakurai, Hidetoshi			Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PLURIPOTENT STEM-CELLS; SKELETAL-MUSCLE; MOUSE; GENE; FIBROBLASTS; DYSFERLIN; PROGENITORS; DEFICIENCY; EXPRESSION	The establishment of human induced pluripotent stem cells (hiPSCs) has enabled the production of in vitro, patient-specific cell models of human disease. In vitro recreation of disease pathology from patient-derived hiPSCs depends on efficient differentiation protocols producing relevant adult cell types. However, myogenic differentiation of hiPSCs has faced obstacles, namely, low efficiency and/or poor reproducibility. Here, we report the rapid, efficient, and reproducible differentiation of hiPSCs into mature myocytes. We demonstrated that inducible expression of myogenic differentiation1 (MYOD1) in immature hiPSCs for at least 5 days drives cells along the myogenic lineage, with efficiencies reaching 70-90%. Myogenic differentiation driven by MYOD1 occurred even in immature, almost completely undifferentiated hiPSCs, without mesodermal transition. Myocytes induced in this manner reach maturity within 2 weeks of differentiation as assessed by marker gene expression and functional properties, including in vitro and in vivo cell fusion and twitching in response to electrical stimulation. Miyoshi Myopathy (MM) is a congenital distal myopathy caused by defective muscle membrane repair due to mutations in DYSFERLIN. Using our induced differentiation technique, we successfully recreated the pathological condition of MM in vitro, demonstrating defective membrane repair in hiPSC-derived myotubes from an MM patient and phenotypic rescue by expression of full-length DYSFERLIN (DYSF). These findings not only facilitate the pathological investigation of MM, but could potentially be applied in modeling of other human muscular diseases by using patient-derived hiPSCs.	[Tanaka, Akihito; Woltjen, Knut; Hotta, Akitsu; Ikeya, Makoto; Yamamoto, Takuya; Nishino, Tokiko; Shoji, Emi; Sakurai, Hidetoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto, Japan; [Tanaka, Akihito; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Miyake, Katsuya] Kagawa Univ, Dept Histol & Cell Biol, Sch Med, Miki, Kagawa, Japan; [Shoji, Emi; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Sakyo Ku, Kyoto, Japan; [Manabe, Yasuko; Fujii, Nobuharu] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo, Japan; [Hanaoka, Kazunori] Kitasato Univ, Dept Biosci, Sch Sci, Minami Ku, Sagamihara, Kanagawa 228, Japan; [Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, Kumamoto, Japan; [Yamashita, Satoshi; Kimura, En] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, Kumamoto, Japan	Kyoto University; Nagoya University; Kagawa University; Kyoto University; Tokyo Metropolitan University; Kitasato University; Kumamoto University; Kumamoto University	Sakurai, H (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto, Japan.	hsakurai@cira.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017; Wilson, Matthew H/K-3193-2013; Fujii, Nobuharu/J-2724-2014; Kimura, En/B-3869-2010	Yamamoto, Takuya/0000-0002-0022-3947; Fujii, Nobuharu/0000-0002-0974-3033; Kimura, En/0000-0002-7865-5918; Yamashita, Satoshi/0000-0001-9315-3492; Ikeya, Makoto/0000-0002-3930-8032; Shoji, Emi/0000-0003-2576-5491; Woltjen, Knut/0000-0003-2293-1183; Hotta, Akitsu/0000-0002-2619-7441	Japan Society for the Promotion of Science (JSPS) [22790284]; MEXT; Ministry of Health, Labor, and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22122007] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by the FIRST Program, Scientific Research Grant No. 22790284 (to HS) from the Japan Society for the Promotion of Science (JSPS), and a grant from the Leading Project of MEXT (to HS and AS). This research was also supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan (to TE) and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (to TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Goudenege S, 2012, MOL THERAPY J AM SOC; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HASHIMOTO K, 1987, DEVELOPMENT, V100, P587; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hashimoto N, 2006, BIOCHEM BIOPH RES CO, V348, P1383, DOI 10.1016/j.bbrc.2006.08.006; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Kunkel LM, 2006, J HUM GENET, V51, P397, DOI 10.1007/s10038-006-0374-9; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; MIYOSHI K, 1986, BRAIN, V109, P31, DOI 10.1093/brain/109.1.31; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; NIGRO JM, 1987, AM J HUM GENET, V40, P115; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; OTT MO, 1991, DEVELOPMENT, V111, P1097; Ozasa S, 2007, BIOCHEM BIOPH RES CO, V357, P957, DOI 10.1016/j.bbrc.2007.04.032; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; SARKER S, 1970, BIOCHEM BIOPH RES CO, V41, P918, DOI 10.1016/0006-291X(70)90171-3; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tedesco F.S., 2012, SCI TRANSL MED, V4; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	146	155	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61540	10.1371/journal.pone.0061540	http://dx.doi.org/10.1371/journal.pone.0061540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626698	Green Published, gold			2022-12-25	WOS:000318008400062
J	Wang, HB; Jiang, JF; Chen, SM; Qi, XY; Peng, H; Li, PR; Song, AP; Guan, ZY; Fang, WM; Liao, Y; Chen, FD				Wang, Haibin; Jiang, Jiafu; Chen, Sumei; Qi, Xiangyu; Peng, Hui; Li, Pirui; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Liao, Yuan; Chen, Fadi			Next-Generation Sequencing of the Chrysanthemum nankingense (Asteraceae) Transcriptome Permits Large-Scale Unigene Assembly and SSR Marker Discovery	PLOS ONE			English	Article							TAG EST LIBRARY; POLYMORPHISM SNP DISCOVERY; MICROSATELLITES; GENOME; TOOL; ANNOTATION; REPEAT; MODEL; L.	Background: Simple sequence repeats (SSRs) are ubiquitous in eukaryotic genomes. Chrysanthemum is one of the largest genera in the Asteraceae family. Only few Chrysanthemum expressed sequence tag (EST) sequences have been acquired to date, so the number of available EST-SSR markers is very low. Methodology/Principal Findings: Illumina paired-end sequencing technology produced over 53 million sequencing reads from C. nankingense mRNA. The subsequent de novo assembly yielded 70,895 unigenes, of which 45,789 (64.59%) unigenes showed similarity to the sequences in NCBI database. Out of 45,789 sequences, 107 have hits to the Chrysanthemum Nr protein database; 679 and 277 sequences have hits to the database of Helianthus and Lactuca species, respectively. MISA software identified a large number of putative EST-SSRs, allowing 1,788 primer pairs to be designed from the de novo transcriptome sequence and a further 363 from archival EST sequence. Among 100 primer pairs randomly chosen, 81 markers have amplicons and 20 are polymorphic for genotypes analysis in Chrysanthemum. The results showed that most (but not all) of the assays were transferable across species and that they exposed a significant amount of allelic diversity. Conclusions/Significance: SSR markers acquired by transcriptome sequencing are potentially useful for marker-assisted breeding and genetic analysis in the genus Chrysanthemum and its related genera.	[Wang, Haibin; Jiang, Jiafu; Chen, Sumei; Qi, Xiangyu; Peng, Hui; Li, Pirui; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Liao, Yuan; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			Program for New Century Excellent Talents in University of Chinese Ministry of Education [NCET-10-0492]; 863 Project [2011AA100208]; Fundamental Research Funds for the Central Universities [KYZ201147, KYZ201112]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Youth Science and Technology Innovation Fund from Nanjing Agricultural University [KJ2011009]	Program for New Century Excellent Talents in University of Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)); 863 Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Youth Science and Technology Innovation Fund from Nanjing Agricultural University	This work was supported by funding from the Program for New Century Excellent Talents in University of Chinese Ministry of Education (Grant No. NCET-10-0492); 863 Project (2011AA100208), the Fundamental Research Funds for the Central Universities (KYZ201147, KYZ201112); a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Youth Science and Technology Innovation Fund from Nanjing Agricultural University (KJ2011009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, ACTA PHYTOTAXON SIN; Attitalla Idress Hamad, 2011, Pak J Biol Sci, V14, P998, DOI 10.3923/pjbs.2011.998.999; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x; Cadalen T, 2010, MOL BREEDING, V25, P699, DOI 10.1007/s11032-009-9369-5; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Coetzee G, 2002, J CLIN ONCOL, V20, P3572, DOI 10.1200/JCO.2002.20.17.3572; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Field D, 1996, P ROY SOC B-BIOL SCI, V263, P209, DOI 10.1098/rspb.1996.0033; Fourquin C, 2012, PLANT J, V71, P990, DOI 10.1111/j.1365-313X.2012.05046.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gong L, 2010, MOL BREEDING, V26, P125, DOI 10.1007/s11032-009-9380-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; King DG, 1997, ENDEAVOUR, V21, P36, DOI 10.1016/S0160-9327(97)01005-3; Kondo Katsuhiko, 2002, Chromosome Science, V6, P87; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; Laitinen RAE, 2005, GENOME RES, V15, P475, DOI 10.1101/gr.3043705; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lindqvist C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-16; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Oberprieler C., 2007, FAMILIES GENERA VASC, P342; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Patel RV, 2012, PLANT J, V71, P1038, DOI 10.1111/j.1365-313X.2012.05055.x; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Strozycki PM, 2010, MOL BIOL EVOL, V27, P91, DOI 10.1093/molbev/msp196; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Szulkin M, 2011, MOL ECOL, V20, P3949, DOI 10.1111/j.1365-294X.2011.05277.x; Tang SX, 2003, THEOR APPL GENET, V107, P6, DOI 10.1007/s00122-003-1233-0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Trifonov EN, 2004, EVOLUTIONARY THEORY AND PROCESSES: MODERN HORIZONS, P115; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vendramin E, 2007, MOL ECOL NOTES, V7, P307, DOI 10.1111/j.1471-8286.2006.01590.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xiao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035961; [杨念云 Yang Nianyun], 2005, [中国药科大学学报, Journal of China Pharmaceutical University], V36, P402; Yang WH, 2006, NEW PHYTOL, V171, P875, DOI 10.1111/j.1469-8137.2006.01779.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao HE, 2009, GENET RESOUR CROP EV, V56, P937, DOI 10.1007/s10722-009-9412-8; Zhao HB, 2010, PLANT SYST EVOL, V284, P153, DOI 10.1007/s00606-009-0242-0; Zwenger SR, 2010, PLANT SIGNAL BEHAV, V5, P1330, DOI 10.4161/psb.5.11.12837	61	86	101	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62293	10.1371/journal.pone.0062293	http://dx.doi.org/10.1371/journal.pone.0062293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626799	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400163
J	Clayden, JD; Dayan, M; Clark, CA				Clayden, Jonathan D.; Dayan, Michael; Clark, Chris A.			Principal Networks	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; GRAPH-THEORETICAL ANALYSIS; MAGNETIC-RESONANCE IMAGES; HUMAN BRAIN; CORTICAL THICKNESS; ANATOMICAL NETWORKS; COMMUNITY STRUCTURE; MRI; ORGANIZATION; TRACTOGRAPHY	Graph representations of brain connectivity have attracted a lot of recent interest, but existing methods for dividing such graphs into connected subnetworks have a number of limitations in the context of neuroimaging. This is an important problem because most cognitive functions would be expected to involve some but not all brain regions. In this paper we outline a simple approach for decomposing graphs, which may be based on any measure of interregional association, into coherent "principal networks". The technique is based on an eigendecomposition of the association matrix, and is closely related to principal components analysis. We demonstrate the technique using cortical thickness and diffusion tractography data, showing that the subnetworks which emerge are stable, meaningful and reproducible. Graph-theoretic measures of network cost and efficiency may be calculated separately for each principal network. Unlike some other approaches, all available connectivity information is taken into account, and vertices may appear in none or several of the subnetworks. Subject-by-subject "scores" for each principal network may also be obtained, under certain circumstances, and related to demographic or cognitive variables of interest.	[Clayden, Jonathan D.; Dayan, Michael; Clark, Chris A.] UCL, Inst Child Hlth, London, England; [Dayan, Michael] Fdn Santa Lucia, Neuroimaging Lab, Rome, Italy	University of London; University College London; IRCCS Santa Lucia	Clayden, JD (corresponding author), UCL, Inst Child Hlth, London, England.	j.clayden@ucl.ac.uk	Clayden, Jonathan D/C-1894-2008; Dayan, Michael/G-4760-2016	Clayden, Jonathan D/0000-0002-6608-0619; Dayan, Michael/0000-0002-2666-0969	European Union [FP7-ICT-2009-C 238292]; EPSRC [EP/J016292/1]; Engineering and Physical Sciences Research Council [EP/J016292/1] Funding Source: researchfish; Medical Research Council [G1002276, G0300117] Funding Source: researchfish; MRC [G1002276, G0300117] Funding Source: UKRI	European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was partly supported by European Union grant FP7-ICT-2009-C 238292 (http://cordis.europa.eu/fp7/home_en.html), and by EPSRC grant EP/J016292/1 (http://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Brouwer AE, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-1939-6; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Clayden JD, 2011, J STAT SOFTW, V44, P1; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Euler L., 1741, PETROPOLITANAE, V8, P128; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Kaiser M, 2011, NETWORK-COMP NEURAL, V22, P143, DOI 10.3109/0954898X.2011.638968; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; POTHEN A, 1990, SIAM J MATRIX ANAL A, V11, P430, DOI 10.1137/0611030; R Core Team, 2012, R LANG ENV STAT COMP; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Saerens M, 2004, LECT NOTES COMPUT SC, V3201, P371; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sarkar D, 2008, USE R, P1; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tabelow K, 2011, NEUROIMAGE, V55, P1686, DOI 10.1016/j.neuroimage.2011.01.013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu JS, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016115; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	41	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60997	10.1371/journal.pone.0060997	http://dx.doi.org/10.1371/journal.pone.0060997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630578	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500013
J	Pyles, JA; Verstynen, TD; Schneider, W; Tarr, MJ				Pyles, John A.; Verstynen, Timothy D.; Schneider, Walter; Tarr, Michael J.			Explicating the Face Perception Network with White Matter Connectivity	PLOS ONE			English	Article							HUMAN NEURAL SYSTEM; FUSIFORM GYRUS; DIFFERENTIAL SENSITIVITY; VISUAL-PERCEPTION; CORTICAL NETWORK; HUMAN CORTEX; EYE GAZE; OBJECT; REPRESENTATIONS; IDENTITY	A network of multiple brain regions is recruited in face perception. Our understanding of the functional properties of this network can be facilitated by explicating the structural white matter connections that exist between its functional nodes. We accomplished this using functional MRI (fMRI) in combination with fiber tractography on high angular resolution diffusion weighted imaging data. We identified the three nodes of the core face network: the "occipital face area" (OFA), the "fusiform face area" (mid-fusiform gyrus or mFus), and the superior temporal sulcus (STS). Additionally, a region of the anterior temporal lobe (aIT), implicated as being important for face perception was identified. Our data suggest that we can further divide the OFA into multiple anatomically distinct clusters - a partitioning consistent with several recent neuroimaging results. More generally, structural white matter connectivity within this network revealed: 1) Connectivity between aIT and mFus, and between aIT and occipital regions, consistent with studies implicating this posterior to anterior pathway as critical to normal face processing; 2) Strong connectivity between mFus and each of the occipital face-selective regions, suggesting that these three areas may subserve different functional roles; 3) Almost no connectivity between STS and mFus, or between STS and the other face-selective regions. Overall, our findings suggest a re-evaluation of the "core" face network with respect to what functional areas are or are not included in this network.	[Pyles, John A.; Verstynen, Timothy D.; Schneider, Walter; Tarr, Michael J.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Pyles, John A.; Verstynen, Timothy D.; Schneider, Walter; Tarr, Michael J.] Univ Pittsburgh, Pittsburgh, PA USA; [Pyles, John A.; Verstynen, Timothy D.; Tarr, Michael J.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Schneider, Walter] Univ Pittsburgh, Ctr Learning Res & Dev, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pyles, JA (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	jpyles@cmu.edu		Verstynen, Timothy/0000-0003-4720-0336; Pyles, John/0000-0002-7627-0504	James S. McDonnell Foundation [15573-S6]; National Science Foundation; NSF Science of Learning Center [SBE-0542013]; United States National Institutes of Health (NIH); NIH EUREKA Award [1R01MH084195-01]	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the James S. McDonnell Foundation, http://www.jsmf.org/(#15573-S6); National Science Foundation, http://www.nsf.gov/; NSF Science of Learning Center (SBE-0542013); United States National Institutes of Health (NIH), http://www.nih.gov/; and NIH EUREKA Award 1R01MH084195-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Davies-Thompson J., 2011, J VISION, V11, P647, DOI DOI 10.1167/11.11.647; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Ewbank MP, 2008, NEUROIMAGE, V40, P1857, DOI 10.1016/j.neuroimage.2008.01.049; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Granziera C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005101; Greenberg AS, 2012, J NEUROSCI, V32, P2773, DOI 10.1523/JNEUROSCI.5419-11.2012; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Gschwind M., 2011, CEREB CORTEX; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jiang F, 2011, J NEUROPHYSIOL, V106, P2720, DOI 10.1152/jn.00672.2010; Kadosh KC, 2011, CEREB CORTEX, V21, P1389, DOI 10.1093/cercor/bhq215; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Mur M, 2010, CEREB CORTEX, V20, P2027, DOI 10.1093/cercor/bhp272; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Nestor A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003978; Nummenmaa L, 2010, CEREB CORTEX, V20, P1780, DOI 10.1093/cercor/bhp244; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Pitcher D, 2011, NEUROPSYCHOLOGIA, V49, P3448, DOI 10.1016/j.neuropsychologia.2011.08.020; Pitcher D, 2011, NEUROIMAGE, V56, P2356, DOI 10.1016/j.neuroimage.2011.03.067; Pitcher D, 2011, EXP BRAIN RES, V209, P481, DOI 10.1007/s00221-011-2579-1; Plaut DC, 2011, COGN NEUROPSYCHOL, V28, P251, DOI 10.1080/02643294.2011.609812; Puce A, 1996, J NEUROSCI, V16, P5205; Pyles JA, 2007, VISION RES, V47, P2786, DOI 10.1016/j.visres.2007.07.017; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; RHODES G, 1985, BRIT J PSYCHOL, V76, P249, DOI 10.1111/j.2044-8295.1985.tb01949.x; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Saenz M, 2010, NEUROIMAGE, V52, P1224, DOI 10.1016/j.neuroimage.2010.05.060; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; SERGENT J, 1992, PHILOS T ROY SOC B, V335, P55, DOI 10.1098/rstb.1992.0007; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; Thomas C, 2008, J COGNITIVE NEUROSCI, V20, P268, DOI 10.1162/jocn.2008.20025; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Turk-Browne NB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00176; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; Verstynen TD, 2012, J NEUROPHYSIOL, V107, P2984, DOI 10.1152/jn.00995.2011; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011	62	104	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61611	10.1371/journal.pone.0061611	http://dx.doi.org/10.1371/journal.pone.0061611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630602	Green Published, gold, Green Accepted			2022-12-25	WOS:000317911500052
J	Demeler, J; Ramunke, S; Wolken, S; Ianiello, D; Rinaldi, L; Gahutu, JB; Cringoli, G; von Samson-Himmelstjerna, G; Krucken, J				Demeler, Janina; Ramuenke, Sabrina; Wolken, Sonja; Ianiello, Davide; Rinaldi, Laura; Gahutu, Jean Bosco; Cringoli, Giuseppe; von Samson-Himmelstjerna, Georg; Kruecken, Juergen			Discrimination of Gastrointestinal Nematode Eggs from Crude Fecal Egg Preparations by Inhibitor-Resistant Conventional and Real-Time PCR	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS EGGS; MOLECULAR METHOD; MELTING ANALYSIS; KATO-KATZ; IN-VITRO; DNA; DIAGNOSIS; FLOTAC; IDENTIFICATION; LINE	Diagnosis of gastrointestinal nematodes relies predominantly on coproscopic methods such as flotation, Kato-Katz, McMaster or FLOTAC. Although FLOTAC allows accurate quantification, many nematode eggs can only be differentiated to genus or family level. Several molecular diagnostic tools discriminating closely related species suffer from high costs for DNA isolation from feces and limited sensitivity since most kits use only small amounts of feces (<1 g). A direct PCR from crude egg preparations was designed for full compatibility with FLOTAC to accurately quantify eggs per gram feces (epg) and determine species composition. Eggs were recovered from the flotation solution and concentrated by sieving. Lysis was achieved by repeated boiling and freezing cycles - only Trichuris eggs required additional mechanic disruption. Egg lysates were directly used as template for PCR with Phusion DNA polymerase which is particularly resistant to PCR inhibitors. Qualitative results were obtained with feces of goats, cattle, horses, swine, cats, dogs and mice. The finally established protocol was also compatible with quantitative real-time PCR in the presence of EvaGreen and no PCR inhibition was detectable when extracts were diluted at least fourfold. Sensitivity was comparable to DNA isolation protocols and spiked samples with five epg were reliably detected. For Toxocara cati a detection limit below one epg was demonstrated. It was possible to distinguish T. cati and Toxocara canis using high resolution melt (HRM) analysis, a rapid tool for species identification. In human samples, restriction fragment length polymorphism (RFLP) and HRM analysis were used to discriminate Necator americanus and Ancylostoma duodenale. The method is able to significantly improve molecular diagnosis of gastrointestinal nematodes by increasing speed and sensitivity while decreasing overall costs. For identification of species or resistance alleles, analysis of PCR products with many different post PCR methods can be used such as RFLP, reverse-line-blot, Sanger sequencing and HRM.	[Demeler, Janina; Ramuenke, Sabrina; von Samson-Himmelstjerna, Georg; Kruecken, Juergen] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Wolken, Sonja] Univ Vet Med, Inst Parasitol, Hannover, Germany; [Ianiello, Davide; Rinaldi, Laura; Cringoli, Giuseppe] Univ Naples Federico II, Fac Vet Med, Dept Pathol & Anim Hlth, Naples, Italy; [Gahutu, Jean Bosco] Natl Univ Rwanda, Fac Med, Univ Teaching Hosp Butare, Butare, Rwanda	Free University of Berlin; University of Veterinary Medicine Hannover, Foundation; University of Naples Federico II; University of Rwanda	Krucken, J (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	juergen.kruecken@fu-berlin.de	McKay-Demeler, Janina/AAO-4336-2020; Krücken, Jürgen/AAE-3133-2021; Gahutu, Jean Bosco/I-3994-2016; Demeler, Janina/A-1727-2014; Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/B-6794-2009; von Samson, Georg/R-1123-2016	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Gahutu, Jean Bosco/0000-0002-7969-867X; Ramunke, Sabrina/0000-0003-0195-4175	Freie Universitat Berlin; EU FP7 GLOWORM	Freie Universitat Berlin; EU FP7 GLOWORM	This study was funded from the Freie Universitat Berlin. Also, the study was partially funded by the EU FP7 GLOWORM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areekit Supatra, 2009, J Med Assoc Thai, V92 Suppl 3, pS24; BEHNKE JM, 1993, INT J PARASITOL, V23, P945, DOI 10.1016/0020-7519(93)90061-3; Berberian J. F., 1957, American Midland Naturalist, V57, P421, DOI 10.2307/2422408; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Costa JM, 2011, J MICROBIOL METH, V86, P357, DOI 10.1016/j.mimet.2011.06.017; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; Diawara A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000397; Ebbinghaus P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-272; Fahrion AS, 2011, VET PARASITOL, V177, P186, DOI 10.1016/j.vetpar.2010.11.028; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; Gan LSH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-134; Gasser RB, 1996, ACTA TROP, V62, P15, DOI 10.1016/S0001-706X(96)00015-0; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Habtamu K, 2011, PARASITOL INT, V60, P398, DOI 10.1016/j.parint.2011.06.020; Harmon AF, 2007, PARASITOL RES, V101, P71, DOI 10.1007/s00436-006-0428-0; Harmon AF, 2006, VET PARASITOL, V135, P297, DOI 10.1016/j.vetpar.2005.10.014; Herrmann DC, 2011, BERL MUNCH TIERARZTL, V124, P497, DOI 10.2376/0005-9366-124-497; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Hunt PW, 2011, VET PARASITOL, V180, P12, DOI 10.1016/j.vetpar.2011.05.027; Ionita M, 2010, VET PARASITOL, V168, P332, DOI 10.1016/j.vetpar.2009.11.021; Knopp S, 2009, T ROY SOC TROP MED H, V103, P1190, DOI 10.1016/j.trstmh.2009.05.012; Kotze AC, 2009, AM J TROP MED HYG, V81, P163, DOI 10.4269/ajtmh.2009.81.163; LEJAMBRE LF, 1976, PARASITOLOGY, V73, P223, DOI 10.1017/S0031182000046898; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Pecson BM, 2006, APPL ENVIRON MICROB, V72, P7864, DOI 10.1128/AEM.01983-06; Radvansky J, 2011, PARASITOL RES, V108, P201, DOI 10.1007/s00436-010-2057-x; RICHARDS JC, 1995, INT J PARASITOL, V25, P1185, DOI 10.1016/0020-7519(95)00036-2; Roeber F, 2011, INFECT GENET EVOL, V11, P849, DOI 10.1016/j.meegid.2011.01.013; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schnieder T, 1999, PARASITOL RES, V85, P895, DOI 10.1007/s004360050654; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; Traversa D, 2007, J CLIN MICROBIOL, V45, P2937, DOI 10.1128/JCM.00714-07; Verheij S, 2011, FORENSIC SCI INT GEN; von Samson-Himmestjerna G, 2002, INT J PARASITOL, V32, P1529, DOI 10.1016/S0020-7519(02)00163-7; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Yang P, 2007, NAT METHODS, P20	41	59	62	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61285	10.1371/journal.pone.0061285	http://dx.doi.org/10.1371/journal.pone.0061285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620739	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500019
J	Ye, Q; Cai, W; Zheng, Y; Evers, BM; She, QB				Ye, Q.; Cai, W.; Zheng, Y.; Evers, B. M.; She, Q-B			ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer	ONCOGENE			English	Article						translational regulation; metastasis; ERK; AKT; survivin; colorectal cancer	INITIATION-FACTOR 4E; INTRINSIC RESISTANCE; TUBEROUS SCLEROSIS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; ACTIVATION; MTOR; EIF4E; PHOSPHORYLATION; INHIBITION	The mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase (MEK/ERK) and phosphatidylinositol 3-kinase (PI3K)/AKT pathways are often concurrently activated by separate genetic alterations in colorectal cancer (CRC), which is associated with CRC progression and poor survival. However, how activating both pathways is required for CRC metastatic progression remains unclear. Our recent study showed that both ERK and AKT signaling are required to activate eukaryotic translation initiation factor 4E (eIF4E)-initiated cap-dependent translation via convergent regulation of the translational repressor 4E-binding protein 1 (4E-BP1) for maintaining CRC transformation. Here, we identified that the activation of cap-dependent translation by cooperative ERK and AKT signaling is critical for promotion of CRC motility and metastasis. In CRC cells with coexistent mutational activation of ERK and AKT pathways, inhibition of either MEK or AKT alone showed limited activity in inhibiting cell migration and invasion, but combined inhibition resulted in profound effects. Genetic blockade of the translation initiation complex by eIF4E knockdown or expression of a dominant active 4E-BP1 mutant effectively inhibited migration, invasion and metastasis of CRC cells, whereas overexpression of eIF4E or knockdown of 4E-BP1 had the opposite effect and markedly reduced their dependence on ERK and AKT signaling for cell motility. Mechanistically, we found that these effects were largely dependent on the increase in mammalian target of rapamycin complex 1 (mTORC1)-mediated survivin translation by ERK and AKT signaling. Despite the modest effect of survivin knockdown on tumor growth, reduction of the translationally regulated survivin profoundly inhibited motility and metastasis of CRC. These findings reveal a critical mechanism underlying the translational regulation of CRC metastatic progression, and suggest that targeting cap-dependent translation may provide a promising treatment strategy for advanced CRC.	[Ye, Q.; Cai, W.; Zheng, Y.; Evers, B. M.; She, Q-B] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40506 USA; [Ye, Q.; Cai, W.; Zheng, Y.; She, Q-B] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA; [Evers, B. M.] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky	She, QB (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, 741 South Limestone,B365 BBSRB, Lexington, KY 40506 USA.	qing-bai.she@uky.edu		She, Qing-Bai/0000-0002-7207-0599	NCI [R01CA175105, P30CA147886]; Gastrointestinal Cancer [SPORE P20CA150343]; ACS [IRG85-001-22]; NIH/NCATS [UL1RR033173, KL2RR0033171]; Markey Cancer Center Start-up fund; NATIONAL CANCER INSTITUTE [R01CA175105, P30CA177558, P30CA147886, P20CA150343] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000116, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033171, UL1RR033173] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gastrointestinal Cancer; ACS(American Cancer Society); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Markey Cancer Center Start-up fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs Rina Plattner and Kathleen O'Connor and Ms Donna Gilbreath for critical reading and editing of this manuscript, Dr Ronald Blasberg for providing the SFG-FLuc-IRES2-GFP construct. Dr Piotr Rychahou for the assistance in the animal experiments, and Ms Dana Napier for the histologic tissue processing. This work was supported by grants from NCI (R01CA175105 to Q-B She, P30CA147886 and Gastrointestinal Cancer SPORE P20CA150343 to BM Evers), ACS (IRG85-001-22 to Q-B She), NIH/NCATS UL1RR033173 (KL2RR0033171 to Q-B She), and the Markey Cancer Center Start-up fund (to Q-B She).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Berkel HJ, 2001, CANCER EPIDEM BIOMAR, V10, P663; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [DOI 10.1038/NATURE11252, 10.1038/nature11252]; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134; Dilling MB, 2002, J BIOL CHEM, V277, P13907, DOI 10.1074/jbc.M110782200; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Floc'h N, 2012, CANCER RES, V72, P4483, DOI 10.1158/0008-5472.CAN-12-0283; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin ME, 2000, INT J BIOCHEM CELL B, V32, P633, DOI 10.1016/S1357-2725(00)00007-8; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Thomas H.E., 2012, SCI TRANSL MED, V4, pra184; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057; Zhang M, 2010, INT J RADIAT ONCOL, V78, P1095, DOI 10.1016/j.ijrobp.2009.09.007; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	120	122	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1828	1839		10.1038/onc.2013.122	http://dx.doi.org/10.1038/onc.2013.122			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23624914	Green Accepted			2022-12-25	WOS:000334345500009
J	Gandy, KAO; Adada, M; Canals, D; Carroll, B; Roddy, P; Hannun, YA; Obeid, LM				Gandy, K. Alexa Orr; Adada, Mohamad; Canals, Daniel; Carroll, Brittany; Roddy, Patrick; Hannun, Yusuf A.; Obeid, Lina M.			Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation	FASEB JOURNAL			English	Article						radixin; moesin; actin cytoskeleton; polarization	SPHINGOSINE KINASE-1 EXPRESSION; EGF RECEPTOR; ERM PROTEINS; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; TARGETED THERAPY; PROSTATE-CANCER; CELLS; PHOSPHORYLATION; MIGRATION	Ezrin, radixin, and moesin (ERM) proteins link cortical actin to the plasma membrane and coordinate cellular events that require cytoskeletal rearrangement, including cell division, migration, and invasion. While ERM proteins are involved in many important cellular events, the mechanisms regulating their function are not completely understood. Our laboratory previously identified reciprocal roles for the sphingolipids ceramide and sphingosine-1-phosphate (S1P) in the regulation of ERM proteins. We recently showed that ceramide-induced activation of PP1 leads to dephosphorylation and inactivation of ERM proteins, while S1P results in phosphorylation and activation of ERM proteins. Following these findings, we aimed to examine known inducers of the SK/S1P pathway and evaluate their ability to regulate ERM proteins. We examined EGF, a known inducer of the SK/S1P pathway, for its ability to regulate the ERM family of proteins. We found that EGF induces ERM c-terminal threonine phosphorylation via activation of the SK/S1P pathway, as this was prevented by siRNA knockdown or pharmacological inhibition of SK. Using pharmacological, as well as genetic, knockdown approaches, we determined that EGF induces ERM phosphorylation via activation of S1PR2. In addition, EGF led to cell polarization in the form of lamellipodia, and this occurred through a mechanism involving S1PR2-mediated phosphorylation of ezrin T567. EGF-induced cellular invasion was also found to be dependent on S1PR2-induced T567 ezrin phosphorylation, such that S1PR2 antagonist, JTE-013, and expression of a dominant-negative ezrin mutant prevented cellular invasion toward EGF. In this work, a novel mechanism of EGF-stimulated invasion is unveiled, whereby S1P-mediated activation of S1PR2 and phosphorylation of ezrin T567 is required.	[Gandy, K. Alexa Orr] Med Univ S Carolina, Dept Mol & Cellular Biol & Pathobiol, Charleston, SC 29425 USA; [Roddy, Patrick] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Adada, Mohamad; Canals, Daniel; Carroll, Brittany; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	Medical University of South Carolina; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; obeid, lina/0000-0002-0734-0847; Adada, Mohamad/0000-0002-2988-2081	Office of Research and Development, Department of Veterans Affairs [BX000156-01A1]; Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC, USA); U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) in Lipid Biology and New Technologies [P200A070596]; U.S. National Institutes of Health (NIH) [HL-007260]; National Cancer Institute [R01-CA87584, PO1-CA97132]; NIH National Institute of General Medical Sciences [R01-GM062887]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P01CA097132, P30CA138313, R01CA087584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, T32GM008444, R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC, USA); U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) in Lipid Biology and New Technologies; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This article is based on work supported in part by Merit Award BX000156-01A1 (L.M.O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC, USA); U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) in Lipid Biology and New Technologies grant P200A070596 (K.A.O.G.); U.S. National Institutes of Health (NIH) grant HL-007260 (K.A.O.G.); National Cancer Institute grants R01-CA87584 (Y.A.H.) and PO1-CA97132 (Y.A.H. and L.M.O.), and NIH National Institute of General Medical Sciences grant R01-GM062887 (L.M.O.). The imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center (Medical University of South Carolina). The content of this material does not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government.	Adyshev DM, 2011, CELL SIGNAL, V23, P2086, DOI 10.1016/j.cellsig.2011.08.003; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Balaban N, 1996, BBA-MOL CELL RES, V1314, P147, DOI 10.1016/S0167-4889(96)00068-7; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Batus M, 2010, EXPERT REV ANTICANC, V10, P1589, DOI 10.1586/ERA.10.104; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Brakch N, 2010, EUR HEART J, V31, P67, DOI 10.1093/eurheartj/ehp387; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Cheng L, 2011, FUTURE ONCOL, V7, P519, DOI [10.2217/FON.11.25, 10.2217/fon.11.25]; Cui YZ, 2010, CANCER INVEST, V28, P242, DOI 10.3109/07357900903124498; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Domingo G, 2010, EXPERT REV ANTICANC, V10, P1577, DOI [10.1586/era.10.141, 10.1586/ERA.10.141]; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Estrada-Bernal A, 2011, J NEURO-ONCOL, V102, P353, DOI 10.1007/s11060-010-0345-z; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; French KJ, 2003, CANCER RES, V63, P5962; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Kagesawa T, 2008, MECH DEVELOP, V125, P1020, DOI 10.1016/j.mod.2008.08.001; Kahsai AW, 2010, BBA-MOL CELL RES, V1803, P300, DOI 10.1016/j.bbamcr.2009.11.002; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kim S, 2011, ANTICANCER RES, V31, P3767; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Kunda P, 2012, CURR BIOL, V22, P231, DOI 10.1016/j.cub.2011.12.016; Li Junwei, 2007, Zhongguo Fei Ai Za Zhi, V10, P183, DOI 10.3779/j.issn.1009-3419.2007.03.05; Li MH, 2009, J UROLOGY, V181, P1347, DOI 10.1016/j.juro.2008.10.140; Libotte T, 2001, EXP CELL RES, V270, P129, DOI 10.1006/excr.2001.5339; Lopez-Perez M, 2006, INT J BIOCHEM CELL B, V38, P1716, DOI 10.1016/j.biocel.2006.04.001; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Musial Jacek, 2007, Polish Journal of Pathology, V58, P235; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14; Orr Gandy K. A., 2012, BIOCHEM J, V449, P661; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Rodgers A, 2009, STEM CELLS DEV, V18, P1319, DOI 10.1089/scd.2009.0023; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schenten V, 2011, J LEUKOCYTE BIOL, V89, P587, DOI 10.1189/jlb.0510304; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Wang Longyun, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P969, DOI 10.3969/j.issn.1672-7347.2010.09.012; Yamaguchi H, 2003, BIOCHEM J, V374, P715, DOI 10.1042/BJ20030381; Yotsumoto F, 2009, ANTICANCER RES, V29, P4879; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhai Jian-Wen, 2010, Chin J Cancer, V29, P317	64	26	27	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3155	3166		10.1096/fj.13-228460	http://dx.doi.org/10.1096/fj.13-228460			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23629860	Green Published			2022-12-25	WOS:000329877600022
J	Stephenson, HN; John, CM; Naz, N; Gundogdu, O; Dorrell, N; Wren, BW; Jarvis, GA; Bajaj-Elliott, M				Stephenson, Holly N.; John, Constance M.; Naz, Neveda; Gundogdu, Ozan; Dorrell, Nick; Wren, Brendan W.; Jarvis, Gary A.; Bajaj-Elliott, Mona			Campylobacter jejuni Lipooligosaccharide Sialylation, Phosphorylation, and Amide/Ester Linkage Modifications Fine-tune Human Toll-like Receptor 4 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; DENDRITIC CELLS; SIALIC ACIDS; LIPID-A; 2,3-DIAMINO-2,3-DIDEOXY-D-GLUCOSE; LIPOPOLYSACCHARIDES; PHOSPHOETHANOLAMINE; BIOSYNTHESIS; INDUCTION; INFECTION	Campylobacter jejuni is a leading cause of acute gastroenteritis. C. jejuni lipooligosaccharide (LOS) is a potent activator of Toll-like receptor (TLR) 4-mediated innate immunity. Structural variations of the LOS have been previously reported in the oligosaccharide (OS) moiety, the disaccharide lipid A (LA) backbone, and the phosphorylation of the LA. Here, we studied LOS structural variation between C. jejuni strains associated with different ecological sources and analyzed their ability to activate TLR4 function. MALDI-TOF MS was performed to characterize structural variation in both the OS and LA among 15 different C. jejuni isolates. Cytokine induction in THP-1 cells and primary monocytes was correlated with LOS structural variation in each strain. Additionally, structural variation was correlated with the source of each strain. OS sialylation, increasing abundance of LA D-glucosamine versus 2,3-diamino-2,3-dideoxy-D-glucose, and phosphorylation status all correlated with TLR4 activation as measured in THP-1 cells and monocytes. Importantly, LOS-induced inflammatory responses were similar to those elicited by live bacteria, highlighting the prominent contribution of the LOS component in driving host immunity. OS sialylation status but not LA structure showed significant association with strains clustering with livestock sources. Our study highlights how variations in three structural components of C. jejuni LOS alter TLR4 activation and consequent monocyte activation.	[Stephenson, Holly N.; Bajaj-Elliott, Mona] UCL, Infect Dis & Microbiol Unit, Inst Child Hlth, London WC1N 1EH, England; [John, Constance M.; Jarvis, Gary A.] Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [John, Constance M.; Jarvis, Gary A.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Naz, Neveda; Gundogdu, Ozan; Dorrell, Nick; Wren, Brendan W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Dept 111W1, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Gundogdu, Ozan/0000-0002-3550-0545; Bajaj-Elliott, Mona/0000-0002-5234-576X; Jarvis, Gary/0000-0002-7576-3702; Dorrell, Nick/0000-0003-1144-6502	Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health (NIH)/NCI Cancer Center Support Grant [P30 CA082103]; NIH/National Center for Research Resources (NCRR) [S10RR029446-01]; UCSF Mass Spectrometry Facility; NIH/NCRR [P41RR001614]; Biotechnology and Biological Sciences Research Council [EGA16167, BB/C519670/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR029446] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000727] Funding Source: NIH RePORTER	Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health (NIH)/NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCSF Mass Spectrometry Facility; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We gratefully acknowledge the University of California, San Francisco (UCSF) Mass Spectrometry Core Facility, which is supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, and National Institutes of Health (NIH)/NCI Cancer Center Support Grant P30 CA082103, and the NIH/National Center for Research Resources (NCRR) Shared Instrumentation Grant S10RR029446-01 (to H. E. Witkowska), and the UCSF Mass Spectrometry Facility (A. L. Burlingame, Director), which is supported by NIH/NCRR Grant P41RR001614.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BEUTLER B, 1990, J INVEST DERMATOL, V95, pS81, DOI 10.1111/1523-1747.ep12874797; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Gardner TJ, 2011, CLIN INFECT DIS, V53, P26, DOI 10.1093/cid/cir249; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Gundogdu O, 2011, J BACTERIOL, V193, P4238, DOI 10.1128/JB.05189-11; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Javed MA, 2012, INFECT IMMUN, V80, P2361, DOI 10.1128/IAI.00151-12; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MORAN AP, 1991, J BACTERIOL, V173, P618, DOI 10.1128/jb.173.2.618-626.1991; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; PHILLIPS NJ, 1993, BIOCHEMISTRY-US, V32, P2003, DOI 10.1021/bi00059a017; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; van Mourik A, 2010, J BIOL CHEM, V285, P15828, DOI 10.1074/jbc.M110.102061; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x	42	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19661	19672		10.1074/jbc.M113.468298	http://dx.doi.org/10.1074/jbc.M113.468298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23629657	Green Published, hybrid			2022-12-25	WOS:000321515800037
J	Mosbech, A; Lukas, C; Bekker-Jensen, S; Mailand, N				Mosbech, Anna; Lukas, Claudia; Bekker-Jensen, Simon; Mailand, Niels			The Deubiquitylating Enzyme USP44 Counteracts the DNA Double-strand Break Response Mediated by the RNF8 and RNF168 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							53BP1 RECRUITMENT; DAMAGE; BRCA1; PROMOTES; UBIQUITYLATION; RECOGNITION; PROGRESSION; PATHWAY; SITES	Protein recruitment to DNA double-strand breaks (DSBs) relies on ubiquitylation of the surrounding chromatin by the RING finger ubiquitin ligases RNF8 and RNF168. Flux through this pathway is opposed by several deubiquitylating enzymes (DUBs), including OTUB1 and USP3. By analyzing the effect of individually overexpressing the majority of human DUBs on RNF8/RNF168-mediated 53BP1 retention at DSB sites, we found that USP44 and USP29 powerfully inhibited this response at the level of RNF168 accrual. Both USP44 and USP29 promoted efficient deubiquitylation of histone H2A, but unlike USP44, USP29 displayed nonspecific reactivity toward ubiquitylated substrates. Moreover, USP44 but not other H2A DUBs was recruited to RNF168-generated ubiquitylation products at DSB sites. Individual depletion of these DUBs only mildly enhanced accumulation of ubiquitin conjugates and 53BP1 at DSBs, suggesting considerable functional redundancy among cellular DUBs that restrict ubiquitin-dependent protein assembly at DSBs. Our findings implicate USP44 in negative regulation of the RNF8/RNF168 pathway and illustrate the usefulness of DUB overexpression screens for identification of antagonizers of ubiquitin-dependent cellular responses.	[Mosbech, Anna; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Ubiquitin Signaling Grp, DK-2200 Copenhagen, Denmark; [Lukas, Claudia] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Chromosome Stabil & Dynam Grp, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Bekker-Jensen, S (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Ubiquitin Signaling Grp, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	simon.bekker-jensen@cpr.ku.dk; niels.mailand@cpr.ku.dk		Lukas, Claudia/0000-0001-7169-6883; Bekker-Jensen, Simon/0000-0002-7308-4597	Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeck Foundation; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Center for Protein Research	This work was supported by grants from the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Cancer Society, and the Lundbeck Foundation.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Zhang Y, 2012, J CLIN INVEST, V122, P4362, DOI 10.1172/JCI63084; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023389	42	98	100	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16579	16587		10.1074/jbc.M113.459917	http://dx.doi.org/10.1074/jbc.M113.459917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615962	Green Published, hybrid			2022-12-25	WOS:000320378900034
J	Antonenko, YN; Khailova, LS; Knorre, DA; Markova, OV; Rokitskaya, TI; Ilyasova, TM; Severina, II; Kotova, EA; Karavaeva, YE; Prikhodko, AS; Severin, FF; Skulachev, VP				Antonenko, Yuri N.; Khailova, Ljudmila S.; Knorre, Dmitry A.; Markova, Olga V.; Rokitskaya, Tatyana I.; Ilyasova, Tatyana M.; Severina, Inna I.; Kotova, Elena A.; Karavaeva, Yulia E.; Prikhodko, Anastasia S.; Severin, Fedor F.; Skulachev, Vladimir P.			Penetrating Cations Enhance Uncoupling Activity of Anionic Protonophores in Mitochondria	PLOS ONE			English	Article							BILAYER-LIPID MEMBRANES; OXIDATIVE-PHOSPHORYLATION; TARGETED ANTIOXIDANT; COMPLEX-FORMATION; LIFE-SPAN; CELLS; YEAST; 2,4-DINITROPHENOL; VALINOMYCIN; DERIVATIVES	Protonophorous uncouplers causing a partial decrease in mitochondrial membrane potential are promising candidates for therapeutic applications. Here we showed that hydrophobic penetrating cations specifically targeted to mitochondria in a membrane potential-driven fashion increased proton-translocating activity of the anionic uncouplers 2,4-dinitrophenol (DNP) and carbonylcyanide-p-trifluorophenylhydrazone (FCCP). In planar bilayer lipid membranes (BLM) separating two compartments with different pH values, DNP-mediated diffusion potential of H+ ions was enhanced in the presence of dodecyltriphenylphosphonium cation (C12TPP). The mitochondria-targeted penetrating cations strongly increased DNP-and carbonylcyanide m-chlorophenylhydrazone (CCCP)-mediated steady-state current through BLM when a transmembrane electrical potential difference was applied. Carboxyfluorescein efflux from liposomes initiated by the plastoquinone containing penetrating cation SkQ1 was inhibited by both DNP and FCCP. Formation of complexes between the cation and CCCP was observed spectophotometrically. In contrast to the less hydrophobic tetraphenylphosphonium cation (TPP), SkQ1 and C12TPP promoted the uncoupling action of DNP and FCCP on isolated mitochondria. C12TPP and FCCP exhibited a synergistic effect decreasing the membrane potential of mitochondria in yeast cells. The stimulating action of penetrating cations on the protonophore-mediated uncoupling is assumed to be useful for medical applications of low (non-toxic) concentrations of protonophores.	[Antonenko, Yuri N.; Khailova, Ljudmila S.; Knorre, Dmitry A.; Markova, Olga V.; Rokitskaya, Tatyana I.; Ilyasova, Tatyana M.; Severina, Inna I.; Kotova, Elena A.; Severin, Fedor F.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Antonenko, Yuri N.; Khailova, Ljudmila S.; Knorre, Dmitry A.; Markova, Olga V.; Rokitskaya, Tatyana I.; Ilyasova, Tatyana M.; Severina, Inna I.; Kotova, Elena A.; Severin, Fedor F.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow, Russia; [Karavaeva, Yulia E.; Prikhodko, Anastasia S.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University	Antonenko, YN (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	antonen@genebee.msu.ru; skulach@belozersky.msu.ru	Kotova, Elena/A-6214-2012; Knorre, Dmitry/D-8478-2012; Markova, Olga/J-5261-2013; Rokitskaya, Tatyana/J-3541-2013; Antonenko, Yuri N/K-1323-2013; Severin, Fedor/AAD-5444-2019; Prikhodko, Anastasia/AAD-1867-2019	Knorre, Dmitry/0000-0001-7468-6963; Karavaeva, Iuliia/0000-0003-2450-2585; Severin, Fedor/0000-0001-6703-1256; Skulachev, Vladimir/0000-0001-5141-7517; Rokitskaya, Tatyana/0000-0002-7719-1875	Russian Foundation for Basic Research [12-04-00199]; Institute of Mitoengineering, Moscow State University	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Institute of Mitoengineering, Moscow State University	This work was supported in part by the Russian Foundation for Basic Research grant 12-04-00199 and the Institute of Mitoengineering, Moscow State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED I, 1990, BIOCHIM BIOPHYS ACTA, V1024, P298, DOI 10.1016/0005-2736(90)90358-U; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Fetisova EK, 2010, FEBS LETT, V584, P562, DOI 10.1016/j.febslet.2009.12.002; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; ILIVICKY J, 1969, BIOCHEM PHARMACOL, V18, P1389, DOI 10.1016/0006-2952(69)90252-4; Jennings ML, 2001, AM J PHYSIOL-CELL PH, V281, pC825, DOI 10.1152/ajpcell.2001.281.3.C825; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; KOLAJOVA M, 1993, GEN PHYSIOL BIOPHYS, V12, P213; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825, DOI 10.1152/physrev.1980.60.3.825; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; OBRIEN TA, 1978, J BIOL CHEM, V253, P1749; OMACHI A, 1968, EXPERIENTIA, V24, P244, DOI 10.1007/BF02152795; ORLOV VN, 1994, FEBS LETT, V345, P104, DOI 10.1016/0014-5793(94)00420-X; Padalko VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P986, DOI 10.1007/s10541-005-0213-1; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Rokitskaya TI, 2008, J MEMBRANE BIOL, V224, P9, DOI 10.1007/s00232-008-9124-6; Rokitskaya TI, 2010, BBA-BIOMEMBRANES, V1798, P1698, DOI 10.1016/j.bbamem.2010.05.018; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800; SKULACHEV V. P., 1968, CURR MOD BIOL, V2, P98; SKULACHEV VP, 1967, NATURE, V216, P718, DOI 10.1038/216718a0; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; WINTER CG, 1994, ARCH BIOCHEM BIOPHYS, V314, P17, DOI 10.1006/abbi.1994.1406	38	34	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61902	10.1371/journal.pone.0061902	http://dx.doi.org/10.1371/journal.pone.0061902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626747	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400111
J	Bender, A; Desplats, P; Spencer, B; Rockenstein, E; Adame, A; Elstner, M; Laub, C; Mueller, S; Koob, AO; Mante, M; Pham, E; Klopstock, T; Masliah, E				Bender, Andreas; Desplats, Paula; Spencer, Brian; Rockenstein, Edward; Adame, Anthony; Elstner, Matthias; Laub, Christoph; Mueller, Sarina; Koob, Andrew O.; Mante, Michael; Pham, Emily; Klopstock, Thomas; Masliah, Eliezer			TOM40 Mediates Mitochondrial Dysfunction Induced by alpha-Synuclein Accumulation in Parkinson's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SUBSTANTIA-NIGRA NEURONS; CENTRAL-NERVOUS-SYSTEM; REAL-TIME PCR; ALZHEIMERS-DISEASE; DNA DELETIONS; TRANSGENIC MICE; NEURODEGENERATIVE DISORDERS; INDIVIDUAL CELLS; COMPLEX-I	Alpha-synuclein (alpha-Syn) accumulation/aggregation and mitochondrial dysfunction play prominent roles in the pathology of Parkinson's disease. We have previously shown that postmortem human dopaminergic neurons from PD brains accumulate high levels of mitochondrial DNA (mtDNA) deletions. We now addressed the question, whether alterations in a component of the mitochondrial import machinery -TOM40-might contribute to the mitochondrial dysfunction and damage in PD. For this purpose, we studied levels of TOM40, mtDNA deletions, oxidative damage, energy production, and complexes of the respiratory chain in brain homogenates as well as in single neurons, using laser-capture-microdissection in transgenic mice overexpressing human wildtype alpha-Syn. Additionally, we used lentivirus-mediated stereotactic delivery of a component of this import machinery into mouse brain as a novel therapeutic strategy. We report here that TOM40 is significantly reduced in the brain of PD patients and in alpha-Syn transgenic mice. TOM40 deficits were associated with increased mtDNA deletions and oxidative DNA damage, and with decreased energy production and altered levels of complex I proteins in alpha-Syn transgenic mice. Lentiviral-mediated overexpression of Tom40 in alpha-Syn-transgenic mice brains ameliorated energy deficits as well as oxidative burden. Our results suggest that alterations in the mitochondrial protein transport machinery might contribute to mitochondrial impairment in alpha-Synucleinopathies.	[Bender, Andreas; Elstner, Matthias; Laub, Christoph; Mueller, Sarina; Koob, Andrew O.; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Bender, Andreas; Desplats, Paula; Spencer, Brian; Rockenstein, Edward; Adame, Anthony; Mante, Michael; Pham, Emily; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Desplats, Paula/AFW-5030-2022; Mueller, Sarina/AAJ-9925-2021	Mueller, Sarina/0000-0001-5790-0841; Bender, Andreas/0000-0002-6328-7104; Lipton, Stuart/0000-0002-3490-1259; Desplats, Paula/0000-0002-4758-4280	Else-Kroener-Fresenius Foundation [EKFS P65/06//EKMS06/13]; German Research Foundation (DFG) [BE 4185/1-1]; NIH [AG022072, AG18440, AG010435, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG022072, P50AG005131, P01AG010435, R01AG018440, R37AG018440] Funding Source: NIH RePORTER	Else-Kroener-Fresenius Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a stipend of the Else-Kroener-Fresenius Foundation (to A.B.; #EKFS P65/06//EKMS06/13; www.ekfs.de), the German Research Foundation (DFG, #BE 4185/1-1 to A.B. and T.K.; www.dfg.de), and NIH grants AG022072, AG18440, AG010435, NS057096 (to E.M.; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Beal MF, 2009, PARKINSONISM RELAT D, V15, pS189, DOI 10.1016/S1353-8020(09)70812-0; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BENDER A, 2008, J NEUROL; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; Bruno D, 2012, EXP GERONTOL, V47, P347, DOI 10.1016/j.exger.2011.09.008; Chong MS, 2013, J ALZHEIMERS DIS, V34, P399, DOI 10.3233/JAD-121621; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Devi L, 2008, J BIOL CHEM; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Goncalves S, 2013, MOL NEUROBIOLOGY; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Liu CC, 2013, NATURE REV NEUROLOGY; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; Marr RA, 2003, J NEUROSCI, V23, P1992; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; Naldini L, 2000, ADV VIRUS RES, V55, P599, DOI 10.1016/S0065-3527(00)55020-9; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; PARIHAR MS, 2008, CELL MOL LIFE SCI; Pennington K, 2010, J PROTEOME RES, V9, P2390, DOI 10.1021/pr901102d; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Roses AD, 2009, PHARMACOGENOMICS J; Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Totterdell S, 2005, NEUROSCIENCE, V135, P907, DOI 10.1016/j.neuroscience.2005.06.047; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Zhang L, 2008, BRAIN RES; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	54	100	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62277	10.1371/journal.pone.0062277	http://dx.doi.org/10.1371/journal.pone.0062277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626796	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400160
J	Hausammann, S; Vogel, M; Hovinga, JAK; Lacroix-Desmazes, S; Stadler, BM; Horn, MP				Hausammann, Stefanie; Vogel, Monique; Hovinga, Johanna A. Kremer; Lacroix-Desmazes, Sebastien; Stadler, Beda M.; Horn, Michael P.			Designed Ankyrin Repeat Proteins: A New Approach to Mimic Complex Antigens for Diagnostic Purposes?	PLOS ONE			English	Article							FACTOR-VIII INHIBITOR; HEMOPHILIA-A; IN-VITRO; BINDING-MOLECULES; FVIII ANTIBODIES; RIBOSOME DISPLAY; LIFE; LIBRARIES; EPITOPES; AFFINITY	Inhibitory antibodies directed against coagulation factor VIII (FVIII) can be found in patients with acquired and congenital hemophilia A. Such FVIII-inhibiting antibodies are routinely detected by the functional Bethesda Assay. However, this assay has a low sensitivity and shows a high inter-laboratory variability. Another method to detect antibodies recognizing FVIII is ELISA, but this test does not allow the distinction between inhibitory and non-inhibitory antibodies. Therefore, we aimed at replacing the intricate antigen FVIII by Designed Ankyrin Repeat Proteins (DARPins) mimicking the epitopes of FVIII inhibitors. As a model we used the well-described inhibitory human monoclonal anti-FVIII antibody, Bo2C11, for the selection on DARPin libraries. Two DARPins were selected binding to the antigen-binding site of Bo2C11, which mimic thus a functional epitope on FVIII. These DARPins inhibited the binding of the antibody to its antigen and restored FVIII activity as determined in the Bethesda assay. Furthermore, the specific DARPins were able to recognize the target antibody in human plasma and could therefore be used to test for the presence of Bo2C11-like antibodies in a large set of hemophilia A patients. These data suggest, that our approach might be used to isolate epitopes from different sets of anti-FVIII antibodies in order to develop an ELISA-based screening assay allowing the distinction of inhibitory and non-inhibitory anti-FVIII antibodies according to their antibody signatures.	[Hausammann, Stefanie; Vogel, Monique; Stadler, Beda M.; Horn, Michael P.] Univ Bern, Inselspital, Univ Inst Immunol, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer] Univ Hosp Bern, Dept Hematol, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer] Univ Bern, Bern, Switzerland; [Lacroix-Desmazes, Sebastien] INSERM, UMR S 872, Les Cordeliers, France; [Lacroix-Desmazes, Sebastien] Univ Paris 06, UMR S 872, Les Cordeliers, France; [Lacroix-Desmazes, Sebastien] Univ Paris 05, UMR S 872, Les Cordeliers, France	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Horn, MP (corresponding author), Univ Bern, Inselspital, Univ Inst Immunol, CH-3010 Bern, Switzerland.	michael.horn@iib.unibe.ch	Hovinga, Johanna A Kremer/M-3482-2013	Hovinga, Johanna A Kremer/0000-0002-1300-7135; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447	Early Career Investigator Bayer Hemophilia Award	Early Career Investigator Bayer Hemophilia Award	The study was supported by the Early Career Investigator Bayer Hemophilia Award dedicated to Dr. M.P. Horn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz P, 2006, CELL BIOL LAB HDB; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Dazzi F, 1996, BRIT J HAEMATOL, V93, P688, DOI 10.1046/j.1365-2141.1996.d01-1705.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Ghosh K, 2009, CLIN REV ALLERG IMMU, V37, P58, DOI 10.1007/s12016-009-8118-1; Gilles JGG, 2004, BLOOD, V103, P2617, DOI 10.1182/blood-2003-07-2207; Gringeri A, 2003, BLOOD, V102, P2358, DOI 10.1182/blood-2003-03-0941; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Irigoyen MB, 2011, HAEMOPHILIA, V17, P267, DOI 10.1111/j.1365-2516.2010.02406.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; Klintman J, 2012, HAEMOPHILIA; Kopecky EM, 2006, J IMMUNOL METHODS, V308, P90, DOI 10.1016/j.jim.2005.10.016; Lavigne-Lissalde G, 2008, THROMB HAEMOSTASIS, V99, P1090, DOI 10.1160/TH07-08-0497; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Moreau A, 2000, BLOOD, V95, P3435, DOI 10.1182/blood.V95.11.3435.011k32_3435_3441; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Verbruggen B, 2011, J THROMB HAEMOST, V9, P2003, DOI 10.1111/j.1538-7836.2011.04479.x; Villard S, 2003, BLOOD, V102, P949, DOI 10.1182/blood-2002-06-1886; Vogel M, 2007, ANN NY ACAD SCI, V1109, P9, DOI 10.1196/annals.1398.002; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	26	6	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60688	10.1371/journal.pone.0060688	http://dx.doi.org/10.1371/journal.pone.0060688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626669	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400009
J	Liu, ME; Tsai, SJ; Chang, WC; Hsu, CH; Lu, T; Hung, KS; Chiu, WT; Chang, WP				Liu, Mu-En; Tsai, Shih-Jen; Chang, Wei-Chiao; Hsu, Chun-Hung; Lu, Ti; Hung, Kuo-Sheng; Chiu, Wen-Ta; Chang, Wei-Pin			Population-Based 5-Year Follow-Up Study in Taiwan of Dementia and Risk of Stroke	PLOS ONE			English	Article							CEREBROVASCULAR ACCIDENTS; ATYPICAL ANTIPSYCHOTICS; SYMPTOMS; EVENTS; RATES	Background: This study estimates the risk of stroke within 5 years of newly diagnosed dementia among elderly persons aged 65 and above. We examined the relationship between antipsychotic usage and development of stroke in patients with dementia. Methods: We conducted a nationwide 5-year population-based study using data retrieved from the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan. The study cohort comprised 2243 patients with dementia aged >= 65 years who had at least one inpatient service claim or at least 2 ambulatory care claims, whereas the comparison cohort consisted of 6714 randomly selected subjects (3 for every dementia patient) and were matched with the study group according to sex, age, and index year. We further classified dementia patients into 2 groups based on their history of antipsychotic usage. A total of 1450 patients were classified into the antipsychotic usage group and the remaining 793 patients were classified into the non-antipsychotic usage group. Cox proportional-hazards regressions were performed to compute the 5-year stroke-free survival rates after adjusting for potentially confounding factors. Results: The dementia patients have a 2-fold greater risk of developing stroke within 5 years of diagnosis compared to non-dementia age- and sex-matched subjects, after adjusting for other risk factors (95% confidence interval (CI) = 2.58-3.08; P<.001). Antipsychotic usage among patients with dementia increases risk of stroke 1.17-fold compared to patients without antipsychotic treatment (95% CI = 1.01-1.40; P<.05). Conclusions: Dementia may be an independent risk factor for stroke, and the use of antipsychotics may further increase the risk of stroke in dementia patients.	[Liu, Mu-En; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Phys, Kaohsiung, Taiwan; [Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Hsu, Chun-Hung; Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Med Ctr, Ctr Excellence Clin Trial & Res, Dept Neurosurg, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chang, WP (corresponding author), Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan.	wpchang@mail.ypu.edu.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council [100-2314-B-182-061-MY3]; Center of Excellence for Clinical Trials and Research in Neuroscience from the Department of Health, Taiwan [DOH101-TD-B-111-003]	National Science Council(Ministry of Science and Technology, Taiwan); Center of Excellence for Clinical Trials and Research in Neuroscience from the Department of Health, Taiwan	This study was supported by an National Science Council grant 100-2314-B-182-061-MY3, and also by a grant from the Center of Excellence for Clinical Trials and Research in Neuroscience from the Department of Health, Taiwan, DOH101-TD-B-111-003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett MJ, 2007, J CLIN PSYCHOPHARM, V27, P595, DOI 10.1097/jcp.0b013e31815a2531; Brass LM, 1997, STROKE, V28, P2382, DOI 10.1161/01.STR.28.12.2382; Chan MC, 2010, INT J GERIATR PSYCH, V25, P362, DOI 10.1002/gps.2347; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Ferrucci L, 1996, J AM GERIATR SOC, V44, P237; Fu C, 2004, ARCH PATHOL LAB MED, V128, P32; Harrison-Woolrych M, 2004, BRIT MED J, V328, P1416, DOI 10.1136/bmj.328.7453.1416; Herrmann N, 2005, CNS DRUGS, V19, P91, DOI 10.2165/00023210-200519020-00001; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Kuo RNC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-126; Layton D, 2005, J PSYCHOPHARMACOL, V19, P473, DOI 10.1177/0269881105056524; Lin HW, 2011, LANCET ONCOL, V12, P900, DOI 10.1016/S1470-2045(11)70165-6; Moroney JT, 1999, J AM GERIATR SOC, V47, P824, DOI 10.1111/j.1532-5415.1999.tb03839.x; Percudani M, 2005, J CLIN PSYCHOPHARM, V25, P468, DOI 10.1097/01.jcp.0000178414.14685.c4; Rockwood K, 1997, ARCH NEUROL-CHICAGO, V54, P33, DOI 10.1001/archneur.1997.00550130019010; Sahathevan R, 2012, INT J STROKE, V7, P61, DOI 10.1111/j.1747-4949.2011.00731.x; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Smith David A, 2004, J Am Med Dir Assoc, V5, P129, DOI 10.1097/01.JAM.0000113432.52383.E0; Valiyeva E, 2008, CAN MED ASSOC J, V179, P438, DOI 10.1503/cmaj.071540; Wallaschofski H, 2001, J CLIN ENDOCR METAB, V86, P5912, DOI 10.1210/jc.86.12.5912; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A; Wu CS, 2012, BIOL PSYCHI IN PRESS; Yong H, 2012, CARDIOL REV IN PRESS; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125; Zhu L, 2000, NEUROLOGY, V54, P2103, DOI 10.1212/WNL.54.11.2103; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	27	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61771	10.1371/journal.pone.0061771	http://dx.doi.org/10.1371/journal.pone.0061771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626726	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400090
J	Liu, QL; Zhao, CW; Su, SJ; Li, JJ; Xing, YM; Cheng, BW				Liu, Quanlong; Zhao, Chunwang; Su, Shaojian; Li, Jijun; Xing, Yongming; Cheng, Buwen			Strain Field Mapping of Dislocations in a Ge/Si Heterostructure	PLOS ONE			English	Article							GE FILMS; DISPLACEMENT; GROWTH	Ge/Si heterostructure with fully strain-relaxed Ge film was grown on a Si (001) substrate by using a two-step process by ultra-high vacuum chemical vapor deposition. The dislocations in the Ge/Si heterostructure were experimentally investigated by high-resolution transmission electron microscopy (HRTEM). The dislocations at the Ge/Si interface were identified to be 90 degrees full-edge dislocations, which are the most efficient way for obtaining a fully relaxed Ge film. The only defect found in the Ge epitaxial film was a 60 degrees dislocation. The nanoscale strain field of the dislocations was mapped by geometric phase analysis technique from the HRTEM image. The strain field around the edge component of the 60 degrees dislocation core was compared with those of the Peierls-Nabarro and Foreman dislocation models. Comparison results show that the Foreman model with a = 1.5 can describe appropriately the strain field around the edge component of a 60 degrees dislocation core in a relaxed Ge film on a Si substrate.	[Liu, Quanlong; Zhao, Chunwang; Li, Jijun; Xing, Yongming] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Peoples R China; [Su, Shaojian] Huaqiao Univ, Coll Informat Sci & Engn, Xiamen, Peoples R China; [Cheng, Buwen] Chinese Acad Sci, Inst Semicond, State Key Lab Integrated Optoelect, Beijing, Peoples R China	Inner Mongolia University of Technology; Huaqiao University; Chinese Academy of Sciences; Institute of Semiconductors, CAS	Zhao, CW (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Peoples R China.	zhaocw@imut.edu.cn	Zhao, Chunwang/E-5204-2013	Cheng, Buwen/0000-0002-6547-1458	National Natural Science Foundation of China [11062008, 11272142, 61036003]; Program for New Century Excellent Talents in University [NCET-10-0909]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China Nos. 11062008, 11272142 and 61036003. This work was also supported by the Program for New Century Excellent Talents in University No. NCET-10-0909, the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon D.J., 2011, INTRO DISLOCATIONS; Bharathan J, 2013, J ELECTRON MATER, V42, P40, DOI 10.1007/s11664-012-2337-6; Chung J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821843; FOREMAN AJ, 1951, P PHYS SOC LOND A, V64, P156, DOI 10.1088/0370-1298/64/2/307; Hajime H, 2011, APPL PHYS LETT, V98; HIRSCH PB, 1980, J MICROSC-OXFORD, V118, P3, DOI 10.1111/j.1365-2818.1980.tb00240.x; Hytch MJ, 2003, NATURE, V423, P270, DOI 10.1038/nature01638; Johnson CL, 2008, NAT MATER, V7, P120, DOI 10.1038/nmat2083; Kim TW, 2001, APPL PHYS LETT, V78, P1409, DOI 10.1063/1.1349866; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Miller R, 1998, J MECH PHYS SOLIDS, V46, P1845, DOI 10.1016/S0022-5096(98)00057-X; NABARRO FRN, 1947, P PHYS SOC LOND, V59, P256, DOI 10.1088/0959-5309/59/2/309; Nakamura Y, 2011, CRYST GROWTH DES, V11, P3301, DOI 10.1021/cg200609u; Narayan J, 2013, ACTA MATER, V61, P2703, DOI 10.1016/j.actamat.2012.09.070; Oh SH, 2009, NAT MATER, V8, P95, DOI [10.1038/NMAT2370, 10.1038/nmat2370]; Peierls R, 1940, P PHYS SOC, V52, P34, DOI 10.1088/0959-5309/52/1/305; Sakai A, 1997, APPL PHYS LETT, V71, P3510, DOI 10.1063/1.120375; Simoen E, 2008, MAT SCI SEMICON PROC, V11, P364, DOI 10.1016/j.mssp.2008.08.002; Snedecor G.W., 1989, AMES IOWA STATE U PR; Su SJ, 2011, ACTA PHYS SIN-CH ED, V60, DOI 10.7498/aps.60.028101; Wang H, 2007, INT J PLASTICITY, V23, P1540, DOI 10.1016/j.ijplas.2007.01.004; Warner JH, 2012, SCIENCE, V337, P209, DOI 10.1126/science.1217529; Yao YG, 1999, PHYS REV B, V59, P8232, DOI 10.1103/PhysRevB.59.8232; Zhao CW, 2008, ACTA MATER, V56, P2570, DOI 10.1016/j.actamat.2008.01.045; Zhao CW, 2008, CHIN OPT LETT, V6, P179; Zhao CW, 2012, SCI CHINA PHYS MECH, V55, P1088, DOI 10.1007/s11433-012-4729-2	26	8	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62672	10.1371/journal.pone.0062672	http://dx.doi.org/10.1371/journal.pone.0062672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626845	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400209
J	Matsumoto, A; Kanai, T; Mikami, Y; Chu, PS; Nakamoto, N; Ebinuma, H; Saito, H; Sato, T; Yagita, H; Hibi, T				Matsumoto, Atsuhiro; Kanai, Takanori; Mikami, Yohei; Chu, Po-Sung; Nakamoto, Nobuhiro; Ebinuma, Hirotoshi; Saito, Hidetsugu; Sato, Toshiro; Yagita, Hideo; Hibi, Toshifumi			IL-22-Producing ROR gamma t-Dependent Innate Lymphoid Cells Play a Novel Protective Role in Murine Acute Hepatitis	PLOS ONE			English	Article							ACUTE LIVER INFLAMMATION; CONCANAVALIN-A; INJURY; INTERLEUKIN-22; MICE; DIFFERENTIATION; HEPATOCYTES; LINEAGE; IL-22; MODEL	Retinoid-related orphan receptor (ROR) gamma t is known to be related to the development and function of various immunological compartments in the liver, such as Th17 cells, natural killer T (NKT) cells, and innate lymphoid cells (ILCs). We evaluated the roles of ROR gamma t-expressing cells in mouse acute hepatitis model using ROR gamma t deficient (ROR gamma t(-/-)) mice and RAG-2 and ROR gamma t double deficient (RAG-2(-/-) x ROR gamma t(-/-)) mice. Acute hepatitis was induced in mice by injection with carbon tetrachloride (CCl4), to investigate the regulation of liver inflammation by ROR gamma t-expressing cells. We detected RORC expression in three compartments, CD4(+) T cells, NKT cells, and lineage marker-negative SCA-1(+)Thy1(high) ILCs, of the liver of wild type (WT) mice. CCl4-treated ROR gamma t(-/-) mice developed liver damage in spite of lack of ROR gamma t-dependent cells, but with reduced infiltration of macrophages compared with WT mice. In this regard, ILCs were significantly decreased in RAG-2(-/-) x ROR gamma t(-/-) mice that lacked T and NKT cells. Surprisingly, RAG-2(-/-) x ROR gamma t(-/-) mice developed significantly severer CCl4-induced hepatitis compared with RAG-2(-/-) mice, in accordance with the fact that hepatic ILCs failed to produce IL-22. Lastly, anti-Thy1 monoclonal antibody (mAb), but not anti-NK1.1 mAb or anti-asialo GM1 Ab administration exacerbated liver damage in RAG-2(-/-) mice with the depletion of liver ILCs. Collectively, hepatic ROR gamma t-dependent ILCs play a part of protective roles in hepatic immune response in mice.	[Matsumoto, Atsuhiro; Kanai, Takanori; Mikami, Yohei; Chu, Po-Sung; Nakamoto, Nobuhiro; Ebinuma, Hirotoshi; Saito, Hidetsugu; Sato, Toshiro; Hibi, Toshifumi] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Mikami, Yohei] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Keio University; Keio University; Juntendo University	Kanai, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	takagast@sc.itc.keio.ac.jp; thibi@sc.itc.keio.ac.jp	MIKAMI, YOHEI/GRJ-8133-2022; Sato, Toshiro/J-3522-2014	MIKAMI, YOHEI/0000-0001-5104-4415; Sato, Toshiro/0000-0001-8353-8137; Chu, Po-sung/0000-0002-8687-2760; Kanai, Takanori/0000-0002-1466-4532	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health; Keio University	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health; Keio University	Grant-in-Aid for Scientific Research, Scientific Research on Priority Areas, Exploratory Research and Creative Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, (http://www.mext.go.jp/); Grant-in-Aid for Young Scientists from the Japanese Ministry of Health (http://www.mhlw.go.jp/) and Keio University Grant-in-Aid for Encouragement of Young Medical Scientists from Keio University ( http://www.keio.ac.jp/index-jp.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHELOT P, 1973, GUT, V14, P332, DOI 10.1136/gut.14.4.332; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Heneghan MA, 2002, HEPATOLOGY, V35, P7, DOI 10.1053/jhep.2002.30991; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Nakamoto N, 2012, GASTROENTEROLOGY, V142, P366, DOI 10.1053/j.gastro.2011.10.039; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Raczynski AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033099; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	31	22	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62853	10.1371/journal.pone.0062853	http://dx.doi.org/10.1371/journal.pone.0062853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626860	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400224
J	Piffer, L; Petrazzini, MEM; Agrillo, C				Piffer, Laura; Petrazzini, Maria Elena Miletto; Agrillo, Christian			Large Number Discrimination in Newborn Fish	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; QUANTITY DISCRIMINATION; NUMERICAL COMPETENCE; JUDGMENTS; MAGNITUDE; STIMULI; INFANTS; SPACE; COUNT; TIME	Quantitative abilities have been reported in a wide range of species, including fish. Recent studies have shown that adult guppies (Poecilia reticulata) can spontaneously select the larger number of conspecifics. In particular the evidence collected in literature suggest the existence of two distinct systems of number representation: a precise system up to 4 units, and an approximate system for larger numbers. Spontaneous numerical abilities, however, seem to be limited to 4 units at birth and it is currently unclear whether or not the large number system is absent during the first days of life. In the present study, we investigated whether newborn guppies can be trained to discriminate between large quantities. Subjects were required to discriminate between groups of dots with a 0.50 ratio (e.g., 7 vs. 14) in order to obtain a food reward. To dissociate the roles of number and continuous quantities that co-vary with numerical information (such as cumulative surface area, space and density), three different experiments were set up: in Exp. 1 number and continuous quantities were simultaneously available. In Exp. 2 we controlled for continuous quantities and only numerical information was available; in Exp. 3 numerical information was made irrelevant and only continuous quantities were available. Subjects successfully solved the tasks in Exp. 1 and 2, providing the first evidence of large number discrimination in newborn fish. No discrimination was found in experiment 3, meaning that number acuity is better than spatial acuity. A comparison with the onset of numerical abilities observed in shoal-choice tests suggests that training procedures can promote the development of numerical abilities in guppies.	[Piffer, Laura; Petrazzini, Maria Elena Miletto; Agrillo, Christian] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Piffer, L (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	laura.piffer@unipd.it	miletto petrazzini, maria elena/GSO-3842-2022	miletto petrazzini, maria elena/0000-0002-5204-5863; Agrillo, Christian/0000-0002-7391-8934	University of Padua [CPDA078534/07, GRIC101125]	University of Padua	This study was supported by the research grant "Progetto di Ateneo" (CPDA078534/07) and "Progetto Giovani Studiosi 2010" (prot.: GRIC101125) from the University of Padua to Christian Agrillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2012, Q J EXP PSYCHOL, V65, P2321, DOI 10.1080/17470218.2012.680895; Agrillo C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00483; Agrillo C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00181; Agrillo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031923; Agrillo C, 2012, BEHAV BRAIN RES, V230, P343, DOI 10.1016/j.bbr.2012.02.025; Agrillo C, 2011, COGNITION, V119, P281, DOI 10.1016/j.cognition.2010.10.022; Agrillo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015232; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Benson-Amram S, 2011, ANIM BEHAV, V82, P743, DOI 10.1016/j.anbehav.2011.07.004; Beran MJ, 2008, PLOS BIOL, V6, P221, DOI 10.1371/journal.pbio.0060019; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00357; Beran MJ, 2004, J COMP PSYCHOL, V118, P25, DOI 10.1037/0735-7036.118.1.25; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cohen Kadosh R, 2008, CEREB CORTEX, V22, P1420; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00065; Cutini S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00469; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Evans TA, 2012, ANIM COGN, V15, P539, DOI 10.1007/s10071-012-0482-1; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FU YX, 1992, BIOMETRICS, V48, P1103, DOI 10.2307/2532702; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P565, DOI 10.1007/s10071-011-0392-7; Harris EH, 2007, LEARN BEHAV, V35, P53; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Henik A, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00186; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jaakkola K, 2005, J COMP PSYCHOL, V119, P296, DOI 10.1037/0735-7036.119.3.296; Kilian A, 2003, LEARN BEHAV, V31, P133; KIMMEL HD, 1957, PSYCHOL BULL, V54, P351, DOI 10.1037/h0046737; Krusche P, 2010, J EXP BIOL, V213, P1822, DOI 10.1242/jeb.039297; Lickliter R, 2006, DEVELOPMENTAL SCI, V9, P604, DOI 10.1111/j.1467-7687.2006.00539.x; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Perdue BM, 2012, ANIM COGN, V15, P955, DOI 10.1007/s10071-012-0521-y; Petrazzini MEM, 2012, BEHAV BRAIN RES, V233, P443, DOI 10.1016/j.bbr.2012.05.044; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Sokal RR, 1995, BIOMETRY; Suanda SH, 2008, INFANCY, V13, P308, DOI 10.1080/15250000802188800; Turati C, 2012, COGNITIVE DEV, V28, P10; Vonk J, 2012, ANIM BEHAV, V84, P231, DOI 10.1016/j.anbehav.2012.05.001; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wilson ML, 2002, P ROY SOC B-BIOL SCI, V269, P1107, DOI 10.1098/rspb.2001.1926; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	52	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62466	10.1371/journal.pone.0062466	http://dx.doi.org/10.1371/journal.pone.0062466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626824	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400188
J	Tezuka, Y; Okada, M; Tada, Y; Yamauchi, J; Nishigori, H; Sanbe, A				Tezuka, Yu; Okada, Mizuki; Tada, Yuka; Yamauchi, Junji; Nishigori, Hideo; Sanbe, Atsushi			Regulation of Neurite Growth by Inorganic Pyrophosphatase 1 via JNK Dephosphorylation	PLOS ONE			English	Article							STABILIZER VALPROIC ACID; DESMIN-RELATED CARDIOMYOPATHY; SIGNAL-TRANSDUCTION; RHO GTPASES; OUTGROWTH; PROTEIN; PAXILLIN; PATHWAY; GENE; KINASES	Neural cell differentiation during development is controlled by multiple signaling pathways, in which protein phosphorylation and dephosphorylation play an important role. In this study, we examined the role of pyrophosphatase1 (PPA1) in neuronal differentiation using the loss and gain of function analysis. Neuronal differentiation induced by external factors was studied using a mouse neuroblastoma cell line (N1E115). The neuronal like differentiation in N1E115 cells was determined by morphological analysis based on neurite growth length. In order to analyze the loss of the PPA1 function in N1E115, si-RNA specifically targeting PPA1 was generated. To study the effect of PPA1 overexpression, an adenoviral gene vector containing the PPA1 gene was utilized to infect N1E115 cells. To address the need for pyrophosphatase activity in PPA1, D117A PPA1, which has inactive pyrophosphatase, was overexpressed in N1E115 cells. We used valproic acid (VPA) as a neuronal differentiator to examine the effect of PPA1 in actively differentiated N1E115 cells. Si-PPA1 treatment reduced the PPA1 protein level and led to enhanced neurite growth in N1E115 cells. In contrast, PPA1 overexpression suppressed neurite growth in N1E115 cells treated with VPA, whereas this effect was abolished in D117A PPA1. PPA1 knockdown enhanced the JNK phosphorylation level, and PPA1 overexpression suppressed it in N1E115 cells. It seems that recombinant PPA1 can dephosphorylate JNK while no alteration of JNK phosphorylation level was seen after treatment with recombinant PPA1 D117A. Enhanced neurite growth by PPA1 knockdown was also observed in rat cortical neurons. Thus, PPA1 may play a role in neuronal differentiation via JNK dephosphorylation.	[Tezuka, Yu; Okada, Mizuki; Tada, Yuka; Nishigori, Hideo; Sanbe, Atsushi] Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, Morioka, Iwate, Japan; [Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan	Iwate Medical University; National Center for Child Health & Development - Japan	Sanbe, A (corresponding author), Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, Morioka, Iwate, Japan.	asanbe@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	This work was supported in part by research grants from the Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Astellas Foundation for Research on Metabolic Disorders, the Mitsubishi Pharma Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and The Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Curbo S, 2006, GENOMICS, V87, P410, DOI 10.1016/j.ygeno.2005.09.017; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Einat H, 2003, J NEUROSCI, V23, P7311; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Hafner A, 2012, BIOCHEM J, V443, P439, DOI 10.1042/BJ20111351; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hwangpo TA, 2012, J BIOL CHEM, V287, P13674, DOI 10.1074/jbc.M111.320705; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mizutani R, 2012, J NEUROSCI RES, V90, P721, DOI 10.1002/jnr.22795; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Sanbe A, 2009, N-S ARCH PHARMACOL, V380, P569, DOI 10.1007/s00210-009-0455-3; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Sinner DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039787; Tuominen V, 1998, J MOL BIOL, V284, P1565, DOI 10.1006/jmbi.1998.2266; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Yamauchi J, 2008, EXP CELL RES, V314, P2279, DOI 10.1016/j.yexcr.2008.03.019; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yamauchi J, 2011, J NEUROSCI, V31, P12579, DOI 10.1523/JNEUROSCI.2738-11.2011; Yamauchi J, 2010, J NEUROSCI RES, V88, P3189, DOI 10.1002/jnr.22460; YANG ZH, 1992, J BIOL CHEM, V267, P24641; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zatelli MC, 2005, ENDOCRINOLOGY, V146, P2692, DOI 10.1210/en.2005-0001	38	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61649	10.1371/journal.pone.0061649	http://dx.doi.org/10.1371/journal.pone.0061649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626709	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400073
J	Valenchon, M; Levy, F; Prunier, A; Moussu, C; Calandreau, L; Lansade, L				Valenchon, Mathilde; Levy, Frederic; Prunier, Armelle; Moussu, Chantal; Calandreau, Ludovic; Lansade, Lea			Stress Modulates Instrumental Learning Performances in Horses (Equus caballus) in Interaction with Temperament	PLOS ONE			English	Article							PREDATOR STRESS; MEMORY; FEAR; RESPONSES; BEHAVIOR; TRAIT; TIME; CONSOLIDATION; REACTIVITY; RETRIEVAL	The present study investigates how the temperament of the animal affects the influence of acute stress on the acquisition and reacquisition processes of a learning task. After temperament was assessed, horses were subjected to a stressor before or after the acquisition session of an instrumental task. Eight days later, horses were subjected to a reacquisition session without any stressor. Stress before acquisition tended to enhance the number of successes at the beginning of the acquisition session. Eight days later, during the reacquisition session, contrary to non-stressed animals, horses stressed after acquisition, and, to a lesser extent, horses stressed before acquisition, did not improve their performance between acquisition and reacquisition sessions. Temperament influenced learning performances in stressed horses only. Particularly, locomotor activity improved performances whereas fearfulness impaired them under stressful conditions. Results suggest that direct exposure to a stressor tended to increase acquisition performances, whereas a state of stress induced by the memory of a stressor, because it has been previously associated with the learning context, impaired reacquisition performances. The negative effect of a state of stress on reacquisition performances appeared to be stronger when exposure to the stressor occurred after rather than before the acquisition session. Temperament had an impact on both acquisition and reacquisition processes, but under stressful conditions only. These results suggest that stress is necessary to reveal the influence of temperament on cognitive performances.	[Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Calandreau, Ludovic; Lansade, Lea] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Calandreau, Ludovic; Lansade, Lea] CNRS, Physiol Reprod & Comportements UMR7247, Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Calandreau, Ludovic; Lansade, Lea] Univ Tours, Tours, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Calandreau, Ludovic; Lansade, Lea] IFCE, Nouzilly, France; [Prunier, Armelle] INRA, PEGASE UMR1348, St Gilles, France; [Prunier, Armelle] Agrocampus Ouest, PEGASE UMR1348, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; Institut Agro; Agrocampus Ouest	Lansade, L (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	lea.lansade@tours.inra.fr		Valenchon, Mathilde/0000-0003-0226-8433	COST of the "Institut Francais du Cheval et de l'Equitation"; Region Centre	COST of the "Institut Francais du Cheval et de l'Equitation"; Region Centre(Region Centre-Val de Loire)	This research has been supported by the COST of the "Institut Francais du Cheval et de l'Equitation" (http://www.haras-nationaux.fr/mieux-nousconnaitre/la-recherche-equine/le-comite-dorientation-scientifique-et-technique-cost.html) and the "Region Centre" (http://www.regioncentre.fr/accueil.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, BEHAV ANAL LEARNING; Arbonnier P., 1966, ANN SCI FORESTI RES, V23, P949; Barnet RC, 1996, J EXP PSYCHOL ANIM B, V22, P279; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Cazakoff BN, 2010, PROG NEURO-PSYCHOPH, V34, P733, DOI 10.1016/j.pnpbp.2010.04.002; Coutellier L, 2008, PHYSIOL BEHAV, V94, P393, DOI 10.1016/j.physbeh.2008.02.006; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; DUKAS R, 1995, ANIM BEHAV, V49, P1259, DOI 10.1006/anbe.1995.0158; Faure JM, 2003, HORM BEHAV, V43, P568, DOI 10.1016/S0018-506X(03)00062-X; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Harewood EJ, 2005, J EQUINE VET SCI, V25, P164, DOI 10.1016/j.jevs.2005.03.008; Hay M, 2004, ANIM WELFARE, V13, P27; HETH CD, 1976, J EXP PSYCHOL ANIM B, V2, P117, DOI 10.1037/0097-7403.2.2.117; Janitzky K, 2011, BEHAV BRAIN RES, V219, P142, DOI 10.1016/j.bbr.2010.12.032; Jiao XL, 2011, BEHAV BRAIN RES, V221, P98, DOI 10.1016/j.bbr.2011.02.029; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Jongman EC, 2005, APPL ANIM BEHAV SCI, V93, P147, DOI 10.1016/j.applanim.2004.12.005; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; KEINAN G, 1987, J PERS SOC PSYCHOL, V52, P639, DOI 10.1037/0022-3514.52.3.639; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; McDonnell SM, 2002, APPL ANIM BEHAV SCI, V78, P263, DOI 10.1016/S0168-1591(02)00112-0; McKinley J, 2000, ANIM COGN, V3, P13, DOI 10.1007/s100710050046; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Moons CPH, 2005, APPL ANIM BEHAV SCI, V91, P321, DOI 10.1016/j.applanim.2004.10.007; Nicol CJ, 2002, APPL ANIM BEHAV SCI, V78, P193, DOI 10.1016/S0168-1591(02)00093-X; Parasuraman R., 1984, VARIETIES ATTENTION, P243; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; Peeters M, 2011, EQUINE VET J, V43, P487, DOI 10.1111/j.2042-3306.2010.00294.x; Proops L, 2010, ANIM BEHAV, V79, P1205, DOI 10.1016/j.anbehav.2010.02.015; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Schmidt A, 2010, DOMEST ANIM ENDOCRIN, V38, P179, DOI 10.1016/j.domaniend.2009.10.002; Schmidt A, 2010, HORM BEHAV, V57, P209, DOI 10.1016/j.yhbeh.2009.11.003; Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; Visser EK, 2003, EQUINE VET J, V35, P176, DOI 10.2746/042516403776114108; Whistance LK, 2009, APPL ANIM BEHAV SCI, V117, P128, DOI 10.1016/j.applanim.2009.01.004; Williams JL, 2004, APPL ANIM BEHAV SCI, V88, P331, DOI 10.1016/j.applanim.2004.03.008; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5; Woodson JC, 2003, LEARN MEMORY, V10, P326, DOI 10.1101/lm.62903; Youngblood BD, 1997, PHYSIOL BEHAV, V62, P827, DOI 10.1016/S0031-9384(97)00245-X; Zoladz PR, 2011, PHYSIOL BEHAV, V103, P467, DOI 10.1016/j.physbeh.2011.01.016	47	29	30	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62324	10.1371/journal.pone.0062324	http://dx.doi.org/10.1371/journal.pone.0062324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626801	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400165
J	Zhang, CJ; Ouyang, B; Yang, CX; Zhang, XH; Liu, H; Zhang, YY; Zhang, JH; Li, HX; Ye, ZB				Zhang, Chanjuan; Ouyang, Bo; Yang, Changxian; Zhang, Xiaohui; Liu, Hui; Zhang, Yuyang; Zhang, Junhong; Li, Hanxia; Ye, Zhibiao			Reducing AsA Leads to Leaf Lesion and Defence Response in Knock-Down of the AsA Biosynthetic Enzyme GDP-D-Mannose Pyrophosphorylase Gene in Tomato Plant	PLOS ONE			English	Article							ASCORBIC-ACID CONTENT; L-GALACTOSE GUANYLTRANSFERASE; ACEROLA MALPIGHIA-GLABRA; VITAMIN-C; HYPERSENSITIVE RESPONSE; DISEASE RESISTANCE; OXIDATIVE STRESS; OVER-EXPRESSION; PR PROTEINS; CELL-DEATH	As a vital antioxidant, L-ascorbic acid (AsA) affects diverse biological processes in higher plants. Lack of AsA in cell impairs plant development. In the present study, we manipulated a gene of GDP-mannose pyrophosphorylase which catalyzes the conversion of D-mannose-1-P to GDP-D-mannose in AsA biosynthetic pathway and found out the phenotype alteration of tomato. In the tomato genome, there are four members of GMP gene family and they constitutively expressed in various tissues in distinct expression patterns. As expected, over-expression of SlGMP3 increased total AsA contents and enhanced the tolerance to oxidative stress in tomato. On the contrary, knock-down of SlGMP3 significantly decreased AsA contents below the threshold level and altered the phenotype of tomato plants with lesions and further senescence. Further analysis indicated the causes for this symptom could result from failing to instantly deplete the reactive oxygen species (ROS) as decline of free radical scavenging activity. More ROS accumulated in the leaves and then triggered expressions of defence-related genes and mimic symptom occurred on the leaves similar to hypersensitive responses against pathogens. Consequently, the photosynthesis of leaves was dramatically fallen. These results suggested the vital roles of AsA as an antioxidant in leaf function and defence response of tomato.	[Zhang, Chanjuan; Ouyang, Bo; Yang, Changxian; Zhang, Xiaohui; Liu, Hui; Zhang, Yuyang; Zhang, Junhong; Li, Hanxia; Ye, Zhibiao] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Ye, ZB (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	zbye@mail.hzau.edu.cn		Liu, Hui/0000-0002-4548-2002	National Basic Research Program of China [2011CB100600]; National Natural Science Foundation of China [31230064]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 2011CB100600), and the National Natural Science Foundation of China (No. 31230064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Badejo AA, 2008, PLANT CELL PHYSIOL, V49, P126, DOI 10.1093/pcp/pcm164; Badejo AA, 2007, PLANT PHYSIOL BIOCH, V45, P665, DOI 10.1016/j.plaphy.2007.07.003; Badejo AA, 2012, J EXP BOT, V63, P229, DOI 10.1093/jxb/err275; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Chamnongpol S, 1998, P NATL ACAD SCI USA, V95, P5818, DOI 10.1073/pnas.95.10.5818; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Cronje C, 2012, PLANTA, V235, P553, DOI 10.1007/s00425-011-1525-6; Di Matteo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-163; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; JOOSTEN MHAJ, 1990, PLANT PHYSIOL, V94, P585, DOI 10.1104/pp.94.2.585; Keller R, 1999, PLANT J, V19, P131, DOI 10.1046/j.1365-313X.1999.00507.x; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; LINTHORST HJM, 1991, MOL PLANT MICROBE IN, V4, P586, DOI 10.1094/MPMI-4-586; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Massot C, 2012, PLANTA, V235, P153, DOI 10.1007/s00425-011-1493-x; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; RIZZOLO A, 1984, FOOD CHEM, V14, P189, DOI 10.1016/0308-8146(84)90058-X; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; Stevens R, 2007, PLANT PHYSIOL, V143, P1943, DOI 10.1104/pp.106.091413; Takahashi H, 1997, PLANT J, V11, P993, DOI 10.1046/j.1365-313X.1997.11050993.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wang HH, 2011, PLANT CELL REP, V30, P2037, DOI 10.1007/s00299-011-1111-1; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Weymann K, 1995, PLANT CELL, V7, P2013, DOI 10.1105/tpc.7.12.2013; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zou Li-Ping, 2006, Acta Genetica Sinica, V33, P757, DOI 10.1016/S0379-4172(06)60108-X; Zou LP, 2006, PLANT SCI, V170, P120, DOI 10.1016/j.plantsci.2005.08.009	49	19	21	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61987	10.1371/journal.pone.0061987	http://dx.doi.org/10.1371/journal.pone.0061987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626761	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400125
J	Jessen, C; Lizcano, JFV; Bayer, T; Roder, C; Aranda, M; Wild, C; Voolstra, CR				Jessen, Christian; Lizcano, Javier Felipe Villa; Bayer, Till; Roder, Cornelia; Aranda, Manuel; Wild, Christian; Voolstra, Christian R.			In-situ Effects of Eutrophication and Overfishing on Physiology and Bacterial Diversity of the Red Sea Coral Acropora hemprichii	PLOS ONE			English	Article							NUTRIENT ENRICHMENT; CLIMATE-CHANGE; METAGENOMIC ANALYSIS; MICROBIAL COMMUNITY; NITROGEN-FIXATION; REEF CORALS; GEN. NOV.; PHOSPHORUS; ASSOCIATIONS; RESILIENCE	Coral reefs of the Central Red Sea display a high degree of endemism, and are increasingly threatened by anthropogenic effects due to intense local coastal development measures. Overfishing and eutrophication are among the most significant local pressures on these reefs, but there is no information available about their potential effects on the associated microbial community. Therefore, we compared holobiont physiology and 16S-based bacterial communities of tissue and mucus of the hard coral Acropora hemprichii after 1 and 16 weeks of in-situ inorganic nutrient enrichment (via fertilizer diffusion) and/or herbivore exclusion (via caging) in an offshore reef of the Central Red Sea. Simulated eutrophication and/or overfishing treatments did not affect coral physiology with respect to coral respiration rates, chlorophyll a content, zooxanthellae abundance, or delta N-15 isotopic signatures. The bacterial community of A. hemprichii was rich and uneven, and diversity increased over time in all treatments. While distinct bacterial species were identified as a consequence of eutrophication, overfishing, or both, two bacterial species that could be classified to the genus Endozoicomonas were consistently abundant and constituted two thirds of bacteria in the coral. Several nitrogen-fixing and denitrifying bacteria were found in the coral specimens that were exposed to experimentally increased nutrients. However, no particular bacterial species was consistently associated with the coral under a given treatment and the single effects of manipulated eutrophication and overfishing could not predict the combined effect. Our data underlines the importance of conducting field studies in a holobiont framework, taking both, physiological and molecular measures into account.	[Jessen, Christian; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Lizcano, Javier Felipe Villa; Bayer, Till; Roder, Cornelia; Aranda, Manuel; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); King Abdullah University of Science & Technology; University of Bremen	Voolstra, CR (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa	Aranda Lastra, Manuel/D-9530-2011; Voolstra, Christian R/H-7158-2014; Bayer, Till/H-6826-2016	Aranda Lastra, Manuel/0000-0001-6673-016X; Voolstra, Christian R/0000-0003-4555-3795; Bayer, Till/0000-0002-4704-2449; Roder, Cornelia/0000-0003-1074-2473				Aminot A, 2001, WATER RES, V35, P1777, DOI 10.1016/S0043-1354(00)00429-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Bayer T, 2013, MARINE ECOLOGY PROGR; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke L., 2011, REEFS RISK REVISITED; Ceh J, 2011, FEMS MICROBIOL ECOL, V75, P134, DOI 10.1111/j.1574-6941.2010.00986.x; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; DEVEREUX R, 1990, J BACTERIOL, V172, P3609, DOI 10.1128/jb.172.7.3609-3619.1990; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fernandes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027387; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Fritsche K, 1999, SYST APPL MICROBIOL, V22, P197, DOI 10.1016/S0723-2020(99)80066-6; Garrity G.M., 2004, BERGEYS MANUAL SYSTE; Goffredi SK, 2010, ENVIRON MICROBIOL, V12, P344, DOI 10.1111/j.1462-2920.2009.02072.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grasshoff K, 1999, METHODS SEAWATER ANA; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Jessen C, 2012, P 12 INT COR REEF S; KINSEY DW, 1979, LIMNOL OCEANOGR, V24, P935, DOI 10.4319/lo.1979.24.5.0935; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Loya Y, 2004, MAR POLLUT BULL, V49, P344, DOI 10.1016/j.marpolbul.2004.06.011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McClanahan TR, 2004, MAR POLLUT BULL, V48, P196, DOI 10.1016/j.marpolbul.2003.10.004; McClanahan TR, 2002, MAR POLLUT BULL, V44, P441, DOI 10.1016/S0025-326X(02)00051-6; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Muscatine L., 1994, Pacific Science, V48, P304; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; ONEIL JM, 1989, MAR ECOL PROG SER, V56, P145, DOI 10.3354/meps056145; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R. D. C. Team, 2012, R LANG ENV STAT COMP; Rao AMF, 2012, J COASTAL RES, V28, P477, DOI 10.2112/JCOASTRES-D-11-00057.1; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sohm JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048315; Speck Mark D., 2012, Journal of Marine Biology, P1; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; WILD C, 2009, P 11 INT COR REEF S, P1319; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilkinson C, 2008, STATUS CORAL REEFS W; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07; Xiao Ji-bo, 2012, Yingyong Shengtai Xuebao, V23, P1979; Zielinski FU, 2009, ENVIRON MICROBIOL, V11, P1150, DOI 10.1111/j.1462-2920.2008.01847.x	93	85	85	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62091	10.1371/journal.pone.0062091	http://dx.doi.org/10.1371/journal.pone.0062091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630625	Green Published, gold			2022-12-25	WOS:000317911500080
J	Li, H; Shao, RF; Song, F; Zhou, XG; Yang, QQ; Li, ZH; Cai, WZ				Li, Hu; Shao, Renfu; Song, Fan; Zhou, Xuguo; Yang, Qianqian; Li, Zhihong; Cai, Wanzhi			Mitochondrial Genomes of Two Barklice, Psococerastis albimaculata and Longivalvus hyalospilus (Psocoptera: Psocomorpha): Contrasting Rates in Mitochondrial Gene Rearrangement between Major Lineages of Psocodea	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MULTIPLE ORIGINS; LICE INSECTA; WEB SERVER; EVOLUTION; PHTHIRAPTERA; ALIGNMENT; CLASSIFICATION; RECOMBINATION; REPLICATION	The superorder Psocodea has similar to 10,000 described species in two orders: Psocoptera (barklice and booklice) and Phthiraptera (parasitic lice). One booklouse, Liposcelis bostrychophila and six species of parasitic lice have been sequenced for complete mitochondrial (mt) genomes; these seven species have the most rearranged mt genomes seen in insects. The mt genome of a barklouse, lepidopsocid sp., has also been sequenced and is much less rearranged than those of the booklouse and the parasitic lice. To further understand mt gene rearrangements in the Psocodea, we sequenced the mt genomes of two barklice, Psococerastis albimaculata and Longivalvus hyalospilus, the first representatives from the suborder Psocomorpha, which is the most species-rich suborder of the Psocodea. We found that these two barklice have the least rearranged mt genomes seen in the Psocodea to date: a protein-coding gene (nad3) and five tRNAs (trnN, trnS1, trnE, trnM and trnC) have translocated. Rearrangements of mt genes in these two barklice can be accounted for by two events of tandem duplication followed by random deletions. Phylogenetic analyses of the mt genome sequences support the view that Psocoptera is paraphyletic whereas Phthiraptera is monophyletic. The booklouse, L. bostrychophila (suborder Troctomorpha) is most closely related to the parasitic lice. The barklice (suborders Trogiomorpha and Psocomorpha) are closely related and form a monophyletic group. We conclude that mt gene rearrangement has been substantially faster in the lineage leading to the booklice and the parasitic lice than in the lineage leading to the barklice. Lifestyle change appears to be associated with the contrasting rates in mt gene rearrangements between the two lineages of the Psocodea.	[Li, Hu; Song, Fan; Yang, Qianqian; Li, Zhihong; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Shao, Renfu] Univ Sunshine Coast, GeneCol Res Ctr, Fac Sci Educ & Engn, Maroochydore, Qld, Australia; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; University of the Sunshine Coast; University of Kentucky	Shao, RF (corresponding author), Univ Sunshine Coast, GeneCol Res Ctr, Fac Sci Educ & Engn, Maroochydore, Qld, Australia.	rshao@usc.edu.au; caiwz@cau.edu.cn	li, hu/N-7159-2013	Shao, Renfu/0000-0002-1686-4968	National Natural Science Foundation of China [30825006, 31061160186, 31111140015]; Natural Science Foundation of Beijing [6112013]; Australian Research Council [DP120100240]; Australian Government (Australia-China Science & Research Fund Group Mission grant) [ACSRF00980]; College of Agriculture, University of Kentucky	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Australian Research Council(Australian Research Council); Australian Government (Australia-China Science & Research Fund Group Mission grant)(Australian Government); College of Agriculture, University of Kentucky	This research is supported by grants from the National Natural Science Foundation of China (Nos. 30825006, 31061160186, 31111140015), the Natural Science Foundation of Beijing (No. 6112013) to Wanzhi Cai; the Australian Research Council (DP120100240), the Australian Government (Australia-China Science & Research Fund Group Mission grant ACSRF00980) to Renfu Shao; and College of Agriculture, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker SC, 2003, ZOOL SCR, V32, P407, DOI 10.1046/j.1463-6409.2003.00120.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; Clay T., 1970, Bull. Br. Mus. nat. Hist. (Ent.), V25, P73; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Haruyama N, 2011, MOL BIOL REP, V38, P3367, DOI 10.1007/s11033-010-0444-0; Hennig W., 1966, P263; HOPKINS GHE, 1949, P ZOOL SOC LOND, V119, P387; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jamieson B.G.M., 1999, INSECTS THEIR SPERMA; Johnson KP, 2004, P ROY SOC B-BIOL SCI, V271, P1771, DOI 10.1098/rspb.2004.2798; Johnson KP, 2003, SYST ENTOMOL, V28, P409, DOI 10.1046/j.1365-3113.2003.00220.x; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lee W, 2009, MOL CELLS, V28, P155, DOI 10.1007/s10059-009-0125-9; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Lienhard C, 2002, PSOCOPTERA WORLD CAT; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; MOCKFORD EL, 1967, P ENTOMOL SOC WASH, V69, P307; MORITZ C, 1986, SCIENCE, V233, P1425, DOI 10.1126/science.3018925; Murrell A, 2005, PARASITOL RES, V97, P274, DOI 10.1007/s00436-005-1413-8; Pearman J. V., 1960, Entomologist London, V93, P246; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D., 2007, BIOINFORMATICS, V24, P1104; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yoshizawa K, 2006, SYST ENTOMOL, V31, P350, DOI 10.1111/j.1365-3113.2005.00323.x; Yoshizawa K, 2003, MOL PHYLOGENET EVOL, V29, P102, DOI 10.1016/S1055-7903(03)00073-3; Yoshizawa K, 2002, ZOOL J LINN SOC-LOND, V136, P371, DOI 10.1046/j.1096-3642.2002.00036.x; Yoshizawa K, 2010, ARTHROPOD SYST PHYLO, V68, P181; Yoshizawa K, 2010, MOL PHYLOGENET EVOL, V55, P939, DOI 10.1016/j.ympev.2010.02.026; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61685	10.1371/journal.pone.0061685	http://dx.doi.org/10.1371/journal.pone.0061685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630609	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500060
J	Stettner, GM; Lei, YL; Herr, KB; Kubin, L				Stettner, Georg M.; Lei, Yanlin; Herr, Kate Benincasa; Kubin, Leszek			Evidence That Adrenergic Ventrolateral Medullary Cells Are Activated whereas Precerebellar Lateral Reticular Nucleus Neurons Are Suppressed during REM Sleep	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; FREELY MOVING CATS; LATERODORSAL TEGMENTAL NUCLEUS; SYMPATHETIC-NERVE ACTIVITY; LOCUS-COERULEUS NEURONS; HYPOGLOSSAL MOTONEURONAL ACTIVITY; SPINOCEREBELLAR TRACT NEURONS; TRIGEMINAL SENSORY NEURONS; CARBACHOL-INDUCED ATONIA; DORSAL RAPHE NEURONS	Rapid eye movement sleep (REMS) is generated in the brainstem by a distributed network of neurochemically distinct neurons. In the pons, the main subtypes are cholinergic and glutamatergic REMS-on cells and aminergic REMS-off cells. Pontine REMS-on cells send axons to the ventrolateral medulla (VLM), but little is known about REMS-related activity of VLM cells. In urethane-anesthetized rats, dorsomedial pontine injections of carbachol trigger REMS-like episodes that include cortical and hippocampal activation and suppression of motoneuronal activity; the episodes last 4-8 min and can be elicited repeatedly. We used this model to determine whether VLM catecholaminergic cells are silenced during REMS, as is typical of most aminergic neurons studied to date, and to investigate other REMS-related cells in this region. In 18 anesthetized, paralyzed and artificially ventilated rats, we obtained extracellular recordings from VLM cells when REMS-like episodes were elicited by pontine carbachol injections (10 mM, 10 nl). One major group were the cells that were activated during the episodes (n = 10). Their baseline firing rate of 3.7 +/- 2.1 (SD) Hz increased to 9.7 +/- 2.1 Hz. Most were found in the adrenergic C1 region and at sites located less than 50 mu m from dopamine beta-hydroxylase-positive (DBH+) neurons. Another major group were the silenced or suppressed cells (n = 35). Most were localized in the lateral reticular nucleus (LRN) and distantly from any DBH+ cells. Their baseline firing rates were 6.8 +/- 4.4 Hz and 15.8 +/- 7.1 Hz, respectively, with the activity of the latter reduced to 7.4 +/- 3.8 Hz. We conclude that, in contrast to the pontine noradrenergic cells that are silenced during REMS, medullary adrenergic C1 neurons, many of which drive the sympathetic output, are activated. Our data also show that afferent input transmitted to the cerebellum through the LRN is attenuated during REMS. This may distort the spatial representation of body position during REMS.	[Stettner, Georg M.; Lei, Yanlin; Herr, Kate Benincasa; Kubin, Leszek] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kubin, L (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	lkubin@vet.upenn.edu	Stettner, Georg/J-6989-2019	Stettner, Georg M./0000-0002-0906-8816	United States National Institutes of Health (NIH) [HL-047600]; Deutsche Forschungsgemeinschaft fellowship DFG [Ste1899/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047600] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft fellowship DFG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support was provided by United States National Institutes of Health (NIH) grant HL-047600 and Deutsche Forschungsgemeinschaft fellowship DFG Ste1899/1-1 to GMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SB, 2012, J PHYSIOL-LONDON, V590, P2897, DOI 10.1113/jphysiol.2012.232157; Abbott SBG, 2009, J PHYSIOL-LONDON, V587, P5613, DOI 10.1113/jphysiol.2009.177535; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; AGHAJANIAN GK, 1982, J NEUROSCI, V2, P1786; Alam MN, 2005, J PHYSIOL-LONDON, V563, P569, DOI 10.1113/jphysiol.2004.076927; Arnulf I, 2011, ARCH ITAL BIOL, V149, P367, DOI 10.4449/aib.v149i4.1246; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BADOER E, 1994, BRAIN RES, V657, P258, DOI 10.1016/0006-8993(94)90975-X; Bland BH, 1998, NEUROSCI BIOBEHAV R, V22, P259, DOI 10.1016/S0149-7634(97)00013-4; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Bourgin P, 2000, J NEUROSCI, V20, P7760; BOURGIN P, 1995, NEUROREPORT, V6, P532, DOI 10.1097/00001756-199502000-00031; Braak H, 2003, NEUROPATH APPL NEURO, V29, P60, DOI 10.1046/j.1365-2990.2003.00432.x; Brooks PL, 2008, J NEUROSCI, V28, P3535, DOI 10.1523/JNEUROSCI.5023-07.2008; BROWN DL, 1984, AM J PHYSIOL, V247, P1009, DOI 10.1152/ajpregu.1984.247.6.R1009; BROWN DL, 1985, CIRC RES, V56, P359; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; CAIRNS BE, 1995, J NEUROPHYSIOL, V73, P2486, DOI 10.1152/jn.1995.73.6.2486; Cairns BE, 1996, J NEUROPHYSIOL, V75, P1152, DOI 10.1152/jn.1996.75.3.1152; Card JP, 2006, J COMP NEUROL, V499, P840, DOI 10.1002/cne.21140; CARLI G, 1967, PFLUG ARCH GES PHYS, V298, P163, DOI 10.1007/BF00364697; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CESPUGLIO R, 1981, NEUROSCI LETT, V24, P133, DOI 10.1016/0304-3940(81)90236-6; Chan E, 2006, AM J RESP CRIT CARE, V174, P1264, DOI 10.1164/rccm.200605-597OC; Dampney RAL, 2003, CELL MOL NEUROBIOL, V23, P597, DOI 10.1023/A:1025080314925; Dharani NE, 2005, MED HYPOTHESES, V65, P83, DOI 10.1016/j.mehy.2005.01.033; DUN NJ, 1993, BRAIN RES, V608, P223, DOI 10.1016/0006-8993(93)91462-2; EKEROT CF, 1990, EXP BRAIN RES, V79, P109, DOI 10.1007/BF00228879; ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908; Ezure K, 1997, EXP BRAIN RES, V113, P230, DOI 10.1007/BF02450321; Fenik V, 2004, ARCH ITAL BIOL, V142, P237; Fenik V, 2002, J APPL PHYSIOL, V93, P1448, DOI 10.1152/japplphysiol.00225.2002; Fenik V, 2001, J NEUROSCI METH, V106, P147, DOI 10.1016/S0165-0270(01)00340-5; Fenik VB, 2005, J SLEEP RES, V14, P419, DOI 10.1111/j.1365-2869.2005.00461.x; Fenik VB, 2005, AM J RESP CRIT CARE, V172, P1322, DOI 10.1164/rccm.200412-1750OC; Fenik VB, 2009, J SLEEP RES, V18, P99, DOI 10.1111/j.1365-2869.2008.00687.x; Garifoli A, 2006, ARCH ITAL BIOL, V144, P145; GNADT JW, 1986, BRAIN RES, V384, P29, DOI 10.1016/0006-8993(86)91216-3; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hanak Viktor, 2011, Handb Clin Neurol, V98, P315, DOI 10.1016/B978-0-444-52006-7.00019-8; HEYM J, 1982, BRAIN RES, V251, P259, DOI 10.1016/0006-8993(82)90743-0; HUANGFU DH, 1992, BRAIN RES, V598, P67, DOI 10.1016/0006-8993(92)90169-A; Iranzo A, 2009, SLEEP MED REV, V13, P385, DOI 10.1016/j.smrv.2008.11.003; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; JANSS AJ, 1988, BRAIN RES, V440, P109, DOI 10.1016/0006-8993(88)91163-8; JOUVET M, 1962, Arch Ital Biol, V100, P125; KALIA M, 1985, J COMP NEUROL, V233, P333, DOI 10.1002/cne.902330304; KANAMORI N, 1980, BRAIN RES, V189, P251, DOI 10.1016/0006-8993(80)90024-4; KANJHAN R, 1995, BRAIN RES, V699, P19, DOI 10.1016/0006-8993(95)00814-7; KAYAMA Y, 1987, NEUROSCI LETT, V77, P277, DOI 10.1016/0304-3940(87)90512-X; KIMURA H, 1990, J APPL PHYSIOL, V69, P2280, DOI 10.1152/jappl.1990.69.6.2280; KISHIKAWA K, 1995, J NEUROPHYSIOL, V74, P763, DOI 10.1152/jn.1995.74.2.763; Kohyama J, 1998, SLEEP, V21, P695, DOI 10.1093/sleep/21.7.695; Koyama Y, 1998, NEUROSCIENCE, V83, P1105, DOI 10.1016/S0306-4522(97)00439-9; KOYAMA Y, 1993, NEUROSCIENCE, V55, P1117, DOI 10.1016/0306-4522(93)90325-A; KOYAMA Y, 1994, NEUROSCIENCE, V63, P1021, DOI 10.1016/0306-4522(94)90569-X; KUBIN L, 1993, BRAIN RES, V611, P300, DOI 10.1016/0006-8993(93)90517-Q; Kubin L, 2004, RESP PHYSIOL NEUROBI, V143, P235, DOI 10.1016/j.resp.2004.04.017; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; KUBIN L, 1992, BRAIN RES, V592, P91, DOI 10.1016/0006-8993(92)91662-X; Kubin L, 1981, J NEUROPHYSIOL, V46, P8; Kubin L, 1980, J NEUROPHYSIOL, V44, P923; Kubin L, 2008, SLEEP, V31, P1473, DOI 10.1093/sleep/31.11.1473; Lackner JR, 1997, J VESTIBUL RES-EQUIL, V7, P303, DOI 10.1016/S0957-4271(96)00177-2; Lai YY, 2003, MOL NEUROBIOL, V27, P137, DOI 10.1385/MN:27:2:137; Lai YY, 1999, J COMP NEUROL, V408, P419, DOI 10.1002/(SICI)1096-9861(19990607)408:3<419::AID-CNE8>3.0.CO;2-4; Lee HS, 2001, ANAT REC, V263, P269, DOI 10.1002/ar.1096; LEONARD CS, 1994, NEUROSCIENCE, V59, P309, DOI 10.1016/0306-4522(94)90599-1; LIPSKI J, 1995, NEUROSCIENCE, V69, P601, DOI 10.1016/0306-4522(95)92652-Z; Lu J. W., 2007, J PHYSIOL-LONDON, V582, P52; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; LUPPI PH, 1989, NEUROSCI LETT, V106, P29, DOI 10.1016/0304-3940(89)90197-3; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Madden CJ, 2003, CELL MOL NEUROBIOL, V23, P739, DOI 10.1023/A:1025000919468; McCarley RW, 2004, ARCH ITAL BIOL, V142, P429; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Montplaisir J, 2010, MOVEMENT DISORD, V25, P2044, DOI 10.1002/mds.23257; Morrison J. L., 2003, J PHYSIOL-LONDON, V552, P965; MORRISON SF, 1988, J NEUROSCI, V8, P1286; Murali NS, 2003, FRONT BIOSCI-LANDMRK, V8, pS636, DOI 10.2741/1105; NETICK A, 1977, BRAIN RES, V120, P197, DOI 10.1016/0006-8993(77)90900-3; ODDIE SD, 1994, HIPPOCAMPUS, V4, P454, DOI 10.1002/hipo.450040408; OREM J, 1994, SLEEP, V17, P665, DOI 10.1093/sleep/17.8.665; Orem J, 2005, PRINCIPLES PRACTICE, P213; Orem JM, 2005, SLEEP, V28, P801, DOI 10.1093/sleep/28.7.801; Oudiette D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018056; Parenti R, 1996, EUR J NEUROSCI, V8, P2157, DOI 10.1111/j.1460-9568.1996.tb00737.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pedrino GR, 2008, AUTON NEUROSCI-BASIC, V142, P55, DOI 10.1016/j.autneu.2008.06.006; Peyron C, 1996, J COMP NEUROL, V364, P402; Phillips JK, 2001, J COMP NEUROL, V432, P20, DOI 10.1002/cne.1086; Pollock MS, 2003, BRAIN RES, V962, P68, DOI 10.1016/S0006-8993(02)03956-2; RAJAKUMAR N, 1992, ANAT EMBRYOL, V185, P25, DOI 10.1007/BF00213598; REINER PB, 1986, BRAIN RES, V378, P86, DOI 10.1016/0006-8993(86)90288-X; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Rukhadze I, 2008, NEUROSCIENCE, V152, P208, DOI 10.1016/j.neuroscience.2007.11.013; Rukhadze I, 2007, J CHEM NEUROANAT, V33, P23, DOI 10.1016/j.jchemneu.2006.10.001; SAKAI K, 1979, BRAIN RES, V176, P233, DOI 10.1016/0006-8993(79)90981-8; Sakai K, 2000, NEUROREPORT, V11, P3237, DOI 10.1097/00001756-200009280-00037; Sakai K, 1996, NEUROREPORT, V7, P2449, DOI 10.1097/00001756-199611040-00009; SAKAI K, 1988, ARCH ITAL BIOL, V126, P239; Sakai K, 1981, BRAIN MECH PERCEPTUA, P405; Sanford LD, 2003, J NEUROPHYSIOL, V90, P938, DOI 10.1152/jn.00993.2002; SCHENCK CH, 1992, ANN NEUROL, V32, P3, DOI 10.1002/ana.410320103; SHIROMANI PJ, 1990, BRAIN RES, V517, P224, DOI 10.1016/0006-8993(90)91030-K; Siegel J. M., 1994, PRINCIPLES PRACTICE, P125; SIEGEL JM, 1983, BRAIN RES, V268, P344, DOI 10.1016/0006-8993(83)90501-2; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; SIEGEL JM, 1979, BRAIN RES, V179, P49, DOI 10.1016/0006-8993(79)90488-8; Sirieix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028724; Soja PJ, 2001, NEUROSCIENCE, V104, P199, DOI 10.1016/S0306-4522(01)00060-4; Soja PJ, 1996, J NEUROSCI, V16, P1260; STERIADE M, 1984, EXP BRAIN RES, V54, P463; Stettner GM, 2012, NEUR M PLANN; Stornetta RL, 1999, J COMP NEUROL, V415, P482, DOI 10.1002/(SICI)1096-9861(19991227)415:4<482::AID-CNE5>3.0.CO;2-4; Taepavarapruk N, 2002, J NEUROSCI, V22, P5777; TAGUCHI O, 1992, BRAIN RES, V595, P107, DOI 10.1016/0006-8993(92)91458-Q; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; TAKAKUSAKI K, 1994, EXP BRAIN RES, V99, P361; Takakusaki K, 2001, NEUROSCIENCE, V103, P511, DOI 10.1016/S0306-4522(00)00586-8; TRULSON ME, 1982, BRAIN RES, V237, P232, DOI 10.1016/0006-8993(82)90572-8; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Verberne AJM, 1999, J PHYSIOL-LONDON, V517, P477, DOI 10.1111/j.1469-7793.1999.0477t.x; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; VERTES RP, 1993, EXP BRAIN RES, V96, P419; Woch G, 1996, J PHYSIOL-LONDON, V490, P745, DOI 10.1113/jphysiol.1996.sp021182; Woch G, 2000, EXP BRAIN RES, V130, P508, DOI 10.1007/s002210050053; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Xi MC, 1997, J NEUROPHYSIOL, V78, P137, DOI 10.1152/jn.1997.78.1.137; Yoshimoto M, 2011, SLEEP, V34, P1093, DOI 10.5665/SLEEP.1168	132	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62410	10.1371/journal.pone.0062410	http://dx.doi.org/10.1371/journal.pone.0062410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630631	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500088
J	Ferreira, R; Schlichter, LC				Ferreira, Roger; Schlichter, Lyanne C.			Selective Activation of KCa3.1 and CRAC Channels by P2Y2 Receptors Promotes Ca2+ Signaling, Store Refilling and Migration of Rat Microglial Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; HUMAN T-LYMPHOCYTES; POTASSIUM CHANNELS; SMALL-CONDUCTANCE; INTERMEDIATE-CONDUCTANCE; PROTEIN-KINASE; ION CHANNELS; DEPENDENT REGULATION; THERAPEUTIC TARGETS; CALCIUM	Microglial activation involves Ca2+ signaling, and numerous receptors can evoke elevation of intracellular Ca2+. ATP released from damaged brain cells can activate ionotropic and metabotropic purinergic receptors, and act as a chemoattractant for microglia. Metabotropic P2Y receptors evoke a Ca2+ rise through release from intracellular Ca2+ stores and store-operated Ca2+ entry, and some have been implicated in microglial migration. This Ca2+ rise is expected to activate small-conductance Ca2+-dependent K+ (SK) channels, if present. We previously found that SK3 (KCa2.3) and KCa3.1 (SK4/IK1) are expressed in rat microglia and contribute to LPS-mediated activation and neurotoxicity. However, neither current has been studied by elevating Ca2+ during whole-cell recordings. We hypothesized that, rather than responding only to Ca2+, each channel type might be coupled to different receptor-mediated pathways. Here, our objective was to determine whether the channels are differentially activated by P2Y receptors, and, if so, whether they play differing roles. We used primary rat microglia and a rat microglial cell line (MLS-9) in which riluzole robustly activates both SK3 and KCa3.1 currents. Using electrophysiological, Ca2+ imaging and pharmacological approaches, we show selective functional coupling of KCa3.1 to UTP-mediated P2Y2 receptor activation. KCa3.1 current is activated by Ca2+ entry through Ca2+-release-activated Ca2+ (CRAC/Orai1) channels, and both CRAC/Orai1 and KCa3.1 channels facilitate refilling of Ca2+ stores. The Ca2+ dependence of KCa3.1 channel activation was skewed to abnormally high concentrations, and we present evidence for a close physical association of the two channel types. Finally, migration of primary rat microglia was stimulated by UTP and inhibited by blocking either KCa3.1 or CRAC/Orai1 channels. This is the first report of selective coupling of one type of SK channel to purinergic stimulation of microglia, transactivation of KCa3.1 channels by CRAC/Orai1, and coordinated roles for both channels in store refilling, Ca2+ signaling and microglial migration.	[Ferreira, Roger; Schlichter, Lyanne C.] Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Ferreira, Roger; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Schlichter, LC (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca			Heart and Stroke Foundation, Ontario chapter (HSFO) [T6766]; HSFO (Ontario Graduate Scholarship in Science and Technology); Natural Sciences and Engineering Research Council (NSERC)	Heart and Stroke Foundation, Ontario chapter (HSFO)(Heart & Stroke Foundation of Canada); HSFO (Ontario Graduate Scholarship in Science and Technology); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an operating grant to LCS from the Heart and Stroke Foundation, Ontario chapter (HSFO, #T6766), and graduate scholarships to RF from HSFO (Ontario Graduate Scholarship in Science and Technology) and the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Eder C, 2010, J NEUROIMMUNOL, V224, P51, DOI 10.1016/j.jneuroim.2010.05.008; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Gao YD, 2010, CELL CALCIUM, V48, P19, DOI 10.1016/j.ceca.2010.06.002; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Gyoneva S, 2009, PARKINSONISM RELAT D, V15, pS195, DOI 10.1016/S1353-8020(09)70813-2; Hayashi M, 2004, AM J PHYSIOL-CELL PH, V286, pC635, DOI 10.1152/ajpcell.00283.2003; Hede SE, 2005, PFLUG ARCH EUR J PHY, V450, P429, DOI 10.1007/s00424-005-1433-3; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Jacobson KA, 2009, PURINERG SIGNAL, V5, P75, DOI 10.1007/s11302-008-9106-2; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Klein H, 2009, AM J PHYSIOL-CELL PH, V296, pC285, DOI 10.1152/ajpcell.00418.2008; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; Lam J, 2011, DRUG DEVELOP RES, V72, P573, DOI 10.1002/ddr.20467; MAHAUTSMITH MP, 1989, J PHYSIOL-LONDON, V415, P69, DOI 10.1113/jphysiol.1989.sp017712; Moller T, 2002, GLIA, V40, P184, DOI 10.1002/glia.10152; Neylon CB, 2004, PFLUG ARCH EUR J PHY, V448, P613, DOI 10.1007/s00424-004-1302-5; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schmidt EM, 2011, BIOCHEM BIOPH RES CO, V415, P54, DOI 10.1016/j.bbrc.2011.10.009; Schwab A, 2006, J CELL PHYSIOL, V206, P86, DOI 10.1002/jcp.20434; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; von Hahn T, 2001, CELL PHYSIOL BIOCHEM, V11, P219, DOI 10.1159/000051936; Wei CL, 2012, CURR OPIN CELL BIOL, V24, P254, DOI 10.1016/j.ceb.2011.12.002; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wulf A, 2002, J MEMBRANE BIOL, V187, P71, DOI 10.1007/s00232-001-0149-3; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; YAO J, 1990, J NEUROSCI RES, V27, P36, DOI 10.1002/jnr.490270106; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019	66	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62345	10.1371/journal.pone.0062345	http://dx.doi.org/10.1371/journal.pone.0062345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620825	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500106
J	Haitjema, A; Brandt, BW; Ameziane, N; May, P; Heringa, J; de Winter, JP; Joenje, H; Dorsman, JC				Haitjema, Anneke; Brandt, Bernd W.; Ameziane, Najim; May, Patrick; Heringa, Jaap; de Winter, Johan P.; Joenje, Hans; Dorsman, Josephine C.			A Protein Prioritization Approach Tailored for the FA/BRCA Pathway	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; CROSS-LINK REPAIR; ONTOLOGY LOOKUP SERVICE; GROUP-A GENE; DNA-DAMAGE; MONOUBIQUITINATED FANCD2; POSITIONAL CLONING; HELICASE BRIP1; IDENTIFICATION; CANCER	Fanconi anemia (FA) is a heterogeneous recessive disorder associated with a markedly elevated risk to develop cancer. To date sixteen FA genes have been identified, three of which predispose heterozygous mutation carriers to breast cancer. The FA proteins work together in a genome maintenance pathway, the so-called FA/BRCA pathway which is important during the S phase of the cell cycle. Since not all FA patients can be linked to (one of) the sixteen known complementation groups, new FA genes remain to be identified. In addition the complex FA network remains to be further unravelled. One of the FA genes, FANCI, has been identified via a combination of bioinformatic techniques exploiting FA protein properties and genetic linkage. The aim of this study was to develop a prioritization approach for proteins of the entire human proteome that potentially interact with the FA/BRCA pathway or are novel candidate FA genes. To this end, we combined the original bioinformatics approach based on the properties of the first thirteen FA proteins identified with publicly available tools for protein-protein interactions, literature mining (Nermal) and a protein function prediction tool (FuncNet). Importantly, the three newest FA proteins FANCO/RAD51C, FANCP/SLX4, and XRCC2 displayed scores in the range of the already known FA proteins. Likewise, a prime candidate FA gene based on next generation sequencing and having a very low score was subsequently disproven by functional studies for the FA phenotype. Furthermore, the approach strongly enriches for GO terms such as DNA repair, response to DNA damage stimulus, and cell cycle-regulated genes. Additionally, overlaying the top 150 with a haploinsufficiency probability score, renders the approach more tailored for identifying breast cancer related genes. This approach may be useful for prioritization of putative novel FA or breast cancer genes from next generation sequencing efforts.	[Haitjema, Anneke; Ameziane, Najim; de Winter, Johan P.; Joenje, Hans; Dorsman, Josephine C.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Brandt, Bernd W.; Heringa, Jaap] Vrije Univ Amsterdam, Ctr Integrat Bioinformat VU IBIVU, Amsterdam, Netherlands; [Brandt, Bernd W.] Univ Amsterdam, ACTA, Dept Prevent Dent, Amsterdam, Netherlands; [May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [May, Patrick] Inst Syst Biol, Seattle, WA USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Luxembourg; Institute for Systems Biology (ISB)	Dorsman, JC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	jc.dorsman@vumc.nl	May, Patrick/B-1238-2010; May, Patrick/N-1019-2019	May, Patrick/0000-0001-8698-3770; May, Patrick/0000-0001-8698-3770; Brandt, Bernd/0000-0002-1155-1989	ENFIN, a Network of Excellence; European Commission [LSHG-CT-2005-518254]	ENFIN, a Network of Excellence; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area 'Life sciences, genomics and biotechnology for health' (contract number LSHG-CT-2005-518254 to B.B. and J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alende N, 2011, PROTEINS, V79, P1635, DOI 10.1002/prot.22990; Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; [Anonymous], 2009, PLOS COMPUT BIOL, V5, DOI [10.1371/journal.pcbi.1000431, DOI 10.1371/JOURNAL.PCBI.1000431]; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; Auerbach AD, 2001, FANCONI ANEMIA, V1, P753; Blom E, 2002, ACTA HAEMATOL-BASEL, V108, P231, DOI 10.1159/000065659; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cote R, 2010, NUCLEIC ACIDS RES, V38, pW155, DOI 10.1093/nar/gkq331; Cote RG, 2008, NUCLEIC ACIDS RES, V36, pW372, DOI 10.1093/nar/gkn252; Cote RG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-401; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; de Winter JP, 2000, AM J HUM GENET, V67, P1306, DOI 10.1016/S0002-9297(07)62959-0; Domchek SM, 2013, CANCER DISCOV, V3, P399, DOI 10.1158/2159-8290.CD-12-0421; Dorsman JC, 2007, CELL ONCOL, V29, P211; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; ISHIDA R, 1982, CANCER RES, V42, P4000; Kahlem P, 2009, CR BIOL, V332, P1050, DOI 10.1016/j.crvi.2009.09.003; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kundrotas PJ, 2006, BIOPHYS J, V91, P1724, DOI 10.1529/biophysj.106.086025; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lange SS, 2012, NUCLEIC ACIDS RES, V40, P4473, DOI 10.1093/nar/gks054; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rooimans MA, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Shamseldin HE, 2012, J MED GENET, V49, P184, DOI 10.1136/jmedgenet-2011-100585; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942	61	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62017	10.1371/journal.pone.0062017	http://dx.doi.org/10.1371/journal.pone.0062017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620800	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500080
J	Goulart, PRK; Bonci, DMO; Galvao, OD; Silveira, LCD; Ventura, DF				Kilpp Goulart, Paulo Roney; Oliveira Bonci, Daniela Maria; Galvao, Olavo de Faria; de Lima Silveira, Luiz Carlos; Ventura, Dora Fix			Color Discrimination in the Tufted Capuchin Monkey, Sapajus spp	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; NEW-WORLD MONKEYS; CEBUS-APELLA; SQUIRREL-MONKEYS; MERCURY-VAPOR; VISUAL AREA; ASYMPTOMATIC CARRIERS; MOLECULAR-GENETICS; VISION IMPAIRMENT; SAIMIRI-SCIUREUS	The present study evaluated the efficacy of an adapted version of the Mollon-Reffin test for the behavioral investigation of color vision in capuchin monkeys. Ten tufted capuchin monkeys (Sapajus spp., formerly referred to as Cebus apella) had their DNA analyzed and were characterized as the following: one trichromat female, seven deuteranope dichromats (six males and one female), and two protanope males, one of which was identified as an "ML protanope." For their behavioral characterization, all of the subjects were tested at three regions of the Commission International de l'Eclairage (CIE) 1976 u'v' diagram, with each test consisting of 20 chromatic variation vectors that were radially distributed around the chromaticity point set as the test background. The phenotypes inferred from the behavioral data were in complete agreement with those predicted from the genetic analysis, with the threshold distribution clearly differentiating between trichromats and dichromats and the estimated confusion lines characteristically converging for deuteranopes and the "classic" protanope. The discrimination pattern of the ML protanope was intermediate between protan and deutan, with confusion lines horizontally oriented and parallel to each other. The observed phenotypic differentiation confirmed the efficacy of the Mollon-Reffin test paradigm as a useful tool for evaluating color discrimination in nonhuman primates. Especially noteworthy was the demonstration of behavioral segregation between the "classic" and "ML" protanopes, suggesting identifiable behavioral consequences of even slight variations in the spectral sensitivity of M/L photopigments in dichromats.	[Kilpp Goulart, Paulo Roney; Galvao, Olavo de Faria] Fed Univ Para, Nucleo Teoria Pesquisa Comportamento, BR-66059 Belem, Para, Brazil; [Oliveira Bonci, Daniela Maria; Ventura, Dora Fix] Univ Sao Paulo, Inst Psicol, Dept Psicol Expt, Sao Paulo, Brazil; [Oliveira Bonci, Daniela Maria; Ventura, Dora Fix] Univ Sao Paulo, Nucleo Neurociencias & Comportamento, Sao Paulo, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Para	Goulart, PRK (corresponding author), Fed Univ Para, Nucleo Teoria Pesquisa Comportamento, BR-66059 Belem, Para, Brazil.	goulartprk@gmail.com	Ventura, Dora F/B-9071-2012; de Faria Galvao, Olavo/I-9498-2012; Galvao, Olavo/GLT-7219-2022; Silveira, Luiz Carlos L/H-9647-2014	Ventura, Dora F/0000-0002-7616-4031; de Faria Galvao, Olavo/0000-0001-9912-3833; Silveira, Luiz Carlos L/0000-0001-9414-1573	FINEP/FADESP (IBN Net) [4191/05, 01.06.0842-00, 1723]; CNPq (INCT-ECCE) [573972/2008-7]; NIEHS [5-R21-ES015464-02, 6125894/RFS2011138]; FAPESP; CNPq	FINEP/FADESP (IBN Net); CNPq (INCT-ECCE)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was partially funded by FINEP/FADESP (Ref. 4191/05, Proc. No. 01.06.0842-00, Conv. 1723, IBN Net), CNPq (Proc. No. 573972/2008-7, INCT-ECCE), and NIEHS (Prime award No. 5-R21-ES015464-02, Subaward No. 6125894/RFS2011138). Additional support was provided by FAPESP to D.M.O. Bonci (Doctoral Fellowship) and by CNPq to P.R.K. Goulart (Postdoctoral Fellowship), D.F. Ventura, O.F. Galvao and L.C.L. Silveira (Research Productivity Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Canto-Pereira LHM, 2005, ENVIRON TOXICOL PHAR, V19, P517, DOI 10.1016/j.etap.2004.12.015; Costa MF, 2007, AM J HUM GENET, V80, P1064, DOI 10.1086/518127; da Costa BLSA, 2000, VISION RES, V40, P2395, DOI 10.1016/S0042-6989(00)00104-8; Moura ALD, 2008, VISUAL NEUROSCI, V25, P463, DOI 10.1017/S0952523808080437; Diogo ACM, 2003, J NEUROSCI, V23, P3881; Dos Reis JWL, 2002, J COMP NEUROL, V443, P105, DOI 10.1002/cne.10105; Feitosa-Santana C, 2007, BRAZ J MED BIOL RES, V40, P409, DOI 10.1590/S0100-879X2006005000063; Feitosa-Santana C, 2008, VISUAL NEUROSCI, V25, P487, DOI 10.1017/S0952523808080590; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Finlay BL, 2005, VISUAL NEUROSCI, V25, P289; FIORANI M, 1989, J COMP NEUROL, V287, P98, DOI 10.1002/cne.902870108; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; GATTASS R, 1987, J COMP NEUROL, V259, P529, DOI 10.1002/cne.902590404; Goulart PRK, 2008, VISUAL NEUROSCI, V25, P445, DOI 10.1017/S0952523808080589; Grether WF, 1937, PSYCHOL BULL, V34, P792; Grether WF, 1939, COMP PSYCHOL MONOGR, V15, P38; GUNTER R, 1965, J COMP PHYSIOL PSYCH, V60, P107, DOI 10.1037/h0022324; HARADA ML, 1995, MOL PHYLOGENET EVOL, V4, P331, DOI 10.1006/mpev.1995.1029; JACOBS GH, 1993, VISION RES, V33, P269, DOI 10.1016/0042-6989(93)90083-9; Jacobs GH, 2003, VISION RES, V43, P227, DOI 10.1016/S0042-6989(02)00565-5; JACOBS GH, 1984, VISION RES, V24, P1267, DOI 10.1016/0042-6989(84)90181-0; JACOBS GH, 1984, J COMP PSYCHOL, V98, P347, DOI 10.1037/0735-7036.98.4.347; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1985, VISION RES, V25, P141, DOI 10.1016/0042-6989(85)90088-4; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; JACOBS GH, 1987, VISION RES, V27, P1263, DOI 10.1016/0042-6989(87)90202-1; Jansen-Amorim AK, 2004, VISUAL NEUROSCI, V28, P513; Kraft TW, 1998, VISION RES, V38, P3663, DOI 10.1016/S0042-6989(97)00371-4; Lameirao SVOC, 2009, VISUAL NEUROSCI, V26, P389, DOI 10.1017/S0952523809990186; Lee BB, 2000, J PHYSIOL-LONDON, V528, P573, DOI 10.1111/j.1469-7793.2000.00573.x; Lima B, 2005, BRAZ J MED BIOL RES, V38, P59, DOI 10.1590/S0100-879X2005000100010; Lima SMA, 1996, J COMP NEUROL, V368, P538; Mancuso K, 2006, VISUAL NEUROSCI, V23, P695, DOI 10.1017/S0952523806233364; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MOLLON JD, 1989, J PHYSIOL-LONDON, V414, pP5; Mollon JD, 2000, HDB CAMBRIDGE COLOUR; Nathans J, 1996, ANNU REV GENET, V26, P403; Neitz M, 2000, ARCH OPHTHALMOL-CHIC, V118, P691; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; ROSA MGP, 1988, J COMP NEUROL, V275, P326, DOI 10.1002/cne.902750303; Rowe MP, 2004, VISUAL NEUROSCI, V21, P217, DOI 10.1017/S0952523804213104; Barboni MTS, 2009, J OCCUP ENVIRON MED, V51, P1403, DOI 10.1097/JOM.0b013e3181bca9ea; Shyue SK, 1998, J MOL EVOL, V46, P697, DOI 10.1007/PL00006350; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; Silveira LCL, 2001, COLOR RES APPL, V26, pS118, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL26>3.0.CO;2-9; SILVEIRA LCL, 1994, NEUROREPORT, V5, P2077; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Silveira LCL, 1998, VISION RES, V38, P3329, DOI 10.1016/S0042-6989(97)00335-0; Soares JGM, 2010, VISION RES, V50, P99, DOI 10.1016/j.visres.2009.10.017; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2005, INVEST OPHTH VIS SCI, V46, P4809, DOI 10.1167/iovs.05-0455; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; Ventura DF, 2002, 18 ANN M INT SOC PSY, V18, P218; Ventura DF, 2003, NORMAL DEFECTIVE COL, P327; Ventura DF, 2007, INVEST OPHTH VIS SCI, V48, P2362, DOI 10.1167/iovs.06-0331; Yamada Elizabeth S., 1996, Revista Brasileira de Biologia, V56, P381; Yamada ES, 1996, VISUAL NEUROSCI, V13, P1011, DOI 10.1017/S0952523800007677; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	61	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62255	10.1371/journal.pone.0062255	http://dx.doi.org/10.1371/journal.pone.0062255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620819	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500099
J	Ling, H; Hu, X; Xu, XL; Liu, ZB; Shao, ZM				Ling, Hong; Hu, Xin; Xu, Xiao-Li; Liu, Zhe-Bin; Shao, Zhi-Min			Patients with Nipple-Areola Paget's Disease and Underlying Invasive Breast Carcinoma Have Very Poor Survival: A Matched Cohort Study	PLOS ONE			English	Article							EXPERIENCE	Paget's disease (PD) of the breast is a rare disease. The survival rate of PD was reported to depend on the characteristics of the underlying carcinoma. This study aimed to investigate the characteristics and survival rate of PD patients with underlying invasive breast carcinoma (IBC). Fifty-two patients were diagnosed with PD and an associated IBC from 2001 to 2005 in Fudan University Shanghai Cancer Center. Twenty-four (46.2%) had no clinical manifestation of PD and were diagnosed unexpectedly by a histologic examination. The 52 patients were all recruited in this study as the PD group. They tended to have greater chances of lymph node involvement (53.8% vs. 35.7%), lower hormone receptor expression (34.6% vs. 69.7%), higher human epidermal growth factor receptor 2 (HER2) expression (76.9% vs. 21.3%), and worse survival (5-year relapse-free survival (RFS) 52.2% vs. 86.7%, P<0.01; breast cancer-specific overall survival (OS) 62.1% vs. 91.8%, P<0.01) when compared with patients diagnosed with IBC. A matched study was then performed to investigate whether the poor survival of patients in the PD group was due to the unfavorable prognosis of the underlying IBC. One hundred and fifty-six (3: 1 ratio of controls to PD patients) patients diagnosed with IBC only were recruited into the matched group. The match was conducted according to four variables: dimension of IBC, lymph node status, hormone receptor status and HER2 status. The 5-year RFS (52.2% vs. 81.4%, P<0.01) and OS (62.1% vs. 85.9%, P<0.01) were both lower for patients in the PD group than those in the matched group. Patients with PD and underlying IBC had poor survival. Their survival was worse than that of patients with IBC of similar stage and characteristics. For patients with no clinical PD manifestation who were histologically diagnosed as PD, survival might be worse compared to patients with clinically diagnosed PD.	[Ling, Hong; Hu, Xin; Xu, Xiao-Li; Liu, Zhe-Bin; Shao, Zhi-Min] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ling, Hong; Hu, Xin; Liu, Zhe-Bin; Shao, Zhi-Min] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Inst Canc, Shanghai 200433, Peoples R China; [Xu, Xiao-Li] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com						ASCENSAO AC, 1985, DERMATOLOGICA, V170, P170, DOI 10.1159/000249526; ASHIKARI R, 1970, CANCER, V26, P680, DOI 10.1002/1097-0142(197009)26:3<680::AID-CNCR2820260329>3.0.CO;2-P; Caliskan M, 2008, BREAST CANCER RES TR, V112, P513, DOI 10.1007/s10549-007-9880-5; CHAUDARY MA, 1986, BREAST CANCER RES TR, V8, P139, DOI 10.1007/BF01807702; Dalberg K, 2008, BREAST CANCER RES TR, V111, P313, DOI 10.1007/s10549-007-9783-5; DIXON AR, 1991, BRIT J SURG, V78, P722, DOI 10.1002/bjs.1800780627; INWANG ER, 1990, BRIT J HOSP MED, V44, P392; Jamali FR, 1970, AM J SURG, V76, P365; Kollmorgen DR, 1998, J AM COLL SURGEONS, V187, P171, DOI 10.1016/S1072-7515(98)00143-4; Kothari AS, 2002, CANCER, V95, P1, DOI 10.1002/cncr.10638; Lohsiriwat V, 2012, ANN SURG ONCOL, V19, P1850, DOI 10.1245/s10434-012-2226-5; MENZIES D, 1989, EUR J SURG ONCOL, V15, P271; NANCE FC, 1970, ANN SURG, V171, P864, DOI 10.1097/00000658-197006010-00007; Paget J., 1874, ST BARTHOLOMEWS HOSP, V10, P87; PETERSE JL, 1988, EUR J SURG ONCOL, V14, P123; Plastaras John P, 2005, Clin Breast Cancer, V6, P349, DOI 10.3816/CBC.2005.n.039; Sakorafas GH, 2001, LANGENBECK ARCH SURG, V386, P444, DOI 10.1007/s004230100250; Velpeau S., 1856, TREATISE DIS BREAST; WOLBER RA, 1991, AM J CLIN PATHOL, V96, P243, DOI 10.1093/ajcp/96.2.243	19	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61455	10.1371/journal.pone.0061455	http://dx.doi.org/10.1371/journal.pone.0061455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620755	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500035
J	Chen, L; Liu, LY; Wang, MP; Fu, JF; Zhang, ZJ; Hou, J; Bao, XM				Chen, Lei; Liu, Liangyu; Wang, Mingpeng; Fu, Jiafang; Zhang, Zhaojie; Hou, Jin; Bao, Xiaoming			Hal2p Functions in Bdf1p-Involved Salt Stress Response in Saccharomyces cerevisiae	PLOS ONE			English	Article							BROMODOMAIN FACTOR-1 BDF1; CELL-DEATH; YEAST; GENE; DEGRADATION; TOLERANCE; MECHANISM; EXPRESSION; AUTOPHAGY; DELETION	The Saccharomyces cerevisiae Bdf1p associates with the basal transcription complexes TFIID and acts as a transcriptional regulator. Lack of Bdf1p is salt sensitive and displays abnormal mitochondrial function. The nucleotidase Hal2p detoxifies the toxic compound 3' -phosphoadenosine-5'-phosphate (pAp), which blocks the biosynthesis of methionine. Hal2p is also a target of high concentration of Na+. Here, we reported that HAL2 overexpression recovered the salt stress sensitivity of bdf1 Delta. Further evidence demonstrated that HAL2 expression was regulated indirectly by Bdf1p. The salt stress response mechanisms mediated by Bdf1p and Hal2p were different. Unlike hal2 Delta, high Na+ or Li+ stress did not cause pAp accumulation in bdf1 Delta and methionine supplementation did not recover its salt sensitivity. HAL2 overexpression in bdf1 Delta reduced ROS level and improved mitochondrial function, but not respiration. Further analyses suggested that autophagy was apparently defective in bdf1 Delta, and autophagy stimulated by Hal2p may play an important role in recovering mitochondrial functions and Na+ sensitivity of bdf1 Delta. Our findings shed new light towards our understanding about the molecular mechanism of Bdf1p-involved salt stress response in budding yeast.	[Chen, Lei; Liu, Liangyu; Wang, Mingpeng; Fu, Jiafang; Hou, Jin; Bao, Xiaoming] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Zhaojie] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Shandong University; University of Wyoming	Bao, XM (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	bxm@sdu.edu.cn			National Natural Science Foundation of China [30170021, 30671143, 30570031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30170021, 30671143 and 30570031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi MM, 2004, MOL MICROBIOL, V53, P953, DOI 10.1111/j.1365-2958.2004.04184.x; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Camougrand N, 2003, MOL MICROBIOL, V47, P495, DOI 10.1046/j.1365-2958.2003.03311.x; Casalone E, 1999, YEAST, V15, P1691, DOI 10.1002/(SICI)1097-0061(199911)15:15<1691::AID-YEA489>3.0.CO;2-0; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; de Nadal E, 1999, J BACTERIOL, V181, P6456, DOI 10.1128/JB.181.20.6456-6462.1999; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; DUNN T, 1994, J BIOL CHEM, V269, P7273; Ferreira MCD, 2001, CURR GENET, V40, P27, DOI 10.1007/s002940100237; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; HIRATA D, 1995, MOL GEN GENET, V249, P257, DOI 10.1007/BF00290525; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Knorre D, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1254, DOI 10.1134/S0006297908110126; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; LIM CK, 1989, J CHROMATOGR, V461, P259, DOI 10.1016/S0021-9673(00)94291-2; Liu XY, 2007, CURR MICROBIOL, V54, P325, DOI 10.1007/s00284-006-0525-4; Liu XY, 2009, FEMS YEAST RES, V9, P240, DOI 10.1111/j.1567-1364.2008.00469.x; LYGEROU Z, 1994, NUCLEIC ACIDS RES, V22, P5332, DOI 10.1093/nar/22.24.5332; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; Pamblanco M, 2001, FEBS LETT, V496, P31, DOI 10.1016/S0014-5793(01)02397-3; Petrangeli E, 2009, J CELL PHYSIOL, V219, P69, DOI 10.1002/jcp.21648; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; RODRIGUEZNAVARRO A, 1994, BBA-BIOENERGETICS, V1187, P203, DOI 10.1016/0005-2728(94)90111-2; RODRIGUEZNAVARRO A, 1982, FEBS LETT, V138, P205, DOI 10.1016/0014-5793(82)80442-0; Sawa C, 2004, MOL CELL BIOL, V24, P4734, DOI 10.1128/MCB.24.11.4734-4742.2004; SERRANO R, 1994, CRIT REV PLANT SCI, V13, P121, DOI 10.1080/713608057; Serrano R, 1999, J EXP BOT, V50, P1023, DOI 10.1093/jexbot/50.suppl_1.1023; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; THOMAS D, 1989, MOL CELL BIOL, V9, P3292, DOI 10.1128/MCB.9.8.3292; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Todeschini AL, 2006, J BIOL CHEM, V281, P3276, DOI 10.1074/jbc.M511688200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2009, AUTOPHAGY, V5, P217, DOI 10.4161/auto.5.2.7201	46	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62110	10.1371/journal.pone.0062110	http://dx.doi.org/10.1371/journal.pone.0062110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614021	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200120
J	Corriveau, M; Mullins, MR; Baus, D; Harris, ME; Taylor, DJ				Corriveau, Mark; Mullins, Michael R.; Baus, Diane; Harris, Michael E.; Taylor, Derek J.			Coordinated Interactions of Multiple POT1-TPP1 Proteins with Telomere DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HUMAN POT1; HUMAN-CHROMOSOMES; LENGTH REGULATOR; END-PROTECTION; TPP1; COMPLEX; BINDING; TRF2; PROCESSIVITY	Telomeres are macromolecular nucleoprotein complexes that protect the ends of eukaryotic chromosomes from degradation, end-to-end fusion events, and from engaging the DNA damage response. However, the assembly of this essential DNA-protein complex is poorly understood. Telomere DNA consists of the repeated double-stranded sequence 5'-TTAGGG-3' in vertebrates, followed by a single-stranded DNA overhang with the same sequence. Both double-and single-stranded regions are coated with high specificity by telomere end-binding proteins, including POT1 and TPP1, that bind as a heterodimer to single-stranded telomeric DNA. Multiple POT1-TPP1 proteins must fully coat the single-stranded telomere DNA to form a functional telomere. To better understand the mechanism of multiple binding, we mutated or deleted the two guanosine nucleotides residing between adjacent POT1-TPP1 recognition sites in single-stranded telomere DNA that are not required for multiple POT1-TPP1 binding events. Circular dichroism demonstrated that spectra from the native telomere sequence are characteristic of a G-quadruplex secondary structure, whereas the altered telomere sequences were devoid of these signatures. The altered telomere strands, however, facilitated more cooperative loading of multiple POT1-TPP1 proteins compared with the wild-type telomere sequence. Finally, we show that a 48-nucleotide DNA with a telomere sequence is more susceptible to nuclease digestion when coated with POT1-TPP1 proteins than when it is left uncoated. Together, these data suggest that POT1-TPP1 binds telomeric DNA in a coordinated manner to facilitate assembly of the nucleoprotein complexes into a state that is more accessible to enzymatic activity.	[Corriveau, Mark; Mullins, Michael R.; Baus, Diane; Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Harris, Michael E.; Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Taylor, DJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	derek.taylor@case.edu			American Heart Association Scientist Development Grant [11SDB5580010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056740] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Scientist Development Grant 11SDB5580010 (to D. J. T.).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Buczek P, 2006, J BIOL CHEM, V281, P40124, DOI 10.1074/jbc.M607749200; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Horvath MP, 2011, CRIT REV BIOCHEM MOL, V46, P409, DOI 10.3109/10409238.2011.609295; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; MANTELL LL, 1994, EMBO J, V13, P3211, DOI 10.1002/j.1460-2075.1994.tb06620.x; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nandakumar J, 2012, NUCLEIC ACIDS RES, V40, P235, DOI 10.1093/nar/gkr721; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Wright WE, 1996, DEV GENET, V18, P173; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	52	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16361	16370		10.1074/jbc.M113.471896	http://dx.doi.org/10.1074/jbc.M113.471896			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23616058	Green Published, hybrid			2022-12-25	WOS:000320378900014
J	Brown, SM; Harrisson, KA; Clarke, RH; Bennett, AF; Sunnucks, P				Brown, Sarah M.; Harrisson, Katherine A.; Clarke, Rohan H.; Bennett, Andrew F.; Sunnucks, Paul			Limited Population Structure, Genetic Drift and Bottlenecks Characterise an Endangered Bird Species in a Dynamic, Fire-Prone Ecosystem	PLOS ONE			English	Article							COMPUTER-PROGRAM; FAIRY-WREN; HABITAT; DIVERSITY; DIFFERENTIATION; MANAGEMENT; INFERENCE; G(ST); RECOLONIZATION; METAPOPULATION	Fire is a major disturbance process in many ecosystems world-wide, resulting in spatially and temporally dynamic landscapes. For populations occupying such environments, fire-induced landscape change is likely to influence population processes, and genetic patterns and structure among populations. The Mallee Emu-wren Stipiturus mallee is an endangered passerine whose global distribution is confined to fire-prone, semi-arid mallee shrublands in south-eastern Australia. This species, with poor capacity for dispersal, has undergone a precipitous reduction in distribution and numbers in recent decades. We used genetic analyses of 11 length-variable, nuclear loci to examine population structure and processes within this species, across its global range. Populations of the Mallee Emu-wren exhibited a low to moderate level of genetic diversity, and evidence of bottlenecks and genetic drift. Bayesian clustering methods revealed weak genetic population structure across the species' range. The direct effects of large fires, together with associated changes in the spatial and temporal patterns of suitable habitat, have the potential to cause population bottlenecks, serial local extinctions and subsequent recolonisation, all of which may interact to erode and homogenise genetic diversity in this species. Movement among temporally and spatially shifting habitat, appears to maintain long-term genetic connectivity. A plausible explanation for the observed genetic patterns is that, following extensive fires, recolonisation exceeds in-situ survival as the primary driver of population recovery in this species. These findings suggest that dynamic, fire-dominated landscapes can drive genetic homogenisation of populations of species with low-mobility and specialised habitat that otherwise would be expected to show strongly structured populations. Such effects must be considered when formulating management actions to conserve species in fire-prone systems.	[Brown, Sarah M.; Bennett, Andrew F.] Deakin Univ, Sch Life & Environm Sci, Burwood, Australia; [Brown, Sarah M.; Harrisson, Katherine A.; Clarke, Rohan H.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Deakin University; Monash University	Brown, SM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Australia.	sarah.brown@monash.edu	Harrisson, Katherine/AFA-8905-2022	Harrisson, Katherine/0000-0002-8070-8070; Sunnucks, Paul/0000-0002-8139-7059	Holsworth Wildlife Research Fund; Winifred Scott Charitable Trust	Holsworth Wildlife Research Fund; Winifred Scott Charitable Trust	This research was funded by the Holsworth Wildlife Research Fund and the Winifred Scott Charitable Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bos DG, 2002, AUSTRAL ECOL, V27, P103, DOI 10.1046/j.1442-9993.2002.01163.x; Bouzat JL, 1998, CONSERV BIOL, V12, P836, DOI 10.1046/j.1523-1739.1998.97164.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradstock Ross A., 2002, P238; Brooker MG, 1998, EMU, V98, P276, DOI 10.1071/MU98039; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Brown S, 2011, THESIS DEAKIN U; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Cai WJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00702; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clarke MF, 2008, WILDLIFE RES, V35, P385, DOI 10.1071/WR07137; Clarke Rohan H., 2005, Pacific Conservation Biology, V11, P174; Cleary DFR, 2006, ECOL LETT, V9, P301, DOI 10.1111/j.1461-0248.2005.00876.x; Collevatti RG, 2007, GENET MOL BIOL, V30, P112, DOI 10.1590/S1415-47572007000100020; Cornuet JM, 1996, GENETICS, V144, P2001; de Ita AO, 2012, CONSERV GENET, V13, P283, DOI 10.1007/s10592-011-0283-0; Dimond WJ, 2007, CONSERV BIOL, V21, P114, DOI 10.1111/j.1523-1739.2006.00537.x; Double MC, 1997, MOL ECOL, V6, P691, DOI 10.1046/j.1365-294X.1997.00228.x; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Durand E, 2009, BIOINFORMATICS, V25, P1802, DOI 10.1093/bioinformatics/btp337; Ellner SP, 2003, ECOLOGY, V84, P882, DOI 10.1890/0012-9658(2003)084[0882:EOSDOM]2.0.CO;2; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Falush D, 2003, GENETICS, V164, P1567; Fauvelot C, 2006, J HERED, V97, P367, DOI 10.1093/jhered/esl010; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Harris C. R., 1990, MALLEE LANDS CONSERV, P147; Harrisson KA, J ANIMAL EC IN PRESS; Harrisson KA, 2012, LANDSCAPE ECOL, V27, P813, DOI 10.1007/s10980-012-9743-2; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; HOLSINGER KE, 2009, NATURE REV GENETICS, V6, P639, DOI DOI 10.1038/NRG2611); Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kelly LT, LANDSCAPE U IN PRESS; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lindenmayer DB, 2009, INT J WILDLAND FIRE, V18, P84, DOI 10.1071/WF07048; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Maguire GS, 2006, MOL ECOL NOTES, V6, P422, DOI 10.1111/j.1471-8286.2006.01257.x; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; McDonough CM, 2005, WILDLIFE SOC B, V33, P1198, DOI 10.2193/0091-7648(2005)33[1198:IOLMPO]2.0.CO;2; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Murphy EC, 1998, J WILDLIFE MANAGE, V62, P1359, DOI 10.2307/3802002; Noble J. C., 1993, Rangeland Journal, V15, P270, DOI 10.1071/RJ9930270; Norris K, 2004, J APPL ECOL, V41, P413, DOI 10.1111/j.0021-8901.2004.00910.x; Pannell JR, 1999, EVOLUTION, V53, P664, DOI 10.1111/j.1558-5646.1999.tb05362.x; Panzer R, 2003, NAT AREA J, V23, P14; Pavlova A, 2012, ECOLOGY, V93, P1717, DOI 10.1890/11-1891.1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Porter AH, 1999, CONSERV BIOL, V13, P850, DOI 10.1046/j.1523-1739.1999.98308.x; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2008, CLIMATIC CHANGE, V86, P23, DOI 10.1007/s10584-007-9332-6; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rowley I., 1997, FAIRY WRENS GRASSWRE; Sambrook J, 2001, MOL CLONING LAB MANU; Sandell Peter, 2006, Proceedings of the Royal Society of Victoria, V118, P395; Sanz-Aguilar A, 2011, BIOL CONSERV, V144, P1040, DOI 10.1016/j.biocon.2010.12.023; Schrey AW, 2011, MOL ECOL, V20, P56, DOI 10.1111/j.1365-294X.2010.04925.x; Schurbon JM, 2003, CONSERV BIOL, V17, P1338, DOI 10.1046/j.1523-1739.2003.01514.x; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spear SF, 2010, BIOL CONSERV, V143, P778, DOI 10.1016/j.biocon.2009.12.021; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steffen, 2009, AUSTR BIODIVERSITY C; Stow A, 2007, J HERED, V98, P60, DOI 10.1093/jhered/esl045; Suarez NM, 2012, CONSERV GENET, V13, P499, DOI 10.1007/s10592-011-0302-1; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; TEMPLETON AR, 1994, EXS, V68, P91; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Ujvari B, 2008, MOL ECOL, V17, P3557, DOI 10.1111/j.1365-294X.2008.03849.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Watson SJ, 2012, ANIM CONSERV, V15, P499, DOI 10.1111/j.1469-1795.2012.00542.x; Webster MS, 2004, BEHAV ECOL, V15, P907, DOI 10.1093/beheco/arh093; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Whelan R.J.., 1995, ECOLOGY FIRE; Whelan Robert J., 2002, P94; Woinarski J. C. Z., 1997, Pacific Conservation Biology, V3, P183	98	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e59732	10.1371/journal.pone.0059732	http://dx.doi.org/10.1371/journal.pone.0059732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626668	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400001
J	Estevez-Calvar, N; Romero, A; Figueras, A; Novoa, B				Estevez-Calvar, Noelia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz			Genes of the Mitochondrial Apoptotic Pathway in Mytilus galloprovincialis	PLOS ONE			English	Article							OXYGEN SPECIES ROS; REACTIVE OXYGEN; CELL-DEATH; ENDOTHELIAL-CELLS; BAX INHIBITOR-1; PIFITHRIN-ALPHA; IMMUNE-RESPONSE; DNA-DAMAGE; P53; EXPRESSION	Bivalves play vital roles in marine, brackish, freshwater and terrestrial habitats. In recent years, these ecosystems have become affected through anthropogenic activities. The ecological success of marine bivalves is based on the ability to modify their physiological functions in response to environmental changes. One of the most important mechanisms involved in adaptive responses to environmental and biological stresses is apoptosis, which has been scarcely studied in mollusks, although the final consequence of this process, DNA fragmentation, has been frequently used for pollution monitoring. Environmental stressors induce apoptosis in molluscan cells via an intrinsic pathway. Many of the proteins involved in vertebrate apoptosis have been recognized in model invertebrates; however, this process might not be universally conserved. Mytilus galloprovincialis is presented here as a new model to study the linkage between molecular mechanisms that mediate apoptosis and marine bivalve ecological adaptations. Therefore, it is strictly necessary to identify the key elements involved in bivalve apoptosis. In the present study, six mitochondrial apoptotic-related genes were characterized, and their gene expression profiles following UV irradiation were evaluated. This is the first step for the development of potential biomarkers to assess the biological responses of marine organisms to stress. The results confirmed that apoptosis and, more specifically, the expression of the genes involved in this process can be used to assess the biological responses of marine organisms to stress.	[Estevez-Calvar, Noelia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz] CSIC, IIM, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Novoa, B (corresponding author), CSIC, IIM, Vigo, Spain.	virus@iim.csic.es	Figueras, Antonio/B-5133-2015; Figueras, Antonio/AAB-8921-2019; Novoa, Beatriz/K-3785-2014; Romero, Alejandro/R-4565-2019	Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Romero, Alejandro/0000-0002-9343-3352; Novoa, Beatriz/0000-0003-4888-8419	EU [266157, 245119]	EU(European Commission)	This work was partially funded through the EU Projects BIVALIFE (266157) and REPROSEED (245119). These funding agencies played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ainsworth TD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00160; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Apraiz I, 2006, MOL CELL PROTEOMICS, V5, P1274, DOI 10.1074/mcp.M500333-MCP200; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bjornstad A, 2006, J TOXICOL ENV HEAL A, V69, P77, DOI 10.1080/15287390500259277; Bottger S, 2008, CANCER RES, V68, P777, DOI 10.1158/0008-5472.CAN-06-0968; Borja A, 2008, MAR POLLUT BULL, V56, P1519, DOI 10.1016/j.marpolbul.2008.07.005; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027; Chatel A, 2011, ECOTOXICOLOGY, V20, P2030, DOI 10.1007/s10646-011-0746-6; Chevre N, 2003, CHEMOSPHERE, V51, P13, DOI 10.1016/S0045-6535(02)00818-4; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Santis LP, 2003, DNA REPAIR, V2, P891, DOI 10.1016/S1568-7864(03)00088-0; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V27, P423, DOI 10.1016/j.fsi.2009.06.019; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; Donaghy L, 2009, FISH SHELLFISH IMMUN, V27, P296, DOI 10.1016/j.fsi.2009.05.010; Dondero F, 2006, GENE, V376, P24, DOI 10.1016/j.gene.2006.02.015; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Eckhart L, 2007, BIOCHEM BIOPH RES CO, V356, P293, DOI 10.1016/j.bbrc.2007.02.122; Everaarts JM, 1996, WATER SCI TECHNOL, V34, P157, DOI 10.1016/S0273-1223(96)00739-1; Fernandez-Tajes J, 2011, ENVIRON MONIT ASSESS, V177, P289, DOI 10.1007/s10661-010-1634-x; Fleischer A, 2004, FEBS LETT, V557, P283, DOI 10.1016/S0014-5793(03)01519-9; Gamulin V, 2000, BIOL J LINN SOC, V71, P821, DOI [10.1111/j.1095-8312.2000.tb01293.x, 10.1006/bijl.2000.0476]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Huang WB, 2010, FISH SHELLFISH IMMUN, V28, P587, DOI 10.1016/j.fsi.2009.12.016; Igaki T, 2004, BBA-MOL CELL RES, V1644, P73, DOI 10.1016/j.bbamcr.2003.09.007; Jernelov A, 1996, SCI TOTAL ENVIRON, V188, pS37; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lacoste A, 2002, J CELL SCI, V115, P761; Lambert C, 2007, AQUACULTURE, V270, P413, DOI 10.1016/j.aquaculture.2007.04.074; Lasi M, 2010, APOPTOSIS, V15, P269, DOI 10.1007/s10495-009-0442-7; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; LeGrand EK, 1997, Q REV BIOL, V72, P135, DOI 10.1086/419763; Li G, 1998, BRIT J DERMATOL, V139, P3; Li L, 2009, FISH SHELLFISH IMMUN, V27, P625, DOI 10.1016/j.fsi.2009.07.009; Liu PT, 2006, SHOCK, V26, P608, DOI 10.1097/01.shk.0000232273.11225.af; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorgis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044677; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Montagnani C, 2004, FEBS LETT, V561, P75, DOI 10.1016/S0014-5793(04)00124-3; Moreira R, 2012, DEV COMP IMMUNOL, V36, P140, DOI 10.1016/j.dci.2011.06.012; Morga B, 2012, FISH SHELLFISH IMMUN, V32, P958, DOI 10.1016/j.fsi.2012.01.026; Murahashi H, 2003, J LEUKOCYTE BIOL, V73, P399, DOI 10.1189/jlb.0702335; Muttray AF, 2005, COMP BIOCHEM PHYS C, V140, P237, DOI 10.1016/j.cca.2005.02.011; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; OUWEMISSIOUKEMBOYER O, 1994, DEV COMP IMMUNOL, V18, P211, DOI 10.1016/0145-305X(94)90013-2; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Prado-Alvarez M, 2012, FISH SHELLFISH IMMUN, V32, P69, DOI 10.1016/j.fsi.2011.10.019; Qiu LM, 2009, FISH SHELLFISH IMMUN, V26, P359, DOI 10.1016/j.fsi.2008.10.010; Raymond MA, 2003, FASEB J, V17, P515, DOI 10.1096/fj.02-0500fje; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; Robinson KS, 2011, ONCOGENE, V30, P2391, DOI 10.1038/onc.2010.636; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez BC, 2011, ENVIRON TOXICOL CHEM, V30, P274, DOI 10.1002/etc.402; Shibue T, 2006, INT J CANCER, V119, P2036, DOI 10.1002/ijc.21751; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Steele AJ, 2008, BLOOD, V112, P3827, DOI 10.1182/blood-2008-05-156380; Stifanic M, 2009, COMP BIOCHEM PHYS B, V154, P264, DOI 10.1016/j.cbpb.2009.06.011; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Terahara K, 2008, CURR PHARM DESIGN, V14, P131, DOI 10.2174/138161208783378725; Tittel JN, 2000, GENOME BIOL, V1, P1; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; VIARENGO A, 1991, AQUACULTURE, V94, P225, DOI 10.1016/0044-8486(91)90120-V; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker CW, 2011, ADV MAR BIOL, V59, P1, DOI 10.1016/B978-0-12-385536-7.00001-7; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Walter DH, 1998, CIRCULATION, V98, P1153, DOI 10.1161/01.CIR.98.12.1153; Wells PG, 2001, MAR POLLUT BULL, V42, P799, DOI 10.1016/S0025-326X(01)00054-6; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Wiens M, 2001, CELL DEATH DIFFER, V8, P887, DOI 10.1038/sj.cdd.4400906; Wu CY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-159; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yang JL, 2011, DEV COMP IMMUNOL, V35, P827, DOI 10.1016/j.dci.2011.02.013; Yang SB, 2010, DEV COMP IMMUNOL, V34, P538, DOI 10.1016/j.dci.2009.12.014; Zhang G, 2012, NATURE, V1, P1; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zhu BJ, 2008, MOL IMMUNOL, V45, P3198, DOI 10.1016/j.molimm.2008.02.026	102	48	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61502	10.1371/journal.pone.0061502	http://dx.doi.org/10.1371/journal.pone.0061502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626691	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400055
J	Hung, PF; Hong, TM; Hsu, YC; Chen, HY; Chang, YL; Wu, CT; Chang, GC; Jou, YS; Pan, SH; Yang, PC				Hung, Pei-Fang; Hong, Tse-Ming; Hsu, Yi-Chiung; Chen, Hsuan-Yu; Chang, Yih-Leong; Wu, Chen-Tu; Chang, Gee-Chen; Jou, Yuh-Shan; Pan, Szu-Hua; Yang, Pan-Chyr			The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma	PLOS ONE			English	Article							FAMILY-MEMBER 14; CHROMOSOMAL INSTABILITY; HEPATOCELLULAR-CARCINOMA; CYTOKINESIS FAILURE; THERAPEUTIC TARGET; PROGNOSTIC MARKER; RNA INTERFERENCE; CELLS; GENE; TUMORIGENESIS	The motor protein kinesin superfamily proteins (KIFs) are involved in cancer progression. The depletion of one of the KIFs, KIF14, might delay the metaphase-to-anaphase transition, resulting in a binucleated status, which enhances tumor progression; however, the exact correlation between KIF14 and cancer progression remains ambiguous. In this study, using loss of heterozygosity and array comparative genomic hybridization analyses, we observed a 30% loss in the regions surrounding KIF14 on chromosome 1q in lung adenocarcinomas. In addition, the protein expression levels of KIF14 in 122 lung adenocarcinomas also indicated that approximately 30% of adenocarcinomas showed KIF14 down-regulation compared with the expression in the bronchial epithelial cells of adjacent normal counterparts. In addition, the reduced expression of KIF14 mRNA or proteins was correlated with poor overall survival (P = 0.0158 and <0.0001, respectively), and the protein levels were also inversely correlated with metastasis (P<0.0001). The overexpression of KIF14 in lung adenocarcinoma cells inhibited anchorage-independent growth in vitro and xenograft tumor growth in vivo. The overexpression and silencing of KIF14 also inhibited or enhanced cancer cell migration, invasion and adhesion to the extracellular matrix proteins laminin and collagen IV. Furthermore, we detected the adhesion molecules cadherin 11 (CDH11) and melanoma cell adhesion molecule (MCAM) as cargo on KIF14. The overexpression and silencing of KIF14 enhanced or reduced the recruitment of CDH11 in the membrane fraction, suggesting that KIF14 might act through recruiting adhesion molecules to the cell membrane and modulating cell adhesive, migratory and invasive properties. Thus, KIF14 might inhibit tumor growth and cancer metastasis in lung adenocarcinomas.	[Hung, Pei-Fang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hong, Tse-Ming] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Hong, Tse-Ming; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Hsu, Yi-Chiung; Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 10764, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Jou, Yuh-Shan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Szu-Hua; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan	National Defense Medical Center; National Cheng Kung University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Taichung Veterans General Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Yang, PC (corresponding author), Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan.	pcyang@ntu.edu.tw	Jou, Yuh-Shan/O-5921-2018; Chen, Hsuan-Yu/AAE-8428-2019	Jou, Yuh-Shan/0000-0001-5090-3732; YANG, PAN-CHYR/0000-0001-6330-6048; WU, CHEN-TU/0000-0001-8458-4119; CHANG, YIH-LEONG/0000-0001-5309-0554; Pan, Szu-Hua/0000-0002-0138-0434	National Science Council of the Republic of China [NSC98-2628-B-002-086-MY3, NSC100-2321-B-002-071, NSC100-3112-B-006-005]; National Taiwan University [NTU101R7601-2, NTU102R7601-2]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This research was supported through grants from the National Science Council of the Republic of China (NSC98-2628-B-002-086-MY3, NSC100-2321-B-002-071, and NSC100-3112-B-006-005) and National Taiwan University (NTU101R7601-2 and NTU102R7601-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2009, MOL CANCER THER, V8, P1494, DOI 10.1158/1535-7163.MCT-08-0755; Alonso ME, 2005, ONCOL REP, V13, P539; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Ban S, 2001, MUTAT RES-FUND MOL M, V474, P15, DOI 10.1016/S0027-5107(00)00152-4; Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006; Carmona FJ, 2012, J PATHOL; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen D, 2002, CANCER RES, V62, P967; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; FISHER PB, 1979, NATURE, V281, P591, DOI 10.1038/281591a0; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gao J, 2011, TUMOR BIOL, V32, P53, DOI 10.1007/s13277-010-0090-0; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Haruki T, 2010, SURG TODAY, V40, P162, DOI 10.1007/s00595-009-4005-x; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lipka E, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00158; Liu ZJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-156; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Molina I, 1997, J CELL BIOL, V139, P1361, DOI 10.1083/jcb.139.6.1361; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Ohkura H, 1997, J CELL SCI, V110, P945; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Robbins SL, 2010, ROBBINS COTRAN PATHO; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Scanlan M J, 2001, Cancer Immun, V1, P4; Shih LM, 1997, AM J PATHOL, V151, P745; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stevens KN, 2011, BREAST CANCER RES TR, V129, P617, DOI 10.1007/s10549-011-1587-y; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Taniuchi K, 2005, CANCER RES, V65, P105; Taniwaki M, 2007, CLIN CANCER RES, V13, P6624, DOI 10.1158/1078-0432.CCR-07-1328; Theriault BL, 2012, INT J CANCER, V130, P1844, DOI 10.1002/ijc.26189; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; van den Berg R, 2012, ADV EXP MED BIOL, V970, P173, DOI 10.1007/978-3-7091-0932-8_8; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang Q, 2013, CANCER EPIDEMIOL, V37, P79, DOI 10.1016/j.canep.2012.08.011; Yanagawa T, 2004, LAB INVEST, V84, P513, DOI 10.1038/labinvest.3700057; Yu Y, 2010, CANCER-AM CANCER SOC, V116, P5150, DOI 10.1002/cncr.25461; Yuan SS, 2011, J CLIN ONCOL, V29, P3435, DOI 10.1200/JCO.2011.35.3979; Zhou Wei, 2011, Chin J Cancer, V30, P287; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	63	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61664	10.1371/journal.pone.0061664	http://dx.doi.org/10.1371/journal.pone.0061664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626713	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400077
J	Lesterhuis, WJ; Salmons, J; Nowak, AK; Rozali, EN; Khong, A; Dick, IM; Harken, JA; Robinson, BW; Lake, RA				Lesterhuis, W. Joost; Salmons, Joanne; Nowak, Anna K.; Rozali, Esdy N.; Khong, Andrea; Dick, Ian M.; Harken, Julie A.; Robinson, Bruce W.; Lake, Richard A.			Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity	PLOS ONE			English	Article							TUMOR-BEARING MICE; T-CELL RESPONSES; IMMUNOTHERAPY; COMBINATION	Several chemotherapeutics exert immunomodulatory effects. One of these is the nucleoside analogue gemcitabine, which is widely used in patients with lung cancer, ovarian cancer, breast cancer, mesothelioma and several other types of cancer, but with limited efficacy. We hypothesized that the immunopotentiating effects of this drug are partly restrained by the inhibitory T cell molecule CTLA-4 and thus could be augmented by combining it with a blocking antibody against CTLA-4, which on its own has recently shown beneficial clinical effects in the treatment of patients with metastatic melanoma. Here we show, using two non-immunogenic murine tumor models, that treatment with gemcitabine chemotherapy in combination with CTLA-4 blockade results in the induction of a potent anti-tumor immune response. Depletion experiments demonstrated that both CD4(+) and CD8(+) T cells are required for optimal therapeutic effect. Mice treated with the combination exhibited tumor regression and long-term protective immunity. In addition, we show that the efficacy of the combination is moderated by the timing of administration of the two agents. Our results show that immune checkpoint blockade and cytotoxic chemotherapy can have a synergistic effect in the treatment of cancer. These results provide a basis to pursue combination therapies with anti-CTLA-4 and immunopotentiating chemotherapy and have important implications for future studies in cancer patients. Since both drugs are approved for use in patients our data can be immediately translated into clinical trials.	[Lesterhuis, W. Joost; Salmons, Joanne; Nowak, Anna K.; Rozali, Esdy N.; Khong, Andrea; Dick, Ian M.; Harken, Julie A.; Robinson, Bruce W.; Lake, Richard A.] Univ Western Australia, Natl Ctr Asbestos Related Dis, Crawley, WA, Australia; [Lesterhuis, W. Joost; Salmons, Joanne; Nowak, Anna K.; Rozali, Esdy N.; Khong, Andrea; Dick, Ian M.; Harken, Julie A.; Robinson, Bruce W.; Lake, Richard A.] Univ Western Australia, Sir Charles Gairdner Hosp, Sch Med & Pharmacol, Tumour Immunol Grp, Nedlands, WA 6009, Australia; [Lesterhuis, W. Joost] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [Nowak, Anna K.] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA 6009, Australia; [Robinson, Bruce W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; Radboud University Nijmegen; University of Western Australia; University of Western Australia	Lake, RA (corresponding author), Univ Western Australia, Natl Ctr Asbestos Related Dis, Crawley, WA, Australia.	rlake@cyllene.uwa.edu.au	Nowak, Anna K/B-2487-2013; Robinson, Bruce/N-1900-2014	Nowak, Anna K/0000-0002-9317-9526; Lesterhuis, Willem Joost/0000-0002-2718-276X	National Health and Medical Research Council of Australia; Insurance Commission of Western Australia; WJL; Dutch Cancer Society	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia; WJL; Dutch Cancer Society(KWF Kankerbestrijding)	This work was funded by grants from the National Health and Medical Research Council of Australia and the Insurance Commission of Western Australia. WJL is supported by a translational research fellowship of the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty M, 2007, CANCER IMMUNOL IMMUN, V56, P1471, DOI 10.1007/s00262-007-0291-6; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; Gregor PD, 2004, VACCINE, V22, P1700, DOI 10.1016/j.vaccine.2003.10.048; Hersh EM, 2011, INVEST NEW DRUG, V29, P489, DOI 10.1007/s10637-009-9376-8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Lynch TJ, 2012, J CLIN ONCOL; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Mokyr MB, 1998, CANCER RES, V58, P5301; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Nowak AK, 2003, CANCER RES, V63, P4490; Nowak AK, 2002, CANCER RES, V62, P2353; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pedicord VA, 2011, P NATL ACAD SCI USA, V108, P266, DOI 10.1073/pnas.1016791108; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Rettig L, 2011, INT J CANCER, V129, P832, DOI 10.1002/ijc.25756; Robert C, 2011, N ENGL J MED; Topalian SL, 2012, N ENGL J MED; Weber J, 2009, CANCER IMMUNOL IMMUN, V58, P823, DOI 10.1007/s00262-008-0653-8; Wu L, 2012, MOL CANC THER	25	116	124	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61895	10.1371/journal.pone.0061895	http://dx.doi.org/10.1371/journal.pone.0061895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626745	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400109
J	Matziridi, M; Brenner, E; Smeets, JBJ				Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.			Is Mislocalization during Saccades Related to the Position of the Saccade Target within the Image or to the Gaze Position at the End of the Saccade?	PLOS ONE			English	Article							MULLER-LYER-ILLUSION; EYE-MOVEMENTS; PSYCHOPHYSICS TOOLBOX; VISUAL SPACE; INFORMATION; LOCALIZATION; COMPRESSION; PERCEPTION; STIMULATION; SYSTEM	A stimulus that is flashed around the time of a saccade tends to be mislocalized in the direction of the saccade target. Our question is whether the mislocalization is related to the position of the saccade target within the image or to the gaze position at the end of the saccade. We separated the two with a visual illusion that influences the perceived distance to the target of the saccade and thus saccade endpoint without affecting the perceived position of the saccade target within the image. We asked participants to make horizontal saccades from the left to the right end of the shaft of a Muller-Lyer figure. Around the time of the saccade, we flashed a bar at one of five possible positions and asked participants to indicate its location by touching the screen. As expected, participants made shorter saccades along the fins-in (<->) configuration than along the fins-out (>-<) configuration of the figure. The illusion also influenced the mislocalization pattern during saccades, with flashes presented with the fins-out configuration being perceived beyond flashes presented with the fins-in configuration. The difference between the patterns of mislocalization for bars flashed during the saccade for the two configurations corresponded quantitatively with a prediction based on compression towards the saccade endpoint considering the magnitude of the effect of the illusion on saccade amplitude. We conclude that mislocalization is related to the eye position at the end of the saccade, rather than to the position of the saccade target within the image.	[Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Matziridi, M (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands.	m.matziridi@vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Greek State Scholarships Foundation [10079]; Netherlands Organization for Scientific Research, NWO Vici grant [453-08-004]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); Netherlands Organization for Scientific Research, NWO Vici grant(Netherlands Organization for Scientific Research (NWO))	The research leading to these results has received funding from the Greek State Scholarships Foundation (www.iky.gr) under grant agreement number 10079 and the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awater H, 2006, J NEUROSCI, V26, P12, DOI 10.1523/JNEUROSCI.2407-05.2006; Awater H, 2004, J NEUROPHYSIOL, V91, P2457, DOI 10.1152/jn.00821.2003; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bernardis P, 2005, EXP BRAIN RES, V162, P133, DOI 10.1007/s00221-004-2121-9; Binsted G, 1999, EXP BRAIN RES, V127, P193, DOI 10.1007/s002210050789; BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; de Grave DDJ, 2004, EXP BRAIN RES, V155, P56, DOI 10.1007/s00221-003-1708-x; de Grave DDJ, 2006, EXP BRAIN RES, V175, P177, DOI 10.1007/s00221-006-0536-1; de Grave DDJ, 2010, EXP BRAIN RES, V203, P671, DOI 10.1007/s00221-010-2275-6; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; Deubel H, 2002, PROG BRAIN RES, V140, P165; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; FESTINGER L, 1968, PERCEPT PSYCHOPHYS, V3, P376; GILLAM B, 1985, PERCEPT PSYCHOPHYS, V37, P549, DOI 10.3758/BF03204921; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; MACK A, 1985, PERCEPT PSYCHOPHYS, V37, P335, DOI 10.3758/BF03211356; Maij F, 2011, J NEUROSCI, V31, P3708, DOI 10.1523/JNEUROSCI.5097-10.2011; Maij F, 2011, VISION RES, V51, P154, DOI 10.1016/j.visres.2010.10.024; Maij F, 2010, J VISION, V10, DOI 10.1167/10.4.7; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MCILWAIN JT, 1991, VISUAL NEUROSCI, V6, P3, DOI 10.1017/S0952523800000857; Morrone MC, 1997, J NEUROSCI, V17, P7941; Ostendorf F, 2007, J NEUROSCI, V27, P7559, DOI 10.1523/JNEUROSCI.2074-07.2007; Pola J, 2004, VISION RES, V44, P2799, DOI 10.1016/j.visres.2004.06.008; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Smeets JBJ, 2002, EXP BRAIN RES, V147, P135, DOI 10.1007/s00221-002-1185-7; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62436	10.1371/journal.pone.0062436	http://dx.doi.org/10.1371/journal.pone.0062436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626819	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400183
J	Peng, ZL; Ji, ZY; Mei, F; Lu, ML; Ou, Y; Cheng, XD				Peng, Zhonglu; Ji, Zhengyu; Mei, Fang; Lu, Meiling; Ou, Yu; Cheng, Xiaodong			Lithium Inhibits Tumorigenic Potential of PDA Cells through Targeting Hedgehog-GLI Signaling Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PANCREATIC-CANCER CELLS; PHASE-III TRIAL; IN-VITRO; CYCLIN-E; KAPPA-B; GROWTH; GSK3; PROTEINS; DEPHOSPHORYLATION	Hedgehog signaling pathway plays a critical role in the initiation and development of pancreatic ductal adenocarcinoma (PDA) and represents an attractive target for PDA treatment. Lithium, a clinical mood stabilizer for mental disorders, potently inhibits the activity of glycogen synthase kinase 3 beta (GSK3 beta) that promotes the ubiquitin-dependent proteasome degradation of GLI1, an important downstream component of hedgehog signaling. Herein, we report that lithium inhibits cell proliferation, blocks G1/S cell-cycle progression, induces cell apoptosis and suppresses tumorigenic potential of PDA cells through down-regulation of the expression and activity of GLI1. Moreover, lithium synergistically enhances the anticancer effect of gemcitabine. These findings further our knowledge of mechanisms of action for lithium and provide a potentially new therapeutic strategy for PDA through targeting GLI1.	[Peng, Zhonglu; Lu, Meiling; Ou, Yu] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Peng, Zhonglu; Lu, Meiling; Ou, Yu] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Ji, Zhengyu; Mei, Fang; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	China Pharmaceutical University; China Pharmaceutical University; University of Texas System; University of Texas Medical Branch Galveston	Ou, Y (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	ouyu2008@126.com; xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	"111 Project" from the Ministry of Education of China	"111 Project" from the Ministry of Education of China	This work is supported by the "111 Project" from the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; Blotta S, 2012, BLOOD, V120, P5002, DOI 10.1182/blood-2011-07-368142; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Johnson G, 1999, AUST NZ J PSYCHIAT, V33, pS48, DOI 10.1111/j.1440-1614.1999.000668.x; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Kim R, 2011, LANCET ONCOL, V12, P8, DOI 10.1016/S1470-2045(10)70237-0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mazumdar T, 2011, ONCOTARGET, V2, P638; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Philip PA, 2008, LANCET ONCOL, V9, P7, DOI 10.1016/S1470-2045(07)70391-1; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Ronchi A, 2010, INT J ONCOL, V37, P745, DOI 10.3892/ijo_00000724; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schotte P, 2001, J BIOL CHEM, V276, P25939, DOI 10.1074/jbc.M104014200; Shimasaki T, 2012, J GASTROENTEROL, V47, P321, DOI 10.1007/s00535-011-0484-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Spiegelberg BD, 2005, J BIOL CHEM, V280, P5400, DOI 10.1074/jbc.M407890200; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1949, DOI 10.1200/JCO.2006.09.4664; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Vidal F, 2011, INT J ONCOL, V38, P1365, DOI 10.3892/ijo.2011.955; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043119; Zhao QS, 2010, CELL CYCLE, V9, P647; Zhu ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023341	58	31	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61457	10.1371/journal.pone.0061457	http://dx.doi.org/10.1371/journal.pone.0061457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626687	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400050
J	Pickering, JW; Endre, ZH				Pickering, John W.; Endre, Zoltan H.			Linking Injury to Outcome in Acute Kidney Injury: A Matter of Sensitivity	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; URINARY BIOMARKERS; CRITICALLY-ILL; CYSTATIN C; MORTALITY; NGAL; PERFORMANCE; INCREASES; THERAPY; SURGERY	Current consensus definitions of Acute Kidney Injury (AKI) utilise thresholds of change in serum or plasma creatinine and urine output. Biomarkers of renal injury have been validated against these definitions. These biomarkers have also been shown to be independently associated with mortality and need for dialysis. For AKI definitions to include these structural biomarkers, there is a need for an independent outcome against which to judge both markers of functional change and structural markers of injury. We illustrate how sensitivity to need for dialysis and death can be used to link functional and structural (biomarker) based definitions of AKI. We demonstrated the methodology in a representative cohort of critically ill patients, in which an increase of plasma creatinine of >26.4 mu mol/L in 48 hours or >50% in 7 days (Functional-AKI) had a sensitivity of 62% for death or dialysis within 30 days. In a development sub-cohort the urinary neutrophil-gelatinase-associated-lipocalin threshold with a 62% sensitivity for death or dialysis was 140 ng/ml (Structural-AKI). Using these thresholds in a validation sub-cohort, the risk of death or dialysis relative to those with no AKI by either definition was, for combined Structural-AKI and Functional-AKI 3.11 (95% Confidence interval: 2.53 to 3.55), for those with Structural-AKI but not Functional-AKI 1.51 (1.26 to 1.62), and for those with Functional-AKI but not Structural-AKI 1.34 (1.16 to 1.42). Linking functional and structural biomarkers via sensitivity for death and dialysis is a viable method by which to define thresholds for novel biomarkers of AKI.	[Pickering, John W.; Endre, Zoltan H.] Univ Otago, Sch Med & Hlth Sci, Dept Med, Christchurch Kidney Res Grp, Christchurch, New Zealand; [Endre, Zoltan H.] Univ New S Wales, Prince Wales Clin Sch, Dept Nephrol, Sydney, NSW, Australia	University of Otago; University of New South Wales Sydney	Pickering, JW (corresponding author), Univ Otago, Sch Med & Hlth Sci, Dept Med, Christchurch Kidney Res Grp, Christchurch, New Zealand.	john.pickering@otago.ac.nz	Pickering, John/ABC-8089-2021; Pickering, John W/A-9453-2009; Endre, Zoltan/A-3331-2009	Pickering, John/0000-0001-9475-0344; Pickering, John W/0000-0001-9475-0344; Endre, Zoltan/0000-0002-4782-8695	Marsden Foundation New Zealand government [10_UOO_165]; The Health Research Council of New Zealand [05/131]; Lottery Health New Zealand [264923]	Marsden Foundation New Zealand government(Royal Society of New ZealandMarsden Fund (NZ)); The Health Research Council of New Zealand(Health Research Council of New Zealand); Lottery Health New Zealand	JWP was supported by a Marsden Foundation New Zealand government grant administered by the Royal Society of New Zealand (10_UOO_165). The Health Research Council of New Zealand funded the EARLYARF study (grant 05/131) and Lottery Health New Zealand the study (grant 264923) which produced the data for figure 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Endre ZH, 2013, PEDIATR NEPHROL, V28, P207, DOI 10.1007/s00467-012-2171-3; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Guo Y, 2011, EXP THER MED, V2, P1133, DOI 10.3892/etm.2011.339; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; KDIGO Work Group, 2012, KIDNEY INT S, V17, P19, DOI DOI 10.1038/KISUP.2011.32; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a; Liangos O, 2007, J AM SOC NEPHROL, V18, P904, DOI 10.1681/ASN.2006030221; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Nejat M, 2010, CRIT CARE, V14, DOI 10.1186/cc9014; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Pickering JW, 2009, LANCET, V373, P1318, DOI 10.1016/S0140-6736(09)60751-0; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Shibata M, 2000, CYTOKINE, V12, P1526, DOI 10.1006/cyto.2000.0740; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543	29	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62691	10.1371/journal.pone.0062691	http://dx.doi.org/10.1371/journal.pone.0062691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626850	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400214
J	Pipparelli, A; Arsenijevic, Y; Thuret, G; Gain, P; Nicolas, M; Majo, F				Pipparelli, Aurelien; Arsenijevic, Yvan; Thuret, Gilles; Gain, Philippe; Nicolas, Michael; Majo, Francois			ROCK Inhibitor Enhances Adhesion and Wound Healing of Human Corneal Endothelial Cells	PLOS ONE			English	Article							RHO; TRANSPLANTATION; PROLIFERATION; EXPRESSION; MICROSCOPY; MIGRATION; MEMBRANE; PROTEINS; SURVIVAL; THERAPY	Maintenance of corneal transparency is crucial for vision and depends mainly on the endothelium, a non-proliferative monolayer of cells covering the inner part of the cornea. When endothelial cell density falls below a critical threshold, the barrier and "pump" functions of the endothelium are compromised which results in corneal oedema and loss of visual acuity. The conventional treatment for such severe disorder is corneal graft. Unfortunately, there is a worldwide shortage of donor corneas, necessitating amelioration of tissue survival and storage after harvesting. Recently it was reported that the ROCK inhibitor Y-27632 promotes adhesion, inhibits apoptosis, increases the number of proliferating monkey corneal endothelial cells in vitro and enhance corneal endothelial wound healing both in vitro and in vivo in animal models. Using organ culture human cornea (N = 34), the effect of ROCK inhibitor was evaluated in vitro and ex vivo. Toxicity, corneal endothelial cell density, cell proliferation, apoptosis, cell morphometry, adhesion and wound healing process were evaluated by live/dead assay standard cell counting method, EdU labelling, Ki67, Caspase3, Zo-1 and Actin immunostaining. We demonstrated for the first time in human corneal endothelial cells ex vivo and in vitro, that ROCK inhibitor did not induce any toxicity effect and did not alter cell viability. ROCK inhibitor treatment did not induce human corneal endothelial cells proliferation. However, ROCK inhibitor significantly enhanced adhesion and wound healing. The present study shows that the selective ROCK inhibitor Y-27632 has no effect on human corneal endothelial cells proliferative capacities, but alters cellular behaviours. It induces changes in cell shape, increases cell adhesion and enhances wound healing ex vivo and in vitro. Its absence of toxicity, as demonstrated herein, is relevant for its use in human therapy.	[Pipparelli, Aurelien] Univ Western Australia, SCGH, Crawley, Australia; [Arsenijevic, Yvan] Univ Lausanne, Jules Gonin Eye Hosp, Serv Ophthalmol, Unit Gene Therapy & Stem Cell Biol, Lausanne, Switzerland; [Thuret, Gilles] Univ St Etienne, Fac Med, Lab Biol Engn & Imaging Corneal Graft, BiiGC,EA2521, St Etienne, France; [Thuret, Gilles; Gain, Philippe] Inst Univ France, Paris, France; [Pipparelli, Aurelien; Nicolas, Michael; Majo, Francois] Univ Lausanne, Jules Gonin Eye Hosp, Unit Res Lens & Cornea, Lausanne, Switzerland	University of Western Australia; University of Lausanne; Universite Jean Monnet; Institut Universitaire de France; University of Lausanne	Nicolas, M (corresponding author), Univ Lausanne, Jules Gonin Eye Hosp, Unit Res Lens & Cornea, Lausanne, Switzerland.	michael.nicolas@fa2.ch; francois.majo@fa2.ch	Majo, François/GWV-5910-2022	Arsenijevic, Yvan/0000-0001-6960-1291	Explora Pro project, Region Rhone Alpes; region Rhone Alpes (France)	Explora Pro project, Region Rhone Alpes(Region Auvergne-Rhone-Alpes); region Rhone Alpes (France)(Region Auvergne-Rhone-Alpes)	Partly supported by Explora Pro project 2010, Region Rhone Alpes. The region Rhone Alpes (France) allows through Explora Pro funding the sending abroad of french researcher. Aurelien Pipparelli is profitable of this grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon J, 2000, INVEST OPHTH VIS SCI, V41, P2887; BAUM JL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1136; BIGAR F, 1982, OPHTHALMOLOGY, V89, P596; Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; Fuchsluger TA, 2011, GENE THER, V18, P778, DOI 10.1038/gt.2011.20; He ZG, 2012, STEM CELLS, V30, P2523, DOI 10.1002/stem.1212; He ZG, 2011, MOL VIS, V17, P3494; Heindl LM, 2011, AM J OPHTHALMOL, V152, P523, DOI 10.1016/j.ajo.2011.03.021; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Koizumi N, 2010, AGENT PROMOTING CORN; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Leung T, 1996, MOL CELL BIOL, V16, P5313; MATSUDA M, 1985, INVEST OPHTH VIS SCI, V26, P443; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; MISHIMA S, 1982, AM J OPHTHALMOL, V93, P1; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Pipparelli A, 2011, INVEST OPHTH VIS SCI, V52, P6018, DOI 10.1167/iovs.10-6641; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P2930; STAINER GA, 1982, AM J OPHTHALMOL, V93, P456, DOI 10.1016/0002-9394(82)90134-9; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; TREFFERS WF, 1982, OPHTHALMOLOGY, V89, P605; WULLE KG, 1972, INVEST OPHTH VISUAL, V11, P897; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018271; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212	40	88	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62095	10.1371/journal.pone.0062095	http://dx.doi.org/10.1371/journal.pone.0062095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626771	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400135
J	Shah, KP; Douglas, JA				Shah, Kaanan P.; Douglas, Julie A.			A Method to Prioritize Quantitative Traits and Individuals for Sequencing in Family-Based Studies	PLOS ONE			English	Article							OLD ORDER AMISH; LANCASTER COUNTY; PLASMA-LEVELS; CHOLESTEROL; PEDIGREES; VARIANTS	Owing to recent advances in DNA sequencing, it is now technically feasible to evaluate the contribution of rare variation to complex traits and diseases. However, it is still cost prohibitive to sequence the whole genome (or exome) of all individuals in each study. For quantitative traits, one strategy to reduce cost is to sequence individuals in the tails of the trait distribution. However, the next challenge becomes how to prioritize traits and individuals for sequencing since individuals are often characterized for dozens of medically relevant traits. In this article, we describe a new method, the Rare Variant Kinship Test (RVKT), which leverages relationship information in family-based studies to identify quantitative traits that are likely influenced by rare variants. Conditional on nuclear families and extended pedigrees, we evaluate the power of the RVKT via simulation. Not unexpectedly, the power of our method depends strongly on effect size, and to a lesser extent, on the frequency of the rare variant and the number and type of relationships in the sample. As an illustration, we also apply our method to data from two genetic studies in the Old Order Amish, a founder population with extensive genealogical records. Remarkably, we implicate the presence of a rare variant that lowers fasting triglyceride levels in the Heredity and Phenotype Intervention (HAPI) Heart study (p = 0.044), consistent with the presence of a previously identified null mutation in the APOC3 gene that lowers fasting triglyceride levels in HAPI Heart study participants.	[Shah, Kaanan P.; Douglas, Julie A.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Douglas, JA (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	jddoug@umich.edu			National Institutes of Health (NIH) [R01 CA122844, T32 HG00040]; NIH [U01 HL02010]; NATIONAL CANCER INSTITUTE [R01CA122844] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by National Institutes of Health (NIH) grants R01 CA122844 and T32 HG00040. Collection of the HAPI Heart study data was previously supported by NIH U01 HL02010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Agarwala R, 2001, HUM BIOL, V73, P533, DOI 10.1353/hub.2001.0045; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Douglas JA, 2008, CANCER EPIDEM BIOMAR, V17, P3509, DOI 10.1158/1055-9965.EPI-08-0480; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; LANDER ES, 1989, GENETICS, V121, P185; Lange K., 2002, MATH STAT METHODS GE; Lee WJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-68; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu F, 2008, EUR J HUM GENET, V16, P854, DOI 10.1038/ejhg.2008.24; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nelson MR, 2012, SCIENCE; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62545	10.1371/journal.pone.0062545	http://dx.doi.org/10.1371/journal.pone.0062545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626830	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400194
J	van Hees, VT; Gorzelniak, L; Leon, ECD; Eder, M; Pias, M; Taherian, S; Ekelund, U; Renstrom, F; Franks, PW; Horsch, A; Brage, S				van Hees, Vincent T.; Gorzelniak, Lukas; Leon, Emmanuel Carlos Dean; Eder, Martin; Pias, Marcelo; Taherian, Salman; Ekelund, Ulf; Renstrom, Frida; Franks, Paul W.; Horsch, Alexander; Brage, Soren			Separating Movement and Gravity Components in an Acceleration Signal and Implications for the Assessment of Human Daily Physical Activity	PLOS ONE			English	Article							LIVING ENERGY-EXPENDITURE; ACCELEROMETRY; ORIENTATION; VALIDATION	Introduction: Human body acceleration is often used as an indicator of daily physical activity in epidemiological research. Raw acceleration signals contain three basic components: movement, gravity, and noise. Separation of these becomes increasingly difficult during rotational movements. We aimed to evaluate five different methods (metrics) of processing acceleration signals on their ability to remove the gravitational component of acceleration during standardised mechanical movements and the implications for human daily physical activity assessment. Methods: An industrial robot rotated accelerometers in the vertical plane. Radius, frequency, and angular range of motion were systematically varied. Three metrics (Euclidian norm minus one [ENMO], Euclidian norm of the high-pass filtered signals [HFEN], and HFEN plus Euclidean norm of low-pass filtered signals minus 1 g [HFEN+]) were derived for each experimental condition and compared against the reference acceleration (forward kinematics) of the robot arm. We then compared metrics derived from human acceleration signals from the wrist and hip in 97 adults (22-65 yr), and wrist in 63 women (20-35 yr) in whom daily activity-related energy expenditure (PAEE) was available. Results: In the robot experiment, HFEN+ had lowest error during (vertical plane) rotations at an oscillating frequency higher than the filter cut-off frequency while for lower frequencies ENMO performed better. In the human experiments, metrics HFEN and ENMO on hip were most discrepant (within- and between-individual explained variance of 0.90 and 0.46, respectively). ENMO, HFEN and HFEN+ explained 34%, 30% and 36% of the variance in daily PAEE, respectively, compared to 26% for a metric which did not attempt to remove the gravitational component (metric EN). Conclusion: In conclusion, none of the metrics as evaluated systematically outperformed all other metrics across a wide range of standardised kinematic conditions. However, choice of metric explains different degrees of variance in daily human physical activity.	[van Hees, Vincent T.; Ekelund, Ulf; Brage, Soren] Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [van Hees, Vincent T.] Newcastle Univ, Inst Cellular Med, MoveLab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorzelniak, Lukas; Horsch, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany; [Leon, Emmanuel Carlos Dean; Eder, Martin] Tech Univ Munich, Fak Informat, Munich, Germany; [Pias, Marcelo; Taherian, Salman] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Renstrom, Frida; Franks, Paul W.] Umea Univ Hosp, Dept Publ Hlth & Clin Med, Genet Epidemiol & Clin Res Grp, Med Sect, S-90185 Umea, Sweden; [Renstrom, Frida; Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden	University of Cambridge; Newcastle University - UK; Technical University of Munich; Technical University of Munich; University of Cambridge; Norwegian School of Sport Sciences; Umea University; Lund University	van Hees, VT (corresponding author), Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England.	vincent.van-hees@newcastle.ac.uk; soren.brage@mrc-epid.cam.ac.uk	Brage, Soren/C-6415-2013; Horsch, Alexander/W-8322-2018; Franks, Paul/AAA-3300-2020; Pias, Marcelo/S-5865-2019; Ekelund, Ulf/AAE-8471-2019	Brage, Soren/0000-0002-1265-7355; Horsch, Alexander/0000-0001-7745-0139; Pias, Marcelo/0000-0001-6728-2725; Ekelund, Ulf/0000-0003-2115-9267; Franks, Paul/0000-0002-0520-7604; van Hees, Vincent/0000-0003-0182-9008	Medical Research Council [MC_U106179473]; BBSRC industry CASE studentship (Unilever, UK); LifeGene (Torsten and Ragnar Soderbergs Foundation); Fredrik and Ingrid Thurings Foundation; Umea University Young Investigator's Award; Vasterbottens regional health authority; Medical Research Council [MC_UU_12015/3] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U106179473] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC industry CASE studentship (Unilever, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LifeGene (Torsten and Ragnar Soderbergs Foundation); Fredrik and Ingrid Thurings Foundation; Umea University Young Investigator's Award; Vasterbottens regional health authority; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Medical Research Council funded the study (MC_U106179473). VVH was funded by a BBSRC industry CASE studentship (Unilever, UK). The Doubly labelled water pat of the study was supported by Grants from LifeGene (Torsten and Ragnar Soderbergs Foundation), Fredrik and Ingrid Thurings Foundation, Umea University Young Investigator's Award, and the Vasterbottens regional health authority (all grants to PWF). GENEA monitors in the Swedish study were loaned pro gratis from Unilever Discover Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminian K, 1999, MED BIOL ENG COMPUT, V37, P304, DOI 10.1007/BF02513304; Assah FK, 2009, OBESITY, V17, P1588, DOI 10.1038/oby.2009.39; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; BOURKE AK, 2011, C P IEEE ENG MED BIO, P7896; Bouten CVC, 1997, MED BIOL ENG COMPUT, V35, P50, DOI 10.1007/BF02510392; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Colley RC, 2010, HLTH REP, V22, P15; Corder K, 2011, OBESITY SILVER SPRIN, V18, P2212; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Kyriakopoulos KJ, 1988, IEEE INT C ROB AUT 2; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Piazzi A, 1997, IEEE DECIS CONTR P, P1924, DOI 10.1109/CDC.1997.657874; Plasqui G, 2005, OBES RES, V13, P1363, DOI 10.1038/oby.2005.165; Redmond DP, 1985, BEHAV RES METHODS, V17, P11; Roetenberg D, 2007, IEEE T BIO-MED ENG, V54, P883, DOI 10.1109/TBME.2006.889184; Rothney MP, 2010, MED SCI SPORT EXER, V42, P1785, DOI 10.1249/MSS.0b013e3181d5a984; Sabatini AM, 2006, IEEE T BIO-MED ENG, V53, P1346, DOI 10.1109/TBME.2006.875664; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; van Hees VT, 2010, 2 IEEE INT WOWMOM WO, P1; VanSomeren EJW, 1996, J NEUROSCI METH, V65, P55, DOI 10.1016/0165-0270(95)00146-8; Veltink P H, 1996, IEEE Trans Rehabil Eng, V4, P375, DOI 10.1109/86.547939; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Yun X., 2003, 2003 IEEE RSJ INT C, V2, P1074	25	366	369	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61691	10.1371/journal.pone.0061691	http://dx.doi.org/10.1371/journal.pone.0061691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626718	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400082
J	Atanasov, AG; Blunder, M; Fakhrudin, N; Liu, X; Noha, SM; Malainer, C; Kramer, MP; Cocic, A; Kunert, O; Schinkovitz, A; Heiss, EH; Schuster, D; Dirsch, VM; Bauer, R				Atanasov, Atanas G.; Blunder, Martina; Fakhrudin, Nanang; Liu, Xin; Noha, Stefan M.; Malainer, Clemens; Kramer, Matthias P.; Cocic, Amina; Kunert, Olaf; Schinkovitz, Andreas; Heiss, Elke H.; Schuster, Daniela; Dirsch, Verena M.; Bauer, Rudolf			Polyacetylenes from Notopterygium incisum-New Selective Partial Agonists of Peroxisome Proliferator-Activated Receptor-Gamma	PLOS ONE			English	Article							PPAR-GAMMA; INSIGHTS; AFFINITY; LIGAND; EXPRESSION; COMPLEX; FAMILY; FAT	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a key regulator of glucose and lipid metabolism and therefore an important pharmacological target to combat metabolic diseases. Since the currently used full PPAR gamma agonists display serious side effects, identification of novel ligands, particularly partial agonists, is highly relevant. Searching for new active compounds, we investigated extracts of the underground parts of Notopterygium incisum, a medicinal plant used in traditional Chinese medicine, and observed significant PPAR gamma activation using a PPAR gamma-driven luciferase reporter model. Activity-guided fractionation of the dichloromethane extract led to the isolation of six polyacetylenes, which displayed properties of selective partial PPAR gamma agonists in the luciferase reporter model. Since PPAR gamma activation by this class of compounds has so far not been reported, we have chosen the prototypical polyacetylene falcarindiol for further investigation. The effect of falcarindiol (10 mu M) in the luciferase reporter model was blocked upon co-treatment with the PPAR gamma antagonist T0070907 (1 mu M). Falcarindiol bound to the purified human PPAR gamma receptor with a K-i of 3.07 mu M. In silico docking studies suggested a binding mode within the ligand binding site, where hydrogen bonds to Cys285 and Glu295 are predicted to be formed in addition to extensive hydrophobic interactions. Furthermore, falcarindiol further induced 3T3-L1 preadipocyte differentiation and enhanced the insulin-induced glucose uptake in differentiated 3T3-L1 adipocytes confirming effectiveness in cell models with endogenous PPAR gamma expression. In conclusion, we identified falcarindiol-type polyacetylenes as a novel class of natural partial PPAR gamma agonists, having potential to be further explored as pharmaceutical leads or dietary supplements.	[Atanasov, Atanas G.; Fakhrudin, Nanang; Malainer, Clemens; Kramer, Matthias P.; Cocic, Amina; Heiss, Elke H.; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, Vienna, Austria; [Blunder, Martina; Liu, Xin; Schinkovitz, Andreas; Bauer, Rudolf] Karl Franzens Univ Graz, Dept Pharmacognosy, Inst Pharmaceut Sci, Graz, Austria; [Noha, Stefan M.; Schuster, Daniela] Univ Innsbruck, Inst Pharm Pharmaceut Chem, A-6020 Innsbruck, Austria; [Noha, Stefan M.; Schuster, Daniela] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Fakhrudin, Nanang] Gadjah Mada Univ, Fac Pharm, Dept Pharmaceut Biol, Yogyakarta, Indonesia; [Kunert, Olaf] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Inst Pharmaceut Sci, Graz, Austria	University of Vienna; University of Graz; University of Innsbruck; University of Innsbruck; Gadjah Mada University; University of Graz	Atanasov, AG (corresponding author), Univ Vienna, Dept Pharmacognosy, Vienna, Austria.	atanas.atanasov@univie.ac.at	Schuster, Daniela/C-1024-2014; Kramer, Matthias/L-1782-2016; Bauer, Rudolf/F-8468-2010; Heiss, Elke/B-6086-2015; Blunder, Martina/I-5948-2013; Atanasov, Atanas G./C-5535-2013; Fakhrudin, Nanang/AED-3803-2022; Kramer, Matthias P/A-6224-2009	Schuster, Daniela/0000-0002-9933-8938; Kramer, Matthias/0000-0002-0289-5261; Bauer, Rudolf/0000-0002-0057-5547; Heiss, Elke/0000-0001-7618-5505; Blunder, Martina/0000-0002-0066-8217; Atanasov, Atanas G./0000-0003-2545-0967; Kunert, Olaf/0000-0002-7091-5973; Dirsch, Verena/0000-0002-9261-5293; fakhrudin, nanang/0000-0001-7954-9503	Austrian Science Fund (FWF-NFN) [S10704, S10705, S10711]; Austrian Federal Ministry for Science and Research [ACM-2007-00178, ACM-2008-00857, ACM-2009-01206]	Austrian Science Fund (FWF-NFN)(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research	This work was financed by the Austrian Science Fund (FWF-NFN; project "Drugs from Nature Targeting Inflammation" (DNTI), project parts S10704, S10705, and S10711), and the Austrian Federal Ministry for Science and Research (ACM-2007-00178, ACM-2008-00857, and ACM-2009-01206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P246, DOI 10.1016/j.reprotox.2008.10.001; Agrawal R, 2012, MINI-REV MED CHEM, V12, P87, DOI 10.2174/138955712798995048; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378; Bhalla K, 2011, J BIOL CHEM, V286, P41626, DOI 10.1074/jbc.M111.257915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandalia A, 2009, PPAR RES, V2009, DOI 10.1155/2009/706852; Chang F, 2007, ANN PHARMACOTHER, V41, P973, DOI 10.1345/aph.1K013; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chien SC, 2009, PHYTOCHEMISTRY, V70, P1246, DOI 10.1016/j.phytochem.2009.07.011; Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005; Christensen LP, 2006, J PHARMACEUT BIOMED, V41, P683, DOI 10.1016/j.jpba.2006.01.057; Christensen Lars P, 2011, Recent Pat Food Nutr Agric, V3, P64; Chung JY, 2009, J CHEM INF MODEL, V49, P2382, DOI 10.1021/ci900231p; Copland JA, 2006, ONCOGENE, V25, P2304, DOI 10.1038/sj.onc.1209267; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Fredenrich A, 2005, DIABETES METAB, V31, P23, DOI 10.1016/S1262-3636(07)70162-3; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Guasch L, 2011, J COMPUT AID MOL DES, V25, P717, DOI 10.1007/s10822-011-9446-9; Hansen MK, 2008, CURR OPIN INVEST DR, V9, P247; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liu X, 2009, J ETHNOPHARMACOL, V126, P474, DOI 10.1016/j.jep.2009.09.011; Marion-Letellier R, 2009, GUT, V58, P586, DOI 10.1136/gut.2008.162859; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Patsouris David, 2004, Curr Opin Investig Drugs, V5, P1045; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Soltoft M, 2010, J AGR FOOD CHEM, V58, P7673, DOI 10.1021/jf101921v; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Yumuk VD, 2006, ANN NY ACAD SCI, V1083, P306, DOI 10.1196/annals.1367.019; Zhang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028253; Ziouzenkova O, 2004, CURR OPIN CLIN NUTR, V7, P369, DOI 10.1097/01.mco.0000134358.46159.61; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007; Zschocke S, 1997, PLANTA MED, V63, P203, DOI 10.1055/s-2006-957653	51	51	55	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61755	10.1371/journal.pone.0061755	http://dx.doi.org/10.1371/journal.pone.0061755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630612	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500065
J	McMurdie, PJ; Holmes, S				McMurdie, Paul J.; Holmes, Susan			phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data	PLOS ONE			English	Article							CD-HIT; DIVERSITY; SEQUENCE; SERVER; BIOINFORMATICS; METAGENOMICS; COMMUNITIES; RESOURCE; TOOLS	Background: The analysis of microbial communities through DNA sequencing brings many challenges: the integration of different types of data with methods from ecology, genetics, phylogenetics, multivariate statistics, visualization and testing. With the increased breadth of experimental designs now being pursued, project-specific statistical analyses are often needed, and these analyses are often difficult (or impossible) for peer researchers to independently reproduce. The vast majority of the requisite tools for performing these analyses reproducibly are already implemented in R and its extensions (packages), but with limited support for high throughput microbiome census data. Results: Here we describe a software project, phyloseq, dedicated to the object-oriented representation and analysis of microbiome census data in R. It supports importing data from a variety of common formats, as well as many analysis techniques. These include calibration, filtering, subsetting, agglomeration, multi-table comparisons, diversity analysis, parallelized Fast UniFrac, ordination methods, and production of publication-quality graphics; all in a manner that is easy to document, share, and modify. We show how to apply functions from other R packages to phyloseq-represented data, illustrating the availability of a large number of open source analysis techniques. We discuss the use of phyloseq with tools for reproducible research, a practice common in other fields but still rare in the analysis of highly parallel microbiome census data. We have made available all of the materials necessary to completely reproduce the analysis and figures included in this article, an example of best practices for reproducible research. Conclusions: The phyloseq project for R is a new open-source software package, freely available on the web from both GitHub and Bioconductor.	[McMurdie, Paul J.; Holmes, Susan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University	Holmes, S (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	susan@stat.stanford.edu		McMurdie, Paul/0000-0001-8879-3954; Holmes, Susan/0000-0002-2208-8168	 [NIH-R01GM086884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086884] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant NIH-R01GM086884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire J, 2013, MARKDOWN PACKAGE MAR; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2011, 8 ANN BIOT BIOINF S; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Beck D., 2011, BIOINFORMATICS; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carey VJ, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P149, DOI 10.1007/978-1-4419-5714-6_8; Chakerian J, 2010, DISTORY DISTANCES TR; Chambers JM, 2008, STAT COMPUT SER, P1; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Copeland WK, 2012, BIOINFORMATICS, V28, P2198, DOI 10.1093/bioinformatics/bts338; Csardi N., 2006, INT J COMP SYST, V1695, P1; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donoho DL, 2010, BIOSTATISTICS, V11, P385, DOI 10.1093/biostatistics/kxq028; Efron B., 1993, INTRO BOOTSTRAP, V57; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gentleman R., 2004, BIOCONDUCTOR PROJECT, V2; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Greenacre M., 2007, CORRES ANAL PRACTICE; Greenacre M.J., 1984, THEORY APPL CORRES A; Hamady M, 2009, ISME J; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hardle W, 2002, COMPST 2002 P COMP S; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Holmes S, 2003, STAT SCI, V18, P241, DOI 10.1214/ss/1063994979; Holmes S, 2012, PNAS SOCIAL IN PRESS; Holmes S, 2011, BIOCOMPUT-PAC SYM, P142; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Kunin V, 2010, OPEN J; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; McDonald D, 2012, BIOL OBSERVATION MAT; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; McMurdie PJ, 2013, PACKAGE MANUAL PHYLO; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Nelson T, 2010, GASTROENTEROLOGY; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Pollard KS, 2010, MULTTEST RESAMPLING; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; R Development Core Team, 2012, WRIT R EXT COMPR R A; Rajaram S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-45; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Simpson GL, 2013, CRAN TASK VIEW ANAL; Stroustrup B, 2000, C PROGRAMMING LANGUA; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thioulouse J, 2011, ANN APPL STAT, V5, P2300, DOI 10.1214/10-AOAS372; Tufte ER, 2001, VISUAL DISPLAY QUANT, P178; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wickham H, ROXYGEN2 IN SOURCE D; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Wilkinson L., 2005, GRAMMAR GRAPHICS STA, V2nd; Xie Y., 2012, KNITR GEN PURPOSE PA	87	7474	7532	22	452	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61217	10.1371/journal.pone.0061217	http://dx.doi.org/10.1371/journal.pone.0061217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630581	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500023
J	Anderson, RD; Blanford, S; Jenkins, NE; Thomas, MB				Anderson, Robert D.; Blanford, Simon; Jenkins, Nina E.; Thomas, Matthew B.			Discriminating Fever Behavior in House Flies	PLOS ONE			English	Article							MUSCA-DOMESTICA DIPTERA; BODY-TEMPERATURE; INFECTION; MUSCIDAE; GROWTH; LOCUST; IMPACT; COST	Fever has generally been shown to benefit infected hosts. However, fever temperatures also carry costs. While endotherms are able to limit fever costs physiologically, the means by which behavioral thermoregulators constrain these costs are less understood. Here we investigated the behavioral fever response of house flies (Musca domestica L.) challenged with different doses of the fungal entomopathogen, Beauveria bassiana. Infected flies invoked a behavioral fever selecting the hottest temperature early in the day and then moving to cooler temperatures as the day progressed. In addition, flies infected with a higher dose of fungus exhibited more intense fever responses. These variable patterns of fever are consistent with the observation that higher fever temperatures had greater impact on fungal growth. The results demonstrate the capacity of insects to modulate the degree and duration of the fever response depending on the severity of the pathogen challenge and in so doing, balance the costs and benefits of fever.	[Anderson, Robert D.; Blanford, Simon; Jenkins, Nina E.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Anderson, Robert D.; Blanford, Simon; Jenkins, Nina E.; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Blanford, Simon; Thomas, Matthew B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blanford, S (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	stb13@psu.edu			NSF-EID [EF-0914384]; Pennsylvania Department of Health	NSF-EID; Pennsylvania Department of Health	This research was funded, in part, by an NSF-EID grant (EF-0914384), and a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.	Anderson RD, 2013, ECOL ENTOMOL, V38, P1, DOI 10.1111/j.1365-2311.2012.01394.x; Anderson RD, 2011, J INVERTEBR PATHOL, V107, P179, DOI 10.1016/j.jip.2011.04.004; ARORA KL, 1979, TERATOLOGY, V19, P251, DOI 10.1002/tera.1420190216; Blanford S, 2000, ENVIRON ENTOMOL, V29, P1060, DOI 10.1603/0046-225X-29.5.1060; BRONSTEIN SM, 1984, J INSECT PHYSIOL, V30, P327, DOI 10.1016/0022-1910(84)90134-3; Bundey S, 2003, ARCH INSECT BIOCHEM, V52, P183, DOI 10.1002/arch.10081; DALECY LG, 1975, J PHYSIOL-LONDON, V253, P223, DOI 10.1113/jphysiol.1975.sp011188; do Amaral JPS, 2002, PHYSIOL BIOCHEM ZOOL, V75, P273, DOI 10.1086/341816; Elliot SL, 2005, BIOL LETT-UK, V1, P181, DOI 10.1098/rsbl.2004.0279; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hanson DF, 1997, ANN NY ACAD SCI, V813, P453, DOI 10.1111/j.1749-6632.1997.tb51733.x; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; Kalsbeek V, 2001, BIOL CONTROL, V21, P264, DOI 10.1006/bcon.2001.0943; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; KLUGER MJ, 1979, FED PROC, V38, P30; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; MUCHLINSKI AE, 1985, COMP BIOCHEM PHYS A, V81, P577, DOI 10.1016/0300-9629(85)91028-X; Ouedraogo RM, 2003, J INVERTEBR PATHOL, V82, P103, DOI 10.1016/S0022-2011(02)00185-4; RAMOS AB, 1993, COMP BIOCHEM PHYS A, V105, P479, DOI 10.1016/0300-9629(93)90423-2; Rasband W., 2006, IMAGEJ; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sherman E, 1998, J THERM BIOL, V23, P49, DOI 10.1016/S0306-4565(97)00045-4; Stanley D, 2009, J INNATE IMMUN, V1, P282, DOI 10.1159/000210371; Stanley DW, 1998, AM ZOOL, V38, P369; TOMS GL, 1977, BRIT J EXP PATHOL, V58, P444; WATSON DW, 1993, J INVERTEBR PATHOL, V61, P10, DOI 10.1006/jipa.1993.1003	28	20	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62269	10.1371/journal.pone.0062269	http://dx.doi.org/10.1371/journal.pone.0062269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620820	Green Published, gold			2022-12-25	WOS:000317909500100
J	Bjorum, SM; Simonette, RA; Alanis, R; Wang, JE; Lewis, BM; Trejo, MH; Hanson, KA; Beckingham, KM				Bjorum, Sonia M.; Simonette, Rebecca A.; Alanis, Raul, Jr.; Wang, Jennifer E.; Lewis, Benjamin M.; Trejo, Michael H.; Hanson, Keith A.; Beckingham, Kathleen M.			The Drosophila BTB Domain Protein Jim Lovell Has Roles in Multiple Larval and Adult Behaviors	PLOS ONE			English	Article							CHORION GENE AMPLIFICATION; DORSAL TISSUES; PRONEURAL GENE; BROAD-COMPLEX; DNA-BINDING; EXPRESSION; SPECIFICATION; ECDYSONE; MELANOGASTER; AMNIOSEROSA	Innate behaviors have their origins in the specification of neural fates during development. Within Drosophila, BTB (Bric-a-brac, Tramtrack, Broad) domain proteins such as Fruitless are known to play key roles in the neural differentiation underlying such responses. We previously identified a gene, which we have termed jim lovell (lov), encoding a BTB protein with a role in gravity responses. To understand more fully the behavioral roles of this gene we have investigated its function through several approaches. Transcript and protein expression patterns have been examined and behavioral phenotypes of new lov mutations have been characterized. Lov is a nuclear protein, suggesting a role as a transcriptional regulator, as for other BTB proteins. In late embryogenesis, Lov is expressed in many CNS and PNS neurons. An examination of the PNS expression indicates that lov functions in the late specification of several classes of sensory neurons. In particular, only two of the five abdominal lateral chordotonal neurons express Lov, predicting functional variation within this highly similar group. Surprisingly, Lov is also expressed very early in embryogenesis in ways that suggests roles in morphogenetic movements, amnioserosa function and head neurogenesis. The phenotypes of two new lov mutations that delete adjacent non-coding DNA regions are strikingly different suggesting removal of different regulatory elements. In lov(47), Lov expression is lost in many embryonic neurons including the two lateral chordotonal neurons. lov(47) mutant larvae show feeding and locomotor defects including spontaneous backward movement. Adult lov(47) males perform aberrant courtship behavior distinguished by courtship displays that are not directed at the female. lov(47) adults also show more defective negative gravitaxis than the previously isolated lov(91Y) mutant. In contrast, lov(66) produces largely normal behavior but severe female sterility associated with ectopic lov expression in the ovary. We propose a negative regulatory role for the DNA deleted in lov(66).	[Bjorum, Sonia M.; Simonette, Rebecca A.; Alanis, Raul, Jr.; Wang, Jennifer E.; Lewis, Benjamin M.; Trejo, Michael H.; Hanson, Keith A.; Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Beckingham, KM (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	kate@rice.edu		Hanson, Keith Andreas/0000-0002-8517-5621	NASA [NNX09AH43G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA grant NNX09AH43G to Kathleen M. Beckingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM M, 1987, DEVELOPMENT, V101, P1; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Armstrong JD, 2006, GENES BRAIN BEHAV, V5, P222, DOI 10.1111/j.1601-183X.2005.00154.x; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Beckingham KM, 2005, ADV GENET, V55, P105, DOI 10.1016/S0065-2660(05)55004-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bjorum SM, 2010, THESIS RICE U, P60; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Bogart K., 2006, 200610 CGB, DOI [10.2506/cgbtr-200610, DOI 10.2506/CGBTR-200610]; Boyle MJ, 2009, DEVELOPMENT, V136, P4187, DOI 10.1242/dev.042770; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Colas JF, 1999, MECH DEVELOP, V87, P77, DOI 10.1016/S0925-4773(99)00141-0; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; Deng WM, 1997, DEVELOPMENT, V124, P4639; Doggett K, 2011, DEV BIOL, V355, P381, DOI 10.1016/j.ydbio.2011.04.030; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; French RL, 2003, DEV BIOL, V253, P18, DOI 10.1006/dbio.2002.0856; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; GODT D, 1993, DEVELOPMENT, V119, P799; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; HALLER J, 1987, GENE DEV, V1, P862, DOI 10.1101/gad.1.8.862; Heitzler P, 1996, GENETICS, V143, P1271; Hou HY, 2009, DEV BIOL, V335, P442, DOI 10.1016/j.ydbio.2009.08.004; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JACKSON PD, 1994, DEV DYNAM, V199, P28, DOI 10.1002/aja.1001990104; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; Koseki T, 2004, CHEM SENSES, V29, P703, DOI 10.1093/chemse/bjh075; Lamka ML, 1999, DEV BIOL, V214, P102, DOI 10.1006/dbio.1999.9409; Landis G, 1999, DEVELOPMENT, V126, P4281; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Mellert DJ, 2012, GENETICS, V191, P1129, DOI 10.1534/genetics.112.140475; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Okabe M, 1997, DEVELOPMENT, V124, P1045; Orgogozo V, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-4; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; ROBERTSON HM, 1988, GENETICS, V118, P461; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Shim K, 2001, DEVELOPMENT, V128, P4923; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Stagg SB, 2011, DEVELOPMENT, V138, P2171, DOI 10.1242/dev.056507; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Tzolovsky G, 1999, GENETICS, V153, P1371; Van Doren M, 1998, CURR BIOL, V8, P243; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; WINICK J, 1993, DEVELOPMENT, V119, P1055; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	61	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61270	10.1371/journal.pone.0061270	http://dx.doi.org/10.1371/journal.pone.0061270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620738	Green Published, gold			2022-12-25	WOS:000317909500018
J	Moiset, G; Cirac, AD; Stuart, MCA; Marrink, SJ; Sengupta, D; Poolman, B				Moiset, Gemma; Cirac, Anna D.; Stuart, Marc C. A.; Marrink, Siewert-Jan; Sengupta, Durba; Poolman, Bert			Dual Action of BPC194: A Membrane Active Peptide Killing Bacterial Cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PLANT-PATHOGENIC BACTERIA; ANTIMICROBIAL PEPTIDES; PENETRATING PEPTIDES; VESICLE FUSION; ALTERNATIVE MECHANISMS; MEDIATED FUSION; CYCLIC-PEPTIDES; PORE FORMATION; AGGREGATION	Membrane active peptides can perturb the lipid bilayer in several ways, such as poration and fusion of the target cell membrane, and thereby efficiently kill bacterial cells. We probe here the mechanistic basis of membrane poration and fusion caused by membrane-active, antimicrobial peptides. We show that the cyclic antimicrobial peptide, BPC194, inhibits growth of Gram-negative bacteria and ruptures the outer and inner membrane at the onset of killing, suggesting that not just poration is taking place at the cell envelope. To simplify the system and to better understand the mechanism of action, we performed Forster resonance energy transfer and cryogenic transmission electron microscopy studies in model membranes and show that the BPC194 causes fusion of vesicles. The fusogenic action is accompanied by leakage as probed by dual-color fluorescence burst analysis at a single liposome level. Atomistic molecular dynamics simulations reveal how the peptides are able to simultaneously perturb the membrane towards porated and fused states. We show that the cyclic antimicrobial peptides trigger both fusion and pore formation and that such large membrane perturbations have a similar mechanistic basis.	[Moiset, Gemma; Cirac, Anna D.; Stuart, Marc C. A.; Marrink, Siewert-Jan; Sengupta, Durba; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands; [Moiset, Gemma; Cirac, Anna D.; Stuart, Marc C. A.; Marrink, Siewert-Jan; Sengupta, Durba; Poolman, Bert] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands; [Moiset, Gemma; Cirac, Anna D.; Stuart, Marc C. A.; Marrink, Siewert-Jan; Sengupta, Durba; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Cirac, Anna D.] Univ Girona, Inst Computat Chem, Girona, Spain; [Sengupta, Durba] CSIR Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India	University of Groningen; University of Groningen; University of Groningen; Universitat de Girona; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sengupta, D (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands.	d.sengupta@ncl.res.in; b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Marrink, Siewert J/G-3706-2014; Stuart, Marc/B-6274-2008	Marrink, Siewert J/0000-0001-8423-5277; Stuart, Marc/0000-0003-0667-6338; Sengupta, Durba/0000-0002-3138-1024	Zernike Institute for Advanced Materials; Spanish Ministerio de Ciencia e Innovacion [BES-2006-11671]; HPC-EUROPA2 [228398]; European Commission-Capacities Area-Research Infrastructures; SysMo via the Biotechnology and Biological Sciences Research Council; Netherlands Organization for Scientific Research, NWO [700-56-302]; NWO	Zernike Institute for Advanced Materials; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); HPC-EUROPA2; European Commission-Capacities Area-Research Infrastructures; SysMo via the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Netherlands Organization for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	GM and BP acknowledge the Zernike Institute for Advanced Materials to support the appointment of GM and research. ADC thanks the Spanish Ministerio de Ciencia e Innovacion (grant No. BES-2006-11671) and HPC-EUROPA2 (project No. 228398) with the support of the European Commission-Capacities Area-Research Infrastructures; BP thanks SysMo via the Biotechnology and Biological Sciences Research Council-funded KosmoBac program and the Netherlands Organization for Scientific Research, NWO, for the TOP-subsidy grant No. 700-56-302; DS and SJM acknowledge the NWO for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Baoukina S, 2010, BIOPHYS J, V99, P2134, DOI 10.1016/j.bpj.2010.07.049; Bechinger B, 2009, CURR OPIN COLLOID IN, V14, P349, DOI 10.1016/j.cocis.2009.02.004; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bond PJ, 2010, PROTEIN PEPTIDE LETT, V17, P1313; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cirac AD, 2011, BIOPHYS J, V100, P2422, DOI 10.1016/j.bpj.2011.03.057; Cummings JE, 2007, BBA-BIOMEMBRANES, V1768, P1796, DOI 10.1016/j.bbamem.2007.04.016; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Fuertes G, 2011, EUR BIOPHYS J BIOPHY, V40, P399, DOI 10.1007/s00249-011-0693-4; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Fuhrmans M, 2009, J AM CHEM SOC, V131, P9166, DOI 10.1021/ja903224q; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Haney EF, 2010, CHEM PHYS LIPIDS, V163, P82, DOI 10.1016/j.chemphyslip.2009.09.002; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOBOT JA, 1984, J BACTERIOL, V160, P143, DOI 10.1128/JB.160.1.143-152.1984; Jarver P, 2006, BBA-BIOMEMBRANES, V1758, P260, DOI 10.1016/j.bbamem.2006.02.012; Katsov K, 2006, BIOPHYS J, V90, P915, DOI 10.1529/biophysj.105.071092; Khalfa A, 2010, J PHYS CHEM B, V114, P2676, DOI 10.1021/jp9064196; Knecht V, 2007, BIOPHYS J, V92, P4254, DOI 10.1529/biophysj.106.103572; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Lai AL, 2010, J BIOL CHEM, V285, P37467, DOI 10.1074/jbc.M110.153700; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; Markvoort AJ, 2011, CURR TOP MEMBR, V68, P259, DOI 10.1016/B978-0-12-385891-7.00011-8; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; Matyus E, 2007, CURR MED CHEM, V14, P2789, DOI 10.2174/092986707782360105; Melo MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028549; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mika JT, 2011, BBA-BIOMEMBRANES, V1808, P2197, DOI 10.1016/j.bbamem.2011.05.001; Mirjanian D, 2010, J PHYS CHEM B, V114, P11061, DOI 10.1021/jp1055182; Monroc S, 2006, PEPTIDES, V27, P2567, DOI 10.1016/j.peptides.2006.04.019; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Noguchi H, 2001, J CHEM PHYS, V115, P9547, DOI 10.1063/1.1414314; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Risselada HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038302; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shai Y, 2002, CURR PHARM DESIGN, V8, P715, DOI 10.2174/1381612023395367; Smeijers AF, 2006, J PHYS CHEM B, V110, P13212, DOI 10.1021/jp060824o; Smirnova YG, 2010, J AM CHEM SOC, V132, P6710, DOI 10.1021/ja910050x; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; van den Bogaart G, 2008, METHODS, V46, P123, DOI 10.1016/j.ymeth.2008.06.016; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Yang ST, 2010, BIOPHYS J, V99, P2525, DOI 10.1016/j.bpj.2010.08.029; Yesylevskyy S, 2009, BIOPHYS J, V97, P40, DOI 10.1016/j.bpj.2009.03.059	60	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61541	10.1371/journal.pone.0061541	http://dx.doi.org/10.1371/journal.pone.0061541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620763	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500043
J	Shen, B; Han, XQ; Jones, G; Rossiter, SJ; Zhang, SY				Shen, Bin; Han, Xiuqun; Jones, Gareth; Rossiter, Stephen J.; Zhang, Shuyi			Adaptive Evolution of the Myo6 Gene in Old World Fruit Bats (Family: Pteropodidae)	PLOS ONE			English	Article							MYOSIN-VI ISOFORM; SOUND-LOCALIZATION; MEDIATED ENDOCYTOSIS; SEQUENCE EVOLUTION; CELLULAR FUNCTIONS; ECHOLOCATING BATS; FRUGIVOROUS BAT; HUMAN HOMOLOG; MOTOR; METABOLISM	Myosin VI (encoded by the Myo6 gene) is highly expressed in the inner and outer hair cells of the ear, retina, and polarized epithelial cells such as kidney proximal tubule cells and intestinal enterocytes. The Myo6 gene is thought to be involved in a wide range of physiological functions such as hearing, vision, and clathrin-mediated endocytosis. Bats (Chiroptera) represent one of the most fascinating mammal groups for molecular evolutionary studies of the Myo6 gene. A diversity of specialized adaptations occur among different bat lineages, such as echolocation and associated high-frequency hearing in laryngeal echolocating bats, large eyes and a strong dependence on vision in Old World fruit bats (Pteropodidae), and specialized high-carbohydrate but low-nitrogen diets in both Old World and New World fruit bats (Phyllostomidae). To investigate what role(s) the Myo6 gene might fulfill in bats, we sequenced the coding region of the Myo6 gene in 15 bat species and used molecular evolutionary analyses to detect evidence of positive selection in different bat lineages. We also conducted real-time PCR assays to explore the expression levels of Myo6 in a range of tissues from three representative bat species. Molecular evolutionary analyses revealed that the Myo6 gene, which was widely considered as a hearing gene, has undergone adaptive evolution in the Old World fruit bats which lack laryngeal echolocation and associated high-frequency hearing. Real-time PCR showed the highest expression level of the Myo6 gene in the kidney among ten tissues examined in three bat species, indicating an important role for this gene in kidney function. We suggest that Myo6 has undergone adaptive evolution in Old World fruit bats in relation to receptor-mediated endocytosis for the preservation of protein and essential nutrients.	[Shen, Bin; Han, Xiuqun; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of Bristol; University of London; Queen Mary University London	Zhang, SY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011	Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985" Project and "211" Project; Royal Society Research Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); East China Normal University; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	Key Construction Program of the National "985" Project and "211" Project; Royal Society Research Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); East China Normal University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants awarded by the Key Construction Program of the National "985" Project and "211" Project to SZ, the Royal Society Research Fellowship and a Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award to SJR, the Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award to GJ, and the PhD Candidate Fund of East China Normal University for overseas Studies, International Conference and Domestic Scholarly Visits to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Altingham JD, 1998, BATS BIOL BEHAV; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barclay RMR, 2006, ACTA CHIROPTEROL, V8, P549, DOI 10.3161/1733-5329(2006)8[549:DIBTFB]2.0.CO;2; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Biemesderfer D, 2002, AM J PHYSIOL-RENAL, V282, pF785, DOI 10.1152/ajprenal.00287.2001; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Breckler J, 2000, EXP EYE RES, V70, P121, DOI 10.1006/exer.1999.0758; Buckland-Wright J.C., 1973, International Zoo Yearbook, V13, P271, DOI 10.1111/j.1748-1090.1973.tb02174.x; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Cavaleros M, 2003, GEN COMP ENDOCR, V133, P109, DOI 10.1016/S0016-6480(03)00150-3; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Courts SE, 1998, MAMMAL REV, V28, P185, DOI 10.1046/j.1365-2907.1998.00033.x; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Davies K T J, 2012, Heredity (Edinb), V108, P480, DOI 10.1038/hdy.2011.119; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dierenfeld ES, 2000, J ZOO WILDLIFE MED, V31, P315, DOI 10.1638/1042-7260(2000)031[0315:PFSVAM]2.0.CO;2; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Fenton MB, 1998, CAN J ZOOL, V76, P1174, DOI 10.1139/cjz-76-6-1174; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; Gotoh N, 2010, CYTOSKELETON, V67, P178, DOI 10.1002/cm.20435; GOTTSBERGER G, 1984, PLANT SYST EVOL, V145, P55, DOI 10.1007/BF00984031; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Heffner RS, 2007, HEARING RES, V234, P1, DOI 10.1016/j.heares.2007.06.001; Heffner RS, 2001, J ACOUST SOC AM, V109, P412, DOI 10.1121/1.1329620; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; HERBST LH, 1986, BIOTROPICA, V18, P39, DOI 10.2307/2388360; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Herrera LG, 2001, J MAMMAL, V82, P352, DOI 10.1644/1545-1542(2001)082&lt;0352:SOPITS&gt;2.0.CO;2; Hertzano R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000207; Hilgert N, 2008, EUR J HUM GENET, V16, P593, DOI 10.1038/sj.ejhg.5202000; Holland B, 1992, MCCANCE WIDDOWSONS C; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; Kitamoto J, 2005, EXP EYE RES, V81, P116, DOI 10.1016/j.exer.2005.02.014; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026618; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Neuweiler G., 2000, BIOL BATS; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; PARRY-JONES K, 1992, Bat Research News, V33, P9; PETERSON PA, 1969, J CLIN INVEST, V48, P1189, DOI 10.1172/JCI106083; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raghurm H, 2009, MAMM BIOL, V74, P9, DOI 10.1016/j.mambio.2008.02.008; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossiter Stephen J., 2011, Communicative & Integrative Biology, V4, P236, DOI 10.4161/cib.4.2.14647; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Shen B, 2011, J MOL EVOL, V73, P109, DOI 10.1007/s00239-011-9460-5; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEDMAN RA, 1985, AUST J ZOOL, V33, P625, DOI 10.1071/ZO9850625; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THOMAS DW, 1984, PHYSIOL ZOOL, V57, P457, DOI 10.1086/physzool.57.4.30163347; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uberti B, 2009, AM J VET RES, V70, P1551, DOI 10.2460/ajvr.70.12.1551; VANDERWESTHUYZEN J, 1981, J NEUROCHEM, V37, P543, DOI 10.1111/j.1471-4159.1982.tb12521.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANTONDER SV, 1975, BRIT J NUTR, V34, P397, DOI 10.1017/S0007114575000463; Voigt CC, 2011, BIOTROPICA, V43, P108, DOI 10.1111/j.1744-7429.2010.00632.x; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	90	10	10	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62307	10.1371/journal.pone.0062307	http://dx.doi.org/10.1371/journal.pone.0062307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620821	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500102
J	Stichtenoth, G; Herting, E; Rudiger, M; Wemhoner, A				Stichtenoth, Guido; Herting, Egbert; Ruediger, Mario; Wemhoener, Andreas			Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro	PLOS ONE			English	Article							EXOCYTOSIS; RELEASE; GROWTH	Background: Exogenous surfactant derived from animal lungs is applied for treatment of surfactant deficiency. By means of its rapid spreading properties, it could transport pharmaceutical agents to the terminal air spaces. The antimicrobial peptide Polymyxin B (PxB) is used as a topical antibiotic for inhalation therapy. Whereas it has been shown that PxB mixed with surfactant is not inhibiting surface activity while antimicrobiotic activity is preserved, little is known concerning the effects on synthesis of endogenous surfactant in alveolar type II cells (ATIIC). Objective: To investigate ATIIC viability and surfactant-exocytosis depending on PxB and/or surfactant exposure. Methods: ATIIC were isolated from rat lungs as previously described and were cultivated for 48 h. After incubation for a period of 1-5 h with either PxB (0.05 or 0.1 mg/ml), modified porcine surfactant (5 or 10 mg/ml) or mixtures of both, viability and exocytosis (spontanously and after stimulation) were determined by fluorescence staining of intracellular surfactant. Results: PxB 0.1 mg/ml, but not porcine surfactant or porcine surfactant plus PxB reduces ATIIC-viability. Only PxB alone, but not in combination with porcine surfactant, rapidly reduces fluorescence in ATIIC at maximum within 3 h, indicating stimulation of exocytosis. Subsequent ionomycin-stimulation does not further increase exocytosis of PxB incubated ATIIC. In presence of surfactant, stimulating effects of PxB and ionomycin on exocytosis are reduced. Conclusion: PxB alone shows negative effects on ATIIC, which are counterbalanced in mixtures with surfactant. So far, our studies found no results discouraging the concept of a combined treatment with PxB and surfactant mixtures.	[Stichtenoth, Guido; Herting, Egbert] Med Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany; [Ruediger, Mario; Wemhoener, Andreas] Tech Univ Dresden, Dept Pediat Intens Care & Neonatol, D-01062 Dresden, Germany	University of Lubeck; Technische Universitat Dresden	Stichtenoth, G (corresponding author), Med Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany.	guido.stichtenoth@uksh.de			University of Luebeck; Technical University Dresden; Chiesi Farmaceutici S.p.A., Parma, Italy; Nycomed, Opfikon, Switzerland	University of Luebeck; Technical University Dresden; Chiesi Farmaceutici S.p.A., Parma, Italy; Nycomed, Opfikon, Switzerland	The study was supported by indepandent research grants of the University of Luebeck and of the Technical University Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests: GS and EH received travel support and/or speaking fees from surfactant producing companies (Chiesi Farmaceutici S.p.A., Parma, Italy and Nycomed, Opfikon, Switzerland). EH has received grant support and served as advisor for surfactant manufacturers (Chiesi Farmaceutici S.p.A., Parma, Italy and Nycomed, Opfikon, Switzerland). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alipour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005724; Calkovska A, 2005, BIOL NEONATE, V88, P101, DOI 10.1159/000085524; Cappelli C, 2012, IMMUNOBIOLOGY, V217, P307, DOI 10.1016/j.imbio.2011.10.006; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Jennings P, 2007, AM J PHYSIOL-RENAL, V293, pF831, DOI 10.1152/ajprenal.00005.2007; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Mishra A, 2011, J CELL SCI, V124, P657, DOI 10.1242/jcs.066977; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Omri A, 2002, BIOCHEM PHARMACOL, V64, P1407, DOI 10.1016/S0006-2952(02)01346-1; Sarkar S, 2007, AM J HEALTH-SYST PH, V64, P2462, DOI 10.2146/ajhp060501; Stichtenoth G, 2006, PEDIATR RES, V59, P407, DOI 10.1203/01.pdr.0000200806.32822.e6; Stichtenoth G, 2010, PEDIATR RES, V67, P369, DOI 10.1203/PDR.0b013e3181d026f6; Vaara M, 2008, ANTIMICROB AGENTS CH, V52, P3229, DOI 10.1128/AAC.00405-08; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; Valentinis B, 2005, J BIOL CHEM, V280, P14264, DOI 10.1074/jbc.M410791200; Wemhoner A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-11; Wemhoner A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-52; Wemhoner A, 2006, J BIOMOL SCREEN, V11, P286, DOI 10.1177/1087057105285284; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	22	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62105	10.1371/journal.pone.0062105	http://dx.doi.org/10.1371/journal.pone.0062105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620808	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500088
J	Woudstra, S; van Tol, MJ; Bochdanovits, Z; van der Wee, NJ; Zitman, FG; van Buchem, MA; Opmeer, EM; Aleman, A; Penninx, BW; Veltman, DJ; Hoogendijk, WJ				Woudstra, Saskia; van Tol, Marie-Jose; Bochdanovits, Zoltan; van der Wee, Nic J.; Zitman, Frans G.; van Buchem, Mark A.; Opmeer, Esther M.; Aleman, Andre; Penninx, Brenda W.; Veltman, Dick J.; Hoogendijk, Witte J.			Modulatory Effects of the Piccolo Genotype on Emotional Memory in Health and Depression	PLOS ONE			English	Article							MAJOR DEPRESSION; BRAIN ACTIVITY; FACIAL EXPRESSIONS; PROCESSING BIASES; AMYGDALA ACTIVITY; GENETIC-VARIATION; IMAGING GENETICS; RECEPTOR-BINDING; DISORDER; STIMULI	Major depressive disorder (MDD) has been associated with biased memory formation for mood-congruent information, which may be related to altered monoamine levels. The piccolo (PCLO) gene, involved in monoaminergic neurotransmission, has previously been linked to depression in a genome-wide association study. Here, we investigated the role of the PCLO risk allele on functional magnetic resonance imaging (MRI) correlates of emotional memory in a sample of 89 MDD patients (64 PCLO risk allele carriers) and 29 healthy controls (18 PCLO risk allele carriers). During negative word encoding, risk allele carriers showed significant lower activity relative to non-risk allele carriers in the insula, and trend-wise in the anterior cingulate cortex and inferior frontal gyrus. Moreover, depressed risk allele carriers showed significant lower activity relative to non-risk allele carriers in the striatum, an effect which was absent in healthy controls. Finally, amygdalar response during processing new positive words vs. known words was blunted in healthy PCLO+ carriers and in MDD patients irrespective of genotype, which may indicate that signalling of salient novel information does not occur to the same extent in PCLO+ carriers and MDD patients. The PCLO risk allele may increase vulnerability for MDD by modulating local brain function with regard to responsiveness to salient stimuli (i.e. insula) and processing novel negative information. Also, depression-specific effects of PCLO on dorsal striatal activation during negative word encoding and the absence of amygdalar salience signalling for novel positive information further suggest a role of PCLO in symptom maintenance in MDD.	[Woudstra, Saskia; Penninx, Brenda W.; Veltman, Dick J.; Hoogendijk, Witte J.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Bochdanovits, Zoltan] Vrije Univ Amsterdam Med Ctr, Dept Med Genom, Amsterdam, Netherlands; [van der Wee, Nic J.; Zitman, Frans G.; Penninx, Brenda W.] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Wee, Nic J.; van Buchem, Mark A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Woudstra, Saskia; Bochdanovits, Zoltan; Penninx, Brenda W.; Veltman, Dick J.; Hoogendijk, Witte J.] Vrije Univ Amsterdam, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van Tol, Marie-Jose; Opmeer, Esther M.; Aleman, Andre; Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, NeuroImaging Ctr, Groningen, Netherlands; [van Tol, Marie-Jose; Opmeer, Esther M.; Aleman, Andre; Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; Otto Von Guericke Univ, Clin Affect Neuroimaging Lab, Ctr Behav Brain Sci, Magdeburg, Germany; [van Tol, Marie-Jose] Leibniz Inst Neurobiol, Dept Behav Neurol, Magdeburg, Germany; [van Buchem, Mark A.] Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Hoogendijk, Witte J.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Leiden University; Leiden University Medical Center (LUMC); University of Groningen; Erasmus University Rotterdam; Erasmus MC	Woudstra, S (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	s.woudstra@vumc.nl	van Buchem, Mark/AAC-9843-2022; van Tol, 5/O-3108-2013; Penninx, Brenda WJH/S-7627-2017	van Buchem, Mark/0000-0003-1881-1998; Penninx, Brenda WJH/0000-0001-7779-9672	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL); VU University institute for Health and Care Research (EMGO+); VU University institute for Neuroscience Campus Amsterdam (NCA); Eli Lilly; Wyeth; Brystol-Myers Squibb; Lundbeck; Servier; Bristol-Myers Squibb; Organon	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL); VU University institute for Health and Care Research (EMGO+); VU University institute for Neuroscience Campus Amsterdam (NCA); Eli Lilly(Eli Lilly); Wyeth(Wyeth); Brystol-Myers Squibb; Lundbeck(Lundbeck Corporation); Servier(Servier); Bristol-Myers Squibb(Bristol-Myers Squibb); Organon	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations: VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL), Netherlands Institute of Mental Health and Addiction (Trimbos Institute), the Center for Medical Systems Biology (CSMB, NWO Genomics), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL), and VU University's institutes for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA). The genotyping of the samples was provided through the Genetic Association Information Network (GAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N.J.A. van der Wee received speaking fees from Eli Lilly and Wyeth and served on advisory panels of Eli Lilly, Pfizer, Wyeth, and Servier. A. Aleman received an investigator-initiated unrestricted research grant from Brystol-Myers Squibb and speakers bureau honoraria from AstraZeneca, Brystol-Myers Squibb, and GlaxoSmithKline. W.J. Hoogendijk lectured and advised for, and received unrestricted research grants from, Eli Lilly, Lundbeck, Servier, Bristol-Myers Squibb, and Organon for which payments were made to the independent research foundation of GGZ inGeest. W.J. Hoogendijk holds the following patent for gene-expression profiling in peripheral blood as a biomarker for depression (Name: Means and methods for typing a cell isolate of an individual suffering from a psychiatric disorder or at risk of suffering there from; Number: PCT/NL2008/050837; Date: December 19, 2008 [19.12.2008]). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 2002, DIAGN STAT MAN MENT, Vfifth; Betts MJ, 2007, BIOINFORMATICS GENET, P289; Bigos KL, 2010, NEUROIMAGE, V53, P804, DOI 10.1016/j.neuroimage.2010.01.035; Bogdan R, 2012, NEUROBIOL D IN PRESS; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Chamberlain Samuel R, 2006, Curr Psychiatry Rep, V8, P458, DOI 10.1007/s11920-006-0051-x; Choi KH, 2011, BIOL PSYCHIAT, V69, P353, DOI 10.1016/j.biopsych.2010.09.042; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Demenescu LR, 2011, PSYCHOL MED, V41, P2253, DOI 10.1017/S0033291711000596; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Ibi D, 2010, NEUROCHEM INT, V56, P77, DOI 10.1016/j.neuint.2009.09.004; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Lau JYF, 2009, BIOL PSYCHIAT, V65, P349, DOI 10.1016/j.biopsych.2008.08.037; Lee BT, 2008, NEUROREPORT, V19, P515, DOI 10.1097/WNR.0b013e3282f94294; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Li Y, 2010, BEHAV PROCESS, V83, P331, DOI 10.1016/j.beproc.2010.01.020; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Lisiecka DM, 2012, J PSYCHIATR RES, V46, P181, DOI 10.1016/j.jpsychires.2011.10.010; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, 2012, MOL PSYCHIA IN PRESS; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murrough JW, 2011, PSYCHOPHARMACOLOGY, V213, P547, DOI 10.1007/s00213-010-1881-0; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Scharinger C, 2011, WORLD J BIOL PSYCHIA, V12, P474, DOI 10.3109/15622975.2011.596220; Schuhmacher A, 2011, INT J NEUROPSYCHOPH, V14, P237, DOI 10.1017/S1461145710000854; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; Shestyuk AY, 2005, BIOL PSYCHIAT, V57, P1089, DOI 10.1016/j.biopsych.2005.02.013; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Smoski MJ, 2009, J AFFECT DISORDERS, V118, P69, DOI 10.1016/j.jad.2009.01.034; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; van Tol MJ, 2011, ACTA PSYCHIAT SCAND, V124, P273, DOI 10.1111/j.1600-0447.2011.01702.x; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; van Wingen GA, 2011, PSYCHOL MED, V41, P1397, DOI 10.1017/S0033291710002084; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Woudstra S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.29; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	62	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61494	10.1371/journal.pone.0061494	http://dx.doi.org/10.1371/journal.pone.0061494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620758	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500038
J	Wilson, NO; Solomon, W; Anderson, L; Patrickson, J; Pitts, S; Bond, V; Liu, ML; Stiles, JK				Wilson, Nana O.; Solomon, Wesley; Anderson, Leonard; Patrickson, John; Pitts, Sidney; Bond, Vincent; Liu, Mingli; Stiles, Jonathan K.			Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM MALARIA; INTERCELLULAR-ADHESION MOLECULE-1; ENDOTHELIAL CELL-INTERACTIONS; GAMMA-INDUCIBLE PROTEIN-10; CENTRAL-NERVOUS-SYSTEM; KAPPA-B ACTIVITY; CD8(+) T-CELLS; NITRIC-OXIDE; HEME OXYGENASE-1	Despite appropriate anti-malarial treatment, cerebral malaria (CM)-associated mortalities remain as high as 30%. Thus, adjunctive therapies are urgently needed to prevent or reduce such mortalities. Overproduction of CXCL10 in a subset of CM patients has been shown to be tightly associated with fatal human CM. Mice with deleted CXCL10 gene are partially protected against experimental cerebral malaria (ECM) mortality indicating the importance of CXCL10 in the pathogenesis of CM. However, the direct effect of increased CXCL10 production on brain cells is unknown. We assessed apoptotic effects of CXCL10 on human brain microvascular endothelial cells (HBVECs) and neuroglia cells in vitro. We tested the hypothesis that reducing overexpression of CXCL10 with a synthetic drug during CM pathogenesis will increase survival and reduce mortality. We utilized atorvastatin, a widely used synthetic blood cholesterol-lowering drug that specifically targets and reduces plasma CXCL10 levels in humans, to determine the effects of atorvastatin and artemether combination therapy on murine ECM outcome. We assessed effects of atorvastatin treatment on immune determinants of severity, survival, and parasitemia in ECM mice receiving a combination therapy from onset of ECM (day 6 through 9 post-infection) and compared results with controls. The results indicate that CXCL10 induces apoptosis in HBVECs and neuroglia cells in a dose-dependent manner suggesting that increased levels of CXCL10 in CM patients may play a role in vasculopathy, neuropathogenesis, and brain injury during CM pathogenesis. Treatment of ECM in mice with atorvastatin significantly reduced systemic and brain inflammation by reducing the levels of the anti-angiogenic and apoptotic factor (CXCL10) and increasing angiogenic factor (VEGF) production. Treatment with a combination of atorvastatin and artemether improved survival (100%) when compared with artemether monotherapy (70%), p<0.05. Thus, adjunctively reducing CXCL10 levels and inflammation by atorvastatin treatment during anti-malarial therapy may represent a novel approach to treating CM patients.	[Wilson, Nana O.; Solomon, Wesley; Bond, Vincent; Liu, Mingli; Stiles, Jonathan K.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Anderson, Leonard] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Patrickson, John; Pitts, Sidney] Morehouse Sch Med, Dept Pathol, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine	Wilson, NO (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	nwilson@msm.edu; jstiles@msm.edu	Stiles, Jonathan K./AFM-1940-2022	Stiles, Jonathan Kwamina/0000-0003-0829-1482	National Institutes of Health [NIH/FIC T90-HG004151, NIH/FIC/NINDS R21TW006804, NIH/MBRS/RISE S06GM08248, NIH/NIMHD/8G12 MD007602]; National Center for Advancing Translational Sciences of the National Institutes of Health [TL1TR000456]; American Society of Microbiology; FOGARTY INTERNATIONAL CENTER [R21TW006804] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000456, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008248] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Society of Microbiology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grant numbers NIH/FIC T90-HG004151 for postdoctoral training in Genomics and Hemoglobinopathies, NIH/FIC/NINDS R21TW006804, NIH/MBRS/RISE S06GM08248 and NIH/NIMHD/8G12 MD007602 awarded to JKS and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number TL1TR000456 for TL1 Trainees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The support of American Society of Microbiology's Robert D. Watkins Graduate Research Fellowship to nana Wilson is acknowledged.	Achtman AH, 2012, SCI TRANSL MED, V4; AHLQVIST J, 1985, SCAND J HAEMATOL, V35, P531; AIKAWA M, 1990, AM J TROP MED HYG, V43, P30, DOI 10.4269/ajtmh.1990.43.30; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Bienvenu AL, 2008, ANTIMICROB AGENTS CH, V52, P4203, DOI 10.1128/AAC.00513-08; Bouton C, 2000, J BIOL CHEM, V275, P32688, DOI 10.1074/jbc.275.42.32688; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 1999, J INFECT DIS, V180, P1742, DOI 10.1086/315078; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Cabrales P, 2011, J INFECT DIS, V203, P1454, DOI 10.1093/infdis/jir058; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Carreau V, 2011, PEDIATR DRUGS, V13, P267, DOI 10.2165/11591650-000000000-00000; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen K, 2000, CELL MOL BIOL, V46, P609; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Cordoliani YS, 1998, AM J NEURORADIOL, V19, P871; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Deininger MH, 2002, EUR CYTOKINE NETW, V13, P173; Diederich K, 2012, HIPPOCAMPUS, V22, P1051, DOI 10.1002/hipo.20904; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; ECKWALANGA M, 1994, P NATL ACAD SCI USA, V91, P8097, DOI 10.1073/pnas.91.17.8097; Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Faille D, 2009, THROMB HAEMOSTASIS, V102, P1093, DOI 10.1160/TH09-05-0337; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Faiz MA, 2005, LANCET, V366, P717; Franek WR, 2002, J BIOL CHEM, V277, P42694, DOI 10.1074/jbc.M202623200; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Gao HX, 2009, CYTOKINE, V46, P24, DOI 10.1016/j.cyto.2008.12.001; Gay F, 2012, REV NEUROL-FRANCE, V168, P239, DOI 10.1016/j.neurol.2012.01.582; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; Grip O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005263; Grote CL, 1997, CORTEX, V33, P385, DOI 10.1016/S0010-9452(08)70014-5; Gueler F, 2007, AM J PATHOL, V170, P1192, DOI 10.2353/ajpath.2007.060782; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hawkes M, 2011, MED HYPOTHESES, V77, P437, DOI 10.1016/j.mehy.2011.06.003; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Helmers AJ, 2009, AM J TROP MED HYG, V81, P631, DOI 10.4269/ajtmh.2009.09-0204; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; Huang Z, 2007, NEUROSCI LETT, V417, P160, DOI 10.1016/j.neulet.2007.01.086; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Idro R, 2006, ARCH DIS CHILD, V91, P142, DOI 10.1136/adc.2005.077784; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; JAKOBSEN PH, 1994, INFECT IMMUN, V62, P4374, DOI 10.1128/IAI.62.10.4374-4379.1994; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; John CC, 2010, EXPERT REV ANTI-INFE, V8, P997, DOI [10.1586/eri.10.90, 10.1586/ERI.10.90]; Jones KL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005967.pub2; Kanda N, 2011, ENDOCRINOLOGY, V152, P3155, DOI 10.1210/en.2010-1481; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kobbe R, 2008, ANTIMICROB AGENTS CH, V52, P1583, DOI 10.1128/AAC.01428-07; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lahrtz F, 1997, EUR J IMMUNOL, V27, P2484, DOI 10.1002/eji.1830271004; Lamb Tracey J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010581; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Li DY, 2002, J PHARMACOL EXP THER, V302, P601, DOI 10.1124/jpet.102.034959; Li J, 2003, J INVEST MED, V51, P128, DOI 10.1136/jim-51-03-15; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; LOOAREESUWAN S, 1995, CLIN INFECT DIS, V21, P300, DOI 10.1093/clinids/21.2.300; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; MACKEY LJ, 1980, CLIN EXP IMMUNOL, V42, P412; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Martins YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032048; Martins YC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-85; McElroy PD, 1997, AM J EPIDEMIOL, V145, P945, DOI 10.1093/oxfordjournals.aje.a009054; McIntosh H M, 2000, Cochrane Database Syst Rev, pCD000527, DOI 10.1002/14651858.CD000527; Medana IM, 1996, GLIA, V16, P51, DOI 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.3.CO;2-2; Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MILLAN JM, 1993, AM J NEURORADIOL, V14, P493; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Moreno M, 2009, AM J PHYSIOL-GASTR L, V296, pG147, DOI 10.1152/ajpgi.00462.2007; Mshana R N, 1991, J Clin Lab Immunol, V34, P131; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Nath N, 2004, J IMMUNOL, V172, P1273, DOI 10.4049/jimmunol.172.2.1273; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OWENS T, 1994, IMMUNOL TODAY, V15, P566, DOI 10.1016/0167-5699(94)90218-6; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Patankar TF, 2002, RADIOLOGY, V224, P811, DOI 10.1148/radiol.2243010588; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Penafuerte C, 2011, J IMMUNOL, V186, P6933, DOI 10.4049/jimmunol.1003816; PEYRON F, 1994, CLIN EXP IMMUNOL, V95, P300, DOI 10.1111/j.1365-2249.1994.tb06527.x; Potter S, 1999, REDOX REP, V4, P333, DOI 10.1179/135100099101535070; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Potter SM, 2006, J NEUROIMMUNOL, V173, P96, DOI 10.1016/j.jneuroim.2005.12.004; Qiu G, 2007, J LIPID RES, V48, P2112, DOI 10.1194/jlr.M600510-JLR200; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rentzos M, 2012, ACTA NEUROL SCAND, V125, P77, DOI 10.1111/j.1600-0404.2011.01524.x; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Saito M, 2002, EXP HEMATOL, V30, P1115, DOI 10.1016/S0301-472X(02)00889-5; Sarfo BY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-69; Sarthou JL, 1997, INFECT IMMUN, V65, P3271, DOI 10.1128/IAI.65.8.3271-3276.1997; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Sasmazel A, 2010, HEART SURG FORUM, V13, pE243, DOI 10.1532/HSF98.20091185; Schijns OEMG, 2008, SEIZURE-EUR J EPILEP, V17, P731, DOI 10.1016/j.seizure.2008.04.006; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714; Souraud JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-13; Spiecker M, 1997, J BIOL CHEM, V272, P30969, DOI 10.1074/jbc.272.49.30969; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stein EA, 2007, CIRCULATION, V116, P594, DOI 10.1161/CIRCULATIONAHA.107.717777; Sui YJ, 2003, J MED PRIMATOL, V32, P229, DOI 10.1034/j.1600-0684.2003.00030.x; Sumagin R, 2008, AM J PHYSIOL-HEART C, V295, pH969, DOI 10.1152/ajpheart.00400.2008; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Togashi H, 1997, P NATL ACAD SCI USA, V94, P2676, DOI 10.1073/pnas.94.6.2676; TURNER GDH, 1994, AM J PATHOL, V145, P1057; vanHensbroek MB, 1996, J INFECT DIS, V174, P1091, DOI 10.1093/infdis/174.5.1091; Vareille M, 2008, J IMMUNOL, V180, P5720, DOI 10.4049/jimmunol.180.8.5720; Vogel SN, 2003, BIOCHEM SOC T, V31, P664, DOI 10.1042/bst0310664; Vuorio A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006401.pub2; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Waknine-Grinberg JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-227; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Wenisch C, 1999, J INFECT DIS, V179, P747, DOI 10.1086/314630; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Wilson NO, 2011, DIS MARKERS, V30, P39, DOI [10.1155/2011/828256, 10.3233/DMA-2011-0763]; Wimbicki AS, 2010, DRUG SAFETY, V33, P115, DOI 10.2165/11319490-000000000-00000; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Zambrano A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-82; Zimmerman GA, 2010, EXPERT REV ANTI-INFE, V8, P1209, DOI 10.1586/ERI.10.117; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	178	41	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60898	10.1371/journal.pone.0060898	http://dx.doi.org/10.1371/journal.pone.0060898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23630573	Green Published, gold, Green Submitted			2022-12-25	WOS:000319109800112
J	Zhu, M; Van Dyke, TE; Gyurko, R				Zhu, Min; Van Dyke, Thomas E.; Gyurko, Robert			Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1	FASEB JOURNAL			English	Article						osteoimmunology; inflammation resolution; lipid mediator	BONE-RESORPTION; CELL-FUSION; INFLAMMATION; RESOLUTION; RECEPTOR; MECHANISMS; IMMUNE; DIFFERENTIATION; ACTIVATION; RANKL	Interactions between the immune and skeletal systems in inflammatory bone diseases are well appreciated, but the underlying molecular mechanisms that coordinate the resolution phase of inflammation and bone turnover have not been unveiled. Here we investigated the direct actions of the proresolution mediator resolvin E1 (RvE1) on bone-marrow-cell-derived osteoclasts in an in vitro murine model of osteoclast maturation and inflammatory bone resorption. Investigation of the actions of RvE1 treatment on the specific stages of osteoclast maturation revealed that RvE1 targeted late stages of osteoclast maturation to decrease osteoclast formation by 32.8%. Time-lapse vital microscopy and migration assays confirmed that membrane fusion of osteoclast precursors was inhibited. The osteoclast fusion protein DC-STAMP was specifically targeted by RvE1 receptor binding and was down-regulated by 65.4%. RvE1 did not affect the induction of the essential osteoclast transcription factor nuclear factor of activated T cells c1 (NFATc1) or its nuclear translocation; however, NFATc1 binding to the DC-STAMP promoter was significantly inhibited by 60.9% with RvE1 treatment as shown in electrophoresis mobility shift assay. Our findings suggest that proresolution mediators act directly on osteoclasts, in addition to down-regulation of inflammation, providing a novel mechanism for modulating osteoclast signaling in osteolytic inflammatory disease.Zhu, M., Van Dyke, T. E., Gyurko, R. Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.	[Zhu, Min; Gyurko, Robert] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA; [Van Dyke, Thomas E.] Forsyth Inst, Dept Periodontol, Cambridge, MA USA	Boston University; Harvard University; Forsyth Institute	Gyurko, R (corresponding author), Boston Univ, 650 Albany St,Rm X-344A, Boston, MA 02118 USA.	gyurko@bu.edu		Gyurko, Robert/0000-0003-1457-6812	U.S. Public Health Service from the National Institutes of Dental and Craniofacial Research [DE19938]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER	U.S. Public Health Service from the National Institutes of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. B. S. Nikolajczyk and Dr. V. Trinkaus-Randall for technical support and discussion. RvE1 was kindly provided by Dr. C. N. Serhan, (Brigham and Women's Hospital, Boston, MA, USA). This work was supported by U.S. Public Health Service grant DE19938 from the National Institutes of Dental and Craniofacial Research. M.Z. designed and carried out experiments, analyzed data, and wrote the manuscript; T. E. V. D. was involved in experimental design and provided reagents, data analysis, and preparation of the manuscript; R. G was involved in experimental design, data analysis, and manuscript preparation. Conflicts of interest: T. E. V. D. is an inventor on patents (resolvins) assigned to Boston University and licensed to Resolvyx Pharmaceuticals. T. E. V. D. is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. T.E.V.D.'s interests were reviewed and managed by Boston University and now the Forsyth Institute in accordance with their conflict of interest policies.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Cheng YLJ, 2012, DIABETES CARE, V35, P1686, DOI 10.2337/dc12-0046; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fierro IM, 2002, J PHARMACOL EXP THER, V300, P385, DOI 10.1124/jpet.300.2.385; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gao L, 2013, J IMMUNOL, V190, P689, DOI 10.4049/jimmunol.1103688; Garcia C, 1996, J BONE MINER RES, V11, P1619; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hartgers FC, 2000, EUR J IMMUNOL, V30, P3585, DOI 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Herrera BS, 2008, BRIT J PHARMACOL, V155, P1214, DOI 10.1038/bjp.2008.367; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Hwang SY, 2011, BBA-MOL CELL RES, V1813, P979, DOI 10.1016/j.bbamcr.2010.11.002; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Izumi Y, 2000, PERIODONTOL, V56, P166; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Schett G, 2010, NAT REV ENDOCRINOL, V6, P698, DOI 10.1038/nrendo.2010.190; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Van Dyke TE, 2008, J PERIODONTOL, V79, P1601, DOI 10.1902/jop.2008.080173; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yuan JZ, 2010, PROSTAG OTH LIPID M, V92, P85, DOI 10.1016/j.prostaglandins.2010.04.001	55	38	38	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3344	3353		10.1096/fj.12-220228	http://dx.doi.org/10.1096/fj.12-220228			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23629863	Green Published			2022-12-25	WOS:000329877600039
J	Brown, NG; Chow, DC; Ruprecht, KE; Palzkill, T				Brown, Nicholas G.; Chow, Dar-Chone; Ruprecht, Kevin E.; Palzkill, Timothy			Identification of the beta-Lactamase Inhibitor Protein-II (BLIP-II) Interface Residues Essential for Binding Affinity and Specificity for Class A beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-EXFOLIATUS SMF19; HOT-SPOTS; MODULAR ARCHITECTURE; DRUG DISCOVERY; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL BIOLOGY; IMMUNITY PROTEIN; ASSOCIATION; COMPLEX; TEM-1	The interactions between beta-lactamase inhibitory proteins (BLIPs) and beta-lactamases have been used as model systems to understand the principles of affinity and specificity in protein-protein interactions. The most extensively studied tight binding inhibitor, BLIP, has been characterized with respect to amino acid determinants of affinity and specificity for binding beta-lactamases. BLIP-II, however, shares no sequence or structural homology to BLIP and is a femtomolar to picomolar potency inhibitor, and the amino acid determinants of binding affinity and specificity are unknown. In this study, alanine scanning mutagenesis was used in combination with determinations of on and off rates for each mutant to define the contribution of residues on the BLIP-II binding surface to both affinity and specificity toward four beta-lactamases of diverse sequence. The residues making the largest contribution to binding energy are heavily biased toward aromatic amino acids near the center of the binding surface. In addition, substitutions that reduce binding energy do so by increasing off rates without impacting on rates. Also, residues with large contributions to binding energy generally exhibit low temperature factors in the structures of complexes. Finally, with the exception of D206A, BLIP-II alanine substitutions exhibit a similar trend of effect for all beta-lactamases, i.e., a substitution that reduces affinity for one beta-lactamase usually reduces affinity for all beta-lactamases tested.	[Brown, Nicholas G.; Chow, Dar-Chone; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brown, Nicholas G.; Ruprecht, Kevin E.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu		Brown, Nicholas/0000-0002-6141-0164	National Institutes of Health Grant [AI32956, 1 T90 DA022885-04]; Biomedical Discovery Training Program of the Gulf Coast Consortia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R01AI032956, R37AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Discovery Training Program of the Gulf Coast Consortia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant AI32956 (to T. P.) and a training fellowship from the Biomedical Discovery Training Program of the Gulf Coast Consortia supported by National Institutes of Health Grant 1 T90 DA022885-04.	Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brown NG, 2010, PROTEIN ENG DES SEL, V23, P469, DOI 10.1093/protein/gzq017; Brown N. G., 2013, ANTIMICROB IN PRESS; Brown NG, 2011, J BIOL CHEM, V286, P32723, DOI 10.1074/jbc.M111.265058; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; CURTIS MD, 1991, MOL MICROBIOL, V5, P2727, DOI 10.1111/j.1365-2958.1991.tb01981.x; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Guruprasad K, 2004, INT J BIOL MACROMOL, V34, P55, DOI 10.1016/j.ijbiomac.2004.03.003; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanes MS, 2011, PROTEINS, V79, P1267, DOI 10.1002/prot.22961; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Ishii Y, 2007, INT J ANTIMICROB AG, V29, P159, DOI 10.1016/j.ijantimicag.2006.09.005; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Jubb H, 2012, TRENDS PHARMACOL SCI, V33, P241, DOI 10.1016/j.tips.2012.03.006; Kang SG, 2000, J BIOL CHEM, V275, P16851; Kuhlmann UC, 2000, J MOL BIOL, V301, P1163, DOI 10.1006/jmbi.2000.3945; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Materon IC, 2003, ANTIMICROB AGENTS CH, V47, P2040, DOI 10.1128/AAC.47.6.2040-2042.2003; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Park HU, 1998, MICROBIOL-SGM, V144, P2161, DOI 10.1099/00221287-144-8-2161; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Potapov V, 2008, J MOL BIOL, V384, P109, DOI 10.1016/j.jmb.2008.08.078; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Stachyra T, 2009, J ANTIMICROB CHEMOTH, V64, P326, DOI 10.1093/jac/dkp197; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Yuan J, 2009, J MOL BIOL, V389, P401, DOI 10.1016/j.jmb.2009.04.028; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zhou HX, 1997, BIOPHYS J, V73, P2441, DOI 10.1016/S0006-3495(97)78272-9	51	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17156	17166		10.1074/jbc.M113.463521	http://dx.doi.org/10.1074/jbc.M113.463521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625930	Green Published, hybrid			2022-12-25	WOS:000320380600013
J	Pracheil, T; Liu, ZC				Pracheil, Tammy; Liu, Zhengchang			Tiered Assembly of the Yeast Far3-7-8-9-10-11 Complex at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; GENETIC INTERACTIONS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; GCKIII PROTEINS; PHOSPHATASE 2A; GROWTH-CONTROL; FISSION YEAST	Target of rapamycin signaling is a conserved, essential pathway integrating nutritional cues with cell growth and proliferation. The target of rapamycin kinase exists in two distinct complexes, TORC1 and TORC2. It has been reported that protein phosphatase 2A (PP2A) and the Far3-7-8-9-10-11 complex (Far complex) negatively regulate TORC2 signaling in yeast. The Far complex, originally identified as factors required for pheromone-induced cell cycle arrest, and PP2A form the yeast counterpart of the STRIPAK complex, which was first isolated in mammals. The cellular localization of the Far complex has yet to be fully characterized. Here, we show that the Far complex localizes to the endoplasmic reticulum (ER) by analyzing functional GFP-tagged Far proteins in vivo. We found that Far9 and Far10, two homologous proteins each with a tail-anchor domain, localize to the ER in mutant cells lacking the other Far complex components. Far3, Far7, and Far8 form a subcomplex, which is recruited to the ERby Far9/10. The Far3-7-8-complex in turn recruits Far11 to the ER. Finally, we show that the tail-anchor domain of Far9 is required for its optimal function in TORC2 signaling. Our study reveals tiered assembly of the yeast Far complex at the ER and a function for Far complex's ER localization in TORC2 signaling.	[Pracheil, Tammy; Liu, Zhengchang] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Liu, ZC (corresponding author), Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	zliu5@uno.edu			National Institutes of Health [1R15GM094772-01A1]; State of Louisiana Board of Regents Grant [LEQSF(2008-11)-RD-A-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Louisiana Board of Regents Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM094772-01A1. This work was also supported by State of Louisiana Board of Regents Grant LEQSF(2008-11)-RD-A-31.	Amberg DC., 2005, METHODS YEAST GENETI; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Byers JT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-48; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; FERGUSON B, 1994, CELL MOL BIOL RES, V40, P223; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Helliwell SB, 1998, GENETICS, V148, P99; Horecka J, 1996, GENETICS, V144, P905; Hou MC, 2000, CURR BIOL, V10, P619, DOI 10.1016/S0960-9822(00)00492-9; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kamada Y, 2010, AUTOPHAGY, V6, P415, DOI 10.4161/auto.6.3.11390; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Lai FJ, 2011, FEMS YEAST RES, V11, P72, DOI 10.1111/j.1567-1364.2010.00691.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Lisa-Santamaria P, 2012, J BIOL CHEM, V287, P29636, DOI 10.1074/jbc.M112.344192; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wielowieyski PA, 2000, J BIOL CHEM, V275, P38474, DOI 10.1074/jbc.M007682200; Xiang QJ, 2002, GENETICS, V160, P169; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	48	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16986	16997		10.1074/jbc.M113.451674	http://dx.doi.org/10.1074/jbc.M113.451674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625923	Green Published, hybrid			2022-12-25	WOS:000320378900070
J	Bayne, ACV; Boltz, D; Owen, C; Betz, Y; Maia, G; Azadi, P; Archer-Hartmann, S; Zirkle, R; Lippmeier, JC				Bayne, Anne-Cecile V.; Boltz, David; Owen, Carole; Betz, Yelena; Maia, Goncalo; Azadi, Parastoo; Archer-Hartmann, Stephanie; Zirkle, Ross; Lippmeier, J. Casey			Vaccination against Influenza with Recombinant Hemagglutinin Expressed by Schizochytrium sp Confers Protective Immunity	PLOS ONE			English	Article							VIRUS HEMAGGLUTININ; RECEPTOR-BINDING; NEURAMINIDASE; GLYCOPROTEIN; GLYCOSYLATION; LABYRINTHULA; ANTIBODIES; CHALLENGE; TRANSPORT; VACCINES	For the rapid production of influenza vaccine antigens in unlimited quantities, a transition from conventional egg-based production to cell-based and recombinant systems is required. The need for higher-yield, lower-cost, and faster production processes is critical to provide adequate supplies of influenza vaccine to counter global pandemic threats. In this study, recombinant hemagglutinin proteins of influenza virus were expressed in the microalga Schizochytrium sp., an established, fermentable organism grown in large scale for the manufacture of polyunsaturated fatty acids for animal and human health applications. Schizochytrium was capable of exporting the full-length membrane-bound proteins in a secreted form suitable for vaccine formulation. One recombinant hemagglutinin (rHA) protein derived from A/Puerto Rico/8/34 (H1N1) influenza virus was evaluated as a vaccine in a murine challenge model. Protective immunity from lethal challenge with homologous virus was elicited by a single dose of 1.7, 5 or 15 mu g rHA with or without adjuvant at survival rates between 80-100%. Full protection (100%) was established at all dose levels with or without adjuvant when mice were given a second vaccination. These data demonstrate the potential of Schizochytrium sp. as a platform for the production of recombinant antigens useful for vaccination against influenza.	[Bayne, Anne-Cecile V.; Owen, Carole; Betz, Yelena; Maia, Goncalo; Zirkle, Ross; Lippmeier, J. Casey] DSM Nutrit Prod, Columbia, MD USA; [Boltz, David] IIT, IIT Res Inst, Div Microbiol & Mol Biol, Chicago, IL 60616 USA; [Azadi, Parastoo; Archer-Hartmann, Stephanie] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	DSM NV; Illinois Institute of Technology; University System of Georgia; University of Georgia	Lippmeier, JC (corresponding author), DSM Nutrit Prod, Columbia, MD USA.	casey.lippmeier@dsm.com		Archer-Hartmann, Stephanie/0000-0001-8752-7363; Lippmeier, J./0000-0002-8157-1491	National Institutes of Health (NIH/NCRR) [8P41GM103490]; Royal DSM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Royal DSM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by the National Institutes of Health (NIH/NCRR)-funded grant entitled "Integrated Technology Resource for Biomedical Glycomics" (grant no. 8P41GM103490) to the Complex Carbohydrate Research Center and by Royal DSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier S, 2009, BIOLOGICALS, V37, P128, DOI 10.1016/j.biologicals.2009.02.006; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Athmaram TN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-524; Bailey RB, 2010, US Patent, Patent No. [7,732,170, 7732170]; Barclay W., 2005, SINGLE CELL OIL, P36, DOI [10.1201/9781439822364.ch3, DOI 10.1201/9781439822364.CH3]; Bosch D, 2010, EXPERT REV VACCINES, V9, P835, DOI 10.1586/erv.10.83; Butters TD, 1998, GLYCOCONJUGATE J, V15, P83, DOI 10.1023/A:1006999718552; Cann A, 1999, VIRUS CULTURE PRACTI, P201; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; DAVIS AR, 1983, GENE, V21, P273, DOI 10.1016/0378-1119(83)90011-2; DOWNIE JC, 1970, J IMMUNOL, V105, P620; GALLAGHER P, 1988, J CELL BIOL, V107, P2059, DOI 10.1083/jcb.107.6.2059; GALLAGHER PJ, 1992, J VIROL, V66, P7136, DOI 10.1128/JVI.66.12.7136-7145.1992; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Haynes JR, 2009, EXPERT REV VACCINES, V8, P435, DOI [10.1586/erv.09.8, 10.1586/ERV.09.8]; Hunkapiller MW, 1985, ABI USER B, V14; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lippmeier JC, 2009, LIPIDS, V44, P621, DOI 10.1007/s11745-009-3311-9; Lippmeier JC, 2011, US Patent, Patent No. 20110195448; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Montomoli E, 2012, EXPERT REV VACCINES, V11, P587, DOI [10.1586/ERV.12.24, 10.1586/erv.12.24]; PERKINS FO, 1972, ARCH MIKROBIOL, V84, P95, DOI 10.1007/BF00412431; PORTER D, 1969, PROTOPLASMA, V67, P1, DOI 10.1007/BF01256763; Preston TM, 2005, J EUKARYOT MICROBIOL, V52, P461, DOI 10.1111/j.1550-7408.2005.00064.x; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROESSLER PG, 2006, Patent No. 7001772; Ross TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006032; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Simpson D, 2010, US Patent, Patent No. 20100233760; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Stokes J, 1937, J CLIN INVEST, V16, P237, DOI 10.1172/JCI100853; VANLANDSCHOOT P, 1993, VACCINE, V11, P1185, DOI 10.1016/0264-410X(93)90040-5; Wagner R, 2005, J VIROL, V79, P6449, DOI 10.1128/JVI.79.10.6449-6458.2005; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Weaver CA, 2011, US Patent, Patent No. [8,003,772, 8003772]; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	45	29	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61790	10.1371/journal.pone.0061790	http://dx.doi.org/10.1371/journal.pone.0061790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626728	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400092
J	Hong, Y; Peng, RM; Wang, M; Qu, HQ; Hong, J				Hong, Ying; Peng, Rong-mei; Wang, Miao; Qu, Hong-qiang; Hong, Jing			Suture Pull-Through Insertion Techniques for Descemet Stripping Automated Endothelial Keratoplasty in Chinese Phakic Eyes: Outcomes and Complications	PLOS ONE			English	Article							POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; DONOR INSERTION; DYSTROPHY; FORCEPS	Purpose: To investigate the outcomes and complications of suture pull-through insertion techniques for Descemet stripping automated endothelial keratoplasty (DSAEK) in Chinese phakic eyes. Patients and Methods: Retrospective case series. Included in the study were all Chinese patients with phakic eyes who underwent DSAEK at Peking University Third Hospital from August 2008 to August 2011. All ocular diseases of the patients were recorded. Distance visual acuity (DVA), near visual acuity (NVA), intraocular pressure (IOP), anterior chamber depth (ACD), central corneal thickness (CCT), and corneal endothelial cell density (ECD) were compared prior to and 12 months after DSAEK. The DSAEK success rate, endothelial cell loss (ECL), complications, and prognosis were analyzed. All patients had at least 12 months of follow up. Results: Twenty-one eyes of 16 patients were included (11 males and 5 females). Ages ranged from 2 to 47 years with an average age of 29.8 years. The average follow up was 15.4 months (ranging from 12 to 36 months). Diagnoses included 7 eyes (4 patients) with corneal endothelial dystrophy and 14 eyes (12 patients) with bullous keratopathy. Presurgical DVA and NVA (LogMAR) were 1.7 +/- 0.7 and 1.2 +/- 0.4; postsurgical DVA and NVA were 0.8 +/- 0.6 and 0.7 +/- 0.5; Z = 23.517, 22.764; P, 0.001 and P = 0.006 respectively. Presurgical IOP was 15.863.7 mm Hg; postsurgical IOP was 15.2 +/- 2.6 mm Hg; Z= 20.505, P = 0.614. Presurgical ACD was 3.0 +/- 60.74 mm; postsurgical ACD was 2.72 +/- 0.59 mm; Z = 20.524, P = 0.600. Donor ECD was 29926163 cells/mm 2, ECD was 18366412 cells/mm 2 with a 12-month postsurgical ECL of 39%. Success rate was 86%. Surgery complications included pupillary block-induced hypertension in 5 eyes (24%), graft detachment in 3 eyes (14%), and graft dislocation in 1 eye (5%). Conclusions: DSAEK on Chinese phakic eyes can significantly improve DVA and NVA by preserving the patient's own crystalline lens. DSAEK is an optional surgery for patients who need to preserve accommodative function. More attention should be given to postsurgical pupillary block-induced hypertension.	[Hong, Ying; Peng, Rong-mei; Qu, Hong-qiang; Hong, Jing] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Wang, Miao] Capital Inst Pediat, Beijing, Peoples R China	Peking University; Capital Institute of Pediatrics (CIP)	Hong, J (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	hongjing64@yahoo.com			National Natural Science Foundation of China [3127104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China 3127104 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Bahar I, 2009, CORNEA, V28, P485, DOI 10.1097/ICO.0b013e3181901df4; Bahar I, 2009, AM J OPHTHALMOL, V147, P220, DOI 10.1016/j.ajo.2008.08.029; Busin M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1140, DOI 10.1001/archophthalmol.2011.114; Chen ES, 2008, CORNEA, V27, P514, DOI 10.1097/ICO.0b013e3181611c50; Hjortdal J, 2009, ACTA OPHTHALMOL, V87, P310, DOI 10.1111/j.1755-3768.2008.01492.x; Huang T, 2011, OPHTHALMIC RES, V46, P44, DOI 10.1159/000321528; Kaiserman I, 2008, AM J OPHTHALMOL, V145, P986, DOI 10.1016/j.ajo.2008.02.003; Kobayashi A, 2008, CORNEA, V27, pS62, DOI 10.1097/ICO.0b013e31817f38e9; Koenig SB, 2010, CORNEA, V29, P531, DOI 10.1097/ICO.0b013e3181bd4bab; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Macsai MS, 2007, CORNEA, V26, P1123, DOI 10.1097/ICO.0b013e318124a443; Mittal V, 2011, CORNEA, V30, P354, DOI 10.1097/ICO.0b013e3181e8441a; Price MO, 2004, J CATARACT REFR SURG, V30, P1310, DOI 10.1016/j.jcrs.2003.10.028; Rao SK, 2008, AM J OPHTHALMOL, V145, P991, DOI 10.1016/j.ajo.2008.01.017; Rosenberg EA, 2008, AM FAM PHYSICIAN, V77, P1431; Sarnicola V, 2008, CORNEA, V27, P825, DOI 10.1097/ICO.0b013e31816f62bd; Terry MA, 2008, OPHTHALMOLOGY, V115, P488, DOI 10.1016/j.ophtha.2007.10.035; Tsui JYM, 2011, CORNEA, V30, P291, DOI 10.1097/ICO.0b013e3181eeb5ba	19	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61929	10.1371/journal.pone.0061929	http://dx.doi.org/10.1371/journal.pone.0061929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626753	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400117
J	Moon, S; Lee, S; Kim, H; Freitas-Junior, LH; Kang, M; Ayong, L; Hansen, MAE				Moon, Seunghyun; Lee, Sukjun; Kim, Heechang; Freitas-Junior, Lucio H.; Kang, Myungjoo; Ayong, Lawrence; Hansen, Michael A. E.			An Image Analysis Algorithm for Malaria Parasite Stage Classification and Viability Quantification	PLOS ONE			English	Article							BLOOD; SEGMENTATION; DESIGN; ASSAY	With more than 40% of the world's population at risk, 200-300 million infections each year, and an estimated 1.2 million deaths annually, malaria remains one of the most important public health problems of mankind today. With the propensity of malaria parasites to rapidly develop resistance to newly developed therapies, and the recent failures of artemisinin-based drugs in Southeast Asia, there is an urgent need for new antimalarial compounds with novel mechanisms of action to be developed against multidrug resistant malaria. We present here a novel image analysis algorithm for the quantitative detection and classification of Plasmodium lifecycle stages in culture as well as discriminating between viable and dead parasites in drug-treated samples. This new algorithm reliably estimates the number of red blood cells (isolated or clustered) per fluorescence image field, and accurately identifies parasitized erythrocytes on the basis of high intensity DAPI-stained parasite nuclei spots and Mitotracker-stained mitochondrial in viable parasites. We validated the performance of the algorithm by manual counting of the infected and non-infected red blood cells in multiple image fields, and the quantitative analyses of the different parasite stages (early rings, rings, trophozoites, schizonts) at various time-point post-merozoite invasion, in tightly synchronized cultures. Additionally, the developed algorithm provided parasitological effective concentration 50 (EC50) values for both chloroquine and artemisinin, that were similar to known growth inhibitory EC50 values for these compounds as determined using conventional SYBR Green I and lactate dehydrogenase-based assays.	[Moon, Seunghyun; Kim, Heechang; Hansen, Michael A. E.] Inst Pasteur Korea, IM Grp, Songnam, Gyeonggi Do, South Korea; [Lee, Sukjun; Ayong, Lawrence] Inst Pasteur Korea, Malaria Drug Discovery MRA Unit, Songnam, Gyeonggi Do, South Korea; [Freitas-Junior, Lucio H.] Inst Pasteur Korea, Ctr Neglected Dis CND3, Songnam, Gyeonggi Do, South Korea; [Moon, Seunghyun; Kang, Myungjoo] SNU, Dept Math, Seoul, South Korea	Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea; Seoul National University (SNU)	Hansen, MAE (corresponding author), Inst Pasteur Korea, IM Grp, Songnam, Gyeonggi Do, South Korea.	edberg@ip-korea.org	Hansen, Michael Adsetts Edberg/C-9028-2011; Freitas-Junior, Lucio H/C-8677-2011	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Freitas-Junior, Lucio H/0000-0002-8904-7897	National Research Foundation of Korea (NRF); Korea government (MEST), Gyeonggi-do [2012-00011]; KISTI; Basic Science Research Program through the National Research Foundation of Korea [(2012-001766]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI)); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST)(No. 2012-00011), Gyeonggi-do and KISTI. Myungjoo Kang was supported by the Basic Science Research Program (2012-001766) through the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Coeurjolly D., 2001, Visual Form 2001. 4th International Workshop on Visual Form IWVF4. Proceedings (Lecture Notes in Computer Science Vol.2059), P303; Di Ruberto C., 2001, Visual Form 2001. 4th International Workshop on Visual Form IWVF4. Proceedings (Lecture Notes in Computer Science Vol.2059), P739; Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005; Freeman H., 1961, IRE T ELECT COMPUT, V10, P260, DOI [10.1109/TEC.1961.5219197, DOI 10.1109/TEC.1961.5219197]; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Hobbs Charlotte, 2011, F1000 Biol Rep, V3, P24, DOI 10.3410/B3-24; Le MT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-15; Li G, 2008, J MICROSC-OXFORD, V231, P47, DOI 10.1111/j.1365-2818.2008.02016.x; Ma C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-348; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perlmann P, 2000, FOLIA BIOL-PRAGUE, V46, P210; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Ritter N., 2007, P 30 AUSTR C COMP SC, V62, P161; Ross NE, 2006, MED BIOL ENG COMPUT, V44, P427, DOI 10.1007/s11517-006-0044-2; Sharif J. M., 2012, 2012 International Conference on Biomedical Engineering (ICoBE), P258, DOI 10.1109/ICoBE.2012.6179016; Suzuki K, 2003, COMPUT VIS IMAGE UND, V89, P1, DOI 10.1016/S1077-3142(02)00030-9; Tek FB, 2005, COMPUT IMAGING VIS, V30, P441; Tilley L, 2011, INT J BIOCHEM CELL B, V43, P839, DOI 10.1016/j.biocel.2011.03.012; Vossen MG, 2010, AM J TROP MED HYG, V82, P398, DOI 10.4269/ajtmh.2010.09-0417; Vromen J, 2009, 2009 24TH INTERNATIONAL CONFERENCE IMAGE AND VISION COMPUTING NEW ZEALAND (IVCNZ 2009), P44, DOI 10.1109/IVCNZ.2009.5378364; Wang R., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1109/IEVC2012.6183284.URL; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; World Health Organization, 2012, MAL FACT SHEET 94	27	32	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61812	10.1371/journal.pone.0061812	http://dx.doi.org/10.1371/journal.pone.0061812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626733	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400097
J	Sarhan, MA; Chen, AY; Michalak, TI				Sarhan, Mohammed A.; Chen, Annie Y.; Michalak, Tomasz I.			Differential Expression of Candidate Virus Receptors in Human T Lymphocytes Prone or Resistant to Infection with Patient-Derived Hepatitis C Virus	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; B TYPE-I; PERIPHERAL-BLOOD; SCAVENGER RECEPTOR; LYMPHOID-CELLS; TRANSLATIONAL EFFICIENCY; LIVER-TRANSPLANTATION; ANTIVIRAL TREATMENT; OCCULT INFECTION; ENTRY	Accumulated evidence implies that hepatitis C virus (HCV) infects not only the liver but also the immune system. A lymphocyte-specific CD5 molecule was recently identified as essential for infection of T cells with native, patient-derived HCV. To assess whether the proposed hepatocyte receptors may also contribute to HCV lymphotropism, expression of scavenger receptor-class B type 1 (SR-B1), claudin-1 (CLDN-1), claudin-6 (CLDN-6), occludin (OCLN), CD5 and CD81 was examined by real-time RT-PCR and the respective proteins quantified by immunoblotting in HCV-prone and resistant T cell lines, peripheral blood mononuclear cells (PBMC), primary T cells and their subsets, and compared to hepatoma Huh7.5 and HepG2 cells. SR-B1 protein was found in T and hepatoma cell lines but not in PBMC or primary T lymphocytes, CLDN-1 in HCV-resistant PM1 T cell line and hepatoma cells only, while CLDN-6 equally in the cells investigated. OCLN protein occurred in HCV-susceptible Molt4 and Jurkat T cells and its traces in primary T cells, but not in PBMC. CD5 was displayed by HCV-prone T cell lines, primary T cells and PBMC, but not by non-susceptible T and hepatoma cell lines, while CD81 in all cell types except HepG2. Knocking-down OCLN in virus-prone T cell line inhibited HCV infection, while de novo infection downregulated OCLN and CD81, and upregulated CD5 without modifying SR-B1 expression. Overall, while no association between SR-B1, CLDN-1 or CLDN-6 and the susceptibility to HCV was found, CD5 and CD81 expression coincided with virus lymphotropism and that of OCLN with permissiveness of T cell lines but unlikely primary T cells. This study narrowed the range of factors potentially utilized by HCV to infect T lymphocytes amongst those uncovered using laboratory HCV and Huh7.5 cells. Together with the demonstrated role for CD5 in HCV lymphotropism, the findings indicate that virus utilizes different molecules to enter hepatocytes and lymphocytes.	[Sarhan, Mohammed A.; Chen, Annie Y.; Michalak, Tomasz I.] Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, Mol Virol & Hepatol Res Grp,Div BioMed Sci, St John, NF, Canada	Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Michalak, TI (corresponding author), Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, Mol Virol & Hepatol Res Grp,Div BioMed Sci, St John, NF, Canada.	timich@mun.ca	Sarhan, Mohammed A/A-4985-2013	Sarhan, Mohammed A/0000-0002-8197-2025	Canadian Institutes of Health Research (CIHR) [MOP-77544]; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC); National Liver Institute, Menofia University, Egypt; Canada Research Chair Program; CIHR; Canada Foundation for Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National CIHR Research Training Program in Hepatitis C (NCRTP-HepC)(Canadian Institutes of Health Research (CIHR)); National Liver Institute, Menofia University, Egypt; Canada Research Chair Program(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was supported by an operating grant MOP-77544 from the Canadian Institutes of Health Research (CIHR) awarded to TIM. MAS received fellowships from the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) and the National Liver Institute, Menofia University, Egypt. TIM holds the Senior Canada Research Chair in Viral Hepatitis/Immunology sponsored by the Canada Research Chair Program and funds from the CIHR and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bare P, 2005, J GEN VIROL, V86, P1717, DOI 10.1099/vir.0.80882-0; Barth H, 2005, J VIROL, V79, P5774, DOI 10.1128/JVI.79.9.5774-5785.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2008, HEPATOLOGY, V48, P1044, DOI 10.1002/hep.22465; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Blackard JT, 2006, HEPATOLOGY, V44, P15, DOI 10.1002/hep.21283; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Butt AA, 2012, CLIN INFECT DIS, V54, P96, DOI 10.1093/cid/cir774; Chuang SS, 2010, J CLIN PATHOL, V63, P595, DOI 10.1136/jcp.2010.076810; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; Coffin CS, 2011, LIVER TRANSPLANT, V17, P955, DOI 10.1002/lt.22312; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; Durand T, 2010, GUT, V59, P934, DOI 10.1136/gut.2009.192088; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Francisco M, 2012, CLIN INFECT DIS, V55, P10; Friedlein G, 2007, J IMMUNOL, V178, P6821, DOI 10.4049/jimmunol.178.11.6821; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Giannini C, 2006, HEPATOLOGY, V43, P1166, DOI 10.1002/hep.21132; Girish V, 2004, Indian J Cancer, V41, P47; Guy CS, 2008, HEPATOLOGY, V47, P1691, DOI 10.1002/hep.22228; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kasama Y, 2010, BLOOD, V116, P4926, DOI 10.1182/blood-2010-05-283358; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Korenaga M, 2005, J CLIN GASTROENTEROL, V39, pS162, DOI 10.1097/01.mcg.0000155517.02468.46; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Laskus T, 2002, J INFECT DIS, V185, P417, DOI 10.1086/338635; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MacParland SA, 2006, J GEN VIROL, V87, P3577, DOI 10.1099/vir.0.81868-0; MacParland SA, 2009, HEPATOLOGY, V49, P1431, DOI 10.1002/hep.22802; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Michalak TI, 2000, J VIROL, V74, P4483, DOI 10.1128/JVI.74.10.4483-4494.2000; Morsica G, 1999, BLOOD, V94, P1138; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Okuda M, 1999, HEPATOLOGY, V29, P217, DOI 10.1002/hep.510290117; Oldstone MBA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000523; Pham TNQ, 2012, J VIRAL HEPATITIS, V19, P103, DOI 10.1111/j.1365-2893.2011.01442.x; Pham TNQ, 2009, J VIRAL HEPATITIS, V16, P547, DOI 10.1111/j.1365-2893.2009.01092.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TNQ, 2005, J GEN VIROL, V86, P657, DOI 10.1099/vir.0.80624-0; Pham TNQ, 2008, GASTROENTEROLOGY, V134, P812, DOI 10.1053/j.gastro.2007.12.011; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Radkowski M, 1998, TRANSPLANTATION, V66, P664, DOI 10.1097/00007890-199809150-00022; Richiardi L, 2010, CANCER EPIDEMIOL, V34, P709, DOI 10.1016/j.canep.2010.07.014; Sarhan MA, 2012, J GEN VIROL, V93, P2399, DOI 10.1099/vir.0.045393-0; Sarhan MA, 2012, J VIROL, V86, P3723, DOI 10.1128/JVI.06956-11; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SHIMIZU YK, 1992, P NATL ACAD SCI USA, V89, P5477, DOI 10.1073/pnas.89.12.5477; Toubi E, 2004, J VIROL, V78, P11379, DOI 10.1128/JVI.78.20.11379-11384.2004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; WILLEMS M, 1994, J MED VIROL, V42, P272, DOI 10.1002/jmv.1890420314; Yamada E, 2005, J GEN VIROL, V86, P2507, DOI 10.1099/vir.0.81169-0; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zuckerman E, 2003, J VIROL, V77, P10432, DOI 10.1128/JVI.77.19.10432-10436.2003	71	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62159	10.1371/journal.pone.0062159	http://dx.doi.org/10.1371/journal.pone.0062159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626783	gold, Green Published, Green Accepted			2022-12-25	WOS:000318008400147
J	Stroka, KM; Hayenga, HN; Aranda-Espinoza, H				Stroka, Kimberly M.; Hayenga, Heather N.; Aranda-Espinoza, Helim			Human Neutrophil Cytoskeletal Dynamics and Contractility Actively Contribute to Trans-Endothelial Migration	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; SUBSTRATE STIFFNESS; LEUKOCYTE TRANSMIGRATION; CELL CONTRACTILITY; MECHANICAL FORCES; CADHERIN; UROPOD; EXTRAVASATION; DIAPEDESIS; ADHESION	Transmigration through the endothelium is a key step in the immune response. In our recent work, the mechanical properties of the subendothelial matrix and biophysical state of the endothelium have been identified as key modulators of leukocyte trans-endothelial migration. Here, we demonstrated that neutrophil contractile forces and cytoskeletal dynamics also play an active biophysical role during transmigration through endothelial cell-cell junctions. Using our previously-established model for leukocyte transmigration, we first discovered that >93% of human neutrophils preferentially exploit the paracellular mode of transmigration in our in vitro model, and that is independent of subendothelial matrix stiffness. We demonstrated that inhibition of actin polymerization or depolymerization completely blocks transmigration, thus establishing a critical role for neutrophil actin dynamics in transmigration. Next, inhibition of neutrophil myosin II-mediated contractile forces renders 44% of neutrophils incapable of retracting their trailing edge under the endothelium for several minutes after the majority of the neutrophil transmigrates. Meanwhile, inhibition of neutrophil contractile forces or stabilization of microtubules doubles the time to complete transmigration for the first neutrophils to cross the endothelium. Notably, the time to complete transmigration is significantly reduced for subsequent neutrophils that cross through the same path as a previous neutrophil and is less dependent on neutrophil contractile forces and microtubule dynamics. These results suggest that the first neutrophil induces a gap in endothelial cell-cell adhesions, which "opens the door" in the endothelium and facilitates transmigration of subsequent neutrophils through the same hole. Collectively, this work demonstrates that neutrophils play an active biophysical role during the transmigration step of the immune response.	[Stroka, Kimberly M.; Hayenga, Heather N.; Aranda-Espinoza, Helim] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Aranda-Espinoza, H (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	helim@umd.edu	Hayenga, Heather/H-1053-2011	Hayenga, Heather/0000-0001-7581-8294	National Institute of Health National Research Service Award [F31NS068028]; National Institute of Health Human Frontier Science Project Award [RGP0058/2011]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS068028] Funding Source: NIH RePORTER	National Institute of Health National Research Service Award; National Institute of Health Human Frontier Science Project Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health National Research Service Award F31NS068028 (KMS) and a Human Frontier Science Project Award RGP0058/2011 (HAE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; Balzer EM, 2012, FASEB J; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; Garcia JGN, 1998, J APPL PHYSIOL, V84, P1817, DOI 10.1152/jappl.1998.84.5.1817; Hashimoto K, 2011, INT J CARDIOL, V149, P232, DOI 10.1016/j.ijcard.2010.12.018; Heasman SJ, 2010, J CELL BIOL, V190, P553, DOI 10.1083/jcb.201002067; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Johnson JL, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-28; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Liu ZJ, 2010, CELL MOL BIOENG, V3, P50, DOI 10.1007/s12195-010-0105-3; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Norman LL, 2010, CELL MOL BIOENG, V3, P398, DOI 10.1007/s12195-010-0137-8; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Peloquin J, 2011, J BIOMECH, V44, P815, DOI 10.1016/j.jbiomech.2010.12.018; Rabodzey A, 2008, BIOPHYS J, V95, P1428, DOI 10.1529/biophysj.107.119156; Rape A, 2011, J CELL SCI, V124, P4233, DOI 10.1242/jcs.090563; Saito H, 1998, J IMMUNOL, V161, P1533; Saito H, 2002, J LEUKOCYTE BIOL, V72, P829; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Smith LA, 2007, BIOPHYS J, V92, pL58, DOI 10.1529/biophysj.106.102822; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Stroka KM, 2010, FEBS J, V277, P1145, DOI 10.1111/j.1742-4658.2009.07545.x; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Wang N, 1998, HYPERTENSION, V32, P162, DOI 10.1161/01.HYP.32.1.162; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wee H, 2009, EXP MOL MED, V41, P341, DOI 10.3858/emm.2009.41.5.038; Wojcikiewicz EP, 2009, BIOPHYS J, V96, P285, DOI 10.1529/biophysj.108.135491; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	44	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61377	10.1371/journal.pone.0061377	http://dx.doi.org/10.1371/journal.pone.0061377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626676	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400039
J	Yan, WR; Palm, L; Lu, X; Nie, SF; Xu, B; Zhao, Q; Tao, T; Cheng, LW; Tan, L; Dong, HJ; Diwan, VK				Yan, Weirong; Palm, Lars; Lu, Xin; Nie, Shaofa; Xu, Biao; Zhao, Qi; Tao, Tao; Cheng, Liwei; Tan, Li; Dong, Hengjin; Diwan, Vinod K.			ISS - An Electronic Syndromic Surveillance System for Infectious Disease in Rural China	PLOS ONE			English	Article								Background: syndromic surveillance system has great advantages in promoting the early detection of epidemics and reducing the necessities of disease confirmation, and it is especially effective for surveillance in resource poor settings. However, most current syndromic surveillance systems are established in developed countries, and there are very few reports on the development of an electronic syndromic surveillance system in resource-constrained settings. Objective: this study describes the design and pilot implementation of an electronic surveillance system (ISS) for the early detection of infectious disease epidemics in rural China, complementing the conventional case report surveillance system. Methods: ISS was developed based on an existing platform 'Crisis Information Sharing Platform' (CRISP), combining with modern communication and GIS technology. ISS has four interconnected functions: 1) work group and communication group; 2) data source and collection; 3) data visualization; and 4) outbreak detection and alerting. Results: As of Jan. 31st 2012, ISS has been installed and pilot tested for six months in four counties in rural China. 95 health facilities, 14 pharmacies and 24 primary schools participated in the pilot study, entering respectively 74256, 79701, and 2330 daily records into the central database. More than 90% of surveillance units at the study sites are able to send daily information into the system. In the paper, we also presented the pilot data from health facilities in the two counties, which showed the ISS system had the potential to identify the change of disease patterns at the community level. Conclusions: The ISS platform may facilitate the early detection of infectious disease epidemic as it provides near real-time syndromic data collection, interactive visualization, and automated aberration detection. However, several constraints and challenges were encountered during the pilot implementation of ISS in rural China.	[Yan, Weirong; Lu, Xin; Diwan, Vinod K.] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Palm, Lars] Future Posit X FPX, Gavle, Sweden; [Yan, Weirong; Nie, Shaofa; Cheng, Liwei; Tan, Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Xu, Biao; Zhao, Qi; Tao, Tao] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Dong, Hengjin] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Lu, Xin] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Lu, Xin] Natl Univ DefenseTechnol, Dept Informat Syst & Management, Changsha, Hunan, Peoples R China; [Dong, Hengjin] Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China	Karolinska Institutet; Huazhong University of Science & Technology; Fudan University; Ruprecht Karls University Heidelberg; Stockholm University; National University of Defense Technology - China; Zhejiang University	Yan, WR (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	weirongy@ki.se	lu, xin/C-1940-2009	lu, xin/0000-0002-3547-6493	European Union [241900]	European Union(European Commission)	The project is financially supported by a grant under the European Union Framework Program 7 (project no: 241900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Cho Joon Pil, 2008, J Prev Med Public Health, V41, P219, DOI 10.3961/jpmph.2008.41.4.219; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Cooper DL, 2009, J PUBLIC HEALTH-UK, V31, P17, DOI 10.1093/pubmed/fdm068; Dara J, 2008, J BIOMED INFORM, V41, P613, DOI 10.1016/j.jbi.2007.11.004; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; Flamand C, 2008, EUROSURVEILLANCE, V13, P1; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hubei Provential Bureau of Statistics, 2011, 6 NAT CENS DAT JINGM; Hubei Provential Bureau of Statistics, 2011, 6 NAT CENS DAT QIANJ; Lemay R, 2008, BIOSECUR BIOTERROR, V6, P161, DOI 10.1089/bsp.2007.0056; Lewis SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019750; Li Zhong-Jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P942; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Lu HM, 2009, INT J MED INFORM, V78, P308, DOI 10.1016/j.ijmedinf.2008.08.004; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Moore KM, 2008, CAN J EMERG MED, V10, P114; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Ritter T, 2002, P SOC PHOTO-OPT INS, V4722, P110, DOI 10.1117/12.472254; Siswoyo Hadi, 2008, BMC Proc, V2 Suppl 3, pS3; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; Soto Giselle, 2008, BMC Proc, V2 Suppl 3, pS4; Sugawara Tamie, 2007, Kansenshogaku Zasshi, V81, P235; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Wagner MM., 2006, HDB BIOSURVEILLANCE; World Health Organization, 2000, Weekly Epidemiological Record, V75, P1; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yan WR, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-4; Yan WR, 2007, CHIN J DIS CONTROL P, V11, P79	31	24	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62749	10.1371/journal.pone.0062749	http://dx.doi.org/10.1371/journal.pone.0062749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626853	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400217
J	Noronha, V; Prabhash, K; Thavamani, A; Chougule, A; Purandare, N; Joshi, A; Sharma, R; Desai, S; Jambekar, N; Dutt, A; Mulherkar, R				Noronha, Vanita; Prabhash, Kumar; Thavamani, Abhishek; Chougule, Anuradha; Purandare, Nilendu; Joshi, Amit; Sharma, Rashmi; Desai, Saral; Jambekar, Nirmala; Dutt, Amit; Mulherkar, Rita			EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy	PLOS ONE			English	Article							ACTIVATING MUTATIONS; NEVER-SMOKERS; GEFITINIB; CHEMOTHERAPY	Screening for EGFR mutation is a key molecular test for management of lung cancer patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is known to be better across different ethnic populations. However, frequency of EGFR mutations and the clinical response in most other ethnic populations, including India, remains to be explored. We conducted a retrospective analysis of Indian lung cancer patients who were managed with oral tyrosine kinase inhibitors. Majority of the patients in the study had adenocarcinoma and were non-smokers. 39/111 patients tested positive for EGFR kinase domain mutations determined by Taqman based real time PCR. The overall response to oral TKI therapy was 30%. Patients with an activating mutation of EGFR had a response rate of 74%, while the response rate in patients with wild type EGFR was 5%, which was a statistically significant difference. Progression free survival of patients with EGFR mutations was 10 months compared to 2 months for EGFR mutation negative patients. Overall survival was 19 months for EGFR mutation patients and 13 months for mutation negative patients. This study emphasizes EGFR mutation as an important predictive marker for response to oral tyrosine kinase inhibitors in the Indian population.	[Noronha, Vanita; Prabhash, Kumar; Thavamani, Abhishek; Chougule, Anuradha; Joshi, Amit; Sharma, Rashmi] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India; [Purandare, Nilendu] Tata Mem Hosp, Tata Mem Ctr, Dept Radiol, Bombay 400012, Maharashtra, India; [Desai, Saral; Jambekar, Nirmala] Tata Mem Hosp, Tata Mem Ctr, Dept Pathol, Bombay 400012, Maharashtra, India; [Dutt, Amit; Mulherkar, Rita] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Prabhash, K (corresponding author), Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India.	kprabhash1@gmail.com; adutt@actrec.gov.in	Thavamani, Abhishek/I-3207-2018; Dutt, Amit/I-1911-2013	Thavamani, Abhishek/0000-0001-7187-9188; Dutt, Amit/0000-0002-1119-4774	Wellcome Trust/Department of Biotechnology India Alliance	Wellcome Trust/Department of Biotechnology India Alliance	A.D. is supported by an Intermediate fellowship from the Wellcome Trust/Department of Biotechnology India Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Krishnamurthy A, 2012, INDIAN J CANCER, V49, P82, DOI 10.4103/0019-509X.98928; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Noronha V, 2012, INDIAN J CANCER, V49, P74, DOI 10.4103/0019-509X.98925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Sahoo R, 2011, LUNG CANCER, V73, P316, DOI 10.1016/j.lungcan.2011.01.004; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Zhang XT, 2005, ANN ONCOL, V16, P1334, DOI 10.1093/annonc/mdi340	16	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61561	10.1371/journal.pone.0061561	http://dx.doi.org/10.1371/journal.pone.0061561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620765	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500045
J	Yip, PK; Pizzasegola, C; Gladman, S; Biggio, ML; Marino, M; Jayasinghe, M; Ullah, F; Dyall, SC; Malaspina, A; Bendotti, C; Michael-Titus, A				Yip, Ping K.; Pizzasegola, Chiara; Gladman, Stacy; Biggio, Maria Luigia; Marino, Marianna; Jayasinghe, Maduka; Ullah, Farhan; Dyall, Simon C.; Malaspina, Andrea; Bendotti, Caterina; Michael-Titus, Adina			The Omega-3 Fatty Acid Eicosapentaenoic Acid Accelerates Disease Progression in a Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RANDOMIZED CONTROLLED-TRIAL; CU/ZN-SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; SPINAL-CORD COMPRESSION; AGE-RELATED DECREASES; FAMILIAL ALS; MUTANT SOD1; MOUSE MODEL; DOCOSAHEXAENOIC ACID	Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative disease characterised by loss of motor neurons that currently has no cure. Omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA), have many health benefits including neuroprotective and myoprotective potential. We tested the hypothesis that a high level of dietary EPA could exert beneficial effects in ALS. The dietary exposure to EPA (300 mg/kg/day) in a well-established mouse model of ALS expressing the G93A superoxide dismutase 1 (SOD1) mutation was initiated at a pre-symptomatic or symptomatic stage, and the disease progression was monitored until the end stage. Daily dietary EPA exposure initiated at the disease onset did not significantly alter disease presentation and progression. In contrast, EPA treatment initiated at the pre-symptomatic stage induced a significantly shorter lifespan. In a separate group of animals sacrificed before the end stage, the tissue analysis showed that the vacuolisation detected in G93A-SOD1 mice was significantly increased by exposure to EPA. Although EPA did not alter motor neurone loss, EPA reversed the significant increase in activated microglia and the astrocytic activation seen in G93A-SOD1 mice. The microglia in the spinal cord of G93A-SOD1 mice treated with EPA showed a significant increase in 4-hydroxy-2-hexenal, a highly toxic aldehydic oxidation product of omega-3 fatty acids. These data show that dietary EPA supplementation in ALS has the potential to worsen the condition and accelerate the disease progression. This suggests that great caution should be exerted when considering dietary omega-3 fatty acid supplements in ALS patients.	[Yip, Ping K.; Gladman, Stacy; Jayasinghe, Maduka; Ullah, Farhan; Dyall, Simon C.; Malaspina, Andrea; Michael-Titus, Adina] Queen Mary Univ London, Blizard Inst, London, England; [Pizzasegola, Chiara; Biggio, Maria Luigia; Marino, Marianna; Bendotti, Caterina] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Milan, Italy; [Dyall, Simon C.] Univ Roehampton, Dept Life Sci, London, England; [Malaspina, Andrea] Royal London Hosp, North East London & Essex MND Care Ctr, London E1 1BB, England	University of London; Queen Mary University London; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Roehampton University; Barts Health NHS Trust; Royal London Hospital	Michael-Titus, A (corresponding author), Queen Mary Univ London, Blizard Inst, London, England.	a.t.michael-titus@qmul.ac.uk	Dyall, Simon/AHB-8887-2022; Bendotti, Caterina/AAB-2273-2020	Bendotti, Caterina/0000-0003-1055-1271; Gladman, Stacy/0000-0002-7112-4516; Dyall, Simon/0000-0001-7591-4219	Motor Neuron Disease Association (U.K.)	Motor Neuron Disease Association (U.K.)	The study was supported by the Motor Neuron Disease Association (U.K.). The authors thank Croda Healthcare for the donation of Incromega oil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet JN, 2012, NEUROSCIENCE, V209, P136, DOI 10.1016/j.neuroscience.2011.12.047; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Boston PF, 2004, PROSTAG LEUKOTR ESS, V71, P341, DOI 10.1016/j.plefa.2004.07.001; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005; Clement MV, 2003, CELL DEATH DIFFER, V10, P1273, DOI 10.1038/sj.cdd.4401302; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; de Aguilar JLG, 2005, BIOMED PHARMACOTHER, V59, P190, DOI 10.1016/j.biopha.2005.03.003; Dorsey ER, 2008, ARCH NEUROL-CHICAGO, V65, P1582, DOI 10.1001/archneur.65.12.1582; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Grignaschi G, 2007, AMYOTROPH LATERAL SC, V8, P31, DOI 10.1080/17482960600783456; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jokic N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-633; Kim HY, 2010, PROSTAG LEUKOTR ESS, V82, P165, DOI 10.1016/j.plefa.2010.02.025; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kong JM, 1998, J NEUROSCI, V18, P3241; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lim SN, 2010, PROSTAG LEUKOTR ESS, V83, P193, DOI 10.1016/j.plefa.2010.08.003; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; McDermott CJ, 2008, BMJ-BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shibata N, 2004, BRAIN RES, V1019, P170, DOI 10.1016/j.brainres.2004.05.110; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos Artemis P, 2007, Curr Sports Med Rep, V6, P230, DOI 10.1007/s11932-007-0037-4; Soleman S, 2010, EXP NEUROL, V222, P13, DOI 10.1016/j.expneurol.2009.11.007; Song C, 2004, J LIPID RES, V45, P1112, DOI [10.1194/jlr.M300526-JLR200, 10.1194/jlr.M300526-JLr200]; Song C, 2004, STRESS, V7, P43, DOI 10.1080/10253890410001667188; Trebble TM, 2005, BRIT J NUTR, V94, P253, DOI 10.1079/BJN20051466; Van Raamsdonk JM, 2005, EXP NEUROL, V196, P266, DOI 10.1016/j.expneurol.2005.07.021; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Yamada S, 2004, J LIPID RES, V45, P626, DOI 10.1194/jlr.M300376-JLR200; Yip PK, 2009, J NEUROSCI METH, V183, P223, DOI 10.1016/j.jneumeth.2009.07.002; ZIBOH VA, 1986, ARCH DERMATOL, V122, P1277, DOI 10.1001/archderm.122.11.1277	58	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61626	10.1371/journal.pone.0061626	http://dx.doi.org/10.1371/journal.pone.0061626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620776	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500056
J	Iacobelli, S; Bonsante, F; Quantin, C; Robillard, PY; Binquet, C; Gouyon, JB				Iacobelli, Silvia; Bonsante, Francesco; Quantin, Catherine; Robillard, Pierre-Yves; Binquet, Christine; Gouyon, Jean-Bernard			Total Plasma Protein in Very Preterm Babies: Prognostic Value and Comparison with Illness Severity Scores	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEONATAL INTENSIVE-CARE; CLINICAL RISK INDEX; CRIB-II; MORTALITY RISK; SNAPPE-II; HYPOTENSION; PRESSURE; LIFE	Objective: We aimed to investigate the predictive value for severe adverse outcome of plasma protein measurements on day one of life in very preterm infants and to compare total plasma protein levels with the validated illness severity scores CRIB, CRIB-II, SNAP-II and SNAPPE-II, regarding their predictive ability for severe adverse outcome. Methods: We analyzed a cohort of infants born at 24-31 weeks gestation, admitted to the tertiary intensive care unit of a university hospital over 10.5 years. The outcome measure was "severe adverse outcome" defined as death before discharge or severe neurological injury on cranial ultrasound. The adjusted odd ratio (aOR) and 95% confidence interval (95% CI) of severe adverse outcome for hypoproteinemia (total plasma protein level <40 g/L) was calculated by univariate and multivariate analyses. Calibration (Hosmer-Lemeshow goodness-of-fit) was performed and the predictive ability for severe adverse outcome was assessed for total plasma protein and compared with CRIB, CRIB-II, SNAP-II and SNAPPE-II, by calculating receiver operating characteristic (ROC) curves and their associated area under the curve (AUC). Results: 761 infants were studied: 14.4% died and 4.1% survived with severe cerebral ultrasound findings. The aOR of severe adverse outcome for hypoproteinemia was 6.1 (95% CI 3.8-9.9). The rank order for variables, as assessed by AUCs and 95% CIs, in predicting outcome was: total plasma protein [0.849 (0.821-0.873)], SNAPPE-II [0.822 (0.792-0.848)], CRIB [0.821 (0.792-0.848)], SNAP-II [0.810 (0.780-0.837)] and CRIB-II [0.803 (0.772-0.830)]. Total plasma protein predicted severe adverse outcome significantly better than CRIB-II and SNAP-II (both p<0.05). Calibration for total plasma protein was very good. Conclusions: Early hypoproteinemia has prognostic value for severe adverse outcome in very preterm, sick infants. Total plasma protein has a predictive performance comparable with CRIB and SNAPPE-II and greater than other validated severity scores.	[Iacobelli, Silvia; Bonsante, Francesco; Robillard, Pierre-Yves; Gouyon, Jean-Bernard] CHU La Reunion, St Pierre, France; [Iacobelli, Silvia; Bonsante, Francesco; Robillard, Pierre-Yves; Gouyon, Jean-Bernard] CHU La Reunion, Ctr Etud Perinatales Ocean Indien, St Pierre, France; [Quantin, Catherine] CHRU, Serv Biostat & Informat Med, Dijon, France; [Quantin, Catherine] Univ Bourgogne, INSERM, U866, Dijon, France; [Binquet, Christine] INSERM CIE1, Dijon, France; [Binquet, Christine] CHRU Dijon, Ctr Invest Clin Epidemiol Clin Essais Clin, Dijon, France; [Binquet, Christine] Univ Bourgogne, Dijon, France	CHU Reunion; CHU Reunion; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Universite de Bourgogne	Iacobelli, S (corresponding author), CHU La Reunion, Site Sud, St Pierre, France.	silvia.iacobelli@chu-reunion.fr	Robillard, Pierre-Yves/AAD-9774-2021; Binquet, Christine/E-8953-2018	Binquet, Christine/0000-0002-9417-5754; Quantin, Catherine/0000-0001-5134-9411				Bode MM, 2009, PEDIATRICS, V124, P866, DOI 10.1542/peds.2008-1669; Buhrer C, 2008, ACTA PAEDIATR, V97, P899, DOI 10.1111/j.1651-2227.2008.00793.x; COCKBURN F, 1993, LANCET, V342, P193; De Felice C, 2005, J MATERN-FETAL NEO M, V17, P257, DOI 10.1080/14767050500072557; De Felice C, 2004, EUR J PEDIATR, V163, P550, DOI 10.1007/s00431-004-1488-8; De Felice Claudio, 2005, Pediatr Crit Care Med, V6, P298, DOI 10.1097/01.PCC.0000160658.35437.65; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Dorling JS, 2005, ARCH DIS CHILD-FETAL, V90, pF11, DOI 10.1136/adc.2003.048488; Fanaroff JM, 2006, PEDIATRICS, V117, P1131, DOI 10.1542/peds.2005-1230; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Gagliardi L, 2004, ARCH DIS CHILD-FETAL, V89, pF419, DOI 10.1136/adc.2003.031286; GRAY JE, 1992, PEDIATRICS, V90, P561; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOSMER DW, 1989, APPL LOGISTIC REGRES, P135; Hussain F, 2009, J PAEDIATR CHILD H, V45, P263, DOI 10.1111/j.1440-1754.2009.01488.x; Iacobelli S, 2012, J PERINATOL, V32, P520, DOI 10.1038/jp.2011.137; MIALLALLEN VM, 1987, ARCH DIS CHILD, V62, P1068, DOI 10.1136/adc.62.10.1068; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Pellicer A, 2009, PEDIATRICS, V123, P1369, DOI 10.1542/peds.2008-0673; Phillips LA, 2011, ARCH DIS CHILD-FETAL, V96, pF275, DOI 10.1136/adc.2010.185793; READING RF, 1990, EARLY HUM DEV, V22, P81, DOI 10.1016/0378-3782(90)90082-T; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; RICHARDSON DK, 1993, PEDIATRICS, V91, P617; Soleymani S, 2010, J PERINATOL, V30, pS38, DOI 10.1038/jp.2010.101; Stark MJ, 2008, ARCH DIS CHILD-FETAL, V93, pF271, DOI 10.1136/adc.2007.123539; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Zimmerman B, 1997, ARCH PEDIATRIE, V4, P952, DOI 10.1016/S0929-693X(97)86090-3	30	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62210	10.1371/journal.pone.0062210	http://dx.doi.org/10.1371/journal.pone.0062210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614036	Green Published, Green Submitted, gold			2022-12-25	WOS:000317893400163
J	Solomonson, M; Huesgen, PF; Wasney, GA; Watanabe, N; Gruninger, RJ; Prehna, G; Overall, CM; Strynadka, NCJ				Solomonson, Matthew; Huesgen, Pitter F.; Wasney, Gregory A.; Watanabe, Nobuhiko; Gruninger, Robert J.; Prehna, Gerd; Overall, Christopher M.; Strynadka, Natalie C. J.			Structure of the Mycosin-1 Protease from the Mycobacterial ESX-1 Protein Type VII Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS; PE; PROLINE; PATHWAY; UNIQUE; PPE	Mycobacteria use specialized type VII (ESX) secretion systems to export proteins across their complex cell walls. Mycobacterium tuberculosis encodes five nonredundant ESX secretion systems, with ESX-1 being particularly important to disease progression. All ESX loci encode extracellular membrane-bound proteases called mycosins (MycP) that are essential to secretion and have been shown to be involved in processing of type VII-exported proteins. Here, we report the first x-ray crystallographic structure of MycP1(24-407) to 1.86 angstrom, defining a subtilisin-like fold with a unique N-terminal extension previously proposed to function as a propeptide for regulation of enzyme activity. The structure reveals that this N-terminal extension shows no structural similarity to previously characterized protease propeptides and instead wraps intimately around the catalytic domain where, tethered by a disulfide bond, it forms additional interactions with a unique extended loop that protrudes from the catalytic core. We also show MycP1 cleaves the ESX-1 secreted protein EspB from both M. tuberculosis and Mycobacterium smegmatis at a homologous cut site in vitro.	[Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca	Huesgen, Pitter/E-9246-2019	Huesgen, Pitter/0000-0002-0335-2242; Solomonson, Matthew/0000-0002-5344-9026; Prehna, Gerd/0000-0001-5539-7533	Canadian Institute of Health Research; Howard Hughes Medical Institute International Senior Scholar Program; University of British Columbia 4-year Ph.D. fellowship; Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Senior Scholar Program; University of British Columbia 4-year Ph.D. fellowship; Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund	This work was supported in part by operating grants from the Canadian Institute of Health Research and the Howard Hughes Medical Institute International Senior Scholar Program.; Supported by a University of British Columbia 4-year Ph.D. fellowship.; We thank the staff at the Canadian Light Source beamline CMCF-1 for assistance with data collection, the Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund for infrastructure funding, Marija Vuckovic for technical aid, and Julien Bergeron and Antonio Ruzzini for helpful discussion.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Dave JA, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-30; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Khan AR, 1998, PROTEIN SCI, V7, P815; Larsson A. M., 2009, PROTEIN CRYSTALLIZAT, P137; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHINDE U, 1995, J MOL BIOL, V247, P390, DOI 10.1006/jmbi.1994.0147; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vevodova J, 2010, STRUCTURE, V18, P744, DOI 10.1016/j.str.2010.03.008; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	41	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17782	17790		10.1074/jbc.M113.462036	http://dx.doi.org/10.1074/jbc.M113.462036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620593	Green Published, hybrid			2022-12-25	WOS:000320380600067
J	Gross, A; Levine, RD				Gross, Ayelet; Levine, Raphael D.			Surprisal Analysis of Transcripts Expression Levels in the Presence of Noise: A Reliable Determination of the Onset of a Tumor Phenotype	PLOS ONE			English	Article							INFORMATION; PROFILES; NETWORKS	Towards a reliable identification of the onset in time of a cancer phenotype, changes in transcription levels in cell models were tested. Surprisal analysis, an information-theoretic approach grounded in thermodynamics, was used to characterize the expression level of mRNAs as time changed. Surprisal Analysis provides a very compact representation for the measured expression levels of many thousands of mRNAs in terms of very few - three, four - transcription patterns. The patterns, that are a collection of transcripts that respond together, can be assigned definite biological phenotypic role. We identify a transcription pattern that is a clear marker of eventual malignancy. The weight of each transcription pattern is determined by surprisal analysis. The weight of this pattern changes with time; it is never strictly zero but it is very low at early times and then rises rather suddenly. We suggest that the low weights at early time points are primarily due to experimental noise. We develop the necessary formalism to determine at what point in time the value of that pattern becomes reliable. Beyond the point in time when a pattern is deemed reliable the data shows that the pattern remain reliable. We suggest that this allows a determination of the presence of a cancer forewarning. We apply the same formalism to the weight of the transcription patterns that account for healthy cell pathways, such as apoptosis, that need to be switched off in cancer cells. We show that their weight eventually falls below the threshold. Lastly we discuss patient heterogeneity as an additional source of fluctuation and show how to incorporate it within the developed formalism.	[Gross, Ayelet; Levine, Raphael D.] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, IL-91904 Jerusalem, Israel; [Levine, Raphael D.] David Geffen Sch Med Calif, Crump Inst Mol Imaging, Dept Chem & Biochem, Los Angeles, CA USA; [Levine, Raphael D.] David Geffen Sch Med Calif, Dept Mol & Med Pharmacol, Los Angeles, CA USA	Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Levine, RD (corresponding author), Hebrew Univ Jerusalem, Fritz Haber Res Ctr, IL-91904 Jerusalem, Israel.	Rafi@chem.ucla.edu			Prostate Cancer Foundation	Prostate Cancer Foundation	This work was supported by a Prostate Cancer Foundation Creativity Grant to R. D. Levine. (http://www.pcf.org/site/c.leJRIROrEpH/b.5800789/k.AD57/Creativity_Awards.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F; Aghagolzadeh M, 2011, ENTROPY-SWITZ, V13, P450, DOI 10.3390/e13020450; ALHASSID Y, 1980, CHEM PHYS LETT, V73, P16, DOI 10.1016/0009-2614(80)85192-X; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Arfken GB., 1999, MATH METHODS PHYS; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Golub GH., 2013, MATRIX COMPUTATIONS; Gross A, 2013, BIOCHEMISTRY; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; KINSEY JL, 1979, CHEM PHYS LETT, V65, P413, DOI 10.1016/0009-2614(79)80261-4; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Levine RD, 1980, MAXIMUM ENTROPY FORM; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Shin YS, 2011, BIOPHYS J, V100, P2378, DOI 10.1016/j.bpj.2011.04.025; Stickel JS, 2009, CANCER IMMUNOL IMMUN, V58, P1407, DOI 10.1007/s00262-008-0655-6; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Varshavsky R, 2006, BIOINFORMATICS, V22, pE507, DOI 10.1093/bioinformatics/btl214; Wall M. E., 2003, PRACTICAL APPROACH M, P91, DOI [10.1007/0-306-47815-3_5, DOI 10.1007/0-306-47815-3_5]	24	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61554	10.1371/journal.pone.0061554	http://dx.doi.org/10.1371/journal.pone.0061554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626699	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400063
J	Rutten, MJM; Bouwman, AC; Sprong, RC; van Arendonk, JAM; Visker, MHPW				Rutten, Marc J. M.; Bouwman, Aniek C.; Sprong, R. Corinne; van Arendonk, Johan A. M.; Visker, Marleen H. P. W.			Genetic Variation in Vitamin B-12 Content of Bovine Milk and Its Association with SNP along the Bovine Genome	PLOS ONE			English	Article							COBALT; FOLATE; FAT	Vitamin B-12 (also called cobalamin) is essential for human health and current intake levels of vitamin B-12 are considered to be too low. Natural enrichment of the vitamin B-12 content in milk, an important dietary source of vitamin B-12, may help to increase vitamin B-12 intake. Natural enrichment of the milk vitamin B-12 content could be achieved through genetic selection, provided there is genetic variation between cows with respect to the vitamin B-12 content in their milk. A substantial amount of genetic variation in vitamin B-12 content was detected among raw milk samples of 544 first-lactation Dutch Holstein Friesian cows. The presence of genetic variation between animals in vitamin B-12 content in milk indicates that the genotype of the cow affects the amount of vitamin B-12 that ends up in her milk and, consequently, that the average milk vitamin B-12 content of the cow population can be increased by genetic selection. A genome-wide association study revealed significant association between 68 SNP and vitamin B-12 content in raw milk of 487 first-lactation Dutch Holstein Friesian cows. This knowledge facilitates genetic selection for milk vitamin B-12 content. It also contributes to the understanding of the biological mechanism responsible for the observed genetic variation in vitamin B-12 content in milk. None of the 68 significantly associated SNP were in or near known candidate genes involved in transport of vitamin B-12 through the gastrointestinal tract, uptake by ileum epithelial cells, export from ileal cells, transport through the blood, uptake from the blood, intracellular processing, or reabsorption by the kidneys. Probably, associations relate to genes involved in alternative pathways of well-studied processes or to genes involved in less well-studied processes such as ruminal production of vitamin B-12 or secretion of vitamin B-12 by the mammary gland.	[Rutten, Marc J. M.; Bouwman, Aniek C.; van Arendonk, Johan A. M.; Visker, Marleen H. P. W.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Sprong, R. Corinne] NIZO Food Res BV, Ede, Netherlands	Wageningen University & Research; NIZO Food Research	Visker, MHPW (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands.	marleen.visker@wur.nl	van Arendonk, Johan/E-2536-2011; Bouwman, Aniek/H-7684-2019; Visker, Marleen/E-1394-2012	van Arendonk, Johan/0000-0003-2592-3947; Bouwman, Aniek/0000-0001-5079-7108; 	Wageningen University (Wageningen, the Netherlands); Dutch Dairy Association (NZO, Zoetermeer, the Netherlands); Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands); Dutch Technology Foundation (STW, Utrecht, the Netherlands); Dutch Ministry of Economic Affairs (The Hague, the Netherlands); Province of Gelderland (Arnhem, the Netherlands); Province of Overijssel (Zwolle, the Netherlands); Cooperative Cattle Improvement Organization CRV	Wageningen University (Wageningen, the Netherlands)(Netherlands Government); Dutch Dairy Association (NZO, Zoetermeer, the Netherlands)(Netherlands Government); Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands)(Netherlands Government); Dutch Technology Foundation (STW, Utrecht, the Netherlands)(Technologiestichting STWNetherlands Government); Dutch Ministry of Economic Affairs (The Hague, the Netherlands)(Ministry of Economic Affairs, Netherlands); Province of Gelderland (Arnhem, the Netherlands)(Netherlands Government); Province of Overijssel (Zwolle, the Netherlands)(Netherlands Government); Cooperative Cattle Improvement Organization CRV	This study is part of the Dutch Milk Genomics Initiative and the project 'Melk op Maat', funded by Wageningen University (Wageningen, the Netherlands), the Dutch Dairy Association (NZO, Zoetermeer, the Netherlands), the Cooperative Cattle Improvement Organization CRV (Arnhem, the Netherlands), the Dutch Technology Foundation (STW, Utrecht, the Netherlands), the Dutch Ministry of Economic Affairs (The Hague, the Netherlands), the Province of Gelderland (Arnhem, the Netherlands) and the Province of Overijssel (Zwolle, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R. Corinne Sprong was employed by NIZO Food Research B.V. at the time of this study. This study was partly funded by the Cooperative Cattle Improvement Organization CRV. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adkins Y, 2001, BBA-GEN SUBJECTS, V1528, P43, DOI 10.1016/S0304-4165(01)00171-4; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Bor MV, 2010, AM J CLIN NUTR, V91, P571, DOI 10.3945/ajcn.2009.28082; Bor MV, 2006, AM J CLIN NUTR, V83, P52; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; COLLINS RA, 1953, J DAIRY SCI, V36, P24, DOI 10.3168/jds.S0022-0302(53)91450-7; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Dhonukshe-Rutten RAM, 2009, EUR J CLIN NUTR, V63, P18, DOI 10.1038/sj.ejcn.1602897; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Gilmour A., 2006, ASREML USER GUIDE RE; Green R, 2009, AM J CLIN NUTR, V89, p712S, DOI 10.3945/ajcn.2008.26947E; HENDERSON CR, 1975, J DAIRY SCI, V58, P1727, DOI 10.3168/jds.S0022-0302(75)84776-X; Heringstad B, 2006, J DAIRY SCI, V89, P2236, DOI 10.3168/jds.S0022-0302(06)72295-0; Kincaid RL, 2007, J DAIRY SCI, V90, P1880, DOI 10.3168/jds.2006-296; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; MacPherson A, 2000, FORAGE EVALUATION IN RUMINANT NUTRITION, P345, DOI 10.1079/9780851993447.0345; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Puls R, 1988, MINERAL LEVELS ANIMA; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; SMITH SE, 1957, J DAIRY SCI, V40, P1215, DOI 10.3168/jds.S0022-0302(57)94618-0; Stoop WM, 2008, J DAIRY SCI, V91, P385, DOI 10.3168/jds.2007-0181; Tucker KL, 2000, AM J CLIN NUTR, V71, P514; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598; WALKER CK, 1972, J DAIRY SCI, V55, P474, DOI 10.3168/jds.S0022-0302(72)85518-8; WILMINK JBM, 1987, LIVEST PROD SCI, V16, P335, DOI 10.1016/0301-6226(87)90003-0; Winkels RM, 2008, AM J CLIN NUTR, V88, P348, DOI 10.1093/ajcn/88.2.348; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	31	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62382	10.1371/journal.pone.0062382	http://dx.doi.org/10.1371/journal.pone.0062382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626813	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400177
J	Santos, GA; Pereira, VD; Roman, EAFR; Ignacio-Souza, L; Vitorino, DC; de Moura, RF; Razolli, DS; Torsoni, AS; Velloso, LA; Torsoni, MA				Santos, Gustavo A.; Pereira, Vinicius D.; Roman, Erika A. F. R.; Ignacio-Souza, Leticia; Vitorino, Daniele C.; de Moura, Rodrigo Ferreira; Razolli, Daniela S.; Torsoni, Adriana S.; Velloso, Licio A.; Torsoni, Marcio A.			Hypothalamic Inhibition of Acetyl-CoA Carboxylase Stimulates Hepatic Counter-Regulatory Response Independent of AMPK Activation in Rats	PLOS ONE			English	Article							PROTEIN-KINASE; FOOD-INTAKE; GLUCOSE-PRODUCTION; ENERGY HOMEOSTASIS; FEEDING-BEHAVIOR; LIPID-METABOLISM; BODY-WEIGHT; NUTRIENT; NEURONS; SIGNALS	Background: Hypothalamic AMPK acts as a cell energy sensor and can modulate food intake, glucose homeostasis, and fatty acid biosynthesis. Intrahypothalamic fatty acid injection is known to suppress liver glucose production, mainly by activation of hypothalamic ATP-sensitive potassium (K(ATP)) channels. Since all models employed seem to involve malonyl-CoA biosynthesis, we hypothesized that acetyl-CoA carboxylase can modulate the counter-regulatory response independent of nutrient availability. Methodology/Principal Findings: In this study employing immunoblot, real-time PCR, ELISA, and biochemical measurements, we showed that reduction of the hypothalamic expression of acetyl-CoA carboxylase by antisense oligonucleotide after intraventricular injection increased food intake and NPY mRNA, and diminished the expression of CART, CRH, and TRH mRNA. Additionally, as in fasted rats, in antisense oligonucleotide-treated rats, serum glucagon and ketone bodies increased, while the levels of serum insulin and hepatic glycogen diminished. The reduction of hypothalamic acetyl-CoA carboxylase also increased PEPCK expression, AMPK phosphorylation, and glucose production in the liver. Interestingly, these effects were observed without modification of hypothalamic AMPK phosphorylation. Conclusion/Significance: Hypothalamic ACC inhibition can activate hepatic counter-regulatory response independent of hypothalamic AMPK activation.	[Santos, Gustavo A.; Pereira, Vinicius D.; Roman, Erika A. F. R.; Ignacio-Souza, Leticia; de Moura, Rodrigo Ferreira; Razolli, Daniela S.; Velloso, Licio A.] Univ Estadual Campinas, Fac Ciencias Med, Campinas, SP, Brazil; [Vitorino, Daniele C.] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Torsoni, Adriana S.; Torsoni, Marcio A.] Univ Estadual Campinas, Fac Ciencias Aplicadas, Limeira, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Torsoni, MA (corresponding author), Univ Estadual Campinas, Fac Ciencias Aplicadas, Limeira, SP, Brazil.	marcio.torsoni@fca.unicamp.br	Razolli, Daniela S/B-1630-2014; Torsoni, Marcio/AAH-3450-2020; Velloso, Licio/AAJ-3778-2020; Torsoni, Marcio A/E-9982-2012; Torsoni, Adriana/HGC-4584-2022; Ignacio-Souza, Leticia/D-7510-2013	Razolli, Daniela S/0000-0002-2217-0946; Torsoni, Adriana/0000-0003-2287-7180; de Moura, Rodrigo Ferreira/0000-0002-6617-6434; Torsoni, Marcio/0000-0002-9663-5291; Ignacio-Souza, Leticia/0000-0002-2040-1851	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/05660-5, 2009/12523-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant n. 2006/05660-5 and 2009/12523-2) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Bultot L, 2012, BIOCHEM J, V443, P193, DOI 10.1042/BJ20112026; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Cabral A, 2012, NEUROSCI LETT, V518, P86, DOI 10.1016/j.neulet.2012.04.059; Cesquini M, 2008, LIFE SCI, V82, P1262, DOI 10.1016/j.lfs.2008.04.015; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Dieguez C, 2009, OBESITY FACTS, V2, P126, DOI 10.1159/000209251; FELDMAN S, 1966, NATURE, V210, P860, DOI 10.1038/210860a0; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 1997, BIOCHEM SOC T, V25, P1229, DOI 10.1042/bst0251229; Hillebrand JJG, 2002, PEPTIDES, V23, P2283, DOI 10.1016/S0196-9781(02)00269-3; Kawashima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036335; Kinote A, 2012, ENDOCRINOLOGY; Kinote A, 2012, ENDOCRINOLOGY, V153, P3633, DOI 10.1210/en.2012-1341; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Kohno D, 2011, NEUROSCI LETT, V499, P194, DOI 10.1016/j.neulet.2011.05.060; Lane MD, 2005, BIOCHEM SOC T, V33, P1063, DOI 10.1042/BST20051063; Lee K, 2005, ENDOCRINOLOGY, V146, P3, DOI 10.1210/en.2004-0968; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; McKinley MJ, 2001, CLIN EXP PHARMACOL P, V28, P990, DOI 10.1046/j.1440-1681.2001.03592.x; Michelotto JB, 2002, BRAIN RES BULL, V57, P613, DOI 10.1016/S0361-9230(01)00754-7; Migrenne S, 2011, DIABETES METAB, V37, P83, DOI 10.1016/j.diabet.2010.11.001; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mountjoy PD, 2007, DIABETOLOGIA, V50, P168, DOI 10.1007/s00125-006-0473-3; Nogueiras R, 2010, OBES REV, V11, P185, DOI 10.1111/j.1467-789X.2009.00669.x; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Roman EA, 2005, J PHYSIOL-LONDON, V568, P993, DOI 10.1113/jphysiol.2005.095687; Ross RA, 2010, AM J PHYSIOL-ENDOC M, V299, pE633, DOI 10.1152/ajpendo.00190.2010; Stark R, 2012, MOL CELL ENDOCRINOL; Stoppa GR, 2008, J ENDOCRINOL, V198, P157, DOI 10.1677/JOE-07-0428; Su Y, 2012, DIABETES, V61, P85, DOI 10.2337/db11-0857; Tokutake Y, 2010, BIOCHEM BIOPH RES CO, V402, P158, DOI 10.1016/j.bbrc.2010.10.009; Uehara Y, 1998, DIABETES, V47, P890, DOI 10.2337/diabetes.47.6.890; Wolfgang MJ, 2008, MOL ENDOCRINOL, V22, P2012, DOI 10.1210/me.2007-0538	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62669	10.1371/journal.pone.0062669	http://dx.doi.org/10.1371/journal.pone.0062669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626844	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400208
J	Saphirstein, RJ; Gao, YZ; Jensen, MH; Gallant, CM; Vetterkind, S; Moore, JR; Morgan, KG				Saphirstein, Robert J.; Gao, Yuan Z.; Jensen, Mikkel H.; Gallant, Cynthia M.; Vetterkind, Susanne; Moore, Jeffrey R.; Morgan, Kathleen G.			The Focal Adhesion: A Regulated Component of Aortic Stiffness	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; PROTEIN-KINASE; CELL; INTEGRINS; FORCE; SRC; PHOSPHORYLATION; CONTRACTION	Increased aortic stiffness is an acknowledged predictor and cause of cardiovascular disease. The sources and mechanisms of vascular stiffness are not well understood, although the extracellular matrix (ECM) has been assumed to be a major component. We tested here the hypothesis that the focal adhesions (FAs) connecting the cortical cytoskeleton of vascular smooth muscle cells (VSMCs) to the matrix in the aortic wall are a component of aortic stiffness and that this component is dynamically regulated. First, we examined a model system in which magnetic tweezers could be used to monitor cellular cortical stiffness, serum-starved A7r5 aortic smooth muscle cells. Lysophosphatidic acid (LPA), an activator of myosin that increases cell contractility, increased cortical stiffness. A small molecule inhibitor of Src-dependent FA recycling, PP2, was found to significantly inhibit LPA-induced increases in cortical stiffness, as well as tension-induced increases in FA size. To directly test the applicability of these results to force and stiffness development at the level of vascular tissue, we monitored mouse aorta ring stiffness with small sinusoidal length oscillations during agonist-induced contraction. The alpha-agonist phenylephrine, which also increases myosin activation and contractility, increased tissue stress and stiffness in a PP2- and FAK inhibitor 14-attenuated manner. Subsequent phosphotyrosine screening and follow-up with phosphosite-specific antibodies confirmed that the effects of PP2 and FAK inhibitor 14 in vascular tissue involve FA proteins, including FAK, CAS, and paxillin. Thus, in the present study we identify, for the first time, the FA of the VSMC, in particular the FAK-Src signaling complex, as a significant subcellular regulator of aortic stiffness and stress.	[Saphirstein, Robert J.; Gao, Yuan Z.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Saphirstein, Robert J.; Gao, Yuan Z.; Gallant, Cynthia M.; Vetterkind, Susanne; Morgan, Kathleen G.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Jensen, Mikkel H.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Jensen, Mikkel H.; Moore, Jeffrey R.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University	Morgan, KG (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	kmorgan@bu.edu		Morgan, Kathleen/0000-0003-3300-3630	NIH Quantitative Biology and Physiology Training Grant, Evans Center for Interdisciplinary Biomedical Research ARC on Aortic Stiffness at Boston University [NIH HL086655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER	NIH Quantitative Biology and Physiology Training Grant, Evans Center for Interdisciplinary Biomedical Research ARC on Aortic Stiffness at Boston University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH HL086655, NIH Quantitative Biology and Physiology Training Grant, Evans Center for Interdisciplinary Biomedical Research ARC on Aortic Stiffness at Boston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barany M., 1996, BIOCH SMOOTH MUSCLE; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; BROZOVICH FV, 1989, AM J PHYSIOL, V257, pH1573, DOI 10.1152/ajpheart.1989.257.5.H1573; Bulter W. E., 1996, NEUROSURGERY, V38, P787; Butler WE, 1996, NEUROSURGERY, V38, P781, DOI 10.1227/00006123-199604000-00029; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; DRISKA SP, 1981, AM J PHYSIOL, V240, pC222, DOI 10.1152/ajpcell.1981.240.5.C222; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; JIANG MJ, 1989, PFLUG ARCH EUR J PHY, V413, P637, DOI 10.1007/BF00581814; JONES LG, 1994, J BIOL CHEM, V269, P23790; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; KHALIL RA, 1995, CIRC RES, V76, P1101, DOI 10.1161/01.RES.76.6.1101; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Li YP, 2007, J CELL BIOCHEM, V100, P129, DOI 10.1002/jcb.21033; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Min J, 2012, J CELL PHYSL; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mogford JE, 1997, J CLIN INVEST, V100, P1647, DOI 10.1172/JCI119689; NORTH AJ, 1994, J CELL SCI, V107, P445; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Rhee AY, 2000, BIOPHYS J, V79, P1511, DOI 10.1016/S0006-3495(00)76402-2; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SMALL JV, 1985, EMBO J, V4, P45, DOI 10.1002/j.1460-2075.1985.tb02315.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007; Vetterkind S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030409; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS	58	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62461	10.1371/journal.pone.0062461	http://dx.doi.org/10.1371/journal.pone.0062461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626821	gold, Green Published			2022-12-25	WOS:000318008400185
J	Teng, ZZ; Sadat, U; Wang, WK; Bahaei, NS; Chen, SY; Young, VE; Graves, MJ; Gillard, JH				Teng, Zhongzhao; Sadat, Umar; Wang, Wenkai; Bahaei, Nasim S.; Chen, Shengyong; Young, Victoria E.; Graves, Martin J.; Gillard, Jonathan H.			Intraplaque Stretch in Carotid Atherosclerotic Plaque - an Effective Biomechanical Predictor for Subsequent Cerebrovascular Ischemic Events	PLOS ONE			English	Article							DEEP VENOUS THROMBOSIS; IN-VIVO ACCURACY; STRUCTURAL STRESSES; TISSUE-COMPONENTS; STRAIN; VULNERABILITY; HEMORRHAGE; ARTERIES	Background: Stretch is a mechanical parameter, which has been proposed previously to affect the biological activities in different tissues. This study explored its utility in determining plaque vulnerability. Methods: One hundred and six patients with mild to moderate carotid stenosis were recruited in this study (53 symptomatic and 53 asymptomatic). High resolution, multi-sequence magnetic resonance (MR) imaging was performed to delineate various plaque components. Finite element method was used to predict high stretch concentration within the plaque. Results: During a two-year follow-up, 11 patients in symptomatic group and 3 in asymptomatic group experienced recurrent cerebrovascular events. Plaque stretch at systole and stretch variation during one cardiac cycle was greater in symptomatic group than those in the asymptomatic. Within the symptomatic group, a similar trend was observed in patients with recurrent events compared to those without. Conclusion: Plaques with high stretch concentration and large stretch variation are associated with increased risk of future cerebrovascular events.	[Teng, Zhongzhao; Wang, Wenkai; Bahaei, Nasim S.; Young, Victoria E.; Graves, Martin J.; Gillard, Jonathan H.] Univ Cambridge, Univ Dept Radiol, Cambridge, England; [Teng, Zhongzhao] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Sadat, Umar] Cambridge Univ Hosp NHS Fdn Trust, Dept Surg, Cambridge, England; [Chen, Shengyong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China	University of Cambridge; University of Cambridge; University of Cambridge; Zhejiang University of Technology	Teng, ZZ (corresponding author), Univ Cambridge, Univ Dept Radiol, Cambridge, England.	zt215@cam.ac.uk	Chen, S./H-3083-2011; Graves, Martin J/K-9630-2017	Graves, Martin J/0000-0003-4327-3052; Chen, S.Y./0000-0002-6705-3831; Teng, Zhongzhao/0000-0003-3973-6157; sheikh bahaei, nasim/0000-0001-7029-7215	ARTreat European Union FP7; BHF [PG/11/74/29100]; NIHR Cambridge Biomedical Research Centre; Cambridge-CSC (China Scholarship Council) International Scholarship; British Heart Foundation [PG/11/74/29100] Funding Source: researchfish; National Institute for Health Research [ACF-2010-14-011] Funding Source: researchfish	ARTreat European Union FP7; BHF(British Heart Foundation); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge-CSC (China Scholarship Council) International Scholarship; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research is supported by ARTreat European Union FP7, BHF PG/11/74/29100 and the NIHR Cambridge Biomedical Research Centre. Mr. Wang is supported by Cambridge-CSC (China Scholarship Council) International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaussier H, 2011, JACC-CARDIOVASC IMAG, V4, P468, DOI 10.1016/j.jcmg.2011.01.017; Corti R, 2011, EUR HEART J, V32, P1709, DOI 10.1093/eurheartj/ehr068; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; de Korte CL, 2002, CIRCULATION, V105, P1627, DOI 10.1161/01.CIR.0000014988.66572.2E; Drzewiecki GM, 1984, DEFORMATIONAL FORCES, P642; Du JA, 2011, MAGN RESON MED, V65, P1013, DOI 10.1002/mrm.22682; Gao H, 2011, J BIOMECH, V44, P2551, DOI 10.1016/j.jbiomech.2011.07.012; Gao H, 2011, ANN BIOMED ENG, V39, P2203, DOI 10.1007/s10439-011-0314-5; Gao H, 2009, J MAGN RESON IMAGING, V30, P85, DOI 10.1002/jmri.21799; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P657, DOI 10.1115/1.1800557; Hu XB, 2011, ULTRASOUND MED BIOL, V37, P1579, DOI 10.1016/j.ultrasmedbio.2011.06.025; Huang Y, 2011, J BIOMECH, V44, P2316, DOI 10.1016/j.jbiomech.2011.06.014; Humphery JD, 2002, CARDIOVASCULAR SOLID; IZZARD AS, 1991, CLIN SCI, V81, P65, DOI 10.1042/cs0810065; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kobayashi S, 2003, FLOW COMPRESSION ART, P497; Koktzoglou I, 2012, MAGN RESON MED; Kume S, 2010, NEUROSURG REV, V33, P419, DOI 10.1007/s10143-010-0270-9; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; MACIVER DH, 1993, J VASC RES, V30, P13; MACKAY RS, 1960, SCIENCE, V131, P1668, DOI 10.1126/science.131.3414.1668; Meairs S, 1999, STROKE, V30, P1807, DOI 10.1161/01.STR.30.9.1807; Mitsumori LM, 2003, J MAGN RESON IMAGING, V17, P410, DOI 10.1002/jmri.10264; Rubin JM, 2003, J ULTRAS MED, V22, P443, DOI 10.7863/jum.2003.22.5.443; Rubin JM, 2006, J ULTRAS MED, V25, P1179, DOI 10.7863/jum.2006.25.9.1179; Sadat U, 2011, EUR J VASC ENDOVASC, V41, P83, DOI 10.1016/j.ejvs.2010.09.006; Sadat U, 2010, EUR J VASC ENDOVASC, V40, P485, DOI 10.1016/j.ejvs.2010.07.015; Sadat U, 2011, INT J CARDIOVAS IMAG, V27, P397, DOI 10.1007/s10554-010-9679-z; Sadat U, 2010, EXPERT REV CARDIOVAS, V8, P1469, DOI [10.1586/erc.10.130, 10.1586/ERC.10.130]; Sadat U, 2010, J NEUROL NEUROSUR PS, V81, P286, DOI 10.1136/jnnp.2009.190363; Sadat U, 2009, ATHEROSCLEROSIS, V207, P434, DOI 10.1016/j.atherosclerosis.2009.05.002; Shi HR, 2008, PHYS MED BIOL, V53, P6377, DOI 10.1088/0031-9155/53/22/008; Tang DL, 2004, ANN BIOMED ENG, V32, P947, DOI 10.1023/B:ABME.0000032457.10191.e0; Teng Z, 2011, EUR J VASC ENDOVASC, V42, P427, DOI 10.1016/j.ejvs.2011.05.009; Teng ZZ, 2012, ATHEROSCLEROSIS, V223, P321, DOI 10.1016/j.atherosclerosis.2012.06.015; Teng ZZ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001028; Teng ZZ, 2009, J BIOMECH, V42, P2535, DOI 10.1016/j.jbiomech.2009.07.009; Williamson SD, 2003, J BIOMECH ENG-T ASME, V125, P147, DOI 10.1115/1.1537736; Xie H, 2005, ULTRASOUND MED BIOL, V31, P1351, DOI 10.1016/j.ultrasmedbio.2005.06.005; Xie H, 2004, ULTRASOUND MED BIOL, V30, P1385, DOI 10.1016/j.ultrasmedbio.2004.08.015; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Zhang L, 2010, ATHEROSCLEROSIS, V211, P146, DOI 10.1016/j.atherosclerosis.2010.01.023; Zhang PF, 2011, INT J CARDIOVAS IMAG, V27, P39, DOI 10.1007/s10554-010-9659-3	44	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61522	10.1371/journal.pone.0061522	http://dx.doi.org/10.1371/journal.pone.0061522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626694	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400058
J	Amin, N; Gastpar, M; Theunissen, FE				Amin, Noopur; Gastpar, Michael; Theunissen, Frederic E.			Selective and Efficient Neural Coding of Communication Signals Depends on Early Acoustic and Social Environment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; WHITE-NOISE EXPOSURE; AUDITORY-CORTEX; CRITICAL PERIOD; INFORMATION-TRANSMISSION; SYNAPTIC PLASTICITY; NATURAL SOUNDS; SINGLE CELLS; SONG SYSTEM; EXPERIENCE	Previous research has shown that postnatal exposure to simple, synthetic sounds can affect the sound representation in the auditory cortex as reflected by changes in the tonotopic map or other relatively simple tuning properties, such as AM tuning. However, their functional implications for neural processing in the generation of ethologically-based perception remain unexplored. Here we examined the effects of noise-rearing and social isolation on the neural processing of communication sounds such as species-specific song, in the primary auditory cortex analog of adult zebra finches. Our electrophysiological recordings reveal that neural tuning to simple frequency-based synthetic sounds is initially established in all the laminae independent of patterned acoustic experience; however, we provide the first evidence that early exposure to patterned sound statistics, such as those found in native sounds, is required for the subsequent emergence of neural selectivity for complex vocalizations and for shaping neural spiking precision in superficial and deep cortical laminae, and for creating efficient neural representations of song and a less redundant ensemble code in all the laminae. Our study also provides the first causal evidence for 'sparse coding', such that when the statistics of the stimuli were changed during rearing, as in noise-rearing, that the sparse or optimal representation for species-specific vocalizations disappeared. Taken together, these results imply that a layer-specific differential development of the auditory cortex requires patterned acoustic input, and a specialized and robust sensory representation of complex communication sounds in the auditory cortex requires a rich acoustic and social environment.	[Amin, Noopur; Theunissen, Frederic E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Gastpar, Michael] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Theunissen, Frederic E.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Theunissen, FE (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	theunissen@berkeley.edu		Theunissen, Frederic/0000-0001-8980-0650	NIH (NIDCD); NASA (GSRP); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010132] Funding Source: NIH RePORTER	NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NASA (GSRP)(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH research grant to FET (NIDCD) and a graduate research fellowship from NASA (GSRP) to NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; Billimoria CP, 2008, J NEUROSCI, V28, P6304, DOI 10.1523/JNEUROSCI.0961-08.2008; Blattler F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025506; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; Ding L, 2004, J NEUROSCI, V24, P488, DOI 10.1523/JNEUROSCI.4358-03.2004; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FOX K, 1992, J NEUROSCI, V12, P1826; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gao F, 2009, PHYSIOL BEHAV, V97, P369, DOI 10.1016/j.physbeh.2009.03.004; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gastpar MC, 2010, IEEE T INFORM THEORY, V56, P890, DOI 10.1109/TIT.2009.2037053; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Hogsden JL, 2009, EUR J NEUROSCI, V30, P376, DOI 10.1111/j.1460-9568.2009.06835.x; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Machens CK, 2005, NEURON, V47, P447, DOI 10.1016/j.neuron.2005.06.015; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL, V100, P441, DOI 10.1152/jn.01239.2007; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Ryals BM, 1999, HEARING RES, V131, P71, DOI 10.1016/S0378-5955(99)00022-2; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Talathi SS, 2008, J COMPUT NEUROSCI, V25, P262, DOI 10.1007/s10827-008-0077-7; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Theunissen FE, 2000, J NEUROSCI, V20, P2315; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WILD JM, 1993, J COMP NEUROL, V337, P32; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Xu JH, 2010, CEREB CORTEX, V20, P804, DOI 10.1093/cercor/bhp143; Zevin JD, 2004, J NEUROSCI, V24, P5849, DOI 10.1523/JNEUROSCI.1891-04.2004; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P4423, DOI 10.1073/pnas.0800009105; Zhou XM, 2011, J NEUROSCI, V31, P5625, DOI 10.1523/JNEUROSCI.6470-10.2011	70	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61417	10.1371/journal.pone.0061417	http://dx.doi.org/10.1371/journal.pone.0061417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630587	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500034
J	Pacheco, P; White, D; Sulchek, T				Pacheco, Patricia; White, David; Sulchek, Todd			Effects of Microparticle Size and Fc Density on Macrophage Phagocytosis	PLOS ONE			English	Article							PARTICLE-SIZE; RECEPTOR; MICROSPHERES; RESPONSES; INTERLEUKIN-12; COORDINATION; ENDOCYTOSIS; COMPLEMENT; ANTIBODIES; MECHANICS	Controlled induction of phagocytosis in macrophages offers the ability to therapeutically regulate the immune system as well as improve delivery of chemicals or biologicals for immune processing. Maximizing particle uptake by macrophages through Fc receptor-mediated phagocytosis could lead to new delivery mechanisms in drug or vaccine development. Fc ligand density and particle size were examined independently and in combination in order to optimize and tune the phagocytosis of opsonized microparticles. We show the internalization efficiency of small polystyrene particles (0.5 mu m to 2 mm) is significantly affected by changes in Fc ligand density, while particles greater than 2 mu m show little correlation between internalization and Fc density. We found that while macrophages can efficiently phagocytose a large number of smaller particles, the total volume of phagocytosed particles is maximized through the non-specific uptake of larger microparticles. Therefore, larger microparticles may be more efficient at delivering a greater therapeutic payload to macrophages, but smaller opsonized microparticles can deliver bio-active substances to a greater percentage of the macrophage population. This study is the first to treat as independent variables the physical and biological properties of Fc density and microparticle size that initiate macrophage phagocytosis. Defining the physical and biological parameters that affect phagocytosis efficiency will lead to improved methods of microparticle delivery to macrophages.	[Pacheco, Patricia; Sulchek, Todd] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [White, David] Ctr Dis Control & Prevent Atlanta, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Centers for Disease Control & Prevention - USA	Sulchek, T (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	todd.sulchek@me.gatech.edu			Bill and Melinda Gates Foundation; National Institutes of Health [1R21EB013413-01]; National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB013413] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank the Bill and Melinda Gates Foundation and the National Institutes of Health (Grant No. 1R21EB013413-01) for support of this research. PP received support from the National Science Foundation Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; Akewanlop C, 2001, CANCER RES, V61, P4061; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; Herant M, 2011, PLOS COMPUTATIONAL B, P7; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; KOBZIK L, 1995, J IMMUNOL, V155, P367; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6; Tollis S, 2010, BMC SYSTEMS BIOL, P4; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Yue TT, 2011, SOFT MATTER, V7, P9104, DOI 10.1039/c1sm05398a; Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107	41	133	134	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60989	10.1371/journal.pone.0060989	http://dx.doi.org/10.1371/journal.pone.0060989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630577	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500012
J	Avellino, R; Carrella, S; Pirozzi, M; Risolino, M; Salierno, FG; Franco, P; Stoppelli, P; Verde, P; Banfi, S; Conte, I				Avellino, Raffaella; Carrella, Sabrina; Pirozzi, Marinella; Risolino, Maurizio; Salierno, Francesco Giuseppe; Franco, Paola; Stoppelli, Patrizia; Verde, Pasquale; Banfi, Sandro; Conte, Ivan			miR-204 Targeting of Ankrd13A Controls Both Mesenchymal Neural Crest and Lens Cell Migration	PLOS ONE			English	Article							FOCAL ADHESION; MATRIX ADHESIONS/; BREAST-CANCER; EXPRESSION; MICRORNAS; MOUSE; GENE; ACTIN; IDENTIFICATION; TRANSITION	Loss of cell adhesion and enhancement of cell motility contribute to epithelial-to-mesenchymal transition during development. These processes are related to a) rearrangement of cell-cell and cell-substrate adhesion molecules; b) cross talk between extra-cellular matrix and internal cytoskeleton through focal adhesion molecules. Focal adhesions are stringently regulated transient structures implicated in cell adhesion, spreading and motility during tissue development. Importantly, despite the extensive elucidation of the molecular composition of focal adhesions, the complex regulation of their dynamics is largely unclear. Here, we demonstrate, using live-imaging in medaka, that the microRNA miR-204 promotes both mesenchymal neural crest and lens cell migration and elongation. Overexpression of miR-204 results in upregulated cell motility, while morpholino-mediated ablation of miR-204 activity causes abnormal lens morphogenesis and neural crest cell mislocalization. Using a variety of in vivo and in vitro approaches, we demonstrate that these actions are mediated by the direct targeting of the Ankrd13A gene, which in turn controls focal cell adhesion formation and distribution. Significantly, in vivo restoration of abnormally elevated levels of Ankrd13A resulting from miR-204 inactivation rescued the aberrant lens phenotype in medaka fish. These data uncover, for the first time in vivo, the role of a microRNA in developmental control of mesenchymal cell migration and highlight miR-204 as a "master regulator" of the molecular networks that regulate lens morphogenesis in vertebrates.	[Avellino, Raffaella; Carrella, Sabrina; Pirozzi, Marinella; Salierno, Francesco Giuseppe; Banfi, Sandro; Conte, Ivan] Telethon Inst Genet & Med, Naples, Italy; [Risolino, Maurizio; Franco, Paola; Stoppelli, Patrizia; Verde, Pasquale] Inst Genet & Biophys, Naples, Italy; [Banfi, Sandro] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita della Campania Vanvitelli	Banfi, S (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	banfi@tigem.it; conte@tigem.it	Carrella, Sabrina/AAD-3103-2020; Franco, Paola/O-5897-2015; Banfi, Sandro/K-3963-2018	Franco, Paola/0000-0002-3289-7284; Banfi, Sandro/0000-0002-6541-8833; Carrella, Sabrina/0000-0002-3302-1698; Conte, Ivan/0000-0002-8968-9021; PIROZZI, MARINELLA/0000-0002-1714-2000	Italian Telethon Foundation [TGM11SB2]; MAE/MOST Israel-Italy	Italian Telethon Foundation(Fondazione Telethon); MAE/MOST Israel-Italy	This study was supported by the Italian Telethon Foundation (GRANT TGM11SB2 to SB) and by the MAE/MOST Israel-Italy Joint Innovation Program (to IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Carriero MV, 1999, CANCER RES, V59, P5307; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; de Bont H, 2012, J CELL SCI; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Findlay VJ, 2008, CANCER RES, V68, P8499, DOI 10.1158/0008-5472.CAN-08-0907; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gabriely G, 2011, AUTOPHAGY, V7, P1384, DOI 10.4161/auto.7.11.17371; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Grunwald GB, 2012, J BIOL CHEM; HALES AM, 1994, CURR EYE RES, V13, P885, DOI 10.3109/02713689409015091; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoffmann A, 2012, MOL MED, V18, P528, DOI 10.2119/molmed.2011.00463; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SL, 2010, PROTEIN CELL, V1, P916, DOI 10.1007/s13238-010-0116-9; Janas MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002330; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kiyokawa E, 2009, CELL ADHES MIGR, V3, P281, DOI 10.4161/cam.3.3.8857; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; O'Neill GM, 2009, CELL ADHES MIGR, V3, P355, DOI 10.4161/cam.3.4.9468; Porter RM, 1998, J BIOL CHEM, V273, P32265, DOI 10.1074/jbc.273.48.32265; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Ryan D, 2006, MOL VIS, V12, P1175; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Tachibana M, 2009, EXP CELL RES, V315, P863, DOI 10.1016/j.yexcr.2008.12.005; Tanno H, 2012, MOL BIOL CELL, V23, P1343, DOI 10.1091/mbc.E11-09-0817; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Vocca I, 2009, INT J CANCER, V124, P316, DOI 10.1002/ijc.23933; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577; Zelenka PS, 2004, INT J DEV BIOL, V48, P857, DOI 10.1387/ijdb.041871pz; ZUK A, 1994, DEV DYNAM, V201, P378, DOI 10.1002/aja.1002010409	53	25	27	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61099	10.1371/journal.pone.0061099	http://dx.doi.org/10.1371/journal.pone.0061099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620728	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500008
J	Cysique, LA; Moffat, K; Moore, DM; Lane, TA; Davies, NWS; Carr, A; Brew, BJ; Rae, C				Cysique, Lucette A.; Moffat, Kirsten; Moore, Danielle M.; Lane, Tammy A.; Davies, Nicholas W. S.; Carr, Andrew; Brew, Bruce J.; Rae, Caroline			HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A H-1 MRS Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; SYSTEM IMMUNE ACTIVATION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; QUANTIFICATION; INDIVIDUALS; DYSFUNCTION	Background: Cardiovascular disease (CVD) and premature aging have been hypothesized as new risk factors for HIV associated neurocognitive disorders (HAND) in adults with virally-suppressed HIV infection. Moreover, their significance and relation to more classical HAND biomarkers remain unclear. Methods: 92 HIV- infected (HIV+) adults stable on combined antiretroviral therapy (cART) and 30 age-comparable HIV-negative (HIV-) subjects underwent H-1 Magnetic Resonance Spectroscopy (MRS) of the frontal white matter (targeting HIV, normal aging or CVD-related neurochemical injury), caudate nucleus (targeting HIV neurochemical injury), and posterior cingulate cortex (targeting normal/pathological aging, CVD-related neurochemical changes). All also underwent standard neuropsychological (NP) testing. CVD risk scores were calculated. HIV disease biomarkers were collected and cerebrospinal fluid (CSF) neuroinflammation biomarkers were obtained in 38 HIV+ individuals. Results: Relative to HIV- individuals, HIV+ individuals presented mild MRS alterations: in the frontal white matter: lower N-Acetyl-Aspartate (NAA) (p<.04) and higher myo-inositol (mIo) (p<.04); in the caudate: lower NAA (p=.01); and in the posterior cingulate cortex: higher mIo (p<.008- also significant when Holm-Sidak corrected) and higher Choline/NAA (p<.04). Regression models showed that an HIV*age interaction was associated with lower frontal white matter NAA. CVD risk factors were associated with lower posterior cingulate cortex and caudate NAA in both groups. Past acute CVD events in the HIV+ group were associated with increased mIo in the posterior cingulate cortex. HIV duration was associated with lower caudate NAA; greater CNS cART penetration was associated with lower mIo in the posterior cingulate cortex and the degree of immune recovery on cART was associated with higher NAA in the frontal white matter. CSF neopterin was associated with higher mIo in the posterior cingulate cortex and frontal white matter. Conclusions: In chronically HIV+ adults with long-term viral suppression, current CVD risk, past CVD and age are independent factors for neuronal injury and inflammation. This suggests a tripartite model of HIV, CVD and age likely driven by chronic inflammation.	[Cysique, Lucette A.; Brew, Bruce J.; Rae, Caroline] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Cysique, Lucette A.; Rae, Caroline] Neurosci Res Australia, Sydney, NSW, Australia; [Cysique, Lucette A.; Moffat, Kirsten; Moore, Danielle M.; Carr, Andrew; Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Cysique, Lucette A.; Moffat, Kirsten; Moore, Danielle M.; Carr, Andrew; Brew, Bruce J.] St Vincents Hosp, Imaging & HIV Dept, Sydney, NSW 2010, Australia; [Cysique, Lucette A.; Moore, Danielle M.; Carr, Andrew; Brew, Bruce J.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Davies, Nicholas W. S.] Chelsea & Westminster Hosp, Dept Neurol, London, England; [Lane, Tammy A.] Sydney Hosp, AIDS Dementia & HIV Psychiat Serv ADAHPS, Sydney, NSW, Australia; [Lane, Tammy A.] Sydney Eye Hosp, Sydney, NSW, Australia	University of New South Wales Sydney; Neuroscience Research Australia; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Imperial College London	Cysique, LA (corresponding author), Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia.	lcysique@unsw.edu.au	McLean, Emma/F-4616-2012; Cysique, Lucette A./U-1357-2017; Brew, Bruce/J-6513-2012; Rae, Caroline/B-7537-2008	Cysique, Lucette A./0000-0002-7711-6373; Rae, Caroline/0000-0003-0673-8084; brew, bruce/0000-0003-0622-1392	National Health and Medical Research Council (NHMRC) [ID568746]; post-doctoral Brain Science University of New South Wales (UNSW) fellowship; Merck-Sereno; Baxter; ViiV Healthcare; MSD; Pfizer; Gilead Sciences; Abbott; Bristol-Myers Squibb	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); post-doctoral Brain Science University of New South Wales (UNSW) fellowship; Merck-Sereno; Baxter; ViiV Healthcare; MSD; Pfizer(Pfizer); Gilead Sciences(Gilead Sciences); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was supported by the National Health and Medical Research Council (NHMRC) project grant ID568746 (Cysique-CIA) and the post-doctoral Brain Science University of New South Wales (UNSW) fellowship and salary support for the year 2012 by Merck-Sereno. In addition, Dr. Cysique has received honoraria from ViiV Healthcare and Abbott Ltd. Prof. Brew has received honoraria from ViiV Healthcare, speaker, 2005-2009, ViiV Healthcare, 2010, Boehringer Ingelheim, 2005-2010, Abbott, 2009-2010, Biogen Idec 2006, 2008, and has served on a scientific advisory board for ViiV Healthcare, member 2008, BiogenIdec, member 2007, ViiV Healthcare, member 2010, Merck Serono, member 2010. Prof. Carr has received research funding from Baxter, ViiV Healthcare, MSD and Pfizer, consultancy fees from Gilead Sciences, ViiV Healthcare, and MSD, and speaking fees from Abbott, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare and MSD, and has participated in advisory boards of Gilead Sciences, ViiV Healthcare. The other authors have no potential competing interests to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Becker JT, 2009, NEUROLOGY, V73, P1292, DOI 10.1212/WNL.0b013e3181bd10e7; Becker JT, 2012, NEURORADIOLOGY, V54, P113, DOI 10.1007/s00234-011-0854-2; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Carr A, 2008, CURR OPIN HIV AIDS, V3, P234, DOI 10.1097/COH.0b013e3282fb7be0; Cui JS, 2009, EUR J CARDIOV PREV R, V16, P660, DOI 10.1097/HJR.0b013e32832f3b2b; Cysique LA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-148; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DEBEER R, 1992, NMR BIOMED, V5, P171, DOI 10.1002/nbm.1940050403; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gruber S, 2008, EUR J RADIOL, V68, P320, DOI 10.1016/j.ejrad.2007.08.038; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Haley AP, 2010, METAB BRAIN DIS, V25, P397, DOI 10.1007/s11011-010-9221-y; Haley AP, 2010, BRAIN RES, V1344, P54, DOI 10.1016/j.brainres.2010.05.006; Harezlak J, 2011, AIDS, V2011, P3; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holt JL, 2012, J NEUROVIROL, V18, P291, DOI 10.1007/s13365-012-0114-1; Howell D., 2009, STAT METHODS PSYCHOL, V7th; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Lane TA, 2013, NEUROPSYCHO IN PRESS; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Lee PL, 2003, J MAGN RESON IMAGING, V17, P625, DOI 10.1002/jmri.10295; Letendre Scott, 2011, Top Antivir Med, V19, P137; Licata SC, 2010, ANN NY ACAD SCI, V1187, P148, DOI 10.1111/j.1749-6632.2009.05143.x; MEYERHOFF DJ, 1993, NEUROLOGY, V43, P509, DOI 10.1212/WNL.43.3_Part_1.509; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Murray JM, 2009, SEX HEALTH, V6, P83, DOI 10.1071/SH08063; National Centre in HIV Epidemiology and Clinical Research, 2010, HIV VIR HEP SEX TRAN; Olson BLB, 2008, ALZ DIS ASSOC DIS, V22, P269, DOI 10.1097/WAD.0b013e3181750a65; Paul RH, 2008, J INT NEUROPSYCH SOC, V14, P725, DOI 10.1017/S1355617708080910; Raininko R, 2010, ACTA RADIOL, V51, P309, DOI 10.3109/02841850903476564; Ratai EM, 2011, MAGN RESON MED, V66, P625, DOI 10.1002/mrm.22821; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Valcour VG, 2006, JAIDS-J ACQ IMM DEF, V43, P405, DOI 10.1097/01.qai.0000243119.67529.f5; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	40	78	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61738	10.1371/journal.pone.0061738	http://dx.doi.org/10.1371/journal.pone.0061738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620788	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500068
J	Prusty, BK; Siegl, C; Hauck, P; Hain, J; Korhonen, SJ; Hiltunen-Back, E; Puolakkainen, M; Rudel, T				Prusty, Bhupesh K.; Siegl, Christine; Hauck, Petra; Hain, Johannes; Korhonen, Suvi J.; Hiltunen-Back, Eija; Puolakkainen, Mirja; Rudel, Thomas			Chlamydia trachomatis Infection Induces Replication of Latent HHV-6	PLOS ONE			English	Article							HUMAN-HERPESVIRUS 6; CHRONIC-FATIGUE-SYNDROME; HUMAN BETA-HERPESVIRUSES; MULTIPLE-SCLEROSIS MS; EPSTEIN-BARR-VIRUS; CERVICAL-CANCER; SIMPLEX-VIRUS; HUMAN-HERPESVIRUS-6 HHV-6; DNA-REPLICATION; CELL-LINE	Human herpesvirus-6 (HHV-6) exists in latent form either as a nuclear episome or integrated into human chromosomes in more than 90% of healthy individuals without causing clinical symptoms. Immunosuppression and stress conditions can reactivate HHV-6 replication, associated with clinical complications and even death. We have previously shown that co-infection of Chlamydia trachomatis and HHV-6 promotes chlamydial persistence and increases viral uptake in an in vitro cell culture model. Here we investigated C. trachomatis-induced HHV-6 activation in cell lines and fresh blood samples from patients having Chromosomally integrated HHV-6 (CiHHV-6). We observed activation of latent HHV-6 DNA replication in CiHHV-6 cell lines and fresh blood cells without formation of viral particles. Interestingly, we detected HHV-6 DNA in blood as well as cervical swabs from C. trachomatis-infected women. Low virus titers correlated with high C. trachomatis load and vice versa, demonstrating a potentially significant interaction of these pathogens in blood cells and in the cervix of infected patients. Our data suggest a thus far underestimated interference of HHV-6 and C. trachomatis with a likely impact on the disease outcome as consequence of co-infection.	[Prusty, Bhupesh K.; Siegl, Christine; Hauck, Petra; Rudel, Thomas] Univ Wurzburg, Bioctr, Chair Microbiol, D-97070 Wurzburg, Germany; [Hain, Johannes] Univ Wurzburg, Inst Math, Chair Math Stat 7, Wurzburg, Germany; [Korhonen, Suvi J.; Puolakkainen, Mirja] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Hiltunen-Back, Eija] Helsinki Univ Cent Hosp, Skin & Allergy Hosp, Clin Venereal Dis, Helsinki, Finland; [Hiltunen-Back, Eija] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Puolakkainen, Mirja] Helsinki Univ Cent Hosp, Lab Div HUSLAB, Dept Virol & Immunol, Helsinki, Finland	University of Wurzburg; University of Wurzburg; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Rudel, T (corresponding author), Univ Wurzburg, Bioctr, Chair Microbiol, D-97070 Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Korhonen, Suvi J/C-3189-2018; Prusty, Bhupesh/AAF-4843-2020; Puolakkainen, Mirja/F-1767-2011	Korhonen, Suvi J/0000-0001-9424-8450; Prusty, Bhupesh/0000-0001-7051-4670; Puolakkainen, Mirja/0000-0001-7413-6793	German Federal Ministry of Education and Research [0315834]; Interdisciplinary Center for Clinical Research of the University of Wurzburg [B-192]; Finnish Society against Sexually Transmitted Diseases; Academy of Finland in the frame of the ERA-NET PathoGenoMics [130043/ChlamyTrans]; Helsinki-Uusimaa Hospital District [TYH2013405]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research of the University of Wurzburg; Finnish Society against Sexually Transmitted Diseases; Academy of Finland in the frame of the ERA-NET PathoGenoMics; Helsinki-Uusimaa Hospital District	This work was supported by the German Federal Ministry of Education and Research, grant 0315834 A (TR), grant B-192 from the Interdisciplinary Center for Clinical Research of the University of Wurzburg (TR), The Finnish Society against Sexually Transmitted Diseases (SJK), by the Academy of Finland in the frame of the ERA-NET PathoGenoMics #130043/ChlamyTrans (MP), and by a research grant from Helsinki-Uusimaa Hospital District (TYH2013405)(MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 2000, J CLIN VIROL, V16, P179, DOI 10.1016/S1386-6532(99)00079-7; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Berti R, 2002, J NEUROVIROL, V8, P250, DOI 10.1080/13550280290049615-1; Broccolo F, 2008, J MED VIROL, V80, P147, DOI 10.1002/jmv.21054; Campadelli-Fiume G, 1999, EMERG INFECT DIS, V5, P353, DOI 10.3201/eid0503.990306; Caselli E, 2006, VIROLOGY, V346, P402, DOI 10.1016/j.virol.2005.11.018; Caselli E, 2002, J CLIN MICROBIOL, V40, P4131, DOI 10.1128/JCM.40.11.4131-4137.2002; Chan PKS, 2001, J CLIN PATHOL, V54, P48, DOI 10.1136/jcp.54.1.48; Chapenko S, 2006, J CLIN VIROL, V37, pS47, DOI 10.1016/S1386-6532(06)70011-7; Chapenko S, 2003, J MED VIROL, V69, P111, DOI 10.1002/jmv.10258; CHEN M, 1994, AM J PATHOL, V145, P1509; CHEN M, 1994, J VIROL, V68, P1173, DOI 10.1128/JVI.68.2.1173-1178.1994; Clark DA, 1996, J GEN VIROL, V77, P2271, DOI 10.1099/0022-1317-77-9-2271; Clark DA, 2000, REV MED VIROL, V10, P155, DOI 10.1002/(SICI)1099-1654(200005/06)10:3&lt;155::AID-RMV277&gt;3.0.CO;2-6; Cohen S, 2002, EMBO REP, V3, P1168, DOI 10.1093/embo-reports/kvf240; Collot S, 2002, J CLIN MICROBIOL, V40, P2445, DOI 10.1128/JCM.40.7.2445-2451.2002; Cosentino LA, 2003, J CLIN MICROBIOL, V41, P3592, DOI 10.1128/JCM.41.8.3592-3596.2003; CUENDE JI, 1994, J MED VIROL, V43, P115, DOI 10.1002/jmv.1890430203; Daibata M, 1998, BRIT J HAEMATOL, V102, P1307, DOI 10.1046/j.1365-2141.1998.00903.x; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Fischer N, 2002, EUR J GYNAECOL ONCOL, V23, P247; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; HORN JE, 1986, J INFECT DIS, V153, P1155, DOI 10.1093/infdis/153.6.1155; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Lanham S, 2001, J CLIN MICROBIOL, V39, P2946, DOI 10.1128/JCM.39.8.2946-2950.2001; LEACH CT, 1994, J INFECT DIS, V169, P1281, DOI 10.1093/infdis/169.6.1281; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; LINDQUESTER GJ, 1991, VIROLOGY, V182, P102, DOI 10.1016/0042-6822(91)90653-S; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; MARKS JR, 1984, J VIROL, V52, P24, DOI 10.1128/JVI.52.1.24-28.1984; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Munger KL, 2003, EPIDEMIOLOGY, V14, P141, DOI 10.1097/00001648-200303000-00006; Nicolson GL, 2003, APMIS, V111, P557, DOI 10.1034/j.1600-0463.2003.1110504.x; OKUNO T, 1995, J CLIN MICROBIOL, V33, P1968, DOI 10.1128/JCM.33.7.1968-1970.1995; Paavonen J, 1988, Obstet Gynecol Surv, V43, P373, DOI 10.1097/00006254-198807000-00001; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Prusty BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047427; Rennekamp AJ, 2010, FUTURE VIROL, V5, P65, DOI 10.2217/FVL.09.69; SATO H, 1990, J VIROL, V64, P5295, DOI 10.1128/JVI.64.11.5295-5300.1990; Seeley WW, 2007, NEUROLOGY, V69, P156, DOI 10.1212/01.wnl.0000265591.10200.d7; Skaliter R, 1996, J VIROL, V70, P1132, DOI 10.1128/JVI.70.2.1132-1136.1996; Swanborg RH, 2002, MICROBES INFECT, V4, P1327, DOI 10.1016/S1286-4579(02)00009-6; Szostek S, 2009, ACTA BIOCHIM POL, V56, P337; Tanaka-Taya K, 2004, J MED VIROL, V73, P465, DOI 10.1002/jmv.20113; Tran-Thanh D, 2002, J MED VIROL, V68, P606, DOI 10.1002/jmv.10229; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; WANG H, 1994, J VIROL METHODS, V47, P297, DOI 10.1016/0166-0934(94)90026-4; Wu CA, 1998, J GEN VIROL, V79, P1247, DOI 10.1099/0022-1317-79-5-1247; Yadav M, 1996, CLIN DIAGN VIROL, V7, P23, DOI 10.1016/S0928-0197(96)00250-4; Yoshikawa T, 2002, J MED VIROL, V66, P497, DOI 10.1002/jmv.2172	50	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61400	10.1371/journal.pone.0061400	http://dx.doi.org/10.1371/journal.pone.0061400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620749	gold, Green Published			2022-12-25	WOS:000317909500029
J	Yang, W; Liu, J; Zheng, FF; Jia, MX; Zhao, LN; Lu, TL; Ruan, YY; Zhang, JS; Yue, WH; Zhang, D; Wang, LF				Yang, Wen; Liu, Jing; Zheng, Fanfan; Jia, Meixiang; Zhao, Linnan; Lu, Tianlan; Ruan, Yanyan; Zhang, Jishui; Yue, Weihua; Zhang, Dai; Wang, Lifang			The Evidence for Association of ATP2B2 Polymorphisms with Autism in Chinese Han Population	PLOS ONE			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; PERVASIVE DEVELOPMENTAL DISORDERS; COMMON GENETIC-VARIANTS; GENOME-WIDE; LINKAGE DISEQUILIBRIUM; DISEASE GENES; RAT-BRAIN; SPECTRUM DISORDERS; INFANTILE-AUTISM; COMPLEX DISEASES	Background: Autism is a neurodevelopmental disorder with a high estimated heritability. ATP2B2, located on human chromosome 3p25.3, encodes the plasma membrane calcium-transporting ATPase 2 which extrudes Ca2+ from cytosol into extracellular space. Recent studies reported association between ATP2B2 and autism in samples from Autism Genetic Resource Exchange (AGRE) and Italy. In this study, we investigated whether ATP2B2 polymorphisms were associated with autism in Chinese Han population. Methods: We performed a family based association study between five SNPs (rs35678 in exon, rs241509, rs3774180, rs3774179, and rs2278556 in introns) in ATP2B2 and autism in 427 autism trios of Han Chinese descent. All SNPs were genotyped using the Sequenom genotyping platform. The family-based association test (FBAT) program was used to perform association test for SNPs and haplotype analyses. Results: This study demonstrated a preferential transmission of T allele of rs3774179 to affected offsprings under an additive model (T>C, Z = 2.482, p = 0.013). While C allele of rs3774179 showed an undertransmission from parents to affected children under an additive and a dominant model, respectively (Z = -2.482, p = 0.013; Z = -2.591, p = 0.0096). Haplotype analyses revealed that three haplotypes were significantly associated with autism. The haplotype C-C (rs3774180-rs3774179) showed a significant undertransmission from parents to affected offsprings both in specific and global haplotype FBAT (Z = -2.037, p = 0.042; Global p = 0.03). As for the haplotype constructed by rs3774179 and rs2278556, C-A might be a protective haplotype (Z = -2.206, p = 0.027; Global p = 0.04), while T-A demonstrated an excess transmission from parents to affected offsprings (Z = 2.143, p = 0.032). These results were still significant after using the permutation method to obtain empirical p values. Conclusions: Our research suggested that ATP2B2 might play a role in the etiology of autism in Chinese Han population.	[Yang, Wen; Liu, Jing; Zheng, Fanfan; Jia, Meixiang; Zhao, Linnan; Lu, Tianlan; Ruan, Yanyan; Yue, Weihua; Zhang, Dai; Wang, Lifang] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Yang, Wen; Liu, Jing; Zheng, Fanfan; Jia, Meixiang; Zhao, Linnan; Lu, Tianlan; Ruan, Yanyan; Yue, Weihua; Zhang, Dai; Wang, Lifang] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Jishui] Capital Univ Med Sci, Beijing Childrens Hosp, Beijing, Peoples R China; [Zhang, Dai] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Capital Medical University	Zhang, D (corresponding author), Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn; lifangwang@bjmu.edu.cn	Jia, Mei/GXZ-9967-2022		National Basic Research Development Program of China (973 program) [2010CB833905]; National Natural Science Foundation [81071110]	National Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by research grants from the National Basic Research Development Program of China (973 program 2010CB833905), and National Natural Science Foundation (grant number 81071110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; Burette A, 2003, J COMP NEUROL, V467, P464, DOI 10.1002/cne.10933; Burette AC, 2010, NEUROSCIENCE, V169, P987, DOI 10.1016/j.neuroscience.2010.05.062; Carayol J, 2011, BIOL PSYCHIAT, V70, P880, DOI 10.1016/j.biopsych.2011.05.020; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COURCHESNE E, 1994, LANCET, V343, P63, DOI 10.1016/S0140-6736(94)90923-7; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Dodson HC, 2001, J NEUROCYTOL, V30, P281, DOI 10.1023/A:1014489527996; Empson RM, 2007, J NEUROSCI, V27, P3753, DOI 10.1523/JNEUROSCI.0069-07.2007; Empson RM, 2010, FUNCT NEUROL, V25, P153; Empson RM, 2010, J PHYSIOL-LONDON, V588, P907, DOI 10.1113/jphysiol.2009.182196; Fakira AK, 2012, MOL CELL NEUROSCI, V51, P22, DOI 10.1016/j.mcn.2012.07.001; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Garside ML, 2009, NEUROSCIENCE, V162, P383, DOI 10.1016/j.neuroscience.2009.04.059; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kurnellas MP, 2007, MOL CELL NEUROSCI, V34, P178, DOI 10.1016/j.mcn.2006.10.010; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu PY, 2005, J MED GENET, V42, P221, DOI 10.1136/jmg.2004.024752; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Paul Oeth MBCP, 2007, IPLEX ASSAY INCREASE; Prandini P, 2012, PSYCHIAT GENET, V22, P177, DOI 10.1097/YPG.0b013e32835185c9; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; STAHL WL, 1992, MOL BRAIN RES, V16, P223, DOI 10.1016/0169-328X(92)90229-5; Stauffer TP, 1997, BRAIN RES, V748, P21, DOI 10.1016/S0006-8993(96)01282-6; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Storm Niels, 2003, Methods Mol Biol, V212, P241; Ueno T, 2002, NEUROSCI RES, V42, P287, DOI 10.1016/S0168-0102(02)00008-1; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Zacharias DA, 1997, MOL BRAIN RES, V45, P173, DOI 10.1016/S0169-328X(97)00009-0	61	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61021	10.1371/journal.pone.0061021	http://dx.doi.org/10.1371/journal.pone.0061021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620727	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500007
J	Hoehndorf, R; Hardy, NW; Osumi-Sutherland, D; Tweedie, S; Schofield, PN; Gkoutos, GV				Hoehndorf, Robert; Hardy, Nigel W.; Osumi-Sutherland, David; Tweedie, Susan; Schofield, Paul N.; Gkoutos, Georgios V.			Systematic Analysis of Experimental Phenotype Data Reveals Gene Functions	PLOS ONE			English	Article							SIMILARITY MEASURES; ONTOLOGY; ANNOTATION; RESOURCE; TOOL	High-throughput phenotyping projects in model organisms have the potential to improve our understanding of gene functions and their role in living organisms. We have developed a computational, knowledge-based approach to automatically infer gene functions from phenotypic manifestations and applied this approach to yeast (Saccharomyces cerevisiae), nematode worm (Caenorhabditis elegans), zebrafish (Danio rerio), fruitfly (Drosophila melanogaster) and mouse (Mus musculus) phenotypes. Our approach is based on the assumption that, if a mutation in a gene G leads to a phenotypic abnormality in a process P, then G must have been involved in P, either directly or indirectly. We systematically analyze recorded phenotypes in animal models using the formal definitions created for phenotype ontologies. We evaluate the validity of the inferred functions manually and by demonstrating a significant improvement in predicting genetic interactions and protein-protein interactions based on functional similarity. Our knowledge-based approach is generally applicable to phenotypes recorded in model organism databases, including phenotypes from large-scale, high throughput community projects whose primary mode of dissemination is direct publication on-line rather than in the literature.	[Hoehndorf, Robert; Schofield, Paul N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Hoehndorf, Robert; Hardy, Nigel W.; Gkoutos, Georgios V.] Aberystwyth Univ, Old Coll, Dept Comp Sci, Aberystwyth, Dyfed, Wales; [Tweedie, Susan] Univ Cambridge, Wellcome Trust Canc Res United Kingdom Gurdon Ins, Cambridge, England; [Osumi-Sutherland, David] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; Aberystwyth University; University of Cambridge; University of Cambridge	Hoehndorf, R (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	rh497@cam.ac.uk	Hoehndorf, Robert/H-6127-2019; Schofield, Paul/AAA-9414-2020; Tweedie, Susan/B-3695-2019; Gkoutos, Georgios/AAS-9936-2020	Hoehndorf, Robert/0000-0001-8149-5890; Schofield, Paul/0000-0002-5111-7263; Tweedie, Susan/0000-0003-1818-8243; Gkoutos, Georgios/0000-0002-2061-091X; Osumi-Sutherland, David/0000-0002-7073-9172	European Commission [248502]; National Institutes of Health [R01 HG004838-02]; Medical Research Council [G1000968]; National Human Genome Research Institute at the United States National Institutes of Health [P41 HG000739]; MRC [G1000968] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG000739, P41HG000739, R01HG004838] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Human Genome Research Institute at the United States National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	RH was supported by the European Commission's 7th Framework Programme, RICORDO project [grant number 248502]. RH, PNS and GVG were supported by the National Institutes of Health [grant number R01 HG004838-02]. ST was supported by the Medical Research Council [grant number G1000968]. DOS was supported by a grant to FlyBase from the National Human Genome Research Institute at the United States National Institutes of Health [grant number P41 HG000739]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aubry M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-241; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Brckstmmer T, 2009, NATURE IMMUNOLOGY, V10, P266; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaudan S, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/342746; Gkoutos Georgios V, 2012, J Biomed Semantics, V3 Suppl 2, pS6, DOI 10.1186/2041-1480-3-S2-S6; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Gomez A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-49; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Park J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas001; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Sarac OS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012382; Schindelman G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-32; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stoica Emilia, 2006, Pac Symp Biocomput, P88, DOI 10.1142/9789812701626_0009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tranchevent LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/bib/bbq007; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472	34	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60847	10.1371/journal.pone.0060847	http://dx.doi.org/10.1371/journal.pone.0060847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23626672	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400022
J	Ostner, G; Lindstrom, V; Christensen, PH; Kozak, M; Abrahamson, M; Grubb, A				Ostner, Gustav; Lindstrom, Veronica; Christensen, Per Hjort; Kozak, Maciej; Abrahamson, Magnus; Grubb, Anders			Stabilization, Characterization, and Selective Removal of Cystatin C Amyloid Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; MAMMALIAN LEGUMAIN; COMMON MECHANISM; ION CHANNELS; PROTEIN; FIBRILS; BETA; PATHOGENESIS; TOXICITY	The pathophysiological process in amyloid disorders usually involves the transformation of a functional monomeric protein via potentially toxic oligomers into amyloid fibrils. The structure and properties of the intermediary oligomers have been difficult to study due to their instability and dynamic equilibrium with smaller and larger species. In hereditary cystatin C amyloid angiopathy, a cystatin C variant is deposited in arterial walls and cause brain hemorrhage in young adults. In the present investigation, we use redox experiments of monomeric cystatin C, stabilized against domain swapping by an intramolecular disulfide bond, to generate stable oligomers (dimers, trimers, tetramers, decamers, and high molecular weight oligomers). These oligomers were characterized concerning size by gel filtration, polyacrylamide gel electrophoresis, and mass spectrometry, shape by electron and atomic force microscopy, and, function by assays of their capacity to inhibit proteases. The results showed the oligomers to be highly ordered, domain-swapped assemblies of cystatin C and that the oligomers could not build larger oligomers, or fibrils, without domain swapping. The stabilized oligomers were used to induce antibody formation in rabbits. After immunosorption, using immobilized monomeric cystatin C, and elution from columns with immobilized cystatin C oligomers, oligomer-specific antibodies were obtained. These could be used to selectively remove cystatin C dimers from biological fluids containing both dimers and monomers.	[Ostner, Gustav; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; [Christensen, Per Hjort] Dako Denmark AS, DK-2600 Glostrup, Denmark; [Kozak, Maciej] Adam Mickiewicz Univ, Dept Macromol Phys, PL-61614 Poznan, Poland	Lund University; Skane University Hospital; Adam Mickiewicz University	Grubb, A (corresponding author), Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden.	anders.grubb@med.lu.se	Abrahamson, Magnus/CAG-9507-2022; Kozak, Maciej/A-6588-2008	Grubb, Anders/0000-0002-0125-3662; Kozak, Maciej/0000-0003-3312-6518	Swedish Science Research Council [5196]; A. Osterlund Foundation; G. Foundation; J. Kock Foundation; Royal Physiographic Society in Lund, Sweden; National Science Centre, Poland [2012/06/M/ST4/00036]	Swedish Science Research Council; A. Osterlund Foundation; G. Foundation; J. Kock Foundation; Royal Physiographic Society in Lund, Sweden; National Science Centre, Poland(National Science Centre, Poland)	This work was supported in part by the Swedish Science Research Council Project 5196 and by grants from the A. Osterlund, G. and J. Kock Foundations, and the Royal Physiographic Society in Lund, Sweden, and HARMO-NIA3 Project Grant 2012/06/M/ST4/00036 from the National Science Centre, Poland (to M. K. and A. G.)	ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Fasman G.D., 1989, PRACTICAL HDB BIOCH; Gerhartz B, 1998, BIOCHEMISTRY-US, V37, P17309, DOI 10.1021/bi980873u; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klapetek P, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/2/025501; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodziejczyk R, 2010, FEBS J, V277, P1726, DOI 10.1111/j.1742-4658.2010.07596.x; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Nilsson L. A., 1983, SCAND J IMMUNOL S10, V17, P57; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Ostner G, 2011, SCAND J CLIN LAB INV, V71, P676, DOI 10.3109/00365513.2011.621026; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rasband W, IMAGEJ; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Schrodinger L., 2020, PYMOL; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	44	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16438	16450		10.1074/jbc.M113.469593	http://dx.doi.org/10.1074/jbc.M113.469593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629649	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000320378900021
J	Chung, WC; Chen, LL; Lo, WS; Lin, CP; Kuo, CH				Chung, Wan-Chia; Chen, Ling-Ling; Lo, Wen-Sui; Lin, Chan-Pin; Kuo, Chih-Horng			Comparative Analysis of the Peanut Witches'-Broom Phytoplasma Genome Reveals Horizontal Transfer of Potential Mobile Units and Effectors	PLOS ONE			English	Article							SEQUENCE; PROTEIN; ALIGNMENT; INSECT; PLANTS; IDENTIFICATION; AUSTRALIENSE; ANNOTATION; CHROMOSOME; DISEASES	Phytoplasmas are a group of bacteria that are associated with hundreds of plant diseases. Due to their economical importance and the difficulties involved in the experimental study of these obligate pathogens, genome sequencing and comparative analysis have been utilized as powerful tools to understand phytoplasma biology. To date four complete phytoplasma genome sequences have been published. However, these four strains represent limited phylogenetic diversity. In this study, we report the shotgun sequencing and evolutionary analysis of a peanut witches'-broom (PnWB) phytoplasma genome. The availability of this genome provides the first representative of the 16SrII group and substantially improves the taxon sampling to investigate genome evolution. The draft genome assembly contains 13 chromosomal contigs with a total size of 562,473 bp, covering similar to 90% of the chromosome. Additionally, a complete plasmid sequence is included. Comparisons among the five available phytoplasma genomes reveal the differentiations in gene content and metabolic capacity. Notably, phylogenetic inferences of the potential mobile units (PMUs) in these genomes indicate that horizontal transfer may have occurred between divergent phytoplasma lineages. Because many effectors are associated with PMUs, the horizontal transfer of these transposon-like elements can contribute to the adaptation and diversification of these pathogens. In summary, the findings from this study highlight the importance of improving taxon sampling when investigating genome evolution. Moreover, the currently available sequences are inadequate to fully characterize the pan-genome of phytoplasmas. Future genome sequencing efforts to expand phylogenetic diversity are essential in improving our understanding of phytoplasma evolution.	[Chung, Wan-Chia; Chen, Ling-Ling; Lo, Wen-Sui; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Lo, Wen-Sui; Kuo, Chih-Horng] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Lo, Wen-Sui; Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Lo, Wen-Sui; Kuo, Chih-Horng] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lin, Chan-Pin] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Kuo, Chih-Horng/E-2045-2013; Chen, Ling-Ling/AAY-3547-2021	Kuo, Chih-Horng/0000-0002-2857-0529; Lin, Chan-Pin/0000-0002-9951-687X	National Science Council of Taiwan [NSC 99-2313-B-001-006-MY2]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding for this work was provided by research grants from the National Science Council of Taiwan (NSC 99-2313-B-001-006-MY2) and Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034407; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hogenhout SA, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P19; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Kube M, 2012, SCI WORLD J, DOI 10.1100/2012/185942; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Namba S, 2011, J GEN PLANT PATHOL, V77, P345, DOI 10.1007/s10327-011-0341-y; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Padovan AC, 2000, MICROBIOL-SGM, V146, P893, DOI 10.1099/00221287-146-4-893; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sugio A, 2012, CURR OPIN MICROBIOL, V15, P247, DOI 10.1016/j.mib.2012.04.002; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Wei W, 2008, P NATL ACAD SCI USA, V105, P11827, DOI 10.1073/pnas.0805237105; White DT, 1998, INT J SYST BACTERIOL, V48, P941, DOI 10.1099/00207713-48-3-941; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	64	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62770	10.1371/journal.pone.0062770	http://dx.doi.org/10.1371/journal.pone.0062770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626855	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400219
J	Henig, N; Avidan, N; Mandel, I; Staun-Ram, E; Ginzburg, E; Paperna, T; Pinter, RY; Miller, A				Henig, Noa; Avidan, Nili; Mandel, Ilana; Staun-Ram, Elsebeth; Ginzburg, Elizabeta; Paperna, Tamar; Pinter, Ron Y.; Miller, Ariel			Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; TNF-ALPHA; IMMUNE-RESPONSE; DENDRITIC CELLS; PROTEIN; ACTIVATION; THERAPY; IFN; MACROPHAGES; HMGB1	Background: Monocytes, which are key players in innate immunity, are outnumbered by neutrophils and lymphocytes among peripheral white blood cells. The cytokine interferon-beta (IFN-beta) is widely used as an immunomodulatory drug for multiple sclerosis and its functional pathways in peripheral blood mononuclear cells (PBMCs) have been previously described. The aim of the present study was to identify novel, cell-specific IFN-beta functions and pathways in tumor necrosis factor (TNF)-alpha-activated monocytes that may have been missed in studies using PBMCs. Methodology/Principal Findings: Whole genome gene expression profiles of human monocytes and T cells were compared following in vitro priming to TNF-alpha and overnight exposure to IFN-beta. Statistical analyses of the gene expression data revealed a cell-type-specific change of 699 transcripts, 667 monocyte-specific transcripts, 21 T cell-specific transcripts and 11 transcripts with either a difference in the response direction or a difference in the magnitude of response. RT-PCR revealed a set of differentially expressed genes (DEGs), exhibiting responses to IFN-beta that are modulated by TNF-alpha in monocytes, such as RIPK2 and CD83, but not in T cells or PBMCs. Known IFN-beta promoter response elements, such as ISRE, were enriched in T cell DEGs but not in monocyte DEGs. The overall directionality of the gene expression regulation by IFN-beta was different in T cells and monocytes, with up-regulation more prevalent in T cells, and a similar extent of up and down-regulation recorded in monocytes. Conclusions: By focusing on the response of distinct cell types and by evaluating the combined effects of two cytokines with pro and anti-inflammatory activities, we were able to present two new findings First, new IFN-beta response pathways and genes, some of which were monocytes specific; second, a cell-specific modulation of the IFN-beta response transcriptome by TNF-alpha.	[Henig, Noa; Mandel, Ilana; Staun-Ram, Elsebeth; Paperna, Tamar; Miller, Ariel] Carmel Hosp, Div Neuroimmunol, Haifa, Israel; [Henig, Noa; Mandel, Ilana; Staun-Ram, Elsebeth; Paperna, Tamar; Miller, Ariel] Carmel Hosp, Multiple Sclerosis Ctr, Haifa, Israel; [Henig, Noa; Pinter, Ron Y.] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Henig, Noa; Avidan, Nili; Staun-Ram, Elsebeth; Ginzburg, Elizabeta; Paperna, Tamar; Pinter, Ron Y.; Miller, Ariel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Henig, Noa; Avidan, Nili; Staun-Ram, Elsebeth; Ginzburg, Elizabeta; Paperna, Tamar; Pinter, Ron Y.; Miller, Ariel] Technion Israel Inst Technol, Res Inst, Haifa, Israel	Clalit Health Services; Carmel Medical Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Miller, A (corresponding author), Carmel Hosp, Div Neuroimmunol, Haifa, Israel.	millera@tx.technion.ac.il		Miller, Ariel/0000-0001-5843-6841	Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Galil Center for Medical Informatics, Telemedicine and Personalized Medicine; Adelis Foundation	Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Galil Center for Medical Informatics, Telemedicine and Personalized Medicine; Adelis Foundation	This study was supported by the Wolfson Family Charitable Trust, the Sacta-Rashi Foundation, Galil Center for Medical Informatics, Telemedicine and Personalized Medicine, and the Adelis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Anguille S, 2011, HUM VACCINES, V7, P579, DOI 10.4161/hv.7.5.14652; Bartee E, 2009, J VIROL, V83, P498, DOI 10.1128/JVI.01376-08; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen X, 2011, FEBS LETT, V585, P3611, DOI 10.1016/j.febslet.2011.04.025; Comabella M, 2011, CURR NEUROL NEUROSCI, V11, P484, DOI 10.1007/s11910-011-0211-1; Conrad AT, 2011, CELL RES, V21, P213, DOI 10.1038/cr.2011.9; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eder C, 2010, J NEUROIMMUNOL, V224, P51, DOI 10.1016/j.jneuroim.2010.05.008; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Farrell RA, 2010, J INTERF CYTOK RES, V30, P715, DOI 10.1089/jir.2010.0089; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Floris S, 2002, J NEUROIMMUNOL, V127, P69, DOI 10.1016/S0165-5728(02)00098-X; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Galboiz Y, 2001, ANN NEUROL, V50, P443, DOI 10.1002/ana.1218; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Gougeon ML, 2012, CELL DEATH DIFFER, V19, P96, DOI 10.1038/cdd.2011.134; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Haves-Zburof D, 2011, J CELL MOL MED, V15, P2421, DOI 10.1111/j.1582-4934.2010.01229.x; Hecker M, 2012, PHARMACOGENOMICS J, V12, P134, DOI 10.1038/tpj.2010.77; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Khan OA, 1998, NEUROLOGY, V51, P738, DOI 10.1212/WNL.51.3.738; Kim SY, 2010, NAT REV RHEUMATOL, V6, P165, DOI 10.1038/nrrheum.2009.279; Kouwenhoven M, 2001, J NEUROIMMUNOL, V112, P197, DOI 10.1016/S0165-5728(00)00396-9; Lee JJ, 2010, ARCH PHARM RES, V33, P387, DOI 10.1007/s12272-010-0307-1; Li Y, 2010, ARCH IMMUNOL THER EX, V58, P355, DOI 10.1007/s00005-010-0093-y; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longhi MS, 2009, HEPATOLOGY, V50, P130, DOI 10.1002/hep.22914; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Ma CY, 2012, RHEUMATOL INT, V32, P395, DOI 10.1007/s00296-010-1636-6; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Namdar A, 2010, J NEUROIMMUNOL, V218, P120, DOI 10.1016/j.jneuroim.2009.10.013; Narushima I, 2003, PHARMACOL TOXICOL, V92, P21, DOI 10.1034/j.1600-0773.2003.920104.x; Oliver-Martos B, 2011, J NEUROIMMUNOL, V230, P153, DOI 10.1016/j.jneuroim.2010.10.033; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Pappas DJ, 2009, PHYSL GENOMICS; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Paz A, 2011, NUCLEIC ACIDS RES, V39, pD793, DOI 10.1093/nar/gkq1167; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Portaccio E, 2006, MULT SCLER J, V12, P281, DOI 10.1191/135248506ms1278oa; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Satoh J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-18; Seguin R, 2003, J NEUROIMMUNOL, V135, P96, DOI 10.1016/S0165-5728(02)00431-9; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Skapenko Alla, 2007, V136, P87; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Spuler S, 1996, J NEUROIMMUNOL, V66, P57; Staun-Ram E, 2011, J NEUROIMMUNOL, V232, P200, DOI 10.1016/j.jneuroim.2010.10.015; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107; Yen JH, 2010, J IMMUNOL, V184, P3478, DOI 10.4049/jimmunol.0902542; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	80	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62366	10.1371/journal.pone.0062366	http://dx.doi.org/10.1371/journal.pone.0062366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626809	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400173
J	Tang, SJ; Cui, HY; Yao, L; Hao, XH; Shen, Y; Fan, L; Sun, H; Zhang, ZJ; Huang, JA				Tang, Shenjie; Cui, Haiyan; Yao, Lan; Hao, Xiaohui; Shen, Yun; Fan, Lin; Sun, Hua; Zhang, Zhanjun; Huang, Jian An			Increased Cytokines Response in Patients with Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							IFN-GAMMA; SYSTEMIC INFLAMMATION; INTERFERON-GAMMA; LUNG-FUNCTION; PATTERNS; AIRWAY; ALPHA; SERUM; INTERLEUKIN-6; EXACERBATION	Objectives: To explore the change and its significance of cytokines in patients with pulmonary tuberculosis complicated with COPD. Methods: The immune function of 152 cases of pulmonary tuberculosis with COPD was detected to compare with 150 cases of patients with pulmonary tuberculosis, 157 cases of patients with COPD and 50 cases of healthy volunteers who were in the hospital during the same period. T lymphocyte cell population in peripheral blood was detected by flow cytometry. The serum levels of sIL-2R, IL-6, IFN-gamma, TNF-alpha were measured using ELISA. Results: The percentage of CD4+ T cells in TB patients with or without COPD and COPD patients without TB was significantly lower than that in control group. The percentage of CD4+ T cells in patients with TB and COPD was significantly lower than that in the non-COPD TB patients. The percentage of CD8+ T cells was higher in the TB patients group than that in control group. The CD4+/CD8+ ratio in the TB patients group was significantly lower than that in control group. The concentrations of sIL-2R, IL-6, TNF-alpha, IFN-gamma in TB patients with or without COPD and COPD patients without TB were significantly higher than those in control group. In addition, sIL-2R, IL-6, TNF-alpha concentrations in the patients with TB and COPD were higher than those in the non-COPD TB patients. The concentrations of sIL-2R, IL-6, TNF-alpha, IFN-gamma in COPD patients with TB were significantly higher than those in COPD patients without TB. There was a significant negative correlation between serum levels of TNF-alpha, IL-6 and FEV1 (%, predicted) in COPD without TB group. Conclusions: The patients with pulmonary tuberculosis complicated with COPD were impaired in cellular immunity, and its extent of immune impairment is more serious than those of the patients with pulmonary tuberculosis and the patients with COPD.	[Tang, Shenjie; Huang, Jian An] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Peoples R China; [Tang, Shenjie; Cui, Haiyan; Yao, Lan; Hao, Xiaohui; Shen, Yun; Fan, Lin; Sun, Hua; Zhang, Zhanjun] Tongji Univ, Sch Med, Shanghai Pulm Hosp, TB Ctr Diag & Treatment, Shanghai 200092, Peoples R China	Soochow University - China; Tongji University	Huang, JA (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Peoples R China.	huang_jian_an@163.com						Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Al-Attiyah R, 2012, SCAND J IMMUNOL, V75, P623, DOI 10.1111/j.1365-3083.2012.02692.x; [Anonymous], GLOB STRAT DIAGN MAN; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Bucchioni E, 2003, RESP MED, V97, P1299, DOI 10.1016/j.rmed.2003.07.008; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Cava F, 2000, CYTOKINE, V12, P1423, DOI 10.1006/cyto.2000.0714; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Gadgil Aneal, 2006, Proc Am Thorac Soc, V3, P487, DOI 10.1513/pats.200603-064MS; He JQ, 2009, THORAX, V64, P698, DOI 10.1136/thx.2008.111278; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Karadag F, 2008, LUNG, V186, P403, DOI 10.1007/s00408-008-9106-6; Katti MK, 2011, ARCH MED RES, V42, P199, DOI 10.1016/j.arcmed.2011.04.012; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Kim WD, 2002, CHEST, V122, P437, DOI 10.1378/chest.122.2.437; Kiran B, 2010, ARCH MED SCI, V6, P77, DOI 10.5114/aoms.2010.13511; Koch A, 2007, EUR RESPIR J, V29, P42, DOI 10.1183/09031936.00133205; Kupli E, 2008, RESPIRATION, V75, P73, DOI 10.1159/000110744; Lago PM, 2012, INT J TUBERC LUNG D, V16, P656, DOI 10.5588/ijtld.11.0707; Liu CH, 2011, RESPIROLOGY, V16, P918, DOI 10.1111/j.1440-1843.2011.01990.x; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Moermans C, 2011, CYTOKINE, V56, P298, DOI 10.1016/j.cyto.2011.07.010; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Paats MS, 2012, EUR RESPIR J, V40, P330, DOI 10.1183/09031936.00079611; Rajavelu P, 2005, FEMS IMMUNOL MED MIC, V45, P95, DOI 10.1016/j.femsim.2005.02.011; Ray JCJ, 2008, J THEOR BIOL, V252, P24, DOI 10.1016/j.jtbi.2008.01.010; Shitrit D, 2006, LUNG, V184, P21, DOI 10.1007/s00408-005-2558-2; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Tsao TCY, 2002, INT J TUBERC LUNG D, V6, P720; WHO, 2008, GLOBAL TUBERCULOSIS; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181; Zhang Shao-jun, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P884	42	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62385	10.1371/journal.pone.0062385	http://dx.doi.org/10.1371/journal.pone.0062385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626814	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400178
J	Tesson, B; Hildebrand, M				Tesson, Benoit; Hildebrand, Mark			Characterization and Localization of Insoluble Organic Matrices Associated with Diatom Cell Walls: Insight into Their Roles during Cell Wall Formation	PLOS ONE			English	Article							ACHNANTHES-LONGIPES; VALVE MORPHOGENESIS; FINE-STRUCTURE; ATOMIC-FORCE; BACILLARIOPHYCEAE; SILICA; POLYSACCHARIDES; NANOSTRUCTURE; BIOSILICA; FRUSTULE	Organic components associated with diatom cell wall silica are important for the formation, integrity, and function of the cell wall. Polysaccharides are associated with the silica, however their localization, structure, and function remain poorly understood. We used imaging and biochemical approaches to describe in detail characteristics of insoluble organic components associated with the cell wall in 5 different diatom species. Results show that an insoluble organic matrix enriched in mannose, likely the diatotepum, is localized on the proximal surface of the silica cell wall. We did not identify any organic matrix embedded within the silica. We also identified a distinct material consisting of glucose polymer with variable localization depending on the species. In some species this component was directly involved in the morphogenesis of silica structure while in others it appeared to be only a structural component of the cell wall. A novel glucose-rich structure located between daughter cells during division was also identified. This work for the first time correlates the structure, composition, and localization of insoluble organic matrices associated with diatom cell walls. Additionally we identified a novel glucose polymer and characterized its role during silica structure formation.	[Tesson, Benoit; Hildebrand, Mark] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Tesson, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	btesson@ucsd.edu; mhildebrand@ucsd.edu			AFOSR MURI [FA9550-10-1-0555]	AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI)	This work was supported by AFOSR MURI grant FA9550-10-1-0555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Bridoux MC, 2010, GEOCHIM COSMOCHIM AC, V74, P4044, DOI 10.1016/j.gca.2010.04.010; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; Chiovitti A, 2005, J PHYCOL, V41, P1154, DOI 10.1111/j.1529-8817.2005.00140.x; CRAWFORD R M, 1973, British Phycological Journal, V8, P257; Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x; DARLEY WM, 1969, EXP CELL RES, V58, P334, DOI 10.1016/0014-4827(69)90514-X; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; DRUM RW, 1964, J ULTRA MOL STRUCT R, V10, P217, DOI 10.1016/S0022-5320(64)80006-X; FORD CW, 1965, J CHEM SOC, P7042, DOI 10.1039/jr9650007042; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Higgins MJ, 2003, J PHYCOL, V39, P1181, DOI 10.1111/j.0022-3646.2003.03-027.x; Hildebrand M, 2009, J MICROSC-OXFORD, V235, P172, DOI 10.1111/j.1365-2818.2009.03198.x; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Ingalls AE, 2010, GEOCHIM COSMOCHIM AC, V74, P104, DOI 10.1016/j.gca.2009.09.012; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1996, EUR J BIOCHEM, V239, P259, DOI 10.1111/j.1432-1033.1996.0259u.x; Lau RKL, 2007, J NANOSCI NANOTECHNO, V7, P452, DOI 10.1166/jnn.2007.110; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; McConville MJ, 1999, PROTOPLASMA, V206, P188, DOI 10.1007/BF01279266; Morrison Vicki A, 2006, Expert Rev Anti Infect Ther, V4, P325, DOI 10.1586/14787210.4.2.325; PERCIVAL E, 1980, PHYTOCHEMISTRY, V19, P809, DOI 10.1016/0031-9422(80)85116-8; Pickett-Heaps J., 1990, CELL BIOL DIATOM VAL; Pittenger B., 2010, 128 BRUK; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; REIMANN BEF, 1966, J PHYCOL, V2, P74, DOI 10.1111/j.1529-8817.1966.tb04597.x; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; SCHNEPF E, 1977, BRIT PHYCOL J, V12, P145, DOI 10.1080/00071617700650161; Shrestha R, 2012, BMC GENOMICS, V13; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Tesson B, 2009, CHEMBIOCHEM, V10, P2011, DOI 10.1002/cbic.200800811; Tesson B, 2009, BOT MAR, V52, P104, DOI 10.1515/BOT.2009.012; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; van de Meene AML, 2002, J PHYCOL, V38, P351, DOI 10.1046/j.1529-8817.2002.01124.x; Volcani B., 1981, SILICON SILICEOUS ST, P157; Von Stosch H.A., 1981, P 6 S REC FOSS DIAT, P231; Wang Y, 2000, J PHYCOL, V36, P367, DOI 10.1046/j.1529-8817.2000.99102.x; Waterkeyn L., 1987, CELLULE, V74, P199; Wustman BA, 1997, PLANT PHYSIOL, V113, P1059, DOI 10.1104/pp.113.4.1059	43	60	60	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61675	10.1371/journal.pone.0061675	http://dx.doi.org/10.1371/journal.pone.0061675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626714	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400078
J	Liu, Q; Kwoh, CK; Hoi, SCH				Liu, Qian; Kwoh, Chee Keong; Hoi, Steven C. H.			Beta Atomic Contacts: Identifying Critical Specific Contacts in Protein Binding Interfaces	PLOS ONE			English	Article							SUBUNIT INTERFACES; HOT-SPOTS; SURFACE; PREFERENCES; INFERENCE; DATABASE; VECTORS; SITES	Specific binding between proteins plays a crucial role in molecular functions and biological processes. Protein binding interfaces and their atomic contacts are typically defined by simple criteria, such as distance-based definitions that only use some threshold of spatial distance in previous studies. These definitions neglect the nearby atomic organization of contact atoms, and thus detect predominant contacts which are interrupted by other atoms. It is questionable whether such kinds of interrupted contacts are as important as other contacts in protein binding. To tackle this challenge, we propose a new definition called beta (beta) atomic contacts. Our definition, founded on the beta-skeletons in computational geometry, requires that there is no other atom in the contact spheres defined by two contact atoms; this sphere is similar to the van der Waals spheres of atoms. The statistical analysis on a large dataset shows that beta contacts are only a small fraction of conventional distance-based contacts. To empirically quantify the importance of beta contacts, we design beta ACV, an SVM classifier with beta contacts as input, to classify homodimers from crystal packing. We found that our beta ACV is able to achieve the state-of-the-art classification performance superior to SVM classifiers with distance-based contacts as input. Our beta ACV also outperforms several existing methods when being evaluated on several datasets in previous works. The promising empirical performance suggests that beta contacts can truly identify critical specific contacts in protein binding interfaces. beta contacts thus provide a new model for more precise description of atomic organization in protein quaternary structures than distance-based contacts.	[Liu, Qian; Kwoh, Chee Keong; Hoi, Steven C. H.] Nanyang Technol Univ, BIRC, Sch Comp Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, Q (corresponding author), Nanyang Technol Univ, BIRC, Sch Comp Engn, Singapore 639798, Singapore.	liuq0011@e.ntu.edu.sg; chhoi@ntu.edu.sg	HOI, Steven C. H./A-3736-2011	Hoi, Steven/0000-0002-4584-3453	Singapore MOE (Ministry Of Education) ARC (Academic Research Council) [T208B2203]	Singapore MOE (Ministry Of Education) ARC (Academic Research Council)(Ministry of Education, Singapore)	This work was supported by Singapore MOE (Ministry Of Education) ARC (Academic Research Council) funding project (Tier-2 grant T208B2203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Block P, 2006, PROTEINS, V65, P607, DOI 10.1002/prot.21104; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouvier B, 2009, PROTEINS, V76, P677, DOI 10.1002/prot.22381; Carugo O, 1997, PROTEIN SCI, V6, P2261; Cazals F, 2006, PROTEIN SCI, V15, P2082, DOI 10.1110/ps.062245906; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen P, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S2; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; GABRIEL KR, 1969, SYST ZOOL, V18, P259, DOI 10.2307/2412323; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gong S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-207; Headd JJ, 2007, J PROTEOME RES, V6, P2576, DOI 10.1021/pr070018+; Hubbard S. J., 1993, TECHNICAL REPORT; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kim DS, 2006, COMPUT AIDED DESIGN, V38, P1179, DOI 10.1016/j.cad.2006.07.002; Kirkpatrick DG, 1985, MACHINE INTELLIGENCE, V2, P217; Korkin D, 2005, PROTEIN SCI, V14, P2350, DOI 10.1110/ps.051571905; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li ZH, 2010, PROTEINS, V78, P3304, DOI 10.1002/prot.22838; Liu Q, 2010, PROTEINS, V78, P589, DOI 10.1002/prot.22583; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MATULA DW, 1980, GEOGR ANAL, V12, P205; McConkey BJ, 2002, BIOINFORMATICS, V18, P1365, DOI 10.1093/bioinformatics/18.10.1365; Mintseris J, 2003, PROTEINS, V53, P629, DOI 10.1002/prot.10432; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ponstingl H, 2000, PROTEINS, V41, P47; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Preissner R, 1998, J MOL BIOL, V280, P535, DOI 10.1006/jmbi.1998.1878; Selvaraj S, 2003, BIOPHYS J, V84, P1919, DOI 10.1016/S0006-3495(03)75000-0; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	46	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e59737	10.1371/journal.pone.0059737	http://dx.doi.org/10.1371/journal.pone.0059737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630569	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000317911500004
J	Luo, Y; Yan, X; Qi, N; Wang, XD; Wang, LJ				Luo, Yi; Yan, Xu; Qi, Na; Wang, Xiaodong; Wang, Liangjiang			Study of Double-Side Ultrasonic Embossing for Fabrication of Microstructures on Thermoplastic Polymer Substrates	PLOS ONE			English	Article							MICROFLUIDIC CHIP	Double-side replication of polymer substrates is beneficial to the design and the fabrication of 3-demensional devices. The ultrasonic embossing method is a promising, high efficiency and low cost replication method for thermoplastic substrates. It is convenient to apply silicon molds in ultrasonic embossing, because microstructures can be easily fabricated on silicon wafers with etching techniques. To reduce the risk of damaging to silicon molds and to improve the replication uniformity on both sides of the polymer substrates, thermal assisted ultrasonic embossing method was proposed and tested. The processing parameters for the replication of polymethyl methacrylate (PMMA), including ultrasonic amplitude, ultrasonic force, ultrasonic time, and thermal assisted temperature were studied using orthogonal array experiments. The influences of the substrate thickness, pattern style and density were also investigated. The experiment results show that the principal parameters for the upper and lower surface replication are ultrasonic amplitude and thermal assisted temperature, respectively. As to the replication uniformity on both sides, the ultrasonic force has the maximal influence. Using the optimized parameters, the replication rate reached 97.5% on both sides of the PMMA substrate, and the cycle time was less than 50 s.	[Luo, Yi; Yan, Xu; Qi, Na; Wang, Xiaodong; Wang, Liangjiang] Dalian Univ Technol, Key Lab Micro Nano Technol & Syst Liaoning Prov, Dalian, Peoples R China	Dalian University of Technology	Luo, Y (corresponding author), Dalian Univ Technol, Key Lab Micro Nano Technol & Syst Liaoning Prov, Dalian, Peoples R China.	luoy@dlut.edu.cn	Luo, Yi/B-3277-2013	Luo, Yi/0000-0001-6390-8639	National Natural Science Foundation of China [50975037]; State Key Development Program for Basic Research of China [2011CB013105]; Fundamental Research Funds for the Central Universities [DUT12ZD212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by National Natural Science Foundation of China (no. 50975037), the State Key Development Program for Basic Research of China (no. 2011CB013105), and the Fundamental Research Funds for the Central Universities (no. DUT12ZD212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUCKNER A, 2009, J FLYING INSECTS ROB, P127, DOI DOI 10.1007/978-3-540-89393-6_10; Burlage K, 2012, J MICROMECH MICROENG, DOI [10.1007/978-94-007-2721-2_11, DOI 10.1007/978-94-007-2721-2_11]; Feng GH, 2010, SENSOR ACTUAT A-PHYS, V162, P100, DOI 10.1016/j.sna.2010.06.019; Liu SJ, 2010, OPT LASER TECHNOL, V42, P794, DOI 10.1016/j.optlastec.2009.12.005; Liu SJ, 2008, J OPT SOC AM, V20, P18083; Makela T, 2012, MICROELECTRON ENG, V97, P89, DOI 10.1016/j.mee.2012.03.031; Mekaru H, 2007, MICROSYST TECHNOL, V13, P385, DOI 10.1007/s00542-006-0203-2; Okagbare PI, 2010, ELECTROPHORESIS, V31, P3074, DOI 10.1002/elps.201000209; Park DSW, 2008, BIOMED MICRODEVICES, V10, P21, DOI 10.1007/s10544-007-9106-y; Senn T, 2011, MICROELECTRON ENG, V88, P11, DOI 10.1016/j.mee.2010.08.003; Seo YS, 2012, J MICROSYST TECHNOL, DOI [10.1007/s00542-012-1524_y, DOI 10.1007/S00542-012-1524_Y]; Tsao CW, 2012, MICROSYST TECHNOL, V18, P713, DOI 10.1007/s00542-012-1513-1; Wang Y, 2010, SENSOR ACTUAT B-CHEM, V145, P553, DOI 10.1016/j.snb.2009.11.068; Yi L, 2008, J MATER PROCESS TECH, V208, P63, DOI 10.1016/j.jmatprotec.2007.12.146; Yu HW, 2009, J MICRO-NANOLITH MEM, V8, P11	15	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61647	10.1371/journal.pone.0061647	http://dx.doi.org/10.1371/journal.pone.0061647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630605	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500055
J	Peterson, JD; Steffen, JE; Reinert, LK; Cobine, PA; Appel, A; Rollins-Smith, L; Mendonca, MT				Peterson, John D.; Steffen, John E.; Reinert, Laura K.; Cobine, Paul A.; Appel, Arthur; Rollins-Smith, Louise; Mendonca, Mary T.			Host Stress Response Is Important for the Pathogenesis of the Deadly Amphibian Disease, Chytridiomycosis, in Litoria caerulea	PLOS ONE			English	Article							LARVAL AMBYSTOMA-TIGRINUM; COAL-COMBUSTION-WASTE; FROG RANA-PIPIENS; CORTICOTROPIN-RELEASING-FACTOR; SALMON SALMO-SALAR; BATRACHOCHYTRIUM-DENDROBATIDIS; BUFO-TERRESTRIS; CAPTIVITY STRESS; XENOPUS-LAEVIS; EXPERIMENTAL-INFECTION	Chytridiomycosis, a disease caused by Batrachochytrium dendrobatidis, has contributed to worldwide amphibian population declines; however, the pathogenesis of this disease is still somewhat unclear. Previous studies suggest that infection disrupts cutaneous sodium transport, which leads to hyponatremia and cardiac failure. However, infection is also correlated with unexplained effects on appetite, skin shedding, and white blood cell profiles. Glucocorticoid hormones may be the biochemical connection between these disparate effects, because they regulate ion homeostasis and can also influence appetite, skin shedding, and white blood cells. During a laboratory outbreak of B. dendrobatidis in Australian Green Tree Frogs, Litoria caerulea, we compared frogs showing clinical signs of chytridiomycosis to infected frogs showing no signs of disease and determined that diseased frogs had elevated baseline corticosterone, decreased plasma sodium and potassium, and altered WBC profiles. Diseased frogs also showed evidence of poorer body condition and elevated metabolic rates compared with frogs showing no signs of disease. Prior to displaying signs of disease, we also observed changes in appetite, body mass, and the presence of shed skin associated with infected but not yet diseased frogs. Collectively, these results suggest that elevated baseline corticosterone is associated with chytridiomycosis and correlates with some of the deleterious effects observed during disease development.	[Peterson, John D.; Cobine, Paul A.; Mendonca, Mary T.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Peterson, John D.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Steffen, John E.] Penn State Erie, Sch Sci, Erie, PA USA; [Reinert, Laura K.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Appel, Arthur] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Rollins-Smith, Louise] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Auburn University System; Auburn University; Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Vanderbilt University; Auburn University System; Auburn University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Peterson, JD (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	johndorlandpeterson@gmail.com	Cobine, Paul A/G-3107-2011; Cobine, Paul/AAH-6619-2020; Steffen, John E./W-1668-2019	Cobine, Paul A/0000-0001-6012-0985; Cobine, Paul/0000-0001-6012-0985; 	National Science Foundation [IOS-0619536, IOS-0843207]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation Grants IOS-0619536 and IOS-0843207 (to LR-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2009, PHILOS T R SOC B, V364, P3429, DOI 10.1098/rstb.2009.0128; Al-Afaleq AI, 1998, J VET MED B, V45, P513, DOI 10.1111/j.1439-0450.1998.tb00822.x; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Belden LK, 2005, J PARASITOL, V91, P686, DOI 10.1645/GE-397R; BENNETT MF, 1968, BIOL BULL-US, V135, P92, DOI 10.2307/1539616; BENNETT MF, 1972, J COMP PHYSIOL, V80, P233, DOI 10.1007/BF00696493; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BREWER KJ, 1980, COMP BIOCHEM PHYS C, V66, P203, DOI 10.1016/0306-4492(80)90127-6; BUDTZ PE, 1979, J ZOOL, V189, P57; Carr JA, 2002, COMP BIOCHEM PHYS B, V132, P151, DOI 10.1016/S1096-4959(01)00545-0; CODDINGTON EJ, 1995, GEN COMP ENDOCR, V100, P33, DOI 10.1006/gcen.1995.1129; Crespi EJ, 2005, COMP BIOCHEM PHYS A, V141, P381, DOI 10.1016/j.cbpb.2004.12.007; Crespi EJ, 2004, J NEUROENDOCRINOL, V16, P279, DOI 10.1111/j.0953-8194.2004.01168.x; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Davis Andrew K., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/735937; Denver RJ, 1998, GEN COMP ENDOCR, V110, P326, DOI 10.1006/gcen.1998.7082; DERUYTER ML, 1986, GEN COMP ENDOCR, V62, P298, DOI 10.1016/0016-6480(86)90120-6; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DuRant SE, 2008, GEN COMP ENDOCR, V156, P126, DOI 10.1016/j.ygcen.2007.12.004; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Feder ME, 1992, ENV PHYSL AMPHIBIANS, P646; Finstad B, 2000, AQUAC RES, V31, P795, DOI 10.1046/j.1365-2109.2000.00511.x; Fleming MW, 1997, COMP BIOCHEM PHYS B, V116, P41, DOI 10.1016/S0305-0491(96)00157-5; Fleming MW, 1998, COMP BIOCHEM PHYS A, V119, P315, DOI 10.1016/S1095-6433(97)00430-3; Gabor CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056054; GARRIDO E, 1987, DEV COMP IMMUNOL, V11, P375, DOI 10.1016/0145-305X(87)90081-4; Gendron AD, 1997, ENVIRON TOXICOL CHEM, V16, P1694, DOI [10.1897/1551-5028(1997)016&lt;1694:IVTOTF&gt;2.3.CO;2, 10.1002/etc.5620160818]; Glennemeier KA, 2001, ENVIRON TOXICOL, V16, P287, DOI 10.1002/tox.1035; Gobbetti A, 1996, J ENDOCRINOL, V148, P233, DOI 10.1677/joe.0.1480233; Goulet BN, 2003, ENVIRON TOXICOL CHEM, V22, P2106, DOI 10.1897/02-255; Hanley KA, 2002, ANIM BEHAV, V63, P311, DOI 10.1006/anbe.2001.1874; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; HENEY HW, 1983, GEN COMP ENDOCR, V49, P122, DOI 10.1016/0016-6480(83)90015-1; HERMANN G, 1995, J NEUROIMMUNOL, V56, P179, DOI 10.1016/0165-5728(94)00145-E; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Hopkins WA, 1997, GEN COMP ENDOCR, V108, P237, DOI 10.1006/gcen.1997.6969; Hopkins WA, 1999, COMP BIOCHEM PHYS C, V122, P191, DOI 10.1016/S0742-8413(98)10104-4; JORGENSEN CB, 1961, GEN COMP ENDOCR, V1, P145, DOI 10.1016/0016-6480(61)90042-9; JORGENSEN CB, 1964, GEN COMP ENDOCR, V4, P389, DOI 10.1016/0016-6480(64)90006-1; JURANI M, 1973, J ENDOCRINOL, V57, P385, DOI 10.1677/joe.0.0570385; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; LAIDLEY CW, 1988, J FISH BIOL, V32, P253, DOI 10.1111/j.1095-8649.1988.tb05359.x; Larson DL, 1998, PHYSIOL ZOOL, V71, P671, DOI 10.1086/515999; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mendonca MT, 1996, HORM BEHAV, V30, P153, DOI 10.1006/hbeh.1996.0019; MIDDLER SA, 1969, GEN COMP ENDOCR, V12, P290, DOI 10.1016/0016-6480(69)90201-9; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Peterson JD, 2009, COMP BIOCHEM PHYS C, V149, P36, DOI 10.1016/j.cbpc.2008.06.009; PICKERING AD, 1981, GEN COMP ENDOCR, V44, P487, DOI 10.1016/0016-6480(81)90337-3; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Ramakrishnan L, 1997, INFECT IMMUN, V65, P767, DOI 10.1128/IAI.65.2.767-773.1997; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Raouf SA, 2006, ANIM BEHAV, V71, P39, DOI 10.1016/j.anbehav.2005.03.027; ROLLINS LA, 1980, DEV COMP IMMUNOL, V4, P283, DOI 10.1016/S0145-305X(80)80032-2; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seber G., 1989, NONLINEAR REGRESSION; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; STEFANO FJE, 1964, GEN COMP ENDOCR, V4, P473, DOI 10.1016/0016-6480(64)90055-3; STIFFLER DF, 1986, GEN COMP ENDOCR, V62, P290, DOI 10.1016/0016-6480(86)90119-X; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sures B, 2002, ENVIRON POLLUT, V119, P333, DOI 10.1016/S0269-7491(01)00340-2; Sures B, 2001, PARASITOLOGY, V123, P179, DOI 10.1017/S003118200100823X; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wack CL, 2012, COMP BIOCHEM PHYS A, V161, P153, DOI 10.1016/j.cbpa.2011.10.017; Ward CK, 2007, GEN COMP ENDOCR, V152, P82, DOI 10.1016/j.ygcen.2007.02.031; Ward CK, 2006, COMP BIOCHEM PHYS A, V143, P353, DOI 10.1016/j.cbpa.2005.12.023; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; YORIO T, 1978, J ENDOCRINOL, V79, P283, DOI 10.1677/joe.0.0790283; ZERANI M, 1991, COMP BIOCHEM PHYS A, V98, P491, DOI 10.1016/0300-9629(91)90436-G	83	54	58	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62146	10.1371/journal.pone.0062146	http://dx.doi.org/10.1371/journal.pone.0062146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630628	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500083
J	Nie, HZ; Cao, QZ; Zhu, L; Gong, YH; Gu, JR; He, ZP				Nie, Huizhen; Cao, Qingzhen; Zhu, Lei; Gong, Yuehua; Gu, Jianren; He, Zuping			Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; SEX-HORMONES; ACTIVATION; PATHWAY; STAT3; PROLIFERATION; TRANSCRIPTION	Hepatocellular carcinoma (HCC) is one of the most fatal cancers. In almost all populations, males have a higher HCC rate than females. Here we sought to explore the roles and mechanisms of acetylcholine (Ach) and androgen receptor (AR) on regulating the fate determinations of HCC. Ach activated AR and promoted its expression in HCC cells. Ach enhanced HCC cell migration and invasion but inhibited their apoptosis. Ach had no obvious effects on the migration, invasion, or apoptosis in AR-negative HCC cells. Elevation of migration and invasion induced by Ach was eliminated in AR-knockdown HCC cells. In contrast, Ach stimulated the migration and invasion but suppressed apoptosis in AR over-expressed HCC cells. Additionally, AR agonist R1881 promoted the migration and invasion but reduced the apoptosis of SNU-449 cells, whereas AR antagonist casodex inhibited the migration and invasion but stimulated the apoptosis of SNU-449 cells. STAT3 and AKT phosphorylation was activated by Ach in HCC cells. Collectively, these data suggest that Ach activates STAT3 and AKT pathways and acts on AR to promote the migration and invasion but inhibit the apoptosis of HCC cells. This study thus provides novel insights into carcinogenesis of liver cancer by local interaction between neurotransmitter Ach and hormone receptor AR in HCC.	[Nie, Huizhen; Cao, Qingzhen; Zhu, Lei; Gu, Jianren; He, Zuping] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China; [Gong, Yuehua; He, Zuping] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Stem Cell Res Ctr, Shanghai 200030, Peoples R China; [He, Zuping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Shanghai 200030, Peoples R China; [He, Zuping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Assisted Reprod & Reprod Genet, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	He, ZP (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China.	zupinghe@sjtu.edu.cn		Nie, Hui-zhen/0000-0002-0447-8138; Migliaccio, Antimo/0000-0002-4197-2055	National Nature Science Foundation of China [31230048]; National Science Foundation of China [31171422]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Pujiang Program [11PJ1406400]; Science and Technology Commission of Shanghai Municipality [12JC1405900]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by a key grant from National Nature Science Foundation of China (31230048 to ZH), a grant from National Science Foundation of China (31171422 to ZH), The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Pujiang Program (11PJ1406400 to ZH), and a key grant from the Science and Technology Commission of Shanghai Municipality (12JC1405900 to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JP, 2012, MOL ONCOL, V6, P507, DOI 10.1016/j.molonc.2012.06.005; Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109; Bubser Michael, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-23274-9_7; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; De Maria N, 2002, MOL CELL ENDOCRINOL, V193, P59; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; He ZP, 2009, STEM CELLS, V27, P2580, DOI 10.1002/stem.198; Improgo MR, 2011, BIOCHEM PHARMACOL, V82, P1015, DOI 10.1016/j.bcp.2011.05.020; Ma AH, 2012, ONCOGENE, DOI [10.1038/onc.2012.425, DOI 10.1038/ONC.2012.425.]; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Ma WL, 2012, HEPATOLOGY, V56, P176, DOI 10.1002/hep.25644; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuda T, 2001, BIOCHEM BIOPH RES CO, V283, P179, DOI 10.1006/bbrc.2001.4758; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramachandran B, 2011, ENDOCR-RELAT CANCER, V18, pR41, DOI 10.1530/ERC-10-0332; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Wen Y, 2000, CANCER RES, V60, P6841; Yamamoto T, 2003, BIOCHEM BIOPH RES CO, V306, P610, DOI 10.1016/S0006-291X(03)01026-X; Yeh SH, 2010, ONCOLOGY-BASEL, V78, P172, DOI 10.1159/000315247; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079	23	22	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61678	10.1371/journal.pone.0061678	http://dx.doi.org/10.1371/journal.pone.0061678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620780	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500060
J	Souza, LM; Gazaffi, R; Mantello, CC; Silva, CC; Garcia, D; Le Guen, V; Cardoso, SEA; Garcia, AAF; Souza, AP				Souza, Livia Moura; Gazaffi, Rodrigo; Mantello, Camila Campos; Silva, Carla Cristina; Garcia, Dominique; Le Guen, Vincent; Almeida Cardoso, Saulo Emilio; Franco Garcia, Antonio Augusto; Souza, Anete Pereira			QTL Mapping of Growth-Related Traits in a Full-Sib Family of Rubber Tree (Hevea brasiliensis) Evaluated in a Sub-Tropical Climate	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; MAXIMUM-LIKELIHOOD-ESTIMATION; MICROCYCLUS-ULEI; CROSS-AMPLIFICATION; LOCI QTL; MARKERS; MICROSATELLITE; CONSTRUCTION; RESISTANCE; FRAMEWORK	The rubber tree (Hevea spp.), cultivated in equatorial and tropical countries, is the primary plant used in natural rubber production. Due to genetic and physiological constraints, inbred lines of this species are not available. Therefore, alternative approaches are required for the characterization of this species, such as the genetic mapping of full-sib crosses derived from outbred parents. In the present study, an integrated genetic map was obtained for a full-sib cross family with simple sequence repeats (SSRs) and expressed sequence tag (EST-SSR) markers, which can display different segregation patterns. To study the genetic architecture of the traits related to growth in two different conditions (winter and summer), quantitative trait loci (QTL) mapping was also performed using the integrated map. Traits evaluated were height and girth growth, and the statistical model was based in an extension of composite interval mapping. The obtained molecular genetic map has 284 markers distributed among 23 linkage groups with a total length of 2688.8 cM. A total of 18 QTLs for growth traits during the summer and winter seasons were detected. A comparison between the different seasons was also conducted. For height, QTLs detected during the summer season were different from the ones detected during winter season. This type of difference was also observed for girth. Integrated maps are important for genetics studies in outbred species because they represent more accurately the polymorphisms observed in the genitors. QTL mapping revealed several interesting findings, such as a dominance effect and unique segregation patterns that each QTL could exhibit, which were independent of the flanking markers. The QTLs identified in this study, especially those related to phenotypic variation associated with winter could help studies of marker-assisted selection that are particularly important when the objective of a breeding program is to obtain phenotypes that are adapted to sub-optimal regions.	[Souza, Livia Moura; Mantello, Camila Campos; Silva, Carla Cristina; Souza, Anete Pereira] Univ Estadual Campinas, Ctr Mol Biol, Campinas, SP, Brazil; [Souza, Livia Moura; Mantello, Camila Campos; Silva, Carla Cristina; Souza, Anete Pereira] Univ Estadual Campinas, Campinas, SP, Brazil; [Gazaffi, Rodrigo; Franco Garcia, Antonio Augusto] ESALQ Univ Sao Paulo, Dept Genet, Piracicaba, SP, Brazil; [Garcia, Dominique; Le Guen, Vincent] CIRAD, UMR AGAP, Montpellier, Herault, France; [Almeida Cardoso, Saulo Emilio] Plantacoes Michelin Bahia LTDA, Lab Pesquisa & Desenvolvimento Plantacoes Micheli, Igrapiuna, BA, Brazil; [Souza, Anete Pereira] Univ Estadual Campinas, Dept Plant Biol, Inst Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; CIRAD; Universite de Montpellier; Michelin; Universidade de Sao Paulo; Universidade Estadual de Campinas	Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Mol Biol, Campinas, SP, Brazil.	anete@unicamp.br	Garcia, Antonio A F/A-4538-2010; Le Guen, Vincent/I-2229-2012; Gazaffi, Rodrigo/D-8182-2017; DE SOUZA, ANETE PEREIRA/B-8663-2012	Garcia, Antonio A F/0000-0003-0634-3277; Gazaffi, Rodrigo/0000-0001-6549-4222; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Garcia, Dominique/0000-0002-0034-1927; Da Silva, Carla/0000-0003-4779-0014; Campos Mantello, Camila/0000-0002-9716-0400	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50562-4, 2009/14068-0, 2008/55974-1, 2009/52975-0]; Technological Development (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to acknowledge funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support (2007/50562-4) and scholarships to LMS (2009/14068-0), CCM (2008/55974-1), CCS (2009/52975-0) and RG (2009/14068-0). The authors are also thankful to the Technological Development (CNPq) for support to APS and AAFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSE P, 1994, THEOR APPL GENET, V88, P199, DOI 10.1007/BF00225898; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Bundock PC, 2008, TREE GENET GENOMES, V4, P85, DOI 10.1007/s11295-007-0090-4; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; CHURCHILL GA, 1994, GENETICS, V138, P963; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Gazaffi R, 2009, THESIS U SAO PAULO; Goncalves PDS, 2005, GENET MOL BIOL, V28, P765, DOI 10.1590/S1415-47572005000500019; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Jacob James, 1999, Indian Journal of Natural Rubber Research, V12, P1; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Le Guen V, 2007, NEW PHYTOL, V173, P335, DOI 10.1111/j.1469-8137.2006.01911.x; Le Guen V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/j.1439-0523.2010.01774.x; Le Guen V, 2003, THEOR APPL GENET, V108, P160, DOI 10.1007/s00122-003-1407-9; Le Guen V, 2011, TREE GENET GENOMES, V7, P877, DOI 10.1007/s11295-011-0381-7; Lespinasse D, 2000, THEOR APPL GENET, V100, P127, DOI 10.1007/s001220050018; Gouvea LRL, 2010, GENET MOL BIOL, V33, P308, DOI 10.1590/S1415-47572010005000039; Lin M, 2003, GENETICS, V165, P901; Low F. C., 1996, Journal of Natural Rubber Research, V11, P32; Ma CX, 2002, GENETICS, V161, P1751; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Mollinari M, 2009, HEREDITY, V103, P494, DOI 10.1038/hdy.2009.96; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Oliveira EJ, 2008, J AM SOC HORTIC SCI, V133, P35, DOI 10.21273/JASHS.133.1.35; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Payne RW, 2010, GENSTAT WINDOWS; Pires JM, 2002, TAXONOMIA FITOGEOGRA; Priyadarshan PM, 2003, GENET RESOUR CROP EV, V50, P101, DOI 10.1023/A:1022972320696; Raj S, 2005, INT J BIOMETEOROL, V49, P189, DOI 10.1007/s00484-004-0222-6; Rao PS, 1998, AGR FOREST METEOROL, V90, P235, DOI 10.1016/S0168-1923(98)00051-3; Roy CB, 2004, CURR SCI INDIA, V87, P807; Saha T, 2005, PLANT BREEDING, V124, P86, DOI 10.1111/j.1439-0523.2004.01053.x; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Souza LM, 2009, CONSERV GENET RESOUR, V1, P75, DOI 10.1007/s12686-009-9018-7; Thumma BR, 2010, TREE GENET GENOMES, V6, P877, DOI 10.1007/s11295-010-0298-6; Tong CF, 2011, BIOINFORMATICS, V27, P2006, DOI 10.1093/bioinformatics/btr306; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Truco MJ, 2007, THEOR APPL GENET, V115, P735, DOI 10.1007/s00122-007-0599-9; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Varghese YA, 1997, PLANT BREEDING, V116, P47, DOI 10.1111/j.1439-0523.1997.tb00973.x; Volker PW, 2008, TREE GENET GENOMES, V4, P445, DOI 10.1007/s11295-007-0122-0; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; Yan Z, 2005, THEOR APPL GENET, V110, P766, DOI 10.1007/s00122-004-1903-6; Yu F, 2011, PLANT CELL REP, V30, P335, DOI 10.1007/s00299-010-0908-7; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	57	42	44	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61238	10.1371/journal.pone.0061238	http://dx.doi.org/10.1371/journal.pone.0061238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620732	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500012
J	Liu, YJ; Lin, YF; Chen, YF; Luo, EC; Sher, YP; Tsai, MH; Chuang, EY; Lai, LC				Liu, Yi-Jyun; Lin, Yu-Fen; Chen, Yi-Fan; Luo, En-Ching; Sher, Yuh-Ping; Tsai, Mong-Hsun; Chuang, Eric Y.; Lai, Liang-Chuan			MicroRNA-449a Enhances Radiosensitivity in CL1-0 Lung Adenocarcinoma Cells	PLOS ONE			English	Article							HUMAN CANCER-CELLS; RADIATION-INDUCED APOPTOSIS; IONIZING-RADIATION; PROSTATE-CANCER; GROWTH ARREST; DNA-REPAIR; IN-VITRO; CYCLE; METASTASIS; TARGETS	Lung cancer is the leading cause of cancer-related mortality worldwide. Radiotherapy is often applied for treating lung cancer, but it often fails because of the relative non-susceptibility of lung cancer cells to radiation. MicroRNAs (miRNAs) have been reported to modulate the radiosensitivity of lung cancer cells and have the potential to improve the efficacy of radiotherapy. The purpose of this study was to identify a miRNA that can adjust radiosensitivity in lung adenocarcinoma cells. Two lung adenocarcinoma cell lines (CL1-0 and CL1-5) with different metastatic ability and radiosensitivity were used. In order to understand the regulatory mechanisms of differential radiosensitivity in these isogenic tumor cells, both CL1-0 and CL1-5 were treated with 10 Gy radiation, and were harvested respectively at 0, 1, 4, and 24 h after radiation exposure. The changes in expression of miRNA upon irradiation were examined using Illumina Human microRNA BeadChips. Twenty-six miRNAs were identified as having differential expression post-irradiation in CL1-0 or CL1-5 cells. Among these miRNAs, miR-449a, which was down-regulated in CL1-0 cells at 24 h after irradiation, was chosen for further investigation. Overexpression of miR-449a in CL1-0 cells effectively increased irradiation-induced DNA damage and apoptosis, altered the cell cycle distribution and eventually led to sensitization of CL1-0 to irradiation.	[Liu, Yi-Jyun; Luo, En-Ching; Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Lin, Yu-Fen; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Sher, Yuh-Ping] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan; [Chen, Yi-Fan; Chuang, Eric Y.] Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; China Medical University Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Lai, LC (corresponding author), Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan.	llai@ntu.edu.tw	Lin, Yu-Fen/A-2570-2016; Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; LUO, EN-CHING/0000-0001-7941-4924; TSAI, MONG-HSUN/0000-0001-8777-5818	National Science Council [NSC 100-2314-B-002-054]; National Taiwan University [101R70602C7]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This research was supported in part by grants from the National Science Council (Grant No. NSC 100-2314-B-002-054; http://web1.nsc.gov.tw/mp.aspx?mp=7) and National Taiwan University (Grant No. 101R70602C7; http://www.ntu.edu.tw/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arora H, 2011, EXP MOL MED, V43, P298, DOI 10.3858/emm.2011.43.5.031; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Balca-Silva J, 2012, ANTICANCER RES, V32, P1603; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chang YW, 2005, INT J CANCER, V116, P243, DOI 10.1002/ijc.21089; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chen SS, 2011, INT J RADIAT ONCOL, V81, P1524, DOI 10.1016/j.ijrobp.2011.05.031; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao M, 2008, BIOCHEM BIOPH RES CO, V376, P283, DOI 10.1016/j.bbrc.2008.08.144; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Han Y, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-183; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hunakova L, 2000, NEOPLASMA, V47, P25; Jeggo P, 2009, INT J RADIAT BIOL, V85, P1061, DOI 10.3109/09553000903261263; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeon HS, 2012, LUNG CANCER, V76, P171, DOI 10.1016/j.lungcan.2011.10.012; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee KM, 2011, RADIOTHER ONCOL, V101, P171, DOI 10.1016/j.radonc.2011.05.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; QUIET CA, 1991, INT J RADIAT ONCOL, V20, P733, DOI 10.1016/0360-3016(91)90016-W; ROFSTAD EK, 1992, CANCER RES, V52, P4453; Rowell NP, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002140.PUB2; Salem SD, 2012, GENE, V498, P300, DOI 10.1016/j.gene.2012.01.099; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; SUIT H, 1994, CANCER RES, V54, P1736; Tell R, 1998, BRIT J CANCER, V77, P643, DOI 10.1038/bjc.1998.103; THOMAS CP, 1995, CANCER LETT, V88, P221, DOI 10.1016/0304-3835(94)03624-R; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Yan D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011397; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhang B, 2012, MED ONCOL, V29, P340, DOI 10.1007/s12032-010-9559-3	55	32	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62383	10.1371/journal.pone.0062383	http://dx.doi.org/10.1371/journal.pone.0062383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614048	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200130
J	Rodriguez-Garcia, M; Biswas, N; Patel, MV; Barr, FD; Crist, SG; Ochsenbauer, C; Fahey, JV; Wira, CR				Rodriguez-Garcia, Marta; Biswas, Nabanita; Patel, Mickey V.; Barr, Fiona D.; Crist, Sarah G.; Ochsenbauer, Christina; Fahey, John V.; Wira, Charles R.			Estradiol Reduces Susceptibility of CD4(+) T Cells and Macrophages to HIV-Infection	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; ESTROGEN-RECEPTOR; PERIPHERAL-BLOOD; MENSTRUAL-CYCLE; MOLECULAR CLONES; GENITAL-TRACT; RNA LEVELS; WOMEN; REPLICATION; TRANSMISSION	The magnitude of the HIV epidemic in women requires urgent efforts to find effective preventive methods. Even though sex hormones have been described to influence HIV infection in epidemiological studies and regulate different immune responses that may affect HIV infection, the direct role that female sex hormones play in altering the susceptibility of target cells to HIV-infection is largely unknown. Here we evaluated the direct effect of 17-beta-estradiol (E-2) and ethinyl estradiol (EE) in HIV-infection of CD4(+) T-cells and macrophages. Purified CD4(+) T-cells and monocyte-derived macrophages were generated in vitro from peripheral blood and infected with R5 and X4 viruses. Treatment of CD4(+) T-cells and macrophages with E-2 prior to viral challenge reduced their susceptibility to HIV infection in a dose-dependent manner. Addition of E-2 2 h after viral challenge however did not result in reduced infection. In contrast, EE reduced infection in macrophages to a lesser extent than E-2 and had no effect on CD4(+) T-cell infection. Reduction of HIV-infection induced by E-2 in CD4(+) T-cells was not due to CCR5 down-regulation, but was an entry-mediated mechanism since infection with VSV-G pseudotyped HIV was not modified by E-2. In macrophages, despite the lack of an effect of E-2 on CCR5 expression, E-2-treatment reduced viral entry 2 h after challenge and increased MIP-1 beta secretion. These results demonstrate the direct effect of E-2 on susceptibility of HIV-target cells to infection and indicate that inhibition of target cell infection involves cell-entry related mechanisms.	[Rodriguez-Garcia, Marta; Biswas, Nabanita; Patel, Mickey V.; Barr, Fiona D.; Crist, Sarah G.; Fahey, John V.; Wira, Charles R.] Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH USA; [Ochsenbauer, Christina] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Dartmouth College; University of Alabama System; University of Alabama Birmingham	Rodriguez-Garcia, M (corresponding author), Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH USA.	Marta.Rodriguez.Garcia@dartmouth.edu			NIH [HHSN272201000001C, AI102838, AI071761, AI013541]; Advanced BioScience Laboratories, Inc.; UAB Center for AIDS Research Virology and Developmental Cores [P30-AI-27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013541, R55AI013541, R56AI071761, R01AI071761, R37AI013541, R01AI102838, P30AI027767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced BioScience Laboratories, Inc.; UAB Center for AIDS Research Virology and Developmental Cores; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH contract HHSN272201000001C, which was indirectly funded by Advanced BioScience Laboratories, Inc., and by NIH grants AI102838, AI071761 and AI013541 (CRW). CO was supported by the UAB Center for AIDS Research (P30-AI-27767) Virology and Developmental Cores. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Anderson JL, 2005, GENE THER, V12, P1667, DOI 10.1038/sj.gt.3302591; [Anonymous], PROGR REP 2011 GLOB; Asin SN, 2008, AIDS RES HUM RETROV, V24, P701, DOI 10.1089/aid.2007.0108; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Benki S, 2008, JAIDS-J ACQ IMM DEF, V47, P529, DOI 10.1097/QAI.0b013e318165b952; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; BOURINBAIAR AS, 1992, FEBS LETT, V302, P206, DOI 10.1016/0014-5793(92)80441-I; Bruce-Keller AJ, 2001, J NEUROCHEM, V78, P1315, DOI 10.1046/j.1471-4159.2001.00511.x; Clark RA, 1997, J ACQ IMMUN DEF SYND, V15, P341, DOI 10.1097/00042560-199708150-00003; Cobos-Jimenez V, 2011, CURR OPIN HIV AIDS, V6, P385, DOI 10.1097/COH.0b013e3283497203; Cu-Uvin S, 2005, JAIDS-J ACQ IMM DEF, V38, pS33, DOI 10.1097/01.qai.0000167039.58181.ee; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Escribese MM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-118; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Gilad J, 2003, EUR J OBSTET GYN R B, V109, P199, DOI 10.1016/S0301-2115(03)00048-4; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P1332, DOI 10.1210/jc.82.5.1332; Heffron R, 2011, 6 IAS C HIV PATH TRE; Heron PM, 2009, AIDS RES HUM RETROV, V25, P1071, DOI 10.1089/aid.2009.0065; Hickey DK, 2013, AM J REPROD IMMUNOL, V69, P159, DOI 10.1111/aji.12021; Hickey DK, 2011, J REPROD IMMUNOL; Katagiri D, 2006, INT IMMUNOPHARMACOL, V6, P170, DOI 10.1016/j.intimp.2005.07.017; KOLESNITCHENKO V, 1992, AIDS RES HUM RETROV, V8, P1977, DOI 10.1089/aid.1992.8.1977; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Lee YW, 2004, CARDIOVASC RES, V63, P139, DOI 10.1016/j.cardiores.2004.03.006; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Mostad SB, 1998, J INFECT DIS, V178, P983, DOI 10.1086/515665; Moulton VR, 2012, MOL MED, V18, P370, DOI 10.2119/molmed.2011.00506; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; NIAID, 2010, HIV INF WOM; Ochiel DO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014306; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Patel MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035654; Pierdominici M, 2010, IMMUNOL LETT, V132, P79, DOI 10.1016/j.imlet.2010.06.003; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; UNAIDS, 2010, WOM GIRLS GEND EQ HI; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; White HD, 1997, AM J REPROD IMMUNOL, V37, P30; White HD, 2001, J INFECT DIS, V183, P977, DOI 10.1086/319253; Wilson ME, 2006, AIDS RES HUM RETROV, V22, P350, DOI 10.1089/aid.2006.22.350; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633	52	57	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62069	10.1371/journal.pone.0062069	http://dx.doi.org/10.1371/journal.pone.0062069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614015	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200119
J	Struh, CM; Jager, S; Kersten, A; Schempp, CM; Scheffler, A; Martin, SF				Strueh, Christian M.; Jaeger, Sebastian; Kersten, Astrid; Schempp, Christoph M.; Scheffler, Armin; Martin, Stefan F.			Triterpenoids Amplify Anti-Tumoral Effects of Mistletoe Extracts on Murine B16.F10 Melanoma In Vivo	PLOS ONE			English	Article							VISCUM-ALBUM-L.; OLEANOLIC ACID; URSOLIC ACID; LECTIN-I; AVISCUMINE RVISCUMIN; METASTATIC MELANOMA; ANTICANCER ACTIVITY; PLANT-EXTRACTS; BETULINIC ACID; SOLID TUMORS	Purpose: Mistletoe extracts are often used in complementary cancer therapy although the efficacy of that therapy is controversially discussed. Approved mistletoe extracts contain mainly water soluble compounds of the mistletoe plant, i.e. mistletoe lectins. However, mistletoe also contains water-insoluble triterpenoids (mainly oleanolic acid) that have anti-tumorigenic effects. To overcome their loss in watery extracts we have solubilized mistletoe triterpenoids with cyclodextrins, thus making them available for in vivo cancer experiments. Experimental design: B16.F10 subcutaneous melanoma bearing C57BL/6 mice were treated with new mistletoe extracts containing both water soluble compounds and solubilized triterpenoids. Tumor growth and survival was monitored. In addition, histological examinations of the tumor material and tumor surrounding tissue were performed. Results: Addition of solubilized triterpenoids increased the anti-tumor effects of the mistletoe extracts, resulting in reduced tumor growth and prolonged survival of the mice. Histological examination of the treated tumors showed mainly tumor necrosis and some apoptotic cells with active caspase-3 and TUNEL staining. A significant decrease of CD31-positive tumor blood vessels was observed after treatment with solubilized triterpenoids and different mistletoe extracts. Conclusion: We conclude that the addition of solubilized mistletoe triterpenoids to conventional mistletoe extracts improves the efficacy of mistletoe treatment and may represent a novel treatment option for malignant melanoma.	[Strueh, Christian M.; Martin, Stefan F.] Univ Med Ctr Freiburg, Allergy Res Grp, Freiburg, Germany; [Schempp, Christoph M.] Univ Med Ctr Freiburg, Competence Ctr Skintegral, Dept Dermatol, Freiburg, Germany; [Strueh, Christian M.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kersten, Astrid] Dermatohistol Lab Dr Laaff, Freiburg, Germany; [Jaeger, Sebastian] Betulin Inst, Darmstadt, Germany; [Jaeger, Sebastian; Scheffler, Armin] Birken AG, Niefern Oschelbronn, Germany; [Strueh, Christian M.; Jaeger, Sebastian; Scheffler, Armin] Carl Gustav Carus Inst, Niefern Oschelbronn, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Struh, CM (corresponding author), Univ Med Ctr Freiburg, Allergy Res Grp, Freiburg, Germany.	christian.strueh@uniklinik-freiburg.de			Software AG-Stiftung, Darmstadt, Germany [471-P 4831]; Rudolf Steiner Fonds fur Wissenschaftliche Forschung, Nurnberg, Germany; Birken AG	Software AG-Stiftung, Darmstadt, Germany; Rudolf Steiner Fonds fur Wissenschaftliche Forschung, Nurnberg, Germany; Birken AG	This work was supported by a grant from the Software AG-Stiftung (http://www.software-ag-stiftung.com/), Darmstadt, Germany (ID 471-P 4831) and the Rudolf Steiner Fonds fur Wissenschaftliche Forschung, Nurnberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. Scheffler (CEO) and S. Jager are employees of Birken AG. C. M. Schempp has received funding from Birken AG and is a member of the Birken AG advisory board. S. F. Martin has received honoraria and research grants from Birken AG. C. M. Struh has received travel grants from Birken AG. A patent, EP 1852105 A3, has been filed by Birken AG. The patent affects commercial reproduction and use of triterpene containing plant extracts like viscumTT, while non-commercial use for research is not affected. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Augustin M, 2005, ARZNEIMITTELFORSCH, V55, P38; Augustine CK, 2010, MOL CANCER THER, V9, P2090, DOI 10.1158/1535-7163.MCT-10-0073; Beuth J, 1997, ANTI-CANCER DRUG, V8, pS53, DOI 10.1097/00001813-199704001-00012; Burger AM, 2001, ANTICANCER RES, V21, P1965; Bussing A, 1999, ANTICANCER RES, V19, P23; Delebinski CI, 2012, CELL PROLIFERATION; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Elluru SR, 2009, ANTICANCER RES, V29, P2945; FELES M, 1991, Patent No. 0288603; FIDLER IJ, 1975, CANCER RES, V35, P218; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Foote M, 2007, BIOTECHNOL ANN REV, V13, P345, DOI 10.1016/S1387-2656(07)13012-X; FRANZ H, 1986, ACTA HISTOCHEM, V78, P123, DOI 10.1016/S0065-1281(86)80043-5; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gardin NE, 2009, PHYTOTHER RES, V23, P407, DOI 10.1002/ptr.2643; Horneber MA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003297.pub2; Hsu HY, 1997, CANCER LETT, V111, P7, DOI 10.1016/S0304-3835(96)04481-3; Huber R, 2000, J ALTERN COMPLEM MED, V6, P305, DOI 10.1089/10755530050120664; Huber R, 2005, EUR J MED RES, V10, P411; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jager Sebastian, 2011, Sci Pharm, V79, P145, DOI 10.3797/scipharm.1006-06; JANSSEN O, 1993, ARZNEIMITTELFORSCH, V43-2, P1221; Jeong DW, 2007, BIOPHARM DRUG DISPOS, V28, P51, DOI 10.1002/bdd.530; Ji HY, 2009, ARCH PHARM RES, V32, P251, DOI 10.1007/s12272-009-1230-1; Juan ME, 2008, BRIT J NUTR, V100, P36, DOI 10.1017/S0007114508882979; Kanjoormana M, 2010, INTEGR CANCER THER, V9, P224, DOI 10.1177/1534735410367647; Kienle GS, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-79; Kleeberg UR, 2004, EUR J CANCER, V40, P390, DOI 10.1016/j.ejca.2003.07.004; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Legnani W, 2008, INTEGR CANCER THER, V7, P162, DOI 10.1177/1534735408319894; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Muthing J, 2004, FASEB J, V18, P103, DOI 10.1096/fj.04-2494fje; Nabrotzki M, 2001, MISTEL TUMORTHERAPIE, P413; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Place AE, 2003, CLIN CANCER RES, V9, P2798; Rostock M, 2005, ANTICANCER RES, V25, P1969; Saleem M, 2008, CLIN CANCER RES, V14, P2119, DOI 10.1158/1078-0432.CCR-07-4413; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Schoffski P, 2005, EUR J CANCER, V41, P1431, DOI 10.1016/j.ejca.2005.03.019; Schoffski P, 2004, ANN ONCOL, V15, P1816, DOI 10.1093/annonc/mdh469; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; SHON KH, 1995, CANCER LETT, V94, P213, DOI 10.1016/0304-3835(95)03856-R; Stein G.E., 2000, MISTLETOE GENUS VISC, P183; Struh C. M., 2012, PHYTOTHERAPY RES; Terheyden P, 2007, J CANCER RES CLIN, V133, P437, DOI 10.1007/s00432-006-0182-9; Thies A, 2008, BRIT J CANCER, V98, P106, DOI 10.1038/sj.bjc.6604106; Thies A, 2005, TOXICOLOGY, V207, P105, DOI 10.1016/j.tox.2004.09.009; Wack C, 2002, CANCER IMMUNOL IMMUN, V51, P431, DOI 10.1007/s00262-002-0292-4; Wack C, 2001, MELANOMA RES, V11, P247, DOI 10.1097/00008390-200106000-00006	54	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62168	10.1371/journal.pone.0062168	http://dx.doi.org/10.1371/journal.pone.0062168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614029	gold, Green Published, Green Submitted			2022-12-25	WOS:000317907200123
J	Evani, SJ; Prabhu, RG; Gnanaruban, V; Finol, EA; Ramasubramanian, AK				Evani, Shankar J.; Prabhu, Rajesh G.; Gnanaruban, V.; Finol, Ender A.; Ramasubramanian, Anand K.			Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow	FASEB JOURNAL			English	Article						MDA-MB-231; shear; aggregation	CANCER-CELLS; MELANOMA ADHESION; TNF-ALPHA; CARCINOMA; PROGRESSION; INFLAMMATION; MACROPHAGES; EXTRAVASATION; MIGRATION; INVASION	Endothelial adhesion is necessary for the hematogenous dissemination of tumor cells. However, the metastatic breast tumor cell MDA-MB-231 does not bind to the endothelium under physiological flow conditions, suggesting alternate mechanisms of adhesion. Since monocytes are highly represented in the tumor microenvironment, and also bind to endothelium during inflammation, we hypothesized that the monocytes assist in the arrest of MDA-MB-231 on the endothelium. Using in vitro models of the dynamic shear environment of the vasculature, we show that TNF--activated THP1/primary human monocytes and MDA-MB-231 cells form stable aggregates, and that the monocytes in these aggregates mediate the adhesion of otherwise nonadherent MDA-MB-231 cells to inflamed endothelium under flow (55 +/- 2.4 vs. 1.7 +/- 0.82 at a shear stress of 0.5 dyn/cm(2), P<0.01). We also show that the hydrodynamic forces determine the size and orientation of aggregates adhered to the endothelium, and strongly favor the attachment of small aggregates with tumor cells downstream of flow (74-86% doublets at 0.5-2 dyn/cm(2), P<0.01). The 5-fold up-regulation of ICAM-1 on TNF--activated MDA-MB-231 cells through the Nf-B pathway was found to be critical in MDA-MB-231-monocyte aggregation and endothelial adhesion. Our results demonstrate that, under inflammatory conditions, monocytes may serve to disseminate tumor cells through circulation, and the tumor-monocyte-endothelial axis may represent a new therapeutic target to reduce cancer metastasis.	[Evani, Shankar J.; Prabhu, Rajesh G.; Gnanaruban, V.; Finol, Ender A.; Ramasubramanian, Anand K.] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX 78249 USA; [Ramasubramanian, Anand K.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Ramasubramanian, AK (corresponding author), Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX 78249 USA.	anand.ramasubramanian@utsa.edu	Finol, Ender/C-4585-2016; evani, shankar jaikishan/Z-3198-2019	Finol, Ender/0000-0002-0811-9482; 	Breast Cancer Research Program, U.S. Department of Defense [W81XWH-10-1-0754]; U.S. National Institutes of Health [HL112629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL112629] Funding Source: NIH RePORTER	Breast Cancer Research Program, U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the Breast Cancer Research Program, U.S. Department of Defense (W81XWH-10-1-0754), and partially by a grant from the U.S. National Institutes of Health (HL112629).	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bailey C, 2007, CLIN EXP METASTAS, V24, P121, DOI 10.1007/s10585-007-9060-3; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Blot E, 2003, BRIT J CANCER, V88, P1207, DOI 10.1038/sj.bjc.6600872; Brown ER, 2008, ANN ONCOL, V19, P1340, DOI 10.1093/annonc/mdn054; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Geng Y, 2010, CELL MOL BIOENG, V3, P361, DOI 10.1007/s12195-010-0145-8; Gramling MW, 2010, EXP CELL RES, V316, P314, DOI 10.1016/j.yexcr.2009.10.024; Haidari M, 2012, J BIOL CHEM, V287, P32981, DOI 10.1074/jbc.M112.395905; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Jadhav S, 2001, J IMMUNOL, V167, P5986, DOI 10.4049/jimmunol.167.10.5986; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Kumar RA, 2003, BIOPHYS J, V85, P4099, DOI 10.1016/S0006-3495(03)74822-X; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Leek RD, 1996, CANCER RES, V56, P4625; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Narasimhan M, 2008, CANCER RES, V68, P5185, DOI 10.1158/0008-5472.CAN-07-6883; Peng HH, 2007, EXP CELL RES, V313, P551, DOI 10.1016/j.yexcr.2006.10.030; Peyri N, 2009, ANTICANCER RES, V29, P2347; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; SheenChen SM, 1997, BREAST CANCER RES TR, V43, P211, DOI 10.1023/A:1005736712307; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494; Zhang XH, 2004, BIOPHYS J, V87, P3470, DOI 10.1529/biophysj.104.045690	47	72	76	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3017	3029		10.1096/fj.12-224824	http://dx.doi.org/10.1096/fj.12-224824			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23616566	Green Published			2022-12-25	WOS:000329877600010
J	Krishnamoorthy, GP; Guida, T; Alfano, L; Avilla, E; Santoro, M; Carlomagno, F; Melillo, RM				Krishnamoorthy, Gnana Prakasam; Guida, Teresa; Alfano, Luigi; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina			Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; MYELOID-LEUKEMIA CELLS; THERAPEUTIC TARGET; CHAPERONE COMPLEX; TRANSFORMING GENE; LUNG-CANCER; ATP BINDING; E3 LIGASE; IN-VIVO; PHASE-I	The receptor tyrosine kinase AXL is overexpressed in many cancer types including thyroid carcinomas and has well established roles in tumor formation and progression. Proper folding, maturation, and activity of several oncogenic receptor tyrosine kinases require HSP90 chaperoning. HSP90 inhibition by the antibiotic geldanamycin or its derivative 17-allylamino-17-demethoxygeldanamycin (17-AAG) causes destabilization of its client proteins. Here we show that AXL is a novel client protein of HSP90. 17-AAG induced a time- and dose-dependent down-regulation of endogenous or ectopically expressed AXL protein, thereby inhibiting AXL-mediated signaling and biological activity. 17-AAG-induced AXL down-regulation specifically affected fully glycosylated mature receptor present on cell membrane. By using biotin and [S-35] methionine labeling, we showed that 17-AAG caused depletion of membrane-localized AXL by mediating its degradation in the intracellular compartment, thus restricting its exposure on the cell surface. 17-AAG induced AXL polyubiquitination and subsequent proteasomal degradation; under basal conditions, AXL co-immunoprecipitated with HSP90. Upon 17-AAG treatment, AXL associated with the cochaperone HSP70 and the ubiquitin E3 ligase carboxyl terminus	[Krishnamoorthy, Gnana Prakasam; Guida, Teresa; Alfano, Luigi; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina] Consiglio Nazl Ric G Salvatore, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Carlomagno, F (corresponding author), Ist Endocrinol & Oncol Sperimentale, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	francesca.carlomagno@unina.it; rosmelil@unina.it	melillo, rosa marina/O-5255-2015; Alfano, Luigi/B-8330-2015; Krishnamoorthy, Gnana P./J-8660-2019	Alfano, Luigi/0000-0002-4516-9956; MELILLO, Rosa Marina/0000-0002-9233-5275	Associazione Italiana per la Ricerca sul Cancro; Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro) of the Health Ministry, Italian Ministero della Salute Grant [PIO-2]; Istituto Superiore di Oncologia, Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" of the Health Ministry, Italian Ministero della Salute Grant [PIO-2, RF-CAM-353005]; Ministero dell'Universita e della Ricerca [E61J11000300001, E61J10000210001]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro) of the Health Ministry, Italian Ministero della Salute Grant; Istituto Superiore di Oncologia, Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" of the Health Ministry, Italian Ministero della Salute Grant; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Associazione Italiana per la Ricerca sul Cancro, the Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro), Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" RF-CAM-353005 of the Health Ministry, Italian Ministero della Salute Grant PIO-2, and Ministero dell'Universita e della Ricerca Grants E61J11000300001 and E61J10000210001.	Alfano L, 2010, J CLIN ENDOCR METAB, V95, P3552, DOI 10.1210/jc.2009-2315; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Amann J, 2005, CANCER RES, V65, P226; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; Carlomagno F, 1996, EMBO J, V15, P2717, DOI 10.1002/j.1460-2075.1996.tb00632.x; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Farina AR, 2009, ONCOGENE, V28, P4075, DOI 10.1038/onc.2009.256; Fumo G, 2004, BLOOD, V103, P1078, DOI 10.1182/blood-2003-07-2477; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ghosh AK, 2011, BLOOD, V117, P1928, DOI 10.1182/blood-2010-09-305649; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Hubbard J, 2011, INVEST NEW DRUG, V29, P473, DOI 10.1007/s10637-009-9381-y; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Ramalingam SS, 2008, CLIN CANCER RES, V14, P3456, DOI 10.1158/1078-0432.CCR-07-5088; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tikhomirov O, 2003, CANCER RES, V63, P39; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	51	36	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17481	17494		10.1074/jbc.M112.439422	http://dx.doi.org/10.1074/jbc.M112.439422			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629654	hybrid, Green Published			2022-12-25	WOS:000320380600040
J	Feng, L; Sharma, A; Slaughter, A; Jena, N; Koh, Y; Shkriabai, N; Larue, RC; Patel, PA; Mitsuya, H; Kessl, JJ; Engelman, A; Fuchs, JR; Kvaratskhelia, M				Feng, Lei; Sharma, Amit; Slaughter, Alison; Jena, Nivedita; Koh, Yasuhiro; Shkriabai, Nikolozi; Larue, Ross C.; Patel, Pratiq A.; Mitsuya, Hiroaki; Kessl, Jacques J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka			The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; DNA INTEGRATION; LEDGF/P75; DOMAIN; SITE	Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a very promising new class of anti-HIV-1 agents that exhibit a multimodal mechanism of action by allosterically modulating IN multimerization and interfering with IN-lens epithelium-derived growth factor (LEDGF)/p75 binding. Selection of viral strains under ALLINI pressure has revealed an A128T substitution in HIV-1 IN as a primary mechanism of resistance. Here, we elucidated the structural and mechanistic basis for this resistance. The A128T substitution did not affect the hydrogen bonding between ALLINI and IN that mimics the IN-LEDGF/p75 interaction but instead altered the positioning of the inhibitor at the IN dimer interface. Consequently, the A128T substitution had only a minor effect on the ALLINI IC50 values for IN-LEDGF/p75 binding. Instead, ALLINIs markedly altered the multimerization of IN by promoting aberrant higher order WT (but not A128T) IN oligomers. Accordingly, WT IN catalytic activities and HIV-1 replication were potently inhibited by ALLINIs, whereas the A128T substitution in IN resulted in significant resistance to the inhibitors both in vitro and in cell culture assays. The differential multimerization of WT and A128T INs induced by ALLINIs correlated with the differences in infectivity of HIV-1 progeny virions. We conclude that ALLINIs primarily target IN multimerization rather than IN-LEDGF/p75 binding. Our findings provide the structural foundations for developing improved ALLINIs with increased potency and decreased potential to select for drug resistance.	[Feng, Lei; Sharma, Amit; Slaughter, Alison; Shkriabai, Nikolozi; Larue, Ross C.; Kessl, Jacques J.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Feng, Lei; Sharma, Amit; Slaughter, Alison; Shkriabai, Nikolozi; Larue, Ross C.; Kessl, Jacques J.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jena, Nivedita; Patel, Pratiq A.; Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Koh, Yasuhiro; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan; [Koh, Yasuhiro; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 8608556, Japan; [Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Kumamoto University; Kumamoto University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, 500 West 12th Ave, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/AAV-2526-2021; Kessl, Jacques/J-6073-2015	Fuchs, James/0000-0002-8743-6389; Larue, Ross/0000-0002-0170-7345	National Institutes of Health [AI081581, AI062520, GM103368, AI097044]; NATIONAL CANCER INSTITUTE [ZIASC006738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520, R21AI097044, R01AI081581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081581 and AI062520 (to M. K.), GM103368 (to A. E. and M. K.), AI097044 (to J.J.K. and J.R.F.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown P. O., 1997, P161; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FENWICK C, 2011, INT WORKSH HIV HEP V; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Johnson AA, 2004, CURR TOP MED CHEM, V4, P1059, DOI 10.2174/1568026043388394; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pesant M, 2007, International Patent, Patent No. [PCT/CA2007/000845, 2007000845]; Raghavendra NK, 2007, VIROLOGY, V360, P1, DOI 10.1016/j.virol.2006.12.022; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2009, TRENDS PHARMACOL SCI, V30, P610, DOI 10.1016/j.tips.2009.09.003; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534	27	72	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15813	15820		10.1074/jbc.M112.443390	http://dx.doi.org/10.1074/jbc.M112.443390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23615903	Green Published, hybrid			2022-12-25	WOS:000319822300035
J	Bobowski, M; Vincent, A; Steenackers, A; Colomb, F; Van Seuningen, I; Julien, S; Delannoy, P				Bobowski, Marie; Vincent, Audrey; Steenackers, Agata; Colomb, Florent; Van Seuningen, Isabelle; Julien, Sylvain; Delannoy, Philippe			Estradiol Represses the G(D3) Synthase Gene ST8SIA1 Expression in Human Breast Cancer Cells by Preventing NF kappa B Binding to ST8SIA1 Promoter	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GD3 SYNTHASE; ENHANCES PROLIFERATION; FUNCTIONAL-ANALYSIS; ANTI-GD2 ANTIBODY; MESSENGER-RNA; C-MET; GANGLIOSIDE; ACTIVATION; MELANOMA	Recent data have underlined a possible role of G(D3) synthase (GD3S) and complex gangliosides in Estrogen Receptor (ER) negative breast cancer progression. Here, we describe the main transcript of the GD3S coding gene ST8SIA1 expressed in breast tumors. We characterized the corresponding core promoter in Hs578T breast cancer cells and showed that estradiol decreases ST8SIA1 mRNA expression in ER-positive MCF-7 cells and ER alpha-transfected ER-negative Hs578T cells. The activity of the core promoter sequence of ST8SIA1 is also repressed by estradiol. The core promoter of ST8SIA1 contains two putative Estrogen Response Elements (ERE) that were not found to be involved in the promoter activity pathway. However, NF kappa B was shown to be involved in ST8SIA1 transcriptional activation and we demonstrated that estradiol prevents NF kappa B to bind to ST8SIA1 core promoter in ER alpha expressing breast cancer cells by inhibiting p65 and p50 nucleus localization. The activation of NF kappa B pathway in ER-negative tumors, due to the absence of estradiol signaling, might explain the overexpression of G(D3) synthase in this tumor subtype.	[Bobowski, Marie; Vincent, Audrey; Steenackers, Agata; Colomb, Florent; Van Seuningen, Isabelle; Julien, Sylvain; Delannoy, Philippe] Univ Lille Nord France, Lille, France; [Bobowski, Marie; Steenackers, Agata; Colomb, Florent; Julien, Sylvain; Delannoy, Philippe] USTL, UGSF, Villeneuve Dascq, France; [Bobowski, Marie; Steenackers, Agata; Colomb, Florent; Julien, Sylvain; Delannoy, Philippe] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; [Vincent, Audrey; Van Seuningen, Isabelle] INSERM, Jean Pierre Aubert Res Ctr, F-59045 Lille, France; [Vincent, Audrey; Van Seuningen, Isabelle] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Delannoy, P (corresponding author), Univ Lille Nord France, Lille, France.	philippe.delannoy@univ-lille1.fr	Vincent, Audrey/I-2934-2016; VAN SEUNINGEN, Isabelle/N-6176-2016	Vincent, Audrey/0000-0003-0058-2058; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Delannoy, Philippe/0000-0001-6467-7553; Bobowski-Gerard, Marie/0000-0002-0915-0799	Canon Foundation fellowship; University of Sciences and Technologies of Lille; CNRS; Association pour la Recherche sur le Cancer [7936, 5023]; le comite de l'Aisne de La Ligue contre le Cancer	Canon Foundation fellowship; University of Sciences and Technologies of Lille; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); le comite de l'Aisne de La Ligue contre le Cancer	M.B. was recipient of a Canon Foundation fellowship. We also thank the Guy's and St Thomas' NHS foundation Trust for providing breast tumor tissues.; This work was supported by the University of Sciences and Technologies of Lille, the CNRS, the Association pour la Recherche sur le Cancer (Grant no 7936 and 5023), le comite de l'Aisne de La Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Caldon C, 2008, ONCOGENE, V27, P126, DOI 10.1038/sj.onc.1210622; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Cazet A, 2010, MOL CANCER RES, V8, P1526, DOI 10.1158/1541-7786.MCR-10-0302; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; Chapman PB, 2004, CLIN CANCER RES, V10, P4717, DOI 10.1158/1078-0432.CCR-04-0345; Dae HM, 2009, ACTA BIOCH BIOPH SIN, V41, P237, DOI 10.1093/abbs/gmp007; Fougere M, 2010, ONCOGENE, V29, P2292, DOI 10.1038/onc.2009.499; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Furukawa K, 2003, BBA-GENE STRUCT EXPR, V1627, P71, DOI 10.1016/S0167-4781(03)00076-9; Furukawa K, 2006, ANN NY ACAD SCI, V1086, P185, DOI 10.1196/annals.1377.017; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Han YQ, 2008, MOL CANCER RES, V6, P1347, DOI 10.1158/1541-7786.MCR-07-2179; Hatano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031234; Hsu SM, 2000, BIOCHEM BIOPH RES CO, V279, P47, DOI 10.1006/bbrc.2000.3891; Jonckheere N, 2011, FEBS J, V278, P282, DOI 10.1111/j.1742-4658.2010.07945.x; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kang NY, 2007, BBA-GENE STRUCT EXPR, V1769, P622, DOI 10.1016/j.bbaexp.2007.08.001; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Kwon HY, 2009, MOL CELLS, V27, P113, DOI 10.1007/s10059-009-0012-4; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Marquina G, 1996, CANCER RES, V56, P5165; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Nakayama J, 1996, J BIOL CHEM, V271, P3684; Nara K, 1996, EUR J BIOCHEM, V238, P647, DOI 10.1111/j.1432-1033.1996.0647w.x; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Oblinger JL, 2006, NEUROPATH APPL NEURO, V32, P410, DOI 10.1111/j.1365-2990.2006.00742.x; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; Peyrat Jean-Philippe, 2000, Molecular Cell Biology Research Communications, V3, P48, DOI 10.1006/mcbr.2000.0185; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Ray S, 2012, P NATL ACAD SCI USA, V109, pE1334, DOI 10.1073/pnas.1118515109; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P1005, DOI 10.1007/s00432-008-0536-6; SAITO M, 1985, BIOCHEM BIOPH RES CO, V127, P1, DOI 10.1016/S0006-291X(85)80117-0; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; Tafani M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00013; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Welboren WJ, 2007, MOL ONCOL, V1, P138, DOI 10.1016/j.molonc.2007.04.001; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	54	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62559	10.1371/journal.pone.0062559	http://dx.doi.org/10.1371/journal.pone.0062559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626833	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400197
J	Chen, FQ; Zheng, HW; Schacht, J; Sha, SH				Chen, Fu-Quan; Zheng, Hong-Wei; Schacht, Jochen; Sha, Su-Hua			Mitochondrial Peroxiredoxin 3 Regulates Sensory Cell Survival in the Cochlea	PLOS ONE			English	Article							OXIDATIVE STRESS; HEARING-LOSS; AMINOGLYCOSIDE OTOTOXICITY; IRON CHELATORS; DEATH; MICE; REDUCTION; FAMILY; DAMAGE	This study delineates the role of peroxiredoxin 3 (Prx3) in hair cell death induced by several etiologies of acquired hearing loss (noise trauma, aminoglycoside treatment, age). In vivo, Prx3 transiently increased in mouse cochlear hair cells after traumatic noise exposure, kanamycin treatment, or with progressing age before any cell loss occurred; when Prx3 declined, hair cell loss began. Maintenance of high Prx3 levels via treatment with the radical scavenger 2,3-dihydroxybenzoate prevented kanamycin-induced hair cell death. Conversely, reducing Prx3 levels with Prx3 siRNA increased the severity of noise-induced trauma. In mouse organ of Corti explants, reactive oxygen species and levels of Prx3 mRNA and protein increased concomitantly at early times of drug challenge. When Prx3 levels declined after prolonged treatment, hair cells began to die. The radical scavenger p-phenylenediamine maintained Prx3 levels and attenuated gentamicin-induced hair cell death. Our results suggest that Prx3 is up-regulated in response to oxidative stress and that maintenance of Prx3 levels in hair cells is a critical factor in their susceptibility to acquired hearing loss.	[Chen, Fu-Quan; Zheng, Hong-Wei; Sha, Su-Hua] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Schacht, Jochen] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol, Ann Arbor, MI 48109 USA	Medical University of South Carolina; University of Michigan System; University of Michigan	Sha, SH (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	shasu@musc.edu	Chen, Fuquan/AAL-2322-2021	Chen, Fuquan/0000-0002-4625-073X	National Institute on Deafness and Other Communication Disorders [DC009222, DC003685]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003685, R01DC009222] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research project described was supported by grants DC009222 (to SHS) and DC003685 (to JS) from the National Institute on Deafness and Other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen FQ, 2012, J NEUROSCI, V32, P12421, DOI 10.1523/JNEUROSCI.6381-11.2012; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; Choung YH, 2009, NEUROSCIENCE, V161, P214, DOI 10.1016/j.neuroscience.2009.02.085; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Francis SP, 2013, J NEUROSCI, V33, P3079, DOI 10.1523/JNEUROSCI.3430-12.2013; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; Kopke RD, 2000, HEARING RES, V149, P138, DOI 10.1016/S0378-5955(00)00176-3; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masaki M, 2003, EUR J BIOCHEM, V270, P76, DOI 10.1046/j.1432-1033.2003.03363.x; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Matt T, 2012, P NATL ACAD SCI USA, V109, P10984, DOI 10.1073/pnas.1204073109; Menardo J, 2012, ANTIOXID REDOX SIGN, V16, P263, DOI 10.1089/ars.2011.4037; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Oishi N, 2012, HEAR RES; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Sha SH, 2009, HEARING RES, V254, P92, DOI 10.1016/j.heares.2009.04.019; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Song BB, 1998, FREE RADICAL BIO MED, V25, P189, DOI 10.1016/S0891-5849(98)00037-9; Song BB, 1997, J PHARMACOL EXP THER, V282, P369; Vicente-Torres MA, 2006, J NEUROSCI RES, V83, P1564, DOI 10.1002/jnr.20832; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wu WJ, 2001, HEARING RES, V158, P165, DOI 10.1016/S0378-5955(01)00303-3; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104	38	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61999	10.1371/journal.pone.0061999	http://dx.doi.org/10.1371/journal.pone.0061999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626763	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400127
J	Johnston, HR; Cutler, DJ				Johnston, Henry R.; Cutler, David J.			A Comprehensive Search for Recombinogenic Motifs in the Human Genome	PLOS ONE			English	Article							RECOMBINATION HOTSPOTS; MEIOTIC RECOMBINATION; PRDM9; INSTABILITY; SPOT; MAP	The patterns of male and female recombination vary greatly on a macro scale. A unique motif in each gender, triggering a double strand break at its location, much in the way Chi sites operate in E. coli, could logically explain this difference. As such, we have undertaken a comprehensive search of all small motifs in an attempt to identify one or more that match to the available data. In the end, we conclude that no such motifs appear to exist in the human genome.	[Johnston, Henry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Cutler, David J.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA	Johns Hopkins University; Emory University	Cutler, DJ (corresponding author), Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA.	dcutler@genetics.emory.edu			NIH (National Institutes of Health) [5R01HG003461-05]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003461] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from the NIH (National Institutes of Health) to D Cutler (5R01HG003461-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auton A, 2012, SCIENCE; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Johnston HR, 2012, AM J HUM GENET, V90, P774, DOI 10.1016/j.ajhg.2012.03.011; Kendall M. G., 1987, KENDALLS ADV THEORY; Kong A, 2002, NATURE GENETICS; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; McVean G, 2010, NAT GENET, V42, P821, DOI 10.1038/ng1010-821; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Stahl FW, 2005, GENETICS, V170, P487	16	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62920	10.1371/journal.pone.0062920	http://dx.doi.org/10.1371/journal.pone.0062920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626862	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400226
J	Sanada, Y; Kumoto, T; Suehiro, H; Nishimura, F; Kato, N; Hata, Y; Sorisky, A; Yanaka, N				Sanada, Yohei; Kumoto, Takahiro; Suehiro, Haruna; Nishimura, Fusanori; Kato, Norihisa; Hata, Yutaka; Sorisky, Alexander; Yanaka, Noriyuki			RASSF6 Expression in Adipocytes Is Down-Regulated by Interaction with Macrophages	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN SENSITIVITY; INFLAMMATION; VITAMIN-B-6; CELLS; ACCUMULATION; ASSOCIATION; RECRUITMENT; MICROARRAY; DEFICIENT	Macrophage infiltration into adipose tissue is associated with obesity and the crosstalk between adipocytes and infiltrated macrophages has been investigated as an important pathological phenomenon during adipose tissue inflammation. Here, we sought to identify adipocyte mRNAs that are regulated by interaction with infiltrated macrophages in vivo. An anti-inflammatory vitamin, vitamin B6, suppressed macrophage infiltration into white adipose tissue and altered mRNA expression. We identified > 3500 genes whose expression is significantly altered during the development of obesity in db/db mice, and compared them to the adipose tissue mRNA expression profile of mice supplemented with vitamin B6. We identified PTX3 and MMP3 as candidate genes regulated by macrophage infiltration. PTX3 and MMP3 mRNA expression in 3T3-L1 adipocytes was up-regulated by activated RAW264.7 cells and these mRNA levels were positively correlated with macrophage number in adipose tissue in vivo. Next, we screened adipose genes down-regulated by the interaction with macrophages, and isolated RASSF6 (Ras association domain family 6). RASSF6 mRNA in adipocytes was decreased by culture medium conditioned by activated RAW264.7 cells, and RASSF6 mRNA level was negatively correlated with macrophage number in adipose tissue, suggesting that adipocyte RASSF6 mRNA expression is down-regulated by infiltrated macrophages in vivo. Finally, this study also showed that decreased RASSF6 expression up-regulates mRNA expression of several genes, such as CD44 and high mobility group protein HMGA2. These data provide novel insights into the biological significance of interactions between adipocytes and macrophages in adipose tissue during the development of obesity.	[Sanada, Yohei; Kumoto, Takahiro; Suehiro, Haruna; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashihiroshima 724, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Tokyo, Japan; [Sorisky, Alexander] Univ Ottawa, Ottawa Hosp, Res Inst, Chron Dis Program,Dept Med, Ottawa, ON, Canada; [Sorisky, Alexander] Univ Ottawa, Ottawa Hosp, Res Inst, Chron Dis Program,Dept Biochem Microbiol & Immuno, Ottawa, ON, Canada	Hiroshima University; Hiroshima University; Tokyo Medical & Dental University (TMDU); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Yanaka, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashihiroshima 724, Japan.	yanaka@hiroshima-u.ac.jp	Yanaka, Noriyuki/P-9096-2016		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and NA 6634 from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; ASHAR HR, 1995, CELL, V82, P57; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Chiang EP, 2005, ARTHRITIS RES THER, V7, pR1254, DOI 10.1186/ar1821; Chiang EPI, 2003, J NUTR, V133, P1056, DOI 10.1093/jn/133.4.1056; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jones GT, 2009, ATHEROSCLEROSIS, V207, P603, DOI 10.1016/j.atherosclerosis.2009.05.036; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Lotto V, 2011, BR J NUTR, V13, P1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Markowski DN, 2011, CYTOKINE, V56, P811, DOI 10.1016/j.cyto.2011.09.025; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Molgat ASD, 2011, EXP CELL RES, V317, P521, DOI 10.1016/j.yexcr.2010.10.024; Molgat ASD, 2009, AM J PHYSIOL-CELL PH, V296, pC757, DOI 10.1152/ajpcell.00617.2008; MOON WHY, 1973, J NUTR, V103, P123, DOI 10.1093/jn/103.1.123; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Moshfegh AJ, 2005, NHANES 2001 2002 US; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Saibeni S, 2003, AM J GASTROENTEROL, V98, P112, DOI 10.1111/j.1572-0241.2003.07160.x; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shen J, 2010, AM J CLIN NUTR, V91, P337, DOI 10.3945/ajcn.2009.28571; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SMOLIN LA, 1983, J NUTR, V113, P2022, DOI 10.1093/jn/113.10.2022; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; TRAKATELLIS AC, 1965, BIOCHEM J, V95, P344, DOI 10.1042/bj0950344; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu TC, 2005, EUR J CLIN INVEST, V35, P537, DOI 10.1111/j.1365-2362.2005.01548.x; Yamashita A, 2008, INT J OBESITY, V32, P1725, DOI 10.1038/ijo.2008.153; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305; Yanaka N, 2011, MOL NUTR FOOD RES, V55, P635, DOI 10.1002/mnfr.201000282; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	44	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61931	10.1371/journal.pone.0061931	http://dx.doi.org/10.1371/journal.pone.0061931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626755	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400119
J	He, XL; Zhou, AF; Lu, H; Chen, Y; Huang, GC; Yue, X; Zhao, PW; Wu, YX				He, Xuelian; Zhou, Aifen; Lu, Hao; Chen, Yong; Huang, Guochang; Yue, Xin; Zhao, Peiwei; Wu, Yanxiang			Suppression of Mitochondrial Complex I Influences Cell Metastatic Properties	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BREAST-CANCER; TUMOR PROGRESSION; INTERFERON-BETA; GRIM-19; DEATH; ROS; IDENTIFICATION; FIBRONECTIN; DEFICIENCY	Despite the fact that mitochondrial dysfunction has an important role in tumorigenesis and metastasis, the underlying mechanism remains to be elucidated. Mitochondrial Complex I (NADH: ubiquinone oxidoreductase) is the first and the largest protein complex of the mitochondrial electron-transport chain (ETC), which has an essential role in maintaining mitochondrial function and integrity. In this study, we separately knocked down two subunits of mitochondrial complex I, GRIM-19 or NDUFS3, and investigated their effects on metastatic behaviors and explored the possible mechanisms. Our data showed that stable down-modulation of GRIM-19 or NDUFS3 decreased complex I activity and reactive oxygen species (ROS) production; led to enhanced cell adhesion, migration, invasion, and spheroid formation; and influenced the expressions of extracellular matrix (ECM) molecules and its related proteins. We also observed that the expressions of GRIM-19, NDUFS3, and ECM elements were correlated with invasive capabilities of breast cancer cell lines. These results suggest that inhibition of complex I affects metastatic properties of cancer cells, and mitochondrial ROS might play a crucial role in these processes by regulating ECM.	[Zhou, Aifen] Wuhan Med & Healthcare Ctr Women & Children, Dept Healthcare, Wuhan, Hubei, Peoples R China; [He, Xuelian; Lu, Hao; Chen, Yong; Huang, Guochang] ASTAR, Inst Mol & Cell Biol, Biopolis, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)		hxljm07@hotmail.com; yxwu2009@yahoo.com			Agency for Science, Technology and Research of Singapore; Ministry of Human Resource of China	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Human Resource of China	This work was supported by the Agency for Science, Technology and Research of Singapore and the supporting program of the Ministry of Human Resource of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He XL, 2010, J HUM GENET, V55, P507, DOI 10.1038/jhg.2010.57; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kaspar M, 2006, INT J CANCER, V118, P1331, DOI 10.1002/IJC.21677; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Putignani L, 2008, BREAST CANCER RES TR, V110, P439, DOI 10.1007/s10549-007-9738-x; Putignani L, 2012, MITOCHONDRION, V12, P363, DOI 10.1016/j.mito.2012.02.003; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	23	46	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61677	10.1371/journal.pone.0061677	http://dx.doi.org/10.1371/journal.pone.0061677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630608	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500059
J	Li, T; Pan, YW; Wang, WB; Abel, G; Zou, JH; Xu, LH; Storm, DR; Xia, ZG				Li, Tan; Pan, Yung-Wei; Wang, Wenbin; Abel, Glen; Zou, Junhui; Xu, Lihong; Storm, Daniel R.; Xia, Zhengui			Targeted Deletion of the ERK5 MAP Kinase Impairs Neuronal Differentiation, Migration, and Survival during Adult Neurogenesis in the Olfactory Bulb	PLOS ONE			English	Article							NEURAL STEM-CELLS; ACTIVATED PROTEIN-KINASE; NEWLY GENERATED NEURONS; SUBVENTRICULAR ZONE; POSTNATAL NEUROGENESIS; NEUROBLAST MIGRATION; CYCLE PROGRESSION; NERVOUS-SYSTEM; DISTINCT ROLES; SONIC HEDGEHOG	Recent studies have led to the exciting idea that adult-born neurons in the olfactory bulb (OB) may be critical for complex forms of olfactory behavior in mice. However, signaling mechanisms regulating adult OB neurogenesis are not well defined. We recently reported that extracellular signal-regulated kinase (ERK) 5, a MAP kinase, is specifically expressed in neurogenic regions within the adult brain. This pattern of expression suggests a role for ERK5 in the regulation of adult OB neurogenesis. Indeed, we previously reported that conditional deletion of erk5 in adult neurogenic regions impairs several forms of olfactory behavior in mice. Thus, it is important to understand how ERK5 regulates adult neurogenesis in the OB. Here we present evidence that shRNA suppression of ERK5 in adult neural stem/progenitor cells isolated from the subventricular zone (SVZ) reduces neurogenesis in culture. By contrast, ectopic activation of endogenous ERK5 signaling via expression of constitutive active MEK5, an upstream activating kinase for ERK5, stimulates neurogenesis. Furthermore, inducible and conditional deletion of erk5 specifically in the neurogenic regions of the adult mouse brain interferes with cell cycle exit of neuroblasts, impairs chain migration along the rostral migratory stream and radial migration into the OB. It also inhibits neuronal differentiation and survival. These data suggest that ERK5 regulates multiple aspects of adult OB neurogenesis and provide new insights concerning signaling mechanisms governing adult neurogenesis in the SVZ-OB axis.	[Li, Tan; Wang, Wenbin; Abel, Glen; Zou, Junhui; Xia, Zhengui] Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Li, Tan; Xu, Lihong] Zhejiang Univ, Dept Biochem & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Yung-Wei; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Zhejiang University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xia, ZG (corresponding author), Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	zxia@u.washington.edu	xu, li/GNH-3667-2022	Li, Tan/0000-0002-4480-5674	National Institutes of Health [MH95840, DC004156, T32HD007183, F31DC011216]; China Scholarship Council [2011632117]; National Institute of Child Health and Human Development [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274, T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156, F31DC011216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (MH95840 to Z. X., DC004156 to D. R. S., T32HD007183 and F31DC011216 to Y.W.P.), the China Scholarship Council (2011632117 to T. L.), and facilitated by grant P30 HD02274 from the National Institute of Child Health and Human Development (P30 HD02274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Battista D, 2010, J NEUROSCI, V30, P3995, DOI 10.1523/JNEUROSCI.4382-09.2010; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Belvindrah R, 2009, REV NEUROSCIENCE, V20, P331, DOI 10.1515/REVNEURO.2009.20.5-6.331; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Herold S, 2010, MOL CELL NEUROSCI; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Imura T, 2010, STEM CELLS, V28, P2053, DOI 10.1002/stem.524; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kempermann G, 2006, NEUROGENESIS ADULT O, P140; Kendrick TS, 2007, FRONT BIOSCI-LANDMRK, V12, P591, DOI 10.2741/2085; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Mejia-Gervacio S, 2012, MOL CELL NEUROSCI, V49, P97, DOI 10.1016/j.mcn.2011.10.006; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, J BIOL CHEM, V287, P23306, DOI 10.1074/jbc.M112.344762; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Petreanu L, 2002, J NEUROSCI, V22, P6106; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pozniak Christine D, 2006, Sci STKE, V2006, ppe5, DOI 10.1126/stke.3192006pe5; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Saha B, 2012, J NEUROSCI, V32, P16892, DOI 10.1523/JNEUROSCI.0344-12.2012; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shook BA, 2012, J NEUROSCI, V32, P6947, DOI 10.1523/JNEUROSCI.5987-11.2012; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; Wang WB, 2013, J BIOL CHEM, V288, P2623, DOI 10.1074/jbc.M112.401091; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yokoyama TK, 2011, NEURON, V71, P883, DOI 10.1016/j.neuron.2011.05.046; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	83	25	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61948	10.1371/journal.pone.0061948	http://dx.doi.org/10.1371/journal.pone.0061948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630619	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500072
J	Varga, S; Nuortila, C; Kytoviita, MM				Varga, Sandra; Nuortila, Carolin; Kytoviita, Minna-Maarit			Nectar Sugar Production across Floral Phases in the Gynodioecious Protandrous Plant Geranium sylvaticum	PLOS ONE			English	Article							PHACELIA-LINEARIS HYDROPHYLLACEAE; SSP SPICATA MALVACEAE; POLLINATOR VISITATION; SEED PRODUCTION; NATURAL-SELECTION; FLOWER VISITORS; BREEDING SYSTEM; POLLEN TRANSFER; BIOLOGY; GENDER	Many zoophilous plants attract their pollinators by offering nectar as a reward. In gynodioecious plants (i.e. populations are composed of female and hermaphrodite individuals) nectar production has been repeatedly reported to be larger in hermaphrodite compared to female flowers even though nectar production across the different floral phases in dichogamous plants (i.e. plants with time separation of pollen dispersal and stigma receptivity) has rarely been examined. In this study, sugar production in nectar standing crop and secretion rate were investigated in Geranium sylvaticum, a gynodioecious plant species with protandry (i.e. with hermaphrodite flowers releasing their pollen before the stigma is receptive). We found that flowers from hermaphrodites produced more nectar than female flowers in terms of total nectar sugar content. In addition, differences in nectar production among floral phases were found in hermaphrodite flowers but not in female flowers. In hermaphrodite flowers, maximum sugar content coincided with pollen presentation and declined slightly towards the female phase, indicating nectar reabsorption, whereas in female flowers sugar content did not differ between the floral phases. These differences in floral reward are discussed in relation to visitation patterns by pollinators and seed production in this species.	[Varga, Sandra; Kytoviita, Minna-Maarit] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Jyvaskyla	Varga, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	Sandra.varga@jyu.fi	Varga, Sandra/AAO-7881-2021; Varga, Sandra/B-6044-2012	Varga, Sandra/0000-0001-9799-714X; Varga, Sandra/0000-0001-9799-714X; Kytoviita, Minna-Maarit/0000-0002-8928-6951	Finnish Cultural Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 1998, AM J BOT, V85, P245, DOI 10.2307/2446312; Aizen MA, 1996, OIKOS, V76, P312, DOI 10.2307/3546203; Anstett MC, 1999, ACTA OECOL, V20, P551, DOI 10.1016/S1146-609X(00)86622-9; ASHMAN TL, 1991, ECOLOGY, V72, P993, DOI 10.2307/1940599; Ashman TL, 2000, OIKOS, V90, P347, DOI 10.1034/j.1600-0706.2000.900216.x; ASHMAN TL, 1994, AM J BOT, V81, P433, DOI 10.2307/2445492; Asikainen E, 2005, AM J BOT, V92, P487, DOI 10.3732/ajb.92.3.487; Asikainen E, 2005, ANN BOT-LONDON, V95, P879, DOI 10.1093/aob/mci094; Asikainen E, 2003, AM J BOT, V90, P226, DOI 10.3732/ajb.90.2.226; ATSATT PR, 1982, ANN MO BOT GARD, V69, P199, DOI 10.2307/2398790; Bai YP, 2011, PLANT SPEC BIOL, V26, P33, DOI 10.1111/j.1442-1984.2010.00298.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; BELL G, 1984, OECOLOGIA, V64, P287, DOI 10.1007/BF00379123; BERNHARDT P, 1984, ANN MO BOT GARD, V71, P17, DOI 10.2307/2399054; Boose DL, 1997, OECOLOGIA, V110, P493, DOI 10.1007/s004420050185; CAMPBELL DR, 1993, ECOLOGY, V74, P1043, DOI 10.2307/1940474; Carlson JE, 2006, BOT REV, V72, P179, DOI 10.1663/0006-8101(2006)72[179:TEOGNP]2.0.CO;2; CORBET SA, 1984, AUST J ECOL, V9, P125, DOI 10.1111/j.1442-9993.1984.tb01351.x; Cresswell JE, 1999, J ECOL, V87, P670, DOI 10.1046/j.1365-2745.1999.00385.x; De la Barrera E, 2004, TRENDS PLANT SCI, V9, P65, DOI 10.1016/j.tplants.2003.12.003; DELPH LF, 1992, OIKOS, V63, P161, DOI 10.2307/3545374; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI [10.1111/j.1558-5646.1989.tb02572.x, 10.2307/2409360]; DEVLIN B, 1985, AM J BOT, V72, P303, DOI 10.2307/2443557; Diaz L, 2003, PLANT BIOLOGY, V5, P1, DOI [10.1055/s-2003-44783, DOI 10.1055/S-2003-44783]; Eckhart V.M., 1999, GENDER SEXUAL DIMORP, P123, DOI [DOI 10.1007/978-3-662-03908-3_5, 10.1007/978-3-662-03908-3_5]; ECKHART VM, 1992, EVOLUTION, V46, P1313, DOI 10.1111/j.1558-5646.1992.tb01126.x; ECKHART VM, 1992, AM J BOT, V79, P792, DOI 10.2307/2444946; Erhardt A, 2005, OECOLOGIA, V146, P311, DOI 10.1007/s00442-005-0182-5; FAHN A., 1949, PALESTINE JOUR BOT JERUSALEM SER, V4, P207; Feinsinger P., 1983, Coevolution, P282; Gardener MC, 2001, J CHEM ECOL, V27, P2545, DOI 10.1023/A:1013687701120; GILBERT FS, 1991, FUNCT ECOL, V5, P29, DOI 10.2307/2389553; GONZALEZ A, 1995, OECOLOGIA, V101, P258, DOI 10.1007/BF00317292; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Human H, 2008, INT J PLANT SCI, V169, P263, DOI 10.1086/524113; Irwin RE, 2008, ECOLOGY, V89, P2207, DOI 10.1890/07-1359.1; JOLLS CL, 1994, AM J BOT, V81, P60, DOI 10.2307/2445563; JORDANO P, 1993, BIOL J LINN SOC, V50, P65, DOI 10.1111/j.1095-8312.1993.tb00919.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Klinkhamer PGL, 2001, ECOL LETT, V4, P559, DOI 10.1046/j.1461-0248.2001.00267.x; KLINKHAMER PGL, 1993, OIKOS, V66, P180, DOI 10.2307/3545212; KLINKHAMER PGL, 1991, NETH J ZOOL, V41, P130; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Langenberger MW, 2002, AM J BOT, V89, P1588, DOI 10.3732/ajb.89.10.1588; MCKENNA MA, 1988, ECOLOGY, V69, P1306, DOI 10.2307/1941289; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Molano-Flores B, 2002, J TORREY BOT SOC, V129, P187, DOI 10.2307/3088769; Nocentini D, 2012, FLORA, V207, P186, DOI 10.1016/j.flora.2012.01.004; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pacini E, 2007, NECTARIES NECTAR; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Ramula S, 2003, ANN BOT-LONDON, V92, P207, DOI 10.1093/aob/mcg125; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; SHYKOFF JA, 1995, J ECOL, V83, P189, DOI 10.2307/2261557; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; Shykoff JA, 1997, EVOLUTION, V51, P383, DOI 10.1111/j.1558-5646.1997.tb02425.x; SNOW AA, 1995, AM J BOT, V82, P741, DOI 10.2307/2445613; STANTON ML, 1988, AM J BOT, V75, P528, DOI 10.2307/2444218; Talavera S, 1996, BOT ACTA, V109, P333, DOI 10.1111/j.1438-8677.1996.tb00581.x; UNO GE, 1982, AM J BOT, V69, P818, DOI 10.2307/2442973; Vaarama A., 1967, ANN ACAD SCI FENNI A, V108, P1; Varga S, 2010, FUNCT ECOL, V24, P750, DOI 10.1111/j.1365-2435.2010.01708.x; Volkova PA, 2007, PLANT SPEC BIOL, V22, P125, DOI 10.1111/j.1442-1984.2007.00184.x; Williams CF, 2000, AM J BOT, V87, P661, DOI 10.2307/2656852; Willmer P., 2011, POLLINATION FLORAL E; ZIMMERMAN M, 1988, J ECOL, V76, P777, DOI 10.2307/2260573	71	16	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62575	10.1371/journal.pone.0062575	http://dx.doi.org/10.1371/journal.pone.0062575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614053	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000317911500096
J	Mladineo, I; Segvic-Bubic, T; Stanic, R; Desdevises, Y				Mladineo, Ivona; Segvic-Bubic, Tanja; Stanic, Rino; Desdevises, Yves			Morphological Plasticity and Phylogeny in a Monogenean Parasite Transferring between Wild and Reared Fish Populations	PLOS ONE			English	Article							GYRODACTYLUS-SALARIS MALMBERG; OPISTHAPTORAL HARD PARTS; CULTURED ATLANTIC SALMON; MITOCHONDRIAL-DNA; TNF-ALPHA; SEA; DIPLECTANIDAE; SITES; ASSEMBLAGES; VARIABILITY	It is widely accepted that disease interactions between cultured and wild fish occur repeatedly, although reported cases have mainly relied just on the observation of similar symptoms in affected populations. Whether there is an explicit pathogen transfer between fish stocks, or each develops its own pathogen population, has been insufficiently studied and rarely supported by molecular tools. In this study, we used population dynamics and genetic structure of the monogenean Furnestinia echeneis in reared and neighbouring wild sea bream to indicate pathogen transfer, characterized by the phenotypic plasticity of the parasite attachment apparatus and the lack of phylogenetic differentiation. The observed pattern of genetic variation inferred by nuclear DNA Internal Transcribed Spacer 1 (ITS1) and mtDNA cytochrome C oxidase 1 (COI), between parasite populations is most likely caused by a recent shared demographic history like a reduced species area in the last glacial period. In spite of such recent expansion that populations underwent, F. echeneis shows differentiation in haptor morphometry as an adaptive trait in closely related populations at the aquaculture site. This suggests that differentiation in morphology may occur relatively rapidly in this species and that adaptive forces, not the speciation process, drives this monogenean parasitation. On the other hand, the observed phylogenetic inertia suggests a low to moderate gene flow (based on FST) between parasites in cultured and wild fish, evidencing for the first time the transfer of pathogens at the aquaculture site inferred by a molecular tool.	[Mladineo, Ivona; Segvic-Bubic, Tanja] Inst Oceanog & Fisheries, Split, Croatia; [Stanic, Rino] Sardina Doo, Postira, Croatia; [Desdevises, Yves] UPMC Univ Paris 06, BIOM, UMR 7232, Banyuls Sur Mer, France; [Desdevises, Yves] CNRS, BIOM, UMR 7232, Banyuls Sur Mer, France	Croatian Institute of Oceanography & Fisheries (IZOR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mladineo, I (corresponding author), Inst Oceanog & Fisheries, Split, Croatia.	mladineo@izor.hr	Desdevises, Yves/AAH-2097-2019; Segvic-Bubic, Tanja/O-6841-2016; Mladineo, Ivona/AAC-5813-2021; Desdevises, Yves/H-5334-2019	Desdevises, Yves/0000-0001-9774-0336; Segvic-Bubic, Tanja/0000-0003-4405-1611; 	bilateral Croatian-French collaboration "Cogito"; Ministry of Science, Education and Sport [001-0000000-3663]	bilateral Croatian-French collaboration "Cogito"; Ministry of Science, Education and Sport	The work has been financed by bilateral Croatian-French collaboration "Cogito" and Ministry of Science, Education and Sport (grant # 001-0000000-3663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amine F, 2007, ACTA PARASITOL, V52, P305, DOI 10.2478/s11686-007-0052-x; Antonelli L, 2010, AQUACULTURE, V307, P179, DOI 10.1016/j.aquaculture.2010.07.028; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Brackett Jim, 1991, Bulletin of the Aquaculture Association of Canada, V91, P79; Buchmann K, 2002, INT J PARASITOL, V32, P309, DOI 10.1016/S0020-7519(01)00332-0; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Dempster T, 2002, MAR ECOL PROG SER, V242, P237, DOI 10.3354/meps242237; Desdevises Y, 2001, INT J PARASITOL, V31, P205, DOI 10.1016/S0020-7519(00)00163-6; Dezfuli BS, 2010, VET PARASITOL, V174, P359, DOI 10.1016/j.vetpar.2010.08.024; Diamant A, 2000, DIS AQUAT ORGAN, V39, P211, DOI 10.3354/dao039211; Diamant A., 2007, CIESM WORKSHOP MONOG, V32, P49; ERGENS R, 1985, FOLIA PARASIT, V32, P377; Euzet L, 1993, 2 INT S MON MONTP SE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2007, STAT WORLD FISH AQ 2, P180; Fu YX, 1997, GENETICS, V147, P915; HARPENDING HC, 1994, HUM BIOL, V66, P591; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kaci-Chaouchi T, 2008, PARASITOLOGY, V135, P607, DOI 10.1017/S003118200800437X; Kent ML, 2000, INT J PARASITOL, V30, P321, DOI 10.1016/S0020-7519(00)00018-7; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; Li M, 2011, INT J PARASITOL, V41, P1263, DOI 10.1016/j.ijpara.2011.07.012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McVicar AH, 1997, ICES J MAR SCI, V54, P1093, DOI 10.1016/S1054-3139(97)80014-8; Mes THM, 2003, MOL ECOL, V12, P1555, DOI 10.1046/j.1365-294X.2003.01846.x; Mladineo I, 2007, VET RES COMMUN, V31, P153, DOI 10.1007/s11259-006-3184-9; Mladineo I, 2005, DIS AQUAT ORGAN, V64, P77, DOI 10.3354/dao064077; Mladineo I, 2009, AQUACULTURE, V295, P160, DOI 10.1016/j.aquaculture.2009.07.017; Mladineo I, 2010, VET PARASITOL, V174, P131, DOI 10.1016/j.vetpar.2010.08.015; Mladineo I, 2010, FISH SHELLFISH IMMUN, V29, P487, DOI 10.1016/j.fsi.2010.05.008; Mladineo I, 2009, J EXP MAR BIOL ECOL, V374, P51, DOI 10.1016/j.jembe.2009.04.008; MO TA, 1991, SYST PARASITOL, V20, P1, DOI 10.1007/BF00009706; MO TA, 1991, SYST PARASITOL, V20, P11, DOI 10.1007/BF00009707; Nagasawa K, 1998, J MARINE SYST, V15, P269, DOI 10.1016/S0924-7963(97)00062-6; Nei M, 1987, MOL EVOLUTIONARY GEN; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; Nowak BF, 2004, J FISH DIS, V27, P709, DOI 10.1111/j.1365-2761.2004.00593.x; OLIVER G, 1969, VIE MILIEU A BIOL MA, V20, P43; Poisot T, 2010, BIOL J LINN SOC, V99, P559, DOI 10.1111/j.1095-8312.2009.01381.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RADUJKOVIC B M, 1989, Acta Adriatica, V30, P51; Reiczigel J., 2005, QUANTITATIVE PARASIT; REVERSAT J, 1992, MAR BIOL, V112, P43, DOI 10.1007/BF00349726; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Schneider S, 1999, GENETICS, V152, P1079; Sepulveda F, 2004, AQUACULTURE, V235, P89, DOI 10.1016/j.aquaculture.2003.09.015; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd CD, 1997, J EXP MAR BIOL ECOL, V210, P251, DOI 10.1016/S0022-0981(96)02696-2; Valle C, 2007, ESTUAR COAST SHELF S, V72, P299, DOI 10.1016/j.ecss.2006.10.019	58	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62011	10.1371/journal.pone.0062011	http://dx.doi.org/10.1371/journal.pone.0062011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620799	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500079
J	Murugan, NJ; Karbowski, LM; Lafrenie, RM; Persinger, MA				Murugan, Nirosha J.; Karbowski, Lukasz M.; Lafrenie, Robert M.; Persinger, Michael A.			Temporally-Patterned Magnetic Fields Induce Complete Fragmentation in Planaria	PLOS ONE			English	Article							ELECTROMAGNETIC-FIELDS; GEOMAGNETIC-ACTIVITY; LAND SNAIL; REGENERATION; DUGESIA; WEAK; CELLS; WATER; DIFFERENTIATION; ENHANCEMENT	A tandem sequence composed of weak temporally-patterned magnetic fields was discovered that produced 100% dissolution of planarian in their home environment. After five consecutive days of 6.5 hr exposure to a frequency-modulated magnetic field (0.1 to 2 mu T), immediately followed by an additional 6.5 hr exposure on the fifth day, to another complex field (0.5 to 5 mu T) with exponentially increasing spectral power 100% of planarian dissolved within 24 hr. Reversal of the sequence of the fields or presentation of only one pattern for the same duration did not produce this effect. Direct video evidence showed expansion (by visual estimation similar to twice normal volume) of the planarian following the first field pattern followed by size reduction (estimated similar to 1/2 of normal volume) and death upon activation of the second pattern. The contortions displayed by the planarian during the last field exposure suggest effects on contractile proteins and alterations in the cell membrane's permeability to water.	[Murugan, Nirosha J.; Karbowski, Lukasz M.; Lafrenie, Robert M.; Persinger, Michael A.] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Murugan, Nirosha J.; Karbowski, Lukasz M.; Lafrenie, Robert M.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci Program, Sudbury, ON P3E 2C6, Canada; [Karbowski, Lukasz M.; Lafrenie, Robert M.; Persinger, Michael A.] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Lafrenie, Robert M.] Hlth Sci North, Reg Canc Program, Sudbury, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Health Sciences North; Northern Ontario School of Medicine	Persinger, MA (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca		Lafrenie, Robert/0000-0001-9981-997X				Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Blank M, 1997, BIOELECTROMAGNETICS, V18, P111, DOI 10.1002/(SICI)1521-186X(1997)18:2<111::AID-BEM3>3.0.CO;2-5; Blank M, 1998, BIOELECTROCH BIOENER, V45, P253, DOI 10.1016/S0302-4598(98)00086-5; BROWN FA, 1975, PHYSIOL ZOOL, V48, P168, DOI 10.1086/physzool.48.2.30155650; BROWN FA, 1973, BIOL BULL, V144, P437, DOI 10.2307/1540299; BROWN FA, 1962, BIOL BULL, V123, P264, DOI 10.2307/1539273; Buckner C, 2011, EFFECTS ELECTROMAGNE; Cifra M, 2011, PROG BIOPHYS MOL BIO, V105, P223, DOI 10.1016/j.pbiomolbio.2010.07.003; Del Seppia C, 2007, NEUROSCI BIOBEHAV R, V31, P619, DOI 10.1016/j.neubiorev.2007.01.003; DELGIUDICE E, 1994, J BIOL PHYS, V20, P105, DOI 10.1007/BF00700426; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Galic MA, 2007, BIOELECTROMAGNETICS, V28, P577, DOI 10.1002/bem.20353; Gang N, INT J RAD B IN PRESS; Gang N, 2011, ELECTROMAGN BIOL MED, V30, P198, DOI 10.3109/15368378.2011.587928; GOODMAN R, 1983, SCIENCE, V220, P1283, DOI 10.1126/science.6857248; Goodman R, 2009, INT J RADIAT BIOL, V85, P851, DOI [10.3109/09553000903072488, 10.1080/09553000903072488]; JENROW KA, 1995, BIOELECTROMAGNETICS, V16, P106, DOI 10.1002/bem.2250160206; Karbowski LM, 2012, NEUROSCI LETT, V523, P131, DOI 10.1016/j.neulet.2012.06.059; Kavaliers M, 1999, NEUROREPORT, V10, P1863, DOI 10.1097/00001756-199906230-00012; Lisi A, 2008, PR ELECTROMAGN RES S, P902; Martin LJ, 2004, PHARMACOL BIOCHEM BE, V78, P217, DOI 10.1016/j.pbb.2004.03.016; McKay BE, 2003, LIFE SCI, V72, P2489, DOI 10.1016/S0024-3205(03)00140-1; Novikov VV, 2008, BIOELECTROMAGNETICS, V29, P387, DOI 10.1002/bem.20407; OSSENKOPP KP, 1987, BRAIN RES, V418, P356, DOI 10.1016/0006-8993(87)90103-X; Panagopoulos DJ, 2002, BIOCHEM BIOPH RES CO, V298, P95, DOI 10.1016/S0006-291X(02)02393-8; Persinger MA, 2005, INT J BIOMETEOROL, V49, P256, DOI 10.1007/s00484-004-0234-2; Persinger MA, 1996, INT J NEUROSCI, V86, P271, DOI 10.3109/00207459608986718; Pollack GH, 2009, INT J MOL SCI, V10, P1419, DOI 10.3390/ijms10041419; Pollack GH, 2003, ADV COLLOID INTERFAC, V103, P173, DOI 10.1016/S0001-8686(02)00095-7; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reiter RJ, 1998, BIOELECTROCH BIOENER, V47, P135, DOI 10.1016/S0302-4598(98)00152-4; Reuter M, 2004, CAN J ZOOL, V82, P334, DOI 10.1139/Z03-219; Sandblom J, 2000, CHAOS SOLITON FRACT, V11, P1905, DOI 10.1016/S0960-0779(99)00127-7; St-Pierre LS, 2007, LIFE SCI, V81, P1496, DOI 10.1016/j.lfs.2007.09.013; Tessaro L, OPTIMAL DURATI UNPUB; Thomas AW, 1997, NEUROSCI LETT, V222, P107; Tiras Kh. P., 1996, Biophysics, V41, P837	38	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61714	10.1371/journal.pone.0061714	http://dx.doi.org/10.1371/journal.pone.0061714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620783	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500063
J	Carvalho, RA; Omoto, C; Field, LM; Williamson, MS; Bass, C				Carvalho, Renato A.; Omoto, Celso; Field, Linda M.; Williamson, Martin S.; Bass, Chris			Investigating the Molecular Mechanisms of Organophosphate and Pyrethroid Resistance in the Fall Armyworm Spodoptera frugiperda	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; INSECTICIDE RESISTANCE; SODIUM-CHANNEL; HEAD LICE; MUTATIONS; ACETYLCHOLINESTERASE; LEPIDOPTERA; IDENTIFICATION; STRAINS; GENE	The fall armyworm Spodoptera frugiperda is an economically important pest of small grain crops that occurs in all maize growing regions of the Americas. The intensive use of chemical pesticides for its control has led to the selection of resistant populations, however, to date, the molecular mechanisms underlying resistance have not been characterised. In this study the mechanisms involved in the resistance of two S. frugiperda strains collected in Brazil to chlorpyrifos (OP strain) or lambda-cyhalothrin (PYR strain) were investigated using molecular and genomic approaches. To examine the possible role of target-site insensitivity the genes encoding the organophosphate (acetylcholinesterase, AChE) and pyrethroid (voltage-gated sodium channel, VGSC) target-site proteins were PCR amplified. Sequencing of the S. frugiperda ace-1 gene identified several nucleotide changes in the OP strain when compared to a susceptible reference strain (SUS). These result in three amino acid substitutions, A201S, G227A and F290V, that have all been shown previously to confer organophosphate resistance in several other insect species. Sequencing of the gene encoding the VGSC in the PYR strain, identified mutations that result in three amino acid substitutions, T929I, L932F and L1014F, all of which have been shown previously to confer knockdown/super knockdown-type resistance in several arthropod species. To investigate the possible role of metabolic detoxification in the resistant phenotype of the OP and PYR stains all EST sequences available for S. frugiperda were used to design a gene-expression microarray. This was then used to compare gene expression in the resistant strains with the susceptible reference strain. Members of several gene families, previously implicated in metabolic resistance in other insects were found to be overexpressed in the resistant strains including glutathione S-transferases, cytochrome P450s and carboxylesterases. Taken together these results provide evidence that both target-site and metabolic mechanisms underlie the resistance of S. frugiperda to pyrethroids and organophosphates.	[Carvalho, Renato A.; Field, Linda M.; Williamson, Martin S.; Bass, Chris] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England; [Omoto, Celso] Univ Sao Paulo ESALQ USP, Dept Entomol & Acarol, Piracicaba, SP, Brazil	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Universidade de Sao Paulo	Bass, C (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England.	chris.bass@rothamsted.ac.uk	Omoto, Celso/D-9794-2012	Omoto, Celso/0000-0002-6432-830X; Field, Linda/0000-0002-3328-2513; Bass, Chris/0000-0002-2590-1492	Biotechnology and Biological Sciences Research Council of the UK [BB/G023352/1]; National Council for Scientific and Technological Development of Brazil; BBSRC [BBS/E/C/00005193, BB/G023352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023352/1, BBS/E/C/00005193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a fellowship grant (BB/G023352/1) from the Biotechnology and Biological Sciences Research Council of the UK to Dr Chris Bass and a fellowship grant from the National Council for Scientific and Technological Development of Brazil to Dr Renato Carvalho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MC, 2004, INSECT MOL BIOL, V13, P555, DOI 10.1111/j.0962-1075.2004.00517.x; Araujo RA, 2011, INSECT MOL BIOL, V20, P437, DOI 10.1111/j.1365-2583.2011.01079.x; Brazilian Ministry of Agriculture, 2013, AGR SIST AGR FIT; Cassanelli S, 2006, INSECT BIOCHEM MOLEC, V36, P642, DOI 10.1016/j.ibmb.2006.05.007; Cruz I., 1995, 21 TECN CNPMS, P45; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Davies T. G. E., 2009, Bayer CropScience Journal, V62, P159; Devonshire AL, 1998, PHILOS T R SOC B, V353, P1677, DOI 10.1098/rstb.1998.0318; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Figueiredo MLC, 2005, 130 CNPMS, V130, P6; Fontaine S, 2011, PEST MANAG SCI, V67, P881, DOI 10.1002/ps.2224; FOURNIER D, 1992, J BIOL CHEM, V267, P14270; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; Haddi K, 2012, INSECT BIOCHEM MOLEC, V42, P506, DOI 10.1016/j.ibmb.2012.03.008; Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002; Huang HS, 1998, INSECT BIOCH MOL BIO; Jiang X, 2007, BIOCHEM BIOPH RES CO, V353, P591; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kasten Jr P., 1978, REV AGR, V53, P69; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; LAGADIC L, 1993, INSECT BIOCHEM MOLEC, V23, P467, DOI 10.1016/0965-1748(93)90054-V; Lee DW, 2008, INSECT BIOCHEM MOLEC, V38, P296; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Morillo Franklin, 2001, Entomotropica, V16, P79; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; PUNZO F, 1993, COMP BIOCHEM PHYS C, V105, P155, DOI 10.1016/0742-8413(93)90187-P; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; Schuler TH, 1998, PESTIC BIOCHEM PHYS, V59, P169, DOI 10.1006/pest.1998.2320; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; SupYoon K, 2008, INSECT BIOCHEM MOLEC, V38, P296, DOI 10.1016/j.ibmb.2007.11.011; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Walsh SB, 2001, BIOCHEM J, V359, P175, DOI 10.1042/0264-6021:3590175; YOUNG JR, 1979, J ECON ENTOMOL, V72, P202, DOI 10.1093/jee/72.2.202; YU SJ, 1992, J ECON ENTOMOL, V85, P675, DOI 10.1093/jee/85.3.675; YU SJ, 1982, PESTIC BIOCHEM PHYS, V17, P59, DOI 10.1016/0048-3575(82)90126-2; Yu SJ, 2003, PESTIC BIOCHEM PHYS, V77, P1, DOI 10.1016/S0048-3575(03)00079-8; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9	44	156	190	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62268	10.1371/journal.pone.0062268	http://dx.doi.org/10.1371/journal.pone.0062268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614047	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200129
J	Matmati, N; Metelli, A; Tripathi, K; Yan, SQ; Mohanty, BK; Hannun, YA				Matmati, Nabil; Metelli, Alessandra; Tripathi, Kaushlendra; Yan, Shuqi; Mohanty, Bidyut K.; Hannun, Yusuf A.			Identification of C-18:1-Phytoceramide as the Candidate Lipid Mediator for Hydroxyurea Resistance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; ACTIVATED PROTEIN PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; NEUTRAL SPHINGOMYELINASES; SWE1P DEGRADATION; GROWTH-INHIBITION; CERAMIDE; STRESS; ISC1	Recent studies showed that deletion of ISC1, the yeast homologue of the mammalian neutral sphingomyelinase, resulted in an increased sensitivity to hydroxyurea (HU). This raised an intriguing question as to whether sphingolipids are involved in pathways initiated by HU. In this study, we show that HU treatment led to a significant increase in Isc1 activity. Analysis of sphingolipid deletion mutants and pharmacological analysis pointed to a role for ceramide in mediating HU resistance. Lipid analysis revealed that HU induced increases in phytoceramides in WT cells but not in isc1 Delta cells. To probe functions of specific ceramides, we developed an approach to supplement the medium with fatty acids. Oleate (C-18:1) was the only fatty acid protecting isc1 Delta cells from HU toxicity in a ceramide-dependent manner. Because phytoceramide activates protein phosphatases in yeast, we evaluated the role of CDC55, the regulatory subunit of ceramide-activated protein phosphatase PP2A. Overexpression of CDC55 overcame the sensitivity to HU in isc1 Delta cells. However, addition of oleate did not protect the isc1 Delta,cdc55 Delta double mutant from HU toxicity. These results demonstrate that HU launches a lipid pathway mediated by a specific sphingolipid, C-18:1-phytoceramide, produced by Isc1, which provides protection from HU by modulating Swe1 levels through the PP2A subunit Cdc55.	[Matmati, Nabil; Yan, Shuqi; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Matmati, Nabil; Yan, Shuqi; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Metelli, Alessandra; Tripathi, Kaushlendra; Mohanty, Bidyut K.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	tripathi, kaushlendra/O-3022-2013	tripathi, kaushlendra/0000-0002-3578-2917; Yan, Shuqi/0000-0002-6537-4906	National Institutes of Health [R01GM063265, R01GM43825, P30 CA138313, P20 RR017677]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM063265 and R01GM43825 (to Y. A. H.).; We are grateful Dr. Cungui Mao for revising the manuscript and to Lina Obeid, Chiara Luberto, and the Hannun group members for helpful discussions. We thank the Lipidomics Center at the Medical University of South Carolina for all lipid analyses performed in this study. Research at the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina, was supported in part by National Institutes of Health Grant P30 CA138313 and at the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina, by National Institutes of Health Grant P20 RR017677.	Al-Feel W, 2003, P NATL ACAD SCI USA, V100, P3095, DOI 10.1073/pnas.0538069100; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Betz C, 2002, EUR J BIOCHEM, V269, P4033, DOI 10.1046/j.1432-1033.2002.03096.x; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2005, BIOCHEM SOC T, V33, P1166, DOI 10.1042/BST0331166; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Gottlieb D, 1999, Mol Cell Biol Res Commun, V1, P66, DOI 10.1006/mcbr.1999.0109; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kim S, 2000, GENETICS, V156, P1519; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Liu H, 2011, GENETICS, V187, P397, DOI 10.1534/genetics.110.125468; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McCourt PC, 2009, J BIOL CHEM, V284, P11930, DOI 10.1074/jbc.M900857200; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Reid RJD, 1997, J BIOL CHEM, V272, P12091, DOI 10.1074/jbc.272.18.12091; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Tripathi K, 2011, GENETICS, V189, P533, DOI 10.1534/genetics.111.132092; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000	35	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17272	17284		10.1074/jbc.M112.444802	http://dx.doi.org/10.1074/jbc.M112.444802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620586	Green Published, hybrid			2022-12-25	WOS:000320380600023
J	Jiang, X; Huang, QF; Wang, WJ; Dong, HH; Ly, H; Liang, YY; Dong, CJ				Jiang, Xue; Huang, Qinfeng; Wang, Wenjian; Dong, Haohao; Ly, Hinh; Liang, Yuying; Dong, Changjiang			Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIG-I; DNA; TREX1; RNA; BINDING; VIRUS; SITE; AUTOIMMUNITY; PATHOGENESIS	A hallmark of severe Lassa fever is the generalized immune suppression, the mechanism of which is poorly understood. Lassa virus (LASV) nucleoprotein (NP) is the only known 3'-5' exoribonuclease that can suppress type I interferon (IFN) production possibly by degrading immune-stimulatory RNAs. How this unique enzymatic activity of LASV NP recognizes and processes RNA substrates is unknown. We provide an atomic view of a catalytically active exoribonuclease domain of LASV NP (LASV NP-C) in the process of degrading a 5' triphosphate double-stranded (ds) RNA substrate, a typical pathogen-associated molecular pattern molecule, to induce type I IFN production. Additionally, we provide for the first time a high-resolution crystal structure of an active exoribonuclease domain of Tacaribe arenavirus (TCRV) NP. Coupled with the in vitro enzymatic and cell-based interferon suppression assays, these structural analyses strongly support a unified model of an exoribonuclease-dependent IFN suppression mechanism shared by all known arenaviruses. New knowledge learned from these studies should aid the development of therapeutics against pathogenic arenaviruses that can infect hundreds of thousands of individuals and kill thousands annually.	[Jiang, Xue; Dong, Haohao; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Huang, Qinfeng; Ly, Hinh; Liang, Yuying] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China; [Dong, Haohao] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland	University of East Anglia; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; University of St Andrews	Ly, H (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	hly@umn.edu; liangy@umn.edu; c.dong@uea.ac.uk	Huang, Qinfeng/AAJ-7454-2021		National Institutes of Health [R01AI083409, R01AI093580, R56AI091805]; Medical Research Council [G1100110/1]; Welcome Trust Career Development Fellowship [WT083501MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083409, R01AI093580, R56AI091805] Funding Source: NIH RePORTER; Medical Research Council [G1100110] Funding Source: researchfish; MRC [G1100110] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI083409 (to Y. L.), and R01AI093580 and R56AI091805 (to H. L.). This work was also supported by Medical Research Council Grant G1100110/1 (to C. J. D.) and Welcome Trust Career Development Fellowship Grant WT083501MA (to C. J. D.).	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Cisneros GA, 2009, J AM CHEM SOC, V131, P1550, DOI 10.1021/ja8082818; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Silva U, 2009, NUCLEIC ACIDS RES, V37, P2411, DOI 10.1093/nar/gkp025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; Hastie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044211; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraz ML, 2011, EXPERT REV ANTI-INFE, V9, P49, DOI 10.1586/ERI.10.142; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	31	61	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16949	16959		10.1074/jbc.M112.420521	http://dx.doi.org/10.1074/jbc.M112.420521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615902	hybrid, Green Published			2022-12-25	WOS:000320378900067
J	Floreani, M; De Martin, S; Gabbia, D; Barbierato, M; Nassi, A; Mescoli, C; Orlando, R; Bova, S; Angeli, P; Gola, E; Sticca, A; Palatini, P				Floreani, Maura; De Martin, Sara; Gabbia, Daniela; Barbierato, Massimo; Nassi, Alberto; Mescoli, Claudia; Orlando, Rocco; Bova, Sergio; Angeli, Paolo; Gola, Elisabetta; Sticca, Antonietta; Palatini, Pietro			Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; ARYL-HYDROCARBON RECEPTOR; PROTEIN-BINDING DISPLACEMENT; IN-VIVO; DISEASE; EXPRESSION; MICROSOMES; DYSFUNCTION; INHIBITION; ASCITES	Although the induction of cytochrome P450 (CYP) has long been investigated in patients with cirrhosis, the question whether liver dysfunction impairs the response to CYP inducers still remains unresolved. Moreover, the mechanism underlying the possible effect of cirrhosis on induction has not been investigated. Since ethical constraints do not permit methodologically rigorous studies in humans, this question was addressed by investigating the effect of the prototypical inducer benzo[a] pyrene (BP) on CYP1A1 and CYP1A2 in cirrhotic rats stratified according to the severity of liver dysfunction. We simultaneously assessed mRNA level, protein expression and enzymatic activity of the CYP1A enzymes, as well as mRNA and protein expressions of the aryl hydrocarbon receptor (AhR), which mediates the BP effect. Basal mRNA and protein expressions of CYP1A1 were virtually absent in both healthy and cirrhotic rats. On the contrary, CYP1A2 mRNA, protein and enzyme activity were constitutively present in healthy rats and decreased significantly as liver function worsened. BP treatment markedly increased the concentrations of mRNA and immunodetectable protein, and the enzymatic activities of both CYP1A enzymes to similar levels in healthy and non-ascitic cirrhotic rats. Induced mRNA levels, protein expressions and enzymatic activities of both CYPs were much lower in ascitic rats and were proportionally reduced. Both constitutive and induced protein expressions of AhR were significantly lower in ascitic than in healthy rats. These results indicate that the inducibility of CYP1A enzymes is well preserved in compensated cirrhosis, whereas it is markedly reduced when liver dysfunction becomes severe. Induction appears to be impaired at the transcriptional level, due to the reduced expression of AhR, which controls the transcription of CYP1A genes.	[Floreani, Maura; De Martin, Sara; Gabbia, Daniela; Barbierato, Massimo; Nassi, Alberto; Palatini, Pietro] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Mescoli, Claudia] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, Italy; [Orlando, Rocco; Bova, Sergio; Angeli, Paolo; Gola, Elisabetta; Sticca, Antonietta] Univ Padua, Dept Med, Lab Expt Hepatol, Padua, Italy	University of Padua; University of Padua; University of Padua	Palatini, P (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	pietro.palatini@unipd.it	Gabbia, Daniela/J-9984-2019; Angeli, Paolo/A-9759-2015; De Martin, Sara/AAC-7396-2022	Gabbia, Daniela/0000-0003-2247-8227; De Martin, Sara/0000-0001-6398-8237	University of Padova, Italy [CPDA093519]	University of Padova, Italy	This work was supported by a grant (# CPDA093519) from the University of Padova, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Elbekai RH, 2004, CURR DRUG METAB, V5, P157, DOI 10.2174/1389200043489054; Farrell G, 1999, Mol Aspects Med, V20, P55; FARRELL GC, 1984, AUST J EXP BIOL MED, V62, P291, DOI 10.1038/icb.1984.29; Floreani M, 2012, DRUG METAB PHARMACOK, V27, P640, DOI 10.2133/dmpk.DMPK-12-RG-035; Franc MA, 2001, BIOCHEM PHARMACOL, V62, P1565, DOI 10.1016/S0006-2952(01)00820-6; Fuhr U, 2000, CLIN PHARMACOKINET, V38, P493, DOI 10.2165/00003088-200038060-00003; GEORGE J, 1995, BIOCHEM PHARMACOL, V49, P873, DOI 10.1016/0006-2952(94)00515-N; GEORGE J, 1995, HEPATOLOGY, V21, P120, DOI 10.1002/hep.1840210121; Hanioka N, 2000, J CHROMATOGR B, V744, P399, DOI 10.1016/S0378-4347(00)00278-4; HOYUMPA AM, 1982, ANNU REV MED, V33, P113, DOI 10.1146/annurev.me.33.020182.000553; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JIMENEZ W, 1985, HEPATOLOGY, V5, P245, DOI 10.1002/hep.1840050215; JIMENEZ W, 1992, J GASTROEN HEPATOL, V7, P90, DOI 10.1111/j.1440-1746.1992.tb00940.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindros KO, 1997, J PHARMACOL EXP THER, V280, P506; MARSHALL WJ, 1969, BRIT J EXP PATHOL, V50, P578; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; OMURA T, 1964, J BIOL CHEM, V239, P2370; Orlando R, 2004, CLIN PHARMACOL THER, V75, P80, DOI 10.1016/j.clpt.2003.09.007; Orlando R, 2009, CLIN PHARMACOL THER, V85, P319, DOI 10.1038/clpt.2008.216; Orlando R, 2006, CLIN PHARMACOL THER, V79, P489, DOI 10.1016/j.clpt.2006.01.012; Palatini P, 2010, EXPERT OPIN DRUG MET, V6, P1215, DOI 10.1517/17425255.2010.503704; Palatini P, 2008, CURR CLIN PHARMACOL, V3, P56, DOI 10.2174/157488408783329896; Park BK, 1996, BRIT J CLIN PHARMACO, V41, P477, DOI 10.1046/j.1365-2125.1996.03482.x; Pearce RE, 1996, ARCH BIOCHEM BIOPHYS, V331, P145, DOI 10.1006/abbi.1996.0294; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Rosa Darlan Pase da, 2010, Arq. Gastroenterol., V47, P72, DOI 10.1590/S0004-28032010000100013; Shimada T, 1996, DRUG METAB DISPOS, V24, P515; Singh D, 2011, DRUG DISCOV TODAY, V16, P793, DOI 10.1016/j.drudis.2011.08.003; Tucker Geoffrey T., 2001, Clinical Pharmacology and Therapeutics, V70, P103, DOI 10.1067/mcp.2001.116891; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; WU ZQ, 1991, CAN J PHYSIOL PHARM, V69, P426, DOI 10.1139/y91-065	36	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61983	10.1371/journal.pone.0061983	http://dx.doi.org/10.1371/journal.pone.0061983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626760	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400124
J	Fu, H; Yuan, GX; Zhong, JY; Cao, T; Ni, LY; Xie, P				Fu, Hui; Yuan, Guixiang; Zhong, Jiayou; Cao, Te; Ni, Leyi; Xie, Ping			Environmental and Ontogenetic Effects on Intraspecific Trait Variation of a Macrophyte Species across Five Ecological Scales	PLOS ONE			English	Article							FUNCTIONAL TRAITS; POTAMOGETON-MAACKIANUS; PHENOTYPIC PLASTICITY; PLANT ALLOMETRY; SPATIAL SCALES; COMMUNITY; LEAF; BIOMASS; LIGHT; VARIABILITY	Although functional trait variability is increasingly used in community ecology, the scale- and size-dependent aspects of trait variation are usually disregarded. Here we quantified the spatial structure of shoot height, branch length, root/shoot ratio and leaf number in a macrophyte species Potamogeton maackianus, and then disentangled the environmental and ontogenetic effects on these traits. Using a hierarchical nested design, we measured the four traits from 681 individuals across five ecological scales: lake, transect, depth stratus, quadrat and individual. A notable high trait variation (coefficient variation: 48-112%) was observed within species. These traits differed in the spatial structure, depending on environmental factors of different scales. Shoot height and branch length were most responsive to lake, transect and depth stratus scales, while root/shoot ratio and leaf number to quadrat and individual scales. The trait variations caused by environment are nearly three times higher than that caused by ontogeny, with ontogenetic variance ranging from 21% (leaf number) to 33% (branch length) of total variance. Remarkably, these traits showed non-negligible ontogenetic variation (0-60%) in each ecological scale, and significant shifts in allometric trajectories at lake and depth stratus scales. Our results highlight that environmental filtering processes can sort individuals within species with traits values adaptive to environmental changes and ontogenetic variation of functional traits was non-negligible across the five ecological scales.	[Fu, Hui; Yuan, Guixiang; Cao, Te; Ni, Leyi; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China; [Fu, Hui; Zhong, Jiayou] Jiangxi Inst Water Sci, Nanchang, Peoples R China; [Yuan, Guixiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ni, LY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China.	Nily@ihb.ac.cn	Xie, Ping/AAL-7532-2020		National Science Foundation of China [31270508, 41230853]; National High Technology Research and Development Program of China [2012ZX07105-004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Science Foundation of China (Grant No. 31270508, 41230853) and the National High Technology Research and Development Program of China (Grant No. 2012ZX07105-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Albert CH, 2012, OIKOS, V121, P116, DOI 10.1111/j.1600-0706.2011.19672.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Bonser SP, 2003, AM J BOT, V90, P404, DOI 10.3732/ajb.90.3.404; Bonser SP, 2009, PERSPECT PLANT ECOL, V11, P31, DOI 10.1016/j.ppees.2008.10.003; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; CHAMBERS PA, 1987, J ECOL, V75, P611, DOI 10.2307/2260193; CHAMBERS PA, 1985, CAN J FISH AQUAT SCI, V42, P701, DOI 10.1139/f85-090; Cianciaruso MV, 2009, ECOLOGY, V90, P81, DOI 10.1890/07-1864.1; Clark JS, 2011, ECOL LETT, V14, P1273, DOI 10.1111/j.1461-0248.2011.01685.x; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Cook C.D.K., 1990, AQUATIC PLANT BOOK; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Courbaud B, 2012, THEOR ECOL-NETH, V5, P61, DOI 10.1007/s12080-010-0095-8; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; De Frenne P, 2011, ECOGRAPHY, V34, P132, DOI 10.1111/j.1600-0587.2010.06399.x; DUARTE CM, 1990, CAN J FISH AQUAT SCI, V47, P357, DOI 10.1139/f90-037; Duursma RA, 2012, NEW PHYTOL, V193, P397, DOI 10.1111/j.1469-8137.2011.03943.x; Engelhardt KAM, 2006, ECOL APPL, V16, P1808, DOI 10.1890/1051-0761(2006)016[1808:REARTI]2.0.CO;2; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; FALSTER DS, 2003, MATR STANDARDISED MA; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Fu H, 2012, ECOL RES, V27, P1087, DOI 10.1007/s11284-012-0991-z; Garbey C, 2006, HYDROBIOLOGIA, V570, P41, DOI 10.1007/s10750-006-0159-3; Ge JiWen, 2004, Journal of Beijing Forestry University, V26, P14; Going B, 2008, HYDROBIOLOGIA, V607, P75, DOI 10.1007/s10750-008-9368-2; Guo H, 2012, J ECOL, V100, P452, DOI 10.1111/j.1365-2745.2011.01884.x; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; [胡小贞 Hu Xiaozhen], 2005, [环境科学研究, Research of Environmental Sciences], V18, P1; Jin Bao-feng, 2001, Acta Hydrobiologica Sinica, V25, P439; Jin Gang, 1999, Acta Hydrobiologica Sinica, V23, P87; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Li Enhua, 2011, Hupo Kexue, V23, P738; Li H, 1989, LAKE ERHAI SCI RES, P31; Li H, 2007, FUND APPL LIMNOL, V170, P141, DOI 10.1127/1863-9135/2007/0170-0141; Li W, 2004, AQUAT BOT, V80, P227, DOI 10.1016/j.aquabot.2004.07.003; Liu GF, 2010, NEW PHYTOL, V188, P543, DOI 10.1111/j.1469-8137.2010.03388.x; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; Lusk CH, 2008, FUNCT ECOL, V22, P454, DOI 10.1111/j.1365-2435.2008.01384.x; MABERLY SC, 1993, J AQUAT PLANT MANAGE, V31, P34; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mokany K, 2010, OIKOS, V119, P1504, DOI 10.1111/j.1600-0706.2010.18411.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Ni LY, 2001, J FRESHWATER ECOL, V16, P249, DOI 10.1080/02705060.2001.9663809; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Siefert A, 2012, OECOLOGIA IN PRESS; Sokal R. R., 2012, BIOMETRY; Souza L, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00283.1; Sterck F, 2011, P NATL ACAD SCI USA, V108, P20627, DOI 10.1073/pnas.1106950108; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Sun XZ, 1995, FLORA CHINA; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van de Voorde TFJ, 2011, J ECOL, V99, P945, DOI 10.1111/j.1365-2745.2011.01815.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039105; Wantzen K., 2008, ECOLOGICAL EFFECTS W; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wu Q, 1998, J LAKE SCI, V11, P267; Xie JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041502; Yang YQ, 2004, J FRESHWATER ECOL, V19, P69, DOI 10.1080/02705060.2004.9664514; Zhang QA, 2011, ANN BOT-LONDON, V107, P407, DOI 10.1093/aob/mcq249; Zhao C-F, 2012, PLANT SPECI IN PRESS	88	25	28	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62794	10.1371/journal.pone.0062794	http://dx.doi.org/10.1371/journal.pone.0062794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626856	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400220
J	Langan, EA; Vidali, S; Pigat, N; Funk, W; Lisztes, E; Biro, T; Goffin, V; Griffiths, CEM; Paus, R				Langan, Ewan A.; Vidali, Silvia; Pigat, Natascha; Funk, Wolfgang; Lisztes, Erika; Biro, Tamas; Goffin, Vincent; Griffiths, Christopher E. M.; Paus, Ralf			Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin	PLOS ONE			English	Article							HUMAN HAIR FOLLICLE; THYROTROPIN-RELEASING-HORMONE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GROWTH-HORMONE; IN-VITRO; RECEPTOR EXPRESSION; HUMAN KERATINOCYTES; STIMULATING-HORMONE; ALOPECIA-AREATA; MAMMARY-GLAND	Human scalp skin and hair follicles (HFs) are extra-pituitary sources of prolactin (PRL). However, the intracutaneous regulation of PRL remains poorly understood. Therefore we investigated whether well-recognized regulators of pituitary PRL expression, which also impact on human skin physiology and pathology, regulate expression of PRL and its receptor (PRLR) in situ. This was studied in serum-free organ cultures of microdissected human scalp HFs and skin, i.e. excluding pituitary, neural and vascular inputs. Prolactin expression was confirmed at the gene and protein level in human truncal skin, where its expression significantly increased (p = 0.049) during organ culture. There was, however, no evidence of PRL secretion into the culture medium as measured by ELISA. PRL immunoreactivity (IR) in female human epidermis was decreased by substance P (p = 0.009), while neither the classical pituitary PRL inhibitor, dopamine, nor corticotropin-releasing hormone significantly modulated PRL IR in HFs or skin respectively. Interferon (IFN) gamma increased PRL IR in the epithelium of human HFs (p = 0.044) while tumour necrosis factor (TNF) alpha decreased both PRL and PRLR IR. This study identifies substance P, TNF alpha and IFN gamma as novel modulators of PRL and PRLR expression in human skin, and suggests that intracutaneous PRL expression is not under dopaminergic control. Given the importance of PRL in human hair growth regulation and its possible role in the pathogenesis of several common skin diseases, targeting intracutaneous PRL production via these newly identified regulatory pathways may point towards novel therapeutic options for inflammatory dermatoses.	[Langan, Ewan A.; Griffiths, Christopher E. M.; Paus, Ralf] Univ Manchester, Manchester Acad Hlth Sci Ctr, Dermatol Res Ctr, Manchester, Lancs, England; [Langan, Ewan A.; Griffiths, Christopher E. M.; Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Langan, Ewan A.; Vidali, Silvia; Paus, Ralf] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Pigat, Natascha; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Ctr Rech Croissance & Signalisat,INSERM,U845, Paris, France; [Funk, Wolfgang] Klin Dr Kozlowski, Munich, Germany; [Lisztes, Erika; Biro, Tamas] Univ Debrecen, Dept Physiol, DE MTA Lendulet Cellular Physiol Res Grp, Debrecen, Hungary	University of Manchester; University of Manchester; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Debrecen	Paus, R (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Dermatol Res Ctr, Manchester, Lancs, England.	ralf.paus@uksh.de	GOFFIN, Vincent/G-3322-2013; Griffiths, Christopher E.M./P-5448-2014; Paus, Ralf/B-5279-2015	GOFFIN, Vincent/0000-0002-8021-3086; Griffiths, Christopher E.M./0000-0001-5371-4427; Vidali, Silvia/0000-0003-1981-8833; Paus, Ralf/0000-0002-3492-9358	Medical Research Council (UK); Hungarian Academy of Sciences; Medical Research Council [G0901988] Funding Source: researchfish; MRC [G0901988] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EAL is supported by a Medical Research Council (UK) Clinical Research Training Fellowship. TB is supported by the "Lendulet'' grant of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISAWA M, 1990, NEUROENDOCRINOLOGY, V52, P22, DOI 10.1159/000125533; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Bjorntorp E, 1997, J INVEST DERMATOL, V109, P661, DOI 10.1111/1523-1747.ep12337699; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; BURRIS TP, 1992, ENDOCRINOLOGY, V130, P926, DOI 10.1210/en.130.2.926; Cano P, 2005, NEUROIMMUNOMODULAT, V12, P146, DOI 10.1159/000084846; Clapp C, 2008, J MAMMARY GLAND BIOL, V13, P55, DOI 10.1007/s10911-008-9067-7; Dilme-Carreras E, 2011, CLIN EXP DERMATOL, V36, P29, DOI 10.1111/j.1365-2230.2010.03871.x; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; El-Khateeb EA, 2011, INT J DERMATOL, V50, P693, DOI 10.1111/j.1365-4632.2010.04752.x; Ferraris J, 2012, AM J PHYSIOL-ENDOC M, V302, pE356, DOI 10.1152/ajpendo.00333.2011; Foitzik K, 2006, AM J PATHOL, V168, P748, DOI 10.2353/ajpath.2006.050468; Foitzik K, 2003, AM J PATHOL, V162, P1611, DOI 10.1016/S0002-9440(10)64295-2; Foitzik K, 2009, J INVEST DERMATOL, V129, P1071, DOI 10.1038/jid.2008.348; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Galsgaard ED, 2009, J ENDOCRINOL, V201, P115, DOI 10.1677/JOE-08-0479; Gaspar E, 2011, J INVEST DERMATOL, V131, P2368, DOI 10.1038/jid.2011.221; Gaspar E, 2010, FASEB J, V24, P393, DOI 10.1096/fj.08-126417; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Gerlo S, 2006, BIOESSAYS, V28, P1051, DOI 10.1002/bies.20468; Giasuddin ASM, 1998, DERMATOLOGY, V197, P119, DOI 10.1159/000017981; GIROLOMONI G, 1993, J INVEST DERMATOL, V101, P275, DOI 10.1111/1523-1747.ep12365203; GOLANDER A, 1979, J CLIN ENDOCR METAB, V49, P787, DOI 10.1210/jcem-49-5-787; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; HAREL G, 1995, PEPTIDES, V16, P641, DOI 10.1016/0196-9781(95)00019-G; HOFFMANN R, 1994, J INVEST DERMATOL, V103, P530, DOI 10.1111/1523-1747.ep12395722; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ito T, 2005, BRIT J DERMATOL, V152, P623, DOI 10.1111/j.1365-2133.2005.06453.x; Ito T, 2004, AM J PATHOL, V164, P623, DOI 10.1016/S0002-9440(10)63151-3; Kanda N, 2007, ENDOCRINOLOGY, V148, P2317, DOI 10.1210/en.2006-1639; Kanda N, 2009, EUR J IMMUNOL, V39, P996, DOI 10.1002/eji.200838852; Katznelson L, 1998, J CLIN ENDOCR METAB, V83, P761, DOI 10.1210/jc.83.3.761; Krueger JG, 2012, NAT MED, V18, P1750, DOI 10.1038/nm.3025; Langan EA, 2011, CLIN EXP RHEUMATOL, V29, P1060; Langan EA, 2010, BRIT J DERMATOL, V163, P1140, DOI 10.1111/j.1365-2133.2010.09955.x; Langan EA, 2010, BRIT J DERMATOL, V162, P1127, DOI 10.1111/j.1365-2133.2010.09676.x; Langan EA, 2012, BR J DERMATOL; Langan EA, 2012, AM J PHYSIOL-ENDOC M, V302, pE1311, DOI 10.1152/ajpendo.00080.2012; Langan EA, 2012, ARCH DERMATOL RES, V304, P115, DOI 10.1007/s00403-012-1208-6; Langan EA, 2010, TRENDS ENDOCRIN MET, V21, P569, DOI 10.1016/j.tem.2010.06.001; Langan EA, 2010, J INVEST DERMATOL, V130, P886, DOI 10.1038/jid.2009.340; LIMAT A, 1986, J INVEST DERMATOL, V87, P485, DOI 10.1111/1523-1747.ep12455548; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Loli P, 1998, CLIN ENDOCRINOL, V49, P433, DOI 10.1046/j.1365-2265.1998.00531.x; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; Lutz G, 2012, DERM-ENDOCRINOL, V4, P70, DOI 10.4161/derm.19472; Maaskant RA, 1996, J CLIN ENDOCR METAB, V81, P396, DOI 10.1210/jc.81.1.396; Malligarjunan H, 2011, CLIN BIOCHEM, V44, P1209, DOI 10.1016/j.clinbiochem.2011.07.009; MOREL G, 1989, NEUROENDOCRINOLOGY, V49, P669, DOI 10.1159/000125186; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Pavlovic S, 2008, J INVEST DERMATOL, V128, P434, DOI 10.1038/sj.jid.5701079; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Philpott MP, 1996, BRIT J DERMATOL, V135, P942, DOI 10.1046/j.1365-2133.1996.d01-1099.x; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Ramot Y, 2010, FASEB J, V24, P1768, DOI 10.1096/fj.09-146415; Regana MS, 2000, BRIT J DERMATOL, V143, P864, DOI 10.1046/j.1365-2133.2000.03792.x; Richards RG, 1996, J INVEST DERMATOL, V106, P1250, DOI 10.1111/1523-1747.ep12348944; Samuelov L, 2012, J INVEST DERMATOL; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, DERMATOLOGY, V211, P199, DOI 10.1159/000087012; Slominski A, 1996, BBA-GEN SUBJECTS, V1289, P247, DOI 10.1016/0304-4165(95)00159-X; Slominski A, 2000, J LAB CLIN MED, V136, P476, DOI 10.1067/mlc.2000.110605; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Stevens A, 2001, LUPUS, V10, P676, DOI 10.1191/096120301717164903; Stevens A, 2001, ARTHRITIS RHEUM-US, V44, P2358, DOI 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K; Touraine P, 1998, J CLIN ENDOCR METAB, V83, P667, DOI 10.1210/jc.83.2.667; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; Vankelecom H, 1997, MOL CELL ENDOCRINOL, V129, P157, DOI 10.1016/S0303-7207(97)04054-9; YAMAGUCHI M, 1991, J ENDOCRINOL INVEST, V14, P457, DOI 10.1007/BF03346841; Zinger M, 2003, J CLIN ENDOCR METAB, V88, P689, DOI 10.1210/jc.2002-021255; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617; Zouboulis Christos C, 2004, Hormones (Athens), V3, P9	79	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e60819	10.1371/journal.pone.0060819	http://dx.doi.org/10.1371/journal.pone.0060819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626671	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000318008400014
J	Mohawk, JA; Pezuk, P; Menaker, M				Mohawk, Jennifer A.; Pezuk, Pinar; Menaker, Michael			Methamphetamine and Dopamine Receptor D1 Regulate Entrainment of Murine Circadian Oscillators	PLOS ONE			English	Article							GENE-EXPRESSION; COCAINE SENSITIZATION; LOCOMOTOR-ACTIVITY; ACTIVITY RHYTHMS; RATS; MOUSE; LESIONS; MICE; TIME; MECHANISMS	We investigated the effect of methamphetamine (MA) injections on the circadian organization of behavior and individual tissues in the mouse. Scheduled, daily injections of MA resulted in anticipatory activity, with an increase in locomotor activity immediately prior to the time of injection. Daily MA also shifted the peak time of PER2 expression in the liver, pituitary, and salivary glands. It has been suggested that reward pathways, and dopamine signaling in particular, may underlie the effects of MA on the circadian system. To test this hypothesis, we examined the effect of the D1 receptor antagonist SCH23390 (SCH) on circadian rhythms. The MA-induced shift in the phase of pituitary and salivary glands was attenuated by pretreatment with the D1 antagonist SCH23390 (SCH). Interestingly, daily SCH, administered alone, also affected some circadian oscillators. The livers and lungs (but not pituitaries or salivary glands) of mice treated with daily injections of SCH displayed disrupted rhythms of PER2 expression, suggesting that D1 receptor signaling is important for entrainment of these organs. From these results, we conclude that MA has widespread effects within the circadian system, and that these effects are mediated, at least in part, by the dopaminergic system. This study also identifies a role for dopamine signaling in normal entrainment of circadian oscillators.	[Mohawk, Jennifer A.; Pezuk, Pinar; Menaker, Michael] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Menaker, M (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	mm7e@virginia.edu			Conte Center grant [1P50MH074924, NSBRI NCC 9-58-HPF 00406]; NIH [F32DA024542]; UVA GSAS dissertation year fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024542] Funding Source: NIH RePORTER	Conte Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UVA GSAS dissertation year fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Conte Center grant 1P50MH074924 and NSBRI NCC 9-58-HPF 00406 to M. M. J.A.M. was supported by NIH F32DA024542 and P. P. by a UVA GSAS dissertation year fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Aherne AM, 1997, ENDOCRINOLOGY, V138, P1282, DOI 10.1210/en.138.3.1282; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; CARON MG, 1978, J BIOL CHEM, V253, P2244; HONMA K, 1987, PHYSIOL BEHAV, V40, P767, DOI 10.1016/0031-9384(87)90281-2; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MISSALE C, 1989, J CARDIOVASC PHARM, V14, pS29, DOI 10.1097/00005344-198906148-00004; Mohawk JA, 2009, BEHAV PHARMACOL, V20, P174, DOI 10.1097/FBP.0b013e32832a8f43; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Natsubori A, 2013, EUR J NEUROSCI, V37, P251, DOI 10.1111/ejn.12034; Nikaido T, 2001, MOL PHARMACOL, V59, P894, DOI 10.1124/mol.59.4.894; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; SHIBATA S, 1995, J PHARMACOL EXP THER, V274, P688; SHIBATA S, 1994, NEUROSCI LETT, V172, P107, DOI 10.1016/0304-3940(94)90673-4; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tataroglu O, 2006, J BIOL RHYTHM, V21, P185, DOI 10.1177/0748730406287529; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	25	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62463	10.1371/journal.pone.0062463	http://dx.doi.org/10.1371/journal.pone.0062463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626822	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400186
J	Slomp, CP; Mort, HP; Jilbert, T; Reed, DC; Gustafsson, BG; Wolthers, M				Slomp, Caroline P.; Mort, Haydon P.; Jilbert, Tom; Reed, Daniel C.; Gustafsson, Bo G.; Wolthers, Mariette			Coupled Dynamics of Iron and Phosphorus in Sediments of an Oligotrophic Coastal Basin and the Impact of Anaerobic Oxidation of Methane	PLOS ONE			English	Article							NORTHERN BALTIC SEA; CONTINENTAL-MARGIN SEDIMENTS; AUTHIGENIC APATITE FORMATION; MARINE-SEDIMENTS; ORGANIC-MATTER; EARLY DIAGENESIS; AARHUS BAY; BLACK-SEA; WATER; BOTHNIA	Studies of phosphorus (P) dynamics in surface sediments of lakes and coastal seas typically emphasize the role of coupled iron (Fe), sulfur (S) and P cycling for sediment P burial and release. Here, we show that anaerobic oxidation of methane (AOM) also may impact sediment P cycling in such systems. Using porewater and sediment profiles for sites in an oligotrophic coastal basin (Bothnian Sea), we provide evidence for the formation of Fe-bound P (possibly vivianite; Fe-3(PO4)(2)center dot 8H(2)O) below the zone of AOM with sulfate. Here, dissolved Fe2+ released from oxides is no longer scavenged by sulfide and high concentrations of both dissolved Fe2+ (>1 mM) and PO4 in the porewater allow supersaturation with respect to vivianite to be reached. Besides formation of Fe(II)-P, preservation of Fe-oxide bound P likely also contributes to permanent burial of P in Bothnian Sea sediments. Preliminary budget calculations suggest that the burial of Fe-bound P allows these sediments to act as a major sink for P from the adjacent eutrophic Baltic Proper.	[Slomp, Caroline P.; Mort, Haydon P.; Jilbert, Tom; Reed, Daniel C.; Wolthers, Mariette] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Mort, Haydon P.] Univ Fed Pernambuco, Recife, PE, Brazil; [Gustafsson, Bo G.] Stockholm Univ, Balt Nest Inst, S-10691 Stockholm, Sweden; [Wolthers, Mariette] UCL, Dept Chem, London, England	Utrecht University; Universidade Federal de Pernambuco; Stockholm University; University of London; University College London	Slomp, CP (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands.	c.p.slomp@uu.nl	Jilbert, Tom/F-2346-2013; Gustafsson, Bo/GQH-3048-2022; Wolthers, Mariette/V-7994-2017; Jilbert, Tom/AAL-2273-2021; Slomp, Caroline P/A-9406-2012	Jilbert, Tom/0000-0001-8165-0168; Wolthers, Mariette/0000-0003-3908-5622; Slomp, Caroline P/0000-0002-7272-0109	Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO); EU-BONUS project HYPER; European Research Council under the European Community [278364]; Natural Environment Research Council [NE/J018856/1] Funding Source: researchfish; NERC [NE/J018856/1] Funding Source: UKRI	Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO)(Netherlands Organization for Scientific Research (NWO)); EU-BONUS project HYPER; European Research Council under the European Community(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the Baltic Sea 2020 foundation (http://www.balticsea2020.org/), the Netherlands Organisation for Scientific Research (Vidi NWO to C.P. Slomp; http://www.nwo.nl/), the EU-BONUS project HYPER (http://www.bonusportal.org/) and the European Research Council (http://erc.europa.eu/) under the European Community's Seventh Framework Programme for ERC Starting Grant 278364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamdani Z., 2007, 10 BALANCE; ALBORNO A, 1994, GEOCHIM COSMOCHIM AC, V58, P5373, DOI 10.1016/0016-7037(94)90236-4; Algesten G, 2006, J MARINE SYST, V63, P155, DOI 10.1016/j.jmarsys.2006.06.004; Alling V, 2008, LIMNOL OCEANOGR, V53, P2594, DOI 10.4319/lo.2008.53.6.2594; Anschutz P, 1998, LIMNOL OCEANOGR, V43, P53, DOI 10.4319/lo.1998.43.1.0053; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Berg P, 2003, AM J SCI, V303, P905, DOI 10.2475/ajs.303.10.905; Berner R.A., 1980, EARLY DIAGENESIS THE; BOSTROM K, 1982, MAR GEOL, V50, P1, DOI 10.1016/0025-3227(82)90058-5; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Burns S.J., 1997, P OCEAN DRILLING PRO, V155, P497; Cha HJ, 2005, MAR GEOL, V216, P127, DOI 10.1016/j.margeo.2005.02.001; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; EMERSON S, 1978, GEOCHIM COSMOCHIM AC, V42, P1307, DOI 10.1016/0016-7037(78)90035-2; Filippelli GM, 1997, MAR GEOL, V139, P231, DOI 10.1016/S0025-3227(96)00113-2; Fleming-Lehtinen V, 2008, AMBIO, V37, P86, DOI 10.1579/0044-7447(2008)37[86:LDOINA]2.0.CO;2; Fleming-Lehtinen V, 2012, ESTUAR COAST SHELF S, V102, P1, DOI 10.1016/j.ecss.2012.02.015; Gachter R, 2003, LIMNOL OCEANOGR, V48, P929; Gunnars A, 2004, MAR CHEM, V91, P15, DOI 10.1016/j.marchem.2004.01.008; Hensen C, 2003, GEOCHIM COSMOCHIM AC, V67, P2631, DOI 10.1016/S0016-7037(03)00199-6; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; Hyacinthe C, 2006, GEOCHIM COSMOCHIM AC, V70, P4166, DOI 10.1016/j.gca.2006.05.018; INGRI J, 1986, CHEM GEOL, V56, P105, DOI 10.1016/0009-2541(86)90114-2; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; JENSEN HS, 1995, LIMNOL OCEANOGR, V40, P908, DOI 10.4319/lo.1995.40.5.0908; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; Jorgensen BB, 2004, GEOCHIM COSMOCHIM AC, V68, P2095, DOI 10.1016/j.gca.2003.07.017; Josefson AB, 2012, MAR ECOL PROG SER, V455, P33, DOI 10.3354/meps09661; Kasten S, 1998, GEOCHIM COSMOCHIM AC, V62, P2253, DOI 10.1016/S0016-7037(98)00093-3; Knab NJ, 2009, BIOGEOSCIENCES, V6, P1505, DOI 10.5194/bg-6-1505-2009; Korshuk E, 2009, ENGLISH ENV SCI; Kraal P, 2009, GEOCHIM COSMOCHIM AC, V73, P3277, DOI 10.1016/j.gca.2009.02.026; Larsson P., 2001, SYSTEMS ANAL BALTIC; Leipe T, 2011, GEO-MAR LETT, V31, P175, DOI 10.1007/s00367-010-0223-x; LEIVUORI M, 1995, CHEMOSPHERE, V31, P3839, DOI 10.1016/0045-6535(95)00257-9; Lovely DR, 1986, APPL ENVIRON MICROB, V52, P751; Lundberg C, 2009, ESTUAR COAST SHELF S, V82, P152, DOI 10.1016/j.ecss.2009.01.005; Marz C, 2008, MAR GEOL, V255, P118, DOI 10.1016/j.margeo.2008.05.013; Makela K, 2003, HYDROBIOLOGIA, V492, P43, DOI 10.1023/A:1024809710854; MANNING PG, 1991, CAN MINERAL, V29, P77; Martens CS, 1998, CONT SHELF RES, V18, P1741, DOI 10.1016/S0278-4343(98)00056-9; MARTENS CS, 1978, LIMNOL OCEANOGR, V23, P605, DOI 10.4319/lo.1978.23.4.0605; Mattila J, 2006, BOREAL ENVIRON RES, V11, P95; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; NEMBRINI GP, 1983, GEOCHIM COSMOCHIM AC, V47, P1459, DOI 10.1016/0016-7037(83)90304-6; Parkhurst D.L, 1999, WATER RESOUR INVESTI; Pierrou U., 1976, Ecological Bulletins, Swedish Natural Science Research Council, P75; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rozan TF, 2002, LIMNOL OCEANOGR, V47, P1346, DOI 10.4319/lo.2002.47.5.1346; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Savchuk OP, 2005, J MARINE SYST, V56, P1, DOI 10.1016/j.jmarsys.2004.08.005; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Slomp CP, 1998, LIMNOL OCEANOGR, V43, P832, DOI 10.4319/lo.1998.43.5.0832; Slomp CP, 1996, MAR CHEM, V52, P55, DOI 10.1016/0304-4203(95)00078-X; Stockenberg A, 1997, ESTUAR COAST SHELF S, V45, P835, DOI 10.1006/ecss.1997.0271; SUNDBY B, 1992, LIMNOL OCEANOGR, V37, P1129, DOI 10.4319/lo.1992.37.6.1129; Treude T, 2005, LIMNOL OCEANOGR, V50, P1771, DOI 10.4319/lo.2005.50.6.1771; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; van der Zee C, 2002, MAR GEOL, V185, P379, DOI 10.1016/S0025-3227(02)00189-5; van Dongen BE, 2008, MAR CHEM, V112, P203, DOI 10.1016/j.marchem.2008.08.002; VanCappellen P, 1996, AM J SCI, V296, P197, DOI 10.2475/ajs.296.3.197; YAMAMOTO S, 1976, J CHEM ENG DATA, V21, P78, DOI 10.1021/je60068a029	73	98	104	1	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62386	10.1371/journal.pone.0062386	http://dx.doi.org/10.1371/journal.pone.0062386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626815	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400179
J	Wang, E; Sun, SN; Qiao, B; Duan, WY; Huang, GY; An, Y; Xu, SH; Zheng, YF; Su, ZX; Gu, X; Jin, L; Wang, HY				Wang, Erli; Sun, Shuna; Qiao, Bin; Duan, Wenyuan; Huang, Guoying; An, Yu; Xu, Shuhua; Zheng, Yufang; Su, Zhixi; Gu, Xun; Jin, Li; Wang, Hongyan			Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease	PLOS ONE			English	Article							ATRIAL SEPTAL-DEFECT; TRANSCRIPTION FACTORS; GENE-EXPRESSION; TBX5; NKX2.5	Congenital heart disease (CHD) is one of the most prevalent developmental anomalies and the leading cause of noninfectious morbidity and mortality in newborns. Despite its prevalence and clinical significance, the etiology of CHD remains largely unknown. GATA4 is a highly conserved transcription factor that regulates a variety of physiological processes and has been extensively studied, particularly on its role in heart development. With the combination of TBX5 and MEF2C, GATA4 can reprogram postnatal fibroblasts into functional cardiomyocytes directly. In the past decade, a variety of GATA4 mutations were identified and these findings originally came from familial CHD pedigree studies. Given that familial and sporadic CHD cases allegedly share a basic genetic basis, we explore the GATA4 mutations in different types of CHD. In this study, via direct sequencing of the GATA4 coding region and exon-intron boundaries in 384 sporadic Chinese CHD patients, we identified 12 heterozygous non-synonymous mutations, among which 8 mutations were only found in CHD patients when compared with 957 controls. Six of these non-synonymous mutations have not been previously reported. Subsequent functional analyses revealed that the transcriptional activity, subcellular localization and DNA binding affinity of some mutant GATA4 proteins were significantly altered. Our results expand the spectrum of GATA4 mutations linked to cardiac defects. Together with the newly reported mutations, approximately 110 non-synonymous mutations have currently been identified in GATA4. Our future analysis will explore why the evolutionarily conserved GATA4 appears to be hypermutable.	[Wang, Erli; Xu, Shuhua; Jin, Li] Chinese Acad Sci, Key Lab Computat Biol, Max Planck Soc CAS MPG, Shanghai, Peoples R China; [Wang, Erli; Xu, Shuhua; Jin, Li] Chinese Acad Sci, Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Erli; Zheng, Yufang; Su, Zhixi; Gu, Xun; Jin, Li; Wang, Hongyan] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Erli; Zheng, Yufang; Su, Zhixi; Gu, Xun; Jin, Li; Wang, Hongyan] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Sun, Shuna; Huang, Guoying; An, Yu] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Qiao, Bin; Duan, Wenyuan] Inst Cardiovasc Dis Gen Hosp Jinan Mil Reg, Jinan, Peoples R China; [An, Yu; Wang, Hongyan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Fudan University; Fudan University	Jin, L (corresponding author), Chinese Acad Sci, Key Lab Computat Biol, Max Planck Soc CAS MPG, Shanghai, Peoples R China.	ljin007@gmail.com; wanghy@fudan.edu.cn	Jin, Li/C-1468-2009; Zheng, Yufang/F-1091-2011; Xu, Shuhua/AAH-7620-2020; Su, Zhixi/B-6487-2012; Jin, Li/M-5063-2019; XU, SHUHUA/D-5345-2009	Jin, Li/0000-0002-4546-2415; Zheng, Yufang/0000-0002-0488-2624; Xu, Shuhua/0000-0002-1975-1002; XU, SHUHUA/0000-0002-1975-1002	National Science Fund for Distinguished Young Scholars [81025003]; 973 Program [2010CB529601]; Program for Innovative Research Team in University [IRT1010]; Ministry of Education of China [20110071110026]; Commission for Science and Technology of Shanghai Municipality [10JC1401300, 11XD1400900]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); Program for Innovative Research Team in University; Ministry of Education of China(Ministry of Education, China); Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025003), the 973 Program (2010CB529601), the Program for Innovative Research Team in University (IRT1010), Doctoral Fund of Ministry of Education of China (20110071110026), and the Commission for Science and Technology of Shanghai Municipality (10JC1401300, 11XD1400900) to HYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Chen MW, 2010, PEDIATR CARDIOL, V31, P85, DOI 10.1007/s00246-009-9576-1; Chen Y, 2010, CLIN CHIM ACTA, V411, P1741, DOI 10.1016/j.cca.2010.07.021; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu XQ, 2011, J CELL MOL MED, V15, P1865, DOI 10.1111/j.1582-4934.2010.01182.x; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Okubo A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018895; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Reamon-Buettner SM, 2005, FUTUR CARDIOL, V1, P355, DOI 10.1517/14796678.1.3.355; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Schluterman MK, 2007, AM J MED GENET A, V143A, P817, DOI 10.1002/ajmg.a.31652; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Zhang LT, 2006, GENET TEST, V10, P277, DOI 10.1089/gte.2006.10.277; Zhang WM, 2008, EUR J MED GENET, V51, P527, DOI 10.1016/j.ejmg.2008.06.005	37	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62138	10.1371/journal.pone.0062138	http://dx.doi.org/10.1371/journal.pone.0062138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626780	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400144
J	Smith, R; Duguay, A; Bakker, A; Li, P; Weiszmann, J; Thomas, MR; Alba, BM; Wu, XL; Gupte, J; Yang, L; Stevens, J; Hamburger, A; Smith, S; Chen, JY; Komorowski, R; Moore, KW; Veniant, MM; Li, Y				Smith, Richard; Duguay, Amy; Bakker, Alice; Li, Peng; Weiszmann, Jennifer; Thomas, Melissa R.; Alba, Benjamin M.; Wu, Xinle; Gupte, Jamila; Yang, Li; Stevens, Jennitte; Hamburger, Agnes; Smith, Stephen; Chen, Jiyun; Komorowski, Renee; Moore, Kevin W.; Veniant, Murielle M.; Li, Yang			FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/beta-Klotho Bispecific Protein	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN SERUM-ALBUMIN; INDUCED OBESE MICE; BETA-KLOTHO; INSULIN SENSITIVITY; METABOLIC REGULATOR; FUSION PROTEIN; RECEPTOR; FGF19; FIBROBLAST-GROWTH-FACTOR-21	The endocrine hormone FGF21 has attracted considerable interest as a potential therapeutic for treating diabetes and obesity. As an alternative to the native cytokine, we generated bispecific Avimer polypeptides that bind with high affinity and specificity to one of the receptor and coreceptor pairs used by FGF21, FGFR1c and beta-Klotho. These Avimers exhibit FGF21-like activity in in vitro assays with potency greater than FGF21. In a study conducted in obese male cynomolgus monkeys, animals treated with an FGFR1c/beta-Klotho bispecific Avimer showed improved metabolic parameters and reduced body weight comparable to the effects seen with FGF21. These results not only demonstrate the essential roles of FGFR1c and beta-Klotho in mediating the metabolic effects of FGF21, they also describe a first bispecific activator of this unique receptor complex and provide validation for a novel therapeutic approach to target this potentially important pathway for treating diabetes and obesity.	[Smith, Richard; Duguay, Amy; Bakker, Alice; Li, Peng; Thomas, Melissa R.; Alba, Benjamin M.; Moore, Kevin W.] Amgen Inc, Therapeut Discovery, San Francisco, CA USA; [Weiszmann, Jennifer; Wu, Xinle; Gupte, Jamila; Yang, Li; Li, Yang] Amgen Inc, Metab Disorders, San Francisco, CA USA; [Weiszmann, Jennifer; Thomas, Melissa R.; Alba, Benjamin M.] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA; [Chen, Jiyun] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA; [Komorowski, Renee; Veniant, Murielle M.] Amgen Inc, Metab Disorders, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, Metab Disorders, San Francisco, CA USA.	yangl@amgen.com						Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bussiere J L, 2003, Dev Biol (Basel), V112, P135; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dingermann Theo, 2008, Biotechnology Journal, V3, P90, DOI 10.1002/biot.200700214; Dostalova I, 2009, PHYSIOL RES, V58, P1, DOI 10.33549/physiolres.931610; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Gao ZH, 2009, BIOSCI BIOTECH BIOCH, V73, P688, DOI 10.1271/bbb.80742; Ge HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033603; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Huang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020669; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Mai K, 2011, METABOLISM, V60, P306, DOI 10.1016/j.metabol.2010.02.016; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Muller N, 2010, BIOCHEM BIOPH RES CO, V396, P793, DOI 10.1016/j.bbrc.2010.04.134; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Sung C, 2003, J INTERF CYTOK RES, V23, P25, DOI 10.1089/10799900360520423; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2012, CHEM BIOL DRUG DES, V79, P398, DOI 10.1111/j.1747-0285.2012.01325.x; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	44	46	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61432	10.1371/journal.pone.0061432	http://dx.doi.org/10.1371/journal.pone.0061432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630589	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500036
J	Demeyer, S; Michoel, T; Fostier, J; Audenaert, P; Pickavet, M; Demeester, P				Demeyer, Sofie; Michoel, Tom; Fostier, Jan; Audenaert, Pieter; Pickavet, Mario; Demeester, Piet			The Index-Based Subgraph Matching Algorithm (ISMA): Fast Subgraph Enumeration in Large Networks Using Optimized Search Trees	PLOS ONE			English	Article							TOPOLOGICAL MOTIFS; GRAPH; PRINCIPLES; AGGREGATION; TOOL	Subgraph matching algorithms are designed to find all instances of predefined subgraphs in a large graph or network and play an important role in the discovery and analysis of so-called network motifs, subgraph patterns which occur more often than expected by chance. We present the index-based subgraph matching algorithm (ISMA), a novel tree-based algorithm. ISMA realizes a speedup compared to existing algorithms by carefully selecting the order in which the nodes of a query subgraph are investigated. In order to achieve this, we developed a number of data structures and maximally exploited symmetry characteristics of the subgraph. We compared ISMA to a naive recursive tree-based algorithm and to a number of well-known subgraph matching algorithms. Our algorithm outperforms the other algorithms, especially on large networks and with large query subgraphs. An implementation of ISMA in Java is freely available at http://sourceforge.net/projects/isma.	[Demeyer, Sofie; Fostier, Jan; Audenaert, Pieter; Pickavet, Mario; Demeester, Piet] Univ Ghent, Dept Informat Technol, B-9000 Ghent, Belgium; [Michoel, Tom] Freiburg Inst Adv Studies, Sch Life Sci LifeNet, Freiburg, Germany; [Michoel, Tom] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH8 9YL, Midlothian, Scotland	Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Demeyer, S (corresponding author), Univ Ghent, Dept Informat Technol, B-9000 Ghent, Belgium.	Sofie.Demeyer@intec.ugent.be	Fostier, Jan/A-8275-2012; Pickavet, Mario J/E-9530-2019; Demeester, Piet/N-6619-2013	Fostier, Jan/0000-0002-9994-8269; Pickavet, Mario J/0000-0001-5817-7886; Demeester, Piet/0000-0003-2810-3899; Michoel, Tom/0000-0003-4749-4725; Demeyer, Sofie/0000-0002-8193-5734	Ghent University; Freiburg Institute of Advanced Studies; BBSRC [BBS/E/D/20211552] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211552] Funding Source: researchfish	Ghent University(Ghent University); Freiburg Institute of Advanced Studies; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding from Ghent University and Freiburg Institute of Advanced Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Audenaert P, 2011, BIOINFORMATICS, V27, P1587, DOI 10.1093/bioinformatics/btr182; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Conte D, 2004, INT J PATTERN RECOGN, V18, P265, DOI 10.1142/S0218001404003228; Cordella L. P., 1999, Proceedings 10th International Conference on Image Analysis and Processing, P1172, DOI 10.1109/ICIAP.1999.797762; Cordella L. P., 2001, 3 IAPR TC15 WORKSH G, P149; Cordella LP, 1998, INT C PATT RECOG, P1582, DOI 10.1109/ICPR.1998.712014; Cordella LP, 2004, IEEE T PATTERN ANAL, V26, P1367, DOI 10.1109/TPAMI.2004.75; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Even S, 1973, ALGORITHMIC COMBINAT; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Garey MR, 1990, COMPUTERS INTRACTABI; Giugno R, 2002, INT C PATT RECOG, P112, DOI 10.1109/ICPR.2002.1048250; Grochow JA, 2007, LECT NOTES COMPUT SC, V4453, P92; Jasny BR, 2009, SCIENCE, V325, P405, DOI 10.1126/science.325_405; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson S.M., 1963, MATH COMPUT, V17, P282, DOI [https://doi.org/10.1090/mcom/1963-17-083, DOI 10.1090/MCOM/1963-17-083]; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Larrosa J., 2002, Mathematical Structures in Computer Science, V12, P403, DOI 10.1017/S0960129501003577; Messmer BT, 1999, PATTERN RECOGN, V32, P1979, DOI 10.1016/S0031-3203(98)90142-X; Michoel T, 2011, MOL BIOSYST, V7, P2769, DOI 10.1039/c1mb05241a; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinhaus H, 1963, 100 PROBLEMS ELEMENT; Tian YY, 2007, BIOINFORMATICS, V23, P232, DOI 10.1093/bioinformatics/btl571; Tian YY, 2008, PROC INT CONF DATA, P963, DOI 10.1109/ICDE.2008.4497505; TROTTER HF, 1962, COMMUN ACM, V5, P434, DOI 10.1145/368637.368660; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Weber M, 2012, PATTERN RECOGNITION; Yan X., 2004, PROC ACM SIGMOD INT, P335, DOI DOI 10.1145/1007568.1007607; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HY, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r55; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zampelli S, 2010, CONSTRAINTS, V15, P327, DOI 10.1007/s10601-009-9074-3; Zhang S., 2009, P INT C EXT DAT TECH, P192, DOI DOI 10.1145/1516360.1516384; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	37	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61183	10.1371/journal.pone.0061183	http://dx.doi.org/10.1371/journal.pone.0061183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620730	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500010
J	Lewandowski, TJ; Dunfield, KE; Antunes, PM				Lewandowski, Thaddeus J.; Dunfield, Kari E.; Antunes, Pedro M.			Isolate Identity Determines Plant Tolerance to Pathogen Attack in Assembled Mycorrhizal Communities	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; FUNGUS GLOMUS-MOSSEAE; SOIL BIOTA; ALTER; BIODIVERSITY; GROWTH; INOCULATION; PARASITICA; PROTECTION; PHYLOGENY	Arbuscular mycorrhizal fungi (AMF) are widespread soil microorganisms that associate mutualistically with plant hosts. AMF receive photosynthates from the host in return for various benefits. One of such benefits is in the form of enhanced pathogen tolerance. However, this aspect of the symbiosis has been understudied compared to effects on plant growth and its ability to acquire nutrients. While it is known that increased AMF species richness positively correlates with plant productivity, the relationship between AMF diversity and host responses to pathogen attack remains obscure. The objective of this study was to test whether AMF isolates can differentially attenuate the deleterious effects of a root pathogen on plant growth, whether the richest assemblage of AMF isolates provides the most tolerance against the pathogen, and whether AMF-induced changes to root architecture serve as a mechanism for improved plant disease tolerance. In a growth chamber study, we exposed the plant oxeye daisy (Leucanthemum vulgare) to all combinations of three AMF isolates and to the plant root pathogen Rhizoctonia solani. We found that the pathogen caused an 81% reduction in shoot and a 70% reduction in root biomass. AMF significantly reduced the highly deleterious effect of the pathogen. Mycorrhizal plants infected with the pathogen produced 91% more dry shoot biomass and 72% more dry root biomass relative to plants solely infected with R. solani. AMF isolate identity was a better predictor of AMF-mediated host tolerance to the pathogen than AMF richness. However, the enhanced tolerance response did not result from AMF-mediated changes to root architecture. Our data indicate that AMF communities can play a major role in alleviating host pathogen attack but this depends primarily on the capacity of individual AMF isolates to provide this benefit.	[Lewandowski, Thaddeus J.; Antunes, Pedro M.] Algoma Univ, Invas Species Res Inst, Sault Ste Marie, ON, Canada; [Lewandowski, Thaddeus J.; Antunes, Pedro M.] Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada; [Lewandowski, Thaddeus J.; Dunfield, Kari E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	Algoma University; Algoma University; University of Guelph	Antunes, PM (corresponding author), Algoma Univ, Invas Species Res Inst, Sault Ste Marie, ON, Canada.	pedro.antunes@algomau.ca	Madeira Antunes, Pedro/C-2949-2008	Madeira Antunes, Pedro/0000-0003-3596-6983; Dunfield, Kari/0000-0003-1316-0452	Ontario Ministry of Natural Resources; Natural Sciences and Engineering Research Council of Canada	Ontario Ministry of Natural Resources; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded in part by a Research Chairship Grant from the Ontario Ministry of Natural Resources to Algoma University and by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to PMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla ME, 2000, MYCORRHIZA, V10, P29, DOI 10.1007/s005720050284; ANDERSON NA, 1982, ANNU REV PHYTOPATHOL, V20, P329, DOI 10.1146/annurev.py.20.090182.001553; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Borowicz VA, 2001, ECOLOGY, V82, P3057; Brundrett M, 1994, PRACTICAL METHODS MY, P42; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Dugassa GD, 1996, PLANT SOIL, V185, P173, DOI 10.1007/BF02257522; Graham JH, 2001, NEW PHYTOL, V149, P357, DOI 10.1046/j.1469-8137.2001.00077.x; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hart MM, 2003, TRENDS ECOL EVOL, V18, P418, DOI 10.1016/S0169-5347(03)00127-7; HETRICK BAD, 1991, EXPERIENTIA, V47, P355, DOI 10.1007/BF01972077; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Ismail Y, 2012, FUNCT PLANT BIOL, V39, P236, DOI 10.1071/FP11218; Jaiti F, 2007, PHYSIOL MOL PLANT P, V71, P166, DOI 10.1016/j.pmpp.2008.01.002; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Meyers L. S., 2006, APPL MULTIVARIATE RE; Mitchell CE, 2010, ECOL LETT, V13, P1525, DOI 10.1111/j.1461-0248.2010.01543.x; Moreira M, 2007, MYCORRHIZA, V17, P519, DOI 10.1007/s00572-007-0124-7; Mwangi MW, 2011, BRAZ J MICROBIOL, V42, P508, DOI [10.1590/S1517-83822011000200015, 10.1590/S1517-838220110002000015]; Neumann E, 2009, MYCORRHIZA, V20, P13, DOI 10.1007/s00572-009-0259-9; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Newsham KK, 1995, J ECOL, V83, P991, DOI 10.2307/2261180; Norman JR, 1996, PLANT SOIL, V185, P191, DOI 10.1007/BF02257524; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Parmeter JR, 1971, RHIZOCTONIA SOLANI B; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Royer F, 2006, WEEDS CANADA NO US; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Steinkellner S, 2012, MYCORRHIZA, V22, P189, DOI 10.1007/s00572-011-0393-z; Trotta A, 1996, PLANT SOIL, V185, P199, DOI 10.1007/BF02257525; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vigo C, 2000, PLANT PATHOL, V49, P509, DOI 10.1046/j.1365-3059.2000.00473.x; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Watanarojanaporn N, 2011, SCI HORTIC-AMSTERDAM, V128, P423, DOI 10.1016/j.scienta.2011.02.007; Wehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027381; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Wu QS, 2011, PLANT GROWTH REGUL, V65, P273, DOI 10.1007/s10725-011-9598-6; Wu QS, 2011, NOT BOT HORTI AGROBO, V39, P232; Yano K, 1996, MYCORRHIZA, V6, P409, DOI 10.1007/s005720050140; Yao MK, 2002, MYCORRHIZA, V12, P235, DOI 10.1007/s00572-002-0176-7	53	27	30	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61329	10.1371/journal.pone.0061329	http://dx.doi.org/10.1371/journal.pone.0061329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620744	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500024
J	Moiseeva, EP; Roach, KM; Leyland, ML; Bradding, P				Moiseeva, Elena P.; Roach, Katy M.; Leyland, Mark L.; Bradding, Peter			CADM1 Is a Key Receptor Mediating Human Mast Cell Adhesion to Human Lung Fibroblasts and Airway Smooth Muscle Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TUMOR-SUPPRESSOR; PROLIFERATION; MOLECULE; PROTEIN; EXPRESSION; ASTHMA; DIFFERENTIATION; INTERLEUKIN-6; ACTIVATION	Background: Mast cells (MCs) play a central role in the development of many diseases including asthma and pulmonary fibrosis. Interactions of human lung mast cells (HLMCs) with human airway smooth muscle cells (HASMCs) are partially dependent on adhesion mediated by cell adhesion molecule-1 (CADM1), but the adhesion mechanism through which HLMCs interact with human lung fibroblasts (HLFs) is not known. CADM1 is expressed as several isoforms (SP4, SP1, SP6) in HLMCs, with SP4 dominant. These isoforms differentially regulate HLMC homotypic adhesion and survival. Objective: In this study we have investigated the role of CADM1 isoforms in the adhesion of HLMCs and HMC-1 cells to primary HASMCs and HLFs. Methods: CADM1 overexpression or downregulation was achieved using adenoviral delivery of CADM1 short hairpin RNAs or isoform-specific cDNAs respectively. Results: Downregulation of CADM1 attenuated both HLMC and HMC-1 adhesion to both primary HASMCs and HLFs. Overexpression of either SP1 or SP4 isoforms did not alter MC adhesion to HASMCs, whereas overexpression of SP4, but not SP1, significantly increased both HMC-1 cell and HLMC adhesion to HLFs. The expression level of CADM1 SP4 strongly predicted the extent of MC adhesion; linear regression indicated that CADM1 accounts for up to 67% and 32% of adhesion to HLFs for HMC-1 cells and HLMCs, respectively. HLFs supported HLMC proliferation and survival through a CADM1-dependent mechanism. With respect to CADM1 counter-receptor expression, HLFs expressed both CADM1 and nectin-3, whereas HASMCs expressed only nectin-3. Conclusion and Clinical Relevance: Collectively these data indicate that the CADM1 SP4 isoform is a key receptor mediating human MC adhesion to HASMCs and HLFs. The differential expression of CADM1 counter-receptors on HLFs compared to HASMCs may allow the specific targeting of either HLMC-HLF or HLMC-HASMC interactions in the lung parenchyma and airways.	[Moiseeva, Elena P.; Roach, Katy M.; Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Leyland, Mark L.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Bradding, P (corresponding author), Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England.	pb46@le.ac.uk		Moiseeva, Elena/0000-0002-1590-1309; Roach, Katy M/0000-0002-4825-8719; Bradding, Peter/0000-0001-8403-0319	Medical Research Council, UK [87834]; ERDF [05567]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; Medical Research Council [G0801164] Funding Source: researchfish; MRC [G0801164] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERDF(European Commission); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by project grant no. 87834 from the Medical Research Council, UK (P. B. and M. L. L.) and was conducted in laboratories part-funded by ERDF #05567. This work is also supported by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bradding P, 1999, CRIT REV ONCOL HEMAT, V31, P119, DOI 10.1016/S1040-8428(99)00010-4; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; Fitzgerald SM, 2004, AM J RESP CELL MOL, V30, P585, DOI 10.1165/rcmb.2003-0282OC; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Gailit J, 2001, J INVEST DERMATOL, V117, P1113, DOI 10.1046/j.1523-1747.2001.15211.x; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garbuzenko E, 2002, CLIN EXP ALLERGY, V32, P237, DOI 10.1046/j.1365-2222.2002.01293.x; Girodet PO, 2010, ALLERGY, V65, P1004, DOI 10.1111/j.1398-9995.2009.02308.x; HEARD BE, 1992, J PATHOL, V166, P303, DOI 10.1002/path.1711660314; Hirata K, 2007, INT J MOL MED, V19, P565; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Koma Y, 2005, LAB INVEST, V85, P426, DOI 10.1038/labinvest.3700231; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P494; LEVISCHAFFER F, 1990, EXP CELL RES, V188, P42, DOI 10.1016/0014-4827(90)90275-F; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Moiseeva EP, 2013, MOL IMMUNOL, V53, P345, DOI 10.1016/j.molimm.2012.08.024; Moiseeva EP, 2012, CELL MOL LIFE SCI, V69, P2751, DOI 10.1007/s00018-012-0948-y; Moiseeva EP, 2011, ADV EXP MED BIOL, V716, P235, DOI 10.1007/978-1-4419-9533-9_13; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; PESCI A, 1993, CHEST, V103, P989, DOI 10.1378/chest.103.4.989; Piliponsky AM, 2003, BLOOD, V101, P1898, DOI 10.1182/blood-2002-05-1488; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sellge G, 2004, J IMMUNOL, V172, P260, DOI 10.4049/jimmunol.172.1.260; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Trautmann A, 1998, J IMMUNOL, V160, P5053; Wakayama T, 2007, BIOL REPROD, V76, P1081, DOI 10.1095/biolreprod.106.058974; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Yang WD, 2006, J IMMUNOL, V176, P1238, DOI 10.4049/jimmunol.176.2.1238	41	27	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61579	10.1371/journal.pone.0061579	http://dx.doi.org/10.1371/journal.pone.0061579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620770	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500050
J	Wang, F; Segatori, L				Wang, Fan; Segatori, Laura			Remodeling the Proteostasis Network to Rescue Glucocerebrosidase Variants by Inhibiting ER-Associated Degradation and Enhancing ER Folding	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; LYSOSOMAL STORAGE DISORDERS; GAUCHER-DISEASE; BETA-GLUCOSIDASE; MUTANT GLUCOCEREBROSIDASE; CHEMICAL CHAPERONES; GENE-FREQUENCIES; CALCIUM-RELEASE; BCL-2	Gaucher's disease (GD) is characterized by loss of lysosomal glucocerebrosidase (GC) activity. Mutations in the gene encoding GC destabilize the protein's native folding leading to ER-associated degradation (ERAD) of the misfolded enzyme. Enhancing the cellular folding capacity by remodeling the proteostasis network promotes native folding and lysosomal activity of mutated GC variants. However, proteostasis modulators reported so far, including ERAD inhibitors, trigger cellular stress and lead to induction of apoptosis. We show herein that lacidipine, an L-type Ca2+ channel blocker that also inhibits ryanodine receptors on the ER membrane, enhances folding, trafficking and lysosomal activity of the most severely destabilized GC variant achieved via ERAD inhibition in fibroblasts derived from patients with GD. Interestingly, reprogramming the proteostasis network by combining modulation of Ca2+ homeostasis and ERAD inhibition remodels the unfolded protein response and dramatically lowers apoptosis induction typically associated with ERAD inhibition.	[Wang, Fan; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University; Rice University	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.	segatori@rice.edu			Virginia and L.E. Simmons Family Foundation; Sid W. Richardson Foundation	Virginia and L.E. Simmons Family Foundation; Sid W. Richardson Foundation	This work was supported by the Virginia and L.E. Simmons Family Foundation and by the Sid W. Richardson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BEUTLER E, 1993, AM J HUM GENET, V52, P85; Bygrave FL, 1996, CELL CALCIUM, V19, P547, DOI 10.1016/S0143-4160(96)90064-0; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Ficicioglu Can, 2008, Ther Clin Risk Manag, V4, P425; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; HOOGERBRUGGE PM, 1995, LANCET, V345, P1398, DOI 10.1016/S0140-6736(95)92597-X; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Wang F, 2011, ACS CHEM BIOL, V6, P158, DOI 10.1021/cb100321m; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Xu SZ, 2008, J THROMB HAEMOST, V6, P692, DOI 10.1111/j.1538-7836.2008.02913.x; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i	45	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61418	10.1371/journal.pone.0061418	http://dx.doi.org/10.1371/journal.pone.0061418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620750	Green Published, gold			2022-12-25	WOS:000317909500030
J	Tang, J; Du, YP; Petrash, JM; Sheibani, N; Kern, TS				Tang, Jie; Du, Yunpeng; Petrash, J. Mark; Sheibani, Nader; Kern, Timothy S.			Deletion of Aldose Reductase from Mice Inhibits Diabetes-Induced Retinal Capillary Degeneration and Superoxide Generation	PLOS ONE			English	Article							OXIDATIVE-NITROSATIVE STRESS; BASEMENT-MEMBRANE; RETINOPATHY; HYPERGLYCEMIA; INFLAMMATION; ACTIVATION; ELECTRORETINOGRAM; ABNORMALITIES; EXPRESSION; PREVENTION	Purpose: Pharmacologic inhibition of aldose reductase (AR) previously has been studied with respect to diabetic retinopathy with mixed results. Since drugs can have off-target effects, we studied the effects of AR deletion on the development and molecular abnormalities that contribute to diabetic retinopathy. Since recent data suggests an important role for leukocytes in the development of the retinopathy, we determined also if AR in leukocytes contributes to leukocyte-mediated death of retinal endothelial cells in diabetes. Methods: Wild-type (WT; C57BL/6J) and AR deficient (AR(-/-)) mice were made diabetic with streptozotocin. Mice were sacrificed at 2 and 10 months of diabetes to evaluate retinal vascular histopathology, to quantify retinal superoxide production and biochemical and physiological abnormalities in the retina, and to assess the number of retinal endothelial cells killed by blood leukocytes in a co-culture system. Results: Diabetes in WT mice developed the expected degeneration of retinal capillaries, and increased generation of superoxide by the retina. Leukocytes from diabetic WT mice also killed more retinal endothelial cells than did leukocytes from nondiabetic animals (p<0.0001). Deletion of AR largely (P<0.05) inhibited the diabetes-induced degeneration of retinal capillaries, as well as the increase in superoxide production by retina. AR-deficiency significantly inhibited the diabetes-induced increase in expression of inducible nitric oxide synthase (iNOS) in retina, but had no significant effect on expression of intercellular adhesion molecule-1 (ICAM-1), phosphorylated p38 MAPK, or killing of retinal endothelial cells by leukocytes. Conclusions: AR contributes to the degeneration of retinal capillaries in diabetic mice. Deletion of the enzyme inhibits the diabetes-induced increase in expression of iNOS and of superoxide production, but does not correct a variety of other pro-inflammatory abnormalities associated with the development of diabetic retinopathy.	[Tang, Jie; Du, Yunpeng; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Tang, Jie] Heilongjiang Prov Hosp, Dept Ophthalmol, Harbin, Heilongjiang Pr, Peoples R China; [Petrash, J. Mark] Univ Colorado, Dept Ophthalmol, Denver, CO 80202 USA; [Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol, Madison, WI USA; [Kern, Timothy S.] Cleveland VAMC Res Serv 151, Cleveland, OH USA	Case Western Reserve University; University of Colorado System; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Madison	Kern, TS (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.	tsk@case.edu	Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217	PHS [EY00300]; Medical Research Service of the Department of Veteran Affairs; CWRU Visual Science Research Center Core Facilities [P30EY11373]; NATIONAL EYE INSTITUTE [R01EY005856, R01EY000300, P30EY011373, R56EY000300] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Medical Research Service of the Department of Veteran Affairs; CWRU Visual Science Research Center Core Facilities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by PHS grant EY00300 and a grant from the Medical Research Service of the Department of Veteran Affairs. Support services were provided by the CWRU Visual Science Research Center Core Facilities (P30EY11373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; AKAGI Y, 1990, EXP EYE RES, V50, P635, DOI 10.1016/0014-4835(90)90106-5; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Cheung AKH, 2007, EXP EYE RES, V85, P608, DOI 10.1016/j.exer.2007.07.013; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; COHN VH, 1966, ANAL BIOCHEM, V14, P434, DOI 10.1016/0003-2697(66)90286-7; Drel VR, 2008, INT J MOL MED, V21, P667; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; ENGERMAN RL, 1993, DIABETES, V42, P820, DOI 10.2337/diabetes.42.6.820; ENGERMAN RL, 1993, J DIABETES COMPLICAT, V7, P241, DOI 10.1016/0891-6632(93)90007-4; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; Hattori T, 2010, CURR EYE RES, V35, P146, DOI 10.3109/02713680903447918; HENNEKENS, 1990, ARCH OPHTHALMOL-CHIC, V108, P1234; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Hotta N, 1997, EUR J PHARMACOL, V326, P45, DOI 10.1016/S0014-2999(97)00135-0; Hotta N, 1995, EUR J CLIN INVEST, V25, P948, DOI 10.1111/j.1365-2362.1995.tb01972.x; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; KADOR PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1099, DOI 10.1001/archopht.1988.01060140255036; Kador PF, 1991, DIABETES 1991, P373; KERN TS, 1995, INVEST OPHTH VIS SCI, V36, P490; KINOSHITA JH, 1990, EXP EYE RES, V50, P567, DOI 10.1016/0014-4835(90)90096-D; KINOSHITA JH, 1986, AM J OPHTHALMOL, V102, P685, DOI 10.1016/0002-9394(86)90394-6; LAVER NM, 1993, INVEST OPHTH VIS SCI, V34, P2097; Li G, 2012, DIABETES; Li GY, 2011, MOL VIS, V17, P3156; Lo ACY, 2007, J CEREBR BLOOD F MET, V27, P1496, DOI 10.1038/sj.jcbfm.9600452; MACGREGOR LC, 1985, J CLIN INVEST, V76, P887, DOI 10.1172/JCI112048; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Pandey S, 2012, EXPERT OPIN INV DRUG, V21, P329, DOI 10.1517/13543784.2012.656198; Papezikova I, 2008, NEUROENDOCRINOL LETT, V29, P775; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Ramana KV, 2006, CYTOKINE, V36, P115, DOI 10.1016/j.cyto.2006.11.003; Ramana KV, 2006, CIRCULATION, V114, P1838, DOI 10.1161/CIRCULATIONAHA.106.630830; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Ramana KV, 2004, FASEB J, V18, P1209, DOI 10.1096/fj.04-1650com; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Reddy ABM, 2009, CYTOKINE, V48, P170, DOI 10.1016/j.cyto.2009.07.004; ROBISON WG, 1990, EXP EYE RES, V50, P355, DOI 10.1016/0014-4835(90)90136-I; ROBISON WG, 1986, DIABETES, V35, P295, DOI 10.2337/diabetes.35.3.295; ROBISON WG, 1989, INVEST OPHTH VIS SCI, V30, P2285; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Samuels IS, 2012, VISUAL NEUR IN PRESS; Shoeb M, 2011, FREE RADICAL BIO MED, V51, P1686, DOI 10.1016/j.freeradbiomed.2011.07.024; Spite M, 2007, BIOCHEM J, V405, P95, DOI 10.1042/BJ20061743; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R., 2012, J LEUKOC BIOL; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Yadav UCS, 2010, CURR MOL MED, V10, P540; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yadav UCS, 2011, CHEM-BIOL INTERACT, V191, P339, DOI 10.1016/j.cbi.2011.02.014; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	56	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62081	10.1371/journal.pone.0062081	http://dx.doi.org/10.1371/journal.pone.0062081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614016	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400151
J	Watanabe, J; Uehara, K; Mogi, Y				Watanabe, Jun; Uehara, Kenji; Mogi, Yoshinobu			Diversity of Mating-Type Chromosome Structures in the Yeast Zygosaccharomyces rouxii Caused by Ectopic Exchanges between MAT-Like Loci	PLOS ONE			English	Article							EVOLUTION; GENOME; SEX	We investigated sex chromosome diversity in Zygosaccharomyces rouxii (Z. rouxii). In the current study, we show that the organization of the mating-type (MAT) locus is highly variable in the Z. rouxii population, indicating the MAT, HML, and HMR loci are translocation hotspots. Although NBRC1130 and CBS732 were originally two stocks of the type strain of the species, only NBRC1130 retains the original karyotype. A reciprocal translocation between the MAT and HMR loci appears to have occurred during the early passage culture of CBS732, which was used for genome sequencing. In NBRC1733, NBRC0686, NBRC0740 and NBRC1053, the terminal region of the chromosome containing the HMR locus was replaced with the chromosomal region to the left of the MAT or HML loci. The translocation events found in NBRC1733, NBRC0686, NBRC0740, and NBRC1053 were reconstructed under our experimental conditions using the DA2 background, and the reconstruction suggests that the frequency of this type of translocation is approximately 10(-7). These results suggest that the MAT and MAT-like loci were the susceptible regions in the genome, and the diversity of mating-type chromosome structures in Z. rouxii was caused by ectopic exchanges between MAT-like loci.	[Watanabe, Jun; Uehara, Kenji; Mogi, Yoshinobu] Yamasa Corp, Mfg Div, Choshi, Chiba, Japan		Watanabe, J (corresponding author), Yamasa Corp, Mfg Div, Choshi, Chiba, Japan.	j_watanabe@yamasa.com			Yamasa corporation	Yamasa corporation	This study was funded by Yamasa corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Butler Geraldine, 2007, P3; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Gordon JL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002190; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Herskowitz I, 1992, MOL CELLULAR BIOL YE, P583; Iwaki T, 1998, YEAST, V14, P1167, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1167::AID-YEA318>3.0.CO;2-5; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Kinclova O, 2001, J BIOTECHNOL, V88, P151, DOI 10.1016/S0168-1656(01)00274-7; MORI H, 1982, J FERMENT TECHNOL, V60, P157; Pribylova L, 2003, J MICROBIOL METH, V55, P481, DOI 10.1016/S0167-7012(03)00197-0; Pribylova L, 2007, FEMS YEAST RES, V7, P1285, DOI 10.1111/j.1567-1364.2007.00308.x; Pribylova L, 2007, YEAST, V24, P171, DOI 10.1002/yea.1470; Rusche LN, 2010, GENE DEV, V24, P10, DOI 10.1101/gad.1886310; Rusche Laura N., 2007, P189; Sacchetti M, 1932, ARCH MIKROBIOL, V3, P473; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Solieri L, 2008, FUNGAL GENET BIOL, V45, P1582, DOI 10.1016/j.fgb.2008.10.001; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Srikantha T, 2003, EUKARYOT CELL, V2, P328, DOI 10.1128/EC.2.2.328-340.2003; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STRATHERN JN, 1980, P NATL ACAD SCI-BIOL, V77, P2839, DOI 10.1073/pnas.77.5.2839; Watanabe J, 2010, BIOSCI BIOTECH BIOCH, V74, P1092, DOI 10.1271/bbb.90865; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; [No title captured]	31	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62121	10.1371/journal.pone.0062121	http://dx.doi.org/10.1371/journal.pone.0062121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614024	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400156
J	Ishino, T; Wang, MM; Mosyak, L; Tam, A; Duan, WL; Svenson, K; Joyce, A; O'Hara, DM; Lin, L; Somers, WS; Kriz, R				Ishino, Tetsuya; Wang, Mengmeng; Mosyak, Lidia; Tam, Amy; Duan, Weili; Svenson, Kristine; Joyce, Alison; O'Hara, Denise M.; Lin, Laura; Somers, William S.; Kriz, Ronald			Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-G; AMINO-ACID; HUMAN IGG1; RECEPTOR; PHARMACOKINETICS; MICE; VARIANTS; PRIMATES; FRAGMENT	Human IgG is a bivalent molecule that has two identical Fab domains connected by a dimeric Fc domain. For therapeutic purposes, however, the bivalency of IgG and Fc fusion proteins could cause undesired properties. We therefore engineered the conversion of the natural dimeric Fc domain to a highly soluble monomer by introducing two Asn-linked glycans onto the hydrophobic C(H)3-C(H)3 dimer interface. The monomeric Fc (monoFc) maintained the binding affinity for neonatal Fc receptor (FcRn) in a pH-dependent manner. We solved the crystal structure of monoFc, which explains how the carbohydrates can stabilize the protein surface and provides the rationale for molecular recognition between monoFc and FcRn. The monoFc prolonged the in vivo half-life of an antibody Fab domain, and a tandem repeat of the monoFc further prolonged the half-life. This monoFc modality can be used to improve the pharmacokinetics of monomeric therapeutic proteins with an option to modulate the degree of half-life extension.	[Ishino, Tetsuya; Mosyak, Lidia; Tam, Amy; Duan, Weili; Svenson, Kristine; Lin, Laura; Somers, William S.; Kriz, Ronald] Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Wang, Mengmeng; Joyce, Alison; O'Hara, Denise M.] Pfizer Inc, Pharmacokinet Dynam & Metab, Andover, MA 01810 USA	Pfizer; Pfizer	Ishino, T (corresponding author), Pfizer Inc, Global Biotherapeut Technol, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	tetsuya.ishino@pfizer.com						BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BRAMBELL FW, 1964, NATURE, V203, P1352, DOI 10.1038/2031352a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; DEMIGNOT S, 1990, CANCER RES, V50, P2936; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; MARRACK J, 1955, ANNU REV MICROBIOL, V9, P369, DOI 10.1146/annurev.mi.09.100155.002101; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Prat M, 1998, J CELL SCI, V111, P237; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; ROITSCH T, 1989, EUR J BIOCHEM, V181, P525, DOI 10.1111/j.1432-1033.1989.tb14755.x; Rose RJ, 2013, MABS-AUSTIN, V5, P219, DOI 10.4161/mabs.23532; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	31	35	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16529	16537		10.1074/jbc.M113.457689	http://dx.doi.org/10.1074/jbc.M113.457689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615911	hybrid, Green Published			2022-12-25	WOS:000320378900029
J	Rice, SJ; Lai, SC; Wood, LW; Helsley, KR; Runkle, EA; Winslow, MM; Mu, D				Rice, Shawn J.; Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Runkle, E. Aaron; Winslow, Monte M.; Mu, David			MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; TUMOR-SUPPRESSOR; ADENOCARCINOMA; ONCOGENE; LET-7; CHOLESTEROL; EXPRESSION; TARGET; NKX2-1; DIFFERENTIATION	In lung cancers, TTF-1 displays seemingly paradoxical activities. Although TTF-1 is amplified in primary human lung cancers, it inhibits primary lung tumors from metastasizing in a mouse model system. It was reported that the oncogenic proepithelial mesenchymal transition (EMT) high mobility group AT-hook 2 gene (HMGA2) mediates the antimetastatic function of TTF-1. To gain mechanistic insight into the metastasis-critical signaling axis of TTF-1 to HMGA2, we used both reverse and forward strategies and discovered that microRNA-33a (miR-33a) is under direct positive regulation of TTF-1. By chromatin immunoprecipitation, we determined that TTF-1 binds to the promoter of SREBF2, the host gene of miR-33a. The 3'-untranslated region (UTR) of HMGA2 contains three predicted binding sites of miR-33a. We showed that the first two highly conserved sites are conducive to HMGA2 repression by miR-33a, establishing HMGA2 as a genuine target of miR-33a. Functional studies revealed that enforced expression of miR-33a inhibits the motility of lung cancer cells, and this inhibition can be rescued by overexpression of the form of HMGA2 without the 3'-UTR, suggesting that TTF-1 keeps the prometastasis gene HMGA2 in check via up-regulating miR-33a. This study reports the first miRNAs directly regulated by TTF-1 and clarifies how TTF-1 controls HMGA2 expression. Moreover, the documented importance of SREBF2 and miR-33a in regulating cholesterol metabolism suggests that TTF-1 may be a modulator of cholesterol homeostasis in the lung. Future studies will be dedicated to understanding how miRNAs influence the oncogenic activity of TTF-1 and the role of TTF-1 in cholesterol metabolism.	[Rice, Shawn J.] Penn State Univ, Penn State Canc Inst, Hershey, PA 17033 USA; [Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Mu, David] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA; [Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Mu, David] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Runkle, E. Aaron] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Winslow, Monte M.] Stanford Univ Sch Med, Dept Genet, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eastern Virginia Medical School; Eastern Virginia Medical School; University of Pennsylvania; Stanford University	Mu, D (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA.	mud@evms.edu	Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	National Institutes of Health, NCI [CA127547]; NATIONAL CANCER INSTITUTE [R01CA127547] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA127547 (to D.M.).	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kuo PL, 2013, BBA-GEN SUBJECTS, V1830, P3756, DOI 10.1016/j.bbagen.2013.02.022; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Qi Ji, 2012, Front Med, V6, P134, DOI 10.1007/s11684-012-0188-4; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; REDDEL RR, 1988, CANCER RES, V48, P1904; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Smith B, 2012, CELL REP, V2, P580, DOI 10.1016/j.celrep.2012.08.011; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sozzi G, 2011, CELL CYCLE, V10, P2045, DOI 10.4161/cc.10.13.15712; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Thomas M, 2012, ONCOGENE, V31, P918, DOI 10.1038/onc.2011.278; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	61	54	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16348	16360		10.1074/jbc.M113.474643	http://dx.doi.org/10.1074/jbc.M113.474643			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625920	hybrid, Green Published			2022-12-25	WOS:000320378900013
J	Sharma, P; Thakran, S; Deng, X; Elam, MB; Park, EA				Sharma, Pragya; Thakran, Shalini; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.			Nuclear Corepressors Mediate the Repression of Phospholipase A(2) Group IIa Gene Transcription by Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; SMOOTH-MUSCLE CELLS; KINASE 4 PDK4; CPT-I-ALPHA; NEGATIVE REGULATION; RECEPTOR COREPRESSOR; DIFFERENTIAL REGULATION; HISTONE DEACETYLASE; RESPONSE ELEMENT; HEPG2 CELLS	Secretory phospholipase A(2) group IIa (PLA2g2a) is associated with inflammation, hyperlipidemia, and atherogenesis. Transcription of the PLA2g2a gene is induced by multiple cytokines. Here, we report the surprising observation that thyroid hormone (T-3) inhibited PLA2g2a gene expression in human and rat hepatocytes as well as in rat liver. Moreover, T-3 reduced the cytokine-mediated induction of PLA2g2a, suggesting that the thyroid status may modulate aspects of the inflammatory response. In an effort to dissect the mechanism of repression by T-3, we cloned the PLA2g2a gene and identified a negative T-3 response element in the promoter. This T-3 receptor (TR beta)-binding site differed considerably from consensus T-3 stimulatory elements. Using in vitro and in vivo binding assays, we found that TR beta bound directly to the PLA2g2a promoter as a heterodimer with the retinoid X receptor. Knockdown of nuclear corepressor or silencing mediator for retinoid and thyroid receptors by siRNA blocked the T-3 inhibition of PLA2g2a. Using chromatin immunoprecipitation assays, we showed that nuclear corepressor and silencing mediator for retinoid and thyroid receptors were associated with the PLA2g2a gene in the presence of T-3. In contrast with the established role of T3 to promote coactivator association with TR beta, our experiments demonstrate a novel inverse recruitment mechanism in which liganded TR beta recruits corepressors to inhibit PLA2g2a expression.	[Sharma, Pragya; Thakran, Shalini; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.] Univ Tennessee Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Pharmacol, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0059368 (to E. A. P.) and DK075504 (to M. B. E.).	ADAMSON GM, 1994, J BIOCHEM TOXICOL, V9, P181, DOI 10.1002/jbt.2570090403; Angelin B, 2010, CURR OPIN LIPIDOL, V21, P499, DOI 10.1097/MOL.0b013e3283402e9c; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Arsenault BJ, 2011, EUR HEART J, V32, P923, DOI 10.1093/eurheartj/ehq385; Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; Boone LR, 2011, ATHEROSCLEROSIS, V218, P77, DOI 10.1016/j.atherosclerosis.2011.04.028; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304; Couturier C, 2000, ARTERIOSCL THROM VAS, V20, P2559, DOI 10.1161/01.ATV.20.12.2559; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Exeter HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041139; Fan QS, 1997, MOL CELL BIOL, V17, P4238, DOI 10.1128/MCB.17.8.4238; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Garces F, 2010, OBESITY, V18, P2023, DOI 10.1038/oby.2010.9; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; Ichiki T, 2010, VASC PHARMACOL, V52, P151, DOI 10.1016/j.vph.2009.09.004; Ikegami T, 2005, HEPATOLOGY, V41, P896, DOI 10.1002/hep.20630; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Kvetny J, 2004, CLIN ENDOCRINOL, V61, P232, DOI 10.1111/j.1365-2265.2004.02088.x; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; Li QL, 2001, AM J PHYSIOL-ENDOC M, V280, pE160, DOI 10.1152/ajpendo.2001.280.1.E160; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Liu YY, 2011, ENDOCRINOLOGY, V152, P1143, DOI 10.1210/en.2010-0580; Marimuthu A, 2002, MOL ENDOCRINOL, V16, P271, DOI 10.1210/me.16.2.271; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nevalainen TJ, 1996, LAB INVEST, V74, P585; Nygard M, 2003, MOL ENDOCRINOL, V17, P79, DOI 10.1210/me.2002-0107; Nygard M, 2006, J MOL ENDOCRINOL, V36, P517, DOI 10.1677/jme.1.01874; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Putcha BDK, 2009, J BIOL CHEM, V284, P22517, DOI 10.1074/jbc.M109.026682; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sadana P, 2011, ACS CHEM BIOL, V6, P1096, DOI 10.1021/cb200092v; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Thomas G, 2000, J BIOL CHEM, V275, P10876, DOI 10.1074/jbc.275.15.10876; Villa A, 2004, MOL ENDOCRINOL, V18, P863, DOI 10.1210/me.2003-0260; Walker G, 1997, BRIT J PHARMACOL, V121, P787, DOI 10.1038/sj.bjp.0701170; Wang HC, 1996, FASEB J, V10, P1318, DOI 10.1096/fasebj.10.11.8836046; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200	71	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16321	16333		10.1074/jbc.M112.445569	http://dx.doi.org/10.1074/jbc.M112.445569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629656	Green Published, hybrid			2022-12-25	WOS:000320378900011
J	Demurtas, OC; Massa, S; Ferrante, P; Venuti, A; Franconi, R; Giuliano, G				Demurtas, Olivia C.; Massa, Silvia; Ferrante, Paola; Venuti, Aldo; Franconi, Rosella; Giuliano, Giovanni			A Chlamydomonas-Derived Human Papillomavirus 16 E7 Vaccine Induces Specific Tumor Protection	PLOS ONE			English	Article							CERVICAL-CANCER; ANTICANCER ACTIVITY; PLANT; PROTEIN; REINHARDTII; EXPRESSION; TRANSFORMATION; PURIFICATION; CHLOROPLAST; ONCOPROTEIN	Background: The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular transformation, represents a key antigen for developing therapeutic vaccines against HPV-related lesions and cancers. Recombinant production of this vaccine antigen in an active form and in compliance with good manufacturing practices (GMP) plays a crucial role for developing effective vaccines. E7-based therapeutic vaccines produced in plants have been shown to be active in tumor regression and protection in pre-clinical models. However, some drawbacks of in whole-plant vaccine production encouraged us to explore the production of the E7-based therapeutic vaccine in Chlamydomonas reinhardtii, an organism easy to grow and transform and fully amenable to GMP guidelines. Methodology/Principal Findings: An expression cassette encoding E7GGG, a mutated, attenuated form of the E7 oncoprotein, alone or as a fusion with affinity tags (His6 or FLAG), under the control of the C. reinhardtii chloroplast psbD 5' UTR and the psbA 3' UTR, was introduced into the C. reinhardtii chloroplast genome by homologous recombination. The protein was mostly soluble and reached 0.12% of total soluble proteins. Affinity purification was optimized and performed for both tagged forms. Induction of specific anti-E7 IgGs and E7-specific T-cell proliferation were detected in C57BL/6 mice vaccinated with total Chlamydomonas extract and with affinity-purified protein. High levels of tumor protection were achieved after challenge with a tumor cell line expressing the E7 protein. Conclusions: The C. reinhardtii chloroplast is a suitable expression system for the production of the E7GGG protein, in a soluble, immunogenic form. The production in contained and sterile conditions highlights the potential of microalgae as alternative platforms for the production of vaccines for human uses.	[Demurtas, Olivia C.; Massa, Silvia; Ferrante, Paola; Franconi, Rosella; Giuliano, Giovanni] Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, ENEA, Rome, Italy; [Demurtas, Olivia C.] Ylichron Srl, Casaccia Res Ctr, ENEA, Rome, Italy; [Venuti, Aldo] Regina Elena Inst Canc Res, Virol Lab, Rome, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Franconi, R (corresponding author), Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, ENEA, Rome, Italy.	rosella.franconi@enea.it; giovanni.giuliano@enea.it	Massa, Silvia/AFX-5893-2022; Demurtas, Olivia Costantina/AFP-2630-2022; Giuliano, Giovanni/A-2701-2012; Venuti, Aldo/K-9637-2016	Giuliano, Giovanni/0000-0002-2486-0510; Venuti, Aldo/0000-0003-2322-6857	Italian Ministry of Agriculture (Project Hydrobio); FILAS SpA; AIRC [IG 12916]	Italian Ministry of Agriculture (Project Hydrobio); FILAS SpA; AIRC(Fondazione AIRC per la ricerca sul cancro)	Work funded by the Italian Ministry of Agriculture (Project Hydrobio), by FILAS SpA and by AIRC (IG 12916). The funding bodies did not have any role in design or interpretation of experiments or writing of the manuscript.	Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Buyel JF, 2012, J CHROMATOGR B, V880, P19, DOI 10.1016/j.jchromb.2011.11.010; Cerutti ML, 2012, INT J CANCER, V130, P1813, DOI 10.1002/ijc.26294; Da Silva DM, 2001, J CELL PHYSIOL, V186, P169, DOI 10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.3.CO;2-8; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Dreesen IAJ, 2010, J BIOTECHNOL, V145, P273, DOI 10.1016/j.jbiotec.2009.12.006; Dunn LA, 1997, VIROLOGY, V235, P94, DOI 10.1006/viro.1997.8650; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472; Franconi R, 2006, INT J IMMUNOPATH PH, V19, P187; Franconi R, 2002, CANCER RES, V62, P3654; Franconi R, 2010, EXPERT REV VACCINES, V9, P877, DOI [10.1586/erv.10.91, 10.1586/ERV.10.91]; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Futatsumori-Sugai M, 2009, PROTEIN EXPRES PURIF, V67, P148, DOI 10.1016/j.pep.2009.03.012; Giorgi C, 2010, EXPERT REV VACCINES, V9, P913, DOI 10.1586/ERV.10.84; Gregory JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037179; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; KINDLE KL, 1991, P NATL ACAD SCI USA, V88, P1721, DOI 10.1073/pnas.88.5.1721; Li SS, 2009, FISH SHELLFISH IMMUN, V26, P316, DOI 10.1016/j.fsi.2008.07.004; Lin KY, 1996, CANCER RES, V56, P21; Massa S, 2007, VACCINE, V25, P3018, DOI 10.1016/j.vaccine.2007.01.018; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morgenfeld M, 2009, MOL BIOTECHNOL, V43, P243, DOI 10.1007/s12033-009-9195-3; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; De la Rosa GP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-2; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Smahel M, 2001, VIROLOGY, V281, P231, DOI 10.1006/viro.2000.0794; Smal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036457; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Su JH, 2010, BIODRUGS, V24, P109, DOI 10.2165/11532810-000000000-00000; Sun M, 2003, BIOTECHNOL LETT, V25, P1087, DOI 10.1023/A:1024140114505; Surzycki R, 2009, BIOLOGICALS, V37, P133, DOI 10.1016/j.biologicals.2009.02.005; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Twyman RM, 2012, MOLECULAR FARMING IN PLANTS: RECENT ADVANCES AND FUTURE PROSPECTS, P145, DOI 10.1007/978-94-007-2217-0_7; van Steenwijk PJD, 2012, CANCER IMMUNOL IMMUN, V61, P1485, DOI 10.1007/s00262-012-1292-7; Venuti A, 2009, VACCINE, V27, P3395, DOI 10.1016/j.vaccine.2009.01.068; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	47	67	69	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61473	10.1371/journal.pone.0061473	http://dx.doi.org/10.1371/journal.pone.0061473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626690	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400054
J	Liang, GH; Liu, XZ; Chen, XM; Qiu, QY; Zhang, DQ; Chu, GW; Liu, JX; Liu, SZ; Zhou, GY				Liang, Guohua; Liu, Xingzhao; Chen, Xiaomei; Qiu, Qingyan; Zhang, Deqiang; Chu, Guowei; Liu, Juxiu; Liu, Shizhong; Zhou, Guoyi			Response of Soil Respiration to Acid Rain in Forests of Different Maturity in Southern China	PLOS ONE			English	Article							TROPICAL FOREST; MICROBIAL COMMUNITY; CO2 EFFLUX; DEPOSITION; CARBON; ECOSYSTEMS; TEMPERATE; ADDITIONS; ROOT; PRECIPITATION	The response of soil respiration to acid rain in forests, especially in forests of different maturity, is poorly understood in southern China despite the fact that acid rain has become a serious environmental threat in this region in recent years. Here, we investigated this issue in three subtropical forests of different maturity [i.e. a young pine forest (PF), a transitional mixed conifer and broadleaf forest (MF) and an old-growth broadleaved forest (BF)] in southern China. Soil respiration was measured over two years under four simulated acid rain (SAR) treatments (CK, the local lake water, pH 4.5; T1, water pH 4.0; T2, water pH 3.5; and T3, water pH 3.0). Results indicated that SAR did not significantly affect soil respiration in the PF, whereas it significantly reduced soil respiration in the MF and the BF. The depressed effects on both forests occurred mostly in the warm-wet seasons and were correlated with a decrease in soil microbial activity and in fine root biomass caused by soil acidification under SAR. The sensitivity of the response of soil respiration to SAR showed an increasing trend with the progressive maturity of the three forests, which may result from their differences in acid buffering ability in soil and in litter layer. These results indicated that the depressed effect of acid rain on soil respiration in southern China may be more pronounced in the future in light of the projected change in forest maturity. However, due to the nature of this field study with chronosequence design and the related pseudoreplication for forest types, this inference should be read with caution. Further studies are needed to draw rigorous conclusions regarding the response differences among forests of different maturity using replicated forest types.	[Liang, Guohua; Liu, Xingzhao; Chen, Xiaomei; Qiu, Qingyan; Zhang, Deqiang; Chu, Guowei; Liu, Juxiu; Liu, Shizhong; Zhou, Guoyi] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Liang, Guohua; Liu, Xingzhao; Chen, Xiaomei; Qiu, Qingyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, GY (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	gyzhou@scib.ac.cn	Liu, Juxiu/B-3400-2009; Liu, Xingzhao/GRO-2429-2022		Chinese Academy of Sciences [XDA05050205]; National Key Basic Research Development Program (973 Program) [2009CB421101]; Guangdong Provincial Natural Science Foundation [8351065005000001]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research Development Program (973 Program)(National Basic Research Program of China); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was financially supported by the Strategic Priority Research Program of Chinese Academy of Sciences (XDA05050205), the National Key Basic Research Development Program (973 Program) (2009CB421101) and the Guangdong Provincial Natural Science Foundation Project (No. 8351065005000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, TROP SUBTROP ECOSYS; BABA M, 1995, ENVIRON POLLUT, V89, P97, DOI 10.1016/0269-7491(94)00038-F; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Bernhardt ES, 2006, BIOGEOCHEMISTRY, V77, P91, DOI 10.1007/s10533-005-1062-0; BLANK LW, 1985, NATURE, V314, P311, DOI 10.1038/314311a0; Bohan L, 1998, GEODERMA, V86, P295, DOI 10.1016/S0016-7061(98)00041-X; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Busch G, 2001, ENVIRON SCI POLLUT R, V8, P95, DOI 10.1007/BF02987301; Cao YZ, 2009, ATMOS RES, V94, P462, DOI 10.1016/j.atmosres.2009.07.004; Chen ST, 2012, GEODERMA, V189, P65, DOI 10.1016/j.geoderma.2012.05.002; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Dai ZH, 1998, WATER AIR SOIL POLL, V108, P377, DOI 10.1023/A:1005015526022; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; [邓琦 DENG Qi], 2007, [地球科学进展, Advance in Earth Sciences], V22, P976; Dick WA, 2000, SOIL BIOL BIOCHEM, V32, P1915, DOI 10.1016/S0038-0717(00)00166-8; Ding M. M., 2001, IITF17 USDA FOR SERV; Dong Y. S., 1996, ACTA GEOGRAPHICA SIN, V51, P120; FAIRFAX JAW, 1975, NATURE, V255, P324, DOI 10.1038/255324a0; FALAPPI D, 1994, CHEMOSPHERE, V28, P1087, DOI 10.1016/0045-6535(94)90327-1; Fan HB, 2000, FOREST ECOL MANAG, V126, P321, DOI 10.1016/S0378-1127(99)00103-6; FRITZE H, 1992, Silva Fennica, V26, P37; Giardina CP, 2002, ECOSYSTEMS, V5, P487, DOI 10.1007/s10021-002-0130-8; GRESZTA J, 1992, WATER AIR SOIL POLL, V63, P51, DOI 10.1007/BF00475621; [洪江华 HONG Jiang-Hua], 2009, [生态学报, Acta Ecologica Sinica], V29, P5246; Huang C., 1999, ACTA ECOLOGICA SINIC, V19, P324; Huang YH, 2011, FOREST ECOL MANAG, V261, P1170, DOI 10.1016/j.foreco.2010.12.030; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Joner EJ, 2005, PLANT SOIL, V275, P295, DOI 10.1007/s11104-005-2287-3; Kita I, 2004, SCI TOTAL ENVIRON, V327, P285, DOI 10.1016/j.scitotenv.2004.01.012; Kong G., 1997, TROPICS, V6, P335; Kuperman RG, 1996, APPL SOIL ECOL, V4, P125, DOI 10.1016/0929-1393(96)00108-4; Kuzyakov Y, 2005, J PLANT NUTR SOIL SC, V168, P503, DOI 10.1002/jpln.200421703; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; LAWRENCE GB, 1995, NATURE, V378, P162, DOI 10.1038/378162a0; [刘菊秀 Liu Juxiu], 2003, [中国环境科学, China Environmental Science], V23, P90; Liu JuXiu, 2003, Acta Pedologica Sinica, V40, P763; Liu JX, 2006, ENVIRON SCI POLLUT R, V14, P123; [刘楠 Liu Nan], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P108; [刘源月 LIU Yuanyue], 2010, [生态学报, Acta Ecologica Sinica], V30, P2010; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; [马元丹 Ma Yuandan], 2010, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V49, P95; Mcfee WW, 1980, SENSITIVITY SOIL REG, P477; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2007, PLANT SOIL, V296, P125, DOI 10.1007/s11104-007-9303-8; MULDER J, 1989, NATURE, V337, P247, DOI 10.1038/337247a0; MUSSELMAN RC, 1991, J AIR WASTE MANAGE, V41, P798, DOI 10.1080/10473289.1991.10466876; NEUVONEN S, 1990, J APPL ECOL, V27, P857, DOI 10.2307/2404382; Oene VH, 1992, WATER AIR SOIL POLL, V63, P33; Ouyang XJ, 2008, PEDOSPHERE, V18, P503, DOI 10.1016/S1002-0160(08)60041-7; Pabian SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039755; Pan G. X., 1992, Pedosphere, V2, P179; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Pennanen T, 1998, APPL ENVIRON MICROB, V64, P2173; Phillips RP, 2004, WATER AIR SOIL POLL, V159, P339, DOI 10.1023/B:WATE.0000049187.35869.7d; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; REDDY GB, 1991, SOIL BIOL BIOCHEM, V23, P1115, DOI 10.1016/0038-0717(91)90022-C; RENNER R, 1995, ENVIRON SCI TECHNOL, V29, pA464, DOI 10.1021/es00010a750; REUSS JO, 1987, NATURE, V329, P27, DOI 10.1038/329027a0; SALIM R, 1994, J ENVIRON SCI HEAL A, V29, P115, DOI 10.1080/10934529409376025; Salimon CI, 2004, GLOBAL CHANGE BIOL, V10, P833, DOI 10.1111/j.1529-8817.2003.00776.x; SALONIUS PO, 1990, CAN J FOREST RES, V20, P910, DOI 10.1139/x90-122; Schaberg PG, 2001, ECOSYST HEALTH, V7, P214, DOI 10.1046/j.1526-0992.2001.01046.x; SCHAEDLE M, 1989, TREE PHYSIOL, V5, P337, DOI 10.1093/treephys/5.3.337; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; TURNER DP, 1990, WATER AIR SOIL POLL, V49, P205, DOI 10.1007/BF00279522; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang WX, 2009, PROG CHEM, V21, P266; WEN DZ, 2000, CHINESE J ECOL, V19, P11; WILL ME, 1986, J ENVIRON QUAL, V15, P399, DOI 10.2134/jeq1986.00472425001500040015x; Wilson JR, 1987, ADV NITROGEN CYCLING, P368; WOLTERS V, 1991, BIOL FERT SOILS, V11, P151, DOI 10.1007/BF00336381; Wu H., 1982, TROP SUBTROP ECOSYS, V1, P1; [谢小赞 XIE Xiao-Zan], 2009, [生态学报, Acta Ecologica Sinica], V29, P5713; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan JH, 2006, GLOBAL CHANGE BIOL, V12, P810, DOI 10.1111/j.1365-2486.2006.01141.x; Yan JH, 2009, SOIL BIOL BIOCHEM, V41, P991, DOI 10.1016/j.soilbio.2008.12.018; [杨玉盛 Yang Yusheng], 2004, [生态学报, Acta Ecologica Sinica], V24, P583; Yi ZG, 2007, CHINA J, V112, DOI [10.1029/2006JD008048, DOI 10.1029/2006JD008048]; Yu YuanChun, 2001, Journal of Nanjing Forestry University, V25, P39; Zhang DQ, 2006, SCI CHINA SER D, V49, P139, DOI 10.1007/s11430-006-8139-z; Zhang JE, 2007, CHEMOSPHERE, V67, P2131, DOI 10.1016/j.chemosphere.2006.12.095; Zhang Yong, 2011, China Environmental Science, V31, P1541; Zhou C. L., 1988, Journal of Ecology, China, V7, P21	86	25	43	12	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62207	10.1371/journal.pone.0062207	http://dx.doi.org/10.1371/journal.pone.0062207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626790	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400154
J	Araujo, PB; Cheng, S; Mete, O; Serra, S; Morin, E; Asa, SL; Ezzat, S				Araujo, Paula B.; Cheng, Sonia; Mete, Ozgur; Serra, Stefano; Morin, Emilie; Asa, Sylvia L.; Ezzat, Shereen			Evaluation of the WHO 2010 Grading and AJCC/UICC Staging Systems in Prognostic Behavior of Intestinal Neuroendocrine Tumors	PLOS ONE			English	Article							ENETS CONSENSUS GUIDELINES; RECEIVING OCTREOTIDE LAR; CARCINOID-TUMORS; SOMATOSTATIN ANALOG; UNITED-STATES; MANAGEMENT; EPIDEMIOLOGY; EXPRESSION; NEOPLASMS; DIAGNOSIS	Background: The increasing incidence and heterogeneous behavior of intestinal neuroendocrine tumors (iNETs) pose a clinicopathological challenge. Our goal was to decribe the prognostic value of the new WHO 2010 grading and the AJCC/UICC TNM staging systems for iNETs. Moreover, outcomes of patients treated with somatostatin analogs were assessed. Methods: We collected epidemiological and clinicopathological data from 93 patients with histologically proven iNETs including progression and survival outcomes. The WHO 2010 grading and the AJCC/UICC TNM staging systems were applied for all cases. RECIST criteria were used to define progression. Kaplan-Meier analyses for progression free survival (PFS) and overall survival (OS) were performed. Results: Mean follow-up was 58.6 months (4-213 months). WHO 2010 grading yielded PFS and disease-specific OS of 125.0 and 165.8 months for grade 1 (G1), 100.0 and 144.2 months for G2 and 15.0 and 15.8 months for G3 tumors (p = 0.004 and p = 0.001). Using AJCC staging, patients with stage I and II tumors had no progression and no deaths. Stage III and IV patients demonstrated PFS of 138.4 and 84.7 months (p = 0.003) and disease-specific OS of 210.0 and 112.8 months (p = 0.017). AJCC staging also provided informative PFS (91.2 vs. 50.0 months, p = 0.004) and OS (112.3 vs. 80.0 months, p = 0.005) measures with somatostatin analog use in stage IV patients. Conclusion: Our findings underscore the complementarity of WHO 2010 and AJCC classifications in providing better estimates of iNETS disease outcomes and extend the evidence for somatostatin analog benefit in patients with metastatic disease.	[Araujo, Paula B.; Cheng, Sonia; Morin, Emilie; Ezzat, Shereen] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Mete, Ozgur; Serra, Stefano; Asa, Sylvia L.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ezzat, S (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	shereen.ezzat@utoronto.ca		Mete, Ozgur/0000-0003-0469-2801; Asa, Sylvia/0000-0001-8418-5054; serra, stefano/0000-0002-3258-2637	Beverly and Raymond Sackler Foundation	Beverly and Raymond Sackler Foundation	This work was partially funded by the Beverly and Raymond Sackler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anthony L, 2011, PANCREAS, V40, P987, DOI 10.1097/MPA.0b013e31821f66b4; Asnacios A, 2008, J CLIN ONCOL, V26, P963, DOI 10.1200/JCO.2007.12.7431; Bergsand EK, 2013, SEMIN ONCOL, V40, P4, DOI 10.1053/j.seminoncol.2012.11.013; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI 10.1097/SLA.0b013e31818e4641; Boudreaux JP, 2010, PANCREAS, V39, P753, DOI 10.1097/MPA.0b013e3181ebb2a5; Bushnell DL, 2011, ENDOCRIN METAB CLIN, V40, P153, DOI 10.1016/j.ecl.2010.12.002; Cunningham JL, 2007, ACTA ONCOL, V46, P747, DOI 10.1080/02841860701218659; Dhall D, 2012, HUM PATHOL, V43, P489, DOI 10.1016/j.humpath.2011.06.011; Dong M, 2012, CLIN CANCER RES, V18, P1830, DOI 10.1158/1078-0432.CCR-11-2105; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fazio N, 2007, ANN ONCOL, V18, P13, DOI 10.1093/annonc/mdl144; Grozinsky-Glasberg S, 2008, ENDOCR-RELAT CANCER, V15, P701, DOI 10.1677/ERC-07-0288; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Kloppel G, 2010, VIRCHOWS ARCH, V456, P595, DOI 10.1007/s00428-010-0924-6; Landry CS, 2008, AM J SURG, V196, P896, DOI 10.1016/j.amjsurg.2008.07.042; Liu E, 2010, J SURG ONCOL, V102, P338, DOI 10.1002/jso.21634; Mete O, 2011, MODERN PATHOL, V24, P1545, DOI 10.1038/modpathol.2011.119; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Rindi G., 2010, WHO CLASSIFICATION T, P13; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Scherubl H, 2010, WORLD J GASTRO ENDOS, V2, P325, DOI 10.4253/wjge.v2.i10.325; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Toumpanakis C, 2009, ALIMENT PHARM THER, V30, P733, DOI 10.1111/j.1365-2036.2009.04083.x; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Valentino Joseph, 2011, Adv Surg, V45, P285; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; Vogl TJ, 2009, EUR J RADIOL, V72, P517, DOI 10.1016/j.ejrad.2008.08.008; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	31	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61538	10.1371/journal.pone.0061538	http://dx.doi.org/10.1371/journal.pone.0061538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620762	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500042
J	Luo, JC; Peng, YL; Hou, MC; Huang, KW; Huang, HC; Wang, YW; Lin, HC; Lee, FY; Lu, CL				Luo, Jiing-Chyuan; Peng, Yen-Ling; Hou, Ming-Chih; Huang, Kuang-Wei; Huang, Hui-Chun; Wang, Ying-Wen; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang			The Diminished Expression of Proangiogenic Growth Factors and Their Receptors in Gastric Ulcers of Cirrhotic Patients	PLOS ONE			English	Article							PORTAL-HYPERTENSION; LIVER-DISEASE; PEPTIC-ULCER; PLATELETS; PREVALENCE; THERAPY; RELEASE; INJURY	Objectives: The pathogenesis of the higher occurrence of peptic ulcer disease in cirrhotic patients is complex. Platelets can stimulate angiogenesis and promote gastric ulcer healing. We compared the expressions of proangiogenic growth factors and their receptors in the gastric ulcer margin between cirrhotic patients with thrombocytopenia and those of non-cirrhotic patients to elucidate possible mechanisms. Methods: Eligible cirrhotic patients (n = 55) and non-cirrhotic patients (n = 55) who had gastric ulcers were enrolled. Mucosa from the gastric ulcer margin and non-ulcer areas were sampled and the mRNA expressions of the proangiogenic growth factors (vascular endothelial growth factor [VEGF], platelet derived growth factor [PDGF], basic fibroblast growth factor [bFGF]) and their receptors (VEGFR1, VEGFR2, PDGFRA, PDGFRB, FGFR1, FGFR2) were measured and compared. Platelet count and the expressions of these growth factors and their receptors were correlated with each other. Results: The two groups were comparable in terms of gender, ulcer size and infection rate of Helicobacter pylori. However, the cirrhotic group were younger in age, had a lower platelet count than those in the non-cirrhotic group (p<0.05). The cirrhotic patients had diminished mRNA expressions of PDGFB, VEGFR2, FGFR1, and FGFR2 in gastric ulcer margin when compared with those of the non-cirrhotic patients (p<0.05). Diminished expressions of PDGFB and VEGFR2, FGFR1, and FGFR2 were well correlated with the degree of thrombocytopenia in these cirrhotic patients (rho>0.5, p<0.001). Conclusions: Our findings implied that diminished activity of proangiogenic factors and their receptors may contribute to the pathogenesis of gastric ulcers in cirrhotic patients.	[Luo, Jiing-Chyuan; Peng, Yen-Ling; Hou, Ming-Chih; Huang, Kuang-Wei; Huang, Hui-Chun; Wang, Ying-Wen; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Luo, Jiing-Chyuan; Peng, Yen-Ling; Hou, Ming-Chih; Huang, Kuang-Wei; Huang, Hui-Chun; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan; [Hou, Ming-Chih] Taipei Vet Gen Hosp, Endoscop Ctr Diag & Therapy, Dept Med, Taipei, Taiwan; [Wang, Ying-Wen] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Luo, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan.	jcluo@vghtpe.gov.tw			Taipei Veterans General Hospital [V101-028, V102C-006]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The present study was supported by research grants from the Taipei Veterans General Hospital (V101-028 and V102C-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; BECK PL, 1993, AM J PHYSIOL, V265, pG453, DOI 10.1152/ajpgi.1993.265.3.G453; Chen LS, 1996, J GASTROEN HEPATOL, V11, P59, DOI 10.1111/j.1440-1746.1996.tb00011.x; Hsu YC, 2012, HEPATOLOGY, V56, P698, DOI 10.1002/hep.25684; Huo TI, 2008, LIVER TRANSPLANT, V14, P837, DOI 10.1002/lt.21439; Iwao T, 1996, DIGEST DIS SCI, V41, P1727, DOI 10.1007/BF02088737; Jones MK, 2001, GASTROENTEROLOGY, V121, P1040, DOI 10.1053/gast.2001.29308; KAMEYAMA J, 1989, J GASTROEN HEPATOL, V4, P126; Luo JC, 2011, ALIMENT PHARM THER, V34, P519, DOI 10.1111/j.1365-2036.2011.04760.x; Luo JC, 2012, ALIMENT PHARM THER, V36, P542, DOI 10.1111/j.1365-2036.2012.05225.x; Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038; Luo JC, 2008, TRANSL RES, V152, P81, DOI 10.1016/j.trsl.2008.05.010; Luo JC, 2008, BIOCHEM PHARMACOL, V76, P841, DOI 10.1016/j.bcp.2008.07.010; Luo JC, 2012, EUR J PHARMACOL, V695, P112, DOI 10.1016/j.ejphar.2012.07.054; Luo JC, 2009, BRIT J CLIN PHARMACO, V68, P252, DOI 10.1111/j.1365-2125.2009.03445.x; Ma L, 2001, P NATL ACAD SCI USA, V98, P6470, DOI 10.1073/pnas.111150798; Ma L, 2006, GASTROINTESTINAL MUC, P117; MCCORMACK TT, 1985, GUT, V26, P1226, DOI 10.1136/gut.26.11.1226; Milani S, 2001, MICROSC RES TECHNIQ, V53, P360, DOI 10.1002/jemt.1104; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Perini R, 2005, DIG DIS SCI S, V50, P12; Przybylski M, 2009, J Wound Care, V18, P516; RABINOVITZ M, 1990, DIGEST DIS SCI, V35, P705, DOI 10.1007/BF01540171; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SARFEH IJ, 1989, DIGEST DIS SCI, V34, P225, DOI 10.1007/BF01536055; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Wallace JL, 2006, BRIT J PHARMACOL, V148, P274, DOI 10.1038/sj.bjp.0706722	27	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61426	10.1371/journal.pone.0061426	http://dx.doi.org/10.1371/journal.pone.0061426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620752	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500032
J	Hoffmann, CJ; Variava, E; Rakgokong, M; Masonoke, K; van der Watt, M; Chaisson, RE; Martinson, NA				Hoffmann, Christopher J.; Variava, Ebrahim; Rakgokong, Modiehi; Masonoke, Katlego; van der Watt, Martin; Chaisson, Richard E.; Martinson, Neil A.			High Prevalence of Pulmonary Tuberculosis but Low Sensitivity of Symptom Screening among HIV-Infected Pregnant Women in South Africa	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; ANTIRETROVIRAL THERAPY; MATERNAL MORTALITY; INFANTS; CULTURE; DURBAN; ASSAY; AGE	Symptom screening is a recommended component of intensified case-finding (ICF) for pulmonary tuberculosis (TB) among HIV-infected individuals. Symptomatic individuals are further investigated to either exclude or diagnose pulmonary TB, thus reducing the number of individuals requiring costly laboratory investigation. Those with laboratory evaluations negative for pulmonary TB or who lack symptoms may be eligible for antiretroviral therapy (ART) and/or TB isoniazid preventive therapy (IPT). A four-part symptom screen has been recommended by the World Health Organization (WHO) for identifying TB suspects and those unlikely to have TB. A meta-analysis of studies among HIV-infected individuals calculated a sensitivity of 90.1% for the four-part symptoms screen - of any of cough, fever, night sweats, or weight loss - among patients in clinical care, making it an effective tool for identifying most patients with TB. An important population for intensified case-finding not included in that meta-analysis was HIV-infected pregnant women. We undertook a cross-sectional survey among HIV-infected pregnant women receiving prenatal care at community clinics in South Africa. We obtained a four-symptom review and sputum smear microscopy and mycobacterial culture on all participants. Among 1415 women, 226 (16%) had a positive symptom screen, and 35 (2.5%) were newly diagnosed with culture-positive TB. Twelve were on TB treatment at the time of screening, yielding 47 (3.3%) women with prevalent TB. Symptom screening among women without known TB had a sensitivity of 28% and specificity of 84%. The poor performance of symptom screening to identify women with TB suggests that other approaches may be needed for intensified case-finding to be effective for this population.	[Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Variava, Ebrahim] Dept Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp, South Africa; [Rakgokong, Modiehi; Masonoke, Katlego; van der Watt, Martin; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa	Johns Hopkins University; University of Witwatersrand; University of Witwatersrand	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020	Variava, Ebrahim/0000-0003-2888-789X; Motlhaoleng, Katlego/0000-0001-7644-1038; Hoffmann, Christopher/0000-0002-9422-0519	Global Fund to Fight AIDS Tuberculosis and Malaria to the South African National Department of Health; SATBAT a Fogarty International Center [5U2RTW007370/3]; National Heart, Lung, and Blood Institute Lung Health research grant [R01 HL90312]; National Institutes of Health K23 research grant [AI083099]; Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K23AI083099] Funding Source: NIH RePORTER	Global Fund to Fight AIDS Tuberculosis and Malaria to the South African National Department of Health; SATBAT a Fogarty International Center; National Heart, Lung, and Blood Institute Lung Health research grant; National Institutes of Health K23 research grant; Johns Hopkins University Center for AIDS Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a research grant from the Global Fund to Fight AIDS Tuberculosis and Malaria to the South African National Department of Health. EV and MR received research training from SATBAT a Fogarty International Center funded program [5U2RTW007370/3]. REC and NAM are partially supported by a National Heart, Lung, and Blood Institute Lung Health research grant [R01 HL90312]. CJH is supported by a National Institutes of Health K23 research grant [AI083099]. REC is partly supported by the Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chheng R, 2008, INT J TUBERC LUNG D, V12, pS54; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; DeLuca A, 2009, JAIDS-J ACQ IMM DEF, V50, P196, DOI 10.1097/QAI.0b013e3181900201; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Figueroa-Damian R, 2001, ARCH MED RES, V32, P66, DOI 10.1016/S0188-4409(00)00266-6; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V57, pE77, DOI 10.1097/QAI.0b013e31821ac9c1; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Hanrahan CF, 2012, CLIN INFECT DIS, V54, P1377, DOI 10.1093/cid/cis122; Harris J, 2012, C RETR OPP INF SEATT; Kali PBN, 2006, JAIDS-J ACQ IMM DEF, V42, P379, DOI 10.1097/01.qai.0000218434.20404.9c; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2011, AIDS, V25, P2190, DOI 10.1097/QAD.0b013e32834cda4e; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Lin HC, 2010, BJOG-INT J OBSTET GY, V117, P585, DOI 10.1111/j.1471-0528.2010.02504.x; Meintjes G, 2009, CLIN CHEST MED, V30, P797, DOI 10.1016/j.ccm.2009.08.013; Mnyani CN, 2011, BJOG-INT J OBSTET GY, V118, P226, DOI 10.1111/j.1471-0528.2010.02771.x; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pillay T, 2001, SAMJ S AFR MED J, V91, P983; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Swaminathan S, 2004, INT J TUBERC LUNG D, V8, P896; Thind D, 2012, INT J TUBERC LUNG D, V16, P1643, DOI 10.5588/ijtld.12.0074; WHO, 2010, ANT THER HIV INF AD; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2011, GUID INT TUB CAS IS	34	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62211	10.1371/journal.pone.0062211	http://dx.doi.org/10.1371/journal.pone.0062211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614037	Green Published, gold			2022-12-25	WOS:000317907200125
J	Skovgaard, S; Nielsen, LN; Larsen, MH; Skov, RL; Ingmer, H; Westh, H				Skovgaard, Sissel; Nielsen, Lene Norby; Larsen, Marianne Halberg; Skov, Robert Leo; Ingmer, Hanne; Westh, Henrik			Staphylococcus epidermidis Isolated in 1965 Are More Susceptible to Triclosan than Current Isolates	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; CROSS-RESISTANCE; CLINICAL STRAINS; MUTANT STRAIN; BACTERIA; MECHANISM; INHIBITION; REDUCTASE; EXPOSURE; AGENT	Since its introduction to the market in the 1970s, the synthetic biocide triclosan has had widespread use in household and medical products. Although decreased triclosan susceptibility has been observed for several bacterial species, when exposed under laboratory settings, no in vivo studies have associated triclosan use with decreased triclosan susceptibility or cross-resistance to antibiotics. One major challenge of such studies is the lack of strains that with certainty have not been exposed to triclosan. Here we have overcome this challenge by comparing current isolates of the human opportunistic pathogen Staphylococcus epidermidis with isolates collected in the 1960s prior to introduction of triclosan to the market. Of 64 current S. epidermidis isolates 12.5% were found to have tolerance towards triclosan defined as MIC >= 0.25 mg/l compared to none of 34 isolates obtained in the 1960s. When passaged in the laboratory in the presence of triclosan, old and current susceptible isolates could be adapted to the same triclosan MIC level as found in current tolerant isolates. DNA sequence analysis revealed that laboratory-adapted strains carried mutations in fabI encoding the enoyl-acyl carrier protein reductase isoform, FabI, that is the target of triclosan, and the expression of fabI was also increased. However, the majority of the tolerant current isolates carried no mutations in fabI or the putative promoter region. Thus, this study indicates that the widespread use of triclosan has resulted in the occurrence of S. epidermidis with tolerance towards triclosan and that the adaptation involves FabI as well as other factors. We suggest increased caution in the general application of triclosan as triclosan has not shown efficacy in reducing infections and is toxic to aquatic organisms.	[Skovgaard, Sissel; Westh, Henrik] Hvidovre Univ Hosp, Dept Clin Microbiol, Copenhagen, Denmark; [Skovgaard, Sissel; Nielsen, Lene Norby; Larsen, Marianne Halberg; Ingmer, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Skov, Robert Leo] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut; University of Copenhagen	Skovgaard, S (corresponding author), Hvidovre Univ Hosp, Dept Clin Microbiol, Copenhagen, Denmark.	sissel.skovgaard@gmail.com; henrik.torkil.westh@regionh.dk	Skov, Robert/ABB-3105-2020	Skov, Robert/0000-0002-6079-5381; Westh, Henrik/0000-0001-5681-647X; Larsen, Marianne Halberg/0000-0001-6242-6937; Ingmer, Hanne/0000-0002-8350-5631	Danish Council for Strategic Research [09-0030]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Funded by the Danish Council for Strategic Research, 09-0030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2004, ANTIMICROB AGENTS CH, V48, P2973, DOI 10.1128/AAC.48.8.2973-2979.2004; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bayston R, 2007, J ANTIMICROB CHEMOTH, V59, P848, DOI 10.1093/jac/dkm031; Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Cole EC, 2003, J APPL MICROBIOL, V95, P664, DOI 10.1046/j.1365-2672.2003.02022.x; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Escalada MG, 2005, LETT APPL MICROBIOL, V41, P476, DOI 10.1111/j.1472-765X.2005.01790.x; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; European Committee on Antimicrobial Susceptibility Testing, ANT SUSC TEST EUCAST; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; JONES CL, 1988, J DENT RES, V67, P46, DOI 10.1177/00220345880670010901; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Meade MJ, 2001, FEMS MICROBIOL LETT, V204, P45, DOI 10.1111/j.1574-6968.2001.tb10860.x; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Russell AD, 2002, J APPL MICROBIOL, V92, p121S, DOI 10.1046/j.1365-2672.92.5s1.12.x; Saleh S, 2011, LETT APPL MICROBIOL, V52, P87, DOI 10.1111/j.1472-765X.2010.02976.x; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; SCCS, 2010, OP TRICL ANT RES; Schmid MB, 2004, ANTIMICROB AGENTS CH, V48, P1397, DOI 10.1128/AAC.48.4.1397-1399.2004; Seaman PF, 2007, J ANTIMICROB CHEMOTH, V59, P43, DOI 10.1093/jac/dkl450; Slater-Radosti C, 2001, J ANTIMICROB CHEMOTH, V48, P1, DOI 10.1093/jac/48.1.1; Suller MTE, 2000, J ANTIMICROB CHEMOTH, V46, P11, DOI 10.1093/jac/46.1.11; Sullivan A, 2003, CLIN MICROBIOL INFEC, V9, P306, DOI 10.1046/j.1469-0691.2003.00486.x; Tamura I, 2013, J APPL TOXICOL, V33, P1222, DOI 10.1002/jat.2771; Tkachenko O, 2007, RES MICROBIOL, V158, P651, DOI 10.1016/j.resmic.2007.09.003; Turtiainen J, 2012, WORLD J SURG, V36, P2528, DOI 10.1007/s00268-012-1655-4; Wootton M, 2009, INFECT CONT HOSP EP, V30, P226, DOI 10.1086/595691; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	41	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62197	10.1371/journal.pone.0062197	http://dx.doi.org/10.1371/journal.pone.0062197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614034	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400161
J	Taouji, S; Higa, A; Delom, F; Palcy, S; Mahon, FX; Pasquet, JM; Bosse, R; Segui, B; Chevet, E				Taouji, Said; Higa, Arisa; Delom, Frederic; Palcy, Sandrine; Mahon, Francois-Xavier; Pasquet, Jean-Max; Bosse, Roger; Segui, Bruno; Chevet, Eric			Phosphorylation of Serine Palmitoyltransferase Long Chain-1 (SPTLC1) on Tyrosine 164 Inhibits Its Activity and Promotes Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; IMATINIB-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; PROTEIN; CERAMIDE; TRAFFICKING; RESISTANCE; KINASE; CANCER; DEATH	In BCR-ABL-expressing cells, sphingolipid metabolism is altered. Because the first step of sphingolipid biosynthesis occurs in the endoplasmic reticulum (ER), our objective was to identify ABL targets in the ER. A phosphoproteomic analysis of canine pancreatic ER microsomes identified 49 high scoring phosphotyrosine-containing peptides. These were then categorized in silico and validated in vitro. We demonstrated that the ER-resident human protein serine palmitoyltransferase long chain-1 (SPTLC1), which is the first enzyme of sphingolipid biosynthesis, is phosphorylated at Tyr(164) by the tyrosine kinase ABL. Inhibition of BCR-ABL using either imatinib or shRNA-mediated silencing led to the activation of SPTLC1 and to increased apoptosis in both K562 and LAMA-84 cells. Finally, we demonstrated that mutation of Tyr(164) to Phe in SPTLC1 increased serine palmitoyltransferase activity. The Y164F mutation also promoted the remodeling of cellular sphingolipid content, thereby sensitizing K562 cells to apoptosis. Our observations provide a mechanistic explanation for imatinib-mediated cell death and a novel avenue for therapeutic strategies.	[Taouji, Said; Higa, Arisa; Chevet, Eric] INSERM, U1053, F-33076 Bordeaux, France; [Taouji, Said; Higa, Arisa; Mahon, Francois-Xavier; Pasquet, Jean-Max; Chevet, Eric] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Delom, Frederic; Palcy, Sandrine; Chevet, Eric] McGill Univ, Dept Surg, Montreal, PQ H4A 1A1, Canada; [Mahon, Francois-Xavier; Pasquet, Jean-Max] INSERM, U1035, F-33076 Bordeaux, France; [Bosse, Roger] PerkinElmer Biosignal Inc, Montreal, PQ H3J 1R4, Canada; [Segui, Bruno] Ctr Rech Cancerol Toulouse, Equipe 4, INSERM, UMR1037, F-31432 Toulouse 4, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Taouji, S (corresponding author), Univ Bordeaux Segalen, INSERM, U1053, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	said.taouji@inserm.fr; eric.chevet@u-bordeaux2.fr	Ségui, Bruno/O-8957-2014; Delom, Frederic/J-2782-2014; chevet, eric/E-4992-2016; PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019; TAOUJI, Saïd/K-5734-2014	Ségui, Bruno/0000-0002-6119-1889; Delom, Frederic/0000-0002-4600-7633; chevet, eric/0000-0001-5855-4522; PASQUET, JEAN-MAX/0000-0002-1345-3776; TAOUJI, Said/0000-0001-6736-9716	INSERM (Avenir); Institut National du Cancer (INCa); Ligue contre le Cancer; Association de Recherche contre le Cancer; Genome Quebec/Genome Canada; Marie Curie International Reintegration Grant	INSERM (Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue contre le Cancer(Ligue nationale contre le cancer); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Genome Quebec/Genome Canada(Genome Canada); Marie Curie International Reintegration Grant(European Commission)	This work was supported by grants from INSERM (Avenir), Institut National du Cancer (INCa), Ligue contre le Cancer, and the Association de Recherche contre le Cancer and a Marie Curie International Reintegration Grant (to E. C.) and a grant from Genome Quebec/Genome Canada (to the Cell Map project at the Montreal Proteomics Network).	Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Belloc F, 2009, LEUKEMIA, V23, P679, DOI 10.1038/leu.2008.364; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 1998, NUCLEIC ACIDS RES, V26, P382, DOI 10.1093/nar/26.1.382; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Burns TA, 2013, J LIPID RES, V54, P794, DOI 10.1194/jlr.M033985; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; Du YZ, 2006, BLOOD, V107, P1582, DOI 10.1182/blood-2005-06-2318; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hofius D, 2011, CELL DEATH DIFFER, V18, P1257, DOI 10.1038/cdd.2011.43; Ibitayo AI, 1998, AM J PHYSIOL-GASTR L, V275, pG705, DOI 10.1152/ajpgi.1998.275.4.G705; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; John AM, 2004, SEMIN CANCER BIOL, V14, P41, DOI 10.1016/j.semcancer.2003.11.006; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Lowther J, 2011, FEBS LETT, V585, P1729, DOI 10.1016/j.febslet.2011.04.013; Manna SK, 2000, J BIOL CHEM, V275, P13297, DOI 10.1074/jbc.275.18.13297; Nakatani H, 2006, INT J MOL MED, V17, P893; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pattacini L, 2004, LEUKEMIA RES, V28, P191, DOI 10.1016/S0145-2126(03)00218-2; Ricci C, 2006, BBA-BIOMEMBRANES, V1758, P2121, DOI 10.1016/j.bbamem.2006.06.016; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tamehiro N, 2009, J BIOL CHEM, V284, P24881, DOI 10.1074/jbc.M109.014365; Tanimura A, 2009, LEUKEMIA RES, V33, P924, DOI 10.1016/j.leukres.2009.01.027; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041	37	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17190	17201		10.1074/jbc.M112.409185	http://dx.doi.org/10.1074/jbc.M112.409185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629659	Green Published, hybrid			2022-12-25	WOS:000320380600016
J	Davey, L; Ng, CKW; Halperin, SA; Lee, SF				Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.			Functional Analysis of Paralogous Thiol-disulfide Oxidoreductases in Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ISOPEPTIDE BONDS; CYTOCHROME-C MATURATION; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; FORMATION PATHWAY; CRYSTAL-STRUCTURE	Disulfide bonds are important for the stability of many extracellular proteins, including bacterial virulence factors. Formation of these bonds is catalyzed by thiol-disulfide oxidoreductases (TDORs). Little is known about their formation in Gram-positive bacteria, particularly among facultative anaerobic Firmicutes, such as streptococci. To investigate disulfide bond formation in Streptococcus gordonii, we identified five putative TDORs from the sequenced genome. Each of the putative TDOR genes was insertionally inactivated with an erythromycin resistance cassette, and the mutants were analyzed for autolysis, extracellular DNA release, biofilm formation, bacteriocin production, and genetic competence. This analysis revealed a single TDOR, SdbA, which exhibited a pleiotropic mutant phenotype. Using an in silico analysis approach, we identified the major autolysin AtlS as a natural substrate of SdbA and showed that SdbA is critical to the formation of a disulfide bond that is required for autolytic activity. Analysis by BLAST search revealed homologs to SdbA in other Gram-positive species. This study provides the first in vivo evidence of an oxidoreductase, SdbA, that affects multiple phenotypes in a Gram-positive bacterium. SdbA shows low sequence homology to previously identified oxidoreductases, suggesting that it may belong to a different class of enzymes. Our results demonstrate that SdbA is required for disulfide bond formation in S. gordonii and indicate that this enzyme may represent a novel type of oxidoreductase in Gram-positive bacteria.	[Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada; [Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Izaak Walton Killam Hlth Ctr, Halifax, NS B3K 6R8, Canada; [Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Fac Med, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Lee, Song F.] Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Lee, SF (corresponding author), Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, 5981 Univ Ave, Halifax, NS B3H 4R2, Canada.	song.lee@dal.ca		Davey, Lauren/0000-0002-9541-485X; Halperin, Scott/0000-0003-0525-589X	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andisi VF, 2012, INFECT IMMUN, V80, P1037, DOI 10.1128/IAI.05563-11; Baker MD, 2004, PROTEIN SCI, V13, P2285, DOI 10.1110/ps.04826804; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; Chim N, 2010, J MOL BIOL, V396, P1211, DOI 10.1016/j.jmb.2009.12.060; CLAVERYS JP, 1995, GENE, V164, P123, DOI 10.1016/0378-1119(95)00485-O; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Davis E, 2011, APPL ENVIRON MICROB, V77, P1660, DOI 10.1128/AEM.02178-10; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fontaine L, 2008, APPL ENVIRON MICROB, V74, P1102, DOI 10.1128/AEM.02030-07; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Heng NCK, 2007, J BACTERIOL, V189, P1468, DOI 10.1128/JB.01174-06; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Heras B, 2007, ACTA CRYSTALLOGR F, V63, P953, DOI 10.1107/S174430910704821X; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; ISHIHARA T, 1995, J BACTERIOL, V177, P745, DOI 10.1128/jb.177.3.745-749.1995; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Knight JB, 2008, CLIN VACCINE IMMUNOL, V15, P925, DOI 10.1128/CVI.00500-07; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Lee SF, 2002, FEMS MICROBIOL LETT, V208, P175, DOI 10.1016/S0378-1097(02)00457-3; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Liu G, 2009, MICROBIOL-SGM, V155, P584, DOI 10.1099/mic.0.022707-0; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lunsford RD, 1996, J BACTERIOL, V178, P5831, DOI 10.1128/jb.178.19.5831-5835.1996; Mavridou DAI, 2012, FEBS LETT, V586, P1702, DOI 10.1016/j.febslet.2012.04.055; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; van der Kooi-Pol MM, 2012, APPL ENVIRON MICROB, V78, P7124, DOI 10.1128/AEM.01565-12; Wey JJ, 2006, ACTA PHARMACOL SIN, V27, P1238, DOI 10.1111/j.1745-7254.2006.00372.x; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994; Zhang Y, 2005, INFECT IMMUN, V73, P3351, DOI 10.1128/IAI.73.6.3351-3357.2005; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0	63	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16416	16429		10.1074/jbc.M113.464578	http://dx.doi.org/10.1074/jbc.M113.464578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615907	hybrid, Green Published			2022-12-25	WOS:000320378900019
J	Neukamm, SS; Ott, J; Dammeier, S; Lehmann, R; Haring, HU; Schleicher, E; Weigert, C				Neukamm, Sabine S.; Ott, Jennifer; Dammeier, Sascha; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora			Phosphorylation of Serine 1137/1138 of Mouse Insulin Receptor Substrate (IRS) 2 Regulates cAMP-dependent Binding to 14-3-3 Proteins and IRS2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FATTY-ACIDS; DUAL ROLE; 14-3-3-PROTEINS; EXPRESSION; SPECIFICITY; INDUCTION	Insulin receptor substrate (IRS) 2 as intermediate docking platform transduces the insulin/IGF-1 (insulin like growth factor 1) signal to intracellular effector molecules that regulate glucose homeostasis, beta-cell growth, and survival. Previously, IRS2 has been identified as a 14-3-3 interaction protein. 14-3-3 proteins can bind their target proteins via phosphorylated serine/threonine residues located within distinct motifs. In this study the binding of 14-3-3 to IRS2 upon stimulation with forskolin or the cAMP analog 8-(4-chlorophenylthio)-cAMP was demonstrated in HEK293 cells. Binding was reduced with PKA inhibitors H89 or R-p-8-Br-cAMPS. Phosphorylation of IRS2 on PKA consensus motifs was induced by forskolin and the PKA activator N-6-Phe-cAMP and prevented by both PKA inhibitors. The amino acid region after position 952 on IRS2 was identified as the 14-3-3 binding region by GST-14-3-3 pulldown assays. Mass spectrometric analysis revealed serine 1137 and serine 1138 as cAMP-dependent, potential PKA phosphorylation sites. Mutation of serine 1137/1138 to alanine strongly reduced the cAMP-dependent 14-3-3 binding. Application of cycloheximide revealed that forskolin enhanced IRS2 protein stability in HEK293 cells stably expressing IRS2 as well as in primary hepatocytes. Stimulation with forskolin did not increase protein stability either in the presence of a 14-3-3 antagonist or in the double 1137/1138 alanine mutant. Thus the reduced IRS2 protein degradation was dependent on the interaction with 14-3-3 proteins and the presence of serine 1137/1138. We present serine 1137/1138 as novel cAMP-dependent phosphorylation sites on IRS2 and show their importance in 14-3-3 binding and IRS2 protein stability.	[Neukamm, Sabine S.; Lehmann, Rainer; Schleicher, Erwin; Weigert, Cora] Univ Tubingen Hosp, Div Clin Chem & Pathobiochem, D-72076 Tubingen, Germany; [Haering, Hans-Ulrich] Univ Tubingen Hosp, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Dept Internal Med 4, D-72076 Tubingen, Germany; [Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora] Univ Tubingen Hosp, German Ctr Diabet Res DZD, D-72076 Tubingen, Germany; [Ott, Jennifer; Dammeier, Sascha] Univ Tubingen Hosp, Inst Ophtalm Res, Med Proteome Ctr, D-72076 Tubingen, Germany; [Neukamm, Sabine S.; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Paul Langerhans Inst Tuebingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Weigert, C (corresponding author), Univ Tubingen, Dept Internal Med 4, Div Pathobiochem & Clin Chem, Otfried Mueller Str 10, D-72076 Tubingen, Germany.	Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019	Lehmann, Rainer/0000-0003-1218-6810	Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research (BMBF) [GRK 1302/2]; European Community's Seventh Framework Programme [241955]	Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme	This work was supported by Grant GRK 1302/2 from the Deutsche Forschungsgemeinschaft (to H. U. H., E. S., and C. W.) in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), and by European Community's Seventh Framework Programme FP7/2009 Grant 241955.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neukamm SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043296; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Sharfi H, 2008, AM J PHYSIOL-ENDOC M, V294, pE307, DOI 10.1152/ajpendo.00534.2007; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yi ZP, 2005, ANAL CHEM, V77, P5693, DOI 10.1021/ac050760y; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	60	24	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16403	16415		10.1074/jbc.M113.474593	http://dx.doi.org/10.1074/jbc.M113.474593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615913	Green Published, hybrid			2022-12-25	WOS:000320378900018
J	Alhusaini, S; Scanlon, C; Ronan, L; Maguire, S; Meaney, JF; Fagan, AJ; Boyle, G; Borgulya, G; Iyer, PM; Brennan, P; Costello, D; Chaila, E; Fitzsimons, M; Doherty, CP; Delanty, N; Cavalleri, GL				Alhusaini, Saud; Scanlon, Cathy; Ronan, Lisa; Maguire, Sinead; Meaney, James F.; Fagan, Andrew J.; Boyle, Gerard; Borgulya, Gabor; Iyer, Parameswaran M.; Brennan, Paul; Costello, Daniel; Chaila, Elijah; Fitzsimons, Mary; Doherty, Colin P.; Delanty, Norman; Cavalleri, Gianpiero L.			Heritability of Subcortical Volumetric Traits in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HIPPOCAMPAL SCLEROSIS; MAGNETIC-RESONANCE; CORTICAL SURFACE; COORDINATE SYSTEM; MRI; ATROPHY; GENETICS; SEGMENTATION; AMYGDALA	Objectives: We aimed to 1) determine if subcortical volume deficits are common to mesial temporal lobe epilepsy (MTLE) patients and their unaffected siblings 2) assess the suitability of subcortical volumetric traits as endophenotypes for MTLE. Methods: MRI-based volume measurements of the hippocampus, amygdala, thalamus, caudate, putamen and pallidium were generated using an automated brain reconstruction method (FreeSurfer) for 101 unrelated 'sporadic' MTLE patients [70 with hippocampal sclerosis (MTLE+HS), 31 with MRI-negative TLE], 83 unaffected full siblings of patients and 86 healthy control subjects. Changes in the volume of subcortical structures in patients and their unaffected siblings were determined by comparison with healthy controls. Narrow sense heritability was estimated ipsilateral and contralateral to the side of seizure activity. Results: MTLE+HS patients displayed significant volume deficits across the hippocampus, amygdala and thalamus ipsilaterally. In addition, volume loss was detected in the putamen bilaterally. These volume deficits were not present in the unaffected siblings of MTLE+HS patients. Ipsilaterally, the heritability estimates were dramatically reduced for the volume of the hippocampus, thalamus and putamen but remained in the expected range for the amygdala. MRI-negative TLE patients and their unaffected siblings showed no significant volume changes across the same structures and heritability estimates were comparable with calculations from a healthy population. Conclusions: The findings indicate that volume deficits for many subcortical structures in 'sporadic' MTLE+HS are not heritable and likely related to acquired factors. Therefore, they do not represent suitable endophenotypes for MTLE+HS. The findings also support the view that, at a neuroanatomical level, MTLE+HS and MRI-negative TLE represent two distinct forms of MTLE.	[Alhusaini, Saud; Borgulya, Gabor; Delanty, Norman; Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut Dept, Dublin 2, Ireland; [Alhusaini, Saud; Scanlon, Cathy; Ronan, Lisa; Fitzsimons, Mary] Beaumont Hosp, Brain Morphometry Lab, Epilepsy Programme, Dublin 9, Ireland; [Scanlon, Cathy] Natl Univ Ireland, Dept Psychiat, Clin Neuroimaging Lab, Galway, Ireland; [Ronan, Lisa] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England; [Maguire, Sinead; Brennan, Paul] Beaumont Hosp, Dept Radiol, Dublin 9, Ireland; [Meaney, James F.; Fagan, Andrew J.; Boyle, Gerard] St James Hosp, Ctr Adv Med Imaging, Dublin, Ireland; [Iyer, Parameswaran M.; Doherty, Colin P.] St James Hosp, Dept Neurol, Dublin, Ireland; [Costello, Daniel] Cork Univ Hosp, Dept Neurol, Cork, Ireland; [Chaila, Elijah; Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland	Royal College of Surgeons - Ireland; Ollscoil na Gaillimhe-University of Galway; University of Cambridge; Trinity College Dublin; Trinity College Dublin; University College Cork	Cavalleri, GL (corresponding author), Royal Coll Surgeons Ireland, Mol & Cellular Therapeut Dept, Dublin 2, Ireland.	gcavalleri@rcsi.ie	Cavalleri, Gianpiero/A-6632-2010; Fagan, Andrew J/H-7962-2012; Scanlon, Cathy/G-9946-2013	Fagan, Andrew J/0000-0002-5528-9732; Meaney, James FM/0000-0003-1596-4972; Costello, Daniel/0000-0001-6023-8246; Borgulya, Gabor/0000-0001-6396-6126; Doherty, Colin/0000-0002-8869-8567; Delaney, Norman/0000-0002-3953-9842; Cavalleri, Gianpiero/0000-0002-9802-0506	Science Foundation Ireland Research Frontiers Programme [08/RFP/GEN1538]	Science Foundation Ireland Research Frontiers Programme(Science Foundation Ireland)	This work was funded by Science Foundation Ireland Research Frontiers Programme award 08/RFP/GEN1538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhusaini S, 2012, EPILEPSIA, V53, P995, DOI 10.1111/j.1528-1167.2012.03457.x; Alhusaini S, 2012, EPILEPSY RES, V99, P156, DOI 10.1016/j.eplepsyres.2011.11.005; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; BERKOVIC SF, 1991, ANN NEUROL, V29, P175, DOI 10.1002/ana.410290210; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bernasconi N, 2001, NEUROLOGY, V56, P1335, DOI 10.1212/WNL.56.10.1335; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Briellmann RS, 2002, ANN NEUROL, V51, P641, DOI 10.1002/ana.10171; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fuerst D, 2003, ANN NEUROL, V53, P413, DOI 10.1002/ana.10509; Gambardella A, 2009, EPILEPSIA, V50, P55, DOI 10.1111/j.1528-1167.2009.02123.x; Glahn DC, 2007, HUM BRAIN MAPP, V28, P488, DOI 10.1002/hbm.20401; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Hermann BP, 2005, EPILEPSY BEHAV, V7, P279, DOI 10.1016/j.yebeh.2005.05.022; Jackson GD, 1998, NEUROLOGY, V51, P78, DOI 10.1212/WNL.51.1.78; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Kobayashi E, 2002, ARCH NEUROL-CHICAGO, V59, P1891, DOI 10.1001/archneur.59.12.1891; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Labate A, 2011, EPILEPSIA, V52, P712, DOI 10.1111/j.1528-1167.2011.03038.x; Luther N, 2011, EPILEPSIA, V52, P941, DOI 10.1111/j.1528-1167.2011.03061.x; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mueller SG, 2009, NEUROIMAGE, V46, P353, DOI 10.1016/j.neuroimage.2009.02.020; Mueller SG, 2009, EPILEPSIA, V50, P1474, DOI 10.1111/j.1528-1167.2009.02010.x; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; Ronan L, 2011, EPILEPSIA, V52, P28, DOI 10.1111/j.1528-1167.2010.02895.x; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Vadlamudi L, 2003, J NEUROL NEUROSUR PS, V74, P1359, DOI 10.1136/jnnp.74.10.1359; Vossler DG, 2004, EPILEPSIA, V45, P497, DOI 10.1111/j.0013-9580.2004.47103.x; Wieser HG, 2004, EPILEPSIA, V45, P32	40	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61880	10.1371/journal.pone.0061880	http://dx.doi.org/10.1371/journal.pone.0061880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626743	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400107
J	Alvarado-Esquivel, C				Alvarado-Esquivel, Cosme			Toxocara Infection in Psychiatric Inpatients: A Case Control Seroprevalence Study	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; NORTHERN MEXICAN CITY; SEROEPIDEMIOLOGY; DIAGNOSIS	Background: There is poor knowledge about the epidemiology of toxocariasis in psychiatric patients. Aims: Determine the seroepidemiology of Toxocara infection in psychiatric patients. Methods: Through a case-control seroprevalence study, 128 psychiatric inpatients and 276 control subjects were compared for the presence of anti-Toxocara IgG antibodies in Durango, Mexico. Socio-demographic, clinical, and behavioral characteristics of inpatients associated with toxocariasis were also investigated. Results: Six of the 128 (4.7%) psychiatric inpatients, and 3 (1.1%) of the 276 controls were positive for anti-Toxocara IgG antibodies (P = 0.03). Stratification by age showed that Toxocara seroprevalence was significantly (P = 0.02) higher in patients aged <= 50 years old (6/90: 6.7%) than controls of the same age (2/163: 1.2%). While Toxocara seroprevalence was similar in patients and controls aged >50 years old. Stratification by gender showed that Toxocara seroprevalence was significantly (P = 0.03) higher in female patients (2/37:5.4%) than in female controls (0/166.0%). No statistically significant associations between Toxocara seropositivity and clinical characteristics were found. In contrast, Toxocara seropositivity was associated with consumption of goat meat and raw sea snail. Conclusions: This is the first report of toxocariasis in psychiatric inpatients in Mexico. Further studies with larger sample sizes are needed to elucidate the association of toxocariasis with psychiatric diseases. The role of the consumption of goat meat and raw sea snail in the transmission of Toxocara deserve further investigation.	Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico	Universidad Juarez del Estado de Durango	Alvarado-Esquivel, C (corresponding author), Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico.	alvaradocosme@yahoo.com			Faculty of Medicine and Nutrition	Faculty of Medicine and Nutrition	The study was supported by the Faculty of Medicine and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2011, J PARASITOL, V97, P40, DOI 10.1645/GE-2612.1; Alvarado-Esquivel C, 2013, J HELMINTHOL, V3, P1; Alvarado-Esquivel C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-178; Alvarado-Esquivel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054897; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; Di Fiore M, 1989, Boll Ist Sieroter Milan, V68, P93; Finsterer J, 2010, REV MED CHILE, V138, P483, DOI /S0034-98872010000400014; Guillot J, 2007, B ACAD NAT MED PARIS, V191, P67, DOI 10.1016/S0001-4079(19)33116-4; Kaplan M, 2008, YONSEI MED J, V49, P224, DOI 10.3349/ymj.2008.49.2.224; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1, DOI 10.3347/kjp.2001.39.1.1; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P215, DOI 10.3109/10408419709115137; Pelloux H, 2004, REV MED INTERNE, V25, P201, DOI 10.1016/S0248-8663(03)00258-3; Richartz E, 2002, NERVENARZT, V73, P458, DOI 10.1007/s001150001028; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Sariego I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001382; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Woodhall D, 2012, OPHTHALMOLOGY, V119, P1211, DOI 10.1016/j.ophtha.2011.12.013	17	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62606	10.1371/journal.pone.0062606	http://dx.doi.org/10.1371/journal.pone.0062606			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626838	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400202
J	John, AM; George, PDC; Ebenazer, A; Seshadri, MS; Nair, A; Rajaratnam, S; Pai, R				John, Anulekha Mary; George, Priya Doss C.; Ebenazer, Andrew; Seshadri, Mandalam Subramaniam; Nair, Aravindan; Rajaratnam, Simon; Pai, Rekha			p.Arg82Leu von Hippel-Lindau (VHL) Gene Mutation among Three Members of a Family with Familial Bilateral Pheochromocytoma in India: Molecular Analysis and In Silico Characterization	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; GERMLINE MUTATIONS; UNCLASSIFIED VARIANTS; PROTEIN STABILITY; DISEASE; POLYMORPHISMS; DYNAMICS; BRCA2; PATHOGENICITY; CANCER	Various missense mutations in the VHL gene have been reported among patients with familial bilateral pheochromocytoma. However, the p.Arg82Leu mutation in the VHL gene described here among patients with familial bilateral pheochromocytoma, has never been reported previously in a germline configuration. Interestingly, long-term follow-up of these patients indicated that the mutation might have had little impact on the normal function of the VHL gene, since all of them have remained asymptomatic. We further attempted to correlate this information with the results obtained by in silico analysis of this mutation using SIFT, PhD-SNP SVM profile, MutPred, PolyPhen2, and SNPs&GO prediction tools. To gain, new mechanistic insight into the structural effect, we mapped the mutation on to 3D structure (PDB ID 1LM8). Further, we analyzed the structural level changes in time scale level with respect to native and mutant protein complexes by using 12 ns molecular dynamics simulation method. Though these methods predict the mutation to have a pathogenic potential, it remains to be seen if these patients will eventually develop symptomatic disease.	[John, Anulekha Mary; Seshadri, Mandalam Subramaniam; Rajaratnam, Simon] Christian Med Coll & Hosp, Dept Endocrinol, Vellore, Tamil Nadu, India; [George, Priya Doss C.] VIT Univ, Sch Biosci & Technol, Ctr Nanobiotechnol, Med Biotechnol Div, Vellore, Tamil Nadu, India; [Ebenazer, Andrew; Pai, Rekha] Christian Med Coll & Hosp, Dept Pathol, Vellore, Tamil Nadu, India; [Nair, Aravindan] Christian Med Coll & Hosp, Dept Endocrine Surg, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Vellore Institute of Technology; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Pai, R (corresponding author), Christian Med Coll & Hosp, Dept Pathol, Vellore, Tamil Nadu, India.	rekhapai@cmcvellore.ac.in	JOHN, ANULEKHA/ABI-6460-2020	JOHN, ANULEKHA/0000-0003-3753-1764; C, George Priya Doss/0000-0002-5971-8290	council for Scientific and Industrial Research (CSIR), India [27(0221)/10/EMR-II]	council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant received from the council for Scientific and Industrial Research (CSIR), India, grant no. 27(0221)/10/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MA, 2006, AM J MED GENET A, V140A, P685, DOI 10.1002/ajmg.a.31116; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barontini M, 2010, BEST PRACT RES CL EN, V24, P401, DOI 10.1016/j.beem.2010.01.002; Becker O, 2001, COMPUT BIOCH BIOPHYS; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bikadi Z, 2007, ARCH BIOCHEM BIOPHYS, V461, P225, DOI 10.1016/j.abb.2007.02.020; Blank A, 2010, ENDOCR-RELAT CANCER, V17, P919, DOI 10.1677/ERC-09-0316; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Calo Valentina, 2010, Cancers (Basel), V2, P1644, DOI 10.3390/cancers2031644; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Case DA, 2002, AMBER SIMULATION SOF; Chacon-Camacho OF, 2010, CLIN EXP OPHTHALMOL, V38, P277, DOI 10.1111/j.1442-9071.2010.02241.x; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Cherbal F, 2012, DIS MARKERS, V32, P343, DOI [10.1155/2012/234136, 10.3233/DMA-2012-0893]; Ciftci AO, 2001, J PEDIATR SURG, V36, P447, DOI 10.1053/jpsu.2001.21612; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; De Nicolo A, 2009, CANCER RES, V69, P7030, DOI 10.1158/0008-5472.CAN-09-1440; Dollfus H, 2002, INVEST OPHTH VIS SCI, V43, P3067; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERSHT AR, 1984, TRENDS BIOCHEM SCI, V9, P145, DOI 10.1016/0968-0004(84)90122-1; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kantorovich V, 2010, BEST PRACT RES CL EN, V24, P415, DOI 10.1016/j.beem.2010.04.001; Karchin R, 2008, CANCER INFORM, V6, P203; KNUDSON AG, 1973, PROG MED GENET, V9, P113; LaConte LEW, 2002, BIOPHYS J, V82, p484A; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Markwick PRL, 2010, J AM CHEM SOC, V132, P1220, DOI 10.1021/ja9093692; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; Meyer-Rochow GY, 2009, J SURG RES, V157, P55, DOI 10.1016/j.jss.2008.07.043; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Miteva MA, 2004, BIOPHYS J, V86, P488, DOI 10.1016/S0006-3495(04)74127-2; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mohammadi L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-211; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ong KR, 2007, HUM MUTAT, V28, P143, DOI 10.1002/humu.20385; Peter C, 2003, CHEM-EUR J, V9, P5838, DOI 10.1002/chem.200305147; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Radice P, 2011, ANN ONCOL, V22, pi18, DOI 10.1093/annonc/mdq661; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sovinz P, 2010, AM J MED GENET A, V152A, P1752, DOI 10.1002/ajmg.a.33407; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Steen M, 2003, BLOOD, V102, P1316, DOI 10.1182/blood-2003-01-0116; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477; Walther MM, 1999, J UROLOGY, V162, P1582, DOI 10.1016/S0022-5347(05)68171-2; Walther MM, 1999, J UROLOGY, V162, P659, DOI 10.1097/00005392-199909010-00004; Witham S, 2011, PROTEINS, V79, P2444, DOI 10.1002/prot.23065; Yip L, 2004, J AM COLL SURGEONS, V198, P525, DOI 10.1016/j.jamcollsurg.2003.12.001; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	69	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61908	10.1371/journal.pone.0061908	http://dx.doi.org/10.1371/journal.pone.0061908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626751	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400115
J	Kourtis, IC; Hirosue, S; de Titta, A; Kontos, S; Stegmann, T; Hubbell, JA; Swartz, MA				Kourtis, Iraklis C.; Hirosue, Sachiko; de Titta, Alexandre; Kontos, Stephan; Stegmann, Toon; Hubbell, Jeffrey A.; Swartz, Melody A.			Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice	PLOS ONE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; DENDRITIC CELLS; SUPPRESSOR-CELLS; COMPLEMENT ACTIVATION; HUMORAL IMMUNITY; DELIVERY; IDENTIFICATION; GENERATION; STRATEGIES; INFLUENZA	Nanoparticles have been extensively developed for therapeutic and diagnostic applications. While the focus of nanoparticle trafficking in vivo has traditionally been on drug delivery and organ-level biodistribution and clearance, recent work in cancer biology and infectious disease suggests that targeting different cells within a given organ can substantially affect the quality of the immunological response. Here, we examine the cell-level biodistribution kinetics after administering ultrasmall Pluronic-stabilized poly(propylene sulfide) nanoparticles in the mouse. These nanoparticles depend on lymphatic drainage to reach the lymph nodes and blood, and then enter the spleen rather than the liver, where they interact with monocytes, macrophages and myeloid dendritic cells. They were more readily taken up into lymphatics after intradermal (i.d.) compared to intramuscular administration, leading to similar to 50% increased bioavailability in blood. When administered i.d., their distribution favored antigen-presenting cells, with especially strong targeting to myeloid cells. In tumor-bearing mice, the monocytic and the polymorphonuclear myeloid-derived suppressor cell compartments were efficiently and preferentially targeted, rendering this nanoparticulate formulation potentially useful for reversing the highly suppressive activity of these cells in the tumor stroma.	[Kourtis, Iraklis C.; Hirosue, Sachiko; de Titta, Alexandre; Kontos, Stephan; Hubbell, Jeffrey A.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland; [Stegmann, Toon] Mymet BV, Leiden, Netherlands	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch; melody.swartz@epfl.ch	Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456; /0000-0003-3356-178X	Bill and Melinda Gates Foundation; Carigest SA; Oncosuisse; European Research Council project NanoImmune	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Carigest SA; Oncosuisse; European Research Council project NanoImmune	This study was funded by the Bill and Melinda Gates Foundation (to JAH and MAS), Carigest SA (to MAS), Oncosuisse (to MAS), and the European Research Council project NanoImmune (to JAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gasparini R, 2010, J Prev Med Hyg, V51, P1; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Hamad I, 2010, ACS NANO, V4, P6629, DOI 10.1021/nn101990a; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kaneda Y, 2012, ADV DRUG DELIVER REV, V64, P730, DOI 10.1016/j.addr.2011.03.007; Kang SM, 2012, EXPERT REV VACCINES, V11, P547, DOI [10.1586/ERV.12.25, 10.1586/erv.12.25]; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Maldiney T, 2011, ACS NANO, V5, P854, DOI 10.1021/nn101937h; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; McLellan AD, 2000, IMMUNOL LETT, V72, P101, DOI 10.1016/S0165-2478(00)00167-X; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schrand AM, 2012, ADV EXP MED BIOL, V745, P58, DOI 10.1007/978-1-4614-3055-1_5; Serda RE, 2011, BBA-GEN SUBJECTS, V1810, P317, DOI 10.1016/j.bbagen.2010.05.004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Stephan MT, 2012, BIOMATERIAL IN PRESS; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; van der Vlies AJ, 2010, BIOCONJUGATE CHEM, V21, P653, DOI 10.1021/bc9004443; von Maltzahn G, 2008, BIOCONJUGATE CHEM, V19, P1570, DOI 10.1021/bc800077y	57	106	106	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61646	10.1371/journal.pone.0061646	http://dx.doi.org/10.1371/journal.pone.0061646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626707	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400071
J	Meyns, P; Desloovere, K; Molenaers, G; Swinnen, SP; Duysens, J				Meyns, Pieter; Desloovere, Kaat; Molenaers, Guy; Swinnen, Stephan P.; Duysens, Jacques			Interlimb Coordination during Forward and Backward Walking in Primary School-Aged Children	PLOS ONE			English	Article							USE QUADRUPEDAL COORDINATION; HUMAN LOCOMOTION; CEREBRAL-PALSY; NEURAL-CONTROL; SPINAL-CORD; GAIT; ARM; PATTERNS; BIPEDS; ORGANIZATION	Previous studies comparing forward (FW) and backward (BW) walking suggested that the leg kinematics in BW were essentially those of FW in reverse. This led to the proposition that in adults the neural control of FW and BW originates from the same basic neural circuitry. One aspect that has not received much attention is to what extent development plays a role in the maturation of neural control of gait in different directions. BW has been examined either in adults or infants younger than one year. Therefore, we questioned which changes occur in the intermediate phases (i.e. in primary school-aged children). Furthermore, previous research focused on the lower limbs, thereby raising the question whether upper limb kinematics are also simply reversed from FW to BW. Therefore, in the current study the emphasis was put both on upper and lower limb movements, and the coordination between the limbs. Total body 3D gait analysis was performed in primary school-aged children (N = 24, aged five to twelve years) at a preferred walking speed to record angular displacements of upper arm, lower arm, upper leg, lower leg, and foot with respect to the vertical (i.e. elevation angle). Kinematics and interlimb coordination were compared between FW and BW. Additionally, elevation angle traces of BW were reversed in time (revBW) and correlated to FW traces. Results showed that upper and lower limb kinematics of FW correlated highly to revBW kinematics in children, which appears to be consistent with the proposal that control of FW and BW may be similar. In addition, age was found to mildly alter lower limb kinematic patterns. In contrast, interlimb coordination was similar across all children, but was different compared to adults, measured for comparison. It is concluded that development plays a role in the fine-tuning of neural control of FW and BW.	[Meyns, Pieter; Desloovere, Kaat] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci, Grp Neuromotor Rehabil, Heverlee, Belgium; [Desloovere, Kaat; Molenaers, Guy] Univ Hosp Leuven, CERM, Clin Mot Anal Lab, Louvain, Belgium; [Swinnen, Stephan P.; Duysens, Jacques] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Kinesiol, Motor Control Lab, Heverlee, Belgium; [Duysens, Jacques] Sint Maartensklin, Dept Res Dev & Educ, Nijmegen, Netherlands	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Sint Maartens Clinic	Meyns, P (corresponding author), Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci, Grp Neuromotor Rehabil, Heverlee, Belgium.	pieter.meyns@gmail.com	Desloovere, Kaat/F-3240-2014	Desloovere, Kaat/0000-0002-8507-5276; Meyns, Pieter/0000-0003-2218-187X; Duysens, Jacques/0000-0002-0043-8817	'bijzonder onderzoeksfonds' KU Leuven [OT/08/034]; 'fonds voor wetenschappelijk onderzoek' (FWO) [G.0901.11]	'bijzonder onderzoeksfonds' KU Leuven; 'fonds voor wetenschappelijk onderzoek' (FWO)(FWO)	This project was supported by a grant from 'bijzonder onderzoeksfonds' KU Leuven (OT/08/034). JD was also supported by 'fonds voor wetenschappelijk onderzoek' (FWO grant G.0901.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; BUFORD JA, 1990, J NEUROPHYSIOL, V64, P745, DOI 10.1152/jn.1990.64.3.745; BURNETT CN, 1971, DEV MED CHILD NEUROL, V13, P207; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; COCKELL DL, 1995, PERCEPT MOTOR SKILL, V81, P515, DOI 10.2466/pms.1995.81.2.515; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cupp T, 1999, J PEDIATR ORTHOPED, V19, P475; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2009, ANN NY ACAD SCI, V1164, P97, DOI 10.1111/j.1749-6632.2008.03710.x; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Donker SF, 2002, ACTA PSYCHOL, V110, P265, DOI 10.1016/S0001-6918(02)00037-9; Dusing SC, 2007, GAIT POSTURE, V25, P135, DOI 10.1016/j.gaitpost.2006.06.003; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Duysens J, 2004, NEURO-BEHAVIORAL DETERMINANTS OF INTERLIMB COORDINATION, P3; Duysens J, 1996, J NEUROPHYSIOL, V76, P301, DOI 10.1152/jn.1996.76.1.301; EILAM D, 1992, J EXP BIOL, V173, P155; Elftman H., 1939, HUM BIOL, V11, P529; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Ganley KJ, 2005, GAIT POSTURE, V21, P141, DOI 10.1016/j.gaitpost.2004.01.007; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868, DOI 10.1152/jn.1998.80.4.1868; Hallemans A, 2010, GAIT POSTURE, V32, P547, DOI 10.1016/j.gaitpost.2010.07.018; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Jansen K, 2012, J NEUROPHYSIOL, V107, P3385, DOI 10.1152/jn.01156.2011; Kuhtz-Buschbeck JP, 2012, J ELECTROMYOGR KINES, V22, P199, DOI 10.1016/j.jelekin.2011.08.014; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Ledebt A, 2000, INFANT BEHAV DEV, V23, P79, DOI 10.1016/S0163-6383(00)00027-8; Lythgo N, 2011, GAIT POSTURE, V33, P29, DOI 10.1016/j.gaitpost.2010.09.017; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; McGraw MB, 1940, J PEDIATR-US, V17, P747, DOI 10.1016/S0022-3476(40)80021-8; Meyns P, 2013, GAIT POSTURE, VS0966-6362, P00118, DOI [10.1016/j.gait-post.2013.02.006, DOI 10.1016/J.GAIT-POST.2013.02.006]; Meyns P, 2012, EUR J PAEDIATR NEURO, V16, P528, DOI 10.1016/j.ejpn.2012.01.011; Meyns P, 2012, RES DEV DISABIL, V33, P1418, DOI 10.1016/j.ridd.2012.03.020; Meyns P, 2011, RES DEV DISABIL, V32, P1957, DOI 10.1016/j.ridd.2011.03.029; Musienko PE, 2012, J NEUROSCI, V32, P17442, DOI 10.1523/JNEUROSCI.3757-12.2012; Perry J., 1992, GAIT ANAL NORMAL PAT; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; Sutherland D., 1988, DEV MATURE WALKING; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; THORSTENSSON A, 1986, EXP BRAIN RES, V61, P664; Van de Walle P, 2010, GAIT POSTURE, V31, P495, DOI 10.1016/j.gaitpost.2010.02.008; van Deursen RWM, 1998, GAIT POSTURE, V7, P214, DOI 10.1016/S0966-6362(98)00007-1; Van Emmerik REA, 1998, ANN NY ACAD SCI, V860, P539; Wagenaar RC, 2000, J BIOMECH, V33, P853, DOI 10.1016/S0021-9290(00)00020-8; WINTER DA, 1989, J MOTOR BEHAV, V21, P291; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Yizhar Z, 2009, INT J REHABIL RES, V32, P115, DOI 10.1097/MRR.0b013e32830d3675; Zehr EP, 2005, J NEUROPHYSIOL, V93, P633, DOI 10.1152/jn.00525.2004; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680	51	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62747	10.1371/journal.pone.0062747	http://dx.doi.org/10.1371/journal.pone.0062747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626852	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400216
J	Peter, M; Bathellier, B; Fontinha, B; Pliota, P; Haubensak, W; Rumpel, S				Peter, Manuel; Bathellier, Brice; Fontinha, Bruno; Pliota, Pinelopi; Haubensak, Wulf; Rumpel, Simon			Transgenic Mouse Models Enabling Photolabeling of Individual Neurons In Vivo	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; VISUAL-CORTEX; GABAERGIC NEURONS; C-FOS; MICE; TRACKING; DYNAMICS; CELLS; EXPRESSION; NEOCORTEX	One of the biggest tasks in neuroscience is to explain activity patterns of individual neurons during behavior by their cellular characteristics and their connectivity within the neuronal network. To greatly facilitate linking in vivo experiments with a more detailed molecular or physiological analysis in vitro, we have generated and characterized genetically modified mice expressing photoactivatable GFP (PA-GFP) that allow conditional photolabeling of individual neurons. Repeated photolabeling at the soma reveals basic morphological features due to diffusion of activated PA-GFP into the dendrites. Neurons photolabeled in vivo can be re-identified in acute brain slices and targeted for electrophysiological recordings. We demonstrate the advantages of PA-GFP expressing mice by the correlation of in vivo firing rates of individual neurons with their expression levels of the immediate early gene c-fos. Generally, the mouse models described in this study enable the combination of various analytical approaches to characterize living cells, also beyond the neurosciences.	[Peter, Manuel; Bathellier, Brice; Fontinha, Bruno; Pliota, Pinelopi; Haubensak, Wulf; Rumpel, Simon] Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Rumpel, S (corresponding author), Res Inst Mol Pathol IMP, Vienna, Austria.	simon.rumpel@imp.ac.at		Fontinha, Bruno M./0000-0003-1670-2667; Peter, Manuel/0000-0003-3846-5412; Bathellier, Brice/0000-0001-9211-1960; Pliota, Pinelopi/0000-0002-1406-5978; Haubensak, Wulf/0000-0002-2034-9184	Austrian Science Fund (FWF) [P21930-B09]; HFSP long-term fellowship; GABBA PhD program; Boehringer Ingelheim GmbH	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); HFSP long-term fellowship; GABBA PhD program; Boehringer Ingelheim GmbH(Boehringer Ingelheim)	This work was supported by the Austrian Science Fund (FWF): P21930-B09 (M. P.), HFSP long-term fellowship (B. B.), GABBA PhD program (B. F.) and the Boehringer Ingelheim GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bathellier B, 2012, NEURON, V76, P435, DOI 10.1016/j.neuron.2012.07.008; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brown SC, 2010, PLANT J, V63, P696, DOI 10.1111/j.1365-313X.2010.04272.x; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lien AD, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00016; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohhata T, 2011, GENE DEV, V25, P1702, DOI 10.1101/gad.16997911; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Watanabe W, 2007, OPT EXPRESS, V15, P2490, DOI 10.1364/OE.15.002490; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62132	10.1371/journal.pone.0062132	http://dx.doi.org/10.1371/journal.pone.0062132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626779	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400143
J	Roggenhofer, E; Fidzinski, P; Shor, O; Behr, J				Roggenhofer, Elisabeth; Fidzinski, Pawel; Shor, Oded; Behr, Joachim			Reduced Threshold for Induction of LTP by Activation of Dopamine D1/D5 Receptors at Hippocampal CA1-Subiculum Synapses	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TARGET-SPECIFIC EXPRESSION; VENTRAL SUBICULUM; NMDA RECEPTOR; CA1 REGION; PREFRONTAL CORTEX; RAT SUBICULUM; LATE-PHASE; NEURONS; MODULATION	The phasic release of dopamine in the hippocampal formation has been shown to facilitate the encoding of novel information. There is evidence that the subiculum operates as a detector and distributor of sensory information, which incorporates the novelty and relevance of signals received from CA1. The subiculum acts as the final hippocampal relay station for outgoing information. Subicular pyramidal cells have been classified as regular-and burst-spiking neurons. The goal of the present study was to study the effect of dopamine D1/D5 receptor activation on synaptic transmission and plasticity in the subicular regular-spiking neurons of 4-6 week old Wistar rats. We demonstrate that prior activation of D1/D5 receptors reduces the threshold for the induction of long-term potentiation (LTP) in subicular regular-spiking neurons. Our results indicate that D1/D5 receptor activation facilitates a postsynaptic form of LTP in subicular regular-spiking cells that is NMDA receptor-dependent, relies on postsynaptic Ca2+ signaling, and requires the activation of protein kinase A. The enhanced propensity of subicular regular-spiking cells to express postsynaptic LTP after activation of D1/D5 receptors provides an intriguing mechanism for the encoding of hippocampal output information.	[Roggenhofer, Elisabeth; Fidzinski, Pawel; Shor, Oded; Behr, Joachim] Univ Med Berlin, Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Roggenhofer, Elisabeth; Fidzinski, Pawel; Shor, Oded; Behr, Joachim] Univ Med Berlin, Charite, Johannes Mueller Inst Physiol, Berlin, Germany; [Roggenhofer, Elisabeth] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Behr, Joachim] Ruppiner Kliniken, Dept Psychiat Psychotherapy & Psychosomat, Neuruppin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Ruppiner Kliniken GmbH	Roggenhofer, E (corresponding author), Univ Med Berlin, Charite, Dept Psychiat & Psychotherapy, Berlin, Germany.	roggenhofer@cbs.mpg.de	Fidzinski, Pawel/AAM-8884-2020	Fidzinski, Pawel/0000-0001-6373-4763; Shor, Oded Lipa/0000-0002-4712-3847	German Research Foundation (DFG) [SFB-TR3 B4]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG) grants to JB (SFB-TR3 B4, http://www.charite.de/forschungsberichte/FOB_2010-2011/deutsch/PJ/PJ35340.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKSTEAD RM, 1988, J COMP NEUROL, V268, P131, DOI 10.1002/cne.902680113; Behr J, 2009, PROG NEUROBIOL, V89, P334, DOI 10.1016/j.pneurobio.2009.09.002; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERRY MS, 1976, BRAIN RES, V105, P1, DOI 10.1016/0006-8993(76)90919-7; Blaha CD, 1997, EUR J NEUROSCI, V9, P902, DOI 10.1111/j.1460-9568.1997.tb01441.x; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Cepeda C, 1998, EUR J NEUROSCI, V10, P3491, DOI 10.1046/j.1460-9568.1998.00357.x; Chang EH, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00046; Ciliax BJ, 2000, SYNAPSE, V37, P125, DOI 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7; Deadwyler SA, 2004, NEURON, V42, P465, DOI 10.1016/S0896-6273(04)00195-3; Demers G, 2006, SCIENCE, V312, P700, DOI 10.1126/science.1124036; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Gigg J, 2000, BRAIN RES, V884, P35, DOI 10.1016/S0006-8993(00)02878-X; Greene JRT, 1997, J COMP NEUROL, V380, P395, DOI 10.1002/(SICI)1096-9861(19970414)380:3<395::AID-CNE8>3.0.CO;2-Y; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Harris E, 2001, J COMP NEUROL, V435, P506, DOI 10.1002/cne.1047; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; HJORTH S, 1988, J NEURAL TRANSM, V72, P83, DOI 10.1007/BF01250232; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; KITAI ST, 1993, ADV NEUROL, V60, P40; Knopp A, 2005, J COMP NEUROL, V483, P476, DOI 10.1002/cne.20460; Lapointe V, 2004, J PHYSIOL-LONDON, V555, P125, DOI 10.1113/jphysiol.2003.053603; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Levine MS, 1996, J NEUROSCI, V16, P5870; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matthies H, 1997, NEUROREPORT, V8, P3533, DOI 10.1097/00001756-199711100-00023; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mockett BG, 2004, BRAIN RES, V1021, P92, DOI 10.1016/j.brainres.2004.06.039; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; NICHOLLS JG, 1970, J PHYSIOL-LONDON, V209, P647, DOI 10.1113/jphysiol.1970.sp009184; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Roggenhofer E, 2010, EUR J NEUROSCI, V32, P598, DOI 10.1111/j.1460-9568.2010.07312.x; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Selig DK, 1999, J NEUROSCI, V19, P1236; Snyder GL, 1998, J NEUROSCI, V18, P10297; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Taepavarapruk P, 2000, PSYCHOPHARMACOLOGY, V151, P242, DOI 10.1007/s002130000376; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Varela JA, 2009, J NEUROSCI, V29, P3109, DOI 10.1523/JNEUROSCI.4746-08.2009; Vreugdenhil M, 2002, NEUROSCIENCE, V114, P983, DOI 10.1016/S0306-4522(02)00212-9; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Wojtowicz AM, 2010, NEUROSCIENCE, V171, P367, DOI 10.1016/j.neuroscience.2010.09.028; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Yang SN, 2000, HIPPOCAMPUS, V10, P57, DOI 10.1002/(SICI)1098-1063(2000)10:1<57::AID-HIPO6>3.3.CO;2-S; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	81	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62520	10.1371/journal.pone.0062520	http://dx.doi.org/10.1371/journal.pone.0062520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626827	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400191
J	Song, PH; Song, WF; Liu, XS; Jin, CH; Xie, HY; Zhou, L; Tuo, BG; Zheng, SD				Song, Penghong; Song, Wenfeng; Liu, Xiaosun; Jin, Changhai; Xie, Haiyang; Zhou, Lin; Tuo, Biguang; Zheng, Shusen			Function and Expression of Cystic Fibrosis Transmembrane Conductance Regulator after Small Intestinal Transplantation in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; RAT SMALL-INTESTINE; EPITHELIAL-CELLS; INTERFERON-GAMMA; EXPERIMENTAL COLITIS; HCO3-SECRETION; VAGUS NERVE; CFTR; INFLAMMATION	The secretion function of intestinal graft is one of the most important factors for successful intestinal transplantation. Cystic fibrosis transmembrane conductance regulator (CFTR) mediates HCO3- and Cl- secretions in intestinal epithelial cells. In this study, we made investigation on the expression and function of CFTR in an experimental model of murine small intestinal transplantation. Heterotopic intestinal transplantations were performed in syngeneic mice. The mRNA and protein expressions of CFTR were analyzed by real time PCR and western blot. Murine intestinal mucosal HCO3- and Cl- secretions were examined in vitro in Ussing chambers by the pH stat and short circuit current (I-sc) techniques. The results showed that forskolin, an activator of CFTR, stimulated jejunal mucosal epithelial HCO3- and Cl- secretions in mice, but forskolin-stimulated HCO3- and Cl- secretions in donor and recipient jejunal mucosae of mice after heterotopic jejunal transplantation were markedly decreased, compared with controls (P<0.001). The mRNA and protein expression levels of CFTR in donor and recipient jejunal mucosae of mice were also markedly lower than those in controls (P<0.001), and the mRNA and protein expression levels of tumor necrosis factor alpha (TNF alpha) were markedly increased in donor jejunal mucosae of mice (P<0.001), compared with controls. Further experiments showed that TNF alpha down-regulated the expression of CFTR mRNA in murine jejunal mucosa. In conclusion, after intestinal transplantation, the function of CFTR was impaired, and its mRNA and protein expressions were down-regulated, which may be induced by TNF alpha.	[Song, Penghong; Song, Wenfeng; Jin, Changhai; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Xiaosun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Tuo, Biguang] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi, Peoples R China	Zhejiang University; Zhejiang University; Zunyi Medical University	Zheng, SD (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National Natural Science Foundation of China [31071015, 81160054]; Qianjiang Talents Project of Science Technology Department of Zhejiang Province [2011R10033]; Education Department of Zhejiang Province [Y200804851]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [J20110176]; Science and Technology Innovation Team of Zhejiang Province [2009R50038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of Science Technology Department of Zhejiang Province; Education Department of Zhejiang Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Innovation Team of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (31071015), Qianjiang Talents Project of Science Technology Department of Zhejiang Province (2011R10033), and Education Department of Zhejiang Province (Y200804851). The Project was sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (J20110176) to PS, Science and Technology Innovation Team of Zhejiang Province (2009R50038) to SZ, and the National Natural Science Foundation of China (81160054) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Arumugam TV, 2002, CLIN EXP PHARMACOL P, V29, P996, DOI 10.1046/j.1440-1681.2002.03766.x; Banks MR, 2002, CURR OPIN GASTROEN, V18, P176, DOI 10.1097/00001574-200203000-00004; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; Bueno L, 2000, GUT, V47, P63; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Arruda Marcio Jose Cristiano de, 2006, Clinics, V61, P21, DOI 10.1590/S1807-59322006000100005; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; ECKMANN L, 1995, J CLIN INVEST, V96, P1269, DOI 10.1172/JCI118161; EGGERMONT E, 1991, EUR J PEDIATR, V150, P824, DOI 10.1007/BF01954999; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; Fryer JP, 2008, CURR OPIN ORGAN TRAN, V13, P266, DOI 10.1097/MOT.0b013e3282fd6901; Fryer JP, 2007, GASTROENTEROL CLIN N, V36, P145, DOI 10.1016/j.gtc.2007.01.001; Garg M, 2011, J GASTROEN HEPATOL, V26, P1221, DOI 10.1111/j.1440-1746.2011.06783.x; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Guggino William B, 2004, Proc Am Thorac Soc, V1, P28, DOI 10.1513/pats.2306011; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Julia K, 1998, DIGEST DIS SCI, V43, P1925; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kulka M, 2005, J PHARMACOL EXP THER, V315, P563, DOI 10.1124/jpet.105.087528; NAKAMURA H, 1992, FEBS LETT, V314, P366, DOI 10.1016/0014-5793(92)81507-I; Pakarinen MP, 2000, SCAND J GASTROENTERO, V35, P561; Pilette C, 2007, EUR RESPIR J, V29, P914, DOI 10.1183/09031936.00073005; REINSHAGEN M, 1994, GASTROENTEROLOGY, V106, P1208, DOI 10.1016/0016-5085(94)90011-6; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Sarr Michael G., 1996, Digestive Surgery, V13, P181, DOI 10.1159/000172427; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Straub RH, 2006, GUT, V55, P1640, DOI 10.1136/gut.2006.091322; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Tuo BG, 2009, BRIT J PHARMACOL, V158, P1313, DOI 10.1111/j.1476-5381.2009.00398.x; Ueno T, 2010, SURG TODAY, V40, P1112, DOI 10.1007/s00595-010-4324-y; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; WATSON AJM, 1988, GASTROENTEROLOGY, V94, P863, DOI 10.1016/0016-5085(88)90540-9; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; Yamamoto S, 2001, J SURG RES, V99, P134, DOI 10.1006/jsre.2001.6106; ZHONG R, 1993, MICROSURG, V14, P141, DOI 10.1002/micr.1920140211	40	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62536	10.1371/journal.pone.0062536	http://dx.doi.org/10.1371/journal.pone.0062536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626828	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400192
J	Xu, N; Cheng, XX; Yu, QL; Qian, KF; Ding, XH; Liu, RM; Zhang, B; Xing, LJ; Li, MC				Xu, Ning; Cheng, Xinxin; Yu, Qilin; Qian, Kefan; Ding, Xiaohui; Liu, Ruming; Zhang, Biao; Xing, Laijun; Li, Mingchun			Aft2, a Novel Transcription Regulator, Is Required for Iron Metabolism, Oxidative Stress, Surface Adhesion and Hyphal Development in Candida albicans	PLOS ONE			English	Article							RESPONSIVE TRANSCRIPTION; GENE-EXPRESSION; FUNGAL MORPHOGENESIS; DRUG-RESISTANCE; YEAST; HOMEOSTASIS; ROLES; HYDROPHOBICITY; DETERMINANTS; DEPRIVATION	Morphological transition and iron metabolism are closely relevant to Candida albicans pathogenicity and virulence. In our previous study, we demonstrated that C. albicans Aft2 plays an important role in ferric reductase activity and virulence. Here, we further explored the roles of C. albicans Aft2 in numerous cellular processes. We found that C. albicans Aft2 exhibited an important role in iron metabolism through bi-directional regulation effects on iron-regulon expression. Deletion of AFT2 reduced cellular iron accumulation under iron-deficient conditions. Furthermore, both reactive oxygen species (ROS) generation and superoxide dismutase (SOD) activity were remarkably increased in the aft2 Delta/Delta mutant, which were thought to be responsible for the defective responses to oxidative stress. However, we found that over-expression of C. albicans AFT2 under the regulation of the strong PGK1 promoter could not effectively rescue Saccharomyces cerevisiae aft1 Delta mutant defects in some cellular processes, such as cell-wall assembly, ion homeostasis and alkaline resistance, suggesting a possibility that C. albicans Aft2 weakened its functional role of regulating some cellular metabolism during the evolutionary process. Interestingly, deletion of AFT2 in C. albicans increased cell surface hydrophobicity, cell flocculation and the ability of adhesion to polystyrene surfaces. In addition, our results also revealed that C. albicans Aft2 played a dual role in regulating hypha-specific genes under solid and liquid hyphal inducing conditions. Deletion of AFT2 caused an impaired invasive growth in solid medium, but an increased filamentous aggregation and growth in liquid conditions. Moreover, iron deficiency and environmental cues induced nuclear import of Aft2, providing additional evidence for the roles of Aft2 in transcriptional regulation.	[Xu, Ning; Cheng, Xinxin; Yu, Qilin; Qian, Kefan; Ding, Xiaohui; Liu, Ruming; Xing, Laijun; Li, Mingchun] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Zhang, Biao] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China	Nankai University; Tianjin University of Traditional Chinese Medicine	Li, MC (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	nklimingchun@yahoo.com.cn	Yu, Qilin/Q-2277-2017	Yu, Qilin/0000-0003-0473-5111; Cheng, Xinxin/0000-0001-6485-8960; Xu, Ning/0000-0002-4123-7827	National Natural Science Foundation of China [31070126, 81171541]; Tianjin Research Program of Application Foundation and Advanced Technology [10JCYBJC09700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	This study was supported by the National Natural Science Foundation of China (No. 31070126, No. 81171541) and the Tianjin Research Program of Application Foundation and Advanced Technology (10JCYBJC09700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Assady M, 2011, IRAN J PARASITOL, V6, P17; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Castells-Roca L, 2011, MOL MICROBIOL, V81, P232, DOI 10.1111/j.1365-2958.2011.07689.x; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Silva NCE, 2009, GENETICS, V183, P93, DOI 10.1534/genetics.109.104364; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; de Souza RD, 2009, GERODONTOLOGY, V26, P157, DOI 10.1111/j.1741-2358.2008.00229.x; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029707; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Ferreira C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-238; Finkel JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002525; Goossens K, 2010, BIOTECHNOL LETT, V32, P1571, DOI 10.1007/s10529-010-0352-3; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Hamza A, 2012, J BIOL CHEM, V287, P4139, DOI 10.1074/jbc.M111.319319; Hiller E, 2011, INT J MED MICROBIOL, V301, P384, DOI 10.1016/j.ijmm.2011.04.004; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Jakubowski W, 1997, INT J BIOCHEM CELL B, V29, P1297, DOI 10.1016/S1357-2725(97)00056-3; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Janknegt PJ, 2007, J PHOTOCH PHOTOBIO B, V87, P218, DOI 10.1016/j.jphotobiol.2007.04.002; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KENNEDY MJ, 1988, MYCOPATHOLOGIA, V102, P149, DOI 10.1007/BF00437397; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Liang Y, 2010, MICROBIOL-SGM, V156, P2912, DOI 10.1099/mic.0.037978-0; Liu Y, 2010, EUKARYOT CELL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTHEWS RC, 1994, MICROBIOL-SGM, V140, P1505, DOI 10.1099/13500872-140-7-1505; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; San-Blas G, 2000, MED MYCOL, V38, P79, DOI 10.1080/mmy.38.s1.79.86; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Xu N, 2012, FEMS YEAST RES, V12, P844, DOI 10.1111/j.1567-1364.2012.00835.x; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Zhao R, 2002, EUKARYOT CELL, V1, P353, DOI 10.1128/EC.1.3.353-365.2002	57	16	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62367	10.1371/journal.pone.0062367	http://dx.doi.org/10.1371/journal.pone.0062367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626810	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400174
J	Yasunaga, M; Masui, E; Oji, A; Soma, A; Osaki, M; Nakanishi, T; Sato, K				Yasunaga, Mayu; Masui, Eiji; Oji, Asami; Soma, Atsumi; Osaki, Mitsuhiko; Nakanishi, Tomoko; Sato, Kenzo			Identification of the Control Region of Pancreatic Expression of Bmp4 In Vitro and In Vivo	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; GENE-EXPRESSION; EXONS	Bone morphogenetic protein 4 (Bmp4) was recently shown to be related to glucose homeostasis in mouse adult pancreas through the regulation of insulin production. We previously revealed the predominant expression of Bmp4 in adult pancreas by in vivo imaging of transgenic mice. However, the control regions for predominant Bmp4 expression in the adult pancreas are unclear. In this study, we established transgenic (Tg) mice that allow real time in vivo bioluminescence imaging of the enhancer/promoter activity of the Bmp4 gene. Tg mice expressing firefly luciferase with a 7 kb upstream region and 5'-non-coding sequence (three exons and two introns) of the Bmp4 gene showed pancreatic expression of bioluminescence, while the Tg mice bearing luciferase with the 7 kb upstream region alone did not show pancreatic expression of the reporter gene. Interestingly, pancreatic expression of bioluminescence was also present in Tg mice harboring the truncated promoter without exon IA and IB, indicating the presence of a cryptic promoter in front of exon II. Furthermore, the bioluminescence signal was not detected in embryonic pancreas, but increasing signals were observed in neonatal and infantile Tg mice depending on the genotypes observed. These results suggested that a novel mechanism of transcription is involved in pancreatic expression of the Bmp4 gene.	[Yasunaga, Mayu; Masui, Eiji; Oji, Asami; Soma, Atsumi; Nakanishi, Tomoko; Sato, Kenzo] Tottori Univ, Fac Med, Sch Life Sci, Div Mol Biol, Yonago, Tottori 683, Japan; [Osaki, Mitsuhiko] Tottori Univ, Fac Med, Sch Life Sci, Div Pathol Biochem, Yonago, Tottori 683, Japan; [Osaki, Mitsuhiko; Nakanishi, Tomoko; Sato, Kenzo] Tottori Univ, Fac Med, Chromosome Engn Res Ctr, Yonago, Tottori 683, Japan	Tottori University; Tottori University; Tottori University	Sato, K (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Div Mol Biol, Yonago, Tottori 683, Japan.	kensato@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a City Area Program (Basic Stage) from Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2010, DIABETES, V59, P1948, DOI 10.2337/db09-1010; Chandler KJ, 2009, DEV BIOL, V327, P590, DOI 10.1016/j.ydbio.2008.12.033; Feng JQ, 2002, J DENT RES, V81, P6, DOI 10.1177/154405910208100103; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; Gannon M, 2007, CELL METAB, V5, P157, DOI 10.1016/j.cmet.2007.02.003; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Jumlongras D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038568; Katagiri Takenobu, 2008, P121; KURIHARA T, 1993, BIOCHEM BIOPH RES CO, V192, P1049, DOI 10.1006/bbrc.1993.1523; Long YS, 2008, J NEUROSCI RES, V86, P3375, DOI 10.1002/jnr.21790; Orme CM, 2009, SCIENCE, V324, P1155, DOI 10.1126/science.1174841; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Scott GJ, 2009, GENESIS, V47, P385, DOI 10.1002/dvg.20513; Scully Tony, 2012, Nature, V485, pS2; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yasunaga M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024956; Zhang JH, 2002, BIOCHEM BIOPH RES CO, V293, P1412, DOI 10.1016/S0006-291X(02)00416-3	21	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61821	10.1371/journal.pone.0061821	http://dx.doi.org/10.1371/journal.pone.0061821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626735	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400099
J	Ferguson, DP; Schmitt, EE; Lightfoot, JT				Ferguson, David P.; Schmitt, Emily E.; Lightfoot, J. Timothy			Vivo-Morpholinos Induced Transient Knockdown of Physical Activity Related Proteins	PLOS ONE			English	Article							DOPAMINE TRANSPORTER; MUSCLE; EXPRESSION; MICE; SKELETAL; GLUT4; EXERCISE; MODEL	Physical activity is associated with disease prevention and overall wellbeing. Additionally there has been evidence that physical activity level is a result of genetic influence. However, there has not been a reliable method to silence candidate genes in vivo to determine causal mechanisms of physical activity regulation. Vivo-morpholinos are a potential method to transiently silence specific genes. Thus, the aim of this study was to validate the use of Vivo-morpholinos in a mouse model for voluntary physical activity with several sub-objectives. We observed that Vivo-morpholinos achieved between 60-97% knockdown of Drd1-, Vmat2-, and Glut4-protein in skeletal muscle, the delivery moiety of Vivo-morpholinos (scramble) did not influence physical activity and that a cocktail of multiple Vivo-morpholinos can be given in a single treatment to achieve protein knockdown of two different targeted proteins in skeletal muscle simultaneously. Knocking down Drd1, Vmat2, or Glut4 protein in skeletal muscle did not affect physical activity. Vivo-morpholinos injected intravenously alone did not significantly knockdown Vmat2-protein expression in the brain (p = 0.28). However, the use of a bradykinin analog to increase blood-brain-barrier permeability in conjunction with the Vivo-morpholinos significantly (p = 0.0001) decreased Vmat2-protein in the brain with a corresponding later over-expression of Vmat2 coincident with a significant (p = 0.0016) increase in physical activity. We conclude that Vivo-morpholinos can be a valuable tool in determining causal gene-phenotype relationships in whole animal models.	[Ferguson, David P.; Schmitt, Emily E.; Lightfoot, J. Timothy] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Ferguson, DP (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA.	davidpferguson13@gmail.com	Ferguson, David/AAE-5992-2022; Schmitt, Emily/GOP-0896-2022	Ferguson, David/0000-0003-1203-0920; Schmitt, Emily/0000-0001-6965-9768; Ferguson, David/0000-0001-6448-8701; Lightfoot, J. Timothy/0000-0002-0365-4152	National Institutes of Health [AR050085]; Department of Health and Kinesiology at Texas AM University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Kinesiology at Texas AM University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was funded by National Institutes of Health grant AR050085 and start-up funds from the Department of Health and Kinesiology at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Boger HA, 2011, GENES BRAIN BEHAV, V10, P186, DOI 10.1111/j.1601-183X.2010.00654.x; Carrillo M, 2010, BLOOD CELL MOL DIS, V45, P326, DOI 10.1016/j.bcmd.2010.10.002; Colebrooke RE, 2007, BRAIN RES, V1152, P10, DOI 10.1016/j.brainres.2007.03.032; Colebrooke RE, 2006, EUR J NEUROSCI, V24, P2622, DOI 10.1111/j.1460-9568.2006.05143.x; DOCTROW SR, 1994, J PHARMACOL EXP THER, V271, P229; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Emerich DF, 2001, CLIN PHARMACOKINET, V40, P105, DOI 10.2165/00003088-200140020-00003; Ferguson DP, 2011, EXP BIOL C WASH DC; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fukushima S, 2007, PSYCHOPHARMACOLOGY, V193, P55, DOI 10.1007/s00213-007-0749-4; Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Knab AM, 2010, INT J BIOL SCI, V6, P133; Knab AM, 2009, BEHAV BRAIN RES, V204, P147, DOI 10.1016/j.bbr.2009.05.034; Kowalik L, 2011, DEV BIOL, V354, P221, DOI 10.1016/j.ydbio.2011.03.031; Lightfoot JT, 2011, J NUTR, V141, P526, DOI 10.3945/jn.110.127290; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; Liu YY, 2012, J NEUROSCI, V32, P3563, DOI 10.1523/JNEUROSCI.5197-11.2012; Maki N, 2010, FASEB J, V24, P3462, DOI 10.1096/fj.10-159285; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Nazmi A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00347; Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892; Notch EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029462; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Owen LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033576; Parra MK, 2012, MOL CELL BIOL, V32, P2044, DOI 10.1128/MCB.05716-11; Parra MK, 2011, J BIOL CHEM, V286, P6033, DOI 10.1074/jbc.M110.158154; Quinn M, 2012, AM J PHYSIOL-GASTR L, V302, pG182, DOI 10.1152/ajpgi.00205.2011; Reissner KJ, 2012, J NEUROSCI METH, V203, P354, DOI 10.1016/j.jneumeth.2011.10.009; Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9; Sartor GC, 2012, J NEUROSCI, V32, P4623, DOI 10.1523/JNEUROSCI.4561-11.2012; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Stein DA, 2008, CURR PHARM DESIGN, V14, P2619, DOI 10.2174/138161208786071290; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Taylor TN, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/124165; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Vera T, 2010, AM J PHYSIOL-REG I, V299, pR1044, DOI 10.1152/ajpregu.00316.2010; Warfield KL, 2006, CURR OPIN MOL THER, V8, P93; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Widrick JJ, 2011, MUSCLE NERVE, V44, P563, DOI 10.1002/mus.22126; Wu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019906; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Xiong N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020677; Zammarchi F, 2011, P NATL ACAD SCI USA, V108, P17779, DOI 10.1073/pnas.1108482108; Zhou ZG, 2011, MOL CELL NEUROSCI, V48, P29, DOI 10.1016/j.mcn.2011.06.002	58	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61472	10.1371/journal.pone.0061472	http://dx.doi.org/10.1371/journal.pone.0061472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630592	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500039
J	Kass, MD; Moberly, AH; McGann, JP				Kass, Marley D.; Moberly, Andrew H.; McGann, John P.			Spatiotemporal Alterations in Primary Odorant Representations in Olfactory Marker Protein Knockout Mice	PLOS ONE			English	Article							VECTOR-MEDIATED RESCUE; GENE DELETION CAUSES; SENSORY NEURONS; GLOMERULI; BULB; PATHOPHYSIOLOGY; EXPRESSION; PHENOTYPE	Olfactory marker protein (OMP) is highly and selectively expressed in primary olfactory sensory neurons (OSNs) across species, but its physiological function remains unclear. Previous studies in the olfactory epithelium suggest that it accelerates the neural response to odorants and may modulate the odorant-selectivity of OSNs. Here we used a line of gene-targeted mice that express the fluorescent exocytosis indicator synaptopHluorin in place of OMP to compare spatiotemporal patterns of odorant-evoked neurotransmitter release from OSNs in adult mice that were heterozygous for OMP or OMP-null. We found that these patterns, which constitute the primary neural representation of each odorant, developed more slowly during the odorant presentation in OMP knockout mice but eventually reached the same magnitude as in heterozygous mice. In the olfactory bulb, each glomerulus receives synaptic input from a subpopulation of OSNs that all express the same odor receptor and thus typically respond to a specific subset of odorants. We observed that in OMP knockout mice, OSNs innervating a given glomerulus typically responded to a broader range of odorants than in OMP heterozygous mice and thus each odorant evoked synaptic input to a larger number of glomeruli. In an olfactory habituation task, OMP knockout mice behaved differently than wild-type mice, exhibiting a delay in their onset to investigate an odor stimulus during its first presentation and less habituation to that stimulus over repeated presentations. These results suggest that the actions of OMP in olfactory transduction carry through to the primary sensory representations of olfactory stimuli in adult mice in vivo.	[Kass, Marley D.; Moberly, Andrew H.; McGann, John P.] Rutgers State Univ, Dept Psychol, Behav & Syst Neurosci Sect, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	McGann, JP (corresponding author), Rutgers State Univ, Dept Psychol, Behav & Syst Neurosci Sect, Piscataway, NJ 08854 USA.	jmcgann@rci.rutgers.edu		Kass, Marley/0000-0003-2460-9366	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health [R00 DC009442]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009442] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders (R00 DC009442 to JPM) at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; Czarnecki LA, 2012, TOXICOL SCI, V126, P534, DOI 10.1093/toxsci/kfs030; Czarnecki LA, 2011, NEUROTOXICOLOGY, V32, P441, DOI 10.1016/j.neuro.2011.03.007; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Farbman AI, 1998, ANN NY ACAD SCI, V855, P248, DOI 10.1111/j.1749-6632.1998.tb10576.x; Griff ER, 2000, BRAIN RES, V866, P227, DOI 10.1016/S0006-8993(00)02291-5; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kass MD, 2012, CHEM SENSES IN PRESS; KRISHNA NSR, 1992, BRAIN RES, V593, P295; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Lee AC, 2011, J NEUROSCI, V31, P2974, DOI 10.1523/JNEUROSCI.5067-10.2011; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moberly AH, 2012, NEUROTOXICOLOGY, V33, P996, DOI 10.1016/j.neuro.2012.04.014; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Smith PC, 2002, J MOL BIOL, V319, P807, DOI 10.1016/S0022-2836(02)00242-5; St John JA, 2005, J COMP NEUROL, V488, P61, DOI 10.1002/cne.20573; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; SYDOR W, 1986, ARCH BIOCHEM BIOPHYS, V249, P351, DOI 10.1016/0003-9861(86)90011-1; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wright NT, 2005, J BIOMOL NMR, V33, P63, DOI 10.1007/s10858-005-1281-7; Youngentob SL, 2004, BEHAV NEUROSCI, V118, P636, DOI 10.1037/0735-7044.118.3.636; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 1999, NEUROREPORT, V10, P15, DOI 10.1097/00001756-199901180-00003; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61431	10.1371/journal.pone.0061431	http://dx.doi.org/10.1371/journal.pone.0061431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630588	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500035
J	Berrazeg, M; Diene, SM; Drissi, M; Kempf, M; Richet, H; Landraud, L; Rolain, JM				Berrazeg, Meryem; Diene, Seydina M.; Drissi, Mourad; Kempf, Marie; Richet, Herve; Landraud, Luce; Rolain, Jean-Marc			Biotyping of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates from France and Algeria Using MALDI-TOF MS	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; SPECTRUM BETA-LACTAMASES; ANTIMICROBIAL SUSCEPTIBILITY; ESCHERICHIA-COLI; IDENTIFICATION; ENTEROBACTERIACEAE; CLASSIFICATION; EPIDEMIOLOGY; INFECTIONS	Background: Klebsiella pneumoniae is one of the most important pathogens responsible for nosocomial outbreaks worldwide. Epidemiological analyses are useful in determining the extent of an outbreak and in elucidating the sources and the spread of infections. The aim of this study was to investigate the epidemiological spread of K. pneumoniae strains using a MALDI-TOF MS approach. Methods: Five hundred and thirty-five strains of K. pneumoniae were collected between January 2008 and March 2011 from hospitals in France and Algeria and were identified using MALDI-TOF. Antibiotic resistance patterns were investigated. Clinical and epidemiological data were recorded in an Excel file, including clustering obtained from the MSP dendrogram, and were analyzed using PASW Statistics software. Results: Antibiotic susceptibility and phenotypic tests of the 535 isolates showed the presence of six resistance profiles distributed unequally between the two countries. The MSP dendrogram revealed five distinct clusters according to an arbitrary cut-off at the distance level of 500. Data mining analysis of the five clusters showed that K. pneumoniae strains isolated in Algerian hospitals were significantly associated with respiratory infections and the ESBL phenotype, whereas those from French hospitals were significantly associated with urinary tract infections and the wild-type phenotype. Conclusions: MALDI-TOF was found to be a promising tool to identify and differentiate between K. pneumoniae strains according to their phenotypic properties and their epidemiological distribution. This is the first time that MALDI-TOF has been used as a rapid tool for typing K. pneumoniae clinical isolates.	[Berrazeg, Meryem; Diene, Seydina M.; Kempf, Marie; Richet, Herve; Rolain, Jean-Marc] Aix Marseille Univ, CNRS 7278, Fac Med & Pharm,IRD 198, URMITE,IHU Mediterranee Infect,UM63,Inserm 1095, Marseille, France; [Berrazeg, Meryem; Drissi, Mourad] Univ Abou Bekr Belkaid Tlemcen, Fac Sci Nat Vie Terre & Univers, Lab Antibiot Antifong Physicochim Synth & Act Bio, Tilimsen, Algeria; [Kempf, Marie; Landraud, Luce] CHU Angers, Bacteriol Lab, Inst Biol Sante PBH, Angers, France; CHU Nice, Bacteriol Lab, Hop Archet 2, Nice, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite Abou Bekr Belkaid; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Nice	Rolain, JM (corresponding author), Aix Marseille Univ, CNRS 7278, Fac Med & Pharm,IRD 198, URMITE,IHU Mediterranee Infect,UM63,Inserm 1095, Marseille, France.	jean-marc.rolain@univ-amu.fr	Landraud, Luce/HGB-1249-2022; DIENE, Seydina/AAC-3576-2019; Rolain, Jean-Marc/Y-3788-2019; DIENE, Seydina/E-9839-2014	Landraud, Luce/0000-0001-8486-1403; Rolain, Jean-Marc/0000-0002-2402-4467; DIENE, Seydina/0000-0002-6466-2324; KEMPF, Marie/0000-0002-2943-7500	CNRS; LAPSAB laboratory	CNRS(Centre National de la Recherche Scientifique (CNRS)); LAPSAB laboratory	This work was partly supported by CNRS and LAPSAB laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Baker S, 2010, CURR OPIN MICROBIOL, V13, P640, DOI 10.1016/j.mib.2010.08.002; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Briales A, 2012, INT J ANTIMICROB AG, V39, P431, DOI 10.1016/j.ijantimicag.2011.12.009; Brisse S, 2005, VET MICROBIOL, V105, P307, DOI 10.1016/j.vetmic.2004.11.010; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Decre D, 2011, J CLIN MICROBIOL, V49, P3012, DOI 10.1128/JCM.00676-11; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Diene SM, 2013, MOL BIOL EVOL, V30, P369, DOI 10.1093/molbev/mss236; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; EARS-Net, 2010, ANN REP EUR ANT RES; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Fujinami Y, 2011, MICROBIOL RES, V166, P77, DOI 10.1016/j.micres.2010.02.005; Ilina EN, 2009, J MOL DIAGN, V11, P75, DOI 10.2353/jmoldx.2009.080079; JARLIER V, 1988, REV INFECT DIS, V10, P867; Khan E, 2010, J PAK MED ASSOC, V60, P186; Kumar A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-19; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Malik A, 2003, Indian J Med Microbiol, V21, P82; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nordmann P, 2010, ARCH PEDIATRIE, V17, pS154, DOI 10.1016/S0929-693X(10)70918-0; Okada S, 2001, MOL ECOL, V10, P2499, DOI 10.1046/j.0962-1083.2001.01384.x; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127; de Melo MES, 2011, CURR MICROBIOL, V62, P1596, DOI 10.1007/s00284-011-9903-7; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; Trevino M, 2011, MICROB DRUG RESIST, V17, P433, DOI 10.1089/mdr.2010.0182; Turner PJ, 2005, CLIN INFECT DIS, V41, pS273, DOI 10.1086/430789; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Vimont S, 2008, J MED MICROBIOL, V57, P1308, DOI 10.1099/jmm.0.2008/003798-0; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047152; YIP TT, 1992, FEBS LETT, V308, P149, DOI 10.1016/0014-5793(92)81264-M	39	57	62	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61428	10.1371/journal.pone.0061428	http://dx.doi.org/10.1371/journal.pone.0061428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620754	Green Published, gold			2022-12-25	WOS:000317909500034
J	Glover, KA; Sorvik, AGE; Karlsbakk, E; Zhang, ZW; Skaala, O				Glover, Kevin Alan; Sorvik, Anne Grete Eide; Karlsbakk, Egil; Zhang, Zhiwei; Skaala, Oystein			Molecular Genetic Analysis of Stomach Contents Reveals Wild Atlantic Cod Feeding on Piscine Reovirus (PRV) Infected Atlantic Salmon Originating from a Commercial Fish Farm	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; SALAR L.; GADUS-MORHUA; POPULATION-STRUCTURE; IDENTIFICATION; DNA; RIVER; PREY; PCR; MICROSATELLITES	In March 2012, fishermen operating in a fjord in Northern Norway reported catching Atlantic cod, a native fish forming an economically important marine fishery in this region, with unusual prey in their stomachs. It was speculated that these could be Atlantic salmon, which is not typical prey for cod at this time of the year in the coastal zone. These observations were therefore reported to the Norwegian Directorate of Fisheries as a suspected interaction between a local fish farm and this commercial fishery. Statistical analyses of genetic data from 17 microsatellite markers genotyped on 36 partially-degraded prey, samples of salmon from a local fish farm, and samples from the nearest wild population permitted the following conclusions: 1. The prey were Atlantic salmon, 2. These salmon did not originate from the local wild population, and 3. The local farm was the most probable source of these prey. Additional tests demonstrated that 21 of the 36 prey were infected with piscine reovirus. While the potential link between piscine reovirus and the disease heart and skeletal muscle inflammation is still under scientific debate, this disease had caused mortality of large numbers of salmon in the farm in the month prior to the fishermen's observations. These analyses provide new insights into interactions between domesticated and wild fish.	[Glover, Kevin Alan; Sorvik, Anne Grete Eide; Karlsbakk, Egil; Skaala, Oystein] Inst Marine Res, N-5024 Bergen, Norway; [Zhang, Zhiwei] Jiangsu Inst Marine Fisheries, Nantong City, Peoples R China	Institute of Marine Research - Norway	Glover, KA (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	kevin.glover@imr.no		zhang, zhiwei/0000-0002-0769-5007	Norwegian Department of Fisheries	Norwegian Department of Fisheries	This study was financed by the Norwegian Department of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OPPDATERTE ROMMINGST; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Dalvin S, 2010, BMC INVESTIGATIVE GE, V1, P12; DeWoody JA, 2001, P NATL ACAD SCI USA, V98, P5090, DOI 10.1073/pnas.091102598; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Falush D, 2003, GENETICS, V164, P1567; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2010, ANIM GENET, V41, P515, DOI 10.1111/j.1365-2052.2010.02025.x; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Glover KA, 2011, ICES J MAR SCI, V68, P901, DOI 10.1093/icesjms/fsr048; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-87; Glover KA, 2011, AQUAC RES, V42, P1323, DOI 10.1111/j.1365-2109.2010.02720.x; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Haaland OA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-36; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; HVIDSTEN NA, 1987, J FISH BIOL, V30, P273, DOI 10.1111/j.1095-8649.1987.tb05752.x; HVIDSTEN NA, 1988, J FISH BIOL, V33, P121, DOI 10.1111/j.1095-8649.1988.tb05453.x; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Jonsson B, 2006, ICES J MAR SCI, V63, P1162, DOI 10.1016/j.icesjms.2006.03.004; King TL, 2005, MOL ECOL NOTES, V5, P130, DOI 10.1111/j.1471-8286.2005.00860.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Leclerc LM, 2011, POLAR RES-SWEDEN, V30, DOI 10.3402/polar.v30i0.7342; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Matejusova I, 2008, J APPL ECOL, V45, P632, DOI 10.1111/j.1365-2664.2007.01429.x; MCCONNELL SK, 1995, CAN J FISH AQUAT SCI, V52, P1863, DOI 10.1139/f95-779; Michalsen K, 2008, ICES J MAR SCI, V65, P571, DOI 10.1093/icesjms/fsn019; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; Ogden R, 2010, FORENSIC SCI MED PAT, V6, P172, DOI 10.1007/s12024-010-9178-5; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Paterson S, 2004, MOL ECOL NOTES, V4, P160, DOI 10.1111/j.1471-8286.2004.00598.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Primmer CR, 2000, P ROY SOC B-BIOL SCI, V267, P1699; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saegrov H, 2006, 947 RADG BIOL; Sanchez JA, 1996, HEREDITY, V77, P423, DOI 10.1038/hdy.1996.162; Scribner KT, 1998, MOL ECOL, V7, P1401, DOI 10.1046/j.1365-294x.1998.00434.x; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sivertsen SP, 2006, MAR BIOL RES, V2, P89, DOI 10.1080/17451000600670952; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P147, DOI 10.3354/aei00017; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Withler RE, 2004, ENVIRON BIOL FISH, V69, P275, DOI 10.1023/B:EBFI.0000022901.26754.0b; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zhang Z, 2013, FISHERIES MANAG ECOL, V20, P42, DOI 10.1111/fme.12002	63	18	18	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e60924	10.1371/journal.pone.0060924	http://dx.doi.org/10.1371/journal.pone.0060924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620726	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500006
J	Laviolette, L; Nierat, MC; Hudson, AL; Raux, M; Allard, E; Similowski, T				Laviolette, Louis; Nierat, Marie-Cecile; Hudson, Anna L.; Raux, Mathieu; Allard, Etienne; Similowski, Thomas			The Supplementary Motor Area Exerts a Tonic Excitatory Influence on Corticospinal Projections to Phrenic Motoneurons in Awake Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; CEREBRAL-BLOOD-FLOW; OLD-WORLD MONKEY; RESPIRATORY RHYTHM; INTRACORTICAL INHIBITION; CORTICAL REPRESENTATION; VOLUNTARY CONTRACTION; CORTEX STIMULATION; DIAPHRAGM RESPONSE	Introduction: In humans, cortical mechanisms can interfere with autonomic breathing. Respiratory-related activation of the supplementary motor area (SMA) has been documented during voluntary breathing and in response to inspiratory constraints. The SMA could therefore participate in the increased resting state of the respiratory motor system during wake (i.e. "wakefulness drive to breathe"). Methods: The SMA was conditioned by continuous theta burst magnetic stimulation (cTBS, inhibitory) and 5 Hz conventional rTMS (5 Hz, excitatory). The ensuing effects were described in terms of the diaphragm motor evoked response (DiMEPs) to single-pulse transcranial magnetic stimulation over the motor cortex. DiMEPs were recorded at baseline, and at 3 time-points ("post1", "post2", "post3") up to 15 minutes following conditioning of the SMA. Results: cTBS reduced the amplitude of DiMEPs from 327.5 +/- 159.8 mu V at baseline to 243.3 +/- 118.7 mu V, 217.8 +/- 102.9 mu V and 240.6 +/- 123.9 mu V at post 1, post 2 and post 3, respectively (F = 6.341, p = 0.002). 5 Hz conditioning increased the amplitude of DiMEPs from 184.7 +/- 96.5 mu V at baseline to 270.7 +/- 135.4 mu V at post 3 (F = 4.844, p = 0.009). Conclusions: The corticospinal pathway to the diaphragm can be modulated in both directions by conditioning the SMA. This suggests that the baseline respiratory activity of the SMA represents an equipoise from which it is possible to move in either direction. The resting corticofugal outflow from the SMA to phrenic motoneurones that this study evidences could putatively contribute to the wakefulness drive to breathe.	[Laviolette, Louis; Nierat, Marie-Cecile; Hudson, Anna L.; Raux, Mathieu; Allard, Etienne; Similowski, Thomas] Univ Paris 06, ER10UPMC, Paris, France; [Hudson, Anna L.] Neurosci Res Australia, Sydney, NSW, Australia; [Hudson, Anna L.] Univ New S Wales, Sydney, NSW, Australia; [Similowski, Thomas] Grp Hosp Pitie Salpetriere, AP HP, Serv Pneumol & Reanimat Med, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Neuroscience Research Australia; University of New South Wales Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Similowski, T (corresponding author), Univ Paris 06, ER10UPMC, Paris, France.	thomas.similowski@psl.aphp.fr	Hudson, Anna/C-1280-2012	Hudson, Anna/0000-0002-0192-776X; Allard, Etienne/0000-0002-9141-5943; RAUX, Mathieu/0000-0003-2493-9146	Chancellerie de l'Universite de Paris, "Legs Poix", Paris, France; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil", Paris, France; program "Investissements d'avenir" of the French Government [ANR-10-IAIHU-06]; Institut Universitaire de Cardiologie et Pneumologie de Quebec (IUCPQ) foundation, Quebec, Canada; European Respiratory Society (LTRF) [39-2011]; Fond de la Recherche en Sante du Quebec (FRSQ); National Health and Medical Research Council (NHMRC; Australia)	Chancellerie de l'Universite de Paris, "Legs Poix", Paris, France; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil", Paris, France; program "Investissements d'avenir" of the French Government(French National Research Agency (ANR)); Institut Universitaire de Cardiologie et Pneumologie de Quebec (IUCPQ) foundation, Quebec, Canada; European Respiratory Society (LTRF); Fond de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); National Health and Medical Research Council (NHMRC; Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by Chancellerie de l'Universite de Paris, "Legs Poix", Paris, France; and the "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil", Paris, France and the program "Investissements d'avenir" ANR-10-IAIHU-06 of the French Government. Louis Laviolette was supported by Institut Universitaire de Cardiologie et Pneumologie de Quebec (IUCPQ) foundation, Quebec, Canada (2010-2011); a long-term research fellowship from the European Respiratory Society (LTRF fellowship no39-2011; 2011-2012); and post-doctoral research fellowship from the Fond de la Recherche en Sante du Quebec (FRSQ, 2012). Anna Hudson was supported by a National Health and Medical Research Council (NHMRC; Australia) early career fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINOFF MJ, 1971, J PHYSIOL-LONDON, V215, P557, DOI 10.1113/jphysiol.1971.sp009485; AMINOFF MJ, 1970, J PHYSIOL-LONDON, V208, pP76; Arai N, 2012, EXP BRAIN RES, V220, P79, DOI 10.1007/s00221-012-3117-5; ASMUSSEN E, 1977, ACTA PHYSIOL SCAND, V99, P85, DOI 10.1111/j.1748-1716.1977.tb10355.x; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; BERGER AJ, 1979, J NEUROPHYSIOL, V42, P76, DOI 10.1152/jn.1979.42.1.76; Boy F, 2010, EXP BRAIN RES, V206, P441, DOI 10.1007/s00221-010-2417-x; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; BROUWER B, 1990, ELECTROEN CLIN NEURO, V76, P509, DOI 10.1016/0013-4694(90)90002-2; BULOW K, 1963, Acta Physiol Scand Suppl, V209, P1; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; CHIAPPA KH, 1991, ELECTROEN CLIN NEURO, P186; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; DATTA AK, 1991, J PHYSIOL-LONDON, V440, P17, DOI 10.1113/jphysiol.1991.sp018693; DAVENPORT PW, 1986, J APPL PHYSIOL, V60, P1843, DOI 10.1152/jappl.1986.60.6.1843; DAY BL, 1987, BRAIN, V110, P1191, DOI 10.1093/brain/110.5.1191; Demoule A, 2003, J CLIN NEUROPHYSIOL, V20, P59, DOI 10.1097/00004691-200302000-00008; Demoule A, 2003, J APPL PHYSIOL, V94, P453, DOI 10.1152/japplphysiol.00581.2002; DENOORDHOUT AM, 1992, ANN NEUROL, V32, P365, DOI 10.1002/ana.410320310; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Di Lazzaro V, 2010, CLIN NEUROPHYSIOL, V121, P464, DOI 10.1016/j.clinph.2009.11.007; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Dinomais M, 2009, NEUROREPORT, V20, P1351, DOI 10.1097/WNR.0b013e328330cd43; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; FINK BR, 1963, ANN NY ACAD SCI, V109, P892, DOI 10.1111/j.1749-6632.1963.tb13514.x; FINK BR, 1961, J APPL PHYSIOL, V16, P15, DOI 10.1152/jappl.1961.16.1.15; Fink GR, 1996, J APPL PHYSIOL, V81, P1295, DOI 10.1152/jappl.1996.81.3.1295; Foerster O, 1936, HDB NEUROLOGIE, V6, P50; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Hamada M, 2009, J PHYSIOL-LONDON, V587, P4845, DOI 10.1113/jphysiol.2009.179101; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; Heywood P, 1996, RESP PHYSIOL, V106, P13, DOI 10.1016/0034-5687(96)00060-6; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; IZUMI SI, 1995, AM J PHYS MED REHAB, V74, P207, DOI 10.1097/00002060-199505000-00005; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kiers L, 1997, ELECTROMYOGR MOTOR C, V105, P262, DOI 10.1016/S0921-884X(97)00027-1; Lefaucheur JP, 2011, NEUROPHYSIOL CLIN, V41, P221, DOI 10.1016/j.neucli.2011.10.062; Logie ST, 1998, BRAIN TOPOGR, V11, P153, DOI 10.1023/A:1022210723257; MACEFIELD G, 1991, J PHYSIOL-LONDON, V439, P545, DOI 10.1113/jphysiol.1991.sp018681; Masaoka Y, 2000, NEUROSCI LETT, V283, P21, DOI 10.1016/S0304-3940(00)00895-8; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Mehiri S, 2006, RESP PHYSIOL NEUROBI, V154, P406, DOI 10.1016/j.resp.2005.12.003; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MUNSCHAUER FE, 1991, ARCH NEUROL-CHICAGO, V48, P1190, DOI 10.1001/archneur.1991.00530230098031; MURPHY K, 1990, J PHYSIOL-LONDON, V420, P1; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Onimaru H, 2006, J APPL PHYSIOL, V100, P2094, DOI 10.1152/japplphysiol.00119.2006; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POOL JL, 1949, J NEUROPHYSIOL, V12, P385, DOI 10.1152/jn.1949.12.6.385; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schmahmann JD, 2004, BRAIN, V127, P1269, DOI 10.1093/brain/awh138; Serrien DJ, 2002, NEUROSCI LETT, V328, P89, DOI 10.1016/S0304-3940(02)00499-8; Sharshar T, 2004, J PHYSIOL-LONDON, V560, P897, DOI 10.1113/jphysiol.2004.061150; Sharshar T, 2004, J APPL PHYSIOL, V97, P3, DOI 10.1152/japplphysiol.01099.2003; Sharshar T, 2003, J APPL PHYSIOL, V95, P26, DOI 10.1152/japplphysiol.00918.2002; Shea SA, 1996, EXP PHYSIOL, V81, P1; Similowski T, 1996, AM J RESP CRIT CARE, V154, P436, DOI 10.1164/ajrccm.154.2.8756819; Similowski T, 1996, AM J RESP CRIT CARE, V154, P1771, DOI 10.1164/ajrccm.154.6.8970369; SKATRUD JB, 1983, J APPL PHYSIOL, V55, P813, DOI 10.1152/jappl.1983.55.3.813; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Straus C, 2004, J APPL PHYSIOL, V97, P902, DOI 10.1152/japplphysiol.00989.2003; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006; Zifko UA, 1996, J NEUROL SCI, V139, P197	87	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62258	10.1371/journal.pone.0062258	http://dx.doi.org/10.1371/journal.pone.0062258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614046	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400168
J	Hou, Y; Zhang, Z; Xu, Q; Wang, H; Xu, Y; Chen, K				Hou, Y.; Zhang, Z.; Xu, Q.; Wang, H.; Xu, Y.; Chen, K.			Inhibitor of growth 4 induces NF kappa B/p65 ubiquitin-dependent degradation	ONCOGENE			English	Article						ING4; NF kappa B/p65; ubiquitination; degradation	NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; CELL-GROWTH; DOWN-REGULATION; ING4; ACTIVATION; APOPTOSIS; PROTEINS; BINDING; LIGASES	As a tumor suppressor protein, the inhibitor of growth 4 (ING4) has an important role in many cellular processes including cell cycle progression, proliferation, apoptosis, DNA damage response, tumor angiogenesis and contact inhibition. Here, we report that ING4 functions as an E3 ubiquitin ligase to induce nuclear factor-kappa B (NF kappa B)/p65 degradation. The plant homeodomain finger of ING4 interacted with p65 to undergo robust ubiquitination and degradation. ING4 bound to p65 and delivered the Lys-48-linked polyubiquitin to Lys-62 residue of p65, leading to ubiquitination of p65 and degradation. Lys-62 residue of p65 was required for ING4-mediated ubiquitination of p65 and degradation. Further analysis shows that C239 of ING4 was critical for ING4-induced p65 degradation. These findings demonstrate that ING4 acts as an E3 ubiquitin ligase to induce ubiquitination of p65 and degradation, which is critical to terminate NFkB activation.	[Hou, Y.; Zhang, Z.; Xu, Q.; Xu, Y.; Chen, K.] Jiangsu Univ, Inst Life Sci, Zhenjiang 2121300, Jiangsu, Peoples R China; [Wang, H.] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China	Jiangsu University; Tianjin University of Traditional Chinese Medicine	Hou, Y (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang 2121300, Jiangsu, Peoples R China.	houyz@ujs.edu.cn	hou, YONGZHONG/K-7771-2013	Hou, Yongzhong/0000-0003-2019-8686; xu, qinggang/0000-0002-8659-7041	Start Fund of Jiangsu University [12JDG071]; National Natural Science Foundation of China [81173592]; Tianjin Applied Basic Research and Frontier Technological Program [11JCZDJC21100]	Start Fund of Jiangsu University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Applied Basic Research and Frontier Technological Program	This work was supported by Start Fund of Jiangsu University (12JDG071). National Natural Science Foundation of China (81173592), Tianjin Applied Basic Research and Frontier Technological Program (11JCZDJC21100).	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046823; Cai LM, 2009, MELANOMA RES, V19, P1, DOI 10.1097/CMR.0b013e32831bc42f; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gunduz M, 2005, GENE, V356, P109, DOI 10.1016/j.gene.2005.02.014; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li XM, 2009, J CANCER RES CLIN, V135, P829, DOI 10.1007/s00432-008-0519-7; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Unoki M, 2006, J BIOL CHEM, V281, P34677, DOI 10.1074/jbc.M606296200; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; Xie YF, 2008, CANCER LETT, V271, P105, DOI 10.1016/j.canlet.2008.05.050; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang X, 2005, BIOCHEM BIOPH RES CO, V331, P1032, DOI 10.1016/j.bbrc.2005.04.023; Zhang X, 2004, FEBS LETT, V570, P7, DOI 10.1016/j.febslet.2004.06.010	35	44	45	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1997	2003		10.1038/onc.2013.135	http://dx.doi.org/10.1038/onc.2013.135			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23624912				2022-12-25	WOS:000334346300012
J	Kim, TK; Kleszczynski, K; Janjetovic, Z; Sweatman, T; Lin, ZT; Li, W; Reiter, RJ; Fischer, TW; Slominski, AT				Kim, Tae-Kang; Kleszczynski, Konrad; Janjetovic, Zorica; Sweatman, Trevor; Lin, Zongtao; Li, Wei; Reiter, Russel J.; Fischer, Tobias W.; Slominski, Andrzej T.			Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells	FASEB JOURNAL			English	Article						keratinocytes; melanocytes; 6-hydroxymelatonin; AFMK; 5-methoxytryptamine	REACTIVE OXYGEN; INHIBITS PROLIFERATION; SEROTONINERGIC SYSTEM; VITILIGO PATHOGENESIS; HACAT KERATINOCYTES; AUTOIMMUNE-DISEASE; CALCIUM IMBALANCE; GENETIC-DEFECT; VITAMIN-D; EXPRESSION	Indolic and kynuric pathways of skin melatonin metabolism were monitored by liquid chromatography mass spectrometry in human keratinocytes, melanocytes, dermal fibroblasts, and melanoma cells. Production of 6-hydroxymelatonin [6(OH)M], N-1-acetyl-N-2-formyl-5-methoxykynuramine (AFMK) and 5-methoxytryptamine (5-MT) was detected in a cell type-dependent fashion. The major metabolites, 6(OH)M and AFMK, were produced in all cells. Thus, in immortalized epidermal (HaCaT) keratinocytes, 6(OH)M was the major product with V-max = 63.7 ng/10(6) cells and K-m = 10.2 M, with lower production of AFMK and 5-MT. Melanocytes, keratinocytes, and fibroblasts transformed melatonin primarily into 6(OH)M and AFMK. In melanoma cells, 6(OH)M and AFMK were produced endogenously, a process accelerated by exogenous melatonin in the case of AFMK. In addition, N-acetylserotonin was endogenously produced by normal and malignant melanocytes. Metabolites showed selective antiproliferative effects on human primary epidermal keratinocytes in vitro. In ex vivo human skin, both melatonin and AFMK-stimulated expression of involucrin and keratins-10 and keratins-14 in the epidermis, indicating their stimulatory role in building and maintaining the epidermal barrier. In summary, the metabolism of melatonin and its endogenous production is cell type-dependent and expressed in all three main cell populations of human skin. Furthermore, melatonin and its metabolite AFMK stimulate differentiation in human epidermis, indicating their key role in building the skin barrier.Kim, T.-K., Kleszczyski, K., Janjetovic, Z., Sweatman, T., Lin, Z., Li, W., Reiter, R. J., Fischer, T. W., Slominski, A. T. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells.	[Kim, Tae-Kang; Janjetovic, Zorica; Slominski, Andrzej T.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; [Kim, Tae-Kang; Janjetovic, Zorica; Slominski, Andrzej T.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Dept Lab Med, Memphis, TN 38163 USA; [Sweatman, Trevor] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Lin, Zongtao; Li, Wei] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Slominski, Andrzej T.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Kleszczynski, Konrad; Fischer, Tobias W.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Reiter, Russel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Lubeck; University of Texas System; University of Texas Health San Antonio	Slominski, AT (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol, 930 Madison Ave,RM525, Memphis, TN 38163 USA.	aslominski@uthsc.edu	Lin, Zongtao/GYU-9038-2022; Lin, Zongtao/J-3854-2019	Lin, Zongtao/0000-0002-6017-338X; Li, Wei/0000-0002-9522-4474; Slominski, Andrzej/0000-0001-8963-3995; Kleszczynski, Konrad/0000-0002-1311-263X	U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Muskuloskeletal and Skin Diseases [1R01AR056666-01A2]; University of Lubeck (Lubeck, Germany) [E22-2012]; University of Lubeck medical faculty; NIH [1S10RR026377-01, 1S10OD010678-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056666] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010678] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Muskuloskeletal and Skin Diseases; University of Lubeck (Lubeck, Germany); University of Lubeck medical faculty; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This investigation was supported by U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Muskuloskeletal and Skin Diseases grant 1R01AR056666-01A2 (A. S.), University of Lubeck (Lubeck, Germany) research grant E22-2012 (K. K.), experimental dermatology funds from the University of Lubeck medical faculty (T. W. F.), and NIH grants 1S10RR026377-01 and 1S10OD010678-01 (W.L.).	Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Elias PM, 2010, AM J HUM BIOL, V22, P526, DOI 10.1002/ajhb.21043; Facciola G, 2001, EUR J CLIN PHARMACOL, V56, P881, DOI 10.1007/s002280000245; Fischer TW, 2006, INT J ONCOL, V29, P665; Fischer TW, 2008, EXP DERMATOL, V17, P713, DOI 10.1111/j.1600-0625.2008.00767.x; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Fischer TW, 2006, J PINEAL RES, V40, P18, DOI 10.1111/j.1600-079X.2005.00273.x; Fischer TW, 2012, J PINEAL RES; GRACE MS, 1991, BRAIN RES, V559, P56, DOI 10.1016/0006-8993(91)90286-5; HARDELAND R, 1993, NEUROSCI BIOBEHAV R, V17, P347, DOI 10.1016/S0149-7634(05)80016-8; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Hipler UC, 2003, SKIN PHARMACOL APPL, V16, P379, DOI 10.1159/000072933; HIRATA F, 1974, J BIOL CHEM, V249, P1311; Iriti M, 2010, J PINEAL RES, V49, P101, DOI 10.1111/j.1600-079X.2010.00777.x; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kleszczynski K, 2013, J PINEAL RES, V54, P89, DOI 10.1111/j.1600-079X.2012.01028.x; Kleszczynski K, 2012, ARCH DERMATOL RES, V304, P579, DOI 10.1007/s00403-012-1239-z; Kleszczynski K, 2011, DERM-ENDOCRINOL, V3, P27, DOI 10.4161/derm.3.1.14842; Kobayashi H, 2005, FASEB J, V19, P1710, DOI 10.1096/fj.04-2293fje; Lanoix D, 2012, MOL CELL ENDOCRINOL, V348, P1, DOI 10.1016/j.mce.2011.08.025; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Niu SD, 2010, J PINEAL RES, V49, P106, DOI 10.1111/j.1600-079X.2010.00771.x; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; ROGAWSKI MA, 1979, J NEUROCHEM, V32, P1219, DOI 10.1111/j.1471-4159.1979.tb11049.x; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2008, EXP DERMATOL, V17, P141, DOI 10.1111/j.1600-0625.2007.00666_2.x; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Semak I, 2005, BIOCHEMISTRY-US, V44, P9300, DOI 10.1021/bi050202d; Semak I, 2008, J PINEAL RES, V45, P515, DOI 10.1111/j.1600-079X.2008.00630.x; Slominski A, 1994, Exp Dermatol, V3, P45, DOI 10.1111/j.1600-0625.1994.tb00265.x; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; Slominski A, 1996, J BIOL CHEM, V271, P12281, DOI 10.1074/jbc.271.21.12281; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Slominski A, 2003, BBA-MOL BASIS DIS, V1639, P80, DOI 10.1016/S0925-4439(03)00124-8; Slominski A, 2003, EUR J BIOCHEM, V270, P3335, DOI 10.1046/j.1432-1033.2003.03708.x; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Slominski A, 2002, J INVEST DERMATOL, V119, P934, DOI 10.1046/j.1523-1747.2002.00156.x; Slominski A, 2002, FEBS LETT, V511, P102, DOI 10.1016/S0014-5793(01)03319-1; SLOMINSKI A, 1993, EXP CELL RES, V206, P189, DOI 10.1006/excr.1993.1137; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2011, J INVEST DERMATOL, V131, P1167, DOI 10.1038/jid.2010.425; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2001, FASEB J, V15, P2294, DOI 10.1096/fj.01-0309fje; Tan DX, 2003, J PINEAL RES, V34, P75, DOI 10.1034/j.1600-079X.2003.02111.x; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Yu H. L., 2020, ARXIV PREPRINT ARXIV	66	103	106	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2742	2755		10.1096/fj.12-224691	http://dx.doi.org/10.1096/fj.12-224691			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23620527	Bronze, Green Published			2022-12-25	WOS:000328841000023
J	Gold, MG; Fowler, DM; Means, CK; Pawson, CT; Stephany, JJ; Langeberg, LK; Fields, S; Scott, JD				Gold, Matthew G.; Fowler, Douglas M.; Means, Christopher K.; Pawson, Catherine T.; Stephany, Jason J.; Langeberg, Lorene K.; Fields, Stanley; Scott, John D.			Engineering A-kinase Anchoring Protein (AKAP)-selective Regulatory Subunits of Protein Kinase A (PKA) through Structure-based Phage Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP; DYNAMICS; BINDING; SPECIFICITY; NEURONS; COMPLEX; RII	PKA is retained within distinct subcellular environments by the association of its regulatory type II (RII) subunits with A-kinase anchoring proteins (AKAPs). Conventional reagents that universally disrupt PKA anchoring are patterned after a conserved AKAP motif. We introduce a phage selection procedure that exploits high-resolution structural information to engineer RII mutants that are selective for a particular AKAP. Selective RII (R-Select) sequences were obtained for eight AKAPs following competitive selection screening. Biochemical and cell-based experiments validated the efficacy of RSelect proteins for AKAP2 and AKAP18. These engineered proteins represent a new class of reagents that can be used to dissect the contributions of different AKAP-targeted pools of PKA. Molecular modeling and high-throughput sequencing analyses revealed the molecular basis of AKAP-selective interactions and shed new light on native RII-AKAP interactions. We propose that this structure-directed evolution strategy might be generally applicable for the investigation of other protein interaction surfaces.	[Gold, Matthew G.; Fowler, Douglas M.; Means, Christopher K.; Pawson, Catherine T.; Stephany, Jason J.; Langeberg, Lorene K.; Fields, Stanley; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Gold, Matthew G.; Means, Christopher K.; Pawson, Catherine T.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Fowler, Douglas M.; Stephany, Jason J.; Fields, Stanley] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gold, MG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	m.gold@ucl.ac.uk; scottjdw@uw.edu	Gold, Matthew/AAL-2546-2021	Gold, Matthew/0000-0002-1281-0815	National Institutes of Health [P41 GM103533, F32 GM084699, GM48231]; Experimental Pathology of Cardiovascular Disease Training Grant [T32 HL07312]; Sir Henry Wellcome postdoctoral research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084699, R01GM048231, P41GM103533, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Pathology of Cardiovascular Disease Training Grant; Sir Henry Wellcome postdoctoral research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 GM103533 (to S. F.), F32 GM084699 (to D. M. F.), and GM48231 (to J. D. S.) and Experimental Pathology of Cardiovascular Disease Training Grant T32 HL07312 (to C. K. M.). This work was also supported by a Sir Henry Wellcome postdoctoral research fellowship (to M. G. G.).	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Christian F, 2011, J BIOL CHEM, V286, P9079, DOI 10.1074/jbc.M110.160614; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; KEELY SL, 1977, RES COMMUN CHEM PATH, V18, P283; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	38	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17111	17121		10.1074/jbc.M112.447326	http://dx.doi.org/10.1074/jbc.M112.447326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625929	Green Published, hybrid			2022-12-25	WOS:000320380600009
J	Sun, ZZ; Smrcka, AV; Chen, SH				Sun, Zhizeng; Smrcka, Alan V.; Chen, Songhai			WDR26 Functions as a Scaffolding Protein to Promote G beta gamma-mediated Phospholipase C beta 2 (PLC beta 2) Activation in Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTIONAL CELL-MIGRATION; SMALL-MOLECULE DISRUPTION; REPEAT PROTEIN; SIGNALING PATHWAY; SUBUNITS; ASSOCIATION; ALPHA; CHEMOTAXIS; PI3K-GAMMA; EFFECTORS	We have recently identified WDR26 as a novel WD40 repeat protein that binds G beta gamma and promotes G beta gamma signaling during leukocyte migration. Here, we have determined the mechanism by which WDR26 enhances G beta gamma-mediated phospholipase C beta 2 (PLC beta 2) activation in leukocytes. We show that WDR26 not only directly bound G beta gamma but also PLC beta 2. The binding sites of WDR26 and PLC beta 2 on G beta(1)gamma(2) were overlapping but not identical. WDR26 used the same domains for binding G beta gamma and PLC beta but still formed a signaling complex with G beta gamma and PLC beta 2 probably due to the fact that WDR26 formed a higher order oligomer through its Lis homology and C-terminal to LisH (LisH-CTLH) and WD40 domains. Additional studies indicated that the formation of higher order oligomers was required for WDR26 to promote PLC beta 2 interaction with and activation by G beta gamma. Moreover, WDR26 was required for PLC beta 2 translocation from the cytosol to the membrane in polarized leukocytes, and the translocation of PLC beta 2 was sufficient to cause partial activation of PLC beta 2. Collectively, our data indicate that WDR26 functions as a scaffolding protein to promote PLC beta 2 membrane translocation and interaction with G beta gamma, thereby enhancing PLC beta 2 activation in leukocytes. These findings have identified a novel mechanism of regulating G beta gamma signaling through a scaffolding protein.	[Sun, Zhizeng; Chen, Songhai] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chen, Songhai] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Iowa; University of Iowa; University of Rochester	Chen, SH (corresponding author), Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Bowen Sci Bldg,Rm 2-3452,51 Newton Rd, Iowa City, IA 52242 USA.	songhai-chen@uiowa.edu		Sun, Zhizeng/0000-0002-0033-5885; chen, songhai/0000-0001-7316-7125	National Institutes of Health Grant [GM094255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094255, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094255 (to S. C.).	Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Feng YS, 2012, FREE RADICAL RES, V46, P777, DOI 10.3109/10715762.2012.678840; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gehrmann J, 2002, AM J PHYSIOL-HEART C, V282, pH445, DOI 10.1152/ajpheart.00565.2001; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Mirshahi Tooraj, 2003, Sci STKE, V2003, pPE32, DOI 10.1126/stke.2003.194.pe32; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Runne C, 2013, CELL ADHES MIGR, V7, P214, DOI 10.4161/cam.22940; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Wei X, 2010, BIOCHEM BIOPH RES CO, V393, P860, DOI 10.1016/j.bbrc.2010.02.099; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Yoshikawa DM, 2001, J BIOL CHEM, V276, P11246, DOI 10.1074/jbc.M006073200; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175	33	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16715	16725		10.1074/jbc.M113.462564	http://dx.doi.org/10.1074/jbc.M113.462564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625927	hybrid, Green Published			2022-12-25	WOS:000320378900046
J	Cunningham, DL; Creese, AJ; Auciello, G; Sweet, SMM; Tatar, T; Rappoport, JZ; Grant, MM; Heath, JK				Cunningham, Debbie L.; Creese, Andrew J.; Auciello, Giulio; Sweet, Steve M. M.; Tatar, Tulin; Rappoport, Joshua Z.; Grant, Melissa M.; Heath, John K.			Novel Binding Partners and Differentially Regulated Phosphorylation Sites Clarify Eps8 as a Multi-Functional Adaptor	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-INTERACTION PARTNERS; CELL-MIGRATION; V-SRC; IDENTIFICATION; COMPLEX; KINASE; SUBSTRATE-4; ACTIVATION; EXPRESSION	Eps8 is involved in both cell signalling and receptor trafficking. It is a known phosphorylation substrate for two proteins involved in the fibroblast growth factor receptor (FGFR) signalling pathway: the receptor itself and Src. Here we report a differential proteomic analysis of Eps8 aimed to identify specific FGFR and Src family kinase dependent phosphosites and co-associated phosphodependent binding partners. This study reveals a total of 22 Eps8 pTyr and pSer/Thr phosphorylation sites, including those that are dependent on Src family and FGFR kinase activity. Peptide affinity purification of proteins that bind to a selection of the pTyr phosphosites has identified a range of novel Eps8 binding partners including members of the intracellular vesicle trafficking machinery (clathrin and AP-2), proteins which have been shown to regulate activated receptor trafficking (NBR1 and Vav2), and proteins involved in receptor signalling (IRS4 and Shp2). Collectively this study significantly extends the understanding of Eps8 post-translational modification by regulated phosphorylation, identifies novel Eps8 binding partners implicated in receptor trafficking and signalling, and confirms the functions of Eps8 at the nexus of receptor signalling and vesicular trafficking.	[Cunningham, Debbie L.; Creese, Andrew J.; Sweet, Steve M. M.; Tatar, Tulin; Heath, John K.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Canc Res UK Growth Factor Signalling Grp, Birmingham, W Midlands, England; [Creese, Andrew J.; Grant, Melissa M.] Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Birmingham, W Midlands, England; [Auciello, Giulio; Tatar, Tulin; Rappoport, Joshua Z.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Heath, JK (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Canc Res UK Growth Factor Signalling Grp, Birmingham, W Midlands, England.	J.K.Heath@bham.ac.uk	Sweet, Steve/B-5528-2008; Creese, Andrew/C-8221-2014; Grant, Melissa/A-5590-2010; Cunningham, Debbie L/B-7329-2009	Sweet, Steve/0000-0002-3962-0421; Grant, Melissa/0000-0003-1154-7266; Cunningham, Debbie L/0000-0001-7776-690X; Heath, John/0000-0003-4886-4070; Auciello, Giulio/0000-0003-3494-167X	CRUK [RCCS13677]; MRC; FP6 Endotrack [REAZ 12101]	CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FP6 Endotrack	This work was supported by CRUK (grant no. RCCS13677), www.cancerresearchuk.org/; MRC PhD studentship www.mrc.ac.uk/; and FP6 Endotrack (grant no. REAZ 12101), www.endotrack.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amanchy Ramars, 2005, Sci STKE, V2005, ppl2, DOI 10.1126/stke.2672005pl2; Auciello G, 2013, J CELL SCI, V126, P613, DOI 10.1242/jcs.116228; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blake Richard A., 2000, AMERICA, V181, P20; Boulon S, 2010, MOL CELL PROTEOMICS, V9, P861, DOI 10.1074/mcp.M900517-MCP200; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Chiba T, 2009, NEUROBIOL AGING, V30, P474, DOI 10.1016/j.neurobiolaging.2007.07.008; Chiba T, 2007, MAMM GENOME, V18, P105, DOI 10.1007/s00335-006-0119-2; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cunningham DL, 2010, J PROTEOME RES, V9, P2317, DOI 10.1021/pr9010475; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; DISORBO D, 1988, BIOCHEM BIOPH RES CO, V157, P1007, DOI 10.1016/S0006-291X(88)80974-4; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Escribano O, 2003, HEPATOLOGY, V37, P1461, DOI 10.1053/jhep.2003.50245; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; Hinsby AM, 2004, J BIOL CHEM, V279, P46438, DOI 10.1074/jbc.M404537200; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Mardakheh FK, 2010, MOL CELL BIOL, V30, P5672, DOI 10.1128/MCB.00878-10; MATOSKOVA B, 1995, MOL CELL BIOL, V15, P3805; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Sano H, 2002, J BIOL CHEM, V277, P19439, DOI 10.1074/jbc.M111838200; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; van Bentem SD, 2008, PROTEOMICS, V8, P4453, DOI 10.1002/pmic.200800175; Wang HX, 2009, CARCINOGENESIS, V30, P165, DOI 10.1093/carcin/bgn252; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yap LF, 2009, ONCOGENE, V28, P2524, DOI 10.1038/onc.2009.105	46	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61513	10.1371/journal.pone.0061513	http://dx.doi.org/10.1371/journal.pone.0061513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626693	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400057
J	Kim, JS; Choi, JY; Lee, JH; Park, JB; Fu, Z; Liu, Q; Tao, X; Jin, BR; Skinner, M; Parker, BL; Je, YH				Kim, Jae Su; Choi, Jae Young; Lee, Joo Hyun; Park, Jong Bin; Fu, Zhenli; Liu, Qin; Tao, Xueying; Jin, Byung Rae; Skinner, Margaret; Parker, Bruce L.; Je, Yeon Ho			Bumblebee Venom Serine Protease Increases Fungal Insecticidal Virulence by Inducing Insect Melanization	PLOS ONE			English	Article							SYSTEM; INTEGRATION	Insect-killing (entomopathogenic) fungi have high potential for controlling agriculturally harmful pests. However, their pathogenicity is slow, and this is one reason for their poor acceptance as a fungal insecticide. The expression of bumblebee, Bombus ignitus, venom serine protease (VSP) by Beauveria bassiana (ERL1170) induced melanization of yellow spotted longicorn beetles (Psacothea hilaris) as an over-reactive immune response, and caused substantially earlier mortality in beet armyworm (Spodopetra exigua) larvae when compared to the wild type. No fungal outgrowth or sporulation was observed on the melanized insects, thus suggesting a self-restriction of the dispersal of the genetically modified fungus in the environment. The research is the first use of a multi-functional bumblebee VSP to significantly increase the speed of fungal pathogenicity, while minimizing the dispersal of the fungal transformant in the environment.	[Kim, Jae Su] Chonbuk Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Jeonju, South Korea; [Choi, Jae Young; Lee, Joo Hyun; Park, Jong Bin; Fu, Zhenli; Liu, Qin; Tao, Xueying; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Jin, Byung Rae] Dong A Univ, Dept Appl Biol, Coll Nat Resources & Life Sci, Pusan, South Korea; [Skinner, Margaret; Parker, Bruce L.] Univ Vermont, Entomol Res Lab, Burlington, VT USA; [Je, Yeon Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Jeonbuk National University; Seoul National University (SNU); Dong A University; University of Vermont; Seoul National University (SNU)	Je, YH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea.	btrus@snu.ac.kr	Choi, Jae Young/G-1731-2010; Tao, XueYing/ABG-6993-2021; Kim, Jae Su/L-2194-2013	Tao, XueYing/0000-0002-6539-4659; 	Rural Development Administration, Republic of Korea [PJ008198]; 2nd stage of the Brain Korea 21 project	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); 2nd stage of the Brain Korea 21 project	This work was supported by the grant from the Next-Generation BioGreen 21 Program (number PJ008198), Rural Development Administration, Republic of Korea. Joo Hyun Lee, Jong Bin Park, and Zhenli Fu were supported by 2nd stage of the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5; Bloom M, 1996, LAB DNA SCI; Butt TM, 2000, BIOASSAYS OF ENTOMOPATHOGENIC MICROBES AND NEMATODES, P141, DOI 10.1079/9780851994222.0141; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; COPPING L.G., 2004, MANUAL BIOCONTROL AG, V3rd; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Hajek AE, 1997, ADV MICROB ECOL, V15, P193; Inglis GD, 1997, ENVIRON ENTOMOL, V26, P400, DOI 10.1093/ee/26.2.400; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kim JS, 2011, J IND MICROBIOL BIOT, V38, P697, DOI 10.1007/s10295-010-0850-2; Kim JS, 2010, J INVERTEBR PATHOL, V105, P322, DOI 10.1016/j.jip.2010.08.008; Qin Y, 2010, APPL ENVIRON MICROB, V76, P4611, DOI 10.1128/AEM.00302-10; Scrivener AM, 1997, J INSECT PHYSIOL, V43, P1039, DOI 10.1016/S0022-1910(97)00063-2; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Toombs Christopher F., 2001, Current Opinion in Pharmacology, V1, P164, DOI 10.1016/S1471-4892(01)00030-3; Vass E, 2000, J PARASITOL, V86, P1259, DOI 10.1645/0022-3395(2000)086[1259:DAIAOD]2.0.CO;2; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Yatin B. T., 2006, NEW BIOPESTICIDE MAR; Ying SH, 2006, APPL MICROBIOL BIOT, V72, P206, DOI 10.1007/s00253-006-0447-x	25	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62555	10.1371/journal.pone.0062555	http://dx.doi.org/10.1371/journal.pone.0062555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626832	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400196
J	Lin, YT; Tang, CY; He, H; Duan, RH				Lin, Yunting; Tang, Chengyuan; He, Hua; Duan, Ranhui			Activation of mTOR Ameliorates Fragile X Premutation rCGG Repeat-Mediated Neurodegeneration	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CEREBELLAR-TREMOR/ATAXIA-SYNDROME; MAMMALIAN TARGET; MOUSE MODEL; RAPAMYCIN MTOR; OLIGODENDROCYTE DIFFERENTIATION; POLYGLUTAMINE EXPANSIONS; INTRANUCLEAR INCLUSIONS; DOPAMINERGIC-NEURONS; HUNTINGTONS-DISEASE	Fragile X associated tremor/ataxia syndrome (FXTAS) is a late onset neurodegenerative disorder caused by aberrant expansion of CGG repeats in 5' UTR of FMR1 gene. The elevated mRNA confers a toxic gain-of-function thought to be the critical event of pathogenesis. Expressing rCGG(90) repeats of the human FMR1 5'UTR in Drosophila is sufficient to induce neurodegeneration. Rapamycin has been demonstrated to attenuate neurotoxicity by inducing autophagy in various animal models of neurodegenerative diseases. Surprisingly, we observed rapamycin exacerbated rCGG(90)-induced neurodegenerative phenotypes through an autophagy-independent mechanism. CGG(90) expression levels of FXTAS flies exposed to rapamycin presented no significant differences. We further demonstrated that activation of the mammalian target of rapamycin (mTOR) signaling could suppress neurodegeneration of FXTAS. These findings indicate that rapamycin will exacerbate neurodegeneration, and that enhancing autophagy is insufficient to alleviate neurotoxicity in FXTAS. Moreover, these results suggest mTOR and its downstream molecules as new therapeutic targets for FXTAS by showing significant protection against neurodegeneration.	[Lin, Yunting; Tang, Chengyuan; He, Hua; Duan, Ranhui] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Duan, RH (corresponding author), Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.	duanranhui@sklmg.edu.cn		Lin, Yunting/0000-0001-8974-357X	National Natural Science Foundation of China [81071028, 81172513]; Program for New Century Excellent Talents [7603230006]; Major State Basic Research Development Program of China (973 Program) [2011CB510000, 2012CB944600]; Graduate degree thesis Innovation Foundation of Central South University [2011ssxt255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Graduate degree thesis Innovation Foundation of Central South University	This work was supported in part by National Natural Science Foundation of China (grant number: 81071028, 81172513), Program for New Century Excellent Talents (grant number: 7603230006), the Major State Basic Research Development Program of China (973 Program) (grant number: 2011CB510000, 2012CB944600) and the Graduate degree thesis Innovation Foundation of Central South University (grant number: 2011ssxt255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Beffy P, 2010, INT J BIOCHEM CELL B, V42, P1973, DOI 10.1016/j.biocel.2010.08.010; Berman RF, 2009, J INVEST MED, V57, P837, DOI 10.2310/JIM.0b013e3181af59d6; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Brouwer JR, 2008, J NEUROCHEM, V107, P1671, DOI 10.1111/j.1471-4159.2008.05747.x; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chang HY, 2011, J AGR FOOD CHEM, V59, P5357, DOI 10.1021/jf200598w; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; Gomez O, 2011, BRIT J PHARMACOL, V163, P1520, DOI 10.1111/j.1476-5381.2011.01414.x; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hung CM, 2011, J AGR FOOD CHEM, V59, P9683, DOI 10.1021/jf2021489; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kuo SZ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-556; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Moskalev AA, 2010, REJUV RES, V13, P246, DOI 10.1089/rej.2009.0903; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Qurashi A, 2012, HUM MOL GENET, V21, P2068, DOI 10.1093/hmg/dds024; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Rose C, 2010, HUM MOL GENET, V19, P2144, DOI 10.1093/hmg/ddq093; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Todd PK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001240; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Van Dam D, 2005, BEHAV BRAIN RES, V162, P233, DOI 10.1016/j.bbr.2005.03.007; Wang YH, 2012, NEUROSCI LETT, V531, P170, DOI 10.1016/j.neulet.2012.10.057; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yan HJ, 2006, CANCER RES, V66, P2305, DOI 10.1158/0008-5472.CAN-05-2447	49	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62572	10.1371/journal.pone.0062572	http://dx.doi.org/10.1371/journal.pone.0062572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626835	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400199
J	Luo, XF; Duan, S; Duan, QX; Pu, YC; Yang, YC; Ding, YY; Gao, MY; He, N				Luo, Xiaofeng; Duan, Song; Duan, Qixiang; Pu, Yongcheng; Yang, Yuecheng; Ding, Yingying; Gao, Meiyang; He, Na			Alcohol Use and Subsequent Sex among HIV-Infected Patients in an Ethnic Minority Area of Yunnan Province, China	PLOS ONE			English	Article							RISK BEHAVIORS; PREVALENCE; TRANSMISSION; PATTERNS; CONSUMPTION; ADHERENCE; DRINKING; HIV/AIDS; MEN; MSM	Objective: To examine alcohol use and subsequent HIV risky behaviors among a sample of predominately ethnic minority people living with HIV/AIDS (PLWHA) in a rural community in Yunnan Province, China. Method: A cross-sectional study with a face-to-face questionnaire interview was conducted among eligible participants. Results: In total, 455 (94.4%) out of 482 eligible HIV patients participated in the study. Of them, 82.6% were ethnic minorities; 15.4% were never married; 96.5% were sexually experienced; 55.4% had used drugs, 67% were receiving antiretroviral therapy (ART). Over 65% were ever drinkers; of whom 61.5% were current drinkers. Among current drinkers, 32.4% drank daily and 41.2% were hazardous drinkers. Chinese white wine was the preferred choice. Higher level of alcohol use among drinkers in the preceding month was positively associated with being males (OR = 2.76, 95% CI: 1.03-7.43), ethnic minorities (OR (Jingpo) = 2.21, 95% CI: 1.06-4.59; OR (other minorities) = 3.20, 95% CI: 1.34-7.62), higher education (OR1-6 = 1.98, 95% CI: 0.99-3.96; OR >= 7 = 2.35, 95% CI: 1.09-5.06) and being ART-naive (OR = 2.69, 95% CI: 1.67-4.32). About 39% of ever drinkers reported having engaged in sex after drinking since HIV diagnosis. Those who were younger than 46 years (OR16-25 = 7.77, 95% CI: 1.22-49.60, OR26-35 = 2.79, 95% CI: 1.06-7.35, OR36-45 = 2.96, 95% CI: 1.57-7.58), hazardous drinkers (OR = 1.99, 95% CI: 1.00-3.97) and drug users (OR = 3.01, 95% CI: 1.19-7.58) were more likely to have had sex after drinking. Approximately 56% of drug users had used drugs after drinking. Conclusions: High prevalence of alcohol use and subsequent risky behaviors including sexual engagement and drug use among HIV patients in rural Yunnan require tremendous and integrated efforts for prevention and control of alcohol and drug abuse and HIV spreading.	[Luo, Xiaofeng; Ding, Yingying; Gao, Meiyang; He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Luo, Xiaofeng; Ding, Yingying; Gao, Meiyang; He, Na] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Duan, Song; Yang, Yuecheng] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan Province, Peoples R China; [Duan, Qixiang; Pu, Yongcheng] Longchuan Cty Ctr Dis Control & Prevent, Longchuan, Yunnan Province, Peoples R China	Fudan University; Fudan University	He, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	ding, yy/HHS-9589-2022		National Natural Science Foundation of China [81072345, 81161120407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no. 81072345 and 81161120407 to N.H.). The funding agency played no role in the study design, data collection and analysis, interpretation of study results and writing of the manuscript.	Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Chander G, 2008, HIV MED, V9, P196, DOI 10.1111/j.1468-1293.2008.00545.x; Chander Geetanjali, 2011, Top Antivir Med, V19, P143; Chen GZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-58; China Ministry of Health UNAIDS WHO, 2012, 2011 UPD HIV AIDS EP; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; Davis KC, 2007, J STUD ALCOHOL DRUGS, V68, P843, DOI 10.15288/jsad.2007.68.843; Duan Song, 2008, Zhonghua Yufang Yixue Zazhi, V42, P866; Freiberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P247, DOI 10.1097/QAI.0b013e3181c6c4b7; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Gwati B., 1995, Central African Journal of Medicine, V41, P179; Halkitis PN, 2003, AIDS CARE, V15, P367, DOI 10.1080/0954012031000105423; Hao W, 2005, ADDICTION, V100, P737, DOI 10.1111/j.1360-0443.2005.01036.x; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; He N, 2011, BIOSCI TRENDS, V5, P1, DOI 10.5582/bst.2011.v5.1.1; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Kalichman SC, 2000, CLIN PSYCHOL-SCI PR, V7, P32, DOI 10.1093/clipsy/7.1.32; Kalichman SC, 2002, ANN BEHAV MED, V24, P229, DOI 10.1207/S15324796ABM2403_08; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Li Jianhua, 2010, SHANGHAI ARCH PSYCHI, V22, P440; Lin DH, 2005, DRUG ALCOHOL DEPEN, V79, P103, DOI 10.1016/j.drugalcdep.2005.01.003; Lu L., 2005, J CHINA AIDSSTD, V11, P172; Luo XF, 2012, BIOSCI TRENDS, V6, P288, DOI 10.5582/bst.2012.v6.6.288; Markos AR, 2005, INT J STD AIDS, V16, P123, DOI 10.1258/0956462053057639; Nehl EJ, 2012, AIDS CARE, V24, P324, DOI 10.1080/09540121.2011.608792; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Shaffer D N, 2004, East Afr Med J, V81, P594; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Stein M, 2005, ALCOHOL CLIN EXP RES, V29, P837, DOI 10.1097/01.ALC.0000164363.40533.E0; Wang B, 2010, SEX TRANSM DIS, V37, P629, DOI 10.1097/OLQ.0b013e3181e2118a; WHO, 2005, ALC US SEX RISK BEH; WHO UNAIDS Ministry of Health of the People's Republic of China, 2011, 2011 EST HIV AIDS EP; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2011, GLOB SUMM HIV AIDS E; Yang XS, 2006, AIDS BEHAV, V10, P71, DOI 10.1007/s10461-005-9028-8	40	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61660	10.1371/journal.pone.0061660	http://dx.doi.org/10.1371/journal.pone.0061660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626712	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400076
J	Monroy, CA; Mackie, DI; Roman, DL				Monroy, C. Aaron; Mackie, Duncan I.; Roman, David L.			A High Throughput Screen for RGS Proteins Using Steady State Monitoring of Free Phosphate Formation	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; GTPASE-ACTIVATING PROTEINS; ALPHA-SUBUNITS; INORGANIC-PHOSPHATE; NUCLEOTIDE-BINDING; INTERACTION ASSAY; TRANSITION-STATE; HYDROLYSIS; RECEPTOR; G(I-ALPHA-1)	G-protein coupled receptors are a diverse group that are the target of over 50% of marketed drugs. Activation of these receptors results in the exchange of bound GDP for GTP in the G alpha subunit of the heterotrimeric G-protein. The G alpha subunit dissociates from the beta/gamma subunits and both proceed to affect downstream signaling targets. The signal terminates by the hydrolysis of GTP to GDP and is temporally regulated by Regulators of G-protein Signaling (RGS) proteins that act as GTPase Activating Proteins (GAPs). This makes RGS proteins potentially desirable targets for "tuning" the effects of current therapies as well as developing novel pharmacotherapies. Current methods for evaluating RGS activity depend on laborious and/or expensive techniques. In this study we developed a simple and inexpensive assay for the steady state analysis of RGS protein GAP activity, using RGS4, RGS8 and RGS17 as models. Additionally, we report the use of RGS4 as a model for high throughput assay development. After initial setup, this assay can be conducted in a highly parallel fashion with a read time of less than 8 minutes for a 1536-well plate. The assay exhibited a robust Z-factor of 0.6 in a 1536-well plate. We conducted a pilot screen for inhibitors using a small, 2320 compound library. From this screen, 13 compounds were identified as compounds for further analysis. The successful development of this assay for high-throughput screening provides a low cost, high speed, simple method for assessing RGS protein activity.	[Monroy, C. Aaron; Mackie, Duncan I.; Roman, David L.] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA; [Roman, David L.] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Canc Signaling & Expt Therapeut Program, Iowa City, IA USA	University of Iowa; University of Iowa	Roman, DL (corresponding author), Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA.	david-roman@uiowa.edu	Roman, David/G-2637-2010	Roman, David/0000-0002-8250-0337; Mackie, Duncan/0000-0001-5299-9475	National Cancer Institute [1R01CA160470]; Pharmacological Sciences Training Program [T32GM067795]; American Foundation for Pharmaceutical Education; Biotechnology Training Program [2T32GM008365-21]; Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA160470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, T32GM067795] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pharmacological Sciences Training Program; American Foundation for Pharmaceutical Education; Biotechnology Training Program; Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the following funding sources: 1R01CA160470 from the National Cancer Institute (DLR), T32GM067795 Pharmacological Sciences Training Program (CAM), American Foundation for Pharmaceutical Education (CAM, DIM), and 2T32GM008365-21 Biotechnology Training Program (DIM) and The Holden Comprehensive Cancer Center Oberley Pilot Grant (DLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bell RD, 1920, J BIOL CHEM, V44, P55; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Blazer LL, 2011, BIOCHEMISTRY-US, V50, P3181, DOI 10.1021/bi1019622; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Hansen J, 2010, METHODS MOL BIOL, V648, P303, DOI 10.1007/978-1-60761-756-3_21; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Ingi T, 1998, J NEUROSCI, V18, P7178; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Mackie DI, 2011, J BIOMOL SCREEN, V16, P869, DOI 10.1177/1087057111410427; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Raja SM, 2011, CANCER BIOL THER, V11, P263, DOI 10.4161/cbt.11.2.13959; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Roman DL, 2010, MOL PHARMACOL, V78, P360, DOI 10.1124/mol.109.063388; Roman DL, 2009, J BIOMOL SCREEN, V14, P610, DOI 10.1177/1087057109336590; Roof Rebecca A., 2009, BMC Pharmacology, V9, P9, DOI 10.1186/1471-2210-9-9; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; Young KH, 2004, METHOD ENZYMOL, V389, P277; Zielinski T, 2009, J BIOMOL SCREEN, V14, P1195, DOI 10.1177/1087057109347473	40	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62247	10.1371/journal.pone.0062247	http://dx.doi.org/10.1371/journal.pone.0062247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626793	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400157
J	Reinholt, BM; Ge, XM; Cong, XF; Gerrard, DE; Jiang, HL				Reinholt, Brad M.; Ge, Xiaomei; Cong, Xiaofei; Gerrard, David E.; Jiang, Honglin			Stac3 Is a Novel Regulator of Skeletal Muscle Development in Mice	PLOS ONE			English	Article							MYOGENIC DIFFERENTIATION; MYOBLAST FUSION; SH3 DOMAINS; GENOME-WIDE; MOUSE; EXPRESSION; DISTINCT; MYF-5; MUTATION; PROTEIN	The goal of this study was to identify novel factors that mediate skeletal muscle development or function. We began the study by searching the gene expression databases for genes that have no known functions but are preferentially expressed in skeletal muscle. This search led to the identification of the Src homology three (SH3) domain and cysteine rich (C1) domain 3 (Stac3) gene. We experimentally confirmed that Stac3 mRNA was predominantly expressed in skeletal muscle. We determined if Stac3 plays a role in skeletal muscle development or function by generating Stac3 knockout mice. All Stac3 homozygous mutant mice were found dead at birth, were never seen move, and had a curved body and dropping forelimbs. These mice had marked abnormalities in skeletal muscles throughout the body, including central location of myonuclei, decreased number but increased cross-sectional area of myofibers, decreased number and size of myofibrils, disarrayed myofibrils, and streaming Z-lines. These phenotypes demonstrate that the Stac3 gene plays a critical role in skeletal muscle development and function in mice.	[Reinholt, Brad M.; Ge, Xiaomei; Cong, Xiaofei; Gerrard, David E.; Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Jiang, HL (corresponding author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	hojiang@vt.edu	gerrard, david/AAG-7507-2019; Cong, Xiaofei/W-3872-2019	Cong, Xiaofei/0000-0001-6618-906X; gerrard, david/0000-0002-3482-1400; , Honglin/0000-0001-9540-5788	Agriculture and Food Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture [2012-67015-19452]	Agriculture and Food Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture	This work was supported in part by Agriculture and Food Research Initiative Competitive Grant no. 2012-67015-19452 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAMS CS, 1995, J BIOL CHEM, V270, P333, DOI 10.1074/jbc.270.1.333; Atreya KB, 2008, DEV BIOL, V321, P123, DOI 10.1016/j.ydbio.2008.06.023; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; Bower NI, 2012, J BIOL CHEM, V287, P43936, DOI 10.1074/jbc.M112.361311; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Buchberger A, 2003, DEVELOPMENT, V130, P3297, DOI 10.1242/dev.00557; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DLUGOSZ AA, 1983, CANCER RES, V43, P2780; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Kawai F, 1998, GENOMICS, V47, P140, DOI 10.1006/geno.1997.5107; Legha W, 2010, GENE EXPR PATTERNS, V10, P368, DOI 10.1016/j.gep.2010.08.003; Mayer BJ, 2001, J CELL SCI, V114, P1253; MITCHELL CA, 1992, CELL TISSUE RES, V269, P159, DOI 10.1007/BF00384736; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; PAI AC, 1965, DEV BIOL, V11, P82, DOI 10.1016/0012-1606(65)90038-2; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Suzuki H, 1996, BIOCHEM BIOPH RES CO, V229, P902, DOI 10.1006/bbrc.1996.1900; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoon JK, 1997, DEV BIOL, V188, P349, DOI 10.1006/dbio.1997.8670	33	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62760	10.1371/journal.pone.0062760	http://dx.doi.org/10.1371/journal.pone.0062760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626854	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400218
J	Richter, C; Thieme, S; Bandola, J; Laugsch, M; Anastassiadis, K; Brenner, S				Richter, Cornelia; Thieme, Sebastian; Bandola, Joanna; Laugsch, Magdalena; Anastassiadis, Konstantinos; Brenner, Sebastian			Generation of Inducible Immortalized Dendritic Cells with Proper Immune Function In Vitro and In Vivo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; LARGE T-ANTIGEN; LANGERHANS CELLS; ACTIVATION; MICE; MATURATION; LINE; INFLAMMATION; MONOCYTES; SUBSETS	Dendritic cells are the professional antigen presenting cells of innate immunity and key players in maintaining the balance of immune responses. Studies with dendritic cells are mainly limited by their low numbers in vivo and their difficult maintenance in vitro. We differentiated bone marrow cells from transgenic mice expressing an inducible SV40 large T-antigen into dendritic cells. When immortalized by dexamethasone and doxycycline, these cells were stable in long-term culture. In the absence of dexamethasone and doxycycline (de-induction), dendritic cells displayed properties of primary cells, characterized by expression of classical dendritic cell surface markers CD11c, CD11b, MHCII, CD40 and CD86. Furthermore, de-induced lipopolysaccharide activated dendritic cells secreted IL-1 beta, IL-6, TNF alpha and IL-12. De-induced, Ovalbumin-loaded dendritic cells polarize CD4(+) T cells into Th1, Th17 and Th2 cells, indicating their correct antigen presenting property. Consistent with intratracheal application of Ovalbumin-loaded primary dendritic cells into mice, the application of de-induced dendritic cells resulted in recruitment of lymphocytes to the lungs. In summary, we successfully expanded dendritic cells using conditional immortalization. The generated dendritic cells demonstrate the characteristic immunophenotype of primary dendritic cells and will facilitate further studies on immunomodulatory properties of dendritic cells.	[Richter, Cornelia; Thieme, Sebastian; Bandola, Joanna; Laugsch, Magdalena; Brenner, Sebastian] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dept Pediat, D-01062 Dresden, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany; [Anastassiadis, Konstantinos; Brenner, Sebastian] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Richter, C (corresponding author), Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dept Pediat, D-01062 Dresden, Germany.	cornelia.richter@uniklinikum-dresden.de	Laugsch, Magdalena/AAH-8170-2021; Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559	DFG [SFB-655, RI 2082/1-1]; Center for Regenerative Therapies, Dresden	DFG(German Research Foundation (DFG)); Center for Regenerative Therapies, Dresden	This work was supported by the Collaborative Research Grant SFB-655 (DFG, SFB-655 project B6 to SB, project B1 to KA), the DFG (Grant RI 2082/1-1 to CR) and the Center for Regenerative Therapies, Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baru AM, 2011, EXP BIOL MED, V236, P1291, DOI 10.1258/ebm.2011.011140; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Ebihara S, 2004, J BIOCHEM, V136, P321, DOI 10.1093/jb/mvh120; Elftman MD, 2007, IMMUNOLOGY, V122, P279, DOI 10.1111/j.1365-2567.2007.02637.x; Franchimont D, 2000, J IMMUNOL, V164, P1768, DOI 10.4049/jimmunol.164.4.1768; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Hargadon KM, 2012, CELL IMMUNOL, V272, P275, DOI 10.1016/j.cellimm.2011.10.003; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jones LA, 2010, J IMMUNOL, V185, P4525, DOI 10.4049/jimmunol.0901155; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; KUROKI M, 1992, J LEUKOCYTE BIOL, V52, P551, DOI 10.1002/jlb.52.5.551; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mach N, 2000, CANCER RES, V60, P3239; Marraco SAF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00331; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Montesinos MM, 2012, STEROIDS, V77, P67, DOI 10.1016/j.steroids.2011.10.006; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Roca L, 2007, IMMUNOL CELL BIOL, V85, P610, DOI 10.1038/sj.icb.7100108; Rossetti M, 2011, HUM GENE THER, V22, P177, DOI 10.1089/hum.2010.085; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Ugarte F, 2009, EXP HEMATOL, V37, P867, DOI 10.1016/j.exphem.2009.03.007; Volkmann A, 1996, EUR J IMMUNOL, V26, P2565, DOI 10.1002/eji.1830261105; Vremec D, 2011, INNATE IMMUN-LONDON, V17, P338, DOI 10.1177/1753425910371396; XU S, 1995, J IMMUNOL, V154, P2697	43	6	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62621	10.1371/journal.pone.0062621	http://dx.doi.org/10.1371/journal.pone.0062621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626840	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400204
J	Wang, CT; Lee, CT; Wang, XJ; Lo, CC				Wang, Cheng-Te; Lee, Chung-Ting; Wang, Xiao-Jing; Lo, Chung-Chuan			Top-Down Modulation on Perceptual Decision with Balanced Inhibition through Feedforward and Feedback Inhibitory Neurons	PLOS ONE			English	Article							SPEED-ACCURACY TRADEOFF; PREFRONTAL CORTEX; NETWORK ACTIVITY; GAIN MODULATION; IN-VIVO; EXCITATION; MODEL; MECHANISM; SYSTEMS; CONNECTIONS	Recent physiological studies have shown that neurons in various regions of the central nervous systems continuously receive noisy excitatory and inhibitory synaptic inputs in a balanced and covaried fashion. While this balanced synaptic input (BSI) is typically described in terms of maintaining the stability of neural circuits, a number of experimental and theoretical studies have suggested that BSI plays a proactive role in brain functions such as top-down modulation for executive control. Two issues have remained unclear in this picture. First, given the noisy nature of neuronal activities in neural circuits, how do the modulatory effects change if the top-down control implements BSI with different ratios between inhibition and excitation? Second, how is a top-down BSI realized via only excitatory long-range projections in the neocortex? To address the first issue, we systematically tested how the inhibition/excitation ratio affects the accuracy and reaction times of a spiking neural circuit model of perceptual decision. We defined an energy function to characterize the network dynamics, and found that different ratios modulate the energy function of the circuit differently and form two distinct functional modes. To address the second issue, we tested BSI with long-distance projection to inhibitory neurons that are either feedforward or feedback, depending on whether these inhibitory neurons do or do not receive inputs from local excitatory cells, respectively. We found that BSI occurs in both cases. Furthermore, when relying on feedback inhibitory neurons, through the recurrent interactions inside the circuit, BSI dynamically and automatically speeds up the decision by gradually reducing its inhibitory component in the course of a trial when a decision process takes too long.	[Wang, Cheng-Te; Lee, Chung-Ting] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Wang, Xiao-Jing] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Wang, Xiao-Jing] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Lo, Chung-Chuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; New York University; Yale University; Yale University; National Tsing Hua University	Lo, CC (corresponding author), Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan.	cclo@mx.nthu.edu.tw	Lo, Chung-Chuan/C-3951-2008; Wang, Xiao-Jing/D-2722-2009	Lo, Chung-Chuan/0000-0001-7737-7250; 	National Science council (Taiwan) [98-2311-B-007-005-MY3, 101-2311-B-007-008-MY3]	National Science council (Taiwan)(Ministry of Science and Technology, Taiwan)	The work is supported by National Science council (Taiwan) grants 98-2311-B-007-005-MY3 and 101-2311-B-007-008-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brozovic M, 2008, J COMPUT NEUROSCI, V25, P158, DOI 10.1007/s10827-007-0070-6; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Bunce JG, 2011, NEUROIMAGE, V55, P1461, DOI 10.1016/j.neuroimage.2011.01.064; Burkitt AN, 2003, BIOL CYBERN, V89, P119, DOI 10.1007/s00422-003-0408-8; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Deco G, 2006, EUR J NEUROSCI, V24, P901, DOI 10.1111/j.1460-9568.2006.04940.x; Deco G, 2009, PROG NEUROBIOL, V88, P1, DOI 10.1016/j.pneurobio.2009.01.006; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Liu F, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000253; Lo C-C, 2009, NEUR M; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce R. D., 1986, RESPONSE TIMES; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Medalla M, 2007, CEREB CORTEX, V17, pI136, DOI 10.1093/cercor/bhm068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siegle JH, 2011, CURR BIOL, V21, pR956, DOI 10.1016/j.cub.2011.10.026; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yates D, 2011, NAT REV NEUROSCI, V12, P487, DOI 10.1038/nrn3098; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	56	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62379	10.1371/journal.pone.0062379	http://dx.doi.org/10.1371/journal.pone.0062379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626812	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400176
J	Ward, CS; Eriksson, P; Izquierdo-Garcia, JL; Brandes, AH; Ronen, SM				Ward, Christopher S.; Eriksson, Pia; Izquierdo-Garcia, Jose L.; Brandes, Alissa H.; Ronen, Sabrina M.			HDAC Inhibition Induces Increased Choline Uptake and Elevated Phosphocholine Levels in MCF7 Breast Cancer Cells	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HISTONE DEACETYLASE INHIBITORS; IN-VIVO; PHOSPHOLIPID-METABOLISM; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHARMACODYNAMIC MARKERS; EXPRESSION; NMR; KINASE; MODULATION	Histone deacetylase (HDAC) inhibitors have emerged as effective antineoplastic agents in the clinic. Studies from our lab and others have reported that magnetic resonance spectroscopy (MRS)-detectable phosphocholine (PC) is elevated following SAHA treatment, providing a potential noninvasive biomarker of response. Typically, elevated PC is associated with cancer while a decrease in PC accompanies response to antineoplastic treatment. The goal of this study was therefore to elucidate the underlying biochemical mechanism by which HDAC inhibition leads to elevated PC. We investigated the effect of SAHA on MCF-7 breast cancer cells using C-13 MRS to monitor [1,2-C-13] choline uptake and phosphorylation to PC. We found that PC synthesis was significantly higher in treated cells, representing 154 +/- 19% of control. This was within standard deviation of the increase in total PC levels detected by P-31 MRS (129 +/- 7% of control). Furthermore, cellular choline kinase activity was elevated (177 +/- 31%), while cytidylyltransferase activity was unchanged. Expression of the intermediate-affinity choline transporter SLC44A1 and choline kinase a increased (144% and 161%, respectively) relative to control, as determined by mRNA microarray analysis with protein-level confirmation by Western blotting. Taken together, our findings indicate that the increase in PC levels following SAHA treatment results from its elevated synthesis. Additionally, the concentration of glycerophosphocholine (GPC) increased significantly with treatment to 210 +/- 45%. This is likely due to the upregulated expression of several phospholipase A2 (PLA(2)) isoforms, resulting in increased PLA(2) activity (162 +/- 18%) in SAHA-treated cells. Importantly, the levels of total choline (tCho)-containing metabolites, comprised of choline, PC and GPC, are readily detectable clinically using H-1 MRS. Our findings thus provide an important step in validating clinically translatable non-invasive imaging methods for follow-up diagnostics of HDAC inhibitor treatment.	[Ward, Christopher S.; Eriksson, Pia; Izquierdo-Garcia, Jose L.; Brandes, Alissa H.; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ronen, SM (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	sabrina.ronen@ucsf.edu	Izquierdo Garcia, Jose/L-2654-2015; Izquierdo-Garcia, Jose/L-3293-2013	Izquierdo-Garcia, Jose/0000-0002-7907-3776	National Institutes of Health (NIH) [R01 CA130819, R21 120010-01A1]; NATIONAL CANCER INSTITUTE [R01CA130819] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding by National Institutes of Health (NIH) (www.NIH.gov) grants R01 CA130819 and R21 120010-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2005, CANCER RES, V65, P3356, DOI 10.1158/0008-5472.CAN-03-2981; Beloueche-Babari M, 2010, BRIT J CANCER, V102, P1, DOI 10.1038/sj.bjc.6605457; Beloueche-Babari M, 2012, CANCER RES, V72, P990, DOI 10.1158/0008-5472.CAN-11-2688; Brandes AH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2729; Chang H, 2011, BREAST CANCER RES TR, V125, P55, DOI 10.1007/s10549-010-0825-z; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Chung YL, 2008, NEOPLASIA, V10, P303, DOI 10.1593/neo.07834; DECERTAINES JD, 1993, NMR BIOMED, V6, P345, DOI 10.1002/nbm.1940060602; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Epping MT, 2009, INT J BIOCHEM CELL B, V41, P16, DOI 10.1016/j.biocel.2008.07.020; Evelhoch JL, 2000, NEOPLASIA, V2, P152, DOI 10.1038/sj.neo.7900078; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gabellieri C, 2009, NMR BIOMED, V22, P456, DOI 10.1002/nbm.1361; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Geilen CC, 1996, BBA-LIPID LIPID MET, V1299, P299, DOI 10.1016/0005-2760(95)00221-9; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Koul D, 2010, NEURO-ONCOLOGY, V12, P559, DOI 10.1093/neuonc/nop058; Kvistad KA, 1999, JMRI-J MAGN RESON IM, V10, P159, DOI 10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Leach MO, 1998, NMR BIOMED, V11, P314, DOI 10.1002/(SICI)1099-1492(1998110)11:7<314::AID-NBM522>3.0.CO;2-Z; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Michel V, 2006, EXP BIOL MED, V231, P490; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; Ross J, 2008, MOL CANCER THER, V7, P2556, DOI 10.1158/1535-7163.MCT-08-0015; Sankaranarayanapillai M, 2008, MOL IMAGING, V7, P92, DOI 10.2310/7290.2008.0011; Sankaranarayanapillai M, 2006, MOL CANCER THER, V5, P1325, DOI 10.1158/1535-7163.MCT-05-0494; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005	45	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62610	10.1371/journal.pone.0062610	http://dx.doi.org/10.1371/journal.pone.0062610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626839	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400203
J	Ching, CTS; Chen, YC; Lu, LH; Hsieh, PF; Hsiao, CS; Sun, TP; Shieh, HL; Chang, KM				Ching, Congo Tak-Shing; Chen, Yueh-Chi; Lu, Li-Hua; Hsieh, Peiyuan F.; Hsiao, Chin-Sung; Sun, Tai-Ping; Shieh, Hsiu-Li; Chang, Kang-Ming			Characterization of the Muscle Electrical Properties in Low Back Pain Patients by Electrical Impedance Myography	PLOS ONE			English	Article							PARASPINAL MUSCLES; WORKERS; DISEASE	Objectives: This study aims to investigate the electrical properties of lumbar paraspinal muscles (LPM) of patients with acute lower back pain (LBP) and to study a new approach, namely Electrical Impedance Myography (EIM), for reliable, low-cost, non-invasive, and real-time assessment of muscle-strained acute LBP. Design: Patients with muscle-strained acute LBP (n = 30) are compared to a healthy reference group (n = 30). Electrical properties of LPM are studied. Background: EIM is a novel technique under development for the assessment of neuromuscular disease. Therefore, it is speculated that EIM can be employed for the assessment of muscle-strained acute LBP. Methods: Surface electrodes, in 2-electrode configurations, was used to measure the electrical properties of patient's and healthy subject's LPM at six different frequencies (0.02, 25.02, 50.02, 1000.02, 3000.02, and 5000.02 kHz), with the amplitude of the applied voltage limited to 200 mV. Parameters of impedance (Z), extracellular resistance (R-e), intracellular resistance (R-i), and the ratio of extracellular resistance to intracellular resistance (R-e/R-i) of LBP patient's and healthy subject's LPM were assessed to see if significant difference in values obtained in muscle-strained acute LBP patients existed. Results: Intraclass correlation coefficient (ICC) showed that all measurements (ICC>0.96 for all studying parameters: Z, R-e, R-i, and R-e/R-i) had good reliability and validity. Significant differences were found on Z between LBP patient's and healthy subject's LPM at all studying frequencies, with p<0.05 for all frequencies. It was also found that R-e (p<0.05) and R-e/R-i (p<0.05) of LBP patient's LPM was significant smaller than that of healthy subjects while R-i (p<0.05) of LBP patient's LPM was significant greater than that of healthy subjects. No statistical significant difference was found between the left and right LPM of LBP patients and healthy subjects on the four studying parameters. Conclusion: EIM is a promising technique for assessing muscle-strained acute LBP.	[Ching, Congo Tak-Shing; Sun, Tai-Ping; Shieh, Hsiu-Li] Natl Chi Nan Univ, Dept Elect Engn, Nantou, Taiwan; [Ching, Congo Tak-Shing; Sun, Tai-Ping] Natl Chi Nan Univ, Dept Appl Mat & Optoelect Engn, Nantou, Taiwan; [Ching, Congo Tak-Shing; Hsiao, Chin-Sung; Chang, Kang-Ming] Asia Univ, Dept Photon & Commun Engn, Taichung, Taichung County, Taiwan; [Chen, Yueh-Chi; Lu, Li-Hua] Chung Shan Med Univ, Sch Phys Therapy, Taichung, Taiwan; [Chen, Yueh-Chi; Lu, Li-Hua] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Hsieh, Peiyuan F.] Taichung Vet Gen Hosp, Div Neurol, Taichung, Taiwan; [Hsieh, Peiyuan F.] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Chang, Kang-Ming] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Chi Nan University; National Chi Nan University; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; National Chi Nan University; China Medical University Taiwan	Ching, CTS (corresponding author), Natl Chi Nan Univ, Dept Elect Engn, Nantou, Taiwan.	tsching@ncnu.edu.tw; tps@ncnu.edu.tw; changkm@asia.edu.tw		Ching, Congo Tak Shing/0000-0001-9796-9827	National Science Council, Taiwan, Republic of China [NSC 101-2221-E-260-001-, NSC 98-2221-E-260-024-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (NSC 101-2221-E-260-001- and NSC 98-2221-E-260-024-MY3) from National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. And, no additional external funding received for this study.	Aaron R, 1997, PHYS MED BIOL, V42, P1245, DOI 10.1088/0031-9155/42/7/002; Aaron R, 2000, ANN NY ACAD SCI, V904, P171; Aaron R, 2006, PHYSIOL MEAS, V27, P953, DOI 10.1088/0967-3334/27/10/002; Chiu TTW, 2001, SPINE, V26, P1884, DOI 10.1097/00007632-200109010-00013; Cohen-Mansfield J, 1993, J GERONTOL, V48, P96; Danneels LA, 2000, EUR SPINE J, V9, P266, DOI 10.1007/s005860000190; ELLEBY B, 1990, CLIN PHYS PHYSIOL M, V11, P159, DOI 10.1088/0143-0815/11/2/006; FERRELL BA, 1990, J AM GERIATR SOC, V38, P409, DOI 10.1111/j.1532-5415.1990.tb03538.x; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Gibbons LE, 1997, SCAND J REHABIL MED, V29, P187; Guo HR, 2004, J OCCUP HEALTH, V46, P26, DOI 10.1539/joh.46.26; HELIOVAARA M, 1991, SPINE, V16, P608, DOI 10.1097/00007632-199106000-00002; KONNO S, 1994, SPINE, V19, P2186, DOI 10.1097/00007632-199410000-00011; Lee JH, 1998, J ORTHOPAEDIC SURG, V13, P55; Nurminen M, 1997, OCCUP ENVIRON MED, V54, P807, DOI 10.1136/oem.54.11.807; Parmelee PA, 1991, J GERONTOL, V46, P15; Patel AT, 2000, AM FAM PHYSICIAN, V61, P1779; Portney L, 2000, WATKINS M FDN CLIN R; Rabbat A, 1990, ELECT IMPEDANCE TOMO, P8; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Rutkove SB, 2005, MUSCLE NERVE, V32, P335, DOI 10.1002/mus.20377; Rutkove SB, 2002, MUSCLE NERVE, V25, P390, DOI 10.1002/mus.10048; Shiffman CA, 2003, PHYSIOL MEAS, V24, P213, DOI 10.1088/0967-3334/24/1/316; SIHVONEN T, 1991, ARCH PHYS MED REHAB, V72, P1080; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; Waddell G., 1998, BACK PAIN REVOLUTION; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227; Wei HH, 2000, UNITED DAILY NEWS; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741	30	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61639	10.1371/journal.pone.0061639	http://dx.doi.org/10.1371/journal.pone.0061639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630604	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500054
J	Sweet, M; Burn, D; Croquer, A; Leary, P				Sweet, Michael; Burn, Deborah; Croquer, Aldo; Leary, Peter			Characterisation of the Bacterial and Fungal Communities Associated with Different Lesion Sizes of Dark Spot Syndrome Occurring in the Coral Stephanocoenia intersepta	PLOS ONE			English	Article							BLACK BAND DISEASE; DIVERSITY; PATTERNS; HEALTHY; SPREAD; MUCUS	The number and prevalence of coral diseases/syndromes are increasing worldwide. Dark Spot Syndrome (DSS) afflicts numerous coral species and is widespread throughout the Caribbean, yet there are no known causal agents. In this study we aimed to characterise the microbial communities (bacteria and fungi) associated with DSS lesions affecting the coral Stephanocoenia intersepta using nonculture molecular techniques. Bacterial diversity of healthy tissues (H), those in advance of the lesion interface (apparently healthy AH), and three sizes of disease lesions (small, medium, and large) varied significantly (ANOSIM R = 0.052 p < 0.001), apart from the medium and large lesions, which were similar in their community profile. Four bacteria fitted into the pattern expected from potential pathogens; namely absent from H, increasing in abundance within AH, and dominant in the lesions themselves. These included ribotypes related to Corynebacterium (KC190237), Acinetobacter (KC190251), Parvularculaceae (KC19027), and Oscillatoria (KC190271). Furthermore, two Vibrio species, a genus including many proposed coral pathogens, dominated the disease lesion and were absent from H and AH tissues, making them candidates as potential pathogens for DSS. In contrast, other members of bacteria from the same genus, such as V. harveyii were present throughout all sample types, supporting previous studies where potential coral pathogens exist in healthy tissues. Fungal diversity varied significantly as well, however the main difference between diseased and healthy tissues was the dominance of one ribotype, closely related to the plant pathogen, Rhytisma acerinum, a known causal agent of tar spot on tree leaves. As the corals' symbiotic algae have been shown to turn to a darker pigmented state in DSS (giving rise to the syndromes name), the two most likely pathogens are R. acerinum and the bacterium Oscillatoria, which has been identified as the causal agent of the colouration in Black Band Disease, another widespread coral disease.	[Sweet, Michael; Burn, Deborah; Leary, Peter] Newcastle Univ, Sch Biol, Mol Hlth & Dis Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Croquer, Aldo] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela	Newcastle University - UK; Simon Bolivar University	Sweet, M (corresponding author), Newcastle Univ, Sch Biol, Mol Hlth & Dis Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.sweet@ncl.ac.uk	Croquer, Aldo/ABE-6554-2021; Sweet, Michael/E-9661-2012	Croquer, Aldo/0000-0001-8880-9338; Sweet, Michael/0000-0003-4983-8333	Natural Environmental Research Council, UK [NE/H020616/1]	Natural Environmental Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environmental Research Council, UK (NE/H020616/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Borger JL, 2003, REV BIOL TROP, V51, P25; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Cervino JM, 2005, SYMBIOSIS, V38, P101; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Divya B, 2011, RES J BIOTECHNOL, V6, P72; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Garzon-Ferreira Jaime, 1999, Boletin de Investigaciones Marinas y Costeras, V28, P137; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Hill JE, 2002, APPL ENVIRON MICROB, V68, P3055, DOI 10.1128/AEM.68.6.3055-3066.2002; Hou CL, 2010, MYCOPATHOLOGIA, V169, P225, DOI 10.1007/s11046-009-9250-4; Huang AH, 2006, J CLIN MICROBIOL, V44, P3299, DOI 10.1128/JCM.00417-06; Jain P K, 2003, Hindustan Antibiot Bull, V45-46, P5; Kim K, 2004, AM NAT, V164, P52; Kim K, 2006, DIS AQUAT ORGAN, V69, P95, DOI 10.3354/dao069095; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; O'Sullivan D J, 2000, Curr Issues Intest Microbiol, V1, P39; Ouhdouch Y, 2001, EUR J SOIL BIOL, V37, P69, DOI 10.1016/S1164-5563(01)01069-X; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Porter JW, 2011, J EXP MAR BIOL ECOL, V408, P79, DOI 10.1016/j.jembe.2011.07.027; Renegar D.-E.A., 2008, P 11 INT COR REEF S, P7; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Smith GW, 2004, CORAL HEALTH AND DISEASE, P279; Solano Oscar David, 1993, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V22, P97; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Sweet MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021195; Toledo-Hernandez C, 2008, CORAL REEFS, V27, P707, DOI 10.1007/s00338-008-0387-2; Vermeij M.J.A., 2010, PLOS ONE, V5; VICK CM, 1976, ENVIRON POLLUT, V11, P203, DOI 10.1016/0013-9327(76)90085-9; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005	46	30	31	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62580	10.1371/journal.pone.0062580	http://dx.doi.org/10.1371/journal.pone.0062580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630635	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500097
J	Wu, CK; Wang, JH; Lee, CH; Wu, KL; Tai, WC; Lu, SN; Hu, TH; Chuah, SK				Wu, Cheng-Kun; Wang, Jing-Houng; Lee, Chen-Hsiang; Wu, Keng-Liang; Tai, Wei-Chen; Lu, Sheng-Nan; Hu, Tsung-Hui; Chuah, Seng-Kee			The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage	PLOS ONE			English	Article							PREVENTS BACTERIAL-INFECTION; ANTIBIOTIC-PROPHYLAXIS; NORFLOXACIN; THERAPY	Antibiotic prophylaxis with norfloxacin, intravenous ciprofloxacin, or ceftriaxone has been recommended for cirrhotic patients with gastrointestinal hemorrhage but little is known about intravenous cefazolin. This study aimed to compare the outcome of intravenous cefazolin and ceftriaxone as prophylactic antibiotics among cirrhotic patients at different clinical stages, and to identify the associated risk factors. The medical records of 713 patients with acute variceal bleeding who had received endoscopic procedures from were reviewed. Three hundred and eleven patients were entered for age-matched adjustment after strict exclusion criteria. After the adjustment, a total of 102 patients were enrolled and sorted into 2 groups according to the severity of cirrhosis: group A (Child's A patients, n = 51) and group B (Child's B and C patients, n = 51). The outcomes were prevention of infection, time of rebleeding, and death. Our subgroup analysis results failed to show a significant difference in infection prevention between patients who received prophylactic cefazolin and those who received ceftriaxone among Child's A patients (93.1% vs. 90.9%, p = 0.641); however, a trend of significance in favor of ceftriaxone prophylaxis (77.8% vs. 87.5%, p = 0.072) was seen among Child's B and C patients. More rebleeding cases were observed in patients who received cefazolin than in those who received ceftriaxone among Child's B and C patients (66.7% vs. 25.0%, p = 0.011) but not in Child's A patients (32% vs. 40.9%, p = 0.376). The risk factors associated with rebleeding were history of bleeding and use of prophylactic cefazolin among Child's B and C patients. In conclusion, this study suggests that prophylactic intravenous cefazolin may not be inferior to ceftriaxone in preventing infections and reducing rebleeding among Child's A cirrhotic patients after endoscopic interventions for acute variceal bleeding. Prophylactic intravenous ceftriaxone yields better outcome among Child's B and C patients.	[Wu, Cheng-Kun; Wang, Jing-Houng; Wu, Keng-Liang; Tai, Wei-Chen; Lu, Sheng-Nan; Hu, Tsung-Hui; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Wu, Cheng-Kun; Wang, Jing-Houng; Lee, Chen-Hsiang; Wu, Keng-Liang; Tai, Wei-Chen; Lu, Sheng-Nan; Hu, Tsung-Hui; Chuah, Seng-Kee] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	chuahsk@seed.net.tw						Aldeyab MA, 2012, BRIT J CLIN PHARMACO, V74, P171, DOI 10.1111/j.1365-2125.2011.04161.x; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002907; Banerjee S, 2008, GASTROINTEST ENDOSC, V67, P791, DOI 10.1016/j.gie.2008.02.068; BERGERON MG, 1973, ANTIMICROB AGENTS CH, V4, P396, DOI 10.1128/AAC.4.4.396; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; BLAISE M, 1994, HEPATOLOGY, V20, P34, DOI 10.1016/0270-9139(94)90131-7; CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria for Specific Types of Infections in the Acute Care Setting, 2013, CDC WEBSITE, V17, P1; Chavez-Tapia NC, 2011, ALIMENT PHARM THER, V34, P509, DOI 10.1111/j.1365-2036.2011.04746.x; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Hou MC, 2004, HEPATOLOGY, V39, P746, DOI 10.1002/hep.20126; Hsieh WJ, 1998, AM J GASTROENTEROL, V93, P962; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Lee J, 2007, J ANTIMICROB CHEMOTH, V60, P629, DOI 10.1093/jac/dkm225; Lin Ying-Tsun, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P365; Pauwels A, 1996, HEPATOLOGY, V24, P802; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RIMOLA A, 1985, HEPATOLOGY, V5, P463, DOI 10.1002/hep.1840050320; SELBY WS, 1994, GASTROINTEST ENDOSC, V40, P680, DOI 10.1016/S0016-5107(94)70109-1; Soares-Weiser K, 2010, COCHRANE DB SYST REV; SORIANO G, 1992, GASTROENTEROLOGY, V103, P1267, DOI 10.1016/0016-5085(92)91514-5; WYKE RJ, 1987, GUT, V28, P623, DOI 10.1136/gut.28.5.623; Xu HW, 2011, SURG ENDOSC, V25, P2911, DOI 10.1007/s00464-011-1642-0	26	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61666	10.1371/journal.pone.0061666	http://dx.doi.org/10.1371/journal.pone.0061666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630607	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500058
J	Keszei, M; Detre, C; Castro, W; Magelky, E; O'Keeffe, M; Kis-Toth, K; Tsokos, GC; Wang, NH; Terhorst, C				Keszei, Marton; Detre, Cynthia; Castro, Wilson; Magelky, Erica; O'Keeffe, Michael; Kis-Toth, Katalin; Tsokos, George C.; Wang, Ninghai; Terhorst, Cox			Expansion of an osteopontin-expressing T follicular helper cell subset correlates with autoimmunity in B6.Sle1b mice and is suppressed by the H1-isoform of the Slamf6 receptor	FASEB JOURNAL			English	Article						Ly108; SAP; systemic lupus erythematosus; OPN; T-FH	SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL; SUSCEPTIBILITY LOCUS; MURINE LUPUS; GENE; LY108; DISEASE; FAMILY; DIFFERENTIATION; POLYMORPHISMS	The costimulatory receptor Slamf6 partially controls lupus-related autoimmunity in congenic Sle1b mice; for instance, the presence of the protein isoform Slamf6-H1 in Sle1b.Slamf6-H1 mice mitigates disease. Here, we report that young Sle1b mice, but not Sle1b.Slamf6-H1 or B6 mice, contain a memory T-helper cell subset identified by ]mt]2-fold increase in expression of 17 genes, chief among which is Spp1, encoding the cytokine osteopontin (OPN). These T follicular helper (T-FH) cells, including OPN+ T-FH cells, expand concomitantly with severity of the disease. By contrast, Sle1b.Slamf6-H1 or Sle1b.SAP(-)/(-) mice do not develop autoantibodies and the number of T-FH cells is 5 times lower than in age-matched Sle1b mice. By comparing Sle1b and Sle1b.OPN-/(-) mice, we find that the lack of OPN expression impedes early autoantibody production. Furthermore, on the adoptive transfer of Sle1b.OPN-/(-) CD4(+) T cells into bm12 recipients autoantibody production and germinal center formation is reduced compared to recipients of Sle1b.OPN+/+ CD4(+) T cells. We propose a model in which OPN provides a survival signal for a precursor T-FH cell subset, which is a key factor in autoimmunity. Keszei, M., Detre, C., Castro, W., Magelky, E., O'Keeffe, M., Kis-Toth, K., Tsokos, G. C., Wang, N., Terhorst, C. Expansion of an osteopontin-expressing T follicular helper cell subset correlates with autoimmunity in B6.Sle1b mice and is suppressed by the H1-isoform of the Slamf6 receptor.	[Keszei, Marton; Detre, Cynthia; Castro, Wilson; Magelky, Erica; O'Keeffe, Michael; Wang, Ninghai; Terhorst, Cox] Harvard Univ, Div Immunol, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Kis-Toth, Katalin; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Terhorst, C (corresponding author), Harvard Univ, Ctr Life Sci, Sch Med, Div Immunol,Beth Israel Deaconess Med Ctr, Rm CLS 938,3 Blackfan Cir, Boston, MA 02115 USA.	cterhors@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Keszei, Marton/F-3295-2014	tsokos, george C/0000-0001-9589-2360; Keszei, Marton/0000-0002-1158-2179; Castro, Wilson/0000-0002-9649-9883; Magelky, Erica/0000-0003-2393-0713	U.S. National Institutes of Health [PO1 AI-065687, RO1 DK-073339, 8UL1TR000170-05]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK073339] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Xuefang Xie and Shiva Gautam (Beth Israel Deaconess Medical Center) and Mick Correll (Dana-Farber Cancer Institute, Boston, MA, USA) for invaluable help with the gene-expression array experiments and the statistical analyses. The authors are grateful to Gongxian Liao and other members of the C.T. laboratory for discussions and for a critical review of the manuscript. This work was supported by grants from the U.S. National Institutes of Health to C.T. (PO1 AI-065687 and RO1 DK-073339) and to the Harvard Catalyst Statistics consulting service (8UL1TR000170-05).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carlucci F, 2007, J IMMUNOL, V178, P2352, DOI 10.4049/jimmunol.178.4.2352; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Fraser CC, 2002, IMMUNOGENETICS, V53, P843, DOI 10.1007/s00251-001-0415-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Keszei M, 2011, INT IMMUNOL, V23, P149, DOI 10.1093/intimm/dxq465; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; LAMPE MA, 1991, J IMMUNOL, V147, P2902; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; MORRIS SC, 1990, CLIN IMMUNOL IMMUNOP, V57, P263, DOI 10.1016/0090-1229(90)90040-W; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobel ES, 2002, J IMMUNOL, V169, P2694, DOI 10.4049/jimmunol.169.5.2694; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wong EB, 2012, J IMMUNOL, V189, P5667, DOI 10.4049/jimmunol.1201661; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; You Y, 2010, J RHEUMATOL, V37, P2268, DOI 10.3899/jrheum.091390; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	41	20	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3123	3131		10.1096/fj.12-226951	http://dx.doi.org/10.1096/fj.12-226951			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23629864	Green Published			2022-12-25	WOS:000329877600019
J	Sakabe, J; Yamamoto, M; Hirakawa, S; Motoyama, A; Ohta, I; Tatsuno, K; Ito, T; Kabashima, K; Hibino, T; Tokura, Y				Sakabe, Jun-ichi; Yamamoto, Mami; Hirakawa, Satoshi; Motoyama, Akira; Ohta, Isao; Tatsuno, Kazuki; Ito, Taisuke; Kabashima, Kenji; Hibino, Toshihiko; Tokura, Yoshiki			Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL BARRIER FUNCTION; HIGH-MOLECULAR-WEIGHT; STRATUM-CORNEUM; SERINE PROTEASES; MOUSE EPIDERMIS; ATOPIC ECZEMA; AMINO-ACIDS; HUMAN SKIN; FILAGGRIN; EXPRESSION	Filaggrin protein is synthesized in the stratum granulosum of the skin and contributes to the formation of the human skin barrier. Profilaggrin is cleaved by proteolytic enzymes and converted to functional filaggrin, but its processing mechanism remains not fully elucidated. Kallikrein-related peptidase 5 (KLK5) is a major serine protease found in the skin, which is secreted from lamellar granules following its expression in the stratum granulosum and activated in the extracellular space of the stratum corneum. Here, we searched for profilaggrin-processing protease(s) by partial purification of epidermal extracts and found KLK5 as a possible candidate. We used high performance liquid chromatography coupled with electrospray tandem mass spectrometry to show that KLK5 cleaves profilaggrin. Furthermore, based on a proximity ligation assay, immunohistochemistry, and immunoelectron microscopy analysis, we reveal that KLK5 and profilaggrin co-localize in the stratum granulosum in human epidermis. KLK5 knockdown in normal cultured human epidermal keratinocytes resulted in higher levels of profilaggrin, indicating that KLK5 potentially functions in profilaggrin cleavage.	[Sakabe, Jun-ichi; Hirakawa, Satoshi; Tatsuno, Kazuki; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamamoto, Mami; Motoyama, Akira; Hibino, Toshihiko] Shiseido Innovat Sci Res & Dev Ctr, Kanazawa Ku, Yokohama, Kanagawa 2388643, Japan; [Yamamoto, Mami] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan; [Ohta, Isao] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Ohta, Isao] Hamamatsu Univ Sch Med, Cent Lab Ultrastruct Res, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan	Hamamatsu University School of Medicine; Shiseido Company, Limited; Tokyo Medical University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kyoto University	Sakabe, J (corresponding author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	jsakabe@hama-med.ac.jp	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554; Sakabe, Jun-Ichi/0000-0002-8237-0472	Hamamatsu University School of Medicine [101337]; Ministry of Education, Culture, Sports, Science, and Technology [24890082, 24659525]	Hamamatsu University School of Medicine; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 101337 from the Hamamatsu University School of Medicine (to JS), Grant-in-aid for Research Activity Start-up 24890082 (to J. S.), and Grant-in-aid for Challenging Exploratory Research 24659525 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology.	BALL RD, 1978, J BIOL CHEM, V253, P5861; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; DALE BA, 1979, J INVEST DERMATOL, V72, P257, DOI 10.1111/1523-1747.ep12531715; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Hibino T, 2010, J CELL BIOCHEM, V109, P487, DOI 10.1002/jcb.22425; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Kamata Y, 2011, J BIOL CHEM, V286, P8204, DOI 10.1074/jbc.M110.169292; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; LONSDALEECCLES JD, 1984, BIOCHEMISTRY-US, V23, P1239, DOI 10.1021/bi00301a034; Matsui T, 2011, EMBO MOL MED, V3, P320, DOI 10.1002/emmm.201100140; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI 10.1111/j.1365-2133.2009.09406.x; RAMSDEN M, 1983, DIFFERENTIATION, V23, P243; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; ROOP DR, 1983, P NATL ACAD SCI-BIOL, V80, P716, DOI 10.1073/pnas.80.3.716; Sandilands A, 2012, J INVEST DERMATOL, V132, P1507, DOI 10.1038/jid.2011.479; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SCOTT IR, 1981, BIOCHIM BIOPHYS ACTA, V669, P65, DOI 10.1016/0005-2795(81)90224-5; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Takahashi M, 2004, ARCH DERMATOL RES, V295, P448, DOI 10.1007/s00403-003-0448-x; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467	33	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17179	17189		10.1074/jbc.M113.476820	http://dx.doi.org/10.1074/jbc.M113.476820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629652	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000320380600015
J	Kopke, M; Straub, M; Durre, P				Koepke, Michael; Straub, Melanie; Duerre, Peter			Clostridium difficile Is an Autotrophic Bacterial Pathogen	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ACETOGEN; SUPPRESSION; PATHWAY; ETHANOL; TOXIN; CO2	During the last decade, Clostridium difficile infection showed a dramatic increase in incidence and virulence in the Northern hemisphere. This incessantly challenging disease is the leading cause of antibiotic-associated and nosocomial infectious diarrhea and became life-threatening especially among elderly people. It is generally assumed that all human bacterial pathogens are heterotrophic organisms, being either saccharolytic or proteolytic. So far, this has not been questioned as colonization of the human gut gives access to an environment, rich in organic nutrients. Here, we present data that C. difficile (both clinical and rumen isolates) is also able to grow on CO2+H-2 as sole carbon and energy source, thus representing the first identified autotrophic bacterial pathogen. Comparison of several different strains revealed high conservation of genes for autotrophic growth and showed that the ability to use gas mixtures for growth decreases or is lost upon prolonged culturing under heterotrophic conditions. The metabolic flexibility of C. difficile (heterotrophic growth on various substrates as well as autotrophy) could allow the organism in the gut to avoid competition by niche differentiation and contribute to its survival when stressed or in unfavorable conditions that cause death to other bacteria. This may be an important trait for the pathogenicity of C. difficile.	[Koepke, Michael; Straub, Melanie; Duerre, Peter] Univ Ulm, Inst Mikrobiol & Biotechnol, D-89069 Ulm, Germany; [Koepke, Michael] LanzaTech, Auckland, New Zealand	Ulm University	Durre, P (corresponding author), Univ Ulm, Inst Mikrobiol & Biotechnol, D-89069 Ulm, Germany.	peter.duerre@uni-ulm.de	Köpke, Michael/I-3963-2019	Köpke, Michael/0000-0003-0642-1415	BMBF GenoMikPlus project (Competence Network Gottingen); SysMO project COSMIC2	BMBF GenoMikPlus project (Competence Network Gottingen); SysMO project COSMIC2	This work was supported by grants from the BMBF GenoMikPlus project (Competence Network Gottingen) and the SysMO project COSMIC2, www.sysmo.net. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, ENV MICROBIOLOGY; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Bruant G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013033; BUSCHHORN H, 1989, APPL ENVIRON MICROB, V55, P1835, DOI 10.1128/AEM.55.7.1835-1840.1989; Buzolyova LS, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1146; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chakrabarty A N, 2001, Indian J Exp Biol, V39, P962; DANIEL SL, 1990, J BACTERIOL, V172, P4464, DOI 10.1128/jb.172.8.4464-4471.1990; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016; Drake HL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P354, DOI 10.1007/0-387-30742-7_13; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karlsson S, 1999, MICROBIOL-UK, V145, P1683, DOI 10.1099/13500872-145-7-1683; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; Kaster AK, 2011, ARCHAEA, V2011, DOI 10.1155/2011/973848; Kopke M, 2011, APPL ENVIRON MICROB, V77, P5467, DOI 10.1128/AEM.00355-11; Kopke M, 2011, CURR OPIN BIOTECH, V22, P320, DOI 10.1016/j.copbio.2011.01.005; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lever MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00284; Liou JSC, 2005, INT J SYST EVOL MICR, V55, P2085, DOI 10.1099/ijs.0.63482-0; Monot M, 2011, J MED MICROBIOL, V60, P1193, DOI 10.1099/jmm.0.030452-0; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Oren A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00022; Pal D, 1990, Indian J Lepr, V62, P351; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Rieu-Lesme F, 1998, ANAEROBE, V4, P89, DOI 10.1006/anae.1998.0153; Rieu-Lesme F, 1999, Vet Rec, V145, P501; Roh H, 2011, J BACTERIOL, V193, P307, DOI 10.1128/JB.01217-10; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Schiel-Bengelsdorf B, 2012, FEBS LETT, V586, P2191, DOI 10.1016/j.febslet.2012.04.043; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; TANNER RS, 1993, INT J SYST BACTERIOL, V43, P232, DOI 10.1099/00207713-43-2-232; Taubes G, 2008, SCIENCE, V321, P360, DOI 10.1126/science.321.5887.360; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988; WUST J, 1982, J CLIN MICROBIOL, V16, P1096; Zhang Y, 2005, BIOINFORMATICS, V21, P2580, DOI 10.1093/bioinformatics/bti400; Zhu XF, 2011, PROTEIN EXPRES PURIF, V78, P86, DOI 10.1016/j.pep.2011.02.006	50	43	45	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62157	10.1371/journal.pone.0062157	http://dx.doi.org/10.1371/journal.pone.0062157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626782	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400146
J	Shizu, R; Benoki, S; Numakura, Y; Kodama, S; Miyata, M; Yamazoe, Y; Yoshinari, K				Shizu, Ryota; Benoki, Satoshi; Numakura, Yuki; Kodama, Susumu; Miyata, Masaaki; Yamazoe, Yasushi; Yoshinari, Kouichi			Xenobiotic-Induced Hepatocyte Proliferation Associated with Constitutive Active/Androstane Receptor (CAR) or Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha) Is Enhanced by Pregnane X Receptor (PXR) Activation in Mice	PLOS ONE			English	Article							ANDROSTANE RECEPTOR; MOUSE-LIVER; DRUG-METABOLISM; CELL; HEPATOCARCINOGENESIS; EXPRESSION; PROTEIN; ROLES	Xenobiotic-responsive nuclear receptors pregnane X receptor (PXR), constitutive active/androstane receptor (CAR) and peroxisome proliferator-activated receptor alpha (PPAR alpha) play pivotal roles in the metabolic functions of the liver such as xenobiotics detoxification and energy metabolism. While CAR or PPAR alpha activation induces hepatocyte proliferation and hepatocarcinogenesis in rodent models, it remains unclear whether PXR activation also shows such effects. In the present study, we have investigated the role of PXR in the xenobiotic-induced hepatocyte proliferation with or without CAR activation by 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) and phenobarbital, or PPAR alpha activation by Wy-14643 in mice. Treatment with TCPOBOP or phenobarbital increased the percentage of Ki-67-positive nuclei as well as mRNA levels of cell proliferation-related genes in livers as expected. On the other hand, treatment with the PXR activator pregnenolone 16 alpha-carbonitrile (PCN) alone showed no such effects. Surprisingly, PCN co-treatment significantly augmented the hepatocyte proliferation induced by CAR activation with TCPOBOP or phenobarbital in wild-type mice but not in PXR-deficient mice. Intriguingly, PXR activation also augmented the hepatocyte proliferation induced by Wy-14643 treatment. Moreover, PCN treatment increased the RNA content of hepatocytes, suggesting the induction of G0/G1 transition, and reduced mRNA levels of Cdkn1b and Rbl2, encoding suppressors of cell cycle initiation. Our present findings indicate that xenobiotic-induced hepatocyte proliferation mediated by CAR or PPAR alpha is enhanced by PXR co-activation despite that PXR activation alone does not cause the cell proliferation in mouse livers. Thus PXR may play a novel and unique role in the hepatocyte/ liver hyperplasia upon exposure to xenobiotics.	[Shizu, Ryota; Benoki, Satoshi; Numakura, Yuki; Kodama, Susumu; Miyata, Masaaki; Yamazoe, Yasushi; Yoshinari, Kouichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Drug Metab & Mol Toxicol, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University	Yoshinari, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Drug Metab & Mol Toxicol, Aoba Ku, Sendai, Miyagi 980, Japan.	yoshinari@m.tohoku.ac.jp	Yoshinari, Kouichi/X-8070-2019; Shizu, Ryota/ACP-9957-2022; Yoshinari, Kouichi/V-8156-2019	Yoshinari, Kouichi/0000-0002-2027-2017; Shizu, Ryota/0000-0002-0465-5077	Japan Society for the Promotion of Science (JSPS) [22390027, 24659061]; Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI)	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI: #22390027, #24659061) from Japan Society for the Promotion of Science (JSPS) and a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KM, 2008, DEV DYNAM, V237, P672, DOI 10.1002/dvdy.21449; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; BUTLER WH, 1978, BRIT J CANCER, V37, P418, DOI 10.1038/bjc.1978.62; CATTLEY RC, 1989, CANCER RES, V49, P3246; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; DARZYNKIEWICZ Z, 1980, CYTOMETRY, V1, P98, DOI 10.1002/cyto.990010203; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Gao J, 2010, DRUG METAB DISPOS, V38, P2091, DOI 10.1124/dmd.110.035568; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Huynh H, 2004, CARCINOGENESIS, V25, P1485, DOI 10.1093/carcin/bgh154; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Misawa A, 2005, CANCER RES, V65, P10233, DOI 10.1158/0008-5472.CAN-05-1073; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Osabe M, 2008, BIOCHEM BIOPH RES CO, V369, P1027, DOI 10.1016/j.bbrc.2008.02.140; Ouyang N, 2010, BRIT J CANCER, V102, P1753, DOI 10.1038/sj.bjc.6605677; Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Ross PK, 2009, TOXICOL APPL PHARM, V235, P199, DOI 10.1016/j.taap.2008.12.011; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Sun D, 2008, MOL CARCINOGEN, V47, P47, DOI 10.1002/mc.20360; THATCHER NJ, 1994, BIOCHEM SOC T, V22, pS132, DOI 10.1042/bst022132s; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Williams GM, 1996, EXP TOXICOL PATHOL, V48, P189, DOI 10.1016/S0940-2993(96)80041-8; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121	37	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61802	10.1371/journal.pone.0061802	http://dx.doi.org/10.1371/journal.pone.0061802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626729	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400093
J	Silva, FWS; Viol, DL; Faria, SV; Lima, E; Valicente, FH; Elliot, SL				Silva, Farley W. S.; Viol, Daniel L.; Faria, Sirlene V.; Lima, Eraldo; Valicente, Fernando H.; Elliot, Simon L.			Two's a Crowd: Phenotypic Adjustments and Prophylaxis in Anticarsia gemmatalis Larvae Are Triggered by the Presence of Conspecifics	PLOS ONE			English	Article							DENSITY-DEPENDENT PROPHYLAXIS; MAMESTRA-BRASSICAE LEPIDOPTERA; DISEASE RESISTANCE; VELVETBEAN CATERPILLAR; SPODOPTERA-EXEMPTA; HUBNER LEPIDOPTERA; GENE HOMOLOGS; COLOR PHASE; PLANT-AGE; POPULATION	Defence from parasites and pathogens involves a cost. Thus, it is expected that organisms use this only at high population densities, where the risk of pathogen transmission may be high, as proposed by the "density-dependent prophylaxis" (DDP) hypothesis. These predictions have been tested in a wide range of insects, both in comparative and experimental studies. We think it pertinent to consider a continuum between solitarious and gregarious living insects, wherein: (1) solitarious insects are those that are constitutively solitary and do not express any phenotypic plasticity, (2) the middle of the continuum is represented by insects that are subject to fluctuations in local density and show a range of facultative and plastic changes; and (3) constitutively gregarious forms live gregariously and show the gregarious phenotype even in the absence of crowding stimuli. We aimed to chart some of the intermediary continuum with an insect that presents solitarious aspects, but that is subject to fluctuations in density. Thus, Anticarsia gemmatalis (Lepidoptera: Noctuidae) larvae reared at higher densities showed changes in coloration, a greater degree of encapsulation, had higher hemocyte densities and were more resistant to Baculovirus anticarsia, but not to Bacillus thuringiensis. Meanwhile, with increased rearing density there was reduced capsule melanization. Hemocyte density was the only variable that did not vary according to larval phenotype. The observed responses were not a continuous function of larval density, but an all-or-nothing response to the presence of a conspecific. As A. gemmatalis is not known for gregarious living, yet shows these density-dependent changes, it thus seems that this plastic phenotypic adjustment may be a broader phenomenon than previously thought.	[Silva, Farley W. S.; Viol, Daniel L.; Faria, Sirlene V.; Lima, Eraldo; Elliot, Simon L.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Valicente, Fernando H.] Empresa Brasileira Pesquisa Agr Maize & Sorghum, Appl Biol Grp, Sete Lagoas, Brazil	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Elliot, SL (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	selliot@ufv.br	Lima, Eraldo R/S-9585-2018; Lima, Eraldo R/B-6675-2008; Silva, Farley William Souza/D-9067-2013; Agricultura, Inct/I-2434-2013; Elliot, Simon Luke/A-5557-2013	Lima, Eraldo R/0000-0003-4446-5435; Silva, Farley William Souza/0000-0002-2651-9375; Elliot, Simon Luke/0000-0002-7469-2949	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; PPM/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPM/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for supporting FWSS with a Masters grant and EL & SLE with scholarships; the authors also thank PPM/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais for supporting EL & FHV with scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan T.N., 2009, PHENOTYPIC PLASTICIT, P137, DOI DOI 10.1201/B10201-7; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Berggren A, 2009, LANDSCAPE ECOL, V24, P749, DOI 10.1007/s10980-009-9348-6; Beron CM, 2006, BIOCONTROL, V51, P779, DOI 10.1007/s10526-006-9018-4; Bobrowski VL, 2002, BIOL CONTROL, V25, P129, DOI 10.1016/S1049-9644(02)00055-5; Castrol MEB, 1999, ARCH VIROL, V144, P1111, DOI 10.1007/s007050050573; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cotter SC, 2004, J ANIM ECOL, V73, P283, DOI 10.1111/j.0021-8790.2004.00806.x; Crawley MJ., 2007, R BOOK; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; de Negreiro MCC, 2009, IHERINGIA SER ZOOL, V99, P66, DOI 10.1590/S0073-47212009000100010; Dubovskii IM, 2010, J EVOL BIOCHEM PHYS+, V46, P35, DOI 10.1134/S0022093010010044; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Elliot SL, 2003, ECOL LETT, V6, P830, DOI 10.1046/j.1461-0248.2003.00487.x; FESCEMYER HW, 1986, ENVIRON ENTOMOL, V15, P784, DOI 10.1093/ee/15.4.784; FESCEMYER HW, 1988, ENVIRON ENTOMOL, V17, P213, DOI 10.1093/ee/17.2.213; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; GOULSON D, 1995, OECOLOGIA, V104, P416, DOI 10.1007/BF00341338; Hoffmann Campo C. B., 1985, Criacao massal da lagarta da soja (Anticarsia gemmatalis).; Hu CY, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000192; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kazimirova M, 1996, EUR J ENTOMOL, V93, P45; Lee KP, 2004, J INSECT PHYSIOL, V50, P1171, DOI 10.1016/j.jinsphys.2004.10.009; LEONARD DE, 1968, ENTOMOL EXP APPL, V11, P291, DOI 10.1007/BF00333753; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; Lumley T, 2011, SURVIVAL SURVIVAL AN; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; McPherson RM, 2009, J ECON ENTOMOL, V102, P1640, DOI 10.1603/029.102.0431; Mensah BA, 1998, ENTOMOL EXP APPL, V86, P331, DOI 10.1023/A:1003196311580; Milano P, 2010, NEOTROP ENTOMOL, V39, P172, DOI 10.1590/S1519-566X2010000200005; Miller GA, 2010, ECOL ENTOMOL, V35, P236, DOI 10.1111/j.1365-2311.2010.01180.x; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Pan XY, 2007, J GEN VIROL, V88, P3307, DOI 10.1099/vir.0.83363-0; Ponomarev VI, 2009, ZOOL ZH, V88, P446; Porcar M, 2000, J APPL MICROBIOL, V89, P309, DOI 10.1046/j.1365-2672.2000.01115.x; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; Pruijssers AJ, 2009, J EXP BIOL, V212, P2998, DOI 10.1242/jeb.030635; R Core Team, 2022, R LANG ENV STAT COMP; Raymond B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000905; Reeson AF, 2000, OECOLOGIA, V124, P373, DOI 10.1007/s004420000397; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Robb T, 2003, ECOL ENTOMOL, V28, P738, DOI 10.1111/j.1365-2311.2003.00557.x; Rose D.J.W., 1995, Integrated Pest Management Reviews, V1, P49, DOI 10.1007/BF00140333; Sadek MM, 2007, BASIC APPL ECOL, V8, P444, DOI 10.1016/j.baae.2006.08.001; Simpson S. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P147; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; Sokal R. R., 2012, BIOMETRY; Song H, 2008, CLADISTICS, V24, P515, DOI 10.1111/j.1096-0031.2007.00190.x; Sosa-Gomez DR, 2004, GENET MOL BIOL, V27, P378, DOI 10.1590/S1415-47572004000300012; STEINHAUS EA, 1958, ECOLOGY, V39, P503, DOI 10.2307/1931761; Sword GA, 2002, P ROY SOC B-BIOL SCI, V269, P1639, DOI 10.1098/rspb.2002.2060; Sword GA, 2010, J INSECT PHYSIOL, V56, P949, DOI 10.1016/j.jinsphys.2010.05.005; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x	59	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61582	10.1371/journal.pone.0061582	http://dx.doi.org/10.1371/journal.pone.0061582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626700	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400064
J	Sun, MJ; Liu, Y; Walker, WB; Liu, CC; Lin, KJ; Gu, SH; Zhang, YJ; Zhou, JJ; Wang, GR				Sun, Mengjing; Liu, Yang; Walker, William B.; Liu, Chengcheng; Lin, Kejian; Gu, Shaohua; Zhang, Yongjun; Zhou, Jingjiang; Wang, Guirong			Identification and Characterization of Pheromone Receptors and Interplay between Receptors and Pheromone Binding Proteins in the Diamondback Moth, Plutella xyllostella	PLOS ONE			English	Article							SEX-PHEROMONE; ODORANT RECEPTORS; OLFACTORY RECEPTORS; MOLECULAR-BASIS; EXPRESSION; GENE; SIGNALS; FAMILY	Moths depend on olfactory cues such as sex pheromones to find and recognize mating partners. Pheromone receptors (PRs) and Pheromone binding proteins (PBPs) are thought to be associated with olfactory signal transduction of pheromonal compounds in peripheral olfactory reception. Here six candidate pheromone receptor genes in the diamondback moth, Plutella xyllostella were identified and cloned. All of the six candidate PR genes display male-biased expression, which is a typical characteristic of pheromone receptors. In the Xenopus-based functional study and in situ hybridization, PxylOR4 is defined as another pheromone receptor in addition to the previously characterized PxylOR1. In the study of interaction between PRs and PBPs, PxylPBPs could increase the sensitivity of the complex expressing oocyte cells to the ligand pheromone component while decreasing the sensitivity to pheromone analogs. We deduce that activating pheromone receptors in olfactory receptor neurons requires some role of PBPs to pheromone/PBP complex. If the chemical signal is not the pheromone component, but instead, a pheromone analog with a similar structure, the complex would have a decreased ability to activate downstream pheromone receptors.	[Sun, Mengjing; Liu, Yang; Liu, Chengcheng; Lin, Kejian; Gu, Shaohua; Zhang, Yongjun; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Walker, William B.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol Res Grp, Alnarp, Sweden; [Zhou, Jingjiang] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swedish University of Agricultural Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Wang, GR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	grwang2010@hotmail.com	lin, ke/GZM-8300-2022	Liu, Yang/0000-0002-3424-7111	Beijing Natural Science Foundation [6132028]; National Natural Science Foundation of China [31071752, 31230062]; China National "973" Basic Research Program [2012CB114104]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BBS/E/C/00005194] Funding Source: UKRI	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "973" Basic Research Program(National Basic Research Program of China); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	There is some changes in the Financial Disclosure. This work was supported by Beijing Natural Science Foundation (6132028), National Natural Science Foundation of China (31071752 and 31230062) and the China National "973" Basic Research Program (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1979, APPL ENTOMOL ZOOL, V14, P362, DOI 10.1303/aez.14.362; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; CHISHOLM MD, 1983, J CHEM ECOL, V9, P113, DOI 10.1007/BF00987775; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; KOSHIHARA T, 1980, JPN J APPL ENTOMOL Z, V24, P6, DOI 10.1303/jjaez.24.6; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MASSON C, 1990, PHYSIOL REV, V70, P199, DOI 10.1152/physrev.1990.70.1.199; Michereff MFF, 2000, PESQUI AGROPECU BRAS, V35, P1919, DOI 10.1590/S0100-204X2000001000002; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Montagne N, 2012, EUROPEAN J NEUROSCIE; Mottus E, 1997, J CHEM ECOL, V23, P2145, DOI 10.1023/B:JOEC.0000006435.13481.ba; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; REGNIER FE, 1968, J LIPID RES, V9, P541; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Smith DP, 2007, PFLUG ARCH EUR J PHY, V454, P749, DOI 10.1007/s00424-006-0190-2; Sun MJ, 2013, J INSECT PHYSIOL, V59, P46, DOI 10.1016/j.jinsphys.2012.10.020; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tamaki YZ., 1977, APPL ENTOMOL ZOOL, V12, P208; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044190; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159; ZilahiBalogh GMG, 1995, INT J PEST MANAGE, V41, P201, DOI 10.1080/09670879509371949	43	83	95	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62098	10.1371/journal.pone.0062098	http://dx.doi.org/10.1371/journal.pone.0062098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626773	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400137
J	Zhou, DW; Lobo, YA; Batista, IFC; Marques-Porto, R; Gustchina, A; Oliva, MLV; Wlodawer, A				Zhou, Dongwen; Lobo, Yara A.; Batista, Isabel F. C.; Marques-Porto, Rafael; Gustchina, Alla; Oliva, Maria L. V.; Wlodawer, Alexander			Crystal Structures of a Plant Trypsin Inhibitor from Enterolobium contortisiliquum (EcTI) and of Its Complex with Bovine Trypsin	PLOS ONE			English	Article							PROTEINASE-INHIBITOR; FACTOR XA; BINDING	A serine protease inhibitor from Enterolobium contortisiliquum (EcTI) belongs to the Kunitz family of plant inhibitors, common in plant seeds. It was shown that EcTI inhibits the invasion of gastric cancer cells through alterations in integrin-dependent cell signaling pathway. We determined high-resolution crystal structures of free EcTI (at 1.75 angstrom) and complexed with bovine trypsin (at 2 angstrom). High quality of the resulting electron density maps and the redundancy of structural information indicated that the sequence of the crystallized isoform contained 176 residues and differed from the one published previously. The structure of the complex confirmed the standard inhibitory mechanism in which the reactive loop of the inhibitor is docked into trypsin active site with the side chains of Arg64 and Ile65 occupying the S1 and S1' pockets, respectively. The overall conformation of the reactive loop undergoes only minor adjustments upon binding to trypsin. Larger deviations are seen in the vicinity of Arg64, driven by the needs to satisfy specificity requirements. A comparison of the EcTI-trypsin complex with the complexes of related Kunitz inhibitors has shown that rigid body rotation of the inhibitors by as much as 15 degrees is required for accurate juxtaposition of the reactive loop with the active site while preserving its conformation. Modeling of the putative complexes of EcTI with several serine proteases and a comparison with equivalent models for other Kunitz inhibitors elucidated the structural basis for the fine differences in their specificity, providing tools that might allow modification of their potency towards the individual enzymes.	[Zhou, Dongwen; Gustchina, Alla; Wlodawer, Alexander] NCI, Ctr Canc Res, Macromol Crystallog Lab, Frederick, MD 21701 USA; [Lobo, Yara A.; Oliva, Maria L. V.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Batista, Isabel F. C.; Marques-Porto, Rafael] Inst Butantan, Lab Bioquim & Biofis, Unidade Sequenciamento Prot & Peptideos, Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan	Oliva, MLV (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.	olivaml.bioq@epm.br; wlodawer@nih.gov	Oliva, Maria Luiza V/B-9537-2012; Marques-Porto, Rafael/H-3533-2016; Zhou, Dongwen/O-1889-2019; Batista, Isabel FC/B-9535-2015	Batista, Isabel FC/0000-0001-7398-4184; Oliva, Maria Luiza/0000-0002-5822-0060	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/53766-5]; National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Use of the APS was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The authors are grateful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Process 09/53766-5) for providing financial support. This project was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; Bao R, 2009, J BIOL CHEM, V284, P26676, DOI 10.1074/jbc.M109.022095; Batista IFC, 2001, ACTA CRYSTALLOGR D, V57, P602, DOI 10.1107/S0907444901001810; Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5; Birk Y, 2005, PLANT PROTEASE INHIB; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CAGAN RH, 1973, SCIENCE, V181, P32, DOI 10.1126/science.181.4094.32; DAUTER Z, 1991, ACTA CRYSTALLOGR B, V47, P707, DOI 10.1107/S0108768191004202; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUNITZ M, 1947, J GEN PHYSIOL, V30, P311, DOI 10.1085/jgp.30.4.311; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lee KJ, 2012, AMINO ACIDS, V43, P379, DOI 10.1007/s00726-011-1092-y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1992, CURR OPIN STRUC BIOL, V2, P895; Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/bc.2011.031, 10.1515/BC.2011.031]; Patil DN, 2012, FEBS J, V279, P4547, DOI 10.1111/febs.12042; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; Renko M, 2012, BIOL CHEM, V393, P1043, DOI 10.1515/hsz-2012-0159; Richardson MJ., 1991, METHODS PLANT BIOCH, P259; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Salonen LM, 2009, ANGEW CHEM INT EDIT, V48, P811, DOI 10.1002/anie.200804695; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; SWEET RM, 1974, BIOCHEMISTRY-US, V13, P4212, DOI 10.1021/bi00717a024; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662	35	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62252	10.1371/journal.pone.0062252	http://dx.doi.org/10.1371/journal.pone.0062252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626794	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400158
J	Zhou, S; Ma, ZJ; Lu, TH; Janke, L; Gray, JT; Sorrentino, BP				Zhou, Sheng; Ma, Zhijun; Lu, Taihe; Janke, Laura; Gray, John T.; Sorrentino, Brian P.			Mouse Transplant Models for Evaluating the Oncogenic Risk of a Self-Inactivating XSCID Lentiviral Vector	PLOS ONE			English	Article							FUNCTIONAL LYMPHOID RECONSTITUTION; SEVERE COMBINED IMMUNODEFICIENCY; SCID-X1 GENE-THERAPY; RETROVIRAL VECTORS; INSERTIONAL MUTAGENESIS; DEFICIENT MICE; DESIGN; MURINE; INTEGRATION; ACTIVATION	Hematopoietic stem cell gene therapy requires the use of integrating retroviral vectors in order to stably transmit a therapeutic gene to mature blood cells. Human clinical trials have shown that some vector integration events lead to disrupted regulation of proto-oncogenes resulting in disordered hematopoiesis including T-cell leukemia. Newer vectors have been designed to decrease the incidence of these adverse events but require appropriate pre-clinical assays to demonstrate safety. We have used two distinct mouse serial transplant assays to evaluate the safety of a self-inactivating lentiviral vector intended for use in X-linked severe combined immunodeficiency (XSCID) gene therapy trials. These experiments entailed 28 months of total follow-up and included 386 mice. There were no cases in which the XSCID lentiviral vector clearly caused hematopoietic malignancies, although a single case of B cell malignancy was observed that contained the lentiviral vector as a likely passenger event. In contrast, a SFFV-DsRed gamma-retroviral vector resulted in clonal transformation events in multiple secondary recipients. Non-specific pathology not related to vector insertions was noted including T cell leukemias arising from irradiated recipient cells. Overall, this comprehensive study of mouse transplant safety assays demonstrate the relative safety of the XSCID lentiviral vector but also highlight the limitations of these assays.	[Zhou, Sheng; Ma, Zhijun; Lu, Taihe; Gray, John T.; Sorrentino, Brian P.] St Jude Childrens Res Hosp, Dept Hematol, Div Expt Hematol, Memphis, TN 38105 USA; [Janke, Laura] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Sorrentino, BP (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, Div Expt Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Brian.Sorrentino@stjude.org	Gray, John T/D-2916-2016; Janke, Laura/N-8121-2018	Gray, John T/0000-0002-1888-4612; Janke, Laura/0000-0002-9871-6239; Zhou, Sheng/0000-0001-5902-5868	National Heart, Lung, and Blood Institute [P01HL 53749]; Cancer Center [P30 CA 21765]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Center; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (grant P01HL 53749), Cancer Center (support grant P30 CA 21765), the Assisi Foundation of Memphis, and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; ARNOLD LW, 1983, J IMMUNOL, V131, P2064; Baum C, 2011, EMBO MOL MED, V3, P75, DOI 10.1002/emmm.201000110; Benjelloun F, 2008, MOL THER, V16, P1490, DOI 10.1038/mt.2008.118; BONIVER J, 1990, In Vivo (Attiki), V4, P41; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Bunting KD, 1998, NAT MED, V4, P58, DOI 10.1038/nm0198-058; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Corrigan-Curay J, 2012, MOL THER, V20, P1084, DOI 10.1038/mt.2012.93; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Ginn SL, 2010, MOL THER, V18, P965, DOI 10.1038/mt.2010.50; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lachmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021732; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Otsu M, 2000, MOL THER, V1, P145, DOI 10.1006/mthe.1999.0020; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PAIGE CJ, 1978, J IMMUNOL, V121, P641; Parsley TB, 2002, EUKARYOT CELL, V1, P401, DOI 10.1128/EC.1.3.401-413.2002; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rivat C, 2012, HUM GENE THER, V23, P668, DOI 10.1089/hum.2012.116; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Scobie L, 2009, MOL THER, V17, P1031, DOI 10.1038/mt.2009.59; Sharara LI, 1997, EUR J IMMUNOL, V27, P990, DOI 10.1002/eji.1830270428; Shaw KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002594; Shou Y, 2006, P NATL ACAD SCI USA, V103, P11730, DOI 10.1073/pnas.0603635103; Soudais C, 2000, BLOOD, V95, P3071, DOI 10.1182/blood.V95.10.3071.010k06_3071_3077; Throm RE, 2009, BLOOD, V113, P5104, DOI 10.1182/blood-2008-11-191049; Towers GJ, 1999, J GENE MED, V1, P352, DOI 10.1002/(SICI)1521-2254(199909/10)1:5<352::AID-JGM57>3.0.CO;2-I; Treanor LM, 2011, BLOOD, V117, P5453, DOI 10.1182/blood-2010-09-309831; Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007; Will E, 2007, MOL THER, V15, P782, DOI 10.1038/sj.mt.6300083; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhou S, 2010, BLOOD, V116, P900, DOI 10.1182/blood-2009-10-250209	49	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62333	10.1371/journal.pone.0062333	http://dx.doi.org/10.1371/journal.pone.0062333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626802	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400166
J	Heinrich, M; Wiegrebe, L				Heinrich, Melina; Wiegrebe, Lutz			Size Constancy in Bat Biosonar? Perceptual Interaction of Object Aperture and Distance	PLOS ONE			English	Article							FRUIT-EATING BATS; AUDITORY-CORTEX; ECHOLOCATING BAT; VIRTUAL OBJECTS; FM BATS; REPRESENTATION; ORIENTATION; DISCRIMINATION; CLASSIFICATION; SENSITIVITY	Perception and encoding of object size is an important feature of sensory systems. In the visual system object size is encoded by the visual angle (visual aperture) on the retina, but the aperture depends on the distance of the object. As object distance is not unambiguously encoded in the visual system, higher computational mechanisms are needed. This phenomenon is termed "size constancy". It is assumed to reflect an automatic re-scaling of visual aperture with perceived object distance. Recently, it was found that in echolocating bats, the 'sonar aperture', i.e., the range of angles from which sound is reflected from an object back to the bat, is unambiguously perceived and neurally encoded. Moreover, it is well known that object distance is accurately perceived and explicitly encoded in bat sonar. Here, we addressed size constancy in bat biosonar, recruiting virtual-object techniques. Bats of the species Phyllostomus discolor learned to discriminate two simple virtual objects that only differed in sonar aperture. Upon successful discrimination, test trials were randomly interspersed using virtual objects that differed in both aperture and distance. It was tested whether the bats spontaneously assigned absolute width information to these objects by combining distance and aperture. The results showed that while the isolated perceptual cues encoding object width, aperture, and distance were all perceptually well resolved by the bats, the animals did not assign absolute width information to the test objects. This lack of sonar size constancy may result from the bats relying on different modalities to extract size information at different distances. Alternatively, it is conceivable that familiarity with a behaviorally relevant, conspicuous object is required for sonar size constancy, as it has been argued for visual size constancy. Based on the current data, it appears that size constancy is not necessarily an essential feature of sonar perception in bats.	[Heinrich, Melina; Wiegrebe, Lutz] Univ Munich, Dept Biol 2, Bavaria, Germany; [Heinrich, Melina; Wiegrebe, Lutz] Univ Munich, Grad Sch Syst Neurosci, Bavaria, Germany; [Wiegrebe, Lutz] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	University of Munich; University of Munich; Max Planck Society	Wiegrebe, L (corresponding author), Univ Munich, Dept Biol 2, Bavaria, Germany.	lutzw@lmu.de			Volkswagenstiftung [I/83838]; Human Frontier Science Program [HFSP RGP 0062/2009]; Graduate School of Systemic Neurosciences (GSN-LMU) [DFG-GSC 82/1]	Volkswagenstiftung(Volkswagen); Human Frontier Science Program(Human Frontier Science Program); Graduate School of Systemic Neurosciences (GSN-LMU)	This study was funded by the 'Volkswagenstiftung' (I/83838), and by the Human Frontier Science Program (HFSP RGP 0062/2009) to Lutz Wiegrebe and a scholarship by the Graduate School of Systemic Neurosciences (GSN-LMU, DFG-GSC 82/1) to Melina Heinrich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airapetianz E., 1974, ECHOLOCATION NATURE; AU WWL, 2004, ECHOLOCATION BATS DO, pR13; Aubauer R, 2000, J ACOUST SOC AM, V107, P2750, DOI 10.1121/1.428661; Bates ME, 2011, J EXP BIOL, V214, P394, DOI 10.1242/jeb.048983; Carstens Bryan C., 2002, Journal of Mammalian Evolution, V9, P23, DOI 10.1023/A:1021331711108; DEAR SP, 1993, J NEUROPHYSIOL, V70, P1988, DOI 10.1152/jn.1993.70.5.1988; DeLong CM, 2006, J ACOUST SOC AM, V119, P1867, DOI 10.1121/1.2161434; Feng AS, 2011, J COMP PHYSIOL A, V197, P595, DOI 10.1007/s00359-010-0533-5; Firzlaff U, 2007, PLOS BIOL, V5, P1174, DOI 10.1371/journal.pbio.0050100; Foley JM, 2004, VISION RES, V44, P147, DOI 10.1016/j.visres.2003.09.004; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Goerlitz HR, 2012, BEHAV PROCESS, V89, P61, DOI 10.1016/j.beproc.2011.10.018; Goerlitz HR, 2010, J ACOUST SOC AM, V128, P1467, DOI 10.1121/1.3445784; Haber RN, 2001, PERCEPT PSYCHOPHYS, V63, P1140, DOI 10.3758/BF03194530; Hagemann C, 2011, J COMP PHYSIOL A, V197, P605, DOI 10.1007/s00359-010-0530-8; Hagemann C, 2010, J NEUROPHYSIOL, V103, P322, DOI 10.1152/jn.00595.2009; HARTRIDGE H, 1945, NATURE, V156, P490, DOI 10.1038/156490a0; Heffner RS, 2007, HEARING RES, V234, P1, DOI 10.1016/j.heares.2007.06.001; Heinrich M, 2011, J NEUROSCI, V31, P15618, DOI 10.1523/JNEUROSCI.2600-11.2011; Holderied MW, 2006, J EXP BIOL, V209, P3457, DOI 10.1242/jeb.02386; Holler P, 1996, J COMP PHYSIOL A, V179, P245; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JOERMANN G, 1988, ETHOLOGY, V78, P332; Kopco N, 2012, P NATL ACAD SCI USA, V109, P11019, DOI 10.1073/pnas.1119496109; Kwiecinski Gary G., 2006, Mammalian Species, P1, DOI 10.1644/801.1; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MCKEE SP, 1992, VISION RES, V32, P1447, DOI 10.1016/0042-6989(92)90201-S; MISTRY S, 1990, ANIM BEHAV, V39, P314, DOI 10.1016/S0003-3472(05)80876-0; MORGAN MJ, 1992, VISION RES, V32, P1433, DOI 10.1016/0042-6989(92)90200-3; Moss CF, 2006, PLOS BIOL, V4, P615, DOI 10.1371/journal.pbio.0040079; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Moss Cynthia F., 1995, Springer Handbook of Auditory Research, V5, P87; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nachtigall P.E., 1980, ODONTOCETE ECHOLOCAT, P71; Nowak RM, 1994, WALKERS BATS WORLD; O'Neill William E., 1995, Springer Handbook of Auditory Research, V5, P416; ROTHER G, 1982, Z SAUGETIERKD, V47, P324; Schmidt U., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P589; Schornich S, 2008, J COMP PHYSIOL A, V194, P61, DOI 10.1007/s00359-007-0290-2; SCHULLER G, 1991, EUR J NEUROSCI, V3, P1165, DOI 10.1111/j.1460-9568.1991.tb00051.x; Simmons J.A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P353; SIMMONS JA, 1973, J ACOUST SOC AM, V54, P157, DOI 10.1121/1.1913559; SIMMONS JA, 1971, SCIENCE, V171, P925, DOI 10.1126/science.171.3974.925; SIMMONS JA, 1990, J COMP PHYSIOL A, V167, P589; Stilz W, 2004, AKUSTISCHE UNTERSUCH; SUTHERS RA, 1966, SCIENCE, V152, P1102, DOI 10.1126/science.152.3725.1102; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Weissenbacher P, 2003, BEHAV NEUROSCI, V117, P833, DOI 10.1037/0735-7044.117.4.833; Wenstrup JJ, 2011, NEUROSCI BIOBEHAV R, V35, P2073, DOI 10.1016/j.neubiorev.2010.12.015; Wiegrebe L, 2008, BIOL CYBERN, V98, P587, DOI 10.1007/s00422-008-0216-2	50	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61577	10.1371/journal.pone.0061577	http://dx.doi.org/10.1371/journal.pone.0061577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630598	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500048
J	Longrie, N; Poncin, P; Denoel, M; Gennotte, V; Delcourt, J; Parmentier, E				Longrie, Nicolas; Poncin, Pascal; Denoel, Mathieu; Gennotte, Vincent; Delcourt, Johann; Parmentier, Eric			Behaviours Associated with Acoustic Communication in Nile Tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							SOUND PRODUCTION; CICHLID FISH; LAKE MALAWI; MATERNAL AGGRESSION; AGONISTIC BEHAVIOR; MOSSAMBICA PISCES; COURTSHIP SOUNDS; COLOR PATTERNS; FEMALE; EVOLUTION	Background: Sound production is widespread among fishes and accompanies many social interactions. The literature reports twenty-nine cichlid species known to produce sounds during aggressive and courtship displays, but the precise range in behavioural contexts is unclear. This study aims to describe the various Oreochromis niloticus behaviours that are associated with sound production in order to delimit the role of sound during different activities, including agonistic behaviours, pit activities, and reproduction and parental care by males and females of the species. Methodology/Principal Findings: Sounds mostly occur during the day. The sounds recorded during this study accompany previously known behaviours, and no particular behaviour is systematically associated with sound production. Males and females make sounds during territorial defence but not during courtship and mating. Sounds support visual behaviours but are not used alone. During agonistic interactions, a calling Oreochromis niloticus does not bite after producing sounds, and more sounds are produced in defence of territory than for dominating individuals. Females produce sounds to defend eggs but not larvae. Conclusion/Significance: Sounds are produced to reinforce visual behaviours. Moreover, comparisons with O. mossambicus indicate two sister species can differ in their use of sound, their acoustic characteristics, and the function of sound production. These findings support the role of sounds in differentiating species and promoting speciation. They also make clear that the association of sounds with specific life-cycle roles cannot be generalized to the entire taxa.	[Longrie, Nicolas; Parmentier, Eric] Univ Liege, Lab Funct & Evolutionary Morphol, Liege, Belgium; [Poncin, Pascal; Denoel, Mathieu; Delcourt, Johann] Univ Liege, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium; [Gennotte, Vincent] Univ Liege, Aquaculture Res & Educ Ctr CEFRA, Tihange, Belgium	University of Liege; University of Liege; University of Liege	Parmentier, E (corresponding author), Univ Liege, Lab Funct & Evolutionary Morphol, Liege, Belgium.	E.Parmentier@ulg.ac.be	Parmentier, Eric/P-9733-2018	Denoel, Mathieu/0000-0002-3586-8323; Delcourt, Johann/0000-0001-5036-8450; Parmentier, Eric/0000-0002-0391-7530	FRFC grants from the F.R.S.-FNRS [2.4.617. 08]	FRFC grants from the F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the FRFC grants from the F.R.S.-FNRS (no. 2.4.617. 08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Albrecht H, 1966, TILAPIA MARIAE CICHL, pE603; Amorim MCP, 2008, J FISH BIOL, V72, P1355, DOI 10.1111/j.1095-8649.2008.01802.x; Amorim MCP, 2005, ANIM BEHAV, V69, P595, DOI 10.1016/j.anbehav.2004.06.016; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Amorim MCP, 2003, J FISH BIOL, V62, P658, DOI 10.1046/j.1095-8649.2003.00054.x; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; Bauer J., 1963, Aquarien- und Terrarien-Zeitschrift, V16, P171; Bertucci F, 2012, CR BIOL, V335, P529, DOI 10.1016/j.crvi.2012.06.004; Bertucci F, 2010, ETHOLOGY, V116, P1179, DOI 10.1111/j.1439-0310.2010.01841.x; BROWN DH, 1978, BEHAVIOUR, V67, P299, DOI 10.1163/156853978X00378; Castro ALS, 2009, BRAZ J MED BIOL RES, V42, P368, DOI 10.1590/S0100-879X2009000400009; Colleye O, 2009, J FISH BIOL, V75, P908, DOI 10.1111/j.1095-8649.2009.02316.x; Colleye O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049179; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; Denoel M, 2002, BEHAV ECOL SOCIOBIOL, V52, P394, DOI 10.1007/s00265-002-0526-7; Duponchelle F, 2001, AQUAT LIVING RESOUR, V14, P145, DOI 10.1016/S0990-7440(01)01109-3; FALTER U, 1986, ANN SOC ROY ZOOL BEL, V116, P175; FALTER U, 1983, B CL SCI AC ROY BELG, V69, P566; FALTER U, 1987, ANN SOC ROY ZOOL BEL, V117, P201; Falter U, 1989, ANN KON MUS MID AFR, V257, P35; FIGLER MH, 1995, BEHAVIOUR, V132, P107, DOI 10.1163/156853995X00324; Fryer G., 1972, CICHLID FISHES GREAT; He AY, 2011, MOL BIOL REP, V38, P2015, DOI 10.1007/s11033-010-0324-7; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konstantinova NG, 1979, MOSCOW U BIOL SCI B, V34, P35; Ladich F, 1997, MAR FRESHW BEHAV PHY, V29, P87, DOI 10.1080/10236249709379002; Ladich Friedrich, 2006, P3; Lagardere Jean Paul, 2003, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V9, P281; LANZING WJR, 1974, J FISH BIOL, V6, P341, DOI 10.1111/j.1095-8649.1974.tb04551.x; Lobel Phillip S., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P167; Lobel PS, 1998, ENVIRON BIOL FISH, V52, P443, DOI 10.1023/A:1007467818465; Lobel PS, 1999, BIOL BULL, V197, P242, DOI 10.2307/1542627; Longrie N, 2008, J ZOOL, V275, P413, DOI 10.1111/j.1469-7998.2008.00457.x; Longrie N, 2009, J EXP BIOL, V212, P3395, DOI 10.1242/jeb.032946; Lugli M, 1999, J FISH BIOL, V54, P691, DOI 10.1006/jfbi.1998.0898; MARSHALL JA, 1972, AM ZOOL, V12, P663; MARSHALL JA, 1971, AM ZOOL, V11, P632; Millot S, 2011, J EXP BIOL, V214, P3613, DOI 10.1242/jeb.061218; MYRBERG AA, 1965, SCIENCE, V149, P555, DOI 10.1126/science.149.3683.555; N'Gokaka C, 1983, CAHIERS ETHOLOGIE AP, V3, P1; Nelissen M., 1975, Acta Zool Path Antwerp, VNo. 61, P19; NELISSEN M H J, 1976, Annales de la Societe Royale Zoologique de Belgique, V106, P167; NELISSEN MHJ, 1978, BEHAVIOUR, V64, P137, DOI 10.1163/156853978X00477; Nelissen MHJ, 1977, ANN SOC R ZOOL BELG, V106, P155; Nelissen MHJ, 1978, VAKBL BIOL, V21, P373; NOLDUS LPJJ, 1991, BEHAV RES METH INSTR, V23, P415, DOI 10.3758/BF03203406; Oliveira RF, 1998, AGGRESSIVE BEHAV, V24, P187; Oliveira RF, 1998, J FISH BIOL, V52, P1115, DOI 10.1111/j.1095-8649.1998.tb00959.x; Parmentier E, 2005, P ROY SOC B-BIOL SCI, V272, P1697, DOI 10.1098/rspb.2005.3146; Parmentier E, 2003, J COMP PHYSIOL A, V189, P283, DOI 10.1007/s00359-003-0401-7; Parmentier E, 2010, MAR BIOL, V157, P2317, DOI 10.1007/s00227-010-1498-1; PARMIGIANI S, 1988, J COMP PSYCHOL, V102, P287, DOI 10.1037/0735-7036.102.3.287; Ripley JL, 2004, ENVIRON BIOL FISH, V71, P389, DOI 10.1007/s10641-004-4190-9; Rodman D. T., 1966, Ichthyologica, V38, P279; ROWLAND WJ, 1978, BEHAVIOUR, V64, P125, DOI 10.1163/156853978X00468; Russock HI, 1999, BEHAVIOUR, V136, P567, DOI 10.1163/156853999501478; Santiago JA, 1997, J FISH BIOL, V51, P952; SCHWARZ A, 1974, Zeitschrift fuer Tierpsychologie, V35, P508; SCHWARZ A, 1974, Zeitschrift fuer Tierpsychologie, V35, P147; SCHWARZ AL, 1980, ENVIRON BIOL FISH, V5, P335, DOI 10.1007/BF00005187; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; SILVERMAN HI, 1978, ANIM BEHAV, V26, P1081, DOI 10.1016/0003-3472(78)90097-0; Simoes JM, 2008, J FISH BIOL, V72, P2689, DOI 10.1111/j.1095-8649.2008.01828.x; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; Simoes JM, 2006, ADV BIOACOUSTICS 2, V47, P229; SMITH AR, 2007, THESIS BOWLING GREEN; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Verzijden MN, 2010, BEHAV ECOL, V21, P548, DOI 10.1093/beheco/arq018	72	32	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61467	10.1371/journal.pone.0061467	http://dx.doi.org/10.1371/journal.pone.0061467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620756	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500036
J	Markunas, CA; Soldano, K; Dunlap, K; Cope, H; Asiimwe, E; Stajich, J; Enterline, D; Grant, G; Fuchs, H; Gregory, SG; Ashley-Koch, AE				Markunas, Christina A.; Soldano, Karen; Dunlap, Kaitlyn; Cope, Heidi; Asiimwe, Edgar; Stajich, Jeffrey; Enterline, David; Grant, Gerald; Fuchs, Herbert; Gregory, Simon G.; Ashley-Koch, Allison E.			Stratified Whole Genome Linkage Analysis of Chiari Type I Malformation Implicates Known Klippel-Feil Syndrome Genes as Putative Disease Candidates	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; POSTERIOR CRANIAL FOSSA; OF-THE-LITERATURE; EHLERS-DANLOS-SYNDROME; 2 MONOZYGOTIC TWINS; FAMILIAL SYRINGOMYELIA; REGULATORY ELEMENTS; MARFAN-SYNDROME; GDF6; MR	Chiari Type I Malformation (CMI) is characterized by displacement of the cerebellar tonsils below the base of the skull, resulting in significant neurologic morbidity. Although multiple lines of evidence support a genetic contribution to disease, no genes have been identified. We therefore conducted the largest whole genome linkage screen to date using 367 individuals from 66 families with at least two individuals presenting with nonsyndromic CMI with or without syringomyelia. Initial findings across all 66 families showed minimal evidence for linkage due to suspected genetic heterogeneity. In order to improve power to localize susceptibility genes, stratified linkage analyses were performed using clinical criteria to differentiate families based on etiologic factors. Families were stratified on the presence or absence of clinical features associated with connective tissue disorders (CTDs) since CMI and CTDs frequently co-occur and it has been proposed that CMI patients with CTDs represent a distinct class of patients with a different underlying disease mechanism. Stratified linkage analyses resulted in a marked increase in evidence of linkage to multiple genomic regions consistent with reduced genetic heterogeneity. Of particular interest were two regions (Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09) identified within the subset of "CTD-negative" families, both of which harbor growth differentiation factors (GDF6, GDF3) implicated in the development of Klippel-Feil syndrome (KFS). Interestingly, roughly 3-5% of CMI patients are diagnosed with KFS. In order to investigate the possibility that CMI and KFS are allelic, GDF3 and GDF6 were sequenced leading to the identification of a previously known KFS missense mutation and potential regulatory variants in GDF6. This study has demonstrated the value of reducing genetic heterogeneity by clinical stratification implicating several convincing biological candidates and further supporting the hypothesis that multiple, distinct mechanisms are responsible for CMI.	[Markunas, Christina A.; Soldano, Karen; Dunlap, Kaitlyn; Cope, Heidi; Asiimwe, Edgar; Stajich, Jeffrey; Gregory, Simon G.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Enterline, David] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Grant, Gerald; Fuchs, Herbert] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	allison.ashleykoch@duke.edu		Cope, Heidi/0000-0003-0586-9277; Gregory, Simon/0000-0002-7805-1743; Markunas, Christina/0000-0003-3401-733X; Ashley-Koch, Allison/0000-0001-5409-9155	National Institutes of Health [NS063273]; American Syringomyelia and Chiari Alliance Project; Chiari and Syringomyelia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Syringomyelia and Chiari Alliance Project; Chiari and Syringomyelia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was generously provided by the National Institutes of Health (http://www.nih.gov/, NS063273, AAK and SGG), American Syringomyelia and Chiari Alliance Project (http://www.asap.org/, AAK), and Chiari and Syringomyelia Foundation (http://www.csfinfo.org/, CAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abel TJ, 2006, J NEUROSURG, V105, P329, DOI 10.3171/ped.2006.105.4.329; ABOULEZZ AO, 1985, J COMPUT ASSIST TOMO, V9, P1033, DOI 10.1097/00004728-198511000-00005; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Atkinson JLD, 1998, NEUROSURGERY, V42, P401, DOI 10.1097/00006123-199802000-00129; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; Bogdanov EI, 2004, NEUROLOGY, V62, P791, DOI 10.1212/01.WNL.0000113746.47997.CE; Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Braca J, 2005, J NEUROSURG, V103, P552, DOI 10.3171/jns.2005.103.3.0552; Cakmakkaya OS, 2006, PEDIATR ANESTH, V16, P355, DOI 10.1111/j.1460-9592.2005.01795.x; Castori M, 2010, AM J MED GENET A, V152A, P556, DOI 10.1002/ajmg.a.33231; CAVENDER RK, 1995, J NEUROSURG, V82, P497, DOI 10.3171/jns.1995.82.3.0497; CORIA F, 1983, J NEUROL SCI, V62, P147, DOI 10.1016/0022-510X(83)90195-8; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; den Hollander AI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-102; George S, 2006, EYE, V20, P400, DOI 10.1038/sj.eye.6701887; GIMENEZROLDAN S, 1978, J NEUROL SCI, V36, P135, DOI 10.1016/0022-510X(78)90167-3; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Gupta A, 2008, CHILD NERV SYST, V24, P1345, DOI 10.1007/s00381-008-0675-8; Hamilton J, 1998, AM J MED GENET, V80, P128, DOI 10.1002/(SICI)1096-8628(19981102)80:2<128::AID-AJMG7>3.3.CO;2-3; Hamilton J, 1998, AM J NEURORADIOL, V19, P1609; Hara H, 2005, J DERMATOL, V32, P34, DOI 10.1111/j.1346-8138.2005.tb00711.x; HERMAN MD, 1991, PEDIATR NEUROSURG, V16, P183, DOI 10.1159/000120522; Hilal L, 2008, MOL MED, V14, P286, DOI 10.2119/2007-00128.Hilal; Iskandar BJ, 1998, J NEUROSURG, V89, P212, DOI 10.3171/jns.1998.89.2.0212; Iwasaki Y, 2000, NEUROL MED-CHIR, V40, P176, DOI 10.2176/nmc.40.176; Jacome DE, 2001, ACTA NEUROL SCAND, V104, P113, DOI 10.1034/j.1600-0404.2001.104002113.x; Jacome DE, 1999, CEPHALALGIA, V19, P791, DOI 10.1046/j.1468-2982.1999.1909791.x; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kagawa M, 2006, SURG NEUROL, V65, P497, DOI 10.1016/j.surneu.2005.06.034; Khan Abdul Aziz, 2010, J Ayub Med Coll Abbottabad, V22, P75; Kim Se Hee, 2010, Korean J Pediatr, V53, P718, DOI 10.3345/kjp.2010.53.6.718; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Konstantinou DT, 2004, SPINE, V29, pE189, DOI 10.1097/00007632-200405010-00023; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; Markunas CA, 2012, J NEUROSURG-PEDIATR, V9, P372, DOI 10.3171/2011.12.PEDS11113; MARWAHA R, 1992, J CLIN ENDOCR METAB, V74, P654, DOI 10.1210/jc.74.3.654; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Mavinkurve GG, 2005, CHILD NERV SYST, V21, P955, DOI 10.1007/s00381-005-1146-0; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2007, J NEUROSURG-SPINE, V7, P601, DOI 10.3171/SPI-07/12/601; Milhorat TH, 2010, ACTA NEUROCHIR, V152, P1117, DOI 10.1007/s00701-010-0636-3; Miro X, 2009, DIS MODEL MECH, V2, P412, DOI 10.1242/dmm.001602; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Mueller Diane M, 2004, J Am Acad Nurse Pract, V16, P134; Murphy RL, 2007, CHILD NERV SYST, V23, P1221, DOI 10.1007/s00381-007-0374-x; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Owler BK, 2004, ACTA NEUROCHIR, V146, P1137, DOI 10.1007/s00701-004-0323-3; Perrini P, 2008, NEUROSURG REV, V31, P331, DOI 10.1007/s10143-008-0129-5; Portnoy ME, 2005, GENOMICS, V86, P295, DOI 10.1016/j.ygeno.2005.05.003; Puget S, 2007, J NEUROSURG, V106, P48, DOI 10.3171/ped.2007.106.1.48; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reed NP, 2010, DEV DYNAM, V239, P1047, DOI 10.1002/dvdy.22251; RITTERBUSCH JF, 1991, SPINE, V16, pS539, DOI 10.1097/00007632-199110001-00017; Samartzis D, 2010, SPINE, V35, pE119, DOI 10.1097/BRS.0b013e3181c9f957; Sandberg DI, 2007, J NEUROSURG, V106, P490, DOI 10.3171/ped.2007.106.6.490; Schanker BD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11104; Solth A, 2010, BRIT J NEUROSURG, V24, P607, DOI 10.3109/02688697.2010.495173; Speer M C, 2000, Neurosurg Focus, V8, pE12; Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381; STOVNER LJ, 1995, EUR NEUROL, V35, P149; STOVNER LJ, 1992, ANN NEUROL, V31, P220, DOI 10.1002/ana.410310213; Strahle J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11107; Szewka AJ, 2006, PEDIATR NEUROL, V34, P481, DOI 10.1016/j.pediatrneurol.2005.09.008; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Tubbs RS, 2008, J NEUROSURG-PEDIATR, V1, P21, DOI 10.3171/PED-08/01/021; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; Tubbs RS, 2004, PEDIATR NEUROL, V30, P278, DOI 10.1016/j.pediatrneurol.2003.09.013; Tubbs RS, 2004, J CHILD NEUROL, V19, P459, DOI 10.1177/088307380401900613; Tubbs RS, 2003, J NEUROSURG, V99, P291, DOI 10.3171/jns.2003.99.2.0291; Tubbs RS, 2003, PEDIATR NEUROSURG, V38, P324, DOI 10.1159/000070416; Tubbs RS, 2001, NEUROSURGERY, V48, P1050, DOI 10.1097/00006123-200105000-00016; Turgut M, 2001, BRIT J NEUROSURG, V15, P279, DOI 10.1080/026886901750353773; ULMER JL, 1993, J COMPUT ASSIST TOMO, V17, P215, DOI 10.1097/00004728-199303000-00010; Weisfeld-Adams JD, 2007, PEDIATR NEUROSURG, V43, P533, DOI 10.1159/000108803; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WOOSLEY RE, 1982, J NEUROSURG, V56, P373, DOI 10.3171/jns.1982.56.3.0373; Yabe I, 2002, CLIN NEUROL NEUROSUR, V105, P69, DOI 10.1016/S0303-8467(02)00091-4; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496; ZAKERI A, 1995, SURG NEUROL, V44, P48, DOI 10.1016/0090-3019(96)85515-7	83	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61521	10.1371/journal.pone.0061521	http://dx.doi.org/10.1371/journal.pone.0061521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620759	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500039
J	Rosenes, Z; Mok, YF; Yang, S; Griffin, MDW; Mulhern, TD; Hatters, DM; Hensel, F; Howlett, GJ				Rosenes, Zachary; Mok, Yee-Foong; Yang, Shuo; Griffin, Michael D. W.; Mulhern, Terrence D.; Hatters, Danny M.; Hensel, Frank; Howlett, Geoffrey J.			Simultaneous Binding of the Anti-Cancer IgM Monoclonal Antibody PAT-SM6 to Low Density Lipoproteins and GRP78	PLOS ONE			English	Article							CU2+-INDUCED OXIDATION; SOLUTION SCATTERING; TIME-COURSE	The tumour-derived monoclonal IgM antibody PAT-SM6 specifically kills malignant cells by an apoptotic mechanism linked to the excessive uptake of plasma lipids. The mechanism is postulated to occur via the multi-point attachment of PAT-SM6 to the unfolded protein response regulator GRP78, located on the surface of tumour cells, coupled to the simultaneous binding of plasma low density lipoprotein (LDL). We prepared and characterised LDL and oxidized LDL using sedimentation velocity and small-angle X-ray scattering (SAXS) analysis. Enzyme-linked immunosorbent (ELISA) techniques indicated apparent dissociation constants of approximately 20 nM for the binding of LDL or oxidized LDL to PAT-SM6. ELISA experiments showed cross competition with LDL inhibiting PAT-SM6 binding to immobilised GRP78, while, in the reverse experiment, GRP78 inhibited PAT-SM6 binding to immobilized LDL. In contrast to the results of the ELISA experiments, sedimentation velocity experiments indicated relatively weak interactions between LDL and PAT-SM6, suggesting immunoabsorbance to the microtiter plate is driven by an avidity-based binding mechanism. The importance of avidity and the multipoint attachment of antigens to PAT-SM6 was further investigated using antigen-coated polystyrene beads. Absorption of GRP78 or LDL to polystyrene microspheres led to an increase in the inhibition of PAT-SM6 binding to microtiter plates coated with GRP78 or LDL, respectively. These results support the hypothesis that the biological action of PAT-SM6 in tumour cell apoptosis depends on the multivalent nature of PAT-SM6 and the ability to interact simultaneously with LDL and multiple GRP78 molecules clustered on the tumour cell surface.	[Rosenes, Zachary; Mok, Yee-Foong; Yang, Shuo; Griffin, Michael D. W.; Mulhern, Terrence D.; Hatters, Danny M.; Howlett, Geoffrey J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Hensel, Frank] Patrys GmbH, Wurzburg, Germany	University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	ghowlett@unimelb.edu.au		Mulhern, Terrence/0000-0002-1609-7498; Hatters, Danny/0000-0002-9965-2847; Griffin, Michael/0000-0001-9845-7735	ARC [LP100100392]; Patrys Ltd	ARC(Australian Research Council); Patrys Ltd	This work is supported by an ARC linkage grant (LP100100392) and by Patrys Ltd, a company currently conducting clinical trials of PAT-SM6 as a potential anti-cancer treatment. FH is the managing director of Patrys, GmbH. The PAT-SM6 antibody is proprietary to Patrys Limited and the company agrees to make to make freely available any materials and information described in their publication that may be reasonably requested for the purpose of academic, non-commercial research. Due to the proprietary nature of the antibody parties will need to enter into a material transfer agreement. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; Brandlein S, 2007, MOL CANCER THER, V6, P326, DOI 10.1158/1535-7163.MCT-06-0399; ESTERBAUER H, 1987, J LIPID RES, V28, P495; FLESS GM, 1975, BIOCHEMISTRY-US, V14, P1783, DOI 10.1021/bi00679a034; Gagnon P, 2008, BIOPHARM INT, P26; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; MEYER DF, 1995, BIOCHEM J, V310, P417, DOI 10.1042/bj3100417; Meyer DF, 1996, BIOCHEM J, V319, P217, DOI 10.1042/bj3190217; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Rosenes Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044927; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; WINDER AF, 1971, BIOPOLYMERS, V10, P1243, DOI 10.1002/bip.360100713	20	1	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61239	10.1371/journal.pone.0061239	http://dx.doi.org/10.1371/journal.pone.0061239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620733	Green Published, gold			2022-12-25	WOS:000317909500013
J	Rottschy, C; Kleiman, A; Dogan, I; Langner, R; Mirzazade, S; Kronenbuerger, M; Werner, C; Shah, NJ; Schulz, JB; Eickhoff, SB; Reetz, K				Rottschy, Claudia; Kleiman, Alexandra; Dogan, Imis; Langner, Robert; Mirzazade, Shahram; Kronenbuerger, Martin; Werner, Cornelius; Shah, N. Jon; Schulz, Joerg B.; Eickhoff, Simon B.; Reetz, Kathrin			Diminished Activation of Motor Working-Memory Networks in Parkinson's Disease	PLOS ONE			English	Article							COGNITIVE DEFICITS; CYTOARCHITECTONIC AREAS; FUNCTIONAL-ANATOMY; BASAL GANGLIA; BRAIN; DEMENTIA; CORTEX; IMPAIRMENT; ATTENTION; IMAGERY	Parkinson's disease (PD) is characterized by typical extrapyramidal motor features and increasingly recognized non-motor symptoms such as working memory (WM) deficits. Using functional magnetic resonance imaging (fMRI), we investigated differences in neuronal activation during a motor WM task in 23 non-demented PD patients and 23 age-and gender-matched healthy controls. Participants had to memorize and retype variably long visuo-spatial stimulus sequences after short or long delays (immediate or delayed serial recall). PD patients showed deficient WM performance compared to controls, which was accompanied by reduced encoding-related activation in WM-related regions. Mirroring slower motor initiation and execution, reduced activation in motor structures such as the basal ganglia and superior parietal cortex was detected for both immediate and delayed recall. Increased activation in limbic, parietal and cerebellar regions was found during delayed recall only. Increased load-related activation for delayed recall was found in the posterior midline and the cerebellum. Overall, our results demonstrate that impairment of WM in PD is primarily associated with a widespread reduction of task-relevant activation, whereas additional parietal, limbic and cerebellar regions become more activated relative to matched controls. While the reduced WM-related activity mirrors the deficient WM performance, the additional recruitment may point to either dysfunctional compensatory strategies or detrimental crosstalk from "default-mode" regions, contributing to the observed impairment.	[Rottschy, Claudia; Kleiman, Alexandra; Dogan, Imis; Mirzazade, Shahram; Kronenbuerger, Martin; Werner, Cornelius; Shah, N. Jon; Schulz, Joerg B.; Reetz, Kathrin] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Rottschy, Claudia; Kleiman, Alexandra; Dogan, Imis; Langner, Robert; Mirzazade, Shahram; Werner, Cornelius; Shah, N. Jon; Eickhoff, Simon B.; Reetz, Kathrin] Res Ctr Julich GmbH, Inst Neurosci & Med INM 1, INM 4, Julich, Germany; [Rottschy, Claudia; Kleiman, Alexandra; Dogan, Imis; Mirzazade, Shahram; Shah, N. Jon; Schulz, Joerg B.; Eickhoff, Simon B.; Reetz, Kathrin] Julich Aachen Res Alliance JARA Translat Brain Me, Aachen, Germany; [Rottschy, Claudia] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX USA; [Langner, Robert; Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany; [Eickhoff, Simon B.] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich; University of Texas System; University of Texas Health San Antonio; Heinrich Heine University Dusseldorf; RWTH Aachen University	Reetz, K (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.	kreetz@ukaachen.de	Reetz, Kathrin/H-9510-2012; Eickhoff, Simon B./K-2061-2013; Schulz, Jörg B/D-9786-2012; Shah, N. Jon/H-5849-2013	Reetz, Kathrin/0000-0002-9730-9228; Eickhoff, Simon B./0000-0001-6363-2759; Schulz, Jörg B/0000-0002-8903-0593; Shah, N. Jon/0000-0002-8151-6169; Dogan, Imis/0000-0002-6632-197X; Langner, Robert/0000-0002-3237-001X	Medical Faculty of the RWTH Aachen University Rotation Programme; Human Brain Project [R01-MH074457-01A1]; Helmholtz Alliance on Systems Biology (Human Brain Model); Excellence Initiative of the German federal government; Excellence Initiative of the German state government; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	Medical Faculty of the RWTH Aachen University Rotation Programme; Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helmholtz Alliance on Systems Biology (Human Brain Model); Excellence Initiative of the German federal government; Excellence Initiative of the German state government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CR was funded by the Medical Faculty of the RWTH Aachen University Rotation Programme. SBE was funded by the Human Brain Project (R01-MH074457-01A1) and the Helmholtz Alliance on Systems Biology (Human Brain Model). SBE and KR were funded by the Excellence Initiative of the German federal and state governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Axmacher N, 2008, CEREB CORTEX, V18, P2868, DOI 10.1093/cercor/bhn045; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; BRADLEY VA, 1989, J NEUROL NEUROSUR PS, V52, P1228, DOI 10.1136/jnnp.52.11.1228; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Carbon M, 2003, HUM BRAIN MAPP, V19, P197, DOI 10.1002/hbm.10115; Carbon M, 2010, NEUROBIOL DIS, V37, P455, DOI 10.1016/j.nbd.2009.10.025; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; DOMINEY P, 1995, NEUROPSYCHOLOGIA, V33, P727, DOI 10.1016/0028-3932(95)00008-Q; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Eckert T, 2006, J NEUROL, V253, P199, DOI 10.1007/s00415-005-0956-z; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, HUMAN PARIENTAL OPER; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fournet N, 2000, NEUROPSYCHOLOGY, V14, P247, DOI 10.1037//0894-4105.14.2.247; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, ADV ANAT EMBRYOL CEL, V174, P1, DOI [DOI 10.1007/978-3-642-18910-4_1, 10.1007/978-3-642-18910-4_1]; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grafton ST, 1998, J NEUROSCI, V18, P9420; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Helmuth LL, 2000, NEUROPSYCHOLOGIA, V38, P1443, DOI 10.1016/S0028-3932(00)00059-2; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JEANNEROD M, 1994, REV NEUROL, V150, P536; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kellermann TS, 2012, SOC COGN AFFECT NEUR, V7, P263, DOI 10.1093/scan/nsq104; Ketcham CJ, 2003, EXP BRAIN RES, V149, P30, DOI 10.1007/s00221-002-1332-1; Kiebel SJ, 2003, NEUROIMAGE, V20, P591, DOI 10.1016/S1053-8119(03)00308-2; Kurth F, 2010, CEREBRAL CORTEX; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Kwak Y, 2010, J NEUROPHYSIOL, V103, P942, DOI 10.1152/jn.00197.2009; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mentis MJ, 2003, NEUROLOGY; Moody TD, 2004, BEHAV NEUROSCI, V118, P438, DOI 10.1037/0735-7044.118.2.438; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; Nakamura T, 2001, HUM BRAIN MAPP, V12, P42, DOI 10.1002/1097-0193(200101)12:1<42::AID-HBM40>3.0.CO;2-D; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OWEN AM, 1993, NEUROPSYCHOLOGIA, V31, P627, DOI 10.1016/0028-3932(93)90135-M; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Possin KL, 2008, NEUROPSYCHOLOGY, V22, P585, DOI 10.1037/a0012613; Postle BR, 2003, CORTEX, V39, P927, DOI 10.1016/S0010-9452(08)70871-2; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Postle BR, 1997, NEUROPSYCHOLOGY, V11, P171, DOI 10.1037/0894-4105.11.2.171; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Price A, 2009, BRAIN COGNITION, V69, P252, DOI 10.1016/j.bandc.2008.07.013; REITAN RM, 1985, J CLIN PSYCHOL, V41, P245, DOI 10.1002/1097-4679(198503)41:2<245::AID-JCLP2270410219>3.0.CO;2-D; ROLAND PE, 1980, SCAND J REHABIL MED, P27; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Sadeh T, 2011, J COGNITIVE NEUROSCI, V23, P1597, DOI 10.1162/jocn.2010.21549; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Schilbach L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030920; Seidler RD, 2007, BRAIN RES, V1137, P104, DOI 10.1016/j.brainres.2006.12.057; Smith JG, 2006, NEUROPSYCHOLOGIA, V44, P275, DOI 10.1016/j.neuropsychologia.2005.05.001; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Suchan B, 2002, BEHAV BRAIN RES, V136, P533, DOI 10.1016/S0166-4328(02)00204-8; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Thanvi BR, 2003, POSTGRAD MED J, V79, P561, DOI 10.1136/pmj.79.936.561; Thobois S, 2000, NEUROLOGY, V55, P996, DOI 10.1212/WNL.55.7.996; Wechsler D, 1987, PSYCHOLOGY; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wittchen HU, 1997, SKID; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yaguez L, 2006, J NEUROL, V253, P186, DOI 10.1007/s00415-005-0951-4	112	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61786	10.1371/journal.pone.0061786	http://dx.doi.org/10.1371/journal.pone.0061786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620791	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500071
J	Stofanko, M; Goncalves-Dornelas, H; Cunha, PS; Pena, HB; Vianna-Morgante, AM; Pena, SDJ				Stofanko, Martin; Goncalves-Dornelas, Higgor; Cunha, Pricila Silva; Pena, Heloisa B.; Vianna-Morgante, Angela M.; Junho Pena, Sergio Danilo			Simple, Rapid and Inexpensive Quantitative Fluorescent PCR Method for Detection of Microdeletion and Microduplication Syndromes	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; HUMAN ELASTIN GENE; COPY NUMBER; REPEAT POLYMORPHISM; MECP2 DUPLICATIONS; WILLIAMS-SYNDROME; SNP ARRAYS; IDENTIFICATION; REARRANGEMENTS; INDIVIDUALS	Because of economic limitations, the cost-effective diagnosis of patients affected with rare microdeletion or microduplication syndromes is a challenge in developing countries. Here we report a sensitive, rapid, and affordable detection method that we have called Microdeletion/Microduplication Quantitative Fluorescent PCR (MQF-PCR). Our procedure is based on the finding of genomic regions with high homology to segments of the critical microdeletion/microduplication region. PCR amplification of both using the same primer pair, establishes competitive kinetics and relative quantification of amplicons, as happens in microsatellite-based Quantitative Fluorescence PCR. We used patients with two common microdeletion syndromes, the Williams-Beuren syndrome (7q11.23 microdeletion) and the 22q11.2 microdeletion syndromes and discovered that MQF-PCR could detect both with 100% sensitivity and 100% specificity. Additionally, we demonstrated that the same principle could be reliably used for detection of microduplication syndromes, by using patients with the Lubs (MECP2 duplication) syndrome and the 17q11.2 microduplication involving the NF1 gene. We propose that MQF-PCR is a useful procedure for laboratory confirmation of the clinical diagnosis of microdeletion/microduplication syndromes, ideally suited for use in developing countries, but having general applicability as well.	[Stofanko, Martin; Goncalves-Dornelas, Higgor; Pena, Heloisa B.; Junho Pena, Sergio Danilo] GENE Nucleo Genet Med, Belo Horizonte, MG, Brazil; [Cunha, Pricila Silva; Junho Pena, Sergio Danilo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Vianna-Morgante, Angela M.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Pena, SDJ (corresponding author), GENE Nucleo Genet Med, Belo Horizonte, MG, Brazil.	spena@gene.com.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (CNPq) [401983/2010-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (CNPq) for its support of this Project 401983/2010-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; BROWNSTEIN MJ, 1996, BIOTECHNIQUES, V20, P1008; Carr IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043466; Carr IM, 2011, HUM MUTAT, V32, P1350, DOI 10.1002/humu.21584; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Crotwell PL, 2012, CURR PROB PEDIATR AD, V42, P47, DOI 10.1016/j.cppeds.2011.10.004; Deutsch S, 2004, J MED GENET, V41, P908, DOI 10.1136/jmg.2004.023184; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; Gijsbers ACJ, 2011, HORM RES PAEDIAT, V76, P208, DOI 10.1159/000330406; GILBERTDUSSARDIER B, 1995, AM J HUM GENET, V56, P542; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Lanzante JR, 1996, INT J CLIMATOL, V16, P1197, DOI 10.1002/(SICI)1097-0088(199611)16:11<1197::AID-JOC89>3.0.CO;2-L; Lee HH, 1997, HUM GENET, V99, P364, DOI 10.1007/s004390050373; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; Mann K, 2012, PRENATAL DIAG, V32, P309, DOI 10.1002/pd.2945; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Mari A, 1998, CLIN GENET, V53, P226; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P1430, DOI 10.1093/nar/20.6.1430; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moles KJ, 2012, GENET MED, V14, P508, DOI 10.1038/gim.2011.46; MORROW B, 1995, AM J HUM GENET, V56, P1391; MUTTER GL, 1991, NUCLEIC ACIDS RES, V19, P4203, DOI 10.1093/nar/19.15.4203; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schaaf CP, 2011, ANNU REV GENOM HUM G, V12, P25, DOI 10.1146/annurev-genom-092010-110715; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sheskin DJ, 2011, HDB PARAMETRIC NONPA; Tonk V, 1996, AM J MED GENET, V61, P16, DOI 10.1002/(SICI)1096-8628(19960102)61:1<16::AID-AJMG3>3.0.CO;2-V; Truong HT, 2008, GENET TEST, V12, P67, DOI 10.1089/gte.2007.0058; Tukey JW, 1977, EXPLORATORY DATA ANA; Urban Z, 1997, CLIN GENET, V51, P133; Weise A, 2012, J HISTOCHEM CYTOCHEM, V60, P346, DOI 10.1369/0022155412440001; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; ZWEIG MH, 1993, CLIN CHEM, V39, P561	44	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61328	10.1371/journal.pone.0061328	http://dx.doi.org/10.1371/journal.pone.0061328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620743	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500023
J	Sukumaran, P; Lonnfors, M; Langvik, O; Pulli, I; Tornquist, K; Slotte, JP				Sukumaran, Pramod; Lonnfors, Max; Langvik, Otto; Pulli, Ilari; Tornquist, Kid; Slotte, J. Peter			Complexation of C6-Ceramide with Cholesteryl Phosphocholine - A Potent Solvent-Free Ceramide Delivery Formulation for Cells in Culture	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; L-GLYCERIC ACID; KINASE-C-ZETA; PHOSPHATIDYLCHOLINE SYNTHESIS; STEREOSPECIFIC SYNTHESIS; SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; CA2+ CONCENTRATION; INDUCED APOPTOSIS; CHANNEL FORMATION	Ceramides are potent bioactive molecules in cells. However, they are very hydrophobic molecules, and difficult to deliver efficiently to cells. We have made fluid bilayers from a short-chain D-erythro-ceramide (C6-Cer) and cholesteryl phosphocholine (CholPC), and have used this as a formulation to deliver ceramide to cells. C6-Cer complexed with CholPC led to much larger biological effects in cultured cells (rat thyroid FRTL-5 and human HeLa cells in culture) compared to C6-Cer dissolved in dimethyl sulfoxide (DMSO). Inhibition of cell proliferation and induction of apoptosis was significantly more efficient by C6-Cer/CholPC compared to C6-Cer dissolved in DMSO. C6-Cer/CholPC also permeated cell membranes and caused mitochondrial Ca2+ influx more efficiently than C6-Cer in DMSO. Even though CholPC was taken up by cells to some extent (from C6-Cer/CholPC bilayers), and was partially hydrolyzed to free cholesterol (about 9%), none of the antiproliferative effects were due to CholPC or excess cholesterol. The ceramide effect was not limited to D-erythro-C6-Cer, since L-erythro-C6-Cer and D-erythro-C6-dihydroCer also inhibited cell priolifereation and affected Ca2+ homeostasis. We conclude that C6-Cer complexed to CholPC increased the bioavailability of the short-chain ceramide for cells, and potentiated its effects in comparison to solvent-dissolved C6-Cer. This new ceramide formulation appears to be superior to previous solvent delivery approaches, and may even be useful with longer-chain ceramides.	[Sukumaran, Pramod; Pulli, Ilari; Tornquist, Kid] Abo Akad Univ, Turku, Finland; [Lonnfors, Max; Slotte, J. Peter] Abo Akad Univ, Dept Biosci, Turku, Finland; [Langvik, Otto] Abo Akad Univ, Organ Chem Lab, Dept Nat Sci, Turku, Finland; [Tornquist, Kid] Biomedicum Helsinki, Minerva Fdn Inst Med Res, Helsinki, Finland	Abo Akademi University; Abo Akademi University; Abo Akademi University; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, Turku, Finland.	ktornqvi@abo.fi; jpslotte@abo.fi		Sukumaran, Pramod/0000-0002-4781-3389; Pulli, Ilari/0000-0002-4785-8253; Langvik, Otto/0000-0001-7637-7734	Sigrid Juselius foundation; Abo Akademi Foundation (Center of Excellence in Cell Stress and Molecular Ageing); Magnus Ehrnrooth Foundation	Sigrid Juselius foundation(Sigrid Juselius Foundation); Abo Akademi Foundation (Center of Excellence in Cell Stress and Molecular Ageing); Magnus Ehrnrooth Foundation	This work was funded by grants from the Sigrid Juselius foundation, the Abo Akademi Foundation (Center of Excellence in Cell Stress and Molecular Ageing), and the Magnus Ehrnrooth Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, TRENDS IMMUNOL, V23, P1, DOI 10.1016/S1471-4906(01)02091-9; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BHATIA SK, 1988, J ORG CHEM, V53, P5034, DOI 10.1021/jo00256a024; Blazquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chapman H, 2005, J CELL SCI, V118, P5325, DOI 10.1242/jcs.02635; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Detre C, 2006, CELL SIGNAL, V18, P294, DOI 10.1016/j.cellsig.2005.05.012; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gotoh M, 2006, CHEM BIODIVERS, V3, P198, DOI 10.1002/cbdv.200690023; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; HASSLER DF, 1993, ADV LIPID RES, V26, P49; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Koivusalo M, 2004, BIOPHYS J, V86, P923, DOI 10.1016/S0006-3495(04)74168-5; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Leppimaki P, 2000, EUR J BIOCHEM, V267, P6385, DOI 10.1046/j.1432-1327.2000.01726.x; Lepple-Wienhues A, 1999, P NATL ACAD SCI USA, V96, P13795, DOI 10.1073/pnas.96.24.13795; Lonnfors M, 2013, LANGMUIR, V29, P2319, DOI 10.1021/la3051324; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Perera MN, 2012, BBA-BIOMEMBRANES, V1818, P1291, DOI 10.1016/j.bbamem.2012.02.010; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Podbielska M, 2012, NEUROCHEM RES, V37, P1154, DOI 10.1007/s11064-012-0728-y; Ramstrom C, 2004, CELL SIGNAL, V16, P1417, DOI 10.1016/j.cellsig.2004.05.007; Rodriguez-Acebes S, 2009, BIOCHEM J, V420, P305, DOI 10.1042/BJ20081909; Roodsari FS, 1999, J ORG CHEM, V64, P7727, DOI 10.1021/jo990414e; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Satoh Y, 2009, J BIOCHEM, V145, P31, DOI 10.1093/jb/mvn138; Shabbits JA, 2003, BBA-BIOMEMBRANES, V1612, P98, DOI 10.1016/S0005-2736(03)00108-1; SHAPIRO D, 1962, J AM CHEM SOC, V84, P1047, DOI 10.1021/ja00865a036; SINGH D, 1992, BIOCHIM BIOPHYS ACTA, V1103, P268, DOI 10.1016/0005-2736(92)90096-5; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Slotte J P, 1997, Subcell Biochem, V28, P277; SLOTTE JP, 1983, MED BIOL, V61, P223; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; Spiegel S, 1998, BIOCHEMISTRY-MOSCOW+, V63, P69; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tornquist K, 1999, J BIOL CHEM, V274, P9370, DOI 10.1074/jbc.274.14.9370; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Westerlund B, 2009, BBA-BIOMEMBRANES, V1788, P194, DOI 10.1016/j.bbamem.2008.11.010; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	68	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61290	10.1371/journal.pone.0061290	http://dx.doi.org/10.1371/journal.pone.0061290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620740	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500020
J	Zhang, QC; Schenauer, MR; McCarter, JD; Flynn, GC				Zhang, Qingchun; Schenauer, Matthew R.; McCarter, John D.; Flynn, Gregory C.			IgG1 Thioether Bond Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BETA-ELIMINATION; CROSS-LINKS; DISULFIDE BONDS; LANTHIONINE; PROTEIN; ALKALI; SUSCEPTIBILITY; RACEMIZATION; DEGRADATION	During either production or storage, the LC214-HC220 disulfide in therapeutic antibodies can convert to a thioether bond. Here we report that a thioether forms at the same position on antibodies in vivo. An IgG1 kappa therapeutic antibody dosed in humans formed a thioether at this position at a rate of about 0.1%/day while circulating in blood. Thioether modifications were also found at this position in endogenous antibodies isolated from healthy human subjects, at levels consistent with this conversion rate. For both endogenous antibodies and recombinant antibodies studied in vivo, thioether conversion rates were faster for IgG1 antibodies containing lambda light chains than those containing kappa light chains. These light chain reaction rate differences were replicated in vitro. Additional mechanistic studies showed that base-catalyzed thioether formation through the light chain dehydrogenation was more preferred on antibodies with lambda light chains, which may help explain the observed reaction rate differences.	Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA; [McCarter, John D.] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Flynn, GC (corresponding author), Amgen Inc, Mail Stop 30E-1-C,Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com						Amano M, 2011, ANAL CHEM, V83, P3857, DOI 10.1021/ac200321v; BESSEMS GJH, 1987, EXP EYE RES, V44, P691, DOI 10.1016/S0014-4835(87)80139-2; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Datola A, 2007, CHEMMEDCHEM, V2, P1181, DOI 10.1002/cmdc.200700042; EARLAND C, 1961, NATURE, V191, P384, DOI 10.1038/191384a0; FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Goetze AM, 2010, MABS-AUSTIN, V2, P500, DOI 10.4161/mabs.2.5.12897; Gu S, 2010, ANAL BIOCHEM, V400, P89, DOI 10.1016/j.ab.2010.01.019; HAN Y, 1991, POULTRY SCI, V70, P812, DOI 10.3382/ps.0700812; HORN M. J., 1941, Journal of Biological Chemistry, V139, P473; Horn MJ, 1942, J BIOL CHEM, V144, P87; Horn MJ, 1941, J BIOL CHEM, V138, P141; Huang LH, 2010, ANAL CHEM, V82, P6363, DOI 10.1021/ac101348w; Lagrain B, 2010, J AGR FOOD CHEM, V58, P10761, DOI 10.1021/jf102575r; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Lispi M, 2009, J PHARM SCI-US, V98, P4511, DOI 10.1002/jps.21774; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2011, ANAL BIOCHEM, V408, P277, DOI 10.1016/j.ab.2010.09.025; Liu HC, 2010, ANAL CHEM, V82, P5219, DOI 10.1021/ac100575n; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Maggon K, 2007, CURR MED CHEM, V14, P1978; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mozziconacci O, 2010, CHEM RES TOXICOL, V23, P1310, DOI 10.1021/tx100193b; NASHEF AS, 1977, J AGR FOOD CHEM, V25, P245, DOI 10.1021/jf60210a020; Pan H, 2009, ANAL BIOCHEM, V388, P273, DOI 10.1016/j.ab.2009.02.037; Pristatsky P, 2009, ANAL CHEM, V81, P6148, DOI 10.1021/ac9006254; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rombouts I, 2010, J CEREAL SCI, V52, P362, DOI 10.1016/j.jcs.2010.06.006; Tou JS, 2009, PROTEIN J, V28, P87, DOI 10.1007/s10930-009-9167-2; Tous GI, 2005, ANAL CHEM, V77, P2675, DOI 10.1021/ac0500582; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Yin S, 2013, PHARM RES-DORDR, V30, P167, DOI 10.1007/s11095-012-0860-z	36	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16371	16382		10.1074/jbc.M113.468397	http://dx.doi.org/10.1074/jbc.M113.468397			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625924	hybrid, Green Published			2022-12-25	WOS:000320378900015
J	Borbely, E; Hajna, Z; Sandor, K; Kereskai, L; Toth, I; Pinter, E; Nagy, P; Szolcsanyi, J; Quinn, J; Zimmer, A; Stewart, J; Paige, C; Berger, A; Helyes, Z				Borbely, Eva; Hajna, Zsofia; Sandor, Katalin; Kereskai, Laszlo; Toth, Istvan; Pinter, Erika; Nagy, Peter; Szolcsanyi, Janos; Quinn, John; Zimmer, Andreas; Stewart, James; Paige, Christopher; Berger, Alexandra; Helyes, Zsuzsanna			Role of Tachykinin 1 and 4 Gene-Derived Neuropeptides and the Neurokinin 1 Receptor in Adjuvant-Induced Chronic Arthritis of the Mouse	PLOS ONE			English	Article							SUBSTANCE-P-LIKE; SENSORY NERVE-TERMINALS; RHEUMATOID-ARTHRITIS; TARGETED DELETION; SYNOVIAL-FLUID; DEFICIENT MICE; ANIMAL-MODELS; EXPRESSION; NK1; HEMOKININ-1	Objective: Substance P, encoded by the Tac1 gene, is involved in neurogenic inflammation and hyperalgesia via neurokinin 1 (NK1) receptor activation. Its non-neuronal counterpart, hemokinin-1, which is derived from the Tac4 gene, is also a potent NK1 agonist. Although hemokinin-1 has been described as a tachykinin of distinct origin and function compared to SP, its role in inflammatory and pain processes has not yet been elucidated in such detail. In this study, we analysed the involvement of tachykinins derived from the Tac1 and Tac4 genes, as well as the NK1 receptor in chronic arthritis of the mouse. Methods: Complete Freund's Adjuvant was injected intraplantarly and into the tail of Tac1(-/-), Tac4(-/-), Tacr1(-/-) (NK1 receptor deficient) and Tac1(-/-/)Tac4(-/-) mice. Paw volume was measured by plethysmometry and mechanosensitivity using dynamic plantar aesthesiometry over a time period of 21 days. Semiquantitative histopathological scoring and ELISA measurement of IL-1 beta concentrations of the tibiotarsal joints were performed. Results: Mechanical hyperalgesia was significantly reduced from day 11 in Tac4(-/-) and Tacr1(-/-) animals, while paw swelling was not altered in any strain. Inflammatory histopathological alterations (synovial swelling, leukocyte infiltration, cartilage destruction, bone damage) and IL-1 beta concentration in the joint homogenates were significantly smaller in Tac4(-/-) and Tac1 -(/-/)Tac4(-/-) mice. Conclusions: Hemokinin-1, but not substance P increases inflammation and hyperalgesia in the late phase of adjuvant-induced arthritis. While NK1 receptors mediate its antihyperalgesic actions, the involvement of another receptor in histopathological changes and IL-1 beta production is suggested.	[Borbely, Eva; Hajna, Zsofia; Sandor, Katalin; Toth, Istvan; Pinter, Erika; Nagy, Peter; Szolcsanyi, Janos; Helyes, Zsuzsanna] Univ Pecs, Fac Med, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary; [Borbely, Eva; Hajna, Zsofia; Pinter, Erika; Nagy, Peter; Helyes, Zsuzsanna] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Kereskai, Laszlo] Univ Pecs, Dept Pathol, Fac Med, Pecs, Hungary; [Quinn, John] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Zimmer, Andreas] Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, Bonn, Germany; [Stewart, James] Univ Liverpool, Sch Infect & Host Def, Liverpool L69 3BX, Merseyside, England; [Paige, Christopher; Berger, Alexandra] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Paige, Christopher; Berger, Alexandra] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Pecs; University of Pecs; University of Pecs; University of Liverpool; University of Bonn; University of Liverpool; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Helyes, Z (corresponding author), Univ Pecs, Fac Med, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary.	zsuzsanna.helyes@aok.pte.hu	Zimmer, Andreas/B-8357-2009; Zsuzsanna, Helyes/GLU-8236-2022; Quinn, John P/A-2972-2010	Zsuzsanna, Helyes/0000-0003-2435-4367; Quinn, John P/0000-0003-3551-7803; Stewart, James/0000-0002-8928-2037	Developing Competitiveness of Universities in the South Transdanubian Region [SROP-4.2.2. A-11/1/KONV-2012-0024, SROP-4.2.1.B-10/2/KONV-2010-0002, SROP-4.2.2. B-10/1/2010-0029]; Terry Fox Program Project Grant (National Cancer Institute of Canada) [015005]; Canadian Institute of Health Research [9862];  [OTKA-NK78059];  [OTKA-K81984]	Developing Competitiveness of Universities in the South Transdanubian Region; Terry Fox Program Project Grant (National Cancer Institute of Canada); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); ; 	Funding provided by Developing Competitiveness of Universities in the South Transdanubian Region (SROP-4.2.2. A-11/1/KONV-2012-0024, SROP-4.2.1.B-10/2/KONV-2010-0002, SROP-4.2.2. B-10/1/2010-0029), OTKA-NK78059, OTKA-K81984, Terry Fox Program Project Grant (National Cancer Institute of Canada #015005), and the Canadian Institute of Health Research (#9862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelNasser AM, 1997, SEMIN ARTHRITIS RHEU, V27, P123, DOI 10.1016/S0049-0172(97)80012-1; Anichini M, 1997, REV RHUM, V64, P18; Berger A, 2005, J NEUROIMMUNOL, V164, P48, DOI 10.1016/j.jneuroim.2005.03.016; Berger A, 2012, GENES BRAIN BEHAV, V11, P568, DOI 10.1111/j.1601-183X.2012.00787.x; Berger A, 2010, BLOOD, V116, P3792, DOI 10.1182/blood-2010-06-291062; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; BILEVICIUTE I, 1993, NEUROSCI LETT, V153, P37, DOI 10.1016/0304-3940(93)90071-R; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Chen DR, 2012, INT J CLIN RHEUMTOL, V2, P159; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Duffy RA, 2003, NEUROPHARMACOLOGY, V45, P242, DOI 10.1016/S0028-3908(03)00150-3; Endo D, 2006, NEUROSCI LETT, V392, P114, DOI 10.1016/j.neulet.2005.09.005; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Graham GJ, 2004, BLOOD, V104, P1058, DOI 10.1182/blood-2003-11-3979; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Helyes Z, 2006, BRIT J PHARMACOL, V149, P405, DOI 10.1038/sj.bjp.0706876; Helyes Z, 2004, ARTHRITIS RHEUM-US, V50, P1677, DOI 10.1002/art.20184; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; Hong SK, 2002, NEUROSCI LETT, V322, P21, DOI 10.1016/S0304-3940(02)00070-8; Howard MR, 2008, NEUROPEPTIDES, V42, P681, DOI 10.1016/j.npep.2008.09.004; JORGENSEN C, 1994, CLIN EXP RHEUMATOL, V12, P435; Keeble JE, 2004, NEUROSCI LETT, V361, P176, DOI 10.1016/j.neulet.2003.12.020; KRAUSE JE, 1995, CAN J PHYSIOL PHARM, V73, P854, DOI 10.1139/y95-117; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Laird JMA, 2000, NEUROSCIENCE, V98, P345, DOI 10.1016/S0306-4522(00)00148-2; Lam FFY, 2010, BRIT J PHARMACOL, V159, P958, DOI 10.1111/j.1476-5381.2009.00586.x; LARSSON J, 1991, SCAND J RHEUMATOL, V20, P326, DOI 10.3109/03009749109096808; Lavagno L, 2001, NEUROPEPTIDES, V35, P92, DOI 10.1054/npep.2001.0850; LEVINE JD, 1985, J RHEUMATOL, V12, P406; Liu L, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2011.01685.x; Longmore J, 1997, CAN J PHYSIOL PHARM, V75, P612, DOI 10.1139/cjpp-75-6-612; MAGGI CA, 1995, PROG NEUROBIOL, V45, P1, DOI 10.1016/0301-0082(94)E0017-B; Metwali A, 2004, J IMMUNOL, V172, P6528, DOI 10.4049/jimmunol.172.11.6528; Millward-Sadler SJ, 2003, ARTHRITIS RHEUM, V48, P146, DOI 10.1002/art.10711; Naono-Nakayama R, 2010, NEUROPEPTIDES, V44, P57, DOI 10.1016/j.npep.2009.10.002; Nelson DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2166, DOI 10.2741/1372; Origuchi T, 2011, MOD RHEUMATOL, V21, P244, DOI 10.1007/s10165-010-0384-5; Page NM, 2006, VASC PHARMACOL, V45, P200, DOI 10.1016/j.vph.2005.08.028; Page NM, 2004, CELL MOL LIFE SCI, V61, P1652, DOI 10.1007/s00018-004-4035-x; PERNOW B, 1983, GEN PHARMACOL-VASC S, V14, P13, DOI 10.1016/0306-3623(83)90055-1; Popa C, 2007, RHEUMATOLOGY, V46, P626, DOI 10.1093/rheumatology/kel393; Ribeiro-da-Silva A, 2000, NEUROPEPTIDES, V34, P256, DOI 10.1054/npep.2000.0834; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Stewart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001673; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Szolcsanyi J, 1996, PROG BRAIN RES, V113, P343, DOI 10.1016/S0079-6123(08)61097-3; Tauer U, 2012, NEUROPHARMACOLOGY, V63, P958, DOI 10.1016/j.neuropharm.2012.06.041; Tran AH, 2009, NEUROPEPTIDES, V43, P1, DOI 10.1016/j.npep.2008.10.002; Uematsu T, 2011, EUR J PHARMACOL, V668, P163, DOI 10.1016/j.ejphar.2011.06.037; Urban LA, 2000, TRENDS PHARMACOL SCI, V21, P462; Weidler C, 2005, ANN RHEUM DIS, V64, P13, DOI 10.1136/ard.2003.016154; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	55	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61684	10.1371/journal.pone.0061684	http://dx.doi.org/10.1371/journal.pone.0061684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626716	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400080
J	Jahanbakhsh, F; Hattori, J; Matsuda, M; Ibe, S; Monavari, SHR; Memarnejadian, A; Aghasadeghi, MR; Mostafavi, E; Mohraz, M; Jabbari, H; Kamali, K; Keyvani, H; Azadmanesh, K; Sugiura, W				Jahanbakhsh, Fatemeh; Hattori, Junko; Matsuda, Masakazu; Ibe, Shiro; Monavari, Seyed-Hamid R.; Memarnejadian, Arash; Aghasadeghi, Mohammad R.; Mostafavi, Ehsan; Mohraz, Minoo; Jabbari, Hossain; Kamali, Kianoush; Keyvani, Hossein; Azadmanesh, Kayhan; Sugiura, Wataru			Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SURVEILLANCE; ADHERENCE; MUTATIONS	Objective: Drug-resistant (DR) HIV emerges during combined antiretroviral treatment (cART), creating concern about widespread transmission of DR-HIV as cART is expanded in resource-limited countries. The aim of this study was to determine the predominant HIV-1 subtypes and prevalence of transmitted DR mutations among antiretroviral-naive patients in Iran. Design: To monitor transmission of DR HIV, a threshold surveillance based on the world health organization (WHO) guidelines was implemented in Iran. Methods: For this HIVDR threshold surveillance study, blood samples were collected from 50 antiretroviral-naive HIV-1-infected patients. Antiretroviral-resistant mutations were determined by sequencing HIV-1 protease, reverse transcriptase and integrase regions. The HIV-1 subtype was determined by sequencing the p17 and C2-V5 regions of the gag and env genes, respectively. Results: Phylogenetic analyses of the sequenced regions revealed that 45 (95.7%) of 47 samples that were successfully obtained were CRF35_AD. The remaining two cases were subtype B (2.1%) and CRF01_AE (2.1%). Consistent results were obtained also from Env and Gag sequences. Regarding prevalence of transmitted DR viruses, two cases were found to harbor reverse transcriptase-inhibitor-resistant mutations (4.3%). In addition, although not in the WHO list for surveillance of transmitted mutations, 13 minor protease-inhibitor-resistant mutations listed in the International AIDS Society-USA panel of drug resistance mutations were found. No DR mutations were detected in the integrase region. Conclusions: Our study clarified that CRF35_AD is the major subtype among HIV-1-infected patients in Iran. According to the WHO categorization method of HIVDR threshold survey, the prevalence of transmitted drug resistant HIV in Iran was estimated as moderate (5-15%).	[Jahanbakhsh, Fatemeh; Monavari, Seyed-Hamid R.; Keyvani, Hossein] Univ Tehran Med Sci, Dept Virol, Tehran, Iran; [Jahanbakhsh, Fatemeh; Azadmanesh, Kayhan] Pasteur Inst Iran, Dept Virol, Tehran, Iran; [Hattori, Junko; Matsuda, Masakazu; Ibe, Shiro; Sugiura, Wataru] Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Memarnejadian, Arash; Aghasadeghi, Mohammad R.] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Mohraz, Minoo] Iranian Res Ctr HIV AIDS RCHA, Dept Infect Dis, Tehran, Iran; [Jabbari, Hossain] Univ Tehran Med Sci, Digest Dis Res Inst, Iranian Res Ctr HIV AIDS RCHA, Dept Infect Dis, Tehran, Iran; [Jabbari, Hossain] Univ Vienna, Vienna Gen Hosp, Dept Dermatol, Dept Clin Immunol Allergy & Infect Dis, Vienna, Austria; [Kamali, Kianoush] Minist Hlth, Ctr Communicable Dis Control, AIDS Off, Tehran, Iran	Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Nagoya Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; University of Vienna	Azadmanesh, K (corresponding author), Pasteur Inst Iran, Dept Virol, Tehran, Iran.	k.azadmanesh@gmail.com	Jabbari, Hossain/AAX-2641-2020; aghasadeghi, mohammad reza/K-9497-2017; Memarnejadian, Arash/I-3979-2019; Azadmanesh, kayhan/W-2445-2017; Mostafavi, Ehsan/A-7627-2011	aghasadeghi, mohammad reza/0000-0003-2186-0774; Memarnejadian, Arash/0000-0003-4005-8787; Azadmanesh, kayhan/0000-0002-7165-9043; Mostafavi, Ehsan/0000-0002-1997-517X; Keyvani, Hossein/0000-0002-6528-7861	World Health Organization [APW/09/00252]; Iranian Ministry of Health and Medical Education; Ministry of Health, Labour and Welfare of Japan [H22-AIDS-004]	World Health Organization(World Health Organization); Iranian Ministry of Health and Medical Education; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants from the World Health Organization (APW/09/00252), Iranian Ministry of Health and Medical Education, and a Grant-in-Aid for AIDS research from the Ministry of Health, Labour and Welfare of Japan (H22-AIDS-004). The stipendiary of Fatemeh Jahanbakhsh's Ph.D. sabbatical leave in Japan, at Nagoya Medical Center was funded by Ministry of Health and Medical Education of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Applebaum AJ, 2009, AIDS PATIENT CARE ST, V23, P455, DOI 10.1089/apc.2008.0181; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertognolio S, 2008, ANTIVIR THER, V13, P49; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Ministry of Health and Medical Education (MHME) Iran, 2012, AIDS HIV SURV REP; Mousavi SM, 2010, ARCH VIROL, V155, P329, DOI 10.1007/s00705-009-0583-6; Myatt M, 2008, ANTIVIR THER, V13, P37; Naderi H R, 2006, Infect Agent Cancer, V1, P4, DOI 10.1186/1750-9378-1-4; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2012, ISL REP IR PROGR REP; National AIDS Committee Secretariat Ministry of Health and Medical Education. Islamic Repoblic of Iran, 2008, PROGR REP MON UN GEN; Popp D, 2002, AIDS, V16, P676, DOI 10.1097/00002030-200203080-00025; Sarrami-Forooshani R, 2006, J MED VIROL, V78, P853, DOI 10.1002/jmv.20634; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Sugiura W, 1999, JPN J INFECT DIS, V52, P21; Tagliamonte M, 2007, AIDS RES HUM RETROV, V23, P1569, DOI 10.1089/aid.2007.0169; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vazirian Mohsen, 2005, Harm Reduct J, V2, P19, DOI 10.1186/1477-7517-2-19; Zamani S, 2005, AIDS, V19, P709, DOI 10.1097/01.aids.0000166094.24069.72	20	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61864	10.1371/journal.pone.0061864	http://dx.doi.org/10.1371/journal.pone.0061864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626742	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400106
J	Orme, RP; Bhangal, MS; Fricker, RA				Orme, Rowan P.; Bhangal, Manminder S.; Fricker, Rosemary A.			Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; NEUROTROPHIC FACTOR GDNF; PARKINSON-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; PROTEIN EXPRESSION; RAT-BRAIN; INFUSION; DIFFERENTIATION; MOUSE; TRIAL	During development a tightly controlled signaling cascade dictates the differentiation, maturation and survival of developing neurons. Understanding this signaling mechanism is important for developing therapies for neurodegenerative illnesses. In previous work we have sought to understand the complex signaling pathways responsible for the development of midbrain dopamine neurons using a proteomic approach. One protein we have identified as being expressed in developing midbrain tissue is the vitamin D receptor. Therefore we investigated the effect of the biologically active vitamin D-3 metabolite, calcitriol, on primary fetal ventral mesencephalic cultures of dopamine neurons. We observed a dose responsive increase in numbers of rat primary dopamine neurons when calcitriol was added to culture media. Western blot data showed that calcitriol upregulated the expression of glial derived neurotrophic factor (GDNF). Blocking GDNF signaling could prevent calcitriol's ability to increase numbers of dopamine neurons. An apoptosis assay and cell birth dating experiment revealed that calcitriol increases the number of dopamine neurons through neuroprotection and not increased differentiation. This could have implications for future neuroprotective PD therapies.	[Orme, Rowan P.; Fricker, Rosemary A.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Orme, Rowan P.; Fricker, Rosemary A.] Keele Univ, Dept Life Sci, Keele ST5 5BG, Staffs, England; [Bhangal, Manminder S.; Fricker, Rosemary A.] Keele Univ, Sch Med, Keele ST5 5BG, Staffs, England	Keele University; Keele University; Keele University	Fricker, RA (corresponding author), Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.	r.a.fricker@keele.ac.uk	Fricker, Rosemary/ABC-3301-2021		Parkinson's UK [G-0911]; Keele University School of Medicine; Parkinson&quot;s UK [G-0911] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Keele University School of Medicine; Parkinson&quot;s UK(Parkinson&apos;s UK)	The work presented was funded by Parkinson's UK (www.parkinsons.org.uk), grant number G-0911. Additional funding was from Keele University School of Medicine (www.keele.ac.uk), which provided money to support the placement of Manminder Bhangal as part of his degree course. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An BS, 2010, MOL CELL BIOL, V30, P4890, DOI 10.1128/MCB.00180-10; Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; BISHOP JE, 1994, J BONE MINER RES, V9, P1277; Burket R, 2003, NEUROSCI RES COMMUN, V33, P63, DOI 10.1002/nrc.10081; Butler MW, 2011, ANN HUM GENET, V75, P201, DOI 10.1111/j.1469-1809.2010.00631.x; Carlberg C, 2003, RECENT RESULTS CANC, V164, P29; Dace A, 1997, BIOCHEM BIOPH RES CO, V232, P771, DOI 10.1006/bbrc.1997.6372; Diesel B, 2005, CLIN CANCER RES, V11, P5370, DOI 10.1158/1078-0432.CCR-04-1968; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fau CE, 1997, CELL TISSUE RES, V289, P207; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gonzalez MM, 2003, MOL ENDOCRINOL, V17, P2028, DOI 10.1210/me.2003-0072; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; HOLDER N, 1991, DEVELOPMENT, V113, P1159; HOSOMI J, 1983, ENDOCRINOLOGY, V113, P1950, DOI 10.1210/endo-113-6-1950; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; Kim JS, 2005, J KOREAN MED SCI, V20, P495, DOI 10.3346/jkms.2005.20.3.495; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kosakai A, 2011, BRAIN RES, V1382, P109, DOI 10.1016/j.brainres.2011.01.056; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Orme RP, 2010, J NEUROSCI METH, V191, P75, DOI 10.1016/j.jneumeth.2010.06.009; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Piltonen M, 2009, EXP NEUROL, V219, P499, DOI 10.1016/j.expneurol.2009.07.002; Roussa E, 2004, NEUROSCI LETT, V361, P52, DOI 10.1016/j.neulet.2003.12.106; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Zhou QH, 2010, DRUG METAB DISPOS, V38, P566, DOI 10.1124/dmd.109.031534	38	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62040	10.1371/journal.pone.0062040	http://dx.doi.org/10.1371/journal.pone.0062040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626767	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000318008400131
J	Gu, F; Doderer, MS; Huang, YW; Roa, JC; Goodfellow, PJ; Kizer, EL; Huang, THM; Chen, YD				Gu, Fei; Doderer, Mark S.; Huang, Yi-Wen; Roa, Juan C.; Goodfellow, Paul J.; Kizer, E. Lynette; Huang, Tim H. M.; Chen, Yidong			CMS: A Web-Based System for Visualization and Analysis of Genome-Wide Methylation Data of Human Cancers	PLOS ONE			English	Article							DNA METHYLATION; BREAST-CANCER; GENE-EXPRESSION; HIGH-THROUGHPUT; CELLS; HOXB2; METHYLOME; PATTERNS; GROWTH	Background: DNA methylation of promoter CpG islands is associated with gene suppression, and its unique genome-wide profiles have been linked to tumor progression. Coupled with high-throughput sequencing technologies, it can now efficiently determine genome-wide methylation profiles in cancer cells. Also, experimental and computational technologies make it possible to find the functional relationship between cancer-specific methylation patterns and their clinicopathological parameters. Methodology/Principal Findings: Cancer methylome system (CMS) is a web-based database application designed for the visualization, comparison and statistical analysis of human cancer-specific DNA methylation. Methylation intensities were obtained from MBDCap-sequencing, pre-processed and stored in the database. 191 patient samples (169 tumor and 22 normal specimen) and 41 breast cancer cell-lines are deposited in the database, comprising about 6.6 billion uniquely mapped sequence reads. This provides comprehensive and genome-wide epigenetic portraits of human breast cancer and endometrial cancer to date. Two views are proposed for users to better understand methylation structure at the genomic level or systemic methylation alteration at the gene level. In addition, a variety of annotation tracks are provided to cover genomic information. CMS includes important analytic functions for interpretation of methylation data, such as the detection of differentially methylated regions, statistical calculation of global methylation intensities, multiple gene sets of biologically significant categories, interactivity with UCSC via custom-track data. We also present examples of discoveries utilizing the framework. Conclusions/Significance: CMS provides visualization and analytic functions for cancer methylome datasets. A comprehensive collection of datasets, a variety of embedded analytic functions and extensive applications with biological and translational significance make this system powerful and unique in cancer methylation research. CMS is freely accessible at: http://cbbiweb.uthscsa.edu/KMethylomes/.	[Gu, Fei; Huang, Tim H. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA; [Doderer, Mark S.; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Huang, Yi-Wen] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Roa, Juan C.] Univ La Frontera, Dept Pathol, Temuco, Fono, Chile; [Goodfellow, Paul J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Goodfellow, Paul J.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Goodfellow, Paul J.] Siteman Canc Ctr, St Louis, MO USA; [Kizer, E. Lynette; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Gu, Fei; Huang, Tim H. M.; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin; Universidad de La Frontera; University of Texas System; University of Texas Health San Antonio; Washington University (WUSTL); Siteman Cancer Center; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Huang, THM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA.	huangt3@uthscsa.edu; cheny8@uthscsa.edu	Roa, Juan C./K-4749-2014; Doderer, Mark/D-5835-2017	Roa, Juan C./0000-0001-8313-8774; Doderer, Mark/0000-0003-4386-4602	Integrative Cancer Biology Program [R01 CA069065, U54 CA113001]; Cancer Center Support Grant [P30 CA054174]; U.S. National Institutes of Health, Texas [NCATS 8UL1TR000149 (CTSA), CPRIT RP101195-C04]; NATIONAL CANCER INSTITUTE [U54CA113001, P30CA054174, R01CA069065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017594] Funding Source: NIH RePORTER	Integrative Cancer Biology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; U.S. National Institutes of Health, Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01 CA069065, U54 CA113001 (Integrative Cancer Biology Program), P30 CA054174 (Cancer Center Support Grant), NCATS 8UL1TR000149 (CTSA) of the U.S. National Institutes of Health, Texas CPRIT RP101195-C04, and by generous gifts from the Cancer Therapy and Research Center Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2005, MOL CANCER THER, V4, P151; Boimel PJ, 2011, GENOMICS, V98, P164, DOI 10.1016/j.ygeno.2011.05.011; Doderer Mark S, 2011, BMC Res Notes, V4, P182, DOI 10.1186/1756-0500-4-182; Flagiello D, 1996, FEBS LETT, V380, P103, DOI 10.1016/0014-5793(96)00017-8; Gao JG, 2002, DNA CELL BIOL, V21, P819, DOI 10.1089/104454902320908469; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Inamura K, 2008, ANTICANCER RES, V28, P2121; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Romero P, 2005, GENOME BIOL, V6; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39	26	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60980	10.1371/journal.pone.0060980	http://dx.doi.org/10.1371/journal.pone.0060980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630576	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500011
J	Wikner, C; Gigante, B; Hellenius, ML; de Faire, U; Leander, K				Wikner, Cecilia; Gigante, Bruna; Hellenius, Mai-Lis; de Faire, Ulf; Leander, Karin			The Risk of Type 2 Diabetes in Men Is Synergistically Affected by Parental History of Diabetes and Overweight	PLOS ONE			English	Article							FAMILY-HISTORY; LIFE-STYLE; CARDIOVASCULAR-DISEASE; SEX-DIFFERENCES; MELLITUS; ASSOCIATION; POPULATION; PREVALENCE; IMPACT; RATIO	Interactions between genetic-and lifestyle factors may be of specific importance for the development of type 2 diabetes. Only a few earlier studies have evaluated interaction effects for the combination of family history of diabetes and presence of risk factors related to lifestyle. We explored whether 60-year-old men and women from Stockholm with a parental history of diabetes are more susceptible than their counterparts without a parental history of diabetes to the negative influence from physical inactivity, overweight or smoking regarding risk of developing type 2 diabetes. The study comprised 4232 participants of which 205 men and 113 women had diabetes (the vast majority type 2 diabetes considering the age of study participants) and 224 men and 115 women had prediabetes (fasting glucose 6.1-6.9 mmol/l). Prevalence odds ratios (OR) with 95% confidence intervals (95% CI) were calculated using logistic regression. Biologic interaction was analyzed using a Synergy index (S) score. The crude OR for type 2 diabetes associated with a parental history of diabetes was 2.4 (95% CI 1.7-3.5) in men and 1.4 (95% CI 0.9-2.3) in women. Adjustments for overweight, physical inactivity and current smoking had minimal effects on the association observed in men whereas in women it attenuated results. In men, but not in women, a significant interaction effect that synergistically increases the risk of developing type 2 diabetes was observed for the combination of BMI>30 and a parental history of diabetes, S 2.4 (95% CI 1.1-5.1). No signs of interactions were noted for a parental history of diabetes combined with physical inactivity and smoking, respectively. In conclusion, obesity in combination with presence of a parental history of diabetes may be particularly hazardous in men as these two factors were observed to synergistically increase the risk of developing type 2 diabetes in men.	[Wikner, Cecilia; Gigante, Bruna; de Faire, Ulf; Leander, Karin] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Gigante, Bruna; de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Hellenius, Mai-Lis] Karolinska Inst, Inst Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Leander, K (corresponding author), Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	Karin.Leander@ki.se	Leander, Karin/C-7261-2017; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Gigante, Bruna/0000-0003-4508-7990	Swedish Heart and Lung Foundation [20100313]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The Swedish Heart and Lung Foundation supported the work, grant number 20100313. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2011, J INTERN MED, V270, P388, DOI 10.1111/j.1365-2796.2011.02347.x; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Chen Y, 2010, PUBLIC HEALTH NUTR, V13, P461, DOI 10.1017/S1368980009991285; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Grarup N, 2007, CURR OPIN CLIN NUTR, V10, P420, DOI 10.1097/MCO.0b013e3281e2c9ab; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hemminki K, 2010, DIABETES CARE, V33, P293, DOI 10.2337/dc09-0947; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Joseph J, 2010, SCAND J PUBLIC HEALT, V38, P768, DOI 10.1177/1403494810380299; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; KHOURY MJ, 1995, EPIDEMIOLOGY, V6, P511, DOI 10.1097/00001648-199509000-00009; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Natali A, 2010, J CLIN ENDOCR METAB, V95, P4703, DOI 10.1210/jc.2009-2721; Povel CM, 2010, INT J OBESITY, V34, P840, DOI 10.1038/ijo.2009.302; Reichenheim ME, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-66; Ringborg A, 2008, DIABETIC MED, V25, P1178, DOI 10.1111/j.1464-5491.2008.02541.x; Riserus U, 2010, J OBES, V2010, DOI 10.1155/2010/757939; Rothman KJ, 2012, EPIDEMIOLOGY INTRO, V2nd, P198; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008	35	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61763	10.1371/journal.pone.0061763	http://dx.doi.org/10.1371/journal.pone.0061763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630613	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500066
J	Carbone, M; Gavagnin, M; Haber, M; Guo, YW; Fontana, A; Manzo, E; Genta-Jouve, G; Tsoukatou, M; Rudman, WB; Cimino, G; Ghiselin, MT; Mollo, E				Carbone, Marianna; Gavagnin, Margherita; Haber, Markus; Guo, Yue-Wei; Fontana, Angelo; Manzo, Emiliano; Genta-Jouve, Gregory; Tsoukatou, Maria; Rudman, William B.; Cimino, Guido; Ghiselin, Michael T.; Mollo, Ernesto			Packaging and Delivery of Chemical Weapons: A Defensive Trojan Horse Stratagem in Chromodorid Nudibranchs	PLOS ONE			English	Article							DERMAL FORMATIONS MDFS; INDO-WEST PACIFIC; DORID NUDIBRANCHS; OPISTHOBRANCHIA; MOLLUSCA; METABOLITES; DITERPENES; GASTROPODA; HISTOLOGY; ECOLOGY	Background: Storage of secondary metabolites with a putative defensive role occurs in the so-called mantle dermal formations (MDFs) that are located in the more exposed parts of the body of most and very likely all members of an entire family of marine mollusks, the chromodorid nudibranchs (Gastropoda: Opisthobranchia). Given that these structures usually lack a duct system, the mechanism for exudation of their contents remains unclear, as does their adaptive significance. One possible explanation could be that they are adapted so as to be preferentially attacked by predators. The nudibranchs might offer packages containing highly repugnant chemicals along with parts of their bodies to the predators, as a defensive variant of the strategic theme of the Trojan horse. Methodology and Principal Findings: We detected, by quantitative H-1-NMR, extremely high local concentrations of secondary metabolites in the MDFs of six species belonging to five chromodorid genera. The compounds were purified by chromatographic methods and subsequently evaluated for their feeding deterrent properties, obtaining dose-response curves. We found that only distasteful compounds are accumulated in the reservoirs at concentrations that far exceed the values corresponding to maximum deterrent activity in the feeding assays. Other basic evidence, both field and experimental, has been acquired to elucidate the kind of damage that the predators can produce on both the nudibranchs' mantles and the MDFs. Significance: As a result of a long evolutionary process that has progressively led to the accumulation of defensive chemical weapons in localized anatomical structures, the extant chromodorid nudibranchs remain in place when molested, retracting respiratory and chemosensory organs, but offering readily accessible parts of their body to predators. When these parts are masticated or wounded by predators, breakage of the MDFs results in the release of distasteful compounds at extremely high concentration in a way that maximizes their repugnant impact.	[Carbone, Marianna; Gavagnin, Margherita; Fontana, Angelo; Manzo, Emiliano; Cimino, Guido; Mollo, Ernesto] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Haber, Markus] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Guo, Yue-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Genta-Jouve, Gregory] Univ Nice Sophia Antipolis, Inst Chim Nice, Nice, France; [Tsoukatou, Maria] Univ Athens, Dept Pharmacognosy, Athens, Greece; [Rudman, William B.] Australian Museum, Malacol Dept, Sydney, NSW 2000, Australia; [Ghiselin, Michael T.] Calif Acad Sci, Dept Invertebrate Zool, San Francisco, CA 94118 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Tel Aviv University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; UDICE-French Research Universities; Universite Cote d'Azur; National & Kapodistrian University of Athens; Australian Museum; California Academy of Sciences	Mollo, E (corresponding author), CNR, Ist Chim Biomol, Pozzuoli, Italy.	emollo@icb.cnr.it	Fontana, Angelo/C-3354-2012; Fontana, Angelo/AAO-2741-2021; Mollo, Ernesto/F-7842-2013; Haber, Markus/AAG-5640-2020; Gavagnin, Margherita/B-4584-2012; Genta-Jouve, Gregory/I-7680-2012; Genta-Jouve, Gregory/E-9896-2014	Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Mollo, Ernesto/0000-0001-7379-1788; Haber, Markus/0000-0003-2591-6210; Gavagnin, Margherita/0000-0002-9532-4555; CARBONE, MARIANNA/0000-0003-3729-5714; manzo, emiliano/0000-0002-7394-020X; Genta-Jouve, Gregory/0000-0002-9239-4371	CNR-CAS; PRIN; CNR; Chinese National Marine "863" project [2013AA092902]; Natural Science Fundation of China [21021063, 81273430, 21072204]	CNR-CAS(Consiglio Nazionale delle Ricerche (CNR)Chinese Academy of Sciences); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CNR(Consiglio Nazionale delle Ricerche (CNR)); Chinese National Marine "863" project; Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the CNR-CAS bilateral project "Chemical studies on bioactive molecules with biotechnological interest from Chinese marine invertebrates", the PRIN-MIUR 2009 project "Natural products and bioinspired molecules interfering with biological targets involved in control of tumor growth", the CNR Flagship Project "RITMARE - La Ricerca Italiana per il Mare", and grants provided by Chinese National Marine "863" project (No. 2013AA092902) and Natural Science Fundation of China (Nos. 21021063, 81273430, 21072204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila C, 1996, VELIGER, V39, P148; AVILA C, 1991, J CHEM ECOL, V17, P625, DOI 10.1007/BF00982131; Avila C, 1997, MAR ECOL PROG SER, V150, P171, DOI 10.3354/meps150171; CIMINO G, 1993, EXPERIENTIA, V49, P582, DOI 10.1007/BF01955168; Cimino G, 2001, CRC MAR SCI, P115; Cimino G, 1999, CHEMOECOLOGY, V9, P187, DOI 10.1007/s000490050052; Cimino Guido, 2009, Proceedings of the California Academy of Sciences, V60, P175; Edmunds M., 1966, Journal of the Linnean Society Zoology, V46, P27; FAULKNER DJ, 1983, MAR ECOL PROG SER, V13, P295, DOI 10.3354/meps013295; FONTANA A, 1994, EXPERIENTIA, V50, P510, DOI 10.1007/BF01920760; Fontana A, 1996, J NAT PROD, V59, P869, DOI 10.1021/np9600964; FONTANA A, 1993, J CHEM ECOL, V19, P339, DOI 10.1007/BF00993700; Fontana A, 1997, J NAT PROD, V60, P444, DOI 10.1021/np960690d; Fontana A, 1999, J NAT PROD, V62, P1367, DOI 10.1021/np9900932; GARCIAGOMEZ JC, 1991, MALACOLOGIA, V32, P233; GARCIAGOMEZ JC, 1990, MAR BIOL, V106, P245, DOI 10.1007/BF01314807; Gosliner Terrence M., 2001, Bollettino Malacologico, V37, P163; Gosliner TM, 1999, ZOOL J LINN SOC-LOND, V125, P1; GUELLA G, 1985, HELV CHIM ACTA, V68, P1276, DOI 10.1002/hlca.19850680523; Haber M, 2010, BIOL BULL-US, V218, P181, DOI 10.1086/BBLv218n2p181; Johnson PM, 2006, J EXP BIOL, V209, P78, DOI 10.1242/jeb.01972; KAZLAUSKAS R, 1979, AUST J CHEM, V32, P867, DOI 10.1071/CH9790867; MEINWALD J, 1995, P NATL ACAD SCI USA, V92, P14, DOI 10.1073/pnas.92.1.14; Meinwald J, 2008, P NATL ACAD SCI USA, V105, P4539, DOI 10.1073/pnas.0800649105; Mollo E, 2005, CHEMOECOLOGY, V15, P31, DOI 10.1007/s00049-005-0289-5; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Rudman WB, 2007, MOLLUSCAN RES, V27, P60; RUDMAN WB, 1984, ZOOL J LINN SOC-LOND, V81, P115, DOI 10.1111/j.1096-3642.1984.tb01174.x; RUDMAN WB, 1988, ZOOL J LINN SOC-LOND, V93, P133, DOI 10.1111/j.1096-3642.1988.tb01531.x; RUDMAN WB, 1991, J MOLLUS STUD, V57, P5, DOI 10.1093/mollus/57.Supplement_Part_4.5; SCHMITZ FJ, 1985, J ORG CHEM, V50, P2862, DOI 10.1021/jo00216a010; SCHULTE G, 1980, HELV CHIM ACTA, V63, P2159, DOI 10.1002/hlca.19800630805; SCHULTE GR, 1982, TETRAHEDRON, V38, P1857, DOI 10.1016/0040-4020(82)80034-3; Somerville MJ, 2006, J NAT PROD, V69, P1086, DOI 10.1021/np060002i; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Waddell WJ, 2010, J TOXICOL SCI, V35, P1, DOI 10.2131/jts.35.1; Wagele H, 2006, OCEANOGR MAR BIOL, V44, P197; Wagele H, 2004, ORG DIVERS EVOL, V4, P175, DOI 10.1016/j.ode.2004.03.002; Wagele H, 2005, FRONT ZOOL, V2, P1, DOI DOI 10.1186/1742-9994-2-3; Yong KWL, 2008, TETRAHEDRON, V64, P6733, DOI 10.1016/j.tet.2008.05.008	40	35	35	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62075	10.1371/journal.pone.0062075	http://dx.doi.org/10.1371/journal.pone.0062075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620804	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500084
J	Carlo-Stella, C; Locatelli, SL; Giacomini, A; Cleris, L; Saba, E; Righi, M; Guidetti, A; Gianni, AM				Carlo-Stella, Carmelo; Locatelli, Silvia L.; Giacomini, Arianna; Cleris, Loredana; Saba, Elena; Righi, Marco; Guidetti, Anna; Gianni, Alessandro M.			Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR INHIBITOR; MULTIKINASE INHIBITOR; DOWN-REGULATION; RAF/MEK/ERK PATHWAY; MICROVESSEL DENSITY; ANTITUMOR-ACTIVITY; HODGKIN-LYMPHOMA; RAF KINASE; PHASE-II	The anti-lymphoma activity and mechanism(s) of action of the multikinase inhibitor sorafenib were investigated using a panel of lymphoma cell lines, including SU-DHL-4V, Granta-519, HD-MyZ, and KMS-11 cell lines. In vitro, sorafenib significantly decreased cell proliferation and phosphorylation levels of MAPK and PI3K/Akt pathways while increased apoptotic cell death. In vivo, sorafenib treatment resulted in a cytostatic rather than cytotoxic effect on tumor cell growth associated with a limited inhibition of tumor volumes. However, sorafenib induced an average 50% reduction of tumor vessel density and a 2-fold increase of necrotic areas. Upon sorafenib treatment, endothelial and tumor cells from SU-DHL-4V, Granta-519, and KMS-11 nodules showed a potent inhibition of either phospho-ERK or phospho-AKT, whereas a concomitant inhibition of phospho-ERK and phospho-AKT was only observed in HD-MyZ nodules. In conclusion, sorafenib affects the growth of lymphoid cell lines by triggering antiangiogenic mechanism(s) and directly targeting tumor cells.	[Carlo-Stella, Carmelo; Locatelli, Silvia L.; Giacomini, Arianna] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Dept Hematol & Oncol, Milan, Italy; [Carlo-Stella, Carmelo; Locatelli, Silvia L.; Giacomini, Arianna; Saba, Elena] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Cleris, Loredana; Guidetti, Anna; Gianni, Alessandro M.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Righi, Marco] CNR, Inst Neurosci, Milan, Italy; [Guidetti, Anna; Gianni, Alessandro M.] Univ Milan, Dept Med Physiopathol & Transplants, Milan, Italy	University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Carlo-Stella, C (corresponding author), Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Dept Hematol & Oncol, Milan, Italy.	carmelo.carlostella@unimi.it	Locatelli, Silvia Laura/D-7293-2018; Righi, Marco Giovanni Enea/G-5171-2011; Locatelli, Silvia Laura/ABH-9461-2020; Giacomini, Arianna/K-4437-2016; Guidetti, Anna/E-6676-2017; Righi, Marco Giovanni Enea/M-9003-2019; Righi, Marco/P-4332-2019; Saba, Elena/ABH-9313-2020; Cleris, Loredana/T-3144-2018; Giacomini, Arianna/U-6854-2019; Carlo-Stella, Carmelo/B-3805-2010	Locatelli, Silvia Laura/0000-0001-7948-0788; Righi, Marco Giovanni Enea/0000-0003-1181-0327; Locatelli, Silvia Laura/0000-0001-7948-0788; Giacomini, Arianna/0000-0002-9984-9033; Guidetti, Anna/0000-0002-4195-6397; Righi, Marco Giovanni Enea/0000-0003-1181-0327; Saba, Elena/0000-0002-8217-5968; Cleris, Loredana/0000-0001-8778-7931; Carlo-Stella, Carmelo/0000-0003-3144-0124	Ministry of Education, University and Research (Rome, Italy); Ministry of Health; Italian Association for Cancer Research [MCO - 9998]	Ministry of Education, University and Research (Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The work was supported in part by grants from the Ministry of Education, University and Research (Rome, Italy), the Ministry of Health (Ricerca Finalizzata 2008 and 2010 to C.C.-S.), and the Italian Association for Cancer Research (MCO - 9998 to A. M. G. and C.C.-S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bottos A, 2012, P NATL ACAD SCI USA, V109, pE353, DOI 10.1073/pnas.1105026109; Carlo-Stella C, 2006, CANCER RES, V66, P1799, DOI 10.1158/0008-5472.CAN-05-1200; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chapuy B, 2011, BRIT J HAEMATOL, V152, P401, DOI 10.1111/j.1365-2141.2010.08526.x; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ganjoo KN, 2008, J CANCER RES CLIN, V134, P381, DOI 10.1007/s00432-007-0294-x; Grant S, 2008, J CLIN INVEST, P4; Gratzinger D, 2008, LAB INVEST, V88, P38, DOI 10.1038/labinvest.3700697; Gratzinger D, 2007, AM J PATHOL, V170, P1362, DOI 10.2353/ajpath.2007.060901; Guidetti A, 2012, BRIT J HAEMATOL, V158, P108, DOI 10.1111/j.1365-2141.2012.09139.x; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; Hu SY, 2011, J NATL CANCER I, V103, P893, DOI 10.1093/jnci/djr107; Huber S, 2011, LEUKEMIA, V25, P838, DOI 10.1038/leu.2011.2; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Lavazza C, 2010, BLOOD, V115, P2231, DOI 10.1182/blood-2009-08-239632; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Nguyen T. B., 2010, ADV NAT SCI-NANOSCI, V1, P1; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Ramakrishnan V, 2012, AM J HEMATOL, V87, P277, DOI 10.1002/ajh.22263; Righi M, 2009, LAB INVEST, V89, P1063, DOI 10.1038/labinvest.2009.76; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Ullrich K, 2011, BRIT J HAEMATOL, V155, P398, DOI 10.1111/j.1365-2141.2011.08685.x; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328	41	33	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61603	10.1371/journal.pone.0061603	http://dx.doi.org/10.1371/journal.pone.0061603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620775	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500055
J	Fushiki, A; Kohsaka, H; Nose, A				Fushiki, Akira; Kohsaka, Hiroshi; Nose, Akinao			Role of Sensory Experience in Functional Development of Drosophila Motor Circuits	PLOS ONE			English	Article							TARGETED EXPRESSION; CENTRAL PROJECTIONS; NEURONS; LOCOMOTION; PLASTICITY; BEHAVIOR; LARVAL; COORDINATION; CHANNEL; EMBRYO	Neuronal circuits are formed according to a genetically predetermined program and then reconstructed in an experience-dependent manner. While the existence of experience-dependent plasticity has been demonstrated for the visual and other sensory systems, it remains unknown whether this is also the case for motor systems. Here we examined the effects of eliminating sensory inputs on the development of peristaltic movements in Drosophila embryos and larvae. The peristalsis is initially slow and uncoordinated, but gradually develops into a mature pattern during late embryonic stages. We tested whether inhibiting the transmission of specific sensory neurons during this period would have lasting effects on the properties of the sensorimotor circuits. We applied Shibire-mediated inhibition for six hours during embryonic development (15-21 h after egg laying [AEL]) and studied its effects on peristalsis in the mature second-and third-instar larvae. We found that inhibition of chordotonal organs, but not multidendritic neurons, led to a lasting decrease in the speed of larval locomotion. To narrow down the sensitive period, we applied shorter inhibition at various embryonic and larval stages and found that two-hour inhibition during 16-20 h AEL, but not at earlier or later stages, was sufficient to cause the effect. These results suggest that neural activity mediated by specific sensory neurons is involved in the maturation of sensorimotor circuits in Drosophila and that there is a critical period for this plastic change. Consistent with a role of chordotonal neurons in sensory feedback, these neurons were activated during larval peristalsis and acute inhibition of their activity decreased the speed of larval locomotion.	[Fushiki, Akira; Kohsaka, Hiroshi; Nose, Akinao] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan; [Nose, Akinao] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Nose, A (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan.	nose@k.u-tokyo.ac.jp	Kohsaka, Hiroshi/AAT-4177-2021	Kohsaka, Hiroshi/0000-0003-1087-9680; Fushiki, Akira/0000-0002-7987-6405	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22115002]; Japan Society for the Promotion of Science (JSPS) [23300114, 21700344]; Global COE Program "the Physical Sciences Frontier"; Grants-in-Aid for Scientific Research [24700395] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program "the Physical Sciences Frontier"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (No. 22115002) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp/), and for Scientific Research (B) (No. 23300114) of Japan Society for the Promotion of Science (JSPS), to A.N. and Grant-in-Aid for Young Scientists (B) (No. 21700344) of Japan Society for the Promotion of Science (JSPS) to H.K (http://www.jsps.go.jp/) and Global COE Program "the Physical Sciences Frontier" to A.F (http://www.phys.s.u-tokyo.ac.jp/gcoe/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Crisp SJ, 2011, J NEUROSCI, V31, P10445, DOI 10.1523/JNEUROSCI.0346-11.2011; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kohsaka H, 2012, DEV GROWTH DIFFER, V54, P408, DOI 10.1111/j.1440-169X.2012.01347.x; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; MERRITT DJ, 1995, J NEUROSCI, V15, P1755, DOI 10.1523/JNEUROSCI.15-03-01755.1995; ODELL K, 1988, HEREDITY, V61, P199, DOI 10.1038/hdy.1988.106; Pereanu W, 2007, DEV NEUROBIOL, V67, P1669, DOI 10.1002/dneu.20538; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Schrader S, 2000, J COMP NEUROL, V425, P34; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Yuan Q, 2011, SCIENCE, V333, P1458, DOI 10.1126/science.1207121	32	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62199	10.1371/journal.pone.0062199	http://dx.doi.org/10.1371/journal.pone.0062199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620812	Green Published, gold			2022-12-25	WOS:000317909500092
J	Velcheti, V; Schalper, K; Yao, XP; Cheng, H; Kocoglu, M; Dhodapkar, K; Deng, YH; Gettinger, S; Rimm, DL				Velcheti, Vamsidhar; Schalper, Kurt; Yao, Xiaopan; Cheng, Huan; Kocoglu, Mehmet; Dhodapkar, Kavita; Deng, Yanhong; Gettinger, Scott; Rimm, David L.			High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas	PLOS ONE			English	Article							PROTEIN EXPRESSION; BREAST-CARCINOMA; CANCER; DIFFERENTIATION; AMPLIFICATION; ONCOGENE	Background: SOX2 is an embryonic developmental transcription factor, which is important in the development of the respiratory tract. SOX2 overexpression is associated with aggressive disease in several tumor types. However, SOX2 overexpression and gene amplification associates with favorable outcome in lung squamous cell carcinomas (SCC) and dissimilar results have been reported in lung adenocarcinomas (ADC). The aim of the present study was to evaluate SOX2 expression in NSCLC and determine the relationship with clinico-pathological variables and outcome. Methods: SOX2 protein levels were measured in tissue microarrays (TMAs) containing FFPE samples from two independent lung cancer cohorts (n = 340 & 307) using automated quantitative immunofluorescence (QIF). Assay validation was performed using FFPE preparations of cell lines with known SOX2 expression. Associations of SOX2 levels with main clinicopathological characteristics and with overall survival were studied using uni-and multivariate analysis. Results: SOX2 levels were higher in patients with SCC than in ADC in both cohorts (p value<0.0001). In the training cohort, NSCLC patients whose tumors showed high SOX2 (n = 245) had longer survival than those with low SOX2 levels (log rank p = 0.0002). Comparable results were observed in the second independent validation cohort, log rank p = 0.0113. SOX2 positive cases showed a 58% reduction in risk of death in Cox univariate analysis (hazards ratio-HR = 0.42 confidence interval-CI (0.36,0.73), p = 0.0002). SOX2 was associated with significantly longer survival independent of histology in multivariate analysis (hazards ratio-HR = 0.429 confidence interval-CI (0.295, 0.663), p = <0.001). Conclusions: SOX2 is an independent positive prognostic marker in NSCLC. Increased SOX2 levels are more frequent in SCC than in ADC, but the association with better survival is independent from the histological subtype.	[Velcheti, Vamsidhar; Kocoglu, Mehmet; Dhodapkar, Kavita; Gettinger, Scott] Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT 06520 USA; [Schalper, Kurt; Cheng, Huan; Rimm, David L.] Yale Univ, Dept Pathol, New Haven, CT USA; [Yao, Xiaopan; Deng, Yanhong] Yale Ctr Appl Biostat, New Haven, CT USA	Yale University; Yale University	Velcheti, V (corresponding author), Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT 06520 USA.	vamsidhar.velcheti@yale.edu		Rimm, David/0000-0001-5820-4397				Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Ge N, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-94; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Huang PZ, 2011, CLIN BIOCHEM, V44, P582, DOI 10.1016/j.clinbiochem.2011.02.012; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Long KB, 2009, HUM PATHOL, V40, P1768, DOI 10.1016/j.humpath.2009.06.006; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518; Saigusa S, 2011, ONCOL REP, V26, P1069, DOI 10.3892/or.2011.1408; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Tolles J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2882; Wang X, 2012, CANCER INVEST, V30, P79, DOI 10.3109/07357907.2011.630049; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhang X, 2010, J GASTROINTEST SURG, V14, P1220, DOI 10.1007/s11605-010-1246-3	25	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61427	10.1371/journal.pone.0061427	http://dx.doi.org/10.1371/journal.pone.0061427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620753	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500033
J	Shao, YF; Zhao, P; Dong, CY; Li, J; Kong, XP; Wang, HL; Dai, LR; Hou, YP				Shao, Yu-Feng; Zhao, Peng; Dong, Chao-Yu; Li, Jing; Kong, Xiang-Pan; Wang, Hai-Liang; Dai, Li-Rong; Hou, Yi-Ping			Neuropeptide S Facilitates Mice Olfactory Function through Activation of Cognate Receptor-Expressing Neurons in the Olfactory Cortex	PLOS ONE			English	Article							FOOD-INTAKE; C-FOS; POTENT; LOCUS; IDENTIFICATION; ORGANIZATION; ANTAGONIST; RESPONSES; SYSTEM; MEMORY	Neuropeptide S (NPS) is a newly identified neuromodulator located in the brainstem and regulates various biological functions by selectively activating the NPS receptors (NPSR). High level expression of NPSR mRNA in the olfactory cortex suggests that NPS-NPSR system might be involved in the regulation of olfactory function. The present study was undertaken to investigate the effects of intracerebroventricular (i.c.v.) injection of NPS or co-injection of NPSR antagonist on the olfactory behaviors, food intake, and c-Fos expression in olfactory cortex in mice. In addition, dual-immunofluorescence was employed to identify NPS-induced Fos immunereactive (-ir) neurons that also bear NPSR. NPS (0.1-1 nmol) i.c.v. injection significantly reduced the latency to find the buried food, and increased olfactory differentiation of different odors and the total sniffing time spent in olfactory habituation/dishabituation tasks. NPS facilitated olfactory ability most at the dose of 0.5 nmol, which could be blocked by co-injection of 40 nmol NPSR antagonist [D-Val(5)]NPS. NPS administration dose-dependently inhibited food intake in fasted mice. Ex-vivo c-Fos and NPSR immunohistochemistry in the olfactory cortex revealed that, as compared with vehicle-treated mice, NPS markedly enhanced c-Fos expression in the anterior olfactory nucleus (AON), piriform cortex (Pir), ventral tenia tecta (VTT), the anterior cortical amygdaloid nucleus (ACo) and lateral entorhinal cortex (LEnt). The percentage of Fos-ir neurons that also express NPSR were 88.5% and 98.1% in the AON and Pir, respectively. The present findings demonstrated that NPS, via selective activation of the neurons bearing NPSR in the olfactory cortex, facilitates olfactory function in mice.	[Hou, Yi-Ping] Lanzhou Univ, Sch Basic Med Sci, Dept Neurosci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China; Lanzhou Univ, Sch Basic Med Sci, Dept Anat, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China; Lanzhou Univ, Sch Basic Med Sci, Dept Histol, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China; Lanzhou Univ, Sch Basic Med Sci, Dept Embryol, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Hou, YP (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Dept Neurosci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China.	houyiping@lzu.edu.cn	Shao, Yu-Feng/AAF-4899-2020; Yiping, Hou/AFZ-1966-2022	Shao, Yu-Feng/0000-0002-7854-2884; 	National Natural Science Foundation of China [81171254, 81071076, 30670677]; Ministry of Science and Technology of China [2009ZX09503-017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The work was supported by grants from National Natural Science Foundation of China (Nos. 81171254, 81071076 and 30670677), and by grant from the Key National S&T Program "Major New Drug Development" of the Ministry of Science and Technology of China (2009ZX09503-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; Bouret S, 2002, EUR J NEUROSCI, V16, P2371, DOI 10.1046/j.1460-9568.2002.02413.x; Chang M, 2005, REGUL PEPTIDES, V130, P116, DOI 10.1016/j.regpep.2005.04.005; Clark SD, 2011, J COMP NEUROL, V519, P1867, DOI 10.1002/cne.22606; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Duangdao DM, 2009, BEHAV BRAIN RES, V205, P1, DOI 10.1016/j.bbr.2009.07.024; Enquist J, 2012, NEUROPSYCHOPHARMACOL, V37, P2436, DOI 10.1038/npp.2012.102; Fedeli A, 2009, EUR J NEUROSCI, V30, P1594, DOI 10.1111/j.1460-9568.2009.06948.x; Filaferro M, 2013, PEPTIDES, V39, P16, DOI 10.1016/j.peptides.2012.10.013; Guerrini R, 2009, J MED CHEM, V52, P524, DOI 10.1021/jm8012294; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Han RW, 2009, NEUROSCI LETT, V455, P74, DOI 10.1016/j.neulet.2009.03.023; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Jiang MR, 1996, J NEUROSCI, V16, P6319; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kallupi M, 2010, P NATL ACAD SCI USA, V107, P19567, DOI 10.1073/pnas.1004100107; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Leinwand SG, 2011, CURR OPIN GENET DEV, V21, P806, DOI 10.1016/j.gde.2011.07.006; Leonard SK, 2011, NEUROSCIENCE, V172, P153, DOI 10.1016/j.neuroscience.2010.10.020; Li W, 2009, REGUL PEPTIDES, V156, P90, DOI 10.1016/j.regpep.2009.03.013; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng YL, 2010, PEPTIDES, V31, P1878, DOI 10.1016/j.peptides.2010.06.027; Ruzza C, 2012, PEPTIDES, V34, P404, DOI 10.1016/j.peptides.2012.01.024; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Seelke AMH, 2004, BEHAV NEUROSCI, V118, P267, DOI 10.1037/0735-7044.118.2.267; Shipley MT, 1996, J NEUROBIOL, V30, P123; Smith JJ, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/754014; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010; Woodley SK, 2003, HORM BEHAV, V44, P110, DOI 10.1016/S0018-506X(03)00126-0; Wrenn CC, 2004, EUR J NEUROSCI, V19, P1384, DOI 10.1111/j.1460-9568.2004.03214.x; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022	45	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62089	10.1371/journal.pone.0062089	http://dx.doi.org/10.1371/journal.pone.0062089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614017	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400152
J	Fonvielle, M; Le Du, MH; Lequin, O; Lecoq, A; Jacquet, M; Thai, R; Dubois, S; Grach, G; Gondry, M; Belin, P				Fonvielle, Matthieu; Le Du, Marie-Helene; Lequin, Olivier; Lecoq, Alain; Jacquet, Mickael; Thai, Robert; Dubois, Steven; Grach, Guillaume; Gondry, Muriel; Belin, Pascal			Substrate and Reaction Specificity of Mycobacterium tuberculosis Cytochrome P450 CYP121 INSIGHTS FROM BIOCHEMICAL STUDIES AND CRYSTAL STRUCTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN; HYDROXYLATION; TRYPTOPHAN; BENZENE; PHENOL; IDENTIFICATION; METABOLISM; MECHANISM; P450; DIKETOPIPERAZINES	Cytochrome P450 CYP121 is essential for the viability of Mycobacterium tuberculosis. Studies in vitro show that it can use the cyclodipeptide cyclo(L-Tyr-L-Tyr) (cYY) as a substrate. We report an investigation of the substrate and reaction specificities of CYP121 involving analysis of the interaction between CYP121 and 14cYY analogues with various modifications of the side chains or the diketopiperazine (DKP) ring. Spectral titration experiments show that CYP121 significantly bound only cyclodipeptides with a conserved DKP ring carrying two aryl side chains in L-configuration. CYP121 did not efficiently or selectively transform any of the cYY analogues tested, indicating a high specificity for cYY. The molecular determinants of this specificity were inferred from both crystal structures of CYP121-analog complexes solved at high resolution and solution NMR spectroscopy of the analogues. Bound cYY or its analogues all displayed a similar set of contacts with CYP121 residues Asn(85), Phe(168), and Trp(182). The propensity of the cYY tyrosyl to point toward Arg(386) was dependent on the presence of the DKP ring that limits the conformational freedom of the ligand. The correct positioning of the hydroxyl of this tyrosyl was essential for conversion of cYY. Thus, the specificity of CYP121 results from both a restricted binding specificity and a fine-tuned P450 substrate relationship. These results document the catalytic mechanism of CYP121 and improve our understanding of its function in vivo. This work contributes to progress toward the design of inhibitors of this essential protein of M. tuberculosis that could be used for antituberculosis therapy.	[Dubois, Steven; Grach, Guillaume; Gondry, Muriel; Belin, Pascal] Commissariat Energie Atom & Energies Alternat CEA, iBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Le Du, Marie-Helene] CEA, iBiTec S, Serv Bioenerget Biol Struct & Mecanismes, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Lequin, Olivier] Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, F-75252 Paris 05, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Belin, P (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, iBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.	pascal.belin@cea.fr	Belin, Pascal/C-6247-2009; Fonvielle, Matthieu/G-5644-2015	Belin, Pascal/0000-0002-7578-6365; Fonvielle, Matthieu/0000-0002-8013-8311; LEQUIN, Olivier/0000-0001-5307-3068; Thai, Robert/0000-0001-9438-4225; Gondry, Muriel/0000-0003-0398-3404	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); CNRS; Region Ile-de-France; CEA postdoctoral fellowship; Region Ile-de-France postdoctoral fellowship	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France); CEA postdoctoral fellowship; Region Ile-de-France postdoctoral fellowship(Region Ile-de-France)	This work was supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), CNRS, and grants from the Region Ile-de-France. The Service d'Ingenierie Moleculaire des Proteines is a member of the Laboratory of Excellence LERMIT.; Recipient of a CEA postdoctoral fellowship. Present address: Centre de Recherche des Cordeliers, LRMA, Equipe 12, Universite Pierre et Marie Curie-Paris 6, UMR S 872, Paris, F-75006 France.; Recipient of a Region Ile-de-France postdoctoral fellowship.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Belin P, 2012, NAT PROD REP, V29, P961, DOI 10.1039/c2np20010d; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bogatcheva E, 2006, J MED CHEM, V49, P3045, DOI 10.1021/jm050948+; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Bricogne G, 2009, BUSTER VERSION 2 8 0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; de Visser SP, 2003, J AM CHEM SOC, V125, P7413, DOI 10.1021/ja034142f; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; GROSSWEINER LI, 1984, CURR EYE RES, V3, P137, DOI 10.3109/02713688408997195; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Horton DA, 2000, MOL DIVERS, V5, P289, DOI 10.1023/A:1021365402751; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; JAYSON GG, 1954, BIOCHEM J, V57, P386, DOI 10.1042/bj0570386; Jeedigunta S, 2000, TETRAHEDRON, V56, P3303, DOI 10.1016/S0040-4020(00)00249-0; Jung C., 2007, UBIQUITOUS ROLES CYT, V3, P187, DOI 10.1002/9780470028155.ch7/summary; KELL G, 1990, J FOOD SCI, V55, P1120, DOI 10.1111/j.1365-2621.1990.tb01613.x; KOOP DR, 1989, TOXICOL APPL PHARM, V98, P278, DOI 10.1016/0041-008X(89)90233-0; KOPPLE KD, 1967, J AM CHEM SOC, V89, P6193, DOI 10.1021/ja01000a035; KORZEKWA KR, 1989, BIOCHEMISTRY-US, V28, P9019, DOI 10.1021/bi00449a010; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; MARTINEZ J, 1985, J MED CHEM, V28, P1874, DOI 10.1021/jm00150a020; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P514, DOI 10.1016/0003-9861(92)90605-V; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Mizutani H, 2005, SYNLETT, P328, DOI 10.1055/s-2004-836065; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson David R., 2009, Human Genomics, V4, P59; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Powley MW, 2001, TOXICOL LETT, V125, P117, DOI 10.1016/S0378-4274(01)00441-6; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; SCHLOSSER PM, 1993, CARCINOGENESIS, V14, P2477, DOI 10.1093/carcin/14.12.2477; Schmidt JM, 2007, J BIOMOL NMR, V37, P287, DOI 10.1007/s10858-006-9140-8; Simat TJ, 1998, J AGR FOOD CHEM, V46, P490, DOI 10.1021/jf970818c; Stiborova M, 2003, GEN PHYSIOL BIOPHYS, V22, P167; UCHIDA K, 1990, ARCH BIOCHEM BIOPHYS, V279, P14, DOI 10.1016/0003-9861(90)90456-9; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	51	36	40	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17347	17359		10.1074/jbc.M112.443853	http://dx.doi.org/10.1074/jbc.M112.443853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620594	Green Published, hybrid			2022-12-25	WOS:000320380600028
J	Rehault-Godbert, S; Labas, V; Helloin, E; Herve-Grepinet, V; Slugocki, C; Berges, M; Bourin, MC; Brionne, A; Poirier, JC; Gautron, J; Coste, F; Nys, Y				Rehault-Godbert, Sophie; Labas, Valerie; Helloin, Emmanuelle; Herve-Grepinet, Virginie; Slugocki, Cindy; Berges, Magali; Bourin, Marie-Christine; Brionne, Aurelien; Poirier, Jean-Claude; Gautron, Joel; Coste, Franck; Nys, Yves			Ovalbumin-related Protein X Is a Heparin-binding Ov-Serpin Exhibiting Antimicrobial Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE PROTEOME; HEN EGG; CHICK OVIDUCT; GENE FAMILY; COFACTOR-II; IDENTIFICATION; INHIBITION; EVOLUTION; SEQUENCE; PEPTIDE	Ovalbumin family contains three proteins with high sequence similarity: ovalbumin, ovalbumin-related protein Y (OVAY), and ovalbumin-related protein X (OVAX). Ovalbumin is the major egg white protein with still undefined function, whereas the biological activity of OVAX and OVAY has not yet been explored. Similar to ovalbumin and OVAY, OVAX belongs to the ovalbumin serine protease inhibitor family (ov-serpin). We show that OVAX is specifically expressed by the magnum tissue, which is responsible for egg white formation. OVAX is also the main heparin-binding protein of egg white. This glycoprotein with a predicted reactive site at Lys(367)-His(368) is not able to inhibit trypsin, plasmin, or cathepsin G with or without heparin as a cofactor. Secondary structure of OVAX is similar to that of ovalbumin, but the three-dimensional model of OVAX reveals the presence of a cluster of exposed positive charges, which potentially explains the affinity of this ov-serpin for heparin, as opposed to ovalbumin. Interestingly, OVAX, unlike ovalbumin, displays antibacterial activities against both Listeria monocytogenes and Salmonella enterica sv. Enteritidis. These properties partly involve heparin-binding site(s) of the molecule as the presence of heparin reverses its anti-Salmonella but not its anti-Listeria potential. Altogether, these results suggest that OVAX and ovalbumin, although highly similar in sequence, have peculiar sequential and/or structural features that are likely to impact their respective biological functions.	[Rehault-Godbert, Sophie; Berges, Magali; Brionne, Aurelien; Poirier, Jean-Claude; Gautron, Joel; Nys, Yves] INRA, Rech Avicoles Fonct & Regulat Prot CEuF UR83, F-37380 Nouzilly, France; [Labas, Valerie] INRA, Physiol Reprod & Comportements UMR85, Lab Spectrometrie Masse & Sequencage, F-37380 Nouzilly, France; [Helloin, Emmanuelle; Slugocki, Cindy] INRA, ISP311, UMR1282, Ctr Int Ressources Microbiennes Bacteries Pathoge, F-37380 Nouzilly, France; [Herve-Grepinet, Virginie] Ctr Etud Pathol Resp, EA 6305, UMR 1100, INSERM, F-37032 Tours, France; [Bourin, Marie-Christine] Inst Tech Aviculture, Rech Avicoles UR83, F-37380 Nouzilly, France; [Coste, Franck] Ctr Biophys Mol, UPR4301, CNRS, F-45071 Orleans, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Rehault-Godbert, S (corresponding author), INRA, Rech Avicoles Fonct & Regulat Prot CEuF UR83, F-37380 Nouzilly, France.	srehault@tours.inra.fr	GAUTRON, Joël/A-1753-2017; coste, franck/ABC-1407-2020; REHAULT-GODBERT, Sophie/Y-3890-2019; coste, franck/F-6832-2015; BOURIN, Marie/AAV-5212-2021	GAUTRON, Joël/0000-0001-7800-0578; coste, franck/0000-0002-7409-0470; coste, franck/0000-0002-7409-0470; BOURIN, Marie/0000-0002-1222-5325; Rehault-Godbert, Sophie/0000-0003-2800-3417	National French Agency (OVO-mining) [ANR-09-BLAN-0136-01]; European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe,") [FOOD-CT-2006-036018]	National French Agency (OVO-mining); European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe,")	This work was supported by the National French Agency (OVO-mining, ANR-09-BLAN-0136-01) and the European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe," FOOD-CT-2006-036018).	Albrecht MT, 2002, RESPIR RES, V3, DOI 10.1186/rr167; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Baranger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020976; Belleannee C, 2011, PROTEOMICS, V11, P1952, DOI 10.1002/pmic.201000662; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bourin M, 2012, POULTRY SCI, V91, P2288, DOI 10.3382/ps.2011-01910; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COLBERT DA, 1980, BIOCHEMISTRY-US, V19, P5586, DOI 10.1021/bi00565a020; D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y; Fortenberry YM, 2004, J BIOL CHEM, V279, P43237, DOI 10.1074/jbc.M406716200; GREENGARD JS, 1991, THROMB HAEMOSTASIS, V65, P834; HEILIG R, 1982, NUCLEIC ACIDS RES, V10, P4363, DOI 10.1093/nar/10.14.4363; HEILIG R, 1980, CELL, V20, P625, DOI 10.1016/0092-8674(80)90309-8; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Hirose J, 2006, BIOSCI BIOTECH BIOCH, V70, P144, DOI 10.1271/bbb.70.144; Ito K, 2007, J BIOCHEM, V141, P193, DOI 10.1093/jb/mvm021; Kett WC, 2003, BBA-GEN SUBJECTS, V1620, P225, DOI 10.1016/S0304-4165(02)00539-1; KNOLL BJ, 1981, J BIOL CHEM, V256, P7949; LEE YC, 1962, ARCH BIOCHEM BIOPHYS, V97, P9, DOI 10.1016/0003-9861(62)90037-1; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Meyer-Hoffert U, 2008, FASEB J, V22, P2427, DOI 10.1096/fj.07-103440; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Nau F, 2005, J AGR FOOD CHEM, V53, P2158, DOI 10.1021/jf048369l; Nys Y, 2011, WOODHEAD PUBL FOOD S, P83; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; PALMITER RD, 1972, J BIOL CHEM, V247, P6450; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Rehault-Godbert S., 2011, Pat., Patent No. [WO/ 2011/ 151407, 2011151407]; Rehault-Godbert S, 2008, J AGR FOOD CHEM, V56, P6294, DOI 10.1021/jf8003948; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; Sava G, 1996, EXS, V75, P433; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinohara H, 2007, BBA-GEN SUBJECTS, V1770, P5, DOI 10.1016/j.bbagen.2006.06.019; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tian X, 2010, BIOL REPROD, V83, P893, DOI 10.1095/biolreprod.110.085019	44	53	54	8	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17285	17295		10.1074/jbc.M113.469759	http://dx.doi.org/10.1074/jbc.M113.469759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615912	Green Published, hybrid			2022-12-25	WOS:000320380600024
J	Kawada, H; Kaneko, M; Sawanobori, M; Uno, T; Matsuzawa, H; Nakamura, Y; Matsushita, H; Ando, K				Kawada, Hiroshi; Kaneko, Mitsuyo; Sawanobori, Masakazu; Uno, Tomoko; Matsuzawa, Hideyuki; Nakamura, Yoshihiko; Matsushita, Hiromichi; Ando, Kiyoshi			High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1 alpha Transcription	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE MYELOID-LEUKEMIA; DOSE VITAMIN-C; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TERMINAL HUMAN CANCER; HYDROGEN-PEROXIDE; TUMOR-GROWTH; SUPPLEMENTAL ASCORBATE; DEHYDROASCORBIC ACID	We examined the antileukemic effects of high concentrations of L-ascorbic acid (high AA) on human leukemic cells. In vitro, high AA markedly induced apoptosis in various leukemic cell lines by generating hydrogen peroxide (H2O2) but not in normal hematopoietic stem/progenitor cells. High AA significantly repressed leukemic cell proliferation as well as neoangiogenesis in immunodeficient mice. We then noted that in leukemic cells, HIF-1 alpha transcription was strongly suppressed by high AA and correlated with the transcription of VEGF. Our data indicate that exposure to high AA markedly increased the intracellular AA content of leukemic cells and inhibited the nuclear translocation of NF-kappa B, which mediates expression of HIF-1 alpha. We next generated K562 cells that overexpressed HIF-1 alpha (K562-HIF1 alpha cells) and assessed the mechanistic relationship between inhibition of HIF-1 alpha transcription and the antileukemic effect of high AA. The ability of high AA to induce apoptosis was significantly lower in K562-HIF1 alpha cells than in K562 cells in vitro. We found that expression of HIF-1 alpha-regulated antiapoptotic proteins of the Bcl-2 family, such as Mcl-1, Bcl-x(L), and Bcl-2, was significantly suppressed by high AA in K562 cells, but was sustained at higher levels in K562-HIF1 alpha cells, regardless of high AA exposure. Moreover, repression of cell proliferation and neoangiogenesis by high AA was completely abrogated in mice receiving transplants of K562-HIF1 alpha cells. These results indicate that, along with H2O2 generation, downregulation of HIF-1 alpha transcription plays a crucial role in growth inhibition of human leukemic cells by high AA.	[Kawada, Hiroshi; Kaneko, Mitsuyo; Sawanobori, Masakazu; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Med, Div Hematol Oncol, Isehara, Kanagawa 25911, Japan; [Kawada, Hiroshi; Kaneko, Mitsuyo; Uno, Tomoko; Matsuzawa, Hideyuki; Nakamura, Yoshihiko; Matsushita, Hiromichi; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Regenerat Med, Isehara, Kanagawa 25911, Japan; [Matsushita, Hiromichi] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 25911, Japan	Tokai University; Tokai University; Tokai University	Kawada, H (corresponding author), Tokai Univ, Sch Med, Dept Med, Div Hematol Oncol, Isehara, Kanagawa 25911, Japan.	hkawada@is.icc.u-tokai.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630	Tokai University; The Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Tokai University; The Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Tokai University and The Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Aguayo A, 1999, BLOOD, V94, P3717, DOI 10.1182/blood.V94.11.3717.423k09_3717_3721; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Broome HE, 2002, LEUKEMIA RES, V26, P311, DOI 10.1016/S0145-2126(01)00118-7; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; Carcamo JM, 2004, MOL CELL BIOL, V24, P6645, DOI 10.1128/mcb.24.15.6645-6652.2004; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Deeb G, 2011, LEUKEMIA RES, V35, P579, DOI 10.1016/j.leukres.2010.10.020; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; Del Principe MI, 2005, HEMATOLOGY, V10, P25, DOI 10.1080/10245330400020454; Del Principe MI, 2003, BRIT J HAEMATOL, V121, P730, DOI 10.1046/j.1365-2141.2003.04343.x; Drisko JA, 2003, J AM COLL NUTR, V22, P118, DOI 10.1080/07315724.2003.10719284; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Gonzalez MS, 2010, BLOOD CELL MOL DIS, V45, P192, DOI 10.1016/j.bcmd.2010.07.011; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Kawada H, 1999, EXP HEMATOL, V27, P904, DOI 10.1016/S0301-472X(99)00012-0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Knowles HJ, 2003, CANCER RES, V63, P1764; Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; LIEBES L, 1981, P NATL ACAD SCI-BIOL, V78, P6481, DOI 10.1073/pnas.78.10.6481; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; Nemoto S, 1996, J NUTR SCI VITAMINOL, V42, P77, DOI 10.3177/jnsv.42.77; Ohno S, 2009, ANTICANCER RES, V29, P809; Packham G, 2008, BRIT J HAEMATOL, V143, P3, DOI 10.1111/j.1365-2141.2008.07284.x; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2006, CAN MED ASSOC J, V174, P937, DOI 10.1503/cmaj.050346; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Pathi SS, 2011, NUTR CANCER, V63, P1133, DOI 10.1080/01635581.2011.605984; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Reikvam Hakon, 2009, Critical Reviews in Oncogenesis, V15, P1; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Ruas JL, 2005, SEMIN CELL DEV BIOL, V16, P514, DOI 10.1016/j.semcdb.2005.04.001; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sestili P, 1996, J PHARMACOL EXP THER, V277, P1719; STADTMAN ER, 1991, AM J CLIN NUTR, V54, pS1125, DOI 10.1093/ajcn/54.6.1125s; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; VERA JC, 1994, BLOOD, V84, P1628; Verstovsek S, 2002, BLOOD, V99, P2265, DOI 10.1182/blood.V99.6.2265; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Wellmann S, 2004, LEUKEMIA, V18, P926, DOI 10.1038/sj.leu.2403332; Yang CC, 2009, TRANSPLANTATION, V88, P1251, DOI 10.1097/TP.0b013e3181bb4a07	61	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62717	10.1371/journal.pone.0062717	http://dx.doi.org/10.1371/journal.pone.0062717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626851	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400215
J	Samonds, KE; Godfrey, LR; Ali, JR; Goodman, SM; Vences, M; Sutherland, MR; Irwin, MT; Krause, DW				Samonds, Karen E.; Godfrey, Laurie R.; Ali, Jason R.; Goodman, Steven M.; Vences, Miguel; Sutherland, Michael R.; Irwin, Mitchell T.; Krause, David W.			Imperfect Isolation: Factors and Filters Shaping Madagascar's Extant Vertebrate Fauna	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; ISLAND COLONIZATION HISTORY; FRESH-WATER FISHES; K-T BOUNDARY; MOLECULAR PHYLOGENY; TRANSOCEANIC DISPERSAL; EVOLUTIONARY HISTORY; MAEVARANO FORMATION; PREDATORY DINOSAUR; ADAPTIVE RADIATION	Analyses of phylogenetic topology and estimates of divergence timing have facilitated a reconstruction of Madagascar's colonization events by vertebrate animals, but that information alone does not reveal the major factors shaping the island's biogeographic history. Here, we examine profiles of Malagasy vertebrate clades through time within the context of the island's paleogeographical evolution to determine how particular events influenced the arrival of the island's extant groups. First we compare vertebrate profiles on Madagascar before and after selected events; then we compare tetrapod profiles on Madagascar to contemporary tetrapod compositions globally. We show that changes from the Mesozoic to the Cenozoic in the proportions of Madagascar's tetrapod clades (particularly its increase in the representation of birds and mammals) are tied to changes in their relative proportions elsewhere on the globe. Differences in the representation of vertebrate classes from the Mesozoic to the Cenozoic reflect the effects of extinction (i.e., the non-random susceptibility of the different vertebrate clades to purported catastrophic global events 65 million years ago), and new evolutionary opportunities for a subset of vertebrates with the relatively high potential for transoceanic dispersal potential. In comparison, changes in vertebrate class representation during the Cenozoic are minor. Despite the fact that the island's isolation has resulted in high vertebrate endemism and a unique and taxonomically imbalanced extant vertebrate assemblage (both hailed as testimony to its long isolation), that isolation was never complete. Indeed, Madagascar's extant tetrapod fauna owes more to colonization during the Cenozoic than to earlier arrivals. Madagascar's unusual vertebrate assemblage needs to be understood with reference to the basal character of clades originating prior to the K-T extinction, as well as to the differential transoceanic dispersal advantage of other, more recently arriving clades. Thus, the composition of Madagascar's endemic vertebrate assemblage itself provides evidence of the island's paleogeographic history.	[Samonds, Karen E.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Godfrey, Laurie R.; Sutherland, Michael R.] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Goodman, Steven M.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Dept Evolutionary Biol, Braunschweig, Germany; [Irwin, Mitchell T.] No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; [Krause, David W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	Northern Illinois University; University of Massachusetts System; University of Massachusetts Amherst; University of Hong Kong; Field Museum of Natural History (Chicago); Braunschweig University of Technology; Northern Illinois University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Samonds, KE (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	ksamonds@niu.edu	Samonds, Karen/AAL-1766-2021; Godfrey, Laurie/E-5314-2010; Irwin, Mitchell Thomas/AAY-1776-2021; Irwin, Mitchell/A-1482-2012	Irwin, Mitchell Thomas/0000-0003-2088-0028; Irwin, Mitchell/0000-0003-2088-0028; Ali, Jason Richard/0000-0002-5214-620X; Vences, Miguel/0000-0003-0747-0817; Samonds, Karen/0000-0003-3597-9215				Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Andersen K., 1912, CATALOGUE CHIROPTERA; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; Beresford P, 2005, P ROY SOC B-BIOL SCI, V272, P849, DOI 10.1098/rspb.2004.2997; Bibi F, 2006, PALAEONTOL ELECTRON, V9, p2A; Bickelmann C, 2009, FOSS REC, V12, P13, DOI 10.1002/mmng.200800007; Boisserie JR, 2005, ZOOL J LINN SOC-LOND, V143, P1, DOI 10.1111/j.1096-3642.2004.00138.x; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2007, ZOOL J LINN SOC-LOND, V150, P835, DOI 10.1111/j.1096-3642.2007.00315.x; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Burney DA, 1997, J BIOGEOGR, V24, P755, DOI 10.1046/j.1365-2699.1997.00146.x; Caccone A, 1999, MOL PHYLOGENET EVOL, V12, P1, DOI 10.1006/mpev.1998.0594; Cavin L, 2002, GEOLOGICAL AND BIOLOGICAL EFFECTS OF IMPACT EVENTS, P141; Chakrabarty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044083; Chan LM, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1226; Clift PD, 2006, EARTH PLANET SC LETT, V241, P571, DOI 10.1016/j.epsl.2005.11.028; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Crottini A, 2009, MOL PHYLOGENET EVOL, V53, P345, DOI 10.1016/j.ympev.2009.05.024; De Ruijter WPM, 2005, PHILOS T R SOC A, V363, P63, DOI 10.1098/rsta.2004.1478; Dewar RE, 2012, ANNU REV ANTHROPOL, V41, P495, DOI 10.1146/annurev-anthro-092611-145758; Duplantier JM, 2002, HEREDITY, V89, P154, DOI 10.1038/sj.hdy.6800122; Eagles G, 2008, GEOPHYS J INT, V173, P703, DOI [10.1111/j.1365-246X.2008.03753.x, 10.1111/J.1365-246X.2008.03753.X]; Entwistle A, 1997, ORYX, V31, P135, DOI 10.1046/j.1365-3008.1997.d01-7.x; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Fain MG, 2004, EVOLUTION, V58, P2558; Flynn J.J., 2003, P34; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Forster CA, 1996, NATURE, V382, P532, DOI 10.1038/382532a0; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Fovet W, 2011, ZOOSYSTEMA, V33, P61, DOI 10.5252/z2011n1a3; Fuchs J, 2007, MOL PHYLOGENET EVOL, V44, P138, DOI 10.1016/j.ympev.2006.10.014; Gaffney ES, 2003, AM MUS NOVIT, P1; Gaffney ES, 2011, AM MUS NOVIT, P1; Gaffney ES, 2009, AM MUS NOVIT, P1, DOI 10.1206/672.1; GEBCO, 2003, GEN BATHR CHART OC D; Glaw F., 2003, P883; Godfrey LR, 2003, EVOL ANTHROPOL, V12, P252, DOI 10.1002/evan.10123; GODFREY LR, 1986, SCIENCES, V26, P49; Goodman S.M., 2003, P1159; Goodman S. M., 2011, CHAUVES SOURIS MADAG; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2010, J MAMMAL, V91, P593, DOI 10.1644/09-MAMM-A-283.1; Gottfried MD, 1998, J VERTEBR PALEONTOL, V18, P275, DOI 10.1080/02724634.1998.10011056; Gradstein F., 2005, GEOLOGIC TIME SCALE, DOI [10.1017/CBO9780511536045, DOI 10.1017/CBO9780511536045]; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hay WW, 1999, GEOL S AM S, P1; Hekkala ER, 2010, CONSERV GENET, V11, P1435, DOI 10.1007/s10592-009-9970-5; Herold N, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2010PA002041; Hingston M, 2005, J BIOGEOGR, V32, P1549, DOI 10.1111/j.1365-2699.2005.01311.x; Hooker JJ, 2004, J GEOL SOC LONDON, V161, P161, DOI 10.1144/0016-764903-091; Horovitz I., 2004, FANFARE UNCOMMON PAL, V36, P63; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Hutterer R., 1990, P309; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Keller G, 2008, EARTH PLANET SC LETT, V268, P293, DOI 10.1016/j.epsl.2008.01.015; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Kosuch J, 2001, MOL PHYLOGENET EVOL, V21, P398, DOI 10.1006/mpev.2001.1034; Krause D.W., 2003, P40; Krause D.W., 2010, J VERTEBR PALEONTOL; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Krause David W., 1997, P3; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Krause DW, 2013, CANADIAN J IN PRESS; KRAUSE DW, 1999, GSA TODAY, V9, P1; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; Kurabayashi A, 2008, MOL BIOL EVOL, V25, P874, DOI 10.1093/molbev/msn031; Laduke TC, 2010, J VERTEBR PALEONTOL, V30, P109, DOI 10.1080/02724630903409188; Lamb JM, 2011, ACTA CHIROPTEROL, V13, P1, DOI 10.3161/150811011X578589; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; Masters JC, 2006, FOLIA PRIMATOL, V77, P399, DOI 10.1159/000095388; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Melluso L, 2009, J GEOL SOC LONDON, V166, P283, DOI 10.1144/0016-76492007-147; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Morgan J, 2006, EARTH PLANET SC LETT, V251, P264, DOI 10.1016/j.epsl.2006.09.009; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; O'Brien J, 2009, MOL PHYLOGENET EVOL, V51, P294, DOI 10.1016/j.ympev.2009.02.010; O'connor PM, 2010, J VERTEBR PALEONTOL, V30, P1178, DOI 10.1080/02724634.2010.483544; Omar H, 2011, RAFFLES B ZOOL, V59, P237; Palkovacs EP, 2002, MOL PHYLOGENET EVOL, V24, P216, DOI 10.1016/S1055-7903(02)00211-7; Pasquet E, 2007, MOL PHYLOGENET EVOL, V45, P158, DOI 10.1016/j.ympev.2007.03.010; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Raselimanana AP, 2009, MOL PHYLOGENET EVOL, V50, P336, DOI 10.1016/j.ympev.2008.10.004; Raxworthy Christopher J., 1997, P124; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Reddy S, 2012, P ROY SOC B-BIOL SCI, V279, P2062, DOI 10.1098/rspb.2011.2380; Redi CA, 2007, J MOL EVOL, V64, P484, DOI 10.1007/s00239-006-0237-1; REINTHAL PN, 1991, CONSERV BIOL, V5, P231, DOI 10.1111/j.1523-1739.1991.tb00128.x; Rocha S, 2006, J BIOGEOGR, V33, P13, DOI 10.1111/j.1365-2699.2005.01375.x; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Ruane S, 2011, J EVOLUTION BIOL, V24, P274, DOI 10.1111/j.1420-9101.2010.02164.x; Russell AL, 2008, J BIOGEOGR, V35, P995, DOI 10.1111/j.1365-2699.2008.01891.x; Sahney S, 2010, BIOL LETTERS, V6, P544, DOI 10.1098/rsbl.2009.1024; Samonds KE, 2007, ACTA CHIROPTEROL, V9, P39, DOI 10.3161/1733-5329(2007)9[39:LPBFFA]2.0.CO;2; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Samonds KE, 2009, J VERTEBR PALEONTOL, V29, P1233, DOI 10.1671/039.029.0417; Samonds KE, 2010, MALAGASY NATURE, V4, P1; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sampson SD, 2007, SOC VERTEBRATE PALEO, V8; Schettino A, 2005, GEOPHYS J INT, V163, P727, DOI 10.1111/j.1365-246X.2005.02638.x; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; SHEEHAN PM, 1992, GEOLOGY, V20, P556, DOI 10.1130/0091-7613(1992)020<0556:MEOLDV>2.3.CO;2; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simons ELR, 2009, J VERTEBR PALEONTOL, V29, P599; Sparks JS, 2012, AM MUS NOVIT, P1; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Sparks JS, 2004, MOL PHYLOGENET EVOL, V30, P599, DOI 10.1016/S1055-7903(03)00225-2; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Stevens NJ, 2006, FOLIA PRIMATOL, V77, P419, DOI 10.1159/000095389; Stiassny Melanie L., 1994, Systematics Association Special Volume Series, V50, P235; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Stuenes S., 1989, Journal of Vertebrate Paleontology, V9, P241; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thomas DJ, 2002, GEOLOGY, V30, P1067, DOI 10.1130/0091-7613(2002)030<1067:WTFFTF>2.0.CO;2; Tolley KA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0184; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Vargas-Ramirez M, 2010, MOL PHYLOGENET EVOL, V56, P428, DOI 10.1016/j.ympev.2010.03.019; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vences M, 2004, BIOL J LINN SOC, V83, P115, DOI 10.1111/j.1095-8312.2004.00370.x; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; Voelker G, 2002, CONDOR, V104, P725, DOI 10.1650/0010-5422(2002)104[0725:SAHBOW]2.0.CO;2; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2005, BIOL J LINN SOC, V85, P271, DOI 10.1111/j.1095-8312.2005.00492.x; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zuccon D, 2006, MOL PHYLOGENET EVOL, V41, P333, DOI 10.1016/j.ympev.2006.05.007	157	63	64	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62086	10.1371/journal.pone.0062086	http://dx.doi.org/10.1371/journal.pone.0062086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626770	Green Published, gold			2022-12-25	WOS:000318008400134
J	Nishitani, Y; Zhang, L; Yoshida, M; Azuma, T; Kanazawa, K; Hashimoto, T; Mizuno, M				Nishitani, Yosuke; Zhang, Ling; Yoshida, Masaru; Azuma, Takeshi; Kanazawa, Kazuki; Hashimoto, Takashi; Mizuno, Masashi			Intestinal Anti-Inflammatory Activity of Lentinan: Influence on IL-8 and TNFR1 Expression in Intestinal Epithelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR-1; DEXTRAN SULFATE SODIUM; CYTOKINE PRODUCTION; GUT INFLAMMATION; GENE-EXPRESSION; CROHNS-DISEASE; MESSENGER-RNA; FACTOR-ALPHA	Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract. It is unknown whether beta-1,3;1,6-glucan can induce immune suppressive effects. Here, we study intestinal anti-inflammatory activity of Lentinula edodes-derived beta-1,3; 1,6-glucan, which is known as lentinan. Dextran sulfate sodium (DSS)-induced colitis mice were used to elucidate effects of lentinan in vivo. In the cellular level assessment, lentinan was added into a co-culture model consisting of intestinal epithelial Caco-2 cells and LPS-stimulated macrophage RAW264.7 cells. Ligated intestinal loop assay was performed for assessing effects of lentinan on intestinal epithelial cells (IECs) in vivo. Oral administration of lentinan (100 mu g/mouse) significantly ameliorated DSS-induced colitis in body weight loss, shortening of colon lengths, histological score, and inflammatory cytokine mRNA expression in inflamed tissues. Lentinan reduced interleukin (IL)-8 mRNA expression and nuclear factor (NF)-kappa B activation in Caco-2 cells without decreasing of tumor necrosis factor (TNF)-alpha production from RAW264.7 cells. Flow cytometric analysis revealed that surface levels of TNF receptor (TNFR) 1 were decreased by lentinan treatment. A clathrin-mediated endocytosis inhibitor, monodansylcadaverine, canceled lentinan inhibition of IL-8 mRNA expression. Moreover, lentinan inhibited TNFR1 expression in Caco-2 cells in both protein and mRNA level. Lentinan also inhibited TNFR1 mRNA expression in mouse IECs. These results suggest that lentinan exhibits intestinal anti-inflammatory activity through inhibition of IL-8 mRNA expression associated with the inhibition of NF-kappa B activation which is triggered by TNFR1 endocytosis and lowering of their expression in IECs. Lentinan may be effective for the treatment of gut inflammation including IBD.	[Nishitani, Yosuke] Kobe Univ, Team Hlth Biosci, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan; [Zhang, Ling; Kanazawa, Kazuki; Hashimoto, Takashi; Mizuno, Masashi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 657, Japan; [Yoshida, Masaru; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Mizuno, M (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 657, Japan.	mizuno@kobe-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported by grants for project research (Development of fundamental technology for analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Arai F, 1998, DIGEST DIS SCI, V43, P2071, DOI 10.1023/A:1018815432504; Bent S, 2004, AM J MED, V116, P478, DOI 10.1016/j.amjmed.2003.10.036; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Chihara G, 1987, Cancer Detect Prev Suppl, V1, P423; Chin YR, 2006, J GEN VIROL, V87, P3161, DOI 10.1099/vir.0.82001-0; Chin YR, 2005, J VIROL, V79, P13606, DOI 10.1128/JVI.79.21.13606-13617.2005; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Haller D, 2004, J PEDIATR GASTR NUTR, V38, P123, DOI 10.1097/00005176-200402000-00004; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hibi T, 2003, J GASTROENTEROL, V38, P36; Horiguchi M, 1988, Gan To Kagaku Ryoho, V15, P1973; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Izutani R, 1995, Inflamm Bowel Dis, V1, P37, DOI 10.1002/ibd.3780010106; Kerekgyarto C, 1996, INT J IMMUNOPHARMACO, V18, P347, DOI 10.1016/S0192-0561(96)00038-0; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim BO, 2003, BIOSCI BIOTECH BIOCH, V67, P1706, DOI 10.1271/bbb.67.1706; Liu L, 2003, WORLD J GASTROENTERO, V9, P2284; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; McElroy SJ, 2008, AM J PHYSIOL-GASTR L, V295, pG285, DOI 10.1152/ajpgi.00425.2007; MIZUNO M, 1996, BIOCHEM MOL BIOL INT, V39, P679; Mizuno M, 2009, BIOSCI BIOTECH BIOCH, V73, P2324, DOI 10.1271/bbb.90326; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; NAKAMURA M, 1992, GUT, V33, P933, DOI 10.1136/gut.33.7.933; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; PULLMAN WE, 1992, GASTROENTEROLOGY, V102, P529, DOI 10.1016/0016-5085(92)90100-D; Rahman I, 2003, BIOCHEM BIOPH RES CO, V302, P860, DOI 10.1016/S0006-291X(03)00224-9; ROLANDELLI RH, 1988, AM J CLIN NUTR, V47, P715, DOI 10.1093/ajcn/47.4.715; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SASAKI T, 1976, CARBOHYD RES, V47, P99, DOI 10.1016/S0008-6215(00)83552-1; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Struyf S, 2005, EUR J IMMUNOL, V35, P1583, DOI 10.1002/eji.200425753; Tanoue T, 2008, BIOCHEM BIOPH RES CO, V374, P565, DOI 10.1016/j.bbrc.2008.07.063; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Zareie M, 2001, AM J PATHOL, V158, P1101, DOI 10.1016/S0002-9440(10)64057-6; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zhang M, 2009, INT J CANCER, V124, P1404, DOI 10.1002/ijc.24047; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	53	77	84	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62441	10.1371/journal.pone.0062441	http://dx.doi.org/10.1371/journal.pone.0062441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630633	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500090
J	Pankratow, M; Berry, TR; McHugh, TLF				Pankratow, Melanie; Berry, Tanya R.; McHugh, Tara-Leigh F.			Effects of Reading Health and Appearance Exercise Magazine Articles on Perceptions of Attractiveness and Reasons for Exercise	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PERCEIVED BENEFITS; BODY SATISFACTION; COLLEGE; MEDIA; IDENTITY; DISSATISFACTION; TRANSITION; IMPLICIT; BARRIERS	Objective: To examine the effects of reading exercise-related magazine articles (health, appearance, or control) and the moderating effects of exercise self-identity on reasons for exercise and perceptions of attractiveness, among women in first year university. An additional purpose was to use a thought listing technique, the results of which were examined for evidence of internalization of the exercise-related messages. Participants: Female students in their first year of studies between September 2010 and April 2011 (N = 173; mean age = 19.31 years, mean body mass index = 22.01). Methods: Participants read a health, appearance, or control article, listed thoughts, and completed questionnaires measuring reasons for exercising, physical self-perception, and exercise self-identity. Results: Participants in the health condition rated exercise for health significantly higher than control condition participants. Participants with high exercise self-identity rated attractiveness as a reason for exercising significantly higher than low exercise self-identity participants in both the health and appearance conditions. Participants with higher internalization scores (i.e., accepted societal norms of appearance) reported exercising for attractiveness reasons more so than participants with lower internalization scores. Conclusions: The good news is that health messages may be influential and result in wanting to exercise for health purposes. However, exercising for attractiveness was rated highly by participants with high exercise identity who read either the health or appearance articles. Health and appearance are not necessarily distinct concepts for female undergraduate students and the media may influence cited reasons for exercise.	[Pankratow, Melanie; Berry, Tanya R.; McHugh, Tara-Leigh F.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of Alberta	Berry, TR (corresponding author), Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada.	Tanya.berry@ualberta.ca		McHugh, Tara-Leigh/0000-0002-6528-9613	Social Sciences and Humanities Research Council of Canada; Canada Research Chairs Program; Population Health Investigator award from the Alberta Innovates - Health Solutions	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Population Health Investigator award from the Alberta Innovates - Health Solutions	This research was supported in part by a grant from the Social Sciences and Humanities Research Council of Canada. Tanya R. Berry is supported by the Canada Research Chairs Program and by a Population Health Investigator award from the Alberta Innovates - Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; ANDERSON DF, 1994, PERCEPT MOTOR SKILL, V78, P747, DOI 10.2466/pms.1994.78.3.747; [Anonymous], 2010, ALL YOU CAN READ; Baranowski T, 1997, PREV MED, V26, P694, DOI 10.1006/pmed.1997.0193; Berry TR, 2011, HEALTH PSYCHOL, V30, P746, DOI 10.1037/a0025082; Bray SR, 2004, J AM COLL HEALTH, V52, P181, DOI 10.3200/JACH.52.4.181-188; Brown SA, 2006, AM J HEALTH PROMOT, V21, P137, DOI 10.4278/0890-1171-21.2.137; Burke Peter J., 2009, IDENTITY THEORY; Cash TF, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P509; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colley Rachel C, 2011, Health Rep, V22, P15; Dishman RK, 1988, EXERCISE ADHERENCE I, P155; FOX KR, 1989, J SPORT EXERCISE PSY, V11, P408, DOI 10.1123/jsep.11.4.408; Gammage KL, 2004, J APPL SOC PSYCHOL, V34, P1638, DOI 10.1111/j.1559-1816.2004.tb02791.x; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Huang Y, 2008, J CONSUM RES, V35, P98, DOI 10.1086/527340; Jose P. E., 2008, MODGRAPH I PROGRAMME; Kennedy C, 1995, WELLNESS PERSPECTIVE, V11, P3; Koyuncu M, 2010, SOC BEHAV PERSONAL, V38, P561, DOI 10.2224/sbp.2010.38.4.561; Maibach E, 2007, AM J HEALTH PROMOT, V21, P353, DOI 10.4278/0890-1171-21.4s.353; McHugh TLF, 2008, FEM PSYCHOL, V18, P231, DOI 10.1177/0959353507088593; Myers RS, 1997, HEALTH PSYCHOL, V16, P277, DOI 10.1037/0278-6133.16.3.277; Paquette MC, 2004, SOC SCI MED, V59, P1047, DOI 10.1016/j.socscimed.2003.12.016; Petty RE, 2002, MEDIA EFFECTS ADV TH, P155; Sabiston CM, 2009, J APPL BIOBEHAV RES, V14, P165, DOI 10.1111/j.1751-9861.2010.00047.x; SILBERSTEIN LR, 1988, SEX ROLES, V19, P219, DOI 10.1007/BF00290156; Statistics Canada, 2006, CAN CENS; Steptoe A, 1997, PREV MED, V26, P845, DOI 10.1006/pmed.1997.0224; Strachan SM, 2008, J HEALTH PSYCHOL, V13, P575, DOI 10.1177/1359105308090930; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thompson J, 1999, SHEFF ANALY CHEM, V3, P85; Tucci S, 2008, PSICOTHEMA, V20, P521; Vlachopoulos SP, 2011, PSYCHOL SPORT EXERC, V12, P265, DOI 10.1016/j.psychsport.2010.11.006; Vohs KD, 2001, INT J EAT DISORDER, V29, P280, DOI 10.1002/eat.1019; Waldron JJ, 2010, J COLL STUDENT DEV, V51, P65, DOI 10.1353/csd.0.0110; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wharton CM, 2008, J AM COLL HEALTH, V56, P579, DOI 10.3200/JACH.56.5.579-584; WHO. Global Health Observatory (GHO), 2011, MEAN BOD MASS IND BM	40	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61894	10.1371/journal.pone.0061894	http://dx.doi.org/10.1371/journal.pone.0061894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JR	23630618	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500071
J	Angamo, MT; Melese, BH; Ayen, WY				Angamo, Mulugeta Tarekegn; Melese, Belete Habte; Ayen, Wubeante Yenet			Determinants of Glycemic Control among Insulin Treated Diabetic Patients in Southwest Ethiopia: Hospital Based Cross Sectional Study	PLOS ONE			English	Article							LIPOHYPERTROPHY; COMPLICATIONS; PREVALENCE; MELLITUS; DISEASE	Background: Good glycemic control reduces the risk of diabetic complications. Despite this, achieving good glycemic control remains a challenge in diabetic patients. The objective of this study is to identify determinants of glycemic control among insulin treated diabetic patients at Jimma University Hospital, Southwest Ethiopia. Methods: Hospital-based cross-sectional study was conducted on systematically sampled 284 insulin-treated diabetic patients with a regular follow up. Data was collected by interviewing patients during hospital visits and reviewing respective databases of September 2010 to December 2011. Data collection took place from February 20 to May 20, 2012. Poor glycemic control was defined as fasting blood sugar (FBS) >= 126 mg/dL. Binary logistic regression analysis was conducted to identify predictors of poor glycemic control. Results: Patients had a mean age of 41.37 (+/- 15.08) years, 58.5% were males, the mean duration of insulin treatment was 4.9 (+/- 5.1) years, 18.3% achieved good glycemic control (FBS <= 126 mg/dL), 95% self-reported repeated use of disposable insulin syringe-needle and 48% correctly rotating insulin injection sites. Most (83.1%) of study participants had one or more complications. On multivariable logistic regression analyses, body weight of >70 Kg (AOR = 0.21; P<0.001), total daily dose of insulin <= 35 IU/day (AOR = 0.26; P<0.001), total daily dose variation without checking glycemic level (AOR = 3.39; P = 0.020), knowledge deficit about signs and symptoms of hyperglycemia (AOR = 3.60; P = 0.004), and non-adherence to dietary management (AOR = 0.35; P = 0.005) were independent predictors of poor glycemic control. Conclusions: The proportion of patients with poor glycemic control was high, which resulted in the development of one or more complications regardless of duration on insulin treatment. Hence, appropriate management of patients focusing on the relevant associated factors and independent predictors of poor glycemic control would be of great benefit in glycemic control.	[Angamo, Mulugeta Tarekegn; Ayen, Wubeante Yenet] Jimma Univ, Dept Pharm, Jimma, Oromiya, Ethiopia; [Melese, Belete Habte] Jimma Univ, Dept Internal Med, Jimma, Oromiya, Ethiopia	Jimma University; Jimma University	Ayen, WY (corresponding author), Jimma Univ, Dept Pharm, Jimma, Oromiya, Ethiopia.	wubeante.yenet@ju.edu.et	Angamo, Mulugeta/O-9568-2014	Angamo, Mulugeta/0000-0002-8604-6258	Jimma University	Jimma University	This research was carried out as partial fulfillment for a Master of Science in Clinical Pharmacy awarded to Mulugeta Tarekegn Angamo and it was sponsored by Jimma University. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M., 2010, Eastern Mediterranean Health Journal, V16, P732; Ahmed AT, 2008, J GEN INTERN MED, V23, P275, DOI 10.1007/s11606-007-0502-z; Akbar DH, 2000, SAUDI MED J, V21, P539; Al-Sultan F., 2005, KUWAIT MED J, V37, P98; Ashwin K, 2011, INT J BIOL MED RES, V12, P636; Barnard K, 2011, GYLCEMIC CONTROL HOS, P250; Behan KJ, 2011, ADV ADM LAB, V20, P22; Cai XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038962; CHATURVEDI N, 1995, DIABETES CARE, V18, P785, DOI 10.2337/diacare.18.6.785; Collins MM, 2009, BMC ENDOCR DISORD, V9, DOI [10.1186/1472-6823-1189-1186, DOI 10.1186/1472-6823-1189-1186]; Davies M, 2004, MATER WORLD, V12, P28; de Villiers FPR, 2005, SAMJ S AFR MED J, V95, P858; DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x; Fox KM, 2006, CLIN THER, V28, P388, DOI 10.1016/j.clinthera.2006.03.005; Gudina EK, 2011, BMC ENDOCR DISORD, V11, DOI [10.1186/1472-6823-1111-1119, DOI 10.1186/1472-6823-1111-1119]; Habib SS, 2003, SAUDI MED J, V24, P1219; Hauner H, 1996, EXP CLIN ENDOCR DIAB, V104, P106, DOI 10.1055/s-0029-1211431; Jiang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046058; Johansson UB, 2005, DIABETES CARE, V28, P2025, DOI 10.2337/diacare.28.8.2025; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Maysaa K, 2010, J DIABETES COMPLICAT, V24, P84; Misnikova IV., 2011, J DIABETOL, V1, P1; Mooradian AD, 2003, ARCH INTERN MED, V163, P33, DOI 10.1001/archinte.163.1.33; NXP, 2012, MRFE6VS25LR5 DATASHE, V5th; Omar M, 2011, BMC RES NOTES, V4, P1; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; Ramchandani N, 2000, DIABETES EDUCATOR, V26, P656, DOI 10.1177/014572170002600413; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Rosilio M, 1998, DIABETES CARE, V21, P1146, DOI 10.2337/diacare.21.7.1146; Snoek FJ, 2002, INT J CLIN PRACT, P80; Stephen RB, 2005, BMC PUBLIC HEALTH, V5, P1; Vardar B, 2007, DIABETES RES CLIN PR, V77, P231, DOI 10.1016/j.diabres.2006.12.023; Vimalavathini R, 2008, INT J DIABETES DEV C, V28, P86, DOI 10.4103/0973-3930.44079; Vimalavathini R, 2009, INDIAN J MED RES, V130, P166; Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33; Zeinab G, 2010, LIPIDS HLTH DIS, V9, P1; Zhaolan L, 2010, HLTH QUAL LIFE OUT, V8, P1	38	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61759	10.1371/journal.pone.0061759	http://dx.doi.org/10.1371/journal.pone.0061759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620789	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500069
J	Cami, A; Manzi, S; Arnold, A; Reis, BY				Cami, Aurel; Manzi, Shannon; Arnold, Alana; Reis, Ben Y.			Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions	PLOS ONE			English	Article							IN-SILICO; METABOLISM; PHARMACOLOGY; WITHDRAWAL; TOOL	Drug-drug interactions (DDIs) can lead to serious and potentially lethal adverse events. In recent years, several drugs have been withdrawn from the market due to interaction-related adverse events (AEs). Current methods for detecting DDIs rely on the accumulation of sufficient clinical evidence in the post-market stage - a lengthy process that often takes years, during which time numerous patients may suffer from the adverse effects of the DDI. Detection methods are further hindered by the extremely large combinatoric space of possible drug-drug-AE combinations. There is therefore a practical need for predictive tools that can identify potential DDIs years in advance, enabling drug safety professionals to better prioritize their limited investigative resources and take appropriate regulatory action. To meet this need, we describe Predictive Pharmacointeraction Networks (PPINs) - a novel approach that predicts unknown DDIs by exploiting the network structure of all known DDIs, together with other intrinsic and taxonomic properties of drugs and AEs. We constructed an 856-drug DDI network from a 2009 snapshot of a widely-used drug safety database, and used it to develop PPIN models for predicting future DDIs. We compared the DDIs predicted based solely on these 2009 data, with newly reported DDIs that appeared in a 2012 snapshot of the same database. Using a standard multivariate approach to combine predictors, the PPIN model achieved an AUROC (area under the receiver operating characteristic curve) of 0.81 with a sensitivity of 48% given a specificity of 90%. An analysis of DDIs by severity level revealed that the model was most effective for predicting "contraindicated" DDIs (AUROC = 0.92) and less effective for "minor" DDIs (AUROC = 0.63). These results indicate that network based methods can be useful for predicting unknown drug-drug interactions.	[Cami, Aurel; Reis, Ben Y.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Manzi, Shannon; Arnold, Alana] Boston Childrens Hosp, Dept Pharm, Boston, MA USA; [Cami, Aurel; Reis, Ben Y.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Cami, A (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA USA.	aurel.cami@childrens.harvard.edu			National Library of Medicine [1K99LM011014-01, R01 LM009879]; National Institute of General Medical Sciences [R01 GM89731, R01 GM085421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085421, R01GM089731] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011014, R00LM011014, R01LM009879] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine (1K99LM011014-01, R01 LM009879) and the National Institute of General Medical Sciences (R01 GM89731, R01 GM085421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582; Almenoff JS, 2003, PHARMACOEPIDEM DR S, V12, P517, DOI 10.1002/pds.885; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Butina D, 2002, DRUG DISCOV TODAY, V7, pS83, DOI 10.1016/S1359-6446(02)02288-2; Cami A, 2008, NETWORKS, V51, P211, DOI 10.1002/net.20215; Cami A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002774; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Ekins S, 2003, BIOCHEM SOC T, V31, P611, DOI 10.1042/BST0310611; Ekins S, 2001, J PHARMACOL TOX MET, V45, P65, DOI 10.1016/S1056-8719(01)00119-8; Foti RS, 2008, IDRUGS, V11, P900; Gottlieb S, 1999, BRIT MED J, V319, P7, DOI 10.1136/bmj.319.7201.7a; Hisaka A, 2010, PHARMACOL THERAPEUT, V125, P230, DOI 10.1016/j.pharmthera.2009.10.011; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu TM, 2011, J CLIN PHARM THER, V36, P135, DOI 10.1111/j.1365-2710.2009.01103.x; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Hudelson MG, 2008, J MED CHEM, V51, P648, DOI 10.1021/jm701130z; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lin JH, 2000, CURR DRUG METAB, V1, P305, DOI 10.2174/1389200003338947; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Lu C, 2008, DRUG METAB DISPOS, V36, P1255, DOI 10.1124/dmd.107.018796; Noren GN, 2008, STAT MED, V27, P3057, DOI 10.1002/sim.3247; Obach RS, 2009, CURR OPIN DRUG DISC, V12, P81; Opie LH, 2000, CURR PROB CARDIOLOGY, V25, P628, DOI 10.1067/mcd.2000.109090; Patsalos PN, 2003, LANCET NEUROL, V2, P347, DOI 10.1016/S1474-4422(03)00409-5; Robertson S, 2007, DRUG INTERACTIONS PR, P229; Saverno KR, 2011, J AM MED INFORM ASSN, V18, P32, DOI 10.1136/jamia.2010.007609; Shou MG, 2005, CURR OPIN DRUG DISC, V8, P66; SoRelle R, 1998, CIRCULATION, V98, P831, DOI 10.1161/01.CIR.98.9.831; Takarabe Masataka, 2008, Genome Inform, V20, P252; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Trenk D, 2005, EUR J CLIN PHARMACOL, V61, P698; van Puijenbroek EP, 2000, EUR J CLIN PHARMACOL, V56, P733, DOI 10.1007/s002280000215; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang LM, 2010, ANN PHARMACOTHER, V44, P28, DOI 10.1345/aph.1M475; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9	37	45	46	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61468	10.1371/journal.pone.0061468	http://dx.doi.org/10.1371/journal.pone.0061468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620757	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500037
J	Gleichgerrcht, E; Decety, J				Gleichgerrcht, Ezequiel; Decety, Jean			Empathy in Clinical Practice: How Individual Dispositions, Gender, and Experience Moderate Empathic Concern, Burnout, and Emotional Distress in Physicians	PLOS ONE			English	Article							ALEXITHYMIA; PAIN; DECLINE	To better understand clinical empathy and what factors can undermine its experience and outcome in care-giving settings, a large-scale study was conducted with 7,584 board certified practicing physicians. Online validated instruments assessing different aspects of empathy, distress, burnout, altruistic behavior, emotional awareness, and well-being were used. Compassion satisfaction was strongly associated with empathic concern, perspective taking and altruism, while compassion fatigue (burnout and secondary traumatic stress) was more closely related to personal distress and alexithymia. Gender had a highly selective effect on empathic concern, with women displaying higher values, which led to a wide array of negative and devalued feelings. Years of experience did not influence dispositional measures per se after controlling for the effect of age and gender. Participants who experienced compassion fatigue with little to no compassion satisfaction showed the highest scores on personal distress and alexithymia as well as the strongest indicators of compassion fatigue. Physicians who have difficulty regulating their negative arousal and describing and identifying emotions seem to be more prone to emotional exhaustion, detachment, and a low sense of accomplishment. On the contrary, the ability to engage in self-other awareness and regulate one's emotions and the tendency to help others, seem to contribute to the sense of compassion that comes from assisting patients in clinical practice.	[Gleichgerrcht, Ezequiel] Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina; [Gleichgerrcht, Ezequiel] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Gleichgerrcht, Ezequiel] Diego Portales Univ, Neurosci Lab, Santiago, Chile; [Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gleichgerrcht, E (corresponding author), Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina.	egleich@ineco.org.ar		Gleichgerrcht, Ezequiel/0000-0002-4212-4146	INECO Foundation; NSF [BCS-0718480]; John Templeton Foundation (The Chicago Wisdom Project)	INECO Foundation; NSF(National Science Foundation (NSF)); John Templeton Foundation (The Chicago Wisdom Project)	EG received a grant from the INECO Foundation for this project, and JD from NSF (BCS-0718480). This work was supported by a grant from the John Templeton Foundation (The Chicago Wisdom Project) to the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2008, J OCCUP HEALTH, V50, P362, DOI 10.1539/joh.M8002; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Benbassat J, 2004, ACAD MED, V79, P832, DOI 10.1097/00001888-200409000-00004; Brewer E., 2004, HUMAN RESOURCE DEV R, V3, P102, DOI [10.1177/1534484304263335, DOI 10.1177/1534484304263335]; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; Carter SS, 2009, SOCIAL NEUROSCIENCE; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cohen J., 1992, CURRENT DIRECTIONS P, V1, P98, DOI [10.1111/1467-8721.ep10768783, DOI 10.1111/1467-8721.EP10768783]; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P1; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, PROG NEUROBIOL, V98, P38, DOI 10.1016/j.pneurobio.2012.05.001; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Figley CR, 2012, SO NEUROSCI SER, P263; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; Gleichgerrcht E, 2012, SO NEUROSCI SER, P245; Halpern J, 2003, J GEN INTERN MED, V18, P670, DOI 10.1046/j.1525-1497.2003.21017.x; Halpern J, 2001, DATACHED CONCERN EMP; Halpern J, 2012, SO NEUROSCI SER, P229; Hodges S.D., 2001, J SOCIO-ECON, V30, P437, DOI [DOI 10.1016/S1053-5357(01)00112-3, 10.1016/S1053-5357(01)00112-3]; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Hojat M, 2004, MED EDUC, V38, P934, DOI 10.1111/j.1365-2929.2004.01911.x; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Kokkonen P, COMPREHENSIVE PSYCHI, V42, P471; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Mestre-Escriva MV, 2009, SPAN J PSYCHOL, V12, P76, DOI 10.1017/S1138741600001499; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Post S. G., 2007, ALTRUISM HLTH PERSPE; Potter P, 2010, CLIN J ONCOL NURS, V14, P565, DOI 10.1188/10.CJON.E56-E62; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Rueckert L., 2011, PSYCHOLOGY, V2, P574, DOI [10.4236/psych.2011.26088, DOI 10.4236/PSYCH.2011.26088]; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stamm B. H., 2008, PROQOL TEST MANUAL; Stepien KA, 2006, J GEN INTERN MED, V21, P524, DOI 10.1111/j.1525-1497.2006.00443.x	44	270	272	9	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61526	10.1371/journal.pone.0061526	http://dx.doi.org/10.1371/journal.pone.0061526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JA	23620760	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500040
J	Pushker, R; Mooney, C; Davey, NE; Jacque, JM; Shields, DC				Pushker, Ravindra; Mooney, Catherine; Davey, Norman E.; Jacque, Jean-Marc; Shields, Denis C.			Marked Variability in the Extent of Protein Disorder within and between Viral Families	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; INTRINSIC DISORDER; UNSTRUCTURED PROTEINS; DOMAINS; PREDICTION; EVOLUTION; VIRUSES; MIMICRY; BINDING	Intrinsically disordered regions in eukaryotic proteomes contain key signaling and regulatory modules and mediate interactions with many proteins. Many viral proteomes encode disordered proteins and modulate host factors through the use of short linear motifs (SLiMs) embedded within disordered regions. However, the degree of viral protein disorder across different viruses is not well understood, so we set out to establish the constraints acting on viruses, in terms of their use of disordered protein regions. We surveyed predicted disorder across 2,278 available viral genomes in 41 families, and correlated the extent of disorder with genome size and other factors. Protein disorder varies strikingly between viral families (from 2.9% to 23.1% of residues), and also within families. However, this substantial variation did not follow the established trend among their hosts, with increasing disorder seen across eubacterial, archaebacterial, protists, and multicellular eukaryotes. For example, among large mammalian viruses, poxviruses and herpesviruses showed markedly differing disorder (5.6% and 17.9%, respectively). Viral families with smaller genome sizes have more disorder within each of five main viral types (ssDNA, dsDNA, ssRNA+, dsRNA, retroviruses), except for negative single-stranded RNA viruses, where disorder increased with genome size. However, surveying over all viruses, which compares tiny and enormous viruses over a much bigger range of genome sizes, there is no strong association of genome size with protein disorder. We conclude that there is extensive variation in the disorder content of viral proteomes. While a proportion of this may relate to base composition, to extent of gene overlap, and to genome size within viral types, there remain important additional family and virus-specific effects. Differing disorder strategies are likely to impact on how different viruses modulate host factors, and on how rapidly viruses can evolve novel instances of SLiMs subverting host functions, such as innate and acquired immunity.	[Pushker, Ravindra; Mooney, Catherine; Shields, Denis C.] Univ Coll Dublin, UCD Complex & Adapt Syst Lab, Dublin 2, Ireland; [Pushker, Ravindra; Mooney, Catherine; Jacque, Jean-Marc; Shields, Denis C.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Pushker, Ravindra; Mooney, Catherine; Jacque, Jean-Marc; Shields, Denis C.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Davey, Norman E.] EMBL Struct & Computat Biol Unit, Heidelberg, Germany; [Jacque, Jean-Marc] Univ Coll Dublin, Ctr Res Infect Dis, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin; European Molecular Biology Laboratory (EMBL); University College Dublin	Shields, DC (corresponding author), Univ Coll Dublin, UCD Complex & Adapt Syst Lab, Dublin 2, Ireland.	denis.shields@ucd.ie		Mooney, Catherine/0000-0002-7696-1364; Pushker, Ravindra/0000-0001-7314-4898; Davey, Norman/0000-0001-6988-4850	Science Foundation Ireland [08/IN.1/B1864]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland (www.sfi.ie; Principal Investigator Award 08/IN.1/B1864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Goh GKM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-126; Goh GKM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-69; Goh GKM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S4; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hiipakka M, 2007, FEBS LETT, V581, P1735, DOI 10.1016/j.febslet.2007.03.044; Hughes AL, 2010, INFECT GENET EVOL, V10, P50, DOI 10.1016/j.meegid.2009.10.001; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984	46	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e60724	10.1371/journal.pone.0060724	http://dx.doi.org/10.1371/journal.pone.0060724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620725	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500005
J	Bhowmik, D; Shanahan, M				Bhowmik, David; Shanahan, Murray			Metastability and Inter-Band Frequency Modulation in Networks of Oscillating Spiking Neuron Populations	PLOS ONE			English	Article							THETA OSCILLATIONS; GAMMA; SYNCHRONIZATION; CORRELATE; DYNAMICS; RHYTHMS; CORTEX; CELLS	Groups of neurons firing synchronously are hypothesized to underlie many cognitive functions such as attention, associative learning, memory, and sensory selection. Recent theories suggest that transient periods of synchronization and desynchronization provide a mechanism for dynamically integrating and forming coalitions of functionally related neural areas, and that at these times conditions are optimal for information transfer. Oscillating neural populations display a great amount of spectral complexity, with several rhythms temporally coexisting in different structures and interacting with each other. This paper explores inter-band frequency modulation between neural oscillators using models of quadratic integrate-and-fire neurons and Hodgkin-Huxley neurons. We vary the structural connectivity in a network of neural oscillators, assess the spectral complexity, and correlate the inter-band frequency modulation. We contrast this correlation against measures of metastable coalition entropy and synchrony. Our results show that oscillations in different neural populations modulate each other so as to change frequency, and that the interaction of these fluctuating frequencies in the network as a whole is able to drive different neural populations towards episodes of synchrony. Further to this, we locate an area in the connectivity space in which the system directs itself in this way so as to explore a large repertoire of synchronous coalitions. We suggest that such dynamics facilitate versatile exploration, integration, and communication between functionally related neural areas, and thereby supports sophisticated cognitive processing in the brain.	[Bhowmik, David; Shanahan, Murray] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London	Bhowmik, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	d.bhowmik10@imperial.ac.uk			EPSRC	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EPSRC Doctorial Training Award to David Bhowmik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Daubechies I., 1996, WAVELETS MED BIOL, P527; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fidjeland A.K., 2010, 2010 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2010.5596678; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gerstner W., 2002, SPIKING NEURON MODEL; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holland J.H., 1992, ADAPTATION NATURAL A; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lachaux JP, 2003, J NEUROSCI METH, V123, P175, DOI 10.1016/S0165-0270(02)00358-8; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Papp E, 2001, NEUROSCIENCE, V102, P715, DOI 10.1016/S0306-4522(00)00584-4; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Shanahan M., 2012, 2012 INT JOINT C NEU, P1, DOI [10.1109/IJCNN.2012.6252395, DOI 10.1109/IJCNN.2012.6252395]; Shanahan M, 2012, PHILOS T R SOC B, V367, P2704, DOI 10.1098/rstb.2012.0128; Shanahan M, 2010, CHAOS, V20, DOI 10.1063/1.3305451; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 1990, THALAMIC OSCILLATION; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wildie M, 2012, CHAOS, V22, DOI 10.1063/1.4766592; Wildie Mark, 2011, Front Comput Neurosci, V5, P62, DOI 10.3389/fncom.2011.00062; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yu WC, 2005, IMAGE VISION COMPUT, V23, P377, DOI 10.1016/j.imavis.2004.09.006	47	19	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62234	10.1371/journal.pone.0062234	http://dx.doi.org/10.1371/journal.pone.0062234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614040	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400166
J	Gray, LR; Tachedjian, G; Ellett, AM; Roche, MJ; Cheng, WJ; Guillemin, GJ; Brew, BJ; Turville, SG; Wesselingh, SL; Gorry, PR; Churchill, MJ				Gray, Lachlan R.; Tachedjian, Gilda; Ellett, Anne M.; Roche, Michael J.; Cheng, Wan-Jung; Guillemin, Gilles J.; Brew, Bruce J.; Turville, Stuart G.; Wesselingh, Steve L.; Gorry, Paul R.; Churchill, Melissa J.			The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; POTENTIAL ROLE; INFECTION; BRAIN; ERA; REPLICATION; MACROPHAGES; METABOLISM; MECHANISMS	HIV-1 establishes infection in astrocytes and macroage-lineage cells of the central nervous system (CNS). Certain antiretroviral drugs (ARVs) can penetrate the CNS, and are therefore often used in neurologically active combined antiretroviral therapy (Neuro-cART) regimens, but their relative activity in the different susceptible CNS cell populations is unknown. Here, we determined the HIV-1 inhibitory activity of CNS-penetrating ARVs in astrocytes and macrophage-lineage cells. Primary human fetal astrocytes (PFA) and the SVG human astrocyte cell line were used as in vitro models for astrocyte infection, and monocyte-derived macrophages (MDM) were used as an in vitro model for infection of macrophage-lineage cells. The CNS-penetrating ARVs tested were the nucleoside reverse transcriptase inhibitors (NRTIs) abacavir (ABC), lamivudine (3TC), stavudine (d4T) and zidovudine (ZDV), the non-NRTIs efavirenz (EFV), etravirine (ETR) and nevirapine (NVP), and the integrase inhibitor raltegravir (RAL). Drug inhibition assays were performed using single-round HIV-1 entry assays with luciferase viruses pseudotyped with HIV-1 YU-2 envelope or vesicular stomatitis virus G protein (VSV-G). All the ARVs tested could effectively inhibit HIV-1 infection in macrophages, with EC(90)s below concentrations known to be achievable in the cerebral spinal fluid (CSF). Most of the ARVs had similar potency in astrocytes, however the NRTIs 3TC, d4T and ZDV had insufficient HIV-1 inhibitory activity in astrocytes, with EC(90)s 12-, 187- and 110-fold greater than achievable CSF concentrations, respectively. Our data suggest that 3TC, d4T and ZDV may not adequately target astrocyte infection in vivo, which has potential implications for their inclusion in Neuro-cART regimens.	[Gray, Lachlan R.; Tachedjian, Gilda; Ellett, Anne M.; Roche, Michael J.; Cheng, Wan-Jung; Wesselingh, Steve L.; Gorry, Paul R.; Churchill, Melissa J.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Gray, Lachlan R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Tachedjian, Gilda; Churchill, Melissa J.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Tachedjian, Gilda; Churchill, Melissa J.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Gorry, Paul R.] Monash Univ, Dept Infect Dis, Clayton, Vic 3800, Australia; [Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Guillemin, Gilles J.; Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Darlinghurst, NSW 2010, Australia; [Guillemin, Gilles J.; Brew, Bruce J.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia; [Turville, Stuart G.] Kirby Inst, Darlinghurst, NSW, Australia; [Wesselingh, Steve L.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Burnet Institute; Monash University; Monash University; Monash University; Monash University; University of Melbourne; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute; South Australian Health & Medical Research Institute (SAHMRI)	Churchill, MJ (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	churchil@burnet.edu.au	Guillemin, Gilles J/C-3878-2015; Tachedjian, Gilda/AAF-1327-2020; Brew, Bruce/J-6513-2012	Guillemin, Gilles J/0000-0001-8105-4470; Tachedjian, Gilda/0000-0002-7733-7037; Roche, Michael/0000-0001-8819-0096; brew, bruce/0000-0003-0622-1392; Turville, Stuart/0000-0003-1918-5343; Gray, Lachlan/0000-0002-9894-1049; Churchill, Melissa/0000-0001-5510-7954	Australian National Health and Medical Research Council (NHMRC) [603708]; Australian NHMRC [606967, 543105]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a project grant from the Australian National Health and Medical Research Council (NHMRC) to MJC, SLW and PRG (603708). PRG is the recipient of an Australian NHMRC Level 2 Biomedical Career Development Award. LRG is the recipient of an Australian NHMRC Postdoctoral Training Fellowship (606967). GT is the recipient of an Australian NHMRC Senior Research Fellowship (543105). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x; Cysique LA, 2009, NEUROLOGY, V73, P342, DOI 10.1212/WNL.0b013e3181ab2b3b; Cysique LAJ, 2004, ARCH NEUROL-CHICAGO, V61, P1699, DOI 10.1001/archneur.61.11.1699; Almeida Sergio Monteiro de, 2006, Braz J Infect Dis, V10, P41, DOI 10.1590/S1413-86702006000100009; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Drusano GL, 2002, ANTIMICROB AGENTS CH, V46, P913, DOI 10.1128/AAC.46.3.913-916.2002; Drusano GL, 1998, J INFECT DIS, V178, P360, DOI 10.1086/515631; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorry P, 1998, J NEUROVIROL, V4, P377, DOI 10.3109/13550289809114536; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gray L, 2006, J VIROL, V80, P3684, DOI 10.1128/JVI.80.7.3684-3691.2006; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Letendre S, 2010, 17 C RETR OPP INF CR; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Letendre Scott L, 2010, Top HIV Med, V18, P45; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; MAJOR EO, 1986, VIROLOGY, V148, P221, DOI 10.1016/0042-6822(86)90418-6; Marraa CM, 2009, AIDS, V23, P1359, DOI 10.1097/QAD.0b013e32832c4152; MUKHERJI E, 1994, ANTIMICROB AGENTS CH, V38, P1573, DOI 10.1128/AAC.38.7.1573; PERNO CF, 1988, J EXP MED, V168, P1111, DOI 10.1084/jem.168.3.1111; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Thompson KA, 2004, ANN NEUROL, V56, P873, DOI 10.1002/ana.20304; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tyssen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012309; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang ZY, 2004, J NEUROVIROL, V10, P25, DOI 10.1080/13550280490270851; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001	36	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62196	10.1371/journal.pone.0062196	http://dx.doi.org/10.1371/journal.pone.0062196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614033	Green Published, gold			2022-12-25	WOS:000317893400160
J	Pan, H; Xia, K; Zhou, WB; Xue, JQ; Liang, XQ; Cheng, L; Wu, NP; Liang, MD; Wu, D; Ling, LJ; Ding, Q; Chen, L; Zha, XM; Liu, XA; Wang, S				Pan, Hong; Xia, Kai; Zhou, Wenbin; Xue, Jinqiu; Liang, Xiuqing; Cheng, Lin; Wu, Naping; Liang, Mengdi; Wu, Dan; Ling, Lijun; Ding, Qiang; Chen, Lin; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui			Low Serum Creatine Kinase Levels in Breast Cancer Patients: A Case-Control Study	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; SKELETAL-MUSCLE; ENERGY HOMEOSTASIS; ISOENZYMES; TISSUES; CELLS; PROTEIN; PHOSPHOCREATINE; STATISTICS; METABOLISM	Background: Previous studies provide an ambiguous picture of creatine kinase (CK) expression and activities in malignancy. The aim of this study was to investigate the role of serum CK level in breast cancer patients. Patients and Methods: 823 female patients diagnosed with breast cancer were consecutively recruited as cases, and 823 age-match patients with benign breast disease were selected as controls. Serum CK was analyzed by commercially available standardized methods. Results: Serum CK level was significantly associated with breast cancer (P = 0.005) and subtypes of breast cancer, including breast cancer with diameter. 2 cm (P = 0.031) and stage IIIbreast cancer (P = 0.025). The mean serum CK level in patients with. 2 cm tumor was significantly lower than that in <= 2 cm (P = 0.0475), and the mean serum CK level of stage III breast cancer patients was significantly lower than that of stage I and II breast cancer patients (P = 0.0246). Furthermore, a significant difference (P = 0.004) was observed between serum CK level and ERBB2+ breast cancer not other molecular subtypes. Conclusions: Serum CK levels in cases was significantly lower compared with controls. Notably, our results indicated for the first time that there was a negative correlation between serum CK levels and breast cancer stage. Serum CK level, which may reflect the status of host immunity, may be an important factor in determining breast cancer development and progression.	[Pan, Hong; Xia, Kai; Zhou, Wenbin; Xue, Jinqiu; Liang, Xiuqing; Cheng, Lin; Wu, Naping; Liang, Mengdi; Wu, Dan; Ling, Lijun; Ding, Qiang; Chen, Lin; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui] Nanjing Med Univ, Dept Breast Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, XA (corresponding author), Nanjing Med Univ, Dept Breast Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	liuxiaoan@126.com; ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172505, 81202077, 81272916]; Natural Science Foundation of Jiangsu Province [BK201058, BK2011853, BK2011855]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD]	This work was supported in part by the National Natural Science Foundation of China [81071753, 81172505, 81202077 and 81272916], the Natural Science Foundation of Jiangsu Province [BK201058, BK2011853 and BK2011855], the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008] and a project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1992, EUR J CANCER, V28A, P859, DOI 10.1016/0959-8049(92)90134-N; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; An Y, 2009, MOL IMMUNOL, V46, P2666, DOI 10.1016/j.molimm.2009.04.001; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Cramer DW, 2011, CURR OPIN IMMUNOL, V23, P265, DOI 10.1016/j.coi.2011.01.002; Delahunt B, 2001, AM J CLIN PATHOL, V116, P354, DOI 10.1309/HNDA-1RMT-63GP-52FU; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; DINNING JS, 1951, SCIENCE, V114, P502, DOI 10.1126/science.114.2967.502; Disis ML, 1996, BLOOD, V88, P202; Durany N, 2000, BRIT J CANCER, V82, P20; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Gao YY, 2007, J PROTEOME RES, V6, P4321, DOI 10.1021/pr070504x; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Joseph J, 1997, BRIT J CANCER, V76, P600, DOI 10.1038/bjc.1997.432; Kinoshita Y, 1997, NMR BIOMED, V10, P2, DOI 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Kuum M, 2009, CARDIOVASC RES, V83, P89, DOI 10.1093/cvr/cvp125; Lehnhardt FG, 2005, NMR BIOMED, V18, P371, DOI 10.1002/nbm.968; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PASHINTSEVA LP, 1986, EKSP ONKOL, V8, P51; Patra S, 2008, FEBS J, V275, P3236, DOI 10.1111/j.1742-4658.2008.06475.x; Patra S, 2012, AMINO ACIDS, V42, P2319, DOI 10.1007/s00726-011-0974-3; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; PICKERING L, 1985, P NATL ACAD SCI USA, V82, P2310, DOI 10.1073/pnas.82.8.2310; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; TSUNG SH, 1983, CLIN CHEM, V29, P2040; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WALLIMANN T, 1977, J CELL BIOL, V75, P297, DOI 10.1083/jcb.75.2.297; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wong PY, 1998, J SURG RES, V76, P95, DOI 10.1006/jsre.1998.5301; WONG SS, 1987, CLIN CHEM, V33, P809; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YANOKURA M, 1984, BIOCHIM BIOPHYS ACTA, V797, P94, DOI 10.1016/0304-4165(84)90386-6; YANOKURA M, 1982, BIOCHEM BIOPH RES CO, V104, P1464, DOI 10.1016/0006-291X(82)91415-2; Zhang HL, 2012, FISH SHELLFISH IMMUN, V33, P1139, DOI 10.1016/j.fsi.2012.08.025; Zhang YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005000; Zhao TJ, 2007, J BIOL CHEM, V282, P12022, DOI 10.1074/jbc.M610363200	45	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e62112	10.1371/journal.pone.0062112	http://dx.doi.org/10.1371/journal.pone.0062112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23614022	Green Published, Green Submitted, gold			2022-12-25	WOS:000317563300051
J	Chandler, JD; Nichols, DP; Nick, JA; Hondal, RJ; Day, BJ				Chandler, Joshua D.; Nichols, David P.; Nick, Jerry A.; Hondal, Robert J.; Day, Brian J.			Selective Metabolism of Hypothiocyanous Acid by Mammalian Thioredoxin Reductase Promotes Lung Innate Immunity and Antioxidant Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; LACTOPEROXIDASE-THIOCYANATE; CYSTIC-FIBROSIS; MYELOPEROXIDASE; INHIBITION; SYSTEM; OXIDATION; GLUTATHIONE; SALIVA; CHLORINATION	The endogenously produced oxidant hypothiocyanous acid (HOSCN) inhibits and kills pathogens but paradoxically is well tolerated by mammalian host tissue. Mammalian high molecular weight thioredoxin reductase (H-TrxR) is evolutionarily divergent from bacterial low molecular weight thioredoxin reductase (L-TrxR). Notably, mammalian H-TrxR contains a selenocysteine (Sec) and has wider substrate reactivity than L-TrxR. Recombinant rat cytosolic H-TrxR1, mouse mitochondrial H-TrxR2, and a purified mixture of both from rat selectively turned over HOSCN (k(cat) = 357 +/- 16 min(-1); K-m = 31.9 +/- 10.3 mu M) but were inactive against the related oxidant hypochlorous acid. Replacing Sec with Cys or deleting the final eight C-terminal peptides decreased affinity and turnover of HOSCN by H-TrxR. Similarly, glutathione reductase (an H-TrxR homologue lacking Sec) was less effective at HOSCN turnover. In contrast to H-TrxR and glutathione reductase, recombinant Escherichia coli L-TrxR was potently inhibited by HOSCN (IC50 = 2.75 mu M). Similarly, human bronchial epithelial cell (16HBE) lysates metabolized HOSCN, but E. coli and Pseudomonas aeruginosa lysates had little or no activity. HOSCN selectively produced toxicity in bacteria, whereas hypochlorous acid was nonselectively toxic to both bacteria and 16HBE. Treatment with the H-TrxR inhibitor auranofin inhibited HOSCN metabolism in 16HBE lysates and significantly increased HOSCN-mediated cytotoxicity. These findings demonstrate both the metabolism of HOSCN by mammalian H-TrxR resulting in resistance to HOSCN in mammalian cells and the potent inhibition of bacterial L-TrxR resulting in cytotoxicity in bacteria. These data support a novel selective mechanism of host defense in mammals wherein HOSCN formation simultaneously inhibits pathogens while sparing host tissue.	[Chandler, Joshua D.; Day, Brian J.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Chandler, Joshua D.; Nichols, David P.; Nick, Jerry A.; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Nichols, David P.; Nick, Jerry A.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Hondal, Robert J.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; University of Vermont	Day, BJ (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	dayb@njhealth.org		Nichols, David/0000-0001-8611-7960	National Institutes of Health [HL084469]; Cystic Fibrosis Foundation; CCTSI KL2 Scholars Grant [TR000156]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, KL2TR000156, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CCTSI KL2 Scholars Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL084469 (to B. J. D.). This work was also supported by a Cystic Fibrosis Foundation research grant (to B. J. D. and D. P. N.) and CCTSI KL2 Scholars Grant TR000156 (to D. P. N.).	Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; [Anonymous], BIOCH PHARM, V84, P1381; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Courtois P, 1996, BIOCHEM MOL MED, V57, P134, DOI 10.1006/bmme.1996.0019; DAS D, 1995, BIOCHEM J, V305, P59, DOI 10.1042/bj3050059; Eckenroth B, 2006, BIOCHEMISTRY-US, V45, P5158, DOI 10.1021/bi0517887; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Hilliard Jay B, 2002, Methods Mol Med, V70, P409; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Hondal RJ, 2011, AMINO ACIDS, V41, P73, DOI 10.1007/s00726-010-0494-6; Kariya C, 2008, INFECT IMMUN, V76, P4455, DOI 10.1128/IAI.00136-08; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; LENANDERLUMIKARI M, 1992, ORAL MICROBIOL IMMUN, V7, P315, DOI 10.1111/j.1399-302X.1992.tb00595.x; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; MIKOLA H, 1995, ANTIVIR RES, V26, P161, DOI 10.1016/0166-3542(94)00073-H; Minarowski L, 2008, FOLIA HISTOCHEM CYTO, V46, P245, DOI 10.2478/v10042-008-0037-0; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; ORAM JD, 1966, BIOCHEM J, V100, P373, DOI 10.1042/bj1000373; REITER B, 1976, INFECT IMMUN, V13, P800, DOI 10.1128/IAI.13.3.800-807.1976; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Skaff O, 2012, BIOCHEM J, V441, P305, DOI 10.1042/BJ20101762; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Stacey MM, 2012, ANTIOXID REDOX SIGN, V17, P411, DOI 10.1089/ars.2011.4348; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; TENOVUO J, 1985, ANTIMICROB AGENTS CH, V27, P96, DOI 10.1128/AAC.27.1.96; TENOVUO J, 1982, J DENT RES, V61, P982, DOI 10.1177/00220345820610081301; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Wang JG, 2006, J IMMUNOL, V177, P8714, DOI 10.4049/jimmunol.177.12.8714; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Xu YP, 2009, P NATL ACAD SCI USA, V106, P20515, DOI 10.1073/pnas.0911412106; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	47	45	46	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18421	18428		10.1074/jbc.M113.468090	http://dx.doi.org/10.1074/jbc.M113.468090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23629660	hybrid, Green Published			2022-12-25	WOS:000320721900044
J	Liu, Z; Ioerger, TR; Wang, F; Sacchettini, JC				Liu, Zhen; Ioerger, Thomas R.; Wang, Feng; Sacchettini, James C.			Structures of Mycobacterium tuberculosis FadD10 Protein Reveal a New Type of Adenylate-forming Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ACYL-COA SYNTHETASE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CRYSTAL-STRUCTURE; COENZYME; IDENTIFICATION; CLONING; OVEREXPRESSION; PURIFICATION; MYCOSUBTILIN	Mycobacterium tuberculosis has a group of 34 FadD proteins that belong to the adenylate-forming superfamily. They are classified as either fatty acyl-AMP ligases (FAALs) or fatty acyl-CoA ligases based on sequence analysis. FadD10, involved in the synthesis of a virulence-related lipopeptide, was mis-annotated as a fatty acyl-CoA ligase; however, it is in fact a FAAL that transfers fatty acids to an acyl carrier protein (Rv0100). In this study, we have determined the structures of FadD10 in both the apo-form and the complexed form with dodecanoyl-AMP, where we see for the first time an adenylate-forming enzyme that does not adopt a closed conformation for catalysis. Indeed, this novel conformation of FadD10, facilitated by its unique inter-domain and intermolecular interactions, is critical for the enzyme to carry out the acyl transfer onto Rv0100 rather than coenzyme A. This contradicts the existing model of FAALs that rely on an insertion motif for the acyltransferase specificity and thus makes FadD10 a new type of FAAL. We have also characterized the fatty acid preference of FadD10 through biological and structural analyses, and the data indicate long chain saturated fatty acids as the biological substrates of the enzyme.	[Liu, Zhen; Sacchettini, James C.] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Wang, Feng] Calif Inst Biomed Res, La Jolla, CA 92037 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA.	sacchett@tamu.edu		Wang, Feng/0000-0003-2980-4646	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Li-Wei Hung at the Advanced Light Source for collecting the diffraction data of the apo-FadD10. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. We thank Amir Safi and Tracey Musa for editing the manuscript and Dr. Inna Krieger, Anup Aggarwal, and Mallikarjun Lalgondar for helpful comments on the manuscript.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P66, DOI 10.1007/s10295-005-0030-y; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraga H, 2004, CHEMBIOCHEM, V5, P110, DOI 10.1002/cbic.200300735; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Heinzelmann E, 2005, MICROBIOL-SGM, V151, P1963, DOI 10.1099/mic.0.27844-0; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Linne U, 2007, FEBS LETT, V581, P905, DOI 10.1016/j.febslet.2007.01.066; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Miao V, 2006, J IND MICROBIOL BIOT, V33, P129, DOI 10.1007/s10295-005-0028-5; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Raman S, 2006, J BACTERIOL, V188, P8460, DOI 10.1128/JB.01212-06; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rindi L, 2004, MICROBIOLOGICA, V27, P125; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Shah MB, 2009, PROTEINS, V77, P685, DOI 10.1002/prot.22482; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	53	26	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18473	18483		10.1074/jbc.M113.466912	http://dx.doi.org/10.1074/jbc.M113.466912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23625916	Green Published, hybrid			2022-12-25	WOS:000320721900049
J	Guengerich, FP				Guengerich, F. Peter			New Trends in Cytochrome P450 Research at the Half-Century Mark	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MONOXIDE-BINDING PIGMENT; LIVER MICROSOMES; SUPERFAMILY	Cytochrome P450 enzymes have major roles in the metabolism of steroids, drugs, carcinogens, eicosanoids, and numerous other chemicals. The P450s are collectively considered the most diverse catalysts known in biochemistry, although they operate from a basic structural fold and catalytic mechanism. The four minireviews in this thematic series deal with the unusual aspects of catalytic reactions and electron transfer pathway organization, the structural diversity of P450s, and the expanding roles of P450s in disease and medicine.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA090426] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GARFINKEL D, 1958, ARCH BIOCHEM BIOPHYS, V77, P493, DOI 10.1016/0003-9861(58)90095-X; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; MUELLER GC, 1948, J BIOL CHEM, V176, P535; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; Pikuleva IA, 2013, J BIOL CHEM, V288, P17091, DOI 10.1074/jbc.R112.431916; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; RYAN KJ, 1958, BIOCHIM BIOPHYS ACTA, V27, P658, DOI 10.1016/0006-3002(58)90408-6; Sato R., 1987, CYT P 450 NEW TRENDS; Williams RT, 1947, DETOXICATION MECH, V1	18	18	19	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17063	17064		10.1074/jbc.R113.466821	http://dx.doi.org/10.1074/jbc.R113.466821			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632015	Green Published, hybrid			2022-12-25	WOS:000320380600003
J	Okeyo, G; Wang, W; Wei, SP; Kirk, KL				Okeyo, George; Wang, Wei; Wei, Shipeng; Kirk, Kevin L.			Converting Nonhydrolyzable Nucleotides to Strong Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Agonists by Gain of Function (GOF) Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING; CATALYTIC CYCLE; CONFORMATIONAL-CHANGE; P-GLYCOPROTEIN; GAMMA-S; CHANNEL; DOMAIN; HYDROLYSIS; MECHANISM; 2ND	Cystic fibrosis transmembrane conductance regulator (CFTR) is the only ligand-gated ion channel that hydrolyzes its agonist, ATP. CFTR gating has been argued to be tightly coupled to its enzymatic activity, but channels do open occasionally in the absence of ATP and are reversibly activated (albeit weakly) by nonhydrolyzable nucleotides. Why the latter only weakly activates CFTR is not understood. Here we show that CFTR activation by adenosine 5'-O-(thiotriphosphate) (ATP gamma S), adenosine 5'-(beta,gamma-imino)triphosphate (AMP-PNP), and guanosine 5'-3-O-(thio)triphosphate (GTP gamma S) is enhanced substantially by gain of function (GOF) mutations in the cytosolic loops that increase unliganded activity. This enhancement correlated with the base-line nucleotide-independent activity for several GOF mutations. AMP-PNP or ATP gamma S activation required both nucleotide binding domains (NBDs) and was disrupted by a cystic fibrosis mutation in NBD1 (G551D). GOF mutant channels deactivated very slowly upon AMP-PNP or ATP gamma S removal (tau(deac) similar to 100 s) implying tight binding between the two NBDs. Despite this apparently tight binding, neither AMP-PNP nor ATP gamma S activated even the strongest GOF mutant as strongly as ATP. ATP gamma S-activated wild type channels deactivated more rapidly, indicating that GOF mutations in the cytosolic loops reciprocally/allosterically affect nucleotide occupancy of the NBDs. A GOF mutation substantially rescued defective ATP-dependent gating of G1349D-CFTR, a cystic fibrosis NBD2 signature sequence mutant. Interestingly, the G1349D mutation strongly disrupted activation by AMP-PNP but not by ATP gamma S, indicating that these analogs interact differently with the NBDs. We conclude that poorly hydrolyzable nucleotides are less effective than ATP at opening CFTR channels even when they bind tightly to the NBDs but are converted to stronger agonists by GOF mutations.	[Okeyo, George; Wang, Wei; Wei, Shipeng; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982B MCLM,1720 2nd Ave South, Birmingham, AL 35294 USA.	klkirk@uab.edu			National Institutes of Health [R01 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK056796.	Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hennager DJ, 2001, P NATL ACAD SCI USA, V98, P3594, DOI 10.1073/pnas.051633298; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Payen L, 2005, MOL PHARMACOL, V67, P1944, DOI 10.1124/mol.104.007708; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Szentpetery Z, 2004, J BIOL CHEM, V279, P41670, DOI 10.1074/jbc.M406484200; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	44	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17122	17133		10.1074/jbc.M112.442582	http://dx.doi.org/10.1074/jbc.M112.442582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620589	Green Published, hybrid			2022-12-25	WOS:000320380600010
J	Bao, XY; Kolli, D; Ren, JP; Liu, TS; Garofalo, RP; Casola, A				Bao, Xiaoyong; Kolli, Deepthi; Ren, Junping; Liu, Tianshuang; Garofalo, Roberto P.; Casola, Antonella			Human Metapneumovirus Glycoprotein G Disrupts Mitochondrial Signaling in Airway Epithelial Cells	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ANTIVIRAL INNATE IMMUNITY; I-LIKE RECEPTORS; RIG-I; GENE-EXPRESSION; RNA HELICASE; IKK-EPSILON; ACTIVATION; INFECTION; TRANSCRIPTION	Human metapneumovirus (hMPV) is a recently identified RNA virus belonging to the Paramyxoviridae family. It is a common cause of respiratory tract infections in children, adults, and immunocompromised patients, for which no specific treatment or vaccine is available. Recent investigations in our lab identified hMPV glycoprotein G as an important virulence factor, as a recombinant virus lacking the G protein (rhMPV-Delta G) exhibited enhanced production of important immune and antiviral mediators, such as cytokines, chemokines and type I interferon (IFN) in airway epithelial cells, and expression of G protein alone inhibits cellular signaling dependent on retinoic induced gene (RIG)-I, a RNA helicase with a fundamental role in initiating hMPV-induced cellular responses. In this study, we have further investigated the mechanism underlying the inhibitory role of hMPV G protein on RIG-I-dependent signaling. We found that the interaction of hMPV G with RIG-I occurs primarily through the CARD domains of RIG-I N-terminus, preventing RIG-I association with the adaptor protein MAVS (mitochondrial antiviral signaling protein), recruitment of RIG-I to mitochondria, as well as the interaction between mitochondria and mitochondria-associated membrane (MAM) component of the endoplasmic reticulum (ER), which contains STINGS, an important part of the viral-induced RIG-I/MAVS signaling pathway, leading in the end to the inhibition of cytokine, chemokine and type I IFN expression. Mutagenesis analysis showed that hMPV G protein cytoplasmic domain played a major role in the observed inhibitory activity, and recombinant viruses expressing a G protein with amino acid substitution in position 2 and 3 recapitulated most of the phenotype observed with rhMPV-Delta G mutant upon infection of airway epithelial cells.	[Bao, Xiaoyong; Kolli, Deepthi; Ren, Junping; Liu, Tianshuang; Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bao, XY (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	xibao@utmb.edu; ancasola@utmb.edu	Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022		National Institute of Health [AI079246, P01 AI062885, KAI074829A]; Parker B. Francis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885, R01AI079246] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health grants AI079246 (AC), P01 AI062885 (AC), KAI074829A (XB), and Parker B. Francis Foundation (XB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bao X, 2007, VIROLOGY, V368, P91, DOI 10.1016/j.virol.2007.06.023; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Bao XY, 2005, J BIOL CHEM, V280, P8647, DOI 10.1074/jbc.M413536200; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Broor S, 2007, ANN NY ACAD SCI, V1102, P66, DOI 10.1196/annals.1408.005; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Cox RG, 2012, J VIROL; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guerrero-Plata A, 2009, J IMMUNOL, V182, P3072, DOI 10.4049/jimmunol.0802262; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kim Sol, 2012, Immune Netw, V12, P8, DOI 10.4110/in.2012.12.1.8; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0; Lin RT, 1999, MOL CELL BIOL, V19, P959; Mok Hoyin, 2012, Open Virol J, V6, P12, DOI 10.2174/1874357901206010012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024496; Ren JP, 2011, J GEN VIROL, V92, P2153, DOI 10.1099/vir.0.032987-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; VANCE JE, 1990, J BIOL CHEM, V265, P7248; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	44	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62568	10.1371/journal.pone.0062568	http://dx.doi.org/10.1371/journal.pone.0062568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626834	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400198
J	Hui, LP; Zhang, SY; Dong, XJ; Tian, DL; Cui, ZS; Qiu, XS				Hui, Linping; Zhang, Siyang; Dong, Xinjun; Tian, Dali; Cui, Zeshi; Qiu, Xueshan			Prognostic Significance of Twist and N-Cadherin Expression in NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; BREAST-CANCER; GASTRIC-CANCER; INVASION; CARCINOMA; MIGRATION; ACTIVATION; RESISTANCE	Background: Metastasis is the most common cause of disease failure and mortality for non-small cell lung cancer after surgical resection. Twist has been recently identified as a putative oncogene and a key regulator of carcinoma metastasis. N-cadherin is associated with a more aggressive behavior of cell lines and tumors. The aim of this study was to evaluate the clinical relevance of Twist and N-cadherin expression in NSCLC, and the effects of Twist1 knockdown on lung cancer cells. Methods: We examined the expressions of Twist and N-cadherin by immunohistochemistry in 120 cases of non-small cell lung cancer (including 68 cases with follow-up records). We also analyzed Twist1 and N-cadherin mRNA expression in 30 non-small cell lung cancer tissues using quantitative reverse transcription polymerase chain reaction. The functional roles of Twist1 in lung cancer cell lines were evaluated by small interfering RNA-mediated depletion of the protein followed by analyses of cell apoptosis and invasion. Results: In lung cancer tissues, the overexpression rate of Twist was 38.3% in lung cancer tissues. Overexpression of N-cadherin was shown in 40.83% of primary tumors. Moreover, Twist1 mRNA expression levels correlated with N-cadherin mRNA levels. Furthermore, overexpression of Twist1 or N-cadherin in primary non-small cell lung cancers was associated with a shorter overall survival (P<0.01, P<0.01, respectively). Depleting Twist expression inhibited cell invasion and increased apoptosis in lung cancer cell lines. Conclusions: The overexpression of Twist and N-cadherin could be considered as useful biomarkers for predicting the prognosis of NSCLC. Twist1 could inhibit apoptosis and promote the invasion of lung cancer cells, and depletion of Twist1 in lung cancer cells led to inhibition of N-cadherin expression.	[Hui, Linping] China Med Univ, Affiliated Hosp 4, Lab Ctr, Shenyang, Peoples R China; [Hui, Linping; Zhang, Siyang; Cui, Zeshi] China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China; [Dong, Xinjun; Qiu, Xueshan] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Dong, Xinjun; Qiu, Xueshan] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Tian, Dali] China Med Univ, Affiliated Hosp 4, Dept Thorac Surg, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Cui, ZS (corresponding author), China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China.	labczs@mail.cmu.edu.cn			Scientific Research Fund of Liaoning Provincial Education Department [L2010651]; National Natural Science Foundation of China [81101599]; Shenyang Municipal Science and Technology Department [F11-241-00]	Scientific Research Fund of Liaoning Provincial Education Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenyang Municipal Science and Technology Department	This work was supported by grants from the Scientific Research Fund of Liaoning Provincial Education Department (No. L2010651), the National Natural Science Foundation of China (No. 81101599) and the Shenyang Municipal Science and Technology Department (No. F11-241-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haithcock BE, 2009, CLIN LUNG CANCER, V10, P405, DOI 10.3816/CLC.2009.n.076; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hui Linping, 2009, Zhongguo Fei Ai Za Zhi, V12, P294, DOI 10.3779/j.issn.1009-3419.2009.04.07; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Jiang W, 2012, CLIN LUNG CANCER, V13, P280, DOI 10.1016/j.cllc.2011.11.005; Lascombe I, 2006, CLIN CANCER RES, V12, P2780, DOI 10.1158/1078-0432.CCR-05-2387; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Nakashima H, 2012, MOL CARCINOGEN, V51, P400, DOI 10.1002/mc.20802; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; Pallier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029954; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang GH, 2011, EUR J CARDIO-THORAC, V39, P1028, DOI 10.1016/j.ejcts.2011.01.023; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Xie FW, 2009, CLIN EXP METASTAS, V26, P1025, DOI 10.1007/s10585-009-9292-5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Zhang SY, 2012, PATHOLOGY, V44, P434, DOI 10.1097/PAT.0b013e328354ffdf; Zhang XM, 2007, INT J CANCER, V120, P1891, DOI 10.1002/ijc.22489; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x	38	65	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62171	10.1371/journal.pone.0062171	http://dx.doi.org/10.1371/journal.pone.0062171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626784	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400148
J	Regan, S; Losina, E; Chetty, S; Giddy, J; Walensky, RP; Ross, D; Holst, H; Katz, JN; Freedberg, KA; Bassett, IV				Regan, Susan; Losina, Elena; Chetty, Senica; Giddy, Janet; Walensky, Rochelle P.; Ross, Douglas; Holst, Helga; Katz, Jeffrey N.; Freedberg, Kenneth A.; Bassett, Ingrid V.			Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; CARE; INFECTION; DIAGNOSIS; IMPACT	Background: Routine screening for HIV infection leads to early detection and treatment. We examined patient characteristics associated with repeated screening in a high prevalence country. Methods: We analyzed data from a cohort of 5,229 adults presenting for rapid HIV testing in the outpatient departments of 2 South African hospitals from November 2006 to August 2010. Patients were eligible if they were >= 18 years, reported no previous diagnosis with HIV infection, and not pregnant. Before testing, participants completed a questionnaire including gender, age, HIV testing history, health status, and knowledge about HIV and acquaintances with HIV. Enrollment HIV test results and CD4 counts were abstracted from the medical record. We present prevalence of HIV infection and median CD4 counts by HIV testing history (first-time vs. repeat). We estimated adjusted relative risks (ARR's) for repeat testing by demographics, health status, and knowledge of HIV and others with HIV in a generalized linear model. Results: Of 4,877 participants with HIV test results available, 26% (N = 1258) were repeat testers. Repeat testers were less likely than first-time testers to be HIV-infected (34% vs. 54%, p < 0.001). Median CD4 count was higher among repeat than first-time testers (201/uL vs. 147/uL, p < 0.001). Among those HIV negative at enrollment (N = 2,499), repeat testing was more common among those with family or friends living with HIV (ARR 1.50, 95% CI: 1.33-1.68), women (ARR: 1.24, 95% CI: 1.11-1.40), and those self-reporting very good health (ARR: 1.28, 95% CI: 1.12-1.45). Conclusions: In this high prevalence setting, repeat testing was common among those undergoing HIV screening, and was associated with female sex, lower prevalence of HIV infection, and higher CD4 counts at diagnosis.	[Regan, Susan; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Chetty, Senica; Giddy, Janet; Holst, Helga] McCord Hosp, Durban, South Africa; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ross, Douglas] St Marys Hosp, Durban, South Africa; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Regan, Susan; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Regan, S (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.	sregan@partners.org	Bassett, Ingrid V./ABI-7674-2020	Bassett, Ingrid V./0000-0001-6920-6080; Regan, Susan/0000-0003-0940-2017; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Allergy and Infectious Disease [K23 AI068458, K24 AI062476]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; Claflin Distinguished Scholar Award; Burke Global Health Fellowship; Harvard Catalyst [UL1 RR 025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K24AI062476, K23AI001794, K23AI068458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH090326] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Claflin Distinguished Scholar Award; Burke Global Health Fellowship; Harvard Catalyst; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Allergy and Infectious Disease: K23 AI068458; K24 AI062476; the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Mental Health: R01 MH090326; R01 MH073445; the Claflin Distinguished Scholar Award, the Burke Global Health Fellowship, and the Harvard Catalyst (UL1 RR 025758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bradley H, 2011, AIDS BEHAV, V15, P725, DOI 10.1007/s10461-010-9765-1; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; de Wit JBF, 2008, HIV MED, V9, P20, DOI 10.1111/j.1468-1293.2008.00586.x; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Gras L, 2011, AIDS, V25, P813, DOI 10.1097/QAD.0b013e3283454cd7; Kiene SM, 2010, AIDS PATIENT CARE ST, V24, P117, DOI 10.1089/apc.2009.0269; Kranzer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025244; Liddicoat RV, 2006, AIDS PATIENT CARE ST, V20, P84, DOI 10.1089/apc.2006.20.84; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Phakathi Z, 2011, AJAR-AFR J AIDS RES, V10, P173, DOI 10.2989/16085906.2011.593381; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Schwarcz S, 2011, AIDS CARE, V23, P892, DOI 10.1080/09540121.2010.534436; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Silvestri DM, 2011, JAIDS-J ACQ IMM DEF, V56, pE9, DOI 10.1097/QAI.0b013e3181fdb629; Sobrino-Vegas P, 2009, CURR HIV RES, V7, P224, DOI 10.2174/157016209787581535; South Sudan Ministry of Health, 2007, STRAT PLAN HUM RES H; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Topp Stephanie M, 2012, J Int AIDS Soc, V15, P17352, DOI 10.7448/IAS.15.2.17352; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62362	10.1371/journal.pone.0062362	http://dx.doi.org/10.1371/journal.pone.0062362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626808	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400172
J	Townsend, T; Segura, V; Chigeza, G; Penfield, T; Rae, A; Harvey, D; Bowles, D; Graham, IA				Townsend, Theresa; Segura, Vincent; Chigeza, Godfree; Penfield, Teresa; Rae, Anne; Harvey, David; Bowles, Dianna; Graham, Ian A.			The Use of Combining Ability Analysis to Identify Elite Parents for Artemisia annua F1 Hybrid Production	PLOS ONE			English	Article							L.; SELECTION; WHEAT; YIELD	Artemisia annua is an important medicinal crop used for the production of the anti-malarial compound artemisinin. In order to assist in the production of affordable high quality artemisinin we have carried out an A. annua breeding programme aimed at improving artemisinin concentration and biomass. Here we report on a combining ability analysis of a diallel cross to identify robust parental lines for hybrid breeding. The parental lines were selected based on a range of phenotypic traits to encourage heterosis. The general combining ability (GCA) values for the diallel parental lines correlated to the positive alleles of quantitative trait loci (QTL) in the same parents indicating the presence of beneficial alleles that contribute to parental performance. Hybrids generated from crossing specific parental lines with good GCA were identified as having an increase in both artemisinin concentration and biomass when grown either in glasshouse or experimental field trials and compared to controls. This study demonstrates that combining ability as determined by a diallel cross can be used to identify elite parents for the production of improved A. annua hybrids. Furthermore, the selection of material for breeding using this approach was found to be consistent with our QTL-based molecular breeding approach.	[Townsend, Theresa; Segura, Vincent; Chigeza, Godfree; Penfield, Teresa; Rae, Anne; Harvey, David; Bowles, Dianna; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Segura, Vincent] INRA, UR0588, Orleans, France; [Chigeza, Godfree] Agr Res Council, Grain Crops Inst, Potchefstroom, South Africa; [Penfield, Teresa] Univ Exeter, Res & Knowledge Transfer, Exeter, Devon, England; [Rae, Anne] Cherry Valley Farms Ltd, Dept Genet, Caistor, England	University of York - UK; INRAE; Agricultural Research Council of South Africa; University of Exeter	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ian.graham@york.ac.uk	Segura, Vincent/B-4656-2013	Segura, Vincent/0000-0003-1860-2256	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by a grant from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS U LAUSANNE; Balestre M, 2008, GENET MOL RES, V7, P65, DOI 10.4238/vol7-1gmr403; CHRISTIE BR, 1992, PLANT BREED REV, V9, P9; de Magalhaes PM, 1999, ACTA HORTIC, P377, DOI 10.17660/ActaHortic.1999.502.62; Delabays N., 1993, Acta Horticulturae, P203; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; Delabays N., 2002, ARTEMISIA, V330, P197; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ferreira J. F. S., 2005, Plant Genetic Resources Characterization and Utilization, V3, P206, DOI 10.1079/PGR200585; Ferreira J. F. S., 1997, Horticultural Reviews, V19, P319; Ferreira JFS, 2010, J AGR FOOD CHEM, V58, P1691, DOI 10.1021/jf903222j; Gowda M, 2010, CROP SCI, V50, P2224, DOI 10.2135/cropsci2009.10.0637; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; HULL FH, 1945, J AM SOC AGRON, V37, P134; Isik F., 2009, ANAL DIALLEL MATING; Jain DC, 1996, PHYTOCHEMISTRY, V43, P993, DOI 10.1016/S0031-9422(96)00369-X; Khan NU, 2009, PAK J BOT, V41, P131; Laughlin J.C., 2002, ARTEMISIA, V18, P159; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Miedaner T, 1997, PLANT BREEDING, V116, P201, DOI 10.1111/j.1439-0523.1997.tb00985.x; Mohring J, 2011, CROP SCI, V51, P470, DOI 10.2135/cropsci2010.05.0272; PAPADAKIS JS, 1984, P ACAD ATHENS, V59, P326; Paul S, 2010, PLANTA MED, V76, P1468, DOI 10.1055/s-0029-1240940; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; SHATTUCK VI, 1993, GENETICA, V90, P73, DOI 10.1007/BF01435180; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; Wu H, 2001, SILVAE GENET, V50, P265	30	36	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61989	10.1371/journal.pone.0061989	http://dx.doi.org/10.1371/journal.pone.0061989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626762	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400126
J	Verhaegh, SJC; Flores, AR; van Belkum, A; Musser, JM; Hays, JP				Verhaegh, Suzanne J. C.; Flores, Anthony R.; van Belkum, Alex; Musser, James M.; Hays, John P.			Differential Virulence Gene Expression of Group A Streptococcus Serotype M3 in Response to Co-Culture with Moraxella catarrhalis	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; OTITIS-MEDIA; LISTERIA-MONOCYTOGENES; RESPIRATORY-TRACT; GENOME ANALYSIS; BETA-LACTAMASE; STREPTOLYSIN-S; PYOGENES; GROWTH; TRANSCRIPTOME	Streptococcus pyogenes (group A Streptococcus, GAS) and Moraxella catarrhalis are important colonizers and (opportunistic) pathogens of the human respiratory tract. However, current knowledge regarding colonization and pathogenic potential of these two pathogens is based on work involving single bacterial species, even though the interplay between respiratory bacterial species is increasingly important in niche occupation and the development of disease. Therefore, to further define and understand polymicrobial species interactions, we investigated whether gene expression (and hence virulence potential) of GAS would be affected upon co-culture with M. catarrhalis. For co-culture experiments, GAS and M. catarrhalis were cultured in Todd-Hewitt broth supplemented with 0.2% yeast extract (THY) at 37 degrees C with 5% CO2 aeration. Each strain was grown in triplicate so that triplicate experiments could be performed. Bacterial RNA was isolated, cDNA synthesized, and microarray transcriptome expression analysis performed. We observed significantly increased (>= 4-fold) expression for genes playing a role in GAS virulence such as hyaluronan synthase (hasA), streptococcal mitogenic exotoxin Z (smeZ) and IgG endopeptidase (ideS). In contrast, significantly decreased (>= 4-fold) expression was observed in genes involved in energy metabolism and in 12 conserved GAS two-component regulatory systems. This study provides the first evidence that M. catarrhalis increases GAS virulence gene expression during co-culture, and again shows the importance of polymicrobial infections in directing bacterial virulence.	[Verhaegh, Suzanne J. C.; van Belkum, Alex; Hays, John P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Flores, Anthony R.; Musser, James M.] Methodist Hosp, Dept Pathol & Genom Med, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Flores, Anthony R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Flores, Anthony R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [van Belkum, Alex] BioMerieux, Microbiol R&D Unit, La Balme Les Grottes, France	Erasmus University Rotterdam; Erasmus MC; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; bioMerieux	Verhaegh, SJC (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.verhaegh@erasmusmc.nl	Hays, J/I-9007-2017; Flores, Anthony/W-3797-2017	Hays, J/0000-0001-9183-4497; Flores, Anthony/0000-0002-6402-4269	ESCMID; Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences	ESCMID; Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences	This work was financially supported by an ESCMID Travel Grant for Training in a Foreign Institution and the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Armbruster CE, 2010, EXPERT REV ANTI-INFE, V8, P1067, DOI [10.1586/eri.10.109, 10.1586/ERI.10.109]; Attia AS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-207; Berggren K, 2009, BIOORGAN MED CHEM, V17, P3463, DOI 10.1016/j.bmc.2009.03.026; Budhani RK, 1998, ANTIMICROB AGENTS CH, V42, P2521, DOI 10.1128/AAC.42.10.2521; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; DOERN GV, 1990, AM J MED, V88, pS33, DOI 10.1016/0002-9343(90)90259-G; Garcia-Casares E, 2010, JCR-J CLIN RHEUMATOL, V16, P382, DOI 10.1097/RHU.0b013e3181fe8ba3; HOL C, 1994, J INFECT DIS, V170, P1613; Johansson L, 2010, CLIN INFECT DIS, V51, P58, DOI 10.1086/653116; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Lafontaine ER, 2004, INFECT IMMUN, V72, P6689, DOI 10.1128/IAI.72.11.6689-6693.2004; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Marchisio P, 2010, Int J Immunopathol Pharmacol, V23, P20; Massa HM, 2009, MED J AUSTRALIA, V191, pS44; Mellefont LA, 2008, INT J FOOD MICROBIOL, V121, P157, DOI 10.1016/j.ijfoodmicro.2007.10.010; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Roberts AL, 2010, INFECT IMMUN, V78, P4800, DOI 10.1128/IAI.00255-10; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Shea PR, 2011, P NATL ACAD SCI USA, V108, P5039, DOI 10.1073/pnas.1016282108; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009785; Sitkiewicz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006114; Soderberg JJ, 2008, MOL IMMUNOL, V45, P3347, DOI 10.1016/j.molimm.2008.04.013; Sriskandan S, 2007, INT J BIOCHEM CELL B, V39, P12, DOI 10.1016/j.biocel.2006.08.009; Stahelin-Massik J, 2008, EUR J PEDIATR, V167, P541, DOI 10.1007/s00431-007-0549-1; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Torretta S, 2012, OTOLARYNG HEAD NECK, V146, P991, DOI 10.1177/0194599812438169; Trainor VC, 1999, FEMS MICROBIOL LETT, V176, P421, DOI 10.1016/S0378-1097(99)00267-0; Traub WH, 1997, CHEMOTHERAPY, V43, P10, DOI 10.1159/000239529; Unnikrishnan M, 2002, J IMMUNOL, V169, P2561, DOI 10.4049/jimmunol.169.5.2561; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; Wang W, 2007, INFECT IMMUN, V75, P4959, DOI 10.1128/IAI.00073-07; Xu QF, 2009, SCAND J INFECT DIS, V41, P244, DOI 10.1080/00365540902767064	49	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62549	10.1371/journal.pone.0062549	http://dx.doi.org/10.1371/journal.pone.0062549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626831	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400195
J	Wallgren, M; Lidman, M; Pedersen, A; Brannstrom, K; Karlsson, BG; Grobner, G				Wallgren, Marcus; Lidman, Martin; Pedersen, Anders; Brannstrom, Kristoffer; Karlsson, B. Goran; Grobner, Gerhard			Reconstitution of the Anti-Apoptotic Bcl-2 Protein into Lipid Membranes and Biophysical Evidence for Its Detergent-Driven Association with the Pro-Apoptotic Bax Protein	PLOS ONE			English	Article							CELL-DEATH; CANCER; PROTECTOR; BCL-X(L); REMOVAL	The anti-apoptotic B-cell CLL/lymphoma-2 (Bcl-2) protein and its counterpart, the pro-apoptotic Bcl-2-associated X protein (Bax), are key players in the regulation of the mitochondrial pathway of apoptosis. However, how they interact at the mitochondrial outer membrane (MOM) and there determine whether the cell will live or be sentenced to death remains unknown. Competing models have been presented that describe how Bcl-2 inhibits the cell-killing activity of Bax, which is common in treatment-resistant tumors where Bcl-2 is overexpressed. Some studies suggest that Bcl-2 binds directly to and sequesters Bax, while others suggest an indirect process whereby Bcl-2 blocks BH3-only proteins and prevents them from activating Bax. Here we present the results of a biophysical study in which we investigated the putative interaction of solubilized full-length human Bcl-2 with Bax and the scope for incorporating the former into a native-like lipid environment. Far-UV circular dichroism (CD) spectroscopy was used to detect direct Bcl-2-Bax-interactions in the presence of polyoxyethylene-(23)-lauryl-ether (Brij-35) detergent at a level below its critical micelle concentration (CMC). Additional surface plasmon resonance (SPR) measurements confirmed this observation and revealed a high affinity between the Bax and Bcl-2 proteins. Upon formation of this protein-protein complex, Bax also prevented the binding of antimycin A(2) (a known inhibitory ligand of Bcl-2) to the Bcl-2 protein, as fluorescence spectroscopy experiments showed. In addition, Bcl-2 was able to form mixed micelles with Triton X-100 solubilized neutral phospholipids in the presence of high concentrations of Brij-35 (above its CMC). Following detergent removal, the integral membrane protein was found to have been fully reconstituted into a native-like membrane environment, as confirmed by ultracentrifugation and subsequent SDS-PAGE experiments.	[Wallgren, Marcus; Lidman, Martin; Grobner, Gerhard] Umea Univ, Dept Chem, Umea, Sweden; [Pedersen, Anders; Karlsson, B. Goran] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Brannstrom, Kristoffer] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden	Umea University; University of Gothenburg; Umea University	Grobner, G (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	gerhard.grobner@chem.umu.se	Brännström, Kristoffer/AAC-1204-2020; Pedersen, Anders/N-3888-2014; Karlsson, Göran/E-8686-2011	Pedersen, Anders/0000-0001-8704-5129; Karlsson, Goran/0000-0002-1821-4715	SWEDSTRUCT (Swedish Research Council) [2009-3712]	SWEDSTRUCT (Swedish Research Council)(Swedish Research Council)	The authors acknowledge support by SWEDSTRUCT (Swedish Research Council): 2009-3712, URL: www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; AKAO Y, 1994, CANCER RES, V54, P2468; Antharavally BS, 2011, ANAL BIOCHEM, V416, P39, DOI 10.1016/j.ab.2011.05.013; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Berghella AM, 1998, CANCER BIOTHER RADIO, V13, P225, DOI 10.1089/cbr.1998.13.225; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim KM, 2001, BIOCHEMISTRY-US, V40, P4911, DOI 10.1021/bi002368e; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nedelkina S, 2008, PROTEIN EXPRES PURIF, V60, P214, DOI 10.1016/j.pep.2008.04.005; O'Neill J, 2004, BBA-REV CANCER, V1705, P43, DOI 10.1016/j.bbcan.2004.09.004; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Pedersen A, 2011, PROTEIN EXPRES PURIF, V77, P220, DOI 10.1016/j.pep.2011.02.003; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Twomey C, 2005, J CELL MOL MED, V9, P345, DOI 10.1111/j.1582-4934.2005.tb00360.x; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wallgren M, 2012, BBA-BIOMEMBRANES, V1818, P2718, DOI 10.1016/j.bbamem.2012.06.005; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200	37	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61452	10.1371/journal.pone.0061452	http://dx.doi.org/10.1371/journal.pone.0061452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626686	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400049
J	Leavitt, ML; Pieper, F; Sachs, A; Joober, R; Martinez-Trujillo, JC				Leavitt, Matthew L.; Pieper, Florian; Sachs, Adam; Joober, Ridha; Martinez-Trujillo, Julio C.			Structure of Spike Count Correlations Reveals Functional Interactions between Neurons in Dorsolateral Prefrontal Cortex Area 8a of Behaving Primates	PLOS ONE			English	Article							MACAQUE VISUAL-CORTEX; WORKING-MEMORY TASKS; INTERNEURONAL CORRELATIONS; CORTICAL MICROCIRCUITS; RHESUS-MONKEY; ATTENTION; INFORMATION; ORGANIZATION; PERFORMANCE; MT	Neurons within the primate dorsolateral prefrontal cortex (dlPFC) are clustered in microcolumns according to their visuospatial tuning. One issue that remains poorly investigated is how this anatomical arrangement influences functional interactions between neurons during behavior. To investigate this question we implanted 4 mm x 4 mm multielectrode arrays in two macaques' dlPFC area 8a and measured spike count correlations (r(sc)) between responses of simultaneously recorded neurons when animals maintained stationary gaze. Positive and negative r(sc) were significantly higher than predicted by chance across a wide range of inter-neuron distances (from 0.4 to 4 mm). Positive r(sc) were stronger between neurons with receptive fields (RFs) separated by <= 90 degrees of angular distance and progressively decreased as a function of inter-neuron physical distance. Negative r(sc) were stronger between neurons with RFs separated by >90 degrees and increased as a function of inter-neuron distance. Our results show that short- and long-range functional interactions between dlPFC neurons depend on the physical distance between them and the relationship between their visuospatial tuning preferences. Neurons with similar visuospatial tuning show positive r(sc) that decay with inter-neuron distance, suggestive of excitatory interactions within and between adjacent microcolumns. Neurons with dissimilar tuning from spatially segregated microcolumns show negative r(sc) that increase with inter-neuron distance, suggestive of inhibitory interactions. This pattern of results shows that functional interactions between prefrontal neurons closely follow the pattern of connectivity reported in anatomical studies. Such interactions may be important for the role of the prefrontal cortex in the allocation of attention to targets in the presence of competing distracters.	[Leavitt, Matthew L.; Martinez-Trujillo, Julio C.] McGill Univ, Dept Physiol, Cognit Neurophysiol Lab, Montreal, PQ, Canada; [Pieper, Florian] Univ Med Ctr Hamburg Eppendorf UKE, Inst Neuro & Pathophysiol, Hamburg, Germany; [Sachs, Adam] Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Div Neurosurg, Ottawa, ON, Canada; [Joober, Ridha] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada	McGill University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Ottawa; Ottawa Hospital Research Institute; McGill University	Martinez-Trujillo, JC (corresponding author), McGill Univ, Dept Physiol, Cognit Neurophysiol Lab, Montreal, PQ, Canada.	julio.martinez@mcgill.ca	Martinez-Trujillo, Julio C/M-2146-2015	Martinez-Trujillo, Julio C/0000-0003-3338-578X; Leavitt, Matthew/0000-0003-0779-108X; Sachs, Adam/0000-0002-3630-4562	CIHR; NSERC; EJLB Foundation; Canada Research Chair program	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EJLB Foundation; Canada Research Chair program(Canada Research Chairs)	This work was supported by grants to J.M.T. from the CIHR (http://www.cihr-irsc.gc.ca/), NSERC (http://www.nserc-crsng.gc.ca), EJLB Foundation (http://www.ejlb.qc.ca), and Canada Research Chair program (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BUGBEE NM, 1983, J COMP NEUROL, V220, P355, DOI 10.1002/cne.902200309; Cohen JY, 2010, J NEUROSCI, V30, P3227, DOI 10.1523/JNEUROSCI.4600-09.2010; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Heeger David, 2000, HANDOUT U STANDFORD, V5, P76; Hirata Y, 2008, NEUROSCI RES, V61, P1, DOI 10.1016/j.neures.2008.01.003; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Lennert T, 2011, NEURON, V70, P141, DOI 10.1016/j.neuron.2011.02.041; LEVITT JB, 1993, J COMP NEUROL, V338, P360, DOI 10.1002/cne.903380304; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Messinger A, 2009, J NEUROSCI, V29, P5640, DOI 10.1523/JNEUROSCI.3857-08.2009; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; SCOTT AJ, 1983, AM STAT, V37, P319, DOI 10.2307/2682774; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Szabo M, 2004, EUR J NEUROSCI, V19, P1969, DOI 10.1111/j.1460-9568.2004.03211.x; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsujimoto S, 2008, CEREB CORTEX, V18, P2748, DOI 10.1093/cercor/bhn033; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Xiao D, 2009, NEUROSCIENCE, V161, P1067, DOI 10.1016/j.neuroscience.2009.04.034; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61503	10.1371/journal.pone.0061503	http://dx.doi.org/10.1371/journal.pone.0061503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630595	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500044
J	Marcelino, LA; Westneat, MW; Stoyneva, V; Henss, J; Rogers, JD; Radosevich, A; Turzhitsky, V; Siple, M; Fang, A; Swain, TD; Fung, J; Backman, V				Marcelino, Luisa A.; Westneat, Mark W.; Stoyneva, Valentina; Henss, Jillian; Rogers, Jeremy D.; Radosevich, Andrew; Turzhitsky, Vladimir; Siple, Margaret; Fang, Andrew; Swain, Timothy D.; Fung, Jennifer; Backman, Vadim			Modulation of Light-Enhancement to Symbiotic Algae by Light-Scattering in Corals and Evolutionary Trends in Bleaching	PLOS ONE			English	Article							SCLERACTINIAN CORALS; SPATIAL-RESOLUTION; FRACTAL DIMENSIONS; OPTICAL-PROPERTIES; STONY CORALS; REEF; GROWTH; ABSORPTION; HOST; MICROSTRUCTURE	Calcium carbonate skeletons of scleractinian corals amplify light availability to their algal symbionts by diffuse scattering, optimizing photosynthetic energy acquisition. However, the mechanism of scattering and its role in coral evolution and dissolution of algal symbioses during "bleaching'' events are largely unknown. Here we show that differences in skeletal fractal architecture at nano/micro-lengthscales within 96 coral taxa result in an 8-fold variation in light-scattering and considerably alter the algal light environment. We identified a continuum of properties that fall between two extremes: (1) corals with low skeletal fractality that are efficient at transporting and redistributing light throughout the colony with low scatter but are at higher risk of bleaching and (2) corals with high skeletal fractality that are inefficient at transporting and redistributing light with high scatter and are at lower risk of bleaching. While levels of excess light derived from the coral skeleton is similar in both groups, the low-scatter corals have a higher rate of light-amplification increase when symbiont concentration is reduced during bleaching, thus creating a positive feedback-loop between symbiont concentration and light-amplification that exposes the remaining symbionts to increasingly higher light intensities. By placing our findings in an evolutionary framework, in conjunction with a novel empirical index of coral bleaching susceptibility, we find significant correlations between bleaching susceptibility and light-scattering despite rich homoplasy in both characters; suggesting that the cost of enhancing light-amplification to the algae is revealed in decreased resilience of the partnership to stress.	[Marcelino, Luisa A.; Henss, Jillian; Siple, Margaret; Fang, Andrew; Swain, Timothy D.; Fung, Jennifer] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Marcelino, Luisa A.; Westneat, Mark W.; Henss, Jillian; Siple, Margaret; Swain, Timothy D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Stoyneva, Valentina; Rogers, Jeremy D.; Radosevich, Andrew; Turzhitsky, Vladimir; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Field Museum of Natural History (Chicago); Northwestern University	Marcelino, LA (corresponding author), Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA.	l-marcelino@northwestern.edu	Marcelino, Luisa A/B-7030-2009; Rogers, Jeremy/A-4572-2008; Swain, Timothy/M-7702-2013; Backman, Vadim/B-6689-2009	Rogers, Jeremy/0000-0003-3049-2803; Swain, Timothy/0000-0002-6485-6823; Siple, Margaret/0000-0002-4260-9856; Fang, Andrew/0000-0002-1277-1158; Marcelino, Luisa/0000-0003-0363-5901	National Science Foundation [CBET 0937987, DEB-0844745]; MacArthur Foundation EOL support	National Science Foundation(National Science Foundation (NSF)); MacArthur Foundation EOL support	This work was supported by the National Science Foundation (CBET 0937987 and DEB-0844745) and MacArthur Foundation EOL support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch-Gottlib L, 2005, MAT SCI ENG C-BIO S, V25, P81, DOI 10.1016/j.msec.2004.09.006; Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Alberich-Bayarri A, 2010, MED PHYS, V37, P4930, DOI 10.1118/1.3481509; Amoozegar C, 2009, APPL OPTICS, V48, pD20, DOI 10.1364/AO.48.000D20; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Basillais E, 1997, CR ACAD SCI III-VIE, V320, P653, DOI 10.1016/S0764-4469(97)85699-5; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; Cuif JP, 2005, BIOGEOSCIENCES, V2, P61, DOI 10.5194/bg-2-61-2005; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; DUBINSKY Z, 1984, PROC R SOC SER B-BIO, V222, P203, DOI 10.1098/rspb.1984.0059; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Enriquez S, 2008, ICRS 5 18 FORT LAUD, P5; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Inverse Prahl S, 2012, INVERSE ADDING DOUBL; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kim YL, 2004, OPT LETT, V29, P1906, DOI 10.1364/OL.29.001906; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Martin-Garin B, 2007, CORAL REEFS, V26, P541, DOI 10.1007/s00338-007-0256-4; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; Muko S, 2000, B MAR SCI, V66, P225; Muscatine L., 1990, P75; Nothdurft LD, 2007, FACIES, V53, P1, DOI 10.1007/s10347-006-0090-0; PHILIPSON B, 1969, INVEST OPHTH VISUAL, V8, P258; PICKERING JW, 1993, APPL OPTICS, V32, P399, DOI 10.1364/AO.32.000399; Pipich V, 2008, J AM CHEM SOC, V130, P6879, DOI 10.1021/ja801798h; Pogue BW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2335429; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; Rogers JD, 2009, OPT LETT, V34, P1891, DOI 10.1364/OL.34.001891; Roy HK, 2009, CANCER RES, V69, P4476, DOI 10.1158/0008-5472.CAN-08-4780; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Teran E, 2010, APPL OPTICS, V49, P5032, DOI 10.1364/AO.49.005032; Turzhitsky V, 2010, IEEE J SEL TOP QUANT, V16, P619, DOI 10.1109/JSTQE.2009.2032666; Veron J. E., 2000, CORALS WORLD, V1-3; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920	52	72	73	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61492	10.1371/journal.pone.0061492	http://dx.doi.org/10.1371/journal.pone.0061492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630594	Green Published, gold			2022-12-25	WOS:000317911500043
J	Atluri, VSR; Kanthikeel, SP; Reddy, PVB; Yndart, A; Nair, MPN				Atluri, Venkata Subba Rao; Kanthikeel, Sudheesh P.; Reddy, Pichili V. B.; Yndart, Adriana; Nair, Madhavan P. N.			Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)	PLOS ONE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; VPR INDUCES APOPTOSIS; NEUROLOGIC DISORDERS; PROTEIN EXPRESSION; ALZHEIMER-DISEASE; BRAIN CULTURES; FRONTAL-CORTEX; DENTATE GYRUS; ARC/ARG3.1	HIV-associated neurocognitive disorders (HAND) is characterized by development of cognitive, behavioral and motor abnormalities, and occur in approximately 50% of HIV infected individuals. Our current understanding of HAND emanates mainly from HIV-1 subtype B (clade B), which is prevalent in USA and Western countries. However very little information is available on neuropathogenesis of HIV-1 subtype C (clade C) that exists in Sub-Saharan Africa and Asia. Therefore, studies to identify specific neuropathogenic mechanisms associated with HAND are worth pursuing to dissect the mechanisms underlying this modulation and to prevent HAND particularly in clade B infection. In this study, we have investigated 84 key human synaptic plasticity genes differential expression profile in clade B and clade C infected primary human astrocytes by using RT2 Profile PCR Array human Synaptic Plasticity kit. Among these, 31 and 21 synaptic genes were significantly (>= 3 fold) down-regulated and 5 genes were significantly (>= 3 fold) up-regulated in clade B and clade C infected cells, respectively compared to the uninfected control astrocytes. In flow-cytometry analysis, down-regulation of postsynaptic density and dendrite spine morphology regulatory proteins (ARC, NMDAR1 and GRM1) was confirmed in both clade B and C infected primary human astrocytes and SK-N-MC neuroblastoma cells. Further, spine density and dendrite morphology changes by confocal microscopic analysis indicates significantly decreased spine density, loss of spines and decreased dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC neuroblastoma cells compared to uninfected and clade C infected cells. We have also observed that, in clade B infected astrocytes, induction of apoptosis was significantly higher than in the clade C infected astrocytes. In conclusion, this study suggests that down-regulation of synaptic plasticity genes, decreased dendritic spine density and induction of apoptosis in astrocytes may contribute to the severe neuropathogenesis in clade B infection.	[Atluri, Venkata Subba Rao; Kanthikeel, Sudheesh P.; Reddy, Pichili V. B.; Yndart, Adriana; Nair, Madhavan P. N.] Florida Int Univ, Inst NeuroImmune Pharmacol, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Inst NeuroImmune Pharmacol, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institute of Health [R37DA025576, R01DA027049, R01DA021537, R01MH085259]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA027049, R01DA021537, R01DA034547] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health Grants R37DA025576, R01DA027049, R01DA021537 and R01MH085259. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; An SF, 1996, ACTA NEUROPATHOL, V91, P169, DOI 10.1007/s004010050409; Antinori A, 2007, ANTIVIR THER, V12, P1175; Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BUDKA H, 1987, ACTA NEUROPATHOL, V75, P185, DOI 10.1007/BF00687080; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; CONANT K, 1994, ADV NEUROIMMUNOL, V4, P287, DOI 10.1016/S0960-5428(06)80269-X; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; EVERALL IP, 1993, J NEUROL NEUROSUR PS, V56, P481, DOI 10.1136/jnnp.56.5.481; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; GERTZ HJ, 1987, NEUROSCI LETT, V76, P228, DOI 10.1016/0304-3940(87)90720-8; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HOLMES WR, 1989, BRAIN RES, V478, P127, DOI 10.1016/0006-8993(89)91484-4; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; MASLIAH E, 1994, RES P ARNMD, V72, P119; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; MERRILL JE, 1992, J VIROL, V66, P2217, DOI 10.1128/JVI.66.4.2217-2225.1992; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; PAPA M, 1995, J NEUROSCI, V15, P1; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Patel CA, 2002, J NEUROVIROL, V8, P86, DOI 10.1080/13550280290049552; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Puliti A, 2011, AM J PATHOL, V178, P1257, DOI 10.1016/j.ajpath.2010.11.050; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Sacktor N, 2001, NEUROLOGY, V57, P542, DOI 10.1212/WNL.57.3.542; Sacktor N, 2007, NAT CLIN PRACT NEURO, V3, P436, DOI 10.1038/ncpneuro0559; Saiyed ZM, 2011, NEUROCHEM INT, V58, P656, DOI 10.1016/j.neuint.2011.02.004; Satishchandra P, 2000, INDIAN J MED RES, V111, P14; Schubert P, 2001, MECH AGEING DEV, V123, P47, DOI 10.1016/S0047-6374(01)00343-8; Sirzen-Zelenskaya A, 2006, EUR J NEUROSCI, V24, P2978, DOI 10.1111/j.1460-9568.2006.05196.x; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; Tsui CC, 1996, J NEUROSCI, V16, P2463; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wadia R S, 2001, J Assoc Physicians India, V49, P343; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101	65	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61399	10.1371/journal.pone.0061399	http://dx.doi.org/10.1371/journal.pone.0061399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620748	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500028
J	Gu, Y; Cao, F; Wang, L; Hou, WH; Zhang, J; Hew, CL; Li, SW; Yuan, YA; Xia, NS				Gu, Ying; Cao, Fang; Wang, Lei; Hou, Wangheng; Zhang, Jun; Hew, Choy-leong; Li, Shaowei; Yuan, Y. Adam; Xia, Ningshao			Structure of a Novel Shoulder-to-Shoulder p24 Dimer in Complex with the Broad-Spectrum Antibody A10F9 and Its Implication in Capsid Assembly	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; PROTEIN P24; GAG; RESOLUTION; MUTATIONS; HIV-1CA; BINDING; FAB	Mature HIV-1 viral particles assemble as a fullerene configuration comprising p24 capsid hexamers, pentamers and dimers. In this paper, we report the X-ray crystal structures of the p24 protein from natural HIV-1 strain (BMJ4) in complex with Fab A10F9, which recognizes a conserved epitope in the C-terminal domain of the BMJ4 p24 protein. Our structures reveal a novel shoulder-to-shoulder p24 dimerization mode that is mediated by an S-S bridge at C177. Consistent with these structures, the shoulder-to-shoulder dimer that was obtained from the BMJ4 strain was also observed in p24 proteins from other strains by the introduction of a cysteine residue at position 177. The potential biological significance was further validated by the introduction of a C177A mutation in the BMJ4 strain, which then displays a low infectivity. Our data suggest that this novel shoulder-to-shoulder dimer interface trapped by this unique S-S bridge could represent a physiologically relevant mode of HIV-1 capsid assembly during virus maturation, although Cys residue itself may not be critical for HIV-I replication.	[Gu, Ying; Cao, Fang; Wang, Lei; Hou, Wangheng; Zhang, Jun; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Hew, Choy-leong; Yuan, Y. Adam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Hew, Choy-leong; Yuan, Y. Adam] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore	Xiamen University; National University of Singapore; National University of Singapore	Li, SW (corresponding author), Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	shaowei@xmu.edu.cn; dbsyya@nus.edu.sg; nsxia@xmu.edu.cn	Zhang, Jun/G-4598-2010; Hew, Choy Leong/I-1501-2012; Yuan, Adam/I-7035-2012	Zhang, Jun/0000-0002-6601-9180; Hew, Choy Leong/0000-0002-9441-0064; Yuan, Adam/0000-0002-3256-237X; Xia, Ningshao/0000-0003-0179-5266	National Natural Science Foundation [81172895, 81172885]; National Natural Science Foundation for Distinguished Young Scholars [30925030]; Project 111 of the Ministry of Education [B06016]; Science and Technology Major Project of Fujian Province [2010Y4008, 2011J06015]; International Science and Technology Collaborative Program, People's Republic of China [2010DFB30100, 2011DFG33050]; LHK Foundation [R-154-000-450-720]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Project 111 of the Ministry of Education; Science and Technology Major Project of Fujian Province; International Science and Technology Collaborative Program, People's Republic of China; LHK Foundation	This work was supported by the National Natural Science Foundation (Grant no. 81172895, 81172885), the National Natural Science Foundation for Distinguished Young Scholars (Grant no. 30925030), the Project 111 of the Ministry of Education (Grant no. B06016), the Science and Technology Major Project of Fujian Province (Grant no. 2010Y4008, 2011J06015) and International Science and Technology Collaborative Program (Grant no. 2010DFB30100, 2011DFG33050), People's Republic of China. Y.A.Y. acknowledges research grant support from the LHK Foundation (Grant no. R-154-000-450-720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; Lammers M, 2010, NAT CHEM BIOL, V6, P331, DOI 10.1038/nchembio.342; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; McBurney SP, 2006, CURR HIV RES, V4, P475, DOI 10.2174/157016206778560018; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	28	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61314	10.1371/journal.pone.0061314	http://dx.doi.org/10.1371/journal.pone.0061314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620741	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500021
J	Wang, JX; Tian, J; Wang, R; Benson, V				Wang, Jingxin; Tian, Jing; Wang, Rong; Benson, Valerie			Increased Attentional Focus Modulates Eye Movements in a Mixed Antisaccade Task for Younger and Older Adults	PLOS ONE			English	Article							EXECUTIVE CONTROL PROCESSES; WORKING-MEMORY; INHIBITORY CONTROL; AGE-DIFFERENCES; PERFORMANCE; ACTIVATION; SACCADES; ANXIETY	We examined performance in the antisaccade task for younger and older adults by comparing latencies and errors in what we defined as high attentional focus (mixed antisaccades and prosaccades in the same block) and low attentional focus (antisaccades and prosaccades in separate blocks) conditions. Shorter saccade latencies for correctly executed eye movements were observed for both groups in mixed, compared to blocked, antisaccade tasks, but antisaccade error rates were higher for older participants across both conditions. The results are discussed in relation to the inhibitory hypothesis, the goal neglect theory and attentional control theory.	[Wang, Jingxin; Tian, Jing] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China; [Wang, Rong] Taiyuan Univ Sci & Technol, Dept Humanities & Social Sci, Taiyuan, Peoples R China; [Benson, Valerie] Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England	Tianjin Normal University; Taiyuan University of Science & Technology; University of Southampton	Benson, V (corresponding author), Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England.	Vb1@soton.ac.uk		Benson, Valerie/0000-0002-0351-4563	Scientific and Technological Plan Grant of Tianjin [09ZCZDSF04600]; Humanities and Society Project of China Educational Department award [10YJCXLX058]	Scientific and Technological Plan Grant of Tianjin; Humanities and Society Project of China Educational Department award	This work was supported by two grants awarded to the first author, as follows, Scientific and Technological Plan Grant of Tianjin (09ZCZDSF04600) and a Humanities and Society Project of China Educational Department award (10YJCXLX058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LA, 2007, NEUROBIOL AGING, V28, P627, DOI 10.1016/j.neurobiolaging.2006.02.003; Ansari TL, 2008, COGN AFFECT BEHAV NE, V8, P229, DOI 10.3758/CABN.8.3.229; Bell AH, 2000, J NEUROPHYSIOL, V84, P2595, DOI 10.1152/jn.2000.84.5.2595; Bojko A, 2004, PSYCHOL AGING, V19, P226, DOI 10.1037/0882-7974.19.1.226; Butler KM, 2006, PSYCHOL AGING, V21, P638, DOI 10.1037/0882-7974.21.3.638; Butler KM, 1999, MEM COGNITION, V27, P584, DOI 10.3758/BF03211552; Carpenter RHS, 1988, MOVEMENTS EYES; Cherkasova MV, 2002, EXP BRAIN RES, V144, P528, DOI 10.1007/s00221-002-1075-z; Chiappe P, 2000, MEM COGNITION, V28, P8, DOI 10.3758/BF03211570; Clementz BA, 1998, PSYCHOPHYSIOLOGY, V35, P648, DOI 10.1017/S004857729898060X; Colcombe AM, 2003, ACTA PSYCHOL, V113, P205, DOI 10.1016/S0001-6918(03)00019-2; De Jong R, 1999, ACTA PSYCHOL, V101, P379, DOI 10.1016/S0001-6918(99)00012-8; De Jong R, 2001, EUR J COGN PSYCHOL, V13, P71, DOI 10.1080/09541440042000223; Dyckman K, 2005, EXP BRAIN RES, V162, P63, DOI 10.1007/s00221-004-2105-9; Eenshuistra RM, 2004, BRAIN COGNITION, V56, P177, DOI 10.1016/j.bandc.2004.02.077; Engle RW, 2001, SCI CON SER, P297, DOI 10.1037/10394-016; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HARTLEY AA, 1990, J EXP PSYCHOL HUMAN, V16, P523, DOI 10.1037/0096-1523.16.3.523; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Klein C, 2000, EXP BRAIN RES, V135, P141, DOI 10.1007/s002210000506; Klein CH, 2008, PSYCHOPHYSIOLOGY, V40, P17; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Manoach DS, 2002, BIOL PSYCHIAT, V51, P816, DOI 10.1016/S0006-3223(01)01356-7; Mayr U, 2000, PSYCHOL AGING, V15, P29, DOI 10.1037//0882-7974.15.1.29; Nieuwenhuis S, 2000, PSYCHOL AGING, V15, P635, DOI 10.1037//0882-7974.15.4.635; Olincy A, 1997, NEUROBIOL AGING, V18, P483, DOI 10.1016/S0197-4580(97)00109-7; Reuter B, 2006, J PSYCHIATR RES, V40, P122, DOI 10.1016/j.jpsychires.2005.02.007; Ryan JD, 2006, BRIT J PSYCHOL, V97, P339, DOI 10.1348/000712605X74837; Smyrnis N, 2002, EXP BRAIN RES, V147, P53, DOI 10.1007/s00221-002-1207-5; Sweeney JA, 2001, NEUROBIOL AGING, V22, P39, DOI 10.1016/S0197-4580(00)00175-5; The Psychological Corporation, 1999, MAN WECHSL ABBR SCAL; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; West R, 2001, EUR J COGN PSYCHOL, V13, P91, DOI 10.1080/09541440042000232	39	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61566	10.1371/journal.pone.0061566	http://dx.doi.org/10.1371/journal.pone.0061566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JA	23620767	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500047
J	Steinwender, G; Lindner, E; Weger, M; Plainer, S; Renner, W; Ardjomand, N; El-Shabrawi, Y				Steinwender, Gernot; Lindner, Ewald; Weger, Martin; Plainer, Sophie; Renner, Wilfried; Ardjomand, Navid; El-Shabrawi, Yosuf			Association between Polymorphism of the Vitamin D Metabolism Gene CYP27B1 and HLA-B27-Associated Uveitis. Is a State of Relative Immunodeficiency Pathogenic in HLA B27-Positive Uveitis?	PLOS ONE			English	Article							ACUTE ANTERIOR UVEITIS; TYPE-1 DIABETES-MELLITUS; MULTIPLE-SCLEROSIS; ANKYLOSING-SPONDYLITIS; SALMONELLA-ENTERITIDIS; IMMUNE-SYSTEM; HLA-B27; CELLS; SUSCEPTIBILITY; POPULATION	Objective: Polymorphisms of the vitamin D metabolism gene CYP27B1 showed associations with multiple autoimmune diseases. The aim of this study was to investigate a possible association between the rs703842 A>G polymorphism of the CYP27B1 gene and HLA-B27-associated uveitis. Design: One hundred fifty-nine patients with HLA-B27-associated uveitis, 138 HLA-B27-negative controls and 100 HLA-B27-positive controls were recruited for this retrospective case-control study. Main outcome parameters were genotype distribution and allelic frequencies determined by polymerase chain reaction. Results: Carriers of the rs703842G allele were found significantly more often in patients with HLA-B27-associated uveitis than in HLA-B27-positive controls (p = 0.03). Between patients and HLA-B27-negative controls no significant difference in the genotype distribution of the rs703842 A>G polymorphism was found (p = 0.97). Conclusions: Our data suggest that the rs703842 A>G polymorphism may play a role in HLA-B27-associated uveitis.	[Steinwender, Gernot; Weger, Martin; Ardjomand, Navid] Auenbrugger Univ Graz, Dept Ophthalmol, Graz, Austria; [Lindner, Ewald; Plainer, Sophie; El-Shabrawi, Yosuf] Klinikum Klagenfurt, Dept Ophthalmol, Klagenfurt, Austria; [Renner, Wilfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz	El-Shabrawi, Y (corresponding author), Klinikum Klagenfurt, Dept Ophthalmol, Klagenfurt, Austria.	yosuf.elshabrawi@kabeg.at	Lindner, Ewald/CAG-1831-2022; Lindner, Ewald/AEM-1071-2022	Lindner, Ewald/0000-0001-9651-8573; 				Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; BREWERTON DA, 1973, LANCET, V1, P904; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Duan R, 2010, ANN RHEUM DIS, V69, P1724, DOI 10.1136/ard.2009.111690; El-Shabrawi Y, 2006, OPHTHALMOLOGY, V113, P695, DOI 10.1016/j.ophtha.2006.01.004; Falgarone G, 1999, INFECT IMMUN, V67, P3773, DOI 10.1128/IAI.67.8.3773-3779.1999; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Lindner E, 2011, INVEST OPHTH VIS SCI, V52, P8295, DOI 10.1167/iovs.11-8163; LINSSEN A, 1991, INVEST OPHTH VIS SCI, V32, P2568; Lopez ER, 2004, J STEROID BIOCHEM, V89-90, P155, DOI 10.1016/j.jsbmb.2004.03.095; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; Martin TM, 2011, OCUL IMMUNOL INFLAMM, V19, P108, DOI 10.3109/09273948.2011.559302; Maruotti N, 2010, J RHEUMATOL, V37, P491, DOI 10.3899/jrheum.090797; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Pelajo CF, 2010, AUTOIMMUN REV, V9, P507, DOI 10.1016/j.autrev.2010.02.011; Saarinen M, 2002, RHEUMATOLOGY, V41, P651, DOI 10.1093/rheumatology/41.6.651; Suhler Eric B, 2003, Curr Opin Ophthalmol, V14, P378, DOI 10.1097/00055735-200312000-00010; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241; Virtala M, 1997, INFECT IMMUN, V65, P4236, DOI 10.1128/IAI.65.10.4236-4242.1997; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wegscheider BJ, 2005, MOL VIS, V11, P896	32	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62244	10.1371/journal.pone.0062244	http://dx.doi.org/10.1371/journal.pone.0062244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614044	Green Submitted, gold, Green Published			2022-12-25	WOS:000317907200127
J	Cozzi, R; Zerbini, F; Assfalg, M; D'Onofrio, M; Biagini, M; Martinelli, M; Nuccitelli, A; Norais, N; Telford, JL; Maione, D; Rinaudo, CD				Cozzi, Roberta; Zerbini, Francesca; Assfalg, Michael; D'Onofrio, Mariapina; Biagini, Massimiliano; Martinelli, Manuele; Nuccitelli, Annalisa; Norais, Nathalie; Telford, John L.; Maione, Domenico; Rinaudo, C. Daniela			Group B Streptococcus pilus sortase regulation: a single mutation in the lid region induces pilin protein polymerization in vitro	FASEB JOURNAL			English	Article						transpeptidation; backbone protein; limited proteolysis; thermal stability; NMR spectroscopy	CELL-WALL; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; CRYSTAL-STRUCTURES; IDENTIFICATION; INVOLVEMENT; CATALYSIS; INSIGHTS; VACCINE; ANCHOR	Gram-positive bacteria build pili on their cell surface via a class C sortase-catalyzed transpeptidation mechanism from pilin protein substrates. Despite the availability of several crystal structures, pilus-related C sortases remain poorly characterized to date, and their mechanisms of transpeptidation and regulation need to be further investigated. The available 3-dimensional structures of these enzymes reveal a typical sortase fold, except for the presence of a unique feature represented by an N-terminal highly flexible loop known as the lid. This region interacts with the residues composing the catalytic triad and covers the active site, thus maintaining the enzyme in an autoinhibited state and preventing the accessibility to the substrate. It is believed that enzyme activation may occur only after lid displacement from the catalytic domain. In this work, we provide the first direct evidence of the regulatory role of the lid, demonstrating that it is possible to obtain in vitro an efficient polymerization of pilin subunits using an active C sortase lid mutant carrying a single residue mutation in the lid region. Moreover, biochemical analyses of this recombinant mutant reveal that the lid confers thermodynamic and proteolytic stability to the enzyme.	[Cozzi, Roberta; Zerbini, Francesca; Biagini, Massimiliano; Martinelli, Manuele; Nuccitelli, Annalisa; Norais, Nathalie; Telford, John L.; Maione, Domenico; Rinaudo, C. Daniela] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Assfalg, Michael; D'Onofrio, Mariapina] Univ Verona, Dept Biotechnol, Nucl Magnet Resonance Lab, I-37100 Verona, Italy	Novartis; University of Verona	Maione, D (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Assfalg, Michael/0000-0001-9331-3169; martinelli, manuele/0000-0002-9371-076X; D'ONOFRIO, Mariapina/0000-0002-8699-0847	University of Verona; Novartis Vaccines and Diagnostics (Siena, Italy)	University of Verona; Novartis Vaccines and Diagnostics (Siena, Italy)	This work was supported by the Joint Research Project 2010 between the University of Verona and Novartis Vaccines and Diagnostics (Siena, Italy). The authors thank Prof. Henriette Molinari for helpful discussions.	Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cozzi R, 2012, FASEB J, V26, P2008, DOI 10.1096/fj.11-196378; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Lu GW, 2011, PROTEINS, V79, P2764, DOI 10.1002/prot.23093; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Necchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025300; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Persson K, 2011, ACTA CRYSTALLOGR D, V67, P212, DOI 10.1107/S0907444911004215; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Wu CG, 2012, J BACTERIOL, V194, P2531, DOI 10.1128/JB.00093-12; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	41	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3144	3154		10.1096/fj.13-227793	http://dx.doi.org/10.1096/fj.13-227793			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23631841				2022-12-25	WOS:000329877600021
J	Tsai, CJ; Chu, G				Tsai, Chun J.; Chu, Gilbert			Cooperative Assembly of a Protein-DNA Filament for Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; LIGASE-IV COMPLEX; V(D)J RECOMBINATION; GEL-ELECTROPHORESIS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; XRCC4 PROTEIN; CERNUNNOS-XLF; KU; LIGATION	Nonhomologous end joining repairs DNA double-strand breaks created by ionizing radiation and V(D)J recombination. Ku, XRCC4/Ligase IV (XL), and XLF have a remarkable mismatched end (MEnd) ligase activity, particularly for ends with mismatched 3' overhangs, but the mechanism has remained obscure. Here, we showed XL required Ku to bind DNA, whereas XLF required both Ku and XL to bind DNA. We detected cooperative assembly of one or two Ku molecules and up to five molecules each of XL and XLF into a Ku-XL-XLF-DNA (MEnd ligase-DNA) complex. XLF mutations that disrupted its interactions with XRCC4 or DNA also disrupted complex assembly and end joining. Together with published co-crystal structures of truncated XRCC4 and XLF proteins, our data with full-length Ku, XL, and XLF bound to DNA indicate assembly of a filament containing Ku plus alternating XL and XLF molecules. By contrast, in the absence of XLF, we detected cooperative assembly of up to six molecules each of Ku and XL into a Ku-XL-DNA complex, consistent with a filament containing alternating Ku and XL molecules. Despite a lower molecular mass, MEnd ligase-DNA had a lower electrophoretic mobility than Ku-XL-DNA. The anomalous difference in mobility and difference in XL to Ku molar ratio suggests that MEnd ligase-DNA has a distinct structure that successfully aligns mismatched DNA ends for ligation.	[Chu, Gilbert] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Chu, G (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	chu@stanford.edu			National Institutes of Health [R01-GM086579]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM086579 (to G. C.).	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Andres SN, 2011, ACTA CRYSTALLOGR F, V67, P1399, DOI 10.1107/S1744309111033549; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Budman J, 2005, EMBO J, V24, P849, DOI 10.1038/sj.emboj.7600563; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P46; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Malivert L, 2010, J BIOL CHEM, V285, P26475, DOI 10.1074/jbc.M110.138156; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Ropars V, 2011, P NATL ACAD SCI USA, V108, P12663, DOI 10.1073/pnas.1100758108; Slater GW, 1996, METHOD ENZYMOL, V270, P272; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wu PY, 2007, J BIOL CHEM, V282, P31937, DOI 10.1074/jbc.M704554200; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604	40	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18110	18120		10.1074/jbc.M113.464115	http://dx.doi.org/10.1074/jbc.M113.464115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23620595	Green Published, hybrid			2022-12-25	WOS:000320721900017
J	Villacampa, P; Ribera, A; Motas, S; Ramirez, L; Garcia, M; de la Villa, P; Haurigot, V; Bosch, F				Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Ramirez, Laura; Garcia, Miquel; de la Villa, Pedro; Haurigot, Virginia; Bosch, Fatima			Insulin-like Growth Factor I (IGF-I)-induced Chronic Gliosis and Retinal Stress Lead to Neurodegeneration in a Mouse Model of Retinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULLER CELLS; IGF-I; GENE-EXPRESSION; ACTIVATION; PROTEINS; MECHANISMS; RESPONSES; RECEPTOR; FAMILY; S100B	Insulin-like growth factor I (IGF-I) exerts multiple effects on different retinal cell types in both physiological and pathological conditions. Despite the growth factor's extensively described neuroprotective actions, transgenic mice with increased intraocular levels of IGF-I showed progressive impairment of electroretinographic amplitudes up to complete loss of response, with loss of photoreceptors and bipolar, ganglion, and amacrine neurons. Neurodegeneration was preceded by the overexpression of genes related to retinal stress, acute-phase response, and gliosis, suggesting that IGF-I altered normal retinal homeostasis. Indeed, gliosis and microgliosis were present from an early age in transgenic mice, before other alterations occurred, and were accompanied by signs of oxidative stress and impaired glutamate recycling. Older mice also showed overproduction of pro-inflammatory cytokines. Our results suggest that, when chronically increased, intraocular IGF-I is responsible for the induction of deleterious cellular processes that can lead to neurodegeneration, and they highlight the importance that this growth factor may have in the pathogenesis of conditions such as ischemic or diabetic retinopathy.	[Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Bellaterra, Spain; [Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Bellaterra, Spain; [Villacampa, Pilar; Ribera, Albert; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] CIBER Diabet & Associated Metab Disorders, Barcelona 08017, Spain; [Ramirez, Laura; de la Villa, Pedro] Univ Alcala, Sch Med, Dept Physiol, Alcala De Henares 28871, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad de Alcala	Bosch, F (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Edifici H, E-08193 Bellaterra, Spain.	fatima.bosch@uab.es	Ribera, Albert/K-9744-2014; Motas, Sandra/L-2502-2017; Villacampa, Pilar/B-1801-2019; de la Villa, Pedro/G-2322-2016	Ribera, Albert/0000-0002-7120-4276; Motas, Sandra/0000-0003-2748-5952; Villacampa, Pilar/0000-0002-2860-7475; de la Villa, Pedro/0000-0001-9856-6616; Garcia, Miguel/0000-0002-1602-4993; BOSCH, FATIMA/0000-0002-7705-5515; Haurigot, Virginia A./0000-0002-9772-2565	Instituto de Salud Carlos III [PI 061417]; Plan Nacional I + D + I Grant [SAF2011-24698]; Generalitat de Catalunya, Spain [2009 SGR224]; European Community [CLINIGENE LSHB-CT-2006-018933]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional I + D + I Grant; Generalitat de Catalunya, Spain(Generalitat de Catalunya); European Community(European Commission); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Instituto de Salud Carlos III Grant PI 061417, Plan Nacional I + D + I Grant SAF2011-24698, Generalitat de Catalunya Grant 2009 SGR224, Spain, and European Community Grant CLINIGENE LSHB-CT-2006-018933.; Recipient of predoctoral fellowship from Fundacion Ramon Areces.; Recipient of predoctoral fellowship from Ministerio de Educacion y Ciencia.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Barakat DJ, 2012, J NEUROCHEM, V120, P586, DOI 10.1111/j.1471-4159.2011.07595.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Haurigot V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041511; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Inokuchi N, 2001, CURR EYE RES, V23, P368, DOI 10.1076/ceyr.23.5.368.5441; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lieth E, 2000, EXP EYE RES, V70, P723, DOI 10.1006/exer.2000.0840; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Donnell SL, 2002, GLIA, V39, P85, DOI 10.1002/glia.10081; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rodriguez-de la Rosa L, 2012, NEUROBIOL DIS, V46, P476, DOI 10.1016/j.nbd.2012.02.013; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; Shaw LC, 2004, REV ENDOCR METAB DIS, V5, P199, DOI 10.1023/B:REMD.0000032408.18015.b1; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Takeda M, 2002, INVEST OPHTH VIS SCI, V43, P907; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vardatsikos G, 2009, ANTIOXID REDOX SIGN, V11, P1165, DOI 10.1089/ARS.2008.2161; Venteclef N, 2011, TRENDS ENDOCRIN MET, V22, P333, DOI 10.1016/j.tem.2011.04.004; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zelinka CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044477; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7	50	14	16	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17631	17642		10.1074/jbc.M113.468819	http://dx.doi.org/10.1074/jbc.M113.468819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620587	hybrid, Green Published			2022-12-25	WOS:000320380600054
J	Becker, T; Horvath, SE; Bottinger, L; Gebert, N; Daum, G; Pfanner, N				Becker, Thomas; Horvath, Susanne E.; Boettinger, Lena; Gebert, Natalia; Daum, Guenther; Pfanner, Nikolaus			Role of Phosphatidylethanolamine in the Biogenesis of Mitochondrial Outer Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN SUPERCOMPLEXES; SYNTHETIC LETHAL INTERACTION; TAIL-ANCHORED PROTEINS; BETA-BARREL PROTEINS; PHOSPHATIDYLSERINE DECARBOXYLASE; IMPORT CHANNEL; INTERMEMBRANE SPACE; TOM COMPLEX; PRESEQUENCE TRANSLOCASE	The mitochondrial outer membrane contains proteinaceous machineries for the import and assembly of proteins, including TOM (translocase of the outer membrane) and SAM (sorting and assembly machinery). It has been shown that the dimeric phospholipid cardiolipin is required for the stability of TOM and SAM complexes and thus for the efficient import and assembly of beta-barrel proteins and some alpha-helical proteins of the outer membrane. Here, we report that mitochondria deficient in phosphatidylethanolamine (PE), the second non-bilayer-forming phospholipid, are impaired in the biogenesis of beta -barrel proteins, but not of alpha-helical outer membrane proteins. The stability of TOM and SAM complexes is not disturbed by the lack of PE. By dissecting the import steps of beta-barrel proteins, we show that an early import stage involving translocation through the TOM complex is affected. In PE-depleted mitochondria, the TOM complex binds precursor proteins with reduced efficiency. We conclude that PE is required for the proper function of the TOM complex.	[Becker, Thomas; Horvath, Susanne E.; Boettinger, Lena; Gebert, Natalia; Pfanner, Nikolaus] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Becker, Thomas; Pfanner, Nikolaus] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Boettinger, Lena] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Horvath, Susanne E.; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Freiburg; University of Freiburg; University of Freiburg; Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Becker, Thomas/AAS-9404-2020		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments (Spemann Graduate School) [EXC 294 BIOSS, GSC-4]; Bundesministerium fur Bildung und Forschung; Austrian Science Fund FWF Project [21429]; DK Molecular Enzymology Grant [W901-B05]; Austrian Science Fund (FWF) [P 21429, W 901] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments (Spemann Graduate School); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Austrian Science Fund FWF Project(Austrian Science Fund (FWF)); DK Molecular Enzymology Grant(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments Grants EXC 294 BIOSS and GSC-4 (Spemann Graduate School), the Bundesministerium fur Bildung und Forschung, and Austrian Science Fund FWF Project 21429 and DK Molecular Enzymology Grant W901-B05 (to G. D.).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2012, J CELL SCI, V125, P3464, DOI 10.1242/jcs.103804; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Krumpe K, 2012, MOL BIOL CELL, V23, P3927, DOI 10.1091/mbc.E11-12-0994; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lackey SWK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025650; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Mihara K, 2000, BIOESSAYS, V22, P364, DOI 10.1002/(SICI)1521-1878(200004)22:4<364::AID-BIES6>3.0.CO;2-N; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Popov-Celeketic J, 2008, J MOL BIOL, V376, P671, DOI 10.1016/j.jmb.2007.12.006; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Yamano K, 2010, J BIOL CHEM, V285, P41222, DOI 10.1074/jbc.M110.163238; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	98	41	41	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16451	16459		10.1074/jbc.M112.442392	http://dx.doi.org/10.1074/jbc.M112.442392			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625917	Green Published, hybrid			2022-12-25	WOS:000320378900022
J	Blakemore, RL; Hyland, BI; Hammond-Tooke, GD; Anson, JG				Blakemore, Rebekah L.; Hyland, Brian I.; Hammond-Tooke, Graeme D.; Anson, J. Greg			Distinct Modulation of Event-Related Potentials during Motor Preparation in Patients with Motor Conversion Disorder	PLOS ONE			English	Article							PARTIAL ADVANCE INFORMATION; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; HYSTERICAL ANESTHESIA; P3 AMPLITUDE; N1; COMPONENTS; PARALYSIS; RESPONSES; INITIATION	Objective: Conversion paresis patients and healthy people feigning weakness both exhibit weak voluntary movement without detectable neuropathology. Uniquely, conversion patients lack a sense of conscious awareness of the origin of their impairment. We investigated whether conversion paresis patients show distinct electroencephalographic (EEG) markers associated with their unconscious movement deficits. Methods: Six unilateral upper limb conversion paresis patients, 12 feigning participants asked to mimic weakness and 12 control participants performed a precued reaction time task, requiring movements of either hand, depending on precue information. Performance measures (force, reaction and movement time), and event-related EEG potentials (ERP) were compared, between groups and across hands or hemisphere, using linear mixed models. Results: Feigners generated the same inter-hand difference in reaction and movement time as expressed by patients, even though no specific targets were set nor feedback given on these measures. We found novel ERP signatures specific to patients. When the symptomatic hand was precued, the P3 ERP component accompanying the precue was dramatically larger in patients than in feigning participants. Additionally, in patients the earlier N1 ERP component was diminished when the precue signalled either the symptomatic or asymptomatic hand. Conclusions: These results are consistent with previous suggestions that lack of awareness of the origin of their symptoms in conversion disorder patients may result from suppression of brain activity normally related to self-agency. In patients the diminished N1 to all precues is consistent with a generalised reduction in cognitive processing of movement-related precues. The P3 enhancement in patients is unlikely to simply reflect changes required for generation of impaired movements, because it was not seen in feigners showing the same behavioural deficits. Rather, this P3 enhancement in patients may represent a neural biomarker of unconscious processes, including additional emotional loading, related to active suppression of brain circuits involved in the attribution of self-agency.	[Blakemore, Rebekah L.] Univ Otago, Sch Phys Educ, Dunedin, New Zealand; [Blakemore, Rebekah L.; Hyland, Brian I.; Hammond-Tooke, Graeme D.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Hyland, Brian I.] Univ Otago, Dept Physiol, Dunedin, New Zealand; [Hammond-Tooke, Graeme D.] Univ Otago, Dept Med, Dunedin, New Zealand; [Anson, J. Greg] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand; [Anson, J. Greg] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland; University of Auckland	Blakemore, RL (corresponding author), Univ Geneva, Dept Neurosci, Univ Med Ctr, Geneva, Switzerland.	rebekah.blakemore@otago.ac.nz	Hyland, Brian I/F-7840-2012	Hyland, Brian I/0000-0001-7593-4885; Anson, Greg/0000-0002-5717-5595				American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; Critchley HD, 2000, J NEUROSCI, V20, P3033; EDWARDS MJ, 2012, BRAIN; Enge S, 2011, BEHAV BRAIN RES, V216, P122, DOI 10.1016/j.bbr.2010.07.021; Fukuda M, 1996, PSYCHIAT CLIN NEUROS, V50, P85, DOI 10.1111/j.1440-1819.1996.tb01668.x; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Kayser J, 2000, INT J PSYCHOPHYSIOL, V36, P211, DOI 10.1016/S0167-8760(00)00078-7; Kuhn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028657; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; LEVY R, 1973, J PSYCHOSOM RES, V17, P81, DOI 10.1016/0022-3999(73)90007-X; LEVY R, 1970, ELECTROEN CLIN NEURO, V29, P400, DOI 10.1016/0013-4694(70)90048-9; Lorenz J, 1998, NEUROREPORT, V9, P187, DOI 10.1097/00001756-199801260-00003; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; MOLDOFSKY H, 1975, ARCH GEN PSYCHIAT, V32, P193; Mumford JA, 2007, SOC COGN AFFECT NEUR, V2, P251, DOI 10.1093/scan/nsm019; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nicholson TRJ, 2011, J NEUROL NEUROSUR PS, V82, P1267, DOI 10.1136/jnnp.2008.171306; Norusis M.J., 2010, PASW STAT 18 STAT PR; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parees I, 2012, BRAIN, V135, P117, DOI 10.1093/brain/awr292; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Possamai CA, 2002, ACTA PSYCHOL, V111, P125, DOI 10.1016/S0001-6918(02)00019-7; Roelofs K, 2006, BIOL PSYCHOL, V71, P316, DOI 10.1016/j.biopsycho.2005.07.002; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Scott RL, 2009, MOTOR CONTROL, V13, P161, DOI 10.1123/mcj.13.2.161; Spence SA, 2000, LANCET, V355, P1243, DOI 10.1016/S0140-6736(00)02096-1; Stanford MS, 2001, PSYCHIAT RES, V102, P125, DOI 10.1016/S0165-1781(01)00236-0; Stone J, 2002, J NEUROL NEUROSUR PS, V73, P241, DOI 10.1136/jnnp.73.3.241; Stone J, 2007, PSYCHOSOM MED, V69, P961, DOI 10.1097/PSY.0b013e31815b6c14; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; TOWLE VL, 1985, ARCH OPHTHALMOL-CHIC, V103, P47; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Voon V, 2011, MOVEMENT DISORD, V26, P2396, DOI 10.1002/mds.23890; Vuilleumier P, 2001, BRAIN, V124, P1077, DOI 10.1093/brain/124.6.1077; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; *WHO, 1997, COMP INT DIAGN INT V	43	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62539	10.1371/journal.pone.0062539	http://dx.doi.org/10.1371/journal.pone.0062539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626829	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400193
J	D'Agnillo, F; Williams, MC; Moayeri, M; Warfel, JM				D'Agnillo, Felice; Williams, Matthew C.; Moayeri, Mahtab; Warfel, Jason M.			Anthrax Lethal Toxin Downregulates Claudin-5 Expression in Human Endothelial Tight Junctions	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; INHALATIONAL ANTHRAX; BARRIER FUNCTION; GENE-EXPRESSION; VE-CADHERIN; EDEMA TOXIN; IN-VIVO; CELLS; PERMEABILITY	Vascular leakage pathologies such as pleural effusion and hemorrhage are hallmarks of anthrax pathogenesis. We previously reported that anthrax lethal toxin (LT), the major virulence factor of anthrax, reduces barrier function in cultured primary human microvascular endothelial cells. Here, we show that LT-induced barrier dysfunction is accompanied by the reduced expression of the endothelial tight junction (TJ) protein claudin-5 but no change in the expression of other TJ components occludin, ZO-1, ZO-2, or the adherens junction (AJ) protein VE-cadherin. The downregulation of claudin-5 correlated temporally and dose-dependently with the reduction of transendothelial electrical resistance. LT-induced loss of claudin-5 was independent of cell death and preceded the appearance of actin stress fibers and altered AJ morphology. Pharmacological inhibition of MEK-1/2, two kinases that are proteolytically inactivated by LT, showed a similar reduction in claudin-5 expression. We found that LT reduced claudin-5 mRNA levels but did not accelerate the rate of claudin-5 degradation. Mice challenged with LT also showed significant reduction in claudin-5 expression. Together, these findings support a possible role for LT disruption of endothelial TJs in the vascular leakage pathologies of anthrax.	[D'Agnillo, Felice; Williams, Matthew C.] US FDA, Lab Biochem & Vasc Biol, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Warfel, Jason M.] US FDA, Lab Resp & Special Pathogens, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Moayeri, Mahtab] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	D'Agnillo, F (corresponding author), US FDA, Lab Biochem & Vasc Biol, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	felice.dagnillo@fda.hhs.gov		Moayeri, Mahtab/0000-0002-4448-8883	Food and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032] Funding Source: NIH RePORTER	Food and Drug Administration(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the intramural program of the Food and Drug Administration (FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323; Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birdsey GM, 2012, BLOOD, V119, P894, DOI 10.1182/blood-2011-04-350025; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bolcome RE, 2010, INFECT IMMUN, V78, P5043, DOI 10.1128/IAI.00604-10; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dal Molin F, 2008, TOXICON, V52, P824, DOI 10.1016/j.toxicon.2008.08.011; Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c; Deshpande A, 2006, FEBS LETT, V580, P4172, DOI 10.1016/j.febslet.2006.06.070; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Hollenhorst Peter C, 2012, Small GTPases, V3, P154, DOI 10.4161/sgtp.19630; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2013, TOXINS, V5, P1, DOI 10.3390/toxins5010001; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Moayeri M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000456; Mukherjee DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017921; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rolando M, 2009, INFECT IMMUN, V77, P3596, DOI 10.1128/IAI.00186-09; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trescos Y, 2012, TOXINS, V4, P83, DOI 10.3390/toxins4020083; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Warfel JM, 2008, J IMMUNOL, V180, P7516, DOI 10.4049/jimmunol.180.11.7516; Warfel JM, 2011, TOXINS, V3, P1278, DOI 10.3390/toxins3101278; Warfel JM, 2009, J BIOL CHEM, V284, P25761, DOI 10.1074/jbc.M109.036970; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yuan L, 2012, J BIOL CHEM, V287, P6582, DOI 10.1074/jbc.M111.300236	56	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62576	10.1371/journal.pone.0062576	http://dx.doi.org/10.1371/journal.pone.0062576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626836	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400200
J	Hathcock, KS; Bowen, S; Livak, F; Hodes, RJ				Hathcock, Karen S.; Bowen, Steven; Livak, Ferenc; Hodes, Richard J.			ATM Influences the Efficiency of TCR beta Rearrangement, Subsequent TCR beta-Dependent T Cell Development, and Generation of the Pre-Selection TCR beta CDR3 Repertoire	PLOS ONE			English	Article							V(D)J RECOMBINATION; ATAXIA-TELANGIECTASIA; DEFICIENT MICE; RECEPTOR BETA; IN-VIVO; GENE REARRANGEMENT; THYMOCYTES; LOCUS; CHAIN; CYCLE	Generation and resolution of DNA double-strand breaks is required to assemble antigen-specific receptors from the genes encoding V, D, and J gene segments during recombination. The present report investigates the requirement for ataxia telangiectasia-mutated (ATM) kinase, a component of DNA double-strand break repair, during TCR beta recombination and in subsequent TCR beta-dependent repertoire generation and thymocyte development. CD4(-)CD8(-) double negative stage 2/3 thymocytes from ATM-deficient mice have both an increased frequency of cells with DNA break foci at TCR beta loci and reduced V beta-DJ beta rearrangement. Sequencing of TCR beta complementarity-determining region 3 demonstrates that ATM-deficient CD4(+)CD8(+) double positive thymocytes and peripheral T cells have altered processing of coding ends for both in-frame and out-of-frame TCR beta rearrangements, providing the unique demonstration that ATM deficiency alters the expressed TCR beta repertoire by a selection-independent mechanism. ATMKO thymi exhibit a partial developmental block in DN cells as they negotiate the beta-selection checkpoint to become double negative stage 4 and CD4(+)CD8(+) thymocytes, resulting in reduced numbers of CD4(+)CD8(+) cells. Importantly, expression of a rearranged TCR beta transgene substantially reverses this defect in CD4(+)CD8(+) cells, directly linking a requirement for ATM during endogenous TCR beta rearrangement to subsequent TCR beta-dependent stages of development. These results demonstrate that ATM plays an important role in TCR beta rearrangement, generation of the TCR beta CDR3 repertoire, and efficient TCR beta-dependent T cell development.	[Hathcock, Karen S.; Bowen, Steven; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Hathcock, KS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	hathcock@mail.nih.gov			National Cancer Institute; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZICBC009255, ZIABC009265] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural Research Programs of the National Cancer Institute and the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chao C, 2000, J IMMUNOL, V164, P345, DOI 10.4049/jimmunol.164.1.345; Falk I, 2001, EUR J IMMUNOL, V31, P3308, DOI 10.1002/1521-4141(200111)31:11<3308::AID-IMMU3308>3.0.CO;2-5; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goyarts EC, 1998, MOL IMMUNOL, V35, P593, DOI 10.1016/S0161-5890(98)00056-X; Hakim O, GENOME RES, V21, P697; Hathcock KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020639; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Huang CY, 2007, J EXP MED, V204, P1371, DOI 10.1084/jem.20061460; Isoda T, 2012, BLOOD; KATAYAMA CD, 1995, EMBO J, V14, P927, DOI 10.1002/j.1460-2075.1995.tb07074.x; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lieber MR, ANN REV BIOCH, V79, P181; Livak F, 1999, J IMMUNOL, V162, P2575; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Matei IR, 2006, IMMUNOL REV, V209, P142, DOI 10.1111/j.0105-2896.2006.00361.x; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Shibata A, EMBO J, V30, P1079; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; Vacchio MS, 2007, P NATL ACAD SCI USA, V104, P6323, DOI 10.1073/pnas.0611222104; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320	49	13	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62188	10.1371/journal.pone.0062188	http://dx.doi.org/10.1371/journal.pone.0062188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626787	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400151
J	Purser, MJ; Dalvi, PS; Wang, ZC; Belsham, DD				Purser, Matthew J.; Dalvi, Prasad S.; Wang, Zi C.; Belsham, Denise D.			The Cytokine Ciliary Neurotrophic Factor (CNTF) Activates Hypothalamic Urocortin-Expressing Neurons Both In Vitro and In Vivo	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; EDINGER-WESTPHAL NUCLEUS; POMC GENE-EXPRESSION; TYPE-2 CRF RECEPTORS; RAT-BRAIN; ENERGY HOMEOSTASIS; NEUROPEPTIDE-Y; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS	Ciliary neurotrophic factor (CNTF) induces neurogenesis, reduces feeding, and induces weight loss. However, the central mechanisms by which CNTF acts are vague. We employed the mHypoE-20/2 line that endogenously expresses the CNTF receptor to examine the direct effects of CNTF on mRNA levels of urocortin-1, urocortin-2, agouti-related peptide, brain-derived neurotrophic factor, and neurotensin. We found that treatment of 10 ng/ml CNTF significantly increased only urocortin-1 mRNA by 1.84-fold at 48 h. We then performed intracerebroventricular injections of 0.5 mg/mL CNTF into mice, and examined its effects on urocortin-1 neurons post-exposure. Through double-label immunohistochemistry using specific antibodies against c-Fos and urocortin-1, we showed that central CNTF administration significantly activated urocortin-1 neurons in specific areas of the hypothalamus. Taken together, our studies point to a potential role for CNTF in regulating hypothalamic urocortin-1-expressing neurons to mediate its recognized effects on energy homeostasis, neuronal proliferaton/survival, and/or neurogenesis.	[Purser, Matthew J.; Dalvi, Prasad S.; Wang, Zi C.; Belsham, Denise D.] Univ Hlth Network, Toronto Gen Hosp, Dept Physiol, Res Inst, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Obstet, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Gynaecol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Belsham, DD (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Dept Physiol, Res Inst, Toronto, ON, Canada.	d.belsham@utoronto.ca	Dalvi, Prasad/F-1866-2015		Canadian Institutes for Health Research (CIHR); Canadian Diabetes Association; Canada Foundation for Innovation; Canada Research Chairs Program; Banting and Best Diabetes Research Centre (BBDC) Graduate Studentship; Natural Sciences and Engineering Research Council (NSERC) Studentship; Ontario Graduate Scholarship (OGS); NSERC; Endocrine Society Summer Studentships	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Banting and Best Diabetes Research Centre (BBDC) Graduate Studentship; Natural Sciences and Engineering Research Council (NSERC) Studentship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Endocrine Society Summer Studentships	The authors acknowledge funding from the Canadian Institutes for Health Research (CIHR), Canadian Diabetes Association, Canada Foundation for Innovation, and Canada Research Chairs Program to DDB. PSD was supported by a Banting and Best Diabetes Research Centre (BBDC) Graduate Studentship, a Natural Sciences and Engineering Research Council (NSERC) Studentship, and an Ontario Graduate Scholarship (OGS). MJP was supported by NSERC and Endocrine Society Summer Studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati S, 2007, BIOFACTORS, V31, P133, DOI 10.1002/biof.5520310204; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Bittencourt JC, 1999, J COMP NEUROL, V415, P285; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Chen PL, 2010, AM J PHYSIOL-ENDOC M, V298, pE337, DOI 10.1152/ajpendo.00402.2009; Couvreur O, 2012, AM J PHYSIOL-ENDOC M, V302, pE458, DOI 10.1152/ajpendo.00388.2011; Cui H, 2005, J NEUROSCI, V25, P9497, DOI 10.1523/JNEUROSCI.2269-05.2005; Currie PJ, 2011, BRAIN RES, V1385, P127, DOI 10.1016/j.brainres.2011.01.114; Currie PJ, 2001, BRAIN RES, V916, P222, DOI 10.1016/S0006-8993(01)02851-7; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2385, DOI 10.1210/en.2011-2089; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2208, DOI 10.1210/en.2011-1795; Dalvi PS, 2011, AM J PHYSIOL-REG I, V300, pR1030, DOI 10.1152/ajpregu.00649.2010; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Dhillon SS, 2011, INT J OBESITY, V35, P198, DOI 10.1038/ijo.2010.124; Dhillon SS, 2011, REGUL PEPTIDES, V167, P192, DOI 10.1016/j.regpep.2011.01.005; Elias CF, 2000, J COMP NEUROL, V423, P261; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fekete EM, 2011, BRIT J PHARMACOL, V164, P1959, DOI 10.1111/j.1476-5381.2011.01512.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GLOWA JR, 1991, NEUROPEPTIDES, V18, P55, DOI 10.1016/0143-4179(91)90164-E; Iino K, 1999, CLIN ENDOCRINOL, V50, P107, DOI 10.1046/j.1365-2265.1999.00624.x; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Kalra SP, 1998, NEUROSCI LETT, V240, P45, DOI 10.1016/S0304-3940(97)00896-3; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; Kozicz T, 2011, J COMP NEUROL, V519, P1413, DOI 10.1002/cne.22580; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Morin SM, 1999, NEUROSCIENCE, V92, P281, DOI 10.1016/S0306-4522(98)00732-5; Ohata H, 2000, BRAIN RES, V861, P1, DOI 10.1016/S0006-8993(99)02378-1; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pu S, 2000, J NEUROENDOCRINOL, V12, P827, DOI 10.1046/j.1365-2826.2000.00526.x; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Semjonous NM, 2009, INT J OBESITY, V33, P775, DOI 10.1038/ijo.2009.96; SENDTNER M, 1991, J CELL SCI, P103; Severi I, 2012, J ANAT; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Takahashi K, 1998, PEPTIDES, V19, P643, DOI 10.1016/S0196-9781(98)00012-6; Ushikai M, 2011, ENDOCRINE, V39, P113, DOI 10.1007/s12020-010-9420-7; Vacher CM, 2008, FEBS LETT, V582, P3832, DOI 10.1016/j.febslet.2008.10.018; Vasconcelos LAP, 2003, J COMP NEUROL, V463, P157, DOI 10.1002/cne.10742; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wang CF, 2001, AM J PHYSIOL-REG I, V280, pR473, DOI 10.1152/ajpregu.2001.280.2.R473; Wang LX, 2011, PEPTIDES, V32, P51, DOI 10.1016/j.peptides.2010.10.017; Weitemier AZ, 2005, BEHAV NEUROSCI, V119, P1235, DOI 10.1037/0735-7044.119.5.1235; Wong ML, 1996, MOL PSYCHIATR, V1, P307; Xu B, 1998, ENDOCRINOLOGY, V139, P466, DOI 10.1210/en.139.2.466; Xu L, 2009, NEUROSCIENCE, V162, P1141, DOI 10.1016/j.neuroscience.2009.05.003; Xu L, 2012, GEN COMP ENDOCR, V177, P296, DOI 10.1016/j.ygcen.2011.11.039; Xu L, 2011, ENDOCRINOLOGY, V152, P979, DOI 10.1210/en.2010-1143	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61616	10.1371/journal.pone.0061616	http://dx.doi.org/10.1371/journal.pone.0061616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626705	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400069
J	Yamal, G; Sharmila, P; Rao, KS; Pardha-Saradhi, P				Yamal, G.; Sharmila, P.; Rao, K. S.; Pardha-Saradhi, P.			Inbuilt Potential of YEM Medium and Its Constituents to Generate Ag/Ag2O Nanoparticles	PLOS ONE			English	Article							SILVER NANOPARTICLES; METAL NANOPARTICLES; GOLD NANOPARTICLES; GREEN SYNTHESIS	We discovered that Yeast Extract Mannitol (YEM) medium possessed immense potential to generate silver nanoparticles from AgNO3 upon autoclaving, which was evident from (i) alteration in color of the medium; (ii) peak at similar to 410 nm in UV-Vis spectrum due to surface plasmon resonance specific to silver nanoparticles; and (iii) TEM investigations. TEM coupled with EDX confirmed that distinct nanoparticles were composed of silver. Yeast extract and mannitol were key components of YEM medium responsible for the formation of nanoparticles. PXRD analysis indicated crystalline geometry and Ag/Ag2O phases in nanoparticles generated with YEM medium, yeast extract and mannitol. Our investigations also revealed that both mannitol and yeast extract possessed potential to convert similar to 80% of silver ions in 0.5 mM AgNO3 to nanoparticles, on autoclaving for 30 min at 121 degrees C under a pressure of 1.06 kg/cm(2). Addition of filter sterilized AgNO3 under ambient conditions to pre-autoclaved YEM medium and yeast extract brought about color change due to the formation of silver nanoparticles, but required prolonged duration. In general, even after 72 h intensity of color was significantly less than that recorded following autoclaving. Silver nanoparticles formed at room temperature were more heterogeneous compared to that obtained upon autoclaving. In summary, our findings demonstrated that (i) YEM medium and its constituents promote synthesis of silver nanoparticles; and (ii) autoclaving enhances rapid synthesis of silver nanoparticles by YEM medium, yeast extract and mannitol.	[Yamal, G.; Sharmila, P.; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Yamal, G.; Rao, K. S.] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi; University of Delhi	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	ppsaradhi@gmail.com	Rao, K S/I-7548-2012; Kottapalli, Rao S/D-5278-2009	Rao, K S/0000-0003-4919-5067; Kottapalli, Rao S/0000-0003-4919-5067	Council for Scientific and Industrial Research (Government of India), New Delhi; University of Delhi	Council for Scientific and Industrial Research (Government of India), New Delhi; University of Delhi(University of Delhi)	The authors acknowledge the support rendered by the Director and staff of University Science Instrumentation Facility, University of Delhi. The authors are thankful to Mr. Rahul Bhardwaj for providing special assistance during TEM analysis. The authors also thank Mr. Harsh for PXRD studies. GY is thankful to Council for Scientific and Industrial Research (Government of India), New Delhi, for providing research fellowship. The authors acknowledge the University of Delhi for providing financial support under Research & Development and Doctoral Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Puebla RA, 2009, ANAL CHEM, V81, P2280, DOI 10.1021/ac8024416; Badwaik VD, 2011, LANGMUIR, V27, P5549, DOI 10.1021/la105041d; Bagyaraj DJ., 2011, MICROBIAL BIOTECHNOL; Basavaraja S, 2008, MATER RES BULL, V43, P1164, DOI 10.1016/j.materresbull.2007.06.020; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Chatterjee S, 2011, CHEM COMMUN, V47, P11510, DOI 10.1039/c1cc14158a; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Donati I, 2009, BIOMACROMOLECULES, V10, P210, DOI 10.1021/bm801253c; Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8; Gellert G, 1999, CHEMOSPHERE, V39, P467, DOI 10.1016/S0045-6535(99)00002-8; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jiang XC, 2007, LANGMUIR, V23, P2218, DOI 10.1021/la062797z; LINDAN O, 1951, BIOCHEM J, V48, P337, DOI 10.1042/bj0480337; Maheswari M, 2010, BIOL PLANTARUM, V54, P647, DOI 10.1007/s10535-010-0115-y; Masala O, 2004, ANNU REV MATER RES, V34, P41, DOI 10.1146/annurev.matsci.34.052803.090949; Nanda A, 2009, NANOMED-NANOTECHNOL, V5, P452, DOI 10.1016/j.nano.2009.01.012; Pardha Saradhi P, 2008, HDB NEW TECHNOLOGIES, P577; Park Y, 2011, IET NANOBIOTECHNOL, V5, P69, DOI 10.1049/iet-nbt.2010.0033; Piao LH, 2009, J COLLOID INTERF SCI, V334, P208, DOI 10.1016/j.jcis.2009.03.072; Sastry M, 1997, COLLOID SURFACE A, V127, P221, DOI 10.1016/S0927-7757(97)00087-3; Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Singh RP, 2003, PLANT GENETIC ENG, P147; Sivakumar P, 2002, BIOCHEM BIOPH RES CO, V298, P247, DOI 10.1016/S0006-291X(02)02437-3; Song JY, 2010, BIOPROC BIOSYST ENG, V33, P159, DOI 10.1007/s00449-009-0373-2; Stevenson APZ, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-151; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tavakoli A, 2007, CHEM PAP, V61, P151, DOI 10.2478/s11696-007-0014-7; Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Wani IA, 2010, MATER RES BULL, V45, P1033, DOI 10.1016/j.materresbull.2010.03.028; Zhao T, 2010, COLLOID SURFACE A, V366, P197, DOI 10.1016/j.colsurfa.2010.06.005	33	27	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61750	10.1371/journal.pone.0061750	http://dx.doi.org/10.1371/journal.pone.0061750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626722	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400086
J	Chen, DF; Persson, A; Sun, YY; Salford, LG; Nord, DG; Englund, E; Jiang, T; Fan, XL				Chen, Dongfeng; Persson, Annette; Sun, Yingyu; Salford, Leif G.; Nord, David Gisselsson; Englund, Elisabet; Jiang, Tao; Fan, Xiaolong			Better Prognosis of Patients with Glioma Expressing FGF2-Dependent PDGFRA Irrespective of Morphological Diagnosis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; ALPHA-RECEPTOR EXPRESSION; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; HIGH-GRADE GLIOMA; MALIGNANT GLIOMAS; GLIAL PROGENITORS; BRAIN-TUMORS; OLIGODENDROCYTE LINEAGE; GENE-EXPRESSION	Signaling of platelet derived growth factor receptor alpha (PDGFRA) is critically involved in the development of gliomas. However, the clinical relevance of PDGFRA expression in glioma subtypes and the mechanisms of PDGFRA expression in gliomas have been controversial. Under the supervision of morphological diagnosis, analysis of the GSE16011 and the Repository of Molecular Brain Neoplasia Data (Rembrandt) set revealed enriched PDGFRA expression in low-grade gliomas. However, gliomas with the top 25% of PDGFRA expression levels contained nearly all morphological subtypes, which was associated with frequent IDH1 mutation, 1p LOH, 19q LOH, less EGFR amplification, younger age at disease onset and better survival compared to those gliomas with lower levels of PDGFRA expression. SNP analysis in Rembrandt data set and FISH analysis in eleven low passage glioma cell lines showed infrequent amplification of PDGFRA. Using in vitro culture of these low passage glioma cells, we tested the hypothesis of gliogenic factor dependent expression of PDGFRA in glioma cells. Fibroblast growth factor 2 (FGF2) was able to maintain PDGFRA expression in glioma cells. FGF2 also induced PDGFRA expression in glioma cells with low or non-detectable PDGFRA expression. FGF2-dependent maintenance of PDGFRA expression was concordant with the maintenance of a subset of gliogenic genes and higher rates of cell proliferation. Further, concordant expression patterns of FGF2 and PDGFRA were detected in glioma samples by immunohistochemical staining. Our findings suggest a role of FGF2 in regulating PDGFRA expression in the subset of gliomas with younger age at disease onset and longer patient survival regardless of their morphological diagnosis.	[Chen, Dongfeng; Salford, Leif G.; Fan, Xiaolong] Lund Univ, Dept Neurosurg, Rausing Lab, Lund, Sweden; [Persson, Annette; Nord, David Gisselsson; Englund, Elisabet] Lund Univ, Dept Pathol, Lund, Sweden; [Nord, David Gisselsson] Lund Univ, Dept Clin Genet, Lund, Sweden; [Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Glioma Ctr, Beijing, Peoples R China; [Sun, Yingyu; Fan, Xiaolong] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Beijing 100875, Peoples R China	Lund University; Lund University; Lund University; Capital Medical University; Beijing Normal University	Fan, XL (corresponding author), Lund Univ, Dept Neurosurg, Rausing Lab, Lund, Sweden.	XFan@bnu.edu.cn	jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014	Englund, Elisabet/0000-0002-2708-2443	Swedish Cancer Society; National Natural Science Foundation of China [81072080]; Ministry of Science and Technology of China [2012DFA30470]; Hans and Marit Rausing Charitable Foundation	Swedish Cancer Society(Swedish Cancer Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hans and Marit Rausing Charitable Foundation	This study was supported by The Swedish Cancer Society, National Natural Science Foundation of China (grant 81072080), international collaborative program of the Ministry of Science and Technology of China (grant 2012DFA30470), and the Hans and Marit Rausing Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chojnacki A, 2011, J NEUROSCI, V31, P9503, DOI 10.1523/JNEUROSCI.1531-11.2011; Clarke ID, 2003, ONCOGENE, V22, P722, DOI 10.1038/sj.onc.1206160; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fan XL, 2007, SEMIN CANCER BIOL, V17, P214, DOI 10.1016/j.semcancer.2006.04.002; Fortin D, 2005, J NEUROSCI, V25, P7470, DOI 10.1523/JNEUROSCI.2120-05.2005; Fukui S, 2003, CANCER, V97, P3061, DOI 10.1002/cncr.11450; Gisselsson David, 2001, Methods in Cell Science, V23, P23, DOI 10.1023/A:1013129212367; Glanz C, 2007, NEUROPATH APPL NEURO, V33, P440, DOI 10.1111/j.1365-2990.2007.00832.x; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hamer PCDW, 2010, NEURO-ONCOLOGY, V12, P304, DOI 10.1093/neuonc/nop068; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Lokker NA, 2002, CANCER RES, V62, P3729; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mariani L, 2006, J CLIN ONCOL, V24, P4758, DOI 10.1200/JCO.2006.05.9238; Martinho O, 2009, BRIT J CANCER, V101, P973, DOI 10.1038/sj.bjc.6605225; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; MAYER M, 1993, GLIA, V8, P12, DOI 10.1002/glia.440080103; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TAKAHASHI JA, 1990, P NATL ACAD SCI USA, V87, P5710, DOI 10.1073/pnas.87.15.5710; Uhrbom L, 1998, CANCER RES, V58, P5275; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; ZAGZAG D, 1990, CANCER RES, V50, P7393	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61556	10.1371/journal.pone.0061556	http://dx.doi.org/10.1371/journal.pone.0061556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630597	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500047
J	Pfeiffer, C; Lopez, C; Schmutz, V; Duenas, JA; Martuzzi, R; Blanke, O				Pfeiffer, Christian; Lopez, Christophe; Schmutz, Valentin; Duenas, Julio Angel; Martuzzi, Roberto; Blanke, Olaf			Multisensory Origin of the Subjective First-Person Perspective: Visual, Tactile, and Vestibular Mechanisms	PLOS ONE			English	Article							BODILY SELF-CONSCIOUSNESS; OF-BODY EXPERIENCES; GRAVITATIONAL MOTION; SPATIAL ORIENTATION; VERTICAL PERCEPTION; POSTURAL CONTROL; RUBBER HAND; FRAME TEST; GRAVITY; OWNERSHIP	In three experiments we investigated the effects of visuo-tactile and visuo-vestibular conflict about the direction of gravity on three aspects of bodily self-consciousness: self-identification, self-location, and the experienced direction of the first-person perspective. Robotic visuo-tactile stimulation was administered to 78 participants in three experiments. Additionally, we presented participants with a virtual body as seen from an elevated and downward-directed perspective while they were lying supine and were therefore receiving vestibular and postural cues about an upward-directed perspective. Under these conditions, we studied the effects of different degrees of visuo-vestibular conflict, repeated measurements during illusion induction, and the relationship to a classical measure of visuo-vestibular integration. Extending earlier findings on experimentally induced changes in bodily self-consciousness, we show that self-identification does not depend on the experienced direction of the first-person perspective, whereas self-location does. Changes in bodily self-consciousness depend on visual gravitational signals. Individual differences in the experienced direction of first-person perspective correlated with individual differences in visuo-vestibular integration. Our data reveal important contributions of visuo-vestibular gravitational cues to bodily self-consciousness. In particular we show that the experienced direction of the first-person perspective depends on the integration of visual, vestibular, and tactile signals, as well as on individual differences in idiosyncratic visuo-vestibular strategies.	[Pfeiffer, Christian; Schmutz, Valentin; Martuzzi, Roberto; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Pfeiffer, Christian; Schmutz, Valentin; Martuzzi, Roberto; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Lopez, Christophe] CNRS, Lab Neurosci Integrat & Adaptat, UMR 7260, Marseille, France; [Lopez, Christophe] Aix Marseille Univ, Marseille, France; [Duenas, Julio Angel] ETH, Inst Robot & Intelligent Syst, Rehabil Engn Lab, Zurich, Switzerland; [Blanke, Olaf] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.	olaf.blanke@epfl.ch	Lopez, Christophe/AAJ-6155-2020; Lopez, Christophe/ABG-6263-2020	Lopez, Christophe/0000-0001-9298-2969; Schmutz, Valentin/0000-0002-0935-6121	Swiss National Science Foundation [SINERGIA CRSII1-125135]; European Science Foundation; Bertarelli Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Bertarelli Foundation	This work was supported by grants from the Swiss National Science Foundation (SINERGIA CRSII1-125135), the European Science Foundation (FP7 project VERE) and the Bertarelli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Blake R, 2011, VISION RES, V51, P754, DOI 10.1016/j.visres.2010.10.009; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2012, NATURE NEUR IN PRESS; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bonnet C, 2005, PERCEPTION, V34, P835, DOI 10.1068/p5039; Bosco G, 2008, J NEUROSCI, V28, P12071, DOI 10.1523/JNEUROSCI.2869-08.2008; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bray A, 2004, CURR BIOL, V14, pR609, DOI 10.1016/j.cub.2004.07.040; Bremmer F, 2011, J PHYSIOL-LONDON, V589, P815, DOI 10.1113/jphysiol.2010.195537; Cheron G, 2006, BRAIN RES, V1121, P104, DOI 10.1016/j.brainres.2006.08.098; Corradi-Dell'Acqua C, 2008, NEUROIMAGE, V40, P1902, DOI 10.1016/j.neuroimage.2007.12.062; Cramer H., 1946, MATH METHODS STAT; Damasio A, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P3; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Duenas J, 2011, IEEE ENG MED BIO, P8348, DOI 10.1109/IEMBS.2011.6092059; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Golomer E, 2005, NEUROSCI LETT, V381, P31, DOI 10.1016/j.neulet.2005.01.076; Green, 1968, OUT OF BODY EXPERIEN; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; HAGBERG B, 1991, J GERONTOL, V46, pP285, DOI 10.1093/geronj/46.6.P285; Heydrich L, 2011, EPILEPSY BEHAV, V20, P583, DOI 10.1016/j.yebeh.2011.01.008; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2008, J VESTIBUL RES-EQUIL, V18, P239; Jenkin HL, 2003, J VESTIBUL RES-EQUIL, V13, P287; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; LACKNER JR, 1992, PERCEPTION, V21, P803, DOI 10.1068/p210803; Lacour M, 1997, EXP BRAIN RES, V115, P300, DOI 10.1007/PL00005698; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2011, EUR J NEUROSCI, V33, P1935, DOI 10.1111/j.1460-9568.2011.07647.x; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lipshits M, 1999, NEUROREPORT, V10, P1085, DOI 10.1097/00001756-199904060-00033; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C, 2007, NEUROPSYCHOLOGIA, V45, P2025, DOI 10.1016/j.neuropsychologia.2007.02.004; Lopez C, 2006, NEUROREPORT, V17, P797, DOI 10.1097/01.wnr.0000221843.58373.c8; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Lopez C, 2009, J VISION, V9, DOI 10.1167/9.5.1; Luyat M, 1997, ACTA PSYCHOL, V95, P181, DOI 10.1016/S0001-6918(96)00015-7; Marendaz C, 1998, PSYCHOL SCI, V9, P27, DOI 10.1111/1467-9280.00005; MARENDAZ C, 1988, PERCEPT PSYCHOPHYS, V44, P445, DOI 10.3758/BF03210429; MATIN L, 1989, VISION RES, V29, P315, DOI 10.1016/0042-6989(89)90080-1; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Miller WL, 2008, J NEUROPHYSIOL, V99, P1969, DOI 10.1152/jn.00889.2007; OHLMANN T, 1991, FIELD DEPENDENCE-INDEPENDENCE, P105; Palluel E, 2011, J NEUROPHYSIOL, V105, P2239, DOI 10.1152/jn.00744.2010; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Schwabe L, 2009, HUM BRAIN MAPP, V30, P1801, DOI 10.1002/hbm.20764; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; Zago M, 2011, J VISION, V11, DOI 10.1167/11.10.13; ZOCCOLOTTI P, 1992, ACTA PSYCHOL, V79, P171, DOI 10.1016/0001-6918(92)90031-8	75	68	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61751	10.1371/journal.pone.0061751	http://dx.doi.org/10.1371/journal.pone.0061751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130JR	23630611	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500064
J	Braza-Boils, A; Gilabert-Estelles, J; Ramon, LA; Gilabert, J; Mari-Alexandre, J; Chirivella, M; Espana, F; Estelles, A				Braza-Boils, Aitana; Gilabert-Estelles, Juan; Ramon, Luis A.; Gilabert, Juan; Mari-Alexandre, Josep; Chirivella, Melitina; Espana, Francisco; Estelles, Amparo			Peritoneal Fluid Reduces Angiogenesis-Related MicroRNA Expression in Cell Cultures of Endometrial and Endometriotic Tissues from Women with Endometriosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE SYSTEMS; PLASMINOGEN-ACTIVATOR; FACTOR VEGF; SERUM MICRORNAS; MESSENGER-RNA; DISEASE; THROMBOSPONDIN-1; PATHOPHYSIOLOGY; PATHOGENESIS	Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent gynecological diseases. It has been suggested that modifications of both endometrial and peritoneal factors could be implicated in this disease. Endometriosis is a multifactorial disease in which angiogenesis and proteolysis are dysregulated. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the protein expression and may be the main regulators of angiogenesis. Our hypothesis is that peritoneal fluid from women with endometriosis could modify the expression of several miRNAs that regulate angiogenesis and proteolysis in the endometriosis development. The objective of this study has been to evaluate the influence of endometriotic peritoneal fluid on the expression of six miRNAs related to angiogenesis, as well as several angiogenic and proteolytic factors in endometrial and endometriotic cell cultures from women with endometriosis compared with women without endometriosis. Methods: Endometrial and endometriotic cells were cultured and treated with endometriotic and control peritoneal fluid pools. We have studied the expression of six miRNAs (miR-16, -17-5p, -20a, -125a, -221, and -222) by RT-PCR and protein and mRNA levels of vascular endothelial growth factor-A, thrombospondin-1, urokinase plasminogen activator and plasminogen activator inhibitor-1 by ELISA and qRT-PCR respectively. Results: Control and endometriotic peritoneal fluid pools induced a significant reduction of all miRNAs levels in endometrial and endometriotic cell cultures. Moreover, both peritoneal fluids induced a significant increase in VEGF-A, uPA and PAI-1 protein levels in all cell cultures without significant increase in mRNA levels. Endometrial cell cultures from patients treated with endometriotic peritoneal fluid showed lower expression of miRNAs and higher expression of VEGF-A protein levels than cultures from controls. In conclusion, this "in vitro" study indicates that peritoneal fluid from women with endometriosis modulates the expression of miRNAs that could contribute to the angiogenic and proteolytic disequilibrium observed in this disease.	[Braza-Boils, Aitana; Ramon, Luis A.; Mari-Alexandre, Josep] Sanit Hosp La Fe, Inst Invest, Grp Hemostasia Trombosis Arteriosclerosis & Biol, Valencia, Spain; [Gilabert-Estelles, Juan] Hosp Gen Univ, Area Clin Maternoinfantil, Valencia, Spain; [Gilabert, Juan] Hosp Arnau Vilanova, Serv Ginecol, Valencia, Spain; [Chirivella, Melitina] Univ Hosp, Dept Anatomopatol, Valencia, Spain; [Chirivella, Melitina; Espana, Francisco; Estelles, Amparo] Politecn La Fe, Valencia, Spain		Estelles, A (corresponding author), Univ Hosp, Ctr Invest, Valencia, Spain.	estelles_amp@gva.es	Ramon, Luis/ABG-7732-2020; Ramón Núñez, Luis Andrés/F-1584-2010; Gilabert-Estelles, Juan/ABH-9381-2020; Braza Boils, Aitana/L-3932-2017	Ramon, Luis/0000-0002-5789-4506; Ramón Núñez, Luis Andrés/0000-0002-5789-4506; Gilabert-Estelles, Juan/0000-0002-3992-1929; Braza Boils, Aitana/0000-0002-9888-6705; Espana, Francisco/0000-0001-7829-2021	PN de I+D+I (ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion); FEDER [FI12/00012]; Red RECAVA [RD06/0014/0004]; Conselleria de Sanidad [AP-141/11]; Conselleria de Educacion [PROMETEO/2011/027]; Generalitat Valenciana; Fundacion Espanola de Trombosis y Hemostasia; Beca de Investigacion Fundacion Dexeus para la Salud de la Mujer [2011/0469]; Fundacion Investigacion Hospital La Fe, Spain [2011/211]	PN de I+D+I (ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion); FEDER(European Commission); Red RECAVA; Conselleria de Sanidad; Conselleria de Educacion; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion Espanola de Trombosis y Hemostasia; Beca de Investigacion Fundacion Dexeus para la Salud de la Mujer; Fundacion Investigacion Hospital La Fe, Spain	This work was supported by research grants from the PN de I+D+I 2008-2011 (ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion PI0110091), FEDER, FI12/00012 and Red RECAVA (RD06/0014/0004), by Conselleria de Sanidad (AP-141/11) and Conselleria de Educacion (PROMETEO/2011/027), Generalitat Valenciana, by Beca Fibrinolisis 2009 and Becario 2010, 2011 from Fundacion Espanola de Trombosis y Hemostasia, Beca de Investigacion Fundacion Dexeus para la Salud de la Mujer (2011/0469) and by the Fundacion Investigacion Hospital La Fe, Spain (2011/211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2011, REPROD SCI, V18, P229, DOI 10.1177/1933719110386241; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2009, MOL HUM REPROD, V15, P625, DOI 10.1093/molehr/gap068; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Canis M, 1997, FERTIL STERIL, V67, P817; Caporali A, 2011, VASC PHARMACOL, V55, P79, DOI 10.1016/j.vph.2011.06.006; Carvalho LFP, 2013, REPROD SCI, V20, P688, DOI 10.1177/1933719112466301; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cho S, 2012, MICROVASC RES, V83, P237, DOI 10.1016/j.mvr.2011.12.004; Cosin R, 2010, HUM REPROD, V25, P398, DOI 10.1093/humrep/dep419; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Drosdzol-Cop A, 2012, OBSTET GYNECOL SURV, V67, P374, DOI 10.1097/OGX.0b013e31825cb12b; Fasciani A, 2000, MOL HUM REPROD, V6, P50, DOI 10.1093/molehr/6.1.50; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Gilabert-Estelles J, 2007, HUM REPROD, V22, P2120, DOI 10.1093/humrep/dem149; Gilabert-Estelles J, 2005, FRONT BIOSCI-LANDMRK, V10, P1162, DOI 10.2741/1609; Gilabert-Estelles J, 2012, CURR MED CHEM, V19, P2406, DOI 10.2174/092986712800269362; Gilabert-Estelles J, 2003, HUM REPROD, V18, P1516, DOI 10.1093/humrep/deg300; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Girling Jane E., 2005, Angiogenesis, V8, P89, DOI 10.1007/s10456-005-9006-9; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guo SW, 2009, MOL HUM REPROD, V15, P587, DOI 10.1093/molehr/gap064; Hapangama DK, 2012, HUM REPROD, V27, P394, DOI 10.1093/humrep/der412; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hirota Y, 2005, HUM REPROD, V20, P1084, DOI 10.1093/humrep/deh720; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Kawano Y, 2005, FERTIL STERIL, V83, P1056, DOI 10.1016/j.fertnstert.2004.09.035; Kobayashi H, 2000, GYNECOL OBSTET INVES, V50, P26, DOI 10.1159/000052875; Koninckx PR, 1998, HUM REPROD UPDATE, V4, P741, DOI 10.1093/humupd/4.5.741; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Laschke MW, 2011, HUM REPROD UPDATE, V17, P628, DOI 10.1093/humupd/dmr023; Laschke MW, 2007, HUM REPROD UPDATE, V13, P331, DOI 10.1093/humupd/dmm006; Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308; Li YX, 2009, BIOCHEM BIOPH RES CO, V381, P81, DOI 10.1016/j.bbrc.2009.02.013; Liu YH, 2011, FERTIL STERIL, V95, P1836, DOI 10.1016/j.fertnstert.2010.11.039; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; McLaren J, 1996, HUM REPROD, V11, P220; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michaud N, 2011, J REPROD IMMUNOL, V92, P68, DOI 10.1016/j.jri.2011.08.001; Mier-Cabrera J, 2011, BJOG-INT J OBSTET GY, V118, P6, DOI 10.1111/j.1471-0528.2010.02777.x; Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399; Na YJ, 2011, ARCH GYNECOL OBSTET, V283, P1333, DOI 10.1007/s00404-010-1583-1; Ng E.K., 2009, J ONCOL, V2009, P1; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Patella F, 2012, CELL MOL LIFE SCI, V69, P1049, DOI 10.1007/s00018-011-0775-6; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Qin B, 2012, MOL BIOL REP, V39, P4509, DOI 10.1007/s11033-011-1241-0; Ramon L, 2005, HUM REPROD, V20, P272, DOI 10.1093/humrep/deh571; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Ramon LA, 2011, HUM REPROD, V26, P1082, DOI 10.1093/humrep/der025; Sacco K, 2012, GYNECOL ENDOCRINOL, V28, P134, DOI 10.3109/09513590.2011.588753; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sillem M, 2001, EUR J OBSTET GYN R B, V95, P167, DOI 10.1016/S0301-2115(00)00415-2; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Takehara M, 2004, HUM PATHOL, V35, P1369, DOI 10.1016/j.humpath.2004.07.020; Tan XJ, 2002, FERTIL STERIL, V78, P148, DOI 10.1016/S0015-0282(02)03187-4; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Velasco I, 2010, J REPROD IMMUNOL, V84, P199, DOI 10.1016/j.jri.2009.11.004; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Yang Weining, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P140; Zondervan KT, 2007, HUM REPROD, V22, P717, DOI 10.1093/humrep/del446; Zorio E., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P82; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	77	33	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62370	10.1371/journal.pone.0062370	http://dx.doi.org/10.1371/journal.pone.0062370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620826	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500107
J	Yun, CH; Bezerra, HG; Wu, TH; Yang, FS; Liu, CC; Wu, YJ; Kuo, JY; Hung, CL; Lee, JJS; Hou, CJY; Yeh, HI; Longenecker, CT; Cury, RC				Yun, Chun-Ho; Bezerra, Hiram G.; Wu, Tung-Hsin; Yang, Fei-Shih; Liu, Chuan-Chuan; Wu, Yih-Jer; Kuo, Jen-Yuan; Hung, Chung-Lieh; Lee, Jason Jeun-Shenn; Hou, Charles Jia-Yin; Yeh, Hung-I; Longenecker, Chris T.; Cury, Ricardo C.			The Normal Limits, Subclinical Significance, Related Metabolic Derangements and Distinct Biological Effects of Body Site-Specific Adiposity in Relatively Healthy Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; AGE-RELATED-CHANGES; VISCERAL ABDOMINAL FAT; WAIST CIRCUMFERENCE; RISK-FACTORS; CARDIOVASCULAR RISK; PERICARDIAL FAT; CENTRAL OBESITY; TISSUE; HEART	Background: The accumulation of visceral adipose tissue that occurs with normal aging is associated with increased cardiovascular risks. However, the clinical significance, biological effects, and related cardiometabolic derangements of body-site specific adiposity in a relatively healthy population have not been well characterized. Materials and Methods: In this cross-sectional study, we consecutively enrolled 608 asymptomatic subjects (mean age: 47.3 years, 27% female) from 2050 subjects undergoing an annual health survey in Taiwan. We measured pericardial (PCF) and thoracic peri-aortic (TAT) adipose tissue volumes by 16-slice multi-detector computed tomography (MDCT) (Aquarius 3D Workstation, TeraRecon, San Mateo, CA, USA) and related these to clinical characteristics, body fat composition (Tanita 305 Corporation, Tokyo, Japan), coronary calcium score (CCS), serum insulin, high-sensitivity C-reactive protein (Hs-CRP) level and circulating leukocytes count. Metabolic risk was scored by Adult Treatment Panel III guidelines. Results: TAT, PCF, and total body fat composition all increased with aging and higher metabolic scores (all p<0.05). Only TAT, however, was associated with higher circulating leukocyte counts (beta-coef.: 0.24, p<0.05), serum insulin (beta-coef.: 0.17, p<0.05) and high sensitivity C-reactive protein (beta-coef.: 0.24, p<0.05). These relationships persisted after adjustment in multivariable models (all p<0.05). A TAT volume of 8.29 ml yielded the largest area under the receiver operating characteristic curve (AUROC: 0.79, 95% CI: 0.74-0.83) to identify metabolic syndrome. TAT but not PCF correlated with higher coronary calcium score after adjustment for clinical variables (all p<0.05). Conclusion: In our study, we observe that age-related body-site specific accumulation of adipose tissue may have distinct biological effects. Compared to other adiposity measures, peri-aortic adiposity is more tightly associated with cardiometabolic risk profiles and subclinical atherosclerosis in a relatively healthy population.	[Yun, Chun-Ho; Wu, Tung-Hsin; Lee, Jason Jeun-Shenn] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yun, Chun-Ho; Yang, Fei-Shih] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Yun, Chun-Ho; Wu, Yih-Jer; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Yun, Chun-Ho; Wu, Yih-Jer; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Bezerra, Hiram G.; Longenecker, Chris T.] Univ Hosp Cleveland, Harrington Heart & Vasc Inst, Case Med Ctr, Cleveland, OH 44106 USA; [Liu, Chuan-Chuan; Hung, Chung-Lieh] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei 10764, Taiwan; [Liu, Chuan-Chuan] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Wu, Yih-Jer; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Hung, Chung-Lieh] Kainan Univ, Dept Hlth Ind Management, Tao Yuan, Taiwan; [Cury, Ricardo C.] Baptist Cardiac Vasc Inst, Cardiovasc MRI & CT Program, Miami, FL USA	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Case Western Reserve University; University Hospitals of Cleveland; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; Nan Kai University Technology; Baptist Cardiac & Vascular Institute	Hung, CL (corresponding author), Mackay Med Coll, Dept Med, Taipei, Taiwan.	jotaro3791@gmail.com	Kuo, Jen-Yuan/AAX-5448-2021		Mackay Memorial Hospital, Taipei, Taiwan	Mackay Memorial Hospital, Taipei, Taiwan	This work was supported by research grants from the Mackay Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoumou HGN, 2011, METAB SYNDR RELAT D, V9, P281, DOI 10.1089/met.2010.0115; BORKAN GA, 1985, AM J PHYS ANTHROPOL, V66, P289, DOI 10.1002/ajpa.1330660306; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Dupuy AM, 2007, GERONTOLOGY, V53, P329, DOI 10.1159/000103555; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Johannsen Darcy L, 2010, Aging health, V6, P159, DOI 10.2217/ahe.10.12; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; KOTANI K, 1994, INT J OBESITY, V18, P207; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Lemieux I, 2006, DIABETES CARE, V29, P1417, DOI 10.2337/dc06-0441; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Machann J, 2005, MAGN RESON MATER PHY, V18, P128, DOI 10.1007/s10334-005-0104-x; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meijer RI, 2011, CURR DIABETES REP, V11, P211, DOI 10.1007/s11892-011-0186-y; Park JS, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-29; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Santos AC, 2005, INT J OBESITY, V29, P1452, DOI 10.1038/sj.ijo.0803035; Sato Susumu, 2009, Journal of Physiological Anthropology, V28, P231, DOI 10.2114/jpa2.28.231; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Sugihara M, 2011, INTERNAL MED, V50, P679, DOI 10.2169/internalmedicine.50.4292; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	37	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61997	10.1371/journal.pone.0061997	http://dx.doi.org/10.1371/journal.pone.0061997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620798	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500078
J	Ito, K; Maruyama, Z; Sakai, A; Izumi, S; Moriishi, T; Yoshida, CA; Miyazaki, T; Komori, H; Takada, K; Kawaguchi, H; Komori, T				Ito, K.; Maruyama, Z.; Sakai, A.; Izumi, S.; Moriishi, T.; Yoshida, C. A.; Miyazaki, T.; Komori, H.; Takada, K.; Kawaguchi, H.; Komori, T.			Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation	ONCOGENE			English	Article						Cdk6; cyclin D1; chondrocyte; apoptosis; p53; Rb	INTEGRIN-LINKED KINASE; CYCLIN D1; CELL-CYCLE; MICE LACKING; P53 LOSS; EXPRESSION; DIFFERENTIATION; OSTEOSARCOMA; P57(KIP2); PROTEIN	Cell proliferation and differentiation are closely coupled. However, we previously showed that overexpression of cyclin-dependent kinase (Cdk6) blocks chondrocyte differentiation without affecting cell-cycle progression in vitro. To investigate whether Cdk6 inhibits chondrocyte differentiation in vivo, we generated chondrocyte-specific Cdk6 transgenic mice using Col2a1 promoter. Unexpectedly, differentiation and cell-cycle progression of chondrocytes in the Cdk6 transgenic mice were similar to those in wildtype mice. Then, we generated chondrocyte-specific Ccnd1 transgenic mice and Cdk6/Ccnd1 double transgenic mice to investigate the possibility that Cdk6 inhibits chondrocyte differentiation through E2f activation. Bromodeoxyuridine (BrdU)-positive chondrocytes and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive chondrocytes were increased in number, and chondrocyte maturation was inhibited only in Cdk6/Ccnd1 transgenic mice (K6H/D1H mice), which showed dwarfism. Retinoblastoma protein (pRb) was highly phosphorylated but p107 was upregulated, and the expression of E2f target genes was dysregulated as shown by upregulation of Cdc6 but downregulation of cyclin E, dihydrofolate reductase (dhfr), Cdc25a and B-Myb in chondrocytes of K6H/D1H mice. Similarly, overexpression of Cdk6/Ccnd1 in a chondrogenic cell line ATDC5 highly phosphorylated pRb, upregulated p107, induced apoptosis, upregulated Cdc6 and downregulated cyclin E, dhfr and B-Myb and p107 small interfering RNA reversed the expression of downregulated genes. Further, introduction of kinase-negative Cdk6 and cyclin D1 abolished all effects by Cdk6/cyclin D1 in ATDC5 cells, indicating the requirement of the kinase activity on these effects. p53 deletion partially restored the size of the skeleton and almost completely rescued chondrocyte apoptosis, but failed to enhance chondrocyte proliferation in K6(H)/D1(H) mice. These findings indicated that Cdk6/Ccnd1 overexpression inhibited chondrocyte maturation and enhanced G1/S cell-cycle transition by phosphorylating pRb, but the chondrocytes failed to accomplish the cell cycle, and underwent p53-dependent apoptosis probably due to the dysregulation of E2f target genes. Our findings also indicated that p53 deletion in addition to the inactivation of Rb was not sufficient to accelerate chondrocyte proliferation, suggesting the resistance of chondrocytes to sarcomagenesis.	[Ito, K.; Maruyama, Z.; Sakai, A.; Izumi, S.; Moriishi, T.; Yoshida, C. A.; Miyazaki, T.; Komori, H.; Komori, T.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 8528588, Japan; [Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, Nagasaki 8528588, Japan; [Ito, K.] Nagasaki Univ, NRGIC, Ctr Genom Instabil & Carcinogenesis, Nagasaki 8528588, Japan; [Maruyama, Z.; Kawaguchi, H.] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Sakai, A.; Takada, K.] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Suita, Osaka, Japan	Nagasaki University; Nagasaki University; Nagasaki University; University of Tokyo; Osaka University	Komori, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	komorit@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; President's Discretionary Fund of Nagasaki University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); President's Discretionary Fund of Nagasaki University	We thank H Okayama and T Ogasawara for providing DNA plasmids for gene expression, M Hirakawa, M Mori and Y Matsuo for technical assistance, and C Fukuda for secretarial assistance. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the President's Discretionary Fund of Nagasaki University.	Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Chen QH, 2003, ONCOGENE, V22, P992, DOI 10.1038/sj.onc.1206193; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; JIANG W, 1993, ONCOGENE, V8, P3447; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Long FX, 2001, DEVELOPMENT, V128, P5099; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; Moro T, 2005, J CELL PHYSIOL, V204, P927, DOI 10.1002/jcp.20350; Mueller A, 1997, CANCER RES, V57, P5542; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; Ojala PM, 1999, CANCER RES, V59, P4984; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sunters A, 1998, DEV GENET, V22, P386, DOI 10.1002/(SICI)1520-6408(1998)22:4<386::AID-DVG8>3.0.CO;2-2; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Whelan J, 2012, INT J CANCER, V131, pE508, DOI 10.1002/ijc.26426; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	55	20	21	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1862	1871		10.1038/onc.2013.130	http://dx.doi.org/10.1038/onc.2013.130			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23624920				2022-12-25	WOS:000334345500012
J	Kwon, HS; Johnson, TV; Tomarev, SI				Kwon, Heung Sun; Johnson, Thomas V.; Tomarev, Stanislav I.			Myocilin Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells through Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; HUMAN TRABECULAR MESHWORK; OSTEOBLAST DIFFERENTIATION; OSTERIX EXPRESSION; GENE-EXPRESSION; TRANSGENIC MICE; MUTATED MOUSE; MAPK PATHWAY; BONE-MARROW; ER STRESS	Myocilin is a secreted glycoprotein that is expressed in ocular and non-ocular tissues. Mutations in the MYOCILIN gene may lead to juvenile-and adult-onset primary open-angle glaucoma. Here we report that myocilin is expressed in bone marrow-derived mesenchymal stem cells (MSCs) and plays a role in their differentiation into osteoblasts in vitro and in osteogenesis in vivo. Expression of myocilin was detected in MSCs derived from mouse, rat, and human bone marrow, with human MSCs exhibiting the highest level of myocilin expression. Expression of myocilin rose during the course of human MSC differentiation into osteoblasts but not into adipocytes, and treatment with exogenous myocilin further enhanced osteogenesis. MSCs derived from Myoc-null mice had a reduced ability to differentiate into the osteoblastic lineage, which was partially rescued by exogenous extracellular myocilin treatment. Myocilin also stimulated osteogenic differentiation of wild-type MSCs, which was associated with activation of the p38, Erk1/2, and JNK MAP kinase signaling pathways as well as up-regulated expression of the osteogenic transcription factors Runx2 and Dlx5. Finally, cortical bone thickness and trabecular volume, as well as the expression level of osteopontin, a known factor of bone remodeling and osteoblast differentiation, were reduced dramatically in the femurs of Myoc-null mice compared with wild-type mice. These data suggest that myocilin should be considered as a target for improving the bone regenerative potential of MSCs and may identify a new role for myocilin in bone formation and/or maintenance in vivo.	[Kwon, Heung Sun; Johnson, Thomas V.; Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Room 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov	Johnson, Thomas V/C-9351-2011	Johnson, Thomas V/0000-0002-5372-5457	National Institutes of Health; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Eye Institute.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; Gordeladze JO, 2008, EXP CELL RES, V314, P1495, DOI 10.1016/j.yexcr.2007.12.023; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; O'Brien ET, 2000, INVEST OPHTH VIS SCI, V41, P3842; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	57	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16882	16894		10.1074/jbc.M112.422972	http://dx.doi.org/10.1074/jbc.M112.422972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629661	hybrid, Green Published			2022-12-25	WOS:000320378900061
J	Coumans, FAW; van Dalum, G; Beck, M; Terstappen, LWMM				Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.			Filter Characteristics Influencing Circulating Tumor Cell Enrichment from Whole Blood	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CANCER-PATIENTS; SURVIVAL; CHEMOTHERAPY; PREDICT; ENUMERATION; PROGRESSION; EXPRESSION; MARKERS	A variety of filters assays have been described to enrich circulating tumor cells (CTC) based on differences in physical characteristics of blood cells and CTC. In this study we evaluate different filter types to derive the properties of the ideal filter for CTC enrichment. Between 0.1 and 10 mL of whole blood spiked with cells from tumor cell lines were passed through silicon nitride microsieves, polymer track-etched filters and metal TEM grids with various pore sizes. The recovery and size of 9 different culture cell lines was determined and compared to the size of EpCAM+CK+CD45-DNA+CTC from patients with metastatic breast, colorectal and prostate cancer. The 8 mm track-etched filter and the 5 mm microsieve had the best performance on MDA-231, PC3-9 and SKBR-3 cells, enriching>80% of cells from whole blood. TEM grids had poor recovery of similar to 25%. Median diameter of cell lines ranged from 10.9-19.0 mu m, compared to 13.1, 10.7, and 11.0 mu m for breast, prostate and colorectal CTC, respectively. The 11.4 mu m COLO-320 cell line had the lowest recovery of 17%. The ideal filter for CTC enrichment is constructed of a stiff, flat material, is inert to blood cells, has at least 100,000 regularly spaced 5 mu m pores for 1 ml of blood with a <= 10% porosity. While cell size is an important factor in determining recovery, other factors must be involved as well. To evaluate a filtration procedure, cell lines with a median size of 11-13 mu m should be used to challenge the system.	[Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands	University of Twente	Terstappen, LWMM (corresponding author), Univ Twente, MIRA Inst, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018	terstappen, leon/0000-0001-5944-3787; Beck, Markus/0000-0003-1298-4775	Veridex LLC; European Research council	Veridex LLC; European Research council(European Research Council (ERC)European Commission)	This work was supported by Veridex LLC (http://www.veridex.com/). MB is supported by a European Research council starting grant (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2011, ISOLATION CIRCULATIN; Alix-Panabieres C, 2005, CLIN CHEM, V51, P1538, DOI 10.1373/clinchem.2005.049445; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balasubramanian P, 2009, MOL PHARMACEUT, V6, P1402, DOI 10.1021/mp9000519; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; den Toonder J, 2011, LAB CHIP, V11, P375, DOI 10.1039/c0lc90100h; Dharmasiri U, 2011, ANAL CHEM, V83, P2301, DOI 10.1021/ac103172y; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Haubert T, 2008, US Patent, Patent No. [8,114,680 B2, 8114680]; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Kan HC, 1999, ANN BIOMED ENG, V27, P648, DOI 10.1114/1.214; Kowalewska M, 2006, EUR J CANCER, V42, P2671, DOI 10.1016/j.ejca.2006.05.036; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Leong FY, 2011, BIOMECH MODEL MECHAN, V10, P755, DOI 10.1007/s10237-010-0271-1; Ligthart ST, 2013, ANN ONCOL, V24, P1231, DOI 10.1093/annonc/mds625; Ligthart ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027419; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Matsusaka S, 2010, CANCER SCI, V101, P1067, DOI 10.1111/j.1349-7006.2010.01492.x; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nguyen AT, 2011, LANGMUIR, V27, P2587, DOI 10.1021/la104657c; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pierga JY, 2012, ANN ONCOL, V23, P618, DOI 10.1093/annonc/mdr263; Rao C, 2011, INT J ONCOL, V38, P755, DOI 10.3892/ijo.2011.896; Rao CG, 2005, INT J ONCOL, V27, P49; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Stakenborg T, 2010, EXPERT REV MOL DIAGN, V10, P723, DOI 10.1586/ERM.10.66; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Tol J, 2010, ANN ONCOL, V21, P1006, DOI 10.1093/annonc/mdp463; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853; Xu T, 2010, CANCER RES, V70, P6420, DOI 10.1158/0008-5472.CAN-10-0686; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	43	136	150	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61770	10.1371/journal.pone.0061770	http://dx.doi.org/10.1371/journal.pone.0061770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626725	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400089
J	Jung, JJ; Inamdar, SM; Tiwari, A; Ye, D; Lin, F; Choudhury, A				Jung, Jae-Joon; Inamdar, Shivangi M.; Tiwari, Ajit; Ye, Ding; Lin, Fang; Choudhury, Amit			Syntaxin 16 Regulates Lumen Formation during Epithelial Morphogenesis	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; TIGHT JUNCTION FORMATION; E-CADHERIN TRAFFICKING; RETROGRADE TRANSPORT; APICAL SURFACE; CELL ADHESION; ZEBRAFISH; ENDOSOMES; PROTEINS; POLARITY	The formation and maintenance of cell-cell junctions, both under physiological and pathological conditions, requires the targeting and trafficking of junctional proteins. Proteins of the syntaxin (Stx)-family localize to a variety of subcellular membranes and contribute to intracellular transport of cargo by regulating vesicle fusion events at these sites. Unlike plasma membrane localized Stxs, the roles of endosome-and Golgi-localized stx proteins in epithelial morphogenesis are less understood. Here we show that Stx16- an endosome-and Golgi-localized target-membrane soluble N-ethylmaleimide attachment protein receptor (t-SNARE) that plays a role in membrane trafficking between these compartments - is essential for lumen development. In cultured Madin Darby Canine Kidney (MDCK) cells, Stx16 was selectively upregulated as sparsely plated cells attained confluency. Stx16-depleted confluent monolayers consistently showed lower transepithelial resistance than control monolayers, and failed to maintain endogenous and ectopically expressed E-cadherin at the adherens junctions due to decreased recycling. We further found that whereas cysts formed by MDCK cells cultured in Matrigel have a single hollow lumen, those formed by stx16-depleted counterparts had multiple lumens, due to abnormal orientiation of the mitotic spindle. Finally, a similar role for stx16 function in vivo is indicated by our analysis of pronephric-duct development in zebrafish expressing the claudin:B:lynGFP transgene; lack of stx16 function in this structure (in stx16-morphant embryos) led to the development of enlarged, torturous pronephric ducts with more than one lumen. Taken together, our in vitro and in vivo studies establish a role for Stx16 in maintaining the integrity of cell-cell junctions, and thereby in morphogenesis of the kidney epithelial lumen.	[Jung, Jae-Joon; Inamdar, Shivangi M.; Tiwari, Ajit; Ye, Ding; Lin, Fang; Choudhury, Amit] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52240 USA; [Choudhury, Amit] Univ Iowa, Iowa City, IA USA	University of Iowa; University of Iowa	Choudhury, A (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52240 USA.	amit-choudhury@uiowa.edu	Jung, Jae-Joon/I-2186-2014	Lin, Fang/0000-0003-2179-7031; ye, ding/0000-0003-3460-1122	National Institutes of Health [R01HL089599]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant from National Institutes of Health (R01HL089599) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Apodaca G, 2010, NAT CELL BIOL, V12, P1026, DOI 10.1038/ncb1110-1026; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YA, 2010, J CELL PHYSIOL, V225, P326, DOI 10.1002/jcp.22286; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; Kubota F, 2007, INT J DEV BIOL, V51, P123, DOI 10.1387/ijdb.062200fk; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; Mitra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041816; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Pfeffer SR, 2011, COLD SPRING HARB PER, V3; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schluter MA, 2009, J AM SOC NEPHROL, V20, P1444, DOI 10.1681/ASN.2008090949; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; TYTLER P, 1988, J MORPHOL, V195, P189, DOI 10.1002/jmor.1051950206; VEGASALAS DE, 1987, J CELL BIOL, V104, P905, DOI 10.1083/jcb.104.4.905; Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Willenborg C, 2011, J CELL BIOL, V195, P71, DOI 10.1083/jcb.201011112; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61857	10.1371/journal.pone.0061857	http://dx.doi.org/10.1371/journal.pone.0061857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626741	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400105
J	Mayer, CA; Brunkhorst, R; Niessner, M; Pfeilschifter, W; Steinmetz, H; Foerch, C				Mayer, Christoph A.; Brunkhorst, Robert; Niessner, Marion; Pfeilschifter, Waltraud; Steinmetz, Helmuth; Foerch, Christian			Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; SERUM-GFAP	Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate indicative of intracerebral hemorrhage in patients with symptoms suspicious of acute stroke. Comparably little, however, is known about GFAP release in other neurological disorders. In order to identify potential "specificity gaps" of a future GFAP test used to diagnose intracerebral hemorrhage, we measured GFAP in the blood of a large and rather unselected collective of patients with neurological diseases. Methods: Within a one-year period, we randomly selected in-patients of our university hospital for study inclusion. Patients with ischemic stroke, transient ischemic attack and intracerebral hemorrhage were excluded. Primary endpoint was the ICD-10 coded diagnosis reached at discharge. During hospital stay, blood was collected, and GFAP plasma levels were determined using an advanced prototype immunoassay at Roche Diagnostics. Results: A total of 331 patients were included, covering a broad spectrum of neurological diseases. GFAP levels were low in the vast majority of patients, with 98.5% of cases lying below the cut-off that was previously defined for the differentiation of intracerebral hemorrhage and ischemic stroke. No diagnosis or group of diagnoses was identified that showed consistently increased GFAP values. No association with age and sex was found. Conclusion: Most acute and chronic neurological diseases, including typical stroke mimics, are not associated with detectable GFAP levels in the bloodstream. Our findings underline the hypothesis that rapid astroglial destruction as in acute intracerebral hemorrhage is mandatory for GFAP increase. A future GFAP blood test applied to identify patients with intracerebral hemorrhage is likely to have a high specificity.	[Mayer, Christoph A.; Brunkhorst, Robert; Pfeilschifter, Waltraud; Steinmetz, Helmuth; Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Niessner, Marion] Roche Diagnost, Penzberg, Germany	Goethe University Frankfurt; Roche Holding	Foerch, C (corresponding author), Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany.	foerch@em.uni-frankfurt.de			Roche Diagnostics; Novartis Pharma; Biogen Idec; Merck Serono	Roche Diagnostics; Novartis Pharma; Biogen Idec(Biogen); Merck Serono(Merck & Company)	This study was funded by Roche Diagnostics with a grant of Euros 10.000,-. The GFAP- measurements were performed at Roche Diagnostics exempt from charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: C. Mayer received travel grants from Novartis Pharma, Biogen Idec and Merck Serono. C. Mayer received research funding from Novartis Pharma. C. Foerch, designated as inventor in the following European patent application: Use of GFAP for identification of intracerebral hemorrhage (patent application 03021571.9) C. Foerch received honoraria for participation in advisory boards at Roche Diagnostics. M. Niessner is employed at Roche Diagnostics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brommeland T, 2007, ACTA NEUROL SCAND, V116, P380, DOI 10.1111/j.1600-0404.2007.00889.x; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Missler U, 1999, CLIN CHEM, V45, P138; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Storoni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023489; Yates D, 2011, NAT REV NEUROL, V7, P63, DOI [10.1038/nrneurol.2010.202, 10.1038/nrneurol.2010.190]	15	75	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62101	10.1371/journal.pone.0062101	http://dx.doi.org/10.1371/journal.pone.0062101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626774	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400138
J	Nakano, K; Watanabe, M; Matsunari, H; Matsuda, T; Honda, K; Maehara, M; Kanai, T; Hayashida, G; Kobayashi, M; Kuramoto, M; Arai, Y; Umeyama, K; Fujishiro, S; Mizukami, Y; Nagaya, M; Hanazono, Y; Nagashima, H				Nakano, Kazuaki; Watanabe, Masahito; Matsunari, Hitomi; Matsuda, Taisuke; Honda, Kasumi; Maehara, Miki; Kanai, Takahiro; Hayashida, Gota; Kobayashi, Mirina; Kuramoto, Momoko; Arai, Yoshikazu; Umeyama, Kazuhiro; Fujishiro, Shuh-hei; Mizukami, Yoshihisa; Nagaya, Masaki; Hanazono, Yutaka; Nagashima, Hiroshi			Generating Porcine Chimeras Using Inner Cell Mass Cells and Parthenogenetic Preimplantation Embryos	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO PRODUCTION; DEVELOPMENTAL COMPETENCE; BLASTOCYST INJECTION; RETINAL CELLS; MOUSE; OOCYTES; PIGS; DIFFERENTIATION; STAGE	Background: The development and validation of stem cell therapies using induced pluripotent stem (iPS) cells can be optimized through translational research using pigs as large animal models, because pigs have the closest characteristics to humans among non-primate animals. As the recent investigations have been heading for establishment of the human iPS cells with naive type characteristics, it is an indispensable challenge to develop naive type porcine iPS cells. The pluripotency of the porcine iPS cells can be evaluated using their abilities to form chimeras. Here, we describe a simple aggregation method using parthenogenetic host embryos that offers a reliable and effective means of determining the chimera formation ability of pluripotent porcine cells. Methodology/Significant Principal Findings: In this study, we show that a high yield of chimeric blastocysts can be achieved by aggregating the inner cell mass (ICM) from porcine blastocysts with parthenogenetic porcine embryos. ICMs cultured with morulae or 4-8 cell-stage parthenogenetic embryos derived from in vitro-matured (IVM) oocytes can aggregate to form chimeric blastocysts that can develop into chimeric fetuses after transfer. The rate of production of chimeric blastocysts after aggregation with host morulae (20/24, 83.3%) was similar to that after the injection of ICMs into morulae (24/29, 82.8%). We also found that 4-8 cell-stage embryos could be used; chimeric blastocysts were produced with a similar efficiency (17/26, 65.4%). After transfer into recipients, these blastocysts yielded chimeric fetuses at frequencies of 36.0% and 13.6%, respectively. Conclusion/Significance: Our findings indicate that the aggregation method using parthenogenetic morulae or 4-8 cellstage embryos offers a highly reproducible approach for producing chimeric fetuses from porcine pluripotent cells. This method provides a practical and highly accurate system for evaluating pluripotency of undifferentiated cells, such as iPS cells, based on their ability to form chimeras.	[Nakano, Kazuaki; Matsuda, Taisuke; Honda, Kasumi; Maehara, Miki; Kanai, Takahiro; Hayashida, Gota; Kobayashi, Mirina; Kuramoto, Momoko; Arai, Yoshikazu; Nagashima, Hiroshi] Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa, Japan; [Watanabe, Masahito; Matsunari, Hitomi; Umeyama, Kazuhiro; Nagaya, Masaki; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res MUIIBR, Kawasaki, Kanagawa, Japan; [Fujishiro, Shuh-hei; Mizukami, Yoshihisa; Hanazono, Yutaka] Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan; [Hanazono, Yutaka] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Meiji University; Meiji University; Jichi Medical University; Japan Science & Technology Agency (JST)	Nagashima, H (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa, Japan.	hnagas@isc.meiji.ac.jp		Nagashima, Hiroshi/0000-0001-9940-8783	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Meiji University International Institute for Bio-Resource Research (MUIIBR)	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Meiji University International Institute for Bio-Resource Research (MUIIBR)	This work was supported by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency and by the Meiji University International Institute for Bio-Resource Research (MUIIBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 2002, THERIOGENOLOGY, V57, P257, DOI 10.1016/S0093-691X(01)00670-7; Dang-Nguyen TQ, 2011, ANIM SCI J, V82, P374, DOI 10.1111/j.1740-0929.2011.00883.x; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Esteban MA, 2010, IUBMB LIFE, V62, P277, DOI 10.1002/iub.307; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro SH, 2012, STEM CELLS DEV, DOI 101089/scd20120173; FUNAHASHI H, 1993, J REPROD FERTIL, V98, P179; Gajda B, 2009, REPROD BIOL, V9, P97; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Kanai T, 2012, REPROD DOMEST ANIM, V47, P605; KASHIWAZAKI N, 1992, VET REC, V130, P186, DOI 10.1136/vr.130.9.186; KAWARASAKI T, 1995, MOL REPROD DEV, V40, P455, DOI 10.1002/mrd.1080400409; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; Kurihara T, 2002, J REPROD DEVELOP, V48, P271, DOI 10.1262/jrd.48.271; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Maehara M, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100339; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Matsunari H, 2012, J REPROD DEVELOP, V58, P599, DOI 10.1262/jrd.2011-051; Miki K, 2009, CIRCULATION, V120, pS721; MINTZ B, 1962, SCIENCE, V138, P594, DOI 10.1126/science.138.3540.594; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Mueller S, 1999, MOL REPROD DEV, V54, P244, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;244::AID-MRD5&gt;3.0.CO;2-5; Nagashima H, 2004, BIOL REPROD, V70, P702, DOI 10.1095/biolreprod.103.022681; Nagy A, 1993, GENE TARGETING PRACT; Ogawa B, 2010, J REPROD DEVELOP, V56, P356, DOI 10.1262/jrd.10-005H; ONISHI A, 1994, BIOL REPROD, V51, P1069, DOI 10.1095/biolreprod51.6.1069; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; PETTERS RM, 1993, J REPROD FERTIL, P61; Piedrahita JA, 1998, BIOL REPROD, V58, P1321, DOI 10.1095/biolreprod58.5.1321; Prather RS, 1996, MOL REPROD DEV, V45, P38, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;38::AID-MRD5&gt;3.0.CO;2-T; Shim H, 1997, BIOL REPROD, V57, P1089, DOI 10.1095/biolreprod57.5.1089; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tsujii H., 1990, Japanese Journal of Zootechnical Science, V61, P913; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2010, J MOL CELL BIOL, V2, P104, DOI 10.1093/jmcb/mjq004; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Zhao MT, 2011, THERIOGENOLOGY, V75, P1372, DOI 10.1016/j.theriogenology.2010.06.010; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637; Zhu J, 2003, CLONING STEM CELLS, V5, P355, DOI 10.1089/153623003772032853	46	16	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61900	10.1371/journal.pone.0061900	http://dx.doi.org/10.1371/journal.pone.0061900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626746	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400110
J	Taiakina, V; Boone, AN; Fux, J; Senatore, A; Weber-Adrian, D; Guillemette, JG; Spafford, JD				Taiakina, Valentina; Boone, Adrienne N.; Fux, Julia; Senatore, Adriano; Weber-Adrian, Danielle; Guillemette, J. Guy; Spafford, J. David			The Calmodulin-Binding, Short Linear Motif, NSCaTE Is Conserved in L-Type Channel Ancestors of Vertebrate Cav1.2 and Cav1.3 Channels	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; SMOOTH-MUSCLE-CELLS; STRUCTURAL BASIS; CA2+ CHANNELS; CA2+-DEPENDENT INACTIVATION; MOLECULAR-BIOLOGY; ALPHA-1 SUBUNIT; NERVOUS-SYSTEM; C-TERMINUS; N-TERMINUS	NSCaTE is a short linear motif of (xWxxx(I or L)xxxx), composed of residues with a high helix-forming propensity within a mostly disordered N-terminus that is conserved in L-type calcium channels from protostome invertebrates to humans. NSCaTE is an optional, lower affinity and calcium-sensitive binding site for calmodulin (CaM) which competes for CaM binding with a more ancient, C-terminal IQ domain on L-type channels. CaM bound to N- and C- terminal tails serve as dual detectors to changing intracellular Ca2+ concentrations, promoting calcium-dependent inactivation of L-type calcium channels. NSCaTE is absent in some arthropod species, and is also lacking in vertebrate L-type isoforms, Ca(v)1.1 and Ca(v)1.4 channels. The pervasiveness of a methionine just downstream from NSCaTE suggests that L-type channels could generate alternative N- termini lacking NSCaTE through the choice of translational start sites. Long N- terminus with an NSCaTE motif in L-type calcium channel homolog LCa(v)1 from pond snail Lymnaea stagnalis has a faster calcium-dependent inactivation than a shortened N- termini lacking NSCaTE. NSCaTE effects are present in low concentrations of internal buffer (0.5 mM EGTA), but disappears in high buffer conditions (10 mM EGTA). Snail and mammalian NSCaTE have an alpha-helical propensity upon binding Ca2+-CaM and can saturate both CaM N-terminal and C-terminal domains in the absence of a competing IQ motif. NSCaTE evolved in ancestors of the first animals with internal organs for promoting a more rapid, calcium-sensitive inactivation of L-type channels.	[Boone, Adrienne N.; Fux, Julia; Senatore, Adriano; Weber-Adrian, Danielle; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Taiakina, Valentina; Guillemette, J. Guy] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Operating grants; NSERC Canadian Graduate Scholarship Doctoral Award	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Operating grants; NSERC Canadian Graduate Scholarship Doctoral Award	This work was supported by Heart and Stroke Foundation of Canada, Grant-in-Aid to JDS, and Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Operating grants to JDS and JGG. VT received support from an NSERC Canadian Graduate Scholarship Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1981, SCIENCE, V213, P224, DOI 10.1126/science.213.4504.224; Asmara H, 2010, J PHARMACOL SCI, V112, P397, DOI 10.1254/jphs.09342FP; Bannister JP, 2011, J BIOL CHEM, V286, P15058, DOI 10.1074/jbc.M110.182816; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; Bossi Elena, 2007, V375, P107; BREHM P, 1978, J PHYSIOL-LONDON, V274, P639, DOI 10.1113/jphysiol.1978.sp012171; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; BREHM P, 1980, J PHYSIOL-LONDON, V306, P193, DOI 10.1113/jphysiol.1980.sp013391; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; Cheng XY, 2009, AM J PHYSIOL-HEART C, V297, pH680, DOI 10.1152/ajpheart.00109.2009; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DEJONGH KS, 1994, J NEUROCHEM, V63, P1558, DOI 10.1046/j.1471-4159.1994.63041558.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dunlap TB, 2013, PROTEINS, V81, P607, DOI 10.1002/prot.24215; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gonda K, 2007, BIOCHEM BIOPH RES CO, V362, P170, DOI 10.1016/j.bbrc.2007.07.173; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jeziorski MC, 2000, FEBS LETT, V483, P125, DOI 10.1016/S0014-5793(00)02098-6; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; MAROIS R, 1992, J COMP NEUROL, V322, P255, DOI 10.1002/cne.903220211; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; PRESTON RR, 1991, ANNU REV PHYSIOL, V53, P309, DOI 10.1146/annurev.ph.53.030191.001521; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Senatore A, 2013, CHANNELS AUSTIN, P7; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055088; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Terhag J, 2010, METHODS, V51, P66, DOI 10.1016/j.ymeth.2010.01.034; TILLOTSON D, 1979, P NATL ACAD SCI USA, V76, P1497, DOI 10.1073/pnas.76.3.1497; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	72	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61765	10.1371/journal.pone.0061765	http://dx.doi.org/10.1371/journal.pone.0061765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626724	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400088
J	Wu, SG; He, ZY; Li, Q; Sun, JY; Li, FY; Lin, Q; Lin, HX; Guan, XX				Wu, San-Gang; He, Zhen-Yu; Li, Qun; Sun, Jia-Yuan; Li, Feng-Yan; Lin, Qin; Lin, Huan-Xin; Guan, Xun-Xing			Prognostic Value of Metastatic Axillary Lymph Node Ratio for Chinese Breast Cancer Patients	PLOS ONE			English	Article							TERM-FOLLOW-UP; STAGE-I; SURVIVAL; NUMBER; PREDICTORS; RECURRENCE	Objective: The prevalence of breast cancer varies among countries and regions. This retrospective study investigated the prognostic value of the lymph node ratio (LNR) compared with the number of positive lymph nodes (pN) in Chinese breast cancer patients. Methods: The medical records of female breast cancer patients (N = 2591) were retrospectively evaluated. The association of LNR and TMN staging system were compared with respect to overall, disease-free, and distant metastasis-free survival. Results: Out of 2591 patients, 2495 underwent modified radical surgery and 96 received breast conserving surgery. All patients had adjuvant chemotherapy following surgery. The median follow up period 66.9 months (range 5-168 months). The 5-year and 10-year overall survival rates were 89.3% and 78.8%, respectively, and 5-year disease-free survival and distant metastasis-free survival rates were 81.6% and 83.5%, respectively. Univariate analysis indicated that in general T, pN, LNR, as well as tumor expression of the estrogen receptor, progesterone receptor, and HER2 were associated with overall, disease-free, and distant metastasis-free survival (all P-values <0.05). Mutlivariate analysis found pN stage and LNR were independent predictors of overall, disease-free, and distant metastasis-free survival (all P-values <0.001). If pN stage and LNR were both included in a multivariate analysis, LNR was still an independent prognostic factor for overall, disease-free, and distant metastasis-free survival (all P-values <0.001). Conclusion: Our findings support the use of LNR as a predictor of survival in Chinese patients with breast cancer, and that LNR is superior to pN stage in determining disease prognosis.	[Wu, San-Gang; He, Zhen-Yu; Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen City Canc Ctr, Xiamen, Peoples R China; [Li, Qun; Sun, Jia-Yuan; Li, Feng-Yan; Lin, Huan-Xin; Guan, Xun-Xing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Xiamen University; State Key Lab Oncology South China; Sun Yat Sen University	Li, Q (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	Liqun0799@126.com	Wu, San-Gang/AAA-8959-2022					Ahn SH, 2011, BREAST CANCER RES TR, V130, P507, DOI 10.1007/s10549-011-1730-9; AXELSSON CK, 1992, EUR J CANCER, V28A, P1415, DOI 10.1016/0959-8049(92)90534-9; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chagpar AB, 2011, ANN SURG ONCOL, V18, P3143, DOI 10.1245/s10434-011-2012-9; Danko ME, 2010, J AM COLL SURGEONS, V210, P797, DOI 10.1016/j.jamcollsurg.2010.02.045; Han TJ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-131; Recht A, 1999, J CLIN ONCOL, V17, P1689, DOI 10.1200/JCO.1999.17.6.1689; ROSEN PP, 1989, J CLIN ONCOL, V7, P355, DOI 10.1200/JCO.1989.7.3.355; Saxena N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045809; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Tausch C, 2012, ANN SURG ONCOL, V19, P1808, DOI 10.1245/s10434-011-2189-y; Truong PT, 2007, INT J RADIAT ONCOL, V68, P59, DOI 10.1016/j.ijrobp.2006.12.017; Truong PT, 2005, CANCER, V103, P2006, DOI 10.1002/cncr.20969; van der Wal BCH, 2002, EUR J SURG ONCOL, V28, P481, DOI 10.1053/ejso.2002.1239; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Vinh-Hung V, 2003, ONCOL REP, V10, P363; Vinh-Hung V, 2003, INT J ONCOL, V22, P697; Vinh-Hung V, 2009, FUTURE ONCOL, V5, P1585, DOI 10.2217/FON.09.129; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Voordeckers M, 2004, RADIOTHER ONCOL, V70, P225, DOI 10.1016/j.radonc.2003.10.015; Wang F, 2012, CLIN BREAST CANCER, V12, P404, DOI 10.1016/j.clbc.2012.07.009; Woodward WA, 2006, J CLIN ONCOL, V24, P2910, DOI 10.1200/JCO.2005.03.1526; Yang CC, 2012, INT J SURG PATHOL, V20, P546, DOI 10.1177/1066896912451323; 1991, JAMA, V265, P391	24	33	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61410	10.1371/journal.pone.0061410	http://dx.doi.org/10.1371/journal.pone.0061410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626682	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400045
J	Yu, HY; Meng, XQ; Wu, JX; Pan, CC; Ying, XF; Zhou, Y; Liu, RY; Huang, WL				Yu, Hongyan; Meng, Xiangqi; Wu, Jiangxue; Pan, Changchuan; Ying, Xiaofang; Zhou, Yi; Liu, Ranyi; Huang, Wenlin			Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION LEVELS; NIGHT-SHIFT WORK; CIRCADIAN-RHYTHM; CLOCK; RISK; MECHANISM	Background: Clock genes drive about 5-15% of genome-wide mRNA expression, and disruption of the circadian clock may deregulate the cell's normal biological functions. Cryptochrome 1 is a key regulator of the circadian feedback loop and plays an important role in organisms. The present study was conducted to investigate the expression of Cry1 and its prognostic significance in colorectal cancer (CRC). In addition, the function of Cry1 in human CRC was investigated in cell culture models. Methods: Real-time quantitative PCR, Western blot analysis and immunohistochemistry were used to explore Cry1 expression in CRC cell lines and primary CRC clinical specimens. MTT and colony formation assays were used to determine effects on cellular proliferation ability. The animal model was used to explore the Cry1 impact on the tumor cellular proliferation ability in vivo. Transwell assays were performed to detect the migration ability of the cell lines. Statistical analyzes were applied to evaluate the diagnostic value and the associations of Cry1 expression with clinical parameters. Results: Cry1 expression was up regulated in the majority of the CRC cell lines and 168 primary CRC clinical specimens at the protein level. Clinical pathological analysis showed that Cry1 expression was significantly correlated with lymph node metastasis (p = 0.004) and the TNM stage (p = 0.003). High Cry1 expression was associated with poor overall survival in CRC patients (p = 0.010). Experimentally, we found that up-regulation of Cry1 promoted the proliferation and migration of HCT116 cells, while down-regulation of Cry1 inhibited the colony formation and migration of SW480 cells. Conclusions: These results suggest that Cry1 likely plays important roles in CRC development and progression andCry1 may be a prognostic biomarker and a promising therapeutic target for CRC.	[Yu, Hongyan; Meng, Xiangqi; Wu, Jiangxue; Ying, Xiaofang; Zhou, Yi; Liu, Ranyi; Huang, Wenlin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Pan, Changchuan] Second Peoples Hosp Sichuan Prov, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Huang, WL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	hwenl@mail.sysu.edu.cn	huang, wen/GXW-0661-2022; Liu, Ran-yi/L-1008-2019	Meng, Xiangqi/0000-0002-6407-6122	National Basic Research Program of China (973 Program) [2011CB504805, 2010CB52994]; National Natural Science Foundation of China [30973448]; Guangdong Recruitment Program of Creative Research Group	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Recruitment Program of Creative Research Group	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2011CB504805, No. 2010CB52994), from National Natural Science Foundation of China (30973448) and Guangdong Recruitment Program of Creative Research Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YC, 2005, EXP BIOL MED, V230, P731, DOI 10.1177/153537020523001006; Chu GY, 2011, CHRONOBIOL INT, V28, P477, DOI 10.3109/07420528.2011.589933; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Engelen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056623; Filipski E, 2002, J NATL CANCER I, V94, P690; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Hayashida S, 2010, CHRONOBIOL INT, V27, P1735, DOI 10.3109/07420528.2010.515324; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Koyanagi S, 2003, CANCER RES, V63, P7277; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Luo YL, 2009, CHRONOBIOL INT, V26, P1514, DOI 10.3109/07420520903553435; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazzoccoli G, 2011, CHRONOBIOL INT, V28, P841, DOI 10.3109/07420528.2011.615182; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Schibler Ueli, 2007, Dialogues Clin Neurosci, V9, P257; Singh Rajesh, 2011, Front Biosci (Schol Ed), V3, P1569; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tokunaga H, 2008, ACTA OBSTET GYN SCAN, V87, P1060, DOI 10.1080/00016340802348286; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang Y, 2006, ONCOL REP, V16, P755	31	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61679	10.1371/journal.pone.0061679	http://dx.doi.org/10.1371/journal.pone.0061679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626715	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400079
J	MacDougall, HG; McGarvie, LA; Halmagyi, GM; Curthoys, IS; Weber, KP				MacDougall, Hamish Gavin; McGarvie, Leigh Andrew; Halmagyi, Gabor Michael; Curthoys, Ian Stewart; Weber, Konrad Peter			The Video Head Impulse Test (vHIT) Detects Vertical Semicircular Canal Dysfunction	PLOS ONE			English	Article							3-DIMENSIONAL VECTOR ANALYSIS; HUMAN VESTIBULOOCULAR REFLEX; UNILATERAL VESTIBULAR LOSS; ROTATIONS; RESPONSES; SUPERIOR	Background: The video head impulse test (vHIT) is a useful clinical tool to detect semicircular canal dysfunction. However vHIT has hitherto been limited to measurement of horizontal canals, while scleral search coils have been the only accepted method to measure head impulses in vertical canals. The goal of this study was to determine whether vHIT can detect vertical semicircular canal dysfunction as identified by scleral search coil recordings. Methods: Small unpredictable head rotations were delivered by hand diagonally in the plane of the vertical semicircular canals while gaze was directed along the same plane. The planes were oriented along the left-anterior-right-posterior (LARP) canals and right-anterior-left-posterior (RALP) canals. Eye movements were recorded simultaneously in 2D with vHIT (250 Hz) and in 3D with search coils (1000 Hz). Twelve patients with unilateral, bilateral and individual semicircular canal dysfunction were tested and compared to seven normal subjects. Results: Simultaneous video and search coil recordings were closely comparable. Mean VOR gain difference measured with vHIT and search coils was 0.05 (SD = 0.14) for the LARP plane and -0.04 (SD = 0.14) for the RALP plane. The coefficient of determination R-2 was 0.98 for the LARP plane and 0.98 for the RALP plane and the results of the two methods were not significantly different. vHIT and search coil measures displayed comparable patterns of covert and overt catch-up saccades. Conclusions: vHIT detects dysfunction of individual vertical semicircular canals in vestibular patients as accurately as scleral search coils. Unlike search coils, vHIT is non-invasive, easy to use and hence practical in clinics.	[MacDougall, Hamish Gavin; Curthoys, Ian Stewart] Univ Sydney, Vestibular Res Lab, Sch Psychol, Sydney, NSW 2006, Australia; [McGarvie, Leigh Andrew; Halmagyi, Gabor Michael] Royal Prince Alfred Hosp, Dept Neurol, Sydney, NSW, Australia; [Weber, Konrad Peter] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Weber, Konrad Peter] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Sydney; University of Sydney; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Weber, KP (corresponding author), Univ Sydney, Vestibular Res Lab, Sch Psychol, Sydney, NSW 2006, Australia.	konrad.weber@usz.ch	Weber, Konrad P/A-1941-2013; Curthoys, Ian/ABE-6627-2021	Weber, Konrad P/0000-0003-2526-4582; Curthoys, Ian/0000-0002-9416-5038; MacDougall, Hamish/0000-0001-6201-1707	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia [632746]; Betty and David Koetser Foundation for Brain Research; GN Otometrics	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Betty and David Koetser Foundation for Brain Research; GN Otometrics	This work was supported by the Garnett Passe and Rodney Williams Memorial Foundation, the National Health and Medical Research Council of Australia (grant number 632746) and the Betty and David Koetser Foundation for Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have acted as unpaid consultants and have received funding for travel and free equipment for beta testing from GN Otometrics. However, the study was conducted with a custom-built, noncommercial prototype and the authors have no commercial interest in video head impulse systems. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Aw ST, 1996, J NEUROPHYSIOL, V76, P4021, DOI 10.1152/jn.1996.76.6.4021; Aw ST, 1996, J NEUROPHYSIOL, V76, P4009, DOI 10.1152/jn.1996.76.6.4009; Aw ST, 2001, NEUROLOGY, V57, P768, DOI 10.1212/WNL.57.5.768; Bradshaw AP, 2010, JARO-J ASSOC RES OTO, V11, P145, DOI 10.1007/s10162-009-0195-6; Brandt T., 2003, VERTIGO ITS MULTISEN; Carey JP, 2007, OTOL NEUROTOL, V28, P356, DOI 10.1097/01.mao.0000253284.40995.d8; Cremer PD, 1998, BRAIN, V121, P699, DOI 10.1093/brain/121.4.699; Curthoys IS, 2012, LARYNGOSCOPE, V122, P1342, DOI 10.1002/lary.23258; Halmagyi GM, 2008, PROG BRAIN RES, V171, P187, DOI 10.1016/S0079-6123(08)00625-0; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Kim DR, 2011, OTOL NEUROTOL, V32, P1596, DOI 10.1097/MAO.0b013e31823558a0; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; MacDougall HG, 2013, OTOL NEUROTOL ACCEPT; MacDougall HG, 2012, AVOR IPHONE AND IPAD; Migliaccio AA, 2011, J VESTIBUL RES-EQUIL, V21, P227, DOI 10.3233/VES-2011-0421; Weber KP, 2008, NEUROLOGY, V70, P454, DOI 10.1212/01.wnl.0000299117.48935.2e; Weber KP, 2009, NEUROLOGY, V72, P1417, DOI 10.1212/WNL.0b013e3181a18652; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Zar JH., 2010, BIOSTAT ANAL	19	171	178	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61488	10.1371/journal.pone.0061488	http://dx.doi.org/10.1371/journal.pone.0061488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630593	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000317911500042
J	Dauden, MI; Martin-Benito, J; Sanchez-Ferrero, JC; Pulido-Cid, M; Valpuesta, JM; Carrascosa, JL				Dauden, Maria I.; Martin-Benito, Jaime; Sanchez-Ferrero, Juan C.; Pulido-Cid, Mar; Valpuesta, Jose M.; Carrascosa, Jose L.			Large Terminase Conformational Change Induced by Connector Binding in Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PACKAGING MOTOR; PARTICLE ELECTRON CRYOMICROSCOPY; SITE-DIRECTED MUTAGENESIS; IMAGE-PROCESSING PACKAGE; DEFINED INVITRO SYSTEM; IN-VITRO SYSTEM; ATPASE ACTIVITY; FUNCTIONAL DOMAINS; PORTAL PROTEIN; LARGE SUBUNIT	Background: The complex formed by the terminase and the connector provides the structural framework and the chemical energy for DNA packaging during bacteriophage morphogenesis. Results: The terminase builds a pentamer that presents two conformational topologies. Conclusion: The conformational change of the terminase might be coupled to DNA packaging. Significance: Terminase function might be based on concerted intersubunit movement within the connector-terminase complex.	[Dauden, Maria I.; Martin-Benito, Jaime; Pulido-Cid, Mar; Valpuesta, Jose M.; Carrascosa, Jose L.] CSIC, Dept Macromol Struct, Madrid 28049, Spain; [Sanchez-Ferrero, Juan C.] CSIC, Ctr Nacl Biotecnol, Computat Syst Biol Grp, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Carrascosa, JL (corresponding author), CSIC, Dept Macromol Struct, Madrid 28049, Spain.	jlcarras@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Dauden, Maria I./AAA-4248-2021; Valpuesta, José M/T-1977-2017	Dauden, Maria I./0000-0003-2129-3941; Valpuesta, José M/0000-0001-7468-8053; Martin-Benito Romero, Jaime/0000-0002-8541-4709	BFU [2011-29038]; Ministerio de Ciencia e Innovacion (MICINN) [S2009/Mat 1507]; Comunidad de Madrid [2011-25090/BMC]; MICINN	BFU; Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by Grants BFU 2011-29038 of Ministerio de Ciencia e Innovacion (MICINN) and S2009/Mat 1507 from Comunidad de Madrid (to J.L.C.) and BFU 2011-25090/BMC of MICINN (to J.M.-B.).	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cerritelli ME, 2003, ADV PROTEIN CHEM, V64, P301; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Cuervo A., 2012, ELS, DOI [10.1002/9780470015902.A0024053, DOI 10.1002/9780470015902.A0024053]; Cuervo A, 2012, CURR OPIN BIOTECH, V23, P529, DOI 10.1016/j.copbio.2011.11.029; DAVIS RW, 1971, J MOL BIOL, V62, P287, DOI 10.1016/0022-2836(71)90428-1; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FUJISAWA H, 1991, VIROLOGY, V185, P788, DOI 10.1016/0042-6822(91)90550-U; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Goetzinger KR, 2003, J MOL BIOL, V331, P139, DOI 10.1016/S0022-2836(03)00636-3; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HAMADA K, 1986, VIROLOGY, V151, P110, DOI 10.1016/0042-6822(86)90108-X; HAMADA K, 1987, VIROLOGY, V159, P244, DOI 10.1016/0042-6822(87)90461-2; HAMADA K, 1986, VIROLOGY, V151, P119, DOI 10.1016/0042-6822(86)90109-1; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hegde S, 2012, J VIROL, V86, P4046, DOI 10.1128/JVI.07197-11; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Hwang Y, 1996, J MOL BIOL, V261, P524, DOI 10.1006/jmbi.1996.0480; Ionel A, 2011, J BIOL CHEM, V286, P234, DOI 10.1074/jbc.M110.187211; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; KIMURA M, 1991, VIROLOGY, V180, P709, DOI 10.1016/0042-6822(91)90084-O; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; MANNE V, 1982, J BIOL CHEM, V257, P13223; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Mertens J, 2012, SENSOR ACTUAT B-CHEM, V171, P263, DOI 10.1016/j.snb.2012.03.062; Mertens J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/1/015501; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; MORITA M, 1995, VIROLOGY, V211, P516, DOI 10.1006/viro.1995.1433; MORITA M, 1995, J MOL BIOL, V245, P635, DOI 10.1006/jmbi.1994.0052; MORITA M, 1994, J MOL BIOL, V235, P248, DOI 10.1016/S0022-2836(05)80031-2; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Orlova EV, 1999, NAT STRUCT BIOL, V6, P842; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SHIBATA H, 1987, J MOL BIOL, V196, P845, DOI 10.1016/0022-2836(87)90409-8; SHIBATA H, 1987, VIROLOGY, V159, P250, DOI 10.1016/0042-6822(87)90462-4; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; Valpuesta JM, 2000, J STRUCT BIOL, V131, P146, DOI 10.1006/jsbi.2000.4281; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Vlieghe D, 1999, ACTA CRYSTALLOGR D, V55, P1495, DOI 10.1107/S0907444999007933; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016	86	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16998	17007		10.1074/jbc.M112.448951	http://dx.doi.org/10.1074/jbc.M112.448951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632014	Green Published, hybrid			2022-12-25	WOS:000320378900071
J	Tao, Y; Wu, MH; Zhou, X; Yin, W; Hu, B; de Crombrugghe, B; Sinha, KM; Zang, JY				Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; de Crombrugghe, Benoit; Sinha, Krishna M.; Zang, Jianye			Structural Insights into Histone Demethylase NO66 in Interaction with Osteoblast-specific Transcription Factor Osterix and Gene Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; BONE-FORMATION; DIFFERENTIATION; EXPRESSION; CHROMATIN; SOFTWARE	Osterix (Osx) is an osteoblast-specific transcriptional factor and is required for osteoblast differentiation and bone formation. A JmjC domain-containing protein NO66 was previously found to participate in regulation of Osx transcriptional activity and plays an important role in osteoblast differentiation through interaction with Osx. Here, we report the crystal structure of NO66 forming in a functional tetramer. A hinge domain links the N-terminal JmjC domain and C-terminal winged helix-turn-helix domain of NO66, and both domains are essential for tetrameric assembly. The oligomerization interface of NO66 interacts with a conserved fragment of Osx. We show that the hinge domain-dependent oligomerization of NO66 is essential for inhibition of Osx-dependent gene activation. Our findings suggest that homo-oligomerization of JmjC domain containing proteins might play a physiological role through interactions with other regulatory factors during gene expression.	[Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China; [de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Sinha, Krishna M.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sinha, KM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcomb Blvd,Unit 1006, Houston, TX 77030 USA.	ksinha@mdanderson.org; zangjy@ustc.edu.cn	Zang, Jianye/E-5228-2013; hu, bing/B-1030-2010	hu, bing/0000-0001-8627-5272	Chinese Ministry of Science and Technology [2009CB825502, 2012CB917202]; National Natural Science Foundation of China [31171241, 30970576]; Ph.D. Program Foundation of the Ministry of Education of China [20113402110033]; "100 Talents Program" of the Chinese Academy of Sciences; NIAMS, National Institutes of Health [AR061590]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061590] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); "100 Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Chinese Ministry of Science and Technology Grants 2009CB825502 and 2012CB917202, National Natural Science Foundation of China Grants 31171241 and 30970576, the Ph.D. Program Foundation of the Ministry of Education of China Grant 20113402110033, and the "100 Talents Program" of the Chinese Academy of Sciences (to J. Z.). This work was also supported by NIAMS, National Institutes of Health Grant AR061590 (to K. M. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Kato M, 2011, NUCLEIC ACIDS RES, V39, P1576, DOI 10.1093/nar/gkq919; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Youn MY, 2012, J BIOL CHEM, V287, P12994, DOI 10.1074/jbc.M111.323105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2012, ACTA CRYSTALLOGR F, V68, P764, DOI 10.1107/S174430911201740X	29	15	16	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16430	16437		10.1074/jbc.M112.446849	http://dx.doi.org/10.1074/jbc.M112.446849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620590	Green Published, hybrid			2022-12-25	WOS:000320378900020
J	McTaggart, JS; Jenkinson, N; Brittain, JS; Greeley, SAW; Hattersley, AT; Ashcroft, FM				McTaggart, James S.; Jenkinson, Ned; Brittain, John-Stuart; Greeley, Siri A. W.; Hattersley, Andrew T.; Ashcroft, Frances M.			Gain-of-Function Mutations in the K-ATP Channel (KCNJ11) Impair Coordinated Hand-Eye Tracking	PLOS ONE			English	Article							MOVEMENTS; THERAPY; PATIENT; PURSUIT	Background: Gain-of-function mutations in the ATP-sensitive potassium channel can cause permanent neonatal diabetes mellitus (PNDM) or neonatal diabetes accompanied by a constellation of neurological symptoms (iDEND syndrome). Studies of a mouse model of iDEND syndrome revealed that cerebellar Purkinje cell electrical activity was impaired and that the mice exhibited poor motor coordination. In this study, we probed the hand-eye coordination of PNDM and iDEND patients using visual tracking tasks to see if poor motor coordination is also a feature of the human disease. Methods: Control participants (n = 14), patients with iDEND syndrome (n = 6 or 7), and patients with PNDM (n = 7) completed three computer-based tasks in which a moving target was tracked with a joystick-controlled cursor. Patients with PNDM and iDEND were being treated with sulphonylurea drugs at the time of testing. Results: No differences were seen between PNDM patients and controls. Patients with iDEND syndrome were significantly less accurate than controls in two of the three tasks. The greatest differences were seen when iDEND patients tracked blanked targets, i.e. when predictive tracking was required. In this task, iDEND patients incurred more discrepancy errors (p = 0.009) and more velocity errors (p = 0.009) than controls. Conclusions: These results identify impaired hand-eye coordination as a new clinical feature of iDEND. The aetiology of this feature is likely to involve cerebellar dysfunction. The data further suggest that sulphonylurea doses that control the diabetes of these patients may be insufficient to fully correct their neurological symptoms.	[McTaggart, James S.; Jenkinson, Ned; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, Oxon, England; [Jenkinson, Ned] Univ Oxford, Nuffield Dept Surg Sci, Oxford, Oxon, England; [Brittain, John-Stuart] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Ctr Excellence Personalized Healthcare, Oxford OX1 3PJ, Oxon, England; [Jenkinson, Ned; Brittain, John-Stuart] Univ Oxford, John Radcliffe Hosp, Dept Neurol Surg, Oxford OX3 9DU, Oxon, England; [Greeley, Siri A. W.] Univ Chicago, Kovler Diabet Ctr, Chicago, IL 60637 USA; [Hattersley, Andrew T.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Chicago; University of Exeter	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, Oxon, England.	frances.ashcroft@dpag.ox.ac.uk	Brittain, John-Stuart/AAJ-3276-2020; Greeley, Siri Atma W./N-1294-2014; Jenkinson, Ned/B-1718-2009	Brittain, John-Stuart/0000-0002-4172-190X; Greeley, Siri Atma W./0000-0002-0741-3567; Jenkinson, Ned/0000-0002-6803-486X; Hattersley, Andrew/0000-0001-5620-473X	Wellcome Trust; Royal Society; European Union; Medical Research Council (UK); Medical Research Council; Parkinson's Disease UK; Oxford Biomedical Research Centre; US National Institutes of Health Clinical and Translational Science Awards [UL1RR024999]; Diabetes Research and Training Center [P60 DK020595]; Juvenile Diabetes Research Foundation [9-2008-177]; Lewis-Sebring Family Foundation; Kovler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK094866, P60DK020595] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); European Union(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's Disease UK; Oxford Biomedical Research Centre; US National Institutes of Health Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Center; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Lewis-Sebring Family Foundation; Kovler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Ashcroft received research support from the Wellcome Trust, the Royal Society and the European Union; held a Royal Society Research Professorship. Dr. McTaggart held a PhD studentship from the Medical Research Council (UK). Dr. Jenkinson is funded by the Medical Research Council, Parkinson's Disease UK and the Oxford Biomedical Research Centre. Dr. Greeley has been supported by the US National Institutes of Health Clinical and Translational Science Awards UL1RR024999 and Diabetes Research and Training Center P60 DK020595 programs, as well as the Juvenile Diabetes Research Foundation (9-2008-177), the Lewis-Sebring Family Foundation, and the Kovler Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark RH, 2010, SCIENCE, V329, P458, DOI 10.1126/science.1186146; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Liu XG, 1997, MOVEMENT DISORD, V12, P992, DOI 10.1002/mds.870120624; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; Takanaga H, 1998, J PHARM PHARMACOL, V50, P1027, DOI 10.1111/j.2042-7158.1998.tb06918.x	11	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62646	10.1371/journal.pone.0062646	http://dx.doi.org/10.1371/journal.pone.0062646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626843	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400207
J	Ouyang, HF; Qin, Y; Liu, YF; Xie, YH; Liu, J				Ouyang, Huafang; Qin, Yi; Liu, Yanfeng; Xie, Youhua; Liu, Jing			Prox1 Directly Interacts with LSD1 and Recruits the LSD1/NuRD Complex to Epigenetically Co-Repress CYP7A1 Transcription	PLOS ONE			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; BILE-ACID BIOSYNTHESIS; HOMEOBOX PROTEIN PROX1; HETERODIMER PARTNER; NUCLEAR RECEPTORS; LIVER; CHOLESTEROL-7-ALPHA-HYDROXYLASE; COREPRESSOR; ACTIVATOR; INSIGHTS	Cholesterol 7 alpha-hydroxylase (CYP7A1) catalyzes the first and rate-limiting step in the classical pathway of bile acids synthesis in liver and is crucial for maintaining lipid homeostasis. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) and alpha(1)-fetoprotein transcription factor (FTF) are two major transcription factors driving CYP7A1 promoter activity in hepatocytes. Previous researches have shown that Prospero-related homeobox (Prox1) directly interacts with both HNF4 alpha and FTF and potently co-represses CYP7A1 transcription and bile acid synthesis through unidentified mechanisms. In this work, mechanisms involved in Prox1-mediated co-repression were explored by identifying Prox1-associated proteins using immunoprecipitation followed by mass spectrometry (IP-MS) methodology. Multiple components of the epigenetically repressive lysine-specific demethylase 1 (LSD1)/nucleosome remodeling and histone deacetylase (NuRD) complex, most notably LSD1 and histone deacetylase 2 (HDAC2), were found to be associated with Prox1 and GST pulldown assay demonstrated that Prox1 directly interacts with LSD1. Sequential chromatin immunoprecipitation (ChIP) assays showed that Prox1 co-localizes with HNF4 alpha, LSD1 and HDAC2 on CYP7A1 promoter in HepG2 cells. Furthermore, by using ChIP assay on HepG2 cells with endogenous Prox1 knocked down by RNA interference, Prox1 was shown to recruit LSD1 and HDAC2 onto CYP7A1 promoter and cause increased H3K4 demethylation. Finally, bile acids treatment of HepG2 cells, which significantly repressed CYP7A1 transcription, resulted in increased Prox1 and LSD1/NuRD complex occupancy on CYP7A1 promoter with a concurrent increase in H3K4 demethylation and H3/H4 deacetylation. These results showed that Prox1 interacts with LSD1 to recruit the repressive LSD1/NuRD complex to CYP7A1 promoter and co-represses transcription through epigenetic mechanisms. In addition, such Prox1-mediated epigenetic repression is involved in the physiologically essential negative feedback inhibition of CYP7A1 transcription by bile acids.	[Ouyang, Huafang; Qin, Yi; Xie, Youhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Liu, Yanfeng; Xie, Youhua; Liu, Jing] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China; [Liu, Yanfeng; Xie, Youhua; Liu, Jing] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Xie, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China.	yhxie@fudan.edu.cn; liujing212@fudan.edu.cn			National Science and Technology Major Project of China [2008ZX10002-010, 2012ZX10002-006, 2012ZX10004-503]; National Basic Research Program of China [2012CB519002]; Natural Science Foundation of China [31071143, 31170148]; Science and Technology R&D Program of Shanghai [11DZ2291900]	National Science and Technology Major Project of China; National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology R&D Program of Shanghai	This work was supported by the National Science and Technology Major Project of China (2008ZX10002-010, 2012ZX10002-006, 2012ZX10004-503), National Basic Research Program of China (2012CB519002), Natural Science Foundation of China (31071143, 31170148), and Science and Technology R&D Program of Shanghai (11DZ2291900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Chen XR, 2008, INVEST OPHTH VIS SCI, V49, P1542, DOI 10.1167/iovs.07-1300; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; CHIANG JY, 2009, J LIPID RES; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; Choi I, BLOOD, V117, P362; Crestani M, 1998, J LIPID RES, V39, P2192; Davis RA, 2002, J LIPID RES, V43, P533; del Castillo-Olivares A, 2004, J BIOL CHEM, V279, P16813, DOI 10.1074/jbc.M400646200; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li T, J BIOL CHEM, V287, P1861; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; LI YC, 1990, J BIOL CHEM, V265, P12012; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Mitro N, 2007, HEPATOLOGY, V46, P885, DOI 10.1002/hep.21819; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Pandak WM, 1996, AM J PHYSIOL-GASTR L, V270, pG401, DOI 10.1152/ajpgi.1996.270.3.G401; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Qin J, 2004, MOL ENDOCRINOL, V18, P2424, DOI 10.1210/me.2004-0009; Qin J, 2009, J GEN VIROL, V90, P1246, DOI 10.1099/vir.0.006007-0; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Ryter JM, 2002, STRUCTURE, V10, P1541, DOI 10.1016/S0969-2126(02)00883-3; Shan SF, 2008, FEBS LETT, V582, P3723, DOI 10.1016/j.febslet.2008.09.057; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Steffensen KR, 2004, EMBO REP, V5, P613, DOI 10.1038/sj.embor.7400147; Stroup D, 2000, J LIPID RES, V41, P1; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yoo J, PLOS PATHOG, V6	41	39	40	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62192	10.1371/journal.pone.0062192	http://dx.doi.org/10.1371/journal.pone.0062192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626788	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400152
J	Rehak, R; Bartoletti, TM; Engbers, JDT; Berecki, G; Turner, RW; Zamponi, GW				Rehak, Renata; Bartoletti, Theodore M.; Engbers, Jordan D. T.; Berecki, Geza; Turner, Ray W.; Zamponi, Gerald W.			Low Voltage Activation of KCa1.1 Current by Cav3-KCa1.1 Complexes	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTION-POTENTIAL REPOLARIZATION; GATED CA2+ CHANNELS; N-TYPE CA2+; BK CHANNEL; CALCIUM-CHANNELS; INTRINSIC EXCITABILITY; TRANSMEMBRANE HELICES; SPIKE REPOLARIZATION; VESTIBULAR NEURONS	Calcium-activated potassium channels of the KCa1.1 class are known to regulate repolarization of action potential discharge through a molecular association with high voltage-activated calcium channels. The current study examined the potential for low voltage-activated Cav3 (T-type) calcium channels to interact with KCa1.1 when expressed in tsA-201 cells and in rat medial vestibular neurons (MVN) in vitro. Expression of the channel alpha-subunits alone in tsA-201 cells was sufficient to enable Cav3 activation of KCa1.1 current. Cav3 calcium influx induced a 50 mV negative shift in KCa1.1 voltage for activation, an interaction that was blocked by Cav3 or KCa1.1 channel blockers, or high internal EGTA. Cav3 and KCa1.1 channels coimmunoprecipitated from lysates of either tsA-201 cells or rat brain, with Cav3 channels associating with the transmembrane S0 segment of the KCa1.1 N-terminus. KCa1.1 channel activation was closely aligned with Cav3 calcium conductance in that KCa1.1 current shared the same low voltage dependence of Cav3 activation, and was blocked by voltage-dependent inactivation of Cav3 channels or by coexpressing a non calcium-conducting Cav3 channel pore mutant. The Cav3-KCa1.1 interaction was found to function highly effectively in a subset of MVN neurons by activating near -50 mV to contribute to spike repolarization and gain of firing. Modelling data indicate that multiple neighboring Cav3-KCa1.1 complexes must act cooperatively to raise calcium to sufficiently high levels to permit KCa1.1 activation. Together the results identify a novel Cav3-KCa1.1 signaling complex where Cav3-mediated calcium entry enables KCa1.1 activation over a wide range of membrane potentials according to the unique voltage profile of Cav3 calcium channels, greatly extending the roles for KCa1.1 potassium channels in controlling membrane excitability.	[Rehak, Renata; Berecki, Geza; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bartoletti, Theodore M.; Engbers, Jordan D. T.; Turner, Ray W.] Univ Calgary, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	zamponi@ucalgary.ca	Patten, Scott/B-4434-2011; Berecki, Geza/T-5016-2017	Patten, Scott/0000-0001-9871-4041; Zamponi, Gerald W./0000-0002-0644-9066	AIHS; National Sciences and Engineering Research Council	AIHS; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	GWZ holds a Canada Research Chair. RR received studentship support from AIHS and the National Sciences and Engineering Research Council, with Postdoctoral Fellowships from AIHS (GB, TB) and CIHR (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Alvina K, 2008, J PHYSIOL-LONDON, V586, P2523, DOI 10.1113/jphysiol.2007.148197; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Berkefeld H, 2008, J NEUROSCI, V28, P8238, DOI 10.1523/JNEUROSCI.2274-08.2008; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Brandt A, 2003, J NEUROSCI, V23, P10832; Braun AP, 2011, CHANNELS, V5, P1, DOI 10.4161/chan.5.1.14818; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Craig PJ, 1999, EUR J NEUROSCI, V11, P2949, DOI 10.1046/j.1460-9568.1999.00711.x; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Gittis AH, 2007, J NEUROPHYSIOL, V97, P3986, DOI 10.1152/jn.00141.2007; Gittis AH, 2010, J NEUROPHYSIOL, V104, P1625, DOI 10.1152/jn.00378.2010; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Grunnet M, 2004, J BIOL CHEM, V279, P36445, DOI 10.1074/jbc.M402254200; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; JOHNSTON AR, 1994, J PHYSIOL-LONDON, V481, P61, DOI 10.1113/jphysiol.1994.sp020419; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kim EY, 2009, MOL PHARMACOL, V75, P466, DOI 10.1124/mol.108.051912; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Loane DJ, 2007, J CELL SCI, V120, P985, DOI 10.1242/jcs.03399; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Molineux ML, 2008, J NEUROPHYSIOL, V100, P2684, DOI 10.1152/jn.90427.2008; Muller A, 2007, J NEUROSCI, V27, P483, DOI 10.1523/JNEUROSCI.3816-06.2007; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Poolos NP, 1999, J NEUROSCI, V19, P5205; Prakriya M, 1999, J NEUROPHYSIOL, V81, P2267, DOI 10.1152/jn.1999.81.5.2267; Prakriya M, 2000, J NEUROPHYSIOL, V84, P1123, DOI 10.1152/jn.2000.84.3.1123; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Raman IM, 1999, J NEUROSCI, V19, P1663; RANDALL A, 1995, J NEUROSCI, V15, P2995; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Ris L, 2003, NEUROREPORT, V14, P1585, DOI 10.1097/00001756-200308260-00009; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; STORM JF, 1990, PROG BRAIN RES, V83, P161; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Swensen AM, 2003, J NEUROSCI, V23, P9650; Tadayonnejad R, 2010, CEREBELLUM, V9, P352, DOI 10.1007/s12311-010-0168-7; Talley EM, 1999, J NEUROSCI, V19, P1895; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Turner RW, 2011, CHANNELS, V5, P438, DOI 10.4161/chan.5.5.16473; van Welie I, 2011, J NEUROPHYSIOL, V105, P1651, DOI 10.1152/jn.00058.2011; Vandael DH, 2010, MOL NEUROBIOL, V42, P185, DOI 10.1007/s12035-010-8151-3; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059	82	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61844	10.1371/journal.pone.0061844	http://dx.doi.org/10.1371/journal.pone.0061844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626738	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400102
J	Riva, M; He, ZF; Kallberg, E; Ivars, F; Leanderson, T				Riva, Matteo; He, Zhifei; Kallberg, Eva; Ivars, Fredrik; Leanderson, Tomas			Human S100A9 Protein Is Stabilized by Inflammatory Stimuli via the Formation of Proteolytically-Resistant Homodimers	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; NONCOVALENTLY LINKED TETRAMERS; FACTOR-KAPPA-B; CELL-DIFFERENTIATION; PROSTATE-CANCER; MYELOID CELLS; MRP14; MRP-14; FAMILY; CALPROTECTIN	S100A8 and S100A9 are Ca2+-binding proteins that are associated with acute and chronic inflammation and cancer. They form predominantly heterodimers even if there are data supporting homodimer formation. We investigated the stability of the heterodimer in myeloid and S100A8/S100A9 over-expressing COS cells. In both cases, S100A8 and S100A9 proteins were not completely degraded even 48 hrs after blocking protein synthesis. In contrast, in single transfected cells, S100A8 protein was completely degraded after 24 h, while S100A9 was completely unstable. However, S100A9 protein expression was rescued upon S100A8 co-expression or inhibition of proteasomal activity. Furthermore, S100A9, but not S100A8, could be stabilized by LPS, IL-1 beta and TNF alpha treatment. Interestingly, stimulation of S100A9-transfected COS cells with proteasomal inhibitor or IL-1 beta lead to the formation of protease resistant S100A9 homodimers. In summary, our data indicated that S100A9 protein is extremely unstable but can be rescued upon co-expression with S100A8 protein or inflammatory stimuli, via proteolytically resistant homodimer formation. The formation of S100A9 homodimers by this mechanism may constitute an amplification step during an inflammatory reaction.	[Riva, Matteo; He, Zhifei; Kallberg, Eva; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Leanderson, Tomas] Act Biotech AB, Lund, Sweden	Lund University	Riva, M (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	matteo.riva@med.lu.se		Riva, Matteo/0000-0003-2697-6717	Swedish Research Council; Swedish Cancer Foundation; Greta och Johan Kocks Stiftelser; Alfred Osterlunds Stiftelse; Anna-Greta Crafoord stiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Greta och Johan Kocks Stiftelser; Alfred Osterlunds Stiftelse; Anna-Greta Crafoord stiftelsen	Swedish Research Council (www.vr.se), The Swedish Cancer Foundation (www.cancerfonden.se), Greta och Johan Kocks Stiftelser (www.kockskastiftelsen.se), Alfred Osterlunds Stiftelse (www.alfredosterlundsstiftelse.se), and Anna-Greta Crafoord stiftelsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; DELABIE J, 1990, CLIN EXP IMMUNOL, V81, P123; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Jennbacken K, 2012, PROSTATE, V72, P913, DOI 10.1002/pros.21495; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Longbottom D, 1992, INVEST DERMATOL, V123, P23; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mork G, 2003, BRIT J DERMATOL, V149, P484, DOI 10.1046/j.1365-2133.2003.05536.x; Nacken W, 2007, FEBS LETT, V581, P5127, DOI 10.1016/j.febslet.2007.09.060; Newton RA, 1998, J IMMUNOL, V160, P1427; Noskova V, 2009, GYNECOL ONCOL, V115, P121, DOI 10.1016/j.ygyno.2009.06.026; Passey RJ, 1999, J IMMUNOL, V163, P2209; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Sidler MA, 2008, INFLAMM BOWEL DIS, V14, P359, DOI 10.1002/ibd.20336; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Strupat K, 2000, J AM SOC MASS SPECTR, V11, P780, DOI 10.1016/S1044-0305(00)00150-1; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; van Lent PLEM, 2008, ARTHRITIS RHEUM-US, V58, P3776, DOI 10.1002/art.24074; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Zreiqat H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2917; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510; ZWADLO G, 1986, J IMMUNOL, V137, P512	48	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61832	10.1371/journal.pone.0061832	http://dx.doi.org/10.1371/journal.pone.0061832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626736	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400100
J	Chaowanachan, T; Krogstad, E; Ball, C; Woodrow, KA				Chaowanachan, Thanyanan; Krogstad, Emily; Ball, Cameron; Woodrow, Kim A.			Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; POLYMERIC NANOPARTICLES; INTRACELLULAR DELIVERY; TOPICAL MICROBICIDES; SAQUINAVIR; PREVENTION; THERAPY; RELEASE; BRAIN	Background: The use of drug combinations has revolutionized the treatment of HIV but there is no equivalent combination product that exists for prevention, particularly for topical HIV prevention. Strategies to combine chemically incompatible agents may facilitate the discovery of unique drug-drug activities, particularly unexplored combination drug synergy. We fabricated two types of nanoparticles, each loaded with a single antiretroviral (ARV) that acts on a specific step of the viral replication cycle. Here we show unique combination drug activities mediated by our polymeric delivery systems when combined with free tenofovir (TFV). Methodology/Principal Findings: Biodegradable poly(lactide-co-glycolide) nanoparticles loaded with efavirenz (NP-EFV) or saquinavir (NP-SQV) were individually prepared by emulsion or nanoprecipitation techniques. Nanoparticles had reproducible size (d similar to 200 nm) and zeta potential (-25 mV). The drug loading of the nanoparticles was approximately 7% (w/w). NP-EFV and NP-SQV were nontoxic to TZM-bl cells and ectocervical explants. Both NP-EFV and NP-SQV exhibited potent protection against HIV-1 BaL infection in vitro. The HIV inhibitory effect of nanoparticle formulated ARVs showed up to a 50-fold reduction in the 50% inhibitory concentration (IC50) compared to free drug. To quantify the activity arising from delivery of drug combinations, we calculated combination indices (CI) according to the median-effect principle. NP-EFV combined with free TFV demonstrated strong synergistic effects (CI50 = 0.07) at a 1:50 ratio of IC50 values and additive effects (CI50 = 1.05) at a 1:1 ratio of IC50 values. TFV combined with NP-SQV at a 1:1 ratio of IC50 values also showed strong synergy (CI50 = 0.07). Conclusions: ARVs with different physicochemical properties can be encapsulated individually into nanoparticles to potently inhibit HIV. Our findings demonstrate for the first time that combining TFV with either NP-EFV or NP-SQV results in pronounced combination drug effects, and emphasize the potential of nanoparticles for the realization of unique drug-drug activities.	[Chaowanachan, Thanyanan; Krogstad, Emily; Ball, Cameron; Woodrow, Kim A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Woodrow, KA (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	woodrow@uw.edu		Mudzingwa, Emily/0000-0003-2736-8350	United States National Institutes of Health grant [AI094412]; University of Washington; Creative and Novel Ideas in HIV Research award [AI027767]; NSF Graduate Research Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, R33AI094412, R21AI094412] Funding Source: NIH RePORTER	United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); Creative and Novel Ideas in HIV Research award; NSF Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by funding to K.A.W. from United States National Institutes of Health grant AI094412 and partial support from the University of Washington and the Creative and Novel Ideas in HIV Research award (AI027767). C.B. and E.K. are supported by NSF Graduate Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; American Society for Testing and Materials, 1985, D418782 ASTM; Best BM, 2011, J ANTIMICROB CHEMOTH, V66, P354, DOI 10.1093/jac/dkq434; Bilati U, 2005, EUR J PHARM SCI, V24, P67, DOI 10.1016/j.ejps.2004.09.011; Bilati U, 2003, PHARM DEV TECHNOL, V8, P1, DOI 10.1081/PDT-120017517; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; Bousquet L, 2009, ANTIMICROB AGENTS CH, V53, P896, DOI 10.1128/AAC.00733-08; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chen XQ, 2004, PHARM RES, V21, P1758, DOI 10.1023/B:PHAM.0000045225.76650.53; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; das Neves J, 2012, PHARM RES-DORDR, V29, P1468, DOI 10.1007/s11095-011-0622-3; das Neves J, 2010, ADV DRUG DELIVER REV, V62, P458, DOI 10.1016/j.addr.2009.11.017; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Destache CJ, 2010, J ANTIMICROB CHEMOTH, V65, P2183, DOI 10.1093/jac/dkq318; Destache CJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-198; Dou, 2007, BLOOD, V109, P1816; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Feng JY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-44; Flexner C, 2000, ANNU REV PHARMACOL, V40, P649, DOI 10.1146/annurev.pharmtox.40.1.649; Galindo-Rodriguez S, 2004, PHARM RES-DORDR, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be; GRECO WR, 1995, PHARMACOL REV, V47, P331; Ham AS, 2009, PHARM RES-DORDR, V26, P502, DOI 10.1007/s11095-008-9765-2; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Huisman MT, 2001, MOL PHARMACOL, V59, P806, DOI 10.1124/mol.59.4.806; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kim PS, 2010, WIRES NANOMED NANOBI, V2, P693, DOI 10.1002/wnan.118; Kuo YC, 2011, COLLOID SURFACE B, V88, P627, DOI 10.1016/j.colsurfb.2011.07.053; Lai SK, 2011, BIOMATERIALS, V32, P6285, DOI 10.1016/j.biomaterials.2011.05.008; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lindenberg M, 2004, EUR J PHARM BIOPHARM, V58, P265, DOI 10.1016/j.ejpb.2004.03.001; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Mallipeddi R, 2010, INT J NANOMED, V5, P533; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Mert O, 2012, J CONTROL RELEASE, V157, P455, DOI 10.1016/j.jconrel.2011.08.032; Mudigonda K, 2006, BIOMED CHROMATOGR, V20, P1028, DOI 10.1002/bmc.631; Noble S, 1996, DRUGS, V52, P93, DOI 10.2165/00003495-199652010-00007; Nowacek AS, 2011, J CONTROL RELEASE, V150, P204, DOI 10.1016/j.jconrel.2010.11.019; Nowacek AS, 2010, J NEUROIMMUNE PHARM, V5, P592, DOI 10.1007/s11481-010-9198-7; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Palmer S, 2001, AIDS RES HUM RETROV, V17, P1167, DOI 10.1089/088922201316912772; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Panyam J, 2003, PHARM RES-DORDR, V20, P212, DOI 10.1023/A:1022219003551; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Remmel RP, 2000, CLIN CHEM, V46, P73; Rohan LC, 2010, PLOS ONE, V5; Shah LK, 2006, PHARM RES, V23, P2638, DOI 10.1007/s11095-006-9101-7; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; UNAIDS, 2009, AIDS EP UPD DEC 2009, p[21, 27]; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006; Wong HL, 2010, ADV DRUG DELIVER REV, V62, P503, DOI 10.1016/j.addr.2009.11.020; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]	64	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61416	10.1371/journal.pone.0061416	http://dx.doi.org/10.1371/journal.pone.0061416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630586	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500033
J	Vigneswara, V; Cass, S; Wayne, D; Bolt, EL; Ray, DE; Carter, WG				Vigneswara, Vasanthy; Cass, Simon; Wayne, Declan; Bolt, Edward L.; Ray, David E.; Carter, Wayne G.			Molecular Ageing of Alpha- and Beta-Synucleins: Protein Damage and Repair Mechanisms	PLOS ONE			English	Article							L-ISOASPARTYL METHYLTRANSFERASE; POSTTRANSLATIONAL MODIFICATIONS; O-METHYLTRANSFERASE; SYNAPSIN-I; RAT-LIVER; ACCUMULATION; PEPTIDES; GENE; DEAMIDATION; BRAIN	Abnormal alpha-synuclein aggregates are hallmarks of a number of neurodegenerative diseases. Alpha synuclein and beta-synucleins are susceptible to post-translational modification as isoaspartate protein damage, which is regulated in vivo by the action of the repair enzyme protein L-isoaspartyl O-methyltransferase (PIMT). We aged in vitro native alpha-synuclein, the alpha-synuclein familial mutants A30P and A53T that give rise to Parkinsonian phenotypes, and beta-synuclein, at physiological pH and temperature for a time course of up to 20 days. Resolution of native alpha-synuclein and beta-synuclein by two dimensional techniques showed the accumulation of a number of post-translationally modified forms of both proteins. The levels of isoaspartate formed over the 20 day time course were quantified by exogenous methylation with PIMT using S-Adenosyl-L-[H-3-methyl]methionine as a methyl donor, and liquid scintillation counting of liberated H-3-methanol. All alpha-synuclein proteins accumulated isoaspartate at similar to 1% of molecules/day, similar to 20 times faster than for beta-synuclein. This disparity between rates of isoaspartate was confirmed by exogenous methylation of synucleins by PIMT, protein resolution by one-dimensional denaturing gel electrophoresis, and visualisation of H-3-methyl esters by autoradiography. Protein silver staining and autoradiography also revealed that alpha-synucleins accumulated stable oligomers that were resistant to denaturing conditions, and which also contained isoaspartate. Co-incubation of approximately equimolar beta-synuclein with alpha-synuclein resulted in a significant reduction of isoaspartate formed in all alpha-synucleins after 20 days of ageing. Co-incubated alpha- and beta-synucleins, or alpha, or beta synucleins alone, were resolved by non-denaturing size exclusion chromatography and all formed oligomers of similar to 57.5 kDa; consistent with tetramerization. Direct association of alpha-synuclein with beta-synuclein in column fractions or from in vitro ageing co-incubations was demonstrated by their co-immunoprecipitation. These results provide an insight into the molecular differences between alpha- and beta-synucleins during ageing, and highlight the susceptibility of alpha-synuclein to protein damage, and the potential protective role of beta-synuclein.	[Vigneswara, Vasanthy; Cass, Simon; Bolt, Edward L.; Ray, David E.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2RD, England; [Wayne, Declan; Carter, Wayne G.] Univ Nottingham, Sch Med, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England	University of Nottingham; University of Nottingham	Carter, WG (corresponding author), Univ Nottingham, Sch Med, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England.	Wayne.Carter@nottingham.ac.uk		Bolt, Edward/0000-0002-5656-7706	Medical Research Council program grant; University of Nottingham	Medical Research Council program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham	Financial support was gratefully received from a Medical Research Council program grant, and the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Beyer K, 2010, BRAIN, V133, P3724, DOI 10.1093/brain/awq275; Beyer K, 2008, CURR MED CHEM, V15, P2748, DOI 10.2174/092986708786242868; Bohme L, 2008, BIOL CHEM, V389, P1055, DOI 10.1515/BC.2008.125; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; BRENNAN TV, 1995, DEAMIDATION ISOASPAR, P65; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Carter WG, 2010, J CHROMATOGR B, V878, P1312, DOI 10.1016/j.jchromb.2009.10.018; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Farrar CE, 2005, J COMP NEUROL, V493, P524, DOI 10.1002/cne.20780; GEIGER T, 1987, J BIOL CHEM, V262, P785; George JM, 2002, GENOME BIOL, V3; Ghandour H, 2002, J NUTR, V132, P1357, DOI 10.1093/jn/132.6.1357; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; NAJBAUER J, 1990, J BIOL CHEM, V265, P12717; Obeid R, 2009, CLIN CHEM, V55, P1852, DOI 10.1373/clinchem.2009.125021; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; PARANANDI MV, 1995, BIOCHEM BIOPH RES CO, V212, P442, DOI 10.1006/bbrc.1995.1989; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shimizu T, 2002, J NEUROSCI RES, V69, P341, DOI 10.1002/jnr.10301; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tarhoni MH, 2011, MOLECULES, V16, P8535, DOI 10.3390/molecules16108535; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	57	21	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61442	10.1371/journal.pone.0061442	http://dx.doi.org/10.1371/journal.pone.0061442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630590	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500037
J	Chang, RM; Li, Y; Yang, XX; Yue, Y; Dou, LL; Wang, YW; Zhang, WF; Li, XN				Chang, Ruimiao; Li, Yong; Yang, Xingxin; Yue, Yuan; Dou, Lili; Wang, Yanwei; Zhang, Weifang; Li, Xiaoni			Protective Role of Deoxyschizandrin and Schisantherin A against Myocardial Ischemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; FACTOR-ALPHA EXPRESSION; NITRIC-OXIDE SYNTHASE; REDUCES INFARCT SIZE; ISCHEMIA/REPERFUSION INJURY; ANESTHETIZED RATS; ANTIOXIDANT; ARRHYTHMIAS; APOPTOSIS; DAMAGE	Background: Our previous studies suggested that deoxyschizandrin (DSD) and schisantherin A (STA) may have cardioprotective effects, but information in this regard is lacking. Therefore, we explored the protective role of DSD and STA in myocardial ischemia-reperfusion (I/R) injury. Methodology/Principal Findings: Anesthetized male rats were treated once with DSD and STA (each 40 mmol/kg) through the tail vein after 45 min of ischemia, followed by 2-h reperfusion. Cardiac function, infarct size, biochemical markers, histopathology and apoptosis were measured and mRNA expression of gp91(phox) in myocardial tissue assessed by RT-PCR. Neonatal rat cardiomyocytes were pretreated with DSD and STA and then damaged by H2O2. Cell apoptosis was tested by a flow cytometric assay. Compared with the I/R group: (i) DSD and STA could significantly reduce the abnormalities of LVSP, LVEDP, +/- dp/dt(max) and arrhythmias, thereby showing their protective roles in cardiac function; (ii) DSD and STA could significantly attenuate the infarct size and MDA release while increasing SOD activity, suggesting a role in reducing myocardial injury; (iii) tissue morphology and myocardial textual analysis revealed that DSD and STA mitigated changes in myocardial histopathology; (iv) DSD and STA decreased apoptosis (33.56 +/- 2.58% to 10.28 +/- 2.80% and 10.98 +/- 1.99%, respectively) and caspase-3 activity in the myocardium (0.62 +/- 0.02 OD/mg to 0.38 +/- 0.02 OD/mg and 0.32 +/- 0.02 OD/mg, respectively), showing their protective effects upon cardiomyocytes; and (v) DSD and STA had similar protective effects on I/R injury as those seen with the positive control metoprolol. In vitro, DSD and STA could significantly decrease the apoptosis of neonatal cardiomyocytes. Conclusions/Significance: These data suggest that DSD and STA can protect against myocardial I/R injury. The underlining mechanism may be related to their role in inhibiting cardiomyocyte apoptosis.	[Chang, Ruimiao; Li, Yong; Yang, Xingxin; Yue, Yuan; Dou, Lili; Wang, Yanwei; Li, Xiaoni] Shanxi Med Univ, Coll Pharm, Taiyuan, Shanxi Province, Peoples R China; [Zhang, Weifang] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi Province, Peoples R China	Shanxi Medical University; Shanxi Medical University	Li, XN (corresponding author), Shanxi Med Univ, Coll Pharm, Taiyuan, Shanxi Province, Peoples R China.	ninili1235@163.com	Chang, Ruimiao/GWV-2016-2022		Taiyuan Science and Technology Project [120164049]; Department of Physiology of Shanxi Medical University; Taiyuan Science Technology Development Co., Ltd.	Taiyuan Science and Technology Project; Department of Physiology of Shanxi Medical University; Taiyuan Science Technology Development Co., Ltd.	This study was supported by the Taiyuan Science and Technology Project (grant number 120164049). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.; The authors thank Professor RongRui Zhao for his selfless help. We also thank Drs Zehua Chen and Changqing Cao for their study of the Gray Level Co-occurrence Matrix. This work was supported by grants from the Department of Physiology of Shanxi Medical University and Taiyuan Science Technology Development Co., Ltd. The authors also thank Chunyan Liu for carrying out statistical analyses.	Ahmed LA, 2011, EUR J PHARMACOL, V663, P51, DOI 10.1016/j.ejphar.2011.04.038; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Du W, 2012, J SYST EVOL, V50, P36, DOI 10.1111/j.1759-6831.2011.00171.x; Elsherif L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030129; FERRARI R, 1993, EUR HEART J, V14, P25; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Guo R, 2005, PHARMACOL RES, V52, P192, DOI 10.1016/j.phrs.2005.03.001; Hu XR, 2010, EUR J PHARMACOL, V638, P84, DOI 10.1016/j.ejphar.2010.03.059; Inafuku H, 2012, ANN THORAC IN PRESS; Ingec M, 2011, J PHYSIOL PHARMACOL, V62, P575; Ip SP, 1997, BIOCHEM PHARMACOL, V54, P317, DOI 10.1016/S0006-2952(97)00164-0; Kawai K, 2004, AM J PHYSIOL-HEART C, V287, pH1003, DOI 10.1152/ajpheart.00797.2003; Kim YM, 2009, FOOD CHEM TOXICOL, V47, P2097, DOI 10.1016/j.fct.2009.05.031; Ko KM, 1996, PHYTOTHER RES, V10, P450, DOI 10.1002/(SICI)1099-1573(199608)10:5&lt;450::AID-PTR872&gt;3.0.CO;2-P; KO KM, 1995, PHYTOTHER RES, V9, P203, DOI 10.1002/ptr.2650090310; Lakshmi SVV, 2009, INDIAN J BIOCHEM BIO, V46, P421; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Ley JJ, 2008, BIOCHEM PHARMACOL, V75, P448, DOI 10.1016/j.bcp.2007.09.001; Liu C, 2012, FITOTERAPIA IN PRESS; Ma WH, 2009, BIOORG MED CHEM LETT, V19, P4958, DOI 10.1016/j.bmcl.2009.07.078; Mitrega K, 2011, PHARMACOL RES, V64, P218, DOI 10.1016/j.phrs.2011.04.011; Mykytenko J, 2007, BASIC RES CARDIOL, V102, P90, DOI 10.1007/s00395-006-0625-0; Peng TQ, 2005, CIRCULATION, V111, P1637, DOI 10.1161/01.CIR.0000160366.50210.E9; Ren BH, 2007, CLIN CHIM ACTA, V377, P83, DOI 10.1016/j.cca.2006.08.027; Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023; Slaninova I, 2009, TOXICOL IN VITRO, V23, P1047, DOI 10.1016/j.tiv.2009.06.008; Tang SH, 2011, J ETHNOPHARMACOL, V134, P141, DOI 10.1016/j.jep.2010.11.070; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Wang ZY, 2007, BIOCHEM BIOPH RES CO, V359, P685, DOI 10.1016/j.bbrc.2007.05.172; Wu W, 2012, CYTOTECHNOL IN PRESS; Wu Y, 2011, PHARMACOL RES, V64, P195, DOI 10.1016/j.phrs.2011.05.006; Xie YA, 2010, J ETHNOPHARMACOL, V131, P290, DOI 10.1016/j.jep.2010.06.038; Xu MJ, 2005, J CHROMATOGR B, V828, P55, DOI 10.1016/j.jchromb.2005.09.029; Yan F, 2009, PHYTOMEDICINE, V16, P805, DOI 10.1016/j.phymed.2009.02.004; Yang X, 2012, ANAL LETT IN PRESS; Yang XX, 2011, J SEP SCI, V34, P2586, DOI 10.1002/jssc.201100366; You Jyh-Sheng, 2006, Chang Gung Med J, V29, P63; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029; Zhang J, 2011, FOOD CHEM TOXICOL, V49, P3136, DOI 10.1016/j.fct.2011.08.015; Zhang QF, 2010, BRIT J PHARMACOL, V160, P1561, DOI 10.1111/j.1476-5381.2010.00813.x; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zheng CX, 2006, TRENDS FOOD SCI TECH, V17, P113, DOI 10.1016/j.tifs.2005.11.006; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757; Zhu HQ, 2009, J MOL CELL CARDIOL, V47, P264, DOI 10.1016/j.yjmcc.2009.05.002	45	39	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61590	10.1371/journal.pone.0061590	http://dx.doi.org/10.1371/journal.pone.0061590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620773	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500053
J	Kong, PZ; Yang, F; Li, L; Li, XQ; Feng, YM				Kong, Peng-Zhou; Yang, Fan; Li, Lin; Li, Xiao-Qing; Feng, Yu-Mei			Decreased FOXF2 mRNA Expression Indicates Early-Onset Metastasis and Poor Prognosis for Breast Cancer Patients with Histological Grade II Tumor	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; GENE-EXPRESSION; LUMINAL SUBTYPE; HUMAN PROSTATE; BASAL; THERAPY; CARCINOMAS; SIGNATURE; PROFILES; PATTERNS	The transcription factor, FOXF2, plays an important role in tissue development, extracellular matrix synthesis, and epithelial-mesenchymal interactions, implying that it may be associated with the metastatic capabilities of cancer cells. However, the relationship between FOXF2 expression and breast cancer progression, metastasis, and prognosis, remains to be elucidated. In this study, FOXF2 mRNA levels in 305 primary breast cancer tissues were examined using RT-QPCR. Results showed that FOXF2 mRNA levels in primary breast cancer were negatively associated with tumor progression, including tumor size, number of metastatic lymph nodes, and clinical stage. Patients with low FOXF2 mRNA levels had a high risk of relapse and metastasis within three years. Low FOXF2 mRNA levels could predict shorter disease-free survival for those patients with histological grade II and triple-negative breast cancer. Taken together, we conclude that decreased FOXF2 expression indicates the early-onset metastasis and poor prognosis for patients with histological grade II and triple-negative breast cancer.	[Kong, Peng-Zhou; Yang, Fan; Li, Lin; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	ymfeng@tijmu.edu.cn			National Natural Science Foundation of China [30872518, 81272357]; Applied Basic Research Projects of Tianjin [06YFJMJC12900, 09JCZDJC19800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Projects of Tianjin	This work was supported by the National Natural Science Foundation of China (No. 30872518 and No. 81272357) and the Applied Basic Research Projects of Tianjin (06YFJMJC12900 and No. 09JCZDJC19800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Honkoop AH, 1998, BRIT J CANCER, V77, P621, DOI 10.1038/bjc.1998.99; Ignatiadis M, 2009, CLIN CANCER RES, V15, P1848, DOI 10.1158/1078-0432.CCR-08-1844; Katoh M, 2004, INT J ONCOL, V25, P1495; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009; Lo PK, 2010, CANCER RES, V70, P6047, DOI 10.1158/0008-5472.CAN-10-1576; Lumachi F, 2011, CURR MED CHEM, V18, P513, DOI 10.2174/092986711794480177; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Ring AE, 2004, BRIT J CANCER, V91, P2012, DOI 10.1038/sj.bjc.6602235; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Urban P, 2006, J CLIN ONCOL, V24, P4245, DOI 10.1200/JCO.2005.05.1912; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389	40	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61591	10.1371/journal.pone.0061591	http://dx.doi.org/10.1371/journal.pone.0061591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620774	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500054
J	Mitchell, RT; Sharpe, RM; Anderson, RA; McKinnell, C; Macpherson, S; Smith, LB; Wallace, WHB; Kelnar, CJH; van den Driesche, S				Mitchell, Rod T.; Sharpe, Richard M.; Anderson, Richard A.; McKinnell, Chris; Macpherson, Sheila; Smith, Lee B.; Wallace, W. Hamish B.; Kelnar, Christopher J. H.; van den Driesche, Sander			Diethylstilboestrol Exposure Does Not Reduce Testosterone Production in Human Fetal Testis Xenografts	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TESTICULAR DYSGENESIS SYNDROME; MALE REPRODUCTIVE-SYSTEM; IN-UTERO; CANCER; ABNORMALITIES; DISRUPTION; EXPRESSION; RISK; GENE	In rodents, in utero exposure to exogenous estrogens including diethylstilboestrol (DES) results in major suppression of steroidogenesis in fetal testes. Whether similar effects occur in the human fetal testis is equivocal. Based on the results of the rodent studies, we hypothesised that exposure of human fetal testes to DES would result in a reduction in testosterone production. We show, using a xenograft approach, that testosterone production is not reduced in human fetal testis following DES exposure. Human fetal testes (15-19 weeks' gestation, n = 6) were xenografted into castrate male nude mice which were then treated for 35 days with vehicle or 100 mu g/kg DES three times a week. For comparison, similar treatment was applied to pregnant rats from e13.5-e20.5 and effects on fetal testes evaluated at e21.5. Xenograft testosterone production was assessed by measuring host seminal vesicle (SV) weights as an indirect measure over the entire grafting period, and single measurement of serum testosterone at termination. Human fetal testis xenografts showed similar survival in DES and vehicle-exposed hosts. SV weight (44.3 v 26.6 mg, p = 0.01) was significantly increased in DES compared to vehicle-exposed hosts, respectively, indicating an overall increase in xenograft testosterone production over the grafting period, whilst serum testosterone at termination was unchanged. In contrast intra-testicular testosterone levels were reduced by 89%, in fetal rats exposed to DES. In rats, DES effects are mediated via Estrogen Receptor alpha (ESR1). We determined ESR1 protein and mRNA expression in human and rat fetal testis. ESR1 was expressed in rat, but not in human, fetal Leydig cells. We conclude that human fetal testis exposure to DES does not impair testosterone production as it does in rats, probably because ESR1 is not expressed in human fetal Leydig cells. This indicates that DES exposure is likely to pose minimal risk to masculinization of the human fetus.	[Mitchell, Rod T.; Sharpe, Richard M.; Anderson, Richard A.; McKinnell, Chris; Macpherson, Sheila; Smith, Lee B.; van den Driesche, Sander] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Mitchell, Rod T.; Wallace, W. Hamish B.; Kelnar, Christopher J. H.] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Mitchell, RT (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	rod.mitchell@ed.ac.uk	Smith, Lee B/J-4861-2013; van den Driesche, Sander/H-7094-2019; Sharpe, Richard/D-2725-2013	Mitchell, Rod/0000-0003-4650-3765; Smith, Lee/0000-0002-4103-3074; Sharpe, Richard/0000-0003-1686-8085; van den Driesche, Sander/0000-0002-8092-6588; wallace, william, hamish/0000-0001-8080-5674	Medical Research Council [G1100358, G1100357]; British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences; MRC [G1002033, G1100357, G1002118, G1100354, G1100358] Funding Source: UKRI; Medical Research Council [G1002118, G1100354, G1002033] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Grants G1100358 (RMS) and G1100357 (RAA) from the Medical Research Council and research awards from the British Society for Paediatric Endocrinology and Diabetes, and from the Academy of Medical Sciences (both RTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boukari K, 2007, HUM REPROD, V22, P1885, DOI 10.1093/humrep/dem091; Cederroth CR, 2007, ENDOCRINOLOGY, V148, P5507, DOI 10.1210/en.2007-0689; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; Couse JF, 2001, DEV BIOL, V238, P224, DOI 10.1006/dbio.2001.0413; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; DEPUE RH, 1986, J NATL CANCER I, V77, P830, DOI 10.1093/jnci/77.3.830; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Emmen JMA, 2000, ENDOCRINOLOGY, V141, P846, DOI 10.1210/en.141.2.846; Gaskell TL, 2003, J CLIN ENDOCR METAB, V88, P424, DOI 10.1210/jc.2002-020811; GERSHMAN ST, 1988, INT J EPIDEMIOL, V17, P738, DOI 10.1093/ije/17.4.738; Haavisto T, 2001, MOL CELL ENDOCRINOL, V178, P169, DOI 10.1016/S0303-7207(01)00425-7; HENDERSON BE, 1976, PEDIATRICS, V58, P505; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Hughes IA, 2008, EUR J ENDOCRINOL, V159, pS75, DOI 10.1530/EJE-08-0458; Inaoka Y, 2008, MOL REPROD DEV, V75, P931, DOI 10.1002/mrd.20788; Joffe M, 2002, HUM REPROD, V17, P520, DOI 10.1093/humrep/17.2.520; Liu B, 2007, PEDIATR DEVEL PATHOL, V10, P446, DOI 10.2350/06-04-0079.1; MARSELOS M, 1992, EUR J CANCER, V28A, P1182, DOI 10.1016/0959-8049(92)90482-H; Martin OV, 2008, ENVIRON HEALTH PERSP, V116, P149, DOI 10.1289/ehp.10545; Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Mitchell RT, 2010, HUM REPROD, V25, P2405, DOI 10.1093/humrep/deq183; MOSS AR, 1986, AM J EPIDEMIOL, V124, P39, DOI 10.1093/oxfordjournals.aje.a114369; N'Tumba-Byn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051579; Norgaard M, 2009, UROLOGY, V74, P583, DOI 10.1016/j.urology.2009.04.034; Palmer JR, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-37; Polkinghorne J, 1989, REV GUIDANCE RES USE; Qiao L, 2012, J UROLOGY, V187, P1427, DOI 10.1016/j.juro.2011.12.008; SCHOTTENFELD D, 1980, AM J EPIDEMIOL, V112, P232, DOI 10.1093/oxfordjournals.aje.a112989; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Storgaard L, 2006, REPROD TOXICOL, V21, P4, DOI 10.1016/j.reprotox.2005.05.006; Strohsnitter WC, 2001, J NATL CANCER I, V93, P545, DOI 10.1093/jnci/93.7.545; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Walker VR, 2012, ENVIRON HEALTH PERSP, V120, P560, DOI 10.1289/ehp.1103678; Weir HK, 2000, INT J CANCER, V87, P438, DOI 10.1002/1097-0215(20000801)87:3<438::AID-IJC20>3.0.CO;2-1; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; WILCOX AJ, 1995, NEW ENGL J MED, V332, P1411, DOI 10.1056/NEJM199505253322104; Williams K, 2001, HUM REPROD UPDATE, V7, P236, DOI 10.1093/humupd/7.3.236; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	45	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61726	10.1371/journal.pone.0061726	http://dx.doi.org/10.1371/journal.pone.0061726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620786	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500066
J	Patel, SJ; Molinolo, AA; Gutkind, S; Crawford, NPS				Patel, Shashank J.; Molinolo, Alfredo A.; Gutkind, Silvio; Crawford, Nigel P. S.			Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma	PLOS ONE			English	Article							BREAST-CANCER SURVIVAL; TRANSGENIC ADENOCARCINOMA; ENGINEERED MICE; CHROMOGRANIN-A; TRAMP MODEL; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; THERAPY; PROGRAM	Neuroendocrine (NE) differentiation has gained increased attention as a prostate cancer (PC) prognostic marker. The aim of this study is to determine whether host germline genetic variation influences tumor progression and metastasis in C57BL/6-Tg(TRAMP)8247Ng/J (TRAMP) mouse model of aggressive NEPC. TRAMP mice were crossed to the eight progenitor strains of the Collaborative Cross recombinant inbred panel to address this. Tumor growth and metastasis burden were quantified in heterozygous transgene positive F1 male mice at 30 weeks of age. Compared to wild-type C57BL/6J-Tg(TRAMP)824Ng/J males, TRAMP x CAST/EiJ, TRAMP x NOD/ShiLtJ and TRAMP x NZO/HlLtJ F1 males displayed significant increases in tumor growth. Conversely, TRAMP x WSB/EiJ and TRAMP x PWK/PhJ F1 males displayed significant reductions in tumor growth. Interestingly, despite reduced tumor burden, TRAMP x WSB/EiJ males had an increased nodal metastasis burden. Patterns of distant pulmonary metastasis tended to follow the same patterns as that of local dissemination in each of the strains. All tumors and metastases displayed positive staining for NE markers, synaptophysin, and FOXA2. These experiments conclusively demonstrate that the introduction of germline variation by breeding modulates tumor growth, local metastasis burden, and distant metastasis frequency in this model of NEPC. These strains will be useful as model systems to facilitate the identification of germline modifier genes that promote the development of aggressive forms of PC.	[Patel, Shashank J.; Crawford, Nigel P. S.] NHGRI, Metastasis Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Molinolo, Alfredo A.; Gutkind, Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Crawford, NPS (corresponding author), NHGRI, Metastasis Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	crawforn@mail.nih.gov	Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Patel, Shashank/0000-0001-6973-6997	National Human Genome Research Institute, US National Institutes of Health; National Institute of Dental and Craniofacial Research, US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200366] Funding Source: NIH RePORTER	National Human Genome Research Institute, US National Institutes of Health; National Institute of Dental and Craniofacial Research, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Programs of the National Human Genome Research Institute and National Institute of Dental and Craniofacial Research, US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P109, DOI 10.1677/erc.1.00876; Bostwick DG, 2002, J UROLOGY, V168, P1204, DOI 10.1016/S0022-5347(05)64626-5; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; Fixemer T, 2002, PROSTATE, V53, P118, DOI 10.1002/pros.10133; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; Gingrich JR, 1997, CANCER RES, V57, P4687; Grobhotz R, 2005, HUM PATHOL, V36, P562, DOI 10.1016/j.humpath.2005.02.019; Haram KM, 2008, PROSTATE, V68, P1517, DOI 10.1002/pros.20803; Hunter KW, 2012, NAT REV CANCER, V12, P144, DOI 10.1038/nrc3206; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Hunter KW, 2001, CANCER RES, V61, P8866; Hurwitz AA, 2001, TRAMP MOUSE MODEL PR; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Navarro SJ, 2012, G3-GENES GENOM GENET, V2, P99, DOI 10.1534/g3.111.000778; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Ries LAG, 2003, ONCOLOGIST, V8, P541; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Sciarra A, 2003, PROSTATE, V55, P168, DOI 10.1002/pros.10222; Sella A, 2000, EUR UROL, V38, P250, DOI 10.1159/000020289; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Sun Y, 2009, AM J TRANSL RES, V1, P148; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tani Y, 2005, VET PATHOL, V42, P306, DOI 10.1354/vp.42-3-306; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Wang F, 2011, PROG MOL BIOL TRANSL, V100, P1, DOI 10.1016/B978-0-12-384878-9.00001-7; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056	41	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61848	10.1371/journal.pone.0061848	http://dx.doi.org/10.1371/journal.pone.0061848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620793	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500073
J	Sarfstein, R; Friedman, Y; Attias-Geva, Z; Fishman, A; Bruchim, I; Werner, H				Sarfstein, Rive; Friedman, Yael; Attias-Geva, Zohar; Fishman, Ami; Bruchim, Ilan; Werner, Haim			Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners	PLOS ONE			English	Article							GROWTH-FACTOR-I; ENDOMETRIAL CANCER-CELLS; BREAST-CANCER; RECEPTOR GENE; TARGETED THERAPY; EXPRESSION; RISK; CHEMOTHERAPY; RESISTANCE; MODEL	Accumulating epidemiological evidence shows that obesity is associated with an increased risk of several types of adult cancers, including endometrial cancer. Chronic hyperinsulinemia, a typical hallmark of diabetes, is one of the leading factors responsible for the obesity-cancer connection. Numerous cellular and circulating factors are involved in the biochemical chain of events leading from hyperinsulinemia and insulin resistance to increased cancer risk and, eventually, tumor development. Metformin is an oral anti-diabetic drug of the biguanide family used for treatment of type 2 diabetes. Recently, metformin was shown to exhibit anti-proliferative effects in ovarian and Type I endometrial cancer, although the mechanisms responsible for this non-classical metformin action remain unclear. The insulin-like growth factors (IGFs) play a prominent role in cancer biology and their mechanisms of action are tightly interconnected with the insulin signaling pathways. Given the cross-talk between the insulin and IGF signaling pathways, the aim of this study was to examine the hypothesis that the anti-proliferative actions of metformin in uterine serous carcinoma (USC) are potentially mediated via suppression of the IGF-I receptor (IGF-IR) pathway. Our results show that metformin interacts with the IGF pathway, and induces apoptosis and inhibition of proliferation and migration of USC cell lines with both wild type and mutant p53. Taken together, our results suggest that metformin therapy could be a novel and attractive therapeutic approach for human USC, a highly aggressive variant of endometrial cancer.	[Sarfstein, Rive; Friedman, Yael; Attias-Geva, Zohar; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Fishman, Ami; Bruchim, Ilan] Meir Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol Unit, Kefar Sava, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	hwerner@post.tau.ac.il						Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Attias-Geva Z, 2012, EUR J CANCER, V48, P1570, DOI 10.1016/j.ejca.2011.09.014; Attias-Geva Z, 2011, EUR J CANCER, V47, P1717, DOI 10.1016/j.ejca.2011.02.019; Augustin LSA, 2003, ANN ONCOL, V14, P78, DOI 10.1093/annonc/dkg022; Beurel E, 2004, EXP CELL RES, V300, P354, DOI 10.1016/j.yexcr.2004.08.001; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Bruchim I, 2009, EXPERT OPIN THER TAR, V13, P1179, DOI 10.1517/14728220903201702; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011; Ciaraldi TP, 2006, AM J PHYSIOL-ENDOC M, V291, pE891, DOI 10.1152/ajpendo.00176.2006; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Dong LL, 2012, J OBSTET GYNAECOL RE, V38, P1077, DOI 10.1111/j.1447-0756.2011.01839.x; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gunter MJ, 2008, CANCER EPIDEM BIOMAR, V17, P921, DOI 10.1158/1055-9965.EPI-07-2686; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kang-Park S, 2003, FEBS LETT, V545, P203, DOI 10.1016/S0014-5793(03)00535-0; Kiang JG, 2004, J APPL PHYSIOL, V97, P564, DOI 10.1152/japplphysiol.00194.2004; Kitchener H, 2006, EJSO-EUR J SURG ONC, V32, P838, DOI 10.1016/j.ejso.2006.03.046; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu Fu-Shing, 2007, Taiwan J Obstet Gynecol, V46, P26, DOI 10.1016/S1028-4559(08)60102-3; Liu SY, 2004, J BIOL CHEM, V279, P51075, DOI 10.1074/jbc.M408607200; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pallares J, 2004, J PATHOL, V204, P569, DOI 10.1002/path.1666; Piura E, 2006, BREAST CANC RES TREA, V123, P271; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Reynolds RK, 1998, GYNECOL ONCOL, V70, P202, DOI 10.1006/gyno.1998.5089; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Sarfstein R, 2006, MOL CELL ENDOCRINOL, V252, P241, DOI 10.1016/j.mce.2006.03.018; Sarfstein Rive, 2010, Cancers (Basel), V2, P233, DOI 10.3390/cancers2020233; Sarfstein R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024468; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; Soliman PT, 2006, CANCER-AM CANCER SOC, V106, P2376, DOI 10.1002/cncr.21866; Song J, 2010, BIOCHEM BIOPH RES CO, V393, P89, DOI 10.1016/j.bbrc.2010.01.086; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Werner H, 2012, ONCOGENE, V31, P2703, DOI 10.1038/onc.2011.447; Werner Haim, 2009, Pediatr Endocrinol Rev, V7, P2; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Xie Y, 2011, J STEROID BIOCHEM, V126, P113, DOI 10.1016/j.jsbmb.2010.12.006; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	58	106	117	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61537	10.1371/journal.pone.0061537	http://dx.doi.org/10.1371/journal.pone.0061537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620761	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500041
J	Juarez, SP; Merlo, J				Juarez, Sol Pia; Merlo, Juan			Revisiting the Effect of Maternal Smoking during Pregnancy on Offspring Birthweight: A Quasi-Experimental Sibling Analysis in Sweden	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; REDUCED FETAL-GROWTH; ACADEMIC-ACHIEVEMENT; CHILD OUTCOMES; PRETERM BIRTH; RISK; ASSOCIATION; BORN; MORTALITY; NICOTINE	Maternal smoking during pregnancy (SDP) seems associated with reduced birthweight in the offspring. This observation, however, is based on conventional epidemiological analyses, and it might be confounded by unobserved maternal characteristics related to both smoking habits and offspring birth weight. Therefore, we apply a quasi-experimental sibling analysis to revisit previous findings. Using the Swedish Medical Birth Register, we identified 677,922 singletons born between 2002 and 2010 from native Swedish mothers. From this population, we isolated 62,941 siblings from 28,768 mothers with discrepant habits of SDP. We applied conventional and mother-specific multilevel linear regression models to investigate the association between maternal SDP and offspring birthweight. Depending on the mother was light or heavy smoker and the timing of exposition during pregnancy (i.e., first or third trimester), the effect of smoking on birthweight reduction was between 6 and 78 g less marked in the sibling analysis than in the conventional analysis. Sibling analysis showed that continuous smoking reduces birthweight by 162 grams for mothers who were light smokers (1 to 9 cigarettes per day) and 226 g on average for those who were heavy smokers throughout the pregnancy in comparison to non-smoker mothers. Quitting smoking during pregnancy partly counteracted the smoking-related birthweight reduction by 1 to 29 g, and a subsequent smoking relapse during pregnancy reduced birthweight by 77 to 83 g. The sibling analysis provides strong evidence that maternal SDP reduces offspring birthweight, though this reduction was not as great as that observed in the conventional analysis. Our findings support public health interventions aimed to prevent SDP and to persuade those who already smoke to quit and not relapse throughout the pregnancy. Besides, further analyses are needed in order to explain the mechanisms through which smoking reduces birthweight and to identify other maternal characteristics that are common causes of both birthweight reduction and maternal smoking.	[Juarez, Sol Pia] Lund Univ, Ctr Econ Demog, Lund, Sweden; [Juarez, Sol Pia; Merlo, Juan] Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Lund, Sweden	Lund University; Lund University	Juarez, SP (corresponding author), Lund Univ, Ctr Econ Demog, Lund, Sweden.	sol.juarez@ekh.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Juarez, Sol Pia/0000-0001-9086-7588	Swedish Council for Working Life and Social Research (FAS) [Dnr 2010-0402]; Swedish Research Council (VR) [Dnr K2011-69X-15377-07-6]	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council (VR)(Swedish Research Council)	This work was supported by the Swedish Council for Working Life and Social Research (FAS) (Dnr 2010-0402, PI JM), the Swedish Research Council (VR) (Dnr K2011-69X-15377-07-6, PI JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberman E, 1980, LANCET, V26, P189; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Breslau N, 2000, BIOL PSYCHIAT, V47, P71, DOI 10.1016/S0006-3223(99)00131-6; Breslau N, 2001, J ABNORM CHILD PSYCH, V29, P273, DOI 10.1023/A:1010396027299; Browne WJ, 2009, J R STAT SOC A STAT, V172, P579, DOI 10.1111/j.1467-985X.2009.00586.x; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Carmines EL, 2008, TOXICOL SCI, V102, P383, DOI 10.1093/toxsci/kfn009; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; D'Onofrio BM, 2003, J CHILD PSYCHOL PSYC, V44, P1130, DOI 10.1111/1469-7610.00196; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2012, ARCH GEN PSYCHIAT, V69, P1140, DOI 10.1001/archgenpsychiatry.2011.2107; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Donovan SJ, 2011, INT J EPIDEMIOL, V40, P345, DOI 10.1093/ije/dyr057; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gardner F, 2004, PEDIATRICS, V114, P676, DOI 10.1542/peds.2003-0763-L; Gillman M. W, 2004, LIFE COURSE APPROACH; Gilman SE, 2008, AM J EPIDEMIOL, V168, P522, DOI 10.1093/aje/kwn175; Goldstein H., 2003, MULTILEVEL STAT MODE; Hegaard HK, 2006, ACTA OBSTET GYN SCAN, V85, P675, DOI 10.1080/00016340600607032; Iliadou AN, 2010, INT J EPIDEMIOL, V39, P1193, DOI 10.1093/ije/dyq064; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Kahn RS, 2002, AM J PUBLIC HEALTH, V92, P1801, DOI 10.2105/AJPH.92.11.1801; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lawlor DA, 2009, LIFE COURSE APPROACH; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lumley J, 2009, COCHRANE DATABASE SY, P8; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; NORDSTROM ML, 1994, EARLY HUM DEV, V37, P195, DOI 10.1016/0378-3782(94)90079-5; Ovrum A, 2011, HEALTH ECON, V20, P971, DOI 10.1002/hec.1662; Rasbash J., 2004, USERS GUIDE MLWIN VE; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Shiono Patricia H, 1997, AM J PUBLIC HLTH, V87; Tamim H, 2004, J PERINAT MED, V32, P509, DOI 10.1515/JPM.2004.120; Thapar A, 2009, BIOL PSYCHIAT, V66, P722, DOI 10.1016/j.biopsych.2009.05.032; Tong SL, 2006, J PAEDIATR CHILD H, V42, P98, DOI 10.1111/j.1440-1754.2006.00805.x; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; WILCOX AJ, 1983, INT J EPIDEMIOL, V12, P319, DOI 10.1093/ije/12.3.319; Wingren CJ, 2012, SCAND J GASTROENTERO, V47, P632, DOI 10.3109/00365521.2012.661760; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	48	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61734	10.1371/journal.pone.0061734	http://dx.doi.org/10.1371/journal.pone.0061734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23616908	Green Published, Green Submitted, gold			2022-12-25	WOS:000317907200080
J	Wang, SP; Kurada, L; Cilz, NI; Chen, XT; Xiao, ZY; Dong, HL; Lei, SB				Wang, Shouping; Kurada, Lalitha; Cilz, Nicholas I.; Chen, Xiaotong; Xiao, Zhaoyang; Dong, Hailong; Lei, Saobo			Adenosinergic Depression of Glutamatergic Transmission in the Entorhinal Cortex of Juvenile Rats via Reduction of Glutamate Release Probability and the Number of Releasable Vesicles	PLOS ONE			English	Article							INHIBITS NEURONAL EXCITABILITY; INCREASES GABA RELEASE; GABAERGIC TRANSMISSION; PRESYNAPTIC INHIBITION; A(2A) RECEPTORS; A(1) RECEPTORS; PROTEIN-KINASE; LAYER-III; ORGANIZATION; ACTIVATION	Adenosine is an inhibitory neuromodulator that exerts antiepileptic effects in the brain and the entorhinal cortex (EC) is an essential structure involved in temporal lobe epilepsy. Whereas microinjection of adenosine into the EC has been shown to exert powerful antiepileptic effects, the underlying cellular and molecular mechanisms in the EC have not been determined yet. We tested the hypothesis that adenosine-mediated modulation of synaptic transmission contributes to its antiepileptic effects in the EC. Our results demonstrate that adenosine reversibly inhibited glutamatergic transmission via activation of adenosine A(1) receptors without effects on GABAergic transmission in layer III pyramidal neurons in the EC. Adenosine-induced depression of glutamatergic transmission was mediated by inhibiting presynaptic glutamate release probability and decreasing the number of readily releasable vesicles. Bath application of adenosine also reduced the frequency of the miniature EPSCs recorded in the presence of TTX suggesting that adenosine may interact with the exocytosis processes downstream of Ca2+ influx. Both G alpha(i/o) proteins and the protein kinase A pathway were required for adenosine-induced depression of glutamatergic transmission. We further showed that bath application of picrotoxin to the EC slices induced stable epileptiform activity and bath application of adenosine dose-dependently inhibited the epileptiform activity in this seizure model. Adenosine-mediated depression of epileptiform activity was mediated by activation of adenosine A(1) receptors and required the functions of G alpha(i/o) proteins and protein kinase A pathway. Our results suggest that the depression of glutamatergic transmission induced by adenosine contributes to its antiepileptic effects in the EC.	[Wang, Shouping; Kurada, Lalitha; Cilz, Nicholas I.; Chen, Xiaotong; Lei, Saobo] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA; [Wang, Shouping] Sun Yat Sen Univ, Dept Anesthesiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiaotong] Sun Yat Sen Univ, Dept Emergency Med, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Zhaoyang; Dong, Hailong] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China	University of North Dakota Grand Forks; Sun Yat Sen University; Sun Yat Sen University; Air Force Military Medical University	Lei, SB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA.	saobo.lei@med.und.edu	Kurada, Lalitha/AAV-8844-2020	Dong, Hailong/0000-0001-8984-9067; Kurada, Lalitha/0000-0001-5239-9285	National Institutes of Mental Health [MH082881]; National Natural Science Foundation of China [81071052, 81128005]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082881] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Mental Health (MH082881), National Natural Science Foundation of China (Grant 81071052; Grant 81128005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avsar E, 2004, NEUROPHARMACOLOGY, V47, P427, DOI 10.1016/j.neuropharm.2004.04.015; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Benarroch EE, 2008, NEUROLOGY, V70, P231, DOI 10.1212/01.wnl.0000297939.18236.ec; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Deng PY, 2008, MOL CELL NEUROSCI, V39, P273, DOI 10.1016/j.mcn.2008.07.005; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Deng PY, 2007, J NEUROPHYSIOL, V97, P727, DOI 10.1152/jn.01089.2006; Deng PY, 2006, J PHYSIOL-LONDON, V577, P497, DOI 10.1113/jphysiol.2006.118141; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; Deng PY, 2006, J PHYSIOL-LONDON, V572, P425, DOI 10.1113/jphysiol.2005.104463; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; DRAGUNOW M, 1988, PROG NEUROBIOL, V31, P85, DOI 10.1016/0301-0082(88)90028-7; DU F, 1992, NEUROSCI LETT, V147, P185, DOI 10.1016/0304-3940(92)90591-T; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Edwards FA, 1999, PROG BRAIN RES, V120, P265; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P228, DOI 10.1111/j.1600-0773.1995.tb00135.x; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Haas HL, 2000, N-S ARCH PHARMACOL, V362, P375, DOI 10.1007/s002100000314; Han TH, 2011, NEUROSCI LETT, V490, P63, DOI 10.1016/j.neulet.2010.12.026; Hosseinmardi N, 2007, PHARMACOL RES, V56, P110, DOI 10.1016/j.phrs.2007.04.011; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Jeong HJ, 2003, J NEUROPHYSIOL, V89, P1214, DOI 10.1152/jn.00516.2002; Joyal CC, 2002, BIOL PSYCHIAT, V51, P1005, DOI 10.1016/S0006-3223(01)01368-3; Kim J, 2001, J NEUROSCI, V21, P9608, DOI 10.1523/JNEUROSCI.21-24-09608.2001; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Lahiria S, 2007, RESP PHYSIOL NEUROBI, V157, P123, DOI 10.1016/j.resp.2007.02.015; Lei S, 2007, J NEUROPHYSIOL, V98, P2868, DOI 10.1152/jn.00679.2007; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Lemos JR, 2012, CELL CALCIUM, V51, P284, DOI 10.1016/j.ceca.2012.01.008; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Mohammad-Zadeh M, 2005, EPILEPSY RES, V65, P1, DOI 10.1016/j.eplepsyres.2005.03.012; Nagao T, 1996, NEUROSCIENCE, V72, P399, DOI 10.1016/0306-4522(95)00534-X; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Oliet SHR, 1999, J PHYSIOL-LONDON, V520, P815, DOI 10.1111/j.1469-7793.1999.00815.x; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; RIBEIRO JA, 1986, PROG NEUROBIOL, V26, P179, DOI 10.1016/0301-0082(86)90015-8; Sawynok J, 2003, PROG NEUROBIOL, V69, P313, DOI 10.1016/S0301-0082(03)00050-9; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shi YR, 2008, J CEREBR BLOOD F MET, V28, P111, DOI 10.1038/sj.jcbfm.9600511; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Trudeau LE, 1998, P NATL ACAD SCI USA, V95, P7163, DOI 10.1073/pnas.95.12.7163; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Wang SP, 2012, CEREB CORTEX, V22, P584, DOI 10.1093/cercor/bhr131; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Xiao ZY, 2009, J BIOL CHEM, V284, P10980, DOI 10.1074/jbc.M806760200; Yum DS, 2008, J NEUROCHEM, V106, P361, DOI 10.1111/j.1471-4159.2008.05400.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	65	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62185	10.1371/journal.pone.0062185	http://dx.doi.org/10.1371/journal.pone.0062185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614032	Green Submitted, gold, Green Published			2022-12-25	WOS:000317893400159
J	Tripathi, P; Wang, Y; Coussens, M; Manda, KR; Casey, AM; Lin, C; Poyo, E; Pfeifer, JD; Basappa, N; Bates, CM; Ma, L; Zhang, H; Pan, M; Ding, L; Chen, F				Tripathi, P.; Wang, Y.; Coussens, M.; Manda, K. R.; Casey, A. M.; Lin, C.; Poyo, E.; Pfeifer, J. D.; Basappa, N.; Bates, C. M.; Ma, L.; Zhang, H.; Pan, M.; Ding, L.; Chen, F.			Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms	ONCOGENE			English	Article						NFAT; tumorigenesis; tumor; microenvironment	TRANSCRIPTION FACTOR; CALCINEURIN; EXPRESSION; CANCER; MICE; CA2+/CALCINEURIN; PROLIFERATION; CALCIUM; GENE	NFAT (the nuclear factor of activated T cells) upregulation has been linked to cellular transformation intrinsically, but it is unclear whether and how tissue cells with NFAT activation change the local environment for tumor initiation and progression. Direct evidence showing NFAT activation initiates primary tumor formation in vivo is also lacking. Using inducible transgenic mouse systems, we show that tumors form in a subset of, but not all, tissues with NFATc1 activation, indicating that NFAT oncogenic effects depend on cell types and tissue contexts. In NFATc1-induced skin and ovarian tumors, both cells with NFATc1 activation and neighboring cells without NFATc1 activation have significant upregulation of c-Myc and activation of Stat3. Besides known and suspected NFATc1 targets, such as Spp1 and Osm, we have revealed the early upregulation of a number of cytokines and cytokine receptors, as key molecular components of an inflammatory microenvironment that promotes both NFATc1(+) and NFATc1(-) cells to participate in tumor formation. Cultured cells derived from NFATc1-induced tumors were able to establish a tumorigenic microenvironment, similar to that of the primary tumors, in an NFATc1-dependent manner in nude mice with T-cell deficiency, revealing an addiction of these tumors to NFATc1 activation and downplaying a role for T cells in the NFATc1-induced tumorigenic microenvironment. These findings collectively suggest that beyond the cell autonomous effects on the upregulation of oncogenic proteins, NFATc1 activation has non-cell autonomous effects through the establishment of a promitogenic microenvironment for tumor growth. This study provides direct evidence for the ability of NFATc1 in inducing primary tumor formation in vivo and supports targeting NFAT signaling in anti-tumor therapy.	[Tripathi, P.; Wang, Y.; Coussens, M.; Manda, K. R.; Casey, A. M.; Lin, C.; Ma, L.; Chen, F.] Washington Univ, Sch Med, Dept Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Poyo, E.] Washington Univ, Sch Med, Dept Engn, St Louis, MO 63110 USA; [Pfeifer, J. D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Basappa, N.] Univ Maryland, Dept Biol, Baltimore, MD 21201 USA; [Bates, C. M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Zhang, H.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Pan, M.] Kaiser Permanente Med Ctr, Div Oncol, Santa Clara, CA USA; [Ding, L.] Washington Univ, Sch Med, Genome Inst, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; Kaiser Permanente; Washington University (WUSTL)	Chen, F (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8126, St Louis, MO 63110 USA.	fchen@dom.wustl.edu	Pan, Minggui/AAB-7371-2020		Department of Medicine at Washington University School of Medicine; NIH [DK81592, DK67386]; George M. O'Brien Center for Kidney Disease Research at Washington University [George M. O'Brien Center for Kidney Disease Research at Washington University (P30DK079333]; Genome Technology Access Center [P30 CA91842, UL1RR024992]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081592, P30DK079333, R01DK067386, R01DK087960] Funding Source: NIH RePORTER	Department of Medicine at Washington University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George M. O'Brien Center for Kidney Disease Research at Washington University; Genome Technology Access Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Crabtree for providing the TetO-NFATc1<SUP>Nuc</SUP> mice and Dr Yuan Zhu for helpful discussion of the study. FC is supported in part by institutional funds from the Department of Medicine at Washington University School of Medicine and NIH grants (DK81592 and DK67386). We also thank the George M. O'Brien Center for Kidney Disease Research at Washington University (P30DK079333) for core services. We thank Michael Heinz from the Genome Technology Access Center (P30 CA91842, UL1RR024992) in the Department of Genetics at Washington University School of Medicine for help with gene expression analysis.	ANDERSON B, 1987, GYNECOL ONCOL, V26, P183, DOI 10.1016/0090-8258(87)90272-1; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guo QS, 2011, J UROLOGY, V185, P2320, DOI 10.1016/j.juro.2011.02.044; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; JANIK P, 1975, CANCER RES, V35, P3698; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Lin CX, 2009, GENESIS, V47, P352, DOI 10.1002/dvg.20506; Marafiot T, 2005, BRIT J HAEMATOL, V128, P333, DOI 10.1111/j.1365-2141.2004.05313.x; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Pan MG, CURR MOL ME IN PRESS; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; Sansone P, 2011, CURR OPIN GENET DEV, V21, P80, DOI 10.1016/j.gde.2010.11.001; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yasaka Nami, 1995, Journal of Dermatology (Tokyo), V22, P88; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	32	24	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1840	1849		10.1038/onc.2013.132	http://dx.doi.org/10.1038/onc.2013.132			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23624921	Green Accepted			2022-12-25	WOS:000334345500010
J	Park, J; Schwarzbauer, JE				Park, J.; Schwarzbauer, J. E.			Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition	ONCOGENE			English	Article						fibronectin; EMT; MCF-10A cells; breast cancer; TGF beta	HUMAN BREAST-CANCER; EXTRACELLULAR-MATRIX COMPONENTS; FOCAL ADHESION KINASE; TGF-BETA; BASEMENT-MEMBRANE; GLAND DEVELOPMENT; UP-REGULATION; E-CADHERIN; EXPRESSION; BINDING	In the mammary gland, the stromal extracellular matrix (ECM) undergoes dramatic changes during development and in tumorigenesis. For example, normal adult breast tissue is largely devoid of the ECM protein fibronectin (FN) whereas high FN levels have been detected in the stroma of breast tumors. FN is an established marker for epithelial-mesenchymal transition (EMT), which occurs during development and has been linked to cancer. During EMT, epithelial cell adhesion switches from cell-cell contacts to mainly cell-ECM interactions, raising the possibility that FN may have a role in promoting this transition. Using MCF-10A mammary epithelial cells, we show that exposure to exogenous FN induces an EMT response including upregulation of the EMT markers FN, Snail, N-cadherin, vimentin, the matrix metalloprotease MMP2, alpha-smooth muscle actin and phospho-Smad2, as well as acquisition of cell migratory behavior. FN-induced EMT depends on Src kinase and extracellular signal-regulated kinase/mitogen-activated protein (ERK/MAP) kinase signaling but not on the immediate early gene EGR-1. FN initiates EMT under serum-free conditions; this response is partially reversed by a transforming growth factor (TGF)beta-neutralizing antibody, suggesting that FN enhances the effect of endogenous TGF beta. EMT marker expression is upregulated in cells on a fragment of FN containing the integrin-binding domain but not other domains. Differences in gene expression between FN and Matrigel are maintained with addition of a subthreshold level of TGF beta 1. Together, these results show that cells interacting with FN are primed to respond to TGF beta. The ability of FN to induce EMT shows an active role for the stromal ECM in this process and supports the notion that the increased levels of FN observed in breast tumors facilitate tumorigenesis.	[Park, J.; Schwarzbauer, J. E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jschwarz@princeton.edu		Schwarzbauer, Jean/0000-0003-1012-7593	NIH [R01 GM059383, R01 CA160611]; Ruth L Kirschstein National Research Service Award [T32 CA 009528]; NATIONAL CANCER INSTITUTE [R01CA160611, T32CA009528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM059383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jina Hong for assistance with some experiments. We thank Dr Keith Johnson (University of Nebraska Medical Center) for generously providing N-cadherin antibody. This work was supported by grants from the NIH (R01 GM059383 and R01 CA160611 to JES). JP received support from a Ruth L Kirschstein National Research Service Award (T32 CA 009528).	BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; CHRISTENSEN L, 1992, APMIS, V100, P1; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Duband JL, 2009, DEV GROWTH DIFFER, V51, P25, DOI 10.1111/j.1440-169X.2009.01076.x; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Neira RE, 2012, INT J BIOCHEM CELL B, V44, P2194, DOI 10.1016/j.biocel.2012.08.018; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Goyal A, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-56; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Kadar A, 2002, SEMIN CANCER BIOL, V12, P243, DOI 10.1016/S1044-579X(02)00027-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Kim ES, 2004, INT J ONCOL, V25, P1375; Klinowska TCM, 1999, DEV BIOL, V215, P13, DOI 10.1006/dbio.1999.9435; Komiya E, 2012, CANCER SCI, V103, P691, DOI 10.1111/j.1349-7006.2012.02203.x; KOUKOULIS GK, 1993, J SUBMICR CYTOL PATH, V25, P285; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Martinez-Orozco R, 2010, EUR J CELL BIOL, V89, P476, DOI 10.1016/j.ejcb.2009.12.005; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; RUELLAND A, 1988, CLIN CHIM ACTA, V178, P283, DOI 10.1016/0009-8981(88)90236-7; Sandal T, 2007, AM J PATHOL, V170, P1739, DOI 10.2353/ajpath.2007.060922; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Slade MJ, 1999, EXP CELL RES, V247, P267, DOI 10.1006/excr.1998.4340; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	48	151	156	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1649	1657		10.1038/onc.2013.118	http://dx.doi.org/10.1038/onc.2013.118			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23624917	Green Accepted			2022-12-25	WOS:000334344700005
J	Ejlerskov, P; Rasmussen, I; Nielsen, TT; Bergstrom, AL; Tohyama, Y; Jensen, PH; Vilhardt, F				Ejlerskov, Patrick; Rasmussen, Izabela; Nielsen, Troels Tolstrup; Bergstrom, Ann-Louise; Tohyama, Yumi; Jensen, Poul Henning; Vilhardt, Frederik			Tubulin Polymerization-promoting Protein (TPPP/p25 alpha) Promotes Unconventional Secretion of alpha-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; QUALITY-CONTROL; CELL-DEATH; MACROAUTOPHAGY; BODY; NEURODEGENERATION; DEGRADATION; PATHOLOGY; DISEASE; RAB7	Aggregation of alpha-synuclein can be promoted by the tubulin polymerization-promoting protein/p25 alpha, which we have used here as a tool to study the role of autophagy in the clearance of alpha-synuclein. In NGF-differentiated PC12 catecholaminergic nerve cells, we show that de novo expressed p25 alpha co-localizes with alpha-synuclein and causes its aggregation and distribution into autophagosomes. However, p25 alpha also lowered the mobility of autophagosomes and hindered the final maturation of autophagosomes by preventing their fusion with lysosomes for the final degradation of alpha-synuclein. Instead, p25 alpha caused a 4-fold increase in the basal level of alpha-synuclein secreted into the medium. Secretion was strictly dependent on autophagy and could be up-regulated (trehalose and Rab1A) or down-regulated (3-methyladenine and ATG5 shRNA) by enhancers or inhibitors of autophagy or by modulating minus-end-directed (HDAC6 shRNA) or plus-end-directed (Rab8) trafficking of autophagosomes along microtubules. Finally, we show in the absence of tubulin polymerization-promoting protein/p25 alpha that alpha-synuclein release was modulated by dominant mutants of Rab27A, known to regulate exocytosis of late endosomal (and amphisomal) elements, and that both lysosomal fusion block and secretion of alpha-synuclein could be replicated by knockdown of the p25 alpha target, HDAC6, the predominant cytosolic deacetylase in neurons. Our data indicate that unconventional secretion of alpha-synuclein can be mediated through exophagy and that factors, which increase the pool of autophagosomes/amphisomes (e.g. lysosomal disturbance) or alter the polarity of vesicular transport of autophagosomes on microtubules, can result in an increased release of alpha-synuclein monomer and aggregates to the surroundings.	[Ejlerskov, Patrick; Rasmussen, Izabela; Nielsen, Troels Tolstrup; Vilhardt, Frederik] Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, DK-2200 Copenhagen N, Denmark; [Ejlerskov, Patrick] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Nielsen, Troels Tolstrup] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Bergstrom, Ann-Louise] Lundbeck AS, DK-2500 Valby, Denmark; [Tohyama, Yumi] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo 6708524, Japan; [Jensen, Poul Henning] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Lundbeck Corporation; Himeji Dokkyo University; Aarhus University	Vilhardt, F (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Panum Inst, 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	vilhardt@sund.ku.dk	Vilhardt, Frederik/AAX-4766-2021; Nielsen, Troels Tolstrup/AAP-8330-2021	Nielsen, Troels Tolstrup/0000-0002-3292-1846; Ejlerskov, Patrick/0000-0002-2514-3185; Vilhardt, Frederik/0000-0001-8604-7165; Jensen, Poul Henning/0000-0002-4439-9020	Danish Parkinson Foundation; JASCHA Foundation; Warwara-Larsen Foundation; Danish Research Council; Aase and Ejnar Danielsens Foundation; NOVO Nordisk Foundation; Lundbeck Foundation; Grants-in-Aid for Scientific Research [23590374] Funding Source: KAKEN	Danish Parkinson Foundation; JASCHA Foundation; Warwara-Larsen Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Aase and Ejnar Danielsens Foundation; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Danish Parkinson Foundation (to F. V. and P. E.), The JASCHA Foundation, The Warwara-Larsen Foundation, The Danish Research Council, Aase and Ejnar Danielsens Foundation, NOVO Nordisk Foundation (to F. V.), and the Lundbeck Foundation (to P. H. J.).	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Denzer K, 2000, J CELL SCI, V113, P3365; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Hasholt L, 2003, J GENE MED, V5, P528, DOI 10.1002/jgm.378; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532	66	154	156	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17313	17335		10.1074/jbc.M112.401174	http://dx.doi.org/10.1074/jbc.M112.401174			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629650	hybrid, Green Published			2022-12-25	WOS:000320380600026
J	Biswas, S; Mukherjee, R; Tapryal, N; Singh, AK; Mukhopadhyay, CK				Biswas, Sudipta; Mukherjee, Reshmi; Tapryal, Nisha; Singh, Amit K.; Mukhopadhyay, Chinmay K.			Insulin Regulates Hypoxia-Inducible Factor-1 alpha Transcription by Reactive Oxygen Species Sensitive Activation of Sp1 in 3T3-L1 Preadipocyte	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR-I; SIGNALING PATHWAY; FACTOR 1-ALPHA; NADPH OXIDASE; INTRACELLULAR ASCORBATE; NONHYPOXIC CONDITIONS; PROLYL HYDROXYLATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION	Oxygen sensing transcription factor HIF-1 is activated due to accumulation of regulatory subunit HIF-1 alpha by posttranslational stability mechanism during hypoxia or by several other stimuli even in normoxia. HIF-1 alpha is also regulated by NF-kB mediated transcription mechanism. Reactive oxygen species (ROS) act as an important regulator of HIF-1 either by affecting prolyl hydroxylase activity, the critical determinant of HIF-1 alpha stabilization or by activating NF-kB to promote HIF-1 alpha transcription. Insulin is known to activate HIF-1 by a ROS dependent mechanism but the molecular mechanism of HIF-1 alpha regulation is not known so far. Here we show that insulin regulates HIF-1 alpha by a novel transcriptional mechanism by a ROS-sensitive activation of Sp1 in 3T3-L1 preadipocyte. Insulin shows little effect on HIF-1 alpha protein stability, but increases HIF-1 alpha promoter activity. Mutation analyses, electrophoretic mobility shift assay and chromatin immunoprecipitation assay confirm the role of Sp1 in HIF-1 alpha transcription. We further demonstrate that insulin-induced ROS generation initiates signaling pathway involving phosphatidylinositol 3-kinase and protein kinase C for Sp1 mediated HIF-1 alpha transcription. In summary, we reveal that insulin regulates HIF-1 alpha by a novel transcriptional mechanism involving Sp1.	[Biswas, Sudipta; Mukherjee, Reshmi; Tapryal, Nisha; Singh, Amit K.; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mukhopadhyay, CK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in			Indian Council of Medical Research [5/3/8/12/2003-RHN]; Jawaharlal Nehru University; Department of Science and Technology of India; Council of Scientific and Industrial Research of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Jawaharlal Nehru University; Department of Science and Technology of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from Indian Council of Medical Research (number 5/3/8/12/2003-RHN), Capacity build up grant from Jawaharlal Nehru University and PURSE program from Department of Science and Technology of India to CKM. SB and AKS acknowledge senior research fellowships from Council of Scientific and Industrial Research of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Biswas S, 2013, BBA-MOL BASIS DIS, V1832, P293, DOI 10.1016/j.bbadis.2012.11.003; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Chou WC, 2005, BLOOD, V106, P304, DOI 10.1182/blood-2005-01-0241; Chu SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL983, DOI 10.1152/ajplung.00454.2005; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Goda N, 2003, ANTIOXID REDOX SIGN, V5, P467, DOI 10.1089/152308603768295212; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim HS, 2009, J BIOL CHEM, V284, P15475, DOI 10.1074/jbc.M808734200; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048393; Mukhopadhyay CK, 2010, METHODS IN REDOX SIGNALING, P118; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roder K, 2002, BIOCHEM BIOPH RES CO, V293, P793, DOI 10.1016/S0006-291X(02)00274-7; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Seshadri V, 2002, J BIOL CHEM, V277, P27903, DOI 10.1074/jbc.M203610200; Singh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038489; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapryal N, 2010, FREE RADICAL BIO MED, V48, P1492, DOI 10.1016/j.freeradbiomed.2010.02.029; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wolf G, 2005, ANTIOXID REDOX SIGN, V7, P1337, DOI 10.1089/ars.2005.7.1337; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	51	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62128	10.1371/journal.pone.0062128	http://dx.doi.org/10.1371/journal.pone.0062128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626778	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400142
J	Deng, Y; Guan, J; Wen, B; Zhu, N; Chen, H; Song, JD; Yang, Y; Wang, Y; Tan, WJ				Deng, Yao; Guan, Jie; Wen, Bo; Zhu, Na; Chen, Hong; Song, Jindong; Yang, Yang; Wang, Yue; Tan, Wenjie			Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; T-CELL RESPONSES; NONSTRUCTURAL PROTEIN-3; VIRAL CLEARANCE; VACCINE; IMMUNIZATION; PSEUDOPARTICLES; IMMUNITY; DELIVERY; ENTRY	Introduction: Integration-deficient lentiviral vectors (IDLVs) are a promising platform for immunisation to elicit both humoral immunity and cellular mediated immunity (CMI). Here, we compared the specific immunity in mice immunised via different regimens (homologous and cocktail) with IDLV-based HCV pseudoparticles (HCVpps) carrying pseudotyped glycoproteins E1E2 and bearing the HCV NS3 gene. Humoral and cell-mediated immune responses were also evaluated after IDLV-HCVpp immunisation combined with heterologous rAd5-CE1E2 priming protocols. Sera from the mice effectively elicited anti-E1, -E2, and -NS3 antibody responses, and neutralised various HCVpp subtypes (1a, 1b, 2a, 3a and 5a). No significant CMI was detected in the groups immunised with IDLV-based HCVpps. In contrast, the combination of rAd5-CE1E2 priming and IDLV-based HCVpp boosting induced significant CMI against multiple antigens (E1, E2, and NS3). Conclusion: IDLV-based HCVpps are a promising vaccination platform and the combination of rAd5-CE1E2 and IDLV-based HCVpp prime-boost strategy should be further explored for the development of a cross-protective HCV vaccine.	[Deng, Yao; Guan, Jie; Wen, Bo; Zhu, Na; Chen, Hong; Song, Jindong; Yang, Yang; Wang, Yue; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China; [Wen, Bo] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Jilin University	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.	euy-tokyo@umin.ac.jp; tanwj28@yahoo.cn	Song, Jin/HHS-8731-2022		863 Hi-Tech Research and Development Program of China [2007AA02Z455]; National Mega-project for Infectious Diseases of China [2009ZX10004-705, 2009ZX10004-715]	863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Mega-project for Infectious Diseases of China	This study was supported by the 863 Hi-Tech Research and Development Program of China (2007AA02Z455) and the National Mega-project for Infectious Diseases of China (2009ZX10004-705 and -715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce F, 2009, MOL THER, V17, P1643, DOI 10.1038/mt.2009.149; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bian T, 2009, BIOCHEM BIOPH RES CO, V378, P118, DOI 10.1016/j.bbrc.2008.11.024; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; Deng Y, 2009, VACCINE, V27, P2085, DOI 10.1016/j.vaccine.2009.02.003; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dreux Marlene, 2009, V510, P427, DOI 10.1007/978-1-59745-394-3_32; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Guan J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-506; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Hu BL, 2010, VACCINE, V28, P6675, DOI 10.1016/j.vaccine.2010.08.012; Karwacz K, 2009, J VIROL, V83, P3094, DOI 10.1128/JVI.02519-08; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; Lin YL, 2008, J VIROL, V82, P7492, DOI 10.1128/JVI.02743-07; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Negri DRM, 2011, EXPERT OPIN BIOL TH, V11, P739, DOI 10.1517/14712598.2011.571670; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Puig M, 2004, VACCINE, V22, P991, DOI 10.1016/j.vaccine.2003.09.010; Qi Xiang-rong, 2011, Bing Du Xue Bao, V27, P34; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Roy P, 2009, ADV EXP MED BIOL, V655, P145, DOI 10.1007/978-1-4419-1132-2_11; Shimakami T, 2009, CURR OPIN PHARMACOL, V9, P537, DOI 10.1016/j.coph.2009.08.008; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Strickland GT, 2008, LANCET INFECT DIS, V8, P379, DOI 10.1016/S1473-3099(08)70126-9; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; Wen B, 2011, ACTA BIOCH BIOPH SIN, V43, P96, DOI 10.1093/abbs/gmq117; Yu MYW, 2004, P NATL ACAD SCI USA, V101, P7705, DOI 10.1073/pnas.0402458101; Zhang Ke, 2008, Chinese Journal of Virology, V24, P287; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	19	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62684	10.1371/journal.pone.0062684	http://dx.doi.org/10.1371/journal.pone.0062684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626846	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400210
J	Gangoso, L; Lopez-Lopez, P; Grande, JM; Mellone, U; Liminana, R; Urios, V; Ferrer, M				Gangoso, Laura; Lopez-Lopez, Pascual; Manuel Grande, Juan; Mellone, Ugo; Liminana, Ruben; Urios, Vicente; Ferrer, Miguel			Ecological Specialization to Fluctuating Resources Prevents Long-Distance Migratory Raptors from Becoming Sedentary on Islands	PLOS ONE			English	Article							FALCO-ELEONORAE; BIRD; EVOLUTION	Background: The adaptive transition between behavioral strategies, such as the shift from migratoriness to sedentariness, remains an outstanding question in evolutionary ecology. Density-dependent variation in the age of first breeding has been proposed as a feasible mechanism through which long-lived migratory birds with deferred sexual maturity should become sedentary to persist on islands. Although this pattern seems to hold for most raptors and herons, a few exceptions have been identified. One of these exceptions is the Eleonora's falcon, a long-distance migratory bird, which shows one of the most peculiar adaptations in the timing of reproduction and food requirements among raptors. Methodology/Principal Findings: Here, we compiled data concerning demography, banding recoveries and satellite tracking of Eleonora's falcons to discuss likely explanations for the exceptional behavior of this insular long-distance migratory species. Conclusions/Significance: New data reveal that Eleonora's falcons do return to the natal colonies in their first year and young birds are able to breed. However, in contrast to previous hypothesis, the highly specialized strategy of this and other ecologically similar species, as well as the virtual lack of food during winter at breeding areas prevent them from becoming sedentary on islands. Although the ultimate mechanisms underlying the process of sedentarization remain poorly understood, the evidence provided reveal the existence of important trade-offs associated with ecological specialization that may become particularly relevant in the present context of global change.	[Gangoso, Laura] CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain; [Lopez-Lopez, Pascual; Mellone, Ugo; Liminana, Ruben; Urios, Vicente] Univ Alicante, CIBIO Res Inst, Vertebrate Zool Res Grp, E-03080 Alicante, Spain; [Manuel Grande, Juan] UNLPam, FCEyN, Inst Ciencias Tierra & Ambientales La Pampa INCIT, CECARA,CONICET, La Pampa, Argentina; [Liminana, Ruben] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, E-41080 Seville, Spain; [Ferrer, Miguel] CSIC, Dept Ethol & Biodivers Conservat, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universitat d'Alacant; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gangoso, L (corresponding author), CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain.	laurag@ebd.csic.es	Gangoso, Laura/C-6575-2015; Ferrer, Miguel/G-3519-2015; López-López, Pascual/C-1039-2011; Urios, Vicente/AAD-4800-2022; Ferrer, Miguel/AFU-8286-2022	Gangoso, Laura/0000-0002-6205-6769; Ferrer, Miguel/0000-0003-0092-8450; López-López, Pascual/0000-0001-5269-652X; Grande, Juan Manuel/0000-0002-8183-0780; Liminana, Ruben/0000-0001-8152-3644	FP7-REGPOT 2010-1 EcoGenes Project [264125]; Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]; FPU from the Spanish Ministry of Education [AP2008-0947]; 'Consejeria de Educacion y Ciencia' (JCCM) [10/12-C]; European Social Fund	FP7-REGPOT 2010-1 EcoGenes Project; Spanish Ministry of Economy and Competitiveness(Spanish Government); FPU from the Spanish Ministry of Education(German Research Foundation (DFG)); 'Consejeria de Educacion y Ciencia' (JCCM); European Social Fund(European Social Fund (ESF))	L.G. is supported by the FP7-REGPOT 2010-1 EcoGenes Project (Grant No. 264125). P.L.-L. is supported by a 'Juan de la Cierva' postdoctoral grant from the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). U. M. is supported by a FPU grant from the Spanish Ministry of Education (reference AP2008-0947). R. L. has a postdoctoral grant (reference 10/12-C) co-funded by 'Consejeria de Educacion y Ciencia' (JCCM) and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corso Andrea, 2012, British Birds, V105, P738; Ferrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022056; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Gschweng M, 2012, J APPL ECOL, V49, P803, DOI 10.1111/j.1365-2664.2012.02170.x; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; Joseph L, 2003, J BIOGEOGR, V30, P925, DOI 10.1046/j.1365-2699.2003.00841.x; Kassara C, 2012, J ORNITHOL, V153, P839, DOI 10.1007/s10336-011-0802-2; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; Lopez-Lopez P, 2009, ZOOL STUD, V48, P485; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Mellone U, 2013, BIRD CONSERV INT, V23, P487, DOI 10.1017/S0959270913000051; Mellone U, 2012, BIRD STUDY, V59, P29, DOI 10.1080/00063657.2011.632401; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Ristow, 2010, IL MERILL, V32, P1; Ristow D., 1983, Vogelwarte, V32, P7; Ristow D., 1989, P321; Ristow D, 1995, IL MERILL, V28, P1; Ristow D, 1979, MERILL, V20, P16; Walter H., 1979, ELEONORAS FALCON ADA	23	13	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61615	10.1371/journal.pone.0061615	http://dx.doi.org/10.1371/journal.pone.0061615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626704	Green Published, gold			2022-12-25	WOS:000318008400068
J	Huang, TP; Lu, KM; Chen, YH				Huang, Tzu-Pi; Lu, Kuan-Min; Chen, Yu-Hsuan			A Novel Two-Component Response Regulator Links rpf with Biofilm Formation and Virulence of Xanthomonas axonopodis pv. citri	PLOS ONE			English	Article							HD-GYP DOMAIN; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; NUCLEOTIDE-SEQUENCE; PATHOGENICITY GENE; ESCHERICHIA-COLI; CHEMOTAXIS GENES; RECEIVER DOMAIN; PROTEIN; CAMPESTRIS	Citrus bacterial canker caused by Xanthomonas axonopodis pv. citri is a serious disease that impacts citrus production worldwide, and X. axonopodis pv. citri is listed as a quarantine pest in certain countries. Biofilm formation is important for the successful development of a pathogenic relationship between various bacteria and their host(s). To understand the mechanisms of biofilm formation by X. axonopodis pv. citri strain XW19, the strain was subjected to transposon mutagenesis. One mutant with a mutation in a two-component response regulator gene that was deficient in biofilm formation on a polystyrene microplate was selected for further study. The protein was designated as BfdR for biofilm formation defective regulator. BfdR from strain XW19 shares 100% amino acid sequence identity with XAC1284 of X. axonopodis pv. citri strain 306 and 30-100% identity with two-component response regulators in various pathogens and environmental microorganisms. The bfdR mutant strain exhibited significantly decreased biofilm formation on the leaf surfaces of Mexican lime compared with the wild type strain. The bfdR mutant was also compromised in its ability to cause canker lesions. The wild-type phenotype was restored by providing pbfdR in trans in the bfdR mutant. Our data indicated that BfdR did not regulate the production of virulence-related extracellular enzymes including amylase, lipase, protease, and lecithinase or the expression of hrpG, rfbC, and katE; however, BfdR controlled the expression of rpfF in XVM2 medium, which mimics cytoplasmic fluids in planta. In conclusion, biofilm formation on leaf surfaces of citrus is important for canker development in X. axonopodis pv. citri XW19. The process is controlled by the two-component response regulator BfdR via regulation of rpfF, which is required for the biosynthesis of a diffusible signal factor.	[Huang, Tzu-Pi; Lu, Kuan-Min; Chen, Yu-Hsuan] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan	National Chung Hsing University	Huang, TP (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	tphuang@nchu.edu.tw		Huang, Tzu-Pi/0000-0003-2904-3373	National Science Council [NSC97-2313-B-005-039-MY3, NSC99-2321-B-005-014-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council (NSC97-2313-B-005-039-MY3 and NSC99-2321-B-005-014-MY3) to TPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANBA J, 1990, J BACTERIOL, V172, P4685, DOI 10.1128/jb.172.8.4685-4689.1990; Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; [Anonymous], 2010, CURRENT RES TECHNOLO; Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Characklis WG, 1990, BIOFILMS, P3; Chatterjee S, 2008, MOL PLANT MICROBE IN, V21, P1309, DOI 10.1094/MPMI-21-10-1309; COLMER AR, 1948, J BACTERIOL, V55, P777, DOI 10.1128/JB.55.6.777-785.1948; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Guo YP, 2010, APPL ENVIRON MICROB, V76, P2234, DOI 10.1128/AEM.02897-09; He YW, 2006, J BIOL CHEM, V281, P33414, DOI 10.1074/jbc.M606571200; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Huang TP, 2007, APPL ENVIRON MICROB, V73, P5034, DOI 10.1128/AEM.00366-07; Huang TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042124; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lee YA, 2009, APPL ENVIRON MICROB, V75, P6831, DOI 10.1128/AEM.01653-09; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Lin HsinCheng, 2005, Plant Pathology Bulletin, V14, P227; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; MUTOH N, 1986, J BACTERIOL, V165, P161, DOI 10.1128/jb.165.1.161-166.1986; Newman KL, 2008, MOL PLANT MICROBE IN, V21, P326, DOI 10.1094/MPMI-21-3-0326; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; PARKINSON JS, 1983, J BACTERIOL, V155, P265, DOI 10.1128/JB.155.1.265-274.1983; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Paul K, 2011, P NATL ACAD SCI USA, V108, P17171, DOI 10.1073/pnas.1110111108; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Qian W, 2008, MOL PLANT MICROBE IN, V21, P151, DOI 10.1094/MPMI-21-2-0151; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryan RP, 2010, VIRULENCE, V1, P404, DOI 10.4161/viru.1.5.12704; Ryan RP, 2009, J BACTERIOL, V191, P5013, DOI 10.1128/JB.00473-09; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J, 2001, MOL CLONING LAB MANU; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Schaad NW, 2005, SYST APPL MICROBIOL, V28, P494, DOI 10.1016/j.syapm.2005.03.017; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Siciliano F, 2006, ELECTRON J BIOTECHN, V9, P199, DOI 10.2225/vol9-issue3-fulltext-20; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Srivastava D, 2012, J BACTERIOL, V194, P4485, DOI 10.1128/JB.00379-12; Stark E, 1953, APPL ENVIRON MICROB; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wang LC, 2012, EMBO J, V31, P2648, DOI 10.1038/emboj.2012.99; WINANS SC, 1986, P NATL ACAD SCI USA, V83, P8278, DOI 10.1073/pnas.83.21.8278; WURTZEL ET, 1982, J BIOL CHEM, V257, P13685; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Yan Q, 2011, J BACTERIOL, V193, P1590, DOI 10.1128/JB.01415-10; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x	74	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62824	10.1371/journal.pone.0062824	http://dx.doi.org/10.1371/journal.pone.0062824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626857	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400221
J	Singh, VV; Chauhan, SK; Rai, R; Kumar, A; Singh, SM; Rai, G				Singh, Vikas Vikram; Chauhan, Sudhir Kumar; Rai, Richa; Kumar, Ashok; Singh, Shiva M.; Rai, Geeta			Decreased Pattern Recognition Receptor Signaling, Interferon-Signature, and Bactericidal/Permeability-Increasing Protein Gene Expression in Cord Blood of Term Low Birth Weight Human Newborns	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MEDIATED RESPONSES; IMMUNE-RESPONSES; INNATE IMMUNITY; RISK-FACTORS; EARLY-LIFE; RIG-I; MORBIDITY; DISTINCT; INFANTS	Background: Morbidity and mortality rates of low birth weight (LBW) newborns at term are higher than rates in normal birth weight (NBW) newborns. LBW newborns are at greater risk to acquire recurrent bacterial and viral infections during their first few weeks of life possibly as an outcome of compromised innate immune functions. As adaptive immunity is in a naive state, increased risk of infection of LBW as compared to NBW newborns may reflect impairments in innate immunity. Methodology: To characterize the increased susceptibility to infections in LBW newborns we used microarray technology to identify differences in gene expression in LBW newborns (n = 8) compared to NBW newborns (n = 4) using cord blood. The results obtained from the microarray study were validated on a larger number of samples using real time RT-PCR (LBW = 22, NBW = 18) and western blotting (LBW = 12, NBW = 12). The Interferome database was used to identify interferon (IFN) signature genes and ingenuity pathway analysis identified canonical pathways and biological functions associated with the differentially expressed genes in LBW newborns. ELISAs for IFNs and bactericidal/permeability-increasing protein were performed in both LBW and NBW newborns and in adults (LBW = 18, NBW= 18, Adults = 8). Principal Findings: Upon microarray analysis, we identified 1,391 differentially expressed genes, of which, 1,065 genes were down-regulated and 326 genes were up-regulated in the LBW compared to NBW newborns. Of note, 70 IFN-signature genes were found to be significantly down-regulated in LBW compared to NBW newborns. Ingenuity pathway analysis revealed pattern recognition receptors signaling including Toll-Like Receptors (TLRs) -1, -5, and -8 genes and IFN signaling as the most significantly impacted pathways. Respiratory infectious diseases were the most significantly affected bio-functions in LBW newborns. Conclusion and Significance: Diminished PRRs, IFN-signature, and BPI gene expression raises the possibility that impairments in these pathways contribute to the susceptibility of LBW term infants to infection.	[Singh, Vikas Vikram; Chauhan, Sudhir Kumar; Rai, Richa; Rai, Geeta] Banaras Hindu Univ, Fac Sci, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Kumar, Ashok] Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India; [Singh, Shiva M.] Univ Western Ontario, Dept Biol, London, ON, Canada	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Western University (University of Western Ontario)	Rai, G (corresponding author), Banaras Hindu Univ, Fac Sci, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India.	geetarair@yahoo.com	Singh, Vikas Vikram/I-7596-2019; Kumar, Ashok/AAX-3875-2020	Kumar, Ashok/0000-0003-2054-8463; Rai, Geeta/0000-0001-8162-8964; Singh, Vikas Vikram/0000-0001-6304-9942	Department of Biotechnology, New Delhi, India [BT/PR11274/GBD/27/149/2008]	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by a grant (grant No. BT/PR11274/GBD/27/149/2008) from Department of Biotechnology, New Delhi, India (http://dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON ED, 1965, BRIT J PREV SOC MED, V19, P164; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alvarez JI, 2005, FRONT BIOSCI, V10, P582, DOI 10.2741/1554; Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; Bendelja K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-143; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calafat J, 1998, BLOOD, V91, P4770, DOI 10.1182/blood.V91.12.4770.412k33_4770_4775; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; CHANDRA RK, 1975, AM J DIS CHILD, V129, P450, DOI 10.1001/archpedi.1975.02120410038013; Chatrath R, 1997, J TROP PEDIATRICS, V43, P345, DOI 10.1093/tropej/43.6.345; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; Dowling DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058164; Eckert M, 2006, J IMMUNOL, V176, P522, DOI 10.4049/jimmunol.176.1.522; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; FERGUSON AC, 1978, J PEDIATR-US, V93, P52, DOI 10.1016/S0022-3476(78)80599-X; Fonseca W, 1996, B WORLD HEALTH ORGAN, V74, P199; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Guerra S, 2004, AM J RESP CRIT CARE, V169, P70, DOI 10.1164/rccm.200304-499OC; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kalanda B, 2009, MALAWI MED J, V21, P69; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Levy O, 2000, ANTIMICROB AGENTS CH, V44, P2925, DOI 10.1128/AAC.44.11.2925-2931.2000; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 1999, PEDIATRICS, V104, P1327, DOI 10.1542/peds.104.6.1327; Levy O, 2002, EXPERT OPIN INV DRUG, V11, P159, DOI 10.1517/13543784.11.2.159; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Lira PIC, 1996, J PEDIATR-US, V128, P497, DOI 10.1016/S0022-3476(96)70360-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; MANNION BA, 1990, J CLIN INVEST, V86, P631, DOI 10.1172/JCI114755; Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; National Neonatology Forum of India World Health Organization (South East Asia Region Organization) United Nations Children's Fund India World Bank Saving Newborn Lives Save the Children/US, 2004, STAT IND NEWB; Nybo M, 1998, ARCH DIS CHILD-FETAL, V78, pF129, DOI 10.1136/fn.78.2.F129; Palmer CD, 2011, BIOCHEM SOC T, V39, P994, DOI 10.1042/BST0390994; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; SAHA K, 1983, J TROP PEDIATRICS, V29, P278, DOI 10.1093/tropej/29.5.278; SAKATA H, 1985, EUR J PEDIATR, V144, P186, DOI 10.1007/BF00451911; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Scagnolari C, 2009, CLIN VACCINE IMMUNOL, V16, P816, DOI 10.1128/CVI.00445-08; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; SINGH M, 1978, INDIAN PEDIATR, V15, P563; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Syddall HE, 2005, AM J EPIDEMIOL, V161, P1074, DOI 10.1093/aje/kwi137; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; TAZAWA Y, 1989, TOHOKU J EXP MED, V158, P221, DOI 10.1620/tjem.158.221; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; Walter EC, 2009, AM J RESP CRIT CARE, V180, P176, DOI 10.1164/rccm.200901-0046OC; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; WEISS J, 1978, J BIOL CHEM, V253, P2664; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yan SR, 2004, INFECT IMMUN, V72, P1223, DOI 10.1128/IAI.72.3.1223-1229.2004; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	79	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62845	10.1371/journal.pone.0062845	http://dx.doi.org/10.1371/journal.pone.0062845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626859	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400223
J	Smith, RM; Nguyen, TA; Ha, HTT; Thang, PH; Thuy, C; Lien, TX; Bui, HT; Le, TH; Struminger, B; McConnell, MS; Fanfair, RN; Park, BJ; Harris, JR				Smith, Rachel M.; Tuan Anh Nguyen; Hoang Thi Thanh Ha; Pham Hong Thang; Cao Thuy; Truong Xuan Lien; Bui, Hien T.; Thai Hung Le; Struminger, Bruce; McConnell, Michelle S.; Fanfair, Robyn Neblett; Park, Benjamin J.; Harris, Julie R.			Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program - Vietnam	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; CHI-MINH-CITY; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC INFECTIONS; PHNOM-PENH; FUNGAL-INFECTIONS; CONTROLLED TRIAL; DOUBLE-BLIND; MENINGITIS	Background: An estimated 120,000 HIV-associated cryptococcal meningitis (CM) cases occur each year in South and Southeast Asia; early treatment may improve outcomes. The World Health Organization (WHO) recently recommended screening HIV-infected adults with CD4<100 cells/mm(3) for serum cryptococcal antigen (CrAg), a marker of early cryptococcal infection, in areas of high CrAg prevalence. We evaluated CrAg prevalence and cost-effectiveness of this screening strategy in HIV-infected adults in northern and southern Vietnam. Methods: Serum samples were collected and stored during 2009-2012 in Hanoi and Ho Chi Minh City, Vietnam, from HIV-infected, ART-naive patients presenting to care in 12 clinics. All specimens from patients with CD4<100 cells/mm(3) were tested using the CrAg lateral flow assay. We obtained cost estimates from laboratory staff, clinicians and hospital administrators in Vietnam, and evaluated cost-effectiveness using WHO guidelines. Results: Sera from 226 patients [104 (46%) from North Vietnam and 122 (54%) from the South] with CD4<100 cells/mm(3) were available for CrAg testing. Median CD4 count was 40 (range 0-99) cells/mm(3). Nine (4%; 95% CI 2-7%) specimens were CrAg-positive. CrAg prevalence was higher in South Vietnam (6%; 95% CI 3-11%) than in North Vietnam (2%; 95% CI 0-6%) (p = 0.18). Cost per life-year gained under a screening scenario was $190, $137, and $119 at CrAg prevalences of 2%, 4% and 6%, respectively. Conclusion: CrAg prevalence was higher in southern compared with northern Vietnam; however, CrAg screening would be considered cost-effective by WHO criteria in both regions. Public health officials in Vietnam should consider adding cryptococcal screening to existing national guidelines for HIV/AIDS care.	[Smith, Rachel M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30329 USA; [Smith, Rachel M.; Fanfair, Robyn Neblett; Park, Benjamin J.; Harris, Julie R.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Tuan Anh Nguyen; Hoang Thi Thanh Ha; Pham Hong Thang] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Cao Thuy] Natl Hosp Trop Dis, Hanoi, Vietnam; [Truong Xuan Lien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Bui, Hien T.; Struminger, Bruce] Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam; [Thai Hung Le; McConnell, Michelle S.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ho Chi Minh City, Vietnam	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE); National Hospital of Tropical Diseases	Smith, RM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30329 USA.	vih9@cdc.gov			PEPFAR/CDC	PEPFAR/CDC	Funding for this study came from PEPFAR/CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimbola TO, 2012, JAIDS-J ACQ IMM DEF, V60, pE8, DOI 10.1097/QAI.0b013e3182478dc0; Bank TW, 2012, GDP PER CAPITA CURRE; Bodri M, 2006, ANTIVIR THER, V11, P63; Chang LW, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004773.pub2; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Chetchotisakd P, 2004, HIV MED, V5, P140, DOI 10.1111/j.1468-1293.2004.00201.x; Chhin S, 2004, INT J STD AIDS, V15, P48, DOI 10.1258/095646204322637263; Control VAoHA, 2009, GUID HIV AIDS DIAGN; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Espie E, 2010, TROP MED INT HEALTH, V15, P1375, DOI 10.1111/j.1365-3156.2010.02622.x; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Govender NP, 2012, SAMJ S AFR MED J, V102, P914, DOI [10.7196/samj.6228, 10.7196/SAMJ.6228]; Huynh Thi Xuan Tuyet, 2003, Sante, V13, P225; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kendi C, 2011, ROUTIME CRYPTOCOCCAL; Klotz SA, 2007, INT J STD AIDS, V18, P482, DOI 10.1258/095646207781147265; Kong B. N., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P62; Le H, 2001, SURVEILLANCE CLIN MA; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Louie JK, 2004, INT J STD AIDS, V15, P758, DOI 10.1258/0956462042395159; McKinsey DS, 1999, CLIN INFECT DIS, V28, P1049, DOI 10.1086/514744; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Organization WH, 2012, TABL THRESH VAL INT; Osazuwa Favour, 2012, Oman Med J, V27, P228, DOI 10.5001/omj.2012.51; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pfizer I, 2011, PFIZ INV HLTH; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, CLIN INFECT DIS, V55, P1742, DOI 10.1093/cid/cis725; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Roy Monika, 2011, Expert Rev Anti Infect Ther, V9, P715, DOI 10.1586/eri.11.86; Senya C, 2003, INT J STD AIDS, V14, P411, DOI 10.1258/095646203765371312; Shah N, 2011, EVALUATING ACCURACY; Smith D E, 2001, HIV Med, V2, P78, DOI 10.1046/j.1468-1293.2001.00060.x; Tassie JM, 2003, JAIDS-J ACQ IMM DEF, V33, P411, DOI 10.1097/00126334-200307010-00019; [Vietnam MoH Control VAoHA], 2009, VIETN HIV AIDS EST P; World Health Organization, 2011, RAP ADV DIAGN PREV M; World Health Organization, 2007, ESSENTIAL PREVENTION; World Health Organization, 2001, MACR HLTH INV HLTH E	47	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62213	10.1371/journal.pone.0062213	http://dx.doi.org/10.1371/journal.pone.0062213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626792	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400156
J	Zaparty, M; Hagemann, A; Brasen, C; Hensel, R; Lupas, AN; Brinkmann, H; Siebers, B				Zaparty, Melanie; Hagemann, Anna; Braesen, Christopher; Hensel, Reinhard; Lupas, Andrei N.; Brinkmann, Henner; Siebers, Bettina			The First Prokaryotic Trehalose Synthase Complex Identified in the Hyperthermophilic Crenarchaeon Thermoproteus tenax	PLOS ONE			English	Article							YEAST TREHALOSE-6-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; METABOLISM; PROTEIN; GENE; ACCUMULATION; BACTERIA; CLONING; THERMOTOLERANCE	The role of the disaccharide trehalose, its biosynthesis pathways and their regulation in Archaea are still ambiguous. In Thermoproteus tenax a fused trehalose-6-phosphate synthase/phosphatase (TPSP), consisting of an N-terminal trehalose-6-phosphate synthase (TPS) and a C-terminal trehalose-6-phosphate phosphatase (TPP) domain, was identified. The tpsp gene is organized in an operon with a putative glycosyltransferase (GT) and a putative mechanosensitive channel (MSC). The T. tenax TPSP exhibits high phosphatase activity, but requires activation by the co-expressed GT for bifunctional synthase-phosphatase activity. The GT mediated activation of TPS activity relies on the fusion of both, TPS and TPP domain, in the TPSP enzyme. Activation is mediated by complex-formation in vivo as indicated by yeast two-hybrid and crude extract analysis. In combination with first evidence for MSC activity the results suggest a sophisticated stress response involving TPSP, GT and MSC in T. tenax and probably in other Thermoproteales species. The monophyletic prokaryotic TPSP proteins likely originated via a single fusion event in the Bacteroidetes with subsequent horizontal gene transfers to other Bacteria and Archaea. Furthermore, evidence for the origin of eukaryotic TPSP fusions via HGT from prokaryotes and therefore a monophyletic origin of eukaryotic and prokaryotic fused TPSPs is presented. This is the first report of a prokaryotic, archaeal trehalose synthase complex exhibiting a much more simple composition than the eukaryotic complex described in yeast. Thus, complex formation and a complex-associated regulatory potential might represent a more general feature of trehalose synthesizing proteins.	[Zaparty, Melanie] Univ Regensburg, Inst Mol & Cellular Anat, D-93053 Regensburg, Germany; [Hagemann, Anna; Braesen, Christopher; Siebers, Bettina] Univ Duisburg Essen, Biofilm Ctr, Dept Chem, Essen, Germany; [Hensel, Reinhard] Univ Duisburg Essen, Dept Biol, Essen, Germany; [Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany; [Brinkmann, Henner] Univ Montreal, Fac Med, Dept Biochim, Montreal, PQ H3C 3J7, Canada	University of Regensburg; University of Duisburg Essen; University of Duisburg Essen; Max Planck Society; Universite de Montreal	Siebers, B (corresponding author), Univ Duisburg Essen, Biofilm Ctr, Dept Chem, Essen, Germany.	Bettina.siebers@uni-due.de		Siebers, Bettina/0000-0002-9905-541X; Brasen, Christopher/0000-0002-8328-9713	Deutsche Forschungsgemeinschaft, DFG [HE 1238/16-2/3]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft, DFG (www.dfg.de), through the grant HE 1238/16-2/3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Avonce N, 2010, MOL BIOL EVOL, V27, P359, DOI 10.1093/molbev/msp241; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Blazquez MA, 1998, PLANT J, V13, P685, DOI 10.1046/j.1365-313X.1998.00063.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Bonini BM, 2000, BIOCHEM J, V350, P261, DOI 10.1042/0264-6021:3500261; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brunner NA, 2001, EXTREMOPHILES, V5, P101, DOI 10.1007/s007920100181; DEVIRGILIO C, 1990, FEBS LETT, V273, P107, DOI 10.1016/0014-5793(90)81062-S; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; KAASEN I, 1994, GENE, V145, P9, DOI 10.1016/0378-1119(94)90316-6; Kloda A, 2001, BIOPHYS J, V80, P229, DOI 10.1016/S0006-3495(01)76009-2; KONIG H, 1982, ARCH MICROBIOL, V132, P297, DOI 10.1007/BF00413378; Kouril T, 2008, ARCH MICROBIOL, V190, P355, DOI 10.1007/s00203-008-0377-3; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le QS, 2008, BIOINFORMATICS, V24, P2316; LONDESBOROUGH J, 1991, J GEN MICROBIOL, V137, P323, DOI 10.1099/00221287-137-2-323; Magill CP, 2001, J BIOL CHEM, V276, P46693, DOI 10.1074/jbc.C100567200; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Martins LO, 1997, APPL ENVIRON MICROB, V63, P896, DOI 10.1128/AEM.63.3.896-902.1997; NICOLAUS B, 1988, SYST APPL MICROBIOL, V10, P215, DOI 10.1016/S0723-2020(88)80003-1; Paytubi S, 2009, MOL MICROBIOL, V72, P1487, DOI 10.1111/j.1365-2958.2009.06737.x; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; Ren YY, 2005, SCI CHINA SER C, V48, P221, DOI 10.1360/04yc0099; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STAYNOV DZ, 1972, NATURE-NEW BIOL, V235, P108, DOI 10.1038/newbio235108a0; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Vogel G, 2001, J EXP BOT, V52, P1817, DOI 10.1093/jexbot/52.362.1817; VUORIO OE, 1993, EUR J BIOCHEM, V216, P849, DOI 10.1111/j.1432-1033.1993.tb18207.x; Zentella R, 1999, PLANT PHYSIOL, V119, P1473, DOI 10.1104/pp.119.4.1473; ZILLIG W, 1981, ZBL BAKT MIK HYG I C, V2, P205, DOI 10.1016/S0721-9571(81)80001-4	50	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61354	10.1371/journal.pone.0061354	http://dx.doi.org/10.1371/journal.pone.0061354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626675	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400038
J	Tsai, HJ; Wu, CC; Tsai, CR; Lin, SF; Chen, LT; Chang, JS				Tsai, Hui-Jen; Wu, Chun-Chieh; Tsai, Chia-Rung; Lin, Sheng-Fung; Chen, Li-Tzong; Chang, Jeffrey S.			The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study	PLOS ONE			English	Article							DIGESTIVE ENDOCRINE TUMORS; CARCINOID-TUMORS; PROGNOSTIC-FACTORS; RISK-FACTORS; GEP-NETS; DIAGNOSIS; SURVIVAL; GRADE; POPULATION; EXPRESSION	Background: The epidemiology of neuroendocrine tumors (NETs) is not well illustrated, particularly for Asian countries. Methods: The age-standardized incidence rates and observed survival rates of NETs diagnosed in Taiwan from January 1, 1996 to December 31, 2008 were calculated using data of the Taiwan Cancer Registry (TCR) and compared to those of the Norwegian Registry of Cancer (NRC) and the US Surveillance, Epidemiology, and End Results (SEER) program. Results: During the study period, a total of 2,187 NET cases were diagnosed in Taiwan, with 62% males and a mean age of 57.9 years-old. The age-standardized incidence rate of NETs increased from 0.30 per 100,000 in 1996 to 1.51 per 100,000 in 2008. The most common primary sites were rectum (25.4%), lung and bronchus (20%) and stomach (7.4%). The 5-year observed survival was 50.4% for all NETs (43.4% for men and 61.8% for women, P<0.0001). The best 5-year observed survivals for NETs by sites were rectum (80.9%), appendix (75.7%), and breast (64.8%). Conclusions: Compared to the data of Norway and the US, the age-standardized incidence rate of NETs in Taiwan is lower and the major primary sites are different, whereas the long-term outcome is similar. More studies on the pathogenesis of NETs are warranted to devise preventive strategies and improve treatment outcomes for NETs.	[Tsai, Hui-Jen; Tsai, Chia-Rung; Chen, Li-Tzong; Chang, Jeffrey S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Tsai, Hui-Jen; Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Tsai, Hui-Jen; Lin, Sheng-Fung; Chen, Li-Tzong] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Hui-Jen] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wu, Chun-Chieh] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University	Lin, SF (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	shlin@cc.kmu.edu.tw; leochen@nhri.org.tw; jeffreychang@nhri.org.tw	Chang, Jeffrey Shu-Ming/AAR-4161-2020; Tsai, Hui-Jen/G-9361-2011; Chen, Li-Tzong/D-2071-2010; Chang, Jeffrey Shu-Ming/B-1092-2010	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; 	Establishment of Cancer Research System Excellence Program, Department of Health, Executive Yuan, Taiwan [DOH-102-TD-C-111-004]; National Health Research Institutes [CA-101-PP-07, CA-101-PP-38]	Establishment of Cancer Research System Excellence Program, Department of Health, Executive Yuan, Taiwan; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the Establishment of Cancer Research System Excellence Program [DOH-102-TD-C-111-004], Department of Health, Executive Yuan, Taiwan. In addition, Dr. H. J. Tsai and Dr. J. S. Chang were supported by the National Health Research Institutes (CA-101-PP-07 and CA-101-PP-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2011, EXP THER MED, V2, P787, DOI 10.3892/etm.2011.291; Aydin E, 2011, EUR J CARDIO-THORAC, V39, P549, DOI 10.1016/j.ejcts.2010.08.010; Boyle P, 2008, WORLD CANC REPORT; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Bureau of Health Promotion Department of Health the Executive Yuan, CANC REG ANN REP; Caldarella A, 2011, PATHOL ONCOL RES, V17, P759, DOI 10.1007/s12253-011-9382-y; Cho MY, 2012, CANCER RES TREAT, V44, P157, DOI 10.4143/crt.2012.44.3.157; Fink G, 2001, CHEST, V119, P1647, DOI 10.1378/chest.119.6.1647; Garcia-Carbonero R, 2010, ANN ONCOL, V21, P1794, DOI 10.1093/annonc/mdq022; Hassan MM, 2008, INT J CANCER, V123, P867, DOI 10.1002/ijc.23529; Hassan MM, 2008, CANCER EPIDEM BIOMAR, V17, P959, DOI 10.1158/1055-9965.EPI-07-0750; Hauso O, 2008, CANCER, V113, P2655, DOI 10.1002/cncr.23883; Hemminki K, 2001, CANCER, V92, P2204, DOI 10.1002/1097-0142(20011015)92:8&lt;2204::AID-CNCR1564&gt;3.0.CO;2-R; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Johnson R, 2011, AM SURGEON, V77, P1669; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lee HW, 2012, PATHOL INT, V62, P583, DOI 10.1111/j.1440-1827.2012.02845.x; Lepage C, 2004, GUT, V53, P549, DOI 10.1136/gut.2003.026401; Lepage C, 2007, GASTROENTEROLOGY, V132, P899, DOI 10.1053/j.gastro.2007.01.006; Li AFY, 2008, CANCER-AM CANCER SOC, V112, P274, DOI 10.1002/cncr.23159; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Gomez JMN, 2010, RESP MED, V104, P1929, DOI 10.1016/j.rmed.2010.08.007; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Oberg KE, 2012, CLIN ONCOL-UK, V24, P282, DOI 10.1016/j.clon.2011.08.006; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Ploeckinger U, 2009, NEUROENDOCRINOLOGY, V90, P349, DOI 10.1159/000242109; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Sun L, 2009, PATHOL INT, V59, P522, DOI 10.1111/j.1440-1827.2009.02402.x; Tsuta K, 2011, AM J CLIN PATHOL, V136, P252, DOI 10.1309/AJCPDXFOPXGEF0RP; Wiedenmann B, 2011, NEUROENDOCRINOLOGY, V94, P177, DOI 10.1159/000329386; Yao JC, 2008, J CLIN ONCOL, V26, P4311, DOI 10.1200/JCO.2008.16.7858; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669	35	77	91	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62487	10.1371/journal.pone.0062487	http://dx.doi.org/10.1371/journal.pone.0062487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614051	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500094
J	Ng, ACC; Chow, V; Yong, ASC; Chung, T; Kritharides, L				Austin Chin Chwan Ng; Chow, Vincent; Yong, Andy Sze Chiang; Chung, Tommy; Kritharides, Leonard			Fluctuation of Serum Sodium and Its Impact on Short and Long-Term Mortality following Acute Pulmonary Embolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; HEART-FAILURE; VENOUS THROMBOEMBOLISM; PROGNOSTIC VALUE; HYPONATREMIA; METAANALYSIS; GUIDELINES; SURVIVAL; WARFARIN; OUTCOMES	Background: Baseline hyponatremia predicts acute mortality following pulmonary embolism (PE). The natural history of serum sodium levels after PE and the relevance to acute and long-term mortality after the PE is unknown. Methods: Clinical details of all patients (n = 1023) admitted to a tertiary institution from 2000-2007 with acute PE were retrieved retrospectively. Serum sodium results from days 1, 3-4, 5-6, and 7 of admission were pre-specified and recorded. We excluded 250 patients without day-1 sodium or had <1 subsequent sodium assessment, leaving 773 patients as the studied cohort. There were 605 patients with normonatremia (sodium >= 135 mmol/L throughout admission), 57 with corrected hyponatremia (day-1 sodium <135 mmol/L, then normalized), 54 with acquired hyponatremia and 57 with persistent hyponatremia. Patients' outcomes were tracked from a state-wide death registry and analyses performed using multivariate-regression modelling. Results: Mean (+/- standard deviation) day-1 sodium was 138.2 +/- 4.3 mmol/L. Total mortality (mean follow-up 3.6 +/- 2.5 years) was 38.8% (in-hospital mortality 3.2%). There was no survival difference between studied (n = 773) and excluded (n = 250) patients. Day-1 sodium (adjusted hazard ratio [aHR] 0.89, 95% confidence interval [CI] 0.83-0.95, p = 0.001) predicted in-hospital death. Relative to normonatremia, corrected hyponatremia increased the risk of in-hospital death 3.6-fold (95% CI 1.20-10.9, p = 0.02) and persistent hyponatremia increased the risk 5.6-fold (95% CI 2.08-15.0, p = 0.001). Patients with either persisting or acquired hyponatremia had worse long-term survival than those who had corrected hyponatremia or had been normonatremic throughout (aHR 1.47, 95% CI 1.06-2.03, p = 0.02). Conclusion: Sodium fluctuations after acute PE predict acute and long-term outcome. Factors mediating the correction of hyponatremia following acute PE warrant further investigation.	[Austin Chin Chwan Ng; Chow, Vincent; Yong, Andy Sze Chiang; Chung, Tommy; Kritharides, Leonard] Univ Sydney, Dept Cardiol, Concord Hosp, Sydney, NSW 2006, Australia	Concord Repatriation General Hospital; University of Sydney	Kritharides, L (corresponding author), Univ Sydney, Dept Cardiol, Concord Hosp, Sydney, NSW 2006, Australia.	leonard.kritharides@sydney.edu.au	Ng, Austin Chin Chwan/AAQ-3192-2021; Kritharides, Leonard/AAQ-2720-2020; Yong, Andy S C/B-2196-2008	Yong, Andy/0000-0002-6268-4300	Pfizer; Actelion Pharmaceuticals, Ltd.	Pfizer(Pfizer); Actelion Pharmaceuticals, Ltd.	This study was partly funded by a Cardiovascular Lipid Research Grant from Pfizer and an unrestricted research grant from Actelion Pharmaceuticals, Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. No sponsors had a role in the study design, data collection, data analysis, data interpretation, or writing of the report, and the authors have declared that no competing interests exist.	Becattini C, 2001, THROMB RES, V103, pV239, DOI 10.1016/S0049-3848(01)00291-2; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; Forfia PR, 2008, AM J RESP CRIT CARE, V177, P1364, DOI 10.1164/rccm.200712-1876OC; Gallus AS, 2000, MED J AUSTRALIA, V172, P600, DOI 10.5694/j.1326-5377.2000.tb124127.x; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Giuntini C, 1995, CHEST S1, V107, P3; Goldberg A, 2006, ARCH INTERN MED, V166, P781, DOI 10.1001/archinte.166.7.781; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Haley H, 2010, AM J MED SCI, V340, P42, DOI 10.1097/MAJ.0b013e3181e5939e; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2008, AM J RESP CRIT CARE, V178, P425, DOI 10.1164/rccm.200803-459OC; Lobo JL, 2006, CHEST, V130, P1817, DOI 10.1378/chest.130.6.1817; National Research Council, 2008, INSTR CLASS UND CAUS, P20001; Ng AC, 2011, INT J CARDIOL; Ng ACC, 2011, CIRC-CARDIOVASC QUAL, V4, P122, DOI 10.1161/CIRCOUTCOMES.110.958397; Scherz N, 2010, AM J RESP CRIT CARE, V182, P1178, DOI 10.1164/rccm.201003-0481OC; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; Spencer FA, 2008, ARCH INTERN MED, V168, P425, DOI 10.1001/archinternmed.2007.69; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Waikar SS, 2011, AM J MED, V124, P77, DOI 10.1016/j.amjmed.2010.07.029; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61966	10.1371/journal.pone.0061966	http://dx.doi.org/10.1371/journal.pone.0061966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620796	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500076
J	Flatt, JW; Kim, R; Smith, JG; Nemerow, GR; Stewart, PL				Flatt, Justin W.; Kim, Robert; Smith, Jason G.; Nemerow, Glen R.; Stewart, Phoebe L.			An Intrinsically Disordered Region of the Adenovirus Capsid Is Implicated in Neutralization by Human Alpha Defensin 5	PLOS ONE			English	Article							CRYOELECTRON MICROSCOPY; MOLECULAR-DYNAMICS; INNATE IMMUNITY; ANTIMICROBIAL PEPTIDES; CRYSTAL-STRUCTURE; I-TASSER; INFECTION; DIMER; VISUALIZATION; DETERMINANTS	Human alpha-defensins are proteins of the innate immune system that suppress viral and bacterial infections by multiple mechanisms including membrane disruption. For viruses that lack envelopes, such as human adenovirus (HAdV), other, less well defined, mechanisms must be involved. A previous structural study on the interaction of an alpha-defensin, human alpha-defensin 5 (HD5), with HAdV led to a proposed mechanism in which HD5 stabilizes the vertex region of the capsid and blocks uncoating steps required for infectivity. Studies with virus chimeras comprised of capsid proteins from sensitive and resistant serotypes supported this model. To further characterize the critical binding site, we determined subnanometer resolution cryo-electron microscopy (cryoEM) structures of HD5 complexed with both neutralization-sensitive and -resistant HAdV chimeras. Models were built for the vertex regions of these chimeras with monomeric and dimeric forms of HD5 in various initial orientations. CryoEM guided molecular dynamics flexible fitting (MDFF) was used to restrain the majority of the vertex model in well-defined cryoEM density. The RGD-containing penton base loops of both the sensitive and resistant virus chimeras are predicted to be intrinsically disordered, and little cryoEM density is observed for them. In simulations these loops from the sensitive virus chimera, interact with HD5, bridge the penton base and fiber proteins, and provides significant stabilization with a three-fold increase in the intermolecular nonbonded interactions of the vertex complex. In the case of the resistant virus chimera, simulations revealed fewer bridging interactions and reduced stabilization by HD5. This study implicates a key dynamic region in mediating a stabilizing interaction between a viral capsid and a protein of the innate immune system with potent anti-viral activity.	[Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Kim, Robert] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Smith, Jason G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Nemerow, Glen R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Case Western Reserve University; Case Western Reserve University; Vanderbilt University; University of Washington; University of Washington Seattle; Scripps Research Institute	Stewart, PL (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	pls47@case.edu		Flatt, Justin/0000-0003-3227-8763; Smith, Jason/0000-0001-6727-5269; Flatt, Justin/0000-0001-5406-8156; Flatt, Justin/0000-0003-2985-0386	United States National Institutes of Health (NIH)/General Medicine [T32 GM008803]; National Institute of Allergy and Infectious Diseases [AI081870, AI042929]; National Eye Institute [EY11431]; Heart Lung and Blood Institute [HL54352]; NATIONAL EYE INSTITUTE [R01EY011431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI081870, R01AI042929, R29AI042929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/General Medicine; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the United States National Institutes of Health (NIH)/General Medicine (T32 GM008803) to JWF; National Institute of Allergy and Infectious Diseases (AI081870) to JGS; National Eye Institute (EY11431) to GRN; Heart Lung and Blood Institute (HL54352) to GRN; and National Institute of Allergy and Infectious Diseases (AI042929) to PLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Chan KY, 2012, BIOPOLYMERS, V97, P678, DOI 10.1002/bip.22042; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Flatt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049607; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; Harvey SAK, 2005, INVEST OPHTH VIS SCI, V46, P3657, DOI 10.1167/iovs.05-0438; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lindert S, 2009, J VIROL, V83, P11491, DOI 10.1128/JVI.01214-09; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moyer CL, 2011, CURR OPIN VIROL, V1, P44, DOI 10.1016/j.coviro.2011.05.002; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Nguyen EK, 2010, J VIROL, V84, P4041, DOI 10.1128/JVI.02471-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Ross PD, 2005, EMBO J, V24, P1352, DOI 10.1038/sj.emboj.7600613; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Shah R, 2012, ACS SYM SER, V1095, P137; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Snijder J, 2012, J VIROL; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j; Zhang Y, 2010, J MOL BIOL, V397, P408, DOI 10.1016/j.jmb.2010.01.030; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	49	35	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61571	10.1371/journal.pone.0061571	http://dx.doi.org/10.1371/journal.pone.0061571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620768	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500048
J	Fu, BS; Wang, HW; Wang, JH; Barouhas, I; Liu, WQ; Shuboy, A; Bushinsky, DA; Zhou, DS; Favus, MJ				Fu, Baisheng; Wang, Hongwei; Wang, Jinhua; Barouhas, Ivana; Liu, Wanqing; Shuboy, Adam; Bushinsky, David A.; Zhou, Dongsheng; Favus, Murray J.			Epigenetic Regulation of BMP2 by 1,25-dihydroxyvitamin D-3 through DNA Methylation and Histone Modification	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GROWTH-FACTOR-BETA; STONE-FORMING RATS; GENE-EXPRESSION; BONE-FORMATION; EXTRACELLULAR-MATRIX; DOWN-REGULATION; CALCIUM; DIFFERENTIATION; HYPERCALCIURIA	Genetic hypercalciuric stone-forming (GHS) rats have increased intestinal Ca absorption, decreased renal tubule Ca reabsorption and low bone mass, all of which are mediated at least in part by elevated tissue levels of the vitamin D receptor (VDR). Both 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) and bone morphogenetic protein 2 (BMP2) are critical for normal maintenance of bone metabolism and bone formation, respectively. The complex nature of bone cell regulation suggests a potential interaction of these two important regulators in GHS rats. In the present study, BMP2 expression is suppressed by the VDR-1,25(OH)(2)D-3 complex in Bone Marrow Stromal Cells (BMSCs) from GHS and SD rat and in UMR-106 cell line. We used chromatin immunoprecipitation (ChIP) assays to identify VDR binding to only one of several potential binding sites within the BMP2 promoter regions. This negative region also mediates suppressor reporter gene activity. The molecular mechanisms underlying the down-regulation of BMP2 by 1,25(OH)(2)D-3 were studied in vitro in BMSCs and UMR-106 cells using the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (DAC) and the histone deacetylase inhibitor trichostatin A (TSA). Both DAC and TSA activate BMP2 expression in combination with 1,25(OH)(2)D-3. Bisulfite DNA pyrosequencing reveals 1,25(OH)(2)D-3 to completely hypermethylate a single CpG site in the same BMP2 promoter region identified by the ChIP and reporter gene assays. ChIP assays also show that 1,25(OH)(2)D-3 can increase the repressive histone mark H3K9me2 and reduce the acetylation of histone H3 at the same BMP2 promoter region. Taken together, our results indicate that 1,25(OH)(2)D-3 binding to VDR down-regulates BMP2 gene expression in BMSCs and osteoblast-like UMR-106 cells by binding to the BMP2 promoter region. The mechanism of this 1,25(OH)(2)D-3-induced transcriptional repression of BMP2 involves DNA methylation and histone modification. The study provides novel evidence that 1,25(OH)(2)D-3 represses bone formation through down-regulating BMP2 expression both in vivo and in vitro.	[Fu, Baisheng; Zhou, Dongsheng] Shandong Univ, Dept Orthoped Surg, Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Hongwei; Wang, Jinhua; Barouhas, Ivana; Shuboy, Adam; Favus, Murray J.] Univ Chicago, Pritzker Sch Med, Endocrinol Sect, Chicago, IL 60637 USA; [Liu, Wanqing] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Bushinsky, David A.] Univ Rochester, Sch Med & Dent, Div Nephrol, Rochester, NY USA	Shandong University; University of Chicago; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Rochester	Zhou, DS (corresponding author), Shandong Univ, Dept Orthoped Surg, Prov Hosp, Jinan 250100, Shandong, Peoples R China.	sdgkxh@yahoo.com.cn; mfavus@medicine.bsd.uchicago.edu		Liu, Wanqing/0000-0001-7727-6900	National Institutes of Health (NIH) [DK075462]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075462] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health (NIH) Grant DK075462. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Asplin JR, 2006, KIDNEY INT, V70, P1463, DOI 10.1038/sj.ki.5001778; Bai SC, 2006, CURR OPIN NEPHROL HY, V15, P381, DOI 10.1097/01.mnh.0000232878.50716.26; Bai SC, 2010, J BONE MINER RES, V25, P830, DOI 10.1359/jbmr.091010; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Bushinsky DA, 1996, SEMIN NEPHROL, V16, P448; BUSHINSKY DA, 1988, J CLIN INVEST, V82, P1585, DOI 10.1172/JCI113770; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; DELUCA HF, 1988, FASEB J, V2, P224, DOI 10.1096/fasebj.2.3.3280376; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Ecarot B, 1999, ENDOCRINOLOGY, V140, P1192, DOI 10.1210/en.140.3.1192; Erben RG, 1998, ENDOCRINOLOGY, V139, P4319, DOI 10.1210/en.139.10.4319; Erben RG, 1997, ENDOCRINOLOGY, V138, P4629, DOI 10.1210/en.138.11.4629; Giannini S, 1998, CLIN NEPHROL, V50, P94; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; Grynpas M, 2009, J BONE MINER RES, V24, P1420, DOI [10.1359/JBMR.090223, 10.1359/jbmr.090223]; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hines ER, 2004, J BIOL CHEM, V279, P46406, DOI 10.1074/jbc.M404278200; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jiang S, 2010, BIOCHEM BIOPH RES CO, V392, P124, DOI 10.1016/j.bbrc.2009.12.157; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; Karnauskas AJ, 2005, J BONE MINER RES, V20, P447, DOI 10.1359/JBMR.041120; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Krishnan AV, 2011, VITAMIN D AND CANCER, P53, DOI 10.1007/978-1-4419-7188-3_3; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; LIBERMAN UA, 1968, J CLIN INVEST, V47, P2580, DOI 10.1172/JCI105940; MacDonald PN, 2001, STEROIDS, V66, P171, DOI 10.1016/S0039-128X(00)00200-2; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIETSCHMANN F, 1992, J BONE MINER RES, V7, P1383; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Sooy K, 2005, J CELL BIOCHEM, V94, P81, DOI 10.1002/jcb.20313; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tasca A, 2002, UROLOGY, V59, P865, DOI 10.1016/S0090-4295(02)01626-6; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Tsuruoka S, 1997, KIDNEY INT, V51, P1540, DOI 10.1038/ki.1997.212; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wang HW, 2007, PANCREAS, V34, P248, DOI 10.1097/01.mpa.0000250136.72273.d7; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yamaguchi M, 2012, INT J MOL MED, V29, P934, DOI 10.3892/ijmm.2012.900; Yao JL, 1998, J CLIN INVEST, V101, P2223, DOI 10.1172/JCI1164	51	43	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61423	10.1371/journal.pone.0061423	http://dx.doi.org/10.1371/journal.pone.0061423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620751	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500031
J	Polovina, JJ; Woodworth-Jefcoats, PA				Polovina, Jeffrey J.; Woodworth-Jefcoats, Phoebe A.			Fishery-Induced Changes in the Subtropical Pacific Pelagic Ecosystem Size Structure: Observations and Theory	PLOS ONE			English	Article							BODY-SIZE; PREDATORS; ABUNDANCE; DYNAMICS; DECLINES; SHARKS; SCALE; OCEAN	We analyzed a 16-year (1996-2011) time series of catch and effort data for 23 species with mean weights ranging from 0.8 kg to 224 kg, recorded by observers in the Hawaii-based deep-set longline fishery. Over this time period, domestic fishing effort, as numbers of hooks set in the core Hawaii-based fishing ground, has increased fourfold. The standardized aggregated annual catch rate for 9 small (<15 kg) species increased about 25% while for 14 large species (>15 kg) it decreased about 50% over the 16-year period. A size-based ecosystem model for the subtropical Pacific captures this pattern well as a response to increased fishing effort. Further, the model projects a decline in the abundance of fishes larger than 15 kg results in an increase in abundance of animals from 0.1 to 15 kg but with minimal subsequent cascade to sizes smaller than 0.1 kg. These results suggest that size-based predation plays a key role in structuring the subtropical ecosystem. These changes in ecosystem size structure show up in the fishery in various ways. The non-commercial species lancetfish (mean weight 7 kg) has now surpassed the target species, bigeye tuna, as the species with the highest annual catch rate. Based on the increase in snake mackerel (mean weight 0.8 kg) and lancetfish catches, the discards in the fishery are estimated to have increased from 30 to 40% of the total catch.	[Polovina, Jeffrey J.; Woodworth-Jefcoats, Phoebe A.] NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA	Polovina, JJ (corresponding author), NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	jeffrey.polovina@noaa.gov						Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Benoit E, 2004, J THEOR BIOL, V226, P9, DOI 10.1016/S0022-5193(03)00290-X; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Blanchard JL, 2011, THEOR ECOL-NETH, V4, P289, DOI 10.1007/s12080-010-0078-9; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; Cox SP, 2002, CAN J FISH AQUAT SCI, V59, P1736, DOI 10.1139/F02-138; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Emery WJ., 1990, DESCRIPTIVE PHYS OCE; Gilman E, 2012, AQUAT CONSERV, V22, P446, DOI 10.1002/aqc.2237; Harley S.J., 2011, 11 SECR PAC COMM; Howell EA, 2013, CLIMATIC CHANGE, V119, P79, DOI 10.1007/s10584-012-0597-z; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Kitchell JF, 2002, ECOSYSTEMS, V5, P202, DOI 10.1007/s10021-001-0065-5; Kitchell JF, 1999, LOW WAKE FI, V16, P665; Law R, 2009, ECOLOGY, V90, P802, DOI 10.1890/07-1900.1; Maury O, 2007, PROG OCEANOGR, V74, P500, DOI 10.1016/j.pocean.2007.05.001; Pauly D, 2005, B MAR SCI, V76, P197; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Polovina JJ, 2012, DEEP-SEA RES PT II, V77-80, P82, DOI 10.1016/j.dsr2.2012.04.006; Polovina JJ, 2009, FISH B-NOAA, V107, P523; Seki MP, 2001, ENCY OCEAN SCI, V4, P1959; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Woodworth-Jefcoats PA, 2013, GLOBAL CHANGE BIOL, V19, P724, DOI 10.1111/gcb.12076; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	27	35	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62341	10.1371/journal.pone.0062341	http://dx.doi.org/10.1371/journal.pone.0062341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620824	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500105
J	Zhang, C; Liu, Y; Ring, BZ; Nie, K; Yang, MJ; Wang, M; Shen, HW; Wu, XY; Ma, XJ				Zhang, Chen; Liu, Ying; Ring, Brian Z.; Nie, Kai; Yang, Mengjie; Wang, Miao; Shen, Hongwei; Wu, Xiyang; Ma, Xuejun			A Novel Multiplex Tetra-Primer ARMS-PCR for the Simultaneous Genotyping of Six Single Nucleotide Polymorphisms Associated with Female Cancers	PLOS ONE			English	Article							BREAST-CANCER; RT-PCR; AMPLIFICATION; MUTATIONS; DNA; CYP19A1; RISK; SNPS	Background: The tetra-primer amplification refractory mutation system PCR (T-ARMS-PCR) is a fast and economical means of assaying SNP's, requiring only PCR amplification and subsequent electrophoresis for the determination of genotypes. To improve the throughput and efficiency of T-ARMS-PCR, we combined T-ARMS-PCR with a chimeric primer-based temperature switch PCR (TSP) strategy, and used capillary electrophoresis (CE) for amplicon separation and identification. We assessed this process in the simultaneous genotyping of four breast cancer-and two cervical cancer risk-related SNPs. Methods: A total of 24 T-ARMS-PCR primers, each 5'-tagged with a universal sequence and a pair of universal primers, were pooled together to amplify the 12 target alleles of 6 SNPs in 186 control female blood samples. Direct sequencing of all samples was also performed to assess the accuracy of this method. Results: Of the 186 samples, as many as 11 amplicons can be produced in one single PCR and separated by CE. Genotyping results of the multiplex T-ARMS-PCR were in complete agreement with direct sequencing of all samples. Conclusions: This novel multiplex T-ARMS-PCR method is the first reported method allowing one to genotype six SNPs in a single reaction with no post-PCR treatment other than electrophoresis. This method is reliable, fast, and easy to perform.	[Zhang, Chen; Liu, Ying; Nie, Kai; Yang, Mengjie; Wang, Miao; Shen, Hongwei; Ma, Xuejun] Chinese Ctr Dis Control & Prevent, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China; [Liu, Ying; Wu, Xiyang] Jinan Univ, Coll Sci & Engn, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Ring, Brian Z.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Jinan University; Huazhong University of Science & Technology	Wu, XY (corresponding author), Jinan Univ, Coll Sci & Engn, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China.	tkentwu@jnu.edu.cn; maxj2004@yahoo.com.cn	Nie, Kai/L-5389-2019		China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215, 2013ZX10004-202]	China Mega-Project for Infectious Disease	This work was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001, 2012ZX10004-215 and 2013ZX10004-202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbi G, 2007, CLIN EXP IMMUNOL, V149, P40, DOI 10.1111/j.1365-2249.2007.03394.x; Beck O, 2006, EUR J HAEMATOL, V76, P237, DOI 10.1111/j.1600-0609.2005.00588.x; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dupont M, 2002, BIOTECHNIQUES, V33, P158, DOI 10.2144/02331md04; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erichsen HC, 2004, BRIT J CANCER, V90, P747, DOI 10.1038/sj.bjc.6601574; Fan AXC, 2008, CLIN CHEM LAB MED, V46, P299, DOI 10.1515/CCLM.2008.071; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Goodman MT, 2008, ENDOCR-RELAT CANCER, V15, P1055, DOI 10.1677/ERC-08-0104; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harlid S, 2012, BRIT J CANCER, V106, P389, DOI 10.1038/bjc.2011.461; Hofmann MA, 2003, J VIROL METHODS, V114, P77, DOI 10.1016/j.jviromet.2003.09.004; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia CY, 2010, BREAST CANCER RES TR, V124, P521, DOI 10.1007/s10549-010-0872-5; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lu PH, 2011, BREAST CANCER RES TR, V126, P663, DOI 10.1007/s10549-010-1151-1; Millis MP, 2011, METHODS MOL BIOL, V700, P61, DOI 10.1007/978-1-61737-954-3_5; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peruzzi B, 2010, MOL CELL PROBE, V24, P401, DOI 10.1016/j.mcp.2010.07.002; Piccioli P, 2006, CLIN CHEM, V52, P739, DOI 10.1373/clinchem.2005.060137; Qin M, 2010, J VIROL METHODS, V168, P255, DOI 10.1016/j.jviromet.2010.04.031; Reeves GK, 2010, JAMA-J AM MED ASSOC, V304, P426, DOI 10.1001/jama.2010.1042; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Shi XL, 2009, ELECTROPHORESIS, V30, P1286, DOI 10.1002/elps.200800450; SHU Y, 1992, NUCLEIC ACIDS RES, V20, P1152, DOI 10.1093/nar/20.5.1152; Shuber AP, 1995, GENOME RES, V5, P488, DOI 10.1101/gr.5.5.488; Sjoqvist F, 1999, EUR J CLIN PHARMACOL, V55, P553, DOI 10.1007/s002280050672; Tebbutt SJ, 2008, BIOTECHNIQUES, V45, P637, DOI 10.2144/000112992; Toubanaki DK, 2009, ANAL CHEM, V81, P218, DOI 10.1021/ac801870x; Wang Qin-Xi, 2009, Yichuan, V31, P552, DOI 10.3724/SP.J.1005.2009.00552; Wiechec E, 2009, EUR J PHARMACOL, V625, P122, DOI 10.1016/j.ejphar.2009.08.045; Yanagawa T, 2009, METHODS MOL BIOL, V578, P425, DOI 10.1007/978-1-60327-411-1_27; Yu KJ, 2009, GYNECOL ONCOL, V114, P319, DOI 10.1016/j.ygyno.2009.04.033	35	20	42	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62126	10.1371/journal.pone.0062126	http://dx.doi.org/10.1371/journal.pone.0062126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614025	Green Published, gold, Green Submitted			2022-12-25	WOS:000317907200121
J	Peng, H; Kang, N; Xu, J; Stanton, PK; Kang, J				Peng, Hong; Kang, Ning; Xu, Jun; Stanton, Patric K.; Kang, Jian			Two Distinct Modes of Exocytotic Fusion Pore Expansion in Large Astrocytic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE SYNAPTIC VESICLES; PANCREATIC BETA-CELLS; YEAST VACUOLE DOCKING; VERTEX RING DOMAIN; MEMBRANE-FUSION; TRANSMITTER RELEASE; HIPPOCAMPAL SLICES; PATCH AMPEROMETRY; NEURONAL-ACTIVITY; CHROMAFFIN CELLS	Formation of the fusion pore is a central question for regulated exocytosis by which secretory cells release neurotransmitters or hormones. Here, by dynamically monitoring exocytosis of large vesicles (2-7 similar to m) in astrocytes with two-photon microscopy imaging, we found that the exocytotic fusion pore was generated from the SNARE-dependent fusion at a ring shape of the docked plasma-vesicular membrane and the movement of a fusion-produced membrane fragment. We observed two modes of fragment movements, 1) a shift fragment that shifted to expand the fusion pore and 2) a fall-in fragment that fell into the collapsed vesicle to expand the fusion pore. Shift and fall-in modes are associated with full and partial collapses of large vesicles, respectively. The astrocytic marker, sulforhodamine 101, stained the fusion-produced membrane fragment more brightly thanFM1-43. Sulforhodamine 101 imaging showed that double fusion pores could simultaneously occur in a single vesicle (16% of large vesicles) to accelerate discharge of vesicular contents. Electron microscopy of large astrocytic vesicles showed shift and fall-in membrane fragments. Two modes of fusion pore formation demonstrate a novel mechanism underlying fusion pore expansion and provide a new explanation for full and partial collapses of large secretory vesicles.	[Peng, Hong; Kang, Ning; Stanton, Patric K.; Kang, Jian] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Xu, Jun] Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China	New York Medical College; Tongji University	Xu, J (corresponding author), Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China.	xunymc2000@yahoo.com; jian_kang@NYMC.edu		Peng, Hong/0000-0001-5522-072X	New York State Spinal Cord Injury [C020925]; United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH 07254001]; Ministry of Science and Technology of China [2011CB966200, 2010CB945200]; National Natural Science Foundation of China [81271369]; National Natural Science Foundation of China (NSFC) [81070910]; Century Excellent Talents in University [NCET-10-0606]; Shanghai RisingStar program [11QA1407100]; International Cooperation and Exchanges NSFC [81261130318]; Fundamental Research Funds for the Central Universities	New York State Spinal Cord Injury; United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Century Excellent Talents in University; Shanghai RisingStar program; International Cooperation and Exchanges NSFC; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by New York State Spinal Cord Injury Grant C020925; United States Army Medical Research and Materiel Command (USAMRMC) Grant W81XWH 07254001; the Ministry of Science and Technology of China (Grants 2011CB966200 and 2010CB945200); the National Natural Science Foundation of China (Grant 81271369); the National Natural Science Foundation of China (NSFC) (Grant 81070910); New Century Excellent Talents in University (Grant NCET-10-0606); the Shanghai RisingStar program (Grant 11QA1407100); Projects of International Cooperation and Exchanges NSFC (Grant 81261130318); and the Fundamental Research Funds for the Central Universities.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cousin MA, 1999, J NEUROCHEM, V73, P2227, DOI 10.1046/j.1471-4159.1999.0732227.x; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kang N, 2013, NEUROSCIENCE, V240, P243, DOI 10.1016/j.neuroscience.2013.02.029; KEIFER J, 1992, J NEUROSCI, V12, P3187, DOI 10.1523/JNEUROSCI.12-08-03187.1992; KENNEDY RT, 1993, ANAL CHEM, V65, P1882, DOI 10.1021/ac00062a012; KJAERULFF O, 1994, J PHYSIOL-LONDON, V478, P265, DOI 10.1113/jphysiol.1994.sp020248; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Loson OC, 2011, J NEUROCHEM, V116, P909, DOI 10.1111/j.1471-4159.2010.07018.x; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Tabares L, 2003, BIOCHEM SOC T, V31, P837, DOI 10.1042/bst0310837; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Xu J, 2007, J BIOL CHEM, V282, P24185, DOI 10.1074/jbc.M700452200; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	50	4	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16872	16881		10.1074/jbc.M113.468231	http://dx.doi.org/10.1074/jbc.M113.468231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620588	Green Published, hybrid			2022-12-25	WOS:000320378900060
J	D'Orsogna, MR; Kendall, R; McBride, M; Short, MB				D'Orsogna, Maria R.; Kendall, Ryan; McBride, Michael; Short, Martin B.			Criminal Defectors Lead to the Emergence of Cooperation in an Experimental, Adversarial Game	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; CRIME; EVOLUTION	While the evolution of cooperation has been widely studied, little attention has been devoted to adversarial settings wherein one actor can directly harm another. Recent theoretical work addresses this issue, introducing an adversarial game in which the emergence of cooperation is heavily reliant on the presence of "Informants," actors who defect at first-order by harming others, but who cooperate at second-order by punishing other defectors. We experimentally study this adversarial environment in the laboratory with human subjects to test whether Informants are indeed critical for the emergence of cooperation. We find in these experiments that, even more so than predicted by theory, Informants are crucial for the emergence and sustenance of a high cooperation state. A key lesson is that successfully reaching and maintaining a low defection society may require the cultivation of criminals who will also aid in the punishment of others.	[D'Orsogna, Maria R.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA; [Kendall, Ryan; McBride, Michael] Univ Calif Irvine, Dept Econ, Irvine, CA 92717 USA; [Short, Martin B.] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA	California State University System; California State University Northridge; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Short, MB (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA.	mbshort@math.ucla.edu		Kendall, Ryan/0000-0001-9592-3534	Army Research Oce MURI [W911NF-11-1-0332]; National Science Foundation [DMS-1021850, DMS-0968309]; Air Force Oce of Scientic Research MURI [FA9550-10-1-0569]; Direct For Mathematical & Physical Scien [0968309] Funding Source: National Science Foundation	Army Research Oce MURI; National Science Foundation(National Science Foundation (NSF)); Air Force Oce of Scientic Research MURI; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by an Army Research Oce MURI grant, no. W911NF-11-1-0332. MRD was supported by the National Science Foundation through grant no. DMS-1021850. MBS was supported by the National Science Foundation through grant no. DMS-0968309. MM and MBS were also supported by an Air Force Oce of Scientic Research MURI grant, no. FA9550-10-1-0569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Breittel J, 2009, MEXICOS DRUG RELATED; Bursik R.J., 1993, NEIGHBORHOODS CRIME; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Conklin J.E., 2007, CRIMINOLOGY, V9th; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Good David, 1988, TRUST MAKING BREAKIN, P38; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Jensen G, 2003, ENCY CRIMINOLOGY SOC; Mallory S, 2007, UNDERSTANDING ORG CR; McBride M, 2012, 121308 UCI DEP EC; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; SAMPSON RJ, 1986, CRIME JUSTICE, V8, P271, DOI 10.1086/449125; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Skogan W.G., 1990, DISORDER DECLINE CRI; Skogan WG, 1988, CRIME JUSTICE, V10, P39, DOI DOI 10.1086/449143	34	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61458	10.1371/journal.pone.0061458	http://dx.doi.org/10.1371/journal.pone.0061458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23630591	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400051
J	Matullo, G; Guarrera, S; Betti, M; Fiorito, G; Ferrante, D; Voglino, F; Cadby, G; Di Gaetano, C; Rosa, F; Russo, A; Hirvonen, A; Casalone, E; Tunesi, S; Padoan, M; Giordano, M; Aspesi, A; Casadio, C; Ardissone, F; Ruffini, E; Betta, PG; Libener, R; Guaschino, R; Piccolini, E; Neri, M; Musk, AWB; de Klerk, NH; Hui, J; Beilby, J; James, AL; Creaney, J; Robinson, BW; Mukherjee, S; Palmer, LJ; Mirabelli, D; Ugolini, D; Bonassi, S; Magnani, C; Dianzani, I				Matullo, Giuseppe; Guarrera, Simonetta; Betti, Marta; Fiorito, Giovanni; Ferrante, Daniela; Voglino, Floriana; Cadby, Gemma; Di Gaetano, Cornelia; Rosa, Fabio; Russo, Alessia; Hirvonen, Ari; Casalone, Elisabetta; Tunesi, Sara; Padoan, Marina; Giordano, Mara; Aspesi, Anna; Casadio, Caterina; Ardissone, Francesco; Ruffini, Enrico; Betta, Pier Giacomo; Libener, Roberta; Guaschino, Roberto; Piccolini, Ezio; Neri, Monica; Musk, Arthur W. B.; de Klerk, Nicholas H.; Hui, Jennie; Beilby, John; James, Alan L.; Creaney, Jenette; Robinson, Bruce W.; Mukherjee, Sutapa; Palmer, Lyle J.; Mirabelli, Dario; Ugolini, Donatella; Bonassi, Stefano; Magnani, Corrado; Dianzani, Irma			Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; LUNG-CANCER; ASBESTOS; REGION; MYC; SUSCEPTIBILITY; IDENTIFICATION; TRANSCRIPTION; SUPPRESSOR; EXPRESSION	Asbestos exposure is the main risk factor for malignant pleural mesothelioma (MPM), a rare aggressive tumor. Nevertheless, only 5-17% of those exposed to asbestos develop MPM, suggesting the involvement of other environmental and genetic risk factors. To identify the genetic risk factors that may contribute to the development of MPM, we conducted a genome-wide association study (GWAS; 370,000 genotyped SNPs, 5 million imputed SNPs) in Italy, among 407 MPM cases and 389 controls with a complete history of asbestos exposure. A replication study was also undertaken and included 428 MPM cases and 1269 controls from Australia. Although no single marker reached the genome-wide significance threshold, several associations were supported by haplotype-, chromosomal region-, gene-and gene-ontology process-based analyses. Most of these SNPs were located in regions reported to harbor aberrant alterations in mesothelioma (SLC7A14, THRB, CEBP350, ADAMTS2, ETV1, PVT1 and MMP14 genes), causing at most a 2-3-fold increase in MPM risk. The Australian replication study showed significant associations in five of these chromosomal regions (3q26.2, 4q32.1, 7p22.2, 14q11.2, 15q14). Multivariate analysis suggested an independent contribution of 10 genetic variants, with an Area Under the ROC Curve (AUC) of 0.76 when only exposure and covariates were included in the model, and of 0.86 when the genetic component was also included, with a substantial increase of asbestos exposure risk estimation (odds ratio, OR: 45.28, 95% confidence interval, CI: 21.52-95.28). These results showed that genetic risk factors may play an additional role in the development of MPM, and that these should be taken into account to better estimate individual MPM risk in individuals who have been exposed to asbestos.	[Matullo, Giuseppe; Guarrera, Simonetta; Fiorito, Giovanni; Voglino, Floriana; Di Gaetano, Cornelia; Rosa, Fabio; Russo, Alessia] HuGeF, Human Genet Fdn, Turin, Italy; [Matullo, Giuseppe; Di Gaetano, Cornelia; Russo, Alessia] Univ Turin, Dept Med Sci, Turin, Italy; [Betti, Marta; Casalone, Elisabetta; Aspesi, Anna; Dianzani, Irma] Univ Piemonte Orientale, Dept Hlth Sci, Lab Genet Pathol, Novara, Italy; [Ferrante, Daniela; Tunesi, Sara; Padoan, Marina; Magnani, Corrado] Univ Piemonte Orientale, CPO Piemonte, Novara, Italy; [Ferrante, Daniela; Tunesi, Sara; Padoan, Marina; Magnani, Corrado] Univ Piemonte Orientale, Dept Translat Med, Unit Med Stat & Epidemiol, Novara, Italy; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Genet Epidemiol & Biostat Platform, Toronto, ON, Canada; [Cadby, Gemma; Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Cadby, Gemma] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [Hirvonen, Ari] Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Giordano, Mara] Univ Piemonte Orientale, Dept Hlth Sci, Genet Lab, Novara, Italy; [Casadio, Caterina] Univ Piemonte Orientale, Thorac Surg Unit, Novara, Italy; [Ardissone, Francesco] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Ruffini, Enrico] Univ Turin, Thorac Surg Unit, Turin, Italy; [Betta, Pier Giacomo; Libener, Roberta] Azienda Osped Nazl SS, Pathol Unit, Alessandria, Italy; [Guaschino, Roberto] Azienda Osped Nazl SS, Transfus Ctr, Alessandria, Italy; [Piccolini, Ezio] Santo Spirito Hosp, Pneumol Unit, Casale Monferrato, Italy; [Neri, Monica; Bonassi, Stefano] IRCCS San Raffaele Pisana, Unit Clin & Mol Epidemiol, Rome, Italy; [Musk, Arthur W. B.; James, Alan L.; Creaney, Jenette; Robinson, Bruce W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Musk, Arthur W. B.; Hui, Jennie; Beilby, John; James, Alan L.; Creaney, Jenette; Robinson, Bruce W.] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Nedlands, WA 6009, Australia; [de Klerk, Nicholas H.] Univ Western Australia, Ctr Child Hlth Res, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John] PathWest Lab Med WA, Nedlands, WA, Australia; [Mukherjee, Sutapa] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mukherjee, Sutapa] Womens Coll Res Inst, Toronto, ON, Canada; [Mukherjee, Sutapa] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; [Mirabelli, Dario] CPO Piemonte, Canc Epidemiol Unit, Turin, Italy; [Mirabelli, Dario] Univ Turin, Turin, Italy; [Mirabelli, Dario; Magnani, Corrado; Dianzani, Irma] Univ Turin, Interdept Ctr Studies Asbestos & Other Tox Partic, Turin, Italy; [Ugolini, Donatella] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ugolini, Donatella] IRCSS AOU San Martino IST Ist Nazl Ric Canc, Genoa, Italy	University of Turin; University of Eastern Piedmont Amedeo Avogadro; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Finnish Institute of Occupational Health; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Turin; IRCCS San Raffaele Pisana; University of Western Australia; University of Western Australia; University of Western Australia; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; University of Turin; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Matullo, G (corresponding author), HuGeF, Human Genet Fdn, Turin, Italy.	giuseppe.matullo@unito.it; irma.dianzani@med.unipmn.it	Cadby, Gemma/AAE-3849-2022; Rosa, Fabio/AGI-6840-2022; Di Gaetano, Cornelia/AAA-5477-2019; Ferrante, Daniela/C-3105-2017; Palmer, Lyle John/K-3196-2014; Guarrera, Simonetta/AAB-8482-2022; Hui, Jennie/A-9543-2013; Tunesi, Sara/I-3746-2013; Robinson, Bruce/N-1900-2014; Mukherjee, Sutapa/U-7262-2017; Aspesi, Anna/ABG-7740-2020; Palmer, Lyle John/N-1948-2019; GIORDANO, Mara/AAB-1379-2019; de Klerk, Nicholas H/D-8388-2016; Matullo, Giuseppe/K-6383-2016; Neri, Monica/J-6308-2012; Bonassi, Stefano/ABI-6281-2020; Betti, Marta/K-4395-2016	Rosa, Fabio/0000-0002-8335-4482; Di Gaetano, Cornelia/0000-0001-8938-7093; Ferrante, Daniela/0000-0003-4929-3759; Palmer, Lyle John/0000-0002-1628-3055; Hui, Jennie/0000-0002-1653-2496; Tunesi, Sara/0000-0002-8576-942X; Mukherjee, Sutapa/0000-0001-5021-1648; Palmer, Lyle John/0000-0002-1628-3055; GIORDANO, Mara/0000-0001-6686-4600; de Klerk, Nicholas H/0000-0001-9223-0767; Matullo, Giuseppe/0000-0003-0674-7757; Neri, Monica/0000-0003-4796-3675; Bonassi, Stefano/0000-0003-3833-6717; Ruffini, Enrico/0000-0002-7225-2456; Betti, Marta/0000-0002-1372-6666; Beilby, John/0000-0002-4915-2254; Betti, Marta/0000-0003-0846-4988; Casalone, Elisabetta/0000-0001-5392-0511; Ardissone, Francesco/0000-0002-8212-9881; libener, roberta/0000-0002-8782-017X; RUSSO, ALESSIA/0000-0002-5494-2218; Fiorito, Giovanni/0000-0002-7651-5452; Aspesi, Anna/0000-0003-4944-0990	Regione Piemonte Ricerca Sanitaria Finalizzata; Fondazione Buzzi Unicem Onlus; CIPE; AIRC; Human Genetics Foundation - HuGeF; Regione Piemonte, Ricerca Scientifica Applicata; Regione Piemonte, Ricerca Sanitaria Finalizzata; Australian National Health and Medical Research Council; Sir Charles Gairdner Hospital; PathWest laboratory Medicine of WA	Regione Piemonte Ricerca Sanitaria Finalizzata(Regione Piemonte); Fondazione Buzzi Unicem Onlus; CIPE; AIRC(Fondazione AIRC per la ricerca sul cancro); Human Genetics Foundation - HuGeF; Regione Piemonte, Ricerca Scientifica Applicata(Regione Piemonte); Regione Piemonte, Ricerca Sanitaria Finalizzata(Regione Piemonte); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sir Charles Gairdner Hospital; PathWest laboratory Medicine of WA	This work was partially supported by the Regione Piemonte Ricerca Sanitaria Finalizzata 2007, 2008, 2009 (to I. D.), Fondazione Buzzi Unicem Onlus 2007 (to I. D., S. B), CIPE (to I. D.), AIRC (to I. D., D. U., S. B) and Human Genetics Foundation - HuGeF (to G. M.). The Turin case-control study was supported by a grant from Regione Piemonte, Ricerca Scientifica Applicata 2003 (to D. M.). The Casale case-control study was supported by a grant from Regione Piemonte, Ricerca Sanitaria Finalizzata 2004 (to C. M.). The Australian studies have been supported by the Australian National Health and Medical Research Council, the Sir Charles Gairdner Hospital and PathWest laboratory Medicine of WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Alfonso H, 2012, INT J CANC IN PRESS; Ascoli V, 2007, AM J IND MED, V50, P357, DOI 10.1002/ajim.20451; Azari MR, 2010, IND HEALTH, V48, P38, DOI 10.2486/indhealth.48.38; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Below JE, 2011, J TOXICOL ENV HEAL B, V14, P246, DOI 10.1080/10937404.2011.556052; Betti M, 2011, MUTAT RES-FUND MOL M, V708, P11, DOI 10.1016/j.mrfmmm.2011.01.001; Bosco N, 2010, CANCER GENET CYTOGEN, V202, P47, DOI 10.1016/j.cancergencyto.2010.06.008; Brims F J H, 2009, J R Nav Med Serv, V95, P4; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Creaney J, 2010, CANCER EPIDEM BIOMAR, V19, P2238, DOI 10.1158/1055-9965.EPI-10-0346; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DEKLERK NH, 1989, BRIT J IND MED, V46, P529; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Russo M, 2011, MUTATION RES; Dianzani I, 2006, MUTAT RES-FUND MOL M, V599, P124, DOI 10.1016/j.mrfmmm.2006.02.005; Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Feng S, 2007, CLIN CANCER RES, V13, P1695, DOI 10.1158/1078-0432.CCR-06-2492; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gray SG, 2009, J THORAC ONCOL, V4, P411, DOI 10.1097/JTO.0b013e3181951ce8; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guarrera S, 2012, AM J EPIDEMIOL, V175, P479, DOI 10.1093/aje/kwr430; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2011, IARC MON EV CARC RIS; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Kamath A, 2008, CANCER GENET CYTOGEN, V183, P117, DOI 10.1016/j.cancergencyto.2008.02.011; Kamio Y, 2010, PANCREAS, V39, P345, DOI 10.1097/MPA.0b013e3181bb9204; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Kucuk C, 2011, P NATL ACAD SCI USA, V108, P20119, DOI 10.1073/pnas.1115128108; Lennon PA, 2007, CANCER GENET CYTOGEN, V177, P37, DOI 10.1016/j.cancergencyto.2007.05.007; Lu CX, 2011, AM J CANCER RES, V1, P1; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marinaccio A, 2007, EUR J CANCER, V43, P2722, DOI 10.1016/j.ejca.2007.09.018; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Montanaro F, 2009, INT J CANCER, V124, P201, DOI 10.1002/ijc.23874; Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047; Neri M, 2008, MUTAT RES-REV MUTAT, V659, P126, DOI 10.1016/j.mrrev.2008.02.002; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Pellucchi C, 2004, BRIT J CANCER, V90, P1022, DOI 10.1038/sj.bjc.6601638; PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team R, 2009, LANG ENV STAT COMP; Ricceri F, 2011, DNA REPAIR, V10, P1044, DOI 10.1016/j.dnarep.2011.08.003; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Roe OD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006554; Storlazzi CT, 2004, HUM MOL GENET, V13, P1479, DOI 10.1093/hmg/ddh164; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Ugolini D, 2008, MUTAT RES-REV MUTAT, V658, P162, DOI 10.1016/j.mrrev.2007.08.001; Ugolini D, 2008, CANCER EPIDEM BIOMAR, V17, P3013, DOI 10.1158/1055-9965.EPI-08-0524; Wang X, 2012, EUR J HUM GENET, V20, P469, DOI 10.1038/ejhg.2011.219; Wojtkowiak J, 2012, CANC RES; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408	66	43	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61253	10.1371/journal.pone.0061253	http://dx.doi.org/10.1371/journal.pone.0061253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626673	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400030
J	Noor, NM; Mollgard, K; Wheaton, BJ; Steer, DL; Truettner, JS; Dziegielewska, KM; Dietrich, WD; Smith, AI; Saunders, NR				Noor, Natassya M.; Mollgard, Kjeld; Wheaton, Benjamin J.; Steer, David L.; Truettner, Jessie S.; Dziegielewska, Katarzyna M.; Dietrich, W. Dalton; Smith, A. Ian; Saunders, Norman R.			Expression and Cellular Distribution of Ubiquitin in Response to Injury in the Developing Spinal Cord of Monodelphis domestica	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ANTERIOR HORN CELLS; PROTEASOME SYSTEM; INTRANEURONAL INCLUSIONS; FUNCTIONAL RECOVERY; PROTEIN EXPRESSION; AMERICAN OPOSSUM; GENE-EXPRESSION; MESSENGER-RNA; RAT	Ubiquitin, an 8.5 kDa protein associated with the proteasome degradation pathway has been recently identified as differentially expressed in segment of cord caudal to site of injury in developing spinal cord. Here we describe ubiquitin expression and cellular distribution in spinal cord up to postnatal day P35 in control opossums (Monodelphis domestica) and in response to complete spinal transection (T10) at P7, when axonal growth through site of injury occurs, and P28 when this is no longer possible. Cords were collected 1 or 7 days after injury, with age-matched controls and segments rostral to lesion were studied. Following spinal injury ubiquitin levels (western blotting) appeared reduced compared to controls especially one day after injury at P28. In contrast, after injury mRNA expression (qRT-PCR) was slightly increased at P7 but decreased at P28. Changes in isoelectric point of separated ubiquitin indicated possible post-translational modifications. Cellular distribution demonstrated a developmental shift between earliest (P8) and latest (P35) ages examined, from a predominantly cytoplasmic immunoreactivity to a nuclear expression; staining level and shift to nuclear staining was more pronounced following injury, except 7 days after transection at P28. After injury at P7 immunostaining increased in neurons and additionally in oligodendrocytes at P28. Mass spectrometry showed two ubiquitin bands; the heavier was identified as a fusion product, likely to be an ubiquitin precursor. Apparent changes in ubiquitin expression and cellular distribution in development and response to spinal injury suggest an intricate regulatory system that modulates these responses which, when better understood, may lead to potential therapeutic targets.	[Noor, Natassya M.; Wheaton, Benjamin J.; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Mollgard, Kjeld] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Truettner, Jessie S.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	University of Melbourne; University of Copenhagen; Monash University; University of Miami	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Saunders, Norman/0000-0001-6660-7639; Smith, Ian/0000-0002-4143-2892; Wheaton, Benjamin/0000-0003-0619-4777	Victorian Neurotrauma Initiative (Transport Accident Commission, Victoria)	Victorian Neurotrauma Initiative (Transport Accident Commission, Victoria)	Funding support for this study was received from the Victorian Neurotrauma Initiative (Transport Accident Commission, Victoria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; BOND U, 1986, MOL CELL BIOL, V6, P4602, DOI 10.1128/MCB.6.12.4602; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley S, 2012, CELL STEM CELL, V11, P1; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Craveiro LM, 2008, EUR J NEUROSCI, V28, P1808, DOI 10.1111/j.1460-9568.2008.06473.x; DWORKINRASTL E, 1984, CELL, V39, P321, DOI 10.1016/0092-8674(84)90010-2; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Forno LS, 2002, ACTA NEUROPATHOL, V103, P599, DOI 10.1007/s00401-001-0509-1; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Fry EJ, 2000, CLIN EXP PHARMACOL P, V27, P542, DOI 10.1046/j.1440-1681.2000.03296.x; Gai WP, 1995, BRAIN, V118, P1447, DOI 10.1093/brain/118.6.1447; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015; HIRAGA T, 1993, J NEUROL SCI, V118, P43, DOI 10.1016/0022-510X(93)90244-S; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Huber AB, 2002, J NEUROSCI, V22, P3553; Ji BX, 2008, MOL CELL NEUROSCI, V39, P258, DOI 10.1016/j.mcn.2008.07.004; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Josephs KA, 2004, NEUROPATH APPL NEURO, V30, P369, DOI 10.1111/j.1365-2990.2003.00545.x; Kunz S, 2005, NEUROSCI LETT, V381, P289, DOI 10.1016/j.neulet.2005.02.022; Lane M, 2007, EUR J NEUROSCI, P25; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Li GL, 1996, ACTA NEUROPATHOL, V91, P155, DOI 10.1007/s004010050407; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; MATSUMOTO S, 1990, ACTA NEUROPATHOL, V80, P233, DOI 10.1007/BF00294639; MATSUMOTO S, 1993, J NEUROL SCI, V115, P208, DOI 10.1016/0022-510X(93)90226-O; Mezquita J, 1997, GENE, V195, P313, DOI 10.1016/S0378-1119(97)00189-3; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MOLLGARD K, 1994, J NEUROCYTOL, V23, P151, DOI 10.1007/BF01181557; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; OKAMOTO K, 1992, J NEUROL, V239, P426, DOI 10.1007/BF00856806; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Ramon Y, 1913, DEGENERATION REGENER; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saunders N, 2000, DEGENERATION REGENER, P17; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SCHIFFER D, 1991, J NEUROPATH EXP NEUR, V50, P463, DOI 10.1097/00005072-199107000-00007; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; Silver J, 2010, NEURON, V66, P619, DOI 10.1016/j.neuron.2010.05.028; Su Y, 2008, MOL VIS, V14, P268; Takimoto C, 2008, CANC MANAGEMENT MULT; Terman JR, 2000, BRAIN RES BULL, V53, P845, DOI 10.1016/S0361-9230(00)00431-7; Tomita K, 2007, GLIA, V55, P1498, DOI 10.1002/glia.20566; Van den Bergh G, 2006, PROTEOMICS, V6, P3821, DOI 10.1002/pmic.200500570; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Zhang L, 2006, THROMB HAEMOSTASIS, V95, P166, DOI 10.1160/TH05-07-0477	59	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62120	10.1371/journal.pone.0062120	http://dx.doi.org/10.1371/journal.pone.0062120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626776	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400140
J	Su, HC; Gu, YY; Li, FY; Wang, QD; Huang, BX; Jin, XL; Ning, G; Sun, FK				Su, Hengchuan; Gu, Yanyun; Li, Fengying; Wang, Qidi; Huang, Baoxing; Jin, Xiaolong; Ning, Guang; Sun, Fukang			The PI3K/AKT/mTOR Signaling Pathway Is Overactivated in Primary Aldosteronism	PLOS ONE			English	Article							MTOR PATHWAY; DIAGNOSIS; APOPTOSIS; INCREASES; SECRETION; CANCER; FORMS	Background: To date, the available non-invasive remedies for primary aldosteronism are not satisfactory in clinical practice. The phosphoinositide 3-kinase (PI3Ks)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway is essential for tumorigenesis and metastasis in many types of human tumors, including renal cancer, adrenal carcinoma and pheochromocytoma. The possibility that this pathway is also necessary for the pathogenesis of primary aldosteronism has not yet been explored. To answer this question, we investigated the activity of the PI3K/AKT/mTOR signaling pathway in normal adrenal glands (NAGs), primary aldosteronism (PA) patients and NCI-H295R cells. Methodology/Principal Findings: Between January 2005 and December 2011, we retrospectively reviewed the records of 45 patients with PA. We compared clinical characteristics (age, gender and biochemical data) and the expression of phospho-AKT (p-AKT), phospho-mTOR (p-mTOR), phospho-S6 (p-S6) and vascular endothelial growth factor (VEGF) by immunohistochemical staining and western blotting, analyzing 30 aldosterone-producing adenomas (APAs), 15 idiopathic hyperaldosteronism (IHA) tissues and 12 NAGs following nephrectomy for renal tumors (control group). Compared with the control group, most of the PA patients presented with polydipsia, polyuria, resistant hypertension, profound hypokalemia, hyperaldosteronemia and decreased plasma renin activity. Compared with normal zona glomerulosa, the levels of p-AKT, p-mTOR, p-S6 and VEGF were significantly upregulated in APA and IHA. No significant differences were found between APA and IHA in the expression of these proteins. Additionally, positive correlations existed between the plasma aldosterone levels and the expression of p-AKT and p-mTOR. In vitro studies showed that mTOR inhibitor rapamycin could inhibit cell proliferation in NCI-H295R cells in a dose-and time-dependent manner. Furthermore, this inhibitor also decreased aldosterone secretion. Conclusions: Our data suggest that the PI3K/AKT/mTOR signaling pathway, which was overactivated in APA and IHA compared with normal zona glomerulosa, may mediate aldosterone hypersecretion and participate in the development of PA.	[Su, Hengchuan; Huang, Baoxing; Sun, Fukang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Gu, Yanyun; Li, Fengying; Wang, Qidi; Ning, Guang] Shanghai Jiao Tong Univ, Dept Endocrinol, Clin Ctr Shanghai Endocrine & Metab Dis, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Jin, Xiaolong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, FK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200030, Peoples R China.	sunfukang6@126.com			Shanghai Municipal Natural Science Foundation [10411960000]	Shanghai Municipal Natural Science Foundation	This study was supported by Shanghai Municipal Natural Science Foundation (No. 10411960000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; De Martino MC, 2010, NEUROENDOCRINOLOGY, V92, P28, DOI 10.1159/000314280; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hanna SC, 2008, EXPERT REV ANTICANC, V8, P283, DOI 10.1586/14737140.8.2.283; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Konings IRHM, 2009, CURR CANCER DRUG TAR, V9, P439, DOI 10.2174/156800909788166556; Lichtenauer UD, 2012, HORM METAB RES; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Mariniello B, 2012, ENDOCR-RELAT CANCER, V19, P527, DOI 10.1530/ERC-11-0337; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Mulatero P, 2005, TRENDS ENDOCRIN MET, V16, P114, DOI 10.1016/j.tem.2005.02.007; Mulatero P, 2008, J CLIN ENDOCR METAB, V93, P1366, DOI 10.1210/jc.2007-2055; Rainey WE, 2004, MOL CELL ENDOCRINOL, V228, P23, DOI 10.1016/j.mce.2003.12.020; Regimbald-Dumas Y, 2011, CELL SIGNAL, V23, P71, DOI 10.1016/j.cellsig.2010.08.005; Stowasser M, 2003, J HYPERTENS, V21, P2149, DOI 10.1097/00004872-200311000-00025; Takekoshi K, 2004, LIFE SCI, V74, P863, DOI 10.1016/J.lfs.2003.07.036; Williams TA, 2010, HYPERTENSION, V55, P1468, DOI 10.1161/HYPERTENSIONAHA.110.150318	19	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62399	10.1371/journal.pone.0062399	http://dx.doi.org/10.1371/journal.pone.0062399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626817	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400181
J	Tene, BF; Poupardin, R; Costantini, C; Awono-Ambene, P; Wondji, CS; Ranson, H; Antonio-Nkondjio, C				Tene, Billy Fossog; Poupardin, Rodolphe; Costantini, Carlo; Awono-Ambene, Parfait; Wondji, Charles S.; Ranson, Hilary; Antonio-Nkondjio, Christophe			Resistance to DDT in an Urban Setting: Common Mechanisms Implicated in Both M and S Forms of Anopheles gambiae in the City of Yaounde Cameroon	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; MALARIA VECTOR; INSECTICIDE RESISTANCE; MOLECULAR-FORMS; PYRETHROID RESISTANCE; CYTOCHROME P450S; S.S. POPULATIONS; DENGUE VECTOR; KDR MUTATION; GENE	Background: In the city of Yaounde in Cameroon malaria is predominately transmitted by the M and S molecular forms of Anopheles gambiae and both are resistant to the pyrethroid insecticides and DDT. Mutations in the target site of these insecticides, present at a high frequency in malaria vectors in this city, contribute to this resistance profile. To identify additional resistance mechanisms, the expression profile of multiple DDT-resistant field populations of M and S molecular forms was compared to laboratory-susceptible populations. Methodology/Principal findings: The prevalence of DDT resistance was highest in the S form population originating from the cultivated site of Nkolondom (mortality after WHO bioassay = 4%). A high prevalence of DDT resistance was also found in two urban M form populations, Messa from a pristine unpolluted environment (DDT mortality = 54%), and Gare, where the breeding sites are heavily polluted with organic matter (DDT mortality = 38%). Microarray analysis showed that several transcripts coding for detoxification enzymes (P450s, GSTs and UDPGTs) and ABC transporters were upregulated in the three populations. Despite the presence of multiple detoxification genes over expressed in the DDT-resistant subset of these field populations, only three were commonly over expressed in resistant populations from all three environments. Two of these genes, CYP6M2 and GSTD1-6, encode enzymes that have been previously shown to metabolize DDT. Conclusion/Significance: Analogous to target site resistance, genes involved in metabolic resistance to DDT are also shared between the M and S forms of An gambiae. Alternative explanations for this occurrence are explored.	[Tene, Billy Fossog; Awono-Ambene, Parfait; Antonio-Nkondjio, Christophe] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Tene, Billy Fossog] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Costantini, Carlo] Univ Montpellier 2, Univ Montpellier 1, UMR IRD CNRS 224 5290, Inst Rech Dev, Montpellier, France; [Poupardin, Rodolphe; Wondji, Charles S.; Ranson, Hilary; Antonio-Nkondjio, Christophe] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	University of Yaounde I; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Liverpool School of Tropical Medicine; University of Liverpool	Antonio-Nkondjio, C (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon.	antonio_nk@yahoo.fr	Wondji, Charles/AAG-1510-2020; Costantini, Carlo/F-3470-2012; Poupardin, Rodolphe/K-3138-2014	Costantini, Carlo/0000-0003-1016-129X; TENE, Billy/0000-0003-0010-0450; Ranson, Hilary/0000-0003-2332-8247; Antonio Nkondjio, Christophe/0000-0003-0073-1578; Wondji, Charles S./0000-0003-0791-3673; Poupardin, Rodolphe/0000-0001-5195-5155	Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine [WTO86423MA]	Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine(Wellcome Trust)	This work was supported by a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (grant number: WTO86423MA) to CAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 1998, TEST PROC INS RES MO; [Anonymous], WHO TECHN REP SER; [Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Carnevale P, 2001, Bull Soc Pathol Exot, V94, P202; CAVALIE P., 1962, Medecine Tropicale, V22, P95; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Djouaka RF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-159; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Hahn MW, 2012, PHILOS T R SOC B, V367, P374, DOI 10.1098/rstb.2011.0188; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; LIVADAS G, 1958, Riv Malariol, V37, P229; LIVAK KJ, 1984, GENETICS, V107, P611; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mireji Paul Odhiambo, 2006, International Journal of Tropical Insect Science, V26, P214, DOI 10.1017/S1742758406658955; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Nwane Philippe, 2011, BMC Res Notes, V4, P463, DOI 10.1186/1756-0500-4-463; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Ranson H, 1998, P NATL ACAD SCI USA, V95, P14284, DOI 10.1073/pnas.95.24.14284; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 1997, BIOCHEM J, V324, P97, DOI 10.1042/bj3240097; Ranson H, 1997, J BIOL CHEM, V272, P5464, DOI 10.1074/jbc.272.9.5464; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Tene Fossog Billy, 2012, J Trop Med, V2012, P429817, DOI 10.1155/2012/429817; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; WHO, 2006, IND RES SPRAYING US; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103	66	61	63	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61408	10.1371/journal.pone.0061408	http://dx.doi.org/10.1371/journal.pone.0061408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626680	gold, Green Published, Green Accepted			2022-12-25	WOS:000318008400043
J	Das, H; Wang, ZH; Niazi, MKK; Aggarwal, R; Lu, JW; Kanji, S; Das, M; Joseph, M; Gurcan, M; Cristini, V				Das, Hiranmoy; Wang, Zhihui; Niazi, M. Khalid Khan; Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Das, Manjusri; Joseph, Matthew; Gurcan, Metin; Cristini, Vittorio			Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer	PLOS ONE			English	Article							GAMMA-DELTA-EXPRESSION; T-CELLS; IFN-GAMMA; LYMPHOCYTES; RECEPTOR; DEATH; MICROENVIRONMENT; RECOGNITION; ACTIVATION; EVOLUTION	Molecular-focused cancer therapies, e. g., molecularly targeted therapy and immunotherapy, so far demonstrate only limited efficacy in cancer patients. We hypothesize that underestimating the role of biophysical factors that impact the delivery of drugs or cytotoxic cells to the target sites (for associated preferential cytotoxicity or cell signaling modulation) may be responsible for the poor clinical outcome. Therefore, instead of focusing exclusively on the investigation of molecular mechanisms in cancer cells, convection-diffusion of cytotoxic molecules and migration of cancer-killing cells within tumor tissue should be taken into account to improve therapeutic effectiveness. To test this hypothesis, we have developed a mathematical model of the interstitial diffusion and uptake of small cytotoxic molecules secreted by T-cells, which is capable of predicting breast cancer growth inhibition as measured both in vitro and in vivo. Our analysis shows that diffusion barriers of cytotoxic molecules conspire with gamma delta T-cell scarcity in tissue to limit the inhibitory effects of gamma delta T-cells on cancer cells. This may increase the necessary ratios of gamma delta T-cells to cancer cells within tissue to unrealistic values for having an intended therapeutic effect, and decrease the effectiveness of the immunotherapeutic treatment.	[Das, Hiranmoy; Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Das, Manjusri; Joseph, Matthew] Ohio State Univ, Dept Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Wang, Zhihui; Cristini, Vittorio] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Niazi, M. Khalid Khan; Gurcan, Metin] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Cristini, Vittorio] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA; [Cristini, Vittorio] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	University System of Ohio; Ohio State University; University of New Mexico; University System of Ohio; Ohio State University; University of New Mexico; University of New Mexico	Das, H (corresponding author), Ohio State Univ, Dept Med, Wexner Med Ctr, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu; metin.gurcan@osumc.edu; vcristini@salud.unm.edu	Wang, Zhihui/B-2464-2009; Gurcan, Metin/F-4536-2012; Cristini, Vittorio/N-3540-2013; Das, Hiranmoy/R-7452-2019	Wang, Zhihui/0000-0001-6262-700X; Gurcan, Metin/0000-0002-2421-8229; Cristini, Vittorio/0000-0002-7909-4278; Das, Hiranmoy/0000-0002-3343-0096	National Cancer Institute [CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, ICBP - 1U54CA149196]; National Institutes of Health [K01 AR054114, SBIR R44 HL092706-01]; Ohio State University; NCI [R01CA134451]; NATIONAL CANCER INSTITUTE [U54CA149196, U54CA143907, R01CA134451, U54CA143837, U54CA151668] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL092706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	VC and ZW were supported by National Cancer Institute grants: CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, and ICBP - 1U54CA149196. VC also acknowledges the Surface Family Professorship. HD was supported by National Institutes of Health grants, K01 AR054114 (NIAMS), SBIR R44 HL092706-01 (NHLBI), and The Ohio State University start-up fund. MG was supported by R01CA134451 from the NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM SM, 1992, IMMUNOL LETT, V31, P279, DOI 10.1016/0165-2478(92)90127-A; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Arya SK, 2012, LAB CHIP, V12, P2362, DOI 10.1039/c2lc21174b; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; BANK I, 1993, CLIN IMMUNOL IMMUNOP, V67, P17, DOI 10.1006/clin.1993.1040; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Das H, 2004, J IMMUNOL, V172, P6578, DOI 10.4049/jimmunol.172.11.6578; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Elden L, 2008, SIAM REV, V50, P154; FERRARINI M, 1995, J IMMUNOL, V154, P3704; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jackson TL, 2003, J THEOR BIOL, V220, P201, DOI 10.1006/jtbi.2003.3156; Jain R, 1999, IEEE MULTIMEDIA, V6, P1, DOI 10.1109/MMUL.1999.809225; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kabelitz D, 2004, INT J CANCER, V112, P727, DOI 10.1002/ijc.20445; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Lee HO, 2011, CANCER RES, V71, P6327, DOI 10.1158/0008-5472.CAN-11-0304; Lu JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023348; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; MELDER RJ, 1988, CANCER RES, V48, P3461; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; ROBERTSON AR, 1990, COLOR RES APPL, V15, P167, DOI 10.1002/col.5080150308; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Wang LS, 2001, J IMMUNOL, V167, P6195, DOI 10.4049/jimmunol.167.11.6195; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; Wang Z, 2010, MATH MED BIOL; Wang Z, 2011, FRONTIERS C IN PRESS; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; WATANABE N, 1995, CLIN EXP IMMUNOL, V102, P167	45	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61398	10.1371/journal.pone.0061398	http://dx.doi.org/10.1371/journal.pone.0061398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620747	Green Published, gold, Green Submitted			2022-12-25	WOS:000317909500027
J	Garre, E; Romero-Santacreu, L; Barneo-Munoz, M; Miguel, A; Perez-Ortin, JE; Alepuz, P				Garre, Elena; Romero-Santacreu, Lorena; Barneo-Munoz, Manuela; Miguel, Ana; Perez-Ortin, Jose E.; Alepuz, Paula			Nonsense-Mediated mRNA Decay Controls the Changes in Yeast Ribosomal Protein Pre-mRNAs Levels upon Osmotic Stress	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; TRANSLATIONAL RESPONSE; DEGRADATION; REVEALS; SURVEILLANCE; INTRONS; PATHWAY; ROLES; TRANSCRIPTION	The expression of ribosomal protein (RP) genes requires a substantial part of cellular transcription, processing and translation resources. Thus, the RP expression must be tightly regulated in response to conditions that compromise cell survival. In Saccharomyces cerevisiae cells, regulation of the RP gene expression at the transcriptional, mature mRNA stability and translational levels during the response to osmotic stress has been reported. Reprogramming global protein synthesis upon osmotic shock includes the movement of ribosomes from RP transcripts to stress-induced mRNAs. Using tiling arrays, we show that osmotic stress yields a drop in the levels of RP pre-mRNAs in S. cerevisiae cells. An analysis of the tiling array data, together with transcription rates data, shows a poor correlation, indicating that the drop in the RP pre-mRNA levels is not merely a result of the lowered RP transcription rates. A kinetic study using quantitative RT-PCR confirmed the decrease in the levels of several RP-unspliced transcripts during the first 15 minutes of osmotic stress, which seems independent of MAP kinase Hog1. Moreover, we found that the mutations in the components of the nonsense-mediated mRNA decay (NMD), Upf1, Upf2, Upf3 or in exonuclease Xrn1, eliminate the osmotic stress-induced drop in RP pre-mRNAs. Altogether, our results indicate that the degradation of yeast RP unspliced transcripts by NMD increases during osmotic stress, and suggest that this might be another mechanism to control RP synthesis during the stress response.	[Garre, Elena; Romero-Santacreu, Lorena; Barneo-Munoz, Manuela; Miguel, Ana; Perez-Ortin, Jose E.; Alepuz, Paula] Univ Valencia, Dept Bioquim & Biol Mol, Fac Ciencias Biol, Valencia, Spain	University of Valencia	Alepuz, P (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, Fac Ciencias Biol, Valencia, Spain.	paula.alepuz@uv.es	Alepuz, Paula/F-7849-2016; Pérez-Ortín, José E./K-8582-2014	Alepuz, Paula/0000-0003-1472-2373; Pérez-Ortín, José E./0000-0002-1992-513X; Romero-Santacreu, Lorena/0000-0001-5394-5073	Spanish Ministry of Science [BFU2008-02114, BFU2010-21975-C03-01]; Generalitat Valenciana [GVACOMP2011-105, PROMETEO2011/088, ACOMP2012/001]; Spanish Ministry of Science	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by grants from the Spanish Ministry of Science to P. A. (BFU2008-02114) and to J.E.P.-O. (BFU2010-21975-C03-01) and by grants from the Generalitat Valenciana to P. A. (GVACOMP2011-105) and to J.E.P.-O. (PROMETEO2011/088) and ACOMP2012/001. L.R.-S. was supported by a Ph.D. fellowship (F. P. I.) from the Spanish Ministry of Science and M. B. was supported by a Geronimo Forteza contract from the Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bergkessel M, 2011, RNA, V17, P1461, DOI 10.1261/rna.2754011; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bragulat M, 2010, RNA, V16, P2033, DOI 10.1261/rna.2366310; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dong SY, 2007, MOL CELL, V25, P559, DOI 10.1016/j.molcel.2007.01.012; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Garre E, 2012, MOL BIOL CELL, V23, P137, DOI 10.1091/mbc.E11-05-0419; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Juneau K, 2006, GENETICS, V174, P511, DOI 10.1534/genetics.106.058560; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2011, GENET RES INT, V2011, DOI 10.4061/2011/989303; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Sayani S, 2012, RNA, V18, P1563, DOI 10.1261/rna.033779.112; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006	51	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61240	10.1371/journal.pone.0061240	http://dx.doi.org/10.1371/journal.pone.0061240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620734	Green Published, Green Submitted, gold			2022-12-25	WOS:000317909500014
J	Pan, YH; Zhang, YJ; Cui, J; Liu, Y; McAllan, BM; Liao, CC; Zhang, SY				Pan, Yi-Hsuan; Zhang, Yijian; Cui, Jie; Liu, Yang; McAllan, Bronwyn M.; Liao, Chen-Chung; Zhang, Shuyi			Adaptation of Phenylalanine and Tyrosine Catabolic Pathway to Hibernation in Bats	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; GROUND-SQUIRREL; CRYSTAL-STRUCTURE; FUMARYLACETOACETATE HYDROLASE; MAMMALIAN HIBERNATION; QUANTITATIVE-ANALYSIS; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; ADIPOSE-TISSUE; SWISS-MODEL	Some mammals hibernate in response to harsh environments. Although hibernating mammals may metabolize proteins, the nitrogen metabolic pathways commonly activated during hibernation are not fully characterized. In contrast to the hypothesis of amino acid preservation, we found evidence of amino acid metabolism as three of five key enzymes, including phenylalanine hydroxylase (PAH), homogentisate 1,2-dioxygenase (HGD), fumarylacetoacetase (FAH), involved in phenylalanine and tyrosine catabolism were co-upregulated during hibernation in two distantly related species of bats, Myotis ricketti and Rhinolophus ferrumequinum. In addition, the levels of phenylalanine in the livers of these bats were significantly decreased during hibernation. Because phenylalanine and tyrosine are both glucogenic and ketogenic, these results indicate the role of this catabolic pathway in energy supply. Since any deficiency in the catabolism of these two amino acids can cause accumulations of toxic metabolites, these results also suggest the detoxification role of these enzymes during hibernation. A higher selective constraint on PAH, HPD, and HGD in hibernators than in non-hibernators was observed, and hibernators had more conserved amino acid residues in each of these enzymes than non-hibernators. These conserved amino acid residues are mostly located in positions critical for the structure and activity of the enzymes. Taken together, results of this work provide novel insights in nitrogen metabolism and removal of harmful metabolites during bat hibernation.	[Pan, Yi-Hsuan; Zhang, Yijian; Cui, Jie; Liu, Yang; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Lab Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [McAllan, Bronwyn M.] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [McAllan, Bronwyn M.] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia; [Liao, Chen-Chung] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan	East China Normal University; University of Sydney; University of Sydney; National Yang Ming Chiao Tung University	Liao, CC (corresponding author), Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan.	ccliao@ym.edu.tw; syzhang@bio.ecnu.edu.cn	Pan, Yi-Hsuan/ABG-6271-2020; Cui, Jie/ABB-3831-2020	Pan, Yi-Hsuan/0000-0001-5156-9887; Cui, Jie/0000-0001-8176-9951; Liu, Yang/0000-0002-9258-7237; McAllan, Bronwyn/0000-0002-6075-3405	grants of key construction program of the National 985 projects; National Natural Science Foundation of China [31100273/C030101-Pan]; Science and Technology Commission, Shanghai Municipality [10R21412400-Pan]	grants of key construction program of the National 985 projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission, Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants of key construction program of the National 985 projects to SZ, National Natural Science Foundation of China (31100273/C030101-Pan), and the Science and Technology Commission, Shanghai Municipality (10R21412400-Pan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar Z, 2006, FUNCTIONAL EVOLUTION; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; Bell E, 2010, CANCER LETT, V293, P144, DOI 10.1016/j.canlet.2010.01.015; Bergeron A, 2001, J BIOL CHEM, V276, P15225, DOI 10.1074/jbc.M009341200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; COCKBURN F, 1993, BRIT MED J, V306, P115; Dark J, 2003, J NEUROENDOCRINOL, V15, P451, DOI 10.1046/j.1365-2826.2003.01020.x; de Bernabe DBV, 1999, J MED GENET, V36, P922; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DODGEN CL, 1956, AM J PHYSIOL, V187, P151, DOI 10.1152/ajplegacy.1956.187.1.151; Epperson LE, 2010, AM J PHYSIOL-REG I, V298, pR329, DOI 10.1152/ajpregu.00416.2009; Epperson LE, 2004, MOL CELL PROTEOMICS, V3, P920, DOI 10.1074/mcp.M400042-MCP200; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fuster G, 2007, CLIN NUTR, V26, P658, DOI 10.1016/j.clnu.2007.07.003; GALSTER W, 1975, AM J PHYSIOL, V228, P325, DOI 10.1152/ajplegacy.1975.228.1.325; GALSTER W, 1976, CAN J ZOOL, V54, P74, DOI 10.1139/z76-008; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Gerhard N, 2000, BIOL BATS; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Horne J, 2002, PROTEIN SCI, V11, P2041, DOI 10.1110/ps.4560102; Kabine M, 2004, BIOCHIMIE, V86, P763, DOI 10.1016/j.biochi.2004.10.003; Kam L, 2008, 11 C ACETOACETATE MO; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLAIN GJ, 1968, COMP BIOCHEM PHYSIOL, V27, P617, DOI 10.1016/0010-406X(68)90261-2; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kondo N, 2006, CELL, V125, P161, DOI 10.1016/j.cell.2006.03.017; KRILOWICZ BL, 1985, AM J PHYSIOL, V249, pR462, DOI 10.1152/ajpregu.1985.249.4.R462; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lee K, 2008, J CELL BIOCHEM, V104, P642, DOI 10.1002/jcb.21653; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson CJ, 2009, PHYSIOL GENOMICS, V37, P43, DOI 10.1152/physiolgenomics.90323.2008; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Pan YH, 2006, J BIOL CHEM, V281, P13083, DOI 10.1074/jbc.M511365200; PASSMORE JC, 1975, J EXP ZOOL, V192, P83, DOI 10.1002/jez.1401920110; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ransome R., 1990, NATURAL HIST HIBERNA; RIEDESEL ML, 1980, FED PROC, V39, P2959; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; RUNDGREN M, 1977, J BIOL CHEM, V252, P5085; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Serkova NJ, 2007, PHYSIOL GENOMICS, V31, P15, DOI 10.1152/physiolgenomics.00028.2007; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Srivastava RK, 2010, COMP BIOCHEM PHYS A, V155, P392, DOI 10.1016/j.cbpa.2009.12.006; Stenson Peter D, 2009, Hum Genomics, V4, P69; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; VANFAASSEN H, 1990, J BIOCHEM BIOPH METH, V20, P317, DOI 10.1016/0165-022X(90)90093-R; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Wojciechowski MS, 2007, COMP BIOCHEM PHYS A, V147, P828, DOI 10.1016/j.cbpa.2006.06.039; YACOE ME, 1983, J COMP PHYSIOL, V152, P137, DOI 10.1007/BF00689738; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189	67	25	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62039	10.1371/journal.pone.0062039	http://dx.doi.org/10.1371/journal.pone.0062039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620802	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500082
J	Vitzel, KF; Bikopoulos, G; Hung, S; Pistor, KE; Patterson, JD; Curi, R; Ceddia, RB				Vitzel, Kaio F.; Bikopoulos, George; Hung, Steven; Pistor, Kathryn E.; Patterson, Jessica D.; Curi, Rui; Ceddia, Rolando B.			Chronic Treatment with the AMP-Kinase Activator AICAR Increases Glycogen Storage and Fatty Acid Oxidation in Skeletal Muscles but Does Not Reduce Hyperglucagonemia and Hyperglycemia in Insulin Deficient Rats	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; EPITROCHLEARIS MUSCLE; RESISTANT RATS; SOLEUS MUSCLE; EXERCISE; SYNTHASE; STIMULATION; CONTRACTION; TRANSPORT	This study tested whether the glycogen-accumulating effect of chronic in vivo pharmacological 5'AMP-activated protein kinase (AMPK) activation could improve glycemic control under conditions of insulin deficiency. Male Wistar rats were rendered diabetic through the administration of streptozotocin (STZ) and then treated for 7 consecutive days with the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Subsequently, glycogen content and synthesis, glucose oxidation, and fatty acid oxidation (FAO) were determined in oxidative and glycolytic skeletal muscles. Glycemia, insulinemia, glucagonemia, and circulating triglycerides (TG) and non-esterified fatty acids (NEFAs) were measured after AICAR treatment. Insulin was almost undetectable in STZ rats and these animals were severely hyperglycemic. Glycogen content was markedly low mainly in glycolytic muscles of STZ rats and AICAR treatment restored it to control values. No differences were found among all muscles studied with regards to the content and phosphorylation of Akt/protein kinase B and glycogen synthase kinase 3. Even though glycogen synthase content was reduced in all muscles from STZ rats, insulin-induced dephosphorylation/activation of this enzyme was preserved and unaffected by AICAR treatment. Glucagon and NEFAS were 2- and 7.4-fold fold higher in STZ rats than controls, respectively. AICAR did not affect hyperglycemia and hyperglucagonemia in STZ rats; however, it normalized circulating NEFAs and significantly increased FAO in glycolytic muscles. In conclusion, even though AICAR-induced AMPK activation enhanced glycogen accumulation in glycolytic muscles and normalized circulating NEFAs and TG levels, the hyperglycemic effects of glucagon likely offset the potentially glucose-lowering effects of AICAR, resulting in no improvement of glycemic control in insulin-deficient rats.	[Vitzel, Kaio F.; Bikopoulos, George; Hung, Steven; Pistor, Kathryn E.; Patterson, Jessica D.; Ceddia, Rolando B.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Vitzel, Kaio F.; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	York University - Canada; Universidade de Sao Paulo	Ceddia, RB (corresponding author), York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	roceddia@yorku.ca	Curi, Rui/C-9351-2012		Natural Science and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF); Canadian Institutes of Health Research (CIHR); Ontario Ministry of Research and Innovation; Brazilian National Research Funding Institution CAPES/PDE	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Brazilian National Research Funding Institution CAPES/PDE	This research was funded by a Discovery Grant from the Natural Science and Engineering Research Council of Canada (NSERC) and by infrastructure grants from the Canada Foundation for Innovation (CFI) and the Ontario Research Fund (ORF) awarded to RBC. RBC is also a recipient of the Canadian Institutes of Health Research (CIHR) New Investigator Award and the Early Research Award from the Ontario Ministry of Research and Innovation. KFV was supported by a Doctoral Student Research Award from the Brazilian National Research Funding Institution CAPES/PDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; ELIA M, 1992, ENERGY METABOLISM, P61; Fediuc S, 2006, ENDOCRINOLOGY, V147, P5170, DOI 10.1210/en.2006-0480; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Jornayvaz FR, 2010, ANNU REV NUTR, V30, P273, DOI 10.1146/annurev.nutr.012809.104726; Lee Y, 2012, P NATL ACAD SCI USA, V109, P14972, DOI 10.1073/pnas.1205983109; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; NESHER R, 1980, AM J PHYSIOL, V239, pE454, DOI 10.1152/ajpendo.1980.239.6.E454; NESHER R, 1980, AM J PHYSIOL, V239, pE461, DOI 10.1152/ajpendo.1980.239.6.E461; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Winder WW, 2000, J APPL PHYSIOL, V89, P2430, DOI 10.1152/jappl.2000.89.6.2430; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62190	10.1371/journal.pone.0062190	http://dx.doi.org/10.1371/journal.pone.0062190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620811	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500091
J	Zhang, XS; Yang, XW; Yuan, ZS; Liu, YX; Li, FY; Peng, B; Zhu, DW; Zhao, JH; Xue, FZ				Zhang, Xiaoshuai; Yang, Xiaowei; Yuan, Zhongshang; Liu, Yanxun; Li, Fangyu; Peng, Bin; Zhu, Dianwen; Zhao, Jinghua; Xue, Fuzhong			A PLSPM-Based Test Statistic for Detecting Gene-Gene Co-Association in Genome-Wide Association Study with Case-Control Design	PLOS ONE			English	Article							COMPLEX HUMAN TRAITS; LINKAGE DISEQUILIBRIUM; MULTIPLE-SCLEROSIS; DISEASES; PATHWAY; LOCI	For genome-wide association data analysis, two genes in any pathway, two SNPs in the two linked gene regions respectively or in the two linked exons respectively within one gene are often correlated with each other. We therefore proposed the concept of gene-gene co-association, which refers to the effects not only due to the traditional interaction under nearly independent condition but the correlation between two genes. Furthermore, we constructed a novel statistic for detecting gene-gene co-association based on Partial Least Squares Path Modeling (PLSPM). Through simulation, the relationship between traditional interaction and co-association was highlighted under three different types of co-association. Both simulation and real data analysis demonstrated that the proposed PLSPM-based statistic has better performance than single SNP-based logistic model, PCA-based logistic model, and other gene-based methods.	[Zhang, Xiaoshuai; Yuan, Zhongshang; Liu, Yanxun; Li, Fangyu; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Yang, Xiaowei; Zhu, Dianwen] CUNY, Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA; [Yang, Xiaowei] Bayessoft Inc, Davis, CA USA; [Peng, Bin] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Zhao, Jinghua] MRC, Epidemiol Unit, Cambridge, England; [Zhao, Jinghua] Inst Metab Sci, Cambridge, England	Shandong University; City University of New York (CUNY) System; Hunter College (CUNY); Chongqing Medical University; University of Cambridge	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020; Yuan, Zhongshang/GVT-8351-2022; Zhang, Xiaoshuai/AAG-7019-2019	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [31071155]; National Institute of Child Health and Human Development, NIH, USA [R01HD061404]; National Institute on Drug Abuse, NIH, USA [R44DA026683]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R44DA026683] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Child Health and Human Development, NIH, USA; National Institute on Drug Abuse, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Natural Science Foundation of China (31071155), http://www.nsfc.gov.cn/Portal0/default152.htm, National Institute of Child Health and Human Development, NIH, USA (R01HD061404), http://www.nichd.nih.gov/, and National Institute on Drug Abuse, NIH, USA (R44DA026683), http://www.nida.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bush WS, 2011, GENES IMMUN, V12, P335, DOI 10.1038/gene.2011.3; Chen Min-Zhi, 2011, Yi Chuan, V33, P239, DOI 10.3724/SP.J.1005.2011.00239; Doerge RW, 1996, GENETICS, V142, P285; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Esposito VV, 2010, HDB PARTIAL LEAST SQ; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P403; Good PI, 2000, WILEY ONLINE LIB, P5; Han B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S9; Hutz JE, 2008, GENET EPIDEMIOL, V32, P779, DOI 10.1002/gepi.20346; Jen-hwa C, 2009, BMC SYSTEMS BIOL, V3, P55; Jia P, 2010, SCHIZOPHR RES, V122, P40; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lohmoller J.B., 1989, PHYSICA, DOI DOI 10.1007/978-3-642-52512-4; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; MIETTINEN O, 1974, AM J EPIDEMIOL, V100, P350, DOI 10.1093/oxfordjournals.aje.a112044; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Rajapakse I, 2012, GENETIC EPIDEMIOLOGY; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Saithong T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030232; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Torkamani A, 2009, METHODS MOL BIOL, V563, P289, DOI 10.1007/978-1-60761-175-2_16; Turkmen Asuman S, 2011, BMC Proc, V5 Suppl 9, pS19, DOI 10.1186/1753-6561-5-S9-S19; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Xue F, 2009, EUR J HUM GENET, V18, P582; Xue FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031927	41	9	9	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62129	10.1371/journal.pone.0062129	http://dx.doi.org/10.1371/journal.pone.0062129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620809	Green Published, gold			2022-12-25	WOS:000317909500089
J	Galan, A; Diaz-Gimeno, P; Poo, ME; Valbuena, D; Sanchez, E; Ruiz, V; Dopazo, J; Montaner, D; Conesa, A; Simon, C				Galan, Amparo; Diaz-Gimeno, Patricia; Eugenia Poo, Maria; Valbuena, Diana; Sanchez, Eva; Ruiz, Veronica; Dopazo, Joaquin; Montaner, David; Conesa, Ana; Simon, Carlos			Defining the Genomic Signature of Totipotency and Pluripotency during Early Human Development	PLOS ONE			English	Article							STEM-CELL LINES; GENE-EXPRESSION; NETWORK; EMBRYO; MASS; DIFFERENTIATION; INTEGRATION; DERIVATION; 4-CELL; BLASTOMERES	The genetic mechanisms governing human pre-implantation embryo development and the in vitro counterparts, human embryonic stem cells (hESCs), still remain incomplete. Previous global genome studies demonstrated that totipotent blastomeres from day-3 human embryos and pluripotent inner cell masses (ICMs) from blastocysts, display unique and differing transcriptomes. Nevertheless, comparative gene expression analysis has revealed that no significant differences exist between hESCs derived from blastomeres versus those obtained from ICMs, suggesting that pluripotent hESCs involve a new developmental progression. To understand early human stages evolution, we developed an undifferentiation network signature (UNS) and applied it to a differential gene expression profile between single blastomeres from day-3 embryos, ICMs and hESCs. This allowed us to establish a unique signature composed of highly interconnected genes characteristic of totipotency (61 genes), in vivo pluripotency (20 genes), and in vitro pluripotency (107 genes), and which are also proprietary according to functional analysis. This systems biology approach has led to an improved understanding of the molecular and signaling processes governing human pre-implantation embryo development, as well as enabling us to comprehend how hESCs might adapt to in vitro culture conditions.	[Galan, Amparo; Eugenia Poo, Maria; Valbuena, Diana; Sanchez, Eva; Ruiz, Veronica; Simon, Carlos] CIPF, Valencia Node Natl Stem Cell Bank, Valencia, Spain; [Diaz-Gimeno, Patricia; Dopazo, Joaquin; Montaner, David; Conesa, Ana] CIPF, Bioinformat Dept, Valencia, Spain; [Diaz-Gimeno, Patricia; Dopazo, Joaquin; Montaner, David; Conesa, Ana] CIPF, Funct Genom Node INB, Valencia, Spain; [Simon, Carlos] Univ Valencia, INCLIVA, Inst Univ IVI IUIVI, Fdn IVI FIVI, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Prince Felipe Research Center; University of Valencia	Simon, C (corresponding author), CIPF, Valencia Node Natl Stem Cell Bank, Valencia, Spain.	carlos.simon@ivi.es	Cegarra, Ana V Conesa/A-9559-2014; Dopazo, Joaquin/A-9270-2014; Simon, Carlos/G-2186-2014; Valbuena, Diana M/I-1949-2015; Galán, Amparo/ABG-8474-2020; Montaner, David/A-9362-2014	Cegarra, Ana V Conesa/0000-0001-9597-311X; Dopazo, Joaquin/0000-0003-3318-120X; Simon, Carlos/0000-0003-0902-9531; Valbuena, Diana M/0000-0002-0742-3669; Galán, Amparo/0000-0003-4265-8516; Diaz Gimeno, Patricia/0000-0003-0031-7545; Montaner, David/0000-0002-2484-3278	Institute of Health Carlos III (ISCIII); Regional Ministry of Health (GVA); CIPF for the Research on Regenerative Medicine; FIS Project from the ISCIII of the Spanish Government [PI08-1134]	Institute of Health Carlos III (ISCIII); Regional Ministry of Health (GVA); CIPF for the Research on Regenerative Medicine; FIS Project from the ISCIII of the Spanish Government	This work was supported by Agreement between Institute of Health Carlos III (ISCIII), Regional Ministry of Health (GVA) and CIPF for the Research on Regenerative Medicine and FIS Project PI08-1134 from the ISCIII of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh PH, 2008, CLIN CANCER RES, V14, P1393, DOI 10.1158/1078-0432.CCR-07-4146; Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aguilar-Gallardo C, 2010, IN VITRO CELL DEV-AN, V46, P317, DOI 10.1007/s11626-010-9285-3; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Chen CC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S19; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cuesta R, 2000, GENE DEV, V14, P1460; Edwards RG, 2005, REPROD BIOMED ONLINE, V11, P206; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Galan Amparo, 2012, Methods Mol Biol, V873, P13, DOI 10.1007/978-1-61779-794-1_2; Galan A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013615; Galan A, 2010, METHODS MOL BIOL, V584, P135, DOI 10.1007/978-1-60761-369-5_8; Giritharan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026570; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Harel A, 2011, METHODS MOL BIOL, V719, P71, DOI 10.1007/978-1-61779-027-0_3; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; HEWITT SM, 1995, J BIOL CHEM, V270, P17908, DOI 10.1074/jbc.270.30.17908; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lin X, 1996, GENOMICS, V31, P335, DOI 10.1006/geno.1996.0056; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Noble D, 2006, BIOSYSTEMS, V83, P75, DOI 10.1016/j.biosystems.2005.05.013; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Park JH, 2008, BIOCHEM BIOPH RES CO, V365, P575, DOI 10.1016/j.bbrc.2007.11.003; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Saitou M, 2008, REPROD BIOMED ONLINE, V16, P26, DOI 10.1016/S1472-6483(10)60554-8; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Simon C, 2005, FERTIL STERIL, V83, P246, DOI 10.1016/j.fertnstert.2004.09.004; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valbuena D, 2006, REPROD BIOMED ONLINE, V13, P875, DOI 10.1016/S1472-6483(10)61038-3; Van de Velde H, 2008, HUM REPROD, V23, P1742, DOI 10.1093/humrep/den190; Varela E, 2011, P NATL ACAD SCI USA, V108, P15207, DOI 10.1073/pnas.1105414108; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZALKIN H, 1992, PROG NUCLEIC ACID RE, V42, P259, DOI 10.1016/S0079-6603(08)60578-4; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	71	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62135	10.1371/journal.pone.0062135	http://dx.doi.org/10.1371/journal.pone.0062135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614026	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200122
J	Chen, GL; Miller, GM				Chen, Guo-Lin; Miller, Gregory M.			Extensive Alternative Splicing of the Repressor Element Silencing Transcription Factor Linked to Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; PPAR-GAMMA; REST; DISEASE; MOUSE; DIFFERENTIATION; ACTIVATION; BINDING; PROTEIN; TARGET	The repressor element silencing transcription factor (REST) is a coordinate transcriptional and epigenetic regulator which functions as a tumor suppressor or an oncogene depending on cellular context, and a truncated splice variant REST4 has been linked to various types of cancer. We performed a comprehensive analysis of alternative splicing (AS) of REST by rapid amplification of cDNA ends and PCR amplification of cDNAs from various tissues and cell lines with specific primers. We identified 8 novel alternative exons including an alternate last exon which doubles the REST gene boundary, along with numerous 5'/3' splice sites and ends in the constitutive exons. With the combination of various splicing patterns (e. g. exon skipping and alternative usage of the first and last exons) that are predictive of altered REST activity, at least 45 alternatively spliced variants of coding and non-coding mRNA were expressed in a species-and cell-type/tissue-specific manner with individual differences. By examining the repertoire of REST pre-mRNA splicing in 27 patients with kidney, liver and lung cancer, we found that all patients without exception showed differential expression of various REST splice variants between paired tumor and adjacent normal tissues, with striking cell-type/tissue and individual differences. Moreover, we revealed that exon 3 skipping, which causes no frame shift but loss of a domain essential for nuclear translocation, was affected by pioglitazone, a highly selective activator of the peroxisome proliferator-activated receptor gamma (PPAR gamma) which contributes to cell differentiation and tumorigenesis besides its metabolic actions. Accordingly, this study demonstrates an extensive AS of REST pre-mRNA which redefines REST gene boundary and structure, along with a general but differential link between REST pre-mRNA splicing and various types of cancer. These findings advance our understanding of the complex, context-dependent regulation of REST gene expression and function, and provide potential biomarkers and therapeutic targets for cancer.	[Chen, Guo-Lin; Miller, Gregory M.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Neurosci, Southborough, MA 01772 USA	Harvard University	Chen, GL (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Div Neurosci, Southborough, MA 01772 USA.	guo-lin_chen@hms.harvard.edu	Chen, Guo-Lin/E-5559-2015	Chen, Guo-Lin/0000-0002-9236-1385	National Institutes of Health [DA025697, DA030177, OD11103]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA025697, R21DA030177] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants DA025697 (GMM), DA030177 (GMM), and OD11103 (NEPRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz L, 2008, J BIOL CHEM, V283, P110, DOI 10.1074/jbc.M707366200; Allo M, 2010, COLD SH Q B, V75, P103, DOI 10.1101/sqb.2010.75.023; Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; Cai L, 2011, NEUROSCIENCE, V181, P196, DOI 10.1016/j.neuroscience.2011.02.059; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chiang MC, 2012, NEUROBIOL DIS, V45, P322, DOI 10.1016/j.nbd.2011.08.016; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson JM, 2000, CANCER RES, V60, P1840; Dutertre M, 2011, RNA BIOL, V8, P740, DOI 10.4161/rna.8.5.16016; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fogg MH, 2009, P NATL ACAD SCI USA, V106, P3318, DOI 10.1073/pnas.0813320106; Fuller GN, 2005, MOL CANCER THER, V4, P343; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Heidler J, 2011, J BIOL CHEM, V286, P32086, DOI 10.1074/jbc.M111.221986; Jiang M, 2011, DIFFERENTIATION, V82, P220, DOI 10.1016/j.diff.2011.05.008; Kalonia H, 2010, PHARMACOL BIOCHEM BE, V96, P115, DOI 10.1016/j.pbb.2010.04.018; Kim S, 2011, N KOREAN REV, V7, P3; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lee JH, 2000, J MOL NEUROSCI, V15, P205, DOI 10.1385/JMN:15:3:205; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Nijholt I, 2004, MOL PSYCHIATR, V9, P174, DOI 10.1038/sj.mp.4001446; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Parihar MS, 2008, BBA-GEN SUBJECTS, V1780, P921, DOI 10.1016/j.bbagen.2008.02.006; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Shimojo M, 2006, NEUROSCI LETT, V398, P161, DOI 10.1016/j.neulet.2005.12.080; Skelhorne-Gross G, 2012, PPAR RES, V2012, P13; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Taylor P, 2012, MOL CANCER THER, V11, P1713, DOI 10.1158/1535-7163.MCT-11-0990; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tsukahara T, 2012, PPAR RES, V2012, P9; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Weissman AM, 2008, CANCER CELL, V13, P381, DOI 10.1016/j.ccr.2008.04.011; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WHITE LA, 1994, J NEUROSCI, V14, P6744	57	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62217	10.1371/journal.pone.0062217	http://dx.doi.org/10.1371/journal.pone.0062217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614038	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400164
J	Ordonez-Moran, P; Irmisch, A; Barbachano, A; Chicote, I; Tenbaum, S; Landolfi, S; Tabernero, J; Huelsken, J; Munoz, A; Palmer, HG				Ordonez-Moran, P.; Irmisch, A.; Barbachano, A.; Chicote, I.; Tenbaum, S.; Landolfi, S.; Tabernero, J.; Huelsken, J.; Munoz, A.; Palmer, H. G.			SPROUTY2 is a beta-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer	ONCOGENE			English	Article						SPROUTY2; wnt pathway; beta-catenin; FOXO3a; colon cancer	GROWTH-FACTOR RECEPTOR; E-CADHERIN; EXPRESSION; PROTEINS; CELLS; TRANSCRIPTION; INHIBITOR; PHOSPHORYLATION; DIFFERENTIATION; BINDING	SPROUTY2 (SPRY2) is an intracellular regulator of receptor tyrosine kinase signaling involved in cell growth, differentiation and tumorigenesis. Here, we show that SPRY2 is a target gene of the Wnt/beta-catenin pathway that is abnormally activated in more than 90% of colon carcinomas. In human colon cancer cells, SPRY2 expression is induced by beta-catenin in co-operation with the transcription factor FOXO3a instead of lymphoid enhancer factor/T-cell factor proteins. We found binding of beta-catenin to the SPRY2 promoter at FOXO3a response elements. In vivo, cells marked by nuclear beta-catenin and FOXO3a express SPRY2 in proliferative epithelial tissues, such as intestinal mucosa and epidermis. Consistently, inducible beta-catenin deletion in mice reduced Spry2 expression in the small intestine. Moreover, SPRY2 protein expression correlated with nuclear beta-catenin and FOXO3a colocalization in human colon carcinomas. Importantly, the amount of SPRY2 protein correlated with shorter overall survival of colon cancer patients. Our data reveal SPRY2 as a novel Wnt beta-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.	[Ordonez-Moran, P.; Barbachano, A.; Munoz, A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Ordonez-Moran, P.; Irmisch, A.; Huelsken, J.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Chicote, I.; Tenbaum, S.; Palmer, H. G.] VHIO, Stem Cells & Canc Lab, Translat Res Program, Barcelona 08035, Spain; [Landolfi, S.] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Tabernero, J.] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Palmer, HG (corresponding author), VHIO, Stem Cells & Canc Lab, Translat Res Program, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	hgpalmer@vhio.net	Barbachano, Antonio/O-7731-2015; Palmer, Héctor G./AAG-8332-2019; Huelsken, Joerg/AAC-9581-2021; Munoz, Alberto/O-6393-2014; Tabernero, Josep/AAG-5026-2019; Ordonez-Moran, Paloma/B-6371-2016	Barbachano, Antonio/0000-0002-1248-5143; Huelsken, Joerg/0000-0003-3105-9606; Munoz, Alberto/0000-0003-3890-4251; Tabernero, Josep/0000-0002-2495-8139; Ordonez-Moran, Paloma/0000-0001-7688-1252; Palmer, Hector/0000-0002-9823-5638; Landolfi, Stefania/0000-0002-1059-635X	Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III; Spanish Cooperative Research Network on Cancer (RTICC) [FIS-PI081356, RD12/0036/0001, RD12/0036/0021, RD12/0036/0012]; Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad [SAF-18302]; Comunidad de Madrid [S2010/BMD-2344 Colomics2]; Miguel Servet Program; Instituto de Salud Carlos III (ISCIII); EMBO	Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III; Spanish Cooperative Research Network on Cancer (RTICC); Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad; Comunidad de Madrid(Comunidad de Madrid); Miguel Servet Program; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank T Martinez for technical assistance and Hans Clevers for providing the LS174T-tetOn-Delta NTCF4 cells. Experiments were supported by grants from Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III and Spanish Cooperative Research Network on Cancer (RTICC) (FIS-PI081356, RD12/0036/0001, RD12/0036/0021 and RD12/0036/0012), Plan Nacional de Biomedicina, Ministerio de Economia y Competitividad (SAF-18302) and Comunidad de Madrid (S2010/BMD-2344 Colomics2). HGP was supported by the Miguel Servet Program, Instituto de Salud Carlos III (ISCIII) and PO-M by an EMBO research fellowship.	Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Ding W, 2003, GENE, V322, P175, DOI 10.1016/j.gene.2003.09.004; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Holgren C, 2010, ONCOGENE, V29, P5241, DOI 10.1038/onc.2010.264; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Oriol A, 2012, PROTOCOL EXCHANGE; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Raghav SK, 2012, METHODS MOL BIOL, V786, P247, DOI 10.1007/978-1-61779-292-2_15; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	51	19	20	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1975	1985		10.1038/onc.2013.140	http://dx.doi.org/10.1038/onc.2013.140			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23624922	Green Submitted			2022-12-25	WOS:000334346300010
J	Vultur, A; Villanueva, J; Krepler, C; Rajan, G; Chen, Q; Xiao, M; Li, L; Gimotty, PA; Wilson, M; Hayden, J; Keeney, F; Nathanson, KL; Herlyn, M				Vultur, A.; Villanueva, J.; Krepler, C.; Rajan, G.; Chen, Q.; Xiao, M.; Li, L.; Gimotty, P. A.; Wilson, M.; Hayden, J.; Keeney, F.; Nathanson, K. L.; Herlyn, M.			MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines	ONCOGENE			English	Article						melanoma; MEK; STAT3; targeted therapy; invasion; resistance	RAF INHIBITORS; ACQUIRED-RESISTANCE; KINASE INHIBITOR; AZD6244 ARRY-142886; DRIVEN RESISTANCE; IMPROVED SURVIVAL; POTENT INHIBITOR; BRAF INHIBITION; ACTIVATION; MIGRATION	Elevated activity of the mitogen-activated protein kinase (MAPK) signaling cascade is found in the majority of human melanomas and is known to regulate proliferation, survival and invasion. Current targeted therapies focus on decreasing the activity of this pathway; however, we do not fully understand how these therapies impact tumor biology, especially given that melanoma is a heterogeneous disease. Using a three-dimensional (3D), collagen-embedded spheroid melanoma model, we observed that MEK and BRAF inhibitors can increase the invasive potential of B20% of human melanoma cell lines. The invasive cell lines displayed increased receptor tyrosine kinase (RTK) activity and activation of the Src/FAK/signal transducers and activators of transcription-3 (STAT3) signaling axis, also associated with increased cell-to-cell adhesion and cadherin engagement following MEK inhibition. Targeting various RTKs, Src, FAK and STAT3 with small molecule inhibitors in combination with a MEK inhibitor prevented the invasive phenotype, but only STAT3 inhibition caused cell death in the 3D context. We further show that STAT3 signaling is induced in BRAF-inhibitor-resistant cells. Our findings suggest that MEK and BRAF inhibitors can induce STAT3 signaling, causing potential adverse effects such as increased invasion. We also provide the rationale for the combined targeting of the MAPK pathway along with inhibitors of RTKs, SRC or STAT3 to counteract STAT3-mediated resistance phenotypes.	[Vultur, A.; Villanueva, J.; Krepler, C.; Rajan, G.; Chen, Q.; Xiao, M.; Li, L.; Herlyn, M.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Gimotty, P. A.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Wilson, M.; Nathanson, K. L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Hayden, J.; Keeney, F.; Herlyn, M.] Wistar Inst Anat & Biol, Div Mol & Cellular Biol, Imaging Facil, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org	Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Wilson, Melissa/0000-0002-5391-7838; Nathanson, Katherine/0000-0002-6740-0901; Vultur, Adina/0000-0003-0068-9496	NIH [PO1 CA114046, P01 CA025874, P30 CA010815, R01 CA047159, CA076674]; Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); NATIONAL CANCER INSTITUTE [R01CA047159, T32CA009615, P30CA016520, K01CA175269, P01CA114046, P01CA025874, P30CA010815] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P Sompalli and F Raman for technical assistance. We thank GlaxoSmithKline for SB590885, and Dr L Raptis (Queen's University, Canada) for CPA-7. We also thank R Delgiacco of the Wistar Histology Facility. AV, JV, KLN and MH are members of the ITMAT-University of Pennsylvania. This work was supported by NIH grants PO1 CA114046, P01 CA025874, P30 CA010815, R01 CA047159 and CA076674, and by the Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF).	Arulanandam R, 2009, MOL CANCER RES, V7, P1310, DOI 10.1158/1541-7786.MCR-08-0469; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gowrishankar K, 2012, J INVEST DERMATOL, V132, P1850, DOI 10.1038/jid.2012.63; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Haass NK, 2004, J MOL HISTOL, V35, P309; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; ILIOPOULOS D, 1989, J NATL CANCER I, V81, P440, DOI 10.1093/jnci/81.6.440; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Littlefield SL, 2008, INORG CHEM, V47, P2798, DOI 10.1021/ic702057q; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nissan MH, 2011, CURR ONCOL REP, V13, P479, DOI 10.1007/s11912-011-0198-4; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; Satyamoorthy K, 2003, CANCER RES, V63, P756; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vultur A, 2004, ONCOGENE, V23, P2600, DOI 10.1038/sj.onc.1207378; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; Weng YI, 2008, ALCOHOL, V42, P397, DOI 10.1016/j.alcohol.2008.02.004; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zipser MC, 2011, PIGM CELL MELANOMA R, V24, P326, DOI 10.1111/j.1755-148X.2010.00823.x; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	55	66	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1850	1861		10.1038/onc.2013.131	http://dx.doi.org/10.1038/onc.2013.131			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23624919	Green Accepted			2022-12-25	WOS:000334345500011
J	Mallick, J; Whiteway, M				Mallick, Jaideep; Whiteway, Malcolm			The Evolutionary Rewiring of the Ribosomal Protein Transcription Pathway Modifies the Interaction of Transcription Factor Heteromer Ifh1-Fhl1 (Interacts with Forkhead 1-Forkhead-like 1) with the DNA-binding Specificity Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; GENE-EXPRESSION; YEAST; GROWTH; IDENTIFICATION; PROMOTERS; DOMAINS; RAP1	The genes encoding the ribosomal proteins of fungi form a regulon whose expression is enhanced under good growth conditions and down-regulated under starvation conditions. The fungal pathogen Candida albicans contains an evolutionarily ancient control circuit for this regulon where a heteromer made up of the transcription regulators Ifh1 (interacts with Forkhead 1) and Fhl1 (Forkhead-like 1) is targeted to the ribosomal protein genes by the DNA binding factor Tbf1. In the more recently evolved circuit in the model yeast Saccharomyces cerevisiae (Sc), the generalist repressor-activator protein Rap1 now directs the Ifh1-Fhl1 module to the ribosomal protein genes. Even though overall sequence similarity is low for the respective Fhl1 and Ifh1 subunits, in both species, the Ifh1 protein links to the Forkhead-associated domain of Fhl1 through its FHB domain. Intriguingly, correlated with the transition to the Rap1-regulated circuit, the Sc-Ifh1 contains a Rap1 binding domain that is not present in the C. albicans protein. Because no extensive common sequences are found in Tbf1 and Rap1, it appears that these targeting proteins must connect to the Ifh1-Fhl1 module in distinct ways. Two-hybrid and co-immunoprecipitation analysis has been used to show that in C. albicans Tbf1 is linked to the heterodimer through direct association with Fhl1. By contrast, in S. cerevisiae, the linkage of the heteromer to Rap1 occurs through Ifh1. Thus, in the ascomycetes, the Ifh1-Fhl1 heterodimer has reconfigured its protein associations to remain connected to the ribosomal protein regulon despite rewiring of the targeting transcription factor from Tbf1 to Rap1.	[Whiteway, Malcolm] Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Concordia University - Canada; McGill University	Whiteway, M (corresponding author), Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, 7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada.	malcolm.whiteway@concordia.ca			Canadian Institute for Health Research Grant [MOP-42516]	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute for Health Research Grant MOP-42516 (to M. W.).	Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cote P, 2011, MBIO, V2, DOI 10.1128/mBio.00230-10; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Habib N, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.50; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lavoie H, 2009, CURR OPIN MICROBIOL, V12, P655, DOI 10.1016/j.mib.2009.09.015; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li H, 2010, CURR BIOL, V20, pR746, DOI 10.1016/j.cub.2010.06.056; Martchenko M, 2007, EUKARYOT CELL, V6, P291, DOI 10.1128/EC.00183-06; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Preti M, 2010, MOL CELL, V38, P614, DOI 10.1016/j.molcel.2010.04.016; Ribaud V, 2012, EMBO J, V31, P138, DOI 10.1038/emboj.2011.349; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; UEMURA H, 1990, MOL CELL BIOL, V10, P6389, DOI 10.1128/MCB.10.12.6389; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zhu L, 2011, METHODS MOL BIOL, V754, P167, DOI 10.1007/978-1-61779-154-3_9; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	47	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17508	17519		10.1074/jbc.M112.436683	http://dx.doi.org/10.1074/jbc.M112.436683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625919	Green Published, hybrid			2022-12-25	WOS:000320380600042
J	Wessel, SR; Marceau, AH; Massoni, SC; Zhou, RB; Ha, T; Sandler, SJ; Keck, JL				Wessel, Sarah R.; Marceau, Aimee H.; Massoni, Shawn C.; Zhou, Ruobo; Ha, Taekjip; Sandler, Steven J.; Keck, James L.			PriC-mediated DNA Replication Restart Requires PriC Complex Formation with the Single-stranded DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; EXONUCLEASE-I; STRUCTURAL BASIS; 2 MODES; SSB; FORKS; RECOMBINATION; PRIMOSOME; HELICASE; INITIATION	Frequent collisions between cellular DNA replication complexes (replisomes) and obstacles such as damaged DNA or frozen protein complexes make DNA replication fork progression surprisingly sporadic. These collisions can lead to the ejection of replisomes prior to completion of replication, which, if left unrepaired, results in bacterial cell death. As such, bacteria have evolved DNA replication restart mechanisms that function to reload replisomes onto abandoned DNA replication forks. Here, we define a direct interaction between PriC, a key Escherichia coli DNA replication restart protein, and the single-stranded DNA-binding protein (SSB), a protein that is ubiquitously associated with DNA replication forks. PriC/SSB complex formation requires evolutionarily conserved residues from both proteins, including a pair of Arg residues from PriC and the C terminus of SSB. In vitro, disruption of the PriC/SSB interface by sequence changes in either protein blocks the first step of DNA replication restart, reloading of the replicative DnaB helicase onto an abandoned replication fork. Consistent with the critical role of PriC/SSB complex formation in DNA replication restart, PriC variants that cannot bind SSB are non-functional in vivo. Single-molecule experiments demonstrate that PriC binding to SSB alters SSB/DNA complexes, exposing single-stranded DNA and creating a platform for other proteins to bind. These data lead to a model in which PriC interaction with SSB remodels SSB/DNA structures at abandoned DNA replication forks to create a DNA structure that is competent for DnaB loading.	[Wessel, Sarah R.; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Massoni, Shawn C.; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Keck, JL (corresponding author), 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Keck, James/0000-0002-5961-0220; Zhou, Ruobo/0000-0001-8628-0282	National Institutes of Health [GM098885, GM065367]; National Science Foundation [0822613]; National Institutes of Health in Molecular Biosciences [GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, R01GM065367, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health in Molecular Biosciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098885 (to J. L. K. and S. J. S.) and GM065367 (to T. H.), National Science Foundation Grant 0822613 (to T. H). T. H. is an employee of the Howard Hughes Medical Institute. J. L. K. is cofounder of Replisoma, Inc.; Supported in part by National Institutes of Health Training Grant GM07215 in Molecular Biosciences.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Heller RC, 2007, DNA REPAIR, V6, P945, DOI 10.1016/j.dnarep.2007.02.014; Inoue J, 2011, J BIOL CHEM, V286, P6720, DOI 10.1074/jbc.M110.164210; James P, 1996, GENETICS, V144, P1425; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Manhart CM, 2013, J BIOL CHEM, V288, P3989, DOI 10.1074/jbc.M112.435966; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; McCool JD, 2004, GENETICS, V167, P569, DOI 10.1534/genetics.103.025296; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; WANG TCV, 1982, J BACTERIOL, V151, P186, DOI 10.1128/JB.151.1.186-192.1982; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yeeles JTP, 2010, DNA REPAIR, V9, P276, DOI 10.1016/j.dnarep.2009.12.016; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	47	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17569	17578		10.1074/jbc.M113.478156	http://dx.doi.org/10.1074/jbc.M113.478156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629733	Green Published, hybrid			2022-12-25	WOS:000320380600048
J	Bai, JS; Li, JG; Mao, Q				Bai, Jiasi; Li, Jungang; Mao, Qing			Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; REGULATED GENE-EXPRESSION; TRANSGENIC MICE; PLASMINOGEN-ACTIVATOR; ANTIVIRAL ACTIVITY; ADENOVIRUS VECTOR; MAMMALIAN-CELLS; MOUSE; DOXYCYCLINE; BRAIN	The SCID-beige/Alb-uPA mouse model is currently the best small animal model available for viral hepatitis infection studies [1]. But the construction procedure is often costly and time-consuming due to logistic and technical difficulties. Thus, the widespread application of these chimeric mice has been hampered [2]. In order to optimize the procedure, we constructed a single lentiviral vector containing modified tetracycline-regulated system to control Alb-uPA gene expression in the cultured hepatocytes. The modified albumin promoter controlled by tetracycline (Tet)-dependent transactivator rtTA2S-M2 was integrated into a lentiviral vector. The full-length uPA cDNA was inserted into another lentiviral vector containing PTight, a modified Tet-responsive promoter. Two vectors were then digested by specific enzymes and ligated by DNA ligase 4. The ligated DNA fragment was inserted into a modified pLKO.1 cloning vector and the final lentiviral vector was then successfully constructed. H2.35 cell, Lewis lung carcinoma, primary kidney, primary hepatic interstitial and CT26 cells were infected with recombinant lentivirus at selected MOI. The expression of uPA induced by DOX was detectable only in the infected H2.35 cells, which was confirmed by real-time PCR and Western blot analysis. Moreover, DOX induced uPA expression on the infected H2.35 cells in a dose-dependent manner. The constructed single lentiviral vector has many biological advantages, including that the interested gene expression under "Tet-on/off" system is controlled by DOX in a dose-depending fashion only in murine liver cells, which provides an advantage for simplifying generation of conditional transgenic animals.	[Bai, Jiasi; Li, Jungang; Mao, Qing] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China	Army Medical University	Mao, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China.	qingmao@tmmu.edu.cn			National Natural Science Foundation of China [0200972597]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This topic is supported by the National Natural Science Foundation of China (0200972597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, CLONTECHNIQUES, VXVIII, P13; Aurisicchio L, 2001, GENE THER, V8, P1817, DOI 10.1038/sj.gt.3301596; Backman CM, 2004, J NEUROSCI METH, V139, P257, DOI 10.1016/j.jneumeth.2004.05.012; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bohl D, 1998, BLOOD, V92, P1512, DOI 10.1182/blood.V92.5.1512.417k43_1512_1517; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; Corti O, 1999, NAT BIOTECHNOL, V17, P349, DOI 10.1038/7901; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Fitzsimons HL, 2001, GENE THER, V8, P1675, DOI 10.1038/sj.gt.3301582; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Julander JG, 2003, ANTIVIR RES, V59, P155, DOI 10.1016/S0166-3542(03)00109-8; Julander JG, 2002, ANTIVIR RES, V55, P27, DOI 10.1016/S0166-3542(01)00223-6; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Sun Y, 2007, ACTA BIOCH BIOPH SIN, V39, P235, DOI 10.1111/j.1745-7270.2007.00258.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Vogel R, 2004, HUM GENE THER, V15, P157, DOI 10.1089/104303404772679968; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Zabala M, 2004, CANCER RES, V64, P2799, DOI 10.1158/0008-5472.CAN-03-3061; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhu Z, 2001, J BIOL CHEM, V276, P25222, DOI 10.1074/jbc.M101512200; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	29	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61412	10.1371/journal.pone.0061412	http://dx.doi.org/10.1371/journal.pone.0061412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626683	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400046
J	Kolb, GS; Palmborg, C; Hamback, PA				Kolb, Gundula S.; Palmborg, Cecilia; Hamback, Peter A.			Ecological Stoichiometry and Density Responses of Plant-Arthropod Communities on Cormorant Nesting Islands	PLOS ONE			English	Article							BOTTOM-UP; TROPHIC CASCADES; TOP-DOWN; NITROGEN; PHOSPHORUS; TERRESTRIAL; LIMITATION; PREDATION; QUALITY; GROWTH	Seabirds deposit large amounts of nutrient rich guano on their nesting islands. The increased nutrient availability strongly affects plants and consumers. Consumer response differs among taxonomic groups, but mechanisms causing these differences are poorly understood. Ecological stoichiometry might provide tools to understand these mechanisms. ES suggests that nutrient rich taxa are more likely to be nutrient limited than nutrient poorer taxa and are more favored under nutrient enrichment. Here, we quantified differences in the elemental composition of soil, plants, and consumers between islands with and without nesting cormorant colonies and tested predictions made based on ES by relating the elemental composition and the eventual mismatch between consumer and resource stoichiometry to observed density differences among the island categories. We found that nesting cormorants radically changed the soil nutrient content and thereby indirectly plant nutrient content and resource quality to herbivores. In contrast, consumers showed only small differences in their elemental composition among the island categories. While we cannot evaluate the cause of the apparent homeostasis of invertebrates without additional data, we can conclude that from the perspective of the next trophic level, there is no difference in diet quality (in terms of N and P content) between island categories. Thus, bottom-up effects seemed mainly be mediated via changes in resource quantity not quality. Despite a large potential trophic mismatch we were unable to observe any relation between the invertebrate stoichiometry and their density response to nesting cormorant colonies. We conclude that in our system stoichiometry is not a useful predictor of arthropod responses to variation in resource nutrient content. Furthermore, we found no strong evidence that resource quality was a prime determinant of invertebrate densities. Other factors like resource quantity, habitat structure and species interactions might be more important or masked stoichiometric effects.	[Kolb, Gundula S.; Hamback, Peter A.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Palmborg, Cecilia] Swedish Univ Agr Sci, Dept Agr Res Northern Sweden, S-90183 Umea, Sweden	Stockholm University; Swedish University of Agricultural Sciences	Kolb, GS (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	gkolb@botan.su.se	Hambäck, Peter A/A-8194-2008	Hambäck, Peter A/0000-0001-6362-6199	Swedish Research Council Formas [2007-458]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Funding was provided by the Swedish Research Council Formas (2007-458 to PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Apple JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007807; Augustine DJ, 2003, J APPL ECOL, V40, P137, DOI 10.1046/j.1365-2664.2003.00778.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BERENDSE F, 1994, OIKOS, V71, P253, DOI 10.2307/3546273; Bishop JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013598; Couture JJ, 2010, CHEMOECOLOGY, V20, P277, DOI 10.1007/s00049-010-0058-y; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Ellis JC, 2011, SEABIRD ISLANDS ECOL; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2005, FRESHWATER BIOL, V50, P1826, DOI 10.1111/j.1365-2427.2005.01453.x; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Hall SR, 2009, ANNU REV ECOL EVOL S, V40, P503, DOI 10.1146/annurev.ecolsys.39.110707.173518; Hamback PA, 2009, OIKOS, V118, P615, DOI 10.1111/j.1600-0706.2009.17177.x; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hesse P. R., 1971, TXB SOIL CHEM ANAL; HESSEN DO, 1992, AM NAT, V140, P799, DOI 10.1086/285441; HUNTER MD, 1992, ECOLOGY, V73, P724; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Iwabuchi T, 2010, ECOL RES, V25, P619, DOI 10.1007/s11284-010-0692-4; Kagata H, 2006, ECOL RES, V21, P26, DOI 10.1007/s11284-005-0124-z; Kagata H, 2005, ECOL ENTOMOL, V30, P58, DOI 10.1111/j.0307-6946.2005.00667.x; Kolb GS, 2011, SEABIRD ISLANDS ECOL; Kolb GS, 2012, ECOGRAPHY, V35, P726, DOI 10.1111/j.1600-0587.2011.06808.x; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; Loaiza V, 2011, INSECT SCI, V18, P533, DOI 10.1111/j.1744-7917.2010.01376.x; Matsumura M, 2004, ECOLOGY, V85, P2601, DOI 10.1890/03-0629; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Small GE, 2010, OECOLOGIA, V162, P581, DOI 10.1007/s00442-009-1489-4; STAAV R, 2008, LEVANDE SKARGARDSNAT; STAAV R, 2010, LEVANDE SKARGARDSNAT; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tecator F, 1992, 500192 ASN; Tecator F, 1984, 5084 AN; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Towns DR, 2009, OIKOS, V118, P420, DOI 10.1111/j.1600-0706.2008.17186.x; Urabe J, 2002, ECOLOGY, V83, P619, DOI 10.2307/3071868; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; Waring G, 1992, PLANT INSECT INTERAC, P197; White T. C. R., 1993, INADEQUATE ENV NITRO; Woods HA, 2004, FUNCT ECOL, V18, P103, DOI 10.1111/j.1365-2435.2004.00823.x	60	8	9	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61772	10.1371/journal.pone.0061772	http://dx.doi.org/10.1371/journal.pone.0061772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626727	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400091
J	Kurabi, A; Pak, K; Dang, XT; Coimbra, R; Eliceiri, BP; Ryan, AF; Baird, A				Kurabi, Arwa; Pak, Kwang; Dang, Xitong; Coimbra, Raul; Eliceiri, Brian P.; Ryan, Allen F.; Baird, Andrew			Ecrg4 Attenuates the Inflammatory Proliferative Response of Mucosal Epithelial Cells to Infection	PLOS ONE			English	Article							CANCER-RELATED GENE; MIDDLE-EAR MUCOSA; INNATE IMMUNE-RESPONSES; TUMOR-SUPPRESSOR ECRG4; ESOPHAGEAL CANCER; PROTEIN-KINASE; GROWTH-FACTORS; MOUSE MODELS; EXPRESSION; RECEPTORS	We report an inverse relationship between expression of the orphan candidate tumor suppressor gene esophageal cancer related gene 4 (Ecrg4), and the mucosal epithelial cell response to infection in the middle ear (ME). First, we found constitutive Ecrg4 mRNA expression in normal, quiescent ME mucosa that was confirmed by immunostainning of mucosal epithelial cells and immunoblotting of tissue lysates for the 14 kDa Ecrg4 protein. Upon experimental ME infection, Ecrg4 gene expression rapidly decreased by over 80%, between 3 to 48 hrs, post infection. When explants of this infected mucosa were placed in culture and transduced with an adenovirus (AD) encoding Ecrg4 gene (ADEcrg4), the proliferative and migratory responses of mucosal cells were significantly inhibited. ADEcrg4 transduction of control explants from uninfected MEs had no effect on basal growth and migration. Over-expression of Ecrg4 in vivo, by pre-injecting MEs with ADEcrg4 48 hrs prior to infection, prevented the natural down-regulation of Ecrg4, reduced mucosal proliferation and prevented inflammatory cell infiltration normally observed after infection. Taken together, these data support a hypothesis that Ecrg4 plays a role in coordinating the inflammatory and proliferative response to infection of mucosal epithelium suggesting a possible mechanism for its putative anti-tumor activity.	[Kurabi, Arwa; Pak, Kwang; Dang, Xitong; Coimbra, Raul; Eliceiri, Brian P.; Ryan, Allen F.; Baird, Andrew] Univ Calif San Diego, Dept Surg, San Diego Sch Med, La Jolla, CA 92093 USA; [Kurabi, Arwa; Pak, Kwang; Ryan, Allen F.] Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Baird, A (corresponding author), Univ Calif San Diego, Dept Surg, San Diego Sch Med, La Jolla, CA 92093 USA.	anbaird@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916; Baird, Andrew/0000-0003-0027-9905	National Institutes of Health [P20-GM78421, RO1-DC000129]; VA Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012595, R01DC000129, R01DC006279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by the National Institutes of Health grants P20-GM78421 (AB) and RO1-DC000129 (AFR), and by the VA Research Service (AFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird A, 2012, J LEUKOCYTE BIOL, V91, P773, DOI 10.1189/jlb.1011503; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Calandra T, 2003, SCAND J INFECT DIS, V35, P573, DOI 10.1080/00365540310016277; Chai JY, 2010, BIOSCI TRENDS, V4, P130; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Dang XT, 2012, CELL TISSUE RES, V348, P505, DOI 10.1007/s00441-012-1396-6; Ebmeyer J, 2005, J ALLERGY CLIN IMMUN, V116, P1129, DOI 10.1016/j.jaci.2005.07.026; Ebmeyer J, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-12; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Gill N, 2010, NAT IMMUNOL, V11, P558, DOI 10.1038/ni0710-558; Gotze S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-447; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Hirano T, 2007, FEMS IMMUNOL MED MIC, V49, P75, DOI 10.1111/j.1574-695X.2006.00186.x; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Husseman J, 2012, AUDIOL NEURO-OTOL, V17, P148, DOI 10.1159/000333805; Istomin AY, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-48; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Leichtle A, 2012, INNATE IMMUN-LONDON, V18, P3, DOI 10.1177/1753425910393539; Leichtle A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-45; Li L, 2011, EXP TOXICOL PATHOL, V4, P1; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Li W, 2010, J EXP CLIN CANC RES, V29, P1, DOI 10.1186/1756-9966-29-89; Matsuzaki J, 2012, CARCINOGENESIS, V33, P996, DOI 10.1093/carcin/bgs118; Menendez A, 2010, NAT IMMUNOL, V11, P49, DOI 10.1038/ni0110-49; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mori Y, 2007, ONCOL REP, V18, P981; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Ozawa A, 2011, MOL ENDOCRINOL, V25, P776, DOI 10.1210/me.2010-0389; Palacios SD, 2004, INFECT IMMUN, V72, P4662, DOI 10.1128/IAI.72.8.4662-4667.2004; Palacios SD, 2002, J INFECT DIS, V186, P1761, DOI 10.1086/345798; Palacios SD, 2002, LARYNGOSCOPE, V112, P420, DOI 10.1097/00005537-200203000-00002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podvin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024609; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Ryan AF, 2006, BRAIN RES, V1091, P3, DOI 10.1016/j.brainres.2006.02.004; Sabatier R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027656; Shaterian A, 2012, ARCH DERMATOL RES; Wang YB, 2012, HEPATO-GASTROENTEROL, V59, P1696, DOI 10.5754/hge12258; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046	46	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61394	10.1371/journal.pone.0061394	http://dx.doi.org/10.1371/journal.pone.0061394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626679	Green Published, gold			2022-12-25	WOS:000318008400042
J	Madhavan, A; Whitwell, JL; Weigand, SD; Duffy, JR; Strand, EA; Machulda, MM; Tosakulwong, N; Senjem, ML; Gunter, JL; Lowe, VJ; Petersen, RC; Jack, CR; Josephs, KA				Madhavan, Ajay; Whitwell, Jennifer L.; Weigand, Stephen D.; Duffy, Joseph R.; Strand, Edythe A.; Machulda, Mary M.; Tosakulwong, Nirubol; Senjem, Matthew L.; Gunter, Jeffrey L.; Lowe, Val J.; Petersen, Ronald C.; Jack, Clifford R., Jr.; Josephs, Keith A.			FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer's Type	PLOS ONE			English	Article							3 VARIANTS; FRONTOTEMPORAL DEMENTIA; DEFINED SUBTYPES; DISEASE; PATHOLOGY; ANATOMY; APRAXIA; SPEECH; IMAGES	Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of Alzheimer's disease which is typically characterized by left temporoparietal atrophy on magnetic resonance imaging and hypometabolism on F-18 fluorodeoxyglucose positron emission tomography. We aimed to characterize and compare patterns of atrophy and hypometabolism in logopenic primary progressive aphasia, and determine which brain regions and imaging modality best differentiates logopenic primary progressive aphasia from typical dementia of the Alzheimer's type. Methods: A total of 27 logopenic primary progressive aphasia subjects underwent fluorodeoxyglucose positron emission tomography and volumetric magnetic resonance imaging. These subjects were matched to 27 controls and 27 subjects with dementia of the Alzheimer's type. Patterns of atrophy and hypometabolism were assessed at the voxel and region-level using Statistical Parametric Mapping. Penalized logistic regression analysis was used to determine what combinations of regions best discriminate between groups. Results: Atrophy and hypometabolism was observed in lateral temporoparietal and medial parietal lobes, left greater than right, and left frontal lobe in the logopenic group. The logopenic group showed greater left inferior, middle and superior lateral temporal atrophy (inferior p = 0.02; middle p = 0.007, superior p = 0.002) and hypometabolism (inferior p = 0.006, middle p = 0.002, superior p = 0.001), and less right medial temporal atrophy (p = 0.02) and hypometabolism (p < 0.001), and right posterior cingulate hypometabolism (p < 0.001) than dementia of the Alzheimer's type. An age-adjusted penalized logistic model incorporating atrophy and hypometabolism achieved excellent discrimination (area under the receiver operator characteristic curve = 0.89) between logopenic and dementia of the Alzheimer's type subjects, with optimal discrimination achieved using right medial temporal and posterior cingulate hypometabolism, left inferior, middle and superior temporal hypometabolism, and left superior temporal volume. Conclusions: Patterns of atrophy and hypometabolism both differ between logopenic primary progressive aphasia and dementia of the Alzheimer's type and both modalities provide excellent discrimination between groups.	[Madhavan, Ajay; Whitwell, Jennifer L.; Lowe, Val J.; Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Weigand, Stephen D.; Tosakulwong, Nirubol] Mayo Clin, Dept Hlth Sci Res Biostat, Rochester, MN USA; [Duffy, Joseph R.; Strand, Edythe A.] Mayo Clin, Dept Neurol Speech Pathol, Rochester, MN USA; [Petersen, Ronald C.; Josephs, Keith A.] Mayo Clin, Dept Neurol Behav Neurol, Rochester, MN USA; [Machulda, Mary M.] Mayo Clin, Dept Psychiat & Psychol Neuropsychol, Rochester, MN USA; [Senjem, Matthew L.; Gunter, Jeffrey L.] Mayo Clin, Dept Informat Technol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Whitwell, JL (corresponding author), Mayo Clin, Dept Radiol, Rochester, MN 55905 USA.	whitwell.jennifer@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X	National Institutes of Health [R01-DC010367, R01-AG011378, P50-AG016574]; NATIONAL INSTITUTE ON AGING [P50AG016574, R01AG011378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was funded by National Institutes of Health grants R01-DC010367 (PI Josephs), R01-AG011378 (PI Jack), and P50-AG016574 (PI Petersen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gefen T, 2012, BRAIN, V135, P1554, DOI 10.1093/brain/aws076; Gorno-Tempini ML, 2008, NEUROLOGY, V71, P1227, DOI 10.1212/01.wnl.0000320506.79811.da; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Harrell FE, 2001, REGRESSION MODELING; Henry ML, 2010, CURR OPIN NEUROL, V23, P633, DOI 10.1097/WCO.0b013e32833fb93e; Hu WT, 2010, NEUROLOGY, V75, P595, DOI 10.1212/WNL.0b013e3181ed9c52; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Josephs KA, 2008, NEUROLOGY, V70, P25, DOI 10.1212/01.wnl.0000287073.12737.35; Josephs KA, 2012, BRAIN, V135, P1522, DOI 10.1093/brain/aws032; Josephs KA, 2010, ARCH NEUROL-CHICAGO, V67, P596, DOI 10.1001/archneurol.2010.78; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meltzer CC, 1999, J NUCL MED, V40, P2053; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; MESULAM MM, 1982, ANN NEUROL, V11, P592, DOI 10.1002/ana.410110607; Migliaccio R, 2009, NEUROLOGY, V73, P1571, DOI 10.1212/WNL.0b013e3181c0d427; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Petersen R C, 1990, Aging (Milano), V2, P408; Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451; Ridgway GR, 2012, NEUROLOGY, V79, P80, DOI 10.1212/WNL.0b013e31825dce28; Rogalski E, 2011, J NEUROSCI, V31, P3344, DOI 10.1523/JNEUROSCI.5544-10.2011; Rohrer JD, 2010, NEUROIMAGE, V49, P984, DOI 10.1016/j.neuroimage.2009.08.002; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tang-Wai DF, 2003, ARCH NEUROL-CHICAGO, V60, P1777, DOI 10.1001/archneur.60.12.1777; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	41	78	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62471	10.1371/journal.pone.0062471	http://dx.doi.org/10.1371/journal.pone.0062471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626825	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400189
J	Manavalan, TT; Teng, Y; Litchfield, LM; Muluhngwi, P; Al-Rayyan, N; Klinge, CM				Manavalan, Tissa T.; Teng, Yun; Litchfield, Lacey M.; Muluhngwi, Penn; Al-Rayyan, Numan; Klinge, Carolyn M.			Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTIONAL DOWN-REGULATION; NEGATIVE FEEDBACK LOOP; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; MICRORNA EXPRESSION; ENDOCRINE THERAPY; REPRESSORS ZEB1; PROMOTES EMT; MCF-7 CELLS	Introduction: The role of miRNAs in acquired endocrine-resistant breast cancer is not fully understood. One hallmark of tumor progression is epithelial-to-mesenchymal transition (EMT), characterized by a loss of cell adhesion resulting from reduced E-cadherin and increased cell mobility. miR-200 family members regulate EMT by suppressing expression of transcriptional repressors ZEB1/2. Previously we reported that the expression of miR-200a, miR-200b, and miR-200c was lower in LY2 endocrine-resistant, mesenchymal breast cancer cells compared to parental, endocrine sensitive, epithelial MCF-7 breast cancer cells. Here we investigated the regulation of miR-200 family members and their role in endocrine-sensitivity in breast cancer cells. Results: miR-200 family expression was progressively reduced in a breast cancer cell line model of advancing endocrine/tamoxifen (TAM) resistance. Concomitant with miR-200 decrease, there was an increase in ZEB1 mRNA expression. Overexpression of miR-200b or miR-200c in LY2 cells altered cell morphology to a more epithelial appearance and inhibited cell migration. Further, miR-200b and miR-200c overexpression sensitized LY2 cells to growth inhibition by estrogen receptor (ER) antagonists TAM and fulvestrant. Knockdown of ZEB1 in LY2 cells recapitulated the effect of miR-200b and miR-200c overexpression resulting in inhibition of LY2 cell proliferation by TAM and fulvestrant, but not the aromatase inhibitor exemestane. Demethylating agent 5-aza-2'-deoxycytidine (5-aza-dC) in combination with histone deacetylase inhibitor trichostatin A (TSA) increased miR-200b and miR-200c in LY2 cells. Concomitant with the increase in miR-200b and miR-200c, ZEB1 expression was decreased and cells appeared more epithelial in morphology and were sensitized to TAM and fulvestrant inhibition. Likewise, knockdown of ZEB1 increased antiestrogen sensitivity of LY2 cells resulting in inhibition of cell proliferation. Conclusions: Our data indicate that reduced miRNA-200b and miR-200c expression contributes to endocrine resistance in breast cancer cells and that the reduced expression of these miR-200 family members in endocrine-resistant cells can be reversed by 5-aza-dC+TSA.	[Manavalan, Tissa T.; Teng, Yun; Litchfield, Lacey M.; Muluhngwi, Penn; Al-Rayyan, Numan; Klinge, Carolyn M.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu		Klinge, Carolyn/0000-0002-3358-4378	National Institutes of Health [R01 CA138410]; National Institute of Environmental Health Sciences [T32 ES011564]; NATIONAL CANCER INSTITUTE [R01CA138410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health R01 CA138410 to CMK. LML was supported by a predoctoral fellowship from National Institute of Environmental Health Sciences T32 ES011564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; BRONZERT DA, 1985, ENDOCRINOLOGY, V117, P1409, DOI 10.1210/endo-117-4-1409; BRUNNER N, 1993, CANCER RES, V53, P3229; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Hiscox S, 2006, ENDOCR-RELAT CANCER, V13, P1085, DOI 10.1677/erc.1.01270; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Hostetter CL, 2009, CANCER LETT, V275, P178, DOI 10.1016/j.canlet.2008.10.005; Howe EN, 2012, J MAMMARY GLAND BIOL; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim MR, 2009, CANCER SCI, V100, P1834, DOI 10.1111/j.1349-7006.2009.01260.x; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li Y, 2009, CANC RES, P0008; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McIlroy M, 2010, CANCER RES, V70, P1585, DOI 10.1158/0008-5472.CAN-09-3713; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Riggins RB, 2005, MOL CANCER THER, V4, P33; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Sarvilinna N, 2006, INT J CANCER, V118, P832, DOI 10.1002/ijc.21431; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vesuna F, 2011, ONCOGENE; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Ward A., 2012, ONCOGENE; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; Wright JA, 2010, J MAMMARY GLAND BIOL, V15, P213, DOI 10.1007/s10911-010-9183-z; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	69	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62334	10.1371/journal.pone.0062334	http://dx.doi.org/10.1371/journal.pone.0062334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626803	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400167
J	Salido, EM; Dorfman, D; Bordone, M; Chianelli, M; Fleitas, MFG; Rosenstein, RE				Salido, Ezequiel M.; Dorfman, Damian; Bordone, Melina; Chianelli, Monica; Gonzalez Fleitas, Maria Florencia; Rosenstein, Ruth E.			Global and Ocular Hypothermic Preconditioning Protect the Rat Retina from Ischemic Damage	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GANGLION-CELLS; GLUTAMINE-SYNTHETASE; CIRCULATORY ARREST; LOCAL HYPOTHERMIA; NMDA RECEPTORS; NEURONS; MECHANISMS; INDUCTION; TOLERANCE	Retinal ischemia could provoke blindness. At present, there is no effective treatment against retinal ischemic damage. Strong evidence supports that glutamate is implicated in retinal ischemic damage. We investigated whether a brief period of global or ocular hypothermia applied 24 h before ischemia (i.e. hypothermic preconditioning, HPC) protects the retina from ischemia/reperfusion damage, and the involvement of glutamate in the retinal protection induced by HPC. For this purpose, ischemia was induced by increasing intraocular pressure to 120 mm Hg for 40 min. One day before ischemia, animals were submitted to global or ocular hypothermia (33 degrees C and 32 degrees C for 20 min, respectively) and fourteen days after ischemia, animals were subjected to electroretinography and histological analysis. Global or ocular HPC afforded significant functional (electroretinographic) protection in eyes exposed to ischemia/reperfusion injury. A marked alteration of the retinal structure and a decrease in retinal ganglion cell number were observed in ischemic retinas, whereas global or ocular HPC significantly preserved retinal structure and ganglion cell count. Three days after ischemia, a significant decrease in retinal glutamate uptake and glutamine synthetase activity was observed, whereas ocular HPC prevented the effect of ischemia on these parameters. The intravitreal injection of supraphysiological levels of glutamate induced alterations in retinal function and histology which were significantly prevented by ocular HPC. These results support that global or ocular HPC significantly protected retinal function and histology from ischemia/reperfusion injury, probably through a glutamate-dependent mechanism.	[Salido, Ezequiel M.; Dorfman, Damian; Bordone, Melina; Chianelli, Monica; Gonzalez Fleitas, Maria Florencia; Rosenstein, Ruth E.] Univ Buenos Aires, Dept Human Biochem, CEFyBO,CONICET, Lab Retinal Neurochem & Expt Ophthalmol,Sch Med, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, Dept Human Biochem, CEFyBO,CONICET, Lab Retinal Neurochem & Expt Ophthalmol,Sch Med, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar	Salido, Ezequiel Martin/AAF-7166-2021	Salido, Ezequiel Martin/0000-0003-3741-3389; Gonzalez Fleitas, Maria Florencia/0000-0001-5795-8365; Bordone, Melina/0000-0003-4912-228X	Agencia Nacional de Promocion Cientifica y Tecnologica; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica; The University of Buenos Aires; and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, EUR J PHARMACOL, V350, P53, DOI 10.1016/S0014-2999(98)00317-3; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Bhagatte Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.84; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; BUCHAN A, 1992, NEUROL CLIN, V10, P49, DOI 10.1016/S0733-8619(18)30233-0; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Cambria RP, 1997, J VASC SURG, V25, P234, DOI 10.1016/S0741-5214(97)70365-3; Cazevieille C, 1997, BRAIN RES, V755, P91, DOI 10.1016/S0006-8993(97)00090-5; Corbett D, 2000, EXP NEUROL, V163, P200, DOI 10.1006/exnr.2000.7369; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; FABEROWSKI N, 1989, INVEST OPHTH VIS SCI, V30, P2309; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; IKEDA H, 1992, EXP EYE RES, V55, P435, DOI 10.1016/0014-4835(92)90116-A; IVERSEN L L, 1991, Eye (London), V5, P194; Izumi Y, 2003, VISUAL NEUROSCI, V20, P97, DOI 10.1017/S0952523803202017; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; Leben J, 1997, ANN NY ACAD SCI, V813, P807, DOI 10.1111/j.1749-6632.1997.tb51785.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; MOSINGER JL, 1991, EXP NEUROL, V113, P10, DOI 10.1016/0014-4886(91)90140-8; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NAKATA N, 1993, NEUROREPORT, V4, P695, DOI 10.1097/00001756-199306000-00023; NAYAK MS, 1995, CURR EYE RES, V14, P81, DOI 10.3109/02713689508999918; NEAL MJ, 1994, J NEUROCHEM, V62, P1025; Ning XH, 1998, AM J PHYSIOL-HEART C, V274, pH786, DOI 10.1152/ajpheart.1998.274.3.H786; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Poitry S, 2000, J NEUROSCI, V20, P1809; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; Roth S, 2004, BRAIN RES BULL, V62, P461, DOI 10.1016/j.brainresbull.2003.07.006; Roth S, 1998, INVEST OPHTH VIS SCI, V39, P777; Sakamoto K, 2004, BRAIN RES, V1015, P154, DOI 10.1016/j.brainres.2004.04.074; SARTHY PV, 1978, J CELL BIOL, V78, P675, DOI 10.1083/jcb.78.3.675; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SOLOMON RA, 1991, NEUROSURGERY, V29, P732, DOI 10.1227/00006123-199111000-00015; Sumioka K, 2000, INVEST OPHTH VIS SCI, V41, P29; Tamai K, 1997, EXP EYE RES, V65, P733, DOI 10.1006/exer.1997.0386; THARION J, 1982, J THORAC CARDIOV SUR, V84, P66; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Wang RB, 2010, J NEUROTRAUM, V27, P763, DOI 10.1089/neu.2009.1005; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Yunoki M, 2002, J NEUROSURG, V97, P650, DOI 10.3171/jns.2002.97.3.0650	54	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61656	10.1371/journal.pone.0061656	http://dx.doi.org/10.1371/journal.pone.0061656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626711	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400075
J	He, B; Li, ZS; Yang, FL; Zheng, JF; Feng, Y; Guo, HC; Li, YY; Wang, YY; Su, N; Zhang, FQ; Fan, QS; Tu, CC				He, Biao; Li, Zuosheng; Yang, Fanli; Zheng, Junfeng; Feng, Ye; Guo, Huancheng; Li, Yingying; Wang, Yiyin; Su, Nan; Zhang, Fuqiang; Fan, Quanshui; Tu, Changchun			Virome Profiling of Bats from Myanmar by Metagenomic Analysis of Tissue Samples Reveals More Novel Mammalian Viruses	PLOS ONE			English	Article							COMPLETE GENOME ANALYSIS; GENETIC DIVERSITY; SEQUENCE-ANALYSIS; VIRAL COMMUNITY; NIPAH VIRUS; CIRCOVIRUSES; ASTROVIRUSES; PREVALENCE; DISCOVERY; IDENTIFICATION	Bats are reservoir animals harboring many important pathogenic viruses and with the capability of transmitting these to humans and other animals. To establish an effective surveillance to monitor transboundary spread of bat viruses between Myanmar and China, complete organs from the thorax and abdomen from 853 bats of six species from two Myanmar counties close to Yunnan province, China, were collected and tested for their virome through metagenomics by Solexa sequencing and bioinformatic analysis. In total, 3,742,314 reads of 114 bases were generated, and over 86% were assembled into 1,649,512 contigs with an average length of 114 bp, of which 26,698 (2%) contigs were recognizable viral sequences belonging to 24 viral families. Of the viral contigs 45% (12,086/26,698) were related to vertebrate viruses, 28% (7,443/26,698) to insect viruses, 27% (7,074/26,698) to phages and 95 contigs to plant viruses. The metagenomic results were confirmed by PCR of selected viruses in all bat samples followed by phylogenetic analysis, which has led to the discovery of some novel bat viruses of the genera Mamastrovirus, Bocavirus, Circovirus, Iflavirus and Orthohepadnavirus and to their prevalence rates in two bat species. In conclusion, the present study aims to present the bat virome in Myanmar, and the results obtained further expand the spectrum of viruses harbored by bats.	[He, Biao; Yang, Fanli; Feng, Ye; Guo, Huancheng; Li, Yingying; Tu, Changchun] Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China; [Li, Zuosheng; Zheng, Junfeng; Li, Yingying; Zhang, Fuqiang; Fan, Quanshui] Chengdu Mil Reg Peoples Liberat Army, Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Fan, QS (corresponding author), Chengdu Mil Reg Peoples Liberat Army, Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China.	fqs168@126.com; changchun_tu@hotmail.com	su, nan/GRS-5213-2022		NSFC-Yunnan Province [U1036601]; National "973" Program [2012CB722501]; National "863" Program [2012AA022006]	NSFC-Yunnan Province(National Natural Science Foundation of China (NSFC)); National "973" Program(National Basic Research Program of China); National "863" Program(National High Technology Research and Development Program of China)	The study was supported by NSFC-Yunnan Province Joint Fund (U1036601), National "973" Program (grant no. 2012CB722501) and National "863" Program (grant no. 2012AA022006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Bassami MR, 1998, VIROLOGY, V249, P453, DOI 10.1006/viro.1998.9324; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Cui J, 2012, J VIROL, V86, P4288, DOI 10.1128/JVI.06624-11; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; International Committee on Taxonomy of Viruses, ICTV 2011 MAST SPEC; International Committee on Taxonomy of Viruses, ICTV 2009 MAST SPEC; Kapoor A, 2012, J VIROL, V86, P7018, DOI 10.1128/JVI.00791-12; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kuzmin IV, 2010, VIRUS RES, V149, P197, DOI 10.1016/j.virusres.2010.01.018; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2010, J GEN VIROL, V91, P2601, DOI 10.1099/vir.0.020032-0; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Qu XW, 2007, EMERG INFECT DIS, V13, P165; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rivera R, 2010, J GEN VIROL, V91, P166, DOI 10.1099/vir.0.015222-0; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Shirato K, 2012, VIRUS GENES, V44, P40, DOI 10.1007/s11262-011-0661-1; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Steward GF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-287; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tidona CA, 2000, VIRUS GENES, V21, P77, DOI 10.1023/A:1008192616923; Todd D, 2007, AVIAN PATHOL, V36, P75, DOI 10.1080/03079450601113654; Todd D, 2001, VIROLOGY, V286, P354, DOI 10.1006/viro.2001.0985; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031; Vereecken M, 1998, AVIAN PATHOL, V27, P333, DOI 10.1080/03079459808419348; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Walls T, 2003, LANCET INFECT DIS, V3, P79, DOI 10.1016/S1473-3099(03)00515-2; Wang JL, 2009, EMERG INFECT DIS, V15, P939, DOI 10.3201/eid1506.081525; Wang PiYu, 2009, China Tropical Medicine, V9, P1561; Wang XC, 2004, J GEN VIROL, V85, P1145, DOI 10.1099/vir.0.19638-0; Weitzman MD, 2011, METHODS MOL BIOL, V807, P1, DOI 10.1007/978-1-61779-370-7_1; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Xiao JP, 2011, ARCH VIROL, V156, P1415, DOI 10.1007/s00705-011-1011-2; ZHANG H, 1989, Chinese Journal of Virology, V5, P31; Zhang Hai-lin, 2001, Virologica Sinica, V16, P74; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0	73	94	108	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61950	10.1371/journal.pone.0061950	http://dx.doi.org/10.1371/journal.pone.0061950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630620	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500073
J	Hoglund, RA; Holmoy, T; Harbo, HF; Maghazachi, AA				Hoglund, Rune A.; Holmoy, Trygve; Harbo, Hanne F.; Maghazachi, Azzam A.			A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)	PLOS ONE			English	Article							T-H-17 CELLS; DIFFERENTIATION; RECEPTOR; CYTOTOXICITY; INHIBITION; EXPRESSION; MECHANISM; MONOCYTES; CNS	Background: Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease. It is thought to be mediated by CD4(+) Th1/Th17 cells. More recently, cells of the innate immune system such as dendritic cells (DCs) and natural killer (NK) cells have been in focus. Glatiramer acetate (GA) is an approved drug for treating MS patients. Methodology/Principal Findings: In the current study we examined the activities of NK and DCs in nine relapsing remitting MS patients for up to one year after initiation of GA treatment. We observed that NK cells isolated from most of these patients have increased cytotoxic activity against K562 cells. Further analysis showed that the same NK cells lysed both autologous immature (i) and mature (m) DCs. In most patients this increased activity was correlated with increased NK cell activating cytotoxicity receptors such as NKp30, NKp44, NKp46 and NKG2D, and reduced expression of the inhibitory molecule CD158 on the surface of these NK cells. The expression of HLA-DR was increased on iDCs and mDCs in the majority of the patients, but no consistency was observed for the expression of HLA-I or HLA-E. Also, the co-stimulatory receptors CD80, CD83 or CD86 expression was down-regulated on iDCs and mDCs in most cases. Further, the expression of CCR6 was increased on mDCs at later time points of therapy (between 32-48 weeks). Conclusions/Significance: Our results are the first showing the effects of GA treatment on NK cells in MS patients, which may impact future use of this and other drugs to treat this disease.	[Hoglund, Rune A.; Maghazachi, Azzam A.] Univ Oslo, Dept Physiol, Inst Med Basal Sci, Oslo, Norway; [Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Oslo, Norway; [Holmoy, Trygve; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Hoglund, RA (corresponding author), Univ Oslo, Dept Physiol, Inst Med Basal Sci, Oslo, Norway.	r.a.hoglund@medisin.uio.no		Hoglund, Rune Alexander/0000-0002-5801-3360; Maghazachi, Azzam/0000-0002-3310-678X	University of Oslo; Vivi Irene Hansens fond til forskning av sykdommen lupus erythematosus disseminatus; Halvor Hoies fond; Faculty of Medicine Research program scholarship, University of Oslo; Biogen Idec; Novarits; Merck Serono; Sanofi Aventis; Bayer Schering; Oslo MS association; Odd Fellow MS society Norway; Novartis Norway; Biogen Idec Norway; Sanofi-Aventis, Norway; Research Council of Norway; South-Eastern Norway Regional Health Authority; Oslo University Hospital	University of Oslo; Vivi Irene Hansens fond til forskning av sykdommen lupus erythematosus disseminatus; Halvor Hoies fond; Faculty of Medicine Research program scholarship, University of Oslo; Biogen Idec(Biogen); Novarits; Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Bayer Schering(Bayer AG); Oslo MS association; Odd Fellow MS society Norway; Novartis Norway(Novartis); Biogen Idec Norway(Biogen); Sanofi-Aventis, Norway; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Oslo University Hospital	This work was supported by grants from the University of Oslo, Vivi Irene Hansens fond til forskning av sykdommen lupus erythematosus disseminatus, and Halvor Hoies fond. Rune A. Hoglund is supported by the Faculty of Medicine Research program scholarship, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Trygve Holmoy has received speakers honoraria and/or research grants from Biogen Idec, Novarits, Merck Serono, Sanofi Aventis, and Bayer Schering. Professor Hanne F. Harbo (MD, PhD) receives research grants to the Multiple Sclerosis (MS) research group at Oslo University Hospital from the Research Council of Norway, South-Eastern Norway Regional Health Authority, University of Oslo and Oslo University Hospital. Some MS research projects in this group are also supported by the Oslo MS association, Odd Fellow MS society Norway, and Novartis Norway. Harbo has during last years received some travel or research support or fee for lectures from Biogen Idec Norway, Novartis Norway and Sanofi-Aventis, Norway. The authors have declared that no competing interests exist in relation to this paper. The authors state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Al-Falahi Y, 2009, J CELL MOL MED, V13, P2693, DOI 10.1111/j.1582-4934.2008.00640.x; Arnon R., 2004, P NATL ACAD SCI U S8, V101; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Berger T, 2009, J NEUROL SCI, V287, pS37, DOI 10.1016/S0022-510X(09)71299-7; Boggild M, 2009, J NEUROL SCI S4, V277; Chanvillard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039625; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Damaj BB, 2007, J IMMUNOL, V179, P7907, DOI 10.4049/jimmunol.179.11.7907; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gauzzi MC, 2005, J LEUKOCYTE BIOL, V77, P944, DOI 10.1189/jlb.0205090; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Kala M, 2011, J NEUROIMMUNOL, V235, P9, DOI 10.1016/j.jneuroim.2011.01.009; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Maghazachi AA, 1998, FASEB J, V12, P913, DOI 10.1096/fasebj.12.11.913; Maghazachi AA, 2013, TOXINS, V5, P363, DOI 10.3390/toxins5020363; Matsumoto Y, 1998, EUR J IMMUNOL, V28, P1681, DOI 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rolin J, 2010, CANCER IMMUNOL IMMUN, V59, P575, DOI 10.1007/s00262-009-0775-7; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Segal BM, 2007, J NEUROIMMUNOL, V191, P2, DOI 10.1016/j.jneuroim.2007.09.006; Takahashi K, 2004, BRAIN, V127, P1917, DOI 10.1093/brain/awh219; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weber MS, 2004, BRAIN, V127, P1370, DOI 10.1093/brain/awh163; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62237	10.1371/journal.pone.0062237	http://dx.doi.org/10.1371/journal.pone.0062237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614042	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500085
J	Kirkeby, C; Bodker, R; Stockmarr, A; Lind, P; Heegaard, PMH				Kirkeby, Carsten; Bodker, Rene; Stockmarr, Anders; Lind, Peter; Heegaard, Peter M. H.			Quantifying Dispersal of European Culicoides (Diptera: Ceratopogonidae) Vectors between Farms Using a Novel Mark-Release-Recapture Technique	PLOS ONE			English	Article							BREEDING SITES; BLUETONGUE; WIND; FLIGHT; ASSOCIATION; EMERGENCE; EPIDEMIC; MODEL; RISK	Studying the dispersal of small flying insects such as Culicoides constitutes a great challenge due to huge population sizes and lack of a method to efficiently mark and objectively detect many specimens at a time. We here describe a novel mark-release-recapture method for Culicoides in the field using fluorescein isothiocyanate (FITC) as marking agent without anaesthesia. Using a plate scanner, this detection technique can be used to analyse thousands of individual Culicoides specimens per day at a reasonable cost. We marked and released an estimated 853 specimens of the Pulicaris group and 607 specimens of the Obsoletus group on a cattle farm in Denmark. An estimated 9,090 (8,918-9,260) Obsoletus group specimens and 14,272 (14,194-14,448) Pulicaris group specimens were captured in the surroundings and subsequently analysed. Two (0.3%) Obsoletus group specimens and 28 (4.6%) Pulicaris group specimens were recaptured. The two recaptured Obsoletus group specimens were caught at the release point on the night following release. Eight (29%) of the recaptured Pulicaris group specimens were caught at a pig farm 1,750 m upwind from the release point. Five of these were recaptured on the night following release and the three other were recaptured on the second night after release. This is the first time that movement of Culicoides vectors between farms in Europe has been directly quantified. The findings suggest an extensive and rapid exchange of disease vectors between farms. Rapid movement of vectors between neighboring farms may explain the the high rate of spatial spread of Schmallenberg and bluetongue virus (BTV) in northern Europe.	[Kirkeby, Carsten; Bodker, Rene; Lind, Peter] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg C, Denmark; [Stockmarr, Anders] Tech Univ Denmark, Dept Appl Math & Comp Sci, DTU Compute, DK-2800 Lyngby, Denmark; [Heegaard, Peter M. H.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Frederiksberg C, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark	Kirkeby, C (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg C, Denmark.	ckir@vet.dtu.dk	Kirkeby, Carsten/GVS-8137-2022; Heegaard, Peter/E-9794-2015	Kirkeby, Carsten/0000-0001-9292-5526; Stockmarr, Anders/0000-0002-8681-2370; BODKER, RENE/0000-0002-8204-3463; Heegaard, Peter/0000-0003-4506-4932	Danish Ministry of Food, Agriculture and Fisheries; EU [GOCE-2003-010284 EDENext]	Danish Ministry of Food, Agriculture and Fisheries; EU(European Commission)	This study was partially funded by the Danish Ministry of Food, Agriculture and Fisheries and by EU grant GOCE-2003-010284 EDENext and is catalogued by the EDENext Steering Committee as EDENext 103 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Benjaminson M, 1969, BIOTECH HISTOCHEM, V44, P27; Bhasin A, 2000, MED VET ENTOMOL, V14, P300, DOI 10.1046/j.1365-2915.2000.00247.x; BRENNER RJ, 1984, MOSQ NEWS, V44, P343; Campbell J. A., 1960, Proceedings of the Royal Society of Edinburgh (Sect B), V67, P181; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; CRUMPACKER DW, 1974, AM MIDL NAT, V91, P118, DOI 10.2307/2424515; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Geier M, 1999, J EXP BIOL, V202, P1639; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; GRACE JK, 1990, SOCIOBIOLOGY, V16, P297; Graesboll K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00863; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hanski I, 2000, ECOLOGY, V81, P239, DOI 10.1890/0012-9658(2000)081[0239:ETPOSA]2.0.CO;2; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Hii J., 2008, MED ENTOMOL, V4, P135; Jamieson IG, 2000, NEW ZEAL J ECOL, V24, P209; Kirkeby C, 2013, PARASITES V IN PRESS; Kirkeby C, 2009, ENTOMOL FENNICA, V20, P228; LILLIE TH, 1985, J AM MOSQUITO CONTR, V1, P463; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; MARQUARDT WC, 2004, BIOL DIS VECTORS; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Nazni W.A., 2005, Tropical Biomedicine, V22, P53; Nielsen SA, 2010, PARASITOL RES, V106, P1197, DOI 10.1007/s00436-010-1791-4; Ninio C, 2011, VET PARASITOL, V183, P125, DOI 10.1016/j.vetpar.2011.07.020; Rigot T, 2013, MED VET ENTOMOL, V27, P29, DOI 10.1111/j.1365-2915.2012.01032.x; Rosewell J, 2008, BIOL J LINN SOC, V32, P373; Sanders C, 2011, J APPL ECOL, V48, P309; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; TURCHIN P, 1993, ECOL APPL, V3, P187, DOI 10.2307/1941801; Zimmer JY, 2008, VET REC, V162, P131, DOI 10.1136/vr.162.4.131	35	28	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61269	10.1371/journal.pone.0061269	http://dx.doi.org/10.1371/journal.pone.0061269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630582	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500026
J	Utkina-Sosunova, IV; Niatsetskaya, ZV; Sosunov, SA; Ratner, VI; Matsiukevich, D; Ten, VS				Utkina-Sosunova, Irina V.; Niatsetskaya, Zoya V.; Sosunov, Sergey A.; Ratner, Veniamin I.; Matsiukevich, Dzmitry; Ten, Vadim S.			Nelfinavir Inhibits Intra-Mitochondrial Calcium Influx and Protects Brain against Hypoxic-Ischemic Injury in Neonatal Mice	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; HIV PROTEASE INHIBITORS; CA-2&-INDUCED MEMBRANE TRANSITION; CYCLOPHILIN-D; CELL-DEATH; COMPLEX-I; PORE; RATS; TRANSLOCATOR; APOPTOSIS	Nelfinavir (NLF), an antiretroviral agent, preserves mitochondrial membranes integrity and protects mature brain against ischemic injury in rodents. Our study demonstrates that in neonatal mice NLF significantly limits mitochondrial calcium influx, the event associated with protection of the brain against hypoxic-ischemic insult (HI). Compared to the vehicle-treated mice, cerebral mitochondria from NLF-treated mice exhibited a significantly greater tolerance to the Ca2+-induced membrane permeabilization, greater ADP-phosphorylating activity and reduced cytochrome C release during reperfusion. Pre-treatment with NLF or Ruthenium red (RuR) significantly improved viability of murine hippocampal HT-22 cells, reduced Ca2+ content and preserved membrane potential (Psi m) in mitochondria following oxygen-glucose deprivation (OGD). Following histamine-stimulated Ca2+ release from endoplasmic reticulum, in contrast to the vehicle-treated cells, the cells treated with NLF or RuR also demonstrated reduced Ca2+ content in their mitochondria, the event associated with preserved Psi m. Because RuR inhibits mitochondrial Ca2+ uniporter, we tested whether the NLF acts via the mechanism similar to the RuR. However, in contrast to the RuR, in the experiment with direct interaction of these agents with mitochondria isolated from naive mice, the NLF did not alter mitochondrial Ca2+ influx, and did not prevent Ca2+ induced collapse of the Psi m. These data strongly argues against interaction of NLF and mitochondrial Ca2+ uniporter. Although the exact mechanism remains unclear, our study is the first to show that NLF inhibits intramitochondrial Ca2+ flux and protects developing brain against HI-reperfusion injury. This novel action of NLF has important clinical implication, because it targets a fundamental mechanism of post-ischemic cell death: intramitochondrial Ca2+ overload -> mitochondrial membrane permeabilization -> secondary energy failure.	[Utkina-Sosunova, Irina V.; Niatsetskaya, Zoya V.; Sosunov, Sergey A.; Ratner, Veniamin I.; Matsiukevich, Dzmitry; Ten, Vadim S.] Columbia Univ, Dept Pediat, New York, NY 10027 USA	Columbia University	Ten, VS (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	vt82@columbia.edu			United States National Institutes of Health [NS071121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071121] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States National Institutes of Health grant NS071121 to VST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Caspersen CS, 2008, DEV NEUROSCI-BASEL, V30, P319, DOI 10.1159/000121416; CROMPTON M, 1990, BIOCHEM J, V266, P33, DOI 10.1042/bj2660033; Dufer M, 2004, N-S ARCH PHARMACOL, V369, P583, DOI 10.1007/s00210-004-0933-6; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1289, DOI 10.1016/j.bbabio.2009.07.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Leger PL, 2010, EXP NEUROL; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lim CS, 2011, CHEM-ASIAN J, V6, P2027, DOI 10.1002/asia.201100156; Liu XD, 2002, ACTA PHARMACOL SIN, V23, P225; Matsiukevich D, 2010, RESUSCITATION, V81, P224, DOI 10.1016/j.resuscitation.2009.11.024; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Puka-Sundvall M, 2001, DEV NEUROSCI-BASEL, V23, P192, DOI 10.1159/000046142; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Ten VS, 2004, STROKE, V35, P2183, DOI 10.1161/01.STR.0000137768.25203.df; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Weaver JGR, 2005, J CLIN INVEST, V115, P1828, DOI 10.1172/JCI22954; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62448	10.1371/journal.pone.0062448	http://dx.doi.org/10.1371/journal.pone.0062448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614049	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500091
J	Hammer, S; de Vries, APJ; de Heer, P; Bizino, MB; Wolterbeek, R; Rabelink, TJ; Doornbos, J; Lamb, HJ				Hammer, Sebastiaan; de Vries, Aiko P. J.; de Heer, Paul; Bizino, Maurice B.; Wolterbeek, Ron; Rabelink, Ton J.; Doornbos, Joost; Lamb, Hildo J.			Metabolic Imaging of Human Kidney Triglyceride Content: Reproducibility of Proton Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; RENAL LIPID-METABOLISM; H-1 MR SPECTROSCOPY; VOLUME TRACKING; SKELETAL-MUSCLE; FAT-CONTENT; IN-VIVO; RISK; MICE; GLOMERULOSCLEROSIS	Objective: To assess the feasibility of renal proton magnetic resonance spectroscopy for quantification of triglyceride content and to compare spectral quality and reproducibility without and with respiratory motion compensation in vivo. Materials and Methods: The Institutional Review Board of our institution approved the study protocol, and written informed consent was obtained. After technical optimization, a total of 20 healthy volunteers underwent renal proton magnetic resonance spectroscopy of the renal cortex both without and with respiratory motion compensation and volume tracking. After the first session the subjects were repositioned and the protocol was repeated to assess reproducibility. Spectral quality (linewidth of the water signal) and triglyceride content were quantified. Bland-Altman analyses and a test by Pitman were performed. Results: Linewidth changed from 11.5 +/- 0.4 Hz to 10.7 +/- 0.4 Hz (all data pooled, p<0.05), without and with respiratory motion compensation respectively. Mean % triglyceride content in the first and second session without respiratory motion compensation were respectively 0.58 +/- 0.12% and 0.51 +/- 0.14% (P=NS). Mean % triglyceride content in the first and second session with respiratory motion compensation were respectively 0.44 +/- 0.10% and 0.43 +/- 0.10% (P=NS between sessions and P=NS compared to measurements with respiratory motion compensation). Bland-Altman analyses showed narrower limits of agreement and a significant difference in the correlated variances (correlation of -0.59, P<0.05). Conclusion: Metabolic imaging of the human kidney using renal proton magnetic resonance spectroscopy is a feasible tool to assess cortical triglyceride content in humans in vivo and the use of respiratory motion compensation significantly improves spectral quality and reproducibility. Therefore, respiratory motion compensation seems a necessity for metabolic imaging of renal triglyceride content in vivo.	[Hammer, Sebastiaan; de Heer, Paul; Bizino, Maurice B.; Doornbos, Joost; Lamb, Hildo J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [de Vries, Aiko P. J.; de Heer, Paul; Doornbos, Joost] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Bizino, Maurice B.] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Wolterbeek, Ron] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hammer, S (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	S.Hammer@lumc.nl	Rabelink, Ton J./A-5316-2008; Lamb, Hildo/ABE-1171-2021; de Vries, Aiko P.J./J-5397-2015	Rabelink, Ton J./0000-0001-6780-5186; Lamb, Hildo/0000-0002-6969-2418; de Vries, Aiko P.J./0000-0002-9284-3595; Hammer, Sebastiaan/0000-0002-1576-1190	Dutch Kidney Foundation [IP11.56]	Dutch Kidney Foundation	This project is supported by an Innovation Grant (IP11.56) from the Dutch Kidney Foundation to APJdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; Boesch C, 2006, NMR BIOMED, V19, P968, DOI 10.1002/nbm.1096; Chughtai HL, 2010, HYPERTENSION, V56, P901, DOI 10.1161/HYPERTENSIONAHA.110.157370; DIXON RM, 1994, MAGNET RESON MED, V31, P482, DOI 10.1002/mrm.1910310503; Dominguez J, 2007, AM J PHYSIOL-RENAL, V293, pF670, DOI 10.1152/ajprenal.00021.2007; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; GOLD M, 1970, LIPIDS, V5, P293, DOI 10.1007/BF02531460; Hammer S, 2008, J AM COLL CARDIOL, V52, P1006, DOI 10.1016/j.jacc.2008.04.068; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Jiang T, 2005, KIDNEY INT, V68, P2608, DOI 10.1111/j.1523-1755.2005.00733.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Katz-Brull R, 2003, MAGNET RESON MED, V50, P461, DOI 10.1002/mrm.10560; Kozerke S, 2002, MAGN RESON MED, V48, P380, DOI 10.1002/mrm.10182; Li ZL, 2011, AM J PHYSIOL-RENAL, V301, pF1078, DOI 10.1152/ajprenal.00333.2011; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.2307/2334971; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reingold JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE935, DOI 10.1152/ajpendo.00095.2005; Rico-Sanz J, 1998, J PHYSIOL-LONDON, V510, P615, DOI 10.1111/j.1469-7793.1998.615bk.x; Schar M, 2004, MAGN RESON MED, V51, P1091, DOI 10.1002/mrm.20123; SCHICK F, 1993, MAGN RESON MED, V29, P158, DOI 10.1007/BF01769418; Sijens PE, 2010, WORLD J GASTROENTERO, V16, P1993, DOI 10.3748/wjg.v16.i16.1993; Sui Y, 2010, AM J PHYSIOL-RENAL, V298, pF391, DOI 10.1152/ajprenal.00445.2009; Szczepaniak LS, 2012, DIABETES CARE, V35, P2377, DOI 10.2337/dc12-0701; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; van der Meer RW, 2007, RADIOLOGY, V245, P251, DOI 10.1148/radiol.2451061904; van der Meer RW, 2012, RADIOLOGY, V264, P21, DOI 10.1148/radiol.12110772; Wang Y, 1996, RADIOLOGY, V198, P55, DOI 10.1148/radiology.198.1.8539406; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641	35	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62209	10.1371/journal.pone.0062209	http://dx.doi.org/10.1371/journal.pone.0062209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620813	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500093
J	Hu, LP; Huang, XT; Mao, JX; Wang, CD; Bao, ZM				Hu, Liping; Huang, Xiaoting; Mao, Junxia; Wang, Chunde; Bao, Zhenmin			Genomic Characterization of Interspecific Hybrids between the Scallops Argopecten purpuratus and A. irradians irradians	PLOS ONE			English	Article							REPETITIVE SEQUENCES; CONCERTED EVOLUTION; PERUVIAN SCALLOP; PACIFIC OYSTER; HYBRIDIZATION; DNA; IDENTIFICATION; CYTOGENETICS; GROWTH	The Peruvian scallop (Argopecten purpuratus) has been introduced to China and has successfully been hybridized with the bay scallop (A. irradians irradians). The F1 hybrids of these two scallops exhibited a large increase in production traits and some other interesting new characteristics. To understand the genetic basis of this heterosis, nuclear gene and partial mtDNA sequences, and genomic in situ hybridization (GISH) were employed to analyze the genomic organization of the hybrids. Amplification of the ribosomal DNA internal transcribed spacer (ITS) showed that the parental ITS sequences were present in all the hybrid individuals, illustrating that the hybrid offspring inherited nuclear DNA from both parents. Sequence analyses of the ITS region further confirmed that the hybrids harbored alleles from their parents; some recombinant variants were also detected, which revealed some alterations in the nuclear genetic material of the hybrids. The analysis of mitochondrial 16S rDNA showed that the hybrids possessed sequences that were identical to the 16S rDNA of the female parents, proving a matrilineal inheritance of mitochondrial genes in scallops. In addition, GISH clearly discriminated between the parental chromosomes and indicated a combination of haploid genomes of duplex parents in the hybrids. The genetic analyses in our study illustrated that the F1 hybrids inherited nuclear material from both parents and cytoplasmic genetic material maternally, and some variations occurred in the genome, which might contribute to a further understanding of crossbreeding and heterosis in scallop species.	[Hu, Liping; Huang, Xiaoting; Mao, Junxia; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding MGB, Minist Educ, Qingdao, Peoples R China; [Wang, Chunde] Qingdao Agr Univ, Coll Marine Sci & Engn, Qingdao, Peoples R China	Ocean University of China; Qingdao Agricultural University	Huang, XT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding MGB, Minist Educ, Qingdao, Peoples R China.	xthuang@ouc.edu.cn			National Natural Science Foundation of China [31270047, 31172404]; National High Tech RD Program [2012AA10A410-4]; National Basic Research Program of China [2010CB126402]; National Key Technology R&D Program of China [2011BAD45B01]; Earmarked Fund for Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech RD Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Earmarked Fund for Modern Agro-industry Technology Research System	This research work was financially supported by National Natural Science Foundation of China (31270047, 31172404), National High Tech R&D Program (2012AA10A410-4), National Basic Research Program of China (2010CB126402), National Key Technology R&D Program of China (2011BAD45B01) and the Earmarked Fund for Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bartley DM, 2000, REV FISH BIOL FISHER, V10, P325, DOI 10.1023/A:1016691725361; Bi K, 2006, CYTOGENET GENOME RES, V112, P307, DOI 10.1159/000089885; [毕克 Bi Ke], 2005, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V35, P283; Chen LZ, 2007, PLANTA, V225, P603, DOI 10.1007/s00425-006-0381-2; Dall WH, 1909, B MOLLUSCA COMP ZOOL, V37, P147; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Epifanio J, 2000, REV FISH BIOL FISHER, V10, P245, DOI 10.1023/A:1016729132297; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fujiwara A, 1997, CHROMOSOMA, V106, P44, DOI 10.1007/s004120050223; Gajardo G, 2002, J SHELLFISH RES, V21, P585; Gardner RJ, 2004, CHROMOSOME ABNORMALI; Huang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027235; KOMARU A, 1985, Venus the Japanese Journal of Malacology, V44, P249; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Kuipers AGJ, 1997, CHROMOSOME RES, V5, P31, DOI 10.1023/A:1018489318300; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leitao A, 2001, AQUACULTURE, V193, P39, DOI 10.1016/S0044-8486(00)00488-9; Liu Xian-jie, 2006, Dalian Shuichan Xueyuan Xuebao, V21, P346; Lu Z, 2006, J FISHERY SCI CHINA, V13; Lu ZM, 2006, HIGH TECH LETT, V16, P853; Marfil CF, 2006, GENOME, V49, P104, DOI 10.1139/G05-088; McCombie H, 2005, AQUACULTURE, V247, P97, DOI 10.1016/j.aquaculture.2005.02.003; Minelli S, 2005, CYTOGENET GENOME RES, V109, P385, DOI 10.1159/000082424; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; RAGGHIANTI M, 1995, CHROMOSOME RES, V3, P497, DOI 10.1007/BF00713965; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sittikraiwong P, 1987, THESIS KASETSART U B; SKIBINSKI DOF, 1994, GENETICS, V138, P801; STANLEY JG, 1976, T AM FISH SOC, V105, P10, DOI 10.1577/1548-8659(1976)105<10:POHAAG>2.0.CO;2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valente GT, 2009, CHROMOSOME RES, V17, P791, DOI 10.1007/s10577-009-9067-5; Waller T.R., 1969, J PALEONTOL, V3, P1; Wang CD, 2011, AQUACULTURE, V310, P380, DOI 10.1016/j.aquaculture.2010.11.014; WANG J, 2006, BIOTECH B, V6, P122; Wang m., 1990, Journal of Ocean University of Qingdao, V20, P81; Wang S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-6; Wang YP, 2004, BIOL BULL-US, V207, P247, DOI 10.2307/1543213; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Xu DD, 2009, GENETICA, V137, P151, DOI 10.1007/s10709-009-9373-z; [杨爱国 Yang Aiguo], 2004, [海洋水产研究, Marine Fisheries Research], V25, P1; Ye Y. Z., 1989, Acta Hydrobiologica Sinica, V13, P234; Zhang Fusui, 1986, Oceanologia et Limnologia Sinica, V17, P367; Zhang H, 2007, AQUACULTURE, V272, pS88, DOI 10.1016/j.aquaculture.2007.08.008; Zhang LL, 2008, DNA SEQUENCE, V19, P195, DOI 10.1080/10425170701462316; Zhang LL, 2008, MAR BIOTECHNOL, V10, P151, DOI 10.1007/s10126-007-9045-x; [赵洋 ZHAO Yang], 2006, [海洋学报, Acta Oceanologica Sinica], V28, P100; Zhou JP, 2008, J INTEGR PLANT BIOL, V50, P452, DOI 10.1111/j.1744-7909.2008.00644.x; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463	51	15	18	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62432	10.1371/journal.pone.0062432	http://dx.doi.org/10.1371/journal.pone.0062432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620828	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500109
J	Parmakelis, A; Kotsakiozi, P; Rand, D				Parmakelis, Aristeidis; Kotsakiozi, Panayiota; Rand, David			Animal Mitochondria, Positive Selection and Cyto-Nuclear Coevolution: Insights from Pulmonates	PLOS ONE			English	Article							AMINO-ACID SITES; LAND SNAIL ALBINARIA; MOLECULAR PHYLOGENY; POPULATION-STRUCTURE; HISTORICAL BIOGEOGRAPHY; EVOLUTIONARY HISTORY; GENETIC-VARIATION; CYTOCHROME-C; ACCELERATED EVOLUTION; MUTATION ACCUMULATION	Pulmonate snails have remarkably high levels of mtDNA polymorphism within species and divergence between species, making them an interesting group for the study of mutation and selection on mitochondrial genomes. The availability of sequence data from most major lineages - collected largely for studies of phylogeography - provides an opportunity to perform several tests of selection that may provide general insights into the evolutionary forces that have produced this unusual pattern. Several protein coding mtDNA datasets of pulmonates were analyzed towards this direction. Two different methods for the detection of positive selection were used, one based on phylogeny, and the other on the McDonald-Kreitman test. The cyto-nuclear coevolution hypothesis, often implicated to account for the high levels of mtDNA divergence of some organisms, was also addressed by assessing the divergence pattern exhibited by a nuclear gene. The McDonald-Kreitman test indicated multiple signs of positive selection in the mtDNA genes, but was significantly biased when sequence divergence was high. The phylogenetic method identified five mtDNA datasets as affected by positive selection. In the nuclear gene, the McDonald-Kreitman test provided no significant results, whereas the phylogenetic method identified positive selection as likely present. Overall, our findings indicate that: 1) slim support for the cyto-nuclear coevolution hypothesis is present, 2) the elevated rates of mtDNA polymorphims and divergence in pulmonates do not appear to be due to pervasive positive selection, 3) more stringent tests show that spurious positive selection is uncovered when distant taxa are compared and 4) there are significant examples of positive selection acting in some cases, so it appears that mtDNA evolution in pulmonates can escape from strict deleterious evolution suggested by the Muller's ratchet effect.	[Parmakelis, Aristeidis] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece; [Kotsakiozi, Panayiota] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Anim & Human Physiol, Athens 11528, Greece; [Rand, David] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Brown University	Parmakelis, A (corresponding author), Natl & Kapodistrian Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece.	aparmakel@biol.uoa.gr	Parmakelis, Aristeidis/AAD-1162-2020	Parmakelis, Aristeidis/0000-0003-3092-4194	"John S. Latsis" Public Benefit Foundation	"John S. Latsis" Public Benefit Foundation	This project was partially funded by the "John S. Latsis" Public Benefit Foundation, and the sole responsibility for the content lies with its authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson FE, 2007, CONSERV GENET, V8, P965, DOI 10.1007/s10592-006-9250-6; Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Elejalde MA, 2008, ZOOL J LINN SOC-LOND, V154, P722, DOI 10.1111/j.1096-3642.2008.00427.x; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Benjamini Y, 2001, ANN STAT, V29, P1165; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Castoe TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002201; Chiba S, 1999, EVOLUTION, V53, P460, DOI 10.1111/j.1558-5646.1999.tb03781.x; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; Davison A, 2006, BIOESSAYS, V28, P642, DOI 10.1002/bies.20424; Davison A, 2000, J MOLLUS STUD, V66, P143, DOI 10.1093/mollus/66.2.143; Davison A, 2005, PLOS BIOL, V3, P1559, DOI 10.1371/journal.pbio.0030282; Davison A, 2002, POPUL ECOL, V44, P129, DOI 10.1007/s101440200016; De Weerd DRU, 2006, BIOL J LINN SOC, V88, P155; de Weerd DRU, 2005, J BIOGEOGR, V32, P1571, DOI 10.1111/j.1365-2699.2005.01313.x; de Weerd DRU, 2004, MOL PHYLOGENET EVOL, V33, P533, DOI 10.1016/j.ympev.2004.07.010; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Douris V, 1998, EVOLUTION, V52, P116, DOI 10.1111/j.1558-5646.1998.tb05144.x; Douris V, 2007, MOL PHYLOGENET EVOL, V44, P1224, DOI 10.1016/j.ympev.2007.01.004; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dowling DK, 2007, GENETICS, V175, P235, DOI 10.1534/genetics.105.052050; Efford M, 2002, J ROY SOC NEW ZEAL, V32, P445, DOI 10.1080/03014223.2002.9517703; Elejalde MA, 2008, J ZOOL SYST EVOL RES, V46, P193, DOI 10.1111/j.1439-0469.2008.00468.x; Elejalde MA, 2005, J MOLLUS STUD, V71, P349, DOI 10.1093/mollus/eyi046; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Fay JC, 2000, GENETICS, V155, P1405; Feher Z, 2009, J ZOOL SYST EVOL RES, V47, P306, DOI 10.1111/j.1439-0469.2009.00534.x; Fiorentino V, 2008, BIOL J LINN SOC, V94, P809, DOI 10.1111/j.1095-8312.2008.01023.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Giokas S, 2006, J EVOLUTION BIOL, V19, P1631, DOI 10.1111/j.1420-9101.2006.01115.x; Giokas S, 2000, BELG J ZOOL, V130, P95; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Goodacre SL, 2006, BIOL J LINN SOC, V87, P167, DOI 10.1111/j.1095-8312.2006.00565.x; Goodacre SL, 2002, MOL ECOL, V11, P55, DOI 10.1046/j.0962-1083.2001.01422.x; Goodacre SL, 2001, P ROY SOC B-BIOL SCI, V268, P121, DOI 10.1098/rspb.2000.1339; Goodacre SL, 2001, BIOL J LINN SOC, V73, P131, DOI 10.1006/bijl.2001.0530; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Harrison JS, 2006, MOL BIOL EVOL, V23, P559, DOI 10.1093/molbev/msj058; Hayashi M, 2000, BIOL J LINN SOC, V70, P391, DOI 10.1111/j.1095-8312.2000.tb01230.x; Holland BS, 2007, MOL ECOL, V16, P2422, DOI 10.1111/j.1365-294X.2007.03246.x; Holland BS, 2004, MOL PHYLOGENET EVOL, V32, P588, DOI 10.1016/j.ympev.2004.01.003; Holland BS, 2002, MOL ECOL, V11, P365, DOI 10.1046/j.1365-294X.2002.01464.x; Horsak M, 2006, MALACOLOGICA BOHEMOS, V5, P51; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Hyman IT, 2007, MOL PHYLOGENET EVOL, V45, P792, DOI 10.1016/j.ympev.2007.08.018; James AC, 2003, GENETICS, V164, P187; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kameda YC, 2007, MOL PHYLOGENET EVOL, V45, P519, DOI 10.1016/j.ympev.2007.03.021; Kerr KCR, 2011, MOL ECOL RESOUR, V11, P1045, DOI 10.1111/j.1755-0998.2011.03049.x; Ketmaier V, 2006, MOL PHYLOGENET EVOL, V39, P439, DOI 10.1016/j.ympev.2005.12.008; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kotsakiozi P, 2012, MOL PHYLOGENET EVOL, V62, P681, DOI 10.1016/j.ympev.2011.11.012; Lee T, 2007, P ROY SOC B-BIOL SCI, V274, P2907, DOI 10.1098/rspb.2007.1009; Lee TW, 2007, CURR BIOL, V17, pR502, DOI 10.1016/j.cub.2007.05.006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liew TS, 2009, ZOOL J LINN SOC-LOND, V157, P515, DOI 10.1111/j.1096-3642.2009.00526.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moussalli A, 2009, MOL PHYLOGENET EVOL, V52, P167, DOI 10.1016/j.ympev.2009.02.018; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neiman M, 2010, MOL BIOL EVOL, V27, P954, DOI 10.1093/molbev/msp300; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; Nekola JC, 2009, MOL PHYLOGENET EVOL, V53, P1010, DOI 10.1016/j.ympev.2009.09.012; Nielsen R, 1998, GENETICS, V148, P929; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Parmakelis A, 2005, EVOLUTION, V59, P991; Parmakelis A, 2004, BIOL J LINN SOC, V83, P131, DOI 10.1111/j.1095-8312.2004.00375.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-8; Piganeau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004396; Pinceel J, 2005, J EVOLUTION BIOL, V18, P1264, DOI 10.1111/j.1420-9101.2005.00932.x; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Ponder Winston F., 2003, Molluscan Research, V23, P159, DOI 10.1071/MR03001; Quinteiro J, 2005, J ZOOL SYST EVOL RES, V43, P139, DOI 10.1111/j.1439-0469.2005.00307.x; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rand DM, 2001, GENETICS, V159, P173; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Rawson PD, 2006, J MOL EVOL, V62, P753, DOI 10.1007/s00239-005-0074-7; Rawson PD, 2000, GENE, V248, P15, DOI 10.1016/S0378-1119(00)00145-1; Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Rundell RJ, 2004, MOL PHYLOGENET EVOL, V31, P246, DOI 10.1016/j.ympev.2003.07.014; Sauer J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-299; Sauer J, 2009, EVOLUTION, V63, P2535, DOI 10.1111/j.1558-5646.2009.00751.x; Schmidt TR, 2001, MOL BIOL EVOL, V18, P563, DOI 10.1093/oxfordjournals.molbev.a003836; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Shimizu Y, 2000, HEREDITY, V85, P84, DOI 10.1046/j.1365-2540.2000.00730.x; Soroka M, 2009, FOLIA BIOL-KRAKOW, V57, P71, DOI 10.3409/fb57_1-2.71-81; Sota T, 2003, MOL PHYLOGENET EVOL, V26, P139, DOI 10.1016/S1055-7903(02)00311-1; Spencer HG, 2006, MOL PHYLOGENET EVOL, V38, P835, DOI 10.1016/j.ympev.2005.10.015; Steinke D, 2004, MOL PHYLOGENET EVOL, V32, P724, DOI 10.1016/j.ympev.2004.03.004; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teshima H, 2003, MOL ECOL, V12, P1869, DOI 10.1046/j.1365-294X.2003.01862.x; Thacker RW, 2000, MOL PHYLOGENET EVOL, V16, P263, DOI 10.1006/mpev.2000.0793; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; Van Riel P, 2005, MOL PHYLOGENET EVOL, V37, P132, DOI 10.1016/j.ympev.2005.03.019; Vialatte A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-339; von Proschwitz T, 2009, J MOLLUS STUD, V75, P315, DOI 10.1093/mollus/eyp038; Wares JP, 2006, SCIENCE, V314, P1388; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Wayne ML, 1998, TRENDS ECOL EVOL, V13, P236, DOI 10.1016/S0169-5347(98)01360-3; Weaver KF, 2006, DIVERS DISTRIB, V12, P756, DOI 10.1111/j.1472-4642.2006.00289.x; Wilke T, 2004, MOL ECOL, V13, P2303, DOI 10.1111/j.1365-294X.2004.02234.x; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Yamazaki N, 1997, GENETICS, V145, P749; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2005, P NATL ACAD SCI USA, V102, P3179, DOI 10.1073/pnas.0500371102; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	130	33	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61970	10.1371/journal.pone.0061970	http://dx.doi.org/10.1371/journal.pone.0061970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620797	gold, Green Submitted, Green Published			2022-12-25	WOS:000317909500077
J	Taylor, SA; Anderson, DJ; Friesen, VL				Taylor, Scott A.; Anderson, David J.; Friesen, Vicki L.			Evidence for Asymmetrical Divergence-Gene Flow of Nuclear Loci, but Not Mitochondrial Loci, between Seabird Sister Species: Blue-Footed (Sula nebouxii) and Peruvian (S. variegata) Boobies	PLOS ONE			English	Article							LINKED HYBRID STERILITY; HAPLOTYPE RECONSTRUCTION; POPULATION-GENETICS; SEX DETERMINATION; SPECIATION; HYBRIDIZATION; INTROGRESSION; MECHANISMS; COALESCENT; CHROMOSOME	Understanding the process of speciation requires understanding how gene flow influences divergence. Recent analyses indicate that divergence can take place despite gene flow and that the sex chromosomes can exhibit different levels of gene flow than autosomes and mitochondrial DNA. Using an eight marker dataset including autosomal, z-linked, and mitochondrial loci we tested the hypothesis that blue-footed (Sula nebouxii) and Peruvian (S. variegata) boobies diverged from their common ancestor with gene flow, paying specific attention to the differences in gene flow estimates from nuclear and mitochondrial markers. We found no gene flow at mitochondrial markers, but found evidence from the combined autosomal and z-linked dataset that blue-footed and Peruvian boobies experienced asymmetrical gene flow during or after their initial divergence, predominantly from Peruvian boobies into blue-footed boobies. This gene exchange may have occurred either sporadically between periods of allopatry, or regularly throughout the divergence process. Our results add to growing evidence that diverging species can remain distinct but exchange genes.	[Taylor, Scott A.; Friesen, Vicki L.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Queens University - Canada; Wake Forest University	Taylor, SA (corresponding author), Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY USA.	dr.scott.a.taylor@gmail.com		Taylor, Scott/0000-0001-9580-9125	NSERC [203320]; National Geographic Research Grant [8331-07]; National Science Foundation [DEB 93-04579]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Research Grant(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	NSERC Discovery Grant (#203320) to Vicki L. Friesen [http://www.nserc-crsng.gc.ca]. National Geographic Research Grant (#8331-07) to David J. Anderson [nationalgeographic.com]. NSERC postgraduate scholarships to Scott A. Taylor. Funding for work in the Galapagos was supplied by the National Science Foundation (DEB 93-04579 to DJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AID C S, 1985, Colonial Waterbirds, V8, P67, DOI 10.2307/1521196; Ayala Liliana, 2006, Marine Ornithology, V34, P81; Backstrom N, 2006, GENETICS, V174, P377, DOI 10.1534/genetics.106.058917; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; Carling MD, 2010, EVOLUTION, V64, P1762, DOI 10.1111/j.1558-5646.2010.00954.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne JA, 2004, SPECIATION, V37; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUFFY D C, 1987, Colonial Waterbirds, V10, P45, DOI 10.2307/1521229; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; de Leon LF, 2010, PHILOS T R SOC B, V365, P1041, DOI 10.1098/rstb.2009.0314; Figueroa Judith, 2008, Marine Ornithology, V36, P75; Fitzpatrick BM, 2009, J EVOLUTION BIOL, V22, P2342, DOI 10.1111/j.1420-9101.2009.01833.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 1997, MOL ECOL, V6, P1047, DOI 10.1046/j.1365-294X.1997.00277.x; Friesen VL, 1997, MOL PHYLOGENET EVOL, V7, P252, DOI 10.1006/mpev.1996.0397; Galligan TH, 2012, MOL ECOL, V21, P2106, DOI 10.1111/j.1365-294X.2012.05511.x; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Harrington RC, 2013, EVOLUTION, V67, P388, DOI 10.1111/j.1558-5646.2012.01797.x; Hartley AJ, 2005, J GEOL SOC LONDON, V162, P421, DOI 10.1144/0016-764904-071; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huyvaert KP, 2004, J AVIAN BIOL, V35, P46; Jacobsen F, 2012, ECOL EVOL, V2, P2413, DOI 10.1002/ece3.365; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Lee YH, 2012, MOL ECOL, V21, P3739, DOI 10.1111/j.1365-294X.2012.05654.x; Mayr E, 1970, POPULATIONS SPECIES; Morris-Pocock JA, 2011, MOL ECOL, V20, P2835, DOI 10.1111/j.1365-294X.2011.05132.x; Murphy R.C., 1925, BIRD ISLANDS PERU RE; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Niemiller ML, 2010, MOL ECOL, V19, P1513, DOI 10.1111/j.1365-294X.2010.04564.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nylander J, 2004, MR MODELTEST V2 PROG; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Patterson SA, 2011, MOL PHYLOGENET EVOL, V58, P181, DOI 10.1016/j.ympev.2010.11.021; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; PIEROTTI R, 1987, EVOLUTION, V41, P559, DOI 10.1111/j.1558-5646.1987.tb05826.x; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruegg K, 2008, EVOLUTION, V62, P452, DOI 10.1111/j.1558-5646.2007.00263.x; Saetre GP, 2010, MOL ECOL, V19, P1091, DOI 10.1111/j.1365-294X.2010.04568.x; Sambrook J, 2001, MOL CLONING LAB MANU; Simeone A, 2002, B CHILENO ORNITOLOGI, V9, P48; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sousa VC, 2011, MOL ECOL, V20, P3956, DOI 10.1111/j.1365-294X.2011.05247.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Stucchi M, 2003, B SOC GEOLOGICA PERU, V96, P95; TAJIMA F, 1983, GENETICS, V105, P437; Taylor SA, 2012, J AVIAN BIOL; Taylor SA, 2011, J BIOGEOGR, V38, P883, DOI 10.1111/j.1365-2699.2010.02445.x; Taylor SA, 2011, J ORNITHOL, V152, P623, DOI 10.1007/s10336-010-0628-3; Taylor SA, 2010, WATERBIRDS, V33, P251, DOI 10.1675/063.033.0215; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; VOGT WILLIAM, 1942, BOL COMPAnIA ADMIN GUANO, V18, P1; Zheng XM, 2010, MOL ECOL, V19, P2439, DOI 10.1111/j.1365-294X.2010.04674.x	76	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e62256	10.1371/journal.pone.0062256	http://dx.doi.org/10.1371/journal.pone.0062256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23614045	Green Submitted, Green Published, gold			2022-12-25	WOS:000317907200128
J	Kyula, JN; Khan, AA; Mansfield, D; Karapanagiotou, EM; McLaughlin, M; Roulstone, V; Zaidi, S; Pencavel, T; Touchefeu, Y; Seth, R; Chen, NG; Yu, YA; Zhang, Q; Melcher, AA; Vile, RG; Pandha, HS; Ajaz, M; Szalay, AA; Harrington, KJ				Kyula, J. N.; Khan, A. A.; Mansfield, D.; Karapanagiotou, E. M.; McLaughlin, M.; Roulstone, V.; Zaidi, S.; Pencavel, T.; Touchefeu, Y.; Seth, R.; Chen, N. G.; Yu, Y. A.; Zhang, Q.; Melcher, A. A.; Vile, R. G.; Pandha, H. S.; Ajaz, M.; Szalay, A. A.; Harrington, K. J.			Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-alpha signaling	ONCOGENE			English	Article						oncolytic vaccinia; GLV-1h68; JNK; TNF-alpha; RT; apoptosis	NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; CELL LUNG; NUDE-MICE; VIRUS; CANCER; ACTIVATION; THERAPY; BRAF; COMBINATION	Melanoma is an aggressive skin cancer that carries an extremely poor prognosis when local invasion, nodal spread or systemic metastasis has occurred. Recent advances in melanoma biology have revealed that RAS-RAF-MEK-ERK signaling has a pivotal role in governing disease progression and treatment resistance. Proof-of-concept clinical studies have shown that direct BRAF inhibition yields impressive responses in advanced disease but these are short-lived as treatment resistance rapidly emerges. Therefore, there is a pressing need to develop new targeted strategies for BRAF mutant melanoma. As such, oncolytic viruses represent a promising cancer-specific approach with significant activity in melanoma. This study investigated interactions between genetically-modified vaccinia virus (GLV-1h68) and radiotherapy in melanoma cell lines with BRAF mutant, Ras mutant or wild-type genotype. Preclinical studies revealed that GLV-1h68 combined with radiotherapy significantly increased cytotoxicity and apoptosis relative to either single agent in (V600D)BRAF/(V600E)BRAF mutant melanoma in vitro and in vivo. The mechanism of enhanced cytotoxicity with GLV-1h68/radiation (RT) was independent of viral replication and due to attenuation of JNK, p38 and ERK MAPK phosphorylation specifically in BRAF mutant cells. Further studies showed that JNK pathway inhibition sensitized BRAF mutant cells to GLV-1h68-mediated cell death, mimicking the effect of RT. GLV-1h68 infection activated MAPK signaling in (V600D)BRAF/(V600E)BRAF mutant cell lines and this was associated with TNF-alpha secretion which, in turn, provided a prosurvival signal. Combination GLV-1h68/RT (or GLV-1h68/JNK inhibition) caused abrogation of TNF-alpha secretion. These data provide a strong rationale for combining GLV-1h68 with irradiation in (V600D/E)BRAF mutant tumors.	[Kyula, J. N.; Khan, A. A.; Mansfield, D.; Karapanagiotou, E. M.; McLaughlin, M.; Roulstone, V.; Zaidi, S.; Pencavel, T.; Touchefeu, Y.; Seth, R.; Harrington, K. J.] Inst Canc Res, Div Canc Biol, Targeted Therapy Team, London SW3 6JB, England; [Chen, N. G.; Yu, Y. A.; Zhang, Q.; Szalay, A. A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Melcher, A. A.; Vile, R. G.] Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Vile, R. G.] Mayo Clin, Mol Med Program, Rochester, MN USA; [Pandha, H. S.; Ajaz, M.] Univ Surrey, Postgrad Med Sch, Guildford GU2 5XH, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leeds; Mayo Clinic; University of Surrey	Kyula, JN (corresponding author), Inst Canc Res, Div Canc Biol, Targeted Therapy Team, 237 Fulham Rd, London SW3 6JB, England.	Joan.Kyula@icr.ac.uk	Touchefeu, Yann/M-2969-2015; Touchefeu, Yann/AGH-7655-2022; Khan, Aadil/AAB-6853-2021	Touchefeu, Yann/0000-0001-8421-3182; Khan, Aadil/0000-0003-1284-6049; Melcher, Alan/0000-0002-2042-3380; McLaughlin, Martin/0000-0002-9739-7133; Harrington, Kevin/0000-0002-6014-348X	Myfanwy Townsend Melanoma Research Fund; Cotswold Trust; Cancer Research UK [13244] Funding Source: researchfish; Rosetrees Trust [M236-CD1] Funding Source: researchfish	Myfanwy Townsend Melanoma Research Fund; Cotswold Trust; Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust)	We would like to thank Dr Khin Thway and Dr Michelle Wilkinson for their assistance with data acquisition and analysis. This work was supported in part by research grants from the Myfanwy Townsend Melanoma Research Fund and the Cotswold Trust.	Amaravadi RK, 2009, CLIN CANCER RES, V15, P7711, DOI 10.1158/1078-0432.CCR-09-2074; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Ascierto ML, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-451; Beyaert R, 2002, INT REV CYTOL, V214, P225; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Comins C, 2010, CLIN CANCER RES, V16, P5564, DOI 10.1158/1078-0432.CCR-10-1233; de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gray-Schopfer VC, 2007, CANCER RES, V67, P122, DOI 10.1158/0008-5472.CAN-06-1880; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gutermann A, 2006, HUM GENE THER, V17, P1241, DOI 10.1089/hum.2006.17.1241; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heinemann L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-221; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Khan N, 2011, INT J RADIAT ONCOL, V80, P645, DOI 10.1016/j.ijrobp.2010.12.071; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Mansfield D, 2013, ORAL ONCOL, V49, P108, DOI 10.1016/j.oraloncology.2012.07.019; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Pandha HS, 2009, CLIN CANCER RES, V15, P6158, DOI 10.1158/1078-0432.CCR-09-0796; Pawlik TM, 2002, CANCER-AM CANCER SOC, V95, P1171, DOI 10.1002/cncr.10776; Post DE, 2004, CLIN CANCER RES, V10, P8603, DOI 10.1158/1078-0432.CCR-04-1432; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Toyoizumi T, 1999, HUM GENE THER, V10, P3013, DOI 10.1089/10430349950016410; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Twigger K, 2008, CLIN CANCER RES, V14, P912, DOI 10.1158/1078-0432.CCR-07-1400; Tyminski E, 2005, CANCER RES, V65, P6850, DOI 10.1158/0008-5472.CAN-05-0154; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Yu ZJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-45; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	42	30	31	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2014	33	13					1700	1712		10.1038/onc.2013.112	http://dx.doi.org/10.1038/onc.2013.112			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9QY	23624923	Bronze, Green Accepted			2022-12-25	WOS:000334344700010
J	Moh, MC; Lorenzini, PA; Gullo, C; Schwarz, H				Moh, Mei Chung; Lorenzini, Paolo Alberto; Gullo, Charles; Schwarz, Herbert			Tumor necrosis factor receptor 1 associates with CD137 ligand and mediates its reverse signaling	FASEB JOURNAL			English	Article						TNFR1; THP-1 cells; monocytes	TNF RECEPTOR; HUMAN 4-1BB; MONOCYTE ACTIVATION; FAMILY; TRANSDUCTION; MEMBRANE; MEMBERS; CELLS; PROLIFERATION; STABILIZATION	Reverse signaling through CD137 ligand (CD137L) potently activates monocytes. However, the underlying mechanism is not well elucidated. This study provides evidence that tumor necrosis factor receptor 1 (TNFR1) acts as a coreceptor for CD137L and mediates CD137L signaling. CD137L colocalizes with TNFR1 on the plasma membrane and binds directly to TNFR1 via its extracellular domain. Using the human monocytic THP-1 cell line, we demonstrate that engagement of CD137L by recombinant CD137 protein promotes cell adhesion, apoptosis, expression of CD14, and production of IL-8 and tumor necrosis factor (TNF). Concomitantly, the expression of TNFR1 protein is down-regulated in response to CD137L activation, due to enhanced extracellular release and internalization of TNFR1. Activation of TNFR1 by TNF protein additively augments CD137L-induced IL-8 expression. Conversely, inhibition of TNFR1 activity by a TNFR1-neutralizing antibody inhibits CD137L-mediated cell adhesion, cell death, CD14 expression, and IL-8 production. Taken together, these data show that TNFR1 associates with CD137L and is required for CD137L reverse signaling.Moh, M. C., Lorenzini, P. A., Gullo, C., Schwarz, H. Tumor necrosis factor receptor 1 associates with CD137 ligand and mediates its reverse signaling.	[Moh, Mei Chung; Lorenzini, Paolo Alberto; Schwarz, Herbert] Duke Natl Univ Singapore Grad Med Sch, Dept Physiol, Singapore, Singapore; [Moh, Mei Chung; Lorenzini, Paolo Alberto; Schwarz, Herbert] Duke Natl Univ Singapore Grad Med Sch, Program Immunol, Singapore, Singapore; [Gullo, Charles] Duke Natl Univ Singapore Grad Med Sch, Dept Med Educ Res & Evaluat, Singapore, Singapore; [Gullo, Charles] Natl Univ Singapore, Dept Microbiol, Singapore 117456, Singapore; [Schwarz, Herbert] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore	Schwarz, H (corresponding author), Natl Univ Singapore, Dept Physiol, Ctr Life Sci, 03-05,28 Med Dr, Singapore 117456, Singapore.	phssh@nus.edu.sg	Gullo, Charles A/X-9938-2019	Gullo, Charles A/0000-0002-4221-0087	Singapore Agency for Science, Technology, and Research (A*STAR)-Hungary National Office for Research and Technology (NKTH) [10/1/21/24/637]	Singapore Agency for Science, Technology, and Research (A*STAR)-Hungary National Office for Research and Technology (NKTH)	This study was supported by a Singapore Agency for Science, Technology, and Research (A*STAR)-Hungary National Office for Research and Technology (NKTH) joint grant (10/1/21/24/637).	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Benslimane N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043070; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; Domonkos A, 2001, EUR CYTOKINE NETW, V12, P411; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; Dri P, 2000, J IMMUNOL, V165, P2165, DOI 10.4049/jimmunol.165.4.2165; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; Gullo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010845; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Ho WT, 2013, CANCER RES, V73, P652, DOI 10.1158/0008-5472.CAN-12-3849; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jones SJ, 1999, J IMMUNOL, V162, P1042; Ju SW, 2009, INT IMMUNOL, V21, P1135, DOI 10.1093/intimm/dxp077; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Kim J.D., 2011, IMMUNE NETW, V11, P216, DOI DOI 10.4110/IN.2011.11.4.216; Kwajah MMS, 2010, EUR J IMMUNOL, V40, P1938, DOI 10.1002/eji.200940105; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; MOSSELMANS R, 1988, J IMMUNOL, V141, P3096; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Saito K, 2004, J BIOL CHEM, V279, P13555, DOI 10.1074/jbc.M303791200; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; SCHWARZ H, 1995, BLOOD, V85, P1043, DOI 10.1182/blood.V85.4.1043.bloodjournal8541043; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Wen T, 2002, J IMMUNOL, V168, P4897, DOI 10.4049/jimmunol.168.10.4897; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442	38	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					2957	2966		10.1096/fj.12-225250	http://dx.doi.org/10.1096/fj.12-225250			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23620528	Bronze			2022-12-25	WOS:000329877600004
J	Arvizo, RR; Moyano, DF; Saha, S; Thompson, MA; Bhattacharya, R; Rotello, VM; Prakash, YS; Mukherjee, P				Arvizo, Rochelle R.; Moyano, Daniel F.; Saha, Sounik; Thompson, Michael A.; Bhattacharya, Resham; Rotello, Vincent M.; Prakash, Y. S.; Mukherjee, Priyabrata			Probing Novel Roles of the Mitochondrial Uniporter in Ovarian Cancer Cells Using Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLD NANOPARTICLES; CALCIUM; PROTEIN; CA2+; BAX; ACTIVATION; MECHANISM; MEMBRANE; ANTIBODY; BCL-2	Nanoparticles provide a potent tool for targeting and understanding disease mechanisms. In this regard, cancer cells are surprisingly resistant to the expected toxic effects of positively charged gold nanoparticles ((+)AuNPs). Our investigations led to the identification of MICU1, regulator of mitochondrial calcium uniporter, as a key molecule conferring cancer cells with resistance to (+)AuNPs. The increase in cytosolic [Ca2+](cyto) in malignant cells induced by (+)AuNPs is counteracted by MICU1, preventing cell death. Pharmacological or siRNA-mediated inhibition of mitochondrial Ca+2 entry leads to endoplasmic reticulum stress and sensitizes cancer cells to +AuNP-induced cytotoxicity. Silencing MICU1 decreases Bcl-2 expression and increases caspase-3 activity and cytosolic cytochrome c levels, thus initiating the mitochondrial pathway for apoptosis: effects further enhanced by (+)AuNPs. This study highlights the potential of nanomaterials as a tool to broaden our understanding of cellular processes, establishes MICU1 as a novel regulator of the machinery in cancer cells that prevents apoptosis, and emphasizes the need to synergize nanoparticle design with understanding of mitochondrial machinery for enhancing targeted cellular toxicity.	[Arvizo, Rochelle R.; Saha, Sounik; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, Michael A.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA; [Prakash, Y. S.; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN 55905 USA; [Moyano, Daniel F.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Massachusetts System; University of Massachusetts Amherst	Prakash, YS (corresponding author), Mayo Clin, W Joseph St Marys Hosp 4 184, Coll Med, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55905 USA.	prakash.ys@mayo.edu; Mukherjee.priyabrata@mayo.edu	Moyano, Daniel/A-7306-2012	Moyano, Daniel/0000-0002-9213-5660; Prakash, Y S/0000-0002-2968-224X	National Institutes of Health [CA135011, CA136494, GM077173, HL088029]; NATIONAL CANCER INSTITUTE [R01CA136494, R01CA135011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135011 and CA136494 (to P. M.), GM077173 (to V. M. R.), and HL088029 (to Y. S. P.).	Agasti SS, 2009, J AM CHEM SOC, V131, P5728, DOI 10.1021/ja900591t; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; Bhattacharyya S, 2012, ANGEW CHEM INT EDIT, V51, P1563, DOI 10.1002/anie.201105432; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s; Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brust M., 1996, J CHEM SOC CHEM COMM, V7, P801; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Delmotte P, 2012, AM J PHYSIOL-CELL PH, V303, pC244, DOI 10.1152/ajpcell.00414.2011; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hostetler MJ, 1996, J AM CHEM SOC, V118, P4212, DOI 10.1021/ja960198g; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Kim C, 2010, NAT CHEM, V2, P962, DOI [10.1038/nchem.858, 10.1038/NCHEM.858]; Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Massich MD, 2010, ACS NANO, V4, P5641, DOI 10.1021/nn102228s; Miranda OR, 2010, J AM CHEM SOC, V132, P5285, DOI 10.1021/ja1006756; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f	38	29	29	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17610	17618		10.1074/jbc.M112.435206	http://dx.doi.org/10.1074/jbc.M112.435206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615904	hybrid, Green Published			2022-12-25	WOS:000320380600052
J	Tsai, CC; Lin, CR; Tsai, HY; Chen, CJ; Li, WT; Yu, HM; Ke, YY; Hsieh, WY; Chang, CY; Wu, CY; Chen, ST; Wong, CH				Tsai, Chia-Che; Lin, Chih-Ru; Tsai, Hsien-Yu; Chen, Chia-Jung; Li, Wen-Tai; Yu, Hui-Ming; Ke, Yi-Yu; Hsieh, Wei-Ying; Chang, Cheng-Yen; Wu, Chung-Yi; Chen, Shui-Tein; Wong, Chi-Huey			The Immunologically Active Oligosaccharides Isolated from Wheatgrass Modulate Monocytes via Toll-like Receptor-2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN; IMMUNE-SYSTEM; POLYSACCHARIDES; INNATE; INTERLEUKIN-12; MACROPHAGES; GANODERMA; DECTIN-1; DIETARY; TLR2	Wheatgrass is one of the most widely used health foods, but its functional components and mechanisms remain unexplored. Herein, wheatgrass-derived oligosaccharides (WG-PS3) were isolated and found to induce CD69 and Th1 cytokine expression in human peripheral blood mononuclear cells. In particular, WG-PS3 directly activated the purified monocytes by inducing the expression of CD69, CD80, CD86, IL-12, and TNF-alpha but affected NK and T cells only in the presence of monocytes. After further purification and structural analysis, maltoheptaose was identified from WG-PS3 as an immunomodulator. Maltoheptaose activated monocytes via Toll-like receptor 2 (TLR-2) signaling, as discovered by pretreatment of blocking antibodies against Toll-like receptors (TLRs) and also determined by click chemistry. This study is the first to reveal the immunostimulatory component of wheatgrass with well defined molecular structures and mechanisms.	[Tsai, Chia-Che; Lin, Chih-Ru; Tsai, Hsien-Yu; Chen, Chia-Jung; Li, Wen-Tai; Hsieh, Wei-Ying; Chang, Cheng-Yen; Chen, Shui-Tein; Wong, Chi-Huey] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yu, Hui-Ming; Ke, Yi-Yu; Wu, Chung-Yi; Chen, Shui-Tein; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Chih-Ru; Chen, Shui-Tein; Wong, Chi-Huey] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 106, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Chen, ST (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	bcchen@gate.sinica.edu.tw	Wu, Chung-Yi/K-8334-2018	Tsai, Hsien-Yu/0000-0003-2842-1133	National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant [098S0030049-AI]	National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant	This work was supported by the National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant 098S0030049-AI.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Alitheen NB, 2011, PAK J PHARM SCI, V24, P243; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Ben-Arye E, 2002, SCAND J GASTROENTERO, V37, P444, DOI 10.1080/003655202317316088; Bland EJ, 2004, CARBOHYD RES, V339, P1673, DOI 10.1016/j.carres.2004.05.009; Chang R, 2002, J ALTERN COMPLEM MED, V8, P559, DOI 10.1089/107555302320825066; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Das A, 2012, INT J FOOD SCI NUTR, V63, P718, DOI 10.3109/09637486.2011.644769; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Keystone EC, 2010, J RHEUMATOL, V37, P27, DOI 10.3899/jrheum.091463; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Lee SM, 1998, LEUKEMIA LYMPHOMA, V29, P427, DOI 10.3109/10428199809050903; Liu JJ, 2009, RECENT PAT ANTI-CANC, V4, P101, DOI 10.2174/157489209788452858; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Murphy EA, 2010, CURR OPIN CLIN NUTR, V13, P656, DOI 10.1097/MCO.0b013e32833f1afb; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shao BM, 2004, BIOCHEM BIOPH RES CO, V323, P133, DOI 10.1016/j.bbrc.2004.08.069; SHERMER M, 2008, SCI AM, V299, P42; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Sletmoen M, 2008, BIOPOLYMERS, V89, P310, DOI 10.1002/bip.20920; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; Tsai CC, 2008, COMB CHEM HIGH T SCR, V11, P834, DOI 10.2174/138620708786734307; Volman JJ, 2010, NUTR RES, V30, P40, DOI 10.1016/j.nutres.2009.10.023; Wu ML, 2010, BIOTECHNOL PROGR, V26, P1391, DOI 10.1002/btpr.429; Yoshikai Yasunobu, 2006, Nihon Rinsho, V64, P1223; Zheng Z, 1998, Chin J Biotechnol, V14, P93	33	29	31	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17689	17697		10.1074/jbc.M112.448381	http://dx.doi.org/10.1074/jbc.M112.448381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629653	Green Published, hybrid			2022-12-25	WOS:000320380600059
J	Gokulan, K; O'Leary, SE; Russell, WK; Russell, DH; Lalgondar, M; Begley, TP; Ioerger, TR; Sacchettini, JC				Gokulan, Kuppan; O'Leary, Sean E.; Russell, William K.; Russell, David H.; Lalgondar, Mallikarjun; Begley, Tadhg P.; Ioerger, Thomas R.; Sacchettini, James C.			Crystal Structure of Mycobacterium tuberculosis Polyketide Synthase 11 (PKS11) Reveals Intermediates in the Synthesis of Methyl-branched Alkylpyrones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STILBENE SYNTHASES; CHALCONE SYNTHASE; NEUROSPORA-CRASSA; PROTEIN CRYSTALS; ACID SYNTHESIS; BIOSYNTHESIS; LIPIDS; ACYLTRANSFERASES; INFECTION; VIRULENCE	PKS11 is one of three type III polyketide synthases (PKSs) identified in Mycobacterium tuberculosis. Although many PKSs in M. tuberculosis have been implicated in producing complex cell wall glycolipids, the biological function of PKS11 is unknown. PKS11 has previously been proposed to synthesize alkylpyrones from fatty acid substrates. We solved the crystal structure of M. tuberculosis PKS11 and found the overall fold to be similar to other type III PKSs. PKS11 has a deep hydrophobic tunnel proximal to the active site Cys-138 to accommodate substrates. We observed electron density in this tunnel from a co-purified molecule that was identified by mass spectrometry to be palmitate. Co-crystallization with malonyl-CoA (MCoA) or methylmalonyl-CoA (MMCoA) led to partial turnover of the substrate, resulting in trapped intermediates. Reconstitution of the reaction in solution confirmed that both co-factors are required for optimal activity, and kinetic analysis shows that MMCoA is incorporated first, then MCoA, followed by lactonization to produce methyl-branched alkylpyrones.	[Gokulan, Kuppan; Lalgondar, Mallikarjun; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [O'Leary, Sean E.; Russell, William K.; Russell, David H.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu	Russell, David H/C-3618-2015; Begley, Tadhg/B-5801-2015	Russell, David H/0000-0003-0830-3914; Gokulan, Kuppan/0000-0003-4045-5993	National Institutes of Health [P01AI095208]; Robert A. Welch Foundation [A-0034, A-0015]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI095208 (to J. C. S.). This work was also supported by Robert A. Welch Foundation Grants A-0034 (to T. P. B.) and A-0015 to (J. C. S.). Use of the Advanced Photon Source (beamline 23ID) was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rubin-Pitel SB, 2008, CHEM BIOL, V15, P1079, DOI 10.1016/j.chembiol.2008.08.011; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P423, DOI 10.1107/S0108768195003661; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Suh DY, 2000, BIOCHEM J, V350, P229, DOI 10.1042/0264-6021:3500229; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x	39	18	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16484	16494		10.1074/jbc.M113.468892	http://dx.doi.org/10.1074/jbc.M113.468892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615910	hybrid, Green Published			2022-12-25	WOS:000320378900025
J	Kunte, A; Zhang, W; Paduraru, C; Veerapen, N; Cox, LR; Besra, GS; Cresswell, P				Kunte, Amit; Zhang, Wei; Paduraru, Crina; Veerapen, Natacha; Cox, Liam R.; Besra, Gurdyal S.; Cresswell, Peter			Endoplasmic Reticulum Glycoprotein Quality Control Regulates CD1d Assembly and CD1d-mediated Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; TRIGLYCERIDE TRANSFER PROTEIN; CLASS-I MOLECULES; NKT CELLS; GLUCOSYLTRANSFERASE RECOGNIZES; ALPHA-GALACTOSYLCERAMIDE; COMPLEX STABILITY; LIPID ANTIGEN; HEAVY-CHAIN; CALRETICULIN	The non-classical major histocompatibility complex (MHC) homologue CD1d presents lipid antigens to innate-like lymphocytes called natural-killer T (NKT) cells. These cells, by virtue of their broad cytokine repertoire, shape innate and adaptive immune responses. Here, we have assessed the role of endoplasmic reticulum glycoprotein quality control in CD1d assembly and function, specifically the role of a key component of the quality control machinery, the enzyme UDP glucose glycoprotein glucosyltransferase (UGT1). We observe that in UGT1-deficient cells, CD1d associates prematurely with beta(2)-microglobulin (beta(2)m) and is able to rapidly exit the endoplasmic reticulum. At least some of these CD1d-beta(2)m heterodimers are shorter-lived and can be rescued by provision of a defined exogenous antigen, alpha-galactosylceramide. Importantly, we show that in UGT1-deficient cells the CD1d-beta(2)m heterodimers have altered antigenicity despite the fact that their cell surface levels are unchanged. We propose that UGT1 serves as a quality control checkpoint during CD1d assembly and further suggest that UGT1-mediated quality control can shape the lipid repertoire of newly synthesized CD1d. The quality control process may play a role in ensuring stability of exported CD1d-beta(2)m complexes, in facilitating presentation of low abundance high affinity antigens, or in preventing deleterious responses to self lipids.	[Kunte, Amit] Yale Univ Sch Med, Howard Hughes Med Inst, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Zhang, Wei; Paduraru, Crina; Cresswell, Peter] Yale Univ Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA; [Veerapen, Natacha; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Cox, Liam R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; University of Birmingham; University of Birmingham	Cresswell, P (corresponding author), 300 Cedar St,TAC S669, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Cox, Liam/AAG-9351-2020	Cox, Liam/0000-0001-7018-3904; Besra, Gurdyal/0000-0002-5605-0395	Birmingham Science City Innovative; Advantage West Midlands; European Regional Development Fund; National Institutes of Health [R01-AI059167]; Howard Hughes Medical Institute; MRC [G1001750] Funding Source: UKRI; Medical Research Council [G1001750] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059167] Funding Source: NIH RePORTER	Birmingham Science City Innovative; Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sebastian Joyce for hybridomas, Maurizio Molinari for cell lines, Yajuan Zhu for constructs, Ralf Leonhardt and Jelena Bezbradica for a critical review of the manuscript, and Nancy Dometios for help with manuscript preparation. The NMR spectrometers used in this research were funded in part through Birmingham Science City Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2) with support from Advantage West Midlands and funded in part by the European Regional Development Fund.; This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI059167 (to P. C.). This work was also supported by the Howard Hughes Medical Institute (to P. C.).	BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Burdin N, 1998, J IMMUNOL, V161, P3271; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; De Libero G, 2012, TRENDS IMMUNOL, V33, P103, DOI 10.1016/j.it.2012.01.005; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gui M, 2001, J IMMUNOL, V167, P6239, DOI 10.4049/jimmunol.167.11.6239; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Mallevaey T, 2012, IMMUNOLOGY, V136, P273, DOI 10.1111/j.1365-2567.2012.03580.x; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Odyniec AN, 2010, J BIOL CHEM, V285, P11937, DOI 10.1074/jbc.M109.077933; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Pearse BR, 2010, J CELL BIOL, V189, P829, DOI 10.1083/jcb.200912105; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Sagiv Y, 2007, J EXP MED, V204, P921, DOI 10.1084/jem.20061568; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Somnay-Wadgaonkar K, 1999, INT IMMUNOL, V11, P383, DOI 10.1093/intimm/11.3.383; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Sriram V, 2008, IMMUNOLOGY, V123, P272, DOI 10.1111/j.1365-2567.2007.02696.x; Tamura T, 2010, MOL MEMBR BIOL, V27, P412, DOI 10.3109/09687688.2010.495354; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zhu YJ, 2010, J BIOL CHEM, V285, P38283, DOI 10.1074/jbc.M110.170530	51	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16391	16402		10.1074/jbc.M113.474221	http://dx.doi.org/10.1074/jbc.M113.474221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615906	Green Published, hybrid			2022-12-25	WOS:000320378900017
J	Beko, G; Weschler, CJ; Langer, S; Callesen, M; Toftum, J; Clausen, G				Beko, Gabriel; Weschler, Charles J.; Langer, Sarka; Callesen, Michael; Toftum, Jorn; Clausen, Geo			Children's Phthalate Intakes and Resultant Cumulative Exposures Estimated from Urine Compared with Estimates from Dust Ingestion, Inhalation and Dermal Absorption in Their Homes and Daycare Centers	PLOS ONE			English	Article							SEMIVOLATILE ORGANIC-COMPOUNDS; BODY TOPICAL APPLICATION; DUPLICATE DIET SAMPLES; SPRAGUE-DAWLEY RAT; N-BUTYL PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; INTERNAL EXPOSURE; RISK-ASSESSMENT; DANISH CHILDREN; BISPHENOL-A	Total daily intakes of diethyl phthalate (DEP), di(n-butyl) phthalate (DnBP), di(isobutyl) phthalate (DiBP), butyl benzyl phthalate (BBzP) and di(2-ethylhexyl) phthalate (DEHP) were calculated from phthalate metabolite levels measured in the urine of 431 Danish children between 3 and 6 years of age. For each child the intake attributable to exposures in the indoor environment via dust ingestion, inhalation and dermal absorption were estimated from the phthalate levels in the dust collected from the child's home and daycare center. Based on the urine samples, DEHP had the highest total daily intake (median: 4.42 mu g/d/kg-bw) and BBzP the lowest (median: 0.49 mu g/d/kg-bw). For DEP, DnBP and DiBP, exposures to air and dust in the indoor environment accounted for approximately 100%, 15% and 50% of the total intake, respectively, with dermal absorption from the gas-phase being the major exposure pathway. More than 90% of the total intake of BBzP and DEHP came from sources other than indoor air and dust. Daily intake of DnBP and DiBP from all exposure pathways, based on levels of metabolites in urine samples, exceeded the Tolerable Daily Intake (TDI) for 22 and 23 children, respectively. Indoor exposures resulted in an average daily DiBP intake that exceeded the TDI for 14 children. Using the concept of relative cumulative Tolerable Daily Intake (TDIcum), which is applicable for phthalates that have established TDIs based on the same health endpoint, we examined the cumulative total exposure to DnBP, DiBP and DEHP from all pathways; it exceeded the tolerable levels for 30% of the children. From the three indoor pathways alone, several children had a cumulative intake that exceeded TDIcum. Exposures to phthalates present in the air and dust indoors meaningfully contribute to a child's total intake of certain phthalates. Such exposures, by themselves, may lead to intakes exceeding current limit values.	[Beko, Gabriel; Weschler, Charles J.; Toftum, Jorn; Clausen, Geo] Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark; [Weschler, Charles J.] Univ Med & Dent New Jersey, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Weschler, Charles J.] Rutgers State Univ, Piscataway, NJ USA; [Langer, Sarka] Swedish Environm Res Inst, S-40258 Gothenburg, Sweden; [Callesen, Michael] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Pediat Res Unit, DK-5000 Odense, Denmark	Technical University of Denmark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; IVL Swedish Environmental Research Institute; University of Southern Denmark; Odense University Hospital	Beko, G (corresponding author), Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark.	gab@byg.dtu.dk	Toftum, Jorn/B-4670-2017; Weschler, Charles J/A-9788-2009; Beko, Gabriel/C-8684-2009; Clausen, Geo/A-9635-2013	Toftum, Jorn/0000-0001-7697-7617; Weschler, Charles J/0000-0002-9097-5850; Beko, Gabriel/0000-0001-6107-8336; Clausen, Geo/0000-0003-3544-8967	Danish VILLUM FOUNDATION [VKR020814]	Danish VILLUM FOUNDATION(Villum Fonden)	The Danish VILLUM FOUNDATION generously supported the study (Grant # VKR020814). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham K, 2005, ARCH TOXICOL, V79, P63, DOI 10.1007/s00204-004-0599-3; Anderson WAC, 2001, FOOD ADDIT CONTAM A, V18, P1068, DOI 10.1080/02652030110050113; Aylward LL, 2011, J EXPO SCI ENV EPID, V21, P615, DOI 10.1038/jes.2011.28; Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074; Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bosgra S, 2005, REGUL TOXICOL PHARM, V43, P104, DOI 10.1016/j.yrtph.2005.06.008; Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI [10.1007/s00128-001-0255-z, 10.1007/s001280255]; Buckley JP, 2012, J EXPO SCI ENV EPID, V22, P468, DOI 10.1038/jes.2012.33; Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059; Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x; CDC, 2012, 4 CDCP; *CDC, 2005, 3 CDCP; CHAN PKL, 1994, ENVIRON CARCIN ECO R, V12, P257; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Clark KE, 2011, HUM ECOL RISK ASSESS, V17, P923, DOI 10.1080/10807039.2011.588157; Clausen G, 2012, INDOOR AIR, V22, P467, DOI 10.1111/j.1600-0668.2012.00777.x; Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712; Deisinger PJ, 1998, FOOD CHEM TOXICOL, V36, P521, DOI 10.1016/S0278-6915(98)00015-5; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; EFSA, 2005, EFSA J, V3; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; European Food Safety Authorities, 2005, EFSA J, V241, P1, DOI [DOI 10.2903/J.EFSA.2005.241, DOI 10.2903/J.EFSA.2004.84]; European Food Safety Authorities, 2005, EFSA J, V3, P241, DOI DOI 10.2903/J.EFSA.2005.241; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001; Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005; Fromme H, 2005, INDOOR AIR, V15, P335, DOI 10.1111/j.1600-0668.2005.00377.x; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1111/j.1600-0668.2004.00223.x; Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Gevao B, 2013, INDOOR AIR, V23, P126, DOI 10.1111/ina.12001; Goen T, 2011, INT J HYG ENVIR HEAL, V215, P36, DOI 10.1016/j.ijheh.2011.07.011; Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x; Guo Y, 2012, J AGR FOOD CHEM, V60, P6913, DOI 10.1021/jf3021128; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106; HAGEDORNLEWEKE U, 1995, PHARMACEUT RES, V12, P1354, DOI 10.1023/A:1016286026462; Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146; Hannas BR, 2011, TOXICOL SCI, V120, P184, DOI 10.1093/toxsci/kfq386; Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; HAWLEY JK, 1985, RISK ANAL, V5, P289, DOI 10.1111/j.1539-6924.1985.tb00185.x; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069; Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Jakubowski M, 2009, ENVIRON TOXICOL PHAR, V28, P311, DOI 10.1016/j.etap.2009.05.011; Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x; Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Just AC, 2012, ENVIRON HEALTH PERSP, V120, P1475, DOI 10.1289/ehp.1104544; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Kang Y, 2012, ENVIRON SCI TECHNOL, V46, P8422, DOI 10.1021/es300379v; Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020; Koch HM, 2012, ARCH TOXICOL, V86, P1829, DOI 10.1007/s00204-012-0908-1; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526; Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009; Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.2307/3435033; Koniecki D, 2011, ENVIRON RES, V111, P329, DOI 10.1016/j.envres.2011.01.013; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x; Langer S, 2014, INT J HYG ENVIR HEAL, V217, P78, DOI 10.1016/j.ijheh.2013.03.014; Langer S, 2010, ATMOS ENVIRON, V44, P2294, DOI 10.1016/j.atmosenv.2010.04.001; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Little JC, 2012, ENVIRON SCI TECHNOL, V46, P11171, DOI 10.1021/es301088a; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x; Mielke H, 2011, TOXICOL LETT, V204, P190, DOI 10.1016/j.toxlet.2011.04.032; MILLER LA, 1989, J UROLOGY, V141, P918, DOI 10.1016/S0022-5347(17)41052-4; Morgan M. K., 2004, PILOT STUDY CHILDREN; Needham LL, 2007, INT J HYG ENVIR HEAL, V210, P229, DOI 10.1016/j.ijheh.2006.11.002; Nomiyama T, 2000, INT ARCH OCC ENV HEA, V73, P121, DOI 10.1007/s004200050017; Nomiyama T, 2001, INT ARCH OCC ENV HEA, V74, P224, DOI 10.1007/s004200000207; NRC (National Research Council),, 2008, PHTHAL CUM RISK ASS, DOI 10.17226/12528; Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231; Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x; Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x; Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478; Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014; Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001; Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766; Schossler P, 2011, SCI TOTAL ENVIRON, V409, P4031, DOI 10.1016/j.scitotenv.2011.06.012; Seckin E, 2009, TOXICOL LETT, V188, P33, DOI 10.1016/j.toxlet.2009.03.002; Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018; Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Soeborg T, 2012, INT J ANDROL, V35, P245, DOI 10.1111/j.1365-2605.2011.01240.x; Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013; Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; SZABO L, 1995, BRIT J UROL, V76, P16, DOI 10.1111/j.1464-410X.1995.tb07580.x; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Teuschler LK, 1995, TOXICOLOGY, V105, P137, DOI 10.1016/0300-483X(95)03207-V; Toft G, 2012, ENVIRON HEALTH PERSP, V120, P458, DOI 10.1289/ehp.1103552; Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474; U.S. Environmental Protection Agency, 1993, 85687 US EPA CASRN; U.S. EPA, 1997, 117817 US EPA CASRN; Weschler CJ, 2012, INDOOR AIR, V22, P356, DOI 10.1111/j.1600-0668.2012.00772.x; Weschler CJ, 2010, ATMOS ENVIRON, V44, P3609, DOI 10.1016/j.atmosenv.2010.06.029; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047; Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Xu Y, 2010, ENVIRON HEALTH PERSP, V118, P253, DOI 10.1289/ehp.0900559; Xu Y, 2009, ENVIRON SCI TECHNOL, V43, P2374, DOI 10.1021/es801354f; Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004; [No title captured]	142	199	204	8	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62442	10.1371/journal.pone.0062442	http://dx.doi.org/10.1371/journal.pone.0062442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626820	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400184
J	Bruses, JL				Bruses, Juan L.			Cell Surface Localization of alpha 3 beta 4 Nicotinic Acetylcholine Receptors Is Regulated by N-Cadherin Homotypic Binding and Actomyosin Contractility	PLOS ONE			English	Article							PDZ PROTEIN SCRIBBLE; SYNAPSE FORMATION; BETA-CATENIN; IN-VIVO; CONTACT FORMATION; EXCHANGE FACTOR; P120 CATENIN; RHO-GTPASES; ADHESION; NEURONS	Neuronal nicotinic acetylcholine receptors (nAChRs) are widely expressed throughout the central and peripheral nervous system and are localized at synaptic and extrasynaptic sites of the cell membrane. However, the mechanisms regulating the localization of nicotinic receptors in distinct domains of the cell membrane are not well understood. N-cadherin is a cell adhesion molecule that mediates homotypic binding between apposed cell membranes and regulates the actin cytoskeleton through protein interactions with the cytoplasmic domain. At synaptic contacts, N-cadherin is commonly localized adjacent to the active zone and the postsynaptic density, suggesting that N-cadherin contributes to the assembly of the synaptic complex. To examine whether N-cadherin homotypic binding regulates the cell surface localization of nicotinic receptors, this study used heterologous expression of N-cadherin and alpha 3 beta 4 nAChR subunits C-terminally fused to a myc-tag epitope in Chinese hamster ovary cells. Expression levels of alpha 3 beta 4 nAChRs at cell-cell contacts and at contact-free cell membrane were analyzed by confocal microscopy. alpha 3 beta 4 nAChRs were found distributed over the entire surface of contacting cells lacking N-cadherin. In contrast, N-cadherin-mediated cell-cell contacts were devoid of alpha 3 beta 4 nAChRs. Cell-cell contacts mediated by N-cadherin-deleted proteins lacking the beta-catenin binding region or the entire cytoplasmic domain showed control levels of alpha 3 beta 4 nAChRs expression. Inhibition of actin polymerization with latrunculin A and cytochalasin D did not affect alpha 3 beta 4 nAChRs localization within N-cadherin-mediated cell-cell contacts. However, treatment with the Rho associated kinase inhibitor Y27632 resulted in a significant increase in alpha 3 beta 4 nAChR levels within N-cadherin-mediated cell-cell contacts. Analysis of alpha 3 beta 4 nAChRs localization in polarized Caco-2 cells showed specific expression on the apical cell membrane and colocalization with apical F-actin and the actin nucleator Arp3. These results indicate that actomyosin contractility downstream of N-cadherin homotypic binding regulates the cell surface localization of alpha 3 beta 4 nAChRs presumably through interactions with a particular pool of F-actin.	[Bruses, Juan L.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Bruses, Juan L.] Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Bruses, JL (corresponding author), Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	jbruses@kumc.edu			National Institutes of Health, National Institute of Mental Health [R21 MH 082245]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH082245] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by National Institutes of Health, National Institute of Mental Health, Grant # R21 MH 082245 to JLB [http://www.nimh.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga M, 2011, J BIOL CHEM, V286, P851, DOI 10.1074/jbc.M110.176305; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 2011, CURR OPIN NEUROBIOL; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borroni V, 2011, J BIOL CHEM, V286, P17122, DOI 10.1074/jbc.M110.211870; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; Flannery R. J., 2012, FRONTIERS NEUROSCIEN, V4, P1; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; Huntley GW, 1999, J COMP NEUROL, V407, P453; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Koh CG, 2001, J CELL SCI, V114, P4239; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lambert M, 2000, J CELL SCI, V113, P2207; Lambert M, 2007, EXP CELL RES, V313, P4025, DOI 10.1016/j.yexcr.2007.07.035; Lukas RJ, 1999, PHARMACOL REV, V51, P397; MATSUZAKI F, 1990, J CELL BIOL, V110, P1239, DOI 10.1083/jcb.110.4.1239; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenberg MM, 2010, J NEUROSCI, V30, P11073, DOI 10.1523/JNEUROSCI.0983-10.2010; Rubio ME, 2005, MOL CELL NEUROSCI, V30, P118, DOI 10.1016/j.mcn.2005.06.005; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shoop RD, 2000, J NEUROSCI, V20, P4021; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; URBANIK E, 1989, ARCH BIOCHEM BIOPHYS, V269, P181, DOI 10.1016/0003-9861(89)90098-2; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	65	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62435	10.1371/journal.pone.0062435	http://dx.doi.org/10.1371/journal.pone.0062435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626818	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400182
J	Cai, M; He, LH; Yu, TY				Cai, Ma; He, Li-Hong; Yu, Tu-Yuan			Molecular Clone and Expression of a NAD(+)-Dependent Glycerol-3-Phosphate Dehydrogenase Isozyme Gene from the Halotolerant alga Dunaliella salina	PLOS ONE			English	Article							GLYCEROL 3-PHOSPHATE DEHYDROGENASE; DIHYDROXYACETONE PHOSPHATE REDUCTASE; FRUCTOSE-1,6-DIPHOSPHATE ALDOLASE; CDNA; STRESS; STARCH; OSMOREGULATION; PHOTOSYNTHESIS; BIOSYNTHESIS; TERTIOLECTA	Glycerol is an important osmotically compatible solute in Dunaliella. Glycerol-3-phosphate dehydrogenase (G3PDH) is a key enzyme in the pathway of glycerol synthesis, which converts dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate. Generally, the glycerol-DHAP cycle pathway, which is driven by G3PDH, is considered as the rate-limiting enzyme to regulate the glycerol level under osmotic shocks. Considering the peculiarity in osmoregulation, the cDNA of a NAD(+)-dependent G3PDH was isolated from D. salina using RACE and RT-PCR approaches in this study. Results indicated that the length of the cDNA sequence of G3PDH was 2,100 bp encoding a 699 amino acid deduced polypeptide whose computational molecular weight was 76.6 kDa. Conserved domain analysis revealed that the G3PDH protein has two independent functional domains, SerB and G3PDH domains. It was predicted that the G3PDH was a nonsecretory protein and may be located in the chloroplast of D. salina. Phylogenetic analysis demonstrated that the D. salina G3PDH had a closer relationship with the G3PDHs from the Dunaliella genus than with those from other species. In addition, the cDNA was subsequently subcloned in the pET-32a(+) vector and was transformed into E. coli strain BL21 (DE3), a expression protein with 100 kDa was identified, which was consistent with the theoretical value.	[Cai, Ma; He, Li-Hong; Yu, Tu-Yuan] Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Cai, M (corresponding author), Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	macai1965@163.com						AHMED AM, 1987, J BASIC MICROB, V27, P419, DOI 10.1002/jobm.3620270804; Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; BENAMOTZ A, 1973, PLANT PHYSIOL, V51, P875, DOI 10.1104/pp.51.5.875; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037578; Chen H, 2011, SCI TOTAL ENVIRON, V409, P1291, DOI 10.1016/j.scitotenv.2010.12.038; Chen H, 2009, J CELL PHYSIOL, V219, P251, DOI 10.1002/jcp.21715; Chen H, 2009, J AGR FOOD CHEM, V57, P6178, DOI 10.1021/jf900447r; Chen XZ, 2008, FEMS YEAST RES, V8, P725, DOI 10.1111/j.1567-1364.2008.00382.x; Cui LQ, 2010, J APPL PHYCOL, V22, P563, DOI 10.1007/s10811-009-9494-x; Foss DL, 1998, ANIM BIOTECHNOL, V9, P67, DOI 10.1080/10495399809525893; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GEE R, 1993, PLANT PHYSIOL, V103, P243, DOI 10.1104/pp.103.1.243; Ghoshal D, 2002, PROTEIN EXPRES PURIF, V24, P404, DOI 10.1006/prep.2001.1588; GIMMLER H, 1981, PLANT CELL ENVIRON, V4, P367, DOI 10.1111/j.1365-3040.1981.tb02114.x; GOYAL A, 1987, J PLANT PHYSIOL, V127, P77, DOI 10.1016/S0176-1617(87)80043-3; Goyal A, 2007, PLANT PHYSIOL BIOCH, V45, P705, DOI 10.1016/j.plaphy.2007.05.009; Goyal A, 2007, PLANT PHYSIOL BIOCH, V45, P696, DOI 10.1016/j.plaphy.2007.05.008; He QH, 2007, J PLANT PHYSIOL, V164, P214, DOI 10.1016/j.jplph.2006.04.004; He YX, 2009, PLANT MOL BIOL, V71, P193, DOI 10.1007/s11103-009-9517-7; Lee DH, 2008, FEMS YEAST RES, V8, P1324, DOI 10.1111/j.1567-1364.2008.00446.x; Peng F, 2010, YEAST, V27, P115, DOI 10.1002/yea.1736; Ramos Ana A., 2011, Algae, V26, P3, DOI 10.4490/algae.2011.26.1.003; RONNOW B, 1993, YEAST, V9, P1121, DOI 10.1002/yea.320091013; SADKA A, 1989, FEBS LETT, V244, P93, DOI 10.1016/0014-5793(89)81170-6; Sambrook J, 2001, MOL CLONING LAB MANU; Thome PE, 2004, YEAST, V21, P119, DOI 10.1002/yea.1070; Wang ZX, 2001, BIOTECHNOL ADV, V19, P201, DOI 10.1016/S0734-9750(01)00060-X; Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P835, DOI 10.1006/bbrc.1997.6198; Yan Y, 2005, J AGR FOOD CHEM, V53, P1466, DOI 10.1021/jf048358s; Yang WG, 2007, J BASIC MICROB, V47, P266, DOI 10.1002/jobm.200610263; Ye ZW, 2008, BIOTECHNOL ADV, V26, P352, DOI 10.1016/j.biotechadv.2008.03.004; Ye ZW, 2010, J AGR FOOD CHEM, V58, P11477, DOI 10.1021/jf102885n; Zhang H, 2004, J SICHUAN U, V41, P439; Zhang XN, 2003, SCI CHINA SER C, V46, P49, DOI 10.1007/BF03182684; Zhang XN, 2002, DNA SEQUENCE, V13, P195, DOI 10.1080/1042517021000003905; Zhu YH, 2005, J AGR FOOD CHEM, V53, P5593, DOI 10.1021/jf0506838; Zhu YH, 2008, BIOCHEM CELL BIOL, V86, P285, DOI [10.1139/O08-012, 10.1139/o08-012]	38	17	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62287	10.1371/journal.pone.0062287	http://dx.doi.org/10.1371/journal.pone.0062287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626797	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400161
J	Hansen, WLJ; van der Donk, CFM; Bruggeman, CA; Stobberingh, EE; Wolffs, PFG				Hansen, Wendy L. J.; van der Donk, Christina F. M.; Bruggeman, Cathrien A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.			A Real-Time PCR-Based Semi-Quantitative Breakpoint to Aid in Molecular Identification of Urinary Tract Infections	PLOS ONE			English	Article							FLOW-CYTOMETRY; BACTERIURIA; PATHOGENS; DIAGNOSIS; CULTURES; SAMPLES; UF-100; CUTOFF; ADULTS; TESTS	This study presents a novel approach to aid in diagnosis of urinary tract infections (UTIs). A real-time PCR assay was used to screen for culture-positive urinary specimens and to identify the causative uropathogen. Semi-quantitative breakpoints were used to screen for significant bacteriuria (presence of > 10(5) CFU/ml of uropathogens) or low-level bacteriuria (containing between 10(3) and 10(4) CFU/ml of uropathogens). The 16S rDNA-based assay could identify the most prevalent uropathogens using probes for Escherichia coli, Pseudomonas species, Pseudomonas aeruginosa, Staphylococcus species, Staphylococcus aureus, Enterococcus species and Streptococcus species. 330 urinary specimens were analysed and results were compared with conventional urine culture. Using a PCR Ct value of 25 as semi-quantitative breakpoint for significant bacteriuria resulted in a sensitivity and specificity of 97% and 80%, respectively. In 78% of the samples with monomicrobial infections the assay contained probes to detect the bacteria present in the urine specimens and 99% of these uropathogens was correctly identified. Concluding, this proof-of-concept approach demonstrates that the assay can distinguish bacteriuria from no bacteriuria as well as detect the involved uropathogen within 4 hours after sampling, allowing adequate therapy decisions within the same day as well as drastically reduce consequent urine culturing.	[Hansen, Wendy L. J.; van der Donk, Christina F. M.; Bruggeman, Cathrien A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.] Maastricht Univ, Med Ctr, Care & Publ Hlth Res Inst CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	Maastricht University	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr, Care & Publ Hlth Res Inst CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	p.wolffs@mumc.nl		Wolffs, Petra/0000-0002-5326-3985				Bouza E, 2001, CLIN MICROBIOL INFEC, V7, P532, DOI 10.1046/j.1198-743x.2001.00324.x; Brilha S, 2010, CLIN CHEM LAB MED, V48, P289, DOI 10.1515/CCLM.2010.047; Broeren MAC, 2011, J CLIN MICROBIOL, V49, P1025, DOI 10.1128/JCM.01669-10; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Hansen WLJ, 2010, J CLIN MICROBIOL, V48, P4432, DOI 10.1128/JCM.00562-10; Jolkkonen S, 2010, J CLIN MICROBIOL, V48, P3117, DOI 10.1128/JCM.00617-10; Kadkhoda K, 2011, DIAGN MICR INFEC DIS, V69, P130, DOI 10.1016/j.diagmicrobio.2010.09.013; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; KASS EH, 1957, ARCH INTERN MED, V100, P709, DOI 10.1001/archinte.1957.00260110025004; Lehmann LE, 2010, BJU INT, V106, P114, DOI 10.1111/j.1464-410X.2009.09017.x; Manoni F, 2009, DIAGN MICR INFEC DIS, V65, P103, DOI 10.1016/j.diagmicrobio.2009.06.003; Medicine ECoL, 2000, SCAND J CLIN LAB I S, V60, P1; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nys S, 2006, J ANTIMICROB CHEMOTH, V57, P955, DOI 10.1093/jac/dkl082; Okada H, 2000, J CLIN MICROBIOL, V38, P2870, DOI 10.1128/JCM.38.8.2870-2872.2000; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; van der Zwet WC, 2010, CLIN CHEM LAB MED, V48, P1765, DOI 10.1515/CCLM.2010.342; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; Wu Q, 2010, J MICROBIOL METH, V83, P175, DOI 10.1016/j.mimet.2010.08.015; Zaman Z, 2001, J CLIN MICROBIOL, V39, P4169, DOI 10.1128/JCM.39.11.4169-4171.2001	24	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61439	10.1371/journal.pone.0061439	http://dx.doi.org/10.1371/journal.pone.0061439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626685	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400048
J	Negandhi, AA; Hyde, A; Dicks, E; Pollett, W; Younghusband, BH; Parfrey, P; Green, RC; Savas, S				Negandhi, Amit A.; Hyde, Angela; Dicks, Elizabeth; Pollett, William; Younghusband, Banfield H.; Parfrey, Patrick; Green, Roger C.; Savas, Sevtap			MTHFR Glu429Ala and ERCC5 His46His Polymorphisms Are Associated with Prognosis in Colorectal Cancer Patients: Analysis of Two Independent Cohorts from Newfoundland	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; NON-MUCINOUS ADENOCARCINOMA; THYMIDYLATE-SYNTHASE; MICROSATELLITE INSTABILITY; NUCLEOTIDE POLYMORPHISM; GROWTH-FACTOR; BRAF V600E; SURVIVAL; COLON; REPAIR	Introduction: In this study, 27 genetic polymorphisms that were previously reported to be associated with clinical outcomes in colorectal cancer patients were investigated in relation to overall survival (OS) and disease free survival (DFS) in colorectal cancer patients from Newfoundland. Methods: The discovery and validation cohorts comprised of 532 and 252 patients, respectively. Genotypes of 27 polymorphisms were first obtained in the discovery cohort and survival analyses were performed assuming the co-dominant genetic model. Polymorphisms associated with disease outcomes in the discovery cohort were then investigated in the validation cohort. Results: When adjusted for sex, age, tumor stage and microsatellite instability (MSI) status, four polymorphisms were independent predictors of OS in the discovery cohort MTHFR Glu429Ala (HR: 1.72, 95%CI: 1.04-2.84, p = 0.036), ERCC5 His46His (HR: 1.78, 95%CI: 1.15-2.76, p = 0.01), SERPINE1 -675indelG (HR: 0.52, 95%CI: 0.32-0.84, p = 0.008), and the homozygous deletion of GSTM1 gene (HR: 1.4, 95%CI: 1.03-1.92, p = 0.033). In the validation cohort, the MTHFR Glu429Ala polymorphism was associated with shorter OS (HR: 1.71, 95%CI: 1.18-2.49, p = 0.005), although with a different genotype than the discovery cohort (CC genotype in the discovery cohort and AC genotype in the validation cohort). When stratified based on treatment with 5-Fluorouracil (5-FU)-based regimens, this polymorphism was associated with reduced OS only in patients not treated with 5-FU. In the DFS analysis, when adjusted for other variables, the TT genotype of the ERCC5 His46His polymorphism was associated with shorter DFS in both cohorts (discovery cohort: HR: 1.54, 95%CI: 1.04-2.29, p = 0.032 and replication cohort: HR: 1.81, 95%CI: 1.11-2.94, p = 0.018). Conclusions: In this study, associations of the MTHFR Glu429Ala polymorphism with OS and the ERCC5 His46His polymorphism with DFS were identified in two colorectal cancer patient cohorts. Our results also suggest that the MTHFR Glu429Ala polymorphism may be an adverse prognostic marker in patients not treated with 5-FU.	[Negandhi, Amit A.; Hyde, Angela; Younghusband, Banfield H.; Green, Roger C.; Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Dicks, Elizabeth; Parfrey, Patrick] Mem Univ Newfoundland, Fac Med, Clin Epidemiol Unit, St John, NF, Canada; [Pollett, William] Mem Univ Newfoundland, Fac Med, Discipline Surg, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.	savas@mun.ca		Savas, Sevtap/0000-0002-7324-938X	Memorial University; Faculty of Medicine, Memorial University; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto; National Cancer Institute of Canada [18223, 18226]; Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; CIHR; Canadian Institute of Health Research Institute of Genetics; Canadian Gene Cure Foundation	Memorial University; Faculty of Medicine, Memorial University; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Canadian Gene Cure Foundation	This study is funded by grants from the Memorial University; the 2010 Cox Award by the Faculty of Medicine, Memorial University; the Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University, the National Cancer Institute of Canada (grants 18223 and 18226) and the Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics. AAN was supported by the CIHR Interdisciplinary Health Research Team Fellowship. AH was supported by the Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation). The funding sources had no involvement in the study design; in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Afzal S, 2009, ANN ONCOL, V20, P1660, DOI 10.1093/annonc/mdp046; Balboa E, 2010, PHARMACOGENOMICS, V11, P747, DOI 10.2217/PGS.10.51; Bange J, 2002, CANCER RES, V62, P840; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Boige V, 2010, J CLIN ONCOL, V28, P2556, DOI 10.1200/JCO.2009.25.2106; Canadian Cancer Society's Steering Committee, 2011, CAN CANC STAT 2011; Carles J, 2006, INT J RADIAT ONCOL, V66, P1022, DOI 10.1016/j.ijrobp.2006.06.029; Cecchin E, 2011, PHARMACOGENOMICS J, V11, P214, DOI 10.1038/tpj.2010.25; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Compton Carolyn C, 2002, Clin Colorectal Cancer, V2, P149, DOI 10.3816/CCC.2002.n.020; Crott JW, 2004, CARCINOGENESIS, V25, P69, DOI 10.1093/carcin/bgg150; Duthie SJ, 2011, J INHERIT METAB DIS, V34, P101, DOI 10.1007/s10545-010-9128-0; Edge SB, 2010, CANC STAGING HDB, P192; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Etienne-Grimaldi MC, 2010, BRIT J CLIN PHARMACO, V69, P58, DOI 10.1111/j.1365-2125.2009.03556.x; Fernandez-Peralta AM, 2010, INT J COLORECTAL DIS, V25, P141, DOI 10.1007/s00384-009-0779-y; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Gusella M, 2009, BRIT J CANCER, V100, P1549, DOI 10.1038/sj.bjc.6605052; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Holmes RS, 2010, CANCER EPIDEM BIOMAR, V19, P2023, DOI 10.1158/1055-9965.EPI-09-1097; Hopkins J, 2008, CANCER EPIDEM BIOMAR, V17, P490, DOI 10.1158/1055-9965.EPI-07-2714; Hyde A, 2010, AM J SURG PATHOL, V34, P1820, DOI 10.1097/PAS.0b013e3181f6a912; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; KANEDA S, 1987, NUCLEIC ACIDS RES, V15, P1259, DOI 10.1093/nar/15.3.1259; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Kim YI, 2006, GUT, V55, P1387, DOI 10.1136/gut.2006.095463; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; KUNE GA, 1992, EUR J CANCER, V28A, P1484, DOI 10.1016/0959-8049(92)90549-H; Kweekel DM, 2009, BRIT J CANCER, V101, P357, DOI 10.1038/sj.bjc.6605134; Lamas MJ, 2011, PHARMACOGENOMICS, V12, P433, DOI [10.2217/PGS.10.196, 10.2217/pgs.10.196]; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lim SB, 2010, DIS COLON RECTUM, V53, P377, DOI 10.1007/DCR.0b013e3181cf8ae5; LIN HJ, 1994, CARCINOGENESIS, V15, P1077, DOI 10.1093/carcin/15.5.1077; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Mandola MV, 2004, PHARMACOGENETICS, V14, P319, DOI 10.1097/00008571-200405000-00007; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; MORIAI T, 1994, P NATL ACAD SCI USA, V91, P10217, DOI 10.1073/pnas.91.21.10217; Odin E, 2006, CLIN COLORECTAL CANC, V5, P344, DOI 10.3816/CCC.2006.n.004; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Rutter JL, 1998, CANCER RES, V58, P5321; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Schmitt CA, 1998, BRIT J CANCER, V77, P588, DOI 10.1038/bjc.1998.95; Sharma R, 2008, CLIN CANCER RES, V14, P817, DOI 10.1158/1078-0432.CCR-07-0425; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Song W, 2009, CHINESE MED J-PEKING, V122, P1486, DOI 10.3760/cma.j.issn.0366-6999.2009.13.002; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; Walsh CS, 2008, J CLIN ONCOL, V26, P2952, DOI 10.1200/JCO.2007.13.5806; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Wang YF, 2003, DNA REPAIR, V2, P901, DOI 10.1016/S1568-7864(03)00085-5; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wish TA, 2010, CANCER EPIDEM BIOMAR, V19, P1831, DOI 10.1158/1055-9965.EPI-10-0055; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; World Health Organization, 2008, The global burden of disease: 2004 update; Xie L, 2009, INT J ONCOL, V34, P1109, DOI 10.3892/ijo_00000238; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Yu JJ, 1997, MUTAT RES-GENOMICS, V382, P13, DOI 10.1016/S1383-5726(97)00004-6; Zarate R, 2010, BRIT J CANCER, V102, P987, DOI 10.1038/sj.bjc.6605595; Zell JA, 2008, CANCER EPIDEM BIOMAR, V17, P3134, DOI 10.1158/1055-9965.EPI-08-0587; Zhang W, 2007, J CLIN ONCOL, V25, P3726, DOI 10.1200/JCO.2007.11.4710	76	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61469	10.1371/journal.pone.0061469	http://dx.doi.org/10.1371/journal.pone.0061469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626689	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400053
J	Soons, ZITA; Ferreira, EC; Patil, KR; Rocha, I				Soons, Zita I. T. A.; Ferreira, Eugenio C.; Patil, Kiran R.; Rocha, Isabel			Identification of Metabolic Engineering Targets through Analysis of Optimal and Sub-Optimal Routes	PLOS ONE			English	Article							ELEMENTARY FLUX MODES; SACCHAROMYCES-CEREVISIAE; KNOCKOUT STRATEGIES; ESCHERICHIA-COLI; OPTIMIZATION; ETHANOL	Identification of optimal genetic manipulation strategies for redirecting substrate uptake towards a desired product is a challenging task owing to the complexity of metabolic networks, esp. in terms of large number of routes leading to the desired product. Algorithms that can exploit the whole range of optimal and suboptimal routes for product formation while respecting the biological objective of the cell are therefore much needed. Towards addressing this need, we here introduce the notion of structural flux, which is derived from the enumeration of all pathways in the metabolic network in question and accounts for the contribution towards a given biological objective function. We show that the theoretically estimated structural fluxes are good predictors of experimentally measured intra-cellular fluxes in two model organisms, namely, Escherichia coli and Saccharomyces cerevisiae. For a small number of fluxes for which the predictions were poor, the corresponding enzyme-coding transcripts were also found to be distinctly regulated, showing the ability of structural fluxes in capturing the underlying regulatory principles. Exploiting the observed correspondence between in vivo fluxes and structural fluxes, we propose an in silico metabolic engineering approach, iStruF, which enables the identification of gene deletion strategies that couple the cellular biological objective with the product flux while considering optimal as well as sub-optimal routes and their efficiency.	[Soons, Zita I. T. A.; Ferreira, Eugenio C.; Rocha, Isabel] Univ Minho, Inst Biotechnol & Bioengn, Braga, Portugal; [Soons, Zita I. T. A.; Patil, Kiran R.] EMBL Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany	Universidade do Minho; European Molecular Biology Laboratory (EMBL)	Soons, ZITA (corresponding author), Heidelberg Univ, Dept Bioinformat & Funct Genom, Heidelberg, Germany.	zita.soons@gmail.com	Rocha, Isabel/A-4279-2013; Patil, Kiran R/B-9709-2009; Ferreira, Eugénio Campos/B-5417-2009	Rocha, Isabel/0000-0001-9494-3410; Patil, Kiran R/0000-0002-6166-8640; Ferreira, Eugénio Campos/0000-0002-5400-3333; Soons, Zita/0000-0002-0767-8856	Portuguese Science Foundation [MIT-Pt/BS-BB/0082/2008, SFRH/BPD/44180/2008]; Fundação para a Ciência e a Tecnologia [COVID/BD/151834/2021, MIT-Pt/BS-BB/0082/2008] Funding Source: FCT	Portuguese Science Foundation(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Science Foundation [grant numbers MIT-Pt/BS-BB/0082/2008, SFRH/BPD/44180/2008 to ZS] (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Beurton-Aimar M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-95; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Boghigian BA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-49; Bohl K., 2010, LECT NOTES INFORM, P71; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Cakir T, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-18; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; Hadicke O, 2010, J BIOTECHNOL, V147, P88, DOI 10.1016/j.jbiotec.2010.03.006; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Kaleta C., 2009, LECT NOTES INFORM P, VP-157, P179; Llaneras F, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753904; Machado D, 2012, BIOINFORMATICS, V28, pI515, DOI 10.1093/bioinformatics/bts401; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Melzer G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-120; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Otero JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054144; Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; PRICE WL, 1977, COMPUT J, V20, P367, DOI 10.1093/comjnl/20.4.367; Raab AM, 2010, METAB ENG, V12, P518, DOI 10.1016/j.ymben.2010.08.005; Rocha I, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-45; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Trinh CT, 2008, APPL ENVIRON MICROB, V74, P3634, DOI 10.1128/AEM.02708-07; Verboven S, 2005, CHEMOMETR INTELL LAB, V75, P127, DOI 10.1016/j.chemolab.2004.06.003; Wagner C, 2005, BIOPHYS J, V89, P3837, DOI 10.1529/biophysj.104.055129; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Zamboni N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-199; Zhang HM, 2003, BIOCHEM ENG J, V16, P211, DOI 10.1016/S1369-703X(03)00070-6; Zhao QY, 2009, BIOINFORMATICS, V25, P1702, DOI 10.1093/bioinformatics/btp298	42	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61648	10.1371/journal.pone.0061648	http://dx.doi.org/10.1371/journal.pone.0061648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626708	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400072
J	Meier, N; Kappeli, SC; Niessen, MH; Billeter, JC; Goodwin, SF; Bopp, D				Meier, Nicole; Kaeppeli, Simone Catherine; Niessen, Monika Hediger; Billeter, Jean-Christophe; Goodwin, Stephen F.; Bopp, Daniel			Genetic Control of Courtship Behavior in the Housefly: Evidence for a Conserved Bifurcation of the Sex-Determining Pathway	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; FRUITLESS GENE; MUSCA-DOMESTICA; DOUBLESEX GENE; NEURAL CIRCUITRY; BTB DOMAIN; DIFFERENTIATION; EXPRESSION; FLY	In Drosophila melanogaster, genes of the sex-determination hierarchy orchestrate the development and differentiation of sex-specific tissues, establishing sex-specific physiology and neural circuitry. One of these sex-determination genes, fruitless (fru), plays a key role in the formation of neural circuits underlying Drosophila male courtship behavior. Conservation of fru gene structure and sex-specific expression has been found in several insect orders, though it is still to be determined whether a male courtship role for the gene is employed in these species due to the lack of mutants and homologous experimental evidence. We have isolated the fru ortholog (Md-fru) from the common housefly, Musca domestica, and show the gene's conserved genomic structure. We demonstrate that male-specific Md-fru transcripts arise by conserved mechanisms of sex-specific splicing. Here we show that Md-fru, is similarly involved in controlling male courtship behavior. A male courtship behavioral function for Md-fru was revealed by the behavioral and neuroanatomical analyses of a hypomorphic allele, Md-tra(man), which specifically disrupted the expression of Md-fru in males, leading to severely impaired male courtship behavior. In line with a role in nervous system development, we found that expression of Md-fru was confined to neural tissues in the brain, most prominently in optic neuropil and in peripheral sensory organs. We propose that, like in Drosophila, overt sexual differentiation of the housefly depends on a sex-determining pathway that bifurcates downstream of the Md-tra gene to coordinate dimorphic development of non-neuronal tissues mediated by Md-dsx with that of neuronal tissues largely mediated by Md-fru.	[Meier, Nicole; Kaeppeli, Simone Catherine; Niessen, Monika Hediger; Bopp, Daniel] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Billeter, Jean-Christophe] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Goodwin, Stephen F.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Zurich; University of Groningen; University of Oxford	Bopp, D (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	daniel.bopp@imls.uzh.ch	Niessen, Monika Hediger/AAR-7643-2020; Bopp, Daniel/L-3517-2018	Bopp, Daniel/0000-0002-0740-9672; Billeter, Jean-Christophe/0000-0001-7796-4068; Hediger, Monika/0000-0003-0036-4245; Goodwin, Stephen/0000-0002-0552-4140	Swiss National Science Foundation [31003A-109690]; Wellcome Trust [GR069590MA]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Swiss National Science Foundation (31003A-109690 to D. B.) and by the Wellcome Trust (GR069590MA to J-C.B. and S. F. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; BAKER BS, 1980, GENETICS, V94, P383; Bertossa RC, 2009, MOL BIOL EVOL, V26, P1557, DOI 10.1093/molbev/msp067; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Boerjan B, 2012, J INSECT PHYSIOL, V58, P265, DOI 10.1016/j.jinsphys.2011.11.017; Boerjan B, 2011, INSECT BIOCHEM MOLEC, V41, P340, DOI 10.1016/j.ibmb.2011.01.012; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clynen E, 2011, DEV GENES EVOL, V221, P43, DOI 10.1007/s00427-011-0352-x; Dauwalder B, 2011, INT REV NEUROBIOL, V99, P87, DOI 10.1016/B978-0-12-387003-2.00004-5; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Dubendorfer Andreas, 1992, Seminars in Developmental Biology, V3, P349; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; GAILEY DA, 1989, GENETICS, V121, P773; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MCDONALD IC, 1978, ANN ENTOMOL SOC AM, V71, P692, DOI 10.1093/aesa/71.5.692; MCROBERT SP, 1985, GENETICS, V111, P89; Meffert LM, 2005, CURR TOP DEV BIOL, V66, P189, DOI 10.1016/S0070-2153(05)66006-1; MEFFERT LM, 1995, GENETICS, V139, P365; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Oliveira DCSG, 2009, INSECT MOL BIOL, V18, P315, DOI 10.1111/j.1365-2583.2009.00874.x; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Saccone G, 2008, INT J DEV BIOL, V52, P1051, DOI 10.1387/ijdb.082657gs; Salvemini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048554; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salvemini M, 2010, J GENET, V89, P287, DOI 10.1007/s12041-010-0040-z; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Schmidt R, 1997, GENETICS, V145, P173; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; STRAUSFELD NJ, 1980, NATURE, V283, P381, DOI 10.1038/283381a0; Sukontason KL, 2008, PARASITOL RES, V103, P123, DOI 10.1007/s00436-008-0939-y; Suzuki MG, 2010, J GENET, V89, P357, DOI 10.1007/s12041-010-0047-5; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Usui-Aoki K, 2005, J NEUROGENET, V19, P109, DOI 10.1080/01677060591007191; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Villella A, 1997, GENETICS, V147, P1107; Villella A, 2006, J COMP PHYSIOL A, V192, P1253, DOI 10.1007/s00359-006-0154-1; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; WEHRHAHN C, 1979, BIOL CYBERN, V32, P239, DOI 10.1007/BF00337647; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	59	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62476	10.1371/journal.pone.0062476	http://dx.doi.org/10.1371/journal.pone.0062476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630634	Green Published, Green Accepted, gold			2022-12-25	WOS:000317911500093
J	Zhao, WN; Breese, E; Bowers, A; Hoggatt, J; Pelus, LM; Broxmeyer, HE; Goebl, M; Harrington, MA				Zhao, Weina; Breese, Erin; Bowers, Allison; Hoggatt, Jonathan; Pelus, Louis M.; Broxmeyer, Hal E.; Goebl, Mark; Harrington, Maureen A.			SIMPL Enhancement of Tumor Necrosis Factor-alpha Dependent p65-MED1 Complex Formation Is Required for Mammalian Hematopoietic Stem and Progenitor Cell Function	PLOS ONE			English	Article							NF-KAPPA-B; NUCLEAR-FACTOR; DEFICIENT MICE; IKK-ALPHA; TRANSCRIPTIONAL ACTIVATION; LIVER DEGENERATION; STATISTICAL-MODEL; KINASE; RECEPTOR; TNF	Significant insight into the signaling pathways leading to activation of the Rel transcription factor family, collectively termed NF-kappa B, has been gained. Less well understood is how subsets of NF-kappa B-dependent genes are regulated in a signal specific manner. The SIMPL protein (signaling molecule that interacts with mouse pelle-like kinase) is required for full Tumor Necrosis Factor-alpha (TNF alpha) induced NF-kappa B activity. We show that SIMPL is required for steady-state hematopoiesis and the expression of a subset of TNF alpha induced genes whose products regulate hematopoietic cell activity. To gain insight into the mechanism through which SIMPL modulates gene expression we focused on the Tnf gene, an immune response regulator required for steady-state hematopoiesis. In response to TNF alpha SIMPL localizes to the Tnf gene promoter where it modulates the initiation of Tnf gene transcription. SIMPL binding partners identified by mass spectrometry include proteins involved in transcription and the interaction between SIMPL and MED1 was characterized in more detail. In response to TNF alpha, SIMPL is found in p65-MED1 complexes where SIMPL enhances p65/MED1/SIMPL complex formation. Together our results indicate that SIMPL functions as a TNF alpha-dependent p65 co-activator by facilitating the recruitment of MED1 to p65 containing transcriptional complexes to control the expression of a subset of TNF alpha-induced genes.	[Zhao, Weina; Breese, Erin; Bowers, Allison; Goebl, Mark; Harrington, Maureen A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hoggatt, Jonathan; Pelus, Louis M.; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Harrington, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	mharrin@iu.edu			Public Health Service from the National Institute of Allergy and Infectious Diseases [AI077705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067384, R01HL112669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077705] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI077705 from the National Institute of Allergy and Infectious Diseases (to MAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson EA, 2010, EXP HEMATOL, V38, P71, DOI 10.1016/j.exphem.2009.11.006; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dybedal I, 2001, BLOOD, V98, P1782, DOI 10.1182/blood.V98.6.1782; Gilmore TD, NF KAPPAB TRANSCRIPT; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ichioka M, 2011, DIABETES, V60, P819, DOI 10.2337/db10-0864; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kwon HJ, 2004, MOL CELL BIOL, V24, P9317, DOI 10.1128/MCB.24.21.9317-9326.2004; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Luo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC1013, DOI 10.1152/ajpcell.00456.2006; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; McClintick JN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-4; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Owen HR, 2005, J PROTEOME RES, V4, P1381, DOI 10.1021/pr0500713; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Stifter G, 2005, EUR J HAEMATOL, V75, P485, DOI 10.1111/j.1600-0609.2005.00551.x; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Urahama N, 2005, GENES CELLS, V10, P1127, DOI 10.1111/j.1365-2443.2005.00906.x; Vig E, 2001, J BIOL CHEM, V276, P7859, DOI 10.1074/jbc.M010399200; WARREN DJ, 1990, EUR J HAEMATOL, V45, P158; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHANG Y, 1995, BLOOD, V86, P2930	47	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61123	10.1371/journal.pone.0061123	http://dx.doi.org/10.1371/journal.pone.0061123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630580	Green Submitted, Green Published, gold			2022-12-25	WOS:000317911500019
J	Lopez, G; Munoz, J; Soriguer, R; Figuerola, J				Lopez, Guillermo; Munoz, Joaquin; Soriguer, Ramon; Figuerola, Jordi			Increased Endoparasite Infection in Late-Arriving Individuals of a Trans-Saharan Passerine Migrant Bird	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; REPRODUCTIVE-PERFORMANCE; MALARIAL PARASITES; PLUMAGE BRIGHTNESS; DISTANCE MIGRATION; SPRING MIGRATION; BREEDING AREAS; DATE; PROTANDRY; WILD	Earlier migration in males than in females is the commonest pattern in migrating passerines and is positively related to size dimorphism and dichromatism. The early arrival of males is a costly trait that may confer reproductive advantages in terms of better territories and/or mates. Given the physiological cost of migration, early migrants are those in best condition and accordingly the prevalence, load, and/or diversity of parasites is expected to increase in both sexes for late migrants. To test this hypothesis, we sampled 187 trans-Saharan migrant garden warblers Sylvia borin and 64 resident serins Serinus serinus (as a control for potential circannual patterns in parasite load) during spring migration in Spain. We assessed the prevalence of blood parasites (Haemoproteus, Plasmodium, and Leucocytozoon) and the prevalence and load of intestinal parasites (mainly coccidians and spirurids). The relationship between parasite (prevalence, load, and richness) and the timing of passage through a stopover area was tested using generalized linear models. Protandry occurs in the monomorphic garden warbler and males migrated on average 5.5 days before females. Intestinal parasite richness increased with the date of migration. The timing of migration was unrelated to the presence or load of the other parasite groups analyzed. Our results support the idea that the timing of migration is a condition-dependent trait and suggests that multiple intestinal parasite infestations could delay migration in birds. Even in monomorphic species parasites may play a role in sexual selection by delaying the arrival of the most infected individuals at breeding grounds, thereby further increasing the benefits of mating with early-arriving individuals.	[Lopez, Guillermo; Soriguer, Ramon] Estn Biol Donana, Dept Biodivers Conservat & Appl Ecol, E-41013 Seville, Andalucia, Spain; [Munoz, Joaquin; Figuerola, Jordi] Estn Biol Donana, Dept Wetland Ecol, E-41013 Seville, Andalucia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lopez, G (corresponding author), Estn Biol Donana, Dept Biodivers Conservat & Appl Ecol, E-41013 Seville, Andalucia, Spain.	guiloza@gmail.com	Figuerola, Jordi/B-7917-2008; Munoz, Joaquin/B-9938-2009; Soriguer, Ramon/J-1494-2014	Figuerola, Jordi/0000-0002-4664-9011; Munoz, Joaquin/0000-0003-3623-2439; Soriguer, Ramon/0000-0002-9165-7766; Lopez, Guillermo/0000-0003-3974-4181	Spanish Ministry of Health through the Thematic Research Net 'EVITAR'; Spanish Ministry of Science [CGL2009-11445]; P.A.I. [RNM118, RNM157]	Spanish Ministry of Health through the Thematic Research Net 'EVITAR'; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); P.A.I.	The Spanish Ministry of Health through the Thematic Research Net 'EVITAR' and the Spanish Ministry of Science project CGL2009-11445 funded the authors' research. The P.A.I. RNM118 and RNM157 supported the authors' work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION; ALLEN PC, 1992, POULTRY SCI, V71, P1615, DOI 10.3382/ps.0711615; ALLEN PC, 1987, POULTRY SCI, V66, P1306, DOI 10.3382/ps.0661306; Alves JA, 2012, OIKOS, V121, P464, DOI 10.1111/j.1600-0706.2011.19678.x; APPLETON CC, 1983, OSTRICH, V54, P238, DOI 10.1080/00306525.1983.9634476; Arriero E, 2008, J EVOLUTION BIOL, V21, P1504, DOI 10.1111/j.1420-9101.2008.01613.x; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Atkinson CT, 2008, PARASITIC DIS WILD B; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Cole RA, 1999, FIELD MANUAL WILDLIF, P48; Coppack T, 2006, J ORNITHOL, V147, P260, DOI 10.1007/s10336-006-0067-3; Cramp S, 1994, HDB BIRDS EUROPE MID, VVI; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; Figuerola J, 1999, FUNCT ECOL, V13, P594, DOI 10.1046/j.1365-2435.1999.00354.x; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; FRANCIS CM, 1986, AUK, V103, P548; Fransson T, 2008, J AVIAN BIOL, V39, P133, DOI 10.1111/j.0908-8857.2008.04361.x; Garvin MC, 2006, J PARASITOL, V92, P990, DOI 10.1645/GE-758R.1; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Grattarola A, 1999, J ORNITHOL, V140, P419, DOI 10.1007/BF01650986; Greiner Ellis C., 2008, P108; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; Ilmonen P, 1999, OIKOS, V86, P79, DOI 10.2307/3546571; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kissner KJ, 2003, J EVOLUTION BIOL, V16, P154, DOI 10.1046/j.1420-9101.2003.00479.x; Klaassen M, 1996, J EXP BIOL, V199, P57; Kokko H, 2006, J ANIM ECOL, V75, P1293, DOI 10.1111/j.1365-2656.2006.01151.x; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Lopez G, 2007, INT J PARASITOL, V37, P559, DOI 10.1016/j.ijpara.2006.12.014; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Moller AP, 2004, ECOLOGY, V85, P206, DOI 10.1890/02-0451; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Mollhagen TR, 1991, STUDY PARASITIC NEMA; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Morbey YE, 2012, J ORNITHOL, V153, pS207, DOI 10.1007/s10336-012-0854-y; Mowlavi GR, 2006, J WILDLIFE DIS, V42, P397, DOI 10.7589/0090-3558-42.2.397; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Ninni P, 2004, OIKOS, V105, P55, DOI 10.1111/j.0030-1299.2004.12516.x; Oppliger A, 1997, BEHAV ECOL, V8, P148, DOI 10.1093/beheco/8.2.148; Ots I, 1998, OECOLOGIA, V116, P441, DOI 10.1007/s004420050608; Potti J, 1998, CONDOR, V100, P702, DOI 10.2307/1369752; RATTI O, 1993, OECOLOGIA, V96, P410, DOI 10.1007/BF00317512; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; Ricklefs Robert E., 2005, P210; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Smith RJ, 2003, OECOLOGIA, V134, P325, DOI 10.1007/s00442-002-1152-9; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Sorci Gabriele, 2010, Open Ornithology Journal, V3, P33, DOI 10.2174/1874453201003010033; Spurgin LG, 2012, OECOLOGIA, V168, P691, DOI 10.1007/s00442-011-2149-z; Svensson L, 1994, IDENTIFICATION GUIDE; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; TYCZKOWSKI JK, 1991, POULTRY SCI, V70, P2074, DOI 10.3382/ps.0702074; WEATHERHEAD PJ, 1992, CAN J ZOOL, V70, P1, DOI 10.1139/z92-001; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a	68	15	16	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61236	10.1371/journal.pone.0061236	http://dx.doi.org/10.1371/journal.pone.0061236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620731	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500011
J	Zhu, JX; Yang, WQ; He, XH				Zhu, Jianxiao; Yang, Wanqin; He, Xinhua			Temporal Dynamics of Abiotic and Biotic Factors on Leaf Litter of Three Plant Species in Relation to Decomposition Rate along a Subalpine Elevation Gradient	PLOS ONE			English	Article							FUMIGATION-INCUBATION METHOD; SNOW COVER; MICROBIAL BIOMASS; SOIL; CARBON; NITROGEN; TUNDRA; FORESTS; CLIMATE; DECAY	Relationships between abiotic (soil temperature and number of freeze-thaw cycles) or biotic factors (chemical elements, microbial biomass, extracellular enzymes, and decomposer communities in litter) and litter decomposition rates were investigated over two years in subalpine forests close to the Qinghai-Tibet Plateau in China. Litterbags with senescent birch, fir, and spruce leaves were placed on the forest floor at 2,704 m, 3,023 m, 3,298 m, and 3,582 m elevation. Results showed that the decomposition rate positively correlated with soil mean temperature during the plant growing season, and with the number of soil freeze-thaw cycles during the winter. Concentrations of soluble nitrogen (N), phosphorus (P) and potassium (K) had positive effects but C: N and lignin: N ratios had negative effects on the decomposition rate (k), especially during the winter. Meanwhile, microbial biomass carbon (MBC), N (MBN), and P (MBP) were positively correlated with k values during the first growing season. These biotic factors accounted for 60.0% and 56.4% of the variation in decomposition rate during the winter and the growing season in the first year, respectively. Specifically, litter chemistry (C, N, P, K, lignin, C: N and lignin: N ratio) independently explained 29.6% and 13.3%, and the microbe-related factors (MBC, MBN, MBP, bacterial and fungal biomass, sucrase and ACP activity) explained 22.9% and 34.9% during the first winter and the first growing season, respectively. We conclude that frequent freeze-thaw cycles and litter chemical properties determine the winter decomposition while microbe-related factors play more important roles in determining decomposition in the subsequent growing season.	[Zhu, Jianxiao; Yang, Wanqin] Sichuan Agr Univ, Insititute Ecol Forestry, Chengdu, Peoples R China; [Zhu, Jianxiao] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Dept Ecol, Beijing 100871, Peoples R China; [He, Xinhua] Yunnan Normal Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Sichuan Agricultural University; Peking University; Yunnan Normal University; University of Western Australia	Yang, WQ (corresponding author), Sichuan Agr Univ, Insititute Ecol Forestry, Chengdu, Peoples R China.	ywq918@yahoo.com	He, Xinhua/B-8047-2015	He, Xinhua/0000-0002-5570-3454	National Natural Science Foundation of China [31170423, 31270498]; Sichuan Youth Sci-tech Foundation [2012JQ0059, 2012JQ0008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Youth Sci-tech Foundation	This work was supported by National Natural Science Foundation of China(31170423 and 31270498): http://www.nsfc.gov.cn/Portal0/default166.htm and Sichuan Youth Sci-tech Foundation (2012JQ0059 and 2012JQ0008): http://xmgl.scst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2005, ARCT CLIM IMP ASS SC; Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; Berg B, 2000, CAN J FOREST RES, V30, P1136, DOI 10.1139/x00-044; Berg B., 2007, PLANT LITTER DECOMPO; Bocock K. L., 1957, Plant and Soil, V9, P179, DOI 10.1007/BF01398924; Bokhorst S, 2010, SOIL BIOL BIOCHEM, V42, P611, DOI 10.1016/j.soilbio.2009.12.011; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Bryant DM, 1998, CAN J BOT, V76, P1295, DOI 10.1139/cjb-76-7-1295; CHRISTENSEN S, 1990, J SOIL SCI, V41, P1, DOI 10.1111/j.1365-2389.1990.tb00039.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; EDMONDS RL, 1980, CAN J FOREST RES, V10, P327, DOI 10.1139/x80-056; Edwards AC, 2007, QUATERN INT, V162, P172, DOI 10.1016/j.quaint.2006.10.027; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; GHOLZ HL, 1985, ECOLOGY, V66, P647, DOI 10.2307/1940526; Gonzalez-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035472; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Grime P., 2001, PLANT STRATEGIES VEG; Guan S.Y., 1986, SOIL ENZYMES RES MET; Hobbie SE, 1996, BIOGEOCHEMISTRY, V35, P327, DOI 10.1007/BF02179958; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Konestabo HS, 2007, APPL SOIL ECOL, V36, P136, DOI 10.1016/j.apsoil.2007.01.003; Legendre P., 1998, NUMERICAL ECOLOGY EL, V20, P1, DOI [10.1016/S0167-8892(12)70002-7, DOI 10.1016/S0167-8892(12)70002-7]; Lu R.K, 1999, SOIL ARGROCHEMISTRY; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; MCCLAUGHERTY CA, 1985, ECOLOGY, V66, P266, DOI 10.2307/1941327; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Murphy KL, 1998, ECOL APPL, V8, P1061, DOI 10.1890/1051-0761(1998)008[1061:TEOLQA]2.0.CO;2; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Rief A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045345; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Saccone P., 2012, PLANT SOIL, P1; Salinas N, 2011, NEW PHYTOL, V189, P967, DOI 10.1111/j.1469-8137.2010.03521.x; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Swift M.J., 1979, DECOMPOSITION TERRES, V5; TATEISHI T, 1989, FEMS MICROBIOL ECOL, V62, P163, DOI 10.1016/0378-1097(89)90109-2; TAYLOR BR, 1990, CAN J BOT, V68, P112, DOI 10.1139/b90-016; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; TAYLOR BR, 1988, SOIL BIOL BIOCHEM, V20, P657, DOI 10.1016/0038-0717(88)90150-2; Uchida M, 2005, AGR FOREST METEOROL, V134, P102, DOI 10.1016/j.agrformet.2005.11.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P697, DOI 10.1016/0038-0717(87)90051-4; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Waring R.H., 1985, FOREST ECOSYSTEMS CO; Weintraub MN, 2007, OECOLOGIA, V154, P327, DOI 10.1007/s00442-007-0804-1; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; Withington CL, 2007, SOIL BIOL BIOCHEM, V39, P68, DOI 10.1016/j.soilbio.2006.06.011; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; YAVITT JB, 1986, J ECOL, V74, P525, DOI 10.2307/2260272; Zhu JX, 2012, SCAND J FOREST RES, V27, P586, DOI 10.1080/02827581.2012.670726	56	48	55	6	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62073	10.1371/journal.pone.0062073	http://dx.doi.org/10.1371/journal.pone.0062073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620803	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500083
J	Leng, WB; Pang, XH; Xia, HW; Li, MX; Chen, L; Tang, QL; Yuan, DD; Li, RH; Li, LB; Gao, FB; Bi, F				Leng, Weibing; Pang, Xiaohui; Xia, Hongwei; Li, Mingxing; Chen, Liu; Tang, Qiulin; Yuan, Dandan; Li, Ronghui; Li, Libo; Gao, Fabao; Bi, Feng			Novel Split-Luciferase-Based Genetically Encoded Biosensors for Noninvasive Visualization of Rho GTPases	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FRAGMENT COMPLEMENTATION; LIVING CELLS; SPATIOTEMPORAL REGULATION; FAMILY PROTEINS; TARGETING RHO; CDC42; ACTIVATION; BIOLUMINESCENCE; RECEPTOR	Rho family GTPases are critical regulators of many important cellular processes and the dysregulation of their activities is implicated in a variety of human diseases including oncogenesis and propagation of malignancy. The traditional methods, such as "pull-down" or two-hybrid procedures, are poorly suited to dynamically evaluate the activity of Rho GTPases, especially in living mammalian cells. To provide a novel alternative approach to analyzing Rho GTPase-associated signaling pathways in vivo, we developed a series of bioluminescent biosensors based on the genetically engineered firefly luciferase. These split-luciferase-based biosensors enable non-invasive visualization and quantification of the activity of Rho GTPases in living subjects. The strategy is to reasonably split the gene of firefly luciferase protein into two inactive fragments and then respectively fuse the two fragments to Rho GTPase and the GTPase-binding domain (GBD) of the specific effector. Upon Rho GTPase interacting with the binding domain in a GTP-dependent manner, these two luciferase fragments are brought into close proximity, leading to luciferase reconstitution and photon production in the presence of the substrate. Using these bimolecular luminescence complementation (BiLC) biosensors, we successfully visualized and quantified the activities of the three best characterized Rho GTPases by measuring the luminescence in living cells. We also experimentally investigated the sensitivity of these Rho GTPase biosensors to upstream regulatory proteins and extracellular ligands without lysing cells and doing labor-intensive works. By virtue of the unique functional characteristics of bioluminescence imaging, the BiLC-based biosensors provide an enormous potential for in vivo imaging of Rho GTPase signaling pathways and high-throughput screening of therapeutic drugs targeted to Rho GTPases and (or) upstream molecules in the near future.	[Leng, Weibing; Pang, Xiaohui; Chen, Liu; Yuan, Dandan; Li, Ronghui; Li, Libo; Bi, Feng] Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu 610064, Sichuan, Peoples R China; [Xia, Hongwei; Li, Mingxing; Tang, Qiulin; Bi, Feng] Sichuan Univ, State Key Lab Biotherapy, Lab Signal Transduct & Mol Targeted Therapy, Chengdu 610064, Sichuan, Peoples R China; [Gao, Fabao] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Bi, F (corresponding author), Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu 610064, Sichuan, Peoples R China.	bifeng@medmail.com.cn	Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; li, li/GPX-3938-2022		National Basic Research Program of China (973 Program) [2011CB935800]; National Natural Science Foundation [30971519]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2011CB935800) (http://www.973.gov.cn/English/Index.aspx), and the National Natural Science Foundation (30971519) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Aoki K, 2008, PHILOS T R SOC B, V363, P2143, DOI 10.1098/rstb.2008.2267; Awais M, 2011, MOL BIOSYST, V7, P1376, DOI 10.1039/c0mb00328j; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178; Ehrhardt D, 2003, CURR OPIN PLANT BIOL, V6, P622, DOI 10.1016/j.pbi.2003.09.014; Endoh T, 2007, BIOCONJUGATE CHEM, V18, P956, DOI 10.1021/bc060351o; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fidyk N, 2006, BIOCHEMISTRY-US, V45, P7750, DOI 10.1021/bi060365h; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Hida N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005868; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Iglesias P, 2009, BIOSENS BIOELECTRON, V24, P3126, DOI 10.1016/j.bios.2009.04.013; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Kato N, 2010, METHODS MOL BIOL, V655, P359, DOI 10.1007/978-1-60761-765-5_24; Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Kurokawa K, 2004, ACTA HISTOCHEM CYTOC, V37, P347, DOI 10.1267/ahc.37.347; Laufs U, 2000, CIRC RES, V87, P526, DOI 10.1161/01.RES.87.7.526; Li WR, 2008, CANCER RES, V68, P4990, DOI 10.1158/0008-5472.CAN-07-5984; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Luker KE, 2004, METHOD ENZYMOL, V385, P349; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Marchioni F, 2009, CURR PHARM DESIGN, V15, P2481, DOI 10.2174/138161209788682334; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vidi PA, 2009, MOL PHARMACOL, V75, P733, DOI 10.1124/mol.108.053819; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	51	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62230	10.1371/journal.pone.0062230	http://dx.doi.org/10.1371/journal.pone.0062230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614039	gold, Green Published, Green Submitted			2022-12-25	WOS:000317893400165
J	Laval, S; Laklai, H; Fanjul, M; Pucelle, M; Laurell, H; Billon-Gales, A; Le Guellec, S; Delisle, MB; Sonnenberg, A; Susini, C; Pyronnet, S; Bousquet, C				Laval, S.; Laklai, H.; Fanjul, M.; Pucelle, M.; Laurell, H.; Billon-Gales, A.; Le Guellec, S.; Delisle, M-B; Sonnenberg, A.; Susini, C.; Pyronnet, S.; Bousquet, C.			Dual roles of hemidesmosomal proteins in the pancreatic epithelium: the phosphoinositide 3-kinase decides	ONCOGENE			English	Article						pancreatic ductal epithelium; hemidesmosome; phosphoinositide 3-kinase; cell migration and invasion; G protein-coupled somatostatin receptor	SST2 SOMATOSTATIN RECEPTOR; BETA-4 INTEGRIN; CANCER; PHOSPHORYLATION; ALPHA-6-BETA-4; PROGRESSION; EXPRESSION; CELLS; ADENOCARCINOMA; MIGRATION	Given the failure of chemo-and biotherapies to fight advanced pancreatic cancer, one major challenge is to identify critical events that initiate invasion. One priming step in epithelia carcinogenesis is the disruption of epithelial cell anchorage to the basement membrane which can be provided by hemidesmosomes (HDs). However, the existence of HDs in pancreatic ductal epithelium and their role in carcinogenesis remain unexplored. HDs have been explored in normal and cancer pancreatic cells, and patient samples. Unique cancer cell models where HD assembly can be pharmacologically manipulated by somatostatin/sst2 signaling have been then used to investigate the role and molecular mechanisms of dynamic HD during pancreatic carcinogenesis. We surprisingly report the presence of mature type-1 HDs comprising the integrin alpha 6 beta 4 and bullous pemphigoid antigen BP180 in the human pancreatic ductal epithelium. Importantly, HDs are shown to disassemble during pancreatic carcinogenesis. HD breakdown requires phosphoinositide 3-kinase (P13K)-dependent induction of the matrix-metalloprotease MMP-9, which cleaves BP180. Consequently, integrin alpha 6 beta 4 delocalizes to the cell-leading edges where it paradoxically promotes cell migration and invasion through S100A4 activation. As S100A4 in turn stimulates MMP-9 expression, a vicious cycle maintains BP180 cleavage. Inactivation of this P13K-MMP9- S100A4 signaling loop conversely blocks BP180 cleavage, induces HD reassembly and inhibits cell invasion. We conclude that mature type-1 HDs are critical anchoring structures for the pancreatic ductal epithelium whose disruption, upon P13K activation during carcinogenesis, provokes pancreatic cancer cell migration and invasion.	[Laval, S.; Laklai, H.; Fanjul, M.; Pucelle, M.; Laurell, H.; Billon-Gales, A.; Susini, C.; Pyronnet, S.; Bousquet, C.] CRCT, INSERM UMR 1037, Lab Excellence Toulouse Canc Labex TOUCAN, Equipe Labellisee Ligue Natl Contre Canc LNCC, Toulouse, France; [Laval, S.; Laklai, H.; Fanjul, M.; Laurell, H.; Billon-Gales, A.; Susini, C.; Pyronnet, S.; Bousquet, C.] Univ Toulouse 3, F-31062 Toulouse, France; [Le Guellec, S.; Delisle, M-B] Hop Rangueil, Serv Anat & Cytol Pathol, Toulouse, France; [Sonnenberg, A.] Netherlands Canc Inst, Dept Cell Biol, Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Netherlands Cancer Institute	Bousquet, C (corresponding author), CRCT, INSERM, UMR 1037, 1 Ave Jean Poulhes,BP84225, F-31432 Toulouse 4, France.	corinne.bousquet@inserm.fr	Fanjul, Marjorie/G-2429-2017; Bousquet, Corinne/P-2917-2014; Pyronnet, Stéphane/P-2419-2014	Bousquet, Corinne/0000-0002-2501-0593; Laurell, Henrik/0000-0001-7328-935X	ARC (Association pour la Recherche Contre le Cancer) [5000]; LNCC (Ligue Nationale Contre le Cancer) [RAB09006BBA]; Laboratoire d'Excellence Toulouse Cancer LABEX TOUCAN; Canceropole Grand Sud-Ouest [RMA04002BPA]; ANR (Agence Nationale pour la Recherche) [R06423BS]; University Paul Sabatier of Toulouse [CR27 A01BQR-2007]; INSERM-Region Midi-Pyrenees	ARC (Association pour la Recherche Contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); LNCC (Ligue Nationale Contre le Cancer); Laboratoire d'Excellence Toulouse Cancer LABEX TOUCAN; Canceropole Grand Sud-Ouest; ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); University Paul Sabatier of Toulouse; INSERM-Region Midi-Pyrenees(Region Occitanie)	This work was supported by ARC (grant no. 5000, Association pour la Recherche Contre le Cancer), LNCC (Ligue Nationale Contre le Cancer RAB09006BBA), the Laboratoire d'Excellence Toulouse Cancer LABEX TOUCAN, the Canceropole Grand Sud-Ouest (RMA04002BPA), the ANR (Agence Nationale pour la Recherche, project no. R06423BS) and the University Paul Sabatier of Toulouse (CR27 A01BQR-2007). SL was recipient of a fellowship from LNCC. HL was recipient of a fellowship from INSERM-Region Midi-Pyrenees. MP was contracted by the RTRS-RITC (Toulouse). We thank Dr K Owaribe (University of Nagoya, Japan) for providing antibodies to BP180, BP230 and plectin, and Dr Tsao, University of Toronto for providing HPV-16E6E7immortalized HPDE cells.	Bausch D, 2011, CLIN CANCER RES, V17, P302, DOI 10.1158/1078-0432.CCR-10-0999; BERGSTRAESSER LM, 1995, AM J PATHOL, V147, P1823; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Bousquet C, 2006, EMBO J, V25, P3943, DOI 10.1038/sj.emboj.7601279; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Buscail L, 1996, CANCER RES, V56, P1823; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Durlik Marek, 2012, Pol Przegl Chir, V84, P377, DOI 10.2478/v10035-012-0064-6; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Fontao L, 1999, EXP CELL RES, V250, P298, DOI 10.1006/excr.1999.4549; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Gleason B, 2005, J HISTOCHEM CYTOCHEM, V53, P799, DOI 10.1369/jhc.4B6522.2005; Hirako Y, 2003, J BIOCHEM, V133, P197, DOI 10.1093/jb/mvg024; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Laklai H, 2009, P NATL ACAD SCI USA, V106, P17769, DOI 10.1073/pnas.0908674106; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yu PT, 2012, INT J CANCER, V131, P1744, DOI 10.1002/ijc.27447	28	34	34	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1934	1944		10.1038/onc.2013.146	http://dx.doi.org/10.1038/onc.2013.146			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23624916				2022-12-25	WOS:000334346300006
J	Pastor, JM; Bernal, V; Salvador, M; Argandona, M; Vargas, C; Csonka, L; Sevilla, A; Iborra, JL; Nieto, JJ; Canovas, M				Pastor, Jose M.; Bernal, Vicente; Salvador, Manuel; Argandona, Montserrat; Vargas, Carmen; Csonka, Laszlo; Sevilla, Angel; Iborra, Jose L.; Nieto, Joaquin J.; Canovas, Manuel			Role of Central Metabolism in the Osmoadaptation of the Halophilic Bacterium Chromohalobacter salexigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HALOMONAS-ELONGATA; CORYNEBACTERIUM-GLUTAMICUM; TRANSCRIPTIONAL REGULATION; GLUCOSE CATABOLISM; GENOME SEQUENCE; CARBON-SOURCES; SP NOV.; PATHWAYS; EXPRESSION	Bacterial osmoadaptation involves the cytoplasmic accumulation of compatible solutes to counteract extracellular osmolarity. The halophilic and highly halotolerant bacterium Chromohalobacter salexigens is able to grow up to 3 M NaCl in a minimal medium due to the de novo synthesis of ectoines. This is an osmoregulated pathway that burdens central metabolic routes by quantitatively drawing off TCA cycle intermediaries. Consequently, metabolism in C. salexigens has adapted to support this biosynthetic route. Metabolism of C. salexigens is more efficient at high salinity than at low salinity, as reflected by lower glucose consumption, lower metabolite overflow, and higher biomass yield. At low salinity, by-products (mainly gluconate, pyruvate, and acetate) accumulate extracellularly. Using [1-C-13]-, [2-C-13]-, [6-C-13]-, and [U-C-13(6)] glucose as carbon sources, we were able to determine the main central metabolic pathways involved in ectoines biosynthesis from glucose. C. salexigens uses the Entner-Doudoroff pathway rather than the standard glycolytic pathway for glucose catabolism, and anaplerotic activity is high to replenish the TCA cycle with the intermediaries withdrawn for ectoines biosynthesis. Metabolic flux ratios at low and high salinity were similar, revealing a certain metabolic rigidity, probably due to its specialization to support high biosynthetic fluxes and partially explaining why metabolic yields are so highly affected by salinity. This work represents an important contribution to the elucidation of specific metabolic adaptations in compatible solute-accumulating halophilic bacteria.	[Pastor, Jose M.; Bernal, Vicente; Sevilla, Angel; Iborra, Jose L.; Canovas, Manuel] Univ Murcia, Fac Quim, Dept Bioquim & Biol Mol & Inmunol B, E-30100 Murcia, Spain; [Salvador, Manuel; Argandona, Montserrat; Vargas, Carmen; Nieto, Joaquin J.] Univ Seville, Dept Microbiol & Parasitol, E-41012 Seville, Spain; [Csonka, Laszlo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Murcia; University of Sevilla; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bernal, V (corresponding author), Ctr Tecnol Repsol, Direcc Tecnol, Grp Bioenergia, Carretera A-5,Km 18, Mostoles Madrid 28935, Spain.	vbernal@um.es; mcanovas@um.es	Argandoña, Montserrat/H-5531-2015; Iborra, JL JL/K-4165-2014; Bernal, Vicente/M-4119-2014; Canovas, Manuel/K-3860-2014; Salvador de Lara, Manuel/H-2960-2015; Hernández, José María Pastor/R-9164-2019; Vargas, Carmen/A-6283-2018; Gutiérrez, Joaquín José Nieto/K-9974-2014	Iborra, JL JL/0000-0003-0936-2465; Bernal, Vicente/0000-0003-2482-3477; Canovas, Manuel/0000-0003-3254-1736; Salvador de Lara, Manuel/0000-0002-1966-2480; Vargas, Carmen/0000-0002-4094-4319; Gutiérrez, Joaquín José Nieto/0000-0001-8879-819X; Argandona, Montserrat/0000-0002-2635-1023; PASTOR, JOSE MARIA/0000-0003-4813-1125	Ministerio de Ciencia e Innovacion (Spain) [BIO2008-04502-01, BIO2011-29233-C02-01, BIO2011-22833]; Junta de Andalucia (Spain) [P08-CVI-03724]; Spanish National Network on Extremophilic Microorganisms Grant [BIO2011-12879-E]; MICINN (Spain); Universidad de Murcia (Programa Propio); Junta de Andalucia; National Science Foundation [IOS-1054977]; Programa Juan de la Cierva (Spain); Fondo Europeo de Desarrollo Regional funds	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Spanish National Network on Extremophilic Microorganisms Grant; MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad de Murcia (Programa Propio); Junta de Andalucia(Junta de Andalucia); National Science Foundation(National Science Foundation (NSF)); Programa Juan de la Cierva (Spain); Fondo Europeo de Desarrollo Regional funds	This work was supported in part by Fondo Europeo de Desarrollo Regional funds, Ministerio de Ciencia e Innovacion (Spain) Projects BIO2008-04502-01, BIO2011-29233-C02-01, and BIO2011-22833, Junta de Andalucia (Spain) Grant P08-CVI-03724, and Spanish National Network on Extremophilic Microorganisms Grant BIO2011-12879-E.; Recipient of Formacion de Profesorado Universitario and Formacion de Personal Investigador fellowships from MICINN (Spain).; Recipient of a post-doctoral contract from Universidad de Murcia (Programa Propio). To whom correspondence may be addressed: Grupo de Bioenergia, Direccion de Tecnologia, Centro de Tecnologia de Repsol, Carretera A-5, Km 18, 28935 Mostoles-Madrid, Spain. Tel.: 34-868-887393; Fax: 34-868-884148; E- mail: vbernal@um.es.; Recipient of a post-doctoral contract from Junta de Andalucia.; Supported by National Science Foundation Award IOS-1054977.; Recipient of a post-doctoral contract from the Programa Juan de la Cierva (Spain).	Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; Aoshima M, 2003, BIOTECHNOL BIOENG, V84, P732, DOI 10.1002/bit.10832; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Ates O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-12; Buch A, 2008, RES MICROBIOL, V159, P635, DOI 10.1016/j.resmic.2008.09.012; Buch A, 2010, BIORESOURCE TECHNOL, V101, P679, DOI 10.1016/j.biortech.2009.08.075; Canovas D, 1996, J BACTERIOL, V178, P7221, DOI 10.1128/jb.178.24.7221-7226.1996; Canovas D, 1999, APPL ENVIRON MICROB, V65, P3774; Canovas D, 1997, J BIOL CHEM, V272, P25794, DOI 10.1074/jbc.272.41.25794; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Cayol JL, 2000, INT J SYST EVOL MICR, V50, P559, DOI 10.1099/00207713-50-2-559; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Copeland A, 2011, STAND GENOMIC SCI, V5, P379, DOI 10.4056/sigs.2285059; Csonka LN, 2005, CELL ORIGIN LIFE EXT, V9, P267; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; ENTNER N, 1952, J BIOL CHEM, V196, P853; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Goss TJ, 2001, J BACTERIOL, V183, P6607, DOI 10.1128/JB.183.22.6607-6619.2001; HOMMES RWJ, 1989, ARCH MICROBIOL, V151, P261, DOI 10.1007/BF00413140; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KEMP RG, 1993, J BACTERIOL, V175, P5723, DOI 10.1128/JB.175.17.5723-5724.1993; Klapa MI, 1999, BIOTECHNOL BIOENG, V62, P375, DOI 10.1002/(SICI)1097-0290(19990220)62:4<375::AID-BIT1>3.3.CO;2-F; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Netzer R, 2004, ARCH MICROBIOL, V182, P354, DOI 10.1007/s00203-004-0710-4; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Oren A, 2003, FEMS MICROBIOL LETT, V223, P83, DOI 10.1016/S0378-1097(03)00345-8; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Roberts MF, 2004, FRONT BIOSCI-LANDMRK, V9, P1999, DOI 10.2741/1366; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; SAWYER MH, 1977, ARCH MICROBIOL, V112, P169, DOI 10.1007/BF00429331; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; SEVERIN J, 1992, J GEN MICROBIOL, V138, P1629, DOI 10.1099/00221287-138-8-1629; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tesch M, 1999, APPL ENVIRON MICROB, V65, P1099; TIWARI NP, 1969, BIOCHIM BIOPHYS ACTA, V192, P395, DOI 10.1016/0304-4165(69)90388-2; Trotsenko Iu A, 2002, Mikrobiologiia, V71, P149; VanderWerf MJ, 1997, ARCH MICROBIOL, V167, P332; Varela CA, 2004, APPL ENVIRON MICROB, V70, P4222, DOI 10.1128/AEM.70.7.4222-4229.2004; Vargas C, 1997, SYST APPL MICROBIOL, V20, P173, DOI 10.1016/S0723-2020(97)80063-X; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Werner S, 2010, J MOL EVOL, V71, P346, DOI 10.1007/s00239-010-9389-0; YAGI T, 1976, FEBS LETT, V61, P34, DOI 10.1016/0014-5793(76)80165-2; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	61	42	42	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17769	17781		10.1074/jbc.M113.470567	http://dx.doi.org/10.1074/jbc.M113.470567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615905	Green Published, hybrid			2022-12-25	WOS:000320380600066
J	Xu, JX; Xu, TT; Wu, B; Ye, YH; You, XJ; Shu, XD; Pei, DQ; Liu, JS				Xu, Jinxin; Xu, Tingting; Wu, Bin; Ye, Yinghua; You, Xiaojuan; Shu, Xiaodong; Pei, Duanqing; Liu, Jinsong			Structure of Sorting Nexin 11 (SNX11) Reveals a Novel Extended Phox Homology (PX) Domain Critical for Inhibition of SNX10-induced Vacuolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RETROMER; ASSOCIATION; TRANSPORT; PROTEINS; ROLES	Sorting nexins are phox homology (PX) domain-containing proteins involved in diverse intracellular endosomal trafficking pathways. The PX domain binds to certain phosphatidylinositols and is recruited to vesicles rich in these lipids. The structure of the PX domain is highly conserved, containing a three-stranded beta-sheet, followed by three alpha-helices. Here, we report the crystal structures of truncated human SNX11 (sorting nexin 11). The structures reveal that SNX11 contains a novel PX domain, hereby named the extended PX (PXe) domain, with two additional alpha-helices at the C terminus. We demonstrate that these alpha-helices are indispensible for the in vitro functions of SNX11. We propose that this PXe domain is present in SNX10 and is responsible for the vacuolation activity of SNX10. Thus, this novel PXe domain constitutes a structurally and functionally important PX domain subfamily.	[Xu, Jinxin; Xu, Tingting; You, Xiaojuan; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Xu, Jinxin; Xu, Tingting; Liu, Jinsong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wu, Bin; Ye, Yinghua; Shu, Xiaodong; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	liu_jinsong@gibh.ac.cn	Wu, Bin/E-7238-2016		National Basic Research Program of China 973 Program [2012CB917200, 2009CB941102]; National Natural Science Foundation of China [30870496, 30871404]; National Science Fund for Distinguished Young Scholars Grant [30725012]; One Hundred Person Project of the Chinese Academy of Sciences	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars Grant(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); One Hundred Person Project of the Chinese Academy of Sciences	The work was supported in part by National Basic Research Program of China 973 Program Grants 2012CB917200 and 2009CB941102, National Natural Science Foundation of China Grants 30870496 and 30871404, National Science Fund for Distinguished Young Scholars Grant 30725012, and the One Hundred Person Project of the Chinese Academy of Sciences (to X. S. and J. L.).	Aker M, 2012, J MED GENET, V49, P221, DOI 10.1136/jmedgenet-2011-100520; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen YQ, 2012, CELL RES, V22, P333, DOI 10.1038/cr.2011.134; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; van Weering JRT, 2012, TRAFFIC, V13, P94, DOI 10.1111/j.1600-0854.2011.01297.x; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Yao D, 2009, CHINESE SCI BULL, V54, P3965, DOI 10.1007/s11434-009-0529-0; Zhang P, 2011, CELL RES, V21, P1677, DOI 10.1038/cr.2011.167; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200; Zhu C, 2012, J CELL BIOCHEM, V113, P1608, DOI 10.1002/jcb.24029	30	13	17	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16598	16605		10.1074/jbc.M112.449306	http://dx.doi.org/10.1074/jbc.M112.449306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615901	hybrid, Green Published			2022-12-25	WOS:000320378900036
J	Mialki, RK; Zhao, J; Wei, JX; Mallampalli, DF; Zhao, YT				Mialki, Rachel K.; Zhao, Jing; Wei, Jianxin; Mallampalli, Daniel F.; Zhao, Yutong			Overexpression of USP14 Protease Reduces I-kappa B Protein Levels and Increases Cytokine Release in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN; PHOSPHORYLATION; EXPRESSION; CANCER	The ubiquitin-proteasome system is the major pathway of non-lysosomal intracellular protein degradation, playing an important role in a variety of cellular responses including cell division, proliferation, and apoptosis. Ubiquitin-specific protease 14 (USP14) is a component of proteasome regulatory subunit 19 S that regulates deubiquitinated proteins entering inside the proteasome core 20 S. The role of USP14 in protein degradation is still controversial. Several studies suggest that USP14 plays an inhibitory role in protein degradation. Here, in contrast, overexpression of USP14 induced I-kappa B degradation, which increased cytokine release in lung epithelial cells. Overexpression of HA-tagged USP14 (HA-USP14) reduced I-kappa Bprotein levels by increasing the I-kappa B degradation rate in mouse lung epithelial cells (MLE12). I-kappa B polyubiquitination was reduced in HA-USP14-overexpressed MLE12 cells, suggesting that USP14 regulates I-kappa B degradation by removing its ubiquitin chain, thus promoting the deubiquitinated I-kappa B degradation within the proteasome. Interestingly, we found that USP14 was associated with RelA, a binding partner of I-kappa B, suggesting that RelA is the linker between USP14 and I-kappa B. Lipopolysaccharide (LPS) treatment induced serine phosphorylation of USP14 as well as further reducing I-kappa B levels in HA-USP14-overexpressed MLE12 cells as compared with empty vector transfected cells. Further, overexpression of HA-USP14 increased the LPS-, TNF alpha-, or Escherichia coli-induced IL-8 release in human lung epithelial cells. This study suggests that USP14 removes the ubiquitin chain of I-kappa B, therefore inducing I-kappa B degradation and increasing cytokine release in lung epithelial cells.	[Zhao, Yutong] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhao, YT (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, 3459 5th Ave,NW 628 MUH, Pittsburgh, PA 15213 USA.	zhaoy3@upmc.edu	Wei, Jianxin/P-5431-2016		National Institutes of Health [RO1 HL091916, HL112791]; American Heart Association Award [12SDG9050005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112791, R01HL091916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091916 and HL112791 (to Y.Z.). This work was also supported by American Heart Association Award 12SDG9050005 (to J.Z.).	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Nagai A, 2009, BIOCHEM BIOPH RES CO, V379, P995, DOI 10.1016/j.bbrc.2008.12.182; Perry JW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002783; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; SCHWARTZ AL, 1992, AM J RESP CELL MOL, V7, P463, DOI 10.1165/ajrcmb/7.5.463; Shinji S, 2006, ONCOL REP, V15, P539; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522	26	50	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15437	15441		10.1074/jbc.C112.446682	http://dx.doi.org/10.1074/jbc.C112.446682			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23615914	Green Published, hybrid			2022-12-25	WOS:000319822300002
J	Gao, WL; Yan, H; Wang, DL; Dang, SN; Pei, LL				Gao, Wenlong; Yan, Hong; Wang, Duolao; Dang, Shaonong; Pei, Leilei			Severity of Anemia among Children under 36 Months Old in Rural Western China	PLOS ONE			English	Article							IRON-DEFICIENCY; EARLY-CHILDHOOD	Objective: To describe severity of anemia and explore its determinants among children under 36 months old in rural western China. Study Design: The family information of 6711 children was collected and their hemoglobin was measured in 2005. A generalized estimated equation (GEE) linear model was used to identify the determinants of severity of childhood anemia. Results: The prevalence of mild, moderate and severe anemia among these children was 27.4%, 21.9% and 3.2% respectively. GEE model analysis showed that province-level region and severity of maternal anemia affected the severity of childhood anemia not only in 0-5 months but also beyond 5 months. In addition, children aged 0-5 months in families using iron pot (coefficient = -0.26 95% CI -0.41, -0.12) had seldom more severe anemia, and children aged 6-36 months in families more than 4 members (coefficient = -0.03 95% CI -0.06, -0.01) or of Han ethnicity (coefficient = -0.08 95% CI -0.13, -0.04) seldom had more severe anemia but boys (coefficient = 0.03 95% CI 0.01,0.06) or younger children (6-11 month vs 30-36 month: coefficient = 0.23 95% CI 0.17, 0.28; 12-17 month vs 30-36 month: coefficient = 0.19 95% CI 0.15,0.24; 18-23 vs 30-36 month: coefficient = 0.09 95% CI 0.04,0.13) had more severe anemia. Conclusion: The prevalence of moderate-to-severe anemia in these children was about 25%. Province-level region, iron pot use, family size, ethnicity, age and gender of children and severity of maternal anemia were important determinants of the severity of childhood anemia. These findings have some important implications for health policy decision for childhood anemia in rural western China.	[Gao, Wenlong; Yan, Hong; Dang, Shaonong; Pei, Leilei] Xi An Jiao Tong Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Wang, Duolao] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	Xi'an Jiaotong University; University of London; London School of Hygiene & Tropical Medicine	Yan, H (corresponding author), Xi An Jiao Tong Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	xjtu_yh.paper@yahoo.com	Gao, Wenlong/E-5687-2013; Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF)	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF)	Financial support came from the Chinese Ministry of Health (MOH) and the United Nations Children's Fund (UNICEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; DALLMAN PR, 1980, AM J CLIN NUTR, V33, P86, DOI 10.1093/ajcn/33.1.86; Dang Shao-nong, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P177; Dang Shao-nong, 2007, Zhonghua Yufang Yixue Zazhi, V41, P108; Santos Rosemary Ferreira dos, 2011, Rev. Bras. Hematol. Hemoter., V33, P100, DOI 10.5581/1516-8484.20110028; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hurtado EK, 1999, AM J CLIN NUTR, V69, P115; Kalton G, 1983, SAGE U PAPER SERIES, p[07, 38]; Kumar A, 2008, PEDIATRICS, V121, pE673, DOI 10.1542/peds.2007-1986; Lin JD, 2010, RES DEV DISABIL, V31, P25, DOI 10.1016/j.ridd.2009.07.017; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Rocha Daniela da Silva, 2008, Rev. paul. pediatr., V26, P6; Rutstein SO, 2004, DHS COMP REPORTS, P8; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; STOLTZFUS RJ, 1998, GUIDELINES USE IRO S; Uddin M. K., 1970, J DHAKA MED COLL, V19, P126, DOI [10.3329/jdmc.v19i2.7084, DOI 10.3329/JDMC.V19I2.7084, DOI 10.3329/jdmc.v19i2.7084]; UNICEF; UNU; WHO, 2001, IR DEF AN ASS PREV C; WALTER T, 1989, PEDIATRICS, V84, P7; WHO/CDC, 2008, WORLDW PREV AN 1993; WHO/UNICEF/USAID, 2003, AN PREV CONTR WHAT W; Wintrobe M, 1981, CLIN HEMATOLOTY, V8th; World Health Organization, 2006, WHO CHILD GROWTH STA; Zhai Fengying, 2007, Wei Sheng Yan Jiu, V36, P539; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660	26	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62883	10.1371/journal.pone.0062883	http://dx.doi.org/10.1371/journal.pone.0062883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626861	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400225
J	Hasenauer, S; Malinger, D; Koschut, D; Pace, G; Matzke, A; von Au, A; Orian-Rousseau, V				Hasenauer, Susanne; Malinger, Dieter; Koschut, David; Pace, Giuseppina; Matzke, Alexandra; von Au, Anja; Orian-Rousseau, Veronique			Internalization of Met Requires the Co-Receptor CD44v6 and Its Link to ERM Proteins	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; C-MET; FACTOR RECEPTOR; CELL-MIGRATION; INVASIVE GROWTH; DOWN-REGULATION; PATHWAY; ADHESION; BINDING	Receptor Tyrosine Kinases (RTKs) are involved in many cellular processes and play a major role in the control of cell fate. For these reasons, RTK activation is maintained under tight control. Met is an essential RTK that induces proliferation, differentiation, migration, survival and branching morphogenesis. Deregulation of Met by overexpression, amplification or lack of effective degradation leads to cancer and metastasis. We have shown that Met relies on CD44v6 for its activation and for signaling in several cancer cell lines and also in primary cells. In this paper, we show that internalization of Met is dependent on CD44v6 and the binding of Ezrin to the CD44v6 cytoplasmic domain. Both CD44v6 and Met are co-internalized upon Hepatocyte Growth Factor induction suggesting that Met-induced signaling from the endosomes relies on its collaboration with CD44v6 and the link to the cytoskeleton provided by ERM proteins.	[Hasenauer, Susanne; Malinger, Dieter; Koschut, David; Pace, Giuseppina; Matzke, Alexandra; von Au, Anja; Orian-Rousseau, Veronique] Karlsruhe Inst Toxicol, Inst Toxicol & Genet, Karlsruhe, Germany		Orian-Rousseau, V (corresponding author), Karlsruhe Inst Toxicol, Inst Toxicol & Genet, Karlsruhe, Germany.	veronique.orian-rousseau@kit.edu	Orian-Rousseau, Véronique/H-5735-2013	Orian-Rousseau, Véronique/0000-0003-2939-9257; Koschut, David/0000-0003-2204-5165	Deutsche Forschungsgemeinschaft [SPP1190, OR 124/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (SPP1190 and OR 124/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; HILLMAN GM, 1982, BIOCHEMISTRY-US, V21, P1667, DOI 10.1021/bi00536a030; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Marion S, 2011, TRAFFIC, V12, P421, DOI 10.1111/j.1600-0854.2011.01158.x; Matzke A, 2005, CANCER RES, V65, P6105, DOI 10.1158/0008-5472.CAN-05-0207; Matzke A, 2007, MOL CELL BIOL, V27, P8797, DOI 10.1128/MCB.01355-07; MATZKU S, 1989, CANCER RES, V49, P1294; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Olaku V, 2011, MOL BIOL CELL, V22, P2777, DOI 10.1091/mbc.E11-02-0134; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; OSTWALD TJ, 1980, EXP EYE RES, V31, P351, DOI 10.1016/S0014-4835(80)80043-1; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parachoniak CA, 2009, J BIOL CHEM, V284, P8382, DOI 10.1074/jbc.M807607200; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pfaff D, 2008, J CELL SCI, V121, P3842, DOI 10.1242/jcs.030627; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zaarour RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037490	58	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62357	10.1371/journal.pone.0062357	http://dx.doi.org/10.1371/journal.pone.0062357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626807	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400171
J	Tan, XB; Xie, GX; Sun, XH; Li, Q; Zhong, W; Qiao, P; Sun, XG; Jia, W; Zhou, ZX				Tan, Xiaobing; Xie, Guoxiang; Sun, Xiuhua; Li, Qiong; Zhong, Wei; Qiao, Peter; Sun, Xinguo; Jia, Wei; Zhou, Zhanxiang			High Fat Diet Feeding Exaggerates Perfluorooctanoic Acid-Induced Liver Injury in Mice via Modulating Multiple Metabolic Pathways	PLOS ONE			English	Article							PEROXISOME PROLIFERATION; HEPATIC LIPOTOXICITY; BINDING PROTEIN; RAT-LIVER; WILD-TYPE; ALPHA; EXPOSURE; PATHOGENESIS; EXPRESSION; RECEPTORS	High fat diet (HFD) is closely linked to a variety of health issues including fatty liver. Exposure to perfluorooctanoic acid (PFOA), a synthetic perfluorinated carboxylic acid, also causes liver injury. The present study investigated the possible interactions between high fat diet and PFOA in induction of liver injury. Mice were pair-fed a high-fat diet (HFD) or low fat control with or without PFOA administration at 5 mg/kg/day for 3 weeks. Exposure to PFOA alone caused elevated plasma alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels and increased liver weight along with reduced body weight and adipose tissue mass. HFD alone did not cause liver damage, but exaggerated PFOA-induced hepatotoxicity as indicated by higher plasma ALT and AST levels, and more severe pathological changes including hepatocyte hypertrophy, lipid droplet accumulation and necrosis as well as inflammatory cell infiltration. These additive effects of HFD on PFOA-induced hepatotoxicity correlated with metabolic disturbance in liver and blood as well as up-regulation of hepatic proinflammatory cytokine genes. Metabolomic analysis demonstrated that both serum and hepatic metabolite profiles of PFOA, HFD, or HFD-PFOA group were clearly differentiated from that of controls. PFOA affected more hepatic metabolites than HFD, but HFD showed positive interaction with PFOA on fatty acid metabolites including long chain fatty acids and acylcarnitines. Taken together, dietary high fat potentiates PFOA-induced hepatic lipid accumulation, inflammation and necrotic cell death by disturbing hepatic metabolism and inducing inflammation. This study demonstrated, for the first time, that HFD increases the risk of PFOA in induction of hepatotoxicity.	[Tan, Xiaobing; Xie, Guoxiang; Sun, Xiuhua; Li, Qiong; Zhong, Wei; Sun, Xinguo; Jia, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Jia, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Dept Nutr, Kannapolis, NC USA; [Qiao, Peter] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Pennsylvania	Zhou, ZX (corresponding author), Univ North Carolina Greensboro, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC USA.	w_jia@uncg.edu; z_zhou@uncg.edu	Li, Qiong/I-4114-2013; Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150; Qiao, Peter/0000-0001-7495-354X				Bjork JA, 2011, TOXICOLOGY, V288, P8, DOI 10.1016/j.tox.2011.06.012; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; Engels W, 1999, MOL CELL BIOCHEM, V192, P53, DOI 10.1023/A:1006855214237; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fordahl S, 2012, NEUROTOXICOL TERATOL, V34, P27, DOI 10.1016/j.ntt.2011.10.003; Gilliland FD, 1996, AM J IND MED, V29, P560; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hundley SG, 2006, DRUG CHEM TOXICOL, V29, P137, DOI 10.1080/01480540600561361; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kudo N, 1997, TOXICOL APPL PHARM, V145, P285, DOI 10.1006/taap.1997.8186; Laskin DL, 2001, TOXICOLOGY, V160, P111, DOI 10.1016/S0300-483X(00)00437-6; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Nelson JW, 2010, ENVIRON HEALTH PERSP, V118, P197, DOI 10.1289/ehp.0901165; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Olsen GE D, 2005, FLUOROS INT S FLUOR; Pan L, 2010, J PHARMACEUT BIOMED, V52, P589, DOI 10.1016/j.jpba.2010.01.046; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Ren HZ, 2009, REPROD TOXICOL, V27, P266, DOI 10.1016/j.reprotox.2008.12.011; Rosen MB, 2008, TOXICOL PATHOL, V36, P592, DOI 10.1177/0192623308318208; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Siviero-Miachon AA, 2009, ARQ BRAS ENDOCRINOL, V53, P190, DOI 10.1590/S0004-27302009000200011; Son HY, 2009, ENVIRON TOXICOL, V24, P580, DOI 10.1002/tox.20459; Swinnen JV, 1998, J BIOL CHEM, V273, P19938, DOI 10.1074/jbc.273.32.19938; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Vacca M, 2011, WIRES SYST BIOL MED, V3, P562, DOI 10.1002/wsbm.137; Wolf DC, 2008, TOXICOL PATHOL, V36, P632, DOI 10.1177/0192623308318216; Xie Y, 2003, BIOCHEM PHARMACOL, V66, P749, DOI 10.1016/S0006-2952(03)00386-1; Xie Y, 2002, LIPIDS, V37, P139, DOI 10.1007/s11745-002-0873-7; Yang JH, 2010, CHEMOSPHERE, V81, P548, DOI 10.1016/j.chemosphere.2010.06.028; Yu M. H., 2000, ENV TOXICOLOGY IMPAC, P47; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	46	39	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61409	10.1371/journal.pone.0061409	http://dx.doi.org/10.1371/journal.pone.0061409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626681	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400044
J	Youn, HS; Kim, MK; Kang, GB; Kim, TG; Lee, JG; An, JY; Park, KR; Lee, Y; Kang, JY; Song, HE; Park, I; Cho, C; Fukuoka, SI; Eom, SH				Youn, Hyung-Seop; Kim, Mun-Kyoung; Kang, Gil Bu; Kim, Tae Gyun; Lee, Jung-Gyu; An, Jun Yop; Park, Kyoung Ryoung; Lee, Youngjin; Kang, Jung Youn; Song, Hye-Eun; Park, Inju; Cho, Chunghee; Fukuoka, Shin-Ichi; Eom, Soo Hyun			Crystal Structure of Sus scrofa Quinolinate Phosphoribosyltransferase in Complex with Nicotinate Mononucleotide	PLOS ONE			English	Article							ACID PHOSPHORIBOSYLTRANSFERASE; ADENINE-DINUCLEOTIDE; PURIFICATION; LIVER; CRYSTALLIZATION; BIOSYNTHESIS; SOFTWARE; KIDNEY; BRAIN	We have determined the crystal structure of porcine quinolinate phosphoribosyltransferase (QAPRTase) in complex with nicotinate mononucleotide (NAMN), which is the first crystal structure of a mammalian QAPRTase with its reaction product. The structure was determined from protein obtained from the porcine kidney. Because the full protein sequence of porcine QAPRTase was not available in either protein or nucleotide databases, cDNA was synthesized using reverse transcriptase-polymerase chain reaction to determine the porcine QAPRTase amino acid sequence. The crystal structure revealed that porcine QAPRTases have a hexameric structure that is similar to other eukaryotic QAPRTases, such as the human and yeast enzymes. However, the interaction between NAMN and porcine QAPRTase was different from the interaction found in prokaryotic enzymes, such as those of Helicobacter pylori and Mycobacterium tuberculosis. The crystal structure of porcine QAPRTase in complex with NAMN provides a structural framework for understanding the unique properties of the mammalian QAPRTase active site and designing new antibiotics that are selective for the QAPRTases of pathogenic bacteria, such as H. pylori and M. tuberculosis.	[Youn, Hyung-Seop; Kim, Mun-Kyoung; Kang, Gil Bu; Kim, Tae Gyun; Lee, Jung-Gyu; An, Jun Yop; Park, Kyoung Ryoung; Lee, Youngjin; Kang, Jung Youn; Song, Hye-Eun; Park, Inju; Cho, Chunghee; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Youn, Hyung-Seop; Kim, Tae Gyun; Lee, Jung-Gyu; An, Jun Yop; Park, Kyoung Ryoung; Lee, Youngjin; Kang, Jung Youn; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Stetiz Ctr Struct Biol, Kwangju, South Korea; [Fukuoka, Shin-Ichi] Aoyama Gakuin Univ, Sch Culture & Creat Studies, Tokyo, Japan	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Aoyama Gakuin University	Eom, SH (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	eom@gist.ac.kr		Park, Inju/0000-0002-8850-5032; Youn, Hyung-Seop/0000-0001-7546-2777	Cell Dynamics Research Center at GIST [20120000771]; GIST Systems Biology infrastructure Establishment Grant; Korea Healthcare technology RD Project [A092006]; National Research Foundation (NRF); MEST [20120005356]	Cell Dynamics Research Center at GIST; GIST Systems Biology infrastructure Establishment Grant; Korea Healthcare technology RD Project; National Research Foundation (NRF); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the grant from the Cell Dynamics Research Center at GIST (20120000771), the GIST Systems Biology infrastructure Establishment Grant (2012), the grant of the Korea Healthcare technology R&D Project (A092006), and the National Research Foundation (NRF) grant funded by the MEST (20120005356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Luccio E, 2008, BIOCHEMISTRY-US, V47, P4039, DOI 10.1021/bi7020475; Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2; ELDEFRAWY SR, 1986, CAN J PHYSIOL PHARM, V64, P369, DOI 10.1139/y86-060; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; HUGHES KT, 1993, J BACTERIOL, V175, P479, DOI 10.1128/JB.175.2.479-486.1993; IWAI K, 1974, BIOCHEM BIOPH RES CO, V56, P884, DOI 10.1016/S0006-291X(74)80271-8; Kim MK, 2006, PROTEINS, V63, P252, DOI 10.1002/prot.20834; Laskowski RA, 1993, J APPL CRYSTALLOGR, V21, P279; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; MANN DF, 1974, J BIOL CHEM, V249, P6817; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKUNO E, 1988, J BIOCHEM, V103, P1054, DOI 10.1093/oxfordjournals.jbchem.a122379; OKUNO E, 1985, BIOCHIM BIOPHYS ACTA, V841, P112, DOI 10.1016/0304-4165(85)90280-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACKMAN PM, 1967, J BIOL CHEM, V242, P2075; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Schwarzenbacher R, 2004, PROTEINS, V55, P768, DOI 10.1002/prot.20029; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; SHIBATA K, 1980, BIOCHIM BIOPHYS ACTA, V611, P280, DOI 10.1016/0005-2744(80)90063-7; Sinclair SJ, 2000, PLANT MOL BIOL, V44, P603, DOI 10.1023/A:1026590521318; Youn HS, 2012, ACTA CRYSTALLOGR F, V68, P1488, DOI 10.1107/S1744309112040638; Zhang QH, 2002, SCIENCE, V295, P1895	29	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62027	10.1371/journal.pone.0062027	http://dx.doi.org/10.1371/journal.pone.0062027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626766	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400130
J	Pirault, P; Danvy, S; Verrier, E; Leroy, G				Pirault, Pauline; Danvy, Sophy; Verrier, Etienne; Leroy, Gregoire			Genetic Structure and Gene Flows within Horses: A Genealogical Study at the French Population Scale	PLOS ONE			English	Article							PEDIGREE ANALYSIS; DIVERSITY; BREEDS; VARIABILITY; CATTLE; INFORMATION; MANAGEMENT; ADMIXTURE; SIZE; DOG	Since horse breeds constitute populations submitted to variable and multiple outcrossing events, we analyzed the genetic structure and gene flows considering horses raised in France. We used genealogical data, with a reference population of 547,620 horses born in France between 2002 and 2011, grouped according to 55 breed origins. On average, individuals had 6.3 equivalent generations known. Considering different population levels, fixation index decreased from an overall species F-IT of 1.37%, to an average (F-IS) over bar of -0.07% when considering the 55 origins, showing that most horse breeds constitute populations without genetic structure. We illustrate the complexity of gene flows existing among horse breeds, a few populations being closed to foreign influence, most, however, being submitted to various levels of introgression. In particular, Thoroughbred and Arab breeds are largely used as introgression sources, since those two populations explain together 26% of founder origins within the overall horse population. When compared with molecular data, breeds with a small level of coancestry also showed low genetic distance; the gene pool of the breeds was probably impacted by their reproducer exchanges.	[Pirault, Pauline; Verrier, Etienne; Leroy, Gregoire] AgroParisTech, Unite Mixte Rech Genet Anim & Biol Integrat 1313, Paris, France; [Danvy, Sophy] Inst Francais Cheval & Equitat, Le Pin Au Haras, France; [Verrier, Etienne; Leroy, Gregoire] INRA, Unite Mixte Rech Genet Anim & Biol Integrat 1313, Jouy En Josas, France	AgroParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Leroy, G (corresponding author), AgroParisTech, Unite Mixte Rech Genet Anim & Biol Integrat 1313, Paris, France.	gregoire.leroy@agroparistech.fr			AgroParisTech	AgroParisTech	Funding is related to AgroParisTech common fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle K, 2004, BERL MUNCH TIERARZTL, V117, P72; Achmann R, 2004, ANIM GENET, V35, P285, DOI 10.1111/j.1365-2052.2004.01157.x; Bartolome E, 2011, LIVEST SCI, V142, P70, DOI 10.1016/j.livsci.2011.06.021; Bigi D, 2012, J HERED, V103, P134, DOI 10.1093/jhered/esr121; Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Boichard D., 2002, PEDIG A FORTRAN PACK; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Cervantes I, 2011, J ANIM BREED GENET, V128, P56, DOI 10.1111/j.1439-0388.2010.00881.x; Cervantes I, 2009, J ANIM BREED GENET, V126, P335, DOI 10.1111/j.1439-0388.2008.00797.x; Danchin-Burge C, 2012, J ANIM BREED GENET, V129, P206, DOI 10.1111/j.1439-0388.2011.00967.x; Druml T, 2007, HEREDITY, V98, P114, DOI 10.1038/sj.hdy.6800910; Fernandez J, 2005, GENETICS, V170, P1313, DOI 10.1534/genetics.104.037325; Hamann H, 2008, J ANIM SCI, V86, P1503, DOI 10.2527/jas.2007-0382; Lauvie A, 2008, LIVEST SCI, V118, P113, DOI 10.1016/j.livsci.2008.01.004; Leroy G, 2011, ANIM GENET, V42, P66, DOI 10.1111/j.1365-2052.2010.02079.x; Leroy G, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-1; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Leroy G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-5; Malecot G, 1948, LES MATHEMATIQUES DE; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Moureaux S, 1996, GENET SEL EVOL, V28, P83, DOI 10.1051/gse:19960105; Mucha S, 2009, J ANIM BREED GENET, V126, P250, DOI 10.1111/j.1439-0388.2008.00757.x; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Plante Y, 2007, J HERED, V98, P594, DOI 10.1093/jhered/esm064; Porter V., 2002, WORLD DICT LIVESTOCK; Pritchard JK, 2000, GENETICS, V155, P945; Prystupa JM, 2012, ANIMAL, V6, P19, DOI 10.1017/S1751731111001212; Quignon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001324; REYNOLDS J, 1983, GENETICS, V105, P767; van de Goor LHP, 2011, ANIM GENET, V42, P627, DOI 10.1111/j.1365-2052.2011.02194.x	30	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61544	10.1371/journal.pone.0061544	http://dx.doi.org/10.1371/journal.pone.0061544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630596	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500046
J	Haney, MJ; Zhao, YL; Harrison, EB; Mahajan, V; Ahmed, S; He, ZJ; Suresh, P; Hingtgen, SD; Klyachko, NL; Mosley, RL; Gendelman, HE; Kabanov, AV; Batrakova, EV				Haney, Matthew J.; Zhao, Yuling; Harrison, Emily B.; Mahajan, Vivek; Ahmed, Shaheen; He, Zhijian; Suresh, Poornima; Hingtgen, Shawn D.; Klyachko, Natalia L.; Mosley, R. Lee; Gendelman, Howard E.; Kabanov, Alexander V.; Batrakova, Elena V.			Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CELL-BASED DELIVERY; NEURAL STEM-CELLS; PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; GENE-TRANSFER; IN-VIVO; ALZHEIMERS-DISEASE; MEDIATED TRANSFER; OXIDATIVE STRESS	The ability to precisely upregulate genes in inflamed brain holds great therapeutic promise. Here we report a novel class of vectors, genetically modified macrophages that carry reporter and therapeutic genes to neural cells. Systemic administration of macrophages transfected ex vivo with a plasmid DNA (pDNA) encoding a potent antioxidant enzyme, catalase, produced month-long expression levels of catalase in the brain resulting in three-fold reductions in inflammation and complete neuroprotection in mouse models of Parkinson's disease (PD). This resulted in significant improvements in motor functions in PD mice. Mechanistic studies revealed that transfected macrophages secreted extracellular vesicles, exosomes, packed with catalase genetic material, pDNA and mRNA, active catalase, and NF-kappa b, a transcription factor involved in the encoded gene expression. Exosomes efficiently transfer their contents to contiguous neurons resulting in de novo protein synthesis in target cells. Thus, genetically modified macrophages serve as a highly efficient system for reproduction, packaging, and targeted gene and drug delivery to treat inflammatory and neurodegenerative disorders.	[Haney, Matthew J.; Zhao, Yuling; Harrison, Emily B.; Mahajan, Vivek; Ahmed, Shaheen; He, Zhijian; Suresh, Poornima; Klyachko, Natalia L.; Kabanov, Alexander V.; Batrakova, Elena V.] Univ Nebraska Med Ctr, Ctr Drug Delivery & Nanomed, Dept Pharmaceut Sci, Omaha, NE USA; [Mahajan, Vivek] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Suresh, Poornima; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska Med Ctr, Ctr Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Hingtgen, Shawn D.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Klyachko, Natalia L.; Kabanov, Alexander V.] Moscow MV Lomonosov State Univ, Fac Chem, Dept Chem Enzymol, Moscow 117234, Russia	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Lomonosov Moscow State University	Batrakova, EV (corresponding author), Univ Nebraska Med Ctr, Ctr Drug Delivery & Nanomed, Dept Pharmaceut Sci, Omaha, NE USA.	batrakov@email.unc.edu	Harrison, Emily B./AAW-1826-2021; Kabanov, Alexander/AAY-5751-2020; He, Zhijian/GPP-3720-2022; Klyachko, Natalia L./AAU-8856-2021; Kabanov, Alexander V/N-3356-2013; Klyachko, Natalia L/J-9512-2013	Harrison, Emily B./0000-0002-6934-3875; Kabanov, Alexander/0000-0002-3665-946X; He, Zhijian/0000-0003-4871-5497; Klyachko, Natalia L./0000-0002-9357-8236; Kabanov, Alexander V/0000-0002-3665-946X; 	US National Institutes of Health [1R01 NS057748, RR021937, R01 CA116591, 2R01 NS034239, 2R37 NS36126, P01 NS31492, P20RR 15635, P01 MH64570, P01 NS43985, 2R01 NS070190]; US Department of Defense [W81XWH-09-1-0386, W81XWH11-1-0770]; Russian Ministry of Science and Education [02.740.11.5231, 11.G34.31.0004]; NATIONAL CANCER INSTITUTE [T32CA196589, P30CA016086, P30CA036727, R01CA116591] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635, P20RR021937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057748, R01NS034239, R01NS070190, R37NS036126, R01NS036126, P01NS043985, P01NS031492] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the grants of the US National Institutes of Health 1R01 NS057748 (to EVB), RR021937 and R01 CA116591 (to AVK), 2R01 NS034239, 2R37 NS36126, P01 NS31492, P20RR 15635, P01 MH64570, P01 NS43985 (to HEG), 2R01 NS070190 (to RLM), US Department of Defense Award No. W81XWH-09-1-0386 (to AVK) and W81XWH11-1-0770 (to AVK and HEG), and the Russian Ministry of Science and Education No. 02.740.11.5231 and No. 11.G34.31.0004 (to AVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, INDIAN J MED RES, V121, P111; Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Balkundi S, 2011, INT J NANOMED, V6, P3393, DOI 10.2147/IJN.S27830; Batrakova EV, 2007, BIOCONJUGATE CHEM, V18, P1498, DOI 10.1021/bc700184b; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Batrakova EV, 2005, BIOCONJUGATE CHEM, V16, P793, DOI 10.1021/bc049730c; Beal MF, 1997, MOL ASPECTS MED, V18, pS169; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Casper D, 2002, CELL TRANSPLANT, V11, P331; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Denzer K, 2000, J CELL SCI, V113, P3365; Ebadi M, 1996, PROG NEUROBIOL, V48, P1, DOI 10.1016/0301-0082(95)00029-1; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Gendelman HE, 2009, ANTIOXID REDOX SIGNA; Gonzalez-Polo RA, 2004, CELL BIOL INT, V28, P373, DOI 10.1016/j.cellbi.2004.03.005; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Haney MJ, 2011, NANOMEDICINE-UK, V6, P1215, DOI [10.2217/nnm.11.32, 10.2217/NNM.11.32]; Henderson RM, 1996, P NATL ACAD SCI USA, V93, P8756, DOI 10.1073/pnas.93.16.8756; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kyritsis AP, 2009, CANCER GENE THER, V16, P741, DOI 10.1038/cgt.2009.52; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; LOW WC, 1982, NATURE, V300, P260, DOI 10.1038/300260a0; Lyubchenko YL, 2009, METHODS MOL BIOL, V543, P337, DOI 10.1007/978-1-60327-015-1_21; Manfredsson FP, 2009, MOL THER, V17, P403, DOI 10.1038/mt.2009.15; Martinez-Serrano A, 1998, P NATL ACAD SCI USA, V95, P1858, DOI 10.1073/pnas.95.4.1858; MartinezSerrano A, 1996, EUR J NEUROSCI, V8, P727, DOI 10.1111/j.1460-9568.1996.tb01258.x; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Papathanou M, 2011, EUR J NEUROSCI, V33, P2247, DOI 10.1111/j.1460-9568.2011.07704.x; Pappert EJ, 1996, NEUROLOGY, V47, P1037, DOI 10.1212/WNL.47.4.1037; Pizzo DP, 2006, MOL THER, V13, P175, DOI 10.1016/j.ymthe.2005.08.001; Prasad KN, 1999, CURR OPIN NEUROL, V12, P761, DOI 10.1097/00019052-199912000-00017; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022; Zhao Y, 2011, J NANOMED NANOTECHNO, V10, P4; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	62	98	101	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61852	10.1371/journal.pone.0061852	http://dx.doi.org/10.1371/journal.pone.0061852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620794	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500074
J	Hulsmans, M; Geeraert, B; Arnould, T; Tsatsanis, C; Holvoet, P				Hulsmans, Maarten; Geeraert, Benjamine; Arnould, Thierry; Tsatsanis, Christos; Holvoet, Paul			PPAR Agonist-Induced Reduction of Mcp1 in Atherosclerotic Plaques of Obese, Insulin-Resistant Mice Depends on Adiponectin-Induced Irak3 Expression	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-ALPHA; ROSIGLITAZONE TREATMENT; ENDOTHELIAL FUNCTION; ANTIOXIDANT DEFENSE; METABOLIC SYNDROME; DYSLIPIDEMIC MICE; HUMAN MONOCYTES; GAMMA	Synthetic peroxisome proliferator-activated receptor (PPAR) agonists are used to treat dyslipidemia and insulin resistance. In this study, we examined molecular mechanisms that explain differential effects of a PPAR alpha agonist (fenofibrate) and a PPAR gamma agonist (rosiglitazone) on macrophages during obesity-induced atherogenesis. Twelve-week-old mice with combined leptin and LDL-receptor deficiency (DKO) were treated with fenofibrate, rosiglitazone or placebo for 12 weeks. Only rosiglitazone improved adipocyte function, restored insulin sensitivity, and inhibited atherosclerosis by decreasing lipid-loaded macrophages. In addition, it increased interleukin-1 receptor-associated kinase-3 (Irak3) and decreased monocyte chemoattractant protein-1 (Mcp1) expressions, indicative of a switch from M1 to M2 macrophages. The differences between fenofibrate and rosiglitazone were independent of Ppar gamma expression. In bone marrow-derived macrophages (BMDM), we identified the rosiglitazone-associated increase in adiponectin as cause of the increase in Irak3. Interestingly, the deletion of Irak3 in BMDM (IRAK3(-/-) BMDM) resulted in activation of the canonical NF kappa B signaling pathway and increased Mcp1 protein secretion. Rosiglitazone could not decrease the elevated Mcp1 secretion in IRAK3(-/-) BMDM directly and fenofibrate even increased the secretion, possibly due to increased mitochondrial reactive oxygen species production. Furthermore, aortic extracts of high-fat insulin-resistant LDL-receptor deficient mice, with lower adiponectin and Irak3 and higher Mcp1, showed accelerated atherosclerosis. In aggregate, our results emphasize an interaction between PPAR agonist-mediated increase in adiponectin and macrophage-associated Irak3 in the protection against atherosclerosis by PPAR agonists.	[Hulsmans, Maarten; Geeraert, Benjamine; Holvoet, Paul] Katholieke Univ Leuven, Dept Cardiovasc Sci, Atherosclerosis & Metab Unit, Louvain, Belgium; [Arnould, Thierry] Univ Namur FUNDP, Lab Biochem & Cell Biol URBC, NAmur Res Inst LIfe Sci NARILIS, Namur, Belgium; [Tsatsanis, Christos] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Greece	KU Leuven; University of Namur; University of Crete	Holvoet, P (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Atherosclerosis & Metab Unit, Louvain, Belgium.	paul.holvoet@med.kuleuven.be	Tsatsanis, Christos/AAM-9362-2020; Hulsmans, Maarten/AAI-9547-2020; HOLVOET, PAUL/T-8434-2017; Tsatsanis, Christos/C-2516-2018	Tsatsanis, Christos/0000-0003-1214-4151; Hulsmans, Maarten/0000-0003-1009-658X; HOLVOET, PAUL/0000-0001-9201-0772; Tsatsanis, Christos/0000-0003-1214-4151	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0548.08, G0846.11]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (Vascular Biology Network); Interdisciplinair Ontwikkelingsfonds - Kennisplatform [KP/12/009]	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (Vascular Biology Network)(FWO); Interdisciplinair Ontwikkelingsfonds - Kennisplatform	Funding was provided by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G.0548.08, G0846.11, and Vascular Biology Network), and by Interdisciplinair Ontwikkelingsfonds - Kennisplatform (KP/12/009). M. Hulsmans is a postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahia L, 2007, ATHEROSCLEROSIS, V195, P138, DOI 10.1016/j.atherosclerosis.2006.09.003; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Burgos-Ramos E, 2012, METABOLISM, V61, P1646, DOI 10.1016/j.metabol.2012.05.001; Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; Chen W, 2012, ARTERIOSCL THROM VAS, V32, P2598, DOI 10.1161/ATVBAHA.112.300310; Chu NV, 2002, DIABETES CARE, V25, P542, DOI 10.2337/diacare.25.3.542; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Duez H, 2002, J BIOL CHEM, V277, P48051, DOI 10.1074/jbc.M206966200; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Geeraert B, 2010, INT J OBESITY, V34, P569, DOI 10.1038/ijo.2009.261; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056071; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kadoglou NPE, 2008, DIABETIC MED, V25, P333, DOI 10.1111/j.1464-5491.2007.02375.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Mertens A, 2003, CIRCULATION, V107, P1640, DOI 10.1161/01.CIR.0000056523.08033.9F; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Padmalayam I, 2013, CURR PHARM DES, DOI CPD-EPUB-20130220-9; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Phillips LS, 2001, DIABETES CARE, V24, P308, DOI 10.2337/diacare.24.2.308; Srivastava RAK, 2011, ATHEROSCLEROSIS, V214, P86, DOI 10.1016/j.atherosclerosis.2010.10.033; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Taleb S, 2007, ARTERIOSCL THROM VAS, V27, P2691, DOI 10.1161/ATVBAHA.107.149567; Tao L, 2010, CIRC RES, V106, P409, DOI 10.1161/CIRCRESAHA.109.211797; Tsai JS, 2010, J CELL BIOCHEM, V110, P1410, DOI 10.1002/jcb.22657; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Verreth W, 2007, BRIT J PHARMACOL, V151, P347, DOI 10.1038/sj.bjp.0707231; Verreth W, 2006, ARTERIOSCL THROM VAS, V26, P922, DOI 10.1161/01.ATV.0000207318.42066.bb; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238	46	27	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62253	10.1371/journal.pone.0062253	http://dx.doi.org/10.1371/journal.pone.0062253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620818	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500098
J	Stagni, F; Magistretti, J; Guidi, S; Ciani, E; Mangano, C; Calza, L; Bartesaghi, R				Stagni, Fiorenza; Magistretti, Jacopo; Guidi, Sandra; Ciani, Elisabetta; Mangano, Chiara; Calza, Laura; Bartesaghi, Renata			Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							FEEDFORWARD INHIBITION; MENTAL-RETARDATION; MEMORY; ABNORMALITIES; NEUROGENESIS; IMPAIRMENT; EXPRESSION; NUMBER; PROLIFERATION; HIPPOCAMPUS	Down syndrome (DS) is a high-incidence genetic pathology characterized by severe impairment of cognitive functions, including declarative memory. Impairment of hippocampus-dependent long-term memory in DS appears to be related to anatomo-functional alterations of the hippocampal trisynaptic circuit formed by the dentate gyrus (DG) granule cells - CA3 pyramidal neurons - CA1 pyramidal neurons. No therapies exist to improve cognitive disability in individuals with DS. In previous studies we demonstrated that pharmacotherapy with fluoxetine restores neurogenesis, granule cell number and dendritic morphology in the DG of the Ts65Dn mouse model of DS. The goal of the current study was to establish whether treatment rescues the impairment of synaptic connectivity between the DG and CA3 that characterizes the trisomic condition. Euploid and Ts65Dn mice were treated with fluoxetine during the first two postnatal weeks and examined 45-60 days after treatment cessation. Untreated Ts65Dn mice had a hypotrophyc mossy fiber bundle, fewer synaptic contacts, fewer glutamatergic contacts, and fewer dendritic spines in the stratum lucidum of CA3, the terminal field of the granule cell projections. Electrophysiological recordings from CA3 pyramidal neurons showed that in Ts65Dn mice the frequency of both mEPSCs and mIPSCs was reduced, indicating an overall impairment of excitatory and inhibitory inputs to CA3 pyramidal neurons. In treated Ts65Dn mice all these aberrant features were fully normalized, indicating that fluoxetine can rescue functional connectivity between the DG and CA3. The positive effects of fluoxetine on the DG-CA3 system suggest that early treatment with this drug could be a suitable therapy, possibly usable in humans, to restore the physiology of the hippocampal networks and, hence, memory functions.	[Stagni, Fiorenza; Guidi, Sandra; Ciani, Elisabetta; Bartesaghi, Renata] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Magistretti, Jacopo] Univ Pavia, Dept Biol & Biotechnol L Spallanzani, I-27100 Pavia, Italy; [Mangano, Chiara; Calza, Laura] Univ Bologna, HST ICIR, Bologna, Italy	University of Bologna; University of Pavia; University of Bologna	Bartesaghi, R (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	renata.bartesaghi@unibo.it	Calza, Laura/G-1059-2014; Stagni, Fiorenza/AAB-7317-2019; Guidi, Sandra/L-9738-2015; Ciani, Elisabetta/AAL-6462-2020	Guidi, Sandra/0000-0002-0011-1443; Mangano, Chiara/0000-0003-0092-4281; Stagni, Fiorenza/0000-0002-2226-7844; ciani, elisabetta/0000-0003-3130-5168; Calza, Laura/0000-0002-4426-8477	Fondation Jerome Lejeune	Fondation Jerome Lejeune	This work was supported by a grant from the "Fondation Jerome Lejeune" to R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acsady L, 1998, J NEUROSCI, V18, P3386; Bartesaghi R, 2011, REV NEUROSCIENCE, V22, P419, DOI 10.1515/RNS.2011.037; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Bianchi P, 2010, J NEUROSCI, V30, P8769, DOI 10.1523/JNEUROSCI.0534-10.2010; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Carlesimo GA, 1997, NEUROPSYCHOLOGIA, V35, P71, DOI 10.1016/S0028-3932(96)00055-3; Castelli L, 2007, BRAIN RES, V1163, P44, DOI 10.1016/j.brainres.2007.05.065; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/578057; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; DEVANE CL, 1994, AM J MED, V97, pS13, DOI 10.1016/0002-9343(94)90359-X; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Guidi S, 2013, BRAIN PATHOL, V23, P129, DOI 10.1111/j.1750-3639.2012.00624.x; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hanson JE, 2007, J PHYSIOL-LONDON, V579, P53, DOI 10.1113/jphysiol.2006.114868; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kurt MA, 2004, BRAIN RES, V1022, P101, DOI 10.1016/j.brainres.2004.06.075; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Liu DP, 2003, BIOTECHNIQUES, V35, P1170, DOI 10.2144/03356st02; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Malberg JE, 2005, TRENDS PHARMACOL SCI, V26, P631, DOI 10.1016/j.tips.2005.10.005; Pollonini G, 2008, NEUROSCIENCE, V156, P99, DOI 10.1016/j.neuroscience.2008.07.025; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; ROBAIN O, 1994, DEV BRAIN RES, V80, P244, DOI 10.1016/0165-3806(94)90109-0; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Sandi C, 2004, LEARN MEMORY, V11, P244, DOI 10.1101/lm.73904; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Strovel J, 1999, CYTOGENET CELL GENET, V86, P285, DOI 10.1159/000015320; Trazzi S, 2011, HUM MOL GENET, V20, P1560, DOI 10.1093/hmg/ddr033; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0	42	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e61689	10.1371/journal.pone.0061689	http://dx.doi.org/10.1371/journal.pone.0061689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620781	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500061
J	Weinmann, AE; Rodder, D; Lotters, S; Langer, MR				Weinmann, Anna E.; Roedder, Dennis; Loetters, Stefan; Langer, Martin R.			Heading for New Shores: Projecting Marine Distribution Ranges of Selected Larger Foraminifera	PLOS ONE			English	Article							SYMBIONT-BEARING FORAMINIFERA; EOCENE THERMAL MAXIMUM; GLOBAL OCEAN CARBONATE; BENTHIC FORAMINIFERA; CLIMATE-CHANGE; SEDIMENT PRODUCTION; REEF; AMPHISTEGINA; HABITAT; DIVERSITY	The distribution of modern symbiont-bearing larger foraminifera is confined to tropical and subtropical shallow water marine habitats and a narrow range of environmental variables (e. g. temperature). Most of today's taxa are restricted to tropical and subtropical regions (between 30 degrees N and 30 degrees S) and their minimum temperature limits are governed by the 14 to 20 degrees C isotherms. However, during times of extensive global warming (e. g., the Eocene and Miocene), larger foraminifera have been found as far north as 50 degrees N (North America and Central Europe) as well as towards 47 degrees S in New Zealand. During the last century, sea surface temperatures have been rising significantly. This trend is expected to continue and climate change scenarios for 2050 suggest a further increase by 1 to 3 degrees C. We applied Species Distribution Models to assess potential distribution range changes of three taxa of larger foraminifera under current and future climate. The studied foraminifera include Archaias angulatus, Calcarina spp., and Amphistegina spp., and represent taxa with regional, superregional and global distribution patterns. Under present environmental conditions, Amphistegina spp. shows the largest potential distribution, apparently due to its temperature tolerance. Both Archaias angulatus and Calcarina spp. display potential distributions that cover currently uninhabited regions. Under climate conditions expected for the year 2050, all taxa should display latitudinal range expansions between 1 to 2.5 degrees both north-and southward. The modeled range projections suggest that some larger foraminifera may colonize biogeographic regions that so far seemed unsuitable. Archaias angulatus and Calcarina spp. also show an increase in habitat suitability within their native occurrence ranges, suggesting that their tolerance for maximum temperatures has yet not been fully exploited and that they benefit from ocean warming. Our findings suggest an increased role of larger foraminifera as carbonate producers and reef framework builders in future oceans.	[Weinmann, Anna E.; Langer, Martin R.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Loetters, Stefan] Univ Trier, Inst Biogeog, Trier, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universitat Trier	Weinmann, AE (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	weinmann@uni-bonn.de	Weinmann, Anna E./AAS-7145-2021; Rödder, Dennis/AAT-8644-2021	Weinmann, Anna E./0000-0002-7999-0486; Rödder, Dennis/0000-0002-6108-1639	German Science Foundation (DFG) [LA 884/10-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Science Foundation (DFG) Grant number: LA 884/10-1 (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, ETOPO1 ARC MINUTE GL, DOI DOI 10.7289/V5C8276M; Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; BARUSSEAU JP, 1988, CONT SHELF RES, V8, P1, DOI 10.1016/0278-4343(88)90021-0; Belasky P, 1996, PALAEOGEOGR PALAEOCL, V122, P119, DOI 10.1016/0031-0182(95)00092-5; Bentlage B, 2009, MAR ECOL PROG SER, V384, P121, DOI 10.3354/meps08012; Boltovskoy E., 1976, Foraminifera, V2, P171; BouDagher-Fadel M., 2008, DEV PALEONTOLOGY STR, V21, P1; Boyer T.P., 2006, NOAA ATLAS NESDIS, P190; Calvo-Marcilese L, 2010, BIOL INVASIONS, V12, P3299, DOI 10.1007/s10530-010-9723-x; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Crouch RW, 1979, J FORAMIN RES, V9, P95; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; Debenay Jean-Pierre, 1997, Revue de Micropaleontologie, V40, P15, DOI 10.1016/S0035-1598(97)90087-8; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferreira CEL, 1999, CORAL REEFS, V18, P352, DOI 10.1007/s003380050211; Fujita K, 2011, BIOGEOSCIENCES, V8, P2089, DOI 10.5194/bg-8-2089-2011; Fujita K, 2009, CORAL REEFS, V28, P29, DOI 10.1007/s00338-008-0441-0; Gallagher SJ, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001660; Gischler E, 2009, FACIES, V55, P27, DOI 10.1007/s10347-008-0162-4; Goldbeck EJ, 2009, SOC SEDIMENT GEOL SP, V93, P187; Guarino L, 2001, DIVA GIS GEOGRAPHIC; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Habel JC, 2010, SURVIVING CHANGING C, P373; HALLOCK P, 1984, J FORAMIN RES, V14, P250, DOI 10.2113/gsjfr.14.4.250; HALLOCK P, 1986, J FORAMIN RES, V16, P1, DOI 10.2113/gsjfr.16.1.1; Hallock P, 1999, MODERN FORAMINIFERA, P123; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HALLOCK P, 1993, MAR MICROPALEONTOL, V20, P277, DOI 10.1016/0377-8398(93)90037-X; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hohenegger J, 1999, MAR MICROPALEONTOL, V36, P109, DOI 10.1016/S0377-8398(98)00030-9; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K., 2008, AQUAMAPS ENV DATASET; Kennedy DM, 2004, AUST J EARTH SCI, V51, P847, DOI 10.1111/j.1400-0952.2004.01089.x; Kiessling W, 2003, LETHAIA, V36, P195, DOI 10.1080/00241160310004648; Kouyoumontzakis G., 1989, Journal of Micropalaeontology, V8, P1; Kouyoumontzakis G., 1984, Revue de Micropaleontologie, V27, P196; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; Langer MR, 2003, CORAL REEFS, V22, P143, DOI 10.1007/s00338-003-0298-1; LARSEN AR, 1976, ISRAEL J EARTH SCI, V25, P1; LEE JJ, 1976, B MAR SCI, V26, P530; Levy Alain, 1997, Revista Espanola de Micropaleontologia, V29, P5; Li QY, 1999, PALAEOGEOGR PALAEOCL, V147, P101, DOI 10.1016/S0031-0182(98)00150-3; Lobegeier MK, 2002, J FORAMIN RES, V32, P201, DOI 10.2113/32.3.201; Loeblich A.R., 1987, FORAMINIFERAL GENERA, P970; Mann KH, 2006, DYNAMICS MARINE ECOS, V3rd, DOI DOI 10.5670/OCEANOG.2006.87; MARTIN RE, 1986, J FORAMIN RES, V16, P201, DOI 10.2113/gsjfr.16.3.201; McGowran B, 1997, PALAEOGEOGR PALAEOCL, V136, P19, DOI 10.1016/S0031-0182(97)00073-4; McIntyre-Wressnig A, 2013, MAR ECOL PROG SER, V472, P45, DOI 10.3354/meps09918; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; MURRAY JW, 1994, MAR MICROPALEONTOL, V24, P43, DOI 10.1016/0377-8398(94)90010-8; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; Owens HL, 2012, BIODIVERS CONSERV, V21, P577, DOI 10.1007/s10531-011-0202-1; Parker JH, 2011, MAR MICROPALEONTOL, V78, P30, DOI 10.1016/j.marmicro.2010.09.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pujalte V, 2009, GEOL ACTA, V7, P161, DOI 10.1344/105.000000276; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Renema W, 2010, CORAL REEFS, V29, P165, DOI 10.1007/s00338-009-0568-7; Renema W, 2001, PALAEOGEOGR PALAEOCL, V175, P125, DOI 10.1016/S0031-0182(01)00389-3; Renema W, 2008, MAR MICROPALEONTOL, V68, P286, DOI 10.1016/j.marmicro.2008.06.002; Renema Willem, 2007, V29, P179; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; ROSE P. R., 1977, SEDIMENTA, V4, P1; Scheibner C, 2005, GEOLOGY, V33, P493, DOI 10.1130/G21237.1; Scheibner C., 2008, eEarth, V3, P19; Schiebel R, 1992, BER REP GEOL PALAONT, V51, P1; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spalding M.D., 2001, WORLD ATLAS CORAL RE; SREMAC J., 2005, GEOLOGIA CROATICA, V58, P1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Todd R., 1976, P382; Todd R, 1960, SCI REPORTS TOHOKU U, P100; Triantaphyllou MV, 2009, MEDITERR MAR SCI, V10, P73, DOI 10.12681/mms.111; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; van Asch N, 2012, PALAEOGEOGR PALAEOCL, V315, P1, DOI 10.1016/j.palaeo.2011.11.003; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186; ZMIRI A, 1974, J PROTOZOOL, V21, P133, DOI 10.1111/j.1550-7408.1974.tb03626.x	93	31	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62182	10.1371/journal.pone.0062182	http://dx.doi.org/10.1371/journal.pone.0062182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620810	Green Submitted, gold, Green Published			2022-12-25	WOS:000317909500090
J	Wulff, JA; Buckman, KA; Wu, KM; Heimpel, GE; White, JA				Wulff, Jason A.; Buckman, Karrie A.; Wu, Kongming; Heimpel, George E.; White, Jennifer A.			The Endosymbiont Arsenophonus Is Widespread in Soybean Aphid, Aphis glycines, but Does Not Provide Protection from Parasitoids or a Fungal Pathogen	PLOS ONE			English	Article							CLASSICAL BIOLOGICAL-CONTROL; SON-KILLER TRAIT; POPULATION-DYNAMICS; HORIZONTAL TRANSFER; SYMBIONT INFECTION; BACTERIUM; TRANSMISSION; WOLBACHIA; ACQUISITION; ANTIBIOTICS	Aphids commonly harbor bacterial facultative symbionts that have a variety of effects upon their aphid hosts, including defense against hymenopteran parasitoids and fungal pathogens. The soybean aphid, Aphis glycines Matsumura (Hemiptera: Aphididae), is infected with the symbiont Arsenophonus sp., which has an unknown role in its aphid host. Our research goals were to document the infection frequency and diversity of the symbiont in field-collected soybean aphids, and to determine whether Arsenophonus is defending soybean aphid against natural enemies. We performed diagnostic PCR and sequenced four Arsenophonus genes in soybean aphids from their native and introduced range to estimate infection frequency and genetic diversity, and found that Arsenophonus infection is highly prevalent and genetically uniform. To evaluate the defensive role of Arsenophonus, we cured two aphid genotypes of their natural Arsenophonus infection through ampicillin microinjection, resulting in infected and uninfected isolines within the same genetic background. These isolines were subjected to parasitoid assays using a recently introduced biological control agent, Binodoxys communis [Braconidae], a naturally recruited parasitoid, Aphelinus certus [Aphelinidae], and a commercially available biological control agent, Aphidius colemani [Braconidae]. We also assayed the effect of the common aphid fungal pathogen, Pandora neoaphidis (Remaudiere & Hennebert) Humber (Entomophthorales: Entomophthoraceae), on the same aphid isolines. We did not find differences in successful parasitism for any of the parasitoid species, nor did we find differences in P. neoaphidis infection between our treatments. Our conclusion is that Arsenophonus does not defend its soybean aphid host against these major parasitoid and fungal natural enemies.	[Wulff, Jason A.; White, Jennifer A.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Buckman, Karrie A.] USDA ARS, Ctr Grain & Anim Hlth Res Unit, Manhattan, KS USA; [Buckman, Karrie A.; Heimpel, George E.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pests, Beijing 100193, Peoples R China	University of Kentucky; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wulff, JA (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	jasonwulff@uky.edu			Kentucky Science and Engineering Foundation [KSEF-148-502-09-248]; Kentucky Science and Technology Corporation; USDA-AFRI [2011-67014-3015]; University of Kentucky	Kentucky Science and Engineering Foundation; Kentucky Science and Technology Corporation; USDA-AFRI(United States Department of Agriculture (USDA)); University of Kentucky	This research was supported in part by a grant from the Kentucky Science and Engineering Foundation as per Grant Agreement #KSEF-148-502-09-248 with the Kentucky Science and Technology Corporation, USDA-AFRI grant # 2011-67014-3015, and the University of Kentucky. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Bressan A, 2012, MICROB ECOL, V63, P628, DOI 10.1007/s00248-011-9933-5; Bressan A, 2009, PHYTOPATHOLOGY, V99, P1289, DOI 10.1094/PHYTO-99-11-1289; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Carletto J, 2008, ENTOMOL EXP APPL, V129, P228, DOI 10.1111/j.1570-7458.2008.00760.x; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Clay K, 2005, P NATL ACAD SCI USA, V102, P12465, DOI 10.1073/pnas.0503059102; Costamagna AC, 2008, BIOL CONTROL, V45, P368, DOI 10.1016/j.biocontrol.2008.01.018; Dale C, 2006, APPL ENVIRON MICROB, V72, P2997, DOI 10.1128/AEM.72.4.2997-3004.2006; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Duron O, 2010, ECOL LETT, V13, P1139, DOI 10.1111/j.1461-0248.2010.01502.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; GRIFFITH.GW, 1974, CELL TISSUE RES, V148, P287; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heimpel GE, 2004, ANN ENTOMOL SOC AM, V97, P249, DOI 10.1603/0013-8746(2004)097[0249:PFIBCO]2.0.CO;2; Heimpel GE, 2000, BIOL CONTROL, V19, P77, DOI 10.1006/bcon.2000.0849; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; hner P, 1965, ENDOSYMBIOSIS ANIMAL; Hoffmann AA, 1998, GENETICS, V148, P221; HUGER AM, 1985, J INVERTEBR PATHOL, V46, P272, DOI 10.1016/0022-2011(85)90069-2; HYPSA V, 1993, J INVERTEBR PATHOL, V61, P32, DOI 10.1006/jipa.1993.1006; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jousselin E, 2013, MOL ECOL, V22, P260, DOI 10.1111/mec.12092; Kaiser ME, 2007, ANN ENTOMOL SOC AM, V100, P196, DOI 10.1603/0013-8746(2007)100[196:HPADPF]2.0.CO;2; Koch KA, 2011, J ECON ENTOMOL, V104, P1824, DOI 10.1603/EC11187; Lin LA, 2003, ECOL ENTOMOL, V28, P542, DOI 10.1046/j.1365-2311.2003.00536.x; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Nielsen C, 2005, ENVIRON ENTOMOL, V34, P1036, DOI 10.1603/0046-225X(2005)034[1036:COISAA]2.0.CO;2; Noma T, 2008, J ECON ENTOMOL, V101, P278, DOI 10.1603/0022-0493(2008)101[278:SAORPA]2.0.CO;2; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Perotti MA, 2007, FASEB J, V21, P1058, DOI 10.1096/fj.06-6808com; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Samson RA, 1988, ATLAS ENTOMOPATHOGEN, DOI 10.1007/978-3-662-05890-9; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Simon JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021831; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Trowbridge RE, 2006, J INVERTEBR PATHOL, V91, P64, DOI 10.1016/j.jip.2005.08.009; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; Wilkes TE, 2012, FRONT MICROBIOL SER, P225; Wille BD, 2009, ENVIRON ENTOMOL, V38, P110, DOI 10.1603/022.038.0113; Wyckhuys KAG, 2008, B ENTOMOL RES, V98, P361, DOI 10.1017/S000748530800566X; Wyckhuys KAG, 2009, BIOL INVASIONS, V11, P857, DOI 10.1007/s10530-008-9299-x; Zreik L, 1998, INT J SYST BACTERIOL, V48, P257, DOI 10.1099/00207713-48-1-257	66	29	29	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e62145	10.1371/journal.pone.0062145	http://dx.doi.org/10.1371/journal.pone.0062145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23614027	gold, Green Submitted, Green Published			2022-12-25	WOS:000317893400157
J	Hayakawa, K; Hirosawa, M; Tabei, Y; Arai, D; Tanaka, S; Murakami, N; Yagi, S; Shiota, K				Hayakawa, Koji; Hirosawa, Mitsuko; Tabei, Yasuyuki; Arai, Daisuke; Tanaka, Satoshi; Murakami, Noboru; Yagi, Shintaro; Shiota, Kunio			Epigenetic Switching by the Metabolism-sensing Factors in the Generation of Orexin Neurons from Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; DNA METHYLATION PROFILE; REGIONS T-DMRS; INSULIN-RESISTANCE; HISTONE MODIFICATION; GENE-EXPRESSION; PROTEIN; GLUCOSE; DIFFERENTIATION; IDENTIFICATION	The orexin system plays a central role in the integration of sleep/wake and feeding behaviors in a broad spectrum of neural-metabolic physiology. Orexin-A and orexin-B are produced by the cleavage of prepro-orexin, which is encoded on the Hcrt gene. To date, methods for generating other peptide neurons could not induce orexin neurons from pluripotent stem cells. Considering that the metabolic status affects orexin expression, we supplemented the culture medium with a nutrient factor, ManNAc, and succeeded in generating functional orexin neurons from mouse ES cells. Because DNA methylation inhibitors and histone deacetylase inhibitors could induce Hcrt expression in mouse ES cells, the epigenetic mechanism may be involved in this orexin neurogenesis. DNA methylation analysis showed the presence of a tissue-dependent differentially methylated region (T-DMR) around the transcription start site of the Hcrt gene. In the orexin neurons induced by supplementation of ManNAc, the T-DMR of the Hcrt gene was hypomethylated in association with higher H3/H4 acetylation. Concomitantly, the histone acetyltransferases p300, CREB-binding protein (CBP), and Mgea5 (also called O-GlcNAcase) were localized to the T-DMR in the orexin neurons. In non-orexin-expressing cells, H3/H4 hypoacetylation and hyper-O-GlcNAc modification were observed at the T-DMRs occupied by O-GlcNAc transferase and Sirt1. Therefore, the results of the present study suggest that the glucose metabolite, ManNAc, induces switching from the inactive state by Ogt-Sirt1 to the active state by Mgea5, p300, and CBP at the Hcrt gene locus.	[Hayakawa, Koji; Hirosawa, Mitsuko; Tabei, Yasuyuki; Arai, Daisuke; Tanaka, Satoshi; Yagi, Shintaro; Shiota, Kunio] Univ Tokyo, Dept Anim Resource Sci Vet Med Sci, Lab Cellular Biochem, Tokyo 1138657, Japan; [Murakami, Noboru] Miyazaki Univ, Fac Agr, Dept Vet Physiol, Physiol Lab, Miyazaki 8892192, Japan	University of Tokyo; University of Miyazaki	Shiota, K (corresponding author), Univ Tokyo, Dept Anim Resource Sci Vet Med Sci, Lab Cellular Biochem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ashiota@mail.ecc.u-tokyo.ac.jp	Arai, Daisuke/AAZ-6229-2021	Arai, Daisuke/0000-0002-1723-5389; Hayakawa, Koji/0000-0003-0453-1303; Tanaka, Satoshi/0000-0002-4745-550X	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan	This work was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan.	Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Armstrong L, 2012, STEM CELL REV REP, V8, P67, DOI 10.1007/s12015-011-9300-4; BALKAN B, 1994, DIABETES, V43, P1173, DOI 10.2337/diabetes.43.10.1173; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Burdakov D, 2007, PFLUG ARCH EUR J PHY, V454, P19, DOI 10.1007/s00424-006-0189-8; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; De la Herran-Arita AK, 2011, NEUROSCIENCE, V183, P134, DOI 10.1016/j.neuroscience.2011.03.029; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dunn-Meynell AA, 2002, DIABETES, V51, P2056, DOI 10.2337/diabetes.51.7.2056; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu XJ, 1998, BIOTECHNOL BIOENG, V58, P642, DOI 10.1002/(SICI)1097-0290(19980620)58:6<642::AID-BIT10>3.0.CO;2-9; Hanover JA, 2010, CHEM BIOL, V17, P1272, DOI 10.1016/j.chembiol.2010.12.001; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; MARSHALL S, 1991, J BIOL CHEM, V266, P10155; Maru I, 1996, J BIOL CHEM, V271, P16294, DOI 10.1074/jbc.271.27.16294; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Panossian L, 2011, J NEUROSCI, V31, P4025, DOI 10.1523/JNEUROSCI.5166-10.2011; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sato S, 2010, GENES CELLS, V15, P607, DOI 10.1111/j.1365-2443.2010.01404.x; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takasugi M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-481; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V403, P178, DOI 10.1016/j.bbrc.2010.11.001; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Toleman CA, 2006, J BIOL CHEM, V281, P3918, DOI 10.1074/JBC.m510485200; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	60	55	59	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17099	17110		10.1074/jbc.M113.455899	http://dx.doi.org/10.1074/jbc.M113.455899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625921	Green Published, hybrid			2022-12-25	WOS:000320380600008
J	Tao, GZ; Lehwald, N; Jang, KY; Baek, J; Xu, BH; Omary, MB; Sylvester, KG				Tao, Guo-Zhong; Lehwald, Nadja; Jang, Kyu Yun; Baek, Joy; Xu, Baohui; Omary, M. Bishr; Sylvester, Karl G.			Wnt/beta-Catenin Signaling Protects Mouse Liver against Oxidative Stress-induced Apoptosis through the Inhibition of Forkhead Transcription Factor FoxO3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CELL-SURVIVAL; COLON-CANCER; INJURY; EXPRESSION; MICE; GROWTH; REGENERATION; HEPATOCYTES; HOMEOSTASIS	Numerous liver diseases are associated with extensive oxidative tissue damage. It is well established that Wnt/beta-catenin signaling directs multiple hepatocellular processes, including development, proliferation, regeneration, nutrient homeostasis, and carcinogenesis. It remains unexplored whether Wnt/beta-catenin signaling provides hepatocyte protection against hepatotoxin-induced apoptosis. Conditional, liver-specific beta-catenin knockdown (KD) mice and their wild-type littermates were challenged by feeding with a hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet to induce chronic oxidative liver injury. Following the DDC diet, mice with beta-catenin-deficient hepatocytes demonstrate increased liver injury, indicating an important role of beta-catenin signaling for liver protection against oxidative stress. This finding was further confirmed in AML12 hepatocytes with beta-catenin signaling manipulation in vitro using paraquat, a known oxidative stress inducer. Immunofluorescence staining revealed an intense nuclear FoxO3 staining in beta-catenin-deficient livers, suggesting active FoxO3 signaling in response to DDC-induced liver injury when compared with wild-type controls. Consistently, FoxO3 target genes p27 and Bim were significantly induced in beta-catenin KD livers. Conversely, SGK1, a beta-catenin target gene, was significantly impaired in beta-catenin KD hepatocytes that failed to inactivate FoxO3. Furthermore, shRNA-mediated deletion of FoxO3 increased hepatocyte resistance to oxidative stress-induced apoptosis, confirming a proapoptotic role of FoxO3 in the stressed liver. Our findings suggest that Wnt/beta-catenin signaling is required for hepatocyte protection against oxidative stress-induced apoptosis. The inhibition of FoxO through its phosphorylation by beta-catenin-induced SGK1 expression reduces the apoptotic function of FoxO3, resulting in increased hepatocyte survival. These findings have relevance for future therapies directed at hepatocyte protection, regeneration, and anti-cancer treatment.	[Tao, Guo-Zhong; Lehwald, Nadja; Jang, Kyu Yun; Baek, Joy; Xu, Baohui; Sylvester, Karl G.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Lehwald, Nadja] Univ Dusseldorf, Sch Med, Dept Surg, D-40545 Dusseldorf, Germany; [Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Dept Pathol, Jeonju 561180, South Korea; [Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Res Inst Clin Med, Jeonju 561180, South Korea; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sylvester, Karl G.] Lucile Packard Childrens Hosp, Stanford, CA 94304 USA	Stanford University; Heinrich Heine University Dusseldorf; Jeonbuk National University; Jeonbuk National University; University of Michigan System; University of Michigan; Lucile Packard Children's Hospital (LPCH)	Sylvester, KG (corresponding author), Stanford Univ, Dept Surg, Div Pediat Surg, Sch Med,Hagey Lab Regenerat Med, 257 Campus Dr, Stanford, CA 94305 USA.	sylvester@stanford.edu		Xu, Baohui/0000-0002-2857-7464; Baek, Han Bit/0000-0001-6597-7216; Sylvester, Karl G./0000-0002-8559-0155; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health, NIDDK, Pilot Grant [DK56339]; National Institutes of Health Grant [DK47918]; Children's Surgical Research Program Fund; Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health; YAEL Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft Grant [NL 2509/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339, R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK, Pilot Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Surgical Research Program Fund; Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health; YAEL Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Pilot Grant DK56339 (Digestive Disease Center at Stanford) (to K. G. S.) and National Institutes of Health Grant DK47918 (to M. B. O.). This work was also supported by grants from the Children's Surgical Research Program Fund and the Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health (to K. G. S.) and the YAEL Foundation and the German Research Foundation (Deutsche Forschungsgemeinschaft Grant NL 2509/2-1) (to N. L.).	Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Diesen DL, 2010, J SURG RES, V162, P95, DOI 10.1016/j.jss.2009.09.019; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Loguercio C, 2003, FREE RADICAL BIO MED, V34, P1, DOI 10.1016/S0891-5849(02)01167-X; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen K, 2013, HEPATOLOGY, V57, P763, DOI 10.1002/hep.26042; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schwartz DR, 2003, CANCER RES, V63, P2913; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Tao GZ, 2008, J PATHOL, V215, P164, DOI 10.1002/path.2344; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Weerasinghe SVW, 2011, HEPATOLOGY, V53, P1323, DOI 10.1002/hep.24203; Wilk A, 2012, CELL CYCLE, V11, P2660, DOI 10.4161/cc.21015; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Yan YB, 2012, NAT MED, V18, P854, DOI 10.1038/nm.2799; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	52	92	98	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17214	17224		10.1074/jbc.M112.445965	http://dx.doi.org/10.1074/jbc.M112.445965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620592	hybrid, Green Published			2022-12-25	WOS:000320380600018
J	Anand, R; Rai, N; Thattai, M				Anand, Rajat; Rai, Navneet; Thattai, Mukund			Interactions among Quorum Sensing Inhibitors	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; TO-CELL COMMUNICATION; VIBRIO-FISCHERI; BACTERIAL COMMUNICATION; AUTOINDUCER; RESISTANCE; INFECTIONS; THERAPIES; DIFFUSION; BIOFILMS	Many pathogenic bacteria use quorum sensing (QS) systems to regulate the expression of virulence genes in a density-dependent manner. In one widespread QS paradigm the enzyme LuxI generates a small diffusible molecule of the acylhomoserine lactone (AHL) family; high cell densities lead to high AHL levels; AHL binds the transcription factor LuxR, triggering it to activate gene expression at a virulence promoter. The emergence of antibiotic resistance has generated interest in alternative anti-microbial therapies that target QS. Inhibitors of LuxI and LuxR have been developed and tested in vivo, and can act at various levels: inhibiting the synthesis of AHL by LuxI, competitively or non-competitively inhibiting LuxR, or increasing the turnover of LuxI, LuxR, or AHL. Here use an experimentally validated computational model of LuxI/LuxR QS to study the effects of using inhibitors individually and in combination. The model includes the effect of transcriptional feedback, which generates highly non-linear responses as inhibitor levels are increased. For the ubiquitous LuxI-feedback virulence systems, inhibitors of LuxI are more effective than those of LuxR when used individually. Paradoxically, we find that LuxR competitive inhibitors, either individually or in combination with other inhibitors, can sometimes increase virulence by weakly activating LuxR. For both LuxI-feedback and LuxR-feedback systems, a combination of LuxR non-competitive inhibitors and LuxI inhibitors act multiplicatively over a broad parameter range. In our analysis, this final strategy emerges as the only robust therapeutic option.	[Anand, Rajat; Rai, Navneet; Thattai, Mukund] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Rai, Navneet] Indian Inst Technol, Dept BioSci & Bioengn, Bombay 400076, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Thattai, M (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, UAS GKVK Campus, Bangalore, Karnataka, India.	thattai@ncbs.res.in	Rai, Navneet/H-4669-2019	Rai, Navneet/0000-0002-2321-2378	Wellcome Trust-DBT India Alliance Intermediate Fellowship [500103/Z/09/Z]	Wellcome Trust-DBT India Alliance Intermediate Fellowship	This work was supported in part by a Wellcome Trust-DBT India Alliance Intermediate Fellowship (500103/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anguige K, 2004, MATH BIOSCI, V192, P39, DOI 10.1016/j.mbs.2004.06.008; Annapoorani A, 2012, J COMPUT AID MOL DES, V26, P1067, DOI 10.1007/s10822-012-9599-1; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Defoirdt T, 2004, AQUACULTURE, V240, P69, DOI 10.1016/j.aquaculture.2004.06.031; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Fagerlind MG, 2005, BIOSYSTEMS, V80, P201, DOI 10.1016/j.biosystems.2004.11.008; Fozard JA, 2012, BIOSYSTEMS, V109, P105, DOI 10.1016/j.biosystems.2012.02.002; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Goryachev AB, 2009, WIRES SYST BIOL MED, V1, P45, DOI 10.1002/wsbm.27; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kohler T, 2010, QUORUM SENSING INHIB; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lesic B, 2007, PLOS PATHOG, V3, P1229, DOI 10.1371/journal.ppat.0030126; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Lyon GJ, 2003, CHEM BIOL, V10, P1007, DOI 10.1016/j.chembiol.2003.11.003; Mae A, 2001, MOL PLANT MICROBE IN, V14, P1035, DOI 10.1094/MPMI.2001.14.9.1035; Maeda T, 2012, ISME J, V6, P493, DOI 10.1038/ismej.2011.122; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Ng WL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002767; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150; Rai N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002361; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Ricard JD, 2012, CURR OPIN PULM MED, V18, P181, DOI 10.1097/MCP.0b013e3283520fec; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 1996, J BACTERIOL, V178, P2897, DOI 10.1128/jb.178.10.2897-2901.1996; Stevens AM, 1997, J BACTERIOL, V179, P557, DOI 10.1128/jb.179.2.557-562.1997; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; von Bodman SB, 2003, J BACTERIOL, V185, P7001, DOI 10.1128/JB.185.23.7001-7007.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607	56	15	16	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62254	10.1371/journal.pone.0062254	http://dx.doi.org/10.1371/journal.pone.0062254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626795	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400159
J	Bjorklund, S; Nowacka, A; Bouwstra, JA; Sparr, E; Topgaard, D				Bjorklund, Sebastian; Nowacka, Agnieszka; Bouwstra, Joke A.; Sparr, Emma; Topgaard, Daniel			Characterization of Stratum Corneum Molecular Dynamics by Natural-Abundance C-13 Solid-State NMR	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PERCUTANEOUS-ABSORPTION; LIPID ORGANIZATION; PHASE-BEHAVIOR; WATER-LOSS; MECHANISM; SKIN; SPECTROSCOPY; HYDRATION; KERATIN	Despite the enormous potential for pharmaceutical applications, there is still a lack of understanding of the molecular details that can contribute to increased permeability of the stratum corneum (SC). To investigate the influence of hydration and heating on the SC, we record the natural-abundance C-13 signal of SC using polarization transfer solid-state NMR methods. Resonance lines from all major SC components are assigned. Comparison of the signal intensities obtained with the INEPT and CP pulse sequences gives information on the molecular dynamics of SC components. The majority of the lipids are rigid at 32 degrees C, and those lipids co-exist with a small pool of mobile lipids. The ratio between mobile and rigid lipids increases with hydration. An abrupt change of keratin filament dynamics occurs at RH = 80-85%, from completely rigid to a structure with rigid backbone and mobile protruding terminals. Heating has a strong effect on the lipid mobility, but only a weak influence on the keratin filaments. The results provide novel molecular insight into how the SC constituents are affected by hydration and heating, and improve the understanding of enhanced SC permeability, which is associated with elevated temperatures and SC hydration.	[Bjorklund, Sebastian; Nowacka, Agnieszka; Sparr, Emma; Topgaard, Daniel] Lund Univ, Div Phys Chem, Ctr Chem & Chem Engn, Lund, Sweden; [Bouwstra, Joke A.] Leiden Univ, Dept Drug Delivery Technol, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands	Lund University; Leiden University; Leiden University - Excl LUMC	Bjorklund, S (corresponding author), Lund Univ, Div Phys Chem, Ctr Chem & Chem Engn, Lund, Sweden.	Sebastian.Bjorklund@fkem1.lu.se	Björklund, Sebastian/R-6863-2018	Björklund, Sebastian/0000-0001-6254-8539; Topgaard, Daniel/0000-0001-9373-6348; Sparr, Emma/0000-0001-8343-9657	Swedish Research Council (VR) [2005-2936, 2009-6794, 2011-4334]; Linnaeus Center of Excellence on Organizing Molecular Matter (DT, ES); Swedish Foundation for Strategic Research (ES)	Swedish Research Council (VR)(Swedish Research Council); Linnaeus Center of Excellence on Organizing Molecular Matter (DT, ES); Swedish Foundation for Strategic Research (ES)(Swedish Foundation for Strategic Research)	This work was financially supported by the Swedish Research Council (VR) through grants no 2005-2936, 2009-6794, and 2011-4334; and through the Linnaeus Center of Excellence on Organizing Molecular Matter (DT, ES) and the Swedish Foundation for Strategic Research (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg C, 2008, LANGMUIR, V24, P8061, DOI 10.1021/la800543r; Aberg C, 2008, BBA-BIOMEMBRANES, V1778, P549, DOI 10.1016/j.bbamem.2007.10.020; Akomeah F, 2004, EUR J PHARM SCI, V21, P337, DOI 10.1016/j.ejps.2003.10.025; Alonso A, 1996, J INVEST DERMATOL, V106, P1058, DOI 10.1111/1523-1747.ep12338682; BENGSCH E, 1986, J MAGN RESON, V68, P1, DOI 10.1016/0022-2364(86)90311-2; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bjorklund S, 2010, J CONTROL RELEASE, V143, P191, DOI 10.1016/j.jconrel.2010.01.005; BLANK IH, 1967, J INVEST DERMATOL, V49, P582, DOI 10.1038/jid.1967.184; BLANK IH, 1953, J INVEST DERMATOL, V21, P259, DOI 10.1038/jid.1953.100; BLANK IH, 1984, J INVEST DERMATOL, V82, P188, DOI 10.1111/1523-1747.ep12259835; Bouwstra JA, 2003, J INVEST DERMATOL, V120, P750, DOI 10.1046/j.1523-1747.2003.12128.x; BOUWSTRA JA, 1995, J LIPID RES, V36, P685; Bouwstra JA, 2000, ACTA DERM-VENEREOL, P23; Brief E, 2009, LANGMUIR, V25, P7523, DOI 10.1021/la9003643; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen L, 2002, J MAGN RESON, V158, P164, DOI 10.1016/S1090-7807(02)00069-1; Chen X, 2007, LANGMUIR, V23, P5548, DOI 10.1021/la063640+; Dvinskikh SV, 2004, MAGN RESON CHEM, V42, P875, DOI 10.1002/mrc.1477; EARL WL, 1979, MACROMOLECULES, V12, P762, DOI 10.1021/ma60070a045; Elena B, 2005, J AM CHEM SOC, V127, P17296, DOI 10.1021/ja054411x; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; ENGBLOM J, 1995, J CONTROL RELEASE, V33, P299, DOI 10.1016/0168-3659(94)00105-4; FORSLIND B, 1994, ACTA DERM-VENEREOL, V74, P1; GAY CL, 1994, J INVEST DERMATOL, V103, P233, DOI 10.1111/1523-1747.ep12393214; Ghadially R, 1996, J INVEST DERMATOL, V107, P558, DOI 10.1111/1523-1747.ep12582813; Hatta I, 2006, BBA-BIOMEMBRANES, V1758, P1830, DOI 10.1016/j.bbamem.2006.08.014; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; HEY MJ, 1978, BIOCHIM BIOPHYS ACTA, V540, P518, DOI 10.1016/0304-4165(78)90181-2; Hill JR, 2003, BBA-BIOMEMBRANES, V1616, P121, DOI 10.1016/S0005-2736(03)00238-4; JOKURA Y, 1995, J INVEST DERMATOL, V104, P806, DOI 10.1111/1523-1747.ep12607005; KISIC A, 1995, J LIPID RES, V36, P787; Krushelnitsky A, 2009, J PHYS CHEM B, V113, P10022, DOI 10.1021/jp900337x; LODEN M, 1992, BRIT J DERMATOL, V126, P137, DOI 10.1111/j.1365-2133.1992.tb07810.x; MACK JW, 1988, BIOCHEMISTRY-US, V27, P5418, DOI 10.1021/bi00415a006; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; MICHAELS AS, 1975, AICHE J, V21, P985, DOI 10.1002/aic.690210522; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nakazawa H, 2012, CHEM PHYS LIPIDS, V165, P238, DOI 10.1016/j.chemphyslip.2012.01.002; Nishikawa N, 1998, POLYM J, V30, P125, DOI 10.1295/polymj.30.125; Norlen L, 1997, ARCH DERMATOL RES, V289, P506, DOI 10.1007/s004030050231; Nowacka A, 2012, SOFT MATTER, V8, P1482, DOI 10.1039/c1sm06273e; Nowacka A, 2013, J MAGN RESO IN PRESS, DOI [10.1016/j.jmr.2013.1002.1016, DOI 10.1016/J.JMR.2013.1002.1016]; Nowacka A, 2010, LANGMUIR, V26, P16848, DOI 10.1021/la102935t; PINES A, 1972, J CHEM PHYS, V56, P1776, DOI 10.1063/1.1677439; POTTS RO, 1990, P NATL ACAD SCI USA, V87, P3871, DOI 10.1073/pnas.87.10.3871; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Schaefer H, 1996, COMPOSITION STRUCTUR, P43; SCHAEFER J, 1975, MACROMOLECULES, V8, P291, DOI 10.1021/ma60045a010; SCHEUPLEIN RJ, 1974, J INVEST DERMATOL, V62, P353, DOI 10.1111/1523-1747.ep12701619; SCHEUPLEIN RJ, 1971, PHYSIOL REV, V51, P702, DOI 10.1152/physrev.1971.51.4.702; Silva CL, 2007, BBA-BIOMEMBRANES, V1768, P2647, DOI 10.1016/j.bbamem.2007.05.028; Soubias O, 2004, CHEM-EUR J, V10, P6005, DOI 10.1002/chem.200400246; Sparr E, 2001, BIOPHYS J, V81, P1014, DOI 10.1016/S0006-3495(01)75759-1; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; SUWELACK D, 1980, J CHEM PHYS, V73, P2559, DOI 10.1063/1.440491; tenGrotenhuis E, 1996, BIOPHYS J, V71, P1389, DOI 10.1016/S0006-3495(96)79341-4; ULMIUS J, 1977, BIOCHEMISTRY-US, V16, P5742, DOI 10.1021/bi00645a014; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; WALDERHAUG H, 1984, J PHYS CHEM-US, V88, P1655, DOI 10.1021/j150652a043; Weerheim A, 2001, ARCH DERMATOL RES, V293, P191, DOI 10.1007/s004030100212; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, J LIPID RES, V24, P759; WHITE SH, 1988, BIOCHEMISTRY-US, V27, P3725, DOI 10.1021/bi00410a031; Xu JD, 2011, J PHYS CHEM B, V115, P9948, DOI 10.1021/jp205663z; YOSHIMIZU H, 1990, MACROMOLECULES, V23, P2908, DOI 10.1021/ma00213a016	66	48	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61889	10.1371/journal.pone.0061889	http://dx.doi.org/10.1371/journal.pone.0061889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626744	Green Submitted, gold, Green Published			2022-12-25	WOS:000318008400108
J	Cai, YX; Zhang, WJ; Xiong, SD				Cai, Yanxing; Zhang, Weijuan; Xiong, Sidong			Mannose-Binding Lectin Blunts Macrophage Polarization and Ameliorates Lupus Nephritis	PLOS ONE			English	Article							IMMUNE-COMPLEXES; APOPTOTIC CELLS; MURINE LUPUS; NUCLEIC-ACID; COMPLEMENT; ERYTHEMATOSUS; CLEARANCE; DISEASE; AUTOIMMUNITY; ASSOCIATION	Background: Deficiency in clearance of self nuclear antigens, including DNA, is the hallmark of systemic lupus erythematosus (SLE), a chronic autoimmnue disease characterized by the production of various autoantibodies, immune complex deposition and severe organ damage. Our previous studies revealed that administration of syngeneic BALB/c mice with activated lymphocyte-derived DNA (ALD-DNA) could induce SLE disease. Mannose-binding lectin (MBL), a secreted pattern recognition receptor with binding activity to DNA, has been proved to be a modulator of inflammation, but whether MBL takes responsibility for DNA clearance, modulates the DNA-mediated immune responses, and is involved in the development of DNA-induced SLE disease remain poorly understood. Methodology/Principal Findings: The levels of serum MBL significantly decreased in lupus mice induced by ALD-DNA and were negatively correlated with SLE disease. MBL blunted macrophage M2b polarization by inhibiting the MAPK and NF-kappa B signaling while enhancing the activation of CREB. Furthermore, MBL suppressed the ability of ALD-DNA-stimulated macrophages to polarize T cells toward Th1 cells and Th17 cells. Importantly, MBL supplement in vivo could ameliorate lupus nephritis. Conclusion/Significance: These results suggest MBL supplement could alleviate SLE disease and might imply a potential therapeutic strategy for DNA-induced SLE, which would further our understanding of the protective role of MBL in SLE disease.	[Cai, Yanxing; Zhang, Weijuan; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200433, Peoples R China; [Cai, Yanxing; Zhang, Weijuan; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China; [Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200433, Peoples R China.	sdxiongfd@126.com	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Natural Science Foundation of China [30890141, 81273300, 31100629, 31270863]; Major State Basic Research Development Program of China [2013CB530501]; Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu Provincial Innovative Research Team; Jiangsu "Pan-Deng" Project [BK2010004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1075]; Shanghai STC [10JC1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu Provincial Innovative Research Team; Jiangsu "Pan-Deng" Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai STC	This work was supported by grants from the National Natural Science Foundation of China (30890141, 81273300, 31100629, 31270863), Major State Basic Research Development Program of China (2013CB530501), Jiangsu "333" project of cultivation of high-level talents, Qing Lan Project of the Jiangsu higher education institutions, Jiangsu Provincial Innovative Research Team, Jiangsu "Pan-Deng" Project (BK2010004), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1075), Shanghai STC grant (10JC1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Bidaud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042396; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Csipo I, 2005, ARTHRITIS RHEUM-US, V52, P2950, DOI 10.1002/art.21245; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fraser DA, 2007, J BIOL CHEM, V282, P7360, DOI 10.1074/jbc.M605741200; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Gupta B, 2006, J AUTOIMMUN, V27, P125, DOI 10.1016/j.jaut.2006.07.002; Hoffmann MH, 2010, J AUTOIMMUN, V34, pJ178, DOI 10.1016/j.jaut.2009.11.013; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Ip WK, 1998, ARTHRITIS RHEUM-US, V41, P1663; Jack DL, 2001, J INFECT DIS, V184, P1152, DOI 10.1086/323803; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kristjansdottir H, 2008, ARTHRITIS RHEUM-US, V58, P3865, DOI 10.1002/art.24129; Lee YH, 2005, ARTHRITIS RHEUM-US, V52, P3966, DOI 10.1002/art.21484; Marzocchi-Machado CM, 2005, J AUTOIMMUN, V25, P289, DOI 10.1016/j.jaut.2005.06.004; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakamura N, 2009, J LEUKOCYTE BIOL, V86, P737, DOI 10.1189/jlb.1008674; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saevarsdottir S, 2007, CLIN EXP IMMUNOL, V148, P248, DOI 10.1111/j.1365-2249.2007.03349.x; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takahashi K, 1997, J IMMUNOL, V159, P1557; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Trouw LA, 2005, MOL IMMUNOL, V42, P731, DOI 10.1016/j.molimm.2004.09.024; Vinuesa CG, 2002, NATURE, V416, P595, DOI 10.1038/416595a; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	53	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62465	10.1371/journal.pone.0062465	http://dx.doi.org/10.1371/journal.pone.0062465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626823	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400187
J	Kandilci, A; Surtel, J; Janke, L; Neale, G; Terranova, S; Grosveld, GC				Kandilci, Ayten; Surtel, Jacqueline; Janke, Laura; Neale, Geoffrey; Terranova, Sabrina; Grosveld, Gerard C.			Mapping of MN1 Sequences Necessary for Myeloid Transformation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEUKEMIA; EXPRESSION; GENE; OVEREXPRESSION; ONCOGENE; DEFECTS; MN1-TEL; PROTEIN; FUSION	The MN1 oncogene is deregulated in human acute myeloid leukemia and its overexpression induces proliferation and represses myeloid differentiation of primitive human and mouse hematopoietic cells, leading to myeloid leukemia in mouse models. To delineate the sequences within MN1 necessary for MN1-induced leukemia, we tested the transforming capacity of in-frame deletion mutants, using retroviral transduction of mouse bone marrow. We found that integrity of the regions between amino acids 12 to 458 and 1119 to 1273 are required for MN1's in vivo transforming activity, generating myeloid leukemia with some mutants also producing T-cell lympho-leukemia and megakaryocytic leukemia. Although both full length MN1 and a mutant that lacks the residues between 12-228 (Delta 12-228 mutant) repressed myeloid differentiation and increased myeloproliferative activity in vitro, the mutant lost its transforming activity in vivo. Both MN1 and Delta 12-228 increased the frequency of common myeloid progentiors (CMP) in vitro and microarray comparisons of purified MN1-CMP and Delta 12-228-CMP cells showed many differentially expressed genes including Hoxa9, Meis1, Myb, Runx2, Cebpa, Cebpb and Cebpd. This collection of immediate MN1-responsive candidate genes distinguishes the leukemic activity from the in vitro myeloproliferative capacity of this oncoprotein.	[Kandilci, Ayten; Surtel, Jacqueline; Terranova, Sabrina; Grosveld, Gerard C.] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Janke, Laura] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Grosveld, GC (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	gerard.grosveld@stjude.org			National Cancer Institute [R01-CA72999]; The Cancer Center [CA021765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01-CA72999 (http://www.cancer.gov/researchandfundig/grantprocess), The Cancer Center (support grant CA021765), and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; BUIJS A, 1995, ONCOGENE, V10, P1511; Buijs A, 2000, MOL CELL BIOL, V20, P9281, DOI 10.1128/MCB.20.24.9281-9293.2000; Cardone M, 2005, MOL CELL BIOL, V25, P2395, DOI 10.1128/MCB.25.6.2395-2405.2005; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carella C, 2006, LEUKEMIA, V20, P1582, DOI 10.1038/sj.leu.2404298; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Heuser M, 2011, CANCER CELL, V20, P39, DOI 10.1016/j.ccr.2011.06.020; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kandilci A, 2009, BLOOD, V114, P1596, DOI 10.1182/blood-2009-02-205443; Kuo YH, 2009, BLOOD, V113, P3323, DOI 10.1182/blood-2008-06-162248; Liu T, 2010, LEUKEMIA, V24, P601, DOI 10.1038/leu.2009.272; Meester-Smoor MA, 2005, MOL CELL BIOL, V25, P4229, DOI 10.1128/MCB.25.10.4229-4236.2005; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61706	10.1371/journal.pone.0061706	http://dx.doi.org/10.1371/journal.pone.0061706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626719	Green Published, Green Submitted, gold			2022-12-25	WOS:000318008400083
J	Ayuso-Mateos, JL; Miret, M; Caballero, FF; Olaya, B; Haro, JM; Kowal, P; Chatterji, S				Luis Ayuso-Mateos, Jose; Miret, Marta; Felix Caballero, Francisco; Olaya, Beatriz; Maria Haro, Josep; Kowal, Paul; Chatterji, Somnath			Multi-Country Evaluation of Affective Experience: Validation of an Abbreviated Version of the Day Reconstruction Method in Seven Countries	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; POSITIVE AFFECT; LIFE	Background: The Day Reconstruction Method (DRM) was developed to assess affective states as measures of experienced well-being. The present study aimed to validate an abbreviated version of the DRM in a representative sample of the population in seven countries (China, Ghana, India, Mexico, Russia, South Africa, and Spain), and to examine whether there are country differences in affect and in the relationships among the activities based on the similarity of the affect associated with each of them. Methods: Interviews were conducted with 47,222 non-institutionalized adults from seven countries, using an abbreviated version of the DRM. A cluster analysis was carried out to classify activities on the basis of the similarity of the associated affect. In each country, the factorial structure of the affect adjectives was tested through Confirmatory Factor Analysis. Internal consistency and construct validity were also assessed. Moreover, the differences in affect across countries and the diurnal cycles of affect were evaluated. Results: The DRM showed adequate psychometric properties regarding reliability and construct validity in all countries. Respondents from Ghana and South Africa reported more positive net affect whereas Indian respondents reported less positive net affect. Most of the countries showed a similar diurnal variation of affect, which tended to improve throughout the day. Conclusions: The results show that this abbreviated version of the DRM is a useful tool for multi-country evaluation of experienced well-being.	[Luis Ayuso-Mateos, Jose; Miret, Marta; Felix Caballero, Francisco; Maria Haro, Josep] CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Luis Ayuso-Mateos, Jose; Miret, Marta; Felix Caballero, Francisco] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IP, Dept Psychiat, Madrid, Spain; [Luis Ayuso-Mateos, Jose; Miret, Marta; Felix Caballero, Francisco] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Olaya, Beatriz; Maria Haro, Josep] Univ Barcelona, Barcelona, Spain; [Kowal, Paul; Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid; University of Barcelona; World Health Organization; University of Newcastle	Chatterji, S (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	chatterjis@who.int	Miret, Marta/C-6103-2019; Olaya, Beatriz/AAB-1952-2020; CHATTERJI, Somnath/ABE-6832-2020; Haro, Josep Maria/D-1423-2011	Miret, Marta/0000-0003-3252-854X; Olaya, Beatriz/0000-0003-2046-3929; Haro, Josep Maria/0000-0002-3984-277X; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Kowal, Paul/0000-0002-6314-8753	United States National Institute on Aging's Division of Behavioral and Social Research [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; World Health Organization's Department of Health Statistics and Information Systems; European Community [223071]; Instituto de Salud Carlos III-FIS [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation ACI-Promociona [ACI2009-1010]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; European Community(European Commission); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation ACI-Promociona(Spanish Government); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This paper uses data from WHO SAGE and from COURAGE in Europe. WHO's Study on Global Ageing and Adult Health is supported by the United States National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479) and the World Health Organization's Department of Health Statistics and Information Systems. The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe), from the Instituto de Salud Carlos III-FIS research grants number PS09/00295 and PS09/01845, and from the Spanish Ministry of Science and Innovation ACI-Promociona (ACI2009-1010). The study was supported by the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM. The authors would like to acknowledge the principal investigators at the SAGE sites: P. Arokiasamy (India), R. Biritwum (Ghana), Wu Fan (China), R. Lopez Riadura (Mexico), T. Maximova (Russian Federation) and N. Phaswanamafuya (South Africa). The views expressed in this paper are those of the author(s) and do not necessarily represent the views or policies of the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bhattacharyya MR, 2008, PSYCHOSOM MED, V70, P1020, DOI 10.1097/PSY.0b013e318189afcc; Burnham K.P., 2011, MODEL SELECTION MULT, VNew ed; Bylsma LM, 2011, J ABNORM PSYCHOL, V120, P155, DOI 10.1037/a0021662; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; Dockray S, 2010, SOC INDIC RES, V99, P269, DOI 10.1007/s11205-010-9578-7; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Goss CH, 2009, J CYST FIBROS, V8, P245, DOI 10.1016/j.jcf.2009.04.003; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kopperud K. H., 2008, J POSIT PSYCHOL, V3, P174, DOI DOI 10.1080/17439760801999420; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Krueger AB, 2008, J PUBLIC ECON, V92, P1833, DOI 10.1016/j.jpubeco.2007.12.015; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Miret M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043887; Miron-Shatz T, 2009, EMOTION, V9, P206, DOI 10.1037/a0015295; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Oishi Shigehiro., 2010, INT DIFFERENCES WELL, P34, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0003; R Core Team, 2021, R LANG ENV STAT COMP; Raykov T., 2011, INTRO PSYCHOMETRIC T; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schumacker R.E., 2004, BEGINNERS GUIDE STRU, V2nd ed.; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Srivastava S, 2008, J RES PERS, V42, P1613, DOI 10.1016/j.jrp.2008.05.002; StataCorp, 2010, STAT STAT SOFTW REL; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Yu C.Y., 2002, EVALUATING CUTOFF CR	35	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61534	10.1371/journal.pone.0061534	http://dx.doi.org/10.1371/journal.pone.0061534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131QH	23626697	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400061
J	Menotti, J; Emmanuel, A; Bouchekouk, C; Chabe, M; Choukri, F; Pottier, M; Sarfati, C; Aliout, EM; Derouin, F				Menotti, Jean; Emmanuel, Alexandra; Bouchekouk, Chafia; Chabe, Magali; Choukri, Firas; Pottier, Muriel; Sarfati, Claudine; Aliout, El Moukhtar; Derouin, Francis			Evidence of Airborne Excretion of Pneumocystis carinii during Infection in Immunocompetent Rats. Lung Involvement and Antibody Response	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; F-SP MURIS; MOLECULAR EVIDENCE; INTERHUMAN TRANSMISSION; JIROVECI PNEUMONIA; OUTBREAK; HOSTS; AIR	To better understand the role of immunocompetent hosts in the diffusion of Pneumocystis in the environment, airborne shedding of Pneumocystis carinii in the surrounding air of experimentally infected Sprague Dawley rats was quantified by means of a real-time PCR assay, in parallel with the kinetics of P. carinii loads in lungs and specific serum antibody titres. Pneumocystis-free Sprague Dawley rats were intratracheally inoculated at day 0 (d0) and then followed for 60 days. P. carinii DNA was detected in lungs until d29 in two separate experiments and thereafter remained undetectable. A transient air excretion of Pneumocystis DNA was observed between d14 and d22 in the first experiment and between d9 and d19 in the second experiment; it was related to the peak of infection in lungs. IgM and IgG anti-P. carinii antibody increase preceded clearance of P. carinii in the lungs and cessation of airborne excretion. In rats receiving a second challenge 3 months after the first inoculation, Pneumocystis was only detected at a low level in the lungs of 2 of 3 rats at d2 post challenge and was never detected in air samples. Anti-Pneumocystis antibody determinations showed a typical secondary IgG antibody response. This study provides the first direct evidence that immunocompetent hosts can excrete Pneumocystis following a primary acquired infection. Lung infection was apparently controlled by the immune response since fungal burdens decreased to become undetectable as specific antibodies reached high titres in serum. This immune response was apparently protective against reinfection 3 months later.	[Menotti, Jean; Emmanuel, Alexandra; Bouchekouk, Chafia; Choukri, Firas; Sarfati, Claudine; Derouin, Francis] Paris Diderot Univ, Dept Parasitol Mycol, EA 3520, Paris, France; [Menotti, Jean; Emmanuel, Alexandra; Bouchekouk, Chafia; Choukri, Firas; Sarfati, Claudine; Derouin, Francis] Hop St Louis, AP HP, Paris, France; [Chabe, Magali; Pottier, Muriel; Aliout, El Moukhtar] Univ Lille, Inst Pasteur, INSERM U1019, CNRS UMR 8204,CIIL,BDEEP, Lille, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Menotti, J (corresponding author), Paris Diderot Univ, Dept Parasitol Mycol, EA 3520, Paris, France.	jean.menotti@sls.aphp.fr	Aliouat, El Moukhtar/D-2859-2018; EMMANUEL, Alexandra/L-9042-2019; Menotti, Jean/AFV-1886-2022; Chabe, Magali/H-6045-2017	Aliouat, El Moukhtar/0000-0003-2905-7126; EMMANUEL, Alexandra/0000-0003-0953-4220; Menotti, Jean/0000-0001-5703-8403; Chabe, Magali/0000-0002-6732-6772	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES) [EST/2011/1/053]; Chancellerie des Universites de Paris (legs Poix)	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES)(French National Research Agency (ANR)); Chancellerie des Universites de Paris (legs Poix)	This work was supported by the Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES, grant EST/2011/1/053) and by the Chancellerie des Universites de Paris (legs Poix). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; An CL, 2003, INFECT IMMUN, V71, P2065, DOI 10.1128/IAI.71.4.2065-2070.2003; Bollee G, 2007, CHEST, V132, P1305, DOI 10.1378/chest.07-0223; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Choukri F, 2011, J INFECT DIS, V203, P1333, DOI 10.1093/infdis/jir018; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; de Boer MGJ, 2007, CLIN INFECT DIS, V44, P1143, DOI 10.1086/513198; Dei-Cas E, 2000, MED MYCOL, V38, P23, DOI 10.1080/mmy.38.s1.23.32; Dei-Cas E, 2006, FEMS MICROBIOL REV, V30, P853, DOI 10.1111/j.1574-6976.2006.00037.x; Dumoulin A, 2000, EUR J CLIN MICROBIOL, V19, P671, DOI 10.1007/s100960000354; Garry S, 2003, MUTAT RES-GEN TOX EN, V538, P19, DOI 10.1016/S1383-5718(03)00082-2; Gianella S, 2010, TRANSPL INFECT DIS, V12, P1, DOI 10.1111/j.1399-3062.2009.00447.x; Gigliotti F, 2003, INFECT IMMUN, V71, P3852, DOI 10.1128/IAI.71.7.3852-3856.2003; Henderson KS, 2012, VET PATHOL, V49, P440, DOI 10.1177/0300985811432351; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; HUGHES WT, 1982, J INFECT DIS, V145, P842, DOI 10.1093/infdis/145.6.842; Larsen HH, 2007, EMERG INFECT DIS, V13, P66, DOI 10.3201/eid1301.060315; Le Gal S, 2012, CLIN INFECT DIS, V54, pE62, DOI 10.1093/cid/cir996; Livingston RS, 2011, COMPARATIVE MED, V61, P45; Martinez A, 2009, J EUKARYOT MICROBIOL, V56, P446, DOI 10.1111/j.1550-7408.2009.00423.x; Miller RF, 2001, J CLIN MICROBIOL, V39, P3877, DOI 10.1128/JCM.39.11.3877-3882.2001; Morris A, 2008, J INFECT DIS, V197, P10, DOI 10.1086/523814; Nevez G, 2001, J EUKARYOT MICROBIOL, p122S; Rabodonirina L, 2004, EMERG INFECT DIS, V10, P1766; Sanches EMC, 2007, MED MYCOL, V45, P395, DOI 10.1080/13693780701385876; Schmoldt S, 2008, J CLIN MICROBIOL, V46, P966, DOI 10.1128/JCM.02016-07; STAGNO S, 1980, PEDIATRICS, V66, P56; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Vestereng VH, 2004, J INFECT DIS, V189, P1540, DOI 10.1086/382486	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62155	10.1371/journal.pone.0062155	http://dx.doi.org/10.1371/journal.pone.0062155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626781	Green Submitted, Green Published, gold			2022-12-25	WOS:000318008400145
J	Senf, SM; Howard, TM; Ahn, B; Ferreira, LF; Judge, AR				Senf, Sarah M.; Howard, Travis M.; Ahn, Bumsoo; Ferreira, Leonardo F.; Judge, Andrew R.			Loss of the Inducible Hsp70 Delays the Inflammatory Response to Skeletal Muscle Injury and Severely Impairs Muscle Regeneration	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; IN-VIVO; MOLECULAR CHAPERONES; CONTRACTILE ACTIVITY; MUSCULAR-DYSTROPHY; ADAPTIVE IMMUNITY; STRESS; HEAT-SHOCK-PROTEIN-70	Skeletal muscle regeneration following injury is a highly coordinated process that involves transient muscle inflammation, removal of necrotic cellular debris and subsequent replacement of damaged myofibers through secondary myogenesis. However, the molecular mechanisms which coordinate these events are only beginning to be defined. In the current study we demonstrate that Heat shock protein 70 (Hsp70) is increased following muscle injury, and is necessary for the normal sequence of events following severe injury induced by cardiotoxin, and physiological injury induced by modified muscle use. Indeed, Hsp70 ablated mice showed a significantly delayed inflammatory response to muscle injury induced by cardiotoxin, with nearly undetected levels of both neutrophil and macrophage markers 24 hours post-injury. At later time points, Hsp70 ablated mice showed sustained muscle inflammation and necrosis, calcium deposition and impaired fiber regeneration that persisted several weeks post-injury. Through rescue experiments reintroducing Hsp70 intracellular expression plasmids into muscles of Hsp70 ablated mice either prior to injury or post-injury, we confirm that Hsp70 optimally promotes muscle regeneration when expressed during both the inflammatory phase that predominates in the first four days following severe injury and the regenerative phase that predominates thereafter. Additional rescue experiments reintroducing Hsp70 protein into the extracellular microenvironment of injured muscles at the onset of injury provides further evidence that Hsp70 released from damaged muscle may drive the early inflammatory response to injury. Importantly, following induction of physiological injury through muscle reloading following a period of muscle disuse, reduced inflammation in 3-day reloaded muscles of Hsp70 ablated mice was associated with preservation of myofibers, and increased muscle force production at later time points compared to WT. Collectively our findings indicate that depending on the nature and severity of muscle injury, therapeutics which differentially target both intracellular and extracellular localized Hsp70 may optimally preserve muscle tissue and promote muscle functional recovery.	[Senf, Sarah M.; Howard, Travis M.; Judge, Andrew R.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32610 USA; [Ahn, Bumsoo; Ferreira, Leonardo F.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Senf, SM (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32610 USA.	smsenf@ufl.edu	Ahn, Bumsoo/GNP-7749-2022; Ahn, Bumsoo/AAK-3818-2021	Ahn, Bumsoo/0000-0002-2743-7099; Ferreira, Leonardo/0000-0001-6581-5882; Judge, Sarah/0000-0002-3974-0247	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R03AR056418, R01AR060209]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060209, R03AR056418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R03AR056418 and R01AR060209 (to A.R.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea Alexzander, 2008, V183, P111; Asea A, 2007, J BIOSCIENCES, V32, P579, DOI 10.1007/s12038-007-0057-5; Bausero MA, 2005, J IMMUNOL, V175, P2900, DOI 10.4049/jimmunol.175.5.2900; Brickson S, 2003, J APPL PHYSIOL, V95, P969, DOI 10.1152/japplphysiol.00005.2003; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chen TY, 2010, EUR J IMMUNOL, V40, P1541, DOI 10.1002/eji.201040616; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Dix DJ, 1998, MOL REPROD DEV, V51, P373, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;373::AID-MRD3&gt;3.0.CO;2-E; Dumont N, 2008, AM J PHYSIOL-REG I, V295, pR1831, DOI 10.1152/ajpregu.90318.2008; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Ferreira LF, 2011, MED SCI SPORT EXER, V43, P1025, DOI 10.1249/MSS.0b013e3182019a78; Ferreira LF, 2010, AM J PHYSIOL-CELL PH, V299, pC552, DOI 10.1152/ajpcell.00065.2010; Foster WH, 2012, MUSCLE NERVE, V45, P266, DOI 10.1002/mus.22289; Frimel TN, 2005, MUSCLE NERVE, V32, P605, DOI 10.1002/mus.20398; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; Giraldo E, 2010, EUR J APPL PHYSIOL, V108, P217, DOI 10.1007/s00421-009-1201-8; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Kimura F, 2004, AM J SURG, V187, P777, DOI 10.1016/j.amjsurg.2003.08.029; Kovalchin JT, 2006, WOUND REPAIR REGEN, V14, P129, DOI 10.1111/j.1743-6109.2006.00102.x; McArdle A, 2003, FASEB J, V17, P355, DOI 10.1096/fj.03-0395fje; McArdle A, 2002, AGEING RES REV, V1, P79, DOI 10.1016/S0047-6374(01)00368-2; Miyabara EH, 2006, AM J PHYSIOL-CELL PH, V290, pC1128, DOI 10.1152/ajpcell.00399.2005; Miyabara EH, PFLUGERS ARCH, V463, P733; Moresi V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005570; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Nguyen HX, 2005, J PHYSIOL-LONDON, V565, P403, DOI 10.1113/jphysiol.2005.085506; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; Oishi Y, 2003, JPN J PHYSIOL, V53, P281, DOI 10.2170/jjphysiol.53.281; Ortega E, 2009, STRESS, V12, P240, DOI 10.1080/10253890802309853; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patel H, 2012, CARDIOL RES PRACT; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Pizza FX, 1998, J LEUKOCYTE BIOL, V64, P427, DOI 10.1002/jlb.64.4.427; Prohaszka Z, 2002, CELL STRESS CHAPERON, V7, P17, DOI 10.1379/1466-1268(2002)007<0017:HSPIAP>2.0.CO;2; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Reed SA, FASEB J; Salomonsson S, 2006, AUTOIMMUNITY, V39, P177, DOI 10.1080/08916930600622256; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schiaffino S, SKELET MUSCLE, V1, P4; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2009, AM J PHYSL CELL PHYS; Senf SM, METHODS MOL BIOL, V798, P461; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Taillandier D, 2004, P NUTR SOC, V63, P357, DOI 10.1079/PAR2004358; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Vasilaki A, 2002, MUSCLE NERVE, V25, P902, DOI 10.1002/mus.10094; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Zerria K, 2006, IMMUNOLOGY, V119, P431, DOI 10.1111/j.1365-2567.2006.02454.x	69	78	79	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e62687	10.1371/journal.pone.0062687	http://dx.doi.org/10.1371/journal.pone.0062687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626847	Green Published, gold, Green Submitted			2022-12-25	WOS:000318008400211
J	Cheng, CY; Zhou, ZX; Nikitin, AY				Cheng, Chieh-Yang; Zhou, Zongxiang; Nikitin, Alexander Yu			Detection and Organ-Specific Ablation of Neuroendocrine Cells by Synaptophysin Locus-Based BAC Cassette in Transgenic Mice	PLOS ONE			English	Article							METASTATIC PROSTATE-CANCER; NEURON-SPECIFIC ENOLASE; L-DOPA DECARBOXYLASE; MOUSE PROSTATE; PROXIMAL REGION; GENE-EXPRESSION; ADRENAL-MEDULLA; RB DEFICIENCY; STEM-CELLS; MODEL	The role of cells of the diffuse neuroendocrine system in development and maintenance of individual organs and tissues remains poorly understood. Here we identify a regulatory region sufficient for accurate in vivo expression of synaptophysin (SYP), a common marker of neuroendocrine differentiation, and report generation of Tg(Syp-EGFP(loxP)-DTA) 147(Ayn) (SypELDTA) mice suitable for flexible organ-specific ablation of neuroendocrine cells. These mice express EGFP and diphtheria toxin fragment A (DTA) in SYP positive cells before and after Cre-loxP mediated recombination, respectively. As a proof of principle, we have crossed SypELDTA mice with EIIA-Cre and PB-Cre4 mice. EIIA-Cre mice express Cre recombinase in a broad range of tissues, while PB-Cre4 mice specifically express Cre recombinase in the prostate epithelium. Double transgenic EIIA-Cre; SypELDTA embryos exhibited massive cell death in SYP positive cells. At the same time, PB-Cre4; SypELDTA mice showed a substantial decrease in the number of neuroendocrine cells and associated prostate hypotrophy. As no increase in cell death and/or Cre-loxP mediated recombination was observed in non-neuroendocrine epithelium cells, these results suggest that neuroendocrine cells play an important role in prostate development. High cell type specificity of Syp locus-based cassette and versatility of generated mouse model should assure applicability of these resources to studies of neuroendocrine cell functions in various tissues and organs.	[Cheng, Chieh-Yang; Zhou, Zongxiang; Nikitin, Alexander Yu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA	Cornell University	Nikitin, AY (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	an58@cornell.edu			Cornell Comparative Cancer Biology Training Program;  [NIH R01CA096823]; NATIONAL CANCER INSTITUTE [R01CA096823] Funding Source: NIH RePORTER	Cornell Comparative Cancer Biology Training Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grant NIH R01CA096823 to AYN and fellowship funding from the Cornell Comparative Cancer Biology Training Program to CYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DE, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r79; Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; BARGOU RCEF, 1991, GENE, V99, P197, DOI 10.1016/0378-1119(91)90127-W; CADIEUX A, 1986, NEUROSCIENCE, V19, P605, DOI 10.1016/0306-4522(86)90285-X; CHANG MP, 1989, J BIOL CHEM, V264, P15261; CHANG MP, 1989, SCIENCE, V246, P1165, DOI 10.1126/science.2531465; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng CY, 2011, CELL CYCLE, V10, P3629, DOI 10.4161/cc.10.21.18034; de Diego AMG, 2008, ACTA PHYSIOL, V192, P287, DOI 10.1111/j.1748-1716.2007.01807.x; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; DISANTAGNESE PA, 1989, ARCH PATHOL LAB MED, V113, P790; Dockray G, 2003, SCAND J GASTROENTERO, V38, P451, DOI 10.1080/00365520310000799; Douglas SA, 2010, CELL MOL NEUROBIOL, V30, P1467, DOI 10.1007/s10571-010-9593-x; GAZDAR AF, 1988, CANCER RES, V48, P4078; GOULD VE, 1987, AM J PATHOL, V126, P243; Gustafsson BI, 2008, CURR OPIN ONCOL, V20, P1, DOI 10.1097/CCO.0b013e3282f1c595; HAIMOTO H, 1985, LAB INVEST, V52, P257; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; JENSEN SM, 1990, CANCER RES, V50, P6068; JIN L, 1991, AM J PATHOL, V138, P961; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kaufmann O, 1997, HUM PATHOL, V28, P1373, DOI 10.1016/S0046-8177(97)90226-4; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; Kuliczkowska-Plaksej J, 2012, GYNECOL ENDOCRINOL, V28, P27, DOI 10.3109/09513590.2012.651930; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lantuejoul S, 1998, AM J SURG PATHOL, V22, P1267, DOI 10.1097/00000478-199810000-00012; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Masumori N, 2001, CANCER RES, V61, P2239; Montuenga LM, 2003, PROG HISTOCHEM CYTO, V38, P155; Mravec B, 2005, AUTON NEUROSCI-BASIC, V120, P10, DOI 10.1016/j.autneu.2005.04.005; Nikitin AY, 1996, GENE DEV, V10, P1870, DOI 10.1101/gad.10.15.1870; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; SCHMECHEL DE, 1985, LAB INVEST, V52, P239; SESHI B, 1988, AM J PATHOL, V131, P258; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Sun Y, 2009, AM J TRANSL RES, V1, P148; SUNDAY ME, 1988, LAB INVEST, V59, P5; TACHIBANA T, 1995, ARCH HISTOL CYTOL, V58, P379, DOI 10.1679/aohc.58.379; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weichselbaum M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-115; WIEDENMANN B, 1986, P NATL ACAD SCI USA, V83, P3500, DOI 10.1073/pnas.83.10.3500; WONG SC, 1995, J NEUROCHEM, V65, P23; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e60905	10.1371/journal.pone.0060905	http://dx.doi.org/10.1371/journal.pone.0060905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630575	gold, Green Published, Green Submitted			2022-12-25	WOS:000317911500009
J	Hagiwara, H; Iyo, M; Hashimoto, K				Hagiwara, Hiroko; Iyo, Masaomi; Hashimoto, Kenji			Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine	PLOS ONE			English	Article							AMINO-ACID OXIDASE; INDUCED COGNITIVE DEFICITS; PREPULSE INHIBITION DEFICITS; RAT-BRAIN; NEGATIVE SYMPTOMS; CEREBROSPINAL-FLUID; MODULATORY SITE; HIGH-RISK; GENE G72; NMDA	Background: D-Serine, an endogenous co-agonist of the N-methyl-D-aspartate (NMDA) receptor, is synthesized from L-serine by serine racemase (SRR). Given the role of D-serine in both neurodevelopment and the pathophysiology of schizophrenia, we examined whether neonatal disruption of D-serine synthesis by SRR inhibition could induce behavioral abnormalities relevant to schizophrenia, in later life. Methodology/Principal Findings: Neonatal mice (7-9 days) were injected with vehicle or phenazine methosulfate (Met-Phen: 3 mg/kg/day), an SRR inhibitor. Behavioral evaluations, such as spontaneous locomotion, novel object recognition test (NORT), and prepulse inhibition (PPI) were performed at juvenile (5-6 weeks old) and adult (10-12 weeks old) stages. In addition, we tested the effects of D-serine on PPI deficits in adult mice after neonatal Met-Phen exposure. Finally, we assessed whether D-serine could prevent the onset of schizophrenia-like behavior in these mice. Neonatal Met-Phen treatment reduced D-serine levels in the brain, 24 hours after the final dose. Additionally, this treatment caused behavioral abnormalities relevant to prodromal symptoms in juveniles and to schizophrenia in adults. A single dose of D-serine improved PPI deficits in adult mice. Interestingly, chronic administration of D-serine (900 mg/kg/day from P35 to P70) significantly prevented the onset of PPI deficits after neonatal Met-Phen exposure. Conclusions/Significance: This study shows that disruption of D-serine synthesis during developmental stages leads to behavioral abnormalities relevant to prodromal symptoms and schizophrenia, in later life. Furthermore, early pharmacological intervention with D-serine may prevent the onset of psychosis in adult.	[Hagiwara, Hiroko; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Hagiwara, Hiroko; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Minister of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Minister of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Minister of Education, Culture, Sports, Science, and Technology of Japan (to KH), and a Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Ferraris DV, 2011, CURR PHARM DESIGN, V17, P103; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2005, EUR J PHARMACOL, V519, P114, DOI 10.1016/j.ejphar.2005.07.002; Hashimoto K, 2013, EUR ARCH PSYCHI 0301; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2008, EUR NEUROPSYCHOPHARM, V18, P414, DOI 10.1016/j.euroneuro.2007.07.009; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-6; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2008, Biol Psychiatry, V64, pe1, DOI 10.1016/j.biopsych.2008.06.025; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hashimoto K, 2009, BIOL PSYCHIAT, V65, P1103, DOI 10.1016/j.biopsych.2009.01.002; Heresco-Levy U, 2005, BIOL PSYCHIAT, V57, P577, DOI 10.1016/j.biopsych.2004.12.037; Horio M, 2012, BIOL PSYCHI IN PRESS; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Javitt DC, 2004, SCI AM, V290, P48, DOI 10.1038/scientificamerican0104-48; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Krystal JH, 1999, HARVARD REV PSYCHIAT, V7, P125, DOI 10.1093/hrp/7.3.125; Kvajo M, 2008, MOL PSYCHIATR, V13, P685, DOI 10.1038/sj.mp.4002052; Labrie V, 2012, NEUROPHARMACOLOGY, V62, P1484, DOI 10.1016/j.neuropharm.2011.01.030; Lencz T, 2004, SCHIZOPHR RES, V68, P37, DOI 10.1016/S0920-9964(03)00214-7; Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Maekawa M, 2010, J NEUROCHEM, V115, P1374, DOI 10.1111/j.1471-4159.2010.07039.x; Mandillo S, 2003, BEHAV PHARMACOL, V14, P533, DOI 10.1097/00008877-200311000-00006; Matsuzawa D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001944; Matsuzawa D, 2011, ANTIOXID REDOX SIGN, V15, P2057, DOI 10.1089/ars.2010.3453; McGorry PD, 2009, J CLIN PSYCHIAT, V70, P1206, DOI 10.4088/JCP.08r04472; McGrath JJ, 2003, ANN MED, V35, P86, DOI 10.1080/07853890310010005; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Sabbag R, 2011, ISR J PSYCHIATR REL, V48, P82; Sams-Dodd F, 1998, NEUROPSYCHOPHARMACOL, V19, P18; Schell MJ, 1997, J NEUROSCI, V17, P1604; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Tsai GE, 2010, CURR PHARM DESIGN, V16, P522, DOI 10.2174/138161210790361452; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2012, AMINO ACIDS, V43, P1895, DOI 10.1007/s00726-012-1370-3; Woods SW, 2013, EUR NEUROPSYCHOPHARM, V23, P931, DOI 10.1016/j.euroneuro.2012.09.008; Wyatt RJ, 1996, ARCH GEN PSYCHIAT, V53, P11; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018; Zakzanis KK, 1998, SCHIZOPHR RES, V29, P227, DOI 10.1016/S0920-9964(97)00102-3; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; 갠지하시모토, 2006, Clinical Psychopharmacology and Neuroscience, V4, P3	69	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62438	10.1371/journal.pone.0062438	http://dx.doi.org/10.1371/journal.pone.0062438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630632	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500089
J	Peltier, H; Baagoe, HJ; Camphuysen, KCJ; Czeck, R; Dabin, W; Daniel, P; Deaville, R; Haelters, J; Jauniaux, T; Jensen, LF; Jepson, PD; Keijl, GO; Siebert, U; Van Canneyt, O; Ridoux, V				Peltier, Helene; Baagoe, Hans J.; Camphuysen, Kees C. J.; Czeck, Richard; Dabin, Willy; Daniel, Pierre; Deaville, Rob; Haelters, Jan; Jauniaux, Thierry; Jensen, Lasse F.; Jepson, Paul D.; Keijl, Guido O.; Siebert, Ursula; Van Canneyt, Olivier; Ridoux, Vincent			The Stranding Anomaly as Population Indicator: The Case of Harbour Porpoise Phocoena phocoena in North-Western Europe	PLOS ONE			English	Article							ECOLOGICAL INDICATORS; TOP PREDATORS; POSTMORTEM FINDINGS; NULL HYPOTHESES; GERMAN WATERS; BY-CATCH; SEA; CETACEANS; MORTALITY; CARCASSES	Ecological indicators for monitoring strategies are expected to combine three major characteristics: ecological significance, statistical credibility, and cost-effectiveness. Strategies based on stranding networks rank highly in cost-effectiveness, but their ecological significance and statistical credibility are disputed. Our present goal is to improve the value of stranding data as population indicator as part of monitoring strategies by constructing the spatial and temporal null hypothesis for strandings. The null hypothesis is defined as: small cetacean distribution and mortality are uniform in space and constant in time. We used a drift model to map stranding probabilities and predict stranding patterns of cetacean carcasses under H-0 across the North Sea, the Channel and the Bay of Biscay, for the period 1990-2009. As the most common cetacean occurring in this area, we chose the harbour porpoise Phocoena phocoena for our modelling. The difference between these strandings expected under H-0 and observed strandings is defined as the stranding anomaly. It constituted the stranding data series corrected for drift conditions. Seasonal decomposition of stranding anomaly suggested that drift conditions did not explain observed seasonal variations of porpoise strandings. Long-term stranding anomalies increased first in the southern North Sea, the Channel and Bay of Biscay coasts, and finally the eastern North Sea. The hypothesis of changes in porpoise distribution was consistent with local visual surveys, mostly SCANS surveys (1994 and 2005). This new indicator could be applied to cetacean populations across the world and more widely to marine megafauna.	[Peltier, Helene; Ridoux, Vincent] Univ La Rochelle, Lab Littoral Environm & Soc, UMR 7266, La Rochelle, France; [Peltier, Helene; Dabin, Willy; Van Canneyt, Olivier; Ridoux, Vincent] Univ La Rochelle, CNRS, Observ PELAGIS, UMS 3462, La Rochelle, France; [Baagoe, Hans J.] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark; [Camphuysen, Kees C. J.] Royal Netherlands Inst Sea Res NIOZ, Marine Ecol Dept, Texel, Netherlands; [Czeck, Richard] Wadden Sea Natl Pk Author Lower Saxony, Wilhelmshaven, Germany; [Daniel, Pierre] Meteo France, Dprevi MAR, Toulouse, France; [Deaville, Rob; Jepson, Paul D.] Zool Soc London, Inst Zool, Cetacean Strandings Invest Programme, London NW1 4RY, England; [Haelters, Jan; Jauniaux, Thierry] Royal Belgian Inst Nat Sci RBINS, Management Unit North Sea Math Models MUMM, Oostende, Belgium; [Jauniaux, Thierry] Univ Liege, Vet Coll, Dept Pathol, Liege, Belgium; [Jensen, Lasse F.] Fisheries & Maritime Museum, Esbjerg, Denmark; [Keijl, Guido O.] Nat Biodivers Ctr, Leiden, Netherlands; [Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; University of Copenhagen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Meteo France; Zoological Society of London; Royal Belgian Institute of Natural Sciences; University of Liege; Naturalis Biodiversity Center; University of Veterinary Medicine Hannover, Foundation	Peltier, H (corresponding author), Univ La Rochelle, Lab Littoral Environm & Soc, UMR 7266, La Rochelle, France.	hpeltier@univ-lr.fr		Ridoux, Vincent/0000-0002-9779-9319	CNRS/Region Poitou Charentes; Ministere de l'Ecologie, du Developpement Durable et de l'Energie; Communaute d'Agglomeration de la Ville de La Rochelle; Region Poitou-Charentes; European Union; Centre National de la Recherche Scientifique; Defra in England; Devolved Administrations in Scotland; Devolved Administrations in Wales; Royal Belgian Institute of Natural Sciences; Belgian Science Policy; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; German Federal Ministry for Education and Research; Ministry of Environment, Nature Conservation and Agriculture of Schleswig-Holstein	CNRS/Region Poitou Charentes(Centre National de la Recherche Scientifique (CNRS)Region Nouvelle-Aquitaine); Ministere de l'Ecologie, du Developpement Durable et de l'Energie; Communaute d'Agglomeration de la Ville de La Rochelle; Region Poitou-Charentes(Region Nouvelle-Aquitaine); European Union(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Defra in England; Devolved Administrations in Scotland; Devolved Administrations in Wales; Royal Belgian Institute of Natural Sciences; Belgian Science Policy(Belgian Federal Science Policy Office); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Environment, Nature Conservation and Agriculture of Schleswig-Holstein	This work was funded by a PhD grant (CNRS/Region Poitou Charentes), and hosted by the University of La Rochelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PELAGIS Observatory thanks all members of the French stranding network for their continuous effort in collecting stranding data. PELAGIS Observatory is funded by Ministere de l'Ecologie, du Developpement Durable et de l'Energie, and by Communaute d'Agglomeration de la Ville de La Rochelle, with support of Region Poitou-Charentes and the European Union. The PhD thesis of H. Peltier was supported by the Centre National de la Recherche Scientifique and by Region Poitou-Charentes.; The UK Cetacean Strandings Investigation Programme is funded by Defra in England and the Devolved Administrations in Scotland and Wales.; The Belgian strandings intervention network is supported by the Royal Belgian Institute of Natural Sciences and by the Belgian Science Policy; Data from Schleswig-Holstein, Germany were collected partly funded by the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety, the German Federal Ministry for Education and Research and the Ministry of Environment, Nature Conservation and Agriculture of Schleswig-Holstein. We would like to thank Marion Rademaker and Dr. Andreas Ruser for the data handling and all involved persons for the collection of data. Data from Lower-Saxony, Germany were extracted from a database of stranded animals, held at the Nationalpark Administration Wadden Sea of Lower Saxony, Wilhelmshaven.	Asseburg C, 2006, CONSERV BIOL SER, P262, DOI 10.1017/CBO9780511541964.019; Beineke A, 2005, ENVIRON SCI TECHNOL, V39, P3933, DOI 10.1021/es048709j; Bennett PM, 2001, ENVIRON POLLUT, V112, P33, DOI 10.1016/S0269-7491(00)00105-6; BIBBY CJ, 1977, BIOL CONSERV, V12, P295, DOI 10.1016/0006-3207(77)90048-9; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.1017/CBO9780511541964.002; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Camphuysen Kees C. J., 2008, Lutra, V51, P87; Caughlan L., 2001, ECOL INDIC, V1, DOI [10.1016/S1470-160X(01)00015-2, DOI 10.1016/S1470-160X(01)00015-2]; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Coelingh JP, 1996, J WIND ENG IND AEROD, V61, P51, DOI 10.1016/0167-6105(96)00043-8; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Daniel P, 2002, SPILL SCI TECHNOL B, V7, P279, DOI 10.1016/S1353-2561(02)00075-0; de Azevedo MCC, 2006, ESTUAR COAST SHELF S, V66, P315, DOI 10.1016/j.ecss.2005.09.006; DEGANGE AR, 1994, MAR MAMMAL SCI, V10, P492, DOI 10.1111/j.1748-7692.1994.tb00509.x; Elzinga C. L., 2001, MONITORING PLANT ANI; Epperly SP, 1996, B MAR SCI, V59, P289; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Garshelis DL, 1997, CONSERV BIOL, V11, P905, DOI 10.1046/j.1523-1739.1997.96062.x; Geraci JR., 2005, MARINE MAMMALS ASHOR; Gilles A, 2009, MAR ECOL PROG SER, V383, P295, DOI 10.3354/meps08020; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hammond PS, 2013, BIOL CONSER IN PRESS; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herr H, 2009, BIOL CONSERV, V142, P2962, DOI 10.1016/j.biocon.2009.07.025; HLADY DA, 1993, MAR POLLUT BULL, V26, P495, DOI 10.1016/0025-326X(93)90466-W; Hoyt E., 2005, MARINE PROTECTED ARE; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iverson SJ, 2006, CONSERV BIOL SER, P98, DOI 10.1017/CBO9780511541964.008; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; JEFFERSON TA, 1994, BIOL CONSERV, V67, P167, DOI 10.1016/0006-3207(94)90363-8; Jepson PD, 1999, SCI TOTAL ENVIRON, V243, P339, DOI 10.1016/S0048-9697(99)00417-9; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Kirkwood JK, 1997, VET REC, V141, P94, DOI 10.1136/vr.141.4.94; Kiszka J, 2007, ICES J MAR SCI, V64, P1033, DOI 10.1093/icesjms/fsm067; Koch V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056776; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Macleod CD, 2009, J MAR BIOL ASSOC UK, V89, P1059, DOI 10.1017/S0025315408002828; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; Muller F, 2006, ECOL INDIC, V6, P1, DOI 10.1016/j.ecolind.2005.08.001; Osinga N, 2008, EUR J WILDLIFE RES, V54, P667, DOI 10.1007/s10344-008-0193-8; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Pierce GJ, 2008, ENVIRON POLLUT, V153, P401, DOI 10.1016/j.envpol.2007.08.019; Pyenson ND, 2011, P ROY SOC B-BIOL SCI, V278, P3608, DOI 10.1098/rspb.2011.0441; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; Robinson Kevin P., 2007, Lutra, V50, P19; Schiller A, 2001, CONSERV ECOL, V5; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; STRONG DR, 1980, SYNTHESE, V43, P271, DOI 10.1007/BF00413928; TENHINDS W, 1984, ENVIRON CONSERV, V11, P11, DOI 10.1017/S0376892900013448; Thomsen F, 2006, HELGOLAND MAR RES, V60, P189, DOI 10.1007/s10152-006-0021-z; Tregenza NJC, 1997, ICES J MAR SCI, V54, P896, DOI 10.1006/jmsc.1996.0212; Turnhout E, 2007, ECOL INDIC, V7, P215, DOI 10.1016/j.ecolind.2005.12.003; Vinther Morten, 1999, Journal of Cetacean Research and Management, V1, P123; Wallach AD, 2009, BIOL CONSERV, V142, P43, DOI 10.1016/j.biocon.2008.09.021; Weijs L, 2009, ENVIRON POLLUT, V157, P437, DOI 10.1016/j.envpol.2008.09.024; Weir CR, 2007, J MAR BIOL ASSOC UK, V87, P327, DOI 10.1017/S0025315407052721; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Zeileis A., 2002, J STAT SOFTW, V7, P1, DOI [DOI 10.18637/JSS.V007.I02, 10.18637/jss.v007.i02]	68	47	50	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62180	10.1371/journal.pone.0062180	http://dx.doi.org/10.1371/journal.pone.0062180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23614031	Green Published, gold			2022-12-25	WOS:000317911500084
J	Salahinejad, E; Hadianfard, MJ; Macdonald, DD; Sharifi-Asl, S; Mozafari, M; Walker, KJ; Rad, AT; Madihally, SV; Tayebi, L				Salahinejad, Erfan; Hadianfard, Mohammad Jafar; Macdonald, Digby Donald; Sharifi-Asl, Samin; Mozafari, Masoud; Walker, Kenneth J.; Rad, Armin Tahmasbi; Madihally, Sundararajan V.; Tayebi, Lobat			In Vitro Electrochemical Corrosion and Cell Viability Studies on Nickel-Free Stainless Steel Orthopedic Implants	PLOS ONE			English	Article							NITROGEN; BEHAVIOR; RESISTANCE	The corrosion and cell viability behaviors of nanostructured, nickel-free stainless steel implants were studied and compared with AISI 316L. The electrochemical studies were conducted by potentiodynamic polarization and electrochemical impedance spectroscopic measurements in a simulated body fluid. Cytocompatibility was also evaluated by the adhesion behavior of adult human stem cells on the surface of the samples. According to the results, the electrochemical behavior is affected by a compromise among the specimen's structural characteristics, comprising composition, density, and grain size. The cell viability is interpreted by considering the results of the electrochemical impedance spectroscopic experiments.	[Salahinejad, Erfan; Hadianfard, Mohammad Jafar] Shiraz Univ, Sch Engn, Dept Mat Sci & Engn, Shiraz, Iran; [Salahinejad, Erfan; Macdonald, Digby Donald; Sharifi-Asl, Samin; Mozafari, Masoud] Penn State Univ, Dept Mat Sci & Engn, Ctr Electrochem Sci & Technol, University Pk, PA 16802 USA; [Salahinejad, Erfan; Mozafari, Masoud; Rad, Armin Tahmasbi; Tayebi, Lobat] Oklahoma State Univ, Helmerich Adv Technol Res Ctr, Sch Mat Sci & Engn, Tulsa, OK USA; [Macdonald, Digby Donald] King Fahd Univ Petr & Minerals, Ctr Res Excellence Corros, Dhahran 31261, Saudi Arabia; [Walker, Kenneth J.; Madihally, Sundararajan V.; Tayebi, Lobat] Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA	Shiraz University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oklahoma State University System; Oklahoma State University - Tulsa; King Fahd University of Petroleum & Minerals; Oklahoma State University System; Oklahoma State University - Stillwater	Tayebi, L (corresponding author), Oklahoma State Univ, Helmerich Adv Technol Res Ctr, Sch Mat Sci & Engn, Tulsa, OK USA.	lobat.tayebi@okstate.edu	Mozafari, Masoud/I-3061-2013; hadianfard, m.j./S-4440-2019; Madihally, Sundararajan/D-9285-2012; Sharifi-Asl, Samin/P-3854-2018; Salahinejad, Erfan/AAE-6221-2020	Mozafari, Masoud/0000-0002-0232-352X; Madihally, Sundararajan/0000-0001-7498-5760; Sharifi-Asl, Samin/0000-0002-9390-3035; Salahinejad, Erfan/0000-0002-6610-2021; Tahmasbi Rad, Morva/0000-0003-2883-523X; Hadianfard, Mohammad Jafar/0000-0001-5746-6432	Oklahoma Center for Advancement of Science and Technology [HR12-023]	Oklahoma Center for Advancement of Science and Technology	This work was supported by the Oklahoma Center for Advancement of Science and Technology under Grant no. HR12-023. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addari D, 2008, ELECTROCHIM ACTA, V53, P8078, DOI 10.1016/j.electacta.2008.06.007; Baba H, 2002, CORROS SCI, V44, P2393, DOI 10.1016/S0010-938X(02)00040-9; Buhagiar J, 2010, SURF COAT TECH, V205, P388, DOI 10.1016/j.surfcoat.2010.06.062; Carnot A, 2003, CORROS SCI, V45, P2513, DOI 10.1016/S0010-938X(03)00076-3; Elsener B, 2011, ELECTROCHIM ACTA, V56, P4489, DOI 10.1016/j.electacta.2011.02.049; Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2; Fu Y, 2009, ELECTROCHIM ACTA, V54, P4005, DOI 10.1016/j.electacta.2009.02.024; German RM, 1994, POWDER METALLURGY SC, P99; Hitz C, 2001, J ELECTROANAL CHEM, V500, P213, DOI 10.1016/S0022-0728(00)00317-X; Iyer P, 2012, BIOTECHNOL BIOENG, V109, P1314, DOI 10.1002/bit.24396; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Liu L, 2007, ELECTROCHIM ACTA, V52, P2392, DOI 10.1016/j.electacta.2006.08.070; Liu L, 2010, J MATER SCI TECHNOL, V26, P1, DOI 10.1016/S1005-0302(10)60001-1; Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001; Macdonald DD, 2012, ARAB J SCI ENG, V37, P1143, DOI 10.1007/s13369-012-0281-7; Macdonald DD, 2011, ELECTROCHIM ACTA, V56, P7411, DOI 10.1016/j.electacta.2011.05.031; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Montanaro L, 2006, J MATER SCI-MATER M, V17, P267, DOI 10.1007/s10856-006-7313-3; PAWEL SJ, 1989, CORROSION, V45, P125, DOI 10.5006/1.3577829; Ren YB, 2007, KEY ENG MATER, V342-343, P605, DOI 10.4028/www.scientific.net/KEM.342-343.605; Salahinejad E, 2012, MAT SCI ENG C-MATER, V32, P2215, DOI 10.1016/j.msec.2012.06.004; Salahinejad E, 2012, MATER LETT, V74, P209, DOI 10.1016/j.matlet.2012.01.118; Salahinejad E, 2012, METALL MATER TRANS A, V43A, P2994, DOI 10.1007/s11661-012-1186-5; Samal E., 2007, POWDER METALLURGY ST, P59, DOI [10.1361/pmss2007p001, DOI 10.1361/PMSS2007P001]; Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9; Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5; VANINI AS, 1994, CORROS SCI, V36, P1825, DOI 10.1016/0010-938X(94)90021-3; Jaimes RFVV, 2010, MATER LETT, V64, P1476, DOI 10.1016/j.matlet.2010.03.066; Villamil RFV, 2003, AM SOC TEST MATER, V1438, P168, DOI 10.1520/STP11162S; Wu XQ, 2008, MATER CORROS, V59, P676, DOI 10.1002/maco.200804102; Wu XQ, 2009, J MATER ENG PERFORM, V18, P287, DOI 10.1007/s11665-008-9295-4; Yang K, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014105; Younesi M, 2010, J MECH BEHAV BIOMED, V3, P178, DOI 10.1016/j.jmbbm.2009.08.003; Younesi M, 2010, COMP MATER SCI, V47, P645, DOI 10.1016/j.commatsci.2009.09.019; Younesi M, 2010, MATER DESIGN, V31, P234, DOI 10.1016/j.matdes.2009.06.037	35	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61633	10.1371/journal.pone.0061633	http://dx.doi.org/10.1371/journal.pone.0061633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630603	Green Published, Green Submitted, gold			2022-12-25	WOS:000317911500053
J	LaRock, CN; Yu, J; Horswill, AR; Parsek, MR; Minion, FC				LaRock, Christopher N.; Yu, Jing; Horswill, Alexander R.; Parsek, Matthew R.; Minion, F. Chris			Transcriptome Analysis of Acetyl-Homoserine Lactone-Based Quorum Sensing Regulation in Yersinia pestis	PLOS ONE			English	Article							ISOCITRATE LYASE ACTIVITY; BORNE TRANSMISSION; GENE-EXPRESSION; PSEUDOTUBERCULOSIS; PERSISTENCE; INFECTION; IDENTIFICATION; EVOLUTION; VIRULENT; MOTILITY	The etiologic agent of bubonic plague, Yersinia pestis, senses self-produced, secreted chemical signals in a process named quorum sensing. Though the closely related enteric pathogen Y. pseudotuberculosis uses quorum sensing system to regulate motility, the role of quorum sensing in Y. pestis has been unclear. In this study we performed transcriptional profiling experiments to identify Y. pestis quorum sensing regulated functions. Our analysis revealed that acyl-homoserine lactone-based quorum sensing controls the expression of several metabolic functions. Maltose fermentation and the glyoxylate bypass are induced by acyl-homoserine lactone signaling. This effect was observed at 30 degrees C, indicating a potential role for quorum sensing regulation of metabolism at temperatures below the normal mammalian temperature. It is proposed that utilization of alternative carbon sources may enhance growth and/or survival during prolonged periods in natural habitats with limited nutrient sources, contributing to maintenance of plague in nature.	[Yu, Jing; Minion, F. Chris] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [LaRock, Christopher N.; Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Iowa State University; University of Washington; University of Washington Seattle; University of Iowa	Minion, FC (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	fcminion@iastate.edu	Minion, Chris/A-2955-2015; LaRock, Christopher/E-1554-2013	Minion, Chris/0000-0003-4876-8396; LaRock, Christopher/0000-0003-3035-5331	Office of Naval Research [N00014-06-1-1176]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Office of Naval Research Grant N00014-06-1-1176 to FCM, ARH, and MRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TERENCE SPEED STAT M; Atkinson S, 1999, MOL MICROBIOL, V33, P1267, DOI 10.1046/j.1365-2958.1999.01578.x; Atkinson S, 2008, MOL MICROBIOL, V69, P137, DOI 10.1111/j.1365-2958.2008.06268.x; Bobrov AG, 2007, ADV EXP MED BIOL, V603, P178; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Carruthers MD, 2009, FEMS MICROBIOL LETT, V295, P96, DOI 10.1111/j.1574-6968.2009.01587.x; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; CHEN TH, 1977, INFECT IMMUN, V15, P972, DOI 10.1128/IAI.15.3.972-977.1977; Chen ZL, 2006, MICROBES INFECT, V8, P2501, DOI 10.1016/j.micinf.2006.06.007; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Eisen RJ, 2008, J MED ENTOMOL, V45, P933, DOI 10.1603/0022-2585(2008)45[933:SOHBAP]2.0.CO;2; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Erickson DL, 2007, CELL MICROBIOL, V9, P2658, DOI 10.1111/j.1462-5822.2007.00986.x; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Franchini AG, 2006, MICROBIOL-SGM, V152, P2111, DOI 10.1099/mic.0.28939-0; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gallup JM, 2006, BIOL PROCED ONLINE, V8, P87, DOI 10.1251/bpo122; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; HILLIER SL, 1981, J CLIN MICROBIOL, V13, P661, DOI 10.1128/JCM.13.4.661-665.1981; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; HUGH R, 1953, J BACTERIOL, V66, P24, DOI 10.1128/JB.66.1.24-26.1953; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Kong CS, 2011, ACS COMB SCI, V13, P562, DOI 10.1021/co200111u; Lawson JN, 2006, DNA CELL BIOL, V25, P608, DOI 10.1089/dna.2006.25.608; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Madsen ML, 2006, INFECT IMMUN, V74, P160, DOI 10.1128/IAI.74.1.160-166.2006; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MONCLA BJ, 1983, J BACTERIOL, V153, P340, DOI 10.1128/JB.153.1.340-344.1983; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; QUAN TJ, 1982, J CLIN MICROBIOL, V15, P1178, DOI 10.1128/JCM.15.6.1178-1179.1982; Schaefer AL, 2001, METHOD ENZYMOL, V336, P41, DOI 10.1016/S0076-6879(01)36576-X; Sebbane F, 2004, INFECT IMMUN, V72, P7334, DOI 10.1128/IAI.72.12.7334-7337.2004; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Surette MG, 1999, MOL MICROBIOL, V31, P585, DOI 10.1046/j.1365-2958.1999.01199.x; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	46	19	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e62337	10.1371/journal.pone.0062337	http://dx.doi.org/10.1371/journal.pone.0062337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23620823	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500104
J	Nouvellet, P; Donnelly, CA; De Nardi, M; Rhodes, CJ; De Benedictis, P; Citterio, C; Obber, F; Lorenzetto, M; Dalla Pozza, M; Cauchemez, S; Cattoli, G				Nouvellet, Pierre; Donnelly, Christl A.; Nardi, Marco De; Rhodes, Chris J.; De Benedictis, Paola; Citterio, Carlo; Obber, Federica; Lorenzetto, Monica; Dalla Pozza, Manuela; Cauchemez, Simon; Cattoli, Giovanni			Rabies and Canine Distemper Virus Epidemics in the Red Fox Population of Northern Italy (2006-2010)	PLOS ONE			English	Article							VULPES-VULPES; WILDLIFE; DISEASE; VACCINATION; SURVEILLANCE; EMERGENCE; SUSCEPTIBILITY; PREVALENCE; ANTIBODIES; CARNIVORES	Since 2006 the red fox (Vulpes vulpes) population in north-eastern Italy has experienced an epidemic of canine distemper virus (CDV). Additionally, in 2008, after a thirteen-year absence from Italy, fox rabies was re-introduced in the Udine province at the national border with Slovenia. Disease intervention strategies are being developed and implemented to control rabies in this area and minimise risk to human health. Here we present empirical data and the epidemiological picture relating to these epidemics in the period 2006-2010. Of important significance for epidemiological studies of wild animals, basic mathematical models are developed to exploit information collected from the surveillance program on dead and/or living animals in order to assess the incidence of infection. These models are also used to estimate the rate of transmission of both diseases and the rate of vaccination, while correcting for a bias in early collection of CDV samples. We found that the rate of rabies transmission was roughly twice that of CDV, with an estimated effective contact between infected and susceptible fox leading to a new infection occurring once every 3 days for rabies, and once a week for CDV. We also inferred that during the early stage of the CDV epidemic, a bias in the monitoring protocol resulted in a positive sample being almost 10 times more likely to be collected than a negative sample. We estimated the rate of intake of oral vaccine at 0.006 per day, allowing us to estimate that roughly 68% of the foxes would be immunised. This was confirmed by field observations. Finally we discuss the implications for the eco-epidemiological dynamics of both epidemics in relation to control measures.	[Nouvellet, Pierre; Donnelly, Christl A.; Rhodes, Chris J.; Cauchemez, Simon] Univ London Imperial Coll Sci Technol & Med, Med Res Council Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Nardi, Marco De; De Benedictis, Paola; Cattoli, Giovanni] Ist Zooprofilatt Sperimentale Venezie, Dept Res & Dev, Food & Agr Org Reference Ctr Rabies & World Org A, Padua, Italy; [Lorenzetto, Monica; Dalla Pozza, Manuela] Ist Zooprofilatt Sperimentale Venezie, Reg Ctr Vet Epidemiol, Padua, Italy; [Citterio, Carlo; Obber, Federica] Ist Zooprofilatt Sperimentale Venezie, Sez Terr Belluno, Belluno, Italy	Imperial College London; IZS delle Venezie; IZS delle Venezie; IZS delle Venezie	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Med Res Council Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	c.donnelly@imperial.ac.uk	Obber, Federica/AAD-9200-2020; De Nardi, Marco/AAA-5928-2022; De Benedictis, Paola/T-3273-2019; Citterio, Carlo Vittorio/T-8528-2018	Obber, Federica/0000-0002-5459-7880; De Nardi, Marco/0000-0001-5648-257X; De Benedictis, Paola/0000-0001-6760-1933; Citterio, Carlo Vittorio/0000-0002-4482-1295; Donnelly, Christl/0000-0002-0195-2463; nouvellet, pierre/0000-0002-6094-5722; , Monica/0000-0003-4729-0300	European Union [278433-PREDEMICS]; Istituto Zooprofilattico Sperimentale delle Venezie, Padova; Italian Ministry of Health [RC IZS VE 07/08, RC IZSVE 06/09]; Medical Research Council Centre for Outbreak Analysis and Modelling; Research Council of the United Kingdom; Research Council of the Imperial College London; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	European Union(European Commission); Istituto Zooprofilattico Sperimentale delle Venezie, Padova; Italian Ministry of Health(Ministry of Health, Italy); Medical Research Council Centre for Outbreak Analysis and Modelling(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Council of the United Kingdom; Research Council of the Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no278433-PREDEMICS. MDN, PDB, ML, CC, FO, MDP and GC acknowledge the support of Istituto Zooprofilattico Sperimentale delle Venezie, Padova. This study is partially funded by the Italian Ministry of Health through RC IZS VE 07/08 and RC IZSVE 06/09 projects. PN, CAD, CJR and SC thank the Medical Research Council Centre for Outbreak Analysis and Modelling for support. CJR was supported by the Research Councils of the United Kingdom and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; Bacon P., 1985, POPULATION DYNAMICS; Ballard WB, 2001, J WILDLIFE DIS, V37, P133, DOI 10.7589/0090-3558-37.1.133; Belant Jerrold L., 2010, Human-Wildlife Interactions, V4, P165; Benedictis P. de, 2008, Eurosurveillance, V13, P19033; Benedicts P. de, 2009, Rabies Bulletin Europe, V33, P5; Benetka V, 2011, VET REC, V168, P376, DOI 10.1136/vr.c6404; Boadella M, 2011, EUR J WILDLIFE RES, V57, P697, DOI 10.1007/s10344-011-0550-x; Budd J, 1981, INFECT DIS WILD MAMM; Bugnon P, 2004, J VET MED B, V51, P433, DOI 10.1111/j.1439-0450.2004.00801.x; Capello K, 2010, EURO SURVEILLANCE, V15; Cattoli G, 2007, J WILDLIFE DIS, V43, pS35; Cattoli G, 2012, COMMUNICATION; Damien BC, 2002, J WILDLIFE DIS, V38, P856, DOI 10.7589/0090-3558-38.4.856; Daszak P, 2007, CURR TOP MICROBIOL, V315, P463; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; De Benedictis P, 2012, VACCINE, V30, P5611, DOI 10.1016/j.vaccine.2012.06.089; De Benedictis P, 2011, J CLIN MICROBIOL, V49, P1932, DOI 10.1128/JCM.02015-10; Eisinger D, 2008, J APPL ECOL, V45, P415, DOI 10.1111/j.1365-2664.2007.01439.x; EU European Commission, 2002, REPORT OF THE SCIENT; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Fusaro A, THE INTRODUCTION OF; GREENE CE, 1998, INFECT DIS DOG CAT, P9; Holmala K, 2006, MAMMAL REV, V36, P17, DOI 10.1111/j.1365-2907.2006.00078.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kelly TR, 2003, J WILDLIFE DIS, V39, P467, DOI 10.7589/0090-3558-39.2.467; Kennedy A. H., 1948, CANADIAN JOUR COMP MED, V12, P137; KRAKOWKA S, 1976, J INFECT DIS, V134, P629, DOI 10.1093/infdis/134.6.629; MacDonald D.W., 1995, EUROPEAN MAMMALS EVO; Martella V, 2002, MOL CELL PROBE, V16, P77, DOI 10.1006/mcpr.2001.0387; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2010, EMERG INFECT DIS, V16, P2007, DOI 10.3201/eid1612.100579; Matouch O, 2008, DEV BIOLOGICALS, V131, P27; McCormack RK, 2006, THESIS; McCormack RK, 2007, MATH MED BIOL, V24, P17, DOI 10.1093/imammb/dql021; Meriggi A., 1991, Hystrix, V3, P31; Monne I, 2011, VET MICROBIOLOGY; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; Mulatti P, 2012, EPIDEMIOL INFECT, V140, P591, DOI 10.1017/S0950268811001282; Mulatti P, 2011, GEOSPATIAL HEALTH, V5, P217, DOI 10.4081/gh.2011.174; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; Mutinelli F., 2004, Historical perspective of rabies in Europe and the Mediterranean Basin: a testament to rabies by Dr Arthur A. King, P93; Origgi FC, 2012, VET PATHOL, V49, P913, DOI 10.1177/0300985812436743; Orpetveit I, 2011, EUROSURVEILLANCE, V16, P2; Pandolfi M, 1997, ITAL J ZOOL, V64, P351, DOI 10.1080/11250009709356222; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Rhyan J, 2008, J WILDLIFE DIS, V44, P269, DOI 10.7589/0090-3558-44.2.269; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Russell CA, 2004, P ROY SOC B-BIOL SCI, V271, P21, DOI 10.1098/rspb.2003.2559; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Smith GC, 2003, J WILDLIFE DIS, V39, P278, DOI 10.7589/0090-3558-39.2.278; Sobrino R, 2008, VET MICROBIOL, V126, P251, DOI 10.1016/j.vetmic.2007.06.014; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; VANMOLL P, 1995, VET MICROBIOL, V44, P193, DOI 10.1016/0378-1135(95)00012-Y; Wandeler AI, 2008, DEV BIOLOGICALS, V131, P19; Williams ES, 2001, IN INFECTIOUS DISEAS	57	74	74	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61588	10.1371/journal.pone.0061588	http://dx.doi.org/10.1371/journal.pone.0061588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	24761309	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500049
J	Mukherjee, N; Carroll, BL; Spees, JL; Delay, ER				Mukherjee, Nabanita; Carroll, Brittany L.; Spees, Jeffrey L.; Delay, Eugene R.			Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice	PLOS ONE			English	Article							PATIENTS RECEIVING CHEMOTHERAPY; QUALITY-OF-LIFE; CLINICAL PHARMACOKINETICS; FUNGIFORM PAPILLAE; CANCER-PATIENTS; CELL-TYPES; WR-2721; BUDS; RAT; RADIOTHERAPY	Cyclophosphamide (CYP), a commonly prescribed chemotherapy drug, has multiple adverse side effects including alteration of taste. The effects on taste are a cause of concern for patients as changes in taste are often associated with loss of appetite, malnutrition, poor recovery and reduced quality of life. Amifostine is a cytoprotective agent that was previously shown to be effective in preventing chemotherapy-induced mucositis and nephrotoxicity. Here we determined its ability to protect against chemotherapy-induced damage to taste buds using a mouse model of CYP injury. We conducted detection threshold tests to measure changes in sucrose taste sensitivity and found that administration of amifostine 30 mins prior to CYP injection protected against CYP-induced loss in taste sensitivity. Morphological studies showed that pre-treatment with amifostine prevented CYP-induced reduction in the number of fungiform taste papillae and increased the number of taste buds. Immunohistochemical assays for markers of the cell cycle showed that amifostine administration prevented CYP-induced inhibition of cell proliferation and also protected against loss of mature taste cells after CYP exposure. Our results indicate that treatment of cancer patients with amifostine prior to chemotherapy may improve their sensitivity for taste stimuli and protect the taste system from the detrimental effects of chemotherapy.	[Mukherjee, Nabanita; Carroll, Brittany L.; Delay, Eugene R.] Univ Vermont, Dept Biol, Burlington, VT USA; [Spees, Jeffrey L.] Stem Cell Core, Dept Med, Colchester, VT USA	University of Vermont	Spees, JL (corresponding author), Stem Cell Core, Dept Med, Colchester, VT USA.	Jeffrey.Spees@uvm.edu; edelay@uvm.edu		Carroll, Brittany/0000-0002-4199-7762	National Science Foundation [IOS-0951016]; Ajinomoto 3ARP [11-02]; National Institutes of Health [R01 HL085210]; University of Vermont Undergraduate Student Research Grant (UVM URECA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085210] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Ajinomoto 3ARP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont Undergraduate Student Research Grant (UVM URECA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by National Science Foundation grant IOS-0951016 (to ERD), Ajinomoto 3ARP No. 11-02 (to ERD), National Institutes of Health R01 HL085210 (to JLS), and University of Vermont Undergraduate Student Research Grant (UVM URECA, 2011; to BLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 1999, SEMIN ONCOL, V26, P37; ALLALUNIS-TURNER M J, 1988, NCI (National Cancer Institute) Monographs, P51; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; [Anonymous], 2007, LEARNING BEHAV CONT; Antonadou D, 2002, INT J RADIAT ONCOL, V52, P739, DOI 10.1016/S0360-3016(01)02683-9; Aviles A, 1997, EUR J CANCER, V33, P1323, DOI 10.1016/S0959-8049(97)00127-5; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Berteretche MV, 2004, SUPPORT CARE CANCER, V12, P571, DOI 10.1007/s00520-004-0589-2; Brizel DM, 2007, J CLIN ONCOL, V25, P4084, DOI 10.1200/JCO.2007.11.5816; Capizzi RL, 1999, SEMIN ONCOL, V26, P72; CARSON JAS, 1977, J AM DIET ASSOC, V70, P361; Cassatt DR, 2003, INT J RADIAT ONCOL, V57, P794, DOI 10.1016/S0360-3016(03)00660-6; CHENG LHH, 1991, ARCH ORAL BIOL, V36, P583, DOI 10.1016/0003-9969(91)90108-7; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; COHEN JL, 1970, J PHARMACOL EXP THER, V174, P206; Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; Crowley HH, 1995, TRANSMISSION ELECT M; Culy CR, 2001, DRUGS, V61, P641, DOI 10.2165/00003495-200161050-00012; Davidson W, 2012, ONCOL NURS FORUM, V39, P398, DOI 10.1188/12.ONF.E340-E345; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Epstein JB, 2002, BONE MARROW TRANSPL, V30, P785, DOI 10.1038/sj.bmt.1703716; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Gamper EM, 2012, ACTA ONCOL, V51, P490, DOI 10.3109/0284186X.2011.633554; GENG L, 1992, INT J RADIAT BIOL, V61, P533, DOI 10.1080/09553009214551291; GLICK JH, 1984, INT J RADIAT ONCOL, V10, P1777, DOI 10.1016/0360-3016(84)90548-0; Grochova D., 2007, J APPL BIOMED, V5, P171, DOI [10.32725/jab.2007.023, DOI 10.32725/JAB.2007.023]; HALL JC, 1980, CLIN ONCOL, V6, P137; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; Hong Jae Hee, 2009, J Support Oncol, V7, P58; HUNTER NR, 1992, INT J RADIAT ONCOL, V22, P795, DOI 10.1016/0360-3016(92)90526-N; Kavanagh BD, 1995, CLIN CANCER RES, V1, P1557; Kemp G, 1996, J CLIN ONCOL, V14, P2101, DOI 10.1200/JCO.1996.14.7.2101; Kinnamon J.C., 1987, P277; KINNAMON JC, 1993, MICROSC RES TECHNIQ, V26, P142, DOI 10.1002/jemt.1070260207; KLIGERMAN MM, 1984, INT J RADIAT ONCOL, V10, P1773, DOI 10.1016/0360-3016(84)90547-9; List AF, 1996, SEMIN ONCOL, V23, P58; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; MOORE MJ, 1991, CLIN PHARMACOKINET, V20, P194, DOI 10.2165/00003088-199120030-00002; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Nguyen HM, 2012, J NEUROSCI, V32, P3474, DOI 10.1523/JNEUROSCI.4167-11.2012; Nguyen HM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-129; Praetorius NP, 2008, J PHARM PHARMACOL, V60, P809, DOI 10.1211/jpp.60.7.0001; Shimada IS, 2010, STROKE, V41, pE552, DOI 10.1161/STROKEAHA.110.589010; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; VANLAAR JAM, 1992, CANCER CHEMOTH PHARM, V31, P97, DOI 10.1007/BF00685094; WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3; Wickham R S, 1999, Oncol Nurs Forum, V26, P697; WITT M, 1992, HISTOCHEMISTRY, V98, P173, DOI 10.1007/BF00315876; YUHAS JM, 1980, CANCER TREAT REP, V64, P57; YUHAS JM, 1980, CANCER CLIN TRIALS, V3, P211; Zhang CX, 1996, DIFFERENTIATION, V61, P121, DOI 10.1046/j.1432-0436.1996.6120121.x; Zhang GH, 2008, ARCH ORAL BIOL, V53, P583, DOI 10.1016/j.archoralbio.2008.01.005	54	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61607	10.1371/journal.pone.0061607	http://dx.doi.org/10.1371/journal.pone.0061607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626702	gold, Green Published, Green Submitted			2022-12-25	WOS:000318008400066
J	Miyasaki, Y; Rabenstein, JD; Rhea, J; Crouch, ML; Mocek, UM; Kittell, PE; Morgan, MA; Nichols, WS; Van Benschoten, MM; Hardy, WD; Liu, GY				Miyasaki, Yoko; Rabenstein, John D.; Rhea, Joshua; Crouch, Marie-Laure; Mocek, Ulla M.; Kittell, Patricia Emmett; Morgan, Margie A.; Nichols, Wesley Stephen; Van Benschoten, M. M.; Hardy, William David; Liu, George Y.			Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							INFECTIONS; PLATE	The number of fully active antibiotic options that treat nosocomial infections due to multidrug-resistant Acinetobacter baumannii (A. baumannii) is extremely limited. Magnolia officinalis, Mahonia bealei, Rabdosia rubescens, Rosa rugosa, Rubus chingii, Scutellaria baicalensis, and Terminalia chebula plant extracts were previously shown to have growth inhibitory activity against a multidrug-resistant clinical strain of A. baumannii. In this study, the compounds responsible for their antimicrobial activity were identified by fractionating each plant extract using high performance liquid chromatography, and determining the antimicrobial activity of each fraction against A. baumannii. The chemical structures of the fractions inhibiting >40% of the bacterial growth were elucidated by liquid chromatography/mass spectrometry analysis and nuclear magnetic resonance spectroscopy. The six most active compounds were identified as: ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula. The most potent compound was identified as norwogonin with a minimum inhibitory concentration of 128 mg/mL, and minimum bactericidal concentration of 256 mg/mL against clinically relevant strains of A. baumannii. Combination studies of norwogonin with ten anti-Gram negative bacterial agents demonstrated that norwogonin did not enhance the antimicrobial activity of the synthetic antibiotics chosen for this study. In conclusion, of all identified antimicrobial compounds, norwogonin was the most potent against multidrug-resistant A. baumannii strains. Further studies are warranted to ascertain the prophylactic and therapeutic potential of norwogonin for infections due to multidrug-resistant A. baumannii.	[Miyasaki, Yoko; Hardy, William David] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Rabenstein, John D.; Rhea, Joshua; Crouch, Marie-Laure; Mocek, Ulla M.] Albany Mol Res Inc, Bothell Res Ctr, Bothell, WA USA; [Kittell, Patricia Emmett] Cedars Sinai Med Ctr, Dept Patient Financial Serv, Los Angeles, CA 90048 USA; [Morgan, Margie A.; Nichols, Wesley Stephen] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Van Benschoten, M. M.] MM Van Benschoten OMD MA CA & Associates, Canoga Pk, CA USA; [Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Miyasaki, Y (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	yoko.miyasaki@cshs.org	Hardy, W. David/AHD-8960-2022	Rabenstein, John/0000-0002-9702-6586	Cedars-Sinai Medical Center in Los Angeles, California, USA; Cedars-Sinai Medical Center	Cedars-Sinai Medical Center in Los Angeles, California, USA; Cedars-Sinai Medical Center	This research study was funded by Cedars-Sinai Medical Center in Los Angeles, California, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr. M.M. Van Benschoten is a self-employed community-based, private practitioner of oriental medicine. The title of his practice is M. M. Van Benschoten, O.M.D., M.A., C.A. and Associates. As an experienced oriental medicine practitioner, Dr. Van Benschoten helped conceive the experiments conducted in this study and assisted with obtaining the original plant extracts used in the study. For these services, he received consultation fee of $ 3,500 from Cedars-Sinai Medical Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chan BCL, 2011, J ETHNOPHARMACOL, V137, P767, DOI 10.1016/j.jep.2011.06.039; Chusri S, 2009, J ANTIMICROB CHEMOTH, V64, P1203, DOI 10.1093/jac/dkp381; *CLIN LAB STAND I, 2006, METH ANT DIL DISK SU, P16; Clinical and Laboratory Standards Institute, 2009, PERF STAND ANT SUSC, p[46, 100]; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang H, 2010, PLANTA MED, V76, P76, DOI 10.1055/s-0029-1185943; Huang H, 2009, FITOTERAPIA, V80, P448, DOI 10.1016/j.fitote.2009.06.004; Jones WP, 2010, NATURAL PRODUCT ISOL, P323; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Krueger WA, 2002, AM J RESP CRIT CARE, V166, P1029, DOI 10.1164/rccm.2105141; Lu YJ, 2011, J AGR FOOD CHEM, V59, P10934, DOI 10.1021/jf202741x; Mann CM, 1998, J APPL MICROBIOL, V84, P538, DOI 10.1046/j.1365-2672.1998.00379.x; Miyasaki Y, 2012, FEMS MICROBIOL LETT, V328, P26, DOI 10.1111/j.1574-6968.2011.02480.x; Miyasaki Y, 2010, PHYTOTHER RES, V24, P1202, DOI 10.1002/ptr.3113; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Osterburg A, 2009, CLIN MICROBIOL INFEC, V15, P341, DOI 10.1111/j.1469-0691.2009.02710.x; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Smith CF, 1999, J FOOD PROTECT, V62, P1404, DOI 10.4315/0362-028X-62.12.1404; Sukumaran S, 2011, ASIAN PAC J TROP MED, V4, P735, DOI 10.1016/S1995-7645(11)60183-1; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Wu Jing, 2008, Zhong Yao Cai, V31, P707	25	71	78	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61594	10.1371/journal.pone.0061594	http://dx.doi.org/10.1371/journal.pone.0061594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23724093	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500050
J	Duan, JB; Zhang, JG; Deng, HW; Wang, YP				Duan, Junbo; Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping			Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies	PLOS ONE			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; CANCER; IDENTIFICATION; ALGORITHMS; DISEASE; SEQ	Copy number variation (CNV) has played an important role in studies of susceptibility or resistance to complex diseases. Traditional methods such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH) suffer from low resolution of genomic regions. Following the emergence of next generation sequencing (NGS) technologies, CNV detection methods based on the short read data have recently been developed. However, due to the relatively young age of the procedures, their performance is not fully understood. To help investigators choose suitable methods to detect CNVs, comparative studies are needed. We compared six publicly available CNV detection methods: CNV-seq, FREEC, readDepth, CNVnator, SegSeq and event-wise testing (EWT). They are evaluated both on simulated and real data with different experiment settings. The receiver operating characteristic (ROC) curve is employed to demonstrate the detection performance in terms of sensitivity and specificity, box plot is employed to compare their performances in terms of breakpoint and copy number estimation, Venn diagram is employed to show the consistency among these methods, and F-score is employed to show the overlapping quality of detected CNVs. The computational demands are also studied. The results of our work provide a comprehensive evaluation on the performances of the selected CNV detection methods, which will help biological investigators choose the best possible method.	[Duan, Junbo; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Duan, Junbo; Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Wang, YP (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	wyp@tulane.edu	DUAN, Junbo/A-8795-2010	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR059781, R01AR050496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by the National Institutes of Health and National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Duan JB, 2011, IEEE INT C BIO BIO W, P3, DOI 10.1109/BIBMW.2011.6112348; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Kim TM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-432; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr068; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simpson JT, 2010, BIOINFORMATICS, V26, P565, DOI 10.1093/bioinformatics/btp693; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang CH, 2008, ANN STAT, V36, P1509	33	190	200	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59128	10.1371/journal.pone.0059128	http://dx.doi.org/10.1371/journal.pone.0059128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527109	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600057
J	Ghosh, A; Sarkar, S; Mandal, AK; Das, N				Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu			Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged Rats	PLOS ONE			English	Article							DRUG-DELIVERY; NITRIC-OXIDE; LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; BRAIN; DEATH; FLAVONOIDS; NANOPARTICLES; ANTIOXIDANTS; MEMBRANE	Cerebral stroke is the leading cause of death and permanent disability among elderly people. In both humans and animals, cerebral ischemia damages the nerve cells in vulnerable regions of the brain, viz., hippocampus, cerebral cortex, cerebellum, and hypothalamus. The present study was conducted to evaluate the therapeutic efficacy of nanoencapsulated quercetin (QC) in combating ischemia-reperfusion-induced neuronal damage in young and aged Swiss Albino rats. Cerebral ischemia was induced by occlusion of the common carotid arteries of both young and aged rats followed by reperfusion. Nanoencapsulated quercetin (2.7 mg/kg b wt) was administered to both groups of animals via oral gavage two hours prior to ischemic insults as well as post-operation till day 3. Cerebral ischemia and 30 min consecutive reperfusion caused a substantial increase in lipid peroxidation, decreased antioxidant enzyme activities and tissue osmolality in different brain regions of both groups of animals. It also decreased mitochondrial membrane microviscosity and increased reactive oxygen species (ROS) generation in different brain regions of young and aged rats. Among the brain regions studied, the hippocampus appeared to be the worst affected region showing increased upregulation of iNOS and caspase-3 activity with decreased neuronal count in the CA1 and CA3 subfields of both young and aged rats. Furthermore, three days of continuous reperfusion after ischemia caused massive damage to neuronal cells. However, it was observed that oral treatment of nanoencapsulated quercetin (2.7 mg/kg b wt) resulted in downregulation of iNOS and caspase-3 activities and improved neuronal count in the hippocampal subfields even 3 days after reperfusion. Moreover, the nanoformulation imparted a significant level of protection in the antioxidant status in different brain regions, thus contributing to a better understanding of the given pathophysiological processes causing ischemic neuronal damage.	[Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu] Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India; [Ghosh, Aparajita] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Das, N (corresponding author), Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India.	dasnirmalendu@hotmail.com	; Jabgunde, Amit/I-8155-2018; Ghosh, Sougata/GOH-0726-2022; Mandal, Ardhendu Kumar/R-3694-2018; Pardesi, Karishma/D-5827-2012; Ghosh, Sougata/C-6409-2018	Dhavale, Dilip/0000-0001-8221-6347; Jabgunde, Amit/0000-0002-9324-8552; Jagtap, Soham/0000-0002-8687-7326; Ghosh, Sougata/0000-0001-8631-0357; Mandal, Ardhendu Kumar/0000-0001-8336-1220; Shinde, Vaishali/0000-0001-8800-7247; Patil, Ajay B./0000-0003-0509-4926; Pardesi, Karishma/0000-0001-7535-6317; Ghosh, Sougata/0000-0003-0077-1318	Indian Council of Medical Research (ICMR), Government of India [58/17/2003-BMS]; Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Indian Council of Medical Research (ICMR), Adhoc Project number 58/17/2003-BMS, Government of India, and the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Aebi H, 1984, Methods Enzymol, V105, P121; Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; BORS W, 1990, METHOD ENZYMOL, V186, P343; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Changtam C, 2010, EUR J MED CHEM, V45, P941, DOI 10.1016/j.ejmech.2009.11.035; Chen J, 1997, J NEUROCHEM, V69, P232; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GINSBERG MD, 1994, ANN NEUROL, V36, P553, DOI 10.1002/ana.410360402; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Harry GJ, 2003, NEUROTOXICOLOGY, V24, P343, DOI 10.1016/S0161-813X(03)00039-1; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; ISSA AM, 1990, J NEUROSCI, V10, P3247; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kong LD, 2000, CELL MOL LIFE SCI, V57, P500, DOI 10.1007/PL00000710; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lee JC, 2003, EXP CELL RES, V291, P386, DOI 10.1016/S0014-4827(03)00410-5; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; RECKNAGEL RO, 1984, METHOD ENZYMOL, V105, P331; Rodriguez RJ, 2001, FOOD CHEM TOXICOL, V39, P437, DOI 10.1016/S0278-6915(00)00159-9; Ruozi B, 2007, TALANTA, V73, P12, DOI 10.1016/j.talanta.2007.03.031; Sarkar A, 1995, CANCER BIOCHEM BIOPH, V15, P111; Sarkar S, 2002, J DRUG TARGET, V10, P573, DOI 10.1080/106118021000072681; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Taylor CP, 1999, J NEUROSCI, V19, P619; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	52	114	119	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e57735	10.1371/journal.pone.0057735	http://dx.doi.org/10.1371/journal.pone.0057735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	24367520	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500001
J	Zhou, X; Mao, AQ; Wang, XB; Duan, XX; Yao, Y; Zhang, CX				Zhou, Xian; Mao, Anqiong; Wang, Xiaobin; Duan, Xiaoxia; Yao, Yi; Zhang, Chunxiang			Urine and Serum MicroRNA-1 as Novel Biomarkers for Myocardial Injury in Open-Heart Surgeries with Cardiopulmonary Bypass	PLOS ONE			English	Article							INFARCTION; TROPONIN; MARKER	MicroRNA-1 (miR-1) is a cardio-specific/enriched microRNA. Our recent studies have revealed that serum and urine miR-1 could be a novel sensitive biomarker for acute myocardial infarction. Open-heart surgeries with cardiopulmonary bypass (CPB) are often accompanied with surgery injury and CPB-associated injury on the hearts. However, the association of miR-1 and these intra-operative and post-operative cardiac injures is unknown. The objective of this study was to test the hypothesis that urine and serum miR-1 might be a novel biomarker for myocardial injuries in open-heart surgeries with CPB. Serum and urine miR-1 levels in 20 patients with elective mitral valve surgery were measured at pre-surgery, pre-CPB, 60 min post-CBP, and 24h post-CBP. Serum cardiac troponin-I (cTnI) was used as a positive control biomarker for cardiac injury. Compared with these in pre-operative and pre-CPB groups, the levels of miR-1 in serum and urine from patients after open-heart surgeries and CPB were significant increased at all observed time points. A similar pattern of serum cTnI levels and their strong positive correlation with miR-1 levels were identified in these patients. The results suggest that serum and urine miR-1 may be a novel sensitive biomarker for myocardial injury in open-heart surgeries with CPB.	[Zhou, Xian; Mao, Anqiong; Wang, Xiaobin; Duan, Xiaoxia; Yao, Yi] Luzhou Med Coll, Affiliated Hosp, Dept Internal Med & Anesthesiol & Crit Care Med, Luzhou, Sichuan Provinc, Peoples R China; [Zhang, Chunxiang] Rush Univ, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Rush University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Internal Med & Anesthesiol & Crit Care Med, Luzhou, Sichuan Provinc, Peoples R China.	wangxiaobin67@yahoo.cn; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022; Pan, Ting/AAX-1933-2021; Duan, xiaoxia/GMW-7041-2022	zhang, xiang chun/0000-0001-8303-6495; Duan, xiaoxia/0000-0002-6162-0428	NIH [HL080133, HL095707, HL109651]; American Heart Association [09GRNT2250567]; Projects of International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Projects of International Cooperation, Department of Science & Technology of Sichuan Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants HL080133, HL095707, HL109651 and a grant from the American Heart Association 09GRNT2250567 to C. Zhang. This project was also supported in part by the Projects of International Cooperation, Department of Science & Technology of Sichuan Province (2011HH0031) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Howie-Esquivel J, 2008, J CARDIOVASC NURS, V23, P124, DOI 10.1097/01.JCN.0000305072.49613.92; Knothe C, 1996, J CARDIOVASC SURG, V37, P367; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; MOAT NE, 1993, EUR J CARDIO-THORAC, V7, P563, DOI 10.1016/1010-7940(93)90241-3; Murphy GJ, 2004, J CARDIAC SURG, V19, P481, DOI 10.1111/j.0886-0440.2004.04101.x; Vermes E, 2000, ANN THORAC SURG, V70, P2087, DOI 10.1016/S0003-4975(00)02152-4; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	12	66	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62245	10.1371/journal.pone.0062245	http://dx.doi.org/10.1371/journal.pone.0062245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630629	Green Submitted, gold, Green Published			2022-12-25	WOS:000317911500086
J	Srinivasan, K; Raman, R; Jayaraman, A; Viswanathan, K; Sasisekharan, R				Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram			Quantitative Description of Glycan-Receptor Binding of Influenza A Virus H7 Hemagglutinin	PLOS ONE			English	Article							RESPIRATORY DROPLET TRANSMISSION	In the context of recently emerged novel influenza strains through reassortment, avian influenza subtypes such as H5N1, H7N7, H7N2, H7N3 and H9N2 pose a constant threat in terms of their adaptation to the human host. Among these subtypes, it was recently demonstrated that mutations in H5 and H9 hemagglutinin (HA) in the context of lab-generated reassorted viruses conferred aerosol transmissibility in ferrets (a property shared by human adapted viruses). We previously demonstrated that the quantitative binding affinity of HA to alpha 2 -> 6 sialylated glycans (human receptors) is one of the important factors governing human adaptation of HA. Although the H7 subtype has infected humans causing varied clinical outcomes from mild conjunctivitis to severe respiratory illnesses, it is not clear where the HA of these subtypes stand in regard to human adaptation since its binding affinity to glycan receptors has not yet been quantified. In this study, we have quantitatively characterized the glycan receptor-binding specificity of HAs from representative strains of Eurasian (H7N7) and North American (H7N2) lineages that have caused human infection. Furthermore, we have demonstrated for the first time that two specific mutations; Gln226 -> Leu and Gly228 -> Ser in glycan receptor-binding site of H7 HA substantially increase its binding affinity to human receptor. Our findings contribute to a framework for monitoring the evolution of H7 HA to be able to adapt to human host.	[Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram] MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM R37 GM057073-13]; Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM R37 GM057073-13 and in part by the Singapore - MIT Alliance for Research and Technology (SMART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Ge SQ, 2011, CRIT REV MICROBIOL, V37, P157, DOI 10.3109/1040841X.2010.536523; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2012, PLOS ONE IN PRESS; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	27	67	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e49597	10.1371/journal.pone.0049597	http://dx.doi.org/10.1371/journal.pone.0049597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23626667	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200001
J	Zhou, XX; Luo, J; Mills, L; Wu, SX; Pan, T; Geng, GN; Zhang, J; Luo, HH; Liu, C; Zhang, H				Zhou, Xiuxia; Luo, Juan; Mills, Lisa; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Zhang, Jim; Luo, Haihua; Liu, Chao; Zhang, Hui			DDX5 Facilitates HIV-1 Replication as a Cellular Co-Factor of Rev	PLOS ONE			English	Article							BOX RNA HELICASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CONSTITUTIVE TRANSPORT ELEMENT; TRANSCRIPTIONAL COACTIVATOR; MUTATIONAL ANALYSIS; TUMOR-SUPPRESSOR; D RETROVIRUS; PROTEIN P68; IDENTIFICATION; TRANSLATION	HIV-1 Rev plays an important role in the late phase of HIV-1 replication, which facilitates export of unspliced viral mRNAs from the nucleus to cytoplasm in infected cells. Recent studies have shown that DDX1 and DDX3 are co-factors of Rev for the export of HIV-1 transcripts. In this report, we have demonstrated that DDX5 (p68), which is a multifunctional DEAD-box RNA helicase, functions as a new cellular co-factor of HIV-1 Rev. We found that DDX5 affects Rev function through the Rev-RRE axis and subsequently enhances HIV-1 replication. Confocal microscopy and co-immunoprecipitation analysis indicated that DDX5 binds to Rev and this interaction is largely dependent on RNA. If the DEAD-box motif of DDX5 is mutated, DDX5 loses almost all of its ability to bind to Rev, indicating that the DEAD-box motif of DDX5 is required for the interaction between DDX5 and Rev. Our data indicate that interference of DDX5-Rev interaction could reduce HIV-1 replication and potentially provide a new molecular target for anti-HIV-1 therapeutics.	[Zhou, Xiuxia; Luo, Juan; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Luo, Haihua; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Xiuxia; Luo, Juan; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Luo, Haihua; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Xiuxia] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Suzhou, Peoples R China; [Mills, Lisa; Zhang, Jim; Zhang, Hui] Thomas Jefferson Univ, Ctr Human Virol, Dept Med, Div Infect Dis, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Soochow University - China; Jefferson University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.	chaoliulc2013@126.com; hz08043@gmail.com	zhang, xiang chun/HCH-7063-2022; Pan, Ting/AAX-1933-2021; Duan, xiaoxia/GMW-7041-2022	zhang, xiang chun/0000-0001-8303-6495; Duan, xiaoxia/0000-0002-6162-0428	Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; National Natural Science Foundation of China [30972620, 81101255]; Natural Science Foundation of Guangdong [9251008901000022, 10451008901004204]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110083, 20100171120056]; US NIH [AI078812]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Guangdong Innovative Research Team Program (NO. 2009010058), National Basic Research Program of China (973 Program) (No. 2010CB912202), National Natural Science Foundation of China (No.30972620, No.81101255), Natural Science Foundation of Guangdong (No.9251008901000022, No.10451008901004204), Specialized Research Fund for the Doctoral Program of Higher Education of China (No.20090171110083, No.20100171120056) and also funded by US NIH AI078812 (H.Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bleoo S, 2001, MOL BIOL CELL, V12, P3046, DOI 10.1091/mbc.12.10.3046; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; HOPE T, 1995, CURR TOP MICROBIOL, V193, P91; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Huang J., 2011, MOL CELL PROTEOMICS, V11; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Ishaq M, 2009, J CELL BIOCHEM, V106, P296, DOI 10.1002/jcb.22004; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Kadare G, 1997, J VIROL, V71, P2583; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kjems J, 2000, Adv Pharmacol, V48, P251; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Nicol S.M., 2012, ONCOGENE; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Tang HL, 2000, J BIOL CHEM, V275, P32694, DOI 10.1074/jbc.M003933200; Tang HL, 1997, VIROLOGY, V228, P333, DOI 10.1006/viro.1996.8407; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	66	66	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65040	10.1371/journal.pone.0065040	http://dx.doi.org/10.1371/journal.pone.0065040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23630629	Green Published, Green Submitted, gold			2022-12-25	WOS:000319799900162
J	Ding, WN; Sun, JH; Sun, YW; Zhou, Y; Li, L; Xu, JR; Du, YS				Ding, Wei-na; Sun, Jin-hua; Sun, Ya-wen; Zhou, Yan; Li, Lei; Xu, Jian-rong; Du, Ya-song			Altered Default Network Resting-State Functional Connectivity in Adolescents with Internet Gaming Addiction	PLOS ONE			English	Article							STRIATAL DOPAMINE RELEASE; CINGULATE CORTEX; HUMAN BRAIN; RESPONSE-INHIBITION; PREFRONTAL CORTEX; WORKING-MEMORY; REWARD; ABNORMALITIES; INVOLVEMENT; DYSFUNCTION	Purpose: Excessive use of the Internet has been linked to a variety of negative psychosocial consequences. This study used resting-state functional magnetic resonance imaging (fMRI) to investigate whether functional connectivity is altered in adolescents with Internet gaming addiction (IGA). Methods: Seventeen adolescents with IGA and 24 normal control adolescents underwent a 7.3 minute resting-state fMRI scan. Posterior cingulate cortex (PCC) connectivity was determined in all subjects by investigating synchronized low-frequency fMRI signal fluctuations using a temporal correlation method. To assess the relationship between IGA symptom severity and PCC connectivity, contrast images representing areas correlated with PCC connectivity were correlated with the scores of the 17 subjects with IGA on the Chen Internet Addiction Scale (CIAS) and Barratt Impulsiveness Scale-11 (BIS-11) and their hours of Internet use per week. Results: There were no significant differences in the distributions of the age, gender, and years of education between the two groups. The subjects with IGA showed longer Internet use per week (hours) (p<0.0001) and higher CIAS (p<0.0001) and BIS-11 (p = 0.01) scores than the controls. Compared with the control group, subjects with IGA exhibited increased functional connectivity in the bilateral cerebellum posterior lobe and middle temporal gyrus. The bilateral inferior parietal lobule and right inferior temporal gyrus exhibited decreased connectivity. Connectivity with the PCC was positively correlated with CIAS scores in the right precuneus, posterior cingulate gyrus, thalamus, caudate, nucleus accumbens, supplementary motor area, and lingual gyrus. It was negatively correlated with the right cerebellum anterior lobe and left superior parietal lobule. Conclusion: Our results suggest that adolescents with IGA exhibit different resting-state patterns of brain activity. As these alterations are partially consistent with those in patients with substance addiction, they support the hypothesis that IGA as a behavioral addiction that may share similar neurobiological abnormalities with other addictive disorders.	[Ding, Wei-na; Sun, Ya-wen; Zhou, Yan; Li, Lei; Xu, Jian-rong] Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Sun, Jin-hua; Du, Ya-song] Shanghai Jiao Tong Univ, Dept Child & Adolescent Psychiat, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; yasongdu@yahoo.com.cn	SUN, JIN/GPX-9641-2022		National Natural Science Foundation of China [81171325]; Shanghai Science and Technology Committee Medical Guide Project [114119a0900]; Shanghai Leading Academic Discipline Project [S30203]; National Key Technology RD Program [2007BAI17B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Medical Guide Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Key Technology RD Program(National Key Technology R&D Program)	This research was supported by the National Natural Science Foundation of China (No. 81171325), Shanghai Science and Technology Committee Medical Guide Project (No. 114119a0900), Shanghai Leading Academic Discipline Project (Project No. S30203), and the National Key Technology R&D Program 2007BAI17B03. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2006, CNS SPECTRUMS, V11, P750, DOI 10.1017/S1092852900014875; Alavi SS, 2012, INT J PREVENTIVE MED, V3, P290; Alonso-Solis A, 2012, SCHIZOPHR RES, V139, P13, DOI 10.1016/j.schres.2012.05.005; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Beutel ME, 2011, Z PSYCHOSOM MED PSYC, V57, P77, DOI 10.13109/zptm.2011.57.1.77; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen SH, 2003, CHINESE J PSYCHOL, V45, P279, DOI [DOI 10.1037/T44491-000, 10.1037/t44491-000]; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Collin Guusje, 2011, Front Psychiatry, V2, P73, DOI 10.3389/fpsyt.2011.00073; Corbit LH, 2003, EUR J NEUROSCI, V18, P1286, DOI 10.1046/j.1460-9568.2003.02833.x; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dong GH, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-41; Dong GH, 2012, J PSYCHIATR RES, V46, P1212, DOI 10.1016/j.jpsychires.2012.05.015; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; Janes AC, 2012, DRUG ALCOHOL DEPEN, V125, P252, DOI 10.1016/j.drugalcdep.2012.02.020; KEEPERS GA, 1990, J AM ACAD CHILD PSY, V29, P49, DOI 10.1097/00004583-199001000-00009; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2011, ADDICT BIOL; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Lesieur Henry R., 1993, Journal of Addictive Diseases, V12, P89, DOI 10.1300/J069v12n03_08; Lewald J, 2011, NEUROPSYCHOLOGIA, V49, P209, DOI 10.1016/j.neuropsychologia.2010.11.038; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Paradiso S, 2011, J STROKE CEREBROVASC, V20, P94, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.005; Passamonti L, 2011, BRAIN, V134, P2274, DOI 10.1093/brain/awr164; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Rogers Paul, 1998, J Gambl Stud, V14, P111, DOI 10.1023/A:1023042708217; Ruef A, 2012, J PSYCHIATR NEUROSCI, V37, P305, DOI 10.1503/jpn.110057; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Seiferth NY, 2008, NEUROIMAGE, V40, P289, DOI 10.1016/j.neuroimage.2007.11.020; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P776, DOI 10.1100/tsw.2008.104; Shi J, 2008, EUR J PHARMACOL, V579, P160, DOI 10.1016/j.ejphar.2007.09.042; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Siomos KE, 2008, CYBERPSYCHOL BEHAV, V11, P653, DOI 10.1089/cpb.2008.0088; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Strata P, 2011, PHYSIOL RES, V60, pS39, DOI 10.33549/physiolres.932169; Sun DL, 2009, CNS SPECTRUMS, V14, P75, DOI 10.1017/S1092852900000225; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Tanabe J, 2011, PSYCHOPHARMACOLOGY, V216, P287, DOI 10.1007/s00213-011-2221-8; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Tirapu-Ustarroz J, 2011, REV NEUROLOGIA, V53, P301, DOI 10.33588/rn.5305.2010747; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K, 2010, WORLD PSYCHIATRY, V9, P91; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014; Zhang Y, 2011, BRAIN RES, V1402, P46, DOI 10.1016/j.brainres.2011.05.054; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; Zink CF, 2003, J NEUROSCI, V23, P8092; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	85	89	90	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59902	10.1371/journal.pone.0059902	http://dx.doi.org/10.1371/journal.pone.0059902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555827	gold, Green Submitted, Green Published			2022-12-25	WOS:000317418500103
J	Stiff, T; Alagoz, M; Alcantara, D; Outwin, E; Brunner, HG; Bongers, EMHF; O'Driscoll, M; Jeggo, PA				Stiff, Tom; Alagoz, Meryem; Alcantara, Diana; Outwin, Emily; Brunner, Han G.; Bongers, Ernie M. H. F.; O'Driscoll, Mark; Jeggo, Penny A.			Deficiency in Origin Licensing Proteins Impairs Cilia Formation: Implications for the Aetiology of Meier-Gorlin Syndrome	PLOS GENETICS			English	Article							RECOGNITION COMPLEX; DNA-REPLICATION; PRIMORDIAL DWARFISM; SECKEL-SYNDROME; INTRAFLAGELLAR TRANSPORT; EUKARYOTIC CELLS; PROGENITOR POOL; GROWTH-FACTOR; MUTATIONS; HETEROCHROMATIN	Mutations in ORC1, ORC4, ORC6, CDT1, and CDC6, which encode proteins required for DNA replication origin licensing, cause Meier-Gorlin syndrome (MGS), a disorder conferring microcephaly, primordial dwarfism, underdeveloped ears, and skeletal abnormalities. Mutations in ATR, which also functions during replication, can cause Seckel syndrome, a clinically related disorder. These findings suggest that impaired DNA replication could underlie the developmental defects characteristic of these disorders. Here, we show that although origin licensing capacity is impaired in all patient cells with mutations in origin licensing component proteins, this does not correlate with the rate of progression through S phase. Thus, the replicative capacity in MGS patient cells does not correlate with clinical manifestation. However, ORC1-deficient cells from MGS patients and siRNA-mediated depletion of origin licensing proteins also have impaired centrosome and centriole copy number. As a novel and unexpected finding, we show that they also display a striking defect in the rate of formation of primary cilia. We demonstrate that this impacts sonic hedgehog signalling in ORC1-deficient primary fibroblasts. Additionally, reduced growth factor-dependent signaling via primary cilia affects the kinetics of cell cycle progression following cell cycle exit and re-entry, highlighting an unexpected mechanism whereby origin licensing components can influence cell cycle progression. Finally, using a cell-based model, we show that defects in cilia function impair chondroinduction. Our findings raise the possibility that a reduced efficiency in forming cilia could contribute to the clinical features of MGS, particularly the bone development abnormalities, and could provide a new dimension for considering developmental impacts of licensing deficiency.	[Stiff, Tom; Alagoz, Meryem; Jeggo, Penny A.] Univ Sussex, Genome Damage & Stabil Ctr, Double Strand Break Repair Lab, Brighton, E Sussex, England; [Alcantara, Diana; Outwin, Emily; O'Driscoll, Mark] Univ Sussex, Human DNA Damage Response Disorders Grp, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Brunner, Han G.; Bongers, Ernie M. H. F.] Radboud Univ Nijmegen Med Ctr, Inst Genet & Metab Dis, Dept Human Genet, Nijmegen, Netherlands	University of Sussex; University of Sussex; Radboud University Nijmegen	Stiff, T (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Double Strand Break Repair Lab, Brighton, E Sussex, England.	p.a.jeggo@sussex.ac.uk	Brunner, Han/C-9928-2013; Bongers, M.H.F./L-4214-2015; Sharma, Abhishek/V-9874-2018	Sharma, Abhishek/0000-0003-2554-1025; , Sherif/0000-0003-2721-7763; O'Driscoll, Mark/0000-0003-2765-316X; Alcantara, Diana/0000-0003-3185-1548	Medical Research Council; Wellcome Research Trust; Association for International Cancer Research; Cancer Research UK; Leukaemia Lymphoma Research; Medical Research Council [G0801130B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Research Trust(Wellcome Trust); Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work in the PAJ Laboratory is funded by the Medical Research Council, the Wellcome Research Trust, and the Association for International Cancer Research. The MO Laboratory is funded by the Medical Research Council, Cancer Research UK, and Leukaemia Lymphoma Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Auth T, 2006, EXP CELL RES, V312, P3349, DOI 10.1016/j.yexcr.2006.07.014; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Deng Y, 2007, ARTHRITIS RHEUM-US, V56, P168, DOI 10.1002/art.22300; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Ge XQ, 2009, CELL CYCLE, V8, P2320; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GORLIN RJ, 1992, J MED GENET, V29, P516; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Muhlhans J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026496; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spassky N, 2008, M S-MED SCI, V24, P790, DOI 10.1051/medsci/20082410790; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Stuermer A, 2007, EUR J CELL BIOL, V86, P37, DOI 10.1016/j.ejcb.2006.09.002; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011	56	90	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	MAR	2013	9	3							e1003360	10.1371/journal.pgen.1003360	http://dx.doi.org/10.1371/journal.pgen.1003360			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	116EY	23626666	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000316866700037
J	Wu, W; Ren, QP; Li, CJ; Wang, YY; Sang, M; Zhang, Y; Li, B				Wu, Wei; Ren, Qiuping; Li, Chengjun; Wang, Yanyun; Sang, Ming; Zhang, Yi; Li, Bin			Characterization and Comparative Profiling of MicroRNAs in a Sexual Dimorphism Insect, Eupolyphaga sinensis Walker	PLOS ONE			English	Article							SILKWORM BOMBYX-MORI; DROSOPHILA; EXPRESSION; EVOLUTION; IDENTIFICATION; GROWTH; CELL; RNA; BIOGENESIS; TESTIS	Background: MicroRNAs are now recognized as key post-transcriptional regulators in animal ontogenesis and phenotypic diversity. Eupolyphaga sinensis Walker (Blattaria) is a sexually dimorphic insect, which is also an important source of material used in traditional Chinese medicine. The male E. sinensis have shorter lifecycles and go through fewer instars than the female. Furthermore, the males have forewings, while the females are totally wingless. Results: We used the Illumina/Solexa deep sequencing technology to sequence small RNA libraries prepared from the fourth-instar larvae of male and female E. sinensis. 19,097,799 raw reads were yielded in total: 7,817,445 reads from the female library and 11,280,354 from the male, respectively. As a result, we identified 168 known miRNAs belonging to 55 families as well as 204 novel miRNAs. Moreover, 45 miRNAs showed significantly different expression between the female and the male fourth-instar larvae, and we validated 10 of them by Stem-loop qRT-PCR. Some of these differentially expressed miRNAs are related to metamorphosis, development and phenotypic diversity. Conclusions/Significance: This is the first comprehensive description of miRNAs in E. sinensis. The results provide a useful resource for further in-depth study on molecular regulation and evolution of miRNAs. These findings not only enrich miRNAs for hemimetabolans but also lay the foundation for the study of post-transcriptional regulation on the phenomena of sexual dimorphism.	[Wu, Wei; Ren, Qiuping; Li, Chengjun; Wang, Yanyun; Sang, Ming; Zhang, Yi; Li, Bin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Li, B (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	libin@njnu.edu.cn		Guillemin, Gilles/0000-0001-8105-4470; Lim, Edwin/0000-0003-3526-8405; Wu, Wei/0000-0002-1920-966X; brew, bruce/0000-0003-0622-1392; Chung, Roger/0000-0002-9286-947X	National Natural Science Foundation of China [31172146]; Key Project of Natural Science Foundation of the Jiangsu Higher Education Institutions of China [10KJA180023]; Natural Science Foundation of Jiangsu Province, China [BK2011785]; PAPD of Jiangsu Higher Education Institutions; Excellent Talent Project of Nanjing Normal University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of the Jiangsu Higher Education Institutions of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); PAPD of Jiangsu Higher Education Institutions; Excellent Talent Project of Nanjing Normal University of China	This work was supported by the National Natural Science Foundation of China (No. 31172146), the Key Project of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 10KJA180023), the Natural Science Foundation of Jiangsu Province, China (BK2011785), the PAPD of Jiangsu Higher Education Institutions and the Excellent Talent Project of Nanjing Normal University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032860; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Ge GF, 2012, J ETHNOPHARMACOL, V141, P178, DOI 10.1016/j.jep.2012.02.016; Hipfner DR, 2002, GENETICS, V161, P1527; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hui JHL, 2009, MECH DEVELOP, V126, pS56, DOI 10.1016/j.mod.2009.06.018; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jaubert S, 2007, BIOCHIMIE, V89, P1211, DOI 10.1016/j.biochi.2007.05.012; Jiang HL, 2012, FITOTERAPIA, V83, P1275, DOI 10.1016/j.fitote.2012.06.005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nohata N, 2012, AURIS NASUS LARYNX; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sun J, 2011, OSTEOARTHR CARTILAGE, V19, P1237, DOI 10.1016/j.joca.2011.07.002; Surridge AK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-62; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	51	167	172	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e59016	10.1371/journal.pone.0059016	http://dx.doi.org/10.1371/journal.pone.0059016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	23630570	Green Submitted, Green Published, gold			2022-12-25	WOS:000317909500003
J	Zhao, Z; Su, TJ; Chesters, D; Wang, SD; Ho, SYW; Zhu, CD; Chen, XL; Zhang, CT				Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Wang, Shi-di; Ho, Simon Y. W.; Zhu, Chao-dong; Chen, Xiao-lin; Zhang, Chun-tian			The Mitochondrial Genome of Elodia flavipalpis Aldrich (Diptera: Tachinidae) and the Evolutionary Timescale of Tachinid Flies	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; TRANSFER-RNA GENE; CALYPTRATAE DIPTERA; MOLECULAR PHYLOGENY; FRUIT-FLY; AGROMYZIDAE; PHYLOGEOGRAPHY; REARRANGEMENT; ORGANIZATION	Tachinid flies are natural enemies of many lepidopteran and coleopteran pests of forests, crops, and fruit trees. In order to address the lack of genetic data in this economically important group, we sequenced the complete mitochondrial genome of the Palaearctic tachinid fly Elodia flavipalpis Aldrich, 1933. Usually found in Northern China and Japan, this species is one of the primary natural enemies of the leaf-roller moths (Tortricidae), which are major pests of various fruit trees. The 14,932-bp mitochondrial genome was typical of Diptera, with 13 protein-coding genes, 22 tRNA genes, and 2 rRNA genes. However, its control region is only 105 bp in length, which is the shortest found so far in flies. In order to estimate dipteran evolutionary relationships, we conducted a phylogenetic analysis of 58 mitochondrial genomes from 23 families. Maximum-likelihood and Bayesian methods supported the monophyly of both Tachinidae and superfamily Oestroidea. Within the subsection Calyptratae, Muscidae was inferred as the sister group to Oestroidea. Within Oestroidea, Calliphoridae and Sarcophagidae formed a sister clade to Oestridae and Tachinidae. Using a Bayesian relaxed clock calibrated with fossil data, we estimated that Tachinidae originated in the middle Eocene.	[Zhao, Zhe; Wang, Shi-di; Zhang, Chun-tian] Shenyang Normal Univ, Liaoning Key Lab Evolut & Biodivers, Shenyang, Liaoning, Peoples R China; [Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Zhu, Chao-dong; Chen, Xiao-lin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Shenyang Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney	Zhu, CD (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhucd@ioz.ac.cn; xlchen@ioz.ac.cn; chuntianzhang@yahoo.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Su, Tianjuan/AAJ-6290-2021	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	Knowledge Innovation Program of Chinese Academy of Sciences [KSXC2-EW-B-02]; Public Welfare Project from the Ministry of Agriculture, China [201103024]; National Science Foundation, China [30870268, 31172048, J0930004, 31093430, 31272279]; National Special Science and Technology Foundation of China [2012FY111100]; NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Public Welfare Project from the Ministry of Agriculture, China; National Science Foundation, China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Foundation of China; NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported mainly by a grant from the Knowledge Innovation Program of Chinese Academy of Sciences (grant KSXC2-EW-B-02), Public Welfare Project from the Ministry of Agriculture, China (grant 201103024), and the National Science Foundation, China (grants 30870268, 31172048, J0930004) to Chao-dong Zhu; the National Science Foundation, China (grants 31093430, 31272279) to Chun-tian Zhang; National Special Science and Technology Foundation of China (2012FY111100) to Xiao-lin Chen and Chao-dong Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aldrich JM, 1933, P ENTOMOLOGICAL SOC, V35, P21; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Chao CM, 2009, FAUNA HEBEI PROVINCE, p[1, 555]; Chatterjee S, 2005, GENETICA, V125, P1, DOI 10.1007/s10709-004-6192-0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Griffiths G.C.D., 1972, Series Ent, V8, P1; Grimaldi David, 2005, pi; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han HY, 2000, BIOCHEM SYST ECOL, V28, P501, DOI 10.1016/S0305-1978(99)00097-6; HENNIG W, 1976, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessinger AC, 2000, MED VET ENTOMOL, V14, P71, DOI 10.1046/j.1365-2915.2000.00209.x; Lessinger AC, 2004, GENE, V339, P1, DOI 10.1016/j.gene.2004.06.041; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; LIU YQ, 2002, FAUNA SINICA INSECT, V27, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; McAlpine JF, 1989, MONOGRAPH, V3, P1397; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2012, MITOCHONDR DNA, V23, P42, DOI 10.3109/19401736.2011.644042; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; Nirmala X, 2001, INSECT MOL BIOL, V10, P475, DOI 10.1046/j.0962-1075 .2001.00286.x; O'Hara JE, 2009, ZOOTAXA, P1; O'Hara JE, 2010, WORLD GENERA TACHINI; Oliveira MT, 2006, J MED ENTOMOL, V43, P636, DOI 10.1603/0022-2585(2006)43[636:IATTCR]2.0.CO;2; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PAPE T, 1992, Tijdschrift voor Entomologie, V135, P43; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P991, DOI 10.1603/0013-8746(2006)99[991:MPOTVP]2.0.CO;2; Shao YJ, 2012, MOL BIOL REP, V39, P11023, DOI 10.1007/s11033-012-2005-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stireman JO, 2002, SYST ENTOMOL, V27, P409, DOI 10.1046/j.1365-3113.2002.00187.x; Tachi T, 2010, SYST ENTOMOL, V35, P148, DOI 10.1111/j.1365-3113.2009.00497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; von Tschirnhaus Michael, 2009, Denisia, P171; Wang S., 2009, MOL BIOL REP, V38, P687; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Ye Jun, 2010, Plant Quarantine (Shanghai), V24, P11; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	71	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61814	10.1371/journal.pone.0061814	http://dx.doi.org/10.1371/journal.pone.0061814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23349680	gold, Green Submitted, Green Published			2022-12-25	WOS:000318008400098
J	Zhao, ZG; Zhang, JW; He, J; Zeng, GH				Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua			Clinical Utility of the UPOINT Phenotype System in Chinese Males with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Prospective Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; ERECTILE DYSFUNCTION; SYMPTOM INDEX; MEN; PREVALENCE; CLASSIFICATION; MULTICENTER; MECHANISMS; DISEASE; IMPACT	Background: Recent data showed that a six-domain UPOINT is a flexible and responsive new classification system that has the clinical applicability in CP/CPPS. However, the utility of UPOINT algorithm in men in China with CP/CPPS has not been comprehensively studied. For international validation and adoption, we evaluated this clinical phenotype system for a large cohort of Chinese CP/CPPS patients and correlated it with patient symptoms and erectile dysfunction (ED). We also investigated the addition of an ED domain in regard to symptom correlation. Methods: A total of 389 Chinese males with CP/CPPS were prospectively collected and classified in each domain of the UPOINT system. Symptom severity was measured using the NIH-CPSI and IPSS. The erectile function was evaluated using the IIEF-5. Clinically relevant associations were calculated. Results: The percentage of patients positive for each domain was 54.0%, 42.1%, 41.9%, 20.8%, 26.7%, and 40.4% for the Urinary, Psychosocial, Organ-specific, Infection, Neurological/systemic, and Tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.706, p<0.001), IPSS (r = 0.682, p<0.001) and IIEF-5 scores (r = 0.631, P = 0.007) in Chinese cohort. Except for patients age, symptom duration was associated with a significantly greater number of positive domains (r = 0.638, P = 0.005). After adding an ED domain to create a modified UPOINT system, the correlation between the number of phenotypic domains and symptom severity was improved (0.706 to 0.844, p<0.001). Conclusions: The clinical applicability of using UPOINT phenotyping system has been validated in the Chinese patients with CP/CPPS. In our cohort, the number of positive domains was also correlated with ED symptoms and the significant association between the number of UPOINT domains and NIH-CPSI scores was further refined by adding a domain for ED. Our findings presented here support the utility of using ED as a stand-alone item in the UPOINT domain.	[Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@yahoo.com.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Su, Tianjuan/AAJ-6290-2021	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RU, 2006, J UROLOGY, V176, P1534, DOI 10.1016/j.juro.2006.06.010; Bartoletti R, 2007, J UROLOGY, V178, P2411, DOI 10.1016/j.juro.2007.08.046; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Chou YH., 2011, INCONT PELVIC FLOOR, V5, P31; Chung SD, 2012, BJU INT, V110, P726, DOI 10.1111/j.1464-410X.2011.10807.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Davis SNP, 2009, J SEX MARITAL THER, V35, P182, DOI 10.1080/00926230802716310; Eryildirim B, 2010, INT J IMPOT RES, V22, P349, DOI 10.1038/ijir.2010.26; Gonen M, 2005, J ANDROL, V26, P601, DOI 10.2164/jandrol.04159; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, UROLOGY, V60, P959, DOI 10.1016/S0090-4295(02)01963-5; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Liang CZ, 2004, BJU INT, V93, P568, DOI 10.1111/j.1464-410X.2003.04662.x; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Magri Vittorio, 2008, Arch Ital Urol Androl, V80, P172; Muller Alexander, 2006, Curr Urol Rep, V7, P307, DOI 10.1007/s11934-996-0010-4; Perlmutter AE, 2011, INTERNET J UROLOGY, V9, P1, DOI [10.5580/c54, DOI 10.5580/C54]; Pontari MA, 2004, J UROLOGY, V172, P839, DOI 10.1097/01.ju.0000136002.76898.04; Pontari MA, 2008, J UROLOGY, V179, pS61, DOI 10.1016/j.juro.2008.03.139; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Samplaski MK, 2011, UROLOGY, V78, P653, DOI 10.1016/j.urology.2011.04.016; Schaeffer AJ, 2006, 6 INT C NEW DEV PROS, P343; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Shoskes DA, 2012, CURR UROL REP, V13, P263, DOI 10.1007/s11934-012-0254-0; Shoskes DA, 2011, J UROLOGY, V186, P907, DOI 10.1016/j.juro.2011.04.063; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tan HM, 2012, J SEX MED, V9, P663, DOI 10.1111/j.1743-6109.2011.02582.x; Trinchieri Alberto, 2007, Arch Ital Urol Androl, V79, P67; Tuncel A, 2006, INT UROL NEPHROL, V38, P583, DOI 10.1007/s11255-006-0087-1; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046	37	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52044	10.1371/journal.pone.0052044	http://dx.doi.org/10.1371/journal.pone.0052044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349680	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900004
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
